PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Doi, T; Kozawa, O; Kageyama, Y; Ogura, S				Doi, T.; Kozawa, O.; Kageyama, Y.; Ogura, S.			THE ROLE OF RAC IN HUMAN PLATELETS: AN ANALYSIS OF THE MOLECULAR MECHANISM UNDERLYING RAC-EFFECTS ON THE ACTIVATION	SHOCK			English	Meeting Abstract	38th Annual Conference of the Shock-Society on Shock	JUN 06-09, 2015	Denver, CO	Shock Soc					[Ogura, S.] Gifu Univ Hosp, Gifu, Japan; [Doi, T.] Ichinomiya Municipal Hosp, Dept Emergency & Crit Care Med, Ichinomiya, Japan; [Kozawa, O.; Kageyama, Y.] Gifu Univ, Dept Pharmacol, Grad Sch Med, Gifu, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2015	43	6		1		P207	120	121				2	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CI4QC	WOS:000354736000244		
J	Mayumi, T; Hasegawa, J; Ootubo, H; Takama, T				Mayumi, T.; Hasegawa, J.; Ootubo, H.; Takama, T.			UTILITY OF PROCALCITONIN IN EMERGENCY UNIT	SHOCK			English	Meeting Abstract	38th Annual Conference of the Shock-Society on Shock	JUN 06-09, 2015	Denver, CO	Shock Soc					[Mayumi, T.; Hasegawa, J.; Ootubo, H.; Takama, T.] Univ Occupat & Environm Hlth, Sch Med, Kitakyushu, Fukuoka 807, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2015	43	6		1		P219	125	125				1	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CI4QC	WOS:000354736000256		
J	Tsuchitani, S; Sunahara, T; Miki, H				Tsuchitani, Shigeki; Sunahara, Tokiharu; Miki, Hirofumi			Dielectric elastomer actuators using Slide-Ring Material (R) with increased permittivity	SMART MATERIALS AND STRUCTURES			English	Article						electroactive polymer; dielectric elastomer actuator; Slide-Ring Material; dielectric filler; dielectric nanoparticle; barium titanate	BIOMIMETIC WALKING ROBOTS; ELECTROELASTOMER ROLLS	The inclusion of high permittivity nanoparticles in elastomeric materials for dielectric elastomer actuators (DEAs) is one promising method to achieve large strain at relatively low applied voltages. However, the addition of these nanoparticles tends to increase the stiffness of the elastomer and disturbs the actuation of the DEA. This is attributed to restriction of the chain motion in the elastomer by the nanoparticles. Slide-Ring Material (R) (SRM) is a cross-linked polymeric material with freely movable cross-linking sites. The internal stresses in this structure are dramatically homogenized by the pulley effect; therefore, the restriction of chain motion due to the nanoparticles is expected to be significantly reduced. We have employed SRM as a host elastomer for a DEA with the addition of ferroelectric BaTiO3 (BT) nanoparticles. The effects of BT addition on the permittivity, stiffness and viscosity of the SRM-BT nanocomposites, and the actuation strain of DEAs using SRM were evaluated. The permittivity of the nanocomposites increased linearly with the concentration of BT and reached 3.6 times that for pure SRM at 50 wt%. The elastic modulus and the viscosity remained almost constant up to 20 wt% and then decreased above this concentration. The actuation strain of a planar actuator using SRM and 50 wt% BT was four times larger than that of the DEA with pure SRM.	[Tsuchitani, Shigeki; Miki, Hirofumi] Wakayama Univ, Fac Syst Engn, Dept Optomechatron, Wakayama, Sakaedani 930, Japan; [Sunahara, Tokiharu] Wakayama Univ, Grad Sch Syst Engn, Wakayama, Sakaedani 930, Japan	Tsuchitani, S (reprint author), Wakayama Univ, Fac Syst Engn, Dept Optomechatron, Wakayama, Sakaedani 930, Japan.	tutitani@sys.wakayama-u.ac.jp					Mayumi K, 2010, POLYMER, V51, P959, DOI 10.1016/j.polymer.2009.12.019; Lestriez B, 1998, POLYMER, V39, P6733, DOI 10.1016/S0032-3861(98)00093-7; Herr H, 2004, P SOC PHOTO-OPT INS, V5385, P1, DOI 10.1117/12.544510; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Nelson JK, 2004, NANOTECHNOLOGY, V15, P586, DOI 10.1088/0957-4484/15/5/032; Tomer V, 2010, J APPL PHYS, V108, DOI 10.1063/1.3487275; Goulbourne N, 2003, P SOC PHOTO-OPT INS, V5051, P319, DOI 10.1117/12.484388; Okumura Y, 2001, ADV MATER, V13, P485, DOI 10.1002/1521-4095(200104)13:7<485::AID-ADMA485>3.0.CO;2-T; Ito K, 2007, POLYM J, V39, P489, DOI 10.1295/polymj.PJ2006239; Mc Carthy DN, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/14/145406; Stoyanov H, 2011, SOFT MATTER, V7, P194, DOI 10.1039/c0sm00715c; Iijima M, 2009, COLLOID SURFACE A, V352, P88, DOI 10.1016/j.colsurfa.2009.10.005; Molberg M, 2010, ADV FUNCT MATER, V20, P3280, DOI 10.1002/adfm.201000486; Kim P, 2009, ACS NANO, V3, P2581, DOI 10.1021/nn9006412; Pelrine RE, 1998, SENSOR ACTUAT A-PHYS, V64, P77, DOI 10.1016/S0924-4247(97)01657-9; SCHER H, 1970, J CHEM PHYS, V53, P3759, DOI 10.1063/1.1674565; Huang C, 2004, APPL PHYS LETT, V84, P4391, DOI 10.1063/1.1757632; Koo IM, 2008, IEEE T ROBOT, V24, P549, DOI 10.1109/TRO.2008.921561; Eckerle J, 2001, P SOC PHOTO-OPT INS, V4332, P269, DOI 10.1117/12.429666; Chakraborti P, 2012, SENSOR ACTUAT A-PHYS, V179, P151, DOI 10.1016/j.sna.2012.02.004; Gallegos C, 2010, RHEOLOGY; Ito K, 2010, CURR OPIN SOLID ST M, V14, P28, DOI 10.1016/j.cossms.2009.08.005; Kremer F., 2003, BROADBAND DIELECTRIC; Lehn J.-M., 1995, SUPRAMOLECULAR CHEM; Lotz P., 2009, P SOC PHOTO-OPT INS, V7287; Pei Q, 2003, SYNTHETIC MET, V135, P129, DOI 10.1016/S0379-6779(02)00535-0; Pei QB, 2002, P SOC PHOTO-OPT INS, V4698, P246, DOI 10.1117/12.475071; Carpi F, 2008, DIELECTRIC ELASTOMERS AS ELECTROMECHANICAL TRANSDUCERS: FUNDAMENTALS, MATERIALS, DEVICES, MODELS AND APPLICATIONS OF AN EMERGING ELECTROACTIVE POLYMER TECHNOLOGY, P1; Stoyanov H, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4730953	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0964-1726	1361-665X		SMART MATER STRUCT	Smart Mater. Struct.	JUN	2015	24	6							065030	10.1088/0964-1726/24/6/065030		8	Instruments & Instrumentation; Materials Science, Multidisciplinary	Instruments & Instrumentation; Materials Science	CI6LA	WOS:000354869500031		
J	Zhang, YB; Zhang, J; Chen, GQ; Zheng, L; Li, YG				Zhang, Yingbin; Zhang, Jue; Chen, Guangqi; Zheng, Lu; Li, Yange			Effects of vertical seismic force on initiation of the Daguangbao landslide induced by the 2008 Wenchuan earthquake	SOIL DYNAMICS AND EARTHQUAKE ENGINEERING			English	Article						Seismic slope; Vertical seismic; Near-fault; Large-scale; Tension failure; FLAC(3D)	CHINA; STRENGTH; MOTION	This paper analyses the effects of vertical seismic force on initiation mechanism of near-fault large-scale landslides by using the Daguangbao landslide induced by the 2008 Wenchuan earthquake as an example. Field investigations showed that tension failure plays an important role in failure mechanism, and the tension failure is due to the effect of a large vertical seismic motion that occurred in the meizoseismal area during the earthquake. Firstly, two key issues in seismic analysis of near-fault large-scale landslide are proposed: i) how to select and correct the severe near-fault excitations with significant co-seismic displacements and ii) how to consider the effect of the landslide scale on estimation of material strength. Then, in order to investigate the effect of the severe vertical seismic force on the initiation of the huge Daguangbao landslide, five cases, 1) static; 2) pseudo-static onlyhorizontal; 3) pseudo-static horizontal-and-vertical; 4) dynamic only-horizontal; 5) dynamic horizontaland-vertical, are performed using the finite difference program FLAC(3D). The simulation results are presented in terms of tension failure area, factor of safety, and displacement. The results confirm the significant effects of vertical seismic force on seismic slope failure mechanism as the tension failure areas and the displacements observed in the case of horizontal-and-vertical are larger than those observed in the case of only-horizontal. (C) 2015 Elsevier Ltd. All rights reserved.	[Zhang, Yingbin] Southwest fiaotong Univ, Key Lab Transportat Tunnel Engn, Minist Educ, Chengdu 610031, Peoples R China; [Zhang, Yingbin; Zhang, Jue] Southwest Jiaotong Univ, Sch Civil Engn, Dept Geotech Engn, Chengdu 610031, Sichuan, Peoples R China; [Chen, Guangqi; Li, Yange] Kyushu Univ, Dept Civil & Struct Engn, Fukuoka 8190395, Japan; [Zheng, Lu] Sichuan Univ, IDMR, Chengdu 610207, Peoples R China	Zhang, YB (reprint author), Southwest Jiaotong Univ, Sch Civil Engn, Dept Geotech Engn, 111,1st North Sec,2nd Ring RD, Chengdu 610031, Sichuan, Peoples R China.	yingbinz719@126.com			National Natural Science Foundation of China [51408511]; National Basic Research Program of China (973 Program) [2013CB036204]; opening fund of State Key Laboratory of Geohazard Prevention and Geoenvironment Protection (Chengdu University of Technology) [SKLGP2014K015]; SRF for ROCS, SEM; Fundamental Research Funds for the Central Universities [2682014RC19]	This study has received financial support from the National Natural Science Foundation of China (Grant no. 51408511), the National Basic Research Program of China (973 Program) (Grant no. 2013CB036204), the opening fund of State Key Laboratory of Geohazard Prevention and Geoenvironment Protection (Chengdu University of Technology) (Grant no. SKLGP2014K015), the SRF for ROCS, SEM, and the Fundamental Research Funds for the Central Universities (Grant no. 2682014RC19). These financial supports are gratefully acknowledged. The authors also thank the Editor-in-Chief and anonymous reviewer for their helpful and insightful comments.	Gazetas G, 2009, J GEOTECH GEOENVIRON, V135, P1906, DOI 10.1061/(ASCE)GT.1943-5606.0000174; Aoi S, 2008, SCIENCE, V322, P727, DOI 10.1126/science.1163113; Wu JH, 2009, INT J ROCK MECH MIN, V46, P397, DOI 10.1016/j.ijrmms.2008.07.010; IWAN WD, 1985, B SEISMOL SOC AM, V75, P1225; Wu JH, 2010, COMPUT GEOTECH, V37, P594, DOI 10.1016/j.compgeo.2010.03.007; Wang FW, 2009, LANDSLIDES, V6, P47, DOI 10.1007/s10346-009-0141-z; Yin YP, 2011, B ENG GEOL ENVIRON, V70, P15, DOI 10.1007/s10064-010-0334-7; de Michele M, 2010, GEOPHYS J INT, V183, P1097, DOI 10.1111/j.1365-246X.2010.04807.x; HOEK E, 1990, INT J ROCK MECH MIN, V27, P227, DOI 10.1016/0148-9062(90)94333-O; Boore DM, 2001, B SEISMOL SOC AM, V91, P1199; Yin YP, 2009, LANDSLIDES, V6, P139, DOI 10.1007/s10346-009-0148-5; Huang RQ, 2009, B ENG GEOL ENVIRON, V68, P363, DOI 10.1007/s10064-009-0207-0; Huang RQ, 2012, LANDSLIDES, V9, P131, DOI 10.1007/s10346-011-0276-6; Hoek E, 1997, INT J ROCK MECH MIN, V34, P1165, DOI 10.1016/S1365-1609(97)80069-X; Chen G., 2011, EARTHQUAKE INDUCED C, P383; Dawson EM, 1999, GEOTECHNIQUE, V49, P835; Hoek E., 1988, P 15 CAN ROCK MECH S, P31; Hoek E., 2002, P 5 N AM ROCK MECH S, V1, P267; Huang RQ, 2011, J MT SCI-ENGL, V8, P200, DOI 10.1007/s11629-011-2104-9; [黄润秋 HUANG Runqiu], 2009, [工程地质学报, Journal of Engineering Geology], V17, P725; [黄润秋 HUANG Runqiu], 2008, [工程地质学报, Journal of Engineering Geology], V16, P730; Itasca, 2007, FAST LAGR AN CONT 3; Qian P, 1983, EARTHQ ENG ENG VIB, V3, P44; Sarma SK, 2009, P INT C PERF BAS DES; Sun P, 2011, CHINA ENV EARTH SCI, V66, P1285; Taylor RL, 1989, FINITE ELEMENT METHO, VI; Wu JH, 2011, ENG GEOL, V123, P129, DOI 10.1016/j.enggeo.2011.01.010; [吴树仁 WU Shuren], 2010, [工程地质学报, Journal of Engineering Geology], V18, P145; Zhang Y, 2013, ENG GEOL, V167, P37; Zhang Y, ENG GEOL IN PRESS; Zhang Y., 2012, GEOTECH ENG, V43, P18; Zhang Y., 2011, P INT EL MACH SYST I, P1, DOI DOI 10.1109/NAPS.2011.6025169; Zhang Yuan, 2011, P INT C ADV GEOT ENG, P803; ZHENG Y, 2009, J ROCK MECH GEOTECHN, V1, P21, DOI DOI 10.3724/SP.J.1235.2009.00021	34	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0267-7261	1879-341X		SOIL DYN EARTHQ ENG	Soil Dyn. Earthq. Eng.	JUN	2015	73						91	102		10.1016/j.soildyn.2014.06.036		12	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CI2NL	WOS:000354584200008		
J	Matsumoto, Y; Ikeya, M; Hino, K; Horigome, K; Fukuta, M; Watanabe, M; Nagata, S; Yamamoto, T; Otsuka, T; Toguchida, J				Matsumoto, Yoshihisa; Ikeya, Makoto; Hino, Kyosuke; Horigome, Kazuhiko; Fukuta, Makoto; Watanabe, Makoto; Nagata, Sanae; Yamamoto, Takuya; Otsuka, Takanobu; Toguchida, Junya			New Protocol to Optimize iPS Cells for Genome Analysis of Fibrodysplasia Ossificans Progressiva	STEM CELLS			English	Article						Induced pluripotent stem cell; Fibrodysplasia ossificans progressiva; Heterotopic ossification; Endochondral ossification; Gene correction; Induced mesenchymal stromal cells	PLURIPOTENT STEM-CELLS; PLASMINOGEN-ACTIVATOR INHIBITOR-1; HETEROTOPIC SKELETOGENESIS; PROGENITOR CELLS; SKELETAL-MUSCLE; BONE-FORMATION; I RECEPTOR; MUTATION; ALK2; IDENTIFICATION	Successful in vitro disease-recapitulation using patient-specific induced pluripotent stem cells (iPSCs) requires two fundamental technical issues: appropriate control cells and robust differentiation protocols. To investigate fibrodysplasia ossificans progressiva (FOP), a rare genetic disease leading to extraskeletal bone formation through endochondral ossification, gene-corrected (rescued) iPSC clones (resFOP-iPSC) were generated from patient-derived iPSC (FOP-iPSC) as genetically matched controls, and the stepwise induction method of mesenchymal stromal cells (iMSCs) through neural crest cell (NCC) lineage was used to recapitulate the disease phenotype. FOP-iMSCs possessing enhanced chondrogenic ability were transcriptionally distinguishable from resFOP-iMSCs and activated the SMAD1/5/8 and SMAD2/3 pathways at steady state. Using this method, we identified MMP1 and PAI1 as genes responsible for accelerating the chondrogenesis of FOP-iMSCs. These data indicate that iMSCs through NCC lineage are useful for investigating the molecular mechanism of FOP and corresponding drug discovery. Stem Cells2015;33:1730-1742	[Matsumoto, Yoshihisa; Fukuta, Makoto; Toguchida, Junya] Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Grad Sch Med, Kyoto 6068507, Japan; [Matsumoto, Yoshihisa; Ikeya, Makoto; Hino, Kyosuke; Horigome, Kazuhiko; Fukuta, Makoto; Watanabe, Makoto; Nagata, Sanae; Toguchida, Junya] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Grad Sch Med, Kyoto 6068507, Japan; [Yamamoto, Takuya] Kyoto Univ, Dept Reprogramming Sci, Ctr iPS Cell Res & Applicat, Grad Sch Med, Kyoto 6068507, Japan; [Yamamoto, Takuya] Kyoto Univ, Grad Sch Med, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto 6068507, Japan; [Toguchida, Junya] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto 6068507, Japan; [Matsumoto, Yoshihisa; Fukuta, Makoto; Otsuka, Takanobu] Nagoya City Univ, Dept Orthopaed Surg, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Hino, Kyosuke; Horigome, Kazuhiko] Sumitomo Dainippon Pharma, iPS Cell Based Drug Discovery Grp, Innovat Drug Discovery Labs, Osaka, Japan; [Watanabe, Makoto] Shimadzu Co Ltd, Life Sci Res Ctr, Technol Res Lab, Kyoto, Japan	Ikeya, M (reprint author), Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	mikeya@cira.kyoto-u.ac.jp; togjun@frontier.kyoto-u.ac.jp			JSPS [23791636, 25293320]; Core Center for iPS Cell Research; Research Center Network for Realization of Regenerative Medicine from JST; Leading Project for Realization of Regenerative Medicine from MEXT; iPS Cell Research Fund; The Program for Intractable Diseases Research using Disease-specific iPS cells from JST; A-STEP (Adaptable and Seamless Technology Transfer Program through target-driven R&D, Exploratory Research)	We thank Drs. K. Eto, T. Kato Jr., K. Sekiguchi, Y. Takao, N. Tsumaki, and K. Woltjen for invaluable comments and discussion, Dr. P. Karagiannis for critical reading the manuscript, Dr. K. Osafune for providing cDNA of the Osr1-GFP knock-in hiPSC clone, M. Hiraga, M. Shibata, and M. Nishio for technical assistance, and members of the Toguchida laboratory for their support during this study. This work was supported by Grants-in-aid for Scientific Research from JSPS (#23791636 and #25293320), a grant from Core Center for iPS Cell Research, Research Center Network for Realization of Regenerative Medicine from JST, the Leading Project for Realization of Regenerative Medicine from MEXT, iPS Cell Research Fund, and The Program for Intractable Diseases Research using Disease-specific iPS cells from JST in part to M.I. and J.T. M.I. was also supported by A-STEP (Adaptable and Seamless Technology Transfer Program through target-driven R&D, Exploratory Research). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2003, J BONE JOINT SURG AM, V85A, P667; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Bagarova J, 2013, MOL CELL BIOL, V33, P2413, DOI 10.1128/MCB.01595-12; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Wosczyna MN, 2012, J BONE MINER RES, V27, P1004, DOI 10.1002/jbmr.1562; Ikeya M, 2005, INT J DEV BIOL, V49, P807, DOI 10.1387/ijdb.051975mi; Hamasaki M, 2012, STEM CELLS, V30, P2437, DOI 10.1002/stem.1221; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; de la Pena LS, 2005, J BONE MINER RES, V20, P1168, DOI 10.1359/JBMR.050305; Rundle CH, 2008, CALCIFIED TISSUE INT, V83, P276, DOI 10.1007/s00223-008-9169-7; Shen Q, 2009, J CLIN INVEST, V119, P3462, DOI 10.1172/JCI37412; Nordstrom SM, 2007, BONE, V41, P995, DOI 10.1016/j.bone.2007.08.020; Fukuda T, 2008, BIOCHEM BIOPH RES CO, V377, P905, DOI 10.1016/j.bbrc.2008.10.093; Chakkalakal SA, 2012, J BONE MINER RES, V27, P1746, DOI 10.1002/jbmr.1637; Neirinckx V, 2013, STEM CELL TRANSL MED, V2, P284, DOI 10.5966/sctm.2012-0147; Lounev VY, 2009, J BONE JOINT SURG AM, V91A, P652, DOI 10.2106/JBJS.H.01177; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Shore EM, 2010, NAT REV RHEUMATOL, V6, P518, DOI 10.1038/nrrheum.2010.122; Culbert AL, 2014, STEM CELLS, V32, P1289, DOI 10.1002/stem.1633; Kawao N, 2013, J BONE MINER RES, V28, P1561, DOI 10.1002/jbmr.1921; Billings PC, 2008, J BONE MINER RES, V23, P305, DOI 10.1359/JBMR.071030; Kaplan FS, 2012, DIS MODEL MECH, V5, P756, DOI 10.1242/dmm.010280; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Song GA, 2010, J BIOL CHEM, V285, P22542, DOI 10.1074/jbc.M109.094557; Ohte S, 2011, BIOCHEM BIOPH RES CO, V407, P213, DOI 10.1016/j.bbrc.2011.03.001; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Fiori JL, 2006, J BONE MINER RES, V21, P902, DOI 10.1359/JBMR.060215; Fukuta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112291; Imai K, 2007, AM J PHYSIOL-CELL PH, V293, pC1209, DOI 10.1152/ajpcell.00213.2007; LesDouarin NM, 2003, CURR OPIN GENE DEV, V13, P529; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Matsumoto Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-190; Nasu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053771; Shafritz AB, 1996, NEW ENGL J MED, V335, P555, DOI 10.1056/NEJM199608223350804; Umeda K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00455; vansDinther M, 2010, J BONE MINER RES, V25, P1208	38	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	JUN	2015	33	6					1730	1742		10.1002/stem.1981		13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CI6PJ	WOS:000354882500005		
J	Denham, M; Hasegawa, K; Menheniott, T; Rollo, B; Zhang, DC; Hough, S; Alshawaf, A; Febbraro, F; Ighaniyan, S; Leung, J; Elliott, DA; Newgreen, DF; Pera, MF; Dottori, M				Denham, Mark; Hasegawa, Kouichi; Menheniott, Trevelyan; Rollo, Ben; Zhang, Dongcheng; Hough, Shelley; Alshawaf, Abdullah; Febbraro, Fabia; Ighaniyan, Samiramis; Leung, Jessie; Elliott, David A.; Newgreen, Donald F.; Pera, Martin F.; Dottori, Mirella			Multipotent Caudal Neural Progenitors Derived from Human Pluripotent Stem Cells That Give Rise to Lineages of the Central and Peripheral Nervous System	STEM CELLS			English	Article						Roof plate; Floor plate; Neural crest; Peripheral nervous system; Human embryonic stem cells	HOMEOBOX GENES; CHICK-EMBRYO; SPINAL-CORD; HUMAN ES; DIFFERENTIATION; SPECIFICATION; EXPRESSION; KINASE; INHIBITION; INDUCTION	The caudal neural plate is a distinct region of the embryo that gives rise to major progenitor lineages of the developing central and peripheral nervous system, including neural crest and floor plate cells. We show that dual inhibition of the glycogen synthase kinase 3 and activin/nodal pathways by small molecules differentiate human pluripotent stem cells (hPSCs) directly into a preneuroepithelial progenitor population we named caudal neural progenitors (CNPs). CNPs coexpress caudal neural plate and mesoderm markers, and, share high similarities to embryonic caudal neural plate cells in their lineage differentiation potential. Exposure of CNPs to BMP2/4, sonic hedgehog, or FGF2 signaling efficiently directs their fate to neural crest/roof plate cells, floor plate cells, and caudally specified neuroepithelial cells, respectively. Neural crest derived from CNPs differentiated to neural crest derivatives and demonstrated extensive migratory properties in vivo. Importantly, we also determined the key extrinsic factors specifying CNPs from human embryonic stem cell include FGF8, canonical WNT, and IGF1. Our studies are the first to identify a multipotent neural progenitor derived from hPSCs, that is the precursor for major neural lineages of the embryonic caudal neural tube. Stem Cells2015;33:1759-1770	[Denham, Mark; Hough, Shelley; Leung, Jessie; Pera, Martin F.; Dottori, Mirella] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia; [Denham, Mark; Febbraro, Fabia] Aarhus Univ, Danish Res Inst Translat Neurosci, DK-8000 Aarhus C, Denmark; [Hasegawa, Kouichi] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto, Japan; [Hasegawa, Kouichi] NCBS, InStem, Bangalore, Karnataka, India; [Menheniott, Trevelyan; Rollo, Ben; Zhang, Dongcheng; Ighaniyan, Samiramis; Elliott, David A.; Newgreen, Donald F.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Alshawaf, Abdullah; Dottori, Mirella] Univ Melbourne, Ctr Neural Engn, Dept Elect & Elect Engn, Melbourne, Vic 3010, Australia; [Pera, Martin F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Pera, Martin F.] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia	Dottori, M (reprint author), Univ Melbourne, Ctr Neural Engn, Dept Elect & Elect Engn, Melbourne, Vic 3010, Australia.	mden@biomed.au.dk; mdottori@unimelb.edu.au	PERA, MARTIN/A-9812-2012; Elliott, David/H-3334-2012; Menheniott, Treve/D-7964-2015	PERA, MARTIN/0000-0001-6239-0428; Elliott, David/0000-0003-1052-7407; Menheniott, Treve/0000-0003-2349-8238	University of Melbourne; National Health and Medical Research Council of Australia [NHMRC: 520165]; Australian Research Council Initiative Stem Cells Australia; Friedreich Ataxia Research Association (Australasia); Friedreich Ataxia Research Alliance (USA); Australian Research Council	This study was supported by the University of Melbourne, the National Health and Medical Research Council of Australia (NHMRC: 520165), Australian Research Council Initiative Stem Cells Australia, Friedreich Ataxia Research Association (Australasia), and Friedreich Ataxia Research Alliance (USA). M Dottori is supported by Australian Research Council Future Fellowship.	Stoykova A, 1996, DEVELOPMENT, V122, P3453; Menendez L, 2011, P NATL ACAD SCI USA, V108, P19240, DOI 10.1073/pnas.1113746108; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Andoniadou CL, 2013, CELL MOL LIFE SCI, V70, P3739, DOI 10.1007/s00018-013-1269-5; Vieira C, 2010, INT J DEV BIOL, V54, P7, DOI 10.1387/ijdb.092853cv; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Oliver G, 1995, DEVELOPMENT, V121, P4045; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; Denham M, 2012, STEM CELLS, V30, P2400, DOI 10.1002/stem.1204; Ng ES, 2008, NAT PROTOC, V3, P768, DOI 10.1038/nprot.2008.42; Larsen KB, 2010, J HISTOCHEM CYTOCHEM, V58, P669, DOI 10.1369/jhc.2010.955757; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Wassarman KM, 1997, DEVELOPMENT, V124, P2923; Magner NL, 2013, STEM CELLS, V31, P2095, DOI 10.1002/stem.1478; BONCINELLI E, 1993, J NEUROBIOL, V24, P1356, DOI 10.1002/neu.480241008; Conley BJ, 2005, CURR PROTOC CELL BIO; Delfino-Machin M, 2005, DEVELOPMENT, V132, P4273, DOI 10.1242/dev.02009; Denham M, 2011, METHODS MOL BIOL, V793, P99, DOI 10.1007/978-1-61779-328-8_7; Dottori M, 2001, DEVELOPMENT, V128, P4127; Erskine L, 1998, DEV BIOL, V199, P26, DOI 10.1006/dbio.1998.8912; FEDTSOVA NG, 1995, MECH DEVELOP, V53, P291, DOI 10.1016/0925-4773(95)00435-1; Kirkeby A, 2012, CELL REP, V1, P1; Kondoh H, 2012, CURR OPIN GENET DEV, V22, P374, DOI 10.1016/j.gde.2012.03.006; LesDouarin NM, 2000, METHOD MOL BIOL, V135, P373; LesDreau G, 2012, DEV NEUROBIOL, V72, P1471; Robertshaw E, 2013, P NATL ACAD SCI USA, V110, pE3919, DOI 10.1073/pnas.1304311110; Torres MA, 1999, MOL CELL BIOL, V19, P1427; VANSNOORT M, 2002, J BIOL CHEM, V277, P17901; Zhang DC, 2010, DEV BIOL, V339, P280, DOI 10.1016/j.ydbio.2009.12.014	44	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	JUN	2015	33	6					1759	1770		10.1002/stem.1991		12	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CI6PJ	WOS:000354882500007		
J	Watanabe, S; Uchida, K; Nakajima, H; Matsuo, H; Sugita, D; Yoshida, A; Honjoh, K; Johnson, WEB; Baba, H				Watanabe, Shuji; Uchida, Kenzo; Nakajima, Hideaki; Matsuo, Hideaki; Sugita, Daisuke; Yoshida, Ai; Honjoh, Kazuya; Johnson, William E. B.; Baba, Hisatoshi			Early Transplantation of Mesenchymal Stem Cells After Spinal Cord Injury Relieves Pain Hypersensitivity Through Suppression of Pain-Related Signaling Cascades and Reduced Inflammatory Cell Recruitment	STEM CELLS			English	Article						Spinal cord injury; Bone marrow-derived mesenchymal stem cells; Transplantation; Central neuropathic pain; Mitogen-activated protein kinase (MAPK) pathway; Hematogenous macrophages; Resident microglia; Blood-spinal cord barrier	CENTRAL NEUROPATHIC PAIN; MARROW STROMAL CELLS; BONE-MARROW; NEURONAL HYPEREXCITABILITY; MECHANICAL ALLODYNIA; AXONAL REGENERATION; FUNCTIONAL RECOVERY; UP-REGULATION; MAP KINASE; PKC-GAMMA	Bone marrow-derived mesenchymal stem cells (BMSC) modulate inflammatory/immune responses and promote motor functional recovery after spinal cord injury (SCI). However, the effects of BMSC transplantation on central neuropathic pain and neuronal hyperexcitability after SCI remain elusive. This is of importance because BMSC-based therapies have been proposed for clinical treatment. We investigated the effects of BMSC transplantation on pain hypersensitivity in green fluorescent protein (GFP)-positive bone marrow-chimeric mice subjected to a contusion SCI, and the mechanisms of such effects. BMSC transplantation at day 3 post-SCI improved motor function and relieved SCI-induced hypersensitivities to mechanical and thermal stimulation. The pain improvements were mediated by suppression of protein kinase C- and phosphocyclic AMP response element binding protein expression in dorsal horn neurons. BMSC transplants significantly reduced levels of p-p38 mitogen-activated protein kinase and extracellular signal-regulated kinase (p-ERK1/2) in both hematogenous macrophages and resident microglia and significantly reduced the infiltration of CD11b and GFP double-positive hematogenous macrophages without decreasing the CD11b-positive and GFP-negative activated spinal-microglia population. BMSC transplants prevented hematogenous macrophages recruitment by restoration of the blood-spinal cord barrier (BSCB), which was associated with decreased levels of (a) inflammatory cytokines (tumor necrosis factor-, interleukin-6); (b) mediators of early secondary vascular pathogenesis (matrix metallopeptidase 9); (c) macrophage recruiting factors (CCL2, CCL5, and CXCL10), but increased levels of a microglial stimulating factor (granulocyte-macrophage colony-stimulating factor). These findings support the use of BMSC transplants for SCI treatment. Furthermore, they suggest that BMSC reduce neuropathic pain through a variety of related mechanisms that include neuronal sparing and restoration of the disturbed BSCB, mediated through modulation of the activity of spinal-resident microglia and the activity and recruitment of hematogenous macrophages. Stem Cells2015;33:1902-1914	[Watanabe, Shuji; Uchida, Kenzo; Nakajima, Hideaki; Matsuo, Hideaki; Sugita, Daisuke; Yoshida, Ai; Honjoh, Kazuya; Baba, Hisatoshi] Univ Fukui, Dept Orthopaed & Rehabil Med, Fac Med Sci, Fukui 9101193, Japan; [Johnson, William E. B.] Aston Univ, Life & Hlth Sci, Aston Triangle, Birmingham B4 7ET, W Midlands, England	Uchida, K (reprint author), Univ Fukui, Dept Orthopaed & Rehabil Med, Fac Med Sci, Matsuoka Shimoaizuki 23-3, Fukui 9101193, Japan.	kuchida@u-fukui.ac.jp			Ministry of Education, Science and Culture of Japan [B-24791530, B-24390351]; Japan Orthopaedics and Traumatology Foundation, Inc. [297]	We thank Mr. Hitoshi Takagi and Mrs. Junko Yamamoto from the Life Science Research Laboratory, University of Fukui, Division of Bioresearch, for advice with respect to confocal microscopy and flow cytometry experiments. This work was supported in part by Grants-in-Aid to S.W. and K.U. for General Scientific Research from the Ministry of Education, Science and Culture of Japan (B-24791530 and B-24390351), from the Japan Orthopaedics and Traumatology Foundation, Inc. (#297).	Abrams MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038760; Alexanian AR, 2011, CYTOTHERAPY, V13, P61, DOI 10.3109/14653249.2010.510504; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Martucci C, 2008, PAIN, V137, P81, DOI 10.1016/j.pain.2007.08.017; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Jensen MP, 2005, SPINAL CORD, V43, P704, DOI 10.1038/sj.sc.3101777; Hulsebosch CE, 2009, BRAIN RES REV, V60, P202, DOI 10.1016/j.brainresrev.2008.12.010; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; Crown ED, 2008, EXP NEUROL, V213, P257, DOI 10.1016/j.expneurol.2008.05.025; Siddall PJ, 1997, SPINAL CORD, V35, P69, DOI 10.1038/sj.sc.3100365; Busch SA, 2011, J NEUROSCI, V31, P944, DOI 10.1523/JNEUROSCI.3566-10.2011; Zhao P, 2007, J NEUROSCI, V27, P2357, DOI 10.1523/JNEUROSCI.0138-07.2007; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Tewarie RDSN, 2009, J NEUROTRAUM, V26, P2313, DOI 10.1089/neu.2009.0987; Neumann S, 2008, J NEUROSCI, V28, P7936, DOI 10.1523/JNEUROSCI.1259-08.2008; Koide Y, 2007, STEM CELLS, V25, P1213, DOI 10.1634/stemcells.2006-0325; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Finnerup NB, 2001, SPINAL CORD, V39, P256, DOI 10.1038/sj.sc.3101161; Kay JC, 2013, EXP NEUROL, V250, P366, DOI 10.1016/j.expneurol.2013.10.015; Bouhy D, 2006, FASEB J, V20, P1239, DOI 10.1096/fj.05-4382fje; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Hains BC, 2003, J NEUROSCI, V23, P8881; Kim HT, 2014, SPINE J, V14, P984, DOI 10.1016/j.spinee.2013.09.051; Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381; Fang B, 2013, J VASC SURG, V58, P1043, DOI 10.1016/j.jvs.2012.11.087; Abrams MB, 2009, RESTOR NEUROL NEUROS, V27, P307, DOI 10.3233/RNN-2009-0480; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Kumagai G, 2013, EXP NEUROL, V248, P369, DOI 10.1016/j.expneurol.2013.06.028; Zhang J, 2007, J NEUROSCI, V27, P12396, DOI 10.1523/JNEUROSCI.3016-07.2007; Crown ED, 2006, EXP NEUROL, V199, P397, DOI 10.1016/j.expneurol.2006.01.003; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Babcock AA, 2003, J NEUROSCI, V23, P7922; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Karamouzian S, 2012, CLIN NEUROL NEUROSUR, V114, P935, DOI 10.1016/j.clineuro.2012.02.003; Kim YJ, 2009, GLIA, V57, P13, DOI 10.1002/glia.20731; Ritfeld GJ, 2012, CELL TRANSPLANT, V21, P1561, DOI 10.3727/096368912X640484; Popovich PG, 2001, J NEUROPATH EXP NEUR, V60, P676; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Stirling DP, 2008, J NEUROSCI RES, V86, P1944, DOI 10.1002/jnr.21659; Crown ED, 2005, NEUROSCI LETT, V384, P139, DOI 10.1016/j.neulet.2005.04.066; Davies Jeannette E, 2008, J Biol, V7, P24, DOI 10.1186/jbiol85; Furuya T, 2009, BRAIN RES, V1295, P192, DOI 10.1016/j.brainres.2009.07.087; Gwak YS, 2009, EXP NEUROL, V220, P154, DOI 10.1016/j.expneurol.2009.08.012; Hoschouer EL, 2009, EXP NEUROL, V216, P22, DOI 10.1016/j.expneurol.2008.10.025; Hoschouer EL, 2010, PAIN, V148, P328, DOI 10.1016/j.pain.2009.11.023; Isami K, 2013, PLOS ONE, V30; LEE SC, 1994, GLIA, V12, P309, DOI 10.1002/glia.440120407; Maikos JT, 2007, J NEUROTRAUM, V24, P492, DOI 10.1089/neu.2006.0149; McAdoo DJ, 1999, EXP NEUROL, V159, P538, DOI 10.1006/exnr.1999.7166; Mukaino M, 2010, EXP NEUROL, V224, P403, DOI 10.1016/j.expneurol.2010.04.020; Saiwai H, 2010, AM J PATHOL, V176, P2352, DOI 10.2353/ajpath.2010.090839; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Stormer S, 1997, SPINAL CORD, V35, P446, DOI 10.1038/sj.sc.3100411; Tan Y, 2013, J NEUROPATH EXP NEUR, V72, P980, DOI 10.1097/NEN.0b013e3182a79de9; Tanabe M, 2009, EUR J PHARMACOL, V609, P65, DOI 10.1016/j.ejphar.2009.03.020; Tao F, 2013, STEM CELLS, V31, P83, DOI 10.1002/stem.1258; Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	65	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	JUN	2015	33	6					1902	1914		10.1002/stem.2006		13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CI6PJ	WOS:000354882500019		
J	Ozeki, N; Muneta, T; Matsuta, S; Koga, H; Nakagawa, Y; Mizuno, M; Tsuji, K; Mabuchi, Y; Akazawa, C; Kobayashi, E; Saito, T; Sekiya, I				Ozeki, Nobutake; Muneta, Takeshi; Matsuta, Seiya; Koga, Hideyuki; Nakagawa, Yusuke; Mizuno, Mitsuru; Tsuji, Kunikazu; Mabuchi, Yo; Akazawa, Chihiro; Kobayashi, Eiji; Saito, Tomoyuki; Sekiya, Ichiro			Synovial Mesenchymal Stem Cells Promote Meniscus Regeneration Augmented by an Autologous Achilles Tendon Graft in a Rat Partial Meniscus Defect Model	STEM CELLS			English	Article						Stem cell transplantation; Mesenchymal stem cells; Arthritis; Cellular therapy	BONE MORPHOGENETIC PROTEIN-7; PARTIAL MEDIAL MENISCECTOMY; FOLLOW-UP; INTRAARTICULAR INJECTION; STROMAL CELLS; CARTILAGE REGENERATION; OSTEOARTHRITIS; TRANSPLANTATION; KNEE; MARROW	Although meniscus defects and degeneration are strongly correlated with the later development of osteoarthritis, the promise of regenerative medicine strategies is to prevent and/or delay the disease's progression. Meniscal reconstruction has been shown in animal models with tendon grafting and transplantation of mesenchymal stem cells (MSCs); however, these procedures have not shown the same efficacy in clinical studies. Here, our aim was to investigate the ability of tendon grafts pretreated with exogenous synovial-derived MSCs to prevent cartilage degeneration in a rat partial meniscus defect model. We removed the anterior half of the medial meniscus and grafted autologous Achilles tendons with or without a 10-minute pretreatment of the tendon with synovial MSCs. The meniscus and surrounding cartilage were evaluated at 2, 4, and 8 weeks (n=5). Tendon grafts increased meniscus size irrespective of synovial MSCs. Histological scores for regenerated menisci were better in the tendon + MSC group than in the other two groups at 4 and 8 weeks. Both macroscopic and histological scores for articular cartilage were significantly better in the tendon + MSC group at 8 weeks. Implanted synovial MSCs survived around the grafted tendon and native meniscus integration site by cell tracking assays with luciferase+, LacZ+, DiI+, and/or GFP+ synovial MSCs and/or GFP+ tendons. Flow cytometric analysis showed that transplanted synovial MSCs retained their MSC properties at 7 days and host synovial tissue also contained cells with MSC characteristics. Synovial MSCs promoted meniscus regeneration augmented by autologous Achilles tendon grafts and prevented cartilage degeneration in rats. Stem Cells2015;33:1927-1938	[Ozeki, Nobutake; Muneta, Takeshi; Matsuta, Seiya; Koga, Hideyuki; Nakagawa, Yusuke] Yokohama City Univ, Dept Joint Surg & Sports Med, Yokohama, Kanagawa 232, Japan; [Ozeki, Nobutake; Saito, Tomoyuki] Yokohama City Univ, Dept Orthopaed Surg, Yokohama, Kanagawa 232, Japan; [Mizuno, Mitsuru; Sekiya, Ichiro] Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Tokyo 1138510, Japan; [Tsuji, Kunikazu] Tokyo Med & Dent Univ, Grad Sch Med, Dept Cartilage Regenerat, Tokyo 1138510, Japan; [Mabuchi, Yo; Akazawa, Chihiro] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Biochem & Biophys, Tokyo 1138510, Japan; [Kobayashi, Eiji] Keio Univ, Sch Med, Dept Organ Fabricat, Tokyo, Japan	Sekiya, I (reprint author), Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	sekiya.arm@tmd.ac.jp	Mabuchi, Yo/L-1535-2013	Mabuchi, Yo/0000-0001-8008-3966	Highway Program for Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare	We thank Miyoko Ojima, Mio Udo, Ryusuke Saito, Katsuaki Yanagisawa, Toshiyuki Ohara, and Benjamin L. Larson. This work was supported by the Highway Program for Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science and Technology and a grant-in-aid for Research on Regenerative Medicine for Clinical Application from the Ministry of Health, Labor and Welfare.	Andersson-Molina H, 2002, ARTHROSCOPY, V18, P183, DOI 10.1053/jars.2002.30435; Okuno M, 2014, J ORTHOP RES, V32, P928, DOI 10.1002/jor.22614; Koga H, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2460; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; Pauli C, 2011, OSTEOARTHR CARTILAGE, V19, P1132, DOI 10.1016/j.joca.2011.05.008; Zaffagnini S, 2011, AM J SPORT MED, V39, P977, DOI 10.1177/0363546510391179; Matsukura Y, 2014, CLIN ORTHOP RELAT R, V472, P1357, DOI 10.1007/s11999-013-3418-4; Inoue A, 2006, ARTHRITIS RHEUM, V54, P264, DOI 10.1002/art.21561; Hakamata Y, 2006, TRANSPLANTATION, V81, P1179, DOI 10.1097/01.tp.0000203137.06587.4a; Inoue H, 2005, BIOCHEM BIOPH RES CO, V329, P288, DOI 10.1016/j.bbrc.2005.01.132; Verdonk P, 2012, AM J SPORT MED, V40, P844, DOI 10.1177/0363546511433032; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Hommen JP, 2007, ARTHROSCOPY, V23, P388, DOI 10.1016/j.arthro.2006.11.032; Zaffagnini S, 2012, AM J SPORT MED, V40, P2281, DOI 10.1177/0363546512456835; Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212; Englund M, 2012, NAT REV RHEUMATOL, V8, P412, DOI 10.1038/nrrheum.2012.69; Moriguchi Y, 2013, BIOMATERIALS, V34, P2185, DOI 10.1016/j.biomaterials.2012.11.039; Rodeo SA, 2001, AM J SPORT MED, V29, P246; Garrett WE, 2006, J BONE JOINT SURG AM, V88A, P660, DOI 10.2106/JBJS.E.01208; Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Englund M, 2001, RHEUMATOLOGY, V40, P631, DOI 10.1093/rheumatology/40.6.631; McDermott I, 2011, BRIT J SPORT MED, V45, P292, DOI 10.1136/bjsm.2010.081257; Sekiya I, 2005, CELL TISSUE RES, V320, P269, DOI 10.1007/s00441-004-1075-3; Muneta T, 1999, ARTHROSCOPY, V15, P618, DOI 10.1053/ar.1999.v15.0150611; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Tamai K, 2011, P NATL ACAD SCI USA, V108, P6609, DOI 10.1073/pnas.1016753108; Burks RT, 1997, ARTHROSCOPY, V13, P673, DOI 10.1016/S0749-8063(97)90000-1; KOHN D, 1992, J BONE JOINT SURG BR, V74, P910; Horie M, 2009, STEM CELLS, V27, P878, DOI 10.1634/stemcells.2008-0616; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Horie M, 2012, OSTEOARTHR CARTILAGE, V20, P1197, DOI 10.1016/j.joca.2012.06.002; DesBari C, 2001, ARTHRITIS RHEUM, V44, P1928; FITHIAN DC, 1990, CLIN ORTHOP RELAT R, P19; FRIEDENS.AJ, 1974, EXP HEMATOL, V2, P83; Horie M, 2012, J BONE JOINT SURG AM, V94A, P701, DOI 10.2106/JBJS.K.00176; Johnson LL, 2000, ARTHROSCOPY, V16, P191, DOI 10.1016/S0749-8063(00)90035-5; Katagiri H, 2013, BIOCHEM BIOPH RES CO, V435, P603, DOI 10.1016/j.bbrc.2013.05.026; Kessler MW, 2014, J ORTHOP RES, V32, P500, DOI 10.1002/jor.22564; Koga H, 2007, STEM CELLS, V25, P689, DOI 10.1634/stemcells.2006-0281; Miyamoto T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3182; Mizumoto Y, 2003, J BONE JOINT SURG AM, V85A, P124; Nakagawa Y, 2015, OSTEOARTHRI IN PRESS; Nakamura T, 2012, CYTOTHERAPY, V14, P327, DOI 10.3109/14653249.2011.638912; Ozeki N, 2013, ARTHRITIS RHEUM-US, V65, P2876, DOI 10.1002/art.38099; Shen WL, 2014, STEM CELL TRANSL MED, V3, P387, DOI 10.5966/sctm.2012-0170; Shimaya M, 2010, OSTEOARTHR CARTILAGE, V18, P1300, DOI 10.1016/j.joca.2010.06.005; Suzuki S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3869; Vangsness CT, 2014, J BONE JOINT SURG AM, V96A, P90, DOI 10.2106/JBJS.M.00058	50	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	JUN	2015	33	6					1927	1938		10.1002/stem.2030		12	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CI6PJ	WOS:000354882500021		
J	Lee, JH; Lee, SH; Choi, SH; Asahara, T; Kwon, SM				Lee, Jun Hee; Lee, Sang Hun; Choi, Sung Hyun; Asahara, Takayuki; Kwon, Sang-Mo			The Sulfated Polysaccharide Fucoidan Rescues Senescence of Endothelial Colony-Forming Cells for Ischemic Repair	STEM CELLS			English	Article						Endothelial colony-forming cells; Replicative cellular senescence; Fucoidan; Akt; ERK; Vascular repair	SIGNAL-TRANSDUCTION PATHWAY; PROGENITOR CELLS; CELLULAR SENESCENCE; REDUCES SENESCENCE; CDK INHIBITORS; IN-VIVO; NEOVASCULARIZATION; SURVIVAL; ACTIVATION; EXPRESSION	The efficacy of cell therapy using endothelial colony-forming cells (ECFCs) in the treatment of ischemia is limited by the replicative senescence of isolated ECFCs in vitro. Such senescence must therefore be overcome in order for such cell therapies to be clinically applicable. This study aimed to investigate the potential of sulfated polysaccharide fucoidan to rescue ECFCs from cellular senescence and to improve in vivo vascular repair by ECFCs. Fucoidan-preconditioning of senescent ECFCs was shown by flow cytometry to restore the expression of functional ECFC surface markers (CD34, c-Kit, VEGFR2, and CXCR4) and stimulate the in vitro tube formation capacity of ECFCs. Fucoidan also promoted the expression of cell cycle-associated proteins (cyclin E, Cdk2, cyclin D1, and Cdk4) in senescent ECFCs, significantly reversed cellular senescence, and increased the proliferation of ECFCs via the FAK, Akt, and ERK signaling pathways. Fucoidan was found to enhance the survival, proliferation, incorporation, and endothelial differentiation of senescent ECFCs transplanted in ischemic tissues in a murine hind limb ischemia model. Moreover, ECFC-induced functional recovery and limb salvage were markedly improved by fucoidan pretreatment of ECFCs. To our knowledge, the findings of our study are the first to demonstrate that fucoidan enhances the neovasculogenic potential of ECFCs by rescuing them from replicative cellular senescence. Pretreatment of ECFCs with fucoidan may thus provide a novel strategy for the application of senescent stem cells to therapeutic neovascularization. Stem Cells2015;33:1939-1951	[Lee, Jun Hee; Choi, Sung Hyun; Kwon, Sang-Mo] Pusan Natl Univ, Dept Physiol, Med Res Inst, Lab Vasc Med & Stem Cell Biol,Sch Med, Yangsan, South Korea; [Lee, Sang Hun] Soonchunhyang Univ, Soonchunhyang Med Sci Res Inst, Seoul Hosp, Seoul, South Korea; [Lee, Sang Hun] Soonchunhyang Univ, Sch Med, Dept Biochem, Cheonan, South Korea; [Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa 25911, Japan	Kwon, SM (reprint author), Pusan Natl Univ, Dept Physiol, Med Res Inst, Lab Vasc Med & Stem Cell Biol,Sch Med, Yangsan Si 626870, Gyeongsangnam D, South Korea.	smkwon323@hotmail.com			National Research Foundation - Korean Government [NRF-2010-0020260, NRF-2012M3A9C6049720, NRF-2012R1A2A2A01045085]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI12C0199]	This work was supported by the National Research Foundation funded by Korean Government Grants NRF-2010-0020260, NRF-2012M3A9C6049720, and NRF-2012R1A2A2A01045085, and a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI12C0199).	Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Urata Y, 2006, J BIOL CHEM, V281, P13092, DOI 10.1074/jbc.M601984200; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Lee JH, 2013, ARTERIOSCL THROM VAS, V33, P1622, DOI 10.1161/ATVBAHA.112.301052; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Alekseyenko TV, 2007, B EXP BIOL MED+, V143, P730, DOI 10.1007/s10517-007-0226-4; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Ale MT, 2011, INT J BIOL MACROMOL, V49, P331, DOI 10.1016/j.ijbiomac.2011.05.009; Zheng H, 2007, J CARDIOVASC PHARM, V50, P274; Sarlon G, 2012, J THROMB HAEMOST, V10, P38, DOI 10.1111/j.1538-7836.2011.04554.x; Irhimeh MR, 2007, EXP HEMATOL, V35, P989, DOI 10.1016/j.exphem.2007.02.009; Wang JY, 2009, J CELL PHYSIOL, V219, P617, DOI 10.1002/jcp.21711; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Senthilkumar K, 2013, INT J BIOL MACROMOL, V60, P366, DOI 10.1016/j.ijbiomac.2013.06.030; Thum T, 2007, CIRC RES, V100, P434, DOI 10.1161/01.RES.0000257912.78915.af; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Wang J, 2010, INT J BIOL MACROMOL, V46, P6, DOI 10.1016/j.ijbiomac.2009.10.015; Lake AC, 2006, J BIOL CHEM, V281, P37844, DOI 10.1074/jbc.M600686200; Semenov AV, 1998, VOP MED KHIM, V44, P135; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Zemani F, 2005, BIOCHEM PHARMACOL, V70, P1167, DOI 10.1016/j.bcp.2005.07.014; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Handa S, 2009, BIOL PHARM BULL, V32, P1645; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; Kwak JY, 2014, MAR DRUGS, V12, P851, DOI 10.3390/md12020851; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Minamino T, 2008, NAT CLIN PRACT CARD, V5, P637, DOI 10.1038/ncpcardio1324; Zheng H, 2010, J CELL PHYSIOL, V223, P757, DOI 10.1002/jcp.22086; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Dentelli P, 2007, BLOOD, V109, P4264, DOI 10.1182/blood-2006-06-029603; Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093; Deux JF, 2002, ARTERIOSCL THROM VAS, V22, P1604, DOI 10.1161/01.ATV.0000032034.91020.0A; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Tongers J, 2010, MICROVASC RES, V79, P200, DOI 10.1016/j.mvr.2010.01.012; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Landmesser U, 2004, CIRCULATION, V110, P1933, DOI 10.1161/01.CIR.0000143232.67642.7A; Bruhl T, 2004, CIRC RES, V94, P686, DOI 10.1161/01.RES.0000119922.71855.56; Ciarrocchi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001338; Hidalgo A, 2004, BLOOD, V104, P993, DOI 10.1182/blood-2003-10-3702; Kim KL, 2011, CARDIOVASC RES, V92, P132, DOI 10.1093/cvr/cvr161; LEE S, 2013, ARTERIOSCLER THROMB, V155, P33; Li J, 2013, MOL MED REP, V7, P598, DOI 10.3892/mmr.2012.1180; Ma FX, 2005, HISTOL HISTOPATHOL, V20, P275; Makarenkova I. D., 2010, Voprosy Virusologii, V55, P41; Maruyama H, 2006, PLANTA MED, V72, P1415, DOI 10.1055/s-2006-951703; Narazaki M, 2008, BLOOD, V111, P4126, DOI 10.1182/blood-2007-09-112474; Scott SH, 2011, BIOMOL CONCEPTS, V2, P469; Sumi M, 2007, ARTERIOSCL THROM VAS, V27, P813, DOI 10.1161/01.ATV.0000259299.38843.64; VansCraenenbroeck EM, 2010, MICROVASC RES, V79, P184; Xue ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043483; Yang DG, 2008, AGEING RES REV, V7, P137, DOI 10.1016/j.arr.2008.02.001; Zhu ZX, 2010, THROMB RES, V125, P419, DOI 10.1016/j.thromres.2010.02.011	57	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	JUN	2015	33	6					1939	1951		10.1002/stem.1973		13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CI6PJ	WOS:000354882500022		
J	Nakagomi, T; Kubo, S; Nakano-Doi, A; Sakuma, R; Lu, S; Narita, A; Kawahara, M; Taguchi, A; Matsuyama, T				Nakagomi, Takayuki; Kubo, Shuji; Nakano-Doi, Akiko; Sakuma, Rika; Lu, Shan; Narita, Aya; Kawahara, Maiko; Taguchi, Akihiko; Matsuyama, Tomohiro			Brain Vascular Pericytes Following Ischemia Have Multipotential Stem Cell Activity to Differentiate Into Neural and Vascular Lineage Cells	STEM CELLS			English	Article						Blood-brain barrier; Ischemia; Pericyte; Stem cell plasticity; Reprogramming; Neurovascularization	STEM/PROGENITOR CELLS; ENDOTHELIAL-CELLS; BONE-MARROW; VASCULOGENIC MIMICRY; CEREBRAL INFARCTION; HUMAN FIBROBLASTS; VEGF EXPRESSION; NEURONAL CELLS; BLOOD-VESSELS; TUMOR-GROWTH	Brain vascular pericytes (PCs) are a key component of the blood-brain barrier (BBB)/neurovascular unit, along with neural and endothelial cells. Besides their crucial role in maintaining the BBB, increasing evidence shows that PCs have multipotential stem cell activity. However, their multipotency has not been considered in the pathological brain, such as after an ischemic stroke. Here, we examined whether brain vascular PCs following ischemia (iPCs) have multipotential stem cell activity and differentiate into neural and vascular lineage cells to reconstruct the BBB/neurovascular unit. Using PCs extracted from ischemic regions (iPCs) from mouse brains and human brain PCs cultured under oxygen/glucose deprivation, we show that PCs developed stemness presumably through reprogramming. The iPCs revealed a complex phenotype of angioblasts, in addition to their original mesenchymal properties, and multidifferentiated into cells from both a neural and vascular lineage. These data indicate that under ischemic/hypoxic conditions, PCs can acquire multipotential stem cell activity and can differentiate into major components of the BBB/neurovascular unit. Thus, these findings support the novel concept that iPCs can contribute to both neurogenesis and vasculogenesis at the site of brain injuries. Stem Cells2015;33:1962-1974	[Nakagomi, Takayuki; Nakano-Doi, Akiko; Sakuma, Rika; Lu, Shan; Narita, Aya; Kawahara, Maiko; Matsuyama, Tomohiro] Hyogo Coll Med, Inst Adv Med Sci, Nishinomiya, Hyogo 6638501, Japan; [Kubo, Shuji] Hyogo Coll Med, Dept Genet, Nishinomiya, Hyogo 6638501, Japan; [Lu, Shan] Hangzhou First Peoples Hosp, Dept Neurol, Hangzhou, Zhejiang, Peoples R China; [Kawahara, Maiko] Kwansei Gakuin Univ, Grad Sch Sci & Technol, Sanda, Hyogo, Japan; [Taguchi, Akihiko] Inst Biomed Res & Innovat, Dept Regenerat Med Res, Kobe, Hyogo, Japan	Nakagomi, T (reprint author), Hyogo Coll Med, Inst Adv Med Sci, 1-1 Mukogawacho, Nishinomiya, Hyogo 6638501, Japan.	nakagomi@hyo-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [24650173]; Hyogo College of Medicine	This work was partially supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (24650173; to T. Nakagomi) and Grant-in-Aid for researchers, Hyogo College of Medicine (2013; to T. Nakagomi). We would like to thank Y. Kimoto, H. Kato, T. Soma, Y. Fujimori, H. Yagi, R. Eguchi, Y. Kawamura, N. Nakagomi, Y. Okinaka, and Y. Tatsumi for technical assistance and helpful discussions.	Scully S, 2012, J NEUROSCI, V32, P12950, DOI 10.1523/JNEUROSCI.2017-12.2012; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201; Hale AT, 2014, J BIOL CHEM, V289, P12016, DOI 10.1074/jbc.M113.530956; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018; Birnbaum T, 2011, J NEURO-ONCOL, V105, P57, DOI 10.1007/s11060-011-0561-1; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; Rolny C, 2006, BLOOD, V108, P1877, DOI 10.1182/blood-2006-04-014894; Birbrair A, 2014, AM J PHYSIOL-CELL PH, V307, pC25, DOI 10.1152/ajpcell.00084.2014; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Cimadamore F, 2011, CELL STEM CELL, V8, P538, DOI 10.1016/j.stem.2011.03.011; Geisler JP, 2004, INT J GYNECOL CANCER, V14, P133, DOI 10.1111/j.1048-891x.2004.14027.x; Nakagomi T, 2012, STEM CELLS DEV, V21, P2350, DOI 10.1089/scd.2011.0657; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Giorgetti A, 2012, P NATL ACAD SCI USA, V109, P12556, DOI 10.1073/pnas.1209523109; Banerjee S, 2007, ANNU REV NEUROSCI, V30, P235, DOI 10.1146/annurev.neuro.30.051606.094345; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Hsu HT, 2014, INT J MOL SCI, V15, P9894, DOI 10.3390/ijms15069894; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Nakano-Doi A, 2010, STEM CELLS, V28, P1292, DOI 10.1002/stem.454; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Nakagomi N, 2009, STEM CELLS, V27, P2185, DOI 10.1002/stem.161; Tigges U, 2008, DEVELOPMENT, V135, P523, DOI 10.1242/dev.002071; Takata M, 2012, CELL DEATH DIFFER, V19, P756, DOI 10.1038/cdd.2011.145; Mao XG, 2013, NEURO-ONCOLOGY, V15, P865, DOI 10.1093/neuonc/not029; Nakagomi T, 2011, STEM CELLS DEV, V20, P2037, DOI 10.1089/scd.2011.0279; Ii M, 2009, CIRC RES, V105, P860, DOI 10.1161/CIRCRESAHA.109.199299; Hendriksen EM, 2009, MICROVASC RES, V77, P96, DOI 10.1016/j.mvr.2008.11.002; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Dar A, 2012, CIRCULATION, V125, P87, DOI 10.1161/CIRCULATIONAHA.111.048264; Lin CS, 2013, STEM CELLS DEV, V22, P1018, DOI 10.1089/scd.2012.0504; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; Karow M, 2012, CELL STEM CELL, V11, P471, DOI 10.1016/j.stem.2012.07.007; Gotte M, 2011, FERTIL STERIL, V95, P338, DOI 10.1016/j.fertnstert.2010.08.006; Nakagomi T, 2009, EUR J NEUROSCI, V29, P1842, DOI 10.1111/j.1460-9568.2009.06732.x; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Suzuki S, 2010, J HISTOCHEM CYTOCHEM, V58, P721, DOI 10.1369/jhc.2010.955609; Prandini MH, 2005, ONCOGENE, V24, P2992, DOI 10.1038/sj.onc.1208483; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; Birbrair A, 2012, STEM CELL RES, V10, P67; Gasperini P, 2012, CANCER RES, V72, P1157, DOI 10.1158/0008-5472.CAN-11-3067; Iłzecka J, 1996, Ann Univ Mariae Curie Sklodowska Med, V51, P123; Keramari M, 2010, PLOS ONE, V5; Klein D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020540; Kubo S, 2006, P NATL ACAD SCI USA, V103, P8036, DOI 10.1073/pnas.0601954103; Kubota Y, 2011, J EXP MED, V208, P949, DOI 10.1084/jem.20102187; Kubota Y, 2008, J CLIN INVEST, V118, P2393, DOI 10.1172/JCI34882; Luo Jianying, 2011, J Reprod Dev, V57, P84, DOI 10.1262/jrd.10-008K; Mokry J, 2004, STEM CELLS DEV, V13, P658, DOI 10.1089/scd.2004.13.658; Nagoshi N, 2009, J CELL BIOCHEM, V107, P1046, DOI 10.1002/jcb.22213; Nakagomi T, 2015, HISTOL HISTOPATHOL, V30, P391, DOI 10.14670/HH-30.391; Oishi K, 2006, BIOCHEM BIOPH RES CO, V349, P1065, DOI 10.1016/j.bbrc.2006.08.135; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Teng L, 2006, ADV EXP MED BIOL, V589, P206; Wang CH, 2012, CIRC J, V76, P477, DOI 10.1253/circj.CJ-11-0739; Yamaoka N, 2010, INT J ONCOL, V37, P273, DOI 10.3892/ijo_00000675	67	6	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	JUN	2015	33	6					1962	1974		10.1002/stem.1977		13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CI6PJ	WOS:000354882500024		
J	Murray, A; Letourneau, A; Canzonetta, C; Stathaki, E; Gimelli, S; Sloan-Bena, F; Abrehart, R; Goh, P; Lim, S; Baldo, C; Dagna-Bricarelli, F; Hannan, S; Mortensen, M; Ballard, D; Court, DS; Fusaki, N; Hasegawa, M; Smart, TG; Bishop, C; Antonarakis, SE; Groet, J; Nizetic, D				Murray, Aoife; Letourneau, Audrey; Canzonetta, Claudia; Stathaki, Elisavet; Gimelli, Stefania; Sloan-Bena, Frederique; Abrehart, Robert; Goh, Pollyanna; Lim, Shuhui; Baldo, Chiara; Dagna-Bricarelli, Franca; Hannan, Saad; Mortensen, Martin; Ballard, David; Court, Denise Syndercombe; Fusaki, Noemi; Hasegawa, Mamoru; Smart, Trevor G.; Bishop, Cleo; Antonarakis, Stylianos E.; Groet, Juergen; Nizetic, Dean			Brief Report: Isogenic Induced Pluripotent Stem Cell Lines From an Adult With Mosaic Down Syndrome Model Accelerated Neuronal Ageing and Neurodegeneration	STEM CELLS			English	Article						Down syndrome; Neurodegeneration; Neurogenesis; Neuronal differentiation	IN-VITRO; TRISOMY-21; DIFFERENTIATION; GENERATION; DEFECTS; HEMATOPOIESIS; CHROMOSOME-21; DISEASE; GENES; IPSCS	Trisomy 21 (T21), Down Syndrome (DS) is the most common genetic cause of dementia and intellectual disability. Modeling DS is beginning to yield pharmaceutical therapeutic interventions for amelioration of intellectual disability, which are currently being tested in clinical trials. DS is also a unique genetic system for investigation of pathological and protective mechanisms for accelerated ageing, neurodegeneration, dementia, cancer, and other important common diseases. New drugs could be identified and disease mechanisms better understood by establishment of well-controlled cell model systems. We have developed a first nonintegration-reprogrammed isogenic human induced pluripotent stem cell (iPSC) model of DS by reprogramming the skin fibroblasts from an adult individual with constitutional mosaicism for DS and separately cloning multiple isogenic T21 and euploid (D21) iPSC lines. Our model shows a very low number of reprogramming rearrangements as assessed by a high-resolution whole genome CGH-array hybridization, and it reproduces several cellular pathologies seen in primary human DS cells, as assessed by automated high-content microscopic analysis. Early differentiation shows an imbalance of the lineage-specific stem/progenitor cell compartments: T21 causes slower proliferation of neural and faster expansion of hematopoietic lineage. T21 iPSC-derived neurons show increased production of amyloid peptide-containing material, a decrease in mitochondrial membrane potential, and an increased number and abnormal appearance of mitochondria. Finally, T21-derived neurons show significantly higher number of DNA double-strand breaks than isogenic D21 controls. Our fully isogenic system therefore opens possibilities for modeling mechanisms of developmental, accelerated ageing, and neurodegenerative pathologies caused by T21. Stem Cells2015;33:2077-2084	[Murray, Aoife; Canzonetta, Claudia; Abrehart, Robert; Goh, Pollyanna; Bishop, Cleo; Groet, Juergen; Nizetic, Dean] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, London E1 2AT, England; [Groet, Juergen] Queen Mary Univ London, Natl Ctr Bowel Res & Surg Innovat, Stem Cell Lab, London, England; [Murray, Aoife; Goh, Pollyanna; Groet, Juergen; Nizetic, Dean] Wellcome Trust Res Labs, LonDownS Consortium, London, England; [Letourneau, Audrey; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Stathaki, Elisavet; Gimelli, Stefania; Sloan-Bena, Frederique] Univ Hosp Geneva, Serv Genet Med, Geneva, Switzerland; [Lim, Shuhui; Nizetic, Dean] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 138673, Singapore; [Baldo, Chiara] Galliera Hosp, Human Genet Lab, Genoa, Italy; [Dagna-Bricarelli, Franca] Liguria Dept Genet, Genoa, Italy; [Hannan, Saad; Mortensen, Martin; Smart, Trevor G.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Ballard, David; Court, Denise Syndercombe] Kings Coll London, Dept Forens & Analyt Sci, London WC2R 2LS, England; [Fusaki, Noemi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan; [Hasegawa, Mamoru] DNAVEC Corp, Tokyo, Japan	Nizetic, D (reprint author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Proteos Bldg,Level 4,61 Biopolis Dr, Singapore 138673, Singapore.	j.groet@qmul.ac.uk; d.nizetic@ntu.edu.sg	Nizetic, Dean/F-9509-2015; Ballard, David/B-8392-2014; Antonarakis, Stylianos/N-8866-2014	Antonarakis, Stylianos/0000-0001-8907-5823	Kay Kendall Leukaemia Fund [KKL632]; Fondation Jerome Lejeune [2011B/960]; Wellcome Trust [098330/Z/12/Z]; Lee Kong Chian School of Medicine, Nanyang Technological University-Singapore [M4230024]; EU Commission; SNF [144082]; ERC [249968]; Barts and The London Charity; National Centre for Bowel Research and Surgical Innovation (NCBRSI) [520/1489]; Telethon project [GTB12001]	This work was supported by the project grants from the Kay Kendall Leukaemia Fund (KKL632), and Fondation Jerome Lejeune (2011B/960), by The Wellcome Trust "LonDownS Consortium" Strategic Funding Award (098330/Z/12/Z), and the Lee Kong Chian School of Medicine, Nanyang Technological University-Singapore start-up funding grant M4230024 to D.N., by the "AnEUploidy Consorium" grant from Framework Programme 6 from the EU Commission to D.N. and S.E.A., as well as SNF 144082 and ERC 249968 grants to S.E.A. We also thank Barts and The London Charity and the grant 520/1489: "Development of a National Centre for Bowel Research and Surgical Innovation (NCBRSI)" for purchase of high content imaging equipment. Galliera Genetic Bank as member of the Telethon Network of Genetic Biobanks (Telethon project GTB12001) provided us with specimens. We thank Li Pin for help in setting up the iPSC lab at LKCMedicine in Singapore. We thank Gary Warnes for help with the fluorescence activated cell sorting analysis, and Dominique Bonnet, Silvia Marino, and the BSU Whitechapel for help in using NOD/SCID mice. N.F. is currently affiliated with Dept. of Opthalmology, Keio University School of Medicine, Tokyo, Japan. We dedicate this paper to Prof. Franca Dagna-Bricarelli, our colleague and coauthor who sadly passed away during revision of this manuscript. Her dedicated work in human genetics made all this possible and will remain inspiration to all of us.	Adorno M, 2013, NATURE, V501, P380, DOI 10.1038/nature12530; Weick JP, 2013, P NATL ACAD SCI USA, V110, P9962, DOI 10.1073/pnas.1216575110; Helguera P, 2013, CELL METAB, V17, P132, DOI 10.1016/j.cmet.2012.12.005; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Roper RJ, 2006, P NATL ACAD SCI USA, V103, P1452, DOI 10.1073/pnas.0510750103; Epstein CJ, 2002, AM J HUM GENET, V70, P300, DOI 10.1086/338915; Cataldo AM, 2008, AM J PATHOL, V173, P370, DOI 10.2353/ajpath.2008.071053; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; Briggs JA, 2013, STEM CELLS, V31, P467, DOI 10.1002/stem.1297; Erwin JA, 2014, NAT REV NEUROSCI, V15, P497, DOI 10.1038/nrn3730; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Jiang J, 2013, NATURE, V500, P296, DOI 10.1038/nature12394; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Nizetic D, 2012, NAT REV CANCER, V12, P721, DOI 10.1038/nrc3355; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Hibaoui Y, 2014, EMBO MOL MED, V6, P259, DOI 10.1002/emmm.201302848; Chou ST, 2012, P NATL ACAD SCI USA, V109, P17573, DOI 10.1073/pnas.1211175109; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Luong MX, 2011, CELL STEM CELL, V8, P357, DOI 10.1016/j.stem.2011.03.002; MacLean GA, 2012, P NATL ACAD SCI USA, V109, P17567, DOI 10.1073/pnas.1215468109; Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x; Bahn S, 2002, LANCET, V359, P310, DOI 10.1016/S0140-6736(02)07497-4; Delom F, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-31; De Vita S, 2010, ONCOGENE, V29, P6102, DOI 10.1038/onc.2010.351; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Ng ES, 2008, CURR PROTOC STEM CEL, DOI DOI 10.1002/9780470151808.SC01D03S4; Shi Y, 2012, SCI TRANSL MED, V4; Spencer K, 2001, PRENATAL DIAG, V21, P788, DOI 10.1002/pd.134; Wang Y, 2009, MOL CELL PROTEOMICS, V8, P585, DOI 10.1074/mcp.M800256-MCP200	32	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	JUN	2015	33	6					2077	2084		10.1002/stem.1968		8	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CI6PJ	WOS:000354882500033		
J	Hasegawa, Y; Nitta, H; Sasaki, A; Takahara, T; Itabashi, H; Katagiri, H; Otsuka, K; Nishizuka, S; Wakabayashi, G				Hasegawa, Yasushi; Nitta, Hiroyuki; Sasaki, Akira; Takahara, Takeshi; Itabashi, Hidenori; Katagiri, Hirokatsu; Otsuka, Koki; Nishizuka, Satoshi; Wakabayashi, Go			Long-term outcomes of laparoscopic versus open liver resection for liver metastases from colorectal cancer: A comparative analysis of 168 consecutive cases at a single center	SURGERY			English	Article							SURVIVAL; ULTRASONOGRAPHY; COMPLICATIONS; CHEMOTHERAPY; HEPATECTOMY; EXPERIENCE; MARGIN	Background. Laparoscopic liver resection for liver metastases from colorectal cancer (CRLM) is performed in a relatively small number of institutions. Its operative results have been reported to be comparable with that of open laparotomy; however, information on its oncologic outcomes is scarce. This study aimed to compare the long-term outcomes of laparoscopic hepatectomy (LH) and open hepatectomy (OH) to treat CRLM at a single institution. Methods. We retrospectively reviewed data from 168 consecutive patients who underwent LH (n = 100) or OH (n = 68) for CRLM. The tumor characteristics, operative results, overall survival (OS) rate, recurrence-free survival (RFS) rate, and recurrence patterns were analyzed and compared. A previously published survival-predicting nomogram was applied to compare OS and RFS between the 2 patient groups. Results. The largest tumor diameter and the number of tumors were significantly larger in the OH group than in the LH group; however, no differences in other tumor factors were observed between the 2 groups. When matched by the nomogram, OS and RFS remained comparable between the 2 groups in every examined stratum, not only for low-risk patients but also for those with high risk. The recurrence patterns also were similar (liver: 30.2% vs 26.8%, P = .72; lung: 22.6% vs 34.1%, P = .22; peritoneum: 7.6% vs 4.9%, P = .45). Conclusion. The long-term outcomes of laparoscopic liver resection for CRLM were comparable with those of the open procedure in not only low-risk but also high-risk patients.	[Hasegawa, Yasushi; Nitta, Hiroyuki; Sasaki, Akira; Takahara, Takeshi; Itabashi, Hidenori; Katagiri, Hirokatsu; Otsuka, Koki; Nishizuka, Satoshi; Wakabayashi, Go] Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 0208505, Japan	Hasegawa, Y (reprint author), Iwate Med Univ, Sch Med, Dept Surg, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	hasegawayas@yahoo.co.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Hasegawa Y, 2013, J HEPATO-BIL-PAN SCI, V20, P525, DOI 10.1007/s00534-012-0591-x; Andreou A, 2013, ANN SURG, V257, P1079, DOI 10.1097/SLA.0b013e318283a4d1; Hamady ZZR, 2014, ANN SURG, V259, P543, DOI 10.1097/SLA.0b013e3182902b6e; Tzanis D, 2013, J HEPATO-BIL-PAN SCI, V20, P120, DOI 10.1007/s00534-012-0554-2; Cannon RM, 2012, SURGERY, V152, P567, DOI 10.1016/j.surg.2012.07.013; Kazaryan AM, 2010, ANN SURG, V252, P1005, DOI 10.1097/SLA.0b013e3181f66954; Lin NC, 2013, ANN SURG, V257, P205, DOI 10.1097/SLA.0b013e31827da7fe; Acheson AG, 2012, ANN SURG, V256, P235, DOI 10.1097/SLA.0b013e31825b35d5; Nguyen KT, 2009, ANN SURG, V250, P842, DOI 10.1097/SLA.0b013e3181bc789c; Guerron AD, 2013, SURG ENDOSC, V27, P1138, DOI 10.1007/s00464-012-2563-2; Nitta H, 2010, ANN SURG, V251, P450, DOI 10.1097/SLA.0b013e3181cf87da; Abu Hilal M, 2012, ARCH SURG-CHICAGO, V147, P42, DOI 10.1001/archsurg.2011.856; Sasaki A, 2009, BRIT J SURG, V96, P274, DOI 10.1002/bjs.6472; Buell JF, 2009, ANN SURG, V250, P825, DOI 10.1097/SLA.0b013e3181b3b2d8; Kluger MD, 2013, J HEPATO-BIL-PAN SCI, V20, P131, DOI 10.1007/s00534-012-0571-1; Castaing D, 2009, ANN SURG, V250, P849, DOI 10.1097/SLA.0b013e3181bcaf63; Reissfelder C, 2009, ANN SURG ONCOL, V16, P3279, DOI 10.1245/s10434-009-0654-7; Mavros MN, 2013, BRIT J SURG, V100, P711, DOI 10.1002/bjs.9060; Beppu T, 2012, J HEPATO-BIL-PAN SCI, V19, P72, DOI 10.1007/s00534-011-0460-z; Jiang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076125; Itabashi T, 2014, SURG TODAY, V44, P696, DOI 10.1007/s00595-013-0607-4; Okuno M, 2014, J HEPATO-BIL-PAN SCI, V21, P881, DOI 10.1002/jhbp.149; Saiura A, 2012, WORLD J SURG, V36, P2171, DOI 10.1007/s00268-012-1616-y; Vigano L, 2013, BRIT J SURG, V100, P535, DOI 10.1002/bjs.9025	25	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	JUN	2015	157	6					1065	1072		10.1016/j.surg.2015.01.017		8	Surgery	Surgery	CI6YR	WOS:000354910600011		
J	Okumura, S; Kaido, T; Hamaguchi, Y; Fujimoto, Y; Masui, T; Mizumoto, M; Hammad, A; Mori, A; Takaori, K; Uemoto, S				Okumura, Shinya; Kaido, Toshimi; Hamaguchi, Yuhei; Fujimoto, Yasuhiro; Masui, Toshihiko; Mizumoto, Masaki; Hammad, Ahmed; Mori, Akira; Takaori, Kyoichi; Uemoto, Shinji			Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer	SURGERY			English	Article							DONOR LIVER-TRANSPLANTATION; ADIPOSE-TISSUE; SARCOPENIA; INFLAMMATION; ADENOCARCINOMA; EXERCISE; OUTCOMES; COUNTS; INDEX; TERM	Background. Skeletal muscle depletion, referred to as sarcopenia, is predictive of mortality in patients undergoing digestive operations. The impact of muscle quality on outcomes, however, is unclear. This retrospective study investigated the impact of preoperative skeletal muscle quantity and quality on survival in patients undergoing resection of pancreatic cancer. Methods. We investigated 230 patients who underwent resection of pancreatic cancer between 2004 and 2013. The quantity and quality of skeletal muscle, indicated by psoas muscle mass index (PM) and intramuscular adipose tissue content (IMAC), were measured in preoperative computed tomography images. Overall survival (OS) and recurrence-free survival (RFS) rates were compared according to PMI and IMAC, and prognostic factors after pancreatic resection were assessed. Results. The OS and RFS rates in patients with low PMI were lesser than in those with normal/high PMI (P < .001, P < .001), with a mean survival time of 17.7 and 33.2 months, respectively. The OS and RFS rates in patients with high IMAC also were less than in those with normal/low IMAC (P < .001, P = .003) (mean survival time = 21.5 and 56.5 months, respectively). Low PMI (low muscle mass) and high IMAC (low muscle quality) were independent prognostic factors of poor OS (hazard ratio [HR] = 1.999, P < .001; HR = 2.527, P < .001) and RFS (HR = 1.607, P = .007; HR = 1.640, P = .004), respectively. Conclusion. Preoperative sarcopenia, indicating low quality and quantity of skeletal muscle, is closely related to mortality after resection of pancreatic cancer	[Okumura, Shinya; Kaido, Toshimi; Hamaguchi, Yuhei; Fujimoto, Yasuhiro; Masui, Toshihiko; Mizumoto, Masaki; Hammad, Ahmed; Mori, Akira; Takaori, Kyoichi; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Div Hepato Biliary Pancreat & Transplant Surg, Dept Surg, Kyoto 6068507, Japan	Kaido, T (reprint author), Kyoto Univ, Grad Sch Med, Div Hepato Biliary Pancreat & Transplant Surg, Dept Surg,Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	kaido@kuhp.kyoto-u.ac.jp					Bhatti I, 2010, AM J SURG, V200, P197, DOI 10.1016/j.amjsurg.2009.08.041; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Wang DS, 2012, MED ONCOL, V29, P3092, DOI 10.1007/s12032-012-0226-8; Peng P, 2012, J GASTROINTEST SURG, V16, P1478, DOI 10.1007/s11605-012-1923-5; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Peng PD, 2011, HPB, V13, P439, DOI 10.1111/j.1477-2574.2011.00301.x; Fogar P, 2006, PANCREAS, V32, P22, DOI 10.1097/01.mpa.0000188305.90290.50; Smith RA, 2009, AM J SURG, V197, P466, DOI 10.1016/j.amjsurg.2007.12.057; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; van Vledder MG, 2012, BRIT J SURG, V99, P550, DOI 10.1002/bjs.7823; Sun KY, 2014, J CANCER RES CLIN, V140, P1537, DOI 10.1007/s00432-014-1714-3; Masuda T, 2014, LIVER TRANSPLANT, V20, P401, DOI 10.1002/lt.23811; Kaido T, 2013, AM J TRANSPLANT, V13, P1549, DOI 10.1111/ajt.12221; Harimoto N, 2013, BRIT J SURG, V100, P1523, DOI 10.1002/bjs.9258; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Marcus RL, 2010, J NUTR HEALTH AGING, V14, P362, DOI 10.1007/s12603-010-0081-2; Kitajima Y, 2013, J GASTROEN HEPATOL, V28, P1507, DOI 10.1111/jgh.12227; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157; Proctor MJ, 2011, BRIT J CANCER, V104, P726, DOI 10.1038/sj.bjc.6606087; Suzuki K, 2004, HEPATO-GASTROENTEROL, V51, P847; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; Baracos VE, 2010, AM J CLIN NUTR, V91, P1133; Kitajima Y, 2010, J GASTROENTEROL, V45, P218, DOI 10.1007/s00535-009-0147-2; Rosenberg IH, 1997, J NUTR, V127, P990; Sanjay Pandanaboyana, 2012, JOP, V13, P199; Yamaguchi K, 2000, INT SURG, V85, P71; Zoico E, 2013, ARCH GERONTOL GERIAT, V57, P411, DOI 10.1016/j.archger.2013.06.001	29	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	JUN	2015	157	6					1088	1098		10.1016/j.surg.2015.02.002		11	Surgery	Surgery	CI6YR	WOS:000354910600014		
J	Hirao, M; Kurokawa, Y; Fujita, J; Imamura, H; Fujiwara, Y; Kimura, Y; Takiguchi, S; Mori, M; Doki, Y				Hirao, Motohiro; Kurokawa, Yukinori; Fujita, Junya; Imamura, Hiroshi; Fujiwara, Yoshiyuki; Kimura, Yutaka; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro		Osaka Univ Clin Res Grp Gastroente	Long-term outcomes after prophylactic bursectomy in patients with resectable gastric cancer: Final analysis of a multicenter randomized controlled trial	SURGERY			English	Article							GASTRECTOMY; SURGERY; CELLS; CARCINOMA	Background. Bursectomy, a traditional operative procedure to remove the peritoneal lining covering the pancreas and the anterior plane of the transverse mesocolon, has been performed for serosa-positive gastric cancer in Japan and Eastern Asia. We conducted a multicenter, randomized, controlled trial to demonstrate the noninferiority of the omission of bursectomy. Methods. Between July 2002 and January 2007, 210 patients with cT2-3 gastric adenocarcinoma were randomized intraoperatively to D2 gastrectomy with or without bursectomy. The primary endpoint was overall survival (OS). We provide the results of the final analysis of the complete 5-year follow-up data. Results.. After the median follow-up of 80 months, 5-year OS was 77.5% for the bursectomy group and 71.3% for the nonbursectomy group (2-sided P = .16 for superiority; 1-sided P = .99 for noninferiority). The hazard ratio for death in the nonbursectomy group was 1.40 (95% CI, 0.87-2.25). The 5-year recurrence-free survivals were 73.7% and 66.6% in the bursectomy and nonbursectomy groups, respectively (2-sided P = .33 for superiority; 1-sided P = .99 for noninferiority). Cox multivariate analysis revealed that bursectomy was an independent prognostic factor of good OS (P = .033). Subgroup analysis showed a trend toward improved survival after bursectomy for tumors in the middle or lower third of the stomach and for pathologically serosa-positive tumors. Conclusion. The final analysis could not demonstrate the noninferiority of the omission of bursectomy. Bursectomy should not be abandoned as a futile procedure.	[Hirao, Motohiro] Osaka Natl Hosp, Natl Hosp Org, Dept Surg, Osaka, Japan; [Kurokawa, Yukinori; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Sch Med, Dept Surg Gastroenterol, Suita, Osaka 565, Japan; [Fujita, Junya] NTT West Osaka Hosp, Dept Surg, Osaka, Japan; [Imamura, Hiroshi] Toyonaka City Hosp, Dept Surg, Toyonaka, Osaka, Japan; [Fujiwara, Yoshiyuki] Sakai Municipal Hosp, Dept Surg, Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan; [Kimura, Yutaka] Sakai Municipal Hosp, Dept Surg, Osaka, Japan	Kurokawa, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, 2-2-E2 Yamadaoka, Suita, Osaka 5650871, Japan.	ykurokawa@gesurg.med.osaka-u.ac.jp			Supporting Center for Clinical Research and Education (SCCRE)	This study was supported in part by the Supporting Center for Clinical Research and Education (SCCRE). The authors thank Prof. Kunio Okajima for helpful advices, and Dr Tomoyuki Sugimoto at Hirosaki University and Dr Toshio Shimokawa at Yamanashi University for their statistical analysis.	Groves EWH, 1910, BRIT MED J, V1910, P366; Yamamura Y, 2007, GASTRIC CANCER, V10, P24, DOI 10.1007/s10120-006-0404-5; Kidd JG, 1940, J EXP MED, V71, P813, DOI 10.1084/jem.71.6.813; Kochi M, 2014, AM J CLIN ONCOL-CANC, V37, P222, DOI 10.1097/COC.0b013e31825eb734; MARUYAMA K, 1987, WORLD J SURG, V11, P418; HAGIWARA A, 1993, CANCER RES, V53, P687; Imamura H, 2011, WORLD J SURG, V35, P625, DOI 10.1007/s00268-010-0914-5; Eom BW, 2013, EJSO-EUR J SURG ONC, V39, P1407, DOI 10.1016/j.ejso.2013.09.013; Fujita J, 2012, GASTRIC CANCER, V15, P42, DOI 10.1007/s10120-011-0058-9; Takebayashi K, 2014, ANN SURG ONCOL, V21, P1991, DOI 10.1245/s10434-014-3525-9; Yoshikawa T, 2004, HEPATO-GASTROENTEROL, V51, P1524; Blouhos Konstantinos, 2013, Updates Surg, V65, P95, DOI 10.1007/s13304-013-0210-7; Hagiwara A, 1998, HEPATO-GASTROENTEROL, V45, P1922; Japanese Gastric Cancer Association, 2004, GASTR CANC TREATM GU; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/S101209800016]; Jinnai D, 1967, RINSHO GEKA, V22, P19; Korn EL, 2005, J CLIN ONCOL, V23, P5831, DOI 10.1200/JCO.2005.02.105; Oglivie WH, 1939, SURG GYNECOL OBSTET, V68, P295; Takeda Jinryo, 1992, Kurume Medical Journal, V39, P77	19	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	JUN	2015	157	6					1099	1105		10.1016/j.surg.2014.12.024		7	Surgery	Surgery	CI6YR	WOS:000354910600015		
J	Kawaguchi, Y; Fuks, D; Nomi, T; Levard, H; Gayet, B				Kawaguchi, Yoshikuni; Fuks, David; Nomi, Takeo; Levard, Hughes; Gayet, Brice			Laparoscopic distal pancreatectomy employing radical en bloc procedure for adenocarcinoma: Technical details and outcomes	SURGERY			English	Article							ANTEGRADE MODULAR PANCREATOSPLENECTOMY; SINGLE-INSTITUTION; PROGNOSTIC-FACTORS; RESECTION; SURGERY; CANCER; PANCREAS; EXPERIENCE; SURVIVAL; SPLENECTOMY	Background. Although laparoscopic distal pancreatectomy (LDP) has increasingly gained popularity, there are only a few reports mentioning application and outcomes of LDP for adenocarcinoma of the body and tail of the pancreas. The aim of our study is to demonstrate technical details of LDP employing radical en bloc procedure (en bloc LDP) and to evaluate the short- and long-term outcomes of en bloc LDP applied for adenocarcinoma. Methods. We evaluated 23 consecutive patients who underwent LDP for adenocarcinoma in the body or tail of the pancreas. Our concepts of en bloc LDP for adenocarcinoma comprise 3 principles: en bloc removal of retroperitoneal structures, lymph node (LN) dissection, and preservation of the spleen. Results. En bloc LDP without splenectomy was performed in 17 patients (74%) and en bloc LDP with splenectomy was in 6 patients (26%). Mean +/- standard deviation operation time was 203 +/- 54 minutes, and mean estimated blood loss was 208 +/- 264 mL. Conversion to open distal pancreatectomy was required in I patient (4%) owing to the severe adhesions around the pancreas. The overall morbidity rate following en bloc LDP was 47% (n = 11), and the rate of pancreatic fistula was 39% (n = 9). There were no 30-day or in-hospital mortalities. Mean tumor size was 32 +/- 12 mm, and mean number of harvested LNs was 19.8 +/- 9.3. No patient had positive margins on final histologic diagnosis. The 1-, 3-, and 5-year overall survival rates were 67%, 49%, and 33 %, respectively. Conclusion. En bloc LDP can be applied safely by the surgeon with advanced experience in minimally invasive surgery with satisfactory short- and long-term outcomes, supporting further application of LDP for adenocarcinoma with advances in operative techniques and technological innovations.	[Kawaguchi, Yoshikuni; Fuks, David; Nomi, Takeo; Levard, Hughes; Gayet, Brice] Univ Paris 05, Inst Mutualiste Montsouris, Dept Digest Dis, F-75014 Paris, France; [Kawaguchi, Yoshikuni] Univ Tokyo, Hepatobiliary Pancreat Surg Div, Dept Surg, Grad Sch Med, Tokyo, Japan; [Fuks, David; Gayet, Brice] Univ Paris 06, ISIR, Paris, France	Gayet, B (reprint author), Univ Paris 05, Inst Mutualiste Montsouris, Dept Digest Dis, 42 Blvd Jourdan, F-75014 Paris, France.	brice.gayet@imm.fr					Ammori BJ, 2004, J HEPATO-BILIARY-PAN, V11, P107, DOI 10.1007/s00534-003-0885-0; Ammori Basil J, 2003, JOP, V4, P187; DAVIS CJ, 1988, AM J SURG, V155, P173, DOI 10.1016/S0002-9610(88)80276-9; Hoznek A, 2001, EUR UROL, V40, P38, DOI 10.1159/000049747; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Butturini G, 2012, J SURG ONCOL, V105, P387, DOI 10.1002/jso.22117; Vijan SS, 2010, ARCH SURG-CHICAGO, V145, P616, DOI 10.1001/archsurg.2010.120; Kang CM, 2010, SURG ENDOSC, V24, P1533, DOI 10.1007/s00464-009-0806-7; Gumbs AA, 2008, SURG ENDOSC, V22, P539, DOI 10.1007/s00464-007-9635-8; Kooby DA, 2008, ANN SURG, V248, P438, DOI 10.1097/SLA.0b013e318185a990; Yamamoto J, 2010, JPN J CLIN ONCOL, V40, P530, DOI 10.1093/jjco/hyq015; Howard TJ, 2006, J GASTROINTEST SURG, V10, P1338, DOI 10.1016/j.gassur.2006.09.008; Mitchem JB, 2012, J AM COLL SURGEONS, V214, P46, DOI 10.1016/j.jamcollsurg.2011.10.008; Shimada K, 2006, SURGERY, V139, P288, DOI 10.1016/j.surg.2005.08.004; CULLINGFORD GL, 1991, BRIT J SURG, V78, P716, DOI 10.1002/bjs.1800780626; Nguyen KT, 2009, ANN SURG, V250, P831, DOI 10.1097/SLA.0b013e3181b0c4df; Asoglu O, 2009, SURG ENDOSC, V23, P296, DOI 10.1007/s00464-008-9870-7; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Kim SH, 2013, J HEPATO-BIL-PAN SCI, V20, P375, DOI 10.1007/s00534-012-0549-z; WARSHAW AL, 1988, ARCH SURG-CHICAGO, V123, P550; Strasberg SM, 2003, SURGERY, V133, P521, DOI 10.1067/msy.2003.146; Kneuertz PJ, 2012, J AM COLL SURGEONS, V215, P167, DOI 10.1016/j.jamcollsurg.2012.03.023; Redmond KJ, 2010, ANN SURG ONCOL, V17, P3112, DOI 10.1245/s10434-010-1200-3; Ferrone CR, 2011, ANN SURG, V253, P1136, DOI 10.1097/SLA.0b013e318212c1e2; Karaliotas C, 2009, J GASTROINTEST SURG, V13, P1869, DOI 10.1007/s11605-009-0954-z; Buell JF, 2009, ANN SURG, V250, P825, DOI 10.1097/SLA.0b013e3181b3b2d8; Kendrick ML, 2011, HPB, V13, P454, DOI 10.1111/j.1477-2574.2011.00323.x; Fernandez-Cruz L, 2007, J GASTROINTEST SURG, V11, P1607, DOI 10.1007/s11605-007-0266-0; Giulianotti PC, 2010, SURG ENDOSC, V24, P1646, DOI 10.1007/s00464-009-0825-4; Eiriksson K, 2011, BRIT J SURG, V98, P845, DOI 10.1002/bjs.7457; Fujita T, 2010, PANCREAS, V39, pE48, DOI 10.1097/MPA.0b013e3181bd5cfa; Gagner M, 1997, J Gastrointest Surg, V1, P20, DOI 10.1007/s11605-006-0005-y; GRIFFITH JP, 1995, GUT, V36, P684, DOI 10.1136/gut.36.5.684; HOLDSWORTH RJ, 1991, BRIT J SURG, V78, P1031, DOI 10.1002/bjs.1800780904; Jean-Philippe Adam, 2013, JAMA Surg, V148, P246; Kooby DA, 2010, J AM COLL SURGEONS, V210, P86; Schwarz RE, 1999, J AM COLL SURGEONS, V188, P516, DOI 10.1016/S1072-7515(99)00041-1; Underwood R A, 1999, J Hepatobiliary Pancreat Surg, V6, P154, DOI 10.1007/s005340050099	38	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	JUN	2015	157	6					1106	1112		10.1016/j.surg.2014.12.015		7	Surgery	Surgery	CI6YR	WOS:000354910600016		
J	Chen, TQ; Han, LB				Chen, Tieqiao; Han, Li-Biao			Optically Active H-Phosphinates and Their Stereospecific Transformations into Optically Active P-Stereogenic Organophosphoryl Compounds	SYNLETT			English	Article						H-phosphinates; P-stereogenic organophosphorus compounds; stereoselectivity; transition metals; catalysis; asymmetric hydrogenation; nucleophilic substitutions	PALLADIUM-CATALYZED HYDROPHOSPHORYLATION; TERT-BUTYLPHENYLPHOSPHINE OXIDE; ASYMMETRIC HYDROGENATION; OXIDATIVE ADDITION; P(O)-H BONDS; PHOSPHINOSELENOIC CHLORIDES; ENANTIOSELECTIVE SYNTHESIS; NUCLEOPHILIC-SUBSTITUTION; STEREOSELECTIVE-SYNTHESIS; CHIRAL BISPHOSPHINE	In this account, we summarize our recent work on the preparation of optically active H-phosphinates and their stereospecific transformations, including regio- and stereospecific additions, nucleophilic substitutions with organolithiums and Grignard reagents, halogenation with copper(II) chloride, and dehydrogenative couplings with heteroatom-hydrogen bonds. These reactions provide efficient ways for the synthesis of valuable, optically active, P-stereogenic, organophosphorus compounds from relatively easily prepared, enantiomerically pure, menthyl hydrogen phosphinates. The applications of optically active H-phosphinates in catalytic asymmetric hydrogenations are also discussed. 1 Optically Pure Menthyl Hydrogen Phosphinates: Easily Accessible P-Stereogenic Starting Materials 2 Optically Pure Menthyl Hydrogen Phosphinates as Starting Materials for the Synthesis of P-Chiral Compounds 2.1 Stereospecific Additions 2.1.1 Additions to Alkynes 2.1.2 Addition to Alkenes 2.1.3 Addition to p-Quinones 2.1.4 Additions to Ketones or Aldehydes 2.2 Stereospecific Nucleophilic Substitution by Organolithiums or Grignard Reagents 2.3 Stereospecific Halogenation with Copper(II) Chloride 2.4 Stereospecific Cross-Dehydrogenative Coupling with Nucleophiles (Amines, Alcohols, Thiols, etc.) 2.5 Stereospecific Cross-Coupling with C-X Bonds 3 Asymmetric Catalytic Hydrogenation Reactions with Optically Pure Menthyl Hydrogen Phosphinates as Ligands 4 Conclusion	[Chen, Tieqiao; Han, Li-Biao] Hunan Univ, Coll Chem & Chem Engn, Changsha 410082, Hunan, Peoples R China; [Han, Li-Biao] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan	Han, LB (reprint author), Hunan Univ, Coll Chem & Chem Engn, Changsha 410082, Hunan, Peoples R China.	libiao-han@aist.go.jp			NFSC [21373080]; Fundamental Research Funds for the Central Universities (Hunan University); Canon Foundation	We thank Dr. Qing Xu, Wenzhou University, for help with the literature searches. Financial support from NFSC 21373080, the Fundamental Research Funds for the Central Universities (Hunan University), and the Canon Foundation are also acknowledged.	Wang XB, 2014, CHEM-EUR J, V20, P3631, DOI 10.1002/chem.201304675; Kolodiazhnyi OI, 2014, TETRAHEDRON-ASYMMETR, V25, P865, DOI 10.1016/j.tetasy.2014.05.010; Xie JH, 2011, CHEM REV, V111, P1713, DOI 10.1021/cr100218m; Xu Q, 2011, J ORGANOMET CHEM, V696, P130, DOI 10.1016/j.jorganchem.2010.08.043; Johansson MJ, 2004, MINI-REV ORG CHEM, V1, P233, DOI 10.2174/1570193043403235; Jiang XB, 2003, ORG LETT, V5, P1503, DOI 10.1021/ol034282u; Grabulosa A, 2007, COORDIN CHEM REV, V251, P25, DOI 10.1016/j.ccr.2006.05.009; Clive DLJ, 2001, J ORG CHEM, V66, P6083, DOI 10.1021/jo010371d; Han LB, 2002, J AM CHEM SOC, V124, P3842, DOI 10.1021/ja025816+; [Anonymous], PHOSPH COMP HAV CHIR; Zhang XH, 2011, ORG LETT, V13, P3478, DOI 10.1021/ol201141m; Xu Q, 2008, J AM CHEM SOC, V130, P12648, DOI 10.1021/ja804412k; Zhou YB, 2010, J ORG CHEM, V75, P7924, DOI 10.1021/jo101540d; Waterman R, 2013, CHEM SOC REV, V42, P5629, DOI 10.1039/c3cs60082c; FARNHAM WB, 1970, J AM CHEM SOC, V92, P5809, DOI 10.1021/ja00722a083; Gatineau D, 2011, J AM CHEM SOC, V133, P10728, DOI 10.1021/ja2034816; Jiang XB, 2004, TETRAHEDRON-ASYMMETR, V15, P2223, DOI 10.1016/j.tetasy.2004.05.002; Yeung CS, 2011, CHEM REV, V111, P1215, DOI 10.1021/cr100280d; Han ZXS, 2013, J AM CHEM SOC, V135, P2474, DOI 10.1021/ja312352p; Schroder F, 2014, ORGANOMETALLICS, V33, P4051, DOI 10.1021/om500568q; Cano I, 2014, J AM CHEM SOC, V136, P2520, DOI 10.1021/ja411202h; Demmer CS, 2011, CHEM REV, V111, P7981, DOI 10.1021/cr2002646; Shaikh TM, 2012, COORDIN CHEM REV, V256, P771, DOI 10.1016/j.ccr.2011.11.007; Liu C, 2011, CHEM REV, V111, P1780, DOI 10.1021/cr100379j; KNOWLES WS, 1975, J AM CHEM SOC, V97, P2567, DOI 10.1021/ja00842a058; Fernandez-Perez H, 2011, CHEM REV, V111, P2119, DOI 10.1021/cr100244e; Wang G, 2010, J ORG CHEM, V75, P3890, DOI 10.1021/jo100473s; Nemoto T, 2011, TETRAHEDRON, V67, P667, DOI 10.1016/j.tet.2010.11.069; Leyris A, 2005, TETRAHEDRON LETT, V46, P8677, DOI 10.1016/j.tetlet.2005.10.058; Han LB, 1996, J AM CHEM SOC, V118, P1571, DOI 10.1021/ja953690t; Berger O, 2014, CHEM-EUR J, V20, P12385, DOI 10.1002/chem.201404507; VINEYARD BD, 1977, J AM CHEM SOC, V99, P5946, DOI 10.1021/ja00460a018; Knowles WS, 2003, ADV SYNTH CATAL, V345, P3, DOI 10.1002/adsc.200390028; Fisher HC, 2014, ADV SYNTH CATAL, V356, P1199, DOI 10.1002/adsc.201301157; Crepy KVL, 2003, TOP CURR CHEM, V229, P1, DOI 10.1007/b11148; Han LB, 2005, J ORG CHEM, V70, P10121, DOI 10.1021/jo051582b; Hirai T, 2007, ORG LETT, V9, P53, DOI 10.1021/ol062505l; Au-Yeung TL, 2001, TETRAHEDRON LETT, V42, P453, DOI 10.1016/S0040-4039(00)01950-X; Benschop H. P., 1970, J CHEM SOC D, V1431; Benschop H. P., 1970, CHEM COMMUN, P33; Berger O, 2013, ANGEW CHEM INT EDIT, V52, P11377, DOI 10.1002/anie.201306628; BODALSKI R, 1989, PHOSPHORUS SULFUR, V44, P99, DOI 10.1080/10426508908043711; Chen TQ, 2013, CHEM LETT, V42, P1065, DOI 10.1246/cl.130374; Dai WM, 2003, TETRAHEDRON-ASYMMETR, V14, P2821, DOI 10.1016/j.tetasy.2003.07.008; Drabowicz J, 1999, TETRAHEDRON-ASYMMETR, V10, P2757, DOI 10.1016/S0957-4166(99)00264-5; Drabowicz J, 2002, HETEROATOM CHEM, V13, P437, DOI 10.1002/hc.10077; Dubrovina NV, 2004, ANGEW CHEM INT EDIT, V43, P5883, DOI 10.1002/anie.200460848; EMMICK TL, 1968, J AM CHEM SOC, V90, P3459, DOI 10.1021/ja01015a030; Fild M., 1972, ORGANO PHOSPHOROUS C, V4; Han LB, 1999, CHEM COMMUN, P395, DOI 10.1039/a806537c; Han LB, 2000, J AM CHEM SOC, V122, P5407, DOI 10.1021/ja000444v; Han L.-B., 2006, [No title captured], Patent No. 4649590; Han L.-B., 2002, [No title captured], Patent No. 3777397; Han LB, 1996, ORGANOMETALLICS, V15, P3259, DOI 10.1021/om960328u; Han L.-B., 2008, [No title captured], Patent No. 4963049; HAYNES RK, 1994, J ORG CHEM, V59, P2919, DOI 10.1021/jo00090a003; Imamoto T, 1992, HDB ORGANOPHOSPHORUS; Kagan H. B., 1990, CHEM ORGANOPHOSPHORU, V1, P51; Kimura T, 2005, CHEM COMMUN, P4077, DOI 10.1039/b507755a; KNOWLES WS, 1968, CHEM COMMUN, P1445, DOI 10.1039/c19680001445; KNOWLES WS, 1972, J CHEM SOC CHEM COMM, P10, DOI 10.1039/c39720000010; Knowles WS, 2002, ANGEW CHEM INT EDIT, V41, P1998, DOI 10.1002/1521-3773(20020617)41:12<1998::AID-ANIE1998>3.0.CO;2-8; KNOWLES WS, 1983, ACCOUNTS CHEM RES, V16, P106, DOI 10.1021/ar00087a006; KRAWIECKA B, 1991, J CHEM SOC PERK T 1, P229, DOI 10.1039/p19910000229; Leung PH, 2004, ACCOUNTS CHEM RES, V37, P169, DOI 10.1021/ar030008o; Leyris A, 2007, TETRAHEDRON LETT, V48, P5247, DOI 10.1016/j.tetlet.2007.05.140; Li GY, 2001, ANGEW CHEM INT EDIT, V40, P1513, DOI 10.1002/1521-3773(20010417)40:8<1513::AID-ANIE1513>3.0.CO;2-C; Li YC, 2004, J AM CHEM SOC, V126, P8888, DOI 10.1021/ja048457m; MEPPELDE.FH, 1970, J CHEM SOC CHEM COMM, P431, DOI 10.1039/c29700000431; MICHALSKI J, 1977, J CHEM SOC CHEM COMM, P66, DOI 10.1039/c39770000066; Moraleda D, 2008, CHEM COMMUN, P3031, DOI 10.1039/b802817f; Moriyama M., 1984, YUKI GOSEI KAGAKU KY, V42, P355; Murai T, 2006, CURR ORG CHEM, V10, P1963, DOI 10.2174/138527206778521231; Nemoto T, 2008, CHEM PHARM BULL, V56, P1213, DOI 10.1248/cpb.56.1213; Oliana M, 2006, J ORG CHEM, V71, P2472, DOI 10.1021/jo052575q; Perlikowska W, 2001, TETRAHEDRON LETT, V42, P7841, DOI 10.1016/S0040-4039(01)01694-X; PIETRUSIEWICZ KM, 1994, CHEM REV, V94, P1375, DOI 10.1021/cr00029a009; Wang F, 2000, J ORG CHEM, V65, P7561, DOI 10.1021/jo000923c; Quin L. D., 2000, GUIDE ORGANOPHOSPHOR; Sasaki M., 1998, CHIRALITY AGROCHEMIC, P85; Sun YM, 2014, ORG BIOMOL CHEM, V12, P9457, DOI 10.1039/c4ob01574f; Tang WJ, 2003, CHEM REV, V103, P3029, DOI 10.1021/cr020049i; Xiong BQ, 2014, ADV SYNTH CATAL, V356, P781, DOI 10.1002/adsc.201300913; Xiong BQ, 2012, CHEM-EUR J, V18, P16902, DOI 10.1002/chem.201202074; Xiong BQ, 2013, TETRAHEDRON, V69, P9373, DOI 10.1016/j.tet.2013.09.001; XU Q, 2012, CHINESE J ORG CHEM, V32, P1761; XU YY, 1986, J CHEM SOC CHEM COMM, P1606, DOI 10.1039/c39860001606; XU YY, 1989, TETRAHEDRON LETT, V30, P949, DOI 10.1016/S0040-4039(00)95287-0; Yamamoto H., 2014, SYNFACTS, V10, P621; Zhang H, 2014, CHEM-ASIAN J, V9, P1329, DOI 10.1002/asia.201301650; ZHANG J, 1988, TETRAHEDRON LETT, V29, P1955, DOI 10.1016/S0040-4039(00)82088-2; Zhao CQ, 2001, ANGEW CHEM INT EDIT, V40, P1929, DOI 10.1002/1521-3773(20010518)40:10<1929::AID-ANIE1929>3.3.CO;2-D; Zhou YB, 2014, B CHEM SOC JPN, V87, P400, DOI 10.1246/bcsj.20130310	93	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JUN	2015	26	9					1153	1163	st-2014-a0958-a	10.1055/s-0034-1379996		11	Chemistry, Organic	Chemistry	CI4YF	WOS:000354759100003		
J	Matsuda, T; Yasuoka, S; Watanuki, S; Fukuhara, K				Matsuda, Takanori; Yasuoka, Satoshi; Watanuki, Shoichi; Fukuhara, Keisuke			Rhodium-Catalyzed Addition-Spirocyclization of Arylboronic Esters Containing -Aryl ,-Unsaturated Ester Moiety	SYNLETT			English	Article						addition; boron; cyclization; rhodium; spiro compounds	C-H ACTIVATION; ASYMMETRIC-SYNTHESIS; RH(I)-CATALYZED CYCLIZATION; ENANTIOSELECTIVE SYNTHESIS; 1,4-RHODIUM MIGRATION; STRAINED ALKENES; BOND ACTIVATION; AQUEOUS-MEDIA; REAGENTS; ACIDS	In this study, we developed a rhodium(I)-catalyzed spirocyclization. The reaction includes 1,4-rhodium migration and provides a route for forming spirocyclic 1-indanones.	[Matsuda, Takanori; Yasuoka, Satoshi; Watanuki, Shoichi; Fukuhara, Keisuke] Tokyo Univ Sci, Dept Appl Chem, Shinjuku Ku, Tokyo 1628601, Japan	Matsuda, T (reprint author), Tokyo Univ Sci, Dept Appl Chem, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	mtd@rs.tus.ac.jp	Matsuda, Takanori/A-9118-2010	Matsuda, Takanori/0000-0002-9927-3599	JSPS, Japan [25410054]; Sumitomo Foundation	This work was supported by JSPS, Japan (Grant-in-Aid for Scientific Research (C) No. 25410054) and the Sumitomo Foundation.	Tseng NW, 2009, J ORG CHEM, V74, P1809, DOI 10.1021/jo802622d; Lautens M, 2004, J ORG CHEM, V69, P3478, DOI 10.1021/jo049874k; Hayashi T, 2001, J AM CHEM SOC, V123, P9918, DOI 10.1021/ja0165234; Tian P, 2012, ACS CATAL, V2, P95, DOI 10.1021/cs200562n; Low DW, 2012, ORG LETT, V14, P2548, DOI 10.1021/ol300845q; Sasaki K, 2012, TETRAHEDRON-ASYMMETR, V23, P373, DOI 10.1016/j.tetasy.2012.03.004; Matsuda T, 2006, ORG LETT, V8, P3379, DOI 10.1021/ol061359g; Ma SM, 2005, ANGEW CHEM INT EDIT, V44, P7512, DOI 10.1002/anie.200501298; Zhang J, 2013, J AM CHEM SOC, V135, P17270, DOI 10.1021/ja409049t; Hayashi T, 2003, CHEM REV, V103, P2829, DOI 10.1021/cr020022z; Shintani R, 2005, J AM CHEM SOC, V127, P2872, DOI 10.1021/ja042582g; Shi F, 2010, TOP CURR CHEM, V292, P123, DOI 10.1007/128_2008_46; Sasaki K, 2012, CHEM SCI, V3, P1278, DOI 10.1039/c2sc01093c; Edwards HJ, 2010, CHEM SOC REV, V39, P2093, DOI 10.1039/b919762c; Shintani R, 2011, ORG LETT, V13, P350, DOI 10.1021/ol102674z; Matsuda T, 2012, CHEM COMMUN, V48, P2988, DOI 10.1039/c2cc18098g; Shintani R, 2007, ANGEW CHEM INT EDIT, V46, P3735, DOI 10.1002/anie.200700226; Miura T, 2006, CHEM-ASIAN J, V1, P868, DOI 10.1002/asia.200600254; Yamabe H, 2005, J AM CHEM SOC, V127, P3248, DOI 10.1021/ja042581o; Shintani R, 2008, ANGEW CHEM INT EDIT, V47, P1447, DOI 10.1002/anie.200704818; Miura T, 2005, J AM CHEM SOC, V127, P1390, DOI 10.1021/ja043123i; Shintani R, 2005, ORG LETT, V7, P2071, DOI 10.1021/ol0506819; Ishida N, 2013, J AM CHEM SOC, V135, P19103, DOI 10.1021/ja410910s; Shintani R, 2005, ANGEW CHEM INT EDIT, V44, P3909, DOI 10.1002/anie.200500843; Lennox AJJ, 2014, CHEM SOC REV, V43, P412, DOI 10.1039/c3cs60197h; Oguma K, 2000, J AM CHEM SOC, V122, P10464, DOI 10.1021/ja002601w; Seiser T, 2010, CHEM-EUR J, V16, P3383, DOI 10.1002/chem.200903225; Shintani R, 2010, ANGEW CHEM INT EDIT, V49, P3795, DOI 10.1002/anie.201000937; Zhang N, 2012, J ORG CHEM, V77, P5956, DOI 10.1021/jo300547v; Matsuda T, 2007, J AM CHEM SOC, V129, P12086, DOI 10.1021/ja075141g; Seiser T, 2009, ANGEW CHEM INT EDIT, V48, P6320, DOI 10.1002/anie.200903189; Shigeno M, 2009, CHEM-EUR J, V15, P12929, DOI 10.1002/chem.200902593; Gallego GM, 2012, CHEM SCI, V3, P1338, DOI 10.1039/c2sc01068b; Gourdet B, 2010, ORG LETT, V12, P2554, DOI 10.1021/ol100769p; Ishida N, 2013, CHEM LETT, V42, P1076, DOI 10.1246/cl.130463; Lautens M, 2002, ORG LETT, V4, P2105, DOI 10.1021/ol0260627; Matsuda T, 2015, ORG BIOMOL CHEM, V13, P702, DOI 10.1039/c4ob02210f; Matsuda T, 2005, CHEM LETT, V34, P1416, DOI 10.1246/cl.2005.1416; Miura T, 2005, ORG LETT, V7, P3339, DOI 10.1021/ol051249u; Miura T, 2007, CHEM COMMUN, P217, DOI 10.1039/b609991b; Prakash P, 2013, RSC ADV, V3, P19933, DOI 10.1039/c3ra43191f; Seiser T, 2010, SYNLETT, P1699, DOI 10.1055/s-0029-1219959; Shimizu H, 2010, B KOREAN CHEM SOC, V31, P1461, DOI 10.5012/bkcs.2010.31.6.1461; Shintani R, 2005, CHEM LETT, V34, P1294, DOI 10.1246/cl.2005.1294; Shintani R, 2014, J AM CHEM SOC, V136, P7849, DOI 10.1021/ja5032002; Tobisu M, 2012, CHEM COMMUN, V48, P11437, DOI 10.1039/c2cc36601k; Youn SW, 2009, EUR J ORG CHEM, P2597, DOI 10.1002/ejoc.200900001; Yu YN, 2013, J ORG CHEM, V78, P2736, DOI 10.1021/jo302656s	48	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JUN	2015	26	9					1233	1237	st-2015-u0033-l	10.1055/s-0034-1378691		5	Chemistry, Organic	Chemistry	CI4YF	WOS:000354759100018		
J	Shimizu, K; Uetsu, H; Gotanda, T; Ito, K				Shimizu, Keisuke; Uetsu, Hidenori; Gotanda, Takashi; Ito, Katsuji			Zn(salen)-Catalyzed Enantioselective Phenyl Transfer to Aldehydes and Ketones with Organozinc Reagent	SYNLETT			English	Article						Zn(salen) complex; asymmetric catalysis; phenyl transfer; aldehydes; ketones; diarylmethanol	ASYMMETRIC ARYL TRANSFER; ACID-BASE CATALYSTS; CARBONYL-COMPOUNDS; TERTIARY ALCOHOLS; TITANIUM(IV) CATALYST; SECONDARY ALCOHOLS; AROMATIC-ALDEHYDES; ARYLBORONIC ACIDS; RECENT PROGRESS; AMINO-ALCOHOLS	A chiral zinc complex of salen was found to be an efficient catalyst for the phenyl transfer of organozinc reagent to aromatic aldehydes and ketones. High enantioselectivities were obtained in reactions of both aromatic aldehydes and ketones (up to 97% and 92% ee, respectively).	[Shimizu, Keisuke; Uetsu, Hidenori; Gotanda, Takashi; Ito, Katsuji] Fukuoka Univ Educ, Dept Chem, Fukuoka 8114192, Japan	Ito, K (reprint author), Fukuoka Univ Educ, Dept Chem, Fukuoka 8114192, Japan.	itokat@fukuoka-edu.ac.jp			JSPS KAKENHI [24650532]; Cooperative Research Program of the "Network Joint Research Center for Materials and Devices (IMCE, Kyushu University)'	This work was partially supported by JSPS KAKENHI Grant Number 24650532 and by the Cooperative Research Program of the "Network Joint Research Center for Materials and Devices (IMCE, Kyushu University)'.	Alesi S, 2011, MOLECULES, V16, P5298, DOI 10.3390/molecules16065298; Dosa PI, 1998, J AM CHEM SOC, V120, P445, DOI 10.1021/ja973169u; Binder CM, 2011, ORG PREP PROCED INT, V43, P139, DOI 10.1080/00304948.2011.564538; Garcia C, 2003, ORG LETT, V5, P3641, DOI 10.1021/ol0352963; Hatano M, 2011, TETRAHEDRON, V67, P4417, DOI 10.1016/j.tet.2011.02.042; Bagutski V, 2010, ANGEW CHEM INT EDIT, V49, P5142, DOI 10.1002/anie.201001371; Wu PY, 2006, J ORG CHEM, V71, P833, DOI 10.1021/jo052017b; Hatano M, 2011, CATAL SCI TECHNOL, V1, P1149, DOI 10.1039/c1cy00108f; Hatano M, 2007, ORG LETT, V9, P4535, DOI 10.1021/o1702074a; Wang MC, 2008, J ORG CHEM, V73, P168, DOI 10.1021/jo701943x; DiMauro EF, 2001, ORG LETT, V3, P3053, DOI 10.1021/ol016535u; Song XX, 2014, J ORG CHEM, V79, P6087, DOI 10.1021/jo500796w; Kotani S, 2014, J ORG CHEM, V79, P4817, DOI 10.1021/jo5005394; Hatano M, 2008, CHEM REC, V8, P143, DOI 10.1002/tcr.20146; Prieto O, 2003, TETRAHEDRON-ASYMMETR, V14, P1955, DOI 10.1016/S0957-4166(03)00324-0; Chen CA, 2007, ANGEW CHEM INT EDIT, V46, P5373, DOI 10.1002/anie.200701201; Ahern T, 2006, J ORG CHEM, V71, P7596, DOI 10.1021/jo060894r; Zhong JC, 2007, TETRAHEDRON-ASYMMETR, V18, P734, DOI 10.1016/j.tetasy.2007.03.006; Pu L, 2001, CHEM REV, V101, P757, DOI 10.1021/cr000411y; Lu G, 2006, CHEM-EUR J, V12, P4115, DOI 10.1002/chem.200501048; Schmidt F, 2006, CHEM SOC REV, V35, P454, DOI 10.1039/b600091f; Chen CA, 2008, ADV SYNTH CATAL, V350, P1626, DOI 10.1002/adsc.200800169; Paixao MW, 2007, J MOL CATAL A-CHEM, V261, P120, DOI 10.1016/j.molcata.2006.07.076; Li K, 2013, J ORG CHEM, V78, P6350, DOI 10.1021/jo400850m; Godoi M, 2010, TETRAHEDRON, V66, P1341, DOI 10.1016/j.tet.2009.12.009; Qin YC, 2006, ANGEW CHEM INT EDIT, V45, P273, DOI 10.1002/anie.200503206; STANCHEV S, 1995, TETRAHEDRON-ASYMMETR, V6, P183, DOI 10.1016/0957-4166(94)00374-K; Rudolph J, 2005, J AM CHEM SOC, V127, P1548, DOI 10.1021/ja046254S; MEGURO K, 1985, CHEM PHARM BULL, V33, P3787; Bolm C, 2000, ANGEW CHEM INT EDIT, V39, P3465, DOI 10.1002/1521-3773(20001002)39:19<3465::AID-ANIE3465>3.0.CO;2-4; Chai Z, 2006, TETRAHEDRON-ASYMMETR, V17, P2442, DOI 10.1016/j.tetasy.2006.09.004; Salvi L, 2009, J AM CHEM SOC, V131, P12483, DOI 10.1021/ja9046747; DiMauro EF, 2002, J AM CHEM SOC, V124, P12668, DOI 10.1021/ja026498h; Bolm C, 2002, J AM CHEM SOC, V124, P14850, DOI 10.1021/ja028518l; Betancort JM, 2004, SYNLETT, P749, DOI 10.1055/s-2004-817779; Bolm C., 2001, ANGEW CHEM INT EDIT, V40, P3284, DOI 10.1002/1521-3773(20010917)40:18<3284::AID-ANIE3284>3.0.CO;2-U; Bolm C, 2001, ANGEW CHEM INT EDIT, V40, P1488, DOI 10.1002/1521-3773(20010417)40:8<1488::AID-ANIE1488>3.0.CO;2-B; Botta M, 1996, TETRAHEDRON-ASYMMETR, V7, P1263, DOI 10.1016/0957-4166(96)00138-3; Braga AL, 2006, TETRAHEDRON-ASYMMETR, V17, P2793, DOI 10.1016/j.tetasy.2006.10.025; Cozzi PG, 2003, ANGEW CHEM INT EDIT, V42, P2895, DOI 10.1002/anie.200351230; Cozzi PG, 1996, TETRAHEDRON LETT, V37, P4613, DOI 10.1016/0040-4039(96)00890-8; Forrat VJ, 2009, TETRAHEDRON-ASYMMETR, V20, P65, DOI 10.1016/j.tetasy.2009.01.011; Forrat VJ, 2006, CHEM-EUR J, V12, P6727, DOI 10.1002/chem.200690084; Forrat VJ, 2008, TETRAHEDRON-ASYMMETR, V19, P537, DOI 10.1016/j.tetasy.2008.02.002; Forrat VJ, 2006, CHEM-EUR J, V12, P4431, DOI 10.1002/chem.200501397; Glynn D, 2010, CHEM-EUR J, V16, P1053, DOI 10.1002/chem.200901803; HARMS AF, 1960, J MED PHARMACEUT CH, V2, P57, DOI 10.1021/jm50008a005; Hatano M, 2008, SYNTHESIS-STUTTGART, P1647, DOI 10.1055/s-2008-1067046; Hatano M, 2007, CURR ORG CHEM, V11, P127, DOI 10.2174/138527207779316453; Hatano M, 2006, J ORG CHEM, V71, P6474, DOI 10.1021/jo060908t; Huang X., 2008, TETRAHEDRON LETT, V46, P6823; Ito K, 2005, TETRAHEDRON LETT, V46, P6083, DOI 10.1016/j.tetlet.2005.06.161; Jia XF, 2011, MOLECULES, V16, P2971, DOI 10.3390/molecules16042971; Jin MJ, 2008, ORG LETT, V10, P1235, DOI 10.1021/ol8001249; Li HM, 2004, P NATL ACAD SCI USA, V101, P5425, DOI 10.1073/pnas.0307119101; Paixao MW, 2008, J BRAZIL CHEM SOC, V19, P813, DOI 10.1590/S0103-50532008000500003; Pathak K, 2007, CHIRALITY, V19, P82, DOI 10.1002/chir.20337; Rodriguez-Escrich S, 2008, J ORG CHEM, V73, P5340, DOI 10.1021/jo800615d; Rudolph J, 2004, J ORG CHEM, V69, P3997, DOI 10.1021/jo045079; Saito B, 2004, SYNLETT, P1557, DOI 10.1055/s-2004-829057; Schmidt F, 2007, ADV SYNTH CATAL, V349, P703, DOI 10.1002/adsc.200600390; Sedelmeier J, 2007, J ORG CHEM, V72, P8859, DOI 10.1021/jo7016718; Stymiest JL, 2008, NATURE, V456, P778, DOI 10.1038/nature07592; Sui YZ, 2012, CHEM-EUR J, V18, P7486, DOI 10.1002/chem.201200379; TODA F, 1991, TETRAHEDRON-ASYMMETR, V2, P873, DOI 10.1016/S0957-4166(00)82198-9; Tomita D, 2005, J AM CHEM SOC, V127, P4138, DOI 10.1021/ja0507362; Wang MC, 2006, SYNLETT, P3443, DOI 10.1055/s-2006-956474; Wang MC, 2008, TETRAHEDRON, V64, P2559, DOI 10.1016/j.tet.2008.01.040; Yang XF, 2009, TETRAHEDRON-ASYMMETR, V20, P415, DOI 10.1016/j.tetasy.2009.01.025; Yang YX, 2014, J ORG CHEM, V79, P10696, DOI 10.1021/jo502070r; Zou S., 2009, J ORG CHEM, V74, P3500	71	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JUN	2015	26	9					1238	1242	st-2015-u0055-l	10.1055/s-0034-1380461		5	Chemistry, Organic	Chemistry	CI4YF	WOS:000354759100019		
J	Nakashima, K; Kawada, M; Hirashima, S; Kato, M; Koseki, Y; Miura, T				Nakashima, Kosuke; Kawada, Masahiro; Hirashima, Shin-ichi; Kato, Mana; Koseki, Yuji; Miura, Tsuyoshi			Asymmetric Conjugate Addition of Ketones to Maleimides Using Diaminomethyleneindenedione Organocatalyst	SYNLETT			English	Article						organocatalyst; maleimide; conjugate addition; asymmetric reaction; ketone	ENANTIOSELECTIVE MICHAEL ADDITION; CHIRAL PRIMARY AMINE; ALPHA-SUBSTITUTED CYANOACETATES; PYRROLIDINE-DIAMINOMETHYLENEMALONONITRILE ORGANOCATALYST; ALPHA,ALPHA-DISUBSTITUTED ALDEHYDES; 1,3-DICARBONYL COMPOUNDS; THIOUREA ORGANOCATALYST; BICYCLIC GUANIDINE; ALDOL REACTIONS; CATALYST	A novel diaminomethyleneindenedione (DMI) organocatalyst efficiently promotes the asymmetric conjugate addition of a ketone to a maleimide to afford the corresponding addition product in a high yield with up to 99% enantiomeric excess.	[Nakashima, Kosuke; Kawada, Masahiro; Hirashima, Shin-ichi; Kato, Mana; Koseki, Yuji; Miura, Tsuyoshi] Tokyo Univ Pharm & Life Sci, Hachioji, Tokyo 1920392, Japan	Miura, T (reprint author), Tokyo Univ Pharm & Life Sci, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	tmiura@toyaku.ac.jp					Aboul-Enein MN, 2012, MINI-REV MED CHEM, V12, P671; Alba ANR, 2010, CHEM-EUR J, V16, P9884, DOI 10.1002/chem.201000239; Kokotos CG, 2013, ORG LETT, V15, P2406, DOI 10.1021/ol4008662; Tsakos M, 2013, TETRAHEDRON, V69, P10199, DOI 10.1016/j.tet.2013.09.080; Shirakawa S, 2011, CHEM COMMUN, V47, P10557, DOI 10.1039/c1cc14043d; Yu F, 2010, ORG BIOMOL CHEM, V8, P4767, DOI 10.1039/c0ob00154f; Gomez-Torres E, 2011, ORG LETT, V13, P6106, DOI 10.1021/ol202599h; Uddin J, 2006, BIOORGAN MED CHEM, V14, P6954, DOI 10.1016/j.bmc.2006.06.043; Takemoto Y, 2010, CHEM PHARM BULL, V58, P593; Hirashima S, 2014, TETRAHEDRON LETT, V55, P4619, DOI 10.1016/j.tetlet.2014.06.037; Isaka M, 2005, TETRAHEDRON, V61, P5577, DOI 10.1016/j.tet.2005.03.099; Zhao MX, 2013, TETRAHEDRON, V69, P10763, DOI 10.1016/j.tet.2013.09.084; Miyabe H, 2008, B CHEM SOC JPN, V81, P785, DOI 10.1246/bcsj.81.785; Aleman J, 2011, CHEM-EUR J, V17, P6890, DOI 10.1002/chem.201003694; Jiang ZY, 2009, ANGEW CHEM INT EDIT, V48, P3627, DOI 10.1002/anie.200900964; Ando Y, 2002, CLIN CANCER RES, V8, P1964; Muramulla S, 2013, ADV SYNTH CATAL, V355, P1260, DOI 10.1002/adsc.201300041; Lu J, 2008, ADV SYNTH CATAL, V350, P1796, DOI 10.1002/adsc.200800259; Zu LS, 2007, ADV SYNTH CATAL, V349, P1882, DOI 10.1002/adsc.200700158; Shen J, 2006, J AM CHEM SOC, V128, P13692, DOI 10.1021/ja064636n; Chauhan P, 2013, CHEM-ASIAN J, V8, P328, DOI 10.1002/asia.201200684; Liao YH, 2010, ORG LETT, V12, P2896, DOI 10.1021/ol100822k; Serdyuk OV, 2013, ORG BIOMOL CHEM, V11, P7051, DOI 10.1039/c3ob41403e; Nugent TC, 2012, CHEM-EUR J, V18, P4088, DOI 10.1002/chem.201103005; Freiberg C, 2004, J BIOL CHEM, V279, P26066, DOI 10.1074/jbc.M402989200; Yang W, 2013, CHEM-ASIAN J, V8, P1182, DOI 10.1002/asia.201300141; FREDENHAGEN A, 1987, J AM CHEM SOC, V109, P4409, DOI 10.1021/ja00248a055; Avila A, 2013, EUR J ORG CHEM, V2013, P5085, DOI 10.1002/ejoc.201300492; Avila A, 2012, TETRAHEDRON-ASYMMETR, V23, P1625, DOI 10.1016/j.tetasy.2012.11.002; Avila A, 2013, TETRAHEDRON-ASYMMETR, V24, P1531, DOI 10.1016/j.tetasy.2013.10.001; Bai JF, 2010, TETRAHEDRON, V66, P8928, DOI 10.1016/j.tet2010.09.044; Bartoli G, 2006, ANGEW CHEM INT EDIT, V45, P4966, DOI 10.1002/amie.200600370; Bhadury PS, 2012, SYNLETT, P1108, DOI 10.1055/s-0031-1290193; Connon SJ, 2008, CHEM COMMUN, P2499, DOI 10.1039/b719249e; Connon SJ, 2009, SYNLETT, P354, DOI 10.1055/s-0028-1087557; Durmaz M, 2013, TETRAHEDRON-ASYMMETR, V24, P1443, DOI 10.1016/j.tetasy.2013.09.010; Flores-Ferrandiz J, 2014, TETRAHEDRON-ASYMMETR, V25, P1091, DOI 10.1016/j.tetasy.2014.06.014; Gomez-Torres E, 2013, EUR J ORG CHEM, P1434, DOI 10.1002/ejoc.201201046; Hirashima S, 2014, TETRAHEDRON LETT, V55, P4334, DOI 10.1016/j.tetlet.2014.05.100; Jiang ZY, 2008, ADV SYNTH CATAL, V350, P2345, DOI 10.1002/adsc.200800423; Kanada Y, 2013, TETRAHEDRON LETT, V54, P4896, DOI 10.1016/j.tetlet.2013.06.141; Liao YH, 2011, ADV SYNTH CATAL, V353, P1720, DOI 10.1002/adsc.201100086; Ma ZW, 2011, EUR J ORG CHEM, P6747, DOI 10.1002/ejoc.201101086; Ma ZW, 2011, TETRAHEDRON-ASYMMETR, V22, P1740, DOI 10.1016/j.tetasy.2011.10.002; Ma ZW, 2013, TETRAHEDRON-ASYMMETR, V24, P7, DOI 10.1016/j.tetasy.2012.11.009; MALOCHETGRIVOIS C, 1992, ANTI-CANCER DRUG DES, V7, P493; Mashraqui SH, 1999, J CHEM RES, P492, DOI 10.1039/a901038f; Miura T, 2011, TETRAHEDRON LETT, V52, P4158, DOI 10.1016/j.tetlet.2011.05.145; Miura T, 2011, TETRAHEDRON-ASYMMETR, V22, P1605, DOI 10.1016/j.tetasy.2011.09.006; Zea A, 2010, ADV SYNTH CATAL, V352, P1102, DOI 10.1002/adsc.201000031; Nakashima K, 2015, TETRAHEDRON LETT, V56, P558, DOI 10.1016/j.tetlet.2014.11.117; Nakashima K, 2014, TETRAHEDRON LETT, V55, P2703, DOI 10.1016/j.tetlet.2014.03.042; Orlandi S, 2013, NEW J CHEM, V37, P4140, DOI 10.1039/c3nj00807j; Qiao YP, 2013, GREEN CHEM, V15, P2690, DOI 10.1039/c3gc41024b; Song ZT, 2014, CHIRALITY, V26, P121, DOI 10.1002/chir.22279; Wang JA, 2011, SYNLETT, P473, DOI 10.1055/s-0030-1259517; Wang JJ, 2011, TETRAHEDRON-ASYMMETR, V22, P690, DOI 10.1016/j.tetasy.2011.04.009; Xue F, 2010, CHEM-EUR J, V16, P7979, DOI 10.1002/chem.201001207; Ye WP, 2007, ADV SYNTH CATAL, V349, P2454, DOI 10.1002/adsc.200700326; Yu F, 2010, CHEM COMMUN, V46, P4589, DOI 10.1039/c0cc00774a; Zhao GL, 2007, CHEM COMMUN, P734, DOI 10.1039/b614926f	61	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JUN	2015	26	9					1248	1252	st-2015-u0069-l	10.1055/s-0034-1380382		5	Chemistry, Organic	Chemistry	CI4YF	WOS:000354759100021		
J	Matsubara, H; Niwa, Y; Matake, R				Matsubara, Hiroshi; Niwa, Yuki; Matake, Ryosuke			A Grignard-Type Phase-Vanishing Method: Generation of Organomagnesium Reagent and Its Subsequent Addition to Carbonyl Compounds	SYNLETT			English	Article						fluorous solvent; phase-vanishing; Grignard reaction; Barbier reaction; magnesium; perfluoropolyether	BROMINATION REACTIONS; SCREEN; ALKENES; TRIBROMIDE	A quadraphasic phase-vanishing system comprised of diethyl ether, magnesium, perfluoropolyether, and iodoalkane efficiently generated the corresponding Grignard reagents, which subsequently added to carbonyl compounds in the ether layer to afford alkylated alcohols in good yields.	[Matsubara, Hiroshi; Niwa, Yuki; Matake, Ryosuke] Osaka Prefecture Univ, Grad Sch Sci, Dept Chem, Sakai, Osaka 5998531, Japan	Matsubara, H (reprint author), Osaka Prefecture Univ, Grad Sch Sci, Dept Chem, Sakai, Osaka 5998531, Japan.	matsu@c.s.osakafu-u.ac.jp			Japan Society for the Promotion of Science (JSPS)	We thank the Japan Society for the Promotion of Science (JSPS) for financial support of this work. We also thank Prof. Ilhyong Ryu for helpful discussions.	Nakamura H, 2003, ORG LETT, V5, P1167, DOI 10.1021/ol034060w; Jana NK, 2003, ORG LETT, V5, P3787, DOI 10.1021/ol35391b; Ryu I, 2002, J AM CHEM SOC, V124, P12946, DOI 10.1021/ja027965y; Blagoev B., 1970, SYNTHESIS-STUTTGART, P615; Curran DP, 2004, ORG LETT, V6, P1021, DOI 10.1021/ol0499248; DRAGOVICH PS, 1995, J ORG CHEM, V60, P4922, DOI 10.1021/jo00120a042; Eicher T., 1966, CHEMISTRY CARBONYL G, DOI 10.1002/9780470771051.ch13; Fieser L. F., 1967, REAGENTS ORGANIC SYN, V1, P415; Gladysz J.A., 2004, HDB FLUOROUS CHEM; Iskra J, 2003, CHEM COMMUN, P2496, DOI 10.1039/b305629e; Iskra J, 2006, LETT ORG CHEM, V3, P170, DOI 10.2174/157017806775789976; Kurti L., 2005, STRATEGIC APPL NAMED, P38; Kurti L., 2005, STRATEGIC APPL NAMED, P188; Ma KF, 2008, ORG LETT, V10, P4155, DOI [10.1021/ol801327n, 10.1021/o1801327n]; Matsubara H, 2008, J FLUORINE CHEM, V129, P951, DOI 10.1016/j.jfluchem.2008.06.004; Matsubara H, 2003, SYNLETT, P247; Matsubara H, 2010, SYNLETT, P2014, DOI 10.1055/s-0030-1258482; Pels K, 2009, BEILSTEIN J ORG CHEM, V5, DOI 10.3762/bjoc.5.75; Podgorsek A, 2006, EUR J ORG CHEM, P483, DOI 10.1002/ejoc.200500355; Rahman MT, 2005, SYNLETT, P2664, DOI 10.1055/s-2005-917103; Raston C. L., 1987, CHEM METAL CARBON BO, V4, P159; Ryu I, 2008, CHEM REC, V8, P351, DOI 10.1002/tcr.20161; Tojino M, 2013, TETRAHEDRON LETT, V54, P7124; Van Zee NJ, 2009, ORG LETT, V11, P3190, DOI 10.1021/ol901450h; Van Zee NJ, 2010, CHEM-EUR J, V16, P7950, DOI 10.1002/chem.201000269; Wakefield B. J., 1996, ORGANOMAGNESIUM METH, P21; Windmon N, 2008, BEILSTEIN J ORG CHEM, V4, DOI 10.3762/bjoc.4.29; Windmon N, 2008, TETRAHEDRON LETT, V49, P6543, DOI 10.1016/j.tetlet.2008.09.007	28	2	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	JUN	2015	26	9					1276	1280		10.1055/s-0034-1380381		5	Chemistry, Organic	Chemistry	CI4YF	WOS:000354759100026		
J	Mellott, AJ; Devarajan, K; Shinogle, HE; Moore, DS; Talata, Z; Laurence, JS; Forrest, ML; Noji, S; Tanaka, E; Staecker, H; Detamore, MS				Mellott, Adam J.; Devarajan, Keerthana; Shinogle, Heather E.; Moore, David S.; Talata, Zsolt; Laurence, Jennifer S.; Forrest, M. Laird; Noji, Sumihare; Tanaka, Eiji; Staecker, Hinrich; Detamore, Michael S.			Nonviral Reprogramming of Human Wharton's Jelly Cells Reveals Differences Between ATOH1 Homologues	TISSUE ENGINEERING PART A			English	Article							MESENCHYMAL STEM-CELLS; NOTCH SIGNALING PATHWAY; MAMMALIAN INNER-EAR; COCHLEA IN-VIVO; HAIR-CELLS; STROMAL CELLS; DIRECT TRANSDIFFERENTIATION; EXTRACELLULAR-MATRIX; AUDITORY EPITHELIUM; GENE-EXPRESSION	The transcription factor atonal homolog 1 (ATOH1) has multiple homologues that are functionally conserved across species and is responsible for the generation of sensory hair cells. To evaluate potential functional differences between homologues, human and mouse ATOH1 (HATH1 and MATH-1, respectively) were nonvirally delivered to human Wharton's jelly cells (hWJCs) for the first time. Delivery of HATH1 to hWJCs demonstrated superior expression of inner ear hair cell markers and characteristics than delivery of MATH-1. Inhibition of HES1 and HES5 signaling further increased the atonal effect. Transfection of hWJCs with HATH1 DNA, HES1 siRNA, and HES5 siRNA displayed positive identification of key hair cell and support cell markers found in the cochlea, as well as a variety of cell shapes, sizes, and features not native to hair cells, suggesting the need for further examination of other cell types induced by HATH1 expression. In the first side-by-side evaluation of HATH1 and MATH-1 in human cells, substantial differences were observed, suggesting that the two atonal homologues may not be interchangeable in human cells, and artificial expression of HATH1 in hWJCs requires further study. In the future, this line of research may lead to engineered systems that would allow for evaluation of drug ototoxicity or potentially even direct therapeutic use.	[Mellott, Adam J.; Laurence, Jennifer S.; Forrest, M. Laird; Staecker, Hinrich; Detamore, Michael S.] Univ Kansas, Bioengn Grad Program, Lawrence, KS 66045 USA; [Devarajan, Keerthana] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Shinogle, Heather E.; Moore, David S.] Univ Kansas, Microscopy & Analyt Imaging Lab, Lawrence, KS 66045 USA; [Talata, Zsolt] Univ Kansas, Dept Math, Lawrence, KS 66045 USA; [Laurence, Jennifer S.; Forrest, M. Laird] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA; [Noji, Sumihare] Univ Tokushima, Dept Life Syst, Inst Sci & Technol, Tokushima 770, Japan; [Tanaka, Eiji] Univ Tokushima Grad Sch, Inst Hlth Biosci, Dept Orthodont & Dentofacial Orthoped, Tokushima, Japan; [Staecker, Hinrich] Univ Kansas Med Ctr, Dept Otolaryngol Head & Neck Surg, Kansas City, KS USA; [Detamore, Michael S.] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66045 USA	Detamore, MS (reprint author), Univ Kansas, Dept Chem & Petr Engn, 4149 Learned Hall,1530 W 15th St, Lawrence, KS 66045 USA.	detamore@ku.edu		Staecker, Hinrich/0000-0002-0348-3015	NIH [R01 AR056347]; State of Kansas	This project was funded by NIH R01 AR056347 and the State of Kansas. The authors would like to acknowledge the efforts of the nursing staff at Lawrence Memorial Hospital (Lawrence, KS) for their assistance in obtaining human umbilical cords. The authors would like to acknowledge the efforts of Peggy Keefe, Jenny Nelson-Brantley, Mary Krause, and Talia Martin for their helpful instructions on hWJC harvest, immunocytochemistry, DNA isolation, and DNA cloning, respectively. The authors would like to acknowledge the efforts of Anthony Frei, Megan Godsey, Austin Smith, and Mackenzie Bloom for their assistance on maintaining cells for this project.	Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Roberson DW, 2004, J NEUROSCI RES, V78, P461, DOI 10.1002/jnr.20271; Cotanche DA, 2010, HEARING RES, V266, P18, DOI 10.1016/j.heares.2010.04.012; Kelly MC, 2012, J NEUROSCI, V32, P6699, DOI 10.1523/JNEUROSCI.5420-11.2012; Goodyear RJ, 2002, J NEUROBIOL, V53, P212, DOI 10.1002/neu.10097; Driver EC, 2013, DEV BIOL, V376, P86, DOI 10.1016/j.ydbio.2013.01.005; Jung JY, 2013, MOL THER, V21, P834, DOI 10.1038/mt.2013.18; Wang LM, 2011, REGEN MED, V6, P95, DOI [10.2217/rme.10.98, 10.2217/RME.10.98]; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Masuda M, 2011, NEUROSCIENCE, V197, P48, DOI 10.1016/j.neuroscience.2011.09.033; Fukui H, 2013, HEARING RES, V297, P99, DOI 10.1016/j.heares.2012.11.017; Liu ZY, 2012, J NEUROSCI, V32, P6600, DOI 10.1523/JNEUROSCI.0818-12.2012; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Kong JP, 2012, DIGEST DIS SCI, V57, P845, DOI 10.1007/s10620-011-1998-y; Salsano E, 2004, NEUROSCI LETT, V370, P180, DOI 10.1016/j.neulet.2004.08.053; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Mitchell KE, 2003, STEM CELLS, V21, P50; Leonard JH, 2002, INT J CANCER, V101, P103, DOI 10.1002/ijc.10554; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Du XP, 2013, HEARING RES, V304, P91, DOI 10.1016/j.heares.2013.06.011; Vytla D, 2011, ORG BIOMOL CHEM, V9, P7151, DOI 10.1039/c1ob05963g; Chonko KT, 2013, DEV BIOL, V381, P401, DOI 10.1016/j.ydbio.2013.06.022; Cox BC, 2014, DEVELOPMENT, V141, P816, DOI 10.1242/dev.103036; Driver EC, 2009, BIRTH DEFECTS RES C, V87, P212, DOI 10.1002/bdrc.20154; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kraft S, 2013, LARYNGOSCOPE, V123, P992, DOI 10.1002/lary.22171; Yang JM, 2013, NEUROSCI LETT, V549, P7, DOI 10.1016/j.neulet.2013.04.053; Mellott AJ, 2013, ANN BIOMED ENG, V41, P446, DOI 10.1007/s10439-012-0678-1; Lanford PJ, 1999, NAT GENET, V21, P289; Rooney GE, 2008, TISSUE ENG PT A, V14, P681, DOI 10.1089/tea.2007.0260; Chellappa R, 2008, MOL CELL BIOL, V28, P1905, DOI 10.1128/MCB.01454-07; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Neves J, 2013, HEARING RES, V297, P20, DOI 10.1016/j.heares.2012.11.003; Jahan I, 2013, HEARING RES, V297, P30, DOI 10.1016/j.heares.2012.11.008; Groves AK, 2013, ANNU REV NEUROSCI, V36, P361, DOI 10.1146/annurev-neuro-062012-170309; Chen JC, 2013, HEARING RES, V297, P3, DOI 10.1016/j.heares.2012.11.018; Kiernan AE, 2013, SEMIN CELL DEV BIOL, V24, P470, DOI 10.1016/j.semcdb.2013.04.002; Bailey MM, 2007, TISSUE ENG, V13, P2003, DOI 10.1089/ten.2006.0150; Jarman AP, 2013, SEMIN CELL DEV BIOL, V24, P438, DOI 10.1016/j.semcdb.2013.03.010; Aluigi M, 2006, STEM CELLS, V24, P454, DOI 10.1634/stemcells.2005-0198; Mizutari K, 2013, NEURON, V77, P58, DOI 10.1016/j.neuron.2012.10.032; GERCHMAN E, 1995, DEV DYNAM, V202, P421; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Mulvaney J, 2012, JARO-J ASSOC RES OTO, V13, P281, DOI 10.1007/s10162-012-0317-4; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Boddy SL, 2012, REGEN MED, V7, P757, DOI [10.2217/rme.12.58, 10.2217/RME.12.58]; Cai T, 2014, MOL NEUROBIOL, DOI [10.1007/s12035-014-8925-0, DOI 10.1007/S12035-014-8925-0]; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cesnulevicius K, 2006, STEM CELLS, V24, P2776, DOI 10.1634/stemcells.2006-0176; Davies D, 2011, J NEUROSCI RES, V89, P1375, DOI 10.1002/jnr.22664; Detamore MS, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt353; Devarajan K, 2013, CELL REPROGRAM, V15, P43, DOI 10.1089/cell.2011.0097; Devarajan Keerthana, 2011, J Funct Biomater, V2, P249, DOI 10.3390/jfb2030249; Duan P., 2014, PLOS ONE, V9; Evsen L, 2013, J NEUROSCI, V33, P3879, DOI 10.1523/JNEUROSCI.4030-12.2013; Forge A, 2002, BRIT MED BULL, V63, P5, DOI 10.1093/bmb/63.1.5; Gazit R, 2004, DEVELOPMENT, V131, P903, DOI 10.1242/dev.00982; Gresch O, 2012, METHODS MOL BIOL, V801, P65, DOI 10.1007/978-1-61779-352-3_5; Guan M, 2014, EUR CYTOKINE NETW, V25, P58, DOI 10.1684/ecn.2014.0357; Hongmiao Ren, 2014, Curr Gene Ther, V14, P101; Huat TJ, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-91; Ikeda R, 2015, MOL NEUROBIOL, V51, P672, DOI 10.1007/s12035-014-8801-y; Jahan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011661; Jeon SJ, 2007, MOL CELL NEUROSCI, V34, P59, DOI 10.1016/j.mcn.2006.10.003; Kiernan AE, 2007, GENETICS, V177, P307, DOI 10.1534/genetics.107.075960; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Lin ZY, 2012, OTOL NEUROTOL, V33, P1648, DOI 10.1097/MAO.0b013e3182713680; Liu ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064903; Manohar R, 2009, MOL THER, V17, P936, DOI 10.1038/mt.2009.93; Mellott AJ, 2014, CELL REPROGRAM, V16, P91, DOI 10.1089/cell.2013.0069; Mulvaney JF, 2015, BIOL CELL, V107, P41, DOI 10.1111/boc.201400078; Nandy SB, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0083-1; Park YH, 2014, MOL THER, V22, P873, DOI 10.1038/mt.2013.292; Pauley S, 2008, PANMINERVA MED, V50, P41; Petrovic J., 2014, DEV NEUROBIOL, DOI [10.1002/dneu.22243, DOI 10.1002/DNEU.22243]; Placone AL, 2015, BIOMATERIALS, V42, P134, DOI 10.1016/j.biomaterials.2014.11.046; Ronaghi M, 2014, STEM CELLS DEV, V23, P1275, DOI 10.1089/scd.2014.0033; Rubel E., 1991, CIBA F SYMP, V166, P77; Sanchez JT, 2015, NEUROSCIENCE, V285, P248, DOI 10.1016/j.neuroscience.2014.11.027; Tsai HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104937; WEISLEDER P, 1992, EXP NEUROL, V115, P2, DOI 10.1016/0014-4886(92)90211-8; Wong EYM, 2013, HEARING RES, V297, P13, DOI 10.1016/j.heares.2012.09.009; Yang SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029652; Yoon Heejei, 2011, Anat Cell Biol, V44, P69, DOI 10.5115/acb.2011.44.1.69; Zhao HB, 2014, FOOD CHEM TOXICOL, V71, P60, DOI 10.1016/j.fct.2014.05.031	88	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	JUN 1	2015	21	11-12					1795	1809		10.1089/ten.tea.2014.0340		15	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CI9LO	WOS:000355091800006		
J	Sathi, GA; Kenmizaki, K; Yamaguchi, S; Nagatsuka, H; Yoshida, Y; Matsugaki, A; Ishimoto, T; Imazato, S; Nakano, T; Matsumoto, T				Sathi, Gulsan Ara; Kenmizaki, Kodai; Yamaguchi, Satoshi; Nagatsuka, Hitoshi; Yoshida, Yasuhiro; Matsugaki, Aira; Ishimoto, Takuya; Imazato, Satoshi; Nakano, Takayoshi; Matsumoto, Takuya			Early Initiation of Endochondral Ossification of Mouse Femur Cultured in Hydrogel with Different Mechanical Stiffness	TISSUE ENGINEERING PART C-METHODS			English	Article							MESENCHYMAL STEM-CELLS; IN-VITRO; ARTICULAR-CARTILAGE; OXYGEN-TENSION; STROMAL CELLS; HYPOXIA; BONE; TISSUE; CHONDROGENESIS; PROTEOGLYCAN	Mineralization is one of the most important processes in normal bone tissue development and in disease condition. Developing a novel and standardized in vitro model system that can readily monitor both cellular dynamics and mineralization is crucial for better understanding the bone tissue development and growth. Recent studies indicated that the mechanical environment is a critical condition in mineralization. We hypothesized that hydrogel with different mechanical stiffness can provide a biomimetic mechanical environment that can modulate bone tissue growth and mineralization. A femur of mouse embryo (embryonic day 16) was embedded in agarose hydrogel (2-60 kPa) and cultured in an osteogenic medium for a week. Microcomputed tomography (mu CT) results revealed enhanced mineralization was detected in the femur head cultured in the gel condition, whereas no mineralization in the femur head cultured in the control (floating culture) condition. The mineralized region was corresponding to the region of secondary ossification center. Both histological and quantitative analyses indicated that the mineralized region of femur head cultured in 10 kPa gel condition was the highest and the mineralized area was significantly larger than that cultured in 2, 40, and 60 kPa gel condition. Immunofluorescence results indicated the enhanced mineralization caused by the higher chondrogenic differentiation at that region. This enhancement mainly relating to the mechanical forces and not to the oxygen tension was also confirmed. Since this system enhances and shortens the mineralization procedure compared with the conventional two-dimensional or three-dimensional cell culture system, this hydrogel system would be one of the unique models for better understanding the mineralized tissue development.	[Sathi, Gulsan Ara; Matsumoto, Takuya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biomat, Okayama 7008558, Japan; [Kenmizaki, Kodai; Matsugaki, Aira; Ishimoto, Takuya; Nakano, Takayoshi] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Osaka, Japan; [Yamaguchi, Satoshi; Imazato, Satoshi] Osaka Univ, Grad Sch Dent, Dept Biomat, Osaka, Japan; [Nagatsuka, Hitoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Pathol & Med, Okayama 7008558, Japan; [Yoshida, Yasuhiro] Hokkaido Univ, Grad Sch Dent Med, Dept Biomat & Bioengn, Div Oral Hlth Sci, Sapporo, Hokkaido 060, Japan	Matsumoto, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biomat, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	tmatsu@md.okayama-u.ac.jp	YOSHIDA, Yasuhiro/B-2472-2011		Japan Society for the Promotion of Science (KAKENHI) [24106508, 25293402, 25220912]; Japan Science and Technology [AS2413025P]	The authors are grateful to Kazuko Funakoshi and Miki Tokuyama, for their help in special staining technique. This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (KAKENHI No. 24106508, 25293402, 25220912) and from the Japan Science and Technology (Grant No. AS2413025P).	Wang HP, 2014, NAT IMMUNOL, V15, P393, DOI 10.1038/ni.2846; BRANDT KD, 1991, ARTHRITIS RHEUM, V34, P1560; Sasaki JI, 2012, INTEGR BIOL-UK, V4, P1207, DOI 10.1039/c2ib20027a; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; LeRoux MA, 2000, J ORTHOPAED RES, V18, P383, DOI 10.1002/jor.1100180309; Zhu L, 2001, CURR OPIN GENET DEV, V11, P91, DOI 10.1016/S0959-437X(00)00162-3; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; FROST HM, 1994, ANGLE ORTHOD, V64, P175; Campas O, 2014, NAT METHODS, V11, P183, DOI [10.1038/nmeth.2761, 10.1038/NMETH.2761]; Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Matsumoto T, 2007, TISSUE ENG, V13, P207, DOI 10.1089/ten.2006.0058; Reich A, 2005, J APPL PHYSIOL, V98, P2381, DOI 10.1152/japplphysiol.01073.2004; Kisiday JD, 2009, TISSUE ENG PT A, V15, P2817, DOI 10.1089/ten.TEA.2008.0357; Watanabe J, 2007, J BIOMED MATER RES A, V83A, P845, DOI 10.1002/jbm.a.31435; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Schipani E, 2001, GENE DEV, V15, P2865; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Tabata Y, 2000, TISSUE ENG, V6, P279, DOI 10.1089/10763270050044452; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Stile RA, 2001, BIOMACROMOLECULES, V2, P185, DOI 10.1021/bm0000945; Mauney JR, 2004, CALCIFIED TISSUE INT, V74, P458, DOI 10.1007/s00223-003-0104-7; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Sharir A, 2011, DEVELOPMENT, V138, P3247, DOI 10.1242/dev.063768; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Malladi P, 2006, AM J PHYSIOL-CELL PH, V290, pC1139, DOI 10.1152/ajpcell.00415.2005; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.0.CO;2-4; West ER, 2007, BIOMATERIALS, V28, P4439, DOI 10.1016/j.biomaterials.2007.07.001; Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446; BURTONWURSTER N, 1993, J ORTHOPAED RES, V11, P717, DOI 10.1002/jor.1100110514; Cole HA, 2013, BONE, V52, P337, DOI 10.1016/j.bone.2012.10.011; Giachelli C M, 2005, Orthod Craniofac Res, V8, P229, DOI 10.1111/j.1601-6343.2005.00345.x; Matsumoto T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001211; Miyajima H, 2011, BIOMATERIALS, V32, P6754, DOI 10.1016/j.biomaterials.2011.05.072; Xu Y, 2007, TISSUE ENG, V13, P2981, DOI 10.1089/ten.2007.0050	37	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3384	1937-3392		TISSUE ENG PART C-ME	Tissue Eng. Part C-Methods	JUN 1	2015	21	6					567	575		10.1089/ten.tec.2014.0475		9	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CI6LF	WOS:000354870000006		
J	Motohashi, M; Wakui, S; Takahashi, H; Yoshida, A; Mutou, T; Ikegami, M; Asari, M; Inomata, T				Motohashi, Masaya; Wakui, Shin; Takahashi, Hiroyuki; Yoshida, Ayaka; Mutou, Tomoko; Ikegami, Masahiro; Asari, Masao; Inomata, Tomo			Adenocarcinoma of the Ampullary Glands of the Ductus Deferens in a Sprague-Dawley Rat	TOXICOLOGIC PATHOLOGY			English	Article						adenocarcinoma; ampullary gland; male accessory sex glands; Sprague-Dawley rat	MALE REPRODUCTIVE-SYSTEM; BASAL-CELL HYPERPLASIA; ACCESSORY SEX-ORGANS; PROSTATIC-CARCINOMA; LESIONS; CARCINOGENESIS; MICE	Spontaneously occurring proliferative lesions of the male accessory sex glands are infrequent in various strains of rats. In rodents, the ampullary glands are embedded in the prostate. Although 2 spontaneous cases of atypical hyperplastic lesions at the ampullary gland were previously described in Wistar rats, adenocarcinoma and/or adenoma in this gland have not been reported. This study describes adenocarcinomas in the bilateral ampullary glands in a 52-week-old intact male Sprague-Dawley rat housed as part of a control group in a toxicological experiment. At necropsy, the body weight (644.4 g) and the weight of the prostate with ampullary gland (2.75 g) were similar to others of the same control group, and it had a normal gross appearance. Histopathologically, both ampullary glands revealed microinvasive adenocarcinoma without vascular invasion. The morphological characteristics of the neoplasm varied in different regions of the gland. Other parts of the male accessory sex glands did not show proliferative lesions.	[Motohashi, Masaya; Wakui, Shin; Yoshida, Ayaka; Asari, Masao; Inomata, Tomo] Azabu Univ, Sch Vet Med, Dept Toxicol, Lab Anim Sci & Vet Anat, Sagamihara, Kanagawa 2525201, Japan; [Takahashi, Hiroyuki; Ikegami, Masahiro] Jikei Univ, Dept Pathol, Sch Med, Tokyo 105, Japan; [Mutou, Tomoko] Drug Safety Testing Ctr, Lab 1, Saitama, Japan	Wakui, S (reprint author), Azabu Univ, Sch Vet Med, Dept Toxicol, 1-17-71 Chuo, Sagamihara, Kanagawa 2525201, Japan.	wakui@azabu-u.ac.jp			Azabu University Research Services Division; Promotion and Mutual Aid Corporation for Private Schools of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [25450473]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was partially supported by a research project grant award by the Azabu University Research Services Division, and the Promotion and Mutual Aid Corporation for Private Schools of Japan, Grant-in-Aid for Matching Fund Subsidy for Private Universities, provided funding for this project. This study was supported by Grant-in-Aid (C) #25450473 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alison R., 1997, INT CLASSIFICATION 1, V122; SOLLEVELD HA, 1984, J NATL CANCER I, V72, P929; Aumuller G, 2012, PROSTATE, V72, P326, DOI 10.1002/pros.21437; Bosland M. C., 1992, PATHOBIOLOGY AGING R, P243; Bosland M. C., 1998, GUIDES TOXICOLOGIC P, P1; BOSLAND MC, 1990, CANCER RES, V50, P691; Brawick K., 1983, LAB INVEST, V48, p7A; CHOW PH, 1989, ACTA ANAT, V134, P327; CLEARY KR, 1983, AM J CLIN PATHOL, V80, P850; Creasy D, 2012, TOXICOL PATHOL, V40, p40S, DOI 10.1177/0192623312454337; Cunha GR, 2001, REPROD FERT DEVELOP, V13, P285, DOI 10.1071/RD01010; Faccini J. M., 1990, MOUSE HISTOPATHOLOGY; Frith CH, 1988, COLOR ATLAS NEOPLAST; GA Boorman, 1990, PATHOLOGY FISCHER RA, P405; Gordon L. R., 1996, PATHOBIOLOGY AGING M, V1, P421; Hayward SW, 1996, ACTA ANAT, V155, P81; Huss W. J., 2001, CANC BIOL, V1, P213; Kumar V, 2005, PATHOLOGIC BASIS DIS, P269; LEE CL, 1987, INORG CHIM ACTA, V127, P239; MITSUMORI K, 1988, ENVIRON HEALTH PERSP, V77, P11, DOI 10.2307/3430623; Mitsumori K., 1994, PATHOLOGY TUMOURS LA, V2, P431; Polland M. P., 1986, JNCI-J NATL CANCER I, V32, P583; Rehm S., 2001, INT CLASSIFICATION R, P163; RIVENSON A, 1979, INVEST UROL, V16, P468; Shirai T, 2000, MUTAT RES-REV MUTAT, V462, P219, DOI 10.1016/S1383-5742(00)00039-9; Squire R. A., 1978, PAHTOLOGY LABORATORY, VII, P1213; Suwa T, 2001, TOXICOL PATHOL, V29, P467, DOI 10.1080/01926230152500086; Suwa T, 2002, TOXICOL PATHOL, V30, P228, DOI 10.1080/019262302753559560; WAKUI S, 1989, VET PATHOL, V26, P447; WARD JM, 1980, LAB INVEST, V43, P517	30	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0192-6233	1533-1601		TOXICOL PATHOL	Toxicol. Pathol.	JUN	2015	43	4					593	599		10.1177/0192623314554266		7	Pathology; Toxicology	Pathology; Toxicology	CI5YJ	WOS:000354835400014		
J	Lin, HJ; Zhang, CH; Liao, JM; Yang, F; Zhong, SY; Jiang, PH; Chen, X; Nagashima, Y				Lin, Huajuan; Zhang, Chaohua; Liao, Jianmeng; Yang, Feng; Zhong, Saiyi; Jiang, Peihong; Chen, Xiao; Nagashima, Yuji			Neutralizing effect of hemolymph from the shore crab, Thalamita crenata, on paralytic shellfish toxins	TOXICON			English	Article						Shore crab; Thalamita crenata; Paralytic shellfish toxins (PST); Toxicity neutralization; PST-binding protein; PST-ligand affinity chromatography	SAXITOXIN-BINDING PROTEIN; CORAL-REEF CRABS; ZOSIMUS-AENEUS; XANTHID CRAB; HEMIGRAPSUS-SANGUINEUS; ALEXANDRIUM-TAMARENSE; BODY-FLUID; TETRODOTOXIN; SAXIPHILIN; POISON	Several species of crabs are resistant to paralytic shellfish toxins (PSTs) and/or pufferfish toxin, tetrodotoxin, regardless of toxification by the toxins. The shore crab Thalamita crenata, which inhabits Leizhou Peninsula, China, is tolerant to PST toxicity, and the hemolymph has neutralizing effects against the lethal activity of PST. In the present study, we investigated the PST neutralizing factors in the hemolymph from T. crenata and successfully separated PST-binding proteins by PST-ligand affinity chromatography. The neutralization factors, obtained in the fraction with a molecular weight over 10 kDa by ultrafiltration, were susceptible to proteases such as alcalase, animal complex proteases, pancreatin, and papain. The PST-binding protein had high dose-dependent neutralization effects on PST toxicity. The PST-binding activity of the protein was stable at 25 degrees C and then decreased with an increase in temperature; heating at 65 degrees C for 60 min eliminated the initial activity by two-thirds. The PST-binding activity was strongly inhibited in the presence of Mg2+ and Ca2+, but not Na+ and K+. The PST-binding capability of the protein differed among PST components in descending order of neosaxitoxin, gonyautoxins 1 and 4, saxitoxin, and gonyautoxins 2 and 3, suggesting a structure activity relationship in PST binding. (C) 2015 Elsevier Ltd. All rights reserved.	[Lin, Huajuan; Zhang, Chaohua; Zhong, Saiyi; Jiang, Peihong; Chen, Xiao] Guangdong Ocean Univ, Coll Food Sci & Technol, Zhanjiang 524088, Peoples R China; [Lin, Huajuan; Zhang, Chaohua; Zhong, Saiyi] Guangdong Prov Key Lab Aquat Product Proc & Safet, Zhanjian 524088, Gaunadong Provi, Peoples R China; [Liao, Jianmeng] Zhanjiang Inst Supervis & Test Qual & Measure, Zhanjiang 524096, Peoples R China; [Yang, Feng] Zhanjiang Ocean & Fishery Environm Monitor Stn, Zhanjiang 524039, Peoples R China; [Nagashima, Yuji] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, Tokyo 1088477, Japan	Nagashima, Y (reprint author), Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, Tokyo 1088477, Japan.	huajuanlin@vip.163.com; chz2382@126.com; idk123@126.coth; yangfengde@126.com; zsylxc@126.com; jiangpeihongjph@163.com; zhihanxiaoxiao@126.com; yujicd@kaiyodai.ac.jp	NAGASHIMA, yuji/O-1968-2014		Guangdong Science Province and Technology Plan, Province International Cooperation Projects [[2012] 98]; Earmarked Fund for Modern Agro-industryTechnology Research System of China [CARS-48]; Project of the Establishment of an Asian Research Center of Excellence in Healthy and Safe Marine Food Resources, in Tokyo University of Marine Science and Technology, Japan	This study was supported by 2012 Guangdong Science Province and Technology Plan, Province International Cooperation Projects (Project Number: [2012] 98); the Earmarked Fund for Modern Agro-industryTechnology Research System of China (CARS-48), and Project of the Establishment of an Asian Research Center of Excellence in Healthy and Safe Marine Food Resources, in Tokyo University of Marine Science and Technology, Japan. The authors thank Shin-Nihon Kentei Kyokai for provision and technical instructions of SKit.	OSHIMA Y, 1995, J AOAC INT, V78, P528; Takati N, 2007, TOXICON, V50, P311, DOI 10.1016/j.toxicon.2007.04.016; YASUMOTO T, 1983, B JPN SOC SCI FISH, V49, P633; Llewellyn LE, 1997, P ROY SOC B-BIOL SCI, V264, P891; Shimada Hiroshi, 2011, Plankton & Benthos Research, V6, P35; HWANG DF, 1990, NIPPON SUISAN GAKK, V56, P337; BARBER KG, 1988, TOXICON, V26, P1027, DOI 10.1016/0041-0101(88)90201-2; Lin HJ, 2012, MAR ENVIRON RES, V78, P48, DOI 10.1016/j.marenvres.2012.04.002; BARBER KG, 1988, B ENVIRON CONTAM TOX, V40, P190; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Llewellyn LE, 2002, TOXICON, V40, P1463, DOI 10.1016/S0041-0101(02)00164-2; DAIGO K, 1988, TOXICON, V26, P485, DOI 10.1016/0041-0101(88)90187-0; Negri A, 1998, TOXICON, V36, P283, DOI 10.1016/S0041-0101(97)00119-0; YAMAMORI K, 1992, NIPPON SUISAN GAKK, V58, P1157; KOYAMA K, 1983, B JPN SOC SCI FISH, V49, P485; DAIGO K, 1987, NIPPON SUISAN GAKK, V53, P881; Noguchi T, 2011, TOXIN REV, V30, P91, DOI 10.3109/15569543.2011.640743; Llewellyn LE, 1997, MAR BIOL, V128, P599, DOI 10.1007/s002270050126; KOYAMA K, 1983, B JPN SOC SCI FISH, V49, P1273; Nagashima Y, 2002, TOXICON, V40, P753, DOI 10.1016/S0041-0101(01)00278-1; ALCALA AC, 1988, TOXICON, V26, P105, DOI 10.1016/0041-0101(88)90142-0; Tsai YH, 1996, TOXICON, V34, P467, DOI 10.1016/0041-0101(95)00149-2; SHIOMI K, 1992, TOXICON, V30, P1529, DOI 10.1016/0041-0101(92)90024-Y; Ho PH, 2006, FOOD CONTROL, V17, P439, DOI 10.1016/j.foodcont.2005.02.004; Sato S, 2014, J AOAC INT, V97, P339, DOI 10.5740/jaoacint.SGESato; YASUMURA D, 1986, AGR BIOL CHEM TOKYO, V50, P593; LI Y, 1991, J BIOL CHEM, V266, P15481; MAHAR J, 1991, TOXICON, V29, P53, DOI 10.1016/0041-0101(91)90039-T; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; HASHIMOTO Y, 1969, BULL JAP SOC SCI FISH, V35, P83; [姜沛宏 Jiang Peihong], 2013, [食品科学, Food Science], V34, P170; Lenarcic B, 2000, J BIOL CHEM, V275, P15572, DOI 10.1074/jbc.M001406200; Lin HuaJuan, 2011, Journal of Fisheries of China, V35, P1540; Llewellyn L.E., 1989, TOXICON, V26, P1085; Montoya NG, 2010, TOXICON, V56, P1408, DOI 10.1016/j.toxicon.2010.08.006; Nagashima Y., 1998, HARMFUL ALGAE, P604; NOGUCHI T, 1983, B JPN SOC SCI FISH, V49, P1883; Truckses M. W., 2005, AOAC OFFICIAL METHOD, V18th, P79	38	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0041-0101			TOXICON	Toxicon	JUN 1	2015	99						51	57		10.1016/j.toxicon.2015.03.010		7	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CI8MD	WOS:000355025500007		
J	Fujii, S; Tamaru, H				Fujii, Shinobu; Tamaru, Hiroshi			MOMENT MAPS AND ISOPARAMETRIC HYPERSURFACES IN SPHERES - HERMITIAN CASES	TRANSFORMATION GROUPS			English	Article							4 PRINCIPAL CURVATURES; SYMMETRIC-SPACES	We study a relationship between isoparametric hypersurfaces in spheres with four distinct principal curvatures and the moment maps of certain Hamiltonian actions. In this paper, we consider the isoparametric hypersurfaces obtained from the isotropy representations of compact irreducible Hermitian symmetric spaces of rank two. We prove that the Cartan-Munzner polynomials of these hypersurfaces can be written as squarednorms of the moment maps for some Hamiltonian actions. The proof is based on the structure theory of symmetric spaces.	[Fujii, Shinobu] Oshima Coll, Natl Inst Technol, Gen Educ Div, Suouoshima, Yamaguchi 7422193, Japan; [Tamaru, Hiroshi] Hiroshima Univ, Dept Math, Higashihiroshima 7398526, Japan	Fujii, S (reprint author), Oshima Coll, Natl Inst Technol, Gen Educ Div, 1091-1 Komatsu, Suouoshima, Yamaguchi 7422193, Japan.	shinofu@oshima-k.ac.jp; tamaru@math.sci.hiroshima-u.ac.jp			KAKENHI [20740040, 24654012]	The authors are grateful to Yoshio Agaoka, Osamu Ikawa, Reiko Miyaoka and Yoshihiro Ohnita for valuable discussions and comments. The authors would also like to thank Kazuhiro Shibuya, Takahiro Hashinaga and Akira Kubo for their warm encouragements. The second author was supported in part by KAKENHI (20740040 and 24654012).	Chi QS, 2013, J DIFFER GEOM, V94, P469; Immervoll S, 2008, ANN MATH, V168, P1011; Chi QS, 2011, NAGOYA MATH J, V204, P1, DOI 10.1215/00277630-1431813; Cecil TE, 2007, ANN MATH, V166, P1; Tamaru H, 1999, DIFFER GEOM APPL, V11, P29, DOI 10.1016/S0926-2245(99)00023-6; MUNZNER HF, 1980, MATH ANN, V251, P57, DOI 10.1007/BF01420281; Miyaoka R, 2013, ANN MATH, V177, P53, DOI 10.4007/annals.2013.177.1.2; Cecil T.E., 2008, LIE SPHERE GEOMETRY, DOI Springer; Chi QS, 2009, NAGOYA MATH J, V193, P129; DORFMEISTER J, 1985, COMMUN ALGEBRA, V13, P2299, DOI 10.1080/00927878508823278; FERUS D, 1981, MATH Z, V177, P479, DOI 10.1007/BF01219082; Fujii S, 2010, TOHOKU MATH J, V62, P191; Grove L. C., 1996, GRADUATE TEXTS MATH, V99; Helgason S., 1978, GRADUATE STUDIES MAT, V34; Hsiang W.-Y., 1971, J DIFFER GEOM, V5, P1; Humphreys J. E., 1978, GRADUATE TEXTS MATH, V9; Kirwan F.C., 1984, MATH NOTES, V31; Loos O., 1969, SYMMETRIC SPACES; Miyaoka R, 2013, MATH ANN, V355, P1067, DOI 10.1007/s00208-012-0819-8; MUNZNER HF, 1981, MATH ANN, V256, P215, DOI 10.1007/BF01450799; Nagano T., 2000, TOKYO J MATH, V23, P403, DOI DOI 10.3836/TJM/1255958679; Nagatomo Y., 2010, PREPRINT; Ohnita Y., 2005, P M SUBMANIFOLDS YUZ, P33; Ozeki H., 1976, TOHOKU MATH J, V28, P7, DOI 10.2748/tmj/1178240877; Ozeki Hideki, 1975, TOHOKU MATH J, V27, P515, DOI 10.2748/tmj/1178240941; PALAIS RS, 1987, T AM MATH SOC, V300, P771, DOI 10.2307/2000369; Song H., 2001, TSUKUBA J MATH, V25, P279; Tamaru H, 1999, OSAKA J MATH, V36, P835; Thorbergsson G, 2000, HDB DIFFERENTIAL GEO, VI, P963, DOI 10.1016/S1874-5741(00)80013-8	29	0	0	SPRINGER BIRKHAUSER	NEW YORK	233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA	1083-4362	1531-586X		TRANSFORM GROUPS	Transform. Groups	JUN	2015	20	2					417	436		10.1007/s00031-015-9305-1		20	Mathematics	Mathematics	CI5NR	WOS:000354804300008		
J	Casco-Robles, MM; Miura, T; Chiba, C				Casco-Robles, Martin Miguel; Miura, Tomoya; Chiba, Chikafumi			The newt (Cynops pyrrhogaster) RPE65 promoter: molecular cloning, characterization and functional analysis	TRANSGENIC RESEARCH			English	Article						Newt; RPE65; Retinal pigment epithelium; Transgenesis	RETINAL-PIGMENT EPITHELIUM; I-SCEI MEGANUCLEASE; TRANSCRIPTION FACTOR MITF; ADULT NEWT; BINDING PROTEIN; EFFICIENT TRANSGENESIS; BEST1 EXPRESSION; REGENERATION; GENE; CELLS	The adult newt has the ability to regenerate the neural retina following injury, a process achieved primarily by the retinal pigment epithelium (RPE). To deliver exogenous genes to the RPE for genetic manipulation of regenerative events, we isolated the newt RPE65 promoter region by genome walking. First, we cloned the 2.8 kb RPE65 promoter from the newt, Cynops pyrrhogaster. Sequence analysis revealed several conserved regulatory elements described previously in mouse and human RPE65 promoters. Second, having previously established an I-SceI-mediated transgenic protocol for the newt, we used it here to examine the -657 bp proximal promoter of RPE65. The promoter assay used with F0 transgenic newts confirmed transgene expression of mCherry fluorescent protein in the RPE. Using bioinformatic tools and the TRANSFAC database, we identified a 340 bp CpG island located between -635 and -296 bp in the promoter; this region contains response elements for the microphthalmia-associated transcription factor known as MITF (CACGTG, CATGTG), and E-boxes (CANNTG). Sex-determining region box 9 (or SOX9) response element previously reported in the regulation of RPE genes (including RPE65) was also identified in the newt RPE65 promoter. Third, we identified DNA motif boxes in the newt RPE65 promoter that are conserved among other vertebrates. The newt RPE65 promoter is an invaluable tool for site-specific delivery of exogenous genes or genetic manipulation systems for the study of retinal regeneration in this animal.	[Casco-Robles, Martin Miguel] Univ Tsukuba, Dept Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Miura, Tomoya] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Chiba, Chikafumi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Casco-Robles, MM (reprint author), Univ Tsukuba, Dept Life & Environm Sci, Tennoudai 1-1-1, Tsukuba, Ibaraki 3058572, Japan.	martinmcasco@gmail.com; chichiba@biol.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [23124502, 221S0002]; Japan Society for the Promotion of Science (JSPS) [24650229, 25870096, 21300150, 24240062, 26.04097]; JSPS	We are thankful to all members of the Japan Newt Research Community for their helpful comments and discussion, and to the citizens of Toride City, Ibaraki, Japan, for helping us with daily maintenance of the Imori-no-Sato newt field. We are grateful to the Felsenfeld Group (National Institute of Health, USA) for providing the chicken HS4 insulator. This work was supported by Grants from the Ministry of Education, Culture, Sports, Science and Technology (23124502; 221S0002), the Japan Society for the Promotion of Science (JSPS, 24650229; 25870096; 21300150; 24240062; 26.04097) to C. C., and a JSPS Postdoctoral Fellowship to M. M. Casco-Robles.	Aguirre GD, 1998, MOL VIS, V4, P1; Aksan I, 1998, MOL CELL BIOL, V18, P6930; Barrera V, 2012, NUCLEIC ACIDS RES, V40, P11490, DOI 10.1093/nar/gks928; LICHT LE, 1991, COMP BIOCHEM PHYS B, V100, P83, DOI 10.1016/0305-0491(91)90089-V; Tantin D, 2005, CANCER RES, V65, P10750, DOI 10.1158/0008-5472.CAN-05-2399; Hallsson JH, 2004, GENETICS, V167, P233, DOI 10.1534/genetics.167.1.233; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Goding CR, 2000, GENE DEV, V14, P1712; Chiba C, 2006, J COMP NEUROL, V495, P391, DOI 10.1002/cne.20880; Pan FC, 2006, DEV DYNAM, V235, P247, DOI 10.1002/dvdy.20608; Masuda T, 2010, J BIOL CHEM, V285, P26933, DOI 10.1074/jbc.M110.130294; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Kiser PD, 2010, PROG RETIN EYE RES, V29, P428, DOI 10.1016/j.preteyeres.2010.03.002; Tsonis PA, 2004, EXP EYE RES, V78, P161, DOI 10.1016/j.exer.2003.10.022; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Chiba C, 2014, EXP EYE RES, V123, P107, DOI 10.1016/j.exer.2013.07.009; Bevacqua RJ, 2013, THERIOGENOLOGY, V80, P104, DOI 10.1016/j.theriogenology.2013.03.017; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; Schonthaler HB, 2007, EUR J NEUROSCI, V26, P1940, DOI 10.1111/j.1460-9568.2007.05801.x; Nicoletti A, 1998, INVEST OPHTH VIS SCI, V39, P637; Bailey T. L., 1994, P 2 INT C INT SYST M, P28; Baumer N, 2003, DEVELOPMENT, V130, P2903, DOI 10.1242/dev.00450; Beddaoui M, 2012, DOC OPHTHALMOL, V125, P91, DOI 10.1007/s10633-012-9338-x; Boulanger A, 2000, J BIOL CHEM, V275, P31274, DOI 10.1074/jbc.M003441200; Boulanger A, 2002, CURR EYE RES, V24, P368, DOI 10.1076/ceyr.24.5.368.8523; Casco-Robles MM, 2010, DEV DYNAM, V239, P3275, DOI 10.1002/dvdy.22463; Casco-Robles MM, 2011, NAT PROTOC, V6, P600, DOI 10.1038/nprot.2011.334; Cheon EW, 1998, J COMP NEUROL, V396, P267; Chiba Chakafumi, 2007, P15; Cunningham LL, 2003, J COMP NEUROL, V466, P331, DOI 10.1002/cne.10861; Esumi N, 2009, HUM MOL GENET, V18, P128, DOI 10.1093/hmg/ddn323; Esumi N, 2007, J BIOL CHEM, V282, P1838, DOI 10.1074/jbc.M609517200; Gonzalez-Fernandez F, 2009, INVEST OPHTH VIS SCI, V50, P5577, DOI 10.1167/iovs.08-1857; Grigoryan EN, 1998, ADV SPACE RES, V22, P293, DOI 10.1016/S0273-1177(98)80023-9; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; HAMEL CP, 1994, GENOMICS, V20, P509, DOI 10.1006/geno.1994.1212; Iacvelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI [10.1167/iovs.10-6347, DOI 10.1167/IOVS.10-6347]; Islam Md R, 2014, SCI REP, V4, P1, DOI [10.1038/srep06043, DOI 10.1038/SREP06043]; Kaneko J, 2009, NEUROSCI LETT, V450, P252, DOI 10.1016/j.neulet.2008.11.031; Kennedy BN, 1998, J BIOL CHEM, V273, P5591, DOI 10.1074/jbc.273.10.5591; Khandhadia S, 2012, ADV EXP MED BIOL, V724, P15, DOI 10.1007/978-1-4614-0653-2_2; Kimura A, 2000, J BIOL CHEM, V275, P1152, DOI 10.1074/jbc.275.2.1152; Matsuda T, 2014, J BIOL CHEM, V289, P12908, DOI [10.1074/jbc.M114.556738, DOI 10.1074/JBC.M114.556738]; Mitashov VI, 1996, INT J DEV BIOL, V40, P833; Mizuno A, 2012, NEUROSCI LETT, V523, P39, DOI 10.1016/j.neulet.2012.06.037; Nakamura K, 2007, BRAIN RES, V1136, P28, DOI 10.1016/j.brainres.2006.12.032; Nakamura K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109831; Okada YK, 1947, JPN J EXP MORPHOL, V3, P1; Shaikh N, 2011, GENE, V484, P70, DOI 10.1016/j.gene.2011.06.003; Shihabara S, 2000, PIGMENT CELL RES, V13, P98; Sobkow L, 2006, DEV BIOL, V290, P386, DOI 10.1016/j.ydbio.2005.11.037; Susaki K, 2007, PIGM CELL RES, V20, P364, DOI 10.1111/j.1600-0749.2007.00407.x; Ueda Y, 2005, GENESIS, V41, P87, DOI 10.1002/gene.20105; Vetrini F, 2004, MOL CELL BIOL, V24, P6550, DOI 10.1128/mcb.24.15.6550-6559.2004	55	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-8819	1573-9368		TRANSGENIC RES	Transgenic Res.	JUN	2015	24	3					463	473		10.1007/s11248-014-9857-1		11	Biochemical Research Methods; Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CI4LJ	WOS:000354720100007		
J	Nanchi, I; Yoshimura, Y; Nakamura, K; Masago, Y; Ohbayashi, T; Okuda, T				Nanchi, Isamu; Yoshimura, Yuki; Nakamura, Kazuomi; Masago, Yusaku; Ohbayashi, Tetsuya; Okuda, Tomohiko			Exploring new gene integration sites for gene knock-in by gene-trapping strategy	TRANSGENIC RESEARCH			English	Article						Gene-trapping; Gene integration site; Fluorescent protein; Embryonic stem cell; Chimera embryo	COPY TRANSGENIC MICE; EMBRYONIC STEM-CELLS; BETA-ACTIN LOCUS; MUTAGENESIS; EXPRESSION; MOUSE; GENERATION; REPORTER; VECTORS	The knock-in mouse is a powerful tool for biological research, but the stability of expression of an integrated gene strongly depends on where it is integrated in the mouse genome. At present, there are an insufficient number of loci suitable for gene knock-in, such as the Rosa26 locus. Therefore, in this study, we developed an efficient strategy for identifying genome loci suitable for gene knock-in and characterized the properties of such loci for gene integration. For efficient discovery and characterization, we constructed a new gene-trapping vector that enables monitoring of the expression of both trapped and integrated genes using fluorescence. We successfully obtained fluorescent-positive mouse embryonic stem cell (mESC) clones with the vector. Thorough analysis of the expression of fluorescent proteins in chimera embryos generated with the obtained mESC clones, some of the gene-trapped chimera embryos showed stable and ubiquitous expression of the integrated gene. Furthermore, adult mice derived from one of the gene-trapped mESC clones showed ubiquitous expression of the integrated gene in various tissues without any unusual phenotype. This indicated that the identified locus possesses high potential for foreign gene integration. Our strategy allows for efficient discovery and characterization of mouse genome loci for gene integration.	[Nanchi, Isamu; Yoshimura, Yuki] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Div Mol Genet & Biofunct,Dept Biomed Sci, Yonago, Tottori, Japan; [Nanchi, Isamu; Masago, Yusaku; Okuda, Tomohiko] Shionogi Pharmaceut Res Ctr, Discovery Res Lab Core Therapeut Areas, Toyonaka, Osaka 5610825, Japan; [Nakamura, Kazuomi; Ohbayashi, Tetsuya] Tottori Univ, Res Ctr Biosci & Technol, Div Lab Anim Sci, Yonago, Tottori, Japan	Okuda, T (reprint author), Shionogi Pharmaceut Res Ctr, Discovery Res Lab Core Therapeut Areas, Toyonaka, Osaka 5610825, Japan.	tomohiko.okuda@shionogi.co.jp			Shionogi Co., Ltd.	We wish to appreciate Setsuko Hashimoto (Shionogi TechnoAdvance Research Ltd.) for technical support in the generation and care of gene-trapped mice and Miwa Aoki (Shionogi Pharmaceutical Research Center) for technical advice in histological analysis. We also appreciate Mitsuo Oshimura and Hiroyuki Kugoh (Tottori Univ.) for their perceptive suggestions and great support throughout our study. This work was performed with funding from Shionogi & Co., Ltd. as a joint research project.	Andras N, 2003, MANIPULATING MOUSE E, V3rd; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Shmerling D, 2005, GENESIS, V42, P229, DOI 10.1002/gene.20135; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Araki M, 2009, CURR PHARM BIOTECHNO, V10, P221; Attal J, 1999, GENE EXPRESSION, V8, P299; Clark KJ, 2004, GENESIS, V39, P225, DOI 10.1002/gene.20049; Friedel RH, 2010, METHOD ENZYMOL, V477, P243, DOI 10.1016/S0076-6879(10)77013-0; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gu YX, 2011, MOL CELL BIOCHEM, V357, P107, DOI 10.1007/s11010-011-0880-8; Gu YX, 2011, FEBS LETT, V585, P881, DOI 10.1016/j.febslet.2010.12.045; Jagle U, 2007, GENESIS, V45, P659, DOI 10.1002/dvg.20342; Jasin M, 1996, P NATL ACAD SCI USA, V93, P8804, DOI 10.1073/pnas.93.17.8804; KATOH K, 1987, CELL STRUCT FUNCT, V12, P575; KRIZMAN DB, 1993, NUCLEIC ACIDS RES, V21, P5198, DOI 10.1093/nar/21.22.5198; Ohtsuka M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq860; Olsen PA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-35; Sommer D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4045; Tchorz JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030011; Zhang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050348	29	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-8819	1573-9368		TRANSGENIC RES	Transgenic Res.	JUN	2015	24	3					549	559		10.1007/s11248-015-9872-x		11	Biochemical Research Methods; Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CI4LJ	WOS:000354720100015		
J	Kowaka, E; Shimajiri, Y; Kawakami, K; Tongu, M; Akama, K				Kowaka, Emi; Shimajiri, Yasuka; Kawakami, Kouhei; Tongu, Miki; Akama, Kazuhito			Field trial of GABA-fortified rice plants and oral administration of milled rice in spontaneously hypertensive rats	TRANSGENIC RESEARCH			English	Article						GABA; Hypertension; Glutamate decarboxylase; Koshihikari; Transgenic rice	GAMMA-AMINOBUTYRIC-ACID; GLUTAMATE-DECARBOXYLASE; BLOOD-PRESSURE; SUBCELLULAR-LOCALIZATION; CALMODULIN-BINDING; TRANSGENIC RICE; ORYZA-SATIVA; ACCUMULATION; TRANSAMINASES; METABOLISM	Hypertension is one of the most critical risk factors accompanying cardiovascular diseases. gamma-Aminobutyric acid (GABA) is a non-protein amino acid that functions as a major neurotransmitter in mammals and also as a blood-pressure lowering agent. We previously produced GABA-fortified rice lines of a popular Japonica rice cultivar 'Koshihikari' by genetic manipulation of GABA shunt-related genes. In the study reported here, we grew these same novel rice lines in a field trial and administered the milled rice orally to rats. The yield parameters of the transgenic rice plants were almost unchanged compared to those of untransformed cv. 'Koshihikari' plants, while the rice grains of the transgenic plants contained a high GABA content (3.5 g GABA/kg brown rice; 0.75-0.85 GABA g/kg milled rice) in a greenhouse trial. Oral administration of a diet containing 2.5 % GABA-fortified rice, with a daily intake for 8 weeks, had an approximately 20 mmHg anti-hypertensive effect in spontaneous hypertensive rats but not in normotensive Wistar-Kyoto rats. These results suggest that GABA-fortified rice may be applicable as a staple food to control or prevent hypertension.	[Kowaka, Emi; Shimajiri, Yasuka; Akama, Kazuhito] Shimane Univ, Dept Biol Sci, Matsue, Shimane 6908504, Japan; [Kawakami, Kouhei; Tongu, Miki] Shimane Univ, Dept Expt Anim, Interdisciplinary Ctr Sci Res, Org Res, Izumo, Shimane 6938501, Japan	Akama, K (reprint author), Shimane Univ, Dept Biol Sci, Nishikawatsu 1060, Matsue, Shimane 6908504, Japan.	akama@life.shimane-u.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan [GMC0005]	This research was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan [Genomics for Agricultural Innovation, Development of health promoting transgenic rice (GMC0005)].	ABE Y, 1995, AM J HYPERTENS, V8, P74, DOI 10.1016/0895-7061(94)00141-W; Akama K, 2009, TRANSGENIC RES, V18, P865, DOI 10.1007/s11248-009-9272-1; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Wakasa K, 2006, J EXP BOT, V57, P3069, DOI 10.1093/jxb/erl068; Baum G, 1996, PLANT PHYSIOL, V111, P15; SAIKUSA T, 1994, J AGR FOOD CHEM, V42, P1122, DOI 10.1021/jf00041a015; Yang LJ, 2006, FEBS LETT, V580, P3315, DOI 10.1016/j.febslet.2006.04.092; Koike S, 2013, PLANT CELL PHYSIOL, V54, P793, DOI 10.1093/pcp/pct035; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)17741-1; Shelp BJ, 1999, TRENDS PLANT SCI, V4, P446, DOI 10.1016/S1360-1385(99)01486-7; Perez-Massot E, 2013, GENES NUTR, V8, P29, DOI 10.1007/s12263-012-0315-5; Kimura M, 2002, JPN J PHARMACOL, V89, P388, DOI 10.1254/jjp.89.388; Fait A, 2011, PLANT PHYSIOL, V157, P1026, DOI 10.1104/pp.111.179986; Clark SM, 2009, J EXP BOT, V60, P3255, DOI 10.1093/jxb/erp161; Hayakawa K, 2004, BRIT J NUTR, V92, P411, DOI 10.1079/BJN20041221; Yamakawa H, 2010, PLANT CELL PHYSIOL, V51, P795, DOI 10.1093/pcp/pcq034; Akama K, 2001, BBA-GENE STRUCT EXPR, V1522, P143, DOI 10.1016/S0167-4781(01)00324-4; Akama K, 2007, J EXP BOT, V58, P2699, DOI 10.1093/ixb/erm120; Costa Maria De Los Angeles, 1998, Acta Physiologica Pharmacologica et Therapeutica Latinoamericana, V48, P59; CURTIS DR, 1974, ERG PHYSIOL BIOL CH, V69, P97; Hayashi A, 2007, J NUTR SCI VITAMINOL, V53, P331, DOI 10.3177/jnsv.53.331; Japan Food Research Laboratories Edit, 2007, CRIT POINTS METH AN; Masuda H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00543; Shimajiri Y, 2013, PLANT BIOTECHNOL J, V11, P594, DOI 10.1111/pbi.12050; Shimajiri Y, 2013, J PLANT PHYSIOL, V170, P196, DOI 10.1016/j.jplph.2012.09.007; TAKAHASHI HIDEHIKO, 1955, JAPANESE JOUR PHYSIOL, V5, P334; Trobacher CP, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-144; Yoshimura M, 2010, J AGR FOOD CHEM, V58, P615, DOI 10.1021/jf903008t	29	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-8819	1573-9368		TRANSGENIC RES	Transgenic Res.	JUN	2015	24	3					561	569		10.1007/s11248-014-9859-z		9	Biochemical Research Methods; Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CI4LJ	WOS:000354720100016		
J	Hernandez, W; Aquino-Michaels, K; Drozda, K; Patel, S; Jeong, Y; Takahashi, H; Cavallari, LH; Perera, MA				Hernandez, Wenndy; Aquino-Michaels, Keston; Drozda, Katarzyna; Patel, Shitalban; Jeong, Young; Takahashi, Harumi; Cavallari, Larisa H.; Perera, Minoli A.			Novel single nucleotide polymorphism in CYP2C9 is associated with changes in warfarin clearance and CYP2C9 expression levels in African Americans	TRANSLATIONAL RESEARCH			English	Article							CYTOCHROME P4502C9; GENETIC-VARIANTS; ENANTIOMERS; PHARMACOGENETICS; DETERMINANT; METABOLISM; INFERENCE; DOSAGE; VKORC1	Warfarin is a widely used anticoagulant whose active S-enantiomer is primarily metabolized by the CYP2C9 enzyme. The CYP2C9*2 and CYP2C9*3 alleles are associated with lower warfarin dose requirement and decreased enzyme activity. In contrast, we previously identified a novel single-nucleotide polymorphism (SNP) (rs7089580A > T) in CYP2C9 that is associated with higher warfarin dose requirement in African Americans (AAs). In this study, we examine the effect of rs7089580 on warfarin pharmacokinetics and CYP2C9 expression in 63 AA patients and 32 AA liver tissues, respectively. We found oral clearance of S-warfarin to be higher among carriers of the minor rs7089580 allele (T) compared with wild-type homozygotes (3.73 +/- 1.46 vs 2.95 +/- 1.39 mL/min; P = 0.04). CYP2C9 messenger RNA expression in liver tissue was also higher among A/T and T/T genotypes compared with A/A (P < 0.02). Our findings indicate that rs7089580 is associated with higher S-warfarin clearance and CYP2C9 expression and may help explain the higher dose requirement of warfarin in AAs. Furthermore, rs7089580 is in complete linkage disequilibrium with the promoter SNP rs12251841 in AAs, which may provide a biologically plausible explanation for the observed effect on CYP2C9 expression levels. Given the many clinically relevant substrates of CYP2C9, identifying polymorphisms that affect expression levels and metabolism across ethnicities is essential for individualization of doses with a narrow therapeutic index.	Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL USA; Meiji Pharmaceut Univ, Dept Biopharmaceut, Tokyo, Japan	Perera, MA (reprint author), Univ Chicago, 900 E 57th St,Room 3220B, Chicago, IL 60637 USA.	mperera@bsd.uchicago.edu					Miners JO, 1998, BRIT J CLIN PHARMACO, V45, P525, DOI 10.1046/j.1365-2125.1998.00721.x; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Aquilante CL, 2004, PHARMACOTHERAPY, V24, P720, DOI 10.1592/phco.24.8.720.36074; Pritchard JK, 2000, GENETICS, V155, P945; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Takahashi H, 1997, J CHROMATOGR B, V701, P71, DOI 10.1016/S0378-4347(97)00346-0; Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878; Takahashi H, 2001, CLIN PHARMACOKINET, V40, P587, DOI 10.2165/00003088-200140080-00003; Yu HCM, 1996, QJM-MON J ASSOC PHYS, V89, P127; Van Booven D, 2010, PHARMACOGENET GENOM, V20, P277, DOI 10.1097/FPC.0b013e3283349e84; Absher RK, 2002, ANN PHARMACOTHER, V36, P1512, DOI 10.1345/aph.1C025; Perera MA, 2013, LANCET, V382, P790, DOI 10.1016/S0140-6736(13)60681-9; CRAWFORD JD, 1950, PEDIATRICS, V5, P783; Takahashi H, 1998, CLIN PHARMACOL THER, V63, P519, DOI 10.1016/S0009-9236(98)90103-5; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Blann A, 1999, BRIT J HAEMATOL, V107, P207, DOI 10.1046/j.1365-2141.1999.01672.x; Cavallari LH, 2013, PHARMACOGENET GENOM, V23, P228, DOI 10.1097/FPC.0b013e32835e95c7; CHAN E, 1994, BRIT J CLIN PHARMACO, V37, P563; Choi SY, 2013, DRUG METAB DISPOS, V41, P263, DOI 10.1124/dmd.112.046276; Gan GG, 2003, INT J HEMATOL, V78, P84, DOI 10.1007/BF02983247; Hernandez W, 2014, PHARMACOGENOMICS J, V14, P223, DOI 10.1038/tpj.2013.34; Hruska MW, 2004, CLIN CHEM, V50, P2392, DOI 10.1373/clinchem.2004.040071; Limdi NA, 2008, PHARMACOGENOMICS, V9, P1445, DOI 10.2217/14622416.9.10.1445; Perera MA, 2011, CLIN PHARMACOL THER, V89, P408, DOI 10.1038/clpt.2010.322; Zhao F, 2004, CLIN PHARMACOL THER, V76, P210, DOI 10.1016/j.clpt.2004.05.005	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1931-5244	1878-1810		TRANSL RES	Transl. Res.	JUN	2015	165	6					651	657		10.1016/j.trsl.2014.11.006		7	Medical Laboratory Technology; Medicine, General & Internal; Medicine, Research & Experimental	Medical Laboratory Technology; General & Internal Medicine; Research & Experimental Medicine	CI6ZL	WOS:000354912600002		
J	Akiduki, S; Ito, H; Morishita, K; Kamimura, A				Akiduki, Saori; Ito, Haruo; Morishita, Koji; Kamimura, Ayako			A single-blind, parallel trial of L-hydroxyproline in healthy adult subjects	UROLITHIASIS			English	Article							URINARY OXALATE; EXCRETION; DIETS		[Akiduki, Saori; Kamimura, Ayako] KYOWA HAKKO BIO CO LTD, Healthcare Prod Dev Ctr, Tsukuba, Ibaraki 3050841, Japan; [Ito, Haruo] Chiba Univ, Grad Sch Med, Dept Urol, Chiba 2608677, Japan; [Morishita, Koji] KYOWA HAKKO BIO CO LTD, External Relat Dept, Chiyoda Ku, Tokyo 1008185, Japan	Kamimura, A (reprint author), KYOWA HAKKO BIO CO LTD, Healthcare Prod Dev Ctr, 2 Miyukigaoka, Tsukuba, Ibaraki 3050841, Japan.	ayako.kamimura@kyowa-kirin.co.jp			KYOWA HAKKO BIO CO., LTD.	This study was funded by KYOWA HAKKO BIO CO., LTD. SA, KM and AK are employees of KYOWA HAKKO BIO CO., LTD. HI is a consultant of KYOWA HAKKO BIO CO., LTD.	Knight J, 2006, KIDNEY INT, V70, P1929, DOI 10.1038/sj.ki.5001906; Knight J, 2009, UROL RES, V37, P63, DOI 10.1007/s00240-009-0170-z; Noori N, 2014, AM J KIDNEY DIS, V63, P456, DOI 10.1053/j.ajkd.2013.11.022	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2194-7228	2194-7236		UROLITHIASIS	Urolithiasis	JUN	2015	43	3					289	292		10.1007/s00240-015-0765-5		4	Urology & Nephrology	Urology & Nephrology	CI4MC	WOS:000354722400016		
J	Ge, DX; Matsuno, T; Sun, Y; Ren, C; Tang, YC; Ma, SG				Ge, Dingxin; Matsuno, Takahiro; Sun, Yi; Ren, Chao; Tang, Yongchen; Ma, Shugen			Quantitative study on the attachment and detachment of a passive suction cup	VACUUM			English	Article						Suction cup; Optimal pressing force; Maximum potential detachment force; Vacuum area; Wall climbing robot		To quantitatively evaluate requirements of a suction cup to achieve attachment and detachment on a wall, this paper presents the force analyses and conducts experimental verification for a common comrriercially available passive suction cup. The entire operation process, including the initial, pushing, attachment and detachment phases, are presented. By designing and using a test bed, optimal pushing force that ensures complete attachment of the suction cup is defined and experimentally verified. Other factors that influence the attachment and detachment of the suction cup, such as the area of the vacuum zone on the cup-wall contact surface and the internal elastic force from the elastic deformation of the suction cup, are experimentally investigated. The methods proposed in this study can be used on other types of suction cups and are valuable in guiding the design of suction-cup.,based devices, such as wall-climbing robots. (C) 2015 Elsevier Ltd. All rights reserved.	[Ge, Dingxin; Matsuno, Takahiro; Sun, Yi; Ren, Chao; Tang, Yongchen; Ma, Shugen] Ritsumeikan Univ, Dept Robot, Kyoto, Japan; [Ma, Shugen] Tianjin Univ, Sch Elect Engn & Automat, Tianjin, Peoples R China	Sun, Y (reprint author), Ritsumeikan Univ, Dept Robot, Kyoto, Japan.	yi.sun@ieee.org	Sun, Yi /I-4302-2014	Sun, Yi /0000-0002-8019-6765			Wang W, 2010, VACUUM, V85, P107, DOI 10.1016/j.vacuum.2010.04.010; Mantriota G, 2011, MECH MACH THEORY, V46, P607, DOI 10.1016/j.mechmachtheory.2011.01.003; Wang K, 2012, VACUUM, V86, P1783, DOI 10.1016/j.vacuum.2012.04.008; Kim H, 2008, J MECH SCI TECHNOL, V22, P1490, DOI 10.1007/s12206-008-0413-x; Hong QF, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS (ROBIO 2009), VOLS 1-4, P1609, DOI 10.1109/ROBIO.2009.5420389; Liu JH, 2006, VACUUM, V80, P593, DOI 10.1016/j.vacuum.2005.10.002; Mantriota G, 2007, MECH MACH THEORY, V42, P2, DOI 10.1016/j.mechmachtheory.2006.03.003; Rutkowski MM, 2009, VACUUM, V83, P869, DOI 10.1016/j.vacuum.2008.09.004; Yoshida Y, 2010, P INT C ROB BIOM ROB, P1513; Yoshida Y, 2011, P 2011 IEEE INT C RO, P2014; Zhang HX, 2009, ADV ROBOTICS, V23, P889, DOI 10.1163/156855309X442990	11	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	JUN	2015	116						13	20		10.1016/j.vacuum.2015.02.013		8	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CI2MY	WOS:000354582900003		
J	Ito, A; Joo, HS; Kim, TS; Goto, T				Ito, Akihiko; Joo, Hye-Sook; Kim, Taek-Soo; Goto, Takashi			Synthesis of pseudobrookite titanium oxynitride Ti3-delta O4N films by laser chemical vapor deposition	VACUUM			English	Article						Ti3-delta O4N; Titanium oxynitride; Pseudobrookite; Laser chemical vapor deposition	SYSTEM	Pseudobrookite Ti3-delta O4N films were prepared by laser chemical vapor deposition with titanium tetrai-sopropoxide and NH3 as precursors. By increasing the deposition temperature from 964 K to 1294 K, the phase composition of the films changed from TiO2 to Ti3-delta O4N and subsequently to Ti(O,N). Ti3-delta O4N films with fine columnar grains were obtained at 1030 K and at a total chamber pressure of 0.6-0.8 kPa. The deposition rate of these films reached 7 mu m h(-1). (C) 2015 Elsevier Ltd. All rights reserved.	[Ito, Akihiko; Joo, Hye-Sook; Goto, Takashi] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Joo, Hye-Sook] Yonsei Univ, Dept Adv Mat Engn, Seoul 120749, South Korea; [Kim, Taek-Soo] Korea Adv Inst Sci & Technol, Dept Mech Engn, Taejon 305701, South Korea	Ito, A (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.	itonium@imr.tohoku.ac.jp	Kim, Taek-Soo/C-1843-2011; Ito, Akihiko/C-2848-2011	Ito, Akihiko/0000-0002-6116-1700	Global COE Program of Materials Integration; Japan Society for the Promotion of Science [25709069]	This research was supported in part by the Global COE Program of Materials Integration. This research was also supported in part by the Japan Society for the Promotion of Science, Grant-in-Aid for Young Scientists (A) (No. 25709069).	Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Zhang S, 2014, J AM CERAM SOC, V97, P952, DOI 10.1111/jace.12706; Ito A, 2010, J ALLOY COMPD, V489, P469, DOI 10.1016/j.jallcom.2009.09.088; Hyett G, 2009, J PHOTOCH PHOTOBIO A, V203, P199, DOI 10.1016/j.jphotochem.2009.01.020; Hyett G, 2007, J AM CHEM SOC, V129, P15541, DOI 10.1021/ja073355s; Guo D., 2013, J ASIAN CERAM SOC, V1, P197; NEUMANN G, 1972, MONATSH CHEM, V103, P1130, DOI 10.1007/BF00905189; Tu R, 2010, THIN SOLID FILMS, V518, P6927, DOI 10.1016/j.tsf.2010.07.050; Yonesaki T, 2012, J JPN SOC POWDER POW, V59, P405; You Y, 2011, J CERAM SOC JPN, V119, P310, DOI 10.2109/jcersj2.119.310	10	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	JUN	2015	116						121	123		10.1016/j.vacuum.2015.03.015		3	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CI2MY	WOS:000354582900021		
J	Aryal, R; Furumai, H; Nakajima, F; Beecham, S; Kandasamy, J				Aryal, Rupak; Furumai, Hiroaki; Nakajima, Fumiyuki; Beecham, Simon; Kandasamy, Jaya			Characterisation of Prolonged Deposits of Organic Matter in Infiltration System Inlets and Their Binding with Heavy Metals: a PARAFAC Approach	WATER AIR AND SOIL POLLUTION			English	Article						Excitation-emission matrix; Organic matter; Particle size; PARAFAC	PARALLEL FACTOR-ANALYSIS; EMISSION-MATRIX FLUORESCENCE; DRINKING-WATER TREATMENT; HUMIC SUBSTANCES; MOLECULAR-WEIGHT; SPECTROSCOPY; SOIL; GROUNDWATER; RETENTION; COMPLEXATION	This study investigated and characterised organic matter present in sediment particles deposited in infiltration facilities using an excitation-emission matrix method combined with parallel factor analysis (EEM-PARAFAC). The organic fluorophore identified was correlated with sediment bound metals. The PARAFAC analysis identified three major components. The fluorophore in each of the three components appeared in different locations with different spectral shapes. The maximum fluorescence intensity (F-max) observed for each fluorescent component was correlated with seven heavy metals (Cr, Mn, Co, Ni, Cu, Zn and Pb). F-max of component 1 displayed a negative relationship with all the metals (correlation coefficient=-0.28 to -0.72), and F-max of component 3 showed a positive relationship (0.20 to 0.62), and among them, Cu, Ni and Zn had higher correlation. Our results demonstrate that a PARA FAC approach can help to further elucidate organic matter species, thereby allowing a better understanding of the mobility of elemental species in the deposited sediment.	[Aryal, Rupak; Beecham, Simon] Univ S Australia, Sch Nat & Built Environm, Ctr Water Management & Reuse, Adelaide, SA 50095, Australia; [Furumai, Hiroaki; Nakajima, Fumiyuki] Univ Tokyo, Dept Urban Engn, Tokyo 1138656, Japan; [Kandasamy, Jaya] Univ Technol Sydney, Dept Civil & Environm Engn, Ultimo, NSW 2007, Australia	Aryal, R (reprint author), Univ S Australia, Sch Nat & Built Environm, Ctr Water Management & Reuse, Adelaide, SA 50095, Australia.	rupak.aryal@unisa.edu.au					Aiken G. R., 1985, HUMIC SUBSTANCES SOI; Cory RM, 2005, ENVIRON SCI TECHNOL, V39, P8142, DOI 10.1021/es0506962; Birdwell JE, 2010, ORG GEOCHEM, V41, P270, DOI 10.1016/j.orggeochem.2009.11.002; Christensen JH, 2005, ANAL CHEM, V77, P2210, DOI 10.1021/ac048213k; Stedmon CA, 2003, MAR CHEM, V82, P239, DOI 10.1016/S0304-4203(03)00072-0; Murphy KR, 2011, ENVIRON SCI TECHNOL, V45, P2909, DOI 10.1021/es103015e; Yin YJ, 2002, SCI TOTAL ENVIRON, V287, P107, DOI 10.1016/S0048-9697(01)01000-2; Shutova Y, 2014, WATER RES, V54, P159, DOI 10.1016/j.watres.2014.01.053; Matthews BJH, 1996, MAR CHEM, V55, P317, DOI 10.1016/S0304-4203(96)00039-4; Yamashita Y, 2010, DEEP-SEA RES PT II, V57, P1478, DOI 10.1016/j.dsr2.2010.02.016; Murphy KR, 2013, ANAL METHODS-UK, V5, P6557, DOI 10.1039/c3ay41160e; CHIN YP, 1994, ENVIRON SCI TECHNOL, V28, P1853, DOI 10.1021/es00060a015; Mikkelsen PS, 1997, WATER SCI TECHNOL, V36, P325, DOI 10.1016/S0273-1223(97)00578-7; ELLIOTT HA, 1986, J ENVIRON QUAL, V15, P214; Fuentes M, 2006, ORG GEOCHEM, V37, P1949, DOI 10.1016/j.orggeochem.2006.07.024; Zsolnay A, 1999, CHEMOSPHERE, V38, P45, DOI 10.1016/S0045-6535(98)00166-0; Calace N, 2001, ENVIRON POLLUT, V113, P331, DOI 10.1016/S0269-7491(00)00186-X; Yao X, 2011, CHEMOSPHERE, V82, P145, DOI 10.1016/j.chemosphere.2010.10.049; Stedmon CA, 2008, LIMNOL OCEANOGR-METH, V6, P572; Cerqueira B, 2011, PEDOSPHERE, V21, P603, DOI 10.1016/S1002-0160(11)60162-8; Kalbitz K, 1998, SCI TOTAL ENVIRON, V209, P27, DOI 10.1016/S0048-9697(97)00302-1; Pype ML, 2013, J MEMBRANE SCI, V428, P205, DOI 10.1016/j.memsci.2012.10.027; Jalali M, 2013, ENVIRON MONIT ASSESS, V185, P8831, DOI 10.1007/s10661-013-3216-1; Weng LP, 2002, ENVIRON SCI TECHNOL, V36, P4804, DOI 10.1021/es0200084; Hua B, 2007, INT J ENVIRON AN CH, V87, P135, DOI 10.1080/03067310600922154; Atanassova I, 1999, WATER AIR SOIL POLL, V113, P115, DOI 10.1023/A:1005076821325; Baghoth SA, 2011, WATER RES, V45, P797, DOI 10.1016/j.watres.2010.09.005; Luo XS, 2012, APPL GEOCHEM, V27, P995, DOI 10.1016/j.apgeochem.2011.07.001; Dijkstra JJ, 2004, ENVIRON SCI TECHNOL, V38, P4390, DOI 10.1021/es049885v; Klapper L, 2002, ENVIRON SCI TECHNOL, V36, P3170, DOI 10.1021/es0109702; Zhang YL, 2011, WATER RES, V45, P5110, DOI 10.1016/j.watres.2011.07.014; Ellis JB, 2000, J CHART INST WATER E, V14, P27; Christensen JB, 1996, WATER RES, V30, P3037, DOI 10.1016/S0043-1354(96)00091-7; Coble PG, 1996, MAR CHEM, V51, P325, DOI 10.1016/0304-4203(95)00062-3; Stedmon CA, 2005, LIMNOL OCEANOGR, V50, P686; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38; Murphy KR, 2006, ENVIRON SCI TECHNOL, V40, P2357, DOI 10.1021/es0519381; Wang ZG, 2007, J ENVIRON SCI-CHINA, V19, P787, DOI 10.1016/S1001-0742(07)60132-6; Hossain MA, 2007, WATER SCI TECHNOL, V56, P81, DOI 10.2166/wst.2007.746; Murphy KR, 2008, MAR CHEM, V108, P40, DOI 10.1016/j.marchem.2007.10.003; Baker A, 2003, ENVIRON POLLUT, V124, P57, DOI 10.1016/S0269-7491(02)00408-6; Aryal Rupak Kumar, 2014, Sustainable Environment Research, V24; Aryal R. K., 2006, 7 INT C URB DRAIN MO, P253; Aryal RK, 2006, WATER SCI TECHNOL, V54, P205, DOI 10.2166/wst.2006.584; BUFFLE J, 1995, ANAL CHIM ACTA, V313, P144, DOI 10.1016/0003-2670(95)00204-D; DAVIS JA, 1984, GEOCHIM COSMOCHIM AC, V48, P679, DOI 10.1016/0016-7037(84)90095-4; Furumai H., 2005, MODEL DESCRIPTION ST, P53; Guo WD, 2010, J ENVIRON SCI-CHINA, V22, P1728, DOI 10.1016/S1001-0742(09)60312-0; Hong S, 2012, DESALINATION, V287, P116, DOI 10.1016/j.desal.2011.07.030; Michaelson GJ, 1997, COMMUN SOIL SCI PLAN, V28, P1141, DOI 10.1080/00103629709369861; Murakamia M, 2009, J HAZARD MATER, V164, P707, DOI 10.1016/j.jhazmat.2008.08.052; Muroski AR, 1996, ANAL CHEM, V68, P3534, DOI 10.1021/ac960252b; Pingqing F., 2004, CHIN J GEOCHEM, V23, P309, DOI 10.1007/BF02871302; Sarkanen K. V., 1971, LIGNINS OCCURRENCE F; Stevenson F.J., 1994, HUMUS CHEM GENESIS C; Yuan D. H., 2014, J GREAT LAKES RES N; Yun S. W., 2013, PADDY WATER ENVIRON, V13, P61	57	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0049-6979	1573-2932		WATER AIR SOIL POLL	Water Air Soil Pollut.	JUN	2015	226	6							175	10.1007/s11270-015-2426-2		13	Environmental Sciences; Meteorology & Atmospheric Sciences; Water Resources	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences; Water Resources	CI1IX	WOS:000354498300009		
J	Sun, ZG; Tian, DY; Ning, XY; Yasushi, Y				Sun, Zhiguo; Tian, Danyang; Ning, Xiaoyan; Yasushi, Yamao			Parameter Estimation Technique for the SNCK Scheme Based on the Spectral-Correlation Density	WIRELESS PERSONAL COMMUNICATIONS			English	Article						Sine non-linear chirp keying (SNCK); Spectra-correlation density (SCD); Time-bandwidth product estimation; Root mean square error (RMSE)	DOPPLER; RADAR	The Sine Non-linear Chirp Keying (SNCK) is one kind of the SFM schemes, which play an important role as the commonly useful signals in sonar, radar and wireless communication systems. By adjusting its time-bandwidth product, the SNCK can satisfy different requirements of the quality of service and has better ability in Doppler shift inhibition than the ordinary MSK. However, no mathematical analysis for the time-bandwidth product (modulation factor) estimation of the SNCK scheme has been available. In this paper, a SCD-based estimation algorithm for the modulation factor of the SNCK scheme has been proposed. The mathematical model and diagrams of the three-dimensional SCD and the corresponding bi-frequency plane make it easy to understand how the SCD-based algorithm localizes the center frequency and the keying rate, as well as estimates the modulation factor. The simulation results show that the proposed estimation algorithm is useful under different SNR conditions. The corresponding Cramer-Rao lower bound are derived and used as the reference of the estimation algorithm. Moreover, we improve the estimation algorithm when the modulation factor varies, by using a set of the local ratio data, which compensates the differences between the simulation ratio values and the theoretical ratio results. This algorithm can be effective for the communication system with the SNCK scheme to synchronize the carrier and the symbol, as well as to demodulate the transmitted signals with unknown parameters. It is concluded that the obvious features of the SCD can be extracted for other similar signals with high reliability.	[Sun, Zhiguo; Ning, Xiaoyan] Harbin Engn Univ, Harbin 150001, Heilongjiang, Peoples R China; [Tian, Danyang] Univ Calif Riverside, Riverside, CA 92521 USA; [Yasushi, Yamao] Univ Electrocommun, Adv Wireless Commun Res Ctr, Chofu, Tokyo 182, Japan	Ning, XY (reprint author), Harbin Engn Univ, Room 403,Bldg 21,145 Nantong St, Harbin 150001, Heilongjiang, Peoples R China.	heumcrc@163.com; ningxiaoyan@hrbeu.edu.cn			National Natural Science Foundation of China [61101141]; State Key Laboratory of Rail Traffic Control and Safety [RCS2001k009]; Central University Basic Scientific Research Special Fund [HEUCFD1409]; Project of ZTE Cooperation Forum of Industry, Education and Academy; JASSO	This work was supported by National Natural Science Foundation of China (61101141), the State Key Laboratory of Rail Traffic Control and Safety (RCS2001k009), Central University Basic Scientific Research Special Fund (HEUCFD1409) and Project of ZTE Cooperation Forum of Industry, Education and Academy. The author is supported by JASSO Scholarship.	BELL MR, 1993, IEEE T AERO ELEC SYS, V29, P73, DOI 10.1109/7.249114; Chen VC, 2006, IEEE T AERO ELEC SYS, V42, P2, DOI 10.1109/TAES.2006.1603402; PELEG S, 1991, IEEE T AERO ELEC SYS, V27, P607, DOI 10.1109/7.85033; Collins T., 1988, IEE P, V6, P347; Cong W. X., 1998, APPL OPTICS, V29, P6907; Gardner WA, 1991, IEEE SIGNAL PROC MAG, V8, P14, DOI 10.1109/79.81007; KRAMER SA, 1967, PR INST ELECTR ELECT, V55, P627, DOI 10.1109/PROC.1967.5628; Peleg Shimon, 1991, IEEE T SIGNAL PROCES, V39, P750; 齐林, 2003, [中国科学. E辑, 技术科学, Science in China], V33, P749; Setlur P, 2010, IET SIGNAL PROCESS, V4, P256, DOI 10.1049/iet-spr.2009.0039; Stankovic L, 2005, IEEE T INSTRUM MEAS, V54, P2156, DOI 10.1109/TIM.2005.858567; Stankovic L., 2008, IEEE T SIGNAL PROCES, V4, P1627; Sun Z. G., 2012, J HARBIN ENG U, V10, P1310; Sun Z. G., 2012, J SYSTEMS ENG ELECT, V10, P1973; Sun Z. G., 2012, J SYSTEMS ENG ELECT, V2, P414; Ward S., 2001, P IEEE OC 2001, V4, P2147	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0929-6212	1572-834X		WIRELESS PERS COMMUN	Wirel. Pers. Commun.	JUN	2015	82	3					1505	1529		10.1007/s11277-015-2296-3		25	Telecommunications	Telecommunications	CI4LS	WOS:000354721200023		
J	Reggiani, L; Filiberti, G; Dossi, L				Reggiani, Luca; Filiberti, Gaudenzio; Dossi, Laura			Phase Noise Suppression in MIMO LoS Systems for High Capacity Backhauling	WIRELESS PERSONAL COMMUNICATIONS			English	Article						Phase noise; Multiple input multiple output; Backhauling; Next generation networks	CHANNELS	The ambitious capacity and pervasiveness requirements for future broadband wireless networks pose new challenges in the design of high capacity point-to-point (PtP) wireless microwave backhaul links. Multiple input multiple output (MIMO) architectures are the main solution for multiplying the wireless links capacity and their effectiveness has been already demonstrated in the PtP case, where channel propagation is dominated by the line-of-sight (LoS) component. In this paper we investigate the impact and performance of suppression methods for one of the main impairments in these systems, i.e. phase noise. In LoS-MIMO systems, the phase noise impact increases as the channel matrix leaves the orthogonality condition, in order to achieve practical antenna spacings and link distances. Here architectures for phase noise suppression based on pilots patterns are compared and discussed for the LoS-MIMO (2 x 2) system, revealing the advantages and numerical performance of the design options.	[Reggiani, Luca] Politecn Milan, DEIB, I-20133 Milan, Italy; [Filiberti, Gaudenzio] Univ Pavia, Microwave Dept, Ist Elettron & Comunicaz, I-27100 Pavia, Italy; [Filiberti, Gaudenzio] GTE Telecomunicaz SPA, Res & Dev Labs, Microwave Div, Milan, Italy; [Filiberti, Gaudenzio] High Capac Digital Radios Modem Lab, Area Modemodulat Achieving Responsibil, Yokosuka, Kanagawa, Japan; [Filiberti, Gaudenzio] Syst Architecture Dept, Zurich, Switzerland; [Filiberti, Gaudenzio] HW Dev Labs, New York, NY USA; [Dossi, Laura] Politecn Milan, IEIIT CNR, DEIB, I-20133 Milan, Italy	Dossi, L (reprint author), Politecn Milan, IEIIT CNR, DEIB, I-20133 Milan, Italy.	luca.reggiani@polimi.it; gaudenzio.filiberti@alice.it; laura.dossi@ieiit.cnr.it					Durisi G, 2014, IEEE T COMMUN, V62, P920, DOI 10.1109/TCOMM.2014.012014.130745; Bohagen F, 2007, IEEE T WIREL COMMUN, V6, P1420, DOI 10.1109/TWC.2007.05548; Driessen PF, 1999, IEEE T COMMUN, V47, P173, DOI 10.1109/26.752119; Tipmongkolsilp O, 2011, IEEE COMMUN SURV TUT, V13, P97, DOI 10.1109/SURV.2011.040610.00039; Calabro S, 2004, AEU-INT J ELECTRON C, V58, P51, DOI 10.1078/1434-8411-54100206; Coldrey M., 2012, P 2012 IEEE VEH TECH, P1; Hadaschik N., 2005, IEEE INT C ICASSP; Hansryd J., 2011, ERICSSON REV, P22; Proakis J., 1995, DIGITAL COMMUNICATIO; Reggiani L., 2013, WIRELESS PERS COMMUN, V74, P373; Simon V, 2001, GLOB TELECOMM CONF, P3297, DOI 10.1109/GLOCOM.2001.966296	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0929-6212	1572-834X		WIRELESS PERS COMMUN	Wirel. Pers. Commun.	JUN	2015	82	3					1931	1953		10.1007/s11277-015-2323-4		23	Telecommunications	Telecommunications	CI4LS	WOS:000354721200050		
J	O'Dwyer, F				O'Dwyer, Fergus			An introduction to Irish English	WORLD ENGLISHES			English	Book Review									[O'Dwyer, Fergus] Osaka Univ, Fac Language & Culture, Sch Foreign Studies, Mino, Osaka 5628558, Japan	O'Dwyer, F (reprint author), Osaka Univ, Fac Language & Culture, Sch Foreign Studies, 8-1-1 Aomatani Higashi, Mino, Osaka 5628558, Japan.	fodwyerj@gmail.com					AMADORMORENO CP, 2010, INTRO IRISH ENGLISH; Kallen Jeffrey L, 2013, IRISH ENGLISH, V2; Mufwene Salikoko, 2002, SELECTION, V3, P45, DOI 10.1556/Select.3.2002.1.5	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0883-2919	1467-971X		WORLD ENGLISH	World Englishes	JUN	2015	34	2			SI		306	309		10.1111/weng.12144		4	Linguistics; Language & Linguistics	Linguistics	CI1EJ	WOS:000354484600014		
J	Fried, E; Jabbour, M				Fried, Eliot; Jabbour, Michel			Sessile drops: spreading versus evaporation-condensation	ZEITSCHRIFT FUR ANGEWANDTE MATHEMATIK UND PHYSIK			English	Article						Contact lines; Configurational forces; Kinetics of phase transformations; Constitutive relations	CONTACT LINE; GRAVITY; SURFACE; MODEL; FLOW	The equations that govern the dynamics of the liquid-vapor interface and contact line of a sessile drop in the spreading and evaporation-condensation regimes are derived. During spreading, the liquid-vapor interface and contact line convect with the liquid and are therefore material. In contrast, when evaporation or condensation occurs, the liquid-vapor interface and contact line migrate relative to the liquid and are therefore nonmaterial. For spreading, the evolution equations consist of kinematical constraints on the normal velocities of the liquid-vapor interface and contact line along with the normal and tangential components of the constitutively augmented standard force balances on the liquid-vapor interface and along the contact line. The tangential components of the standard force balances on the liquid-vapor interface and at the contact line, being solely dissipative, are automatically satisfied at equilibrium. The normal component of the standard force balance on the liquid-vapor interface reduces to the Young-Laplace equation, whereas its counterpart along the contact line simplifies to the generalization, accounting for line energy, of the Young equation mentioned by Gibbs. In the presence of evaporation or condensation, the kinematical constraints are no longer valid. Their absence is compensated for by the normal components of the configurational force balances on the liquid-vapor interface and along the contact line. Hence, away from equilibrium and in the presence of dissipation, a complete description of the liquid-vapor interface and contact line of a volatile drop involves the normal and tangential components of the standard force balances along with the normal components of the configurational force balances. At equilibrium, the normal component of the configurational force balance on the liquid-vapor interface simplifies to the condition for chemical equilibrium requiring the continuity of the chemical potential, whereas its counterpart along the contact line, being entirely dissipative, holds trivially. Comparison with recently proposed kinetic laws for the liquid-vapor interface and contact line of a drop is provided.	[Fried, Eliot] Okinawa Inst Sci & Technol, Math Soft Matter Unit, Onna Son, Okinawa 9040495, Japan; [Jabbour, Michel] Univ Kentucky, Dept Math, Lexington, KY 40506 USA	Fried, E (reprint author), Okinawa Inst Sci & Technol, Math Soft Matter Unit, 1919-1 Tancha, Onna Son, Okinawa 9040495, Japan.	eliot.fried@oist.jp; jabbour@ms.uky.edu			Canada Research Chairs Program; National Science Foundation	EF gratefully acknowledges the support of the Canada Research Chairs Program. MJ acknowledges the support of the National Science Foundation and the hospitality extended by the Department of Mechanical Engineering and the Department of Mathematics and Statistics at McGill University.	Anderson DM, 2007, J FLUID MECH, V581, P323, DOI 10.1017/S0022112007005587; ESHELBY JD, 1956, SOLID STATE PHYS, V3, P79; Freund JB, 2003, PHYS FLUIDS, V15, pL33, DOI 10.1063/1.1565112; Fan H, 2006, J PHYS-CONDENS MAT, V18, P4481, DOI 10.1088/0953-8984/18/19/004; Bedeaux D, 2004, J CHEM PHYS, V120, P3744, DOI 10.1063/1.1643901; Billingham J, 2008, IMA J APPL MATH, V73, P4, DOI 10.1093/imamat/hxm042; Billingham J, 2006, EUR J APPL MATH, V17, P347, DOI 10.1017/S0956792506006589; ESHELBY JD, 1953, PHYS REV, V90, P248, DOI 10.1103/PhysRev.90.248; Fan H, 2001, PHYS FLUIDS, V13, P1615, DOI 10.1063/1.1369140; Fried E, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.061601; Fried E, 2012, J FLUID MECH, V703, P204, DOI 10.1017/jfm.2012.209; Gibbs J. W, 1876, T CONNECTICUT ACADEM, VIII, P108; Gurtin ME, 2000, CONFIGURATIONAL FORC; Gurtin ME, 2002, ARCH RATION MECH AN, V163, P171, DOI 10.1007/s002050200193; GURTIN ME, 1995, ARCH RATION MECH AN, V131, P67, DOI 10.1007/BF00386071; Laplace P.S., 1806, TRAITE MECANIQUE C S, VIV; Ward CA, 1998, J CHEM PHYS, V109, P3651, DOI 10.1063/1.476962; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005	18	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0044-2275	1420-9039		Z ANGEW MATH PHYS	Z. Angew. Math. Phys.	JUN	2015	66	3					1037	1059		10.1007/s00033-014-0424-7		23	Mathematics, Applied	Mathematics	CI3GC	WOS:000354634700028		
J	Ichimura, K; Narita, Y; Hawkins, CE				Ichimura, Koichi; Narita, Yoshitaka; Hawkins, Cynthia E.			Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers	ACTA NEUROPATHOLOGICA			English	Review						IDH1; ATRX; BRAF; Molecular classification; Next-generation sequencing; Astrocytoma	LOW-GRADE GLIOMAS; TERT PROMOTER MUTATIONS; NADP(+)-DEPENDENT ISOCITRATE DEHYDROGENASE; ADULT MALIGNANT GLIOMAS; IDH1 MUTATIONS; ANAPLASTIC ASTROCYTOMA; RANDOMIZED-TRIAL; BRAIN-TUMORS; MUTANT IDH1; RADIATION-THERAPY	Diffusely infiltrating astrocytomas include diffuse astrocytomas WHO grade II and anaplastic astrocytomas WHO grade III and are classified under astrocytic tumours according to the current WHO Classification. Although the patients generally have longer survival as compared to those with glioblastoma, the timing of inevitable malignant progression ultimately determines the prognosis. Recent advances in molecular genetics have uncovered that histopathologically diagnosed astrocytomas may consist of two genetically different groups of tumours. The majority of diffusely infiltrating astrocytomas regardless of WHO grade have concurrent mutations of IDH1 or IDH2, TP53 and ATRX. Among these astrocytomas, no other genetic markers that may distinguish grade II and grade III tumours have been identified. Those astrocytomas without IDH mutation tend to have a distinct genotype and a poor prognosis comparable to that of glioblastomas. On the other hand, diffuse astrocytomas that arise in children do not harbour IDH/TP53 mutations, but instead display mutations of BRAF or structural alterations involving MYB/MYBL1 or FGFR1. A molecular classification may thus help delineate diffusely infiltrating astrocytomas into distinct pathogenic and prognostic groups, which could aid in determining individualised therapeutic strategies.	[Ichimura, Koichi] Natl Canc Ctr, Div Brain Tumor Translat Res, Chuo Ku, Tokyo 1040045, Japan; [Narita, Yoshitaka] Natl Canc Ctr, Dept Neurooncol Neurosurg, Chuo Ku, Tokyo 1040045, Japan; [Hawkins, Cynthia E.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Pathol, Toronto, ON M5G 1X8, Canada; [Hawkins, Cynthia E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Ichimura, K (reprint author), Natl Canc Ctr, Div Brain Tumor Translat Res, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	kichimur@ncc.go.jp			Canadian Institutes of Health Research; Canadian Cancer Society Research Institute	The authors thank Dr Kai Yamasaki for his invaluable assistance in data mining, Dr Oltea Sampetrean for her valuable comments on the origin of gliomas, Drs Hiromichi Suzuki and Atsushi Natsume for sharing the information of their accepted manuscript and Dr Sylvia Kocialkowski for the critical reading of the manuscript. The results presented in this review here are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.CEH is funded by the Canadian Institutes of Health Research and the Canadian Cancer Society Research Institute.	Jiao YC, 2012, ONCOTARGET, V3, P709; Hartmann C, 2010, ACTA NEUROPATHOL, V120, P707, DOI 10.1007/s00401-010-0781-z; Pollack IF, 2011, CHILD NERV SYST, V27, P87, DOI 10.1007/s00381-010-1264-1; Reitman ZJ, 2010, J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; de Tayrac M, 2011, CLIN CANCER RES, V17, P317, DOI 10.1158/1078-0432.CCR-10-1126; Sahm F, 2014, ACTA NEUROPATHOL, V128, P551, DOI 10.1007/s00401-014-1326-7; Schomas DA, 2009, NEURO-ONCOLOGY, V11, P437, DOI 10.1215/15228517-2008-102; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Aghili M, 2009, J NEURO-ONCOL, V91, P233, DOI 10.1007/s11060-008-9706-2; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ohka F, 2014, TUMOR BIOL, V35, P5911, DOI 10.1007/s13277-014-1784-5; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Sabha N, 2014, NEURO-ONCOLOGY, V16, P914, DOI 10.1093/neuonc/not299; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Buczkowicz P, 2014, ACTA NEUROPATHOL, V128, P573, DOI 10.1007/s00401-014-1319-6; Watanabe T, 2009, ACTA NEUROPATHOL, V117, P653, DOI 10.1007/s00401-009-0528-x; Arita H, 2013, ACTA NEUROPATHOL, V126, P267, DOI 10.1007/s00401-013-1141-6; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Killela PJ, 2014, ONCOTARGET, V5, P1452; Soffietti R, 2010, EUR J NEUROL, V17, P1124, DOI 10.1111/j.1468-1331.2010.03151.x; Bleeker FE, 2010, ACTA NEUROPATHOL, V119, P487, DOI 10.1007/s00401-010-0645-6; Kato Y, 2009, BIOCHEM BIOPH RES CO, V390, P547, DOI 10.1016/j.bbrc.2009.10.001; Koelsche C, 2013, ACTA NEUROPATHOL, V126, P907, DOI 10.1007/s00401-013-1195-5; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Tortosa A, 2003, CANCER, V97, P1063, DOI 10.1002/cncr.11120; Dubbink HJ, 2009, NEUROLOGY, V73, P1792, DOI 10.1212/WNL.0b013e3181c34ace; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Ramkissoon LA, 2013, P NATL ACAD SCI USA, V110, P8188, DOI 10.1073/pnas.1300252110; Kranendijk M, 2010, SCIENCE, V330, P336, DOI 10.1126/science.1192632; Shaw EG, 2012, J CLIN ONCOL, V30, P3065, DOI 10.1200/JCO.2011.35.8598; Pallud J, 2010, ANN NEUROL, V68, P727, DOI 10.1002/ana.22106; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Wiestler B, 2013, ACTA NEUROPATHOL, V126, P443, DOI 10.1007/s00401-013-1156-z; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Bauman G, 2009, INT J RADIAT ONCOL, V75, P1401, DOI 10.1016/j.ijrobp.2009.01.010; Metellus P, 2010, ACTA NEUROPATHOL, V120, P719, DOI 10.1007/s00401-010-0777-8; Matar E, 2010, J CLIN NEUROSCI, V17, P993, DOI 10.1016/j.jocn.2009.12.015; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Potts MB, 2012, J NEUROSURG, V116, P365, DOI 10.3171/2011.9.JNS111068; Jaeckle KA, 2011, J NEURO-ONCOL, V104, P253, DOI 10.1007/s11060-010-0476-2; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Riemenschneider MJ, 2010, ACTA NEUROPATHOL, V120, P567, DOI 10.1007/s00401-010-0736-4; Remke M, 2013, ACTA NEUROPATHOL, V126, P917, DOI 10.1007/s00401-013-1198-2; van den Bent MJ, 2013, J CLIN ONCOL, V31, P344, DOI 10.1200/JCO.2012.43.2229; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Hughes LAE, 2013, CANCER RES, V73, P5858, DOI 10.1158/0008-5472.CAN-12-4306; Killela PJ, 2014, ONCOTARGET, V5, P1515; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Wiestler B, 2014, ACTA NEUROPATHOL, V128, P561, DOI 10.1007/s00401-014-1315-x; Capper D, 2010, AM J SURG PATHOL, V34, P1199, DOI 10.1097/PAS.0b013e3181e7740d; Brown PD, 2003, J CLIN ONCOL, V21, P2519, DOI 10.1200/JCO.2003.04.172; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Abedalthagafi M, 2013, MODERN PATHOL, V26, P1425, DOI 10.1038/modpathol.2013.90; Wick W, 2012, LANCET ONCOL, V13, P707, DOI 10.1016/S1470-2045(12)70164-X; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Sonoda Y, 2009, CANCER SCI, V100, P1996, DOI 10.1111/j.1349-7006.2009.01270.x; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Kannan K, 2012, ONCOTARGET, V3, P1194; Pallud J, 2009, NEURO-ONCOLOGY, V11, P176, DOI 10.1215/15228517-2008-066; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; Mur P, 2013, ACTA NEUROPATHOL, V126, P277, DOI 10.1007/s00401-013-1130-9; Wakimoto H, 2014, CLIN CANCER RES, V20, P2898, DOI 10.1158/1078-0432.CCR-13-3052; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Ahmadi R, 2012, J NEURO-ONCOL, V109, P15, DOI 10.1007/s11060-012-0863-y; van den Bent MJ, 2005, LANCET, V366, P985, DOI 10.1016/S0140-6736(05)67070-5; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Canoll P, 2008, ACTA NEUROPATHOL, V116, P465, DOI 10.1007/s00401-008-0432-9; ASARI S, 1994, NEURORADIOLOGY, V36, P308; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Horbinski C, 2013, ACTA NEUROPATHOL, V125, P621, DOI 10.1007/s00401-013-1106-9; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kim YH, 2010, AM J PATHOL, V177, P2708, DOI 10.2353/ajpath.2010.100680; Luchman HA, 2012, NEURO-ONCOLOGY, V14, P184, DOI 10.1093/neuonc/nor207; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Hartmann C, 2011, CLIN CANCER RES, V17, P4588, DOI 10.1158/1078-0432.CCR-10-3194; Takano S, 2011, BRAIN TUMOR PATHOL, V28, P115, DOI 10.1007/s10014-011-0023-7; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Karim ABMF, 1996, INT J RADIAT ONCOL, V36, P549, DOI 10.1016/S0360-3016(96)00352-5; Mistry M, 2015, J CLIN ONCOL, V33, P1015, DOI 10.1200/JCO.2014.58.3922; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Weller M, 2014, LANCET ONCOL, V15, pE395, DOI 10.1016/S1470-2045(14)70011-7; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Liu XY, 2012, ACTA NEUROPATHOL, V124, P615, DOI 10.1007/s00401-012-1031-3; Brandes AA, 2006, NEURO-ONCOLOGY, V8, P253, DOI 10.1215/15228517-2006-005; Reitman ZJ, 2015, BLOOD, V125, P336, DOI 10.1182/blood-2014-05-577940; Routhier CA, 2013, HUM PATHOL, V44, P2563, DOI 10.1016/j.humpath.2013.06.018; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Chaichana KL, 2010, J NEUROSURG, V112, P10, DOI 10.3171/2008.10.JNS08608; Mukasa A, 2012, CANCER SCI, V103, P587, DOI 10.1111/j.1349-7006.2011.02175.x; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Petalidis LP, 2008, MOL CANCER THER, V7, P1013, DOI 10.1158/1535-7163.MCT-07-0177; van den Bent MJ, 2013, J NEURO-ONCOL, V112, P173, DOI 10.1007/s11060-013-1056-z; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Shaw EG, 2008, J NEUROSURG, V109, P835, DOI 10.3171/JNS/2008/109/11/0835; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Sanai N, 2011, J NEUROSURG, V115, P948, DOI [10.3171/2011.7.JNS101238, 10.3171/2011.7.JNS10238]; Arita H, 2014, BRAIN TUMOR PATHOL; Arita H, 2015, BRAIN TUMOR PATHOL, V32, P22, DOI 10.1007/s10014-014-0186-0; Bechet D, 2014, ACTA NEUROPATHOL, V128, P733, DOI 10.1007/s00401-014-1337-4; BOGLER O, 1995, GLIA, V15, P308, DOI 10.1002/glia.440150311; Boisselier B, 2010, HUM MUTAT, V31, P1360, DOI 10.1002/humu.21365; Braganza MZ, 2014, BRIT J CANCER, V110, P242, DOI 10.1038/bjc.2013.611; Buckner JC, 2014, J CLIN ONCOL, V2014; Conomos Dimitri, 2013, Front Oncol, V3, P27, DOI 10.3389/fonc.2013.00027; Daikhin Y, 2000, AM SOC NUTR SCI, V130, P1026; Felsberg J, 2010, ACTA NEUROPATHOL, V119, P501, DOI 10.1007/s00401-010-0647-4; Fisher BJ, 2013, ASCO M, V31, P2008; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gibbons R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-15; Gillet E, 2014, J NEURO-ONCOL, V118, P131, DOI 10.1007/s11060-014-1407-4; Guan XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091216; Gupta R, 2013, MODERN PATHOL, V26, P619, DOI 10.1038/modpathol.2012.210; Horbinski C, 2010, J MOL DIAGN, V12, P487, DOI 10.2353/jmoldx.2010.090228; Ihle MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-13; Jakola AS, 2012, JAMA-J AM MED ASSOC, V308, P1; JAMES CD, 1989, P NATL ACAD SCI USA, V86, P2858, DOI 10.1073/pnas.86.8.2858; Kato Y, 2015, BRAIN TUMOR PATHOL, V32, P3, DOI 10.1007/s10014-014-0202-4; Kim SY, 2003, FREE RADICAL RES, V37, P309, DOI 10.1080/1071576021000050429; Kizilbash SH, 2014, J NEURO-ONCOL, V120, P85, DOI 10.1007/s11060-014-1520-4; Lindberg N, 2014, J NEUROSCI, V34, P14644, DOI 10.1523/JNEUROSCI.2977-14.2014; Louis DN, 2007, WHO CLASSIFICATION T; Louis DN, 2014, BRAIN PATHOL; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Mangerel J, 2014, ACTA NEUROPATHOL, V128, P853, DOI 10.1007/s00401-014-1348-1; Thomas D, 2001, J CLIN ONCOL, V19, P509; Narita Y, 2013, NEUROL MED-CHIR, V53, P429; Noble M, 2004, TRENDS NEUROSCI, V27, P148, DOI 10.1016/j.tins.2003.12.007; Olar A, 2015, ACTA NEUROPATHOL; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P1, DOI 10.1093/neuonc/nou223; Patay Z, 2014, J INHERIT METAB DIS, V38, P273; Reuss DE, 2015, ACTA NEUROPATHOL, V129, P133, DOI 10.1007/s00401-014-1370-3; Schwartzentruber J, 2012, NATURE, V482, P226, DOI 10.1038/nature10833; Scoccianti S, 2012, NEURO-ONCOLOGY, V14, P798, DOI 10.1093/neuonc/nos081; Shonka NA, 2013, J NEURO-ONCOL, V113, P305, DOI 10.1007/s11060-013-1116-4; Suzuki H, 2015, NAT GENET; Takami H, 2014, BRAIN PATHOL; The Committee of Brain Tumor Registry of Japan, 2014, NEUROL MED CHIR TOKY, V54, P1; Venneti S, 2013, BRAIN PATHOL; Venneti S, 2014, ACTA NEUROPATHOL, V128, P743, DOI 10.1007/s00401-014-1338-3; Wiestler B, 2014, NEURO-ONCOLOGY, V16, P1630, DOI 10.1093/neuonc/nou138; Zong H, 2015, COLD SPRING HARB PER	163	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	JUN	2015	129	6					789	808		10.1007/s00401-015-1439-7		20	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CI4GO	WOS:000354706600003		
J	Takahashi, M; Miyata, H; Kametani, F; Nonaka, T; Akiyama, H; Hisanaga, S; Hasegawa, M				Takahashi, Muneaki; Miyata, Haruka; Kametani, Fuyuki; Nonaka, Takashi; Akiyama, Haruhiko; Hisanaga, Shin-ichi; Hasegawa, Masato			Extracellular association of APP and tau fibrils induces intracellular aggregate formation of tau	ACTA NEUROPATHOLOGICA			English	Article						Tau; Amyloid precursor protein; Propagation; Alzheimer's disease; Down's syndrome	AMYLOID PRECURSOR PROTEIN; PATHOLOGICAL ALPHA-SYNUCLEIN; TRAUMATIC BRAIN-INJURY; FAMILIAL ALZHEIMERS-DISEASE; LOCUS DUPLICATION; DOWNS-SYNDROME; CEREBROSPINAL-FLUID; MOUSE-BRAIN; RAT; PHOSPHORYLATION	Alzheimer's disease (AD) is characterized by extracellular amyloid beta (A beta) deposition and intracellular tau aggregation. Many studies have indicated some association between these processes, but it remains unknown how the two pathologies are linked. In this study, we investigated whether expression of amyloid precursor protein (APP) influences extracellular seed-dependent intracellular tau accumulation in cultured cells. Treatment of tau-expressing SH-SY5Y cells with A beta fibrils did not induce intracellular tau aggregation. On the other hand, in cells expressing both tau and APP, treatment with tau fibrils or Sarkosyl-insoluble tau from AD brains induced intracellular tau aggregation. The seed-dependent intracellular tau aggregation was not induced by expression of APP lacking the extracellular domain. The amount of phosphorylated tau aggregates in cultured cells was dose dependently elevated in response to increased levels of APP on the cell membrane. Our results indicate that the extracellular region of APP is involved in uptake of tau fibrils into cells, raising the possibility that APP, but not A beta, influences cell-to-cell spreading of tau pathologies in AD by serving as a receptor of abnormal tau aggregates.	[Takahashi, Muneaki; Miyata, Haruka; Kametani, Fuyuki; Nonaka, Takashi; Akiyama, Haruhiko; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Setagaya Ku, Tokyo 1568506, Japan; [Takahashi, Muneaki; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Lab Mol Neurosci, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan	Hasegawa, M (reprint author), Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Setagaya Ku, Tokyo 1568506, Japan.	hasegawa-ms@igakuken.or.jp			MEXT KAKENHI [26117005, 23240050, 24111556]; MHLW [12946221]	This work was supported by MEXT KAKENHI Grant Numbers 26117005, 23240050 (to MH), 24111556 (to TN) and MHLW Grant ID Number 12946221 (to MH).	Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Selkoe DJ, 2001, PHYSIOL REV, V81, P741; Kandalepas PC, 2012, J NEUROCHEM, V120, P55, DOI 10.1111/j.1471-4159.2011.07512.x; Kasuga K, 2009, J NEUROL NEUROSUR PS, V80, P1050, DOI 10.1136/jnnp.2008.161703; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Wilcock DM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-84; Ferrari A, 2003, J BIOL CHEM, V278, P40162, DOI 10.1074/jbc.M308243200; Michel CH, 2014, J BIOL CHEM, V289, P956, DOI 10.1074/jbc.M113.515445; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Rovelet-Lecrux A, 2007, J NEUROL NEUROSUR PS, V78, P1158, DOI 10.1136/jnnp.2006.113514; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Song YL, 2014, PROTEIN SCI, V23, P1, DOI 10.1002/pro.2385; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Lannfelt L, 2014, J INTERN MED, V275, P284, DOI 10.1111/joim.12168; Kume H, 2006, BIOCHEM BIOPH RES CO, V349, P1356, DOI 10.1016/j.bbrc.2006.08.181; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Braak H, 2013, ACTA NEUROPATHOL, V126, P631, DOI 10.1007/s00401-013-1139-0; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Pierce JES, 1996, J NEUROSCI, V16, P1083; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Pierrot N, 2013, EMBO MOL MED, V5, P608, DOI 10.1002/emmm.201202215; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Mairet-Coello G, 2013, NEURON, V78, P94, DOI 10.1016/j.neuron.2013.02.003; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; LEWEN A, 1995, NEUROREPORT, V6, P357; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Sleegers K, 2006, BRAIN, V129, P2977, DOI 10.1092/brain/awl203; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Guyant-Marechal I, 2008, Neurology, V71, P1925, DOI 10.1212/01.wnl.0000339400.64213.56; HAASS C, 1994, J BIOL CHEM, V269, P17741; KAMETANI F, 1994, FEBS LETT, V351, P165, DOI 10.1016/0014-5793(94)00851-5; McNaughton D., 2012, NEUROBIOL AGING, V426, pe13, DOI [10.1016/j.neurobiolaging.2010.10.010, DOI 10.1016/J.NEUR0BI0LAGING]; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; Paudel HK, 1999, J BIOL CHEM, V274, P8029, DOI 10.1074/jbc.274.12.8029; Purushothuman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059740; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203	61	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	JUN	2015	129	6					895	907		10.1007/s00401-015-1415-2		13	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CI4GO	WOS:000354706600009		
J	Takahashi, H; Matsubara, S				Takahashi, Hironori; Matsubara, Shigeki			Intrauterine hypoechoic mass cephalad to cesarean scar pregnancy	ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA			English	Letter									[Takahashi, Hironori; Matsubara, Shigeki] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan.	matsushi@jichi.ac.jp					Cok T, 2015, J OBSTET GYNAECOL RE, V41, P803, DOI 10.1111/jog.12627; Nagy S, 2003, OBSTET GYNECOL, V102, P94, DOI 10.1016/S0029-7844(03)00403-4; Liang FB, 2010, ACTA OBSTET GYN SCAN, V89, P1592, DOI 10.3109/00016349.2010.512973; Timor-Tritsch IE, 2014, ULTRASOUND OBST GYN, V44, P346, DOI 10.1002/uog.13426; Cheng LY, 2014, FERTIL STERIL, V102, P1085; Michener C, 2009, AUST NZ J OBSTET GYN, V49, P451, DOI 10.1111/j.1479-828X.2009.01067.x	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6349	1600-0412		ACTA OBSTET GYN SCAN	Acta Obstet. Gynecol. Scand.	JUN	2015	94	6					670	671		10.1111/aogs.12628		2	Obstetrics & Gynecology	Obstetrics & Gynecology	CI0AP	WOS:000354398300019		
J	Olalla, HR; Velez, LN; Kato, H; Hashiguchi, K; Caceres, AG; Gomez, EA; Zambrano, FC; Romero-Alvarez, DA; Guevara, AG; Hashiguchi, Y				Olalla, Hector R.; Velez, Lenin N.; Kato, Hirotomo; Hashiguchi, Kazue; Caceres, Abraham G.; Gomez, Eduardo A.; Zambrano, Flavio C.; Romero-Alvarez, Daniel A.; Guevara, Angel G.; Hashiguchi, Yoshihisa			An analysis of reported cases of leishmaniasis in the southern Ecuadorian Amazon region, 1986-2012	ACTA TROPICA			English	Article						Cutaneous leishmaniasis; Retrospective analysis; Reported cases; Southern Ecuadorian Amazon region	CUTANEOUS LEISHMANIASIS; NATURAL INFECTION; LUTZOMYIA-AYACUCHENSIS; VIANNIA NAIFFI; IDENTIFICATION; ELECTROPHORESIS; EPIDEMIOLOGY; PARASITES; MEXICANA; VECTOR	An analysis of reported cases of cutaneous leishmaniasis (CL) was performed using the data registered in the southern Ecuadorian Amazon region during 27 years from 1986 to 2012. The cases/subjects with both the suspected CL lesions and the amastigote-positive results were recruited for the analysis. The yearly occurrence of cases showed a markedly higher number during the six years, 1988 and 1993. After 1994 when the insecticide spraying campaign using helicopter in 1993-1994, the number dropped remarkably. Then, the yearly occurrence gradually fluctuated from 101 cases in 1996 to 11 in 2009, maintaining a low number of cases after the campaign. The monthly occurrence of cases showed a markedly high number during March and August, suggesting a correlation to the rainy season (months) in the areas. A statistical significance was found between the monthly average number of the CL case and the average precipitation (p = 0.01474). It was suggested that the time of transmission of CL would depend on the rainy seasons at each endemic area of Ecuador, which has a diverse climatic feature depending on the geographic regions. Such information at given leishmaniasis-endemic areas of Ecuador would be important for the future planning of the disease control. Molecular analysis and characterization of clinical samples revealed the presence of Leishmania (Viannia) braziliensis. (C) 2015 Elsevier B.V. All rights reserved.	[Olalla, Hector R.] Hosp Zumba, Zamora Chinchipe, Ecuador; [Velez, Lenin N.; Gomez, Eduardo A.] Univ Catolica Guayaquil, Fac Med, Dept Med Trop, Guayaquil, Ecuador; [Velez, Lenin N.; Gomez, Eduardo A.; Zambrano, Flavio C.] SNEM, Guayaquil, Ecuador; [Kato, Hirotomo] Hokkaido Univ, Grad Sch Vet Med, Parasitol Lab, Dept Dis Control, Sapporo, Hokkaido, Japan; [Hashiguchi, Kazue; Romero-Alvarez, Daniel A.; Guevara, Angel G.; Hashiguchi, Yoshihisa] Univ Cent Ecuador, Fac Ciencias Med, Ctr Biomed, Quito, Pichincha, Ecuador; [Caceres, Abraham G.] Univ Nacl Mayor San Marcos, Fac Med Humana, Dept Acad Microbiol Med, Lima 14, Peru; [Caceres, Abraham G.] INS, Lima, Peru; [Hashiguchi, Yoshihisa] Secretaria Nacl Educ Super Ciencia Tecnol & Innov, Proyectoprometeo, Quito, Ecuador; [Hashiguchi, Yoshihisa] Kochi Univ, Kochi Med Sch, Dept Parasitol, Kochi 780, Japan	Hashiguchi, Y (reprint author), Univ Cent Ecuador, Fac Ciencias Med, Ctr Biomed, Sodiro N-14121 & Iquique, Quito, Pichincha, Ecuador.	yhashiguchi42@yahoo.co.jp	Kato, Hirotomo/A-4820-2012	Kato, Hirotomo/0000-0001-5429-9536	Ministry of Education, Culture and Sports, Science and Technology (MEXT) of Japan [23256002, 25257501]; Prometeo Project of the Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT), Ecuador	This study was financially supported by the Ministry of Education, Culture and Sports, Science and Technology (MEXT) of Japan (Grant Nos. 23256002 and 25257501), and the Prometeo Project of the Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT), Ecuador.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amunarriz M. U., 1982, SALUD ENFERMEDAD PAT, P71; Franke CR, 2002, EMERG INFECT DIS, V8, P914, DOI 10.3201/eid0809.010523; Kato H, 2013, ACTA TROP, V128, P710, DOI 10.1016/j.actatropica.2013.09.001; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; Calvopina M, 2004, MEM I OSWALDO CRUZ, V99, P663, DOI 10.1590/S0074-02762004000700001; Gomez EA, 2014, ACTA TROP, V137, P118, DOI 10.1016/j.actatropica.2014.05.006; Kato H, 2008, AM J TROP MED HYG, V79, P438; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; GRIMALDI G, 1989, AM J TROP MED HYG, V41, P687; MIMORI T, 1989, AM J TROP MED HYG, V40, P154; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; ARMIJOS RX, 1990, AM J TROP MED HYG, V42, P424; Calero G. H., 1981, ANAL MED CIRUG, V4, P28; Calvopina M., 2012, ECUADOR REV FAC CIEN, V37, P31; Carrera C. T., 1953, REV ECUAT ENTOMOL PA, V1, P76; Chaves L. F., 2006, PLOS MED, V3, pe298; Feliciangeli MD, 1998, MED VET ENTOMOL, V12, P121; Furuya M., 1997, RES REP SERIES, V5, P11; Gomez EA, 2014, ACTA TROP, V140, P41, DOI 10.1016/j.actatropica.2014.07.003; GOMEZ EAL, 1991, ANN TROP MED PARASIT, V85, P407; Hashiguchi Y., 1991, Bulletin of the Pan American Health Organization, V25, P64; HASHIGUCHI Y, 1984, Japanese Journal of Parasitology, V33, P393; HASHIGUCHI Y, 1991, AM J TROP MED HYG, V44, P205; Heinert J. F., 1924, ANAL SOC MED QUIRURU, V3, P450; LEON L A, 1951, Rev Kuba Med Trop Parasitol, V7, P31; LEPONT F, 1994, ANN SOC BELG MED TR, V74, P43; Rabinovich L. E., 2004, AM J TROP MED HYG, V70, P373; RODRIGUEZ J D, 1953, Rev Ecuat Hig Med Trop, V10, P35; Rodriguez J. D. M., 1974, LECCIONES PARASITOLO, P170	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	JUN	2015	146						119	126		10.1016/j.actatropica.2015.03.015		8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CI3QI	WOS:000354662100019		
J	Terao, Y; Taniguchi, K; Tomita, S				Terao, Yasunobu; Taniguchi, Koichiro; Tomita, Shoichi			A New Method for Inframammary Fold Recreation Using a Barbed Suture	AESTHETIC PLASTIC SURGERY			English	Article						Breast reconstruction; Barbed sutures; Inframammary fold; Breast implants	THORACIC ADVANCEMENT FLAP; BREAST RECONSTRUCTION; FASCIAL SYSTEM; MASTECTOMY	There are inherent limitations with previously reported inframammary fold (IMF) recreation methods. The IMF is firmly fixed to the chest wall, but not physiologically, and it is difficult to determine the correct IMF position in the supine position and in the absence of an implant. With our new IMF reconstruction method (i.e., drawstring method), the IMF is recreated by drawing a barbed suture, penetrating the dermis, along the IMF. The barbed suture is fixed to the costal cartilage at the medial IMF, and the head is drawn and cut externally at the lateral IMF. The IMF level and depth can be finely adjusted by the tension, in a seated position after implant insertion. Furthermore, the approach can be from a small incision, and a smooth IMF curve is reconstructed. Our drawstring method was performed in 102 patients who underwent reconstruction using a breast implant (n = 95) or flap (n = 7). The mean patient age was 52.0 years (range 33-77 years) and the follow-up period was 12 months (range 3-18 months). Suture or implant infection or exposure did not occur. Suture slack occurred in ten patients with implant-based reconstruction; their IMF became shallow. Insufficient skin expansion (P < 0.005) and strong traction of the barbed suture from the caudal side (P < 0.05) were related to IMF slack. The total revision rate was 2.9 %. With sufficient skin expansion, the drawstring method using a barbed suture enables smooth and symmetrical IMF reconstruction. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.	[Terao, Yasunobu; Taniguchi, Koichiro] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138677, Japan; [Tomita, Shoichi] Jikei Univ, Sch Med, Dept Plast & Reconstruct Surg, Minato Ku, Tokyo, Japan	Terao, Y (reprint author), Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Plast & Reconstruct Surg, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan.	y.terao@cick.jp					Muntan CD, 2000, PLAST RECONSTR SURG, V105, P549, DOI 10.1097/00006534-200002000-00011; Nava M, 1998, PLAST RECONSTR SURG, V102, P1034, DOI 10.1097/00006534-199809040-00018; Hirsch EM, 2014, ANN PLAS SURG, V72, P388, DOI 10.1097/SAP.0b013e318268a81d; Carlson GW, 1996, PLAST RECONSTR SURG, V98, P447, DOI 10.1097/00006534-199609000-00012; Bogetti P, 2007, J PLAST RECONSTR AES, V60, P1225, DOI 10.1016/j.bjps.2005.11.046; Behranwala KA, 2002, BREAST, V11, P340, DOI 10.1054/brst.448; DOWDEN RV, 1987, ANN PLAS SURG, V19, P524, DOI 10.1097/00000637-198712000-00009; Gui GPH, 2004, BRIT J PLAST SURG, V57, P146, DOI 10.1016/j.bjps.2003.11.030; HANDEL N, 1992, PLAST RECONSTR SURG, V89, P558, DOI 10.1097/00006534-199203000-00030; LOCKWOOD TE, 1991, PLAST RECONSTR SURG, V87, P1009, DOI 10.1097/00006534-199106000-00001; MAY JW, 1987, PLAST RECONSTR SURG, V79, P272, DOI 10.1097/00006534-198702000-00023; PENNISI VR, 1977, PLAST RECONSTR SURG, V60, P523, DOI 10.1097/00006534-197710000-00004; Pinella JW, 1989, PLAST RECONSTR SURG, V83, P925; RYAN JJ, 1982, PLAST RECONSTR SURG, V70, P153, DOI 10.1097/00006534-198208000-00004; VERSACI AD, 1987, PLAST RECONSTR SURG, V80, P387, DOI 10.1097/00006534-198709000-00009; Wechselberger G, 2003, ANN PLAS SURG, V50, P433, DOI 10.1097/01.SAP.0000037279.69711.53	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-216X	1432-5241		AESTHET PLAST SURG	Aesthet. Plast. Surg.	JUN	2015	39	3					379	385		10.1007/s00266-015-0479-7		7	Surgery	Surgery	CI2ZJ	WOS:000354616600014		
J	Takahashi, S; Suzuki, T; Nakamura-Tomizuka, S; Osaki, K; Sotome, Y; Sagawa, T; Uchiyama, M				Takahashi, Sakae; Suzuki, Takahiro; Nakamura-Tomizuka, Sakura; Osaki, Koichi; Sotome, Yuta; Sagawa, Tomoaki; Uchiyama, Makoto			Case history and genome-wide scans for copy number variants in a family with patient having 15q11.1-q11.2 duplication and 22q11.2 deletion, and schizophrenia	AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS			English	Article						schizophrenia; copy number variant; 15q11 duplication; 22q11 deletion	HETEROGENEITY	Many studies have indicated that chromosomes 15q11 and 22q11 may be associated with the genetic etiologies of schizophrenia. We have followed an adult schizophrenia case with 15q11.1-q11.2 duplication and 22q11.2 deletion. Here we report his clinical history, and copy number variants (CNVs) identified by microarray and real-time PCR in the patient and his parents. This is the first report describing a detailed phenotype of an adult schizophrenic case with both 15q11 and 22q11 CNVs as revealed by novel and trustworthy technologies. Subjects were a 33-year-old male patient with 15q11 and 22q11 CNVs, and his normal parents. He fulfilled the DSM-IV criteria for schizophrenia at age 18 years. He was also diagnosed with 22q11.2 deletion syndrome by fluorescence in situ hybridization (FISH) at age 18 years. To search for CNVs in more detail, whole-genome array-CGH analyses including approximate to 420,000 probes were carried out in the patient and his parents. For validations of the CNVs detected by array-CGH, real-time PCR analyses of these CNVs were performed. The patient had two disease-specific CNVs, 15q11.1-q11.2 duplication (approximate to 2.7Mb) and 22q11.21 deletion (approximate to 2.9Mb). These two regions are important for the development of schizophrenia, and this patient had shown symptoms of schizophrenia. Thus, the two areas may contain causal genes for schizophrenia. (c) 2015 Wiley Periodicals, Inc.	[Takahashi, Sakae; Suzuki, Takahiro; Nakamura-Tomizuka, Sakura; Osaki, Koichi; Sotome, Yuta; Sagawa, Tomoaki; Uchiyama, Makoto] Nihon Univ, Sch Med, Div Psychiat, Dept Psychiat, Tokyo 1738610, Japan	Takahashi, S (reprint author), Nihon Univ, Sch Med, Div Psychiat, Dept Psychiat,Itabashi Ku, 30-1 Oyaguchi, Tokyo 1738610, Japan.	takahashi.sakae@nihon-u.ac.jp					Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Takahashi S, 2013, AM J MED GENET B, V162, P648, DOI 10.1002/ajmg.b.32161; Rees E, 2014, HUM MOL GENET, V23, P1669, DOI 10.1093/hmg/ddt540; Ingason A, 2011, AM J PSYCHIAT, V168, P408, DOI 10.1176/appi.ajp.2010.09111660; Williams NM, 2008, HUM MOL GENET, V17, P555, DOI 10.1093/hmg/ddm330; Bassett AS, 2005, AM J MED GENET A, V138A, P307, DOI 10.1002/ajmg.a.30984; TSUANG MT, 1995, SCHIZOPHR RES, V17, P161, DOI 10.1016/0920-9964(95)00057-S; Williams HJ, 2013, AM J MED GENET B, V162B, P177, DOI 10.1002/ajmg.b.32129; Szatkiewicz JP, 2014, MOL PSYCHIATR, V19, P762, DOI 10.1038/mp.2014.40; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Catts VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035511; Domula M, 2007, PHARMACOPSYCHIATRY, V40, P38, DOI 10.1055/s-2006-958525; Kirov G, 2005, J CLIN INVEST, V115, P1440, DOI 10.1172/JCI24759; Manolakos E, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-6; Rodriguez-Murillo L, 2012, ANNU REV MED, V63, P63, DOI 10.1146/annurev-med-072010-091100; Stewart LR, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-154	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4841	1552-485X		AM J MED GENET B	Am. J. Med. Genet. B	JUN	2015	168	4					229	235		10.1002/ajmg.b.32307		7	Genetics & Heredity; Psychiatry	Genetics & Heredity; Psychiatry	CI3IA	WOS:000354640100001		
J	Kamata, T; Yoshida, A; Kosuge, T; Watanabe, S; Asamura, H; Tsuta, K				Kamata, Tsugumasa; Yoshida, Akihiko; Kosuge, Tomoo; Watanabe, Shun-ichi; Asamura, Hisao; Tsuta, Koji			Ciliated Muconodular Papillary Tumors of the Lung A Clinicopathologic Analysis of 10 Cases	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						tumor; lung; mucus; diagnosis	GRADE MALIGNANT-TUMOR; ADENOCARCINOMA; PAPILLOMAS; CARCINOMA; MUCIN	Ciliated muconodular papillary tumors (CMPTs) are rare peripheral nodules of the lung first described in 2002. Because of their rarity and nonstandardized diagnostic terminology, CMPTs have been poorly recognized among pathologists. To better characterize these lesions, we undertook a detailed clinicopathologic and immunohistochemical study of 10 archival cases. Ten CMPTs occurred in 7 men and 3 women with a median age of 62 years. All were small peripheral non-endobronchial nodules with a mean diameter of 1.0 cm. All but 1 tumor were incidentally detected by computed tomography-based screening, all of which were radiologically interpreted as adenocarcinomas. Although limited surgery treated all but 1 CMPT, they followed a benign course with no recurrence at a mean follow-up of 43 months (range: 2 to 88 mo). Histologically, CMPTs showed glandular and/or papillary architecture, comprising a vaguely organized mixture of nonatypical ciliated columnar cells, mucous cells, and basal cells, often enveloped by copious intra-alveolar mucin. Micropapillary tufts of ciliated cells and seemingly discontinuous growth along alveolar walls were occasionally present, mimicking adenocarcinomas. Ciliated cells and basal cells were immunopositive for TTF-1 and p40, respectively, whereas mucous cells lacked HNF4 alpha expression. CMPTs are rare, likely benign, underrecognized processes of the lung that should be distinguished from adenocarcinomas.	[Kamata, Tsugumasa; Yoshida, Akihiko; Tsuta, Koji] Natl Canc Ctr, Div Pathol & Clin Labs, Tokyo 1040045, Japan; [Kamata, Tsugumasa; Watanabe, Shun-ichi] Natl Canc Ctr, Div Thorac Surg, Tokyo 1040045, Japan; [Kosuge, Tomoo] Natl Canc Ctr, Div Hepatobiliary & Pancreat Surg, Tokyo 1040045, Japan; [Kamata, Tsugumasa; Kosuge, Tomoo] Juntendo Univ, Grad Sch Med, Adv Clin Res Canc, Tokyo, Japan; [Asamura, Hisao] Keio Univ, Sch Med, Dept Surg, Div Gen Thorac Surg, Tokyo 160, Japan	Tsuta, K (reprint author), Natl Canc Ctr, Div Pathol & Clin Labs, Chuo Ku, 1-1 Tsukiji 5 Chome, Tokyo 1040045, Japan.	ktsuta@ncc.go.jp			National Cancer Center Research and Development Fund [26-A-13, 24-A-1];  [25460446]	Supported in part by the National Cancer Center Research and Development Fund 26-A-13 and 24-A-1, and Grant-in-Aid for Scientific Research (C) Grant Number 25460446. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.	Tsuta K, 2006, J PATHOL, V209, P78, DOI 10.1002/path.1947; Nair AR, 2014, INT J SURG PATHOL, V22, P540, DOI 10.1177/1066896913510027; Arai Y, 2010, HISTOPATHOLOGY, V56, P265, DOI 10.1111/j.1365-2559.2009.03463.x; Flieder DB, 1998, AM J SURG PATHOL, V22, P1328, DOI 10.1097/00000478-199811000-00003; Inamura K, 2011, PATHOL INT, V61, P252, DOI 10.1111/j.1440-1827.2011.02659.x; Aida S, 2008, AM J SURG PATHOL, V32, P1489, DOI 10.1097/PAS.0b013e31817a9061; Fukuoka J, 2005, AM J SURG PATHOL, V29, P948, DOI 10.1097/01.pas.0000168177.71405.ac; Choi KH, 2008, PATHOL INT, V58, P735, DOI 10.1111/j.1440-1827.2008.02302.x; Chuang HW, 2014, PATHOL INT, V64, P352, DOI 10.1111/pin.12179; Churg A, 2005, THURLBECKS PATHOLOGY; Emerson LL, 2012, PATHOL RES PRACT, V208, P726, DOI 10.1016/j.prp.2012.09.007; Harada T, 2008, RESPIR MED CME, V1, P176, DOI 10.1016/j.rmedc.2008.04.005; Hata Y, 2013, JPN J CLIN ONCOL, V43, P205, DOI 10.1093/jjco/hys218; Ishikawa Y, 2002, BYORI RINSHO, V20, P964; Kaseda K, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-149; KODAMA T, 1984, AM J SURG PATHOL, V8, P845, DOI 10.1097/00000478-198411000-00005; Koss LG, 2005, KOSS DIAGNOSTIC CYTO; NAKAMURA S, 1992, ACTA PATHOL JAPON, V42, P745; Sato S, 2010, INTERACT CARDIOV TH, V11, P685, DOI 10.1510/icvts.2009.229989; Sugano M, 2013, AM J SURG PATHOL, V37, P211, DOI 10.1097/PAS.0b013e31826be303; Travis WD, 2004, WHO CLASSIFICATION T; WENIG BM, 1995, HUM PATHOL, V26, P1099, DOI 10.1016/0046-8177(95)90272-4	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	JUN	2015	39	6					753	760				8	Pathology; Surgery	Pathology; Surgery	CI1EP	WOS:000354485400004		
J	Haratake, J; Yasunaga, C; Ootani, A; Shimajiri, S; Matsuyama, A; Hisaoka, M				Haratake, Joji; Yasunaga, Chikao; Ootani, Akifumi; Shimajiri, Shohei; Matsuyama, Atsuji; Hisaoka, Masanori			Peculiar Histiocytic Lesions With Massive Lanthanum Deposition in Dialysis Patients Treated With Lanthanum Carbonate	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						lanthanum carbonate; mucosal deposition; stomach; histiocytosis; dialysis	GASTROINTESTINAL-TRACT; PHOSPHATE BINDERS; MUCOSAL-INJURY; RENAL-FAILURE; THERAPY	Pathologic lesions caused by lanthanum carbonate (LC), a recently developed phosphate-binding agent, have not been recorded. A peculiar gastroduodenal histiocytic lesion associated with a mucosal lanthanum overload was reported. Our routine gastrointestinal biopsy series included 6 cases with heavy lanthanum burden in the gastroduodenal mucosa. In addition to routine histopathologic examinations, a series of immunohistochemical analysis and electron microscopic examinations associated with x-ray diffraction and elemental analysis were performed. Six cases, 3 of male and 3 of female individuals with ages from 59 to 69 years, were all patients of end-stage renal diseases managed under dialysis and treated with LC for >21 months. Endoscopic examinations demonstrated gastric erosions in 3, gastric polyps in 2, and duodenal ulcer in 1. In the mucosal layer, there were numerous non-Langerhans cell histiocytes, stained with CD68 but not S100 protein, engulfing a large amount of mineral-like materials. An electron microscopic and elemental analysis revealed a similar distribution of lanthanum and phosphorus in the histiocytes. Long-standing LC administration can cause massive mucosal accumulation of lanthanum in the tissue histiocytes associated with several forms of gastroduodenal lesions. A long-standing outcome is not clear at present; hence, careful follow-up studies of these patients may be needed.	[Haratake, Joji] Saiseikai Yahata Gen Hosp, Div Pathol, Kitakyushu, Fukuoka 8050050, Japan; [Yasunaga, Chikao] Saiseikai Yahata Gen Hosp, Kidney Ctr, Kitakyushu, Fukuoka 8050050, Japan; [Ootani, Akifumi] Saiseikai Yahata Gen Hosp, Div Endoscop Res & Gastroenterol, Kitakyushu, Fukuoka 8050050, Japan; [Shimajiri, Shohei; Matsuyama, Atsuji] Univ Occupat & Environm Hlth, Sch Med, Dept Surg Pathol, Kitakyushu, Fukuoka 807, Japan; [Hisaoka, Masanori] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol, Kitakyushu, Fukuoka 807, Japan	Haratake, J (reprint author), Saiseikai Yahata Gen Hosp, Div Pathol, Yahatahigashi Ku, 5-9-27 Harunomachi, Kitakyushu, Fukuoka 8050050, Japan.	haratake@yahata.saiseikai.or.jp					Abraham SC, 1999, MODERN PATHOL, V12, P1152; Davis RL, 2009, NEPHROL DIAL TRANSPL, V24, P3247, DOI 10.1093/ndt/gfp364; Crowder CD, 2009, AM J SURG PATHOL, V33, P963, DOI 10.1097/PAS.0b013e31817ed787; Jamal SA, 2013, LANCET, V382, P1268, DOI 10.1016/S0140-6736(13)60897-1; Nakai S, 2013, THER APHER DIAL, V17, P567, DOI 10.1111/1744-9987.12147; Albaaj F, 2005, INT J CLIN PRACT, V59, P1091, DOI 10.1111/j.1368-5031.2005.00592.x; Lacour B, 2005, KIDNEY INT, V67, P1062, DOI 10.1111/j.1523-1755.2005.00171.x; GREENSON JK, 1993, AM J SURG PATHOL, V17, P45, DOI 10.1097/00000478-199301000-00005; Muller C, 2009, NEPHROL DIAL TRANSPL, V24, P3245, DOI 10.1093/ndt/gfp340; Cerny S, 2006, NEW ENGL J MED, V355, P1160, DOI 10.1056/NEJMicm050535; Ervo R, 2012, J NEPHROL, V25, P490; Haig A, 2006, HISTOPATHOLOGY, V48, P808, DOI 10.1111/j.1365-2559.2006.02448.x; HARATAKE J, 1987, CANCER, V60, P1269, DOI 10.1002/1097-0142(19870915)60:6<1269::AID-CNCR2820600618>3.0.CO;2-A; Kato A, 2010, CLIN EXP NEPHROL, V14, P100, DOI 10.1007/s10157-009-0240-0; Swanson BJ, 2013, AM J SURG PATHOL, V37, P1686, DOI 10.1097/PAS.0b013e3182999d8d; Voltaggio L, 2014, J CLIN PATHOL, V67, P903, DOI 10.1136/jclinpath-2014-202511; Yamada S, 2012, INTERNAL MED, V51, P2097, DOI 10.2169/internalmedicine.51.6814	17	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	JUN	2015	39	6					767	771				5	Pathology; Surgery	Pathology; Surgery	CI1EP	WOS:000354485400006		
J	Sakata, N; Sax, N; Yoshimatsu, G; Tsuchiya, H; Kato, S; Aoki, T; Ishida, M; Katayose, Y; Egawa, S; Kodama, T; Unno, M				Sakata, N.; Sax, N.; Yoshimatsu, G.; Tsuchiya, H.; Kato, S.; Aoki, T.; Ishida, M.; Katayose, Y.; Egawa, S.; Kodama, T.; Unno, M.			Enhanced Ultrasonography Using a Nano/Microbubble Contrast Agent for Islet Transplantation	AMERICAN JOURNAL OF TRANSPLANTATION			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MOUSE PANCREATIC-ISLETS; IN-VIVO; ULTRASOUND; TUMORS; MICROBUBBLES; ANGIOGENESIS; REGENERATION; COMBINATION; PATTERNS	Recent basic and clinical studies have assessed the use of highly sensitive imaging modalities for visualizing transplanted islets. We investigated the utility of enhanced ultrasonography, combined with fluorescent acoustic liposome nano/microbubbles (FALs), for evaluating angiogenesis and the endocrine function of transplanted islets. BALB/c mice were classified into three groups: Diabetic mice that underwent syngeneic islet transplantation into the subrenal capsule and achieved normoglycemia (Tx group); those that failed to achieve normoglycemia (Tx-DM group); and those not receiving any treatment (DM group). Mice were examined by FAL-enhanced high frequency ultrasonography. The echogenicity of the islets increased rapidly within the first minute after injection of FALs and remained at a higher level in the Tx group, while small increases were observed in the other two groups. In histological assessments, fluorescently stained erythrocytes could be seen in and around the transplanted islets, indicating that the transplanted islets were enhanced by infusion of FALs via vessel networks between the engrafted islets and tissue. Furthermore, the echogenicity correlated significantly with endocrine parameters, including blood glucose (BG), serum insulin, and the BG change in the glucose tolerance test. In conclusion, the echogenicity of the islets under FAS-enhanced ultrasonosonography correlated with the endocrine status of transplanted islets.	[Sakata, N.; Yoshimatsu, G.; Tsuchiya, H.; Aoki, T.; Ishida, M.; Katayose, Y.; Unno, M.] Tohoku Univ, Dept Surg, Sendai, Miyagi 980, Japan; [Sax, N.; Kato, S.; Kodama, T.] Tohoku Univ, Grad Sch Biomed Engn, Dept Biomed Engn, Sendai, Miyagi 980, Japan; [Katayose, Y.] Tohoku Univ, Grad Sch Med, Div Integrated Surg & Oncol, Sendai, Miyagi 980, Japan; [Egawa, S.] Tohoku Univ, Int Res Inst Disaster Sci, Div Int Cooperat Disaster Med, Sendai, Miyagi 980, Japan	Sakata, N (reprint author), Tohoku Univ, Dept Surg, Sendai, Miyagi 980, Japan.	n-sakata@surg1.med.tohoku.ac.jp	Unno, Michiaki/A-8633-2010	Unno, Michiaki/0000-0002-2145-6416	Japanese Society for the Promotion of Science, Challenging Exploratory Research [20302151, 22390253, 26462053]; Suzuken Memorial Foundation	We thank Emiko Shibuya and Fumiko Date for technical assistance. This study was funded by Grants-in-Aid for Scientific Research from the Japanese Society for the Promotion of Science, Challenging Exploratory Research (YK: 20302151), Scientific Research B (SE: 22390253), and Scientific Research C (NS: 26462053) and grants from the Suzuken Memorial Foundation (NS).	Wakui N, 2013, EXP THER MED, V6, P3, DOI 10.3892/etm.2013.1094; Heath CH, 2012, OTOLARYNG HEAD NECK, V146, P938, DOI 10.1177/0194599812436648; Kodama T, 2010, J ELECTRON MICROSC, V59, P187, DOI 10.1093/jmicro/dfp056; Sato T, 2014, ULTRASOUND MED BIOL, V40, P1237, DOI 10.1016/j.ultrasmedbio.2013.12.012; Jirak D, 2004, MAGNET RESON MED, V52, P1228, DOI 10.1002/mrm.20282; Virostko J, 2010, MOL IMAGING BIOL, V12, P42, DOI 10.1007/s11307-009-0240-1; Mattsson G, 2002, DIABETES, V51, P1362, DOI 10.2337/diabetes.51.5.1362; Fujii H, 2009, JACC-CARDIOVASC IMAG, V2, P869, DOI 10.1016/j.jcmg.2009.04.008; Chen S, 2010, GENE THER, V17, P1411, DOI 10.1038/gt.2010.85; Kim TK, 2000, RADIOLOGY, V216, P411; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Toso C, 2008, AM J TRANSPLANT, V8, P701, DOI 10.1111/j.1600-6143.2007.02120.x; Johansson H, 2006, AM J TRANSPLANT, V6, P305, DOI 10.1111/j.1600-6143.2005.01186.x; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Eriksson O, 2009, AM J TRANSPLANT, V9, P2816, DOI 10.1111/j.1600-6143.2009.02844.x; Wu Z, 2011, BIOCONJUGATE CHEM, V22, P1587, DOI 10.1021/bc200132t; Barnett BP, 2007, NAT MED, V13, P986, DOI 10.1038/nm1581; Tanaka H, 2014, J GASTROENTEROL, V49, P755, DOI 10.1007/s00535-013-0830-1; Barnett BP, 2011, RADIOLOGY, V258, P182, DOI 10.1148/radiol.10092339; Chan NK, 2009, ISLETS, V1, P249, DOI 10.4161/isl.1.3.9862; Chen SY, 2012, CELL CYCLE, V11, P695, DOI 10.4161/cc.11.4.19120; Chen XJ, 2008, TRANSPLANTATION, V85, P1246, DOI 10.1097/TP.0b013e31816b66b0; DARRIGO JS, 1993, INVEST RADIOL, V28, P218, DOI 10.1097/00004424-199303000-00006; GOLDBERG SJ, 1981, AM HEART J, V101, P793, DOI 10.1016/0002-8703(81)90617-7; Gullace G, 1981, G Ital Cardiol, V11, P2017; Kono Y, 1997, INVEST RADIOL, V32, P120, DOI 10.1097/00004424-199702000-00008; Lu YX, 2004, MOL THER, V9, P428, DOI 10.1016/j.mythe.2004.01.008; Maruyama M, 2013, INT J HEPATOL, V2013; Sakata N, 2011, ISLETS, V3, P259, DOI 10.4161/isl.3.5.17058; Sakata N, 2010, J HEPATO-BIL-PAN SCI, V17, P692, DOI 10.1007/s00534-010-0269-1; Sakata N, 2012, ISLETS, V4, P339, DOI [10.4161/isl.22384, 10.4161/islets.22384]; Sax N, 2013, PHARM RES-DORDR, V30, P218, DOI 10.1007/s11095-012-0864-8; Toso C, 2005, TRANSPLANTATION, V79, P353, DOI 10.1097/01.TP.0000149501.50870.9D; Wakui N, 2013, EXP THER MED, V5, P1551, DOI 10.3892/etm.2013.1048; Wang D, 2012, CLIN IMAG, V36, P717, DOI 10.1016/j.clinimag.2012.01.042; Xie F, 2009, CIRCULATION, V119, P1378, DOI 10.1161/CIRCULATIONAHA.108.825067; Zorzi D, 2013, CELL TRANSPLANT	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-6135	1600-6143		AM J TRANSPLANT	Am. J. Transplant.	JUN	2015	15	6					1531	1542		10.1111/ajt.13152		12	Surgery; Transplantation	Surgery; Transplantation	CI3BA	WOS:000354621200013		
J	Chen, F; Miyamoto, E; Takemoto, M; Minakata, K; Yamada, T; Sato, M; Aoyama, A; Date, H				Chen, F.; Miyamoto, E.; Takemoto, M.; Minakata, K.; Yamada, T.; Sato, M.; Aoyama, A.; Date, H.			Right and Left Inverted Lobar Lung Transplantation	AMERICAN JOURNAL OF TRANSPLANTATION			English	Article						Donors and donation: living; lung transplantation: living donor; surgical technique	LIVING-DONOR; RIGHT THORAX; OUTCOMES	Adult recipients frequently withdraw from living-donor lobar lung transplantation because of the small size of donor grafts. The right lower lobe is 120% larger than the left lower lobe. We developed a novel surgical technique in which an inverted right lower lobe graft can be transplanted into the left thorax. The first patient was a 43-year-old woman with end-stage idiopathic interstitial pneumonia. Her husband was the only eligible donor for living-donor lobar lung transplantation. His right lower lobe was estimated to provide 45% of the recipient's predicted forced vital capacity, which would provide the borderline function required for living-donor lobar lung transplantation. Since lung perfusion scintigraphy of the recipient showed a right-to-left ratio of 64:36, transplanting the right lower lobe graft into the left thorax and sparing the native right lung was considered the only treatment option. We simulated this procedure using three-dimensional models produced by a three-dimensional printer. In living-donor lobar lung transplantation, all anastomoses were performed smoothly as planned preoperatively. Because of the initial success, this procedure was performed successfully in two additional patients. This procedure enables larger grafts to be transplanted, potentially solving critical size matching problems in living-donor lobar lung transplantation.	[Chen, F.; Miyamoto, E.; Yamada, T.; Sato, M.; Aoyama, A.; Date, H.] Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Kyoto, Japan; [Takemoto, M.] Kyoto Univ, Dept Orthopaed Surg, Grad Sch Med, Kyoto, Japan; [Minakata, K.] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Surg, Kyoto, Japan	Date, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Kyoto, Japan.	hdate@kuhp.kyoto-u.ac.jp					Fujinaga T, 2011, J HEART LUNG TRANSPL, V30, P351, DOI 10.1016/j.healun.2010.10.006; Date H, 2003, J THORAC CARDIOV SUR, V126, P476, DOI 10.1016/S0022-5223(03)00235-6; Starnes VA, 2004, J THORAC CARDIOV SUR, V127, P114, DOI 10.1016/j.jtcvs.2003.07.042; Date H, 2004, J THORAC CARDIOV SUR, V128, P933, DOI 10.1016/j.jtcvs.2004.07.032; Chen F, 2013, AM J TRANSPLANT, V13, P1336, DOI 10.1111/ajt.12188; Aigner C, 2004, EUR J CARDIO-THORAC, V25, P179, DOI 10.1016/j.ejects.2003.11.009; Chen F, 2011, AM J TRANSPLANT, V11, P1509, DOI 10.1111/j.1600-6143.2011.03591.x; Chen FS, 2011, J HEART LUNG TRANSPL, V30, P572, DOI 10.1016/j.healun.2010.11.019; Chen FS, 2012, TRANSPL INT, V25, P153, DOI 10.1111/j.1432-2277.2011.01401.x; Chen JY, 2006, TRANSPLANT P, V38, P1535, DOI 10.1016/j.transproceed.2006.03.030; Couetil JP, 2001, ANN THORAC SURG, V72, P933, DOI 10.1016/S0003-4975(01)02394-3; Couetil JPA, 1997, J THORAC CARDIOV SUR, V113, P529, DOI 10.1016/S0022-5223(97)70366-0; Date H, 2014, EUR J CARDIO-THORAC; Mitilian D, 2014, EUR J CARDIO-THORAC, V45, P365, DOI 10.1093/ejcts/ezt353; Saijo H, 2011, INT J ORAL MAX SURG, V40, P955, DOI 10.1016/j.ijom.2011.03.018; Sato Masaaki, 2014, Gen Thorac Cardiovasc Surg, V62, P594, DOI 10.1007/s11748-014-0418-6; Sonobe M, 2011, J HEART LUNG TRANSPL, V30, P471, DOI 10.1016/j.healun.2010.10.008; STARNES VA, 1994, J THORAC CARDIOV SUR, V108, P403	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-6135	1600-6143		AM J TRANSPLANT	Am. J. Transplant.	JUN	2015	15	6					1716	1721		10.1111/ajt.13148		6	Surgery; Transplantation	Surgery; Transplantation	CI3BA	WOS:000354621200032		
J	Kato, H; Suzuki, H; Mimura, M; Inoue, Y; Sugita, M; Suzuki, K; Kobayashi, H				Kato, Hiroyuki; Suzuki, Hiromi; Mimura, Masako; Inoue, Yoshiko; Sugita, Mayu; Suzuki, Katsuya; Kobayashi, Hisamine			Leucine-enriched essential amino acids attenuate muscle soreness and improve muscle protein synthesis after eccentric contractions in rats	AMINO ACIDS			English	Article						Eccentric contractions; Muscle protein synthesis; Muscle soreness; Leucine-enriched essential amino acids; mTOR	MUSCULAR MECHANICAL HYPERALGESIA; SKELETAL-MUSCLE; RESISTANCE EXERCISE; SUPPLEMENTATION; DAMAGE; KINASE; PHOSPHORYLATION; REGENERATION; ACTIVATION; INGESTION	Eccentric exercise results in prolonged muscle weakness and muscle soreness, which are typical symptoms of muscle damage. Recovery from muscle damage is related to mammalian target of rapamycin (mTOR) activity. Leucine-enriched essential amino acids (LEAAs) stimulate muscle protein synthesis via activation of the mTOR pathway. Therefore, we investigated the effect of LEAAs on muscle protein synthesis and muscle soreness after eccentric contractions (EC). Male Sprague-Dawley rats (9-11 weeks old) were administered an LEAA solution (AminoL40; containing 40 % leucine and 60 % other essential amino acids) at 1 g/kg body weight or distilled water (control) 30 min before and 10 min after EC. Tibialis anterior (TA) muscle was exposed to 500 EC by electrical stimulation under anesthesia. The fractional synthesis rate (FSR; %/h) in the TA muscle was measured by incorporating l-[ring-H-2(5)] phenylalanine into skeletal muscle protein. Muscle soreness was evaluated by the paw withdrawal threshold using the Randal-Selitto test with some modifications from 1 to 3 days after EC. The FSR in the EC-control group (0.147 +/- A 0.016 %/h) was significantly lower than in the sedentary group (0.188 +/- A 0.016 %/h, p < 0.05). AminoL40 administration significantly mitigated the EC-induced impairment of the FSR (0.172 +/- A 0.018 %/h). EC decreased the paw withdrawal threshold at 1 and 2 days after EC, which indicated that EC induced muscle soreness. Furthermore, AminoL40 administration alleviated the decreased paw withdrawal threshold. These findings suggest that LEAA supplementation improves the rate of muscle protein synthesis and ameliorates muscle soreness after eccentric exercise.	[Kato, Hiroyuki; Suzuki, Hiromi; Mimura, Masako; Inoue, Yoshiko; Sugita, Mayu; Suzuki, Katsuya; Kobayashi, Hisamine] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa 2108681, Japan	Kato, H (reprint author), Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa 2108681, Japan.	hiroyuki_kato@ajinomoto.com					Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Proske U, 2001, J PHYSIOL-LONDON, V537, P333, DOI 10.1111/j.1469-7793.2001.00333.x; Murase S, 2010, J NEUROSCI, V30, P3752, DOI 10.1523/JNEUROSCI.3803-09.2010; Crozier SJ, 2005, J NUTR, V135, P376; Borgenvik M, 2012, AM J PHYSIOL-ENDOC M, V302, pE510, DOI 10.1152/ajpendo.00353.2011; Cleak MJ, 1992, J SPORT SCI, V10, P325, DOI 10.1080/02640419208729932; Kirby TJ, 2012, AMINO ACIDS, V42, P1987, DOI 10.1007/s00726-011-0928-9; Dreyer HC, 2008, AM J PHYSIOL-ENDOC M, V294, pE392, DOI 10.1152/ajpendo.00582.2007; Nosaka K, 2006, INT J SPORT NUTR EXE, V16, P620; CALDER AG, 1992, RAPID COMMUN MASS SP, V6, P421, DOI 10.1002/rcm.1290060704; Higbie EJ, 1996, J APPL PHYSIOL, V81, P2173; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Anthony JC, 1999, J NUTR, V129, P1102; Dreyer HC, 2006, J PHYSIOL-LONDON, V576, P613, DOI 10.1113/jphysiol.2006.113175; Anthony JC, 2000, J NUTR, V130, P139; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; Cheung K, 2003, SPORTS MED, V33, P145, DOI 10.2165/00007256-200333020-00005; Rennie MJ, 2000, ANNU REV NUTR, V20, P457, DOI 10.1146/annurev.nutr.20.1.457; Biolo G, 1997, AM J PHYSIOL-ENDOC M, V273, pE122; Jackman SR, 2010, MED SCI SPORT EXER, V42, P962, DOI 10.1249/MSS.0b013e3181c1b798; Taguchi T, 2005, J PHYSIOL-LONDON, V564, P259, DOI 10.1113/jphysiol.2004.079483; Pasiakos SM, 2011, AM J CLIN NUTR, V94, P809, DOI 10.3945/ajcn.111.017061; Volpi E, 2003, AM J CLIN NUTR, V78, P250; Escobar J, 2005, AM J PHYSIOL-ENDOC M, V288, pE914, DOI 10.1152/ajpendo.00510.2004; Garlick P J, 1998, Curr Opin Clin Nutr Metab Care, V1, P455, DOI 10.1097/00075197-199809000-00015; Gulbin JP, 2002, INT J SPORTS MED, V23, P471, DOI 10.1055/s-2002-35076; Katta A, 2009, MUSCLE NERVE, V39, P503, DOI 10.1002/mus.21255; Kobayashi H, 2003, AM J PHYSIOL-ENDOC M, V284, pE488, DOI 10.1152/ajpendo.00094.2002; Miranda L, 2008, PFLUG ARCH EUR J PHY, V455, P1129, DOI 10.1007/s00424-007-0368-2; Nicastro H., 2012, J NUTR METAB, V2012, DOI DOI 10.1155/2012/136937; Nosaka K, 2007, INT SPORTMED J, V8, P54; Pereira MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085283; TESCH PA, 1988, MED SCI SPORT EXER, V20, pS132, DOI 10.1249/00005768-198810001-00008	33	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	JUN	2015	47	6					1193	1201		10.1007/s00726-015-1946-9		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CH9VY	WOS:000354385700010		
J	Fu, WY; Wang, XZ; Yang, WL; Takeda, H; Hu, S; Lou, ZY; Zhao, J; Bethune, AN; Guo, YJ				Fu, Wenyan; Wang, Xiaoze; Yang, Weili; Takeda, Hiroaki; Hu, Shi; Lou, Zhiyong; Zhao, Jian; Bethune, Augus N.; Guo, Yajun			Structure-based development and optimization of therapy antibody drugs against TNF alpha	AMINO ACIDS			English	Article						TNF alpha; Targeted therapy; Adalimumab; Epitope; Antibody optimization	NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; INHIBITION; INFLIXIMAB; ADALIMUMAB; EFFICACY; CANCER; DISEASES; BINDING	Previously, we reported on the crystal structures of the Fab fragments of two food and drug administration approved therapeutic antibodies, Infliximab and Adalimumab, in complex with TNF alpha. The structurally identified epitopes on TNF alpha reveal the mechanism of TNF alpha inhibition by partially overlapping with the TNF alpha-receptor interface. In this study, we launched a screen of a phage display library to isolate novel anti-TNF alpha antibodies based on the adalimumab epitope. Structural analysis, the phage display antibody isolation technology, step-by-step antibody optimization, complementarity-determining region residues random mutagenesis, phage ELISA, binding affinity characterization, and cell signaling assays were used for the development and optimization of the novel anti-TNF alpha antibodies. Moreover, one of the novel antibodies, hAta09, has a superior inhibitory effect on TNF alpha function and signaling. Taken together, our report established that the novel anti-TNF alpha antibody hAta09 may achieve clinical efficacy in a TNF alpha-associated disease.	[Fu, Wenyan; Hu, Shi; Zhao, Jian; Guo, Yajun] Chinese Peoples Liberat Army Gen Hosp, Ctr Canc, Key Lab Oncol, Beijing 100853, Peoples R China; [Fu, Wenyan; Hu, Shi; Zhao, Jian; Guo, Yajun] Chinese PLA Med Sch, Beijing, Peoples R China; [Fu, Wenyan; Hu, Shi; Zhao, Jian; Guo, Yajun] Second Mil Med Univ, Translat Med Res Inst, Shanghai, Peoples R China; [Fu, Wenyan; Hu, Shi; Zhao, Jian; Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai, Peoples R China; [Fu, Wenyan; Takeda, Hiroaki; Bethune, Augus N.] Tianjin Joint Acad Biomed & Technol, Tianjin 300457, Peoples R China; [Wang, Xiaoze] Nagoya Univ, Grad Sch Med, Showa Ku, Nagoya, Aichi 4648601, Japan; [Wang, Xiaoze; Yang, Weili; Guo, Yajun] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Takeda, Hiroaki] Nagoya Univ, Dept Biomed, Showa Ku, Nagoya, Aichi 4648601, Japan; [Lou, Zhiyong] Tsinghua Univ, Sch Med, Struct Biol Lab, Beijing 100084, Peoples R China; [Lou, Zhiyong] Tsinghua Univ, Sch Med, MOE Lab Prot Sci, Beijing 100084, Peoples R China; [Bethune, Augus N.] Xian Jinwa Pharmaceut Co Ltd, Mol Drug Discovery Ctr, Xian 710000, Shaanxi, Peoples R China	Bethune, AN (reprint author), Tianjin Joint Acad Biomed & Technol, Tianjin 300457, Peoples R China.	augus.bethune@aftertumor.com; yjguo_smmu@163.com			National Natural Science Foundation of China [31170678, 31000332]	We thank Celplor LLC and ProMab Biotechnologies, Inc., for help on mammalian cell based recombinant protein production; Dr. Cheng Chen, of Tianjin University, and Dr. Tai An, of Union Medical College, for helpful discussions. This work was supported by the National Natural Science Foundation of China (Grant nos. 31170678 and 31000332).	Hu S, 2013, J BIOL CHEM, V288, P27059, DOI 10.1074/jbc.M113.491530; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Weisman MH, 2003, CLIN THER, V25, P1700, DOI 10.1016/S0149-2918(03)80164-9; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Wiens A, 2010, PHARMACOTHERAPY, V30, P339, DOI 10.1592/phco.30.4.339; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Quesnelle KM, 2011, CLIN CANCER RES, V17, P5935, DOI 10.1158/1078-0432.CCR-11-0370; Carter P, 2001, NAT REV CANCER, V1, P118, DOI 10.1038/35101072; Liang SY, 2013, J BIOL CHEM, V288, P13799, DOI 10.1074/jbc.M112.433961; Zhang Q, 2012, P NATL ACAD SCI USA, V109, P13237, DOI 10.1073/pnas.1200105109; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Carter P, 2004, ENDOCR-RELAT CANCER, V11, P659, DOI 10.1677/erc.1.00766; Carter PH, 2001, P NATL ACAD SCI USA, V98, P11879, DOI 10.1073/pnas.211178398; Chan K F, 2000, Immunity, V13, P419; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Fu WY, 2014, MABS-AUSTIN, V6, P978, DOI 10.4161/mabs.28786; Hasegawa Akihiro, 2001, Mini-Reviews in Medicinal Chemistry, V1, P5, DOI 10.2174/1389557013407214; Hu S, 2015, CANCER LETT, V357, P374, DOI 10.1016/j.canlet.2014.11.053; Hu S, 2015, CANCER RES, V75, P159, DOI 10.1158/0008-5472.CAN-14-1670; Hutchinson Lisa, 2014, Nat Rev Clin Oncol, V11, P64, DOI 10.1038/nrclinonc.2013.238; Nakano K, 2001, MOL BIOL CELL, V12, P3515; Presta Leonard G., 2002, Current Pharmaceutical Biotechnology, V3, P237, DOI 10.2174/1389201023378256; Ren XL, 2009, CANCER LETT, V281, P134, DOI 10.1016/j.canlet.2009.02.036; Salfield J, 1998, ARTHRITIS RHEUM, V41, pS57; Shealy D. J., 2008, V181, P101	28	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	JUN	2015	47	6					1259	1266		10.1007/s00726-015-1954-9		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CH9VY	WOS:000354385700016		
J	Taki, M; Kuroiwa, H				Taki, Masumi; Kuroiwa, Hiroyuki			Unexpectedly fast transfer of positron-emittable artificial substrate into N-terminus of peptide/protein mediated by wild-type L/F-tRNA-protein transferase	AMINO ACIDS			English	Article						L/F-transferase; Non-natural amino acid (unnatural amino acid); Positron emission tomography (PET) probe introduction; O-(2-fluoromethyl)-L-tyrosine (FMT); O-(2-fluoroethyl)-L-tyrosine (FET); Enzyme kinetics	AMINO-ACIDS; PEPTIDES	This article demonstrates the fastest enzymatic introduction of a positron emission tomography (PET) probe into acceptor peptides/proteins. It is site-specifically introduced at the basic N-terminus of the acceptors by using L/F-transferase in combination with aminoacyl-tRNA synthetase, namely the NEXT-A/PET reaction. Estimated from kinetic analysis, the transfer efficiency of O-(2-fluoromethyl)-l-tyrosine as an artificial amino acid PET probe mediated by the wild-type transferase is almost as good as that of the natural substrate, phenylalanine.	[Taki, Masumi; Kuroiwa, Hiroyuki] Okayama Univ, Dept Med & Bioengn Sci, Div Chem & Biochem, Chem Biol Area, Okayama 7000082, Japan; [Taki, Masumi] Univ Electrocommun UEC, Grad Sch Informat & Engn, Dept Engn Sci, Biosci & Technol Program, Chofu, Tokyo 1828585, Japan	Taki, M (reprint author), Okayama Univ, Dept Med & Bioengn Sci, Div Chem & Biochem, Chem Biol Area, 1-1-1 Tsushimanaka, Okayama 7000082, Japan.	taki@pc.uec.ac.jp			Japan Science and Technology Agency (JST) [10401005]	This work was supported by Japan Science and Technology Agency (JST) for the Development of Systems and Technology for Advanced Measurement and Analysis Program (10401005). We sincerely thank Prof. Dr. Masahiko Sisido for giving us many useful suggestions and advices. We also thank Dr. Laura Nelson for careful reading and editing of this manuscript.	Wester HJ, 1999, J NUCL MED, V40, P205; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Piroth MD, 2012, STRAHLENTHER ONKOL, V188, P334, DOI 10.1007/s00066-011-0060-5; Okarvi SM, 2001, EUR J NUCL MED, V28, P929; Gray BP, 2014, CHEM REV, V114, P1020, DOI 10.1021/cr400166n; Dolle F, 2008, FLUORINE AND HEALTH: MOLECULAR IMAGING, BIOMEDICAL MATERIALS AND PHARMACEUTICALS, P3, DOI 10.1016/B978-0-444-53086-8.00001-1; Ebhardt HA, 2009, ANAL CHEM, V81, P1937, DOI 10.1021/ac802423d; Ebisu K, 2009, CHEMBIOCHEM, V10, P2460, DOI 10.1002/cbic.200900430; Gauthier MA, 2008, CHEM COMMUN, P2591, DOI 10.1039/b719689j; Iwata R, 2003, J LABELLED COMPD RAD, V46, P555, DOI 10.1002/jlcr.696; Kawaguchi J, 2013, FEBS OPEN BIO, V3, P252, DOI 10.1016/j.fob.2013.06.001; Lin KS, 2015, CANCER RES, V75, P387, DOI 10.1158/0008-5472.CAN-14-1603; Taki M, 2006, CHEMBIOCHEM, V7, P1676, DOI 10.1002/cbic.200600181; Taki M, 2007, BIOPOLYMERS, V88, P263, DOI 10.1002/bip.20678; Tokuda Y, 2013, PEPT SCI, V2012, P41	15	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	JUN	2015	47	6					1279	1282		10.1007/s00726-015-1989-y		4	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CH9VY	WOS:000354385700019		
J	Maehara, T; Murota, K				Maehara, Takanori; Murota, Kazuo			Valuated matroid-based algorithm for submodular welfare problem	ANNALS OF OPERATIONS RESEARCH			English	Article						Submodular welfare problem; Matroid; Heuristic algorithm; Discrete convex analysis	GROSS SUBSTITUTES; INTERSECTION	An algorithm for the submodular welfare problem is proposed based on the theory of discrete convex analysis. The proposed algorithm is a heuristic method built upon the valuated matroid partition algorithms, and gives the exact optimal solution for a reasonable subclass of submodular welfare problems. The algorithm has a guaranteed approximation ratio for a special case. Computational results show fairly good performance of the proposed algorithm.	[Maehara, Takanori] Shizuoka Univ, Dept Math & Syst Engn, Shizuoka, Japan; [Murota, Kazuo] Univ Tokyo, Dept Math Informat, Tokyo, Japan	Maehara, T (reprint author), Shizuoka Univ, Dept Math & Syst Engn, Shizuoka, Japan.	maehara.takanori@shizuoka.ac.jp; murota@mist.i.u-tokyo.ac.jp			KAKENHI [21360045, 26280004]; Aihara Project, the FIRST program from JSPS; JST, ERATO, Kawarabayashi Project	This work is supported by KAKENHI (21360045, 26280004) and the Aihara Project, the FIRST program from JSPS. The first author is supported by JST, ERATO, Kawarabayashi Project.	Abrams Z., 2004, P 3 INT S INF PROC S, P424, DOI 10.1145/984622.984684; ANDELMAN N, 2004, P 9 SCAND WORKSH ALG, V3111, P26; Srinivasan A, 2008, LECT NOTES COMPUT SC, V5171, P247; KELSO AS, 1982, ECONOMETRICA, V50, P1483, DOI 10.2307/1913392; Gul F, 1999, J ECON THEORY, V87, P95, DOI 10.1006/jeth.1999.2531; FISHER ML, 1978, MATH PROGRAM STUD, V8, P73; Chevaleyre Y, 2008, ANN OPER RES, V163, P49, DOI 10.1007/s10479-008-0335-0; Fleischer L, 2006, PROCEEDINGS OF THE SEVENTHEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P611, DOI 10.1145/1109557.1109624; Mirrokni V, 2008, EC'08: PROCEEDINGS OF THE 2008 ACM CONFERENCE ON ELECTRONIC COMMERCE, P70; Glover F, 1996, DISCRETE APPL MATH, V65, P223, DOI 10.1016/0166-218X(94)00037-E; Edmonds J, 2003, LECT NOTES COMPUT SC, V2570, P11; DRESS AWM, 1992, ADV MATH, V93, P214, DOI 10.1016/0001-8708(92)90028-J; Lehmann B, 2006, GAME ECON BEHAV, V55, P270, DOI 10.1016/j.geb.2005.02.006; Ahuja RK, 2002, DISCRETE APPL MATH, V123, P75, DOI 10.1016/S0166-218X(01)00338-9; AZAR Y, 2008, AUTOMATA LANGUAGE PR, V5125, P186, DOI 10.1007/978-3-540-70575-8_16; Beasley J. E., 1990, ORLIB OPERATIONS RES; Bevia C, 1999, MATH SOC SCI, V37, P1, DOI 10.1016/S0165-4896(98)00015-8; Chu PC, 1997, COMPUT OPER RES, V24, P17, DOI 10.1016/S0305-0548(96)00032-9; Conitzer V., 2005, P NAT C ART INT AAAI, P248; Deshpande A, 2008, LECT NOTES COMPUT SC, V4957, P436, DOI 10.1007/978-3-540-78773-0_38; Dress A. W. M., 1990, APPL MATH LETT, V3, P33, DOI 10.1016/0893-9659(90)90009-Z; Frieze A. M., 1995, P 4 IPCO C, P1; Fujishige S, 2005, ANN DISCR MATH, V58, P1; Fujishige S, 2003, MATH OPER RES, V28, P463, DOI 10.1287/moor.28.3.463.16393; GARG R, 2001, APPROX 01 RANDOM 01, V2129, P102, DOI 10.1007/3-540-44666-4_14; Liers F., 2004, NEW OPTIMIZATION ALG, P47, DOI 10.1002/3527603794.ch4; Lovasz L, 1983, MATH PROGRAMMING STA, P235; Murota K., 2000, MATRICES MATROIDS SY; Murota K, 1996, SIAM J DISCRETE MATH, V9, P562, DOI 10.1137/S0895480195280009; Murota K, 1996, SIAM J DISCRETE MATH, V9, P545, DOI 10.1137/S0895480195279994; Murota K, 1998, MATH PROGRAM, V83, P313, DOI 10.1007/BF02680565; Murota K., 2003, DISCRETE CONVEX ANAL; Murota K, 2009, RESEARCH TRENDS IN COMBINATORIAL OPTIMIZATION, P219, DOI 10.1007/978-3-540-76796-1_11; Murota K., 2010, RIMS KOKYUROKU BES B, V23, P193; OXLEY J. G., 1992, MATROID THEORY; Shioura A, 2012, JPN J IND APPL MATH, V29, P535, DOI 10.1007/s13160-012-0082-0; Shioura Akiyoshi, 2012, Journal of the Operations Research Society of Japan, V55; Slijepcevic S., 2001, P IEEE INT C COMM IC, P472; Wiegele A., 2007, BIQ MAC LIB COLLECTI	39	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0254-5330	1572-9338		ANN OPER RES	Ann. Oper. Res.	JUN	2015	229	1					565	590		10.1007/s10479-015-1835-3		26	Operations Research & Management Science	Operations Research & Management Science	CH9WQ	WOS:000354387600025		
J	Salah, S; Ardissone, F; Gonzalez, M; Gervaz, P; Riquet, M; Watanabe, K; Zabaleta, J; Al-Rimawi, D; Toubasi, S; Massad, E; Lisi, E; Hamed, OH				Salah, Samer; Ardissone, Francesco; Gonzalez, Michel; Gervaz, Pascal; Riquet, Marc; Watanabe, Kazuhiro; Zabaleta, Jon; Al-Rimawi, Dalia; Toubasi, Samar; Massad, Ehab; Lisi, Elena; Hamed, Osama H.			Pulmonary Metastasectomy in Colorectal Cancer Patients with Previously Resected Liver Metastasis: Pooled Analysis	ANNALS OF SURGICAL ONCOLOGY			English	Article							LUNG METASTASECTOMY; SURGICAL-TREATMENT; PROGNOSTIC-FACTORS; SURVIVAL; CARCINOMA; SURGERY; BEVACIZUMAB	Data addressing the outcomes and patterns of recurrence after pulmonary metastasectomy (PM) in patients with colorectal cancer (CRC) and previously resected liver metastasis are limited. We searched the PubMed database for studies assessing PM in CRC and gathered individual data for patients who had PM and a previous curative liver resection. The influence of potential factors on overall survival (OS) was analyzed through univariate and multivariate analysis. Between 1983 and 2009, 146 patients from five studies underwent PM and had previous liver resection. The median interval from resection of liver metastasis until detection of lung metastasis and the median follow-up from PM were 23 and 48 months, respectively. Five-year OS and recurrence-free survival rates calculated from the date of PM were 54.4 and 29.3 %, respectively. Factors predicting inferior OS in univariate analysis included thoracic lymph node (LN) involvement and size of largest lung nodule a parts per thousand yen2 cm. Adjuvant chemotherapy and whether lung metastasis was detected synchronous or metachronous to liver metastasis had no influence on survival. In multivariate analysis, thoracic LN involvement emerged as the only independent factor (hazard ratio 4.86, 95 % confidence interval 1.56-15.14, p = 0.006). PM offers a chance for long-term survival in selected patients with CRC and previously resected liver metastasis. Thoracic LN involvement predicted poor prognosis; therefore, significant efforts should be undertaken for adequate staging of the mediastinum before PM. In addition, adequate intraoperative LN sampling allows proper prognostic stratification and enrollment in novel adjuvant therapy trials.	[Salah, Samer] King Hussein Canc Ctr, Dept Med Oncol, Amman, Jordan; [Ardissone, Francesco; Lisi, Elena] Univ Turin, Dept Oncol, Thorac Surg Unit, San Luigi Hosp, Turin, Italy; [Gonzalez, Michel] CHU Vaudois, Dept Thorac Surg, CH-1011 Lausanne, Switzerland; [Gervaz, Pascal] Geneva Univ Hosp & Med Sch, Dept Surg, Geneva, Switzerland; [Riquet, Marc] Paris Descartes Univ, Georges Pompidou European Hosp, Dept Thorac Surg, Paris, France; [Watanabe, Kazuhiro] Tohoku Univ, Dept Surg, Sendai, Miyagi 980, Japan; [Watanabe, Kazuhiro] Natl Canc Ctr Hosp East, Dept Surg Oncol, Chiba, Japan; [Zabaleta, Jon] Hosp Donostia, Thorac Surg Serv, San Sebastian, Spain; [Al-Rimawi, Dalia] King Hussein Canc Ctr, Off Sci Affairs & Res, Amman, Jordan; [Toubasi, Samar] Univ Jordan, Dept Clin Nursing, Amman, Jordan; [Massad, Ehab; Hamed, Osama H.] King Hussein Canc Ctr, Dept Surg, Amman, Jordan	Salah, S (reprint author), King Hussein Canc Ctr, Dept Med Oncol, Amman, Jordan.	ssalah@khcc.jo		Ardissone, Francesco/0000-0002-8212-9881			Iida T, 2013, ANN SURG, V257, P1059, DOI 10.1097/SLA.0b013e31826eda3b; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Borasio P, 2011, INT J COLORECTAL DIS, V26, P183, DOI 10.1007/s00384-010-1075-6; Internullo E, 2008, J THORAC ONCOL, V3, P1257, DOI 10.1097/JTO.0b013e31818bd9da; Salah S, 2012, ANN ONCOL, V23, P2649, DOI 10.1093/annonc/mds100; Simmonds PC, 2006, BRIT J CANCER, V94, P982, DOI 10.1038/sj.bjc.6603033; Gonzalez M, 2013, ANN SURG ONCOL, V20, P572, DOI 10.1245/s10434-012-2726-3; Yedibela S, 2006, ANN SURG ONCOL, V13, P1538, DOI 10.1245/s10434-006-9100-2; Zabaleta J, 2011, EJSO-EUR J SURG ONC, V37, P786, DOI 10.1016/j.ejso.2011.05.014; Welter S, 2007, EUR J CARDIO-THORAC, V31, P167, DOI 10.1016/j.ejcts.2006.11.004; Riquet M, 2010, ANN THORAC SURG, V89, P375, DOI 10.1016/j.athoracsur.2009.10.005; Watanabe K, 2009, BRIT J SURG, V96, P1058, DOI 10.1002/bjs.6682; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Headrick JR, 2001, ANN THORAC SURG, V71, P975, DOI 10.1016/S0003-4975(00)02522-4; Saito Y, 2002, J THORAC CARDIOV SUR, V124, P1007, DOI 10.1067/mtc.2002.125165; Onaitis MW, 2009, ANN THORAC SURG, V87, P1684, DOI 10.1016/j.athoracsur.2009.03.034; Inoue M, 2004, ANN THORAC SURG, V78, P238, DOI 10.1016/j.athoracsur.2004.02.017; Kim HK, 2014, WORLD J GASTROENTERO, V20, P6133, DOI 10.3748/wjg.v20.i20.6133; Shah SA, 2006, J AM COLL SURGEONS, V202, P468, DOI 10.1016/j.jamcollsurg.2005.11.008; Beretta GD, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0486-y; Embun R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002787; Gonzalez M, 2012, WORLD J SURG, V36, P386, DOI 10.1007/s00268-011-1381-3; Hsu CW, 2011, INT J COLORECTAL DIS, V26, P1559, DOI 10.1007/s00384-011-1231-7; Hurwitz H, 2005, ONCOLOGIST, V10, P320, DOI 10.1634/theoncologist.10-5-320; Kobayashi K, 1999, J THORAC CARDIOV SUR, V118, P1090, DOI 10.1016/S0022-5223(99)70106-6; Landes U, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-17; Nojiri K, 2011, ANTICANCER RES, V31, P1049; Regnard JF, 1998, ANN THORAC SURG, V66, P214, DOI 10.1016/S0003-4975(98)00269-0; Suemitsu R, 2011, SURG TODAY, V41, P54, DOI 10.1007/s00595-009-4244-x	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JUN	2015	22	6					1844	1850		10.1245/s10434-014-4173-9		7	Oncology; Surgery	Oncology; Surgery	CH7ON	WOS:000354226600016		
J	Matsuda, S; Tsubosa, Y; Niihara, M; Sato, H; Takebayashi, K; Kawamorita, K; Mori, K; Tsushima, T; Yokota, T; Ogawa, H; Onozawa, Y; Yasui, H; Takeuchi, H; Kitagawa, Y				Matsuda, Satoru; Tsubosa, Yasuhiro; Niihara, Masahiro; Sato, Hiroshi; Takebayashi, Katsushi; Kawamorita, Keisuke; Mori, Keita; Tsushima, Takahiro; Yokota, Tomoya; Ogawa, Hirofumi; Onozawa, Yusuke; Yasui, Hirofumi; Takeuchi, Hiroya; Kitagawa, Yuko			Comparison of Transthoracic Esophagectomy with Definitive Chemoradiotherapy as Initial Treatment for Patients with Esophageal Squamous Cell Carcinoma Who Could Tolerate Transthoracic Esophagectomy	ANNALS OF SURGICAL ONCOLOGY			English	Article							PHASE-II; PREOPERATIVE CHEMOTHERAPY; STAGE-I; CANCER; TRIAL; CISPLATIN; 5-FLUOROURACIL; RADIOTHERAPY; DOCETAXEL; SURGERY	The oncological outcomes of transthoracic esophagectomy (TTE) and definitive chemoradiotherapy (dCRT) as initial treatment in patients with esophageal squamous cell carcinoma (ESCC) who could tolerate TTE remains unclear. Consecutive patients histologically diagnosed with stage I/II/III ESCC (excluding cT4 or cN3) or stage IV ESCC due to supraclavicular lymph node metastasis were eligible for inclusion in this retrospective study. To select patients who could tolerate TTE, respiratory function, Eastern Cooperative Oncology Group performance status, and preoperative complications were considered. Patient characteristics, recurrence-free survival (RFS), 3- and 5-year overall survival (OS), pattern of recurrence, and treatments after initial treatment failure were investigated. Overall, 112 patients were included in the TTE group and 65 were included in the dCRT group. No significant differences were observed in patient characteristics and clinical stage between the TTE and dCRT groups (stage I/II/III/IV of 29/27/46/10 in the TTE group and 23/15/20/7 in the dCRT group). The R0 resection rate was 87 % in the TTE group, and complete response rate was 68 % in the dCRT group. In intention-to-treat analysis, there was no significant difference in RFS. In contrast, 3-year OS of non-stage IA patients was significantly longer in the TTE group than the dCRT group (TTE 66.9 %; dCRT 49.8 %; p = 0.023). In non-stage IA patients, after initial treatment failure significantly more patients could undergo local treatment (radiotherapy or surgery in the TTE group; surgery or endoscopic resection or photodynamic therapy in the dCRT group) in the TTE group than the dCRT group (TTE 74 %; dCRT 40 %; p = 0.003). In locally advanced ESCC patients who could tolerate TTE, TTE extended 3-year OS, which might have been encouraged by utilizing local treatment after initial treatment failure.	[Matsuda, Satoru; Tsubosa, Yasuhiro; Niihara, Masahiro; Takebayashi, Katsushi; Kawamorita, Keisuke] Shizuoka Canc Ctr Hosp, Div Esophageal Surg, Shizuoka, Japan; [Sato, Hiroshi] Saitama Univ, Int Med Ctr, Dept Surg, Div Upper Gastrointestinal Tract, Saitama 3388570, Japan; [Mori, Keita] Shizuoka Canc Ctr Hosp, Clin Trial Coordinat Off, Shizuoka, Japan; [Tsushima, Takahiro; Yokota, Tomoya; Onozawa, Yusuke; Yasui, Hirofumi] Shizuoka Canc Ctr Hosp, Div Gastrointestinal Oncol, Shizuoka, Japan; [Ogawa, Hirofumi] Shizuoka Canc Ctr Hosp, Div Radiat Oncol, Shizuoka, Japan; [Takeuchi, Hiroya; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan	Tsubosa, Y (reprint author), Shizuoka Canc Ctr Hosp, Div Esophageal Surg, Shizuoka, Japan.	y.tsubosa@scchr.jp			Kyowa Hakko Kirin Co., Ltd; Bristol-Myers Co., Ltd; Nippon Kayaku Co., Ltd; Pfizer Co., Ltd; Yakult Honsha Co., Ltd.	Yuko Kitagawa has the following financial relationships to disclose: research funding from Kyowa Hakko Kirin Co., Ltd, Bristol-Myers Co., Ltd, Nippon Kayaku Co., Ltd, Pfizer Co., Ltd, and Yakult Honsha Co., Ltd.	Mariette C, 2014, J CLIN ONCOL, V32, P2416, DOI 10.1200/JCO.2013.53.6532; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Kato H, 2009, JPN J CLIN ONCOL, V39, P638, DOI 10.1093/jjco/hyp069; Takeuchi H, 2014, ANN SURG, V260, P259, DOI 10.1097/SLA.0000000000000644; Nakamura K, 2013, JPN J CLIN ONCOL, V43, P752, DOI 10.1093/jjco/hyt061; Yano T, 2011, ENDOSCOPY, V43, P657, DOI 10.1055/s-0030-1256373; Kato K, 2011, INT J RADIAT ONCOL, V81, P684, DOI 10.1016/j.ijrobp.2010.06.033; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Ishida K, 2004, JPN J CLIN ONCOL, V34, P615, DOI 10.1093/jjco/hyh107; Karran A, 2014, BRIT J SURG, V101, P502, DOI 10.1002/bjs.9437; Bancewicz J, 2002, LANCET, V359, P1727; Hironaka S, 2003, INT J RADIAT ONCOL, V57, P25; Minsky BD, 2002, J CLIN ONCOL, V20, P67; Ozawa S, 2002, ESOPHAGUS, V7, P7; Watanabe M, 2014, ANN SURG ONCOL, V21, P2838, DOI 10.1245/s10434-014-3684-8; Yamashita H, 2009, J SURG ONCOL, V100, P435, DOI 10.1002/jso.21361	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JUN	2015	22	6					1866	1873		10.1245/s10434-014-4337-7		8	Oncology; Surgery	Oncology; Surgery	CH7ON	WOS:000354226600019		
J	Oguro, S; Esaki, M; Kishi, Y; Nara, S; Shimada, K; Ojima, H; Kosuge, T				Oguro, Seiji; Esaki, Minoru; Kishi, Yoji; Nara, Satoshi; Shimada, Kazuaki; Ojima, Hidenori; Kosuge, Tomoo			Optimal Indications for Additional Resection of the Invasive Cancer-Positive Proximal Bile Duct Margin in Cases of Advanced Perihilar Cholangiocarcinoma	ANNALS OF SURGICAL ONCOLOGY			English	Article							CARBOHYDRATE ANTIGEN 19-9; PORTAL-VEIN EMBOLIZATION; HILAR CHOLANGIOCARCINOMA; INTRAHEPATIC CHOLANGIOCARCINOMA; EXTRAHEPATIC CHOLANGIOCARCINOMA; SURGICAL RESECTION; EXTENDED HEPATECTOMY; COLORECTAL-CANCER; PANCREATIC-CANCER; SURVIVAL	The survival benefits of additional resection of the positive proximal ductal margin in cases of perihilar cholangiocarcinoma remain to be elucidated. The purpose of this retrospective study was to clarify the optimal indications for additional resection of the invasive cancer-positive proximal ductal margin (PM) All patients who underwent hepatectomy for perihilar cholangiocarcinoma between 2000 and 2011 were analyzed. Surgical variables, the status of the PM, prognostic factors, and survival were evaluated. A total of 224 patients were enrolled. Additional resection was performed in 52 of 75 positive PMs of invasive cancer, resulting in 43 negative PMs. The survival of patients with a negative PM treated with additional resection (n = 43) was significantly worse than that of the patients with a negative PM treated without additional resection (n = 149; P = 0.031) and did not significantly differ from that of the patients with a positive PM (n = 32; P = 0.215). A multivariate analysis demonstrated that the carbohydrate antigen 19-9 (CA19-9) level (< 64 or a parts per thousand yen64), combined vascular resection, pN, pM, the histological grade, perineural invasion, liver invasion, and R status were independent prognostic factors. Only in the subgroups of CA19-9 < 64 and pM0, the survival of the patients with a negative PM treated with additional resection was significantly better than that of the patients with a positive PM (P = 0.019 and P = 0.021, respectively). Additional resection of the invasive cancer-positive PMs may be warranted only in limited patients with a lower level of CA19-9 and no distant metastatic disease.	[Oguro, Seiji; Esaki, Minoru; Kishi, Yoji; Nara, Satoshi; Shimada, Kazuaki; Kosuge, Tomoo] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Chuo Ku, Tokyo, Japan; [Ojima, Hidenori] Natl Canc Ctr, Div Pathol, Chuo Ku, Tokyo, Japan; [Oguro, Seiji; Kosuge, Tomoo] Juntendo Univ, Grad Sch Med, Bunkyo Ku, Tokyo, Japan	Esaki, M (reprint author), Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Chuo Ku, 1-1 Tsukiji 5 chome, Tokyo, Japan.	mesaki@ncc.go.jp			National Cancer Center Research and Development Fund [21-7-5]	This study was supported by National Cancer Center Research and Development Fund (21-7-5).	Akamatsu N, 2010, J GASTROEN HEPATOL, V25, P731, DOI 10.1111/j.1440-1746.2009.06113.x; Uchiyama K, 2003, ARCH SURG-CHICAGO, V138, P1012, DOI 10.1001/archsurg.138.9.1012; Ferrone CR, 2006, J CLIN ONCOL, V24, P2897, DOI 10.1200/JCO.2005.05.3934; Matsuo K, 2012, J AM COLL SURGEONS, V215, P343, DOI 10.1016/j.jamcollsurg.2012.05.025; Miyazaki M, 2007, SURGERY, V141, P581, DOI 10.1016/j.surg.2006.09.016; Cho SY, 2010, ANN SURG ONCOL, V17, P1823, DOI 10.1245/s10434-010-0938-y; Sano T, 2006, ANN SURG, V244, P240, DOI 10.1097/01.sla.0000217605.66519.38; Ohtsuka M, 2002, BRIT J SURG, V89, P1525, DOI 10.1046/j.1365-2168.2002.02268.x; Endo I, 2008, ANN SURG ONCOL, V15, P2104, DOI 10.1245/s10434-008-0003-2; TEMPERO MA, 1987, CANCER RES, V47, P5501; Neuhaus P, 1999, ANN SURG, V230, P808, DOI 10.1097/00000658-199912000-00010; Narimatsu H, 1998, CANCER RES, V58, P512; Igami T, 2009, ANN SURG, V249, P296, DOI 10.1097/SLA.0b013e318190a647; Kim HJ, 1999, AM J GASTROENTEROL, V94, P1941; Choi AR, 2013, WORLD J GASTROENTERO, V19, P5302, DOI 10.3748/wjg.v19.i32.5302; Kawasaki S, 2003, ANN SURG, V238, P84, DOI 10.1097/01.SLA.0000074984.83031.02; Ribero D, 2011, ANN SURG, V254, P776, DOI 10.1097/SLA.0b013e3182368f85; Singh S, 2011, DIGEST DIS SCI, V56, P2491, DOI 10.1007/s10620-011-1709-8; Chen CC, 2005, J SURG RES, V124, P169, DOI 10.1016/j.jss.2004.08.013; Mann DV, 2000, EUR J SURG ONCOL, V26, P474, DOI 10.1053/ejso.1999.0925; Hatzaras I, 2010, HPB, V12, P134, DOI 10.1111/j.1477-2574.2009.00149.x; Hasegawa S, 2007, WORLD J SURG, V31, P1256, DOI 10.1007/s00268-007-9001-y; DeOliveira ML, 2007, ANN SURG, V245, P755, DOI 10.1097/01.sla.0000251366.62632.d3; Lee SG, 2010, J HEPATO-BIL-PAN SCI, V17, P476, DOI 10.1007/s00534-009-0204-5; Hemming AW, 2005, ANN SURG, V241, P693, DOI 10.1097/01.sla.0000160701.38945.82; Kosuge T, 1999, ANN SURG, V230, P663, DOI 10.1097/00000658-199911000-00008; Chung MJ, 2011, ANN SURG ONCOL, V18, P1651, DOI 10.1245/s10434-010-1529-7; Harder J, 2007, CANCER EPIDEM BIOMAR, V16, P2097, DOI 10.1158/1055-9965.EPi-07-0155; Jarnagin WR, 2001, ANN SURG, V234, P507, DOI 10.1097/00000658-200110000-00010; Konishi M, 2010, BRIT J SURG, V97, P1363, DOI 10.1002/bjs.7122; Marrelli D, 2009, AM J SURG, V198, P333, DOI 10.1016/j.amjsurg.2008.12.031; Miwa S, 2006, J GASTROENTEROL, V41, P893, DOI 10.1007/s00535-006-1877-z; Nagino M, 2012, ANN SURG, V258, P129; Ojima H, 2009, CANCER SCI, V100, P62, DOI 10.1111/j.1349-7006.2008.01009.x; Ribero D, 2011, ANN SURG, V254, P781; Sakamoto Y, 2010, HEPATO-GASTROENTEROL, V57, P22; Sano T, 2008, ANN SURG ONCOL, V15, P590, DOI 10.1245/s10434-007-9687-y; Sasaki R, 2007, WORLD J SURG, V31, P1788, DOI 10.1007/s00268-007-9102-7; Shingu Y, 2010, SURGERY, V147, P49, DOI 10.1016/j.surg.2009.06.030; Sobin LH, 2009, TNM CLASSIFICATION M; Todoroki T, 2000, BRIT J SURG, V87, P306, DOI 10.1046/j.1365-2168.2000.01343.x; Wakai T, 2005, CANCER, V103, P1210, DOI 10.1002/cncr.20906	42	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JUN	2015	22	6					1915	1924		10.1245/s10434-014-4232-2		10	Oncology; Surgery	Oncology; Surgery	CH7ON	WOS:000354226600025		
J	Hinoi, T; Kawaguchi, Y; Hattori, M; Okajima, M; Ohdan, H; Yamamoto, S; Hasegawa, H; Horie, H; Murata, K; Yamaguchi, S; Sugihara, K; Watanabe, M				Hinoi, Takao; Kawaguchi, Yasuo; Hattori, Minoru; Okajima, Masazumi; Ohdan, Hideki; Yamamoto, Seiichiro; Hasegawa, Hirotoshi; Horie, Hisanaga; Murata, Kohei; Yamaguchi, Shigeki; Sugihara, Kenichi; Watanabe, Masahiko		Japan Soc Laparoscopic Colorectal	Laparoscopic Versus Open Surgery for Colorectal Cancer in Elderly Patients: A Multicenter Matched Case-Control Study	ANNALS OF SURGICAL ONCOLOGY			English	Article							PROPENSITY SCORE METHODS; RANDOMIZED CONTROLLED-TRIAL; MRC CLASICC TRIAL; COLON-CANCER; OPEN COLECTOMY; TERM OUTCOMES; RECTAL-CANCER; RESECTION; MORTALITY; CARCINOMA	The safety of laparoscopic surgery (LAP) in elderly patients with colorectal cancer has not been demonstrated. The aim of this study was to compare the outcomes of LAP and open surgery (OP) and estimate the feasibility of LAP in colorectal cancer patients aged a parts per thousand yen80 years. We conducted a propensity scoring matched case-control study of colon and rectal cancer patients aged a parts per thousand yen80 years using data from 41 hospitals between 2003 and 2007. A total of 1,526 colon cancer patients and 282 rectal cancer patients underwent surgery and were included in the analysis. The primary end point was 3-year overall survival (OS). Secondary end points included disease-free survival (DFS), cancer-specific survival (CSS), and postoperative complications. LAP and OP were compared in 804 colon cancer patients (402 pairs) and 114 rectal cancer patients (57 pairs) after all covariates were balanced, and no significant differences were observed, except for tumor size in colon cancer. OS, DFS, and CSS did not differ between the groups for either colon cancer (P = 0.916, 0.968, and 0.799, respectively) or rectal cancer (P = 0.765, 0.519, and 0.950, respectively). In colon cancer cases, LAP was associated with fewer morbidities than was OP (24.9 vs. 36.3 %, P < 0.001); no such difference was observed for rectal cancer patients (47.4 vs. 40.4 %, P = 0.450). LAP is an acceptable alternative to OP in elderly patients with colorectal cancer.	[Hinoi, Takao; Hattori, Minoru; Ohdan, Hideki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg Appl Life Sc, Hiroshima, Japan; [Kawaguchi, Yasuo] Tsuchiya Gen Hosp, Dept Surg, Hiroshima, Japan; [Okajima, Masazumi] Hiroshima City Hiroshima Citizens Hosp, Dept Surg, Hiroshima, Japan; [Yamamoto, Seiichiro] Hiratsuka City Hosp, Dept Surg, Hiratsuka, Kanagawa, Japan; [Hasegawa, Hirotoshi] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; [Horie, Hisanaga] Jichi Med Univ, Dept Surg, Shimotsuke, Japan; [Murata, Kohei] Suita Municipal Hosp, Dept Surg, Osaka, Japan; [Yamaguchi, Shigeki] Saitama Med Univ, Dept Surg Gastroenterol, Int Med Ctr, Saitama, Japan; [Sugihara, Kenichi] Tokyo Med & Dent Univ, Sch Med, Dept Surg Oncol, Tokyo 113, Japan; [Watanabe, Masahiko] Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa 228, Japan	Hinoi, T (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg Appl Life Sc, Hiroshima, Japan.	thinoi@hiroshima-u.ac.jp			Japanese Society for Cancer of the Colon and Rectum	We acknowledge the cooperation of the following doctors: Eiji Kanehira, Kunihisa Shiozawa, Ageo Central General Hospital; Hiroyuki Bando, Daisuke Yamamoto, Ishikawa Prefectural Central Hospital; Seigo Kitano, Masafumi Inomata, Tomonori Akagi, Oita University; Junji Okuda, Keitaro Tanaka, Osaka Medical College; Masayoshi Yasui, Osaka National Hospital; Kosei Hirakawa, Kiyoshi Maeda, Osaka City University; Akiyoshi Kanazawa, Osaka Red Cross Hospital; Junichi Hasegawa, Junichi Nishimura, Osaka Rosai Hospital; Ichio Suzuka, Kagawa Prefectural Central Hospital; Shintaro Akamoto, Kagawa University; Yosuke Fukunaga, Hiroya Kuroyanagi, Cancer Institute Ariake Hospital; Masaki Naito, Kitasato University; Takashi Ueki, Kyushu University; Takashi Yamaguchi, Koya Hida, Kyoto Medical Center; Yousuke Kinjo, Kyoto University; Yukihito Kokuba, Kyoto Prefectural University; Madoka Hamada, Kochi Health Sciences Center; Norio Saito, Masaaki Ito, National Cancer Hospital East; Jou Tashiro, Saitama Medical University; Toshimasa Yatsuoka, Saitama Cancer Center; Tomohisa Furuhata, Kenji Okita, Sapporo Medical University; Yoshiro Kubo, Shikoku Cancer Center; Shuji Saito Yosuke Kinugasa, Shizuoka Cancer Center; Fumio Konishi, Saitama medical Center Jichi Medical University; Michitoshi Goto, Juntendo University; Junichi Tanaka, Shungo Endo, Showa University Northern Yokohama Hospital; Nobuyoshi Miyajima, Tadashi Suda, Tsukasa Shimamura, St. Marianna University; Yoshihisa Saida, Toshiyuki Enomoto, Toho University Ohashi Medical Center; Takeshi Naito, Tohoku University; Yasuhiro Munakata, Souichi Tagami, Nagano Municipal Hospital; Satoshi Maruyama, Niigata Cancer Center Hospital; Takao Ichihara, Nishinomiya Municipal Central Hospital; Hitoshi Idani, Fukuyama Municipal Hospital; Yasuhiro Miyake, Minoh City Hospital; Shoichi Hazama, Yamaguchi University; and Kazuteru Watanabe, Yokohama City University Medical Center. This study was supported by the Japanese Society for Cancer of the Colon and Rectum.	Kang SB, 2010, LANCET ONCOL, V11, P637, DOI 10.1016/S1470-2045(10)70131-5; Rutten HJT, 2008, LANCET ONCOL, V9, P494, DOI 10.1016/S1470-2045(08)70129-3; Law WL, 2002, J AM COLL SURGEONS, V195, P768, DOI 10.1016/S1072-7515(02)01483-7; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Stocchi L, 2000, DIS COLON RECTUM, V43, P326, DOI 10.1007/BF02258297; Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Austin PC, 2009, MED DECIS MAKING, V29, P661, DOI 10.1177/0272989X09341755; Turrentine FE, 2006, J AM COLL SURGEONS, V203, P865, DOI 10.1016/j.jamcollsurg.2006.08.026; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; Hemandas AK, 2010, ANN SURG, V252, P84, DOI 10.1097/SLA.0b013e3181e45b66; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Panis Y, 2011, ANN SURG, V254, P738, DOI 10.1097/SLA.0b013e31823604ac; Leung KL, 2004, LANCET, V363, P1187, DOI 10.1016/S0140-6736(04)15947-3; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Simmonds P, 2000, LANCET, V356, P968, DOI 10.1016/S0140-6736(00)02713-6; Al-Refaie WB, 2011, ANN SURG, V253, P947, DOI 10.1097/SLA.0b013e318216f56e; Bagshaw PF, 2012, ANN SURG, V256, P915, DOI 10.1097/SLA.0b013e3182765ff8; Buunen M, 2009, LANCET ONCOL, V10, P44, DOI DOI 10.1016/S1470-2045(08)70310-3; Cummings LC, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-31; Miyajima N, 2009, SURG ENDOSC, V23, P113, DOI 10.1007/s00464-008-0078-7; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Veldkamp Ruben, 2005, Lancet Oncol, V6, P477; Veldkamp R, 2004, SURG ENDOSC, V18, P1163, DOI 10.1007/s00464-003-8253-3	27	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JUN	2015	22	6					2040	2050		10.1245/s10434-014-4172-x		11	Oncology; Surgery	Oncology; Surgery	CH7ON	WOS:000354226600041		
J	Enomoto, A; Saito, K; Subramanian, S; Krishna, MC; Hirata, H; Devasahayam, N				Enomoto, Ayano; Saito, Keita; Subramanian, Sankaran; Krishna, Murali C.; Hirata, Hiroshi; Devasahayam, Nallathamby			Passive Decoupling Due to Low Q-Factors of Four-Channel Coils in 300-MHz Pulsed EPR Imaging	APPLIED MAGNETIC RESONANCE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; TOOTH DOSIMETRY; PHASED-ARRAY; ACQUISITION; MRI; RESONATORS; DESIGN; SYSTEM	This article describes a four-channel coil array for in vivo time-domain electron paramagnetic resonance (EPR) imaging applications. Decoupling of the individual element coils was achieved with the low-quality factors required in pulsed EPR at radiofrequency to accommodate the imaging bandwidth. No active decoupling method was used in the coil array. Remote control of a coaxial switch connected to the four-channel coil array was performed with voltage signals from a personal computer. To verify the operation of this four-channel coil array, a phantom tube filled with a solution of paramagnetic triarylmethyl radicals (OX063) was visualized by pulsed EPR imaging based on the single-point method involving pure phase encoding. In an in vivo experiment, OX063 in a mouse tumor-bearing right hind leg was visualized by pulsed EPR imaging. Even without active decoupling circuits, there was no shift in resonances for individual coils when those were tuned to the same frequency due to low quality factors and low coupling coefficients with neighboring coils. The coil assembly allowed us to study an object that was larger than an individual coil element, enabling the imaging of larger subjects with reduced overall specific absorption rate. Such strategies should be useful for studying larger objects by EPR imaging.	[Enomoto, Ayano; Hirata, Hiroshi] Hokkaido Univ, Grad Sch Informat Sci & Technol, Div Bioengn & Bioinformat, Kita Ku, Sapporo, Hokkaido 0600814, Japan; [Saito, Keita; Subramanian, Sankaran; Krishna, Murali C.; Devasahayam, Nallathamby] NCI, Radiat Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Hirata, H (reprint author), Hokkaido Univ, Grad Sch Informat Sci & Technol, Div Bioengn & Bioinformat, Kita Ku, North 14,West 9, Sapporo, Hokkaido 0600814, Japan.	hhirata@ist.hokudai.ac.jp			JSPS KAKENHI [26249057]; JSPS [24-1486]; Center for Cancer Research, NCI, NIH	This work was supported in part by JSPS KAKENHI Grant Number 26249057. A.E. was supported by a Research Fellowship for Young Scientists (24-1486) from JSPS. We also thank the Center for Cancer Research, NCI, NIH for intramural research funding.	Ali S.M., 2003, ACTA DERM-VENEREOL, V93, P261; Barberi EA, 2000, MAGNET RESON MED, V43, P284, DOI 10.1002/(SICI)1522-2594(200002)43:2<284::AID-MRM16>3.0.CO;2-C; Lee RF, 2002, MAGNET RESON MED, V48, P203, DOI 10.1002/mrm.10186; Ohliger MA, 2006, NMR BIOMED, V19, P300, DOI 10.1002/nbm.1046; Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107; Devasahayam N, 2000, J MAGN RESON, V142, P168, DOI 10.1006/jmre.1999.1926; Hillman BJ, 2012, RADIOLOGY, V265, P51, DOI 10.1148/radiol.12110600; Devasahayam N, 2007, MAGN RESON MED, V57, P776, DOI 10.1002/mrm.21194; Enomoto A, 2013, J MAGN RESON, V234, P21, DOI 10.1016/j.jmr.2013.06.007; Enomoto A, 2014, MAGN RESON MED, V71, P853, DOI 10.1002/mrm.24702; Enomoto A, 2011, J MAGN RESON, V209, P244, DOI 10.1016/j.jmr.2011.01.021; Haga T, 2013, CONCEPT MAGN RESON B, V43B, P32, DOI 10.1002/cmr.b.21229; He GL, 2002, MAGNET RESON MED, V48, P1057, DOI 10.1002/mrm.10302; HYDE JS, 1986, J MAGN RESON, V70, P512, DOI 10.1016/0022-2364(86)90146-0; Matsumoto S, 2009, P NATL ACAD SCI USA, V106, P17898, DOI 10.1073/pnas.0908447106; RINARD GA, 1994, J MAGN RESON SER A, V108, P71, DOI 10.1006/jmra.1994.1090; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Subramanian S, 2002, MAGNET RESON MED, V48, P370, DOI 10.1002/mrm.10199; Sugawara H, 2014, IEEE T BIO-MED ENG, V61, P1894, DOI 10.1109/TBME.2014.2310217; von Meyenburg J, 2013, RADIOLOGY, V267, P869, DOI 10.1148/radiol.13112776; Willinek WA, 2003, RADIOLOGY, V228, P669, DOI 10.1148/radiol.2283020243	21	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	JUN	2015	46	6					671	683		10.1007/s00723-015-0671-6		13	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CI3AX	WOS:000354620900006		
J	Tsuge, Y; Yamamoto, S; Kato, N; Suda, M; Vertes, AA; Yukawa, H; Inui, M				Tsuge, Yota; Yamamoto, Shogo; Kato, Naoto; Suda, Masako; Vertes, Alain A.; Yukawa, Hideaki; Inui, Masayuki			Overexpression of the phosphofructokinase encoding gene is crucial for achieving high production of D-lactate in Corynebacterium glutamicum under oxygen deprivation	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Corynebacterium glutamicum; Oxygen deprivation; D-Lactic acid; Metabolic engineering; Glycolytic enzyme	EFFICIENT ISOBUTANOL PRODUCTION; D-LACTIC ACID; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; STEREOCOMPLEX FORMATION; DEHYDROGENASE-ACTIVITY; GLUCOSE-METABOLISM; SUCCINATE; STRAIN; BACTERIA	We previously reported on the impacts of the overexpression of individual genes of the glycolytic pathway encoding glucokinase (GLK), glyceraldehyde phosphate dehydrogenase (GAPDH), phosphofructokinase (PFK), triosephosphate isomerase (TPI), and bisphosphate aldolase (FBA) on D-lactate productivity in Corynebacterium glutamicum under oxygen-deprived conditions. Searching for synergies, in the current study, we simultaneously overexpressed the five glycolytic genes in a stepwise fashion to evaluate the effect of the cumulative overexpression of glycolytic genes on D-lactate production. Interestingly, the final D-lactate concentration markedly differed depending on whether or not the PFK encoding gene was overexpressed when combined with overexpressing other glycolytic genes. The simultaneous overexpression of the GLK, GAPDH, TPI, and FBA encoding genes led to the highest initial D-lactate concentration at 10 h. However, this particular recombinant strain dramatically slowed producing D-lactate when a concentration of 1300 mM was reached, typically after 32 h. In contrast, the strain overexpressing the PFK encoding gene together with the GLK, GAPDH, TPI, and FBA encoding genes showed 12.7 % lower initial D-lactate concentration at 10 h than that observed with the strain overexpressing the genes coding for GLK, GAPDH, TPI, and FBA. However, this recombinant strain continued to produce D-lactate after 32 h, reaching 2169 mM after a mineral salts medium bioprocess incubation period of 80 h. These results suggest that overexpression of the PFK encoding gene is essential for achieving high production of D-lactate. Our findings provide interesting options to explore for using C. glutamicum for cost-efficient production of D-lactate at the industrial scale.	[Tsuge, Yota; Yamamoto, Shogo; Kato, Naoto; Suda, Masako; Vertes, Alain A.; Yukawa, Hideaki; Inui, Masayuki] Res Inst Innovat Technol Earth RITE, Kyoto 6190292, Japan; [Inui, Masayuki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Inui, M (reprint author), Res Inst Innovat Technol Earth RITE, 9-2 Kizugawadai, Kyoto 6190292, Japan.	inui@rite.or.jp			New Energy and Industrial Technology Development Organization (NEDO)	This work was supported by a grant from the New Energy and Industrial Technology Development Organization (NEDO).	VERTES AA, 1993, RES MICROBIOL, V144, P181, DOI 10.1016/0923-2508(93)90043-2; Zhou L, 2012, METAB ENG, V14, P560, DOI 10.1016/j.ymben.2012.05.004; Inui M, 2007, MICROBIOL-SGM, V153, P2491, DOI 10.1099/mic.0.2006/005587-0; Yamamoto S, 2013, BIOTECHNOL BIOENG, V110, P2938, DOI 10.1002/bit.24961; Yamamoto S, 2012, APPL ENVIRON MICROB, V78, P4447, DOI 10.1128/AEM.07998-11; Litsanov B, 2012, APPL ENVIRON MICROB, V78, P3325, DOI 10.1128/AEM.07790-11; IKADA Y, 1987, MACROMOLECULES, V20, P904, DOI 10.1021/ma00170a034; Okino S, 2008, APPL MICROBIOL BIOT, V81, P459, DOI 10.1007/s00253-008-1668-y; Emmerling M, 2000, BIOTECHNOL BIOENG, V67, P623, DOI 10.1002/(SICI)1097-0290(20000305)67:5<623::AID-BIT13>3.0.CO;2-W; Blombach B, 2011, APPL ENVIRON MICROB, V77, P3300, DOI 10.1128/AEM.02972-10; Rados D, 2014, APPL ENVIRON MICROB, V80, P3015, DOI 10.1128/AEM.04189-13; Inui M, 2004, J MOL MICROB BIOTECH, V7, P182, DOI 10.1159/000079827; Jojima T, 2010, APPL MICROBIOL BIOT, V87, P159, DOI 10.1007/s00253-010-2493-7; Solem C, 2008, IET SYST BIOL, V2, P64, DOI 10.1049/iet-syb:20070002; Solem C, 2003, J BACTERIOL, V185, P1564, DOI 10.1128/JB.185.5.1564-1571.2003; Hasegawa S, 2013, APPL ENVIRON MICROB, V79, P1250, DOI 10.1128/AEM.02806-12; Grabar TB, 2006, BIOTECHNOL LETT, V28, P1527, DOI 10.1007/s10529-006-9122-7; Nielsen DR, 2009, METAB ENG, V11, P262, DOI 10.1016/j.ymben.2009.05.003; Wang LM, 2011, APPL MICROBIOL BIOT, V89, P1009, DOI 10.1007/s00253-010-2904-9; Becker J, 2011, METAB ENG, V13, P159, DOI 10.1016/j.ymben.2011.01.003; Okino S, 2008, APPL MICROBIOL BIOT, V78, P449, DOI 10.1007/s00253-007-1336-7; Suzuki N, 2005, APPL ENVIRON MICROB, V71, P3369, DOI 10.1128/AEM.71.6.3369-3372.2005; Papagianni M, 2011, ENZYME MICROB TECH, V49, P197, DOI 10.1016/j.enzmictec.2011.05.002; Tsuge Y, 2013, APPL MICROBIOL BIOT, V97, P6693, DOI 10.1007/s00253-013-4986-7; Fukushima K, 2007, MACROMOL BIOSCI, V7, P829, DOI 10.1002/mabi.200700028; Okino S, 2005, APPL MICROBIOL BIOT, V68, P475, DOI 10.1007/s00253-005-1900-y; Arai K, 2002, PROTEIN ENG, V15, P35, DOI 10.1093/protein/15.1.35; Bailey JE, 1996, BIOTECHNOL BIOENG, V52, P109, DOI 10.1002/(SICI)1097-0290(19961005)52:1<109::AID-BIT11>3.0.CO;2-J; Inui M, 2004, J MOL MICROB BIOTECH, V8, P243, DOI 10.1159/000086705; Ishida N, 2006, J BIOSCI BIOENG, V101, P172, DOI 10.1263/jbb.101.172; Joshi DS, 2010, BIOTECHNOL LETT, V32, P517, DOI 10.1007/s10529-009-0187-y; Karjomaa S, 1998, POLYM DEGRAD STABIL, V59, P333, DOI 10.1016/S0141-3910(97)00204-8; Kinoshita S, 1985, BIOL IND MICROORGANI, P115; Sambrook J., 1989, MOL CLONING LAB MANU; STEPHANOPOULOS G, 1991, SCIENCE, V252, P1675, DOI 10.1126/science.1904627; Vertes AA, 2013, CORYNEBACTERIUM GLUT, P1; Wang QZ, 2011, P NATL ACAD SCI USA, V108, P18920, DOI 10.1073/pnas.1111085108; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0	38	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	JUN	2015	99	11					4679	4689		10.1007/s00253-015-6546-9		11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CI2ZT	WOS:000354617800011		
J	Hyakutake, M; Tomizawa, S; Mizuno, K; Hisano, T; Abe, H; Tsuge, T				Hyakutake, Manami; Tomizawa, Satoshi; Mizuno, Kouhei; Hisano, Tamao; Abe, Hideki; Tsuge, Takeharu			A common active site of polyhydroxyalkanoate synthase from Bacillus cereus YB-4 is involved in polymerization and alcoholysis reactions	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Bacillus; Escherichia coli; Polyhydroxyalkanoate; Class IV PHA synthase; Alcoholysis; Catalytic residue	DELFTIA-ACIDOVORANS DS-17; PSEUDOMONAS SP 61-3; ESCHERICHIA-COLI; PHA SYNTHASE; MOLECULAR-WEIGHT; ALCALIGENES-EUTROPHUS; RALSTONIA-EUTROPHA; DEGRADATION; POLY(3-HYDROXYBUTYRATE); MECHANISM	Polyhydroxyalkanoate (PHA) synthase from Bacillus cereus YB-4 (PhaRC(YB4)) catalyzes not only PHA polymerization but also alcoholytic cleavage of PHA chains. The alcoholysis activity of PhaRC(YB4) is expressed when a hydroxyacyl-CoA monomer is absent but an alcohol compound is present. In this study, we performed alanine mutagenesis of the putative catalytic triad (Cys(151), Asp(306), and His(335)) in the PhaC(YB4) subunit to identify the active site residues for polymerization and alcoholysis activities. Individual substitution of each triad residue with alanine resulted in loss of both polymerization and alcoholysis activities, suggesting that these residues are commonly shared between polymerization and alcoholysis reactions. The loss of activity was also observed following mutagenesis of the triad to other amino acids, except for one PhaRC(YB4) mutant with a C151S substitution, which lost polymerization activity but still possessed cleavage activity towards PHA chains. The low-molecular-weight PHA isolated from the PhaRC(YB4)(C151S)-expressing strain showed a lower ratio of alcohol capping at the P(3HB) carboxy terminus than did that from the wild-type-expressing strain. This observation implies that hydrolysis activity of PhaRC(YB4) might be elicited by the C151S mutation.	[Hyakutake, Manami; Abe, Hideki; Tsuge, Takeharu] Tokyo Inst Technol, Dept Innovat & Engn Mat, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Hyakutake, Manami; Abe, Hideki] RIKEN Ctr Sustainable Resource Sci, Biomass Engn Program Cooperat Div, Wako, Saitama 3510198, Japan; [Tomizawa, Satoshi] Kumamoto Natl Coll Technol, Dept Biol & Chem Syst Engn, Yatsushiro, Kumamoto 8668501, Japan; [Mizuno, Kouhei] Kitakyushu Natl Coll Technol, Dept Mat Sci & Chem Engn, Kokuraminami Ku, Kitakyushu, Fukuoka 8020985, Japan; [Hisano, Tamao] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	Tsuge, T (reprint author), Tokyo Inst Technol, Dept Innovat & Engn Mat, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	manami.hyakutake@riken.jp; tsuge.t.aa@m.titech.ac.jp	Tsuge, Takeharu/F-6618-2011	Tsuge, Takeharu/0000-0002-6296-6500	JSPS Young Scientist Fellowship [12J07940];  [KAKENHI 23310060]	We thank Dr. Y. Nakamura (Tokyo Institute of Technology) for NMR analysis. This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI 23310060) to T. Tsuge. M. Hyakutake was a recipient of a JSPS Young Scientist Fellowship (12J07940).	Agus J, 2010, POLYM DEGRAD STABIL, V95, P2250, DOI 10.1016/j.polymdegradstab.2010.09.009; KAWAGUCHI Y, 1990, FEMS MICROBIOL LETT, V70, P151, DOI 10.1016/S0378-1097(05)80030-8; Kusaka S, 1998, J MACROMOL SCI PURE, VA35, P319, DOI 10.1080/10601329808001980; Hiroe A, 2013, J BIOSCI BIOENG, V115, P633, DOI 10.1016/j.jbiosc.2012.12.015; Tomizawa S, 2011, BIOMACROMOLECULES, V12, P2660, DOI 10.1021/bm2004687; Kato M, 1996, APPL MICROBIOL BIOT, V45, P363; Mizuno K, 2010, POLYM DEGRAD STABIL, V95, P1335, DOI 10.1016/j.polymdegradstab.2010.01.033; Rehm BHA, 2003, BIOCHEM J, V376, P15, DOI 10.1042/BJ20031254; Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838; Tomizawa S, 2010, APPL MICROBIOL BIOT, V87, P1427, DOI 10.1007/s00253-010-2601-8; Gupta R, 2004, APPL MICROBIOL BIOT, V64, P763, DOI 10.1007/s00253-004-1568-8; McCool GJ, 1999, J BACTERIOL, V181, P585; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Hyakutake M, 2011, BIOSCI BIOTECH BIOCH, V75, P1615, DOI 10.1271/bbb.110229; Arima J, 2014, APPL MICROBIOL BIOT, V98, P1631, DOI 10.1007/s00253-013-4992-9; HIDE WA, 1992, J LIPID RES, V33, P167; Hisano T, 2006, J MOL BIOL, V356, P993, DOI 10.1016/j.jmb.2005.12.028; Hyakutake M, 2014, APPL ENVIRON MICROB, V80, P1421, DOI 10.1128/AEM.03576-13; Jia Y, 2001, BIOCHEMISTRY-US, V40, P1011, DOI 10.1021/bi002219w; Jia Y, 2000, BIOCHEMISTRY-US, V39, P3927, DOI 10.1021/bi9928086; KAWAGUCHI Y, 1992, MACROMOLECULES, V25, P2324, DOI 10.1021/ma00035a007; Matsusaki H, 2000, APPL MICROBIOL BIOT, V53, P401; SLATER SC, 1988, J BACTERIOL, V170, P4431; Stubbe J, 2003, NAT PROD REP, V20, P445, DOI 10.1039/b209687k; Sudesh K, 2000, PROG POLYM SCI, V25, P1053; Tariq A, 2014, J BIOMOL STRUC DYNAM; Tomizawa S, 2013, APPL MICROBIOL BIOT, V97, P4821, DOI 10.1007/s00253-013-4798-9; Tsuge T, 2004, FEMS MICROBIOL LETT, V231, P77, DOI 10.1016/S0378-1097(03)00930-3; Ushimaru K, 2013, APPL MICROBIOL BIOT, V97, P1175, DOI 10.1007/s00253-012-4089-x	29	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	JUN	2015	99	11					4701	4711		10.1007/s00253-014-6276-4		11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CI2ZT	WOS:000354617800013		
J	Kamon, M; Sumitani, J; Tani, S; Kawaguchi, T; Kamon, M; Sumitani, J; Tani, S; Kawaguchi, T				Kamon, Masahiro; Sumitani, Jun-ichi; Tani, Shuji; Kawaguchi, Takashi; Kamon, M.; Sumitani, J.; Tani, S.; Kawaguchi, T.			Characterization and gene cloning of a maltotriose-forming exo-amylase from Kitasatospora sp MK-1785	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Kitasatospora; Exo-alpha-amylase; Maltotriose; Transglycosylation; Cloning	STEAROTHERMOPHILUS MALTOGENIC AMYLASE; ALPHA-AMYLASE; BACILLUS-STEAROTHERMOPHILUS; MICROBACTERIUM-IMPERIALE; ENZYMATIC PRODUCTION; THERMOBIFIDA-FUSCA; ESCHERICHIA-COLI; BETA-AMYLASE; TRANSGLYCOSYLATION; MECHANISM	A maltotriose-forming amylase (G3Amy) from Kitasatospora sp. MK-1785 was successfully isolated from a soil sample by inhibiting typical extracellular alpha-amylases using a proteinaceous alpha-amylase inhibitor. G3Amy was purified from the MK-1785 culture supernatant and characterized. G3Amy produced maltotriose as the principal product from starch and was categorized as an exo-alpha-amylase. G3Amy could also transfer maltotriose to phenolic and alcoholic compounds. Therefore, G3Amy can be useful for not only maltotriose manufacture but also maltooligosaccharide-glycoside synthesis. Further, the G3Amy gene was cloned and expressed in Escherichia coli cells. Analysis of its deduced amino acid sequence revealed that G3Amy consisted of an N-terminal GH13 catalytic domain and two C-terminal repeat starch-binding domains belonging to CBM20. It is suggested that natural G3Amy was subjected to proteolysis at N-terminal region of the anterior CBM20 in the C-terminal region. As with natural G3Amy, recombinant G3Amy could produce and transfer maltotriose from starch.	[Kamon, Masahiro; Sumitani, Jun-ichi; Tani, Shuji; Kawaguchi, Takashi; Kamon, M.; Sumitani, J.; Tani, S.; Kawaguchi, T.] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Naka Ku, Sakai, Osaka 5998531, Japan	Sumitani, J (reprint author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	monger@biochem.osakafu-u.ac.jp	Tani, Shuji/E-2309-2011		Japan Society for the Promotion of Science [26450100]	This work was financially supported by grants-in-aid for scientific research (26450100) from the Japan Society for the Promotion of Science.	van der Veen BA, 2001, J BIOL CHEM, V276, P44557, DOI 10.1074/jbc.M107533200; Lee HY, 2003, J MOL CATAL B-ENZYM, V26, P293, DOI 10.1016/j.molcatb.2003.08.003; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; ROBYT JF, 1967, ARCH BIOCHEM BIOPHYS, V122, P8, DOI 10.1016/0003-9861(67)90118-X; Desmet T, 2012, CHEM-EUR J, V18, P10786, DOI 10.1002/chem.201103069; Kuriki T, 1999, J BIOSCI BIOENG, V87, P557, DOI 10.1016/S1389-1723(99)80114-5; Yang CH, 2004, ENZYME MICROB TECH, V35, P254, DOI 10.1016/j.enzmictec.2004.05.004; Kashiwagi N, 2014, BIOTECHNOL LETT, V36, P2311, DOI 10.1007/s10529-014-1611-5; Sumitani J, 2000, BIOCHEM J, V350, P477, DOI 10.1042/0264-6021:3500477; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Dauter Z, 1999, BIOCHEMISTRY-US, V38, P8385, DOI 10.1021/bi990256l; Kelly RM, 2008, BIOCHEM J, V413, P517, DOI 10.1042/BJ20080353; Khamna S, 2009, WORLD J MICROB BIOT, V25, P649, DOI 10.1007/s11274-008-9933-x; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Kanai R, 2004, BIOCHEMISTRY-US, V43, P14047, DOI 10.1021/bi048489m; Yang CH, 2007, J IND MICROBIOL BIOT, V34, P325, DOI 10.1007/s10295-006-0200-6; ARAI M, 1989, J FERMENT BIOENG, V68, P56, DOI 10.1016/0922-338X(89)90215-8; Bae HK, 2002, J AGR FOOD CHEM, V50, P3309, DOI 10.1021/jf011550z; Bijttebier A, 2008, BIOLOGIA, V63, P989, DOI 10.2478/s11756-008-0169-x; Derde LJ, 2012, FOOD CHEM, V135, P713, DOI 10.1016/j.foodchem.2012.05.031; Jun SY, 2013, ACTA CRYSTALLOGR D, V69, P442, DOI 10.1107/S0907444912049219; KOBAYASHI T, 1992, J BACTERIOL, V174, P3439; Lee YS, 2014, J MICROBIOL BIOTECHN, DOI [10.1007/s00253-014-6186-5, DOI 10.1007/S00253-014-6186-5]; Makino T, 2013, J NAT MED-TOKYO, V67, P881, DOI 10.1007/s11418-013-0760-5; Mehta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073612; Morishita Y, 1997, J MOL BIOL, V267, P661, DOI 10.1006/jmbi.1996.0887; NAKAKUKI T, 1984, CARBOHYD RES, V128, P297, DOI 10.1016/0008-6215(84)85337-9; Nakano H, 2003, J BIOSCI BIOENG, V95, P583, DOI 10.1016/S1389-1723(03)80166-4; Nasrollahi S, 2013, INT J BIOL MACROMOL, V60, P1, DOI 10.1016/j.ijbiomac.2013.04.063; Roh HJ, 2005, TETRAHEDRON-ASYMMETR, V16, P77, DOI 10.1016/j.tetasy.2004.11.060; SUMITANI J, 1993, BIOSCI BIOTECH BIOCH, V57, P1243; TAKASAKI Y, 1991, AGR BIOL CHEM TOKYO, V55, P687; TAKASAKI Y, 1985, AGR BIOL CHEM TOKYO, V49, P1091; TAKEKAWA S, 1991, J BACTERIOL, V173, P6820; USUI T, 1993, CARBOHYD RES, V250, P57, DOI 10.1016/0008-6215(93)84154-X; USUI T, 1988, J BIOCHEM-TOKYO, V103, P969; Wu CS, 2014, CARBOHYD RES, V384, P46, DOI 10.1016/j.carres.2013.11.014; Yoon JW, 2003, BIOSCI BIOTECH BIOCH, V67, P525, DOI 10.1271/bbb.67.525	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	JUN	2015	99	11					4743	4753		10.1007/s00253-015-6396-5		11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CI2ZT	WOS:000354617800017		
J	Sugioka, K; Tsuboi, Y; Matsuo, S				Sugioka, Koji; Tsuboi, Yasuyuki; Matsuo, Shigeki			Special Issue: Selected articles of the 9th International Conference on Photo-Excited Processes and Applications	APPLIED PHYSICS B-LASERS AND OPTICS			English	Editorial Material									[Sugioka, Koji] RIKEN Ctr Adv Photon, Wako, Saiatam 3510198, Japan; [Tsuboi, Yasuyuki] Osaka City Univ, Sumiyoshi Ku, Osaka 5588585, Japan; [Matsuo, Shigeki] Shibaura Inst Technol, Koto Ku, Tokyo 1358548, Japan	Sugioka, K (reprint author), RIKEN Ctr Adv Photon, Wako, Saiatam 3510198, Japan.	ksugioka@riken.jp						0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUN	2015	119	3			SI		399	399		10.1007/s00340-015-6127-8		1	Optics; Physics, Applied	Optics; Physics	CI2ZV	WOS:000354618000001		
J	Inogamov, NA; Zhakhovsky, VV; Hasegawa, N; Nishikino, M; Yamagiwa, M; Ishino, M; Agranat, MB; Ashitkov, SI; Faenov, AY; Khokhlov, VA; Ilnitsky, DK; Petrov, YV; Migdal, KP; Pikuz, TA; Takayoshi, S; Eyama, T; Kakimoto, N; Tomita, T; Baba, M; Minami, Y; Suemoto, T; Kawachi, T				Inogamov, N. A.; Zhakhovsky, V. V.; Hasegawa, N.; Nishikino, M.; Yamagiwa, M.; Ishino, M.; Agranat, M. B.; Ashitkov, S. I.; Faenov, A. Ya.; Khokhlov, V. A.; Ilnitsky, D. K.; Petrov, Yu. V.; Migdal, K. P.; Pikuz, T. A.; Takayoshi, S.; Eyama, T.; Kakimoto, N.; Tomita, T.; Baba, M.; Minami, Y.; Suemoto, T.; Kawachi, T.			Hydrodynamics driven by ultrashort laser pulse: simulations and the optical pump-X-ray probe experiment	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							ABLATION; METALS; SPALLATION; MATTER; WAVES	Spatial structures of ablative mass flow produced by femtosecond laser pulses are studied. In experiments with a gold film, the Ti:sapp laser pulse having a focal size of 100 microns on a target was used, while a soft X-ray probe pulse was utilized for diagnostics. The experimental data are compared with simulated mass flows obtained by two-temperature hydrodynamics and molecular dynamics methods. Simulation shows evolution of a thin surface layer pressurized after electron-ion thermalization, which leads to melting, cavitation and formation of spallation liquid layer. The calculated asymptotic surface velocity of this layer as a function of fluence is in reasonably good agreement with experimental data.	[Inogamov, N. A.; Khokhlov, V. A.; Petrov, Yu. V.] Russian Acad Sci, LD Landau Theoret Phys Inst, Chernogolovka 142432, Russia; [Inogamov, N. A.; Zhakhovsky, V. V.; Ilnitsky, D. K.; Migdal, K. P.] ROSATOM, All Russia Res Inst Automat, Moscow, Russia; [Zhakhovsky, V. V.; Agranat, M. B.; Ashitkov, S. I.; Faenov, A. Ya.; Pikuz, T. A.] Russian Acad Sci, Joint Inst High Temp, Moscow, Russia; [Hasegawa, N.; Nishikino, M.; Yamagiwa, M.; Ishino, M.; Kawachi, T.] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Kyoto, Japan; [Faenov, A. Ya.] Osaka Univ, Inst Acad Initiat, Suita, Osaka, Japan; [Pikuz, T. A.] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan; [Takayoshi, S.; Eyama, T.; Kakimoto, N.; Tomita, T.] Univ Tokushima, Fac Engn, Tokushima 770, Japan; [Baba, M.; Minami, Y.; Suemoto, T.] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba, Japan	Inogamov, NA (reprint author), Russian Acad Sci, LD Landau Theoret Phys Inst, Chernogolovka 142432, Russia.	nailinogamov@gmail.com			Russian Science Foundation (RSCF) [14-19-01599]; MEXT [25289244]; Japan Society for the Promotion of Science (JSPA) under the JSPS-RAS Joint Research Program (RFBR) [14-02-92107]; Russian Academy of Sciences (RAS) under the JSPS-RAS Joint Research Program (RFBR) [14-02-92107]	The research (NAI, VVZh, VAKh, DKI, YVP, KPM, AYF, TAP) has been performed under financial support from Russian Science Foundation (RSCF) (Project No. 14-19-01599). This work (except NAI, VVZh, VAKh, DKI, YVP, KPM) was partly supported by Grant-in-Aid for Scientific Research (B), No. 25289244 (2013), from MEXT and bilateral program: Japan Society for the Promotion of Science (JSPA) and Russian Academy of Sciences (RAS) under the JSPS-RAS Joint Research Program (RFBR Grant 14-02-92107).	Anisimov SI, 2003, JETP LETT+, V77, P606, DOI 10.1134/1.1600815; Anisimov SI, 1999, APPL PHYS A-MATER, V69, P617, DOI 10.1007/s003390051041; Ivanov DS, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.064114; Nedialkov NN, 2007, APPL SURF SCI, V253, P7761, DOI 10.1016/j.apsusc.2007.02.083; Kanel' GI, 2007, PHYS-USP+, V50, P771, DOI 10.1070/PU2007v050n08ABEH006327; Gill-Comeau M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.224110; Suemoto T, 2010, OPT EXPRESS, V18, P14114, DOI 10.1364/OE.18.014114; Tomita T, 2012, OPT EXPRESS, V20, P29329, DOI 10.1364/OE.20.029329; Inogamov NA, 2008, J EXP THEOR PHYS+, V107, P1, DOI 10.1134/S1063776108070017; Inogamov NA, 2009, APPL SURF SCI, V255, P9712, DOI 10.1016/j.apsusc.2009.04.139; Zhigilei LV, 2009, J PHYS CHEM C, V113, P11892, DOI 10.1021/jp902294m; Zhakhovskii VV, 2009, APPL SURF SCI, V255, P9592, DOI 10.1016/j.apsusc.2009.04.082; [Anonymous], 2014, 9 INT C PHOT PROC AP; Demaske BJ, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.064113; Inogamov NA, 1999, JETP LETT+, V69, P310, DOI 10.1134/1.568029; Povarnitsyn ME, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.235414; Chan WL, 2009, APPL PHYS A-MATER, V97, P287, DOI 10.1007/s00339-009-5383-z; Zhakhovskii VV, 2000, JETP LETT+, V71, P167, DOI 10.1134/1.568306; Antoun T., 2003, SPALL FRACTURE; Ashitkov SI, 2012, JETP LETT+, V95, P176, DOI 10.1134/S0021364012040042; Baba M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.080302; Demaske BJ, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.054109; Inogamov N.A., 2015, ZH EXP THEOR FIZIKI, V147, P20; Inogamov NA, 2012, AIP CONF PROC, V1464, P593, DOI 10.1063/1.4739912; Kanel G. I., 2004, SHOCK WAVE PHENOMENA; Lorazo P, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.225502; Sokolowski-Tinten K, 1998, PHYS REV LETT, V81, P224, DOI 10.1103/PhysRevLett.81.224; Tomita T, 2014, J LASER MICRO NANOEN, V9, P137, DOI 10.2961/jlmn.2014.02.0011; Wu CP, 2014, APPL PHYS A-MATER, V114, P11, DOI 10.1007/s00339-013-8086-4; Zhakhovskii VV, 2008, JETP LETT+, V87, P423, DOI 10.1134/S0021364008080079	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUN	2015	119	3			SI		413	419		10.1007/s00340-015-6039-7		7	Optics; Physics, Applied	Optics; Physics	CI2ZV	WOS:000354618000003		
J	Masuda, M; Tanaka, N; Hane, K; Sunahara, A; Fujioka, S; Nishimura, H				Masuda, Masaya; Tanaka, Nozomi; Hane, Kazuyoshi; Sunahara, Atsushi; Fujioka, Shinsuke; Nishimura, Hiroaki			Spectroscopic observation of ablation plasma generated with a laser-driven extreme ultraviolet light source	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							RADIATION	An extreme ultraviolet (EUV) light source (lambda = 9-25 nm, 10 Hz) was developed to study EUV ablation physics and applications. The EUV source device including an elliptical total reflection mirror was optimized to provide EUV irradiance as high as 4.2 x 10(9) W/cm(2) on ablation samples. Time-resolved spectroscopic observation of ablation plasma from a Si plate was conducted to derive electron temperature and density, and compared with those for laser-produced ablation at the same irradiance. Difference in ablation mechanism between two sources is discussed.	[Masuda, Masaya; Tanaka, Nozomi; Hane, Kazuyoshi; Fujioka, Shinsuke; Nishimura, Hiroaki] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Sunahara, Atsushi] Inst Laser Technol, Suita, Osaka 5650871, Japan	Masuda, M (reprint author), Osaka Univ, Inst Laser Engn, Yamadaoka 2-6, Suita, Osaka 5650871, Japan.	masuda-m@ile.osaka-u.ac.jp	Nishimura, Hiroaki/I-4908-2015; Fujioka, Shinsuke/J-5530-2015; 	Fujioka, Shinsuke/0000-0001-8406-1772; SUNAHARA, ATSUSHI/0000-0001-7543-5226	JSPS [25800303, 22340172]; MEXT	This work was supported by JSPS Grant-in-Aid for Young Scientists (B) number 25800303, Grant-in-Aid for Scientific Research (B) number 22340172, and MEXT Project for Creation of Research Platforms and Sharing of Advanced Research Infrastructure" opening up a new photonics industry through high-intensity lasers".	Claeyssens F, 2002, J APPL PHYS, V92, P6886, DOI 10.1063/1.1518782; HENKE BL, 1993, ATOM DATA NUCL DATA, V54, P181, DOI 10.1006/adnd.1993.1013; Fukugaki K, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2213216; Baldis H.A., 1994, LASER PLASMA THEORY; Bartnik A, 2012, AIP CONF PROC, V1437, P126, DOI 10.1063/1.3703356; Berrill M., 2008, J OPT SOC AM B, V25, P7; Fajardo M, 2004, EUR PHYS J D, V29, P69, DOI 10.1140/epjd/e2004-00004-8; Makimura T., 2010, J NANOPHOTONICS, V4	8	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUN	2015	119	3			SI		421	425		10.1007/s00340-015-6041-0		5	Optics; Physics, Applied	Optics; Physics	CI2ZV	WOS:000354618000004		
J	Kaku, M; Kai, DC; Katto, M; Yokotani, A; Kubodera, S; Sasaki, W				Kaku, Masanori; Kai, Daichi; Katto, Masahito; Yokotani, Atsushi; Kubodera, Shoichi; Sasaki, Wataru			Surface analysis by photo-stimulated desorption using tunable VUV radiation	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							VACUUM-ULTRAVIOLET; KINETICS; PLASMA	We have demonstrated the photon-stimulated surface spectroscopy using broadband vacuum ultraviolet (VUV) emissions from a laser-produced plasma, in which adsorbed atoms or molecules on material surfaces were to be desorbed and dissociated as a result of absorption of the wavelength-selected VUV photons. Desorbed and dissociated atoms or molecules were then detected by a mass spectrometer. Mass spectra of polyethylene and polyvinyl chloride samples were obtained as a function of the irradiation wavelength. We have found sufficient characteristic differences of the mass spectra in the irradiation wavelength shorter than 200 nm in each sample. The desorption and dissociation of atoms or molecules from material surfaces depended on bond energy or molecular structure.	[Kaku, Masanori; Kai, Daichi; Katto, Masahito; Yokotani, Atsushi; Kubodera, Shoichi] Miyazaki Univ, Dept Elect & Elect Engn, Miyazaki 8892192, Japan; [Kaku, Masanori; Kai, Daichi; Katto, Masahito; Yokotani, Atsushi; Kubodera, Shoichi] Miyazaki Univ, Photon Sci Ctr, Miyazaki 8892192, Japan; [Sasaki, Wataru] NTP Inc, Miyazaki 8892192, Japan	Kaku, M (reprint author), Miyazaki Univ, Dept Elect & Elect Engn, Gakuen Kibanadai Nishi 1-1, Miyazaki 8892192, Japan.	kaku@opt.miyazaki-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25870565]	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 25870565.	Duca C, 2014, PHOTOCHEM PHOTOBIOL, V90, P238, DOI 10.1111/php.12157; DECKER C, 1982, EUR POLYM J, V18, P1085, DOI 10.1016/0014-3057(82)90209-9; GELLERT B, 1991, APPL PHYS B-PHOTO, V52, P14, DOI 10.1007/BF00405680; Hatano Y., 1999, Physics Reports, V313, DOI 10.1016/S0370-1573(98)00086-6; Kaku M, 2003, JPN J APPL PHYS 1, V42, P3458, DOI 10.1143/JJAP.42.3458; Kaye G.W.C., 1973, TABLE PHYS CHEM CONS; LAPORTE P, 1987, OPT LETT, V12, P987, DOI 10.1364/OL.12.000987; Ohtsubo T, 2003, APPL PHYS A-MATER, V76, P139, DOI 10.1007/s00339-002-1458-9; Skurat V, 2003, NUCL INSTRUM METH B, V208, P27, DOI 10.1016/S0168-583X(03)00636-0; Wasamoto M, 2009, APPL SURF SCI, V255, P9861, DOI 10.1016/j.apsusc.2009.04.107; Yokotani A, 1996, APPL PHYS LETT, V69, P1399, DOI 10.1063/1.117594	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUN	2015	119	3			SI		427	433		10.1007/s00340-015-6093-1		7	Optics; Physics, Applied	Optics; Physics	CI2ZV	WOS:000354618000005		
J	Kobayashi, T; Matsuo, Y				Kobayashi, T.; Matsuo, Y.			Production of warm aluminum cluster anions by femtosecond laser ablation	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							IONIZATION; REACTIVITY; CARBON; IONS	We report on the production of warm aluminum cluster anions, Al (n) (-) (1 a parts per thousand currency sign n a parts per thousand currency sign 26), after femtosecond laser ablation of an aluminum nitride substrate. Large cluster anions of n a parts per thousand yen 8 suffer metastable dissociation after their production, which indicates the internal energy of the cluster anions is high enough for the dissociation of an Al atom. We find that the efficiency of metastable dissociation is dependent on the size of cluster anions and the dependence can be rationalized by the dissociation energy of an Al atom from the cluster anions calculated with thermochemical data of the clusters.	[Kobayashi, T.] RIKEN Ctr Adv Photon, Wako, Saitama 3510198, Japan; [Matsuo, Y.] Hosei Univ, Dept Adv Sci, Koganei, Tokyo 1848584, Japan	Kobayashi, T (reprint author), RIKEN Ctr Adv Photon, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tokoba@riken.jp			Joint Usage/Research Program on Zero-Emission Energy Research, Institute of Advanced Energy of Kyoto University [ZE25B-15]	The authors are grateful for their generous support by Dr. K. Midorikawa of RIKEN and Prof. T. Nakajima of Kyoto University for this research. The research is partially supported by the Joint Usage/Research Program on Zero-Emission Energy Research, Institute of Advanced Energy of Kyoto University (ZE25B-15).	SCHRIVER KE, 1990, PHYS REV LETT, V64, P2539, DOI 10.1103/PhysRevLett.64.2539; HETTICH RL, 1989, J AM CHEM SOC, V111, P8582, DOI 10.1021/ja00205a004; TAYLOR KJ, 1988, CHEM PHYS LETT, V152, P347, DOI 10.1016/0009-2614(88)80104-0; Kurata-Nishimura M, 2002, APPL SURF SCI, V197, P715, DOI 10.1016/S0169-4332(02)00399-9; Duncan MA, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3697599; DEHEER WA, 1993, REV MOD PHYS, V65, P611, DOI 10.1103/RevModPhys.65.611; Momma C, 1996, OPT COMMUN, V129, P134, DOI 10.1016/0030-4018(96)00250-7; COX DM, 1988, J PHYS CHEM-US, V92, P421, DOI 10.1021/j100313a036; Stoian R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097603; GANTEFOR G, 1988, PHYS REV A, V37, P2716, DOI 10.1103/PhysRevA.37.2716; Chu C, 1999, APPL SURF SCI, V137, P91, DOI 10.1016/S0169-4332(98)00376-6; FLEISCHE.RL, 1965, J APPL PHYS, V36, P3645, DOI 10.1063/1.1703059; Guo L, 2004, J MOL STRUC-THEOCHEM, V677, P105, DOI 10.1016/j.theochem.2004.02.004; Kobayashi T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.066301; Kobayashi T, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3662138; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; Leskiw BD, 2001, J CHEM PHYS, V114, P1165, DOI 10.1063/1.1333017; Panyala N.R., 2011, RAPID COMMUN MASS SP, V2525, P1687; Phipps C., 2007, LASER ABLATION ITS A, V129; RAY U, 1989, J CHEM PHYS, V91, P2912, DOI 10.1063/1.456961; Terasaki A, 1996, J CHEM PHYS, V104, P1387, DOI 10.1063/1.470905	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUN	2015	119	3			SI		435	438		10.1007/s00340-015-6027-y		4	Optics; Physics, Applied	Optics; Physics	CI2ZV	WOS:000354618000006		
J	Kawahara, H; Shimogaki, T; Higashihata, M; Ikenoue, H; Nakamura, D; Okada, T				Kawahara, Hirotaka; Shimogaki, Tetsuya; Higashihata, Mitsuhiro; Ikenoue, Hiroshi; Nakamura, Daisuke; Okada, Tatsuo			Laser doping of Sb into ZnO nanowires in the Sb nanoparticle-dispersed liquid	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							P-TYPE ZNO; THIN-FILMS; PHOTOLUMINESCENCE; DEPOSITION; BOUNDARIES	We succeed in fabricating Sb-doped ZnO nanowires by laser doping using Sb nanoparticles (Sb NPs). Vertically aligned ZnO nanowires with a diameter of 100 nm were synthesized by the nanoparticles-assisted pulsed laser deposition. Sb NPs were prepared by laser ablation in liquid. The average size of 50 nm Sb NPs was successfully fabricated by laser ablation in ethanol. Subsequently, laser doping was performed by irradiating Nd:YAG laser beam (355 nm) in Sb-dispersed ethanol. After laser doping, the tip of ZnO nanowires was slightly deformed into spherical shape by laser heating. A rectifying property with a threshold voltage of 4.5 V was observed between n-type ZnO nanowires and Sb-doped ZnO nanowires.	[Kawahara, Hirotaka; Shimogaki, Tetsuya; Higashihata, Mitsuhiro; Ikenoue, Hiroshi; Nakamura, Daisuke; Okada, Tatsuo] Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Fukuoka 8190395, Japan	Kawahara, H (reprint author), Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Fukuoka 8190395, Japan.	kawahara@laserlab.ees.kyushu-u.ac.jp					Samanta K, 2010, J APPL PHYS, V108, DOI 10.1063/1.3516493; Ryu YR, 2000, J CRYST GROWTH, V216, P330, DOI 10.1016/S0022-0248(00)00437-1; Zang CH, 2008, CHEM PHYS LETT, V452, P148, DOI 10.1016/j.cplett.2007.12.041; Lyons JL, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3274043; Yankovich AB, 2012, NANO LETT, V12, P1311, DOI 10.1021/nl203848t; Chu S, 2011, NAT NANOTECHNOL, V6, P506, DOI [10.1038/nnano.2011.97, 10.1038/NNANO.2011.97]; Yoshikawa H, 1997, JPN J APPL PHYS 1, V36, P6237, DOI 10.1143/JJAP.36.6237; Limpijumnong S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.155504; Kim KK, 2003, APPL PHYS LETT, V83, P63, DOI 10.1063/1.1591064; Aoki T, 2002, PHYS STATUS SOLIDI B, V229, P911, DOI 10.1002/1521-3951(200201)229:2<911::AID-PSSB911>3.3.CO;2-I; Bagnall DM, 1997, APPL PHYS LETT, V70, P2230, DOI 10.1063/1.118824; Ahmad M, 2010, J MATER CHEM, V20, P7169, DOI 10.1039/c0jm01055c; Jang JI, 2012, SOLID STATE COMMUN, V152, P1241, DOI 10.1016/j.ssc.2012.04.028; Vaithianathan V, 2005, J APPL PHYS, V98, DOI 10.1063/1.2011775; Chen LL, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2146309; Fang XA, 2010, THIN SOLID FILMS, V518, P5687, DOI 10.1016/j.tsf.2010.04.031; Huang YC, 2011, J ALLOY COMPD, V509, P1980, DOI 10.1016/j.jallcom.2010.10.108; Mandalapu LJ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2901018; Nakamura D, 2011, APPL PHYS A-MATER, V103, P959, DOI 10.1007/s00339-011-6401-5; Nakamura D, 2012, PROC SPIE, V8245, DOI 10.1117/12.907514; Pan XH, 2007, APPL SURF SCI, V253, P5067, DOI 10.1016/j.apsusc.2006.11.014; Wang GP, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3551628; Wang X, 2012, NANO RES, V5, P412, DOI 10.1007/s12274-012-0222-5; Xiao ZY, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2838330; Xiu FX, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2089183; Yang T, 2011, J ALLOY COMPD, V509, P5426, DOI 10.1016/j.jallcom.2011.02.080; Yang Y, 2008, J PHYS CHEM C, V112, P17916, DOI 10.1021/jp8064213	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUN	2015	119	3			SI		463	467		10.1007/s00340-015-6062-8		5	Optics; Physics, Applied	Optics; Physics	CI2ZV	WOS:000354618000010		
J	Harada, K; Nakao, S; Takahashi, M; Higashihata, M; Ikenoue, H; Nakamura, D; Nakata, Y; Okada, T				Harada, Kosuke; Nakao, Shihomi; Takahashi, Masahiro; Higashihata, Mitsuhiro; Ikenoue, Hiroshi; Nakamura, Daisuke; Nakata, Yoshiki; Okada, Tatsuo			Ultraviolet lasing action in aligned ZnO nanowall	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							RANDOM LASERS; DEPOSITION; NANOWIRES; GROWTH; MODES	A vertically aligned ZnO nanowall arrays have been synthesized on a patterned ZnO buffer layer using an interference laser beam. The average height and thickness of the ZnO nanowall were 4 mu m and 200 nm, respectively. Room-temperature ultraviolet (UV) lasing was obtained from single piece of ZnO nanowall detached from the substrate. The threshold power density for lasing was estimated to be about 80 kW/cm(2). In addition, UV lasing from vertically aligned ZnO nanowall was also observed owing to the presence of holes. The lasing spectra had no regularity in the mode spacing and many different spatial modes, suggesting that the action was supported by the random lasing mechanism. The threshold power density for lasing was about 300 kW/cm(2), which was much higher than that of the single piece of ZnO nanowall because of the leakage of the light into buffer layer.	[Harada, Kosuke; Nakao, Shihomi; Takahashi, Masahiro; Higashihata, Mitsuhiro; Ikenoue, Hiroshi; Nakamura, Daisuke; Okada, Tatsuo] Kyushu Univ, Grad Sch ISEE, Nishi Ku, Fukuoka 8190395, Japan; [Nakata, Yoshiki] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan	Harada, K (reprint author), Kyushu Univ, Grad Sch ISEE, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	harada@laserlab.ees.kyushu-u.ac.jp	Nakata, Yoshiki/L-4957-2015	Nakata, Yoshiki/0000-0002-0680-999X			Kawakami M, 2003, JPN J APPL PHYS 2, V42, pL33, DOI 10.1143/JJAP.42.L33; Suehiro J, 2006, NANOTECHNOLOGY, V17, P2567, DOI 10.1088/0957-4484/17/10/021; Chen YF, 1998, J APPL PHYS, V84, P3912, DOI 10.1063/1.368595; Jeong MC, 2007, SMALL, V3, P568, DOI 10.1002/smll.200600479; Redding B, 2012, NAT PHOTONICS, V6, P355, DOI [10.1038/nphoton.2012.90, 10.1038/NPHOTON.2012.90]; Fallert J, 2009, NAT PHOTONICS, V3, P279, DOI 10.1038/NPHOTON.2009.67; Gargas DJ, 2011, NANO LETT, V11, P3792, DOI 10.1021/nl201850k; Okazaki K, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4768696; Guo RQ, 2007, APPL PHYS A-MATER, V89, P141, DOI 10.1007/s00339-007-4174-7; Fujiwara H, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4792349; Cao H, 2003, IEEE J SEL TOP QUANT, V9, P111, DOI 10.1109/JSTQE.2002.807975; Yu SF, 2004, APPL PHYS LETT, V84, P3241, DOI 10.1063/1.1734681; Cao H, 1999, PHYS REV B, V59, P15107, DOI 10.1103/PhysRevB.59.15107; Zimmler MA, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2965797; Chen J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2910769; Czekalla C, 2010, PHYS STATUS SOLIDI B, V247, P1282, DOI 10.1002/pssb.200945527; Guo R, 2009, APPL SURF SCI, V255, P9671, DOI 10.1016/j.apsusc.2009.04.049; Il W., 2004, ADV MATER, V16, P87; Nakamura D, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/3/034014; Nakao S, 2014, APPL PHYS A-MATER, V117, P63, DOI 10.1007/s00339-014-8426-z	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUN	2015	119	3			SI		469	473		10.1007/s00340-015-6103-3		5	Optics; Physics, Applied	Optics; Physics	CI2ZV	WOS:000354618000011		
J	Kawasoe, K; Ishikawa, Y; Koshizaki, N; Yano, T; Odawara, O; Wada, H				Kawasoe, Kosuke; Ishikawa, Yoshie; Koshizaki, Naoto; Yano, Tetsuji; Odawara, Osamu; Wada, Hiroyuki			Preparation of spherical particles by laser melting in liquid using TiN as a raw material	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							TIO2 HOLLOW SPHERES; SENSITIZED SOLAR-CELLS; BOTTOM-UP CONSTRUCTION; COLLOIDAL NANOPARTICLES; SUBMICROMETER SPHERES; PHOTONIC CRYSTALS; IRRADIATION; MECHANISM; TITANIA; FABRICATION	Submicron spherical particles comprising TiN, TiO2, and TiOxNy were prepared by nanosecond pulsed laser irradiation of TiN colloidal nanoparticles. A second harmonic generation Nd:YAG laser (wavelength: 532 nm) was used. We investigated how laser fluence, irradiation time, and raw material concentration affected spherical particle diameters and compositions. Laser irradiation of about 80 mJ/cm(2) was required to obtain spherical particles. When laser fluence was increased to more than 350 mJ/cm(2), spherical particles disappeared and nanoparticles formed. In the fluence range in which spheronization occurred, particle sizes increased with the laser fluence. XRD spectra showed that the oxidation of particles occurred during melting. From EDS mapping and XPS spectra, oxidization was clearly visible on particle surfaces, and the presence of TiOxNy and TiO2 was confirmed. Irradiation time and raw material concentration had little effect on product grain size.	[Kawasoe, Kosuke; Odawara, Osamu; Wada, Hiroyuki] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 2268502, Japan; [Ishikawa, Yoshie] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki 3058565, Japan; [Koshizaki, Naoto] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan; [Yano, Tetsuji] Tokyo Inst Technol, Grad Sch Sci & Engn, Meguro Ku, Tokyo 1528550, Japan	Wada, H (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 2268502, Japan.	wada.h.ac@m.titech.ac.jp	Wada, Hiroyuki/D-3431-2015	Wada, Hiroyuki/0000-0002-5781-5396	Collaborative Research Project of Materials & Structures Laboratory (Tokyo Tech.); Center for Advanced Materials Analysis (Tokyo Tech.)	The authors wish to thank M. Hara (DLS), K. Nakamura (Nd:YAG laser), M. Suzuki (SEM), and N. Hatakeyama (STEM-EDS) at Tokyo Tech. This study was supported by the Collaborative Research Project of Materials & Structures Laboratory (Tokyo Tech.) and the Center for Advanced Materials Analysis (Tokyo Tech.).	Tsuji T, 2013, J LASER MICRO NANOEN, V8, P292, DOI 10.2961/jlmn.2013.03.0017; Ishikawa Y, 2010, APPL PHYS A-MATER, V99, P797, DOI 10.1007/s00339-010-5745-6; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Wang HQ, 2011, J AM CHEM SOC, V133, P19102, DOI 10.1021/ja2049463; Wang HQ, 2011, ADV MATER, V23, P1865, DOI 10.1002/adma.201100078; Wang HQ, 2012, CHEM-EUR J, V18, P163, DOI 10.1002/chem.201102079; Wang WL, 2012, J APPL ELECTROCHEM, V42, P857, DOI 10.1007/s10800-012-0452-y; Zhang QF, 2010, CHEM MATER, V22, P2427, DOI 10.1021/cm9009942; Ohnishi R, 2013, J ELECTROCHEM SOC, V160, pF501, DOI 10.1149/2.053306jes; Kondo Y, 2008, LANGMUIR, V24, P547, DOI 10.1021/la702157r; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]; Li CC, 2009, CHEM MATER, V21, P4984, DOI 10.1021/cm902126w; Guo CS, 2010, ENVIRON SCI TECHNOL, V44, P419, DOI 10.1021/es9019854; Ishikawa Y, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2799786; Okazaki K, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4768696; Bhabra G, 2009, NAT NANOTECHNOL, V4, P876, DOI [10.1038/nnano.2009.313, 10.1038/NNANO.2009.313]; Fujiwara H, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4792349; Hu XL, 2008, ADV MATER, V20, P4845, DOI 10.1002/adma.200801433; Chen DH, 2010, J AM CHEM SOC, V132, P4438, DOI 10.1021/ja100040p; Zhao WR, 2008, ADV FUNCT MATER, V18, P2780, DOI 10.1002/adfm.200701317; Pyatenko A, 2009, J PHYS CHEM C, V113, P9078, DOI 10.1021/jp808300q; Wijnhoven JEGJ, 1998, SCIENCE, V281, P802, DOI 10.1126/science.281.5378.802; Drygas M, 2006, CHEM MATER, V18, P3122, DOI 10.1021/cm060522z; Park JH, 2009, J POWER SOURCES, V194, P574, DOI 10.1016/j.jpowsour.2009.03.075; Binnewies M., 1999, THERMOCHEMICAL DATA; Colilla M, 2010, CHEM MATER, V22, P1821, DOI 10.1021/cm9033484; Ishikawa Y., 2013, CHEM LETT, V42; Iwase M, 2013, APPL CATAL A-GEN, V455, P86, DOI 10.1016/j.apcata.2013.01.016; Kang DH, 2004, JPN J APPL PHYS 1, V43, P5243, DOI 10.1143/JJAP.43.5243; Li XY, 2011, LANGMUIR, V27, P5076, DOI 10.1021/la200231f; Li XY, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/11/115602; Li XY, 2011, J MATER CHEM, V21, P14406, DOI 10.1039/c1jm12696b; Martin N, 2001, APPL SURF SCI, V185, P123, DOI 10.1016/S0169-4332(01)00774-7; Moriya M, 2009, INORG CHEM, V48, P8544, DOI 10.1021/ic900864a; Pyatenko A, 2013, LASER PHOTONICS REV, V7, P596, DOI 10.1002/lpor.201300013; Pyatenko A, 2014, J PHYS CHEM C, V118, P4495, DOI 10.1021/jp411958v; Sun R.-D., 2014, 3 C ADV NAN GEN EXC, P20; Swiatkowska-Warkocka Z, 2013, RSC ADV, V3, P79, DOI 10.1039/c2ra22119e; Swiatkowska-Warkocka Z, 2012, LANGMUIR, V28, P4903, DOI 10.1021/la2038334; Tsuji T, 2013, PHYS CHEM CHEM PHYS, V15, P3099, DOI 10.1039/c2cp44159d; Wang HQ, 2010, ANGEW CHEM INT EDIT, V49, P6361, DOI 10.1002/anie.201002963; Wang YL, 2006, ADV MATER, V18, P471, DOI 10.1002/adma.200502047	42	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUN	2015	119	3			SI		475	483		10.1007/s00340-015-6101-5		9	Optics; Physics, Applied	Optics; Physics	CI2ZV	WOS:000354618000012		
J	Sakakura, M; Kurita, T; Yoshimura, K; Fukuda, N; Shimotsuma, Y; Miura, K				Sakakura, Masaaki; Kurita, Torataro; Yoshimura, Kouhei; Fukuda, Naoaki; Shimotsuma, Yasuhiko; Miura, Kiyotaka			Control of Si-rich region inside a sodalime glass by parallel femtosecond laser focusing at multiple spots	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							SPACE-SELECTIVE PRECIPITATION; REPETITION-RATE; WAVE-GUIDES; IRRADIATION; CRYSTALS; PHASE; MECHANISM; IMAGE	Thermal modification and elemental distributions inside a sodalime glass were modified by parallel irradiation with focused 250 and 1 kHz femtosecond laser pulses at multiple spots. We found that the shape of a Si distribution was modified and the position of a Si-rich layer depended on the relative focal positions between 250 and 1 kHz laser pulses. We demonstrated the formation of a ribbon-shaped Si-rich glass of about 8 mu m thickness and about 33 mu m width by producing a line of a Si-rich layer by translating a glass sample perpendicular to the laser propagation axis. In addition, we simulated transient temperature distribution during laser exposure and discussed the role of 1 kHz laser irradiation in the modulation of elemental distributions.	[Sakakura, Masaaki; Fukuda, Naoaki] Kyoto Univ, Off Soc Acad Collaborat Innovat, Kyoto 6158245, Japan; [Kurita, Torataro; Yoshimura, Kouhei; Shimotsuma, Yasuhiko; Miura, Kiyotaka] Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Kyoto 6158510, Japan	Sakakura, M (reprint author), Kyoto Univ, Off Soc Acad Collaborat Innovat, Kyoto 6158245, Japan.	msakakura@saci.kyoto-u.ac.jp			JSPS [23246121, 26410240]; Nippon Sheet Glass Foundation for Materials Science and Engineering	This research was supported by JSPS Grant-in-Aid for Scientific Research (A), No. 23246121 and (C), No. 26410240 and by Nippon Sheet Glass Foundation for Materials Science and Engineering.	Sakakura M, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.126507; Schaffer CB, 2001, OPT LETT, V26, P93, DOI 10.1364/OL.26.000093; FIENUP JR, 1980, OPT ENG, V19, P297, DOI 10.1117/12.7972513; Yonesaki Y, 2005, J NON-CRYST SOLIDS, V351, P885, DOI 10.1016/j.jnoncrysol.2005.01.076; Kanehira S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2959820; Luo FF, 2010, OPT EXPRESS, V18, P6262, DOI 10.1364/OE.18.006262; Eaton SM, 2005, OPT EXPRESS, V13, P4708, DOI 10.1364/OPEX.13.004708; Zhong MJ, 2012, OPT MATER EXPRESS, V2, P1156; Shimizu M, 2011, OPT LETT, V36, P2161, DOI 10.1364/OL.36.002161; Paltauf G, 2003, CHEM REV, V103, P487, DOI 10.1021/cr010436c; Fan CX, 2012, OPT LETT, V37, P2955, DOI 10.1364/OL.37.002955; Stone A, 2009, OPT EXPRESS, V17, P23284, DOI 10.1364/OE.17.023284; Sakakura M, 2013, OPT LETT, V38, P4939, DOI 10.1364/OL.38.004939; Hayasaki Y, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1992668; Wu SZ, 2013, OPT EXPRESS, V21, P24049, DOI 10.1364/OE.21.024049; BENGTSSON J, 1994, APPL OPTICS, V33, P6879, DOI 10.1364/AO.33.006879; Du X, 2014, OPT EXPRESS, V22, P17908, DOI 10.1364/OE.22.017908; Fernandez TT, 2014, OPT EXPRESS, V22, P15298, DOI 10.1364/OE.22.015298; GERCHBER.RW, 1972, OPTIK, V35, P237; Mazurin O.V., 1984, PHASE SEPARATION GLA; POWER JF, 1990, APPL OPTICS, V29, P52, DOI 10.1364/AO.29.000052; Sakakura M, 2014, OPT EXPRESS, V22, P16493, DOI 10.1364/OE.22.016493; Sakakura M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3046101; Shimizu M, 2010, APPL PHYS A-MATER, V100, P1001, DOI 10.1007/s00339-010-5879-6; VARSHNEYA AK, 1993, FUNDAMENTALS INORGAN	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUN	2015	119	3			SI		485	492		10.1007/s00340-015-6061-9		8	Optics; Physics, Applied	Optics; Physics	CI2ZV	WOS:000354618000013		
J	Shinonaga, T; Tsukamoto, M; Kawa, T; Chen, P; Nagai, A; Hanawa, T				Shinonaga, T.; Tsukamoto, M.; Kawa, T.; Chen, P.; Nagai, A.; Hanawa, T.			Formation of periodic nanostructures using a femtosecond laser to control cell spreading on titanium	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							SURFACES; PROLIFERATION; POLYSTYRENE; MORPHOLOGY; ALIGNMENT; ABLATION; ADHESION; BEHAVIOR; PLATE	Although titanium (Ti) is a common biomaterial, controlling cell spreading by forming periodic structures using a femtosecond laser should improve its biocompatibility. Herein we investigate the influence of periodic nanostructures formed on the surface of a Ti plate on cell spreading. Nanostructures with a periodicity of 590 nm are formed using a femtosecond laser with a wavelength of 775 nm. Cell spreading on the plate without period structures lacks a definite direction, whereas cell spreading on the Ti plate with periodic structures occurs along the grooves, suggesting that forming periodic structures via a femtosecond laser can control cell spreading.	[Shinonaga, T.; Tsukamoto, M.] Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan; [Kawa, T.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Chen, P.; Nagai, A.; Hanawa, T.] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan	Shinonaga, T (reprint author), Osaka Univ, Joining & Welding Res Inst, 11-1 Mihogaoka, Osaka 5670047, Japan.	togo@jwri.osaka-u.ac.jp					Fujita S, 2009, J R SOC INTERFACE, V6, pS269, DOI 10.1098/rsif.2008.0428.focus; Das SK, 2009, J APPL PHYS, V105, DOI 10.1063/1.3117509; Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0; Miyaji G, 2012, OPT EXPRESS, V20, P14848, DOI 10.1364/OE.20.014848; Miyaji G, 2008, OPT EXPRESS, V16, P16265, DOI 10.1364/OE.16.016265; Reif J, 2002, APPL SURF SCI, V197, P891, DOI 10.1016/S0169-4332(02)00450-6; Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008; Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048; Dumas V, 2012, J BIOMED MATER RES A, V100A, P3108, DOI 10.1002/jbm.a.34239; Shinonaga T, 2014, APPL SURF SCI, V288, P649, DOI 10.1016/j.apsusc.2013.10.090; Fujita S, 2008, BIOMATERIALS, V29, P4494, DOI 10.1016/j.biomaterials.2008.08.027; Landis EC, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752276; Rebollar E, 2008, BIOMATERIALS, V29, P1796, DOI 10.1016/j.biomaterials.2007.12.039; Jia TQ, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.125429; Shimotsuma Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247405; Sakabe S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.033409; Dufft D, 2009, J APPL PHYS, V105, DOI 10.1063/1.3074106; Tsukamoto M, 2006, VACUUM, V80, P1346, DOI 10.1016/j.vacuum.2006.01.016; Hanawa T., 2010, JPN DENT SCI REV, V46, P93; Hashida M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803940; Huang PJ, 1997, THERMOCHIM ACTA, V297, P85, DOI 10.1016/S0040-6031(97)00168-8; Matsugaki A, 2012, BIOMATERIALS, V33, P7327, DOI 10.1016/j.biomaterials.2012.06.022; Miyazaki K, 2013, J APPL PHYS, V114, DOI 10.1063/1.4826078; Okamuro K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.165417; Shinonaga T, 2014, OPT EXPRESS, V22, P14696, DOI 10.1364/OE.22.014696; Tsukamoto M, 2007, J PHYS CONF SER, V59, P666, DOI 10.1088/1742-6596/59/1/140; Tsukamoto M, 2014, PROC SPIE, V8969, DOI 10.1117/12.2040957; Wang XF, 2006, J BIOMED MATER RES A, V78A, P746, DOI 10.1002/jbm.a.30764	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUN	2015	119	3			SI		493	496		10.1007/s00340-015-6082-4		4	Optics; Physics, Applied	Optics; Physics	CI2ZV	WOS:000354618000014		
J	Ishikawa, N; Hanada, Y; Ishikawa, I; Sugioka, K; Midorikawa, K				Ishikawa, Nobuaki; Hanada, Yasutaka; Ishikawa, Ikuko; Sugioka, Koji; Midorikawa, Katsumi			Femtosecond laser-fabricated biochip for studying symbiosis between Phormidium and seedling root	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							GLASS	We present the fabrication of a waveguide-like structure in a polydimethylsiloxane (PDMS) polymer substrate using a femtosecond laser to study the mechanism of symbiosis between filamentous cyanobacteria, Phormidium, and a seedling root. While symbiosis occurring underground promotes the growth of vegetable seedlings, the details of the mechanism remain unclear. Understanding the mechanisms of Phormidium gliding to the seedling root will facilitate improving the mat formation of Phormidium, which will lead to increased vegetable production. We assumed a symbiosis mechanism in which sunlight propagates through the seedling root and is scattered underground to guide the Phormidium gliding. Once attached to the root, Phormidium uses the scattered light for photosynthesis. Photosynthetic products, in turn, promote an increase in Phormidium mat formation and vegetable growth. To verify this assumption, the optical characteristics of the seedling root were investigated. A waveguide-like structure with the same optical characteristics of the root was subsequently fabricated by femtosecond laser in PDMS polymer to assess the light illumination effect on Phormidium behavior.	[Ishikawa, Nobuaki; Hanada, Yasutaka] Hirosaki Univ, Grad Sch Sci & Technol, Hirosaki, Aomori 0368561, Japan; [Hanada, Yasutaka; Sugioka, Koji; Midorikawa, Katsumi] RIKEN Ctr Adv Photon, Wako, Saitama 3510198, Japan; [Ishikawa, Ikuko] RIKEN Brain Sci Inst, Wako, Saitama 3510198, Japan	Hanada, Y (reprint author), Hirosaki Univ, Grad Sch Sci & Technol, 3 Bunkyo Cho, Hirosaki, Aomori 0368561, Japan.	y-hanada@cc.hirosaki-u.ac.jp					Okhrimchuk A, 2012, OPT EXPRESS, V20, P3832, DOI 10.1364/OE.20.003832; Hoiczyk E, 1998, J BACTERIOL, V180, P3923; Crespi A, 2010, LAB CHIP, V10, P1167, DOI 10.1039/b920062b; Hanada Y, 2008, BIOMED MICRODEVICES, V10, P403, DOI 10.1007/s10544-007-9149-0; Davis KM, 1996, OPT LETT, V21, P1729, DOI 10.1364/OL.21.001729; Glezer EN, 1996, OPT LETT, V21, P2023, DOI 10.1364/OL.21.002023; HALFEN LN, 1970, NATURE, V225, P1163, DOI 10.1038/2251163a0; Hanada Y, 2011, LAB CHIP, V11, P2109, DOI 10.1039/c1lc20101h; Sugioka K., 2010, LASER PHOTONICS REV, V3, P386	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUN	2015	119	3			SI		503	508		10.1007/s00340-015-6055-7		6	Optics; Physics, Applied	Optics; Physics	CI2ZV	WOS:000354618000016		
J	Okamoto, Y; Asako, K; Nishi, N; Sakagawa, T; Okada, A				Okamoto, Yasuhiro; Asako, Kiichi; Nishi, Norio; Sakagawa, Tomokazu; Okada, Akira			Effect of surrounding gas condition on surface integrity in micro-drilling of SiC by ns pulsed laser	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							INDUCED PLASMA	The influence of the surrounding gas conditions on the surface integrity in the micro-drilling of silicon carbide was experimentally investigated using ns pulsed laser of 266 nm wavelength. Moreover, micro-machining characteristics were observed using high-speed shutter and video cameras in the micro-drilling of silicon carbide. The size and intensity of the laser-induced plasma were larger, and the plasma affected area was larger and deeper in argon than that in air. Although the intensity of the plasma was lower in helium than that in other gases, the surface around the drilled hole was roughened by the spread of the plasma in the vicinity of the drilled hole. Debris was removed along the flow field generated by laser shot in the opposite direction to the laser irradiation. The gas flow behavior and the spectrum and intensity of the laser-induced plasma were influenced by the surrounding gas type and pressure. The appearance of plasma generation affected the surface integrity at the circumference of the drilled hole, and the surface integrity was improved by reducing the pressure.	[Okamoto, Yasuhiro; Asako, Kiichi; Okada, Akira] Okayama Univ, Kita Ku, Okayama 7008530, Japan; [Nishi, Norio] Kataoka Corp, Minami Ku, Kyoto 6018203, Japan; [Sakagawa, Tomokazu] Kataoka Corp, Kohoku Ku, Yokohama, Kanagawa 2220033, Japan	Okamoto, Y (reprint author), Okayama Univ, Kita Ku, 3-1-1 Tsushimanaka, Okayama 7008530, Japan.	okamoto@mech.okayama-u.ac.jp					Abderrazak H., 2011, SILICON CARBIDE SYNT; Gregorcic P, 2011, OPT LETT, V36, P2782, DOI 10.1364/OL.36.002782; Chryssolouris G, 1991, LASER MACHINING THEO; Ershov-Pavlov EA, 2008, SPECTROCHIM ACTA B, V63, P1024, DOI 10.1016/j.sab.2008.09.009; McMurry J., 2010, MCMURRY GEN CHEM; Narai H., 1997, J CERAM SOC JPN, V105, P15; Tanishita I., 1960, IND THERMODYNAMICS; Vadillo J.M., 2003, ACTA B, V59, P147	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUN	2015	119	3			SI		509	517		10.1007/s00340-015-6060-x		9	Optics; Physics, Applied	Optics; Physics	CI2ZV	WOS:000354618000017		
J	Itoh, S; Sakakura, M; Shimotsuma, Y; Miura, K				Itoh, S.; Sakakura, M.; Shimotsuma, Y.; Miura, K.			Generation of glass nanofibers from back surface of substrate using pulsed UV 355 nm laser	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							SILICA GLASS; FABRICATION	We report a new phenomenon of generating glass nanofibers from substrates. A non-alkaline glass substrate was irradiated with a laser beam of 355 nm wavelength and a pulse width of nanosecond order while scanning the laser beam. This resulted in the generation of nanofibers from the back surface of the substrate. Scanning electron microscope images showed that the diameters of the nanofibers were of 100 nm order. The images also revealed that microparticles existed at the tips of the nanofibers. According to the investigation of the generation conditions, when the laser beam was focused below the top surface, particularly below the back surface, nanofibers were easily generated. By in situ monitoring, it was found that a region wider than the beam diameter (1/e (2)) on the surface was modified. Then, nanofibers were generated in the vicinity of the beam spot along with the ejection of microparticles. Compared with previously reported phenomena, in our process, it is more important for sufficient heat to have accumulated for nanofibers to form.	[Itoh, S.] Nippon Elect Glass Co Ltd, Prod Qual Lab, Otsu, Shiga, Japan; [Itoh, S.; Sakakura, M.; Shimotsuma, Y.; Miura, K.] Kyoto Univ, Dept Chem Mat, Grad Sch Engn, Kyoto, Japan	Itoh, S (reprint author), Nippon Elect Glass Co Ltd, Prod Qual Lab, Otsu, Shiga, Japan.	shitoh@neg.co.jp					Kameoka J, 2004, NANO LETT, V4, P2105, DOI 10.1021/nl048840p; Markillie GAJ, 2002, APPL OPTICS, V41, P5660, DOI 10.1364/AO.41.005660; Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016; Burger C, 2006, ANNU REV MATER RES, V36, P333, DOI 10.1146/annurev.matsci.36.011205.123537; BROWER WE, 1983, NATURE, V301, P497, DOI 10.1038/301497a0; Dai YQ, 2011, POLYM ADVAN TECHNOL, V22, P326, DOI 10.1002/pat.1839; Gattass RR, 2006, OPT EXPRESS, V14, P9408, DOI 10.1364/OE.14.009408; Kumar A., 2010, NANOFIBERS; Quintero F, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2722202; Quintero F, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/6/065501; Sivakumar M, 2009, NANOSCALE RES LETT, V4, P1263, DOI 10.1007/s11671-009-9390-y; Venkatakrishnan K, 2011, OPT EXPRESS, V19, P15770, DOI 10.1364/OE.19.015770	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUN	2015	119	3			SI		519	524		10.1007/s00340-015-6017-0		6	Optics; Physics, Applied	Optics; Physics	CI2ZV	WOS:000354618000018		
J	Sakuma, K; Hasegawa, S; Takahashi, H; Ota, M; Hayasaki, Y				Sakuma, Kazuki; Hasegawa, Satoshi; Takahashi, Hidetomo; Ota, Michiharu; Hayasaki, Yoshio			Holographic laser sweeper for in-process debris removal	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							SURFACE CONTAMINANTS; SOLID-SURFACE; POLYIMIDE; PARTICLES; ABLATION; SILICON; AIR	Debris deposited around laser-processed structures is a critical issue in high-precision laser processing and should be removed. We demonstrated a new debris removal method that is performed during laser processing. A line-focused beam that is radiated onto a target material simultaneously with a processing beam sweeps away the debris generated by laser ablation. Two physical processes are involved: One is direct photon excitation of the attached debris, similar to laser ablation, due to a smaller ablation threshold of the debris, and the other is blowing away the debris with a laser-induced pressure wave. The laser processing setup for debris sweeping has a simple and practical configuration composed of beam transmission optics from a laser source to the target and a spatial light modulator that displays a computer-generated hologram. This in-process debris removal method has the advantages of needing no additional equipment other than the optics, no additional operations, no special materials, and no specific operating environment.	[Sakuma, Kazuki; Hasegawa, Satoshi; Hayasaki, Yoshio] Utsunomiya Univ, CORE, Utsunomiya, Tochigi 3218585, Japan; [Takahashi, Hidetomo; Ota, Michiharu] Aisin Seiki Co Ltd, Kariya, Aichi 4488650, Japan	Hayasaki, Y (reprint author), Utsunomiya Univ, CORE, 7-1-2 Yoto, Utsunomiya, Tochigi 3218585, Japan.	hayasaki@opt.utsunomiya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by a Grant-in-Aid for Scientific Research (B) and a Grant-in-Aid for Challenging Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	SRINIVASAN R, 1987, J APPL PHYS, V61, P372, DOI 10.1063/1.338834; Hasegawa S, 2006, OPT LETT, V31, P1705, DOI 10.1364/OL.31.001705; LU YF, 1994, APPL PHYS A-MATER, V59, P281, DOI 10.1007/BF00348231; Kruusing A, 2004, OPT LASER ENG, V41, P307, DOI 10.1016/S0143-8166(02)00142-2; Fourrier T, 2001, APPL PHYS A-MATER, V72, P1, DOI 10.1007/s003390000683; Tam AC, 1998, APPL SURF SCI, V127, P721, DOI 10.1016/S0169-4332(97)00788-5; Hayasaki Y, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1992668; Bregar VB, 2003, APPL PHYS A-MATER, V77, P633, DOI 10.1007/s00339-002-1593-3; Coupland K, 1998, APPL SURF SCI, V127, P731, DOI 10.1016/S0169-4332(97)00733-2; Dobler V, 1999, APPL PHYS A-MATER, V69, pS335, DOI 10.1007/s003390051412; Geldhauser T, 2007, APPL PHYS A-MATER, V89, P109, DOI 10.1007/s00339-007-4190-7; Hayasaki Y, 2012, APPL PHYS A-MATER, V107, P357, DOI 10.1007/s00339-012-6801-1; Kawamura D, 2006, APPL PHYS A-MATER, V82, P523, DOI 10.1007/s00339-005-3422-y; KOREN G, 1988, APPL PHYS B-PHOTO, V45, P45, DOI 10.1007/BF00692340; Lee JM, 2000, APPL PHYS A-MATER, V71, P671, DOI 10.1007/s003390000583; PARK HK, 1994, IEEE T COMPON PACK A, V17, P631, DOI 10.1109/95.335050; She M, 1999, J APPL PHYS, V86, P6519, DOI 10.1063/1.371617; TAM AC, 1992, J APPL PHYS, V71, P3515, DOI 10.1063/1.350906; VONGUTFELD RJ, 1987, APPL PHYS LETT, V51, P15, DOI 10.1063/1.98889; ZAPKA W, 1991, APPL PHYS LETT, V58, P2217, DOI 10.1063/1.104931	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUN	2015	119	3			SI		533	538		10.1007/s00340-015-6011-6		6	Optics; Physics, Applied	Optics; Physics	CI2ZV	WOS:000354618000020		
J	Okoshi, M; Awaihara, Y; Yamashita, T; Inoue, N				Okoshi, Masayuki; Awaihara, Yuta; Yamashita, Tsugito; Inoue, Narumi			Vacuum ultraviolet fluorine laser formation of corrosion-resistant iron thin films	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							SILICONE-RUBBER; F-2 LASER; DEPOSITION; IRRADIATION; MICROLENSES; FABRICATION; SURFACE	Corrosion-, chemical-resistant pure iron thin films were formed by the vacuum ultraviolet fluorine laser of 157 nm wavelength induced surface modification of 30- to 50-nm-thick iron thin films. Transmission electron microscope and electron energy-loss spectroscopy were conducted to analyze structure and oxidation state of the thin modified layer of iron thin films. No rust was observed on the surface of the fluorine laser-irradiated iron thin films in air for 2 years. The samples also showed high chemical resistance to a HNO3 aqueous solution to fabricate a micropattern of pure iron thin films.	[Okoshi, Masayuki; Awaihara, Yuta; Inoue, Narumi] Natl Def Acad, Dept Elect & Elect Engn, Yokosuka, Kanagawa 2398686, Japan; [Yamashita, Tsugito] Kanto Gakuin Univ, Dept Sci & Engn, Yokohama, Kanagawa 2368501, Japan	Okoshi, M (reprint author), Natl Def Acad, Dept Elect & Elect Engn, Yokosuka, Kanagawa 2398686, Japan.	okoshi@nda.ac.jp			MEXT	We are greatly indebted to Professor Susumu Kasukabe, High Voltage Electron Microscope Laboratory of Nagoya University, for the TEM and EELS analyses. This work was aided by the MEXT-supported Program for the Strategic Research Foundation at Private Universities.	ISSHIKI M, 1977, T JPN I MET, V18, P412; Iwai K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.122702; Iwai K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.022702; Kuroda C. S., 2005, INTERMAG Asia 2005: Digest of the IEEE International Magnetics Conference (IEEE Cat. No.05CH37655), DOI 10.1109/INTMAG.2005.1463657; MIYAKE K, 1993, JPN J APPL PHYS 2, V32, pL120, DOI 10.1143/JJAP.32.L120; MIYAKE K, 1994, SURF COAT TECH, V65, P208, DOI 10.1016/S0257-8972(94)80034-0; Nojima Y, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.072703; Okoshi M, 2007, JPN J APPL PHYS 2, V46, pL356, DOI 10.1143/JJAP.46.L356; Okoshi M, 2009, J KOREAN PHYS SOC, V54, P1203, DOI 10.3938/jkps.54.1203; Okoshi M, 2007, JPN J APPL PHYS 1, V46, P1516, DOI 10.1143/JJAP.46.1516; Okoshi M, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.122503; Okoshi M, 1998, APPL SURF SCI, V127, P462, DOI 10.1016/S0169-4332(97)00673-9; Okoshi M, 2004, JPN J APPL PHYS 1, V43, P3438, DOI 10.1143/JJAP.43.3438; Okoshi M, 1997, JPN J APPL PHYS 2, V36, pL801, DOI 10.1143/JJAP.36.L801; Okoshi M, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.102301; Okoshi M, 2005, OPT LETT, V30, P2730, DOI 10.1364/OL.30.002730; Okoshi M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.122701; Okoshi M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.022702; Rawat RS, 2006, APPL SURF SCI, V253, P1611, DOI 10.1016/j.apsusc.2006.02.047; Takao H, 2002, JPN J APPL PHYS 2, V41, pL1088, DOI 10.1143/JJAP.41.L1088; Takao H, 2003, JPN J APPL PHYS 1, V42, P1284, DOI 10.1143/JJAP.42.1284; Takao H, 2004, IEEE J SEL TOP QUANT, V10, P1426, DOI 10.1109/JSTQE.2004.837707; Takao H, 2004, APPL PHYS A-MATER, V79, P1571, DOI 10.1007/s00339-004-2850-4; Takao H, 2005, JPN J APPL PHYS 1, V44, P1808, DOI 10.1143/JJAP.44.1808	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUN	2015	119	3			SI		539	543		10.1007/s00340-014-6000-1		5	Optics; Physics, Applied	Optics; Physics	CI2ZV	WOS:000354618000021		
J	Sato, Y; Tsukamoto, M; Yamashita, Y				Sato, Y.; Tsukamoto, M.; Yamashita, Y.			Surface morphology of Ti-6Al-4V plate fabricated by vacuum selective laser melting	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							MICROSTRUCTURE	A plate made of Ti-6Al-4V (Ti64) was built by vacuum selective laser melting (SLM) at a pressure of 10(-2) Pa. The vacuum SLM system employed a single-mode fiber laser and three-axis galvanic mirror in order to form 3D metallic structure. In order to investigate the surface morphology on the fabricated plates, Vickers microhardness and surface roughness R (a) were measured. From the results, the Vickers microhardness of the fabricated plates was recorded at 391 HV, higher than the typical 340 HV for a Ti64 plate. It was also determined that crystal orientation was evaluated with X-ray diffraction. From the results, the crystal orientation of powder is composed mainly of martensitic alpha. Diffraction peaks corresponding to beta (110) were detected in vacuum SLM processed samples.	[Sato, Y.; Tsukamoto, M.] Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan; [Yamashita, Y.] Ind Res Inst Ishikawa, Kanazawa, Ishikawa 9208203, Japan	Sato, Y (reprint author), Osaka Univ, Joining & Welding Res Inst, 11-1 Mihogaoka, Osaka 5670047, Japan.	sato@jwri.osaka-u.ac.jp					Yadroitsev I, 2013, J MATER PROCESS TECH, V213, P606, DOI 10.1016/j.jmatprotec.2012.11.014; Sun JF, 2013, MATER DESIGN, V49, P545, DOI 10.1016/j.matdes.2013.01.038; Qiu CL, 2013, MAT SCI ENG A-STRUCT, V578, P230, DOI 10.1016/j.msea2013.04.099; Zhang BC, 2013, VACUUM, V95, P25, DOI 10.1016/j.vacuum.2013.02.003; Santos EC, 2006, INT J MACH TOOL MANU, V46, P1459, DOI 10.1016/j.ijmachtools.2005.09.005; Zhang BC, 2013, J MATER SCI TECHNOL, V29, P757, DOI 10.1016/j.jmst.2013.05.001; da Rocha Sicknan Soares, 2006, Braz Dent J, V17, P126, DOI 10.1590/S0103-64402006000200008; Jia QB, 2014, J ALLOY COMPD, V585, P713, DOI 10.1016/j.jallcom.2013.09.171; Gu DD, 2009, MATER LETT, V63, P1577, DOI 10.1016/j.matlet.2009.04.010; Hamai S., 1992, TETSU TO HAGANE, V78, P125; Wang ZM, 2012, J ALLOY COMPD, V513, P518, DOI 10.1016/j.jallcom.2011.10.107	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUN	2015	119	3			SI		545	549		10.1007/s00340-015-6059-3		5	Optics; Physics, Applied	Optics; Physics	CI2ZV	WOS:000354618000022		
J	Cenker, E; Kondo, K; Bruneaux, G; Dreier, T; Aizawa, T; Schulz, C				Cenker, E.; Kondo, K.; Bruneaux, G.; Dreier, T.; Aizawa, T.; Schulz, C.			Assessment of soot particle-size imaging with LII at Diesel engine conditions	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							LASER-INDUCED INCANDESCENCE; VOLUME FRACTION; TEMPERATURE-MEASUREMENTS; CARBONACEOUS PARTICLES; TIRE-LII; DIAGNOSTICS; FLAME; CALIBRATION; CYLINDER; SPRAYS	Two-time-step laser-induced incandescence (LII) imaging was performed in Diesel engine-relevant combustion to investigate its applicability for spatially resolved measurements of soot primary particle sizes. The method is based on evaluating gated LII signals acquired with two cameras consecutively after the laser pulse and using LII modeling to deduce the particle size from the ratio of local signals. Based on a theoretical analysis, optimized detection times and durations were chosen to minimize measurement uncertainties. Experiments were conducted in a high-temperature high-pressure constant-volume pre-combustion vessel under the Engine Combustion Network's "Spray A" conditions at 61-68 bar with additional parametric variations in injection pressure, gas temperature, and composition. The LII measurements were supported by pyrometric imaging measurements of particle heat-up temperatures. The results were compared to particle-size and size-dispersion measurements from transmission electron microscopy of soot thermophoretically sampled at multiple axial distances from the injector. The discrepancies between the two measurement techniques are discussed to analyze uncertainties and related error sources of the two diagnostics. It is found that in such environment where particles are small and pressure is high, LII signal decay times are such that LII with standard nanosecond laser and detector equipment suffers from a strong bias toward large particles.	[Cenker, E.; Bruneaux, G.] IFP Energies Nouvelles, Inst Carnot IFPEN Transports Energie, F-92852 Rueil Malmaison, France; [Cenker, E.; Bruneaux, G.] Ecole Cent Paris, Chatenay Malabry, France; [Cenker, E.; Dreier, T.; Schulz, C.] Univ Duisburg Essen, Inst Combust & Gas Dynam React Fluids IVG, Duisburg, Germany; [Cenker, E.; Dreier, T.; Schulz, C.] Univ Duisburg Essen, Ctr Nanointegrat Duisburg Essen CENIDE, Duisburg, Germany; [Kondo, K.; Aizawa, T.] Meiji Univ, Tokyo 101, Japan	Cenker, E (reprint author), IFP Energies Nouvelles, Inst Carnot IFPEN Transports Energie, 1 & 4 Ave Bois Preau, F-92852 Rueil Malmaison, France.	emre.cenker@uni-due.de	IFPEN, Publications/A-8028-2008; Moteur, Direction TAE/C-1458-2013		German Science Foundation, DFG [SCHU1369/3]	The authors thank Clement Bramoulle at IFPEN for experimental assistance. The authors are grateful to Hideyuki Yoshimura of Department of Physics, Meiji University, for providing the TEM. The authors also thank Kei Okabe, Kota Suzuki, Hiroyuki Takano, Junya Takahashi, and Yuki Hattori for their assistance in TEM analysis. Thomas Dreier and Christof Schulz acknowledge support from the German Science Foundation, DFG, through SCHU1369/3.	Aizawa T., 2012, SAE INT J FUELS LUBR, V5, P665; Snelling DR, 2004, COMBUST FLAME, V136, P180, DOI 10.1016/j.combustflame.2003.09.013; Kock BF, 2002, P COMBUST INST, V29, P2775, DOI 10.1016/S1540-7489(02)80338-8; Bladh H, 2011, P COMBUST INST, V33, P641, DOI 10.1016/j.proci.2010.06.166; Collier BB, 2012, ANAL CHEM, V84, P4725, DOI 10.1021/ac300023q; Schulz C, 2006, APPL PHYS B-LASERS O, V83, P333, DOI 10.1007/s00340-006-2260-8; Michelsen HA, 2003, J CHEM PHYS, V118, P7012, DOI 10.1063/1.1559483; Schraml S, 2000, COMBUST FLAME, V120, P439, DOI 10.1016/S0010-2180(99)00117-0; Meijer M, 2012, ATOMIZATION SPRAY, V22, P777; Michelsen HA, 2007, APPL PHYS B-LASERS O, V87, P503, DOI 10.1007/s00340-007-2619-5; Charwath M, 2011, APPL PHYS B-LASERS O, V104, P427, DOI 10.1007/s00340-011-4432-4; Hofmann M, 2003, APPL OPTICS, V42, P2052, DOI 10.1364/AO.42.002052; Liu F, 2009, APPL PHYS B-LASERS O, V96, P623, DOI 10.1007/s00340-009-3560-6; Chow JC, 2006, J AIR WASTE MANAGE, V56, P1368; Musculus MPB, 2008, COMBUST FLAME, V153, P216, DOI 10.1016/j.combustflame.2007.10.023; SANTORO RJ, 1983, COMBUST FLAME, V51, P203, DOI 10.1016/0010-2180(83)90099-8; Bolla M, 2013, COMBUST SCI TECHNOL, V185, P766, DOI 10.1080/00102202.2012.752362; Snelling DR, 2005, APPL OPTICS, V44, P6773, DOI 10.1364/AO.44.006773; Mewes B, 1997, APPL OPTICS, V36, P709, DOI 10.1364/AO.36.000709; Bougie B, 2006, APPL PHYS B-LASERS O, V83, P477, DOI 10.1007/s00340-006-2195-0; Axelsson B, 2001, APPL PHYS B-LASERS O, V72, P367, DOI 10.1007/s003400100504; Kook S, 2011, P COMBUST INST, V33, P2911, DOI 10.1016/j.proci.2010.05.073; MELTON LA, 1984, APPL OPTICS, V23, P2201; Michelsen HA, 2006, APPL PHYS B-LASERS O, V83, P443, DOI 10.1007/s00340-006-2226-x; Cenker E, 2015, APPL PHYS B-LASERS O, V119, P745, DOI 10.1007/s00340-015-6009-0; Bougie B, 2007, P COMBUST INST, V31, P685, DOI 10.1016/j.proci.2006.08.040; Reimann J, 2009, APPL PHYS B-LASERS O, V96, P583, DOI 10.1007/s00340-009-3546-4; Kock BF, 2006, COMBUST FLAME, V147, P79, DOI 10.1016/j.combustflame.2006.07.009; Zhao H, 1998, PROG ENERG COMBUST, V24, P221, DOI 10.1016/S0360-1285(97)00033-6; Sun ZW, 2015, P COMBUST INST, V35, P3673, DOI 10.1016/j.proci.2014.07.066; Johnsson J, 2010, APPL PHYS B-LASERS O, V99, P817, DOI 10.1007/s00340-010-3986-x; Cenker E, 2015, APPL PHYS B-LASERS O, V118, P169, DOI 10.1007/s00340-014-5966-z; Cenker E, 2013, SAE INT J ENG, V6, P352; Connelly B.C., 2009, THESIS YALE U NEW HA; Dreier T, 2006, APPL PHYS B-LASERS O, V83, P403, DOI 10.1007/s00340-006-2207-0; Ehn A, 2012, OPT EXPRESS, V20, P3043, DOI 10.1364/OE.20.003043; Hofmann M., 2007, APPL PHYS B, V90, P629; Hofmann M., 2007, EUR COMB M 2007 CHAN; Hottel H.C., 1932, Industrial and Engineering Chemistry (Analytical Edition), V4, DOI 10.1021/ac50078a004; International Council on Clean Transportation (ICCT), 2013, POCK EUR VEH MARK ST; Kondo K., 2013, 2013010908 SAE; Kondo K., 2014, SAE INT J FUELS LUBR, V7, P683; Kook S., 2013, SAE INT J FUELS LUBR, V6, P80; LEVENDIS YA, 1992, REV SCI INSTRUM, V63, P3608, DOI 10.1063/1.1143586; Malbec L, 2013, SAE INT J ENGINES, V6, P1642; Pickett L. M., 2010, SAE INT J ENGINES, V3, P156; Pickett LM, 2011, SAE INT J ENGINES, V4, P764; Pickett L. M., 2006, International Journal of Engine Research, V7, DOI 10.1243/146808705X57793; Ramanathan V., 2008, NAT GEOSCI, V109, P221, DOI [DOI 10.1038/ngeo156, 10.1038/ngeo156]; Tea G, 2011, P COMBUST INST, V33, P783, DOI 10.1016/j.proci.2010.05.074; Will S, 1996, P COMBUST INST, V26, P2277	51	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	JUN	2015	119	4			SI		765	776		10.1007/s00340-015-6106-0		12	Optics; Physics, Applied	Optics; Physics	CI4FS	WOS:000354703800015		
J	Bin Baharudin, MA; Quang, TM; Kamioka, E				Bin Baharudin, Muhammad Ariff; Tran Minh Quang; Kamioka, Eiji			Improvement of Handover Performance Based on Bio-Inspired Approach with Received Signal Strength and Mean Opinion Score	ARABIAN JOURNAL FOR SCIENCE AND ENGINEERING			English	Article						Handover; End-point centric; Mobile network; Mobility management; Host identity protocol; Bio-inspired; Ant colony probabilistic equation	ANT COLONY OPTIMIZATION; NETWORK; DESIGN; INTERNET	In mobile communication environments, handover is a very important process to maintain mobile host's connections to the network. Although a lot of researchers have tried to improve the handover performance, little deployment to satisfy the users can be seen in the real network due to the modification costs. In the current age, the existence of network with different radio access technologies has created a heterogeneous environment. Moreover, the mobile hosts available to users are becoming more sophisticated, which opens the opportunity for end-point approaches to alleviate the deployment issues. Furthermore, real-time applications such as VoIP and video conference are delay and quality sensitive, but not much research has considered qualitative requirement. Hence, a suitable technique is needed to alleviate the deployment issues as well as to cope with the stringent requirements of real-time applications. This paper presents a new end-point centric handover approach based on the ant colony probabilistic equation that utilizes the received signal strength and the mean opinion score to trigger the handover. Some simulations were conducted using OMNeT++ to measure the effectiveness of the proposed approach comparing with an existing method, the Endpoint Centric Handover (ECHO). The results show that the proposed approach has better performance compared to the ECHO.	[Bin Baharudin, Muhammad Ariff; Kamioka, Eiji] Shibaura Inst Technol, Grad Sch Engn & Sci, Koto, Japan; [Tran Minh Quang] Natl Inst Informat, Chiyoda Ku, Tokyo, Japan; [Bin Baharudin, Muhammad Ariff] Univ Teknol Malaysia, Johor Baharu, Malaysia	Bin Baharudin, MA (reprint author), Shibaura Inst Technol, Grad Sch Engn & Sci, Koto, Japan.	nb11507@shibaura-it.ac.jp; quangtran@nii.ac.jp; kamioka@shibaura-it.ac.jp					[Anonymous], 2002, TECHNICAL REPORT; Yan XH, 2010, COMPUT NETW, V54, P1848, DOI 10.1016/j.comnet.2010.02.006; SALTZER JH, 1984, ACM T COMPUT SYST, V2, P277, DOI 10.1145/357401.357402; [Anonymous], 2001, APP 1 PROV PLANN VAL; Okdem S, 2009, SENSORS-BASEL, V9, P909, DOI 10.3390/s90200909; McNair J, 2004, IEEE WIREL COMMUN, V11, P8, DOI 10.1109/MWC.2004.1308935; Handley M, 2006, BT TECHNOL J, V24, P119, DOI 10.1007/s10550-006-0084-z; Marquez-Barja J, 2011, COMPUT COMMUN, V34, P985, DOI 10.1016/j.comcom.2010.11.010; [Anonymous], 2005, E MOD COMP MOD US TR, P107; ASSEM H, 2013, IEEE INT S INT NETW, P1276; Baharudin M. A., 2014, P 8 S E AS TU CONS S; Baharudin M. A., 2014, P 8 S E AS TU CONS S, P19; Bergstra J. A., 2003, ITU T RECOMMENDATIN; Bokor L., 2009, MSWIM 09; Conti JP, 2005, IEE REVIEW, V51, P38, DOI 10.1049/ir:20051003; Dorigo M, 2006, IEEE COMPUT INTELL M, V1, P28, DOI 10.1109/MCI.2006.329691; Engelbrecht A. P., 2007, COMPUTATIONAL INTELL, V2nd, P368; Fitzpatrick J, 2009, COMPUT COMMUN, V32, P1600, DOI 10.1016/j.comcom.2009.06.005; Fitzpatrick J., 2008, WIR COMM NETW C 2008; Fitzpatrick J., 2007, 2007 16 IST MOB WIR; Fu S., 2005, IEEE INT C COMM; Fu S., 2005, IEEE 62 VEH TECHN C; Fu S., 2005, GLOB TEL C 2005 GLOB; Hussain R, 2012, SIMUL MODEL PRACT TH, V26, P151, DOI 10.1016/j.simpat.2012.04.004; Jamian JJ, 2014, ARAB J SCI ENG, V39, P7183, DOI 10.1007/s13369-014-1279-0; Laganier J., 2008, 5204 IETF RFC; Moskowitz R., 2008, 5201 IETF RFC; Muhtazaruddin MN, 2014, ARAB J SCI ENG, V39, P4923, DOI 10.1007/s13369-014-1178-4; Nikander P., 2008, 5206 IETF RFC; Quadros C., 2013, 2013 International Conference on Computing, Networking and Communications (ICNC 2013), DOI 10.1109/ICCNC.2013.6504239; Saleem K., 2010, COMPUTERS SIMULATION, VIV; SALEEM K, 2009, IEEE 9 MAL INT C COM, P305; Schulzrinne H, 2000, IEEE COMMUN MAG, V38, P134, DOI 10.1109/35.874980; Wang J, 1998, BELL LABS TECH J, V3, P79, DOI 10.1002/bltj.2117	34	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1319-8025	2191-4281		ARAB J SCI ENG	Arab. J. Sci. Eng.	JUN	2015	40	6					1623	1636		10.1007/s13369-015-1638-5		14	Multidisciplinary Sciences	Science & Technology - Other Topics	CH9ZR	WOS:000354395800007		
J	Yamamoto, H; Imai, K				Yamamoto, Hiroyuki; Imai, Kohzoh			Microsatellite instability: an update	ARCHIVES OF TOXICOLOGY			English	Review						Microsatellite instability; microRNA; DNA mismatch repair; Frameshift mutation; microRNA processing	NONPOLYPOSIS COLORECTAL-CANCER; DNA MISMATCH REPAIR; ISLAND METHYLATOR PHENOTYPE; COMPREHENSIVE MOLECULAR CHARACTERIZATION; SOMATIC FRAMESHIFT MUTATIONS; SPORADIC COLON CANCERS; LYNCH-SYNDROME; GASTRIC-CANCER; MUTATOR PHENOTYPE; GASTROINTESTINAL CANCER	Deficient DNA mismatch repair (MMR) results in a strong mutator phenotype known as microsatellite instability (MSI), which is a hallmark of Lynch syndrome-associated cancers. MSI is characterized by length alterations within simple repeated sequences that are called microsatellites. Lynch syndrome is primarily caused by mutations in the MMR genes, mainly MLH1 and MSH2, and less frequently in MSH6, and rarely PMS2, and large genomic rearrangements account for 5-20 % of all mutations. Germ line hemiallelic methylations of MLH1 or MSH2 are termed as epimutations and have been identified as causative of Lynch syndrome. Moreover, germ line 3' deletions of EPCAM gene is involved in MSH2 methylation. MSI is also observed in about 15 % of sporadic colorectal cancer (CRC), gastric cancer (GC), and endometrial cancer (EC), and at lower frequencies in other cancers, often in association with hypermethylation of the MLH1 gene. Trimethylation of histone H3 on Lys36 (H3K36 me3) is an epigenetic histone mark that was required for DNA MMR in vivo. Thus, mutations in the H3K36 trimethyltransferase SETD2 have been reported as a potential cause of MSI. Genetic, epigenetic, and transcriptomic differences have been identified between cancers with and without MSI. Recent comprehensive molecular characterizations of CRC, EC, and GC by The Cancer Genome Atlas indicate that MSI+ cancers are distinct biological entities. The BRAF V600E mutation is specifically associated with sporadic MSI+ CRCs with methylated MLH1, but is not associated with Lynch syndrome-related CRCs. Accumulating evidence indicates a role of interactions between MSI and microRNA (miRNA) in the pathogenesis of MSI-positive (MSI+) cancer. As another new mechanism underlying MSI, overexpression of miR-155 or miR-21 has been shown to downregulate the expression of the MMR genes. Gene targets of frameshift mutations caused by MSI are involved in various cellular functions, including DNA repair (MSH3 and MSH6), cell signaling (TGFBR2 and ACVR2A), apoptosis (BAX), epigenetic regulation (HDAC2 and ARID1A), and miRNA processing (TARBP2 and XPO5), and a subset of MSI+ CRCs reportedly shows the mutated miRNA machinery phenotype. Moreover, microsatellite repeats in miRNA genes, such as hsa-miR-1273c, may be novel MSI targets for CRC, and mutations in noncoding regulatory regions of MRE11, BAX (Bax Delta 2), and HSP110 (HSP110 Delta E9) may affect the efficiency of chemotherapy. Thus, analyses of MSI and its related molecular alterations in cancers are increasingly relevant in clinical settings, and MSI is a useful screening marker for identifying patients with Lynch syndrome and a prognostic factor for chemotherapeutic interventions. In this review, we summarize recent advances in the pathogenesis of MSI and focus on genome-wide analyses that indicate the potential use of MSI and related alterations as biomarkers and novel therapeutic targets.	[Yamamoto, Hiroyuki] St Marianna Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med, Kawasaki, Kanagawa 2168511, Japan; [Imai, Kohzoh] Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan	Yamamoto, H (reprint author), St Marianna Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med, Kawasaki, Kanagawa 2168511, Japan.	h-yama@marianna-u.ac.jp					Abdel-Rahman WM, 2006, CRIT REV ONCOL HEMAT, V58, P208, DOI 10.1016/j.critrevonc.2005.11.001; An CH, 2015, PATHOL ONCOL RES, V21, P181, DOI 10.1007/s12253-014-9804-8; Gologan A, 2005, ARCH PATHOL LAB MED, V129, P1390; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Toyota M, 2000, P NATL ACAD SCI USA, V97, P710, DOI 10.1073/pnas.97.2.710; Goel A, 2010, CURR OPIN GASTROEN, V26, P47, DOI 10.1097/MOG.0b013e328332b850; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010; Lax SF, 2004, VIRCHOWS ARCH, V444, P213, DOI 10.1007/s00428-003-0947-3; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Sukawa Y, 2012, WORLD J GASTROENTERO, V18, P6577, DOI 10.3748/wjg.v18.i45.6577; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Dorard C, 2011, NAT MED, V17, P1283, DOI 10.1038/nm.2457; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/j.moldx.2006.060082; Diaz-Padilla I, 2013, CRIT REV ONCOL HEMAT, V88, P154, DOI 10.1016/j.critrevonc.2013.03.002; Miyakura Y, 2004, CLIN GASTROENTEROL H, V2, P147, DOI 10.1053/S1542-3565(03)00314-8; Rossi L, 2007, PHARMACOL RES, V56, P248, DOI 10.1016/j.phrs.2007.07.001; Benatti P, 2005, CLIN CANCER RES, V11, P8332, DOI 10.1158/1078-0432.CCR-05-1030; Calcagno DQ, 2013, WORLD J GASTROENTERO, V19, P1182, DOI 10.3748/wjg.v19.i8.1182; Shia J, 2003, AM J SURG PATHOL, V27, P1407, DOI 10.1097/00000478-200311000-00002; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI 10.1053/j.gastro.2009.12.064; Martin SA, 2010, CLIN CANCER RES, V16, P5107, DOI 10.1158/1078-0432.CCR-10-0821; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Vasen HFA, 2007, J MED GENET, V44, P353, DOI 10.1136/jmg.2007.048991; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Martens-Uzunova ES, 2013, CANCER LETT, V340, P201, DOI 10.1016/j.canlet.2012.11.058; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Gazzoli I, 2002, CANCER RES, V62, P3925; Capper D, 2013, INT J CANCER, V133, P1624, DOI 10.1002/ijc.28183; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Melo S, 2011, P NATL ACAD SCI USA, V108, P4394, DOI 10.1073/pnas.1014720108; Ito M, 2014, INT J CANCER, V135, P2507, DOI 10.1002/ijc.28920; Ulahannan D, 2013, BRIT J CANCER, V109, P827, DOI 10.1038/bjc.2013.416; Cajuso T, 2014, INT J CANCER, V135, P611, DOI 10.1002/ijc.28705; Hallermalm K, 2008, J IMMUNOL, V180, P3766; Domingo E, 2005, ONCOGENE, V24, P3995, DOI 10.1038/sj.onc.1208569; Kim JH, 2014, WORLD J GASTROENTERO, V20, P4230, DOI 10.3748/wjg.v20.i15.4230; Lopez-Serra P, 2012, ONCOGENE, V31, P1609, DOI 10.1038/onc.2011.354; Vilar E, 2011, CANCER RES, V71, P2632, DOI 10.1158/0008-5472.CAN-10-1120; Carethers JM, 2004, GASTROENTEROLOGY, V126, P394, DOI 10.1053/j.gastro.2003.12.023; Yamamoto H, 2012, WORLD J GASTROENTERO, V18, P2745, DOI 10.3748/wjg.v18.i22.2745; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Bettington M, 2013, HISTOPATHOLOGY, V62, P367, DOI 10.1111/his.12055; Lee EJ, 2013, CANCER LETT, V340, P171, DOI 10.1016/j.canlet.2012.10.040; Susini T, 2007, CANCER, V109, P882, DOI 10.1002/cncr.22465; Young J, 2005, CLIN GASTROENTEROL H, V3, P254, DOI 10.1053/S1542-3565(04)00673-1; Abe H, 2012, VIRCHOWS ARCH, V461, P367, DOI 10.1007/s00428-012-1303-2; Je EM, 2013, PATHOLOGY, V45, P645, DOI 10.1097/PAT.0000000000000007; Gylfe AE, 2013, GASTROENTEROLOGY, V145, P540, DOI 10.1053/j.gastro.2013.05.015; Giannini G, 2004, ONCOGENE, V23, P2640, DOI 10.1038/sj.onc.1207409; Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; Oliveira C, 2003, ONCOGENE, V22, P9192, DOI 10.1038/sj.onc.1207061; Vilar E, 2010, NAT REV CLIN ONCOL, V7, P153, DOI 10.1038/nrclinonc.2009.237; Kim MS, 2010, J PATHOL, V221, P139, DOI 10.1002/path.2683; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; Yoon K, 2013, GENOME RES, V23, P1109, DOI 10.1101/gr.145706.112; Findeisen P, 2005, CANCER RES, V65, P8072, DOI 10.1158/0008-5472.CAN-04-4146; Zighelboim I, 2007, J CLIN ONCOL, V25, P2042, DOI 10.1200/JCO.2006.08.2107; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Woerner SM, 2010, NUCLEIC ACIDS RES, V38, pD682, DOI 10.1093/nar/gkp839; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Suzuki H, 2014, BIOCHEM BIOPH RES CO, V455, P35, DOI 10.1016/j.bbrc.2014.07.007; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; Jass JR, 2006, WORLD J GASTROENTERO, V12, P4943; Dhomen N, 2007, CURR OPIN GENET DEV, V17, P31, DOI 10.1016/j.gde.2006.12.005; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Goldstein NS, 2006, AM J CLIN PATHOL, V125, P146, DOI 10.1309/87BD0C6UCGUG126J; Choi YJ, 2014, HUM PATHOL, V45, P1674, DOI 10.1016/j.humpath.2014.04.013; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Jover R, 2006, GUT, V55, P848, DOI 10.1136/gut.2005.073015; Thiel A, 2013, VIRCHOWS ARCH, V463, P613, DOI 10.1007/s00428-013-1470-9; Nagasaka T, 2010, CANCER RES, V70, P3098, DOI 10.1158/0008-5472.CAN-09-3290; Kuan SF, 2014, HUM PATHOL, V45, P464, DOI 10.1016/j.humpath.2013.10.026; Chang DK, 2001, GENOME RES, V11, P1145, DOI 10.1101/gr.186301; Ionov Y, 2000, P NATL ACAD SCI USA, V97, P10872, DOI 10.1073/pnas.190210897; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Yamamoto H, 2002, J GASTROENTEROL, V37, P153, DOI 10.1007/s005350200015; Phillips SM, 2004, BRIT J SURG, V91, P469, DOI 10.1002/bjs.4472; Qu YP, 2013, CLIN CHIM ACTA, V424, P53, DOI 10.1016/j.cca.2013.05.002; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Vasen HFA, 2005, FAM CANCER, V4, P219, DOI 10.1007/s10689-004-3906-5; Yamamoto H, 2014, WORLD J GASTROENTERO, V20, P3927, DOI 10.3748/wjg.v20.i14.3927; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Alhopuro P, 2012, INT J CANCER, V130, P1558, DOI 10.1002/ijc.26167; Hewish M, 2010, NAT REV CLIN ONCOL, V7, P197, DOI 10.1038/nrclinonc.2010.18; Yamamoto H, 1999, GASTROENTEROLOGY, V116, P1348, DOI 10.1016/S0016-5085(99)70499-3; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Tian S, 2012, J PATHOL, V228, P586, DOI 10.1002/path.4092; Imai K, 2008, CARCINOGENESIS, V29, P673, DOI 10.1093/carcin/bgm228; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Tahara T, 2014, CANCER RES, V74, P1311, DOI 10.1158/0008-5472.CAN-13-1865; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Duval A, 2002, CANCER RES, V62, P2447; Woerner SM, 2003, ONCOGENE, V22, P2226, DOI 10.1038/sj.onc.1206421; Yamamoto H, 1997, CANCER RES, V57, P4420; Vasen HFA, 2005, JAMA-J AM MED ASSOC, V293, P2028, DOI 10.1001/jama.293.16.2028; Halvey PJ, 2014, CANCER RES, V74, P387, DOI 10.1158/0008-5472.CAN-13-2488; Gigek CO, 2012, EPIGENOMICS-UK, V4, P279, DOI [10.2217/epi.12.22, 10.2217/EPI.12.22]; Otani K, 2013, EXPERT REV MOL DIAGN, V13, P445, DOI [10.1586/erm.13.32, 10.1586/ERM.13.32]; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Valeri N, 2010, P NATL ACAD SCI USA, V107, P6982, DOI 10.1073/pnas.1002472107; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Xuan JK, 2013, CANCER LETT, V340, P284, DOI 10.1016/j.canlet.2012.11.025; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Melo SA, 2011, FEBS LETT, V585, P2087, DOI 10.1016/j.febslet.2010.08.009; Torlakovic E, 2003, AM J SURG PATHOL, V27, P65, DOI 10.1097/00000478-200301000-00008; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Kloor M, 2011, J CLIN ONCOL, V29, P223, DOI 10.1200/JCO.2010.32.0820; Goldstein NS, 2003, AM J CLIN PATHOL, V119, P778, DOI 10.1309/DRFQ0WFUF1G13CTK; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Nosho K, 2014, CARCINOGENESIS, V35, P776, DOI 10.1093/carcin/bgt374; Woerner SM, 2005, ONCOGENE, V24, P2525, DOI 10.1038/sj.onc.1208456; Choi YY, 2014, J SURG ONCOL, V110, P129, DOI 10.1002/jso.23618; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Hugo H, 2006, GENE CHROMOSOME CANC, V45, P1143, DOI 10.1002/gec.20378; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; Kloor M, 2005, CANCER RES, V65, P6418, DOI 10.1158/0008-5472.CAN-05-0044; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.186; Deng GR, 2004, CLIN CANCER RES, V10, P191, DOI 10.1158/1078-0432.CCR-1118-3; Malkhosyan SR, 2000, GASTROENTEROLOGY, V119, P598, DOI 10.1053/gast.2000.16154; Kim TM, 2013, CELL, V155, P858, DOI 10.1016/j.cell.2013.10.015; Domingo E, 2004, GENE CHROMOSOME CANC, V39, P138, DOI 10.1002/gcc.10310; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Robinson KL, 2007, J NATL CANCER I, V99, P291, DOI 10.1093/jnci/djk051; Kim KJ, 2014, HUM PATHOL, V45, P285, DOI 10.1016/j.humpath.2013.09.004; Arai T, 2013, GASTRIC CANCER, V16, P505, DOI 10.1007/s10120-012-0226-6; Banerjea A, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-21; Bilbao C, 2010, EUR J CANCER, V46, P2821, DOI 10.1016/j.ejca.2010.06.116; Billingsley CC, 2015, CANCER-AM CANCER SOC, V121, P386, DOI 10.1002/cncr.29046; Boland CR, 2005, GASTROENTEROLOGY, V129, P751, DOI 10.1053/j.gastro.2005.05.067; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Collura A, 2014, GASTROENTEROLOGY, V146, P401, DOI 10.1053/j.gastro.2013.10.054; Davalos V, 2007, ONCOGENE, V26, P308, DOI 10.1038/sj.onc.1209780; Davis-Dusenbery Brandi N, 2010, Genes Cancer, V1, P1100, DOI 10.1177/1947601910396213; Dierssen JWF, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-33; Doeberitz MV, 2013, FAM CANCER, V12, P307, DOI 10.1007/s10689-013-9662-7; Domingo E, 2004, J MED GENET, V41, P663; Duchaine T F, 2009, Curr Oncol, V16, P61; Edwards RA, 2009, CANCER RES, V69, P6423, DOI 10.1158/0008-5472.CAN-09-1285; El-Murr N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031862; Fang MG, 2014, MOL CELL, V55, P904, DOI 10.1016/j.molcel.2014.08.010; Gatalica Z, 2014, CANCER EPIDEM BIOMAR, V23, P2965, DOI 10.1158/1055-9965.EPI-14-0654; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gil J, 1999, CANCER RES, V59, P2034; Grady WM, 1999, CANCER RES, V59, P320; Grosshans H, 2010, CANCER CELL, V18, P295, DOI 10.1016/j.ccr.2010.10.005; Haferkamp Bonnie, 2013, Genes Cancer, V4, P501, DOI 10.1177/1947601913515906; Haferkamp B, 2012, J BIOL CHEM, V287, P34722, DOI 10.1074/jbc.M112.374785; Hirata T, 2007, J PATHOL, V211, P516, DOI 10.1002/path.2142; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Inamura K, 2014, J NATL CANC I, V106; Juo YY, 2014, ANN ONCOL, V25, P2314, DOI 10.1093/annonc/mdu149; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Kim TM, 2014, CANCER RES, V74, P6377, DOI 10.1158/0008-5472.CAN-14-1225; Klingbiel D, 2015, ANN ONCOL, V26, P126; Kmieciak M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082544; Koh KH, 2005, LAB INVEST, V85, P1130, DOI 10.1038/labinvest.3700315; Konishi K, 2007, CANCER J, V13, P49, DOI 10.1097/PPO.0b013e31803c72fe; Leung SY, 2007, NAT GENET, V39, P576, DOI 10.1038/ng0507-576; Li GM, 2013, CANCER RES, V73, P6379, DOI 10.1158/0008-5472.CAN-13-1870; Tahara T, 2014, GASTROENTEROLOGY, V146, P530, DOI 10.1053/j.gastro.2013.10.060; Malkhosyan S, 1996, NATURE, V382, P499, DOI 10.1038/382499a0; Mazzolini R, 2013, INT J CANCER, V132, P1790, DOI 10.1002/ijc.27856; McPherson LA, 2014, CANCER LETT, V343, P217, DOI 10.1016/j.canlet.2013.10.034; Melo SA, 2011, CELL CYCLE, V10, P922, DOI 10.4161/cc.10.6.15119; Moorcraft SY, 2013, INVEST NEW DRUG, V31, P1339, DOI 10.1007/s10637-013-9990-3; Morandi L, 2012, INT J COLORECTAL DIS, V27, P647, DOI 10.1007/s00384-011-1365-7; Mori Y, 2003, CANCER RES, V63, P4577; Nagarajan N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r115; Oliveira C, 2004, HUM MOL GENET, V13, P2303, DOI 10.1093/hmg/ddh238; Ollikainen M, 2007, ONCOGENE, V26, P4541, DOI 10.1038/sj.onc.1210236; Papagiorgis P, 2013, GUT, V62, P1519, DOI 10.1136/gutjnl-2013-305209; Patel LR, 2013, CANCER LETT, V340, P152, DOI 10.1016/j.canlet.2012.10.018; Perucho M, 1999, CANCER RES, V59, P249; Perucho M, 2003, ONCOGENE, V22, P2223, DOI 10.1038/sj.onc.1206580; Perucho M, 1996, NAT MED, V2, P630, DOI 10.1038/nm0696-630; Prat J, 2007, PATHOLOGY, V39, P72, DOI 10.1080/00313020601136153; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Ropero S, 2006, NAT GENET, V38, P566, DOI 10.1038/ng1773; Schwartz S, 1999, CANCER RES, V59, P2995; Sehgal R, 2014, GENES-BASEL, V5, P497, DOI 10.3390/genes5030497; Sinicrope FA, 2009, CURR OPIN ONCOL, V21, P369, DOI 10.1097/CCO.0b013e32832c94bd; Tuupanen S, 2014, BRIT J CANCER, V111, P1657, DOI 10.1038/bjc.2014.429; Valeri N, 2010, P NATL ACAD SCI USA, V107, P21098, DOI 10.1073/pnas.1015541107; Yamamoto H, 1998, CANCER RES, V58, P997; Yamamoto H, 2001, GASTROENTEROLOGY, V120, P1565, DOI 10.1053/gast.2001.24497; Yamamoto H, 2000, CELL DEATH DIFFER, V7, P238, DOI 10.1038/sj.cdd.4400651; Zhang HH, 2014, MOL CANCER RES, V12, P1225, DOI 10.1158/1541-7786.MCR-14-0162; Zhang J, 2006, CANCER RES, V66, P659, DOI 10.1158/0008-5472.CAN-05-4043; Zouridis H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004504	209	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5761	1432-0738		ARCH TOXICOL	Arch. Toxicol.	JUN	2015	89	6					899	921		10.1007/s00204-015-1474-0		23	Toxicology	Toxicology	CI1AK	WOS:000354471800006		
J	Rothacher, A				Rothacher, Albrecht			Global alliances, production changes and mature markets: Japanese FDI in the European car industry and their implications for bilateral trade policies	ASIA EUROPE JOURNAL			English	Article								The article reviews the changes in production, investment and trade patterns which have affected Japanese car exports to the EU and their foreign direct investments (FDI) in Europe. Global manufacturing alliances with shared productions and global component sourcing with lean production for most makers have changed the classical trading and FDI patterns beyond recognition. As a result, the trade policy instruments of old have lost most of their meaning and relevance. The abolition of EU import tariffs on Japanese cars in the context of the forthcoming foreign trade association (FTA) with Japan will hence in all likeliness have only a minimal impact on future trade and investment in the sector.	EU Delegat, Minato Ku, Tokyo 1060047, Japan	Rothacher, A (reprint author), EU Delegat, Minato Ku, Europa House,4-6-28 Minami Azabu, Tokyo 1060047, Japan.	Albrecht.ROTHACHER@eeas.europa.eu					Rowley A, 1989, FAR E EC REV, V144, P68; Urata S, 1988, DEV MOTOR VEHICLE IN, V24, P19; Watanabe M, 1993, IND POLICY E ASIA, p[194, 200]	3	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1610-2932	1612-1031		ASIA EUR J	Asia Eur. J.	JUN	2015	13	2					163	174		10.1007/s10308-015-0410-5		12	International Relations	International Relations	CH9XM	WOS:000354389900004		
J	Tada, H; Kawashiri, M; Nohara, A; Saito, R; Tanaka, Y; Nomura, A; Konno, T; Sakata, K; Fujino, N; Takamura, T; Inazu, A; Mabuchi, H; Yamagishi, M; Hayashi, K				Tada, Hayato; Kawashiri, Masa-aki; Nohara, Atsushi; Saito, Reina; Tanaka, Yoshihiro; Nomura, Akihiro; Konno, Tetsuo; Sakata, Kenji; Fujino, Noboru; Takamura, Toshinari; Inazu, Akihiro; Mabuchi, Hiroshi; Yamagishi, Masakazu; Hayashi, Kenshi			Whole exome sequencing combined with integrated variant annotation prediction identifies asymptomatic Tangier disease with compound heterozygous mutations in ABCA1 gene	ATHEROSCLEROSIS			English	Article						Tangier disease; ABCA1; HDL; Exome; Genetics	HIGH-DENSITY-LIPOPROTEIN; ESTER TRANSFER PROTEIN; COLORIMETRIC METHOD; HDL-CHOLESTEROL; PLASMA LECITHIN; DEFICIENCY; GENOME; SERUM; POPULATION; FRAMEWORK	Objective: Molecular diagnosis for subjects with extremely low HDL-C through candidate-gene approaches requires huge effort. Whole exome-sequencing (WES) has already shown approximately similar to 30% success in the diagnosis of Mendelian disorders. Moreover, novel in silico prediction software for the pathogenicity of novel missense variants named Combined Annotation Dependent Depletion (CADD) has recently been developed, enabling the objective integration of many diverse annotations into a single measure (C-score) for each variant. Here, we investigated whether WES combined with integrated variant annotation prediction could facilitate the molecular diagnosis of this rare condition. Methods: WES was performed on 8 individuals including 2 individuals exhibiting extremely low HDL-C (2 mg/dl and 6 mg/dl), 2 unaffected family members, and 4 unrelated individuals as controls. We filtered out the following variants: 1) Benign variants predicted by SnpEff; 2) Minor allele frequency (MAF) > 1%; 3) Segregation unmatched for the recessive form of inheritance; 4) C-score < 10. Results: Among 305,202 variants found in those individuals, we found 21,708 nonsense, missense, or splice site variants, of which 5192 were rare (MAF <= 1% or not reported). Filtering assuming a recessive pattern of inheritance, combined with the use of the C-score, successfully narrowed down the candidates to compound heterozygous mutations in the ABCA1 gene (c.6230C > A or p.P2077H/c.6137G > A or p.S2046N, and c.2842G > A or p.G948R/c.1130C > T or p.P377L). Conclusions: WES combined with integrated variant annotation prediction successfully identified asymptomatic Tangier disease with novel ABCA1 mutations. This comprehensive approach is useful to determine causative variants, especially in recessive inherited diseases. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Tada, Hayato; Kawashiri, Masa-aki; Tanaka, Yoshihiro; Nomura, Akihiro; Konno, Tetsuo; Sakata, Kenji; Fujino, Noboru; Yamagishi, Masakazu; Hayashi, Kenshi] Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, Kanazawa, Ishikawa 9208641, Japan; [Nohara, Atsushi; Mabuchi, Hiroshi] Kanazawa Univ, Grad Sch Med, Dept Lipidol, Kanazawa, Ishikawa 9208641, Japan; [Saito, Reina; Takamura, Toshinari] Kanazawa Univ, Grad Sch Med, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9208641, Japan; [Inazu, Akihiro] Kanazawa Univ, Grad Sch Med, Dept Lab Sci Mol Biochem & Mol Biol, Kanazawa, Ishikawa 9208641, Japan	Tada, H (reprint author), Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.				Ministry of Education, Science, and Culture of Japan [26893094]	This work has been supported by a scientific research grant from the Ministry of Education, Science, and Culture of Japan (No. 26893094).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; deLemos AS, 2002, CIRCULATION, V106, P1321, DOI 10.1161/01.CIR.0000028423.07623.6A; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Frikke-Schmidt R, 2004, J CLIN INVEST, V114, P1343, DOI 10.1172/JC1200420361; Miller M, 2003, CURR OPIN LIPIDOL, V14, P273, DOI 10.1097/01.mol.0000073506.41685.d2; Brooks-Wilson A, 1999, NAT GENET, V22, P336; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Fasano T, 2012, MOL GENET METAB, V107, P534, DOI 10.1016/j.ymgme.2012.08.005; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; FREDRICKSON DS, 1964, J CLIN INVEST, V43, P228, DOI 10.1172/JCI104907; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; FINLEY PR, 1978, CLIN CHEM, V24, P931; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Genest Jr J.J., 1992, CIRCULATION, V85, P2025; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Japanese Genetic Variation Consortium, REF DAT GEN VAR JAP; Kannel W. M., 1983, AM J CARDIOL S6, V52, p9B; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kitaoka M., 2009, J MED ULTRASON, V36, P510; Kiyohara T, 1998, CLIN CHIM ACTA, V271, P109, DOI 10.1016/S0009-8981(97)00202-7; NAGASAKI T, 1977, CLIN CHIM ACTA, V75, P371; NORUM KR, 1968, SCAND J CLIN LAB INV, V22, P94, DOI 10.3109/00365516809160951; NORUM RA, 1982, NEW ENGL J MED, V306, P1513, DOI 10.1056/NEJM198206243062503; Okamura T, 2006, ATHEROSCLEROSIS, V184, P143, DOI 10.1016/j.atherosclerosis.2005.03.042; Rader DJ, 2012, J CLIN ENDOCR METAB, V97, P3399, DOI 10.1210/jc.2012-2185; SUGIURA M, 1977, CLIN CHIM ACTA, V81, P125; Tada H, 2012, CIRC-CARDIOVASC GENE, V5, P35, DOI 10.1161/CIRCGENETICS.111.960948	32	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	JUN	2015	240	2					324	329		10.1016/j.atherosclerosis.2015.04.003		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CI1ZQ	WOS:000354544300004		
J	Toutouzas, K; Chatzizisis, YS; Riga, M; Giannopoulos, A; Antoniadis, AP; Tu, SX; Fujino, Y; Mitsouras, D; Doulaverakis, C; Tsampoulatidis, I; Koutkias, VG; Bouki, K; Li, YG; Chouvarda, I; Cheimariotis, G; Maglaveras, N; Kompatsiaris, I; Nakamura, S; Reiber, JHC; Rybicki, F; Karvounis, H; Stefanadis, C; Tousoulis, D; Giannoglou, GD				Toutouzas, Konstantinos; Chatzizisis, Yiannis S.; Riga, Maria; Giannopoulos, Andreas; Antoniadis, Antonios P.; Tu, Shengxian; Fujino, Yusuke; Mitsouras, Dimitrios; Doulaverakis, Charalampos; Tsampoulatidis, Ioannis; Koutkias, Vassilis G.; Bouki, Konstantina; Li, Yingguang; Chouvarda, Ioanna; Cheimariotis, Grigorios; Maglaveras, Nicos; Kompatsiaris, Ioannis; Nakamura, Sunao; Reiber, Johan H. C.; Rybicki, Frank; Karvounis, Haralambos; Stefanadis, Christodoulos; Tousoulis, Dimitris; Giannoglou, George D.			Accurate and reproducible reconstruction of coronary arteries and endothelial shear stress calculation using 3D OCT: Comparative study to 3D IVUS and 3D QCA	ATHEROSCLEROSIS			English	Article						Optical Coherence Tomography; Intravascular Ultrasound; Quantitative Coronary Angiography; Shear Stress; Method comparison study	OPTICAL COHERENCE TOMOGRAPHY; CORRECT 3-DIMENSIONAL RECONSTRUCTION; INTRAVASCULAR ULTRASOUND; ATHEROSCLEROTIC PLAQUE; BIORESORBABLE SCAFFOLD; BIPLANE ANGIOGRAPHY; RUPTURED PLAQUES; NATURAL-HISTORY; VALIDATION; HUMANS	Background: Geometrically-correct 3D OCT is a new imaging modality with the potential to investigate the association of local hemodynamic microenvironment with OCT-derived high-risk features. We aimed to describe the methodology of 3D OCT and investigate the accuracy, inter-and intra-observer agreement of 3D OCT in reconstructing coronary arteries and calculating ESS, using 3D IVUS and 3D QCA as references. Methods-Results: 35 coronary artery segments derived from 30 patients were reconstructed in 3D space using 3D OCT. 3D OCT was validated against 3D IVUS and 3D QCA. The agreement in artery reconstruction among 3D OCT, 3D IVUS and 3D QCA was assessed in 3-mm-long subsegments using lumen morphometry and ESS parameters. The inter-and intra-observer agreement of 3D OCT, 3D IVUS and 3D QCA were assessed in a representative sample of 61 subsegments (n - 5 arteries). The data processing times for each reconstruction methodology were also calculated. There was a very high agreement between 3D OCT vs. 3D IVUS and 3D OCT vs. 3D QCA in terms of total reconstructed artery length and volume, as well as in terms of segmental morphometric and ESS metrics with mean differences close to zero and narrow limits of agreement (BlandeAltman analysis). 3D OCT exhibited excellent inter-and intra-observer agreement. The analysis time with 3D OCT was significantly lower compared to 3D IVUS. Conclusions: Geometrically-correct 3D OCT is a feasible, accurate and reproducible 3D reconstruction technique that can perform reliable ESS calculations in coronary arteries. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Toutouzas, Konstantinos; Riga, Maria; Stefanadis, Christodoulos; Tousoulis, Dimitris] Univ Athens, Sch Med, Hippokrat Hosp, Dept Cardiol 1, GR-11527 Athens, Greece; [Chatzizisis, Yiannis S.; Antoniadis, Antonios P.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA; [Chatzizisis, Yiannis S.; Giannopoulos, Andreas; Antoniadis, Antonios P.; Karvounis, Haralambos; Giannoglou, George D.] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Sch Med, Dept Cardiol 1, GR-54006 Thessaloniki, Greece; [Tu, Shengxian; Li, Yingguang; Reiber, Johan H. C.] Leiden Univ, Med Ctr, Dept Radiol, Div Image Proc, Leiden, Netherlands; [Tu, Shengxian] Shanghai Jiao Tong Univ, Sch Biomed Engn, Biomed Instrument Inst, Shanghai 200030, Peoples R China; [Fujino, Yusuke; Nakamura, Sunao] New Tokyo Hosp, Dept Cardiol, Chiba, Japan; [Mitsouras, Dimitrios; Rybicki, Frank] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol,Appl Imaging Sci Lab, Boston, MA 02115 USA; [Doulaverakis, Charalampos; Tsampoulatidis, Ioannis; Kompatsiaris, Ioannis] Ctr Res & Technol Hellas, Inst Informat Technol, Thessaloniki, Greece; [Koutkias, Vassilis G.; Chouvarda, Ioanna; Cheimariotis, Grigorios; Maglaveras, Nicos] Aristotle Univ Thessaloniki, Sch Med, Lab Med Informat, GR-54006 Thessaloniki, Greece; [Koutkias, Vassilis G.; Chouvarda, Ioanna; Cheimariotis, Grigorios; Maglaveras, Nicos] Ctr Res & Technol Hellas, Inst Appl Biosci, Thessaloniki, Greece; [Bouki, Konstantina] Gen Hosp Nikaia, Dept Cardiol 2, Piraeus, Greece	Chatzizisis, YS (reprint author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	ychatzizisis@icloud.com	Chouvarda, Ioanna/N-8925-2015; Kompatsiaris, Ioannis/P-8594-2015; 	Chouvarda, Ioanna/0000-0001-8915-6658; Kompatsiaris, Ioannis/0000-0001-6447-9020; Koutkias, Vassilis/0000-0003-4154-850X	European Commission [249303]; Behrakis Foundation, Boston, USA; General Secretariat of Research and Technology, Program: Heracleitus II, Athens, Greece; National Institute of Biomedical Imaging and Bioengineering, NIH, Bethesda, USA [K01-EB015868]	European Commission, Framework Program 7, Marie Curie International Reintegration Grant, Project: SMILE (grant number: 249303); Behrakis Foundation, Boston, USA; General Secretariat of Research and Technology, Program: Heracleitus II, Athens, Greece; National Institute of Biomedical Imaging and Bioengineering (grant Number K01-EB015868), NIH, Bethesda, USA.	Tu SX, 2014, JACC-CARDIOVASC INTE, V7, P768, DOI 10.1016/j.jcin.2014.03.004; Wentzel JJ, 2012, CARDIOVASC RES, V96, P234, DOI 10.1093/cvr/cvs217; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Cheruvu PK, 2007, J AM COLL CARDIOL, V50, P940, DOI 10.1016/j.jacc.2007.04.086; Chatzizisis YS, 2006, CORONARY ARTERY DIS, V17, P545, DOI 10.1097/00019501-200609000-00008; Toutouzas K, 2012, EUROINTERVENTION, V8, P477, DOI 10.4244/EIJV8I4A75; Samady H, 2011, CIRCULATION, V124, P779, DOI 10.1161/CIRCULATIONAHA.111.021824; van Ditzhuijzen NS, 2014, INT J CARDIOVAS IMAG, V30, P1013, DOI 10.1007/s10554-014-0447-3; Giannoglou GD, 2006, CORONARY ARTERY DIS, V17, P533, DOI 10.1097/00019501-200609000-00007; Slager CJ, 2000, CIRCULATION, V102, P511; Stone PH, 2012, CIRCULATION, V126, P172, DOI 10.1161/CIRCULATIONAHA.112.096438; Stone PH, 2003, CIRCULATION, V108, P438, DOI 10.1161/01.CIR.0000080882.35274.AD; Chatzizisis YS, 2011, CIRCULATION, V123, P621, DOI 10.1161/CIRCULATIONAHA.110.970038; Bourantas CV, 2013, EUROINTERVENTION, V9, P582, DOI 10.4244/EIJV9I5A94; Claessen BE, 2011, JACC-CARDIOVASC INTE, V4, P974, DOI 10.1016/j.jcin.2011.07.005; Wentzel JJ, 2003, CIRCULATION, V108, P17, DOI 10.1161/01.CIR.0000078637.21322.D3; Prati F, 2012, EUR HEART J, V33, P2513, DOI 10.1093/eurheartj/ehs095; Tu SX, 2012, INT J CARDIOVAS IMAG, V28, P1315, DOI 10.1007/s10554-012-0016-6; Wang TS, 2013, OPT LETT, V38, P1715, DOI 10.1364/OL.38.001715; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Fedele S, 2012, AM J CARDIOL, V110, P1106, DOI 10.1016/j.amjcard.2012.05.047; Chatzizisis YS, 2014, ATHEROSCLEROSIS, V234, P476, DOI 10.1016/j.atherosclerosis.2014.02.019; Chatzizisis YS, 2008, CIRCULATION, V117, P993, DOI 10.1161/CIRCULATIONAHA.107.695254; Wahle A, 1999, IEEE T MED IMAGING, V18, P686, DOI 10.1109/42.796282; Farooq V, 2013, EUR HEART J, V34, P875, DOI 10.1093/eurheartj/ehr409; Antoniadis AP, 2013, EUR HEART J, V34, P2715, DOI 10.1093/eurheartj/eht226; Athanasiou LS, 2012, IEEE ENG MED BIO, P2647, DOI 10.1109/EMBC.2012.6346508; BLAND JM, 1986, LANCET, V1, P307; Bourantas CV, 2014, INT J CARDIOVAS IMAG, V30, P485, DOI 10.1007/s10554-014-0374-3; Doulaverakis C, 2013, COMPUT BIOL MED, V43, P1793, DOI 10.1016/j.compbiomed.2013.08.013; Giannopoulos Andreas, 2012, Expert Rev Cardiovasc Ther, V10, P539, DOI 10.1586/erc.12.44; Gogas BD, 2013, JACC-CARDIOVASC INTE, V6, P760, DOI 10.1016/j.jcin.2013.04.008; Goubergrits L, 2009, ANN BIOMED ENG, V37, P682, DOI 10.1007/s10439-009-9656-7; Kousera CA, 2014, IEEE T BIO-MED ENG, V61, P1902, DOI 10.1109/TBME.2014.2310954; Papafaklis M.I., 2014, EUROINTERVENTION; Tu SX, 2010, CATHETER CARDIO INTE, V76, P291, DOI 10.1002/ccd.22502; Tu SX, 2013, CIRC-CARDIOVASC INTE, V6, pE15, DOI 10.1161/CIRCINTERVENTIONS.112.000051; Vergallo R, 2014, CIRC-CARDIOVASC IMAG, V7, P905, DOI 10.1161/CIRCIMAGING.114.001932	38	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	JUN	2015	240	2					510	519		10.1016/j.atherosclerosis.2015.04.011		10	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CI1ZQ	WOS:000354544300035		
J	Asakawa, T; Hayashi, T; Tanaka, Y; Joki, N; Hase, H				Asakawa, Takasuke; Hayashi, Toshihide; Tanaka, Yuri; Joki, Nobuhiko; Hase, Hiroki			Changes over the last decade in carotid atherosclerosis in patients with end-stage kidney disease	ATHEROSCLEROSIS			English	Article						Chronic kidney disease; End-stage kidney disease; Carotid artery-intima media thickness; Plaque score; Low-density lipoprotein cholesterol; Non-high-density lipoprotein cholesterol	INTIMA-MEDIA THICKNESS; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR RISK-FACTORS; PLAQUE SCORE; PREDIALYSIS PATIENTS; STATIN THERAPY; ATORVASTATIN; TRIAL; ULTRASONOGRAPHY; ASSOCIATION	Objective: Therapies for chronic kidney disease have changed greatly over the last decade. The aim of this study was to examine the changes in the clinical characteristics and carotid atherosclerosis of patients with end-stage kidney disease (ESKD) over the last 9 years. Methods: A cross-sectional study of 150 consecutive patients with ESKD who had initiated maintenance dialysis between January 2005 and December 2013 was conducted. The patients' mean age was 68 +/- 13 years. The group comprised 73% men, and 63% of the patients had diabetic nephropathy. The carotid artery-intima media thicknesses and the plaque scores (PS) were measured using carotid artery ultrasonography within 3 months of dialysis initiation. Changes in the patients' carotid atherosclerosis and clinical characteristics over the years were examined by categorizing the patients into 3 groups representing 3-year intervals based on when dialysis was initiated. Results: The PS declined from 12.8 to 5.4 (P = 0.001). Low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol levels declined over the 9-year period (P = 0.005 and P = 0.006, respectively), and the ratio of statin users increased markedly from 24% to 54% (P = 0.001). Univariate regression analysis identified a positive correlation between the PS and LDL-C (r = 0.281; P = 0.01), and a strong positive correlationwas found between the PS and LDL-C after adjusting for various risk factors for atherosclerosis. Conclusion: Carotid atherosclerosis in patients with ESKD has decreased over the past 9 years, which may be a consequence of improvements in dyslipidemia management. (C) 2015 The Authors. Published by Elsevier Ireland Ltd.	[Asakawa, Takasuke; Hayashi, Toshihide; Tanaka, Yuri; Joki, Nobuhiko; Hase, Hiroki] Toho Univ, Dept Nephrol, Ohashi Med Ctr, Meguro Ku, Tokyo 1538515, Japan	Joki, N (reprint author), Toho Univ, Dept Nephrol, Ohashi Med Ctr, Meguro Ku, 2-17-6 Ohashi, Tokyo 1538515, Japan.	takasuke30@hotmail.com; thayashi0803@gmail.com; yuri@oha.toho-u.ac.jp; jokinobuhiko@gmail.com; hiroki@oha.toho-u.ac.jp					Agarwal R., 2007, MAYO CLIN P, V82; Sakaguchi M, 2003, ULTRASOUND MED BIOL, V29, P367, DOI 10.1016/S0301-5629(02)00743-3; Szeto CC, 2007, J AM SOC NEPHROL, V18, P1966, DOI 10.1681/ASN.2006101184; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Iwasaki M, 2014, J ATHEROSCLER THROMB, V21, P593; Tonelli M, 2005, CIRCULATION, V112, P171, DOI 10.1161/CIRCULATIONAHA.104.517565; Nakamura H, 2009, ATHEROSCLEROSIS, V206, P512, DOI 10.1016/j.atherosclerosis.2009.03.031; Hirohata A, 2010, J AM COLL CARDIOL, V55, P976, DOI 10.1016/j.jacc.2009.09.062; Reddan DN, 2003, J AM SOC NEPHROL, V14, P2373, DOI 10.1097/01.ASN.0000083900.92829.F5; [Anonymous], 2003, AM J KIDNEY DIS O S3, V41; Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351; Preston E, 2005, AM J KIDNEY DIS, V46, P856, DOI 10.1053/j.ajkd.2005.07.048; Morito N, 2008, J CARDIOL, V51, P25, DOI 10.1016/j.jjcc.2007.09.003; Ikeda N, 2012, EUR HEART J, V33, P113, DOI 10.1093/eurheartj/ehr399; [Anonymous], 2005, AM K KIDNEY DIS S3, V45, pS1; [Anonymous], 2004, AM J KIDNEY DIS S1, V43, pS1; Hollander M, 2002, CIRCULATION, V105, P2872, DOI 10.1161/01.CIR.0000018650.58984.75; [Anonymous], 2003, AM J KIDNEY DIS S3, V41, pS1; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Shoji T, 2002, KIDNEY INT, V61, P2187, DOI 10.1046/j.1523-1755.2002.00372.x; Hiro T, 2009, J AM COLL CARDIOL, V54, P293, DOI 10.1016/j.jacc.2009.04.033; Shepherd J, 2008, J AM COLL CARDIOL, V51, P1448, DOI 10.1016/j.jacc.2007.11.072; Adeseun GA, 2012, AM J NEPHROL, V36, P342, DOI 10.1159/000342794; Kastelein JJP, 2004, AM J MED, V116, P31, DOI 10.1016/j.amjmed.2004.02.009; Bots L., 2007, EUR HEART J, V28, P398; Coll B, 2010, NEPHROL DIAL TRANSPL, V25, P3017, DOI 10.1093/ndt/gfq109; Fang C., 2014, AM J MED, V127, P608; Fellstrom C., 2009, NEW ENGL J MED, V360, P1395; Gregg W., 2014, NEW ENGL J MED, V370, P1514; Japanese Society of Nephrology, 2009, JPN J NEPHROL, V51, P905; Johnsen H., 2009, CURR CARDIOL REP, V11, P21; Joki N, 2014, EUR J NUCL MED MOL I, V41, P1701, DOI 10.1007/s00259-014-2781-z; Ken K., 2001, JPN CIRC J S5, V65, P999; Koren J., 2009, AM J KIDNEY DIS, V53, P741; O'Leary H., 1999, NEW ENGL J MED, V340, P14; SALONEN JT, 1990, INT J EPIDEMIOL, V19, P911, DOI 10.1093/ije/19.4.911; Seliger L., 2002, KIDNEY INT, V61, P297; Stein H., 2008, J AM SOC ECHOCARDIOG, V21, P93; Vidt G., 2011, CLIN THER, V33, P717	40	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	JUN	2015	240	2					535	543		10.1016/j.atherosclerosis.2015.04.784		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CI1ZQ	WOS:000354544300039		
J	Fujii, Y; Kawamoto, H; Tohno, S; Oda, M; Iriana, W; Lestari, P				Fujii, Yusuke; Kawamoto, Haruo; Tohno, Susumu; Oda, Masafumi; Iriana, Windy; Lestari, Puji			Characteristics of carbonaceous aerosols emitted from peatland fire in Riau, Sumatra, Indonesia (2): Identification of organic compounds	ATMOSPHERIC ENVIRONMENT			English	Article						Peatland fire; PM2.5; Lignin; n-alkane; Indonesia	SOURCE APPORTIONMENT; PARTICULATE MATTER; EMISSION FACTORS; COMBUSTION; ATMOSPHERE; PARTICLES; TRACERS; GASES; URBAN	Smoke emitted from Indonesian peatland fires has caused dense haze and serious air pollution in Southeast Asia such as visibility impairment and adverse health impacts. To mitigate the Indonesian peatland fire aerosol impacts, an effective strategy and international framework based on the latest scientific knowledge needs to be established. Although several attempts have been made, limited data exist regarding the chemical characteristics of. peatland fire smoke for the source apportionment. In order to identify the key organic compounds of peatland fire aerosols, we conducted intensive field studies based on ground-based and source-dominated sampling of PM2.5 in Riau Province, Sumatra, Indonesia, during the peatland fire seasons in 2012. Levoglucosan was the most abundant compound among the quantified organic compounds at 8.98 +/- 2.28% of the PM2.5 mass, followed by palmitic acid at 0.782 +/- 0.163% and mannosan at 0.607 +/- 0.0861%. Potassium ion was not appropriate for an indicator of Indonesian peatland fires due to extremely low concentrations associated with smoldering fire at low temperatures. The vanillic/syringic acids ratio was 1.06 +/- 0.155 in this study and this may be a useful signature profile for peatland fire emissions. Particulate n-alkanes also have potential for markers to identify impact of Indonesian peatland fire source at a receptor site. (C) 2015 Elsevier Ltd. All rights reserved.	[Fujii, Yusuke; Kawamoto, Haruo; Tohno, Susumu; Oda, Masafumi] Kyoto Univ, Grad Sch Energy Sci, Dept Socioenvironm Energy Sci, Sakyo Ku, Kyoto 6068501, Japan; [Iriana, Windy; Lestari, Puji] Bandung Inst Technol, Dept Environm Engn, Bandung 40132, Indonesia	Fujii, Y (reprint author), Kyoto Univ, Grad Sch Energy Sci, Dept Socioenvironm Energy Sci, Sakyo Ku, Kyoto 6068501, Japan.	fujii.yusuke.86n@st.kyoto-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [20120005]	This study was partially supported by funds from the Grant-in-Aid for Scientific Research on Innovative Areas under Grant No. 20120005 from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Abas M. R., 2004, CHEMOSPHERE, V55, P1089, DOI [10.1016/j.chemosphere.2004.02.002, DOI 10.1016/J.CHEMOSPHERE.2004.02.002]; Abas MRB, 1996, ATMOS ENVIRON, V15, P2779; Schauer JJ, 1999, ENVIRON SCI TECHNOL, V33, P1566, DOI 10.1021/es980076j; Betha R, 2013, ATMOS RES, V122, P571, DOI 10.1016/j.atmosres.2012.05.024; Reid JS, 2005, ATMOS CHEM PHYS, V5, P799; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Net S, 2011, ATMOS ENVIRON, V45, P3007, DOI 10.1016/j.atmosenv.2011.03.026; SIMONEIT BRT, 1993, ENVIRON SCI TECHNOL, V27, P2533, DOI 10.1021/es00048a034; Guenther A, 2006, ATMOS CHEM PHYS, V6, P3181; Gao S, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002324; Fine PM, 2002, ENVIRON SCI TECHNOL, V36, P1442, DOI 10.1021/es0108988; He J, 2010, ATMOS CHEM PHYS, V10, P11401, DOI 10.5194/acp-10-11401-2010; Chuang MT, 2013, ATMOS ENVIRON, V78, P72, DOI 10.1016/j.atmosenv.2012.06.056; SIMONEIT BRT, 1977, GEOCHIM COSMOCHIM AC, V41, P463, DOI 10.1016/0016-7037(77)90285-X; Simoneit BRT, 1999, ATMOS ENVIRON, V33, P173, DOI 10.1016/S1352-2310(98)00145-9; Bond TC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003697; Pio CA, 2008, ATMOS ENVIRON, V42, P7530, DOI 10.1016/j.atmosenv.2008.05.032; Lin L, 2010, J AIR WASTE MANAGE, V60, P3, DOI 10.3155/1047-3289.60.1.3; Oros DR, 2006, APPL GEOCHEM, V21, P919, DOI 10.1016/j.apgeochem.2006.01.008; ROGGE WF, 1993, ENVIRON SCI TECHNOL, V27, P1892, DOI 10.1021/es00046a019; Nolte CG, 2001, ENVIRON SCI TECHNOL, V35, P1912, DOI 10.1021/es001420r; Page SE, 2006, DEV EARTH S, V9, P145, DOI 10.1016/S0928-2025(06)09007-9; Akagi SK, 2011, ATMOS CHEM PHYS, V11, P4039, DOI 10.5194/acp-11-4039-2011; Ladji R, 2014, ENVIRON SCI POLLUT R, V21, P1819, DOI 10.1007/s11356-013-2074-2; See SW, 2007, ENVIRON SCI TECHNOL, V41, P3488, DOI 10.1021/es061943k; Fujii Y, 2014, ATMOS ENVIRON, V87, P164, DOI 10.1016/j.atmosenv.2014.01.037; ROGGE WF, 1993, ENVIRON SCI TECHNOL, V27, P636, DOI 10.1021/es00041a007; Harrison M.E., 2009, BIOLOGIST, V56, P156; Iinuma Y, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007120; Kavouras I.G., 2002, J GEOPHYS RES, V107; SIMONEIT BRT, 1989, J ATMOS CHEM, V8, P251, DOI 10.1007/BF00051497; Sullivan AP, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010216; Tacconi L., 2003, 38 CIFOR	33	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	JUN	2015	110						1	7		10.1016/j.atmosenv.2015.03.042		7	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CI2QG	WOS:000354591500001		
J	Inomata, S; Fushimi, A; Sato, K; Fujitani, Y; Yamada, H				Inomata, Satoshi; Fushimi, Akihiro; Sato, Kei; Fujitani, Yuji; Yamada, Hiroyuki			4-Nitrophenol, 1-nitropyrene, and 9-nitroanthracene emissions in exhaust particles from diesel vehicles with different exhaust gas treatments	ATMOSPHERIC ENVIRONMENT			English	Article						Diesel exhaust particles (DEPs); Nitro-PAH; Nitrophenol; TD-GC/MS; LC/MS	POLYCYCLIC AROMATIC-HYDROCARBONS; REACTION MASS-SPECTROMETRY; CHEMICAL-COMPOSITION; PARTICULATE FILTERS; NITRO-PAHS; CHROMATOGRAPHY; DERIVATIVES; PHOTOOXIDATION; IDENTIFICATION; NITROMETHANE	The dependence of nitro-organic compound emissions in automotive exhaust particles on the type of aftertreatment used was investigated. Three diesel vehicles with different aftertreatment systems (an oxidation catalyst, vehicle-DOC; a particulate matter and NOx reduction system, vehicle-DPNR; and a urea-based selective catalytic reduction system, vehicle-SCR) and a gasoline car with a three-way catalyst were tested. Nitro-polycyclic aromatic hydrocarbons (nitro-PAHs) and nitrophenols in the particles emitted were analyzed by thermal desorption gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry. The secondary production of nitro-organic compounds on the filters used to collect particles and the adsorption of gaseous nitro-organic compounds by the filters were evaluated. Emissions of 1-nitropyrene, 9-nitroanthracene, and 4-nitrophenol in the diesel exhaust particles were then quantified. The NOx reduction process in vehicle-DPNR appeared to remove nitro-hydrocarbons efficiently but not to remove nitro-oxygenated hydrocarbons efficiently. The nitro-PAH emission factors were lower for vehicle-DOC when it was not fitted with a catalyst than when it was fitted with a catalyst. The 4-nitrophenol emission factors were also lower for vehicle-DOC with a catalyst than vehicle-DOC without a catalyst, suggesting that the oxidation catalyst was a source of both nitro-PAHs and 4-nitrophenol. The time-resolved aerosol mass spectrometry data suggested that nitro-organic compounds are mainly produced when an engine is working under load. The presence of 4-nitrophenol in the particles was not confirmed statistically because of interference from gaseous 4-nitrophenol. Systematic errors in the estimated amounts of gaseous 1-nitropyrene and 9-nitroanthracene adsorbed onto the filters and the estimated amounts of volatile nitro-organic compounds that evaporated during sampling and during post-sampling conditioning could not be excluded. An analytical method in which all gaseous compounds are absorbed before particles are collected, and in which the volatile compounds are derivatized, would improve the precision and the accuracy of the data. (C) 2015 Elsevier Ltd. All rights reserved.	[Inomata, Satoshi; Fushimi, Akihiro; Sato, Kei; Fujitani, Yuji] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Yamada, Hiroyuki] Natl Traff Safety & Environm Lab, Chofu, Tokyo 1820012, Japan	Inomata, S (reprint author), Natl Inst Environm Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	ino@nies.go.jp	Inomata, Satoshi/E-7364-2010; Sato, Kei/A-7202-2012		Ministry of the Environment through the Environmental Technology Development Fund [S2-05, S2-06]	We are grateful to the staff of the National Traffic Safety and Environment Laboratory, Japan, for operating the chassis dynamometer system. We thank Prof. Norimasa Iida (Keio University), Prof. Yutaka Matsumi (Nagoya University), Dr. Kenichi Akiyama (JAM, Dr. Shinji Kobayashi (NIES), Dr. Kiyoshi Tanabe (NIES), and Dr. Akira Suzuki (NIES) for valuable discussions. This work was financially supported by the Ministry of the Environment through the Environmental Technology Development Fund (S2-05 (FY2009-2011) and S2-06 (FY 2009-2011)). Anonymous reviewers are acknowledged for their insightful comments.	Andersson J., 2007, 22775EN EUR ILCELD; Atkinson R, 2000, ATMOS ENVIRON, V34, P2063, DOI 10.1016/S1352-2310(99)00460-4; Albinet A, 2006, J CHROMATOGR A, V1121, P106, DOI 10.1016/j.chroma.2006.04.043; Jenkin ME, 2000, ATMOS ENVIRON, V34, P2499, DOI 10.1016/S1352-2310(99)00478-1; Heeb NV, 2010, ENVIRON SCI TECHNOL, V44, P1078, DOI 10.1021/es9019222; Sato K, 2007, J PHYS CHEM A, V111, P9796, DOI 10.1021/jp071419f; Heeb NV, 2008, ENVIRON SCI TECHNOL, V42, P3773, DOI 10.1021/es7026949; Sato K, 2012, ATMOS CHEM PHYS, V12, P4667, DOI 10.5194/acp-12-4667-2012; Hayakawa K, 1997, CHEM PHARM BULL, V45, P1820; CHOW JC, 1993, ATMOS ENVIRON A-GEN, V27, P1185, DOI 10.1016/0960-1686(93)90245-T; Taneda S, 2004, BIOL PHARM BULL, V27, P835, DOI 10.1248/bpb.27.835; Lloyd AC, 2001, J AIR WASTE MANAGE, V51, P809; Johnson TV, 2009, INT J ENGINE RES, V10, P275, DOI 10.1243/14680874JER04009; Knecht W, 2008, ENERGY, V33, P264, DOI 10.1016/j.energy.2007.10.003; Chow JC, 2001, AEROSOL SCI TECH, V34, P23, DOI 10.1080/027868201300081923; Inomata S, 2013, ATMOS ENVIRON, V73, P195, DOI 10.1016/j.atmosenv.2013.03.035; [Anonymous], 2010, 17 HEI; Monks PS, 2009, ATMOS ENVIRON, V43, P5268, DOI 10.1016/j.atmosenv.2009.08.021; Fushimi A, 2011, ATMOS ENVIRON, V45, P6326, DOI 10.1016/j.atmosenv.2011.08.053; Maricq MM, 2007, J AEROSOL SCI, V38, P1079, DOI 10.1016/j.jaerosci.2007.08.001; PITTS JN, 1978, SCIENCE, V202, P515, DOI 10.1126/science.705341; Brown R.L., NIST STANDARD REFERE, V69; Durant JL, 1998, ENVIRON SCI TECHNOL, V32, P1894, DOI 10.1021/es9706965; Femansez P., 1992, J CHROMATOGR A, V625, P141; Fushimi A, 2012, J CHROMATOGR A, V1252, P164, DOI 10.1016/j.chroma.2012.06.068; Fushimi A., 2008, EAROZORU KENKYU, V23, P163; Fushimi A, 2008, ATMOS ENVIRON, V42, P949, DOI 10.1016/j.atmosenv.2007.10.019; Guo XS, 2014, ATMOS ENVIRON, V94, P428, DOI 10.1016/j.atmosenv.2014.05.042; HAMMERLE R, 1994, ENVIRON HEALTH PERSP, V102, P25, DOI 10.2307/3431927; IARC, 2013, IARC MONOGR EVAL CAR, V105; IARC (International Agency for Research on Cancer), 2010, IARC MONOGR EVAL CAR, V105; Inomata S, 2014, ATMOS ENVIRON, V96, P301, DOI 10.1016/j.atmosenv.2014.07.058; Kobayashi S., 2008, REV AUTOM ENG, V29, P229; LEVSEN K, 1988, FRESEN Z ANAL CHEM, V330, P527, DOI 10.1007/BF00490763; LEVSEN K, 1988, FRESEN Z ANAL CHEM, V331, P467, DOI 10.1007/BF00467033; Mizuno T, 2004, 2004010578 SAE; NIST, 2006, CERT AN STAND REF MA; NIST, 2009, CERT AN STAND REF MA; NIST (National Institute of Standards and Technology), 2007, CERT AN STAND REF MA; NOJIMA K, 1983, CHEM PHARM BULL, V31, P1047; Ratclift M.A., 2010, ENVIRON SCI TECHNOL, V42, P8343; SCHUETZLE D, 1983, ENVIRON HEALTH PERSP, V47, P65, DOI 10.2307/3429500; Sekimoto K, 2013, ATMOS ENVIRON, V81, P523, DOI 10.1016/j.atmosenv.2013.09.031; Shoji A., 2004, 2004010579 SAE; Taneda S, 2004, J HEALTH SCI, V50, P133; Yaffe D, 2001, RISK ANAL, V21, P275, DOI 10.1111/0272-4332.212111; Yamada H, 2011, P COMBUST INST, V33, P2895, DOI 10.1016/j.proci.2010.07.001; Yuuki K, 2003, 2003010383 SAE	48	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	JUN	2015	110						93	102		10.1016/j.atmosenv.2015.03.043		10	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CI2QG	WOS:000354591500011		
J	Lee, SJ; Wolff, D; Kitko, C; Koreth, J; Inamoto, Y; Jagasia, M; Pidala, J; Olivieri, A; Martin, PJ; Przepiorka, D; Pusic, I; Dignan, F; Mitchell, SA; Lawitschka, A; Jacobsohn, D; Hall, AM; Flowers, MED; Schultz, KR; Vogelsang, G; Pavletic, S				Lee, Stephanie J.; Wolff, Daniel; Kitko, Carrie; Koreth, John; Inamoto, Yoshihiro; Jagasia, Madan; Pidala, Joseph; Olivieri, Attilio; Martin, Paul J.; Przepiorka, Donna; Pusic, Iskra; Dignan, Fiona; Mitchell, Sandra A.; Lawitschka, Anita; Jacobsohn, David; Hall, Anne M.; Flowers, Mary E. D.; Schultz, Kirk R.; Vogelsang, Georgia; Pavletic, Steven			Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Chronic graft-versus-host disease; Allogeneic hematopoietic cell transplantation; Response criteria; Consensus; Guidelines	STEM-CELL TRANSPLANTATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; BONE-MARROW-TRANSPLANTATION; CHRONIC GVHD CONSORTIUM; 6-MINUTE WALK TEST; OBLITERANS ORGANIZING PNEUMONIA; HUMAN ACTIVITY PROFILE; FAILURE-FREE SURVIVAL; SLEEP QUALITY INDEX; RHEUMATOID-ARTHRITIS	In 2005, the National Institutes of Health (NIH) Chronic Graft-versus-Host Disease (GVHD) Consensus Response Criteria Working Group recommended several measures to document serial evaluations of chronic GVHD organ involvement. Provisional definitions of complete response, partial response, and progression were proposed for each organ and for overall outcome. Based on publications over the last 9 years, the 2014 Working Group has updated its recommendations for measures and interpretation of organ and overall responses. Major changes include elimination of several clinical parameters from the determination of response, updates to or addition of new organ scales to assess response, and the recognition that progression excludes minimal, clinically insignificant worsening that does not usually warrant a change in therapy. The response definitions have been revised to reflect these changes and are expected to enhance reliability and practical utility of these measures in clinical trials. Clarification is provided about response assessment after the addition of topical or organ-targeted treatment. Ancillary measures are strongly encouraged in clinical trials. Areas suggested for additional research include criteria to identify irreversible organ damage and validation of the modified response criteria, including in the pediatric population. Published by Elsevier Inc.	[Lee, Stephanie J.; Martin, Paul J.; Hall, Anne M.; Flowers, Mary E. D.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Wolff, Daniel] Univ Regensburg, Dept Internal Med 3, D-93053 Regensburg, Germany; [Kitko, Carrie] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Koreth, John] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA; [Inamoto, Yoshihiro] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan; [Jagasia, Madan] Vanderbilt Univ, Div Hematol Oncol, Nashville, TN 37235 USA; [Pidala, Joseph] Univ S Florida, H Lee Moffitt Canc Ctr, Blood & Marrow Transplantat, Tampa, FL 33682 USA; [Olivieri, Attilio] Univ Ancona, Dept Clin & Mol Sci, Ancona, Italy; [Przepiorka, Donna] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Pusic, Iskra] Washington Univ, Dept Med, St Louis, MO USA; [Dignan, Fiona] Univ Manchester, Dept Clin Haematol, Manchester, Lancs, England; [Mitchell, Sandra A.; Pavletic, Steven] NCI, Outcomes Res Branch, Bethesda, MD 20852 USA; [Lawitschka, Anita] Med Univ Vienna, St Anna Childrens Hosp, Stem Cell Transplant Unit, Vienna, Austria; [Jacobsohn, David] Childrens Natl Hlth Syst, Div Blood & Marrow Transplantat, Washington, DC USA; [Schultz, Kirk R.] Univ British Columbia, BC Childrens Hosp, Vancouver, BC V5Z 1M9, Canada; [Vogelsang, Georgia] Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Baltimore, MD 21205 USA	Pavletic, S (reprint author), NCI, GVHD & Autoimmun Unit, Expt Transplantat & Immunol Branch, Ctr Canc Res,NIH, 10 Ctr Dr,Bldg 10,Room CRC 4-3130, Bethesda, MD 20852 USA.	pavletis@mail.nih.gov			Millenium; Otsuka Pharmaceuticals; Prometheus Labs Inc.; Therakos; Johnson and Johnson company	S.L. scientific advisory board meeting: Bristol Myers Squibb, Kadmon Corp. J.K., research funding: Millenium, Otsuka Pharmaceuticals, Prometheus Labs Inc.; scientific advisory board: Kadmon Corp, Amgen, Takeda Pharmaceuticals. P.M., scientific advisory board meeting: Pharmacyclics. F.D., received research funding, honoraria and speaker fees: Therakos, a Johnson and Johnson company.	AGHASSI D, 1995, ARCH DERMATOL, V131, P1160, DOI 10.1001/archderm.131.10.1160; Inamoto Y, 2012, OPHTHALMOLOGY, V119, P487, DOI 10.1016/j.ophtha.2011.08.040; Hoeper MM, 2013, CIRCULATION, V127, P1128, DOI 10.1161/CIRCULATIONAHA.112.000765; Lammers AE, 2008, ARCH DIS CHILD, V93, P464, DOI 10.1136/adc.2007.123653; Osoba D, 1998, J CLIN ONCOL, V16, P139; Cleeland CS, 2000, CANCER, V89, P1634, DOI 10.1002/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V; Anderson JJ, 2001, ARTHRITIS RHEUM, V44, P1876, DOI 10.1002/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F; Acquadro C, 2003, VALUE HEALTH, V6, P522, DOI 10.1046/j.1524-4733.2003.65309.x; Inamoto Y, 2013, BLOOD, V121, P2340, DOI 10.1182/blood-2012-11-465583; Wiklund I, 2004, FUND CLIN PHARMACOL, V18, P351, DOI 10.1111/j.1472-8206.2004.00234.x; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615; HAY EM, 1993, Q J MED, V86, P447; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; Felson DT, 2011, ANN RHEUM DIS, V70, P404, DOI 10.1136/ard.2011.149765; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Luijten KMAC, 2012, AUTOIMMUN REV, V11, P326, DOI 10.1016/j.autrev.2011.06.011; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; McQuellon RP, 1997, BONE MARROW TRANSPL, V19, P357, DOI 10.1038/sj.bmt.1700672; Greinix HT, 2007, BIOL BLOOD MARROW TR, V13, P715, DOI 10.1016/j.bbmt.2007.02.007; Hann DM, 2000, QUAL LIFE RES, V9, P847, DOI 10.1023/A:1008900413113; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Pidala J, 2011, BLOOD, V117, P4651, DOI 10.1182/blood-2010-11-319509; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Akpek G, 2001, BLOOD, V97, P1219, DOI 10.1182/blood.V97.5.1219; Sandborn WJ, 2002, GASTROENTEROLOGY, V122, P512, DOI 10.1053/gast.2002.31072; Li AM, 2005, EUR RESPIR J, V25, P1057, DOI 10.1183/09031936.05.00134904; Brooks D, 2004, ARCH PHYS MED REHAB, V85, P1525, DOI 10.1016/j.apmr.2004.01.023; Koc S, 2002, BLOOD, V100, P48, DOI 10.1182/blood.V100.1.48; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381; Matza LS, 2004, VALUE HEALTH, V7, P79, DOI 10.1111/j.1524-4733.2004.71273.x; Stewart BL, 2004, BLOOD, V104, P3501, DOI 10.1182/blood-2004-01-0200; DAUGHTON DM, 1982, ARCH PHYS MED REHAB, V63, P620; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Jacobsohn DA, 2002, BONE MARROW TRANSPL, V29, P231, DOI 10.1038/sj/bmt/1703352; Lee SJ, 2003, BIOL BLOOD MARROW TR, V9, P215, DOI 10.1053/bbmt.2003.50026; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; LIANG MH, 1989, ARTHRITIS RHEUM, V32, P1107, DOI 10.1002/anr.1780320909; Bergeron A, 2011, MEDICINE, V90, P146, DOI 10.1097/MD.0b013e31821160af; Robinson MR, 2004, BONE MARROW TRANSPL, V33, P1031, DOI 10.1038/sj.bmt.1704453; VITALI C, 1992, CLIN EXP RHEUMATOL, V10, P541; Lee SJ, 2002, BLOOD, V100, P406, DOI 10.1182/blood.V100.2.406; Baird K, 2013, BIOL BLOOD MARROW TR, V19, P632, DOI 10.1016/j.bbmt.2013.01.013; Pavletic SZ, 2006, BIOL BLOOD MARROW TR, V12, P252, DOI 10.1016/j.bbmt.2006.01.008; Lee SJ, 2002, BIOL BLOOD MARROW TR, V8, P444, DOI 10.1053/bbmt.2002.v8.pm12234170; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Jacobsohn DA, 2011, BLOOD, V118, P4472, DOI 10.1182/blood-2011-04-349068; Revicki DA, 2000, QUAL LIFE RES, V9, P887, DOI 10.1023/A:1008996223999; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Mitchell SA, 2010, BONE MARROW TRANSPL, V45, P762, DOI 10.1038/bmt.2009.238; Shanis D, 2012, SEMIN HEMATOL, V49, P83, DOI 10.1053/j.seminhematol.2011.10.002; Oberg JA, 2013, BONE MARROW TRANSPL, V48, P787, DOI 10.1038/bmt.2012.217; Gladman DD, 2002, J RHEUMATOL, V29, P288; Preston CC, 2000, ACTA PSYCHOL, V104, P1, DOI 10.1016/S0001-6918(99)00050-5; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Bassim CW, 2014, BONE MARROW TRANSPL, V49, P116, DOI 10.1038/bmt.2013.137; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Cottlober P., 2003, J EUR ACAD DERMATOL, V17, P402; Craig J, 2003, J NEUROL NEUROSUR PS, V74, P1225, DOI 10.1136/jnnp.74.9.1225; Curtis LM, 2014, BONE MARROW TRANSPL, V49, P1513, DOI 10.1038/bmt.2014.188; Dumford K, 2001, CLIN IMAG, V25, P138, DOI 10.1016/S0899-7071(01)00240-6; Fassil H, 2012, J DENT RES, V91, pS45, DOI 10.1177/0022034512450881; Eiser N, 2003, RESP MED, V97, P407, DOI 10.1053/rmed.2002.1462; Elad S, 2010, BIOL BLOOD MARROW TR, V16, P62, DOI 10.1016/j.bbmt.2009.08.018; FALANGA V, 1993, J AM ACAD DERMATOL, V29, P47; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Freudenberger TD, 2003, BLOOD, V102, P3822, DOI 10.1182/blood-2002-06-1813; Geiger R, 2007, J PEDIATR-US, V150, P395, DOI 10.1016/j.jpeds.2006.12.052; Geiger R, 2007, J PEDIAT, V150-399, pe1; Goodell Teresa T, 2005, Oncol Nurs Forum, V32, pE42, DOI 10.1188/05.ONF.E42-E47; Herzberg PY, 2010, BIOL BLOOD MARROW TR, V16, P1707, DOI 10.1016/j.bbmt.2010.05.018; Herzberg PY, 2013, BONE MARROW TRANSPL, V48, P129, DOI 10.1038/bmt.2012.83; Inamoto Y, 2014, BLOOD, V124, P1363, DOI 10.1182/blood-2014-03-563544; Inamoto Y, 2012, BIOL BLOOD MARROW TR, V18, P1517, DOI 10.1016/j.bbmt.2012.05.016; Inamoto Y, 2014, ARTHRITIS RHEUMATOL, V66, P1044, DOI 10.1002/art.38293; Jacobsohn DA, 2004, TRANSPLANTATION, V77, P1096, DOI 10.1097/01.TP.0000118409.92769.FA; Jacobsohn DA, 2012, BLOOD, V120, P2774; Jacobsohn DA, 2012, BLOOD, V120, P2545, DOI 10.1182/blood-2012-04-424135; Kalhoff H, 2009, J PHYSIOL PHARMACOL, V60, P67; Koller WC, 2004, NEUROLOGY, V62, P730; Kramer M, 2013, SUPPORT CARE CANCER, V21, P1121, DOI 10.1007/s00520-012-1634-1; Lawitschka A, 2014, BONE MARROW TRANSPL, V49, P1093, DOI 10.1038/bmt.2014.96; lmanguli MM, 2010, BIOL BLOOD MARROW TR, V16, P1362; MATHIOWETZ V, 1984, J HAND SURG-AM, V9A, P222; MATHIOWETZ V, 1986, AM J OCCUP THER, V40, P705; Mitchell SA, 2011, BIOL BLOOD MARROW TR, V17, P1619, DOI 10.1016/j.bbmt.2011.04.002; Nagashima M, 2005, CLIN EXP RHEUMATOL, V23, P27; Norman GR, 2003, MED CARE, V41, P599, DOI 10.1097/00005650-200305000-00007; Ogawa Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03419; Olivieri A, 2013, BLOOD, V122, P4111, DOI 10.1182/blood-2013-05-494278; Palmer J, 2014, BIOL BLOOD MARROW TR, V20, P337, DOI 10.1016/j.bbmt.2013.11.025; Parimon T, 2005, AM J RESP CRIT CARE, V172, P384, DOI 10.1164/rccm.200502-212OC; Parsons SK, 2005, QUAL LIFE RES, V14, P1613, DOI 10.1007/s11136-005-1004-2; Parsons S K, 1999, Int J Cancer Suppl, V12, P46; Parsons SK, 2006, J PEDIATR PSYCHOL, V31, P1100, DOI 10.1093/jpepsy/jsj078; Pavletic SZ, 2005, BLOOD, V106, P3308, DOI 10.1182/blood-2005-04-1614; Pidala J, 2013, BIOL BLOOD MARROW TR, V19, P967, DOI 10.1016/j.bbmt.2013.03.014; Plint AC, 2003, J PEDIATR ORTHOPED, V23, P788; PROMIS, 2014, DYN TOOLS MEAS HLTH; SCHUBERT MM, 1992, CANCER, V69, P2469, DOI 10.1002/1097-0142(19920515)69:10<2469::AID-CNCR2820691015>3.0.CO;2-W; Seyger MMB, 1997, J AM ACAD DERMATOL, V37, P793, DOI 10.1016/S0190-9622(97)70121-X; Slade GD, 1998, COMMUNITY DENT ORAL, V26, P52; Spinelli S, 2003, HAEMATOLOGICA, V88, P1163; Stratton P, 2007, OBSTET GYNECOL, V110, P1041, DOI 10.1097/01.AOG.0000285998.75450.86; Stratton P, 2004, J SOC GYNECOL INVEST, V11, p162A; Treister N, 2013, BONE MARROW TRANSPL, V48, P1123, DOI 10.1038/bmt.2012.285; Treister NS, 2010, BIOL BLOOD MARROW TR, V16, P108, DOI 10.1016/j.bbmt.2009.09.010; Walter EC, 2010, BIOL BLOOD MARROW TR, V16, P53, DOI 10.1016/j.bbmt.2009.08.016; Walters Stephen J, 2003, Health Qual Life Outcomes, V1, P4, DOI 10.1186/1477-7525-1-4; Ware J. E., 1993, SF 36 HLTH SURVEY MA; Ware Jr JE, 1994, SF 36 PHYS MENTAL HL; WATERS RL, 1988, J ORTHOPAED RES, V6, P215, DOI 10.1002/jor.1100060208; Wiener L, 2014, SUPPORT CARE CANCER, V22, P295, DOI 10.1007/s00520-013-1957-6; Wolff D, 2009, BLOOD, V114, P204; Yanik GA, 2012, BIOL BLOOD MARROW TR, V18, P1044, DOI 10.1016/j.bbmt.2011.11.031; Yoshihara S, 2007, BIOL BLOOD MARROW TR, V13, P749, DOI 10.1016/j.bbmt.2007.05.001; YOUNG NL, 1995, ARCH PHYS MED REHAB, V76, P913, DOI 10.1016/S0003-9993(95)80066-2; Young NL, 2000, J CLIN EPIDEMIOL, V53, P125, DOI 10.1016/S0895-4356(99)00113-4	119	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	JUN	2015	21	6					984	999		10.1016/j.bbmt.2015.02.025		16	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CI3SO	WOS:000354667900004		
J	Egawa, EY; Kitamura, N; Nakai, R; Arima, Y; Iwata, H				Egawa, Edgar Y.; Kitamura, Narufumi; Nakai, Ryusuke; Arima, Yusuke; Iwata, Hiroo			A DNA hybridization system for labeling of neural stem cells with SPIO nanoparticles for MRI monitoring post-transplantation	BIOMATERIALS			English	Article						Neural cell; Stem cell; Nanoparticle; MRI (magnetic resonance imaging); In vitro test; Transplantation	IRON-OXIDE NANOPARTICLES; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; TRANSPLANTATION; DIFFERENTIATION; MIGRATION; SURVIVAL; AGENTS	Neural stem cells (NSCs) demonstrate encouraging results in cell replacement therapy for neurodegenerative disorders and traumatic injury in the central nervous system. Monitor the survival and migration of transplanted cells would provide us important information concerning the performance and integration of the graft during the therapy time course. Magnetic resonance imaging (MRI) allow us to monitor the transplanted cells in a non-invasive way. The only requirement is to use an appropriate contrast agent to label the transplanted cells. Superparamagnetic iron oxide (SPIO) nanoparticles are one of the most commonly used contrast agent for MRI detection of transplanted cells. SPIO nanoparticles demonstrated to be suitable for labeling several types of cells including NSCs. However, the current methods for SPIO labeling are non-specific, depending mostly on electrostatic interactions, demanding relatively high SPIO concentration, and long incubation time, which can affect the viability of cells. In this study, we propose a specific and relatively fast method to label NSCs with SPIO nanoparticles via DNA hybridization. Two short single stranded DNAs (ssDNAs), oligo[dT](20) and oligo[dA](20) were conjugated with a lipid molecule and SPIO nanoparticle respectively. The labeling process comprises two simple steps; first the cells are modified to present oligo[dT](20) ssDNA on the cell surface, then the oligo[dA](20) ssDNA conjugated with SPIO nanoparticles are presented to the modified cells to allow the oligo[dT](20)-oligo[dA](20) hybridization. The method showed to be non-toxic at concentrations up to 50 mu g/mL oligo[dA](20)-SPIO nanoparticles. Presence of SPIO nanoparticles at cell surface and cell cytoplasm was verified by transmission electron microscopy (TEM). SPIO labeling via DNA hybridization demonstrated to not interfere on NSCs proliferation, aggregates formation, and differentiation. NSCs labeled with SPIO nanoparticles via DNA hybridization system were successfully detected by MRI in vitro as well in vivo. Cells transplanted into the rat brain striatum could be detected by MRI scanning up to 1 month post-transplantation. (C) 2015 Elsevier Ltd. All rights reserved.	[Egawa, Edgar Y.; Kitamura, Narufumi; Nakai, Ryusuke; Arima, Yusuke; Iwata, Hiroo] Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan	Iwata, H (reprint author), Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	iwata@frontier.kuoyo-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [2306]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Nanomedicine Molecular Science" (No. 2306) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Dihne M, 2006, STEM CELLS, V24, P1458, DOI 10.1634/stemcells.2005-0413; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Futterer S, 2013, J PHARMACEUT BIOMED, V86, P151, DOI 10.1016/j.jpba.2013.08.005; Kitamura N, 2013, BIOORGAN MED CHEM, V21, P7175, DOI 10.1016/j.bmc.2013.08.063; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Wen XH, 2014, BIOMATERIALS, V35, P4627, DOI 10.1016/j.biomaterials.2014.02.042; Dodd CH, 2001, J IMMUNOL METHODS, V256, P89, DOI 10.1016/S0022-1759(01)00433-1; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Weinstein JS, 2010, J CEREBR BLOOD F MET, V30, P15, DOI 10.1038/jcbfm.2009.192; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Rahmer J, 2013, PHYS MED BIOL, V58, P3965, DOI 10.1088/0031-9155/58/12/3965; Teramura Y, 2010, BIOMATERIALS, V31, P2229, DOI 10.1016/j.biomaterials.2009.11.098; Crabbe A, 2010, CELL TRANSPLANT, V19, P919, DOI 10.3727/096368910X494623; Kim SU, 2013, NEUROPATHOLOGY, V33, P491, DOI 10.1111/neup.12020; Darsalia V, 2011, J CEREBR BLOOD F MET, V31, P235, DOI 10.1038/jcbfm.2010.81; Lin G, 2009, GLIA, V57, P592, DOI 10.1002/glia.20788; Antonelli A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078542; Arbab Ali Syed, 2004, Mol Imaging, V3, P24, DOI 10.1162/153535004773861697; Bull E, 2014, INT J NANOMED, V9, P1641, DOI 10.2147/IJN.S48979; Castro G, 2013, ISRN OPHTHALMOL, V26; Chen CCV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056125; Deng X., 2013, SCI WORLD J, V2013, P8; Deno S, 2014, BIOORGAN MED CHEM, V22, P350, DOI 10.1016/j.bmc.2013.11.023; Jasmin, 2012, Methods Mol Biol, V906, P239, DOI 10.1007/978-1-61779-953-2_18; Li MF, 2013, CELL PHYSIOL BIOCHEM, V32, P1776, DOI 10.1159/000356611; Lodhia J, 2010, Biomed Imaging Interv J, V6, pe12, DOI 10.2349/biij.6.2.e12; Lundberg C, 1997, EXP NEUROL, V145, P342, DOI 10.1006/exnr.1997.6503; Magnitsky S, 2008, ACAD RADIOL, V15, P1269, DOI 10.1016/j.acra.2008.05.003; Pardal R, 2012, ADV EXP MED BIOL, V741, P206, DOI 10.1007/978-1-4614-2098-9_14; Pickard MR, 2010, INT J MOL SCI, V11, P967, DOI 10.3390/ijms11030967; Rad AM, 2007, BIOTECHNIQUES, V43, P627, DOI 10.2144/000112599; Sakurai K, 2013, BIOMATERIALS, V34, P361, DOI 10.1016/j.biomaterials.2012.09.080; Tang HL, 2013, CELL REPROGRAM, V15, P435, DOI 10.1089/cell.2012.0081; Yoo J, 2013, J CELL BIOCHEM, V114, P743, DOI 10.1002/jcb.24427; Yu B, 2013, ARCH MED SCI, V9, P132, DOI 10.5114/aoms.2012.31438	38	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JUN	2015	54						158	167		10.1016/j.biomaterials.2015.03.017		10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CI2QD	WOS:000354591200016		
J	Li, JJ; Kawazoe, N; Chen, GP				Li, Jia'En Jasmine; Kawazoe, Naoki; Chen, Guoping			Gold nanoparticles with different charge and moiety induce differential cell response on mesenchymal stem cell osteogenesis	BIOMATERIALS			English	Article						Gold; Nanoparticle; Surface modification; Stem cell	TNF-ALPHA; TGF-BETA; OSTEOBLAST DIFFERENTIATION; CALCIUM-PHOSPHATE; BONE REGENERATION; MAPK PATHWAY; IN-VITRO; MINERALIZATION; SURFACE; EXPRESSION	Stem cells exist in an in vivo microenvironment that provides biological and physiochemical cues to direct cell fate decisions. How the stem cells sense and respond to these cues is still not clearly understood. Gold nanoparticles (AuNPs) have been widely used for manipulation of cell behavior due to their ease of synthesis and versatility in surface functionalization. In this study, AuNPs with amine (AuNP -NH2), carboxyl (AuNP-COOH) and hydroxyl (AuNP-OH) functional groups possessing different surface charge were synthesized. Human bone marrow-derived mesenchymal stem cells (hMSCs) were treated with the surface functionalized AuNPs and assessed for cell viability and osteogenic differentiation ability. The surface functionalized AuNPs were well tolerated by hMSCs and showed no acute toxicity. Positively charged AuNPs showed higher cellular uptake. AuNPs did not inhibit osteogenesis but ALP activity and calcium deposition were markedly reduced in AuNP-COOH treatment Gene profiling revealed an upregulation of TGF-beta and FGF-2 expression that promoted cell proliferation over osteogenic differentiation in hMSCs. These results provide some insight on the influence of surface functionalized AuNPs on hMSCs behavior and the use of these materials for strategic tissue engineering. (C) 2015 Elsevier Ltd. All rights reserved.	[Li, Jia'En Jasmine; Kawazoe, Naoki; Chen, Guoping] Natl Inst Mat Sci, Tissue Regenerat Mat Unit, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan	Chen, GP (reprint author), Natl Inst Mat Sci, Tissue Regenerat Mat Unit, Int Ctr Mat Nanoarchitecton, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	Guoping.CHEN@nims.go.jp			World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by the World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001; Niidome T, 2004, CHEM COMMUN, P1978, DOI 10.1039/b406189f; Shenoy D, 2006, INT J NANOMED, V1, P51, DOI 10.2147/nano.2006.1.1.51; Bi XP, 2014, ACTA BIOMATER, V10, P2814, DOI 10.1016/j.actbio.2014.02.018; Libutti SK, 2010, CLIN CANCER RES, V16, P6139, DOI 10.1158/1078-0432.CCR-10-0978; Liu XS, 2013, LANGMUIR, V29, P9138, DOI 10.1021/la401556k; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Gu YJ, 2009, TOXICOL APPL PHARM, V237, P196, DOI 10.1016/j.taap.2009.03.009; Yi CQ, 2010, ACS NANO, V4, P6439, DOI 10.1021/nn101373r; Techane SD, 2011, BIOINTERPHASES, V6, P98, DOI 10.1116/1.3622481; Ding J, 2009, LIFE SCI, V84, P499, DOI 10.1016/j.lfs.2009.01.013; Bosetti M, 2007, BIOMOL ENG, V24, P613, DOI 10.1016/j.bioeng.2007.08.019; Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269; Balasubramanian SK, 2010, BIOMATERIALS, V31, P9023, DOI 10.1016/j.biomaterials.2010.08.012; Lunov O, 2011, ACS NANO, V5, P1657, DOI 10.1021/nn2000756; Heo DN, 2014, J MATER CHEM B, V2, P1584, DOI 10.1039/c3tb21246g; Huhn D, 2013, ACS NANO, V7, P3253, DOI 10.1021/nn3059295; Toworfe GK, 2006, BIOMATERIALS, V27, P631, DOI 10.1016/j.biomaterials.2005.06.017; Alkilany AM, 2013, ACCOUNTS CHEM RES, V46, P650, DOI 10.1021/ar300015b; Glass GE, 2011, P NATL ACAD SCI USA, V108, P1585, DOI 10.1073/pnas.1018501108; Jiang XE, 2011, NANOSCALE, V3, P2028, DOI 10.1039/c0nr00944j; Muroski ME, 2014, J AM CHEM SOC, V136, P14763, DOI 10.1021/ja505190q; Seong JM, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/062001; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Kong LD, 2015, ACS APPL MATER INTER, V7, P4833, DOI 10.1021/am508760w; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Cheng Y, 2011, J AM CHEM SOC, V133, P2583, DOI 10.1021/ja108846h; Arvizo R, 2010, EXPERT OPIN DRUG DEL, V7, P753, DOI 10.1517/17425241003777010; Cho WS, 2009, TOXICOL APPL PHARM, V236, P16, DOI 10.1016/j.taap.2008.12.023; Boonrungsiman S, 2012, P NATL ACAD SCI USA, V109, P14170, DOI 10.1073/pnas.1208916109; Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102; Hutter E, 2011, MICROSC RES TECHNIQ, V74, P592, DOI 10.1002/jemt.20928; Chueh PJ, 2014, J HAZARD MATER, V264, P303, DOI 10.1016/j.jhazmat.2013.11.031; Zhang DW, 2014, MAT SCI ENG C-MATER, V42, P70, DOI 10.1016/j.msec.2014.04.042; Jiang JJ, 2013, ADV HEALTHC MATER, V2, P25, DOI 10.1002/adhm.201200169; Azzopardi PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009330; Castiglioni Sara, 2014, World J Biol Chem, V5, P457, DOI 10.4331/wjbc.v5.i4.457; Herzog F, 2014, BEILSTEIN J NANOTECH, V5, P1357, DOI 10.3762/bjnano.5.149; Hoskins C, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-15; Hughes-Fulford M, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-8; Hutton DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107199; Lee SW, 2006, J CELL BIOCHEM, V98, P981, DOI 10.1002/jcb.20773; Li J, 2005, J BIOMED MATER RES A, V75A, P985, DOI 10.1002/jbm.a.30504; Mutterer B, 2007, BMC GENOMICS, P8; Rides L. M., 2011, INT J NANOMED, V6, P407; Zhang X., 2015, CELL BIOCH BIOPHYS	47	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JUN	2015	54						226	236		10.1016/j.biomaterials.2015.03.001		11	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CI2QD	WOS:000354591200022		
J	Watari, A; Hashegawa, M; Muangman, T; Yagi, K; Kondoh, M				Watari, Akihiro; Hashegawa, Maki; Muangman, Thanchanok; Yagi, Kiyohito; Kondoh, Masuo			Use of cell-based screening to identify small-molecule compounds that modulate claudin-4 expression	BIOTECHNOLOGY LETTERS			English	Article						Claudin; Inflammatory bowel disorder; Reporter assay; Screening; Small-molecule compounds; Tight junction	HISTONE DEACETYLASE INHIBITORS; TIGHT JUNCTION; BARRIER; PROTEINS; COLITIS; STRANDS	Claudins constitute a family of at least 27 proteins with four transmembrane domains, and play a pivotal role in maintaining tight-junctions seals in diverse epithelial tissues. The expression of claudin-4 often changes in intestinal tissues of inflammatory bowel disease and various human cancers. Therefore, claudin-4 is a promising target for treatment of these diseases. In our previous study, we established a reporter cell line to monitor claudin-4 expression on the basis of a functional claudin-4 promoter. Using this cell line, we have performed a cell-based screen of a library containing 2642 biologically active small-molecule compounds to identify modulators of claudin-4 expression. The screen identified 24 potential modulators of the claudin-4 promoter activity. Fourteen of these compounds (12 of them novel) induced endogenous claudin-4 expression. The identified compounds might serve as lead compounds targeting aberrant gene expression in inflammatory bowel disease.	[Watari, Akihiro; Hashegawa, Maki; Yagi, Kiyohito; Kondoh, Masuo] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biofunct Mol Chem, Suita, Osaka 5650871, Japan; [Muangman, Thanchanok] Thailand Inst Sci & Technol Res, Dept Pharmaceut & Nat Prod, Bangkok, Pathumthani, Thailand	Watari, A (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biofunct Mol Chem, Suita, Osaka 5650871, Japan.	akihiro@phs.osaka-u.ac.jp; masuo@phs.osaka-u.ac.jp			Ministry of Health, Labor, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported in part by a grant from the Ministry of Health, Labor, and Welfare, Japan, and by the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; TUJEBAJEVA RM, 1989, FEBS LETT, V257, P254, DOI 10.1016/0014-5793(89)81546-7; Das P, 2012, VIRCHOWS ARCH, V460, P261, DOI 10.1007/s00428-012-1195-1; Cho KJ, 2011, MOL CELL BIOL, V31, P1110, DOI 10.1128/MCB.00989-10; Turksen K, 2011, BBA-REV CANCER, V1816, P73, DOI 10.1016/j.bbcan.2011.04.001; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Richard JL, 2007, INT J FOOD MICROBIOL, V119, P3, DOI 10.1016/j.ijfoodmicro.2007.07.019; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Blagg BSJ, 2006, MED RES REV, V26, P310, DOI 10.1002/med.20052; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Hou JH, 2006, J BIOL CHEM, V281, P36117, DOI 10.1074/jbc.M608853200; Shang XY, 2012, NEOPLASIA, V14, P974, DOI 10.1593/neo.12942; Wray C, 2009, AM J PHYSIOL-LUNG C, V297, pL219, DOI 10.1152/ajplung.00043.2009; Furuse M, 2009, BBA-BIOMEMBRANES, V1788, P813, DOI 10.1016/j.bbamem.2008.07.017; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Kim SO, 2009, BMB REP, V42, P655; Kondoh M, 2005, MOL PHARMACOL, V67, P749, DOI 10.1124/mol.104.008375; Larre I, 2010, P NATL ACAD SCI USA, V107, P11387, DOI 10.1073/pnas.1000500107; Nishikiori N, 2008, JPN J OPHTHALMOL, V52, P195, DOI 10.1007/s10384-008-0524-z; Osanai M, 2007, MOL PHARMACOL, V71, P250, DOI 10.1124/mol.106.029579; Suzuki T, 2001, J NUTR, V139, P965; Watari A, 2012, BIOCHEM BIOPH RES CO, V426, P454, DOI 10.1016/j.bbrc.2012.08.083	26	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-5492	1573-6776		BIOTECHNOL LETT	Biotechnol. Lett.	JUN	2015	37	6					1177	1185		10.1007/s10529-015-1791-7		9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CI1JB	WOS:000354498900006		
J	Mine, Y; Shuto, T; Nikawa, H; Kawai, T; Ohara, M; Kawahara, K; Ohta, K; Kukita, T; Terada, Y; Makihira, S				Mine, Yuichi; Shuto, Takahiro; Nikawa, Hiroki; Kawai, Toshihisa; Ohara, Masaru; Kawahara, Kazuko; Ohta, Kouji; Kukita, Toshio; Terada, Yoshihiro; Makihira, Seicho			Inhibition of RANKL-dependent cellular fusion in pre-osteoclasts by amiloride and a NHE10-specific monoclonal antibody	CELL BIOLOGY INTERNATIONAL			English	Article						amiloride; cell-cell fusion; monoclonal antibody; NHE10; osteoclast; RANKL	NF-KAPPA-B; LESS-THAN-OR-EQUAL-TO-5 NUCLEI OSTEOCLASTS; LARGE GREATER-THAN-OR-EQUAL-TO-10 NUCLEI; NA+/H+ EXCHANGER; BONE-RESORPTION; GIANT-CELLS; IN-VITRO; DIFFERENTIATION; NHA-OC/NHA2; EXPRESSION	The functions of Na+/H+ exchangers (NHEs) during osteoclastic differentiation were investigated using the NHE inhibitor amiloride and a monoclonal antibody (MAb). Compared with sRANKL-stimulated control cells, amiloride decreased the number of large TRAP-positive osteoclast cells (OCs) with 10 nuclei and increased the number of small TRAP-positive OCs with 10 nuclei during sRANKL-dependent osteoclastic differentiation of RAW264.7 cells. NHE10 mRNA expression and OC differentiation markers were increased by sRANKL stimulation in dose- and time-dependent manners. NHEs 1-9 mRNA expression was not increased by sRANKL stimulation. Similar to amiloride, a rat anti-mouse NHE10 MAb (clone 6B11) decreased the number of large TRAP-positive OCs, but increased the number of small TRAP-positive OCs. These findings suggested that inhibition of NHEs by amiloride or an anti-NHE10 MAb prevented sRANKL-promoted cellular fusion. The anti-NHE10 MAb has the potential for use as an effective inhibitor of bone resorption for targeted bone disease therapy.	[Mine, Yuichi; Nikawa, Hiroki; Kawahara, Kazuko] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral Biol & Engn, Integrated Hlth Sci,Minami Ku, Hiroshima 7348553, Japan; [Shuto, Takahiro; Terada, Yoshihiro; Makihira, Seicho] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Fixed Prosthodont,Higashi Ku, Fukuoka 8128582, Japan; [Kawai, Toshihisa; Ohta, Kouji] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA 02142 USA; [Kawai, Toshihisa; Ohta, Kouji] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Ohara, Masaru] Hiroshima Univ Hosp, Dent Clin, Higashihiroshima 7390046, Japan; [Kukita, Toshio] Kyushu Univ, Fac Dent Sci, Dept Mol Cell Biol & Oral Anat, Higashi Ku, Fukuoka 8128582, Japan	Makihira, S (reprint author), Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Fixed Prosthodont,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	makihira@dent.kyushu-u.ac.jp			Japan Society for the Promotion of Science [20390499, 21390516, 24390437]; National Institute of Dental and Craniofacial Research (NIH) [DE-18499, DE-19917]	We thank Shota Okazaki, Ryosuke Miyai, and Yu Yamaguchi (Hiroshima University) for their technical support. This work was partly carried out with the kind cooperation of the Analysis Center of Life Science, Hiroshima University. This study was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (grant No. 20390499, 21390516, and 24390437) and the National Institute of Dental and Craniofacial Research (NIH grants DE-18499 and DE-19917)	Ang E, 2011, J CELL BIOCHEM, V112, P89, DOI 10.1002/jcb.22800; Kim HJ, 2012, LIFE SCI, V91, P928, DOI 10.1016/j.lfs.2012.09.009; Franco GCN, 2011, EXP CELL RES, V317, P1454, DOI 10.1016/j.yexcr.2011.03.014; Choi HJ, 2010, EUR J PHARMACOL, V636, P28, DOI 10.1016/j.ejphar.2010.03.023; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Yagi M, 2006, J BONE MINER METAB, V24, P355, DOI 10.1007/s00774-006-0697-9; Zhu LX, 2012, INT J BIOCHEM CELL B, V44, P1139, DOI 10.1016/j.biocel.2012.04.003; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Lees RL, 2001, BONE, V28, P187, DOI 10.1016/S8756-3282(00)00433-6; Fuster DG, 2008, J AM SOC NEPHROL, V19, P1547, DOI 10.1681/ASN.2007111245; Makihira S, 2008, CELL BIOL INT, V32, P1176, DOI 10.1016/j.cellbi.2008.04.027; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; Xu J, 2007, HISTOL HISTOPATHOL, V22, P443; Hofstetter W, 2010, BONE, V47, P331, DOI 10.1016/j.bone.2010.04.605; Takayanagi H, 2000, ARTHRITIS RHEUM, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W; VAANANEN HK, 1990, J CELL BIOL, V111, P1305, DOI 10.1083/jcb.111.3.1305; Proff P, 2009, CLIN ORAL INVEST, V13, P355, DOI 10.1007/s00784-009-0268-2; Malo ME, 2006, CAN J PHYSIOL PHARM, V84, P1081, DOI 10.1139/Y06-065; Lee SH, 2008, BIOCHEM BIOPH RES CO, V369, P320, DOI 10.1016/j.bbrc.2008.01.168; Han KY, 2007, BIOCHEM PHARMACOL, V74, P911, DOI 10.1016/j.bcp.2007.06.044; Xiang MH, 2007, P NATL ACAD SCI USA, V104, P18677, DOI 10.1073/pnas.0707120104; Kwak HB, 2010, BONE, V46, P724, DOI 10.1016/j.bone.2009.10.042; Bahtiar A, 2009, J BIOL CHEM, V284, P34157, DOI 10.1074/jbc.M109.058933; Battaglino RA, 2008, BONE, V42, P180, DOI 10.1016/j.bone.2007.09.046; Ha BG, 2008, PROTEOMICS, V8, P2625, DOI 10.1002/pmic.200701192; HERKEN R, 1988, HISTOCHEM J, V20, P427, DOI 10.1007/BF01002428; Kim Bong Gyu, 2010, Anat Cell Biol, V43, P310, DOI 10.5115/acb.2010.43.4.310; Lees RL, 2000, AM J PHYSIOL-CELL PH, V279, pC751; Liou SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069468; Makihira S, 2011, EUR J PHARMACOL, V670, P409, DOI 10.1016/j.ejphar.2011.08.044; Manolson MF, 2003, J BIOL CHEM, V278, P49271, DOI 10.1074/jbc.M309914200; MUTASA HCF, 1989, HISTOCHEM J, V21, P249, DOI 10.1007/BF01757177; Pham L, 2007, GENE EXPR PATTERNS, V7, P846, DOI 10.1016/j.modgep.2007.07.002; Takeichi O, 2000, J DENT RES, V79, P1548; Xu H, 2011, AM J PHYSIOL-GASTR L, V300, P647	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-6995	1095-8355		CELL BIOL INT	Cell Biol. Int.	JUN	2015	39	6					696	709		10.1002/cbin.10447		14	Cell Biology	Cell Biology	CI2GT	WOS:000354564500006		
J	Dahlem, MA; Kurths, J; Ferrari, MD; Aihara, K; Scheffer, M; May, A				Dahlem, Markus A.; Kurths, Juergen; Ferrari, Michel D.; Aihara, Kazuyuki; Scheffer, Marten; May, Arne			Understanding migraine using dynamic network biomarkers	CEPHALALGIA			English	Article						Migraine; tipping point; premonitory symptoms; triggers	EARLY-WARNING SIGNALS; CRITICAL TRANSITIONS; COMPLEX DISEASES; ATTACKS; TRIGGERS; AURA	Background Mathematical modeling approaches are becoming ever more established in clinical neuroscience. They provide insight that is key to understanding complex interactions of network phenomena, in general, and interactions within the migraine-generator network, in particular. Purpose In this study, two recent modeling studies on migraine are set in the context of premonitory symptoms that are easy to confuse for trigger factors. This causality confusion is explained, if migraine attacks are initiated by a transition caused by a tipping point. Conclusion We need to characterize the involved neuronal and autonomic subnetworks and their connections during all parts of the migraine cycle if we are ever to understand migraine. We predict that mathematical models have the potential to dismantle large and correlated fluctuations in such subnetworks as a dynamic network biomarker of migraine.	[Dahlem, Markus A.; Kurths, Juergen] Humboldt Univ, Dept Phys, Nonlinear Dynam, Cardiovasc Phys, D-10115 Berlin, Germany; [Kurths, Juergen] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Kurths, Juergen] Univ Aberdeen, Inst Complex Syst & Math Biol, Aberdeen AB9 1FX, Scotland; [Ferrari, Michel D.] Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RA Leiden, Netherlands; [Aihara, Kazuyuki] Univ Tokyo, Collaborat Res Ctr Innovat Math Modelling, Inst Ind Sci, Tokyo 1138654, Japan; [Scheffer, Marten] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AP Wageningen, Netherlands; [May, Arne] Univ Klinikum Hamburg Eppendorf, Dept Syst Neurosci, Ctr Med Expt, Hamburg, Germany	Dahlem, MA (reprint author), Humboldt Univ, Dept Phys, Robert Koch Pl 4, D-10115 Berlin, Germany.	dahlem@physik.hu-berlin.de			Seventh Framework EU-project EuroHeadPain [602633]; FIRST program from JSPS; CSTP	This work was supported by the Seventh Framework EU-project EuroHeadPain (#602633) to AM and MF and the FIRST program from JSPS, initiated by CSTP to KA.	Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Stankewitz A, 2011, J NEUROSCI, V31, P1937, DOI 10.1523/JNEUROSCI.4496-10.2011; Hougaard A, 2013, NEUROLOGY, V80, P428, DOI 10.1212/WNL.0b013e31827f0f10; Maniyar FH, 2014, BRAIN, V137, P232, DOI 10.1093/brain/awt320; Burstein R, 2005, J COMP NEUROL, V493, P9, DOI 10.1002/cne.20688; Goadsby PJ, 2013, NEUROLOGY, V80, P424, DOI 10.1212/WNL.0b013e31827f100c; Borsook D, 2012, CEPHALALGIA, V32, P803, DOI 10.1177/0333102412453952; Goadsby PJ, 1998, ANN NEUROL, V43, P272, DOI 10.1002/ana.410430221; Penzien DB, 2005, HEADACHE, V45, pS110, DOI 10.1111/j.1526-4610.2005.4502004.x; Dahlem MA, 2013, CHAOS, V23, DOI 10.1063/1.4813815; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Charles AC, 2013, NAT REV NEUROL, V9, P637, DOI 10.1038/nrneurol.2013.192; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658; MACKEY MC, 1987, ANN NY ACAD SCI, V504, P16, DOI 10.1111/j.1749-6632.1987.tb48723.x; Chen LN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00342; Dahlem MA, 2013, TRANSL NEUROSCI, V4, P282, DOI 10.2478/s13380-013-0127-0; Dolgin E, 2013, NAT MED, V19, P1083, DOI 10.1038/nm0913-1083; Kleinen T., 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; KROPP P, 1993, CEPHALALGIA, V13, P33, DOI 10.1046/j.1468-2982.1993.1301033.x; Liu R, 2012, SCI REP-UK, V2, DOI 10.1038/srep00813; Magis D, 2011, CURR OPIN NEUROL, V24, P203, DOI 10.1097/WCO.0b013e3283462c3f; Petoukhov V, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013568; Scheffer M, 2013, PLOS ONE, V8	23	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	JUN	2015	35	7					627	630		10.1177/0333102414550108		4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI1EI	WOS:000354484500009		
J	Oshimura, M; Kazuki, Y; Uno, N; Hoshiya, H				Oshimura, M.; Kazuki, Y.; Uno, N.; Hoshiya, H.			Human and mouse artificial chromosomes (HAC/MAC), and their characteristics	CHROMOSOME RESEARCH			English	Meeting Abstract	20th International Chromosome Conference (ICC)	SEP 01-04, 2014	Univ Kent, Canterbury, ENGLAND		Univ Kent				[Oshimura, M.; Kazuki, Y.; Uno, N.] Tottori Univ, Chromosome Engn Res Ctr, Tottori 680, Japan; [Hoshiya, H.] UCL, Cell & Dev Biol, London, England								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-3849	1573-6849		CHROMOSOME RES	Chromosome Res.	JUN	2015	23	2				O1	367	368				2	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CI0EZ	WOS:000354410600049		
J	Hoshiya, H; Benedetti, S; Gerli, MFM; Ragazzi, M; Ueno, E; Kazuki, Y; Messina, G; Oshimura, M; Cossu, G; Tedesco, FS				Hoshiya, H.; Benedetti, S.; Gerli, M. F. M.; Ragazzi, M.; Ueno, E.; Kazuki, Y.; Messina, G.; Oshimura, M.; Cossu, G.; Tedesco, F. S.			Human artificial chromosome-mediated strategies for stem cell-based therapy of muscular dystrophy	CHROMOSOME RESEARCH			English	Meeting Abstract	20th International Chromosome Conference (ICC)	SEP 01-04, 2014	Univ Kent, Canterbury, ENGLAND		Univ Kent				[Hoshiya, H.; Benedetti, S.; Gerli, M. F. M.; Ragazzi, M.; Cossu, G.; Tedesco, F. S.] UCL, Cell & Dev Biol, London, England; [Ueno, E.; Kazuki, Y.; Oshimura, M.] Tottori Univ, Chromosome Engn Res Ctr, Tottori 680, Japan; [Messina, G.] Univ Milan, Biol, Milan, Italy; [Cossu, G.] Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-3849	1573-6849		CHROMOSOME RES	Chromosome Res.	JUN	2015	23	2				O3	368	369				2	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CI0EZ	WOS:000354410600051		
J	Uno, N; Ueda, K; Iida, Y; Yakura, Y; Kurosaki, H; Uno, K; Osaki, M; Obayashi, T; Kazuki, Y; Hiratsuka, M; Oshimura, M				Uno, N.; Ueda, K.; Iida, Y.; Yakura, Y.; Kurosaki, H.; Uno, K.; Osaki, M.; Obayashi, T.; Kazuki, Y.; Hiratsuka, M.; Oshimura, M.			Toward safe and effective gene- and cell-therapies using human artificial chromosomes and stem cells	CHROMOSOME RESEARCH			English	Meeting Abstract	20th International Chromosome Conference (ICC)	SEP 01-04, 2014	Univ Kent, Canterbury, ENGLAND		Univ Kent				[Uno, N.; Ueda, K.; Iida, Y.; Yakura, Y.; Kurosaki, H.; Uno, K.; Kazuki, Y.; Oshimura, M.] Tottori Univ, Grad Sch Med Sci, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Tottori 680, Japan; [Osaki, M.] Tottori Univ, Fac Med, Div Pathol Biochem, Tottori 680, Japan; [Obayashi, T.] Tottori Univ, Res Ctr Biosci & Technol, Tottori 680, Japan; [Kazuki, Y.; Oshimura, M.] Tottori Univ, Chromosome Engn Res Ctr, Tottori 680, Japan; [Hiratsuka, M.] Tottori Univ, Fac Med, Dept Mol & Cellular Biol, Tottori 680, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-3849	1573-6849		CHROMOSOME RES	Chromosome Res.	JUN	2015	23	2				O2	368	368				1	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CI0EZ	WOS:000354410600050		
J	Kasai, F; Hirayama, N; Ozawa, M; Shioda, S; Kohara, A				Kasai, F.; Hirayama, N.; Ozawa, M.; Shioda, S.; Kohara, A.			Genomic changes in tumour cell lines revealed by comparison between culture passages; implications for heterogeneity resulting from progressive rearrangements	CHROMOSOME RESEARCH			English	Meeting Abstract	20th International Chromosome Conference (ICC)	SEP 01-04, 2014	Univ Kent, Canterbury, ENGLAND		Univ Kent				[Kasai, F.; Hirayama, N.; Ozawa, M.; Shioda, S.; Kohara, A.] JCRB Cell Bank, Natl Inst Biomed Innovat, Osaka, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-3849	1573-6849		CHROMOSOME RES	Chromosome Res.	JUN	2015	23	2				O6	370	370				1	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CI0EZ	WOS:000354410600054		
J	Akiyama, K; Bando, M; Shirahige, K				Akiyama, K.; Bando, M.; Shirahige, K.			The analysis of transcriptional regulation by cohesin and its loader with semi-in vitro reconstitution methods	CHROMOSOME RESEARCH			English	Meeting Abstract	20th International Chromosome Conference (ICC)	SEP 01-04, 2014	Univ Kent, Canterbury, ENGLAND		Univ Kent				[Akiyama, K.; Bando, M.; Shirahige, K.] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-3849	1573-6849		CHROMOSOME RES	Chromosome Res.	JUN	2015	23	2					380	380				1	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CI0EZ	WOS:000354410600071		
J	Minamino, M; Ishibashi, M; Nakato, R; Sutani, T; Tanaka, H; Kato, Y; Negishi, L; Hirota, T; Bando, M; Shirahige, K				Minamino, M.; Ishibashi, M.; Nakato, R.; Sutani, T.; Tanaka, H.; Kato, Y.; Negishi, L.; Hirota, T.; Bando, M.; Shirahige, K.			Pds5 recruits Esco1 to establish sister chromatids cohesion	CHROMOSOME RESEARCH			English	Meeting Abstract	20th International Chromosome Conference (ICC)	SEP 01-04, 2014	Univ Kent, Canterbury, ENGLAND		Univ Kent				[Minamino, M.; Ishibashi, M.; Nakato, R.; Sutani, T.; Tanaka, H.; Kato, Y.; Bando, M.; Shirahige, K.] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Lab Genome Struct & Funct, Tokyo, Japan; [Negishi, L.] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Lab Canc Stem Cell Biol, Tokyo, Japan; [Hirota, T.] JFCR, Inst Canc, Tokyo, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-3849	1573-6849		CHROMOSOME RES	Chromosome Res.	JUN	2015	23	2				P8	384	384				1	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CI0EZ	WOS:000354410600078		
J	Ohshima, S; Seyama, A				Ohshima, S.; Seyama, A.			Establishment of Proliferative near-tetraploid cells from immortalized normal human fibroblasts	CHROMOSOME RESEARCH			English	Meeting Abstract	20th International Chromosome Conference (ICC)	SEP 01-04, 2014	Univ Kent, Canterbury, ENGLAND		Univ Kent				[Ohshima, S.] Saitama Med Univ, Biomed Res Ctr, Saitama, Japan; [Seyama, A.] Saitama Med Univ, Int Med Ctr, Saitama, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-3849	1573-6849		CHROMOSOME RES	Chromosome Res.	JUN	2015	23	2				P17	389	389				1	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CI0EZ	WOS:000354410600087		
J	Hirai, H; Hirai, Y; Koga, A				Hirai, H.; Hirai, Y.; Koga, A.			Characteristics of owl monkey chromosomes: large-scale repetitive sequences constituting the short arms of acrocnetrics and karyotypic variation observed in interspecies hybrids	CHROMOSOME RESEARCH			English	Meeting Abstract	20th International Chromosome Conference (ICC)	SEP 01-04, 2014	Univ Kent, Canterbury, ENGLAND		Univ Kent				[Hirai, H.; Hirai, Y.; Koga, A.] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-3849	1573-6849		CHROMOSOME RES	Chromosome Res.	JUN	2015	23	2				P42	402	403				2	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CI0EZ	WOS:000354410600112		
J	Ishibashi, Y; Matsui, T; Ueda, S; Fukami, K; Okuda, S; Ohta, H; Yamagishi, S				Ishibashi, Y.; Matsui, T.; Ueda, S.; Fukami, K.; Okuda, S.; Ohta, H.; Yamagishi, S.			Bazedoxifene blocks AGEs-RAGE-induced superoxide generation and MCP-1 level in endothelial cells	CLIMACTERIC			English	Article						AGES; BAZEDOXIFENE; CARDIOVASCULAR DISEASE; OXIDATIVE STRESS; RAGE; SERM	GLYCATION END-PRODUCTS; VASCULAR-DISEASE; HORMONE-THERAPY; EXPRESSION; RECEPTORS	Advanced glycation endproducts (AGEs) and their receptor (RAGE) play a role in vascular complications in diabetes. We have previously shown that 17 beta-estradiol at 10 nmol/l, a nearly identical plasma concentration to that during mid-pregnancy, up-regulates RAGE expression in endothelial cells. The finding might suggest the involvement of 17 beta-estradiol in the deterioration of vascular complications in diabetes during pregnancy. However, the effects of the selective estrogen receptor modulator, bazedoxifene, on oxidative and inflammatory reactions in AGEs-exposed endothelial cells remain unknown. In this study, we addressed the issue. Ten nmol/l 17 beta-estradiol increased RAGE and monocyte chemoattractant protein-1 (MCP-1) gene and protein expression in human umbilical vein endothelial cells (HUVECs), both of which were blocked by 10 nmol/l bazedoxifene. Bazedoxifene at 10 nmol/l also significantly inhibited the AGEs-induced superoxide generation, RAGE and MCP-1 gene and protein expression in HUVECs. The present study suggests that blockade of the AGEs-RAGE axis by bazedoxifene might be a novel therapeutic target for preventing vascular damage in diabetes, especially in postmenopausal women.	[Ishibashi, Y.; Matsui, T.; Yamagishi, S.] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 8300011, Japan; [Ueda, S.; Fukami, K.; Okuda, S.] Kurume Univ, Sch Med, Dept Med, Div Nephrol, Kurume, Fukuoka 8300011, Japan; [Ohta, H.] Int Univ Hlth & Welf, Womens Med Ctr, Sanno Med Ctr, Clin Med Res Ctr, Tokyo, Japan	Yamagishi, S (reprint author), Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	shoichi@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This study was supported in part by Grants-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to S.Y.), and by MEXT-Supported Program for the Strategic Research Foundation at Private Universities, the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to S.Y.).	Yamagishi S, 2011, CURR DRUG TARGETS, V12, P2096; Yamagishi S, 2005, CURR PHARM DESIGN, V11, P2279, DOI 10.2174/1381612054367300; Bierhaus A, 1998, CARDIOVASC RES, V37, P586, DOI 10.1016/S0008-6363(97)00233-2; Tanaka N, 2000, J BIOL CHEM, V275, P25781, DOI 10.1074/jbc.M001235200; Yamagishi S, 2011, EXP GERONTOL, V46, P217, DOI 10.1016/j.exger.2010.11.007; Hemachandra LPMP, 2014, CANCER PREV RES, V7, P505, DOI 10.1158/1940-6207.CAPR-13-0296; Vlassara H, 1996, DIABETES, V45, pS65; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Persy V, 2009, TRENDS MOL MED, V15, P405, DOI 10.1016/j.molmed.2009.07.001; Yamagishi S, 2006, J BIOL CHEM, V281, P20213, DOI 10.1074/jbc.M602110200; Ide Y, 2010, MICROVASC RES, V80, P227, DOI 10.1016/j.mvr.2010.03.015; Ishibashi Y, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-60; Krolik M, 2012, ADV CLIN EXP MED, V21, P535; Maximov Philipp Y, 2013, Curr Clin Pharmacol, V8, P135; Ojima A, 2013, AM J PATHOL, V182, P132, DOI 10.1016/j.ajpath.2012.09.016; Santen RJ, 2010, J CLIN ENDOCR METAB, V95, pS7, DOI 10.1210/jc.2009-2509; Schmidt A M, 2000, Curr Atheroscler Rep, V2, P430, DOI 10.1007/s11883-000-0082-4	18	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1369-7137	1473-0804		CLIMACTERIC	Climacteric	JUN	2015	18	3					426	430		10.3109/13697137.2014.958073		5	Obstetrics & Gynecology	Obstetrics & Gynecology	CI0CQ	WOS:000354403800019		
J	Madhok, V; Futamura, M; Thomas, KS; Barbarot, S				Madhok, V.; Futamura, M.; Thomas, K. S.; Barbarot, S.			What's new in atopic eczema? An analysis of systematic reviews published in 2012 and 2013. Part 2. Treatment and prevention	CLINICAL AND EXPERIMENTAL DERMATOLOGY			English	Review							ALLERGEN-SPECIFIC IMMUNOTHERAPY; DERMATITIS; METAANALYSIS; PROBIOTICS; SUPPLEMENTATION; PREGNANCY; CHILDHOOD; EFFICACY; CHILDREN; IMPACT	This review provides a summary of key findings from 22 systematic reviews on atopic eczema (AE) published over the 2-year period from January 2012 to 31 December 2013, focusing on prevention and treatment of AE. For an update of systematic reviews on the epidemiology, mechanisms of disease and methodological issues, see Part 1 of this update. Based on current systematic review evidence, the most promising intervention for the prevention of AE is the use of probiotics (and possibly prebiotics) during the late stages of pregnancy and early life. Exposure to household pets, especially dogs, may also be protective, but exclusive breastfeeding for up to 7months does not confer benefit. The role of vitamin D in preventing AE is currently unclear. Very few of the systematic reviews provided additional evidence for the use of specific treatments for AE. Further research is required to establish the role of desensitization, Chinese herbal medicines, homeopathy and specialist clothing. Nevertheless, there is now clear evidence that evening primrose oil and borage oil are not effective for the treatment of AE. There have been no randomized controlled trials on the use of H1 anti-histamines as monotherapy for the treatment of AE.	[Madhok, V.] Univ Dundee, Div Populat Hlth Sci, Dundee, Scotland; [Futamura, M.] Natl Ctr Child Hlth & Dev, Div Allergy, Tokyo, Japan; [Thomas, K. S.; Barbarot, S.] Univ Nottingham, Sch Med, Div Rheumatol Orthopaed & Dermatol, Ctr Evidence Based Dermatol, Nottingham, England; [Barbarot, S.] Nantes Univ Hosp, Dept Dermatol, F-44093 Nantes, France	Barbarot, S (reprint author), Nantes Univ Hosp, Dept Dermatol, 1 Pl Alexis Ricordeau, F-44093 Nantes, France.	sebastien.barbarot@chu-nantes.fr			French College of Professors of Dermatology (CEDEF)	This work was supported by a grant from the French College of Professors of Dermatology (CEDEF) (to SB). VM is a UK Dermatology Clinical trial Network General Practice Fellow (2012-2015).	Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446; Sher LG, 2012, ACTA DERM-VENEREOL, V92, P455, DOI 10.2340/00015555-1360; Doege K, 2012, BRIT J NUTR, V107, P1, DOI 10.1017/S0007114511003400; Foolad N, 2013, JAMA DERMATOL, V149, P350, DOI 10.1001/jamadermatol.2013.1495; Bae JM, 2013, J ALLERGY CLIN IMMUN, V132, P110, DOI 10.1016/j.jaci.2013.02.044; Tan HY, 2013, J AM ACAD DERMATOL, V69, P295, DOI 10.1016/j.jaad.2013.01.019; Ernst E, 2012, BRIT J DERMATOL, V166, P1170, DOI 10.1111/j.1365-2133.2012.10994.x; Pelucchi C, 2012, EPIDEMIOLOGY, V23, P402, DOI 10.1097/EDE.0b013e31824d5da2; Compalati E, 2012, CURR OPIN ALLERGY CL, V12, P427, DOI 10.1097/ACI.0b013e328354e540; Lopes C, 2013, PEDIAT ALLERG IMM-UK, V24, P603, DOI 10.1111/pai.12111; Dang D, 2013, J INT MED RES, V41, P1426, DOI 10.1177/0300060513493692; Flohr C, 2011, BRIT J DERMATOL, V165, P1280, DOI 10.1111/j.1365-2133.2011.10588.x; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Apfelbacher CJ, 2013, COCHRANE DB SYST REV; Bamford IT, 2013, COCHRANE DB SYST REV, V4; Baptista IPND, 2013, NUTR HOSP, V28, P16, DOI 10.3305/nh.2013.28.1.6207; Bath-Hextall F. J., 2012, COCHRANE DB SYST REV, V2; Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1368, DOI 10.1111/aogs.12006; Gu S., 2013, COCHRANE DB SYST REV, V9; Kramer MS, 2012, COCHRANE DB SYST REV, V9; Osborn DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006475.pub2; Pelucchi C, 2013, J ALLERGY CLIN IMMUN, V132, P616, DOI 10.1016/j.jaci.2013.04.009; Shams K, 2011, CLIN EXP DERMATOL, V36, P573, DOI 10.1111/j.1365-2230.2011.04078.x; Shams K, 2011, CLIN EXP DERMATOL, V36, P7; Tam H, 2013, J ALLERGY CLIN IMMUN, V132, P1012, DOI 10.1016/j.jaci.2013.07.021; Tang Lu-jing, 2012, Zhonghua Er Ke Za Zhi, V50, P504; Torley D, 2013, CLIN EXP DERMATOL, V38, P449, DOI 10.1111/ced.12143; [王瑜 Wang Yu], 2012, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V12, P1372; Williams HC, 2003, BRIT MED J, V327, P1358, DOI 10.1136/bmj.327.7428.1358; Yang YW, 2009, BRIT J DERMATOL, V161, P373, DOI 10.1111/j.1365-2133.2009.09049.x	30	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6938	1365-2230		CLIN EXP DERMATOL	Clin. Exp. Dermatol.	JUN	2015	40	4					349	355		10.1111/ced.12591		7	Dermatology	Dermatology	CI1CU	WOS:000354479300001		
J	Horie, K; Ito, K; Hirata, Y; Ito, M				Horie, K.; Ito, K.; Hirata, Y.; Ito, M.			Eccrine poroma on the helix: a rare anatomical presentation	CLINICAL AND EXPERIMENTAL DERMATOLOGY			English	Letter									[Horie, K.; Ito, K.; Hirata, Y.; Ito, M.] JR Sapporo Hosp, Dept Dermatol, Sapporo, Hokkaido 0600033, Japan	Horie, K (reprint author), JR Sapporo Hosp, Dept Dermatol, N3 E1, Sapporo, Hokkaido 0600033, Japan.	itokei@jrhokkaido.co.jp					Abenoza P, 1990, ACKERMANS HISTOLOGIC, V1, P113; Nicolino R, 2007, DERMATOLOGY, V215, P160, DOI 10.1159/000104270; Ferrari A, 2009, ACTA DERM-VENEREOL, V89, P160, DOI 10.2340/00015555-0608; HYMAN AB, 1969, DERMATOLOGICA, V138, P29; Moore TO, 2001, J AM ACAD DERMATOL, V44, P48, DOI 10.1067/mjd.2001.110048	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6938	1365-2230		CLIN EXP DERMATOL	Clin. Exp. Dermatol.	JUN	2015	40	4					442	444		10.1111/ced.12507		3	Dermatology	Dermatology	CI1CU	WOS:000354479300021		
J	Hoshina, D; Furuya, K; Okita, I				Hoshina, D.; Furuya, K.; Okita, I.			Erythema multiforme-like drug reaction with eosinophilia and systemic symptoms (DRESS)	CLINICAL AND EXPERIMENTAL DERMATOLOGY			English	Letter									[Hoshina, D.; Furuya, K.] Hakodate Cent Gen Hosp, Dept Dermatol, Hakodate, Hokkaido 0408585, Japan; [Okita, I.] Hakodate Cent Gen Hosp, Dept Gastroenterol, Hakodate, Hokkaido 0408585, Japan	Hoshina, D (reprint author), Hakodate Cent Gen Hosp, Dept Dermatol, Honcho 33-2, Hakodate, Hokkaido 0408585, Japan.	hoshinad@gmail.com					Cacoub P, 2011, AM J MED, V124, P588, DOI 10.1016/j.amjmed.2011.01.017; Kardaun SH, 2007, BRIT J DERMATOL, V156, P609, DOI 10.1111/j.1365-2133.2006.07704.x; Walsh S, 2013, BRIT J DERMATOL, V168, P391, DOI 10.1111/bjd.12081; Bocquet H, 1996, SEMIN CUTAN MED SURG, V15, P250, DOI 10.1016/S1085-5629(96)80038-1; Toyama M, 2007, BRIT J DERMATOL, V157, P934	5	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6938	1365-2230		CLIN EXP DERMATOL	Clin. Exp. Dermatol.	JUN	2015	40	4					455	456		10.1111/ced.12541		2	Dermatology	Dermatology	CI1CU	WOS:000354479300029		
J	Tanaka, H; Yang, GX; Tomiyama, T; Tsuneyama, K; Zhang, W; Leung, PSC; Coppel, RL; Joh, T; Nadler, SG; Ansari, AA; Bowlus, C; Gershwin, ME				Tanaka, H.; Yang, G-X.; Tomiyama, T.; Tsuneyama, K.; Zhang, W.; Leung, P. S. C.; Coppel, R. L.; Joh, T.; Nadler, S. G.; Ansari, A. A.; Bowlus, C.; Gershwin, M. E.			Immunological potential of cytotoxic T lymphocyte antigen 4 immunoglobulin in murine autoimmune cholangitis	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						autoimmunity; cholangitis; colitis; murine models; primary biliary cirrhosis	PRIMARY BILIARY-CIRRHOSIS; JUVENILE IDIOPATHIC ARTHRITIS; DOMINANT-NEGATIVE FORM; CELL CO-STIMULATION; RHEUMATOID-ARTHRITIS; TGF-BETA; II MICE; CTLA4-IG ABATACEPT; REGULATORY CELLS; COSTIMULATION	Cytotoxic T lymphocyte antigen 4 (CTLA-4) immunoglobulin (Ig) is an important regulator of T cell activation and a fusion protein directed at CD80 and CD86; it blocks co-stimulatory signalling and T cell activation. We have taken advantage of a murine model of human primary biliary cirrhosis (PBC), mice expressing a transforming growth factor (TGF)- receptor II dominant negative (dnTGF-RII) transgene to address the potential therapeutic efficacy of CTLA-4 Ig. To mimic patients with PBC at different stages or duration of disease, we treated mice with either CTLA-4 Ig or control IgG three times weekly from 3 to 12 or 24 weeks of age, or from 12 to 24 weeks of age. CTLA-4 Ig treatment from 3 weeks of age significantly reduced liver inflammation to 12 weeks of age. Treatment initiated at 12 weeks of age also ameliorated the autoimmune cholangitis at 24 weeks of age. However, in mice treated at 3 weeks of age, suppression of liver inflammation was not sustained and colitis was aggravated when treatment was extended to 24 weeks of age. Our data indicate that, in dnTGF-RII mice, CTLA-4 Ig treatment has short-term beneficial effects on autoimmune cholangitis, but the effect varies according to duration of treatment and the time in which therapy was initiated. Further dissection of the events that lead to the reduction in therapeutic effectiveness of CTLA-4 Ig will be critical to determining whether such efforts can be applied to human PBC.	[Tanaka, H.; Yang, G-X.; Tomiyama, T.; Tsuneyama, K.; Zhang, W.; Leung, P. S. C.; Gershwin, M. E.] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Sch Med, Davis, CA 95616 USA; [Bowlus, C.] Univ Calif Davis, Sch Med, Div Gastroenterol & Hepatol, Sacramento, CA 95817 USA; [Nadler, S. G.] Bristol Myers Squibb, Dept Immunol, Princeton, NJ USA; [Ansari, A. A.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Tanaka, H.; Joh, T.] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan; [Tomiyama, T.] Kansai Med Univ, Div Gastroenterol & Hepatol, Dept Internal Med 3, Osaka, Japan; [Tsuneyama, K.] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Diagnost Pathol, Toyama 930, Japan; [Coppel, R. L.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia	Gershwin, ME (reprint author), Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Sch Med, 451 Hlth Sci Dr,Suite 6510, Davis, CA 95616 USA.	megershwin@ucdavis.edu					Ahmadi SM, 2014, TRANSPLANTATION, V98, P1158, DOI 10.1097/TP.0000000000000421; Alvarez-Quiroga C, 2011, J CLIN IMMUNOL, V31, P588, DOI 10.1007/s10875-011-9527-5; Kita H, 2002, J EXP MED, V195, P113, DOI 10.1084/jem.20010956; Wakabayashi K, 2008, HEPATOLOGY, V48, P531, DOI 10.1002/hep.22390; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Daikh DI, 1997, J IMMUNOL, V159, P3104; Oertelt S, 2006, J IMMUNOL, V177, P1655; Ando Y, 2012, HEPATOLOGY, V56, P1418, DOI 10.1002/hep.25803; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Suresh M, 2001, J IMMUNOL, V167, P5565; Wang LF, 2014, SEMIN LIVER DIS, V34, P297, DOI 10.1055/s-0034-1383729; Yoshida K, 2009, HEPATOLOGY, V50, P1494, DOI 10.1002/hep.23132; Linsley PS, 2009, IMMUNOL REV, V229, P307, DOI 10.1111/j.1600-065X.2009.00780.x; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Deppong CM, 2013, J IMMUNOL, V191, P3082, DOI 10.4049/jimmunol.1300830; Huang WT, 2014, J AUTOIMMUN, V50, P123, DOI 10.1016/j.jaut.2014.01.034; Fang M, 2006, J IMMUNOL, V177, P8027; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; Kita H, 2002, J CLIN INVEST, V109, P1231, DOI 10.1172/JCI200214698; Yang CY, 2014, HEPATOLOGY, V59, P1944, DOI 10.1002/hep.26979; Kawata K, 2013, HEPATOLOGY, V58, P1094, DOI 10.1002/hep.26418; Chang LY, 2012, J IMMUNOL, V189, P567, DOI 10.4049/jimmunol.1200266; Hirschfield GM, 2013, ANNU REV PATHOL-MECH, V8, P303, DOI 10.1146/annurev-pathol-020712-164014; Shimoda S, 1998, J CLIN INVEST, V102, P1831, DOI 10.1172/JCI4213; Blazar BR, 1999, J IMMUNOL, V162, P6368; Ruperto N, 2010, ARTHRITIS RHEUM-US, V62, P1792, DOI 10.1002/art.27431; Ruperto N, 2008, LANCET, V372, P383, DOI 10.1016/S0140-6736(08)60998-8; Dhirapong A, 2013, HEPATOLOGY, V57, P708, DOI 10.1002/hep.26067; Brennan FR, 2010, MABS-AUSTIN, V2, P233; Choy EH, 2009, CLIN EXP RHEUMATOL, V27, P510; Tanaka H, 2013, CLIN EXP IMMUNOL, V174, P364, DOI 10.1111/cei.12193; Ando Y, 2013, J AUTOIMMUN, V41, P111, DOI 10.1016/j.jaut.2012.12.013; Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; Tang QZ, 2003, J IMMUNOL, V171, P3348; Buch MH, 2009, ANN RHEUM DIS, V68, P1220, DOI 10.1136/ard.2008.091876; Tsuda M, 2013, HEPATOLOGY, V57, P806, DOI 10.1002/hep.25829; Davis PM, 2008, CLIN IMMUNOL, V126, P38, DOI 10.1016/j.clim.2007.08.019; Davis PM, 2007, J RHEUMATOL, V34, P2204; Fiocco U, 2008, AUTOIMMUN REV, V8, P76, DOI 10.1016/j.autrev.2008.07.035; Graca L, 2008, ACTA REUMATOL PORT, V33, P267; Leung PSC, 2013, J AUTOIMMUN, V41, P79, DOI 10.1016/j.jaut.2012.12.007; Liaskou E, 2014, SEMIN IMMUNOPATHOL, V36, P553, DOI 10.1007/s00281-014-0439-3; Lleo A, 2014, HEPATOLOGY, V60, P1314, DOI 10.1002/hep.27230; Mihara M, 2000, J CLIN INVEST, V106, P91, DOI 10.1172/JCI9244; Moritoki Y, 2009, HEPATOLOGY, V50, P1893, DOI 10.1002/hep.23238; Pieper J, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-34; Rozelle AL, 2007, CLIN EXP RHEUMATOL, V25, pS30; Ruderman EM, 2006, NAT CLIN PRACT RHEUM, V2, P654, DOI 10.1038/noprheum0345; Schiff M, 2011, RHEUMATOLOGY, V50, P437, DOI 10.1093/rheumatology/keq287; Teng GG, 2005, EXPERT OPIN BIOL TH, V5, P1245, DOI 10.1517/14712598.5.9.1245; Wang LF, 2015, HEPATOLOGY, V61, P627, DOI 10.1002/hep.27306; Yang GX, 2008, HEPATOLOGY, V47, P1974, DOI 10.1002/hep.22226; Zhang J, 2014, HEPATOLOGY, V60, P1708, DOI 10.1002/hep.27313	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	JUN	2015	180	3					371	382		10.1111/cei.12581		12	Immunology	Immunology	CI2FU	WOS:000354561700003		
J	Fujisawa, R; Haseda, F; Tsutsumi, C; Hiromine, Y; Noso, S; Kawabata, Y; Mitsui, S; Terasaki, J; Ikegami, H; Imagawa, A; Hanafusa, T				Fujisawa, R.; Haseda, F.; Tsutsumi, C.; Hiromine, Y.; Noso, S.; Kawabata, Y.; Mitsui, S.; Terasaki, J.; Ikegami, H.; Imagawa, A.; Hanafusa, T.			Low programmed cell death-1 (PD-1) expression in peripheral CD4(+) T cells in Japanese patients with autoimmune type 1 diabetes	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						fulminant type 1 diabetes; PD-1; type 1A diabetes	SYSTEMIC-LUPUS-ERYTHEMATOSUS; REGULATORY POLYMORPHISM; RHEUMATOID-ARTHRITIS; MELLITUS; GENE; PANCREAS; SUSCEPTIBILITY; RECEPTORS; PDCD1; ASSOCIATION	Programmed cell death-1 (PD-1) is a co-stimulatory molecule that inhibits T cell proliferation. We aimed to clarify PD-1 expression in CD4(+) T cells and the association between PD-1 expression and the 7785C/T polymorphism of PDCD1, with a focus on the two subtypes of type 1 diabetes, type 1A diabetes (T1AD) and fulminant type 1 diabetes (FT1D), in the Japanese population. We examined 22 patients with T1AD, 15 with FT1D, 19 with type 2 diabetes (T2D) and 29 healthy control (HC) subjects. Fluorescence-activated cell sorting (FACS) and real-time PCR were utilized to analyse PD-1 expression quantitatively. Genotyping of 7785C/T in PDCD1 was performed using the TaqMan method in a total of 63 subjects (21 with T1AD, 15 with FT1D and 27 HC). FACS revealed a significant reduction in PD-1 expression in CD4(+) T cells in patients with T1AD (mean: 42 vs. 60% in FT1D, P=00450; vs. 58% in T2D, P = 00098; vs. 60% in HC, P=00018). PD-1 mRNA expression in CD4(+) T cells was also significantly lower in patients with T1AD than in the HC subjects. Of the 63 subjects, PD-1 expression was significantly lower in individuals with the 7785C/C genotype than in those with the C/T and T/T genotypes (mean: 41 vs. 59%, P=00016). Our results indicate that lower PD-1 expression in CD4(+) T-cells might contribute to the development of T1AD through T cell activation.	[Fujisawa, R.; Haseda, F.; Tsutsumi, C.; Mitsui, S.; Terasaki, J.; Imagawa, A.; Hanafusa, T.] Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka 5698686, Japan; [Hiromine, Y.; Noso, S.; Kawabata, Y.; Ikegami, H.] Kinki Univ, Fac Med, Dept Endocrinol Metab & Diabet, Osaka, Japan; [Imagawa, A.] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan	Haseda, F (reprint author), Osaka Med Coll, Dept Internal Med 1, 2-7 Daigaku Chou, Takatsuki, Osaka 5698686, Japan.	in1301@poh.osaka-med.ac.jp			Japanese Society for the Promotion of Science [KAKENHI 24591345]	We gratefully acknowledge support from Mr. Teruo Ueno for his excellent technical assistance. This study was supported by a Grant-in-Aid from the Japanese Society for the Promotion of Science (KAKENHI 24591345).	American Diabetes Association, 2014, DIABETES CARE S1, V37, pS81, DOI DOI 10.2337/DC14-S081; Imagawa A, 2000, NEW ENGL J MED, V342, P301, DOI 10.1056/NEJM200002033420501; BOTTAZZO GF, 1985, NEW ENGL J MED, V313, P353, DOI 10.1056/NEJM198508083130604; Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102; Kristjansdottir H, 2010, ARTHRITIS RHEUM-US, V62, P1702, DOI 10.1002/art.27417; Pauken KE, 2013, DIABETES, V62, P2859, DOI 10.2337/db12-1475; Shibasaki S, 2010, ENDOCR J, V57, P211; Ni RH, 2007, HUM GENET, V121, P223, DOI 10.1007/s00439-006-0309-8; Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Nagata M, 2004, ANN NY ACAD SCI, V1037, P10, DOI 10.1196/annals.1337.002; GEPTS W, 1965, DIABETES, V14, P619; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Hatachi S, 2003, J RHEUMATOL, V30, P1410; Trabattoni D, 2009, J IMMUNOL, V183, P4984, DOI 10.4049/jimmunol.0901038; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Hanafusa T, 2007, NAT CLIN PRACT ENDOC, V3, P36, DOI 10.1038/ncpendmet0351; Roep BO, 2003, DIABETOLOGIA, V46, P305, DOI 10.1007/s00125-003-1089-5; Flores S, 2010, REV MED CHILE, V138, P543, DOI [/S0034-98872010000500003, 10.4067/S0034-98872010000500003]; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Haseda F, 2011, IMMUNOL LETT, V139, P80, DOI 10.1016/j.imlet.2011.05.003; Imagawa A, 2003, DIABETES CARE, V26, P2345, DOI 10.2337/diacare.26.8.2345; Lin SC, 2004, ARTHRITIS RHEUM, V50, P770, DOI 10.1002/art.20040; Nielsen C, 2003, TISSUE ANTIGENS, V62, P492, DOI 10.1046/j.1399-0039.2003.00136.x; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Asad S, 2007, Diabet Med, V24, P1473; Cooper JD, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-71; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Hawkes CJ, 2000, DIABETES, V49, P356, DOI 10.2337/diabetes.49.3.356; Hiromine Y, 2007, METABOLISM, V56, P905, DOI 10.1016/j.metabol.2007.01.021; Lee YH, 2014, Z RHEUMATOL; Momin S, 2009, DIABETES RES CLIN PR, V83, P289, DOI 10.1016/j.diabres.2008.12.003; Tanaka S, 2000, NEW ENGL J MED, V342, P1835	37	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	JUN	2015	180	3					452	457		10.1111/cei.12603		6	Immunology	Immunology	CI2FU	WOS:000354561700010		
J	Takai, C; Matsumoto, I; Inoue, A; Umeda, N; Tanaka, Y; Kurashima, Y; Wada, Y; Narita, I; Sumida, T				Takai, C.; Matsumoto, I.; Inoue, A.; Umeda, N.; Tanaka, Y.; Kurashima, Y.; Wada, Y.; Narita, I.; Sumida, T.			Specific overexpression of tumour necrosis factor--induced protein (TNFAIP)9 in CD14(+)CD16(-) monocytes in patients with rheumatoid arthritis: comparative analysis with TNFAIP3	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						monocytes; pathogenesis; rheumatoid arthritis; TNFAIP9; TNF--induced proteins	6-TRANSMEMBRANE EPITHELIAL ANTIGEN; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ALPHA-INDUCED PROTEIN; NF-KAPPA-B; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; EXPRESSION; DISEASE; 6Q23; SUSCEPTIBILITY	The tumour necrosis factor (TNF)--induced proteins (TNFAIP)9 and TNFAIP3 play an important pathogenic role in murine arthritis. To clarify their pathophysiological roles in patients with rheumatoid arthritis (RA), we examined their expression and localization in peripheral blood mononuclear cells (PBMC). TNFAIP9 and TNFAIP3 mRNA expression was determined in PBMC of RA patients and healthy subjects (control). Flow cytometry was used to analyse the main TNFAIP9- and TNFAIP3-expressing cell populations. TNFAIP9 and TNFAIP3 mRNA expression levels were examined in vitro on CD14(+) cells stimulated with TNF- and lipopolysaccharide (LPS). The expression levels of TNFAIP9 and TNFAIP3 mRNA were also measured before and 12 weeks after treatment with tocilizumab and abatacept. TNFAIP9 expression was significantly higher, while TNFAIP3 expression was lower in PBMC of RA (n=36) than the control (n=24) (each P<005). TNFAIP9 was expressed on CD14(+) cells, especially in human leucocyte antigen D-related (HLA-DR)(+)CD14(bright)CD16(-)cells, while TNFAIP3 was expressed mainly on CD3(+) T cells. TNF- and LPS induced TNFAIP9 and TNFAIP3 in human CD14(+)monocytes in vitro. Treatment with tocilizumab (n=13), but not abatacept (n=11), significantly reduced TNFAIP9 mRNA expression in PBMC, which was associated with reduction in the number of circulating CD14(bright) monocytes. The expression of TNFAIP9 in CD14(+) cells was specifically elevated in patients with RA, regulated by TNF- and LPS, and suppressed by tocilizumab, while TNFAIP3 in PBMC showed different localization and induction patterns.	[Takai, C.; Matsumoto, I.; Inoue, A.; Umeda, N.; Tanaka, Y.; Kurashima, Y.; Sumida, T.] Univ Tsukuba, Dept Internal Med, Fac Med, Div Rheumatol, Tsukuba, Ibaraki 3058575, Japan; [Takai, C.; Wada, Y.; Narita, I.] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata, Japan	Matsumoto, I (reprint author), Univ Tsukuba, Dept Internal Med, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	ismatsu@md.tsukuba.ac.jp			Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science	We thank Dr F. G. Issa for the critical reading of the manuscript. This work was supported in part by Health and Labour Sciences Research Grants for research on intractable diseases from the Ministry of Health, Labour and Welfare of Japan, and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology and from the Japan Society for the Promotion of Science.	Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Steinman L, 2012, NAT MED, V18, P59, DOI 10.1038/nm.2625; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Orozco G, 2009, HUM MOL GENET, V18, P2693, DOI 10.1093/hmg/ddp193; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Matsumoto I, 2014, CLIN IMMUNOL, V153, P73, DOI 10.1016/j.clim.2014.03.015; Maxwell JR, 2012, RHEUMATOLOGY, V51, P1514, DOI 10.1093/rheumatology/kes134; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; TEWARI M, 1995, J IMMUNOL, V154, P1699; Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Tanaka Y, 2012, MOD RHEUMATOL, V22, P128, DOI 10.1007/s10165-011-0475-y; Tanaka Y, 2012, CLIN EXP RHEUMATOL, V30, P99; Coulthard LR, 2012, CLIN EXP IMMUNOL, V170, P36, DOI 10.1111/j.1365-2249.2012.04626.x; Vereecke L, 2011, BIOCHEM SOC T, V39, P1086, DOI 10.1042/BST0391086; Vaitla PM, 2011, ARTHRITIS RHEUM-US, V63, P1151, DOI 10.1002/art.30215; Al-Shakarchi I, 2013, PATIENT PREFER ADHER, V7, P653, DOI 10.2147/PPA.S41433; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Dieguez-Gonzalez R, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2650; Gilli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008962; Inoue A, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2779; Inoue A, 2012, ARTHRITIS RHEUM-US, V64, P3877, DOI 10.1002/art.34666; International Multiple Sclerosis Genetics Consortium, 2013, NAT GENET, V45, P1353; Navone ND, 2014, J NEUROIMMUNOL, V272, P99, DOI 10.1016/j.jneuroim.2014.04.017; Noh R, 2014, J MICROBIOL BIOTECHN, V24, P119, DOI 10.4014/jmb.1307.07046; Richez C, 2012, J RHEUMATOL, V39, P1192, DOI 10.3899/jrheum.111439; vansGestel AM, 1996, ARTHRITIS RHEUM, V39, P34; Wang X, 2014, J IMMUNOL RES, DOI 10.1155/2014/492872; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	JUN	2015	180	3					458	466		10.1111/cei.12606		9	Immunology	Immunology	CI2FU	WOS:000354561700011		
J	Uchida, K; Satoh, M; Inoue, G; Onuma, K; Miyagi, M; Iwabuchi, K; Takaso, M				Uchida, K.; Satoh, M.; Inoue, G.; Onuma, K.; Miyagi, M.; Iwabuchi, K.; Takaso, M.			CD11c(+) macrophages and levels of TNF- and MMP-3 are increased in synovial and adipose tissues of osteoarthritic mice with hyperlipidaemia	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						hyperlipidaemia; macrophage; matrix metalloprotease-3; osteoarthritis; tumour necrosis factor-	DEGENERATIVE JOINT DISEASE; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; INSULIN-RESISTANCE; MATRIX METALLOPROTEINASES; METABOLIC SYNDROME; KNEE OSTEOARTHRITIS; GENE-EXPRESSION; CRUCIAL ROLE; FATTY-ACIDS	To understand more clearly the link between osteoarthritis and hyperlipidaemia, we investigated the inflammatory macrophage subsets and macrophage-regulated matrix metalloprotease-3 (MMP-3) and A disintegrin and metalloprotease with thrombospondin motifs-4 (ADAMTS4) in synovial (ST) and adipose tissues (AT) of osteoarthritic mice with hyperlipidaemia (STR/Ort). CD11c(+)F4/80(+)CD11b(+) macrophage populations in the ST and AT of 9-month-old STR/Ort and C57BL/6J mice were characterized and compared by flow cytometry and real-time polymerase chain reaction (PCR) analyses. Expression of tumour necrosis factor (TNF)-, MMP-3 and ADAMTS4, and the response of these factors to anionic liposomal clodronate induced-macrophage depletion were also evaluated by real-time PCR. Expression of TNF- in CD11c(+) cells, which were isolated by magnetic beads, was compared to CD11c(-) cells. In addition, the effect of TNF- on cultured synovial fibroblasts and adipocytes was investigated. CD11c(+)F4/80(+)CD11b(+) macrophages were increased in ST and AT of STR/Ort mice. The CD11c(+) cell fraction highly expressed TNF-. Expression of TNF- and MMP3 was increased in ST and AT, and was decreased upon macrophage depletion. TNF- treatment of cultured synovial fibroblasts and adipocytes markedly up-regulated MMP-3. CD11c(+)F4/80(+)CD11b(+) macrophages were identified as a common inflammatory subset in the AT and ST of STR/Ort mice with hyperlipidaemia. The induction of inflammation in AT and ST may be part of a common mechanism that regulates MMP3 expression through TNF-. Our findings suggest that increased numbers of CD11c(+) macrophages and elevated levels of TNF- and MMP-3 in AT and ST may explain the relationship between hyperlipidaemia and OA.	[Uchida, K.; Inoue, G.; Onuma, K.; Miyagi, M.; Takaso, M.] Kitasato Univ, Sch Med, Dept Orthoped Surg, Sagamihara, Kanagawa 2520374, Japan; [Satoh, M.; Iwabuchi, K.] Kitasato Univ, Sch Med, Dept Immunol, Sagamihara, Kanagawa 2520374, Japan	Uchida, K (reprint author), Kitasato Univ, Sch Med, Dept Orthoped Surg, 1-15-1 Minami Ku, Sagamihara, Kanagawa 2520374, Japan.	kuchida@med.kitasato-u.ac.jp			Ministry of Education, Sports, Culture, Science and Technology of Japan; Japanese Ministry of Health; Medical Research Grant from The General Insurance Association of Japan; Kitasato University Research Grant for Young Researchers; Parents' Association of Kitasato University School of Medicine	This investigation was supported in part by Grants-in-Aid from the Ministry of Education, Sports, Culture, Science and Technology of Japan to K. O. and K. U., by a Grant-in-Aid from the Japanese Ministry of Health, by a Medical Research Grant from The General Insurance Association of Japan, by a Kitasato University Research Grant for Young Researchers, and by research grants from the Parents' Association of Kitasato University School of Medicine.	Young L, 2001, ARTHRITIS RHEUM, V44, P343, DOI 10.1002/1529-0131(200102)44:2<343::AID-ANR52>3.0.CO;2-Q; Mason RM, 2001, OSTEOARTHR CARTILAGE, V9, P85, DOI 10.1053/joca.2000.0363; Yang ZH, 2011, J AGR FOOD CHEM, V59, P7482, DOI 10.1021/jf201496h; Benito MJ, 2005, ANN RHEUM DIS, V64, P1263, DOI 10.1136/ard.2004.025270; Fioravanti A, 2009, RHEUMATOL INT, V29, P961, DOI 10.1007/s00296-009-0872-0; Lohmander LS, 2005, ARTHRITIS RHEUM, V52, P3160, DOI 10.1002/art.21345; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Blom AB, 2007, ARTHRITIS RHEUM, V56, P147, DOI 10.1002/art.22337; Verma P, 2011, J CELL BIOCHEM, V112, P3507, DOI 10.1002/jcb.23298; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Magnano MD, 2007, J RHEUMATOL, V34, P1323; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Tsuneyoshi Y, 2012, SCAND J RHEUMATOL, V41, P132, DOI 10.3109/03009742.2011.605391; Guler-Yuksel M, 2010, OSTEOARTHR CARTILAGE, V18, P1256, DOI 10.1016/j.joca.2010.07.011; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI2000319246; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Sturmer T, 1998, J RHEUMATOL, V25, P1827; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Puenpatom RA, 2009, POSTGRAD MED, V121, P9, DOI 10.3810/pgm.2009.11.2073; Gonzalez-Gay MA, 2010, ANN NY ACAD SCI, V1193, P153, DOI 10.1111/j.1749-6632.2009.05287.x; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; FARAHAT MN, 1993, ANN RHEUM DIS, V52, P870, DOI 10.1136/ard.52.12.870; Yoshihara Y, 2000, ANN RHEUM DIS, V59, P455, DOI 10.1136/ard.59.6.455; Grunke M, 2006, ANN RHEUM DIS, V65, P555, DOI 10.1136/ard.2006.053272; HART DJ, 1994, ANN RHEUM DIS, V53, P158, DOI 10.1136/ard.53.3.158; Seriolo B, 2008, CLIN EXP RHEUMATOL, V26, P159; Tam LS, 2007, CLIN RHEUMATOL, V26, P1495, DOI 10.1007/s10067-007-0539-8; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Mimata Y, 2012, INT J RHEUM DIS, V15, P36, DOI 10.1111/j.1756-185X.2011.01656.x; O'Hara A, 2009, PFLUG ARCH EUR J PHY, V458, P1103, DOI 10.1007/s00424-009-0693-8; Bondeson J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2099; Christiaens V, 2008, THROMB HAEMOSTASIS, V99, P290, DOI 10.1160/TH07-10-0589; Duerr S, 2004, CLIN EXP RHEUMATOL, V22, P603; Feng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024358; Gwozdziewiczova Simona, 2005, Biomedical Papers (Olomouc), V149, P109; Hopps E, 2012, EUR J INTERN MED, V23, P99, DOI 10.1016/j.ejim.2011.09.012; Miller RS, 2008, J NUTR, V138, P1033; Naruse K, 2009, CONNECT TISSUE RES, V50, P243, DOI 10.1080/03008200902836065; Păstrăiguş Carmen, 2012, Rev Med Chir Soc Med Nat Iasi, V116, P481; Pelletier J P, 1995, J Rheumatol Suppl, V43, P109; Satoh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030568; Uchida K, 2013, EXP ANIM TOKYO, V62, P255; Uchida K, 2011, J APPL ANIM RES, V39, P149, DOI 10.1080/09712119.2011.565567; Uchida K, 2009, EXP ANIM TOKYO, V58, P181; Voros G, 2003, BBA-GENE STRUCT EXPR, V1625, P36, DOI 10.1016/S0167-4781(02)00589-4; WALTON M, 1977, J PATHOL, V123, P109, DOI 10.1002/path.1711230207; WALTON M, 1977, J PATHOL, V123, P97, DOI 10.1002/path.1711230206; Yaykasli KO, 2015, CELL BIOL INT, V39, P104, DOI 10.1002/cbin.10336	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	JUN	2015	180	3					551	559		10.1111/cei.12607		9	Immunology	Immunology	CI2FU	WOS:000354561700020		
J	Motozono, C; Bridgeman, JS; Price, DA; Sewell, AK; Ueno, T				Motozono, C.; Bridgeman, J. S.; Price, D. A.; Sewell, A. K.; Ueno, T.			Clonotypically similar hybrid T cell receptors can exhibit markedly different surface expression, antigen specificity and cross-reactivity	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						CD8(+) T cells; CDR3; HIV; TCR	ENHANCED ANTITUMOR-ACTIVITY; CANCER REGRESSION; IMMUNE ESCAPE; GENE-THERAPY; HIV-1 NEF; TCR; RECOGNITION; DISPLAY; LYMPHOCYTES; PEPTIDE	Emerging data indicate that particular major histocompatibility complex (MHC)-bound antigenic peptides can be recognized by identical or near-identical T cell receptors (TCRs) in different individuals. To establish the functional relevance of this phenomenon, we artificially paired and chains from closely related TCRs specific for the human leucocyte antigen (HLA)-B*35:01-restricted HIV-1 negative regulatory factor (Nef)-derived epitope VY8 (VPLRPMTY, residues 74-81). Several hybrid TCRs generated in this manner failed to express at the cell surface, despite near homology with naturally isolated chain combinations. Moreover, a substantial proportion of those TCRs that did express lost specificity for the index VY8 peptide sequence. One such hybrid pair gained neo-variant specificity in the context of the VY8 backbone. Collectively, these data show that clonotypically similar TCRs can display profound differences in surface expression, antigen specificity and cross-reactivity with potential relevance for the control of mutable viruses.	[Motozono, C.; Ueno, T.] Kumamoto Univ, Ctr AIDS Res, Honjo, Kumamoto 8600811, Japan; [Motozono, C.; Bridgeman, J. S.; Price, D. A.; Sewell, A. K.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales; [Ueno, T.] Kumamoto Univ, Int Res Ctr Med Res, Honjo, Kumamoto 8600811, Japan	Ueno, T (reprint author), Kumamoto Univ, Ctr AIDS Res, 2-2-1 Chuo Ku, Honjo, Kumamoto 8600811, Japan.	uenotaka@kumamoto-u.ac.jp	Price, David/C-7876-2013; Ueno, Takamasa/F-5788-2013	Ueno, Takamasa/0000-0003-4852-4236	Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labor and Welfare of Japan	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan, and by a grant-in-aid for AIDS research from the Ministry of Health, Labor and Welfare of Japan (to TU). DAP and AKS are Wellcome Trust Senior Investigators.	Iglesias MC, 2011, BLOOD, V118, P2138, DOI 10.1182/blood-2011-01-328781; Irving M, 2012, J BIOL CHEM, V287, P23068, DOI 10.1074/jbc.M112.357673; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; Robbins PF, 2008, J IMMUNOL, V180, P6116; Miles JJ, 2011, IMMUNOL CELL BIOL, V89, P375, DOI 10.1038/icb.2010.139; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Udyavar A, 2009, J IMMUNOL, V182, P4439, DOI 10.4049/jimmunol.0804377; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Ueno T, 2008, J IMMUNOL, V180, P1107; Price DA, 2004, IMMUNITY, V21, P793, DOI 10.1016/j.immuni.2004.10.010; Malecek K, 2013, J IMMUNOL METHODS, V392, P1, DOI 10.1016/j.jim.2013.02.018; Heemskerk MHM, 2007, BLOOD, V109, P235, DOI 10.1182/blood-2006-03-013318; Hofmann C, 2011, BLOOD, V118, P5174, DOI 10.1182/blood-2011-04-347005; Yokosuka T, 2002, J EXP MED, V195, P991, DOI 10.1084/jem.20010809; Schumacher TNM, 2002, NAT REV IMMUNOL, V2, P512, DOI 10.1038/nri841; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Hasegawa A, 2007, J IMMUNOL, V178, P3409; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Kobayashi E, 2013, NAT MED, V19, P1542, DOI 10.1038/nm.3358; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; Hawse WF, 2012, J IMMUNOL, V188, P5819, DOI 10.4049/jimmunol.1200952; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Richman SA, 2007, BIOMOL ENG, V24, P361, DOI 10.1016/j.bioeng.2007.02.009; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bartok I, 2010, MOL IMMUNOL, V47, P1613, DOI 10.1016/j.molimm.2010.01.012; Bennett MS, 2010, AIDS, V24, P2619, DOI 10.1097/QAD.0b013e32833f7b22; Birnbaum ME, 2014, P NATL ACAD SCI USA, V111, P17576, DOI 10.1073/pnas.1420936111; Ekeruche-Makinde J, 2013, BLOOD, V121, P1112, DOI 10.1182/blood-2012-06-437202; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Kessels HWHC, 2000, P NATL ACAD SCI USA, V97, P14578, DOI 10.1073/pnas.97.26.14578; Motozono C, 2014, MICROBES INFECT, V16, P320, DOI 10.1016/j.micinf.2013.12.005; Motozono C, 2009, J IMMUNOL, V182, P5528, DOI 10.4049/jimmunol.0803471; Motozono C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066152; OHNO H, 1991, J IMMUNOL, V146, P3742; Pierce B.G., 2014, PLOS COMPUT BIOL, V10; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Ueno T, 2003, EUR J IMMUNOL, V33, P2910, DOI 10.1002/eji.200324148; Ueno T, 2002, J IMMUNOL, V169, P4961; Ueno T, 2004, EUR J IMMUNOL, V34, P3379, DOI 10.1002/eji.200425568; vansLoenen MM, 2010, P NATL ACAD SCI USA, V107, P10972; Wang YB, 2005, P NATL ACAD SCI USA, V102, P2476, DOI 10.1073/pnas.0409798102	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9104	1365-2249		CLIN EXP IMMUNOL	Clin. Exp. Immunol.	JUN	2015	180	3					560	570		10.1111/cei.12610		11	Immunology	Immunology	CI2FU	WOS:000354561700021		
J	Sugimura, M; Kudo, C; Hanamoto, H; Oyamaguchi, A; Morimoto, Y; Boku, A; Niwa, H				Sugimura, Mitsutaka; Kudo, Chiho; Hanamoto, Hiroshi; Oyamaguchi, Aiko; Morimoto, Yoshinari; Boku, Aiji; Niwa, Hitoshi			Considerations during intravenous sedation in geriatric dental patients with dementia	CLINICAL ORAL INVESTIGATIONS			English	Article						Geriatric; Dementia; Dental treatment; Intravenous sedation; General management; Complications	PROPOFOL ANESTHESIA; BISPECTRAL INDEX; ORAL-HEALTH; RECOVERY; REFLEX	Objectives We retrospectively assessed the usability and precautions required during intravenous sedation (IVS) for dental treatment in geriatric outpatients with dementia. Materials and methods We investigated the intraoperative complications in 65 cases (25 geriatric dental patients with dementia) under IVS, from the standpoint of local anesthesia usage, water usage during treatment, and content of treatment. Results Circulatory complications occurred in 46.2 % and respiratory complications in 52.3 % of all cases (n=65). Bradycardia occurred in 13.8 % and hypotension in 12.3 % of cases in the former, while coughing spells occurred in 41.5 % and snoring in 16.9 % of cases in the latter. Many of the local anesthesia usage cases did not require water usage, such as during tooth extraction (p<0.0001). Water usage cases, such as for caries treatment, needed longer sedation and treatment times, resulting in more propofol usage (p<0.001, p<0.0001, and p<0.01, respectively). Many coughing spells developed in the water usage cases (p<0.05). 81.8 % of snoring and 63.3 % of circulatory complications, such as hypotension and bradycardia, developed in the tooth extraction cases (p<0.05). Conclusions All the scheduled dental treatments in dementia patients were smoothly performed under IVS. However, stringent attention should be paid to the prevention of aspiration of fluids retained in the pharynx, airway obstruction due to therapeutic maneuvers, respiratory inhibition by sedatives, and hemodynamic fluctuations caused by invasive procedures under local anesthesia. Clinical relevance In the future, with the growing need for dental procedures in dementia patients, dentists will require training in the general management of such patients.	[Sugimura, Mitsutaka; Kudo, Chiho; Hanamoto, Hiroshi; Oyamaguchi, Aiko; Morimoto, Yoshinari; Boku, Aiji; Niwa, Hitoshi] Osaka Univ, Grad Sch Dent, Dept Dent Anesthesiol, Suita, Osaka 5650871, Japan	Sugimura, M (reprint author), Osaka Univ, Grad Sch Dent, Dept Dent Anesthesiol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	smit@dent.osaka-u.ac.jp					Ghezzi EM, 2000, ORAL SURG ORAL MED O, V89, P2, DOI 10.1016/S1079-2104(00)80003-7; Ghezzi EM, 2000, J PUBLIC HEALTH DENT, V60, P289, DOI 10.1111/j.1752-7325.2000.tb03337.x; Schnider TW, 1999, ANESTHESIOLOGY, V90, P1502, DOI 10.1097/00000542-199906000-00003; Lobbezoo F, 2011, J OROFAC PAIN, V25, P6; Furuta M, 2013, COMMUNITY DENT ORAL, V41, P173, DOI 10.1111/cdoe.12000; RIMANIOL JM, 1994, ANESTH ANALG, V79, P856; Engstrom S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-194; Erdogan MA, 2012, EUR J ANAESTH, V29, P326, DOI 10.1097/EJA.0b013e32835475c6; Fujisawa Toshiaki, 2007, Spec Care Dentist, V27, P187, DOI 10.1111/j.1754-4505.2007.tb00344.x; Galli M T, 1999, Spec Care Dentist, V19, P275, DOI 10.1111/j.1754-4505.1999.tb01397.x; Hanamoto H, 2013, J ORAL MAXIL SURG, V71, pE158, DOI 10.1016/j.joms.2012.12.014; Henry R G, 1997, J Indiana Dent Assoc, V76, P51; Keita H, 1998, BRIT J ANAESTH, V81, P249; Mochizuki Kiyoshi, 2007, Bull Tokyo Dent Coll, V48, P135, DOI 10.2209/tdcpublication.48.135; Nicolas E, 2009, CLIN INTERV AGING, V4, P67; Peter R, 1993, Anesth Pain Control Dent, V2, P140; Preston A J, 2012, Dent Update, V39, P141; Renna M, 2003, ANESTH ANALG, V96, P1380, DOI 10.1213/01.ANE.0000059223.78879.0F; TOMLIN PJ, 1974, ANAESTHESIA, V29, P551, DOI 10.1111/j.1365-2044.1974.tb00718.x; Yli-Hankala A, 1999, ACTA ANAESTH SCAND, V43, P545, DOI 10.1034/j.1399-6576.1999.430510.x	20	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1432-6981	1436-3771		CLIN ORAL INVEST	Clin. Oral Investig.	JUN	2015	19	5					1107	1114		10.1007/s00784-014-1334-y		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CI2ZG	WOS:000354616300018		
J	Yabe, D; Seino, Y; Fukushima, M; Seino, S				Yabe, Daisuke; Seino, Yutaka; Fukushima, Mitsuo; Seino, Susumu			beta Cell Dysfunction Versus Insulin Resistance in the Pathogenesis of Type 2 Diabetes in East Asians	CURRENT DIABETES REPORTS			English	Article						Type 2 diabetes; Insulin secretion; Insulin resistance; East Asian; Incretin	GLUCAGON-LIKE PEPTIDE-1; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; NORMAL GLUCOSE-TOLERANCE; SERUM EICOSAPENTAENOIC ACID; IMPAIRED FASTING GLUCOSE; GENOME-WIDE ASSOCIATION; MINIMAL MODEL ANALYSIS; JAPANESE-AMERICAN MEN; ETHNIC-DIFFERENCES; INCRETIN SECRETION	Type 2 diabetes (T2DM) is one of the most serious global health problems and is mainly a result of the drastic increase in East Asia, which includes over a fourth of the global diabetes population. Lifestyle factors and ethnicity are two determinants in the etiology of T2DM, and lifestyle changes such as higher fat intake and less physical activity link readily to T2DM in East Asians. It is widely recognized that T2DM in East Asians is characterized primarily by beta cell dysfunction, which is evident immediately after ingestion of glucose or meal, and less adiposity compared to the disease in Caucasians. These pathophysiological differences have an important impact on therapeutic approaches. Here, we revisit the pathogenesis of T2DM in light of beta cell dysfunction versus insulin resistance in East Asians and discuss ethnic differences in the contributions of insulin secretion and insulin resistance, together with incretin secretin and action, to glucose intolerance.	[Yabe, Daisuke; Seino, Yutaka; Fukushima, Mitsuo] Kansai Elect Power Hosp, Ctr Diabet Endocrinol & Metab, Osaka 5530003, Japan; [Yabe, Daisuke] Kansai Elect Power Hosp, Ctr Metab & Clin Nutr, Osaka 5530003, Japan; [Yabe, Daisuke; Fukushima, Mitsuo; Seino, Susumu] Kobe Univ, Div Mol & Metab Med, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Fukushima, Mitsuo] Okayama Prefectural Univ, Dept Nutr Sci, Soujiya, Okayama 7191197, Japan	Yabe, D (reprint author), Kansai Elect Power Hosp, Ctr Diabet Endocrinol & Metab, 2-1-7 Fukushima Ku, Osaka 5530003, Japan.	ydaisuke-kyoto@umin.ac.jp					[Anonymous], 2014, IDF DIAB ATL 2014 UP, VSixth; Kozawa J, 2010, BIOCHEM BIOPH RES CO, V393, P410, DOI 10.1016/j.bbrc.2010.01.134; NAUCK MA, 1986, J CLIN ENDOCR METAB, V63, P492; FUJIMOTO WY, 1987, DIABETES, V36, P721, DOI 10.2337/diabetes.36.6.721; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; McNeely MJ, 2004, DIABETES CARE, V27, P66, DOI 10.2337/diacare.27.1.66; Yabe D, 2010, J DIABETES INVEST, V1, P56, DOI 10.1111/j.2040-1124.2010.00010.x; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Moller JB, 2014, DIABETES CARE, V37, P796, DOI 10.2337/dc13-0598; Seino Y, 2013, J DIABETES INVEST, V4, P108, DOI 10.1111/jdi.12065; Bagger JI, 2011, J CLIN ENDOCR METAB, V96, P737, DOI 10.1210/jc.2010-2435; [Anonymous], 2012, NAT GENET, DOI DOI 10.1038/NG.1019; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Abate N, 2003, J DIABETES COMPLICAT, V17, P39, DOI 10.1016/S1056-8727(02)00190-3; KAGAN A, 1974, J CHRON DIS, V27, P345, DOI 10.1016/0021-9681(74)90014-9; FUJIMOTO WY, 1987, DIABETES, V36, P730, DOI 10.2337/diabetes.36.6.730; Kim YG, 2013, DIABETOLOGIA, V56, P696, DOI 10.1007/s00125-012-2827-3; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; Yabe D, 2012, J DIABETES INVEST, V3, P70, DOI 10.1111/j.2040-1124.2011.00141.x; Nauck MA, 2011, DIABETOLOGIA, V54, P10, DOI 10.1007/s00125-010-1896-4; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Kubota A, 2014, J DIABETES INVEST, V5, P445, DOI 10.1111/jdi.12182; Knop FK, 2007, DIABETES, V56, P1951, DOI 10.2337/db07-0100; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Calanna S, 2013, DIABETES CARE, V36, P3346, DOI 10.2337/dc13-0465; Kim DJ, 2001, METABOLISM, V50, P590, DOI 10.1053/meta.2001.22558; WELCH S, 1990, J CLIN ENDOCR METAB, V71, P1508; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Takahashi H, 2015, DIABETES, V64, P1262, DOI 10.2337/db14-0576; Cho YS, 2012, CURR DIABETES REP, V12, P686, DOI 10.1007/s11892-012-0326-z; Park H, 2012, ANN PHARMACOTHER, V46, P1453, DOI 10.1345/aph.1R041; Ntuk UE, 2014, DIABETES CARE, V37, P2500, DOI 10.2337/dc13-2966; Fukushima M, 2004, METABOLISM, V53, P831, DOI 10.1016/j.metabol.2004.02.012; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; KADOWAKI T, 1984, DIABETOLOGIA, V26, P44; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Qiao Q, 2000, DIABETOLOGIA, V43, P1470, DOI 10.1007/s001250051557; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Vilsboll T, 2002, DIABETOLOGIA, V45, P1111, DOI 10.1007/s00125-002-0878-6; Yabe D, 2014, J DIABETES INVEST, V5, P475, DOI 10.1111/jdi.12229; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Fujimoto WY, 2012, J DIABETES INVEST, V3, P212, DOI 10.1111/j.2040-1124.2012.00195.x; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Southam L, 2009, DIABETOLOGIA, V52, P1846, DOI 10.1007/s00125-009-1419-3; Yabe D, 2011, PROG BIOPHYS MOL BIO, V107, P248, DOI 10.1016/j.pbiomolbio.2011.07.010; Seino Y, 2012, J DIABETES INVEST, V3, P388, DOI 10.1111/j.2040-1124.2012.00193.x; Calanna S, 2013, DIABETOLOGIA, V56, P965, DOI 10.1007/s00125-013-2841-0; NEEL JV, 1962, AM J HUM GENET, V14, P353; Vollmer K, 2008, DIABETES, V57, P678, DOI 10.2337/db07-1124; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Choi Yoon Hee, 2000, Korean Journal of Internal Medicine, V15, P211; DECODE study group, 1998, BMJ-BRIT MED J, V317, P371; FUJIMOTO W Y, 1983, Tohoku Journal of Experimental Medicine, V141, P133; Fukushima M, 2004, DIABETES RES CLIN PR, V66, pS37, DOI 10.1016/j.diabres.2003.11.024; Gheni G, 2014, CELL REP, V9, P661, DOI 10.1016/j.celrep.2014.09.030; GONOI T, 1994, J BIOL CHEM, V269, P16989; Nakagami T, 2003, DIABETOLOGIA, V46, P1063, DOI 10.1007/s00125-003-1158-9; Hamasaki A, 2011, DIABETOLOGIA, V54, pS217; Hwang JY, 2015, DIABETES, V64, P291, DOI 10.2337/db14-0563; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI [10.2337/dc12-0413, 10.2337/dc12-041.3]; Iwahashi H, 2012, J DIABETES INVEST, V3, P271, DOI 10.1111/j.2040-1124.2011.00180.x; Iwasaki M, 2012, J DIABETES INVEST, V3, P464, DOI 10.1111/j.2040-1124.2012.00214.x; Kanamori Akira, 2013, J Clin Med Res, V5, P217, DOI 10.4021/jocmr1256w; Kim YG, 2014, DIABETES OBES METAB, V16, P900, DOI 10.1111/dom.12293; Kimura M, 1997, CYTOGENET CELL GENET, V78, P107, DOI 10.1159/000134639; Kohro T, 2013, INT HEART J, V54, P93; KOSAKA K, 1980, DIABETOLOGIA, V18, P23, DOI 10.1007/BF01228297; Kubota A, 2011, J DIABETES INVEST, V2, P377, DOI 10.1111/j.2040-1124.2011.00109.x; Lee S, 2010, ENDOCR J, V57, P119; Mitsui R, 2012, J DIABETES INVEST, V3, P377, DOI 10.1111/j.2040-1124.2012.00201.x; Moller JB, 2014, J CLIN ENDOCR METAB, V99, P4273, DOI 10.1210/jc.2014-1724; Mukai E, 2010, DIABETES, V60, P218; Nakanishi S, 2004, BIOMED PHARMACOTHER, V58, P571, DOI 10.1016/j.biopha.2004.10.001; Nishi Y, 2005, DIABETES RES CLIN PR, V70, P46, DOI 10.1016/j.diabres.2005.02.015; Ogihara T, 2010, J DIABETES INVEST, V1, P123, DOI 10.1111/j.2040-1124.2010.00021.x; Oh TJ, 2014, CLIN ENDOCRINOL OXF, DOI [10.1111/cen.12623, DOI 10.1111/CEN.12623]; Oh TJ, 2014, CLIN ENDOCRINOL, V80, P221, DOI 10.1111/cen.12167; OLEFSKY JM, 1981, DIABETES, V30, P148; Pang C, 2008, CHINESE MED J-PEKING, V121, P2119; Qian L, 2009, DIABETES-METAB RES, V25, P144, DOI 10.1002/dmrr.922; SEINO Y, 1975, ACTA DIABETOL LAT, V12, P89, DOI 10.1007/BF02624728; SEINO Y, 1978, DIABETES, V27, P1145, DOI 10.2337/diabetes.27.12.1145; SEINO Y, 1977, HORM METAB RES, V9, P28; Senmaru T, 2012, J DIABETES INVEST, V3, P498, DOI 10.1111/j.2040-1124.2012.00220.x; Shibasaki T, 2014, DIABETES OBES METAB, V16, P118, DOI 10.1111/dom.12343; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Sloan R, 1963, JAMA-J AM MED ASSOC, V183, P419; Suzuki H, 2003, DIABETES CARE, V26, P1211, DOI 10.2337/diacare.26.4.1211; Takahashi T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004581; Tanaka S, 2003, ACTA DIABETOL, V40, pS302, DOI 10.1007/s00592-003-0093-z; TANIGUCHI A, 1992, DIABETES, V41, P1540, DOI 10.2337/diabetes.41.12.1540; Tripathy D, 2000, DIABETES, V49, P975, DOI 10.2337/diabetes.49.6.975; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Ullrich S, 2005, PFLUG ARCH EUR J PHY, V451, P428, DOI 10.1007/s00424-005-1479-2; WEST KM, 1974, DIABETES, V23, P841; Yabe D, 2015, DIABETES OBES METAB, V17, P430, DOI 10.1111/dom.12381; Yabe D, 2015, J DIABETES COMPLICAT, V29, P413, DOI 10.1016/j.jdiacomp.2014.12.010; Yabe D, 2014, DIABETES, V64, pLB12	100	3	3	CURRENT MEDICINE GROUP	PHILADELPHIA	400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA	1534-4827	1539-0829		CURR DIABETES REP	Curr. Diabetes Rep.	JUN	2015	15	6								10.1007/s11892-015-0602-9		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CI0TL	WOS:000354450900006		
J	Ayuzawa, N; Fujita, T				Ayuzawa, Nobuhiro; Fujita, Toshiro			Activation of Mineralocorticoid Receptor in Salt-Sensitive Hypertension	CURRENT HYPERTENSION REPORTS			English	Article						Hypertension; Blood pressure; Kidney; Renal injury; Salt-sensitive hypertension; Mineralocorticoid	CORTICAL COLLECTING DUCT; RENAL TUBULAR-ACIDOSIS; NA-CL COTRANSPORTER; BLOOD-PRESSURE; ANGIOTENSIN-II; INTERCALATED CELLS; METABOLIC SYNDROME; SUSTAINED CORRECTION; POTASSIUM-TRANSPORT; ALDOSTERONE BLOCKER	The impaired capacity of the kidney to excrete sodium plays an essential role in the development of hypertension. Adrenal corticosteroids control renal handling of sodium by regulating tubular sodium reabsorption in the distal nephron where both mineralocorticoid receptors (MR) and glucocorticoid receptors are expressed. In addition, cell type-and segment-specific expression of 11 beta-HSD2 and sodium transporters such as Na-Cl cotransporter (NCC), epithelial sodium channel (ENaC), and pendrin/Na+-driven Cl-/HCO3- exchanger (NDCBE) builds a distinctive model of sodium transport in the aldosterone-sensitive distal nephron. Aberrant MR activation in the distal nephron triggers salt-sensitive hypertension and hypokalemia through inappropriate sodium reabsorption and potassium secretion. However, MR activity is not necessarily modulated by the ligand alone. Recently, several lines of evidence revealed alternative mechanisms that regulate the activity of MR in a ligand-independent manner or through ligand binding modulation. This review summarizes the disorders related to MR activation in individual tubular cells and highlights the renal mechanism of salt-sensitive hypertension and new approaches for the prevention and treatment of this disease.	[Ayuzawa, Nobuhiro; Fujita, Toshiro] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Clin Epigenet, Meguro Ku, Tokyo 1538904, Japan; [Fujita, Toshiro] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020076, Japan	Fujita, T (reprint author), Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Clin Epigenet, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	Toshiro.FUJITA@rcast.u-tokyo.ac.jp			Japan Society for the Promotion of Science KAKENHI [21229012]	This work was supported by Japan Society for the Promotion of Science KAKENHI (Grant Number 21229012).	Albiston A.L., 1994, MOL CELL ENDOCRINOL, V105, P11; Ando K, 2014, LANCET DIABETES ENDO, V2, P944, DOI 10.1016/S2213-8587(14)70194-9; Farjah M, 2003, HYPERTENSION, V41, P874, DOI 10.1161/01.HYP.0000063885.48344.EA; BRILLA CG, 1993, J MOL CELL CARDIOL, V25, P563, DOI 10.1006/jmcc.1993.1066; Rossier BC, 2013, FEBS LETT, V587, P1929, DOI 10.1016/j.febslet.2013.05.013; TOMITA K, 1986, J CLIN INVEST, V77, P136, DOI 10.1172/JCI112268; Williams GH, 2004, AM J CARDIOL, V93, P990, DOI 10.1016/j.amjcard.2004.01.007; Verlander JW, 2003, HYPERTENSION, V42, P356, DOI 10.1161/01.HYP.0000088321.67254.B7; Kyossev Z, 1996, KIDNEY INT, V49, P271, DOI 10.1038/ki.1996.39; Gupta IR, 2013, J MED GENET, V50, P330, DOI 10.1136/jmedgenet-2012-101442; Ko B, 2013, AM J PHYSIOL-RENAL, V305, pF645, DOI 10.1152/ajprenal.00053.2013; Elvira-Matelot E, 2010, J AM SOC NEPHROL, V21, P1724, DOI 10.1681/ASN.2009111186; Mihailidou AS, 2009, HYPERTENSION, V54, P1306, DOI 10.1161/HYPERTENSIONAHA.109.136242; Kobori H, 2003, HYPERTENSION, V41, P592, DOI 10.1161/01.HYP.0000056768.03657.B4; BRILLA CG, 1990, CIRC RES, V67, P1355; Kawarazaki W, 2012, J AM SOC NEPHROL, V23, P997, DOI 10.1681/ASN.2011070734; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Tanaka M, 1997, P NATL ACAD SCI USA, V94, P14748, DOI 10.1073/pnas.94.26.14748; Akilesh S, 2011, J CLIN INVEST, V121, P4127, DOI 10.1172/JCI46458; Arroyo JP, 2011, PHYSIOLOGY, V26, P115, DOI 10.1152/physiol.00049.2010; Kidambi S, 2007, HYPERTENSION, V49, P704, DOI 10.1161/01.HYP.0000253258.36141.c7; Reilly RF, 2000, PHYSIOL REV, V80, P277; Pech V, 2010, J AM SOC NEPHROL, V21, P1928, DOI 10.1681/ASN.2009121257; TOMITA K, 1985, J CLIN INVEST, V76, P132, DOI 10.1172/JCI111935; Chambrey R, 2013, P NATL ACAD SCI USA, V110, P7928, DOI 10.1073/pnas.1221496110; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Greene EL, 1996, J CLIN INVEST, V98, P1063, DOI 10.1172/JCI118867; Massaad C, 1999, MOL ENDOCRINOL, V13, P57, DOI 10.1210/me.13.1.57; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Faresse N, 2012, AM J PHYSIOL-RENAL, V302, pF977, DOI 10.1152/ajprenal.00535.2011; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Eladari D, 2012, ANNU REV PHYSIOL, V74, P325, DOI 10.1146/annurev-physiol-020911-153225; Nagase M, 2007, HYPERTENSION, V50, P877, DOI 10.1161/HYPERTENSIONAHA.107.091058; Ronzaud C, 2013, J CLIN INVEST, V123, P657, DOI 10.1172/JCI61110; Wall SM, 2004, HYPERTENSION, V44, P982, DOI 10.1161/01.HYP.0000145863.96091.89; Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; TERADA Y, 1990, AM J PHYSIOL, V259, pF519; Smith AN, 2000, NAT GENET, V26, P71; Mu S, 2011, NAT MED, V17, P573, DOI 10.1038/nm.2337; San-Cristobal P, 2009, P NATL ACAD SCI USA, V106, P4384, DOI 10.1073/pnas.0813238106; Shibata S, 2013, CELL METAB, V18, P660, DOI 10.1016/j.cmet.2013.10.005; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Pech V, 2007, AM J PHYSIOL-RENAL, V292, pF914, DOI 10.1152/ajprenal.00361.2006; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Bochud M, 2006, HYPERTENSION, V48, P239, DOI 10.1161/01.HYP.0000231338.41548.fc; WHITESCARVER SA, 1984, SCIENCE, V223, P1430, DOI 10.1126/science.6322303; KURTZ TW, 1983, SCIENCE, V222, P1139, DOI 10.1126/science.6648527; Rozansky DJ, 2009, J CLIN INVEST, V119, P2601, DOI 10.1172/JCI38323; Gueutin V, 2013, J CLIN INVEST, V123, P4219, DOI 10.1172/JCI63492; KURTZ TW, 1987, NEW ENGL J MED, V317, P1043, DOI 10.1056/NEJM198710223171702; Coffman TM, 2011, NAT MED, V17, P1402, DOI 10.1038/nm.2541; Gee HY, 2013, J CLIN INVEST, V123, P3243, DOI 10.1172/JCI69134; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Leviel F, 2010, J CLIN INVEST, V120, P1627, DOI 10.1172/JCI40145; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; GUYTON AC, 1990, HYPERTENSION, V16, P725; Nagase M, 2006, J AM SOC NEPHROL, V17, P3438, DOI 10.1681/ASN.2006080944; Aoi W, 2006, BIOCHEM BIOPH RES CO, V341, P376, DOI 10.1016/j.bbrc.2005.12.194; Azroyan A, 2012, AM J PHYSIOL-RENAL, V302, pF1180, DOI 10.1152/ajprenal.00403.2011; Bazua-Valenti S, 2014, J AM SOC NEPHROL; Campean V, 2001, AM J PHYSIOL-RENAL, V281, pF1028; de Paula RB, 2004, HYPERTENSION, V43, P41, DOI 10.1161/01.HYP.0000105624.68174.00; Frische S, 2003, AM J PHYSIOL-RENAL, V284, pF584, DOI 10.1152/ajprenal.00254.2002; FUJITA T, 1980, AM J MED, V69, P334, DOI 10.1016/0002-9343(80)90002-9; Funder JW, 2010, ENDOCRINOLOGY, V151, P5098, DOI 10.1210/en.2010-0465; HALL JE, 1990, HYPERTENSION, V15, P547; Jacques T, 2013, J AM SOC NEPHROL, V24, P1104, DOI 10.1681/ASN.2012080787; Luft Friedrich C., 1997, American Journal of Clinical Nutrition, V65, p612S; Luther JM, 2012, KIDNEY INT; ONEIL RG, 1977, AM J PHYSIOL, V233, pF544; Pacheco-Alvarez D, 2011, CELL PHYSIOL BIOCHEM, V28, P1123, DOI 10.1159/000335848; Pavlov TS, 2014, J BIOL CHEM, V289, P28651, DOI 10.1074/jbc.M114.558262; Pelzl L, 2012, CELL PHYSIOL BIOCHEM, V30, P1491, DOI 10.1159/000343337; Piala AT, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005050; ROCCHINI AP, 1989, NEW ENGL J MED, V321, P580, DOI 10.1056/NEJM198908313210905; SATO Y, 1991, HYPERTENSION, V18, P622; Schmidlin O, 2005, HYPERTENSION, V45, P867, DOI 10.1161/01.HYP.0000164628.46415.66; SEBASTIA.A, 1971, J CLIN INVEST, V50, P667, DOI 10.1172/JCI106537; SEBASTIAN A, 1976, J CLIN INVEST, V58, P454, DOI 10.1172/JCI108490; STONER LC, 1974, AM J PHYSIOL, V227, P453; Tapia-Castillo A, 2014, AM J HYPERTENS, V27, P299, DOI 10.1093/ajh/hpt277; Yokota K, 2007, J BIOL CHEM, V282, P1998, DOI 10.1074/jbc.M607741200	84	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1522-6417	1534-3111		CURR HYPERTENS REP	Curr. Hypertens. Rep.	JUN	2015	17	6							44	10.1007/s11906-015-0552-2		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CI2WW	WOS:000354609700005		
J	Nakamura, M; Chen, C; Mitarai, S				Nakamura, Masako; Chen, Chong; Mitarai, Satoshi			Insights into life-history traits of Munidopsis spp. (Anomura: Munidopsidae) from hydrothermal vent fields in the Okinawa Trough, in comparison with the existing data	DEEP-SEA RESEARCH PART I-OCEANOGRAPHIC RESEARCH PAPERS			English	Article						Galatheidae; Sexual maturity; Egg volume; Hydrothermal vent	EAST PACIFIC RISE; MID-ATLANTIC RIDGE; CRUSTACEA-DECAPODA-ANOMURA; COLD SEEPS; REPRODUCTIVE-BIOLOGY; NORTHEAST PACIFIC; LARVAL DISPERSAL; WESTERN PACIFIC; SQUAT LOBSTERS; DECADAL-SCALE	Squat lobsters in the genus Munidopsis are commonly found at, and near, hydrothermal vents. However, the reproductive traits of most Munidopsis spp. are unknown. This study examined the reproductive features of two Munidopsis species sampled from hydrothermal vent fields in the southern Okinawa Trough in February 2014. Three ovigerous females were collected: two Munidopsis ryukyuensis at Irabu Knoll (1661-1675 m depth) and one M. longispinosa at Hatoma Knoll (1482 m depth). Carapace sizes and egg volumes were measured and compared with those of other Munidopsis species. The ovigerous M. ryukyuensis specimens had postorbital carapace lengths of 10.3 and 11.8 mm, without the rostrum, and carapace widths of 8.6 and 9.7 mm. Mean egg volumes of M. ryukyuensis and M. longispinosa were similar to 4 mm(3). These results are consistent with early sexual maturity in M. ryukyuensis and lecithotrophic development in both species, as described in other species of the genus. These life-history traits may enable these vent species to maximize their reproductive and dispersive potential. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakamura, Masako; Mitarai, Satoshi] Okinawa Inst Sci & Technol, Marine Biophys Unit, Okinawa 9040412, Japan; [Chen, Chong] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Nakamura, M (reprint author), 1919-1 Tancha, Okinawa 9040495, Japan.	masako.nakamura@oist.jp			Canon Foundation from Japan Society for the Promotion of Science [24570037]; Marine Biophysics Unit of the Okinawa Institute of Science and Technology Graduate University	We are very grateful to the crew of the R/V KAIYO, the operational team of the ROV Hyper-Dolphin, and the research group of KY14-02. This research was supported by a Canon Foundation Grant-in-Aid for Scientific Research, no. 24570037 from the Japan Society for the Promotion of Science. We gratefully acknowledge the support of this work from Marine Biophysics Unit of the Okinawa Institute of Science and Technology Graduate University. We thank the anonymous reviewers for their very careful reviews and helpful comments, and OIST's technical editor, Dr. Steven D. Aird, for helping us to polish this manuscript.	Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI [10.1093/icb/icj024, 10.1093/icb/024]; Adams DK, 2012, OCEANOGRAPHY, V25, P256; Cuvelier D, 2011, MAR ECOL-EVOL PERSP, V32, P243, DOI 10.1111/j.1439-0485.2010.00431.x; Baba K, 2008, ZOOTAXA, P1; Mullineaux LS, 2010, P NATL ACAD SCI USA, V107, P7829, DOI 10.1073/pnas.0913187107; Nakamura M, 2014, MAR ECOL PROG SER, V505, P119, DOI 10.3354/meps10779; Gebruk A, 2010, CAH BIOL MAR, V51, P383; HESSLER RR, 1988, DEEP-SEA RES, V35, P1681, DOI 10.1016/0198-0149(88)90044-1; MACDONALD KC, 1982, ANNU REV EARTH PL SC, V10, P155, DOI 10.1146/annurev.ea.10.050182.001103; Tyler PA, 2008, J SHELLFISH RES, V27, P107, DOI 10.2983/0730-8000(2008)27[107:ROGFVO]2.0.CO;2; Vrijenhoek RC, 1997, J HERED, V88, P285; Young CM, 2003, ECOSY WORLD, V28, P381; Reznick D, 2002, ECOLOGY, V83, P1509, DOI 10.2307/3071970; Cubelio SS, 2007, ZOOTAXA, P25; Macpherson E, 2007, ZOOTAXA, P1; Goffredi SK, 2004, DEEP-SEA RES PT I, V51, P1295, DOI 10.1016/j.dsr.2004.05.009; CONVERSE DR, 1984, EARTH PLANET SC LETT, V69, P159, DOI 10.1016/0012-821X(84)90080-3; Baba K, 2011, BIOLOGY OF SQUAT LOBSTERS, P105; Copley JTP, 2007, J MAR BIOL ASSOC UK, V87, P859, DOI 10.1017/S0025315407056512; Kelly NE, 2007, MAR BIOL, V151, P649, DOI 10.1007/s00227-006-0505-z; Martin JW, 2005, ZOOL J LINN SOC-LOND, V145, P445, DOI 10.1111/j.1096-3642.2005.00178.x; Schnabel KE, 2011, BIOLOGY OF SQUAT LOBSTERS, P149; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Galkin SV, 1997, MAR GEOL, V142, P197, DOI 10.1016/S0025-3227(97)00051-0; Shanks AL, 2003, ECOL APPL, V13, pS159; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Watanabe H, 2005, MAR ECOL PROG SER, V288, P233, DOI 10.3354/meps288233; GRASSLE JF, 1985, SCIENCE, V229, P713, DOI 10.1126/science.229.4715.713; Osawa Masayuki, 2007, Bulletin of the National Museum of Nature and Science Series A-Zoology, V33, P133; HAYMON RM, 1993, EARTH PLANET SC LETT, V119, P85, DOI 10.1016/0012-821X(93)90008-W; WILKENS H, 1990, J CRUSTACEAN BIOL, V10, P667, DOI 10.2307/1548411; Baba K., 2005, GALATHEA REP, V20, P317; Barry JP, 1996, DEEP-SEA RES PT I, V43, P1739, DOI 10.1016/S0967-0637(96)00075-1; BENNETT BA, 1994, MAR ECOL PROG SER, V108, P205, DOI 10.3354/meps108205; Blicher ME, 2010, MAR ECOL PROG SER, V407, P71, DOI 10.3354/meps08536; Burgess SC, 2013, FUNCT ECOL, V27, P757, DOI 10.1111/1365-2435.12080; Cubelio SS, 2007, J CRUSTACEAN BIOL, V27, P513, DOI 10.1651/0278-0372(2007)27[513:VAMDAG]2.0.CO;2; Cubelio SS, 2008, J MAR BIOL ASSOC UK, V88, P111, DOI 10.1017/S00253154080000180; Cubelio Sherine Sonia, 2007, Crustacean Research, V36, P1; van Dover C.L., 1991, Crustacean Issues, V7, P143; Gustafson Richard G., 1994, P76; HASHIMOTO J, 1995, DEEP-SEA RES PT I, V42, P577, DOI 10.1016/0967-0637(94)00037-S; Kilgour MJ, 2014, ZOOTAXA, V 3754, P381, DOI 10.11646/zootaxa.3754.4.3; Lalou C, 1991, J MARINE SYST, V1, P403, DOI 10.1016/0924-7963(91)90007-H; Lundsten L, 2010, DEEP-SEA RES PT I, V57, P1573, DOI 10.1016/j.dsr.2010.09.003; Macpherson Enrique, 2005, Zootaxa, V1095, P1; Macpherson E, 2014, ZOOTAXA, V3753, P291, DOI 10.11646/zootaxa.3753.3.8; Miyake H, 2010, CAH BIOL MAR, V51, P441; Mullineaux LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050015; Nye V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060319; Ohta Suguru, 2001, Journal of Oceanography, V57, P663, DOI 10.1023/A:1021620023610; PERFIT MR, 1998, MAGMATISM MIDOCEAN R, V106, P59; Ramirez Llodra Eva, 2002, Adv Mar Biol, V43, P87, DOI 10.1016/S0065-2881(02)43004-0; Roff D. A., 2002, LIFE HIST EVOLUTION, V7; Samuelson T.J., 1972, Sarsia, VNo. 48, P91; Scheltema R.S., 1994, REPROD LARVAL BIOL R, V44; Stearns S. C., 1992, EVOLUTION LIFE HIST; Tsuchida Shinji, 2003, Japanese Journal of Benthology, V58, P84; Tyler PA, 1999, J MAR BIOL ASSOC UK, V79, P193, DOI 10.1017/S0025315499000235; Van Dover C., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 1985, B BIOL SOC WASH, V6, P223; WILLIAMS A B, 1983, Proceedings of the Biological Society of Washington, V96, P481	62	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0967-0637	1879-0119		DEEP-SEA RES PT I	Deep-Sea Res. Part I-Oceanogr. Res. Pap.	JUN	2015	100						48	53		10.1016/j.dsr.2015.02.007		6	Oceanography	Oceanography	CI2PG	WOS:000354588900005		
J	Grossmann, MM; Nishikawa, J; Lindsay, DJ				Grossmann, Mary M.; Nishikawa, Jun; Lindsay, Dhugal J.			Diversity and community structure of pelagic cnidarians in the Celebes and Sulu Seas, southeast Asian tropical marginal seas	DEEP-SEA RESEARCH PART I-OCEANOGRAPHIC RESEARCH PAPERS			English	Article						Tropical; Marginal sea; Sill; Pelagic cnidarians; Community structure	PACIFIC-OCEAN; CHINA SEA; SIPHONOPHORA; DISTRIBUTIONS; ZOOGEOGRAPHY; ZOOPLANKTON; CIRCULATION; ADJACENT; REGIONS; WATERS	The Sulu Sea is a semi-isolated, marginal basin surrounded by high sills that greatly reduce water inflow at mesopelagic depths. For this reason, the entire water column below 400 m is stable and homogeneous with respect to salinity (ca. 34.00) and temperature (ca. 10 degrees C). The neighbouring Celebes Sea is more open, and highly influenced by Pacific waters at comparable depths. The abundance, diversity, and community structure of pelagic cnidarians was investigated in both seas in February 2000. Cnidarian abundance was similar in both sampling locations, but species diversity was lower in the Sulu Sea, especially at mesopelagic depths. At the surface, the cnidarian community was similar in both marginal seas, but, at depth, community structure was dependent first on sampling location and then on depth within each Sea. Cnidarians showed different patterns of dominance at the two sampling locations, with Sulu Sea communities often dominated by species that are rare elsewhere in the Indo-Pacific. Mesopelagic and bathypelagic species recorded in the Sulu Sea did not have significantly different vertical distributions in the Celebes Sea. However, some deep mesopelagic genera were absent from the Sulu Sea in the sampled depth range. These results suggest that a combination of environmental and physiological parameters determine the distribution and dominance of pelagic cnidarians. (C) 2015 Elsevier Ltd. All rights reserved.	[Grossmann, Mary M.] Grad Univ OIST, Okinawa Inst Sci & Technol, Onna Son, Okinawa 9040495, Japan; [Nishikawa, Jun] Tokai Univ, Shimizu, Shizuoka 4248610, Japan; [Lindsay, Dhugal J.] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa 2370061, Japan	Grossmann, MM (reprint author), Grad Univ OIST, Okinawa Inst Sci & Technol, Tancha 1919-1, Onna Son, Okinawa 9040495, Japan.	grossmann.mary@gmail.com	Grossmann, Mary/G-3445-2013	Grossmann, Mary/0000-0002-6800-6092	Japanese Society for the Promotion of Science (JSPS) [17780152, 26304030]; JSPS Asian CORE-COMSEA program	We are grateful to the reviewers for critical and constructive comments on the manuscript. We also thank the captain and crew of the R/V Hakuho Maru and the scientific team on board, especially Prof. Shuhei Nishida for their assistance in collection and processing of the samples, and Dr. Hiroshi Itoh and staff at Suidosha Inc. for their help in sorting the cnidarians from the bulk samples. We also thank Stephen Aird of OIST for help with English editing of the manuscript. This study was supported by Grant-in-Aid from the Japanese Society for the Promotion of Science (JSPS) awarded to JN (no. 17780152, 26304030) and a grant from the JSPS Asian CORE-COMSEA program.	Acabado C.S., 2010, SCI DILIMAN, V22, P51; ALVARINO A, 1974, FISH B-NOAA, V72, P527; Alvarino A., 1971, Bull Scripps Inst Oceanogr Berkeley Tech Ser, V16, P1; Bouillon J, 2004, SCI MAR, V68, P5; Metzger EJ, 1996, J GEOPHYS RES-OCEANS, V101, P12331, DOI 10.1029/95JC03861; Nishikawa J, 2007, DEEP-SEA RES PT II, V54, P114, DOI 10.1016/j.dsr2.2006.09.005; Matsuura H, 2010, DEEP-SEA RES PT II, V57, P2098, DOI 10.1016/j.dsr2.2010.09.013; McKinnon AD, 2014, ANNU REV MAR SCI, V6, P415, DOI 10.1146/annurev-marine-010213-135042; Gravili C, 2013, MAR ECOL-EVOL PERSP, V34, P41, DOI 10.1111/maec.12023; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Lucic D, 2011, ACTA ADRIAT, V52, P159; WIEBE PH, 1985, MAR BIOL, V87, P313, DOI 10.1007/BF00397811; SAMEOTO DD, 1984, J PLANKTON RES, V6, P767, DOI 10.1093/plankt/6.5.767; LUKAS R, 1991, J GEOPHYS RES-OCEANS, V96, P7089, DOI 10.1029/91JC00062; Bigelow H. B., 1919, Bulletin United States National Museum, V100 vol. i; Billard A., 1913, SIBOGA EXPEDITIE A, V7a, P1, DOI DOI 10.5962/BHL.TITLE.52043; Chen CTA, 2006, MAR CHEM, V99, P151, DOI 10.1016/j.marchem.2005.05.008; CHEN Y-Q, 1986, California Cooperative Oceanic Fisheries Investigations Reports, V27, P205; Clarke K.R., 2001, CHANGE MARINE COMMUN; Daniel R., 1974, Memoirs zool Surv India, V15, P1; Daniel R., 1985, FAUNA INDIA ADJACENT, P440; EXON NF, 1981, MAR GEOL, V39, P165, DOI 10.1016/0025-3227(81)90071-2; Gamulin T., 2000, FAUNA NATURA CROATIC, V9, P1; Gao S., 2002, FAUNA SINICA INVERTE, V27, P1; Gaston Kevin J., 1993, Biodiversity Letters, V1, P2, DOI 10.2307/2999642; Gibbons MJ, 2002, J MAR BIOL ASSOC UK, V82, P801, DOI 10.1017/S0025315402006161; Gladstone W, 2005, BIODIVERS CONSERV, V14, P3151, DOI 10.1007/s10531-004-0383-y; Grossmann MM, 2013, J OCEANOGR, V69, P395, DOI 10.1007/s10872-013-0181-9; Grossmann M.M., 2014, DIVERSITY COMMUNITY; Grossmann MM, 2014, SYST BIODIVERS, V12, P163, DOI 10.1080/14772000.2014.902867; Hsieh HY, 2013, MAR FRESHWATER RES, V64, P348, DOI 10.1071/MF12151; Johnson Travis B., 2006, Coastal Marine Science, V30, P360; Kallimanis A.S., 2013, ECOL INDIC, V15, P100; Kindt R., 2013, GUI BIODIVERSITY SUI; Kramp P.L, 1961, J MAR BIOL ASSOC UK, V40, P469; Lens A.D., 1908, SIBOGA EXPED, V9; Li KZ, 2012, J PLANKTON RES, V34, P636, DOI 10.1093/plankt/fbs035; Maas O., 1905, SIBOGA EXPED, V10; Mapstone G.M., 2009, SIPHONOPHORA CNIDARI, P302; Musaeva E.I., 1976, Trudy Instituta Okeanologii Akademii Nauk SSSR, V105, P171; Nishida S., 2011, COASTAL MARINE SCI S, P59; Ohtsuka S, 2005, J NAT HIST, V39, P2483, DOI 10.1080/00222930500087408; Pugh P.R., 1999, S ATLANTIC ZOOPLANKT, VI, P467; Pugh P.R., 1999, Bulletin of the Natural History Museum Zoology Series, V65, P51; Pugh PR, 2006, J MAR BIOL ASSOC UK, V86, P997, DOI 10.1017/S002531540601397X; Pugh PR, 1998, SCI MAR, V62, P233; Pugh P.R., 1990, 27778 I OC SCI DEAC, P78; QUADFASEL D, 1990, NATURE, V348, P320, DOI 10.1038/348320a0; SEARS M., 1953, BULL MUS COMP ZOOL, V109, P1; Spintall J., 2012, J GEOPHYS RES, V117; Stensholt BK, 2002, ICES J MAR SCI, V59, P679, DOI 10.1006/jmsc.2002.1249; Tessler ZD, 2010, J PHYS OCEANOGR, V40, P2679, DOI 10.1175/2010JPO4395.1; Toole J.M, 1987, EOS T AM GEOPHYS UN, V68, P2; Totton A. K., 1954, Discovery Reports, V27, P1; Totton A.K., 1965, SYNOPSIS SIPHONOPHOR, P230; World Register of Marine Species, 2014, CNID; Xu Z., 2008, FRONT BIOL CHINA, V3, P300, DOI 10.1007/s11515-008-0057-3; Zhang Jinbiao, 1979, Acta Oceanologica Sinica, V1, P127; Zhang J.B., 2005, PELAGIC SIPHONOPHORA, P151; Zhang Jin-biao, 2001, Journal of Oceanography in Taiwan Strait, V20, P1; Zhang J.B., 1984, P PLANKT TROP REG W, P52	61	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0967-0637	1879-0119		DEEP-SEA RES PT I	Deep-Sea Res. Part I-Oceanogr. Res. Pap.	JUN	2015	100						54	63		10.1016/j.dsr.2015.02.005		10	Oceanography	Oceanography	CI2PG	WOS:000354588900006		
J	Shibuya, M; Yasukawa, M; Takahashi, T; Miyoshi, T; Higa, M; Matsuyama, H				Shibuya, Masafumi; Yasukawa, Masahiro; Takahashi, Tomoki; Miyoshi, Taro; Higa, Mitsuru; Matsuyama, Hideto			Effects of operating conditions and membrane structures on the performance of hollow fiber forward osmosis membranes in pressure assisted osmosis	DESALINATION			English	Article						Forward osmosis (FO); Pressure assisted osmosis (PAO); Hollow fiber membrane; Improvement ratio (IR)	INTERNAL CONCENTRATION POLARIZATION; AMMONIA-CARBON DIOXIDE; DRAW SOLUTE PERMEATION; RETARDED-OSMOSIS; POWER-GENERATION; FLUX BEHAVIOR; WATER FLUX; DRIVEN MEMBRANE; DESALINATION; SYSTEM	Recently, forward osmosis (FO) has received much attention as an advanced water treatment technology. Although the FO process has begun to spread widely worldwide, it still has some problems - such as the low water permeation rate compared with those required for some applications - that must be solved for its commercial application. To achieve the higher water flux and lower reverse salt flux, pressure assisted osmosis (PAO), in which pressure is applied to a feed solution (FS), has recently been proposed. In this work, experiments were carried out to investigate membrane structures and operating conditions in the PAO process by using three types of cellulose triacetate (CTA) - hollow fiber (HF) membranes. The HF membranes are preferable in the FO process because a high packing density and a large specific surface area can be obtained in the HF module. In addition, the HF membrane module has four ports and does not require a spacer between the membranes. The effects of the applied pressure, the draw solution concentration, and the structure parameter of the HF membranes on the PAO performance were investigated. The water flux in the PAO process was theoretically analyzed. The calculated results satisfactorily agreed with experimental data. (C) 2015 Elsevier B.V. All rights reserved.	[Shibuya, Masafumi; Yasukawa, Masahiro; Takahashi, Tomoki; Miyoshi, Taro; Higa, Mitsuru; Matsuyama, Hideto] Kobe Univ, Ctr Membrane & Film Technol, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Higa, Mitsuru] Yamaguchi Univ, Grad Sch Sci & Engn, Dept Appl Fine Chem, Ube, Yamaguchi 7558611, Japan	Higa, M (reprint author), Yamaguchi Univ, Grad Sch Sci & Engn, Dept Appl Fine Chem, 2-16-1 Tokiwadai, Ube, Yamaguchi 7558611, Japan.	mhiga@yamaguchi-u.ac.jp; matuyama@kobe-u.ac.jp	Miyoshi, Taro/F-6919-2013	Miyoshi, Taro/0000-0002-3958-9647	Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by the Regional Innovation Strategy Support Program, Ministry of Education, Culture, Sports, Science and Technology, Japan.	Mi BX, 2010, ENVIRON SCI TECHNOL, V44, P2022, DOI 10.1021/es903623r; Blandin G, 2013, J MEMBRANE SCI, V447, P1, DOI 10.1016/j.memsci.2013.06.002; Hau NT, 2014, J MEMBRANE SCI, V455, P305, DOI 10.1016/j.memsci.2013.12.068; Shibuya M, 2015, DESALINATION, V362, P34, DOI 10.1016/j.desal.2015.01.031; Duan JT, 2014, J MEMBRANE SCI, V470, P323, DOI 10.1016/j.memsci.2014.07.018; McCutcheon JR, 2005, DESALINATION, V174, P1, DOI 10.1016/j.desal.2004.11.002; Lay WCL, 2011, DESALINATION, V283, P123, DOI 10.1016/j.desal.2011.01.036; Mi B, 2008, J MEMBRANE SCI, V320, P292, DOI 10.1016/j.memsci.2008.04.036; Achilli A, 2009, DESALINATION, V239, P10, DOI 10.1016/j.desal.2008.02.022; She QH, 2012, J MEMBRANE SCI, V401, P262, DOI 10.1016/j.memsci.2012.02.014; Kim YC, 2012, ENVIRON SCI TECHNOL, V46, P4673, DOI 10.1021/es3002597; Loeb S, 2002, DESALINATION, V143, P115, DOI 10.1016/S0011-9164(02)00233-3; Achilli A, 2009, J MEMBRANE SCI, V343, P42, DOI 10.1016/j.memsci.2009.07.006; Khawaji AD, 2008, DESALINATION, V221, P47, DOI 10.1016/j.desal.2007.01.067; Park M, 2011, J MEMBRANE SCI, V375, P241, DOI 10.1016/j.memsci.2011.03.052; Phillip WA, 2010, ENVIRON SCI TECHNOL, V44, P5170, DOI 10.1021/es100901n; Tang CYY, 2010, J MEMBRANE SCI, V354, P123, DOI 10.1016/j.memsci.2010.02.059; LEE KL, 1981, J MEMBRANE SCI, V8, P141, DOI 10.1016/S0376-7388(00)82088-8; Duong PHH, 2014, J MEMBRANE SCI, V452, P117, DOI 10.1016/j.memsci.2013.10.030; McCutcheon JR, 2006, J MEMBRANE SCI, V278, P114, DOI 10.1016/j.memsci.2005.10.048; Mi BX, 2010, J MEMBRANE SCI, V348, P337, DOI 10.1016/j.memsci.2009.11.021; Tan CH, 2008, J MEMBRANE SCI, V324, P209, DOI 10.1016/j.memsci.2008.07.020; Oh Y, 2014, J MEMBRANE SCI, V465, P159, DOI 10.1016/j.memsci.2014.04.003; Coday BD, 2013, ENVIRON SCI TECHNOL, V47, P2386, DOI 10.1021/es304519p; Yip NY, 2011, ENVIRON SCI TECHNOL, V45, P4360, DOI 10.1021/es104325z; Yong JS, 2012, J MEMBRANE SCI, V392, P9, DOI 10.1016/j.memsci.2011.11.020; McCutcheon JR, 2007, AICHE J, V53, P1736, DOI 10.1002/aic.11197; McCutcheon JR, 2006, J MEMBRANE SCI, V284, P237, DOI 10.1016/j.memsci.2006.07.049; Hancock NT, 2011, ENVIRON SCI TECHNOL, V45, P8483, DOI 10.1021/es201654k; Xie M, 2013, ENVIRON SCI TECHNOL, V47, P13486, DOI 10.1021/es404056e; Tang CYY, 2011, DESALINATION, V283, P178, DOI 10.1016/j.desal.2011.02.026; Holloway RW, 2007, WATER RES, V41, P4005, DOI 10.1016/j.watres.2007.05.054; Zhang Y, 2013, ENVIRON SCI TECHNOL, V47, P10548, DOI 10.1021/es402534m; Blandin G, 2015, DESALINATION, V363, P26, DOI 10.1016/j.desal.2014.12.011; Carmignani G., 2012, U.S. Patent, Patent No. [0267308 Al, 0267308]; Comelissen E.R., 2008, J MEMBRANE SCI, V319, P158, DOI DOI 10.1016/J.MEMSCI.2008.03.048; Glarer J., 1998, DESALINATION, V117, P297; Itoh Y., IDAWCPER11103; Kekre K.A., 2010, WATER SCI TECHNOL, V62, P8; Modem Water, MEMBR PROC FORW OSM; NASA, 2012, NASA SHOWC INN METH; Quintanilla V.Y., 2011, DESALINATION, V280, P160; REALI M, 1990, J MEMBRANE SCI, V48, P181, DOI 10.1016/0376-7388(90)85004-5; Thompson N.A., IDAWCPER111982011	44	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0011-9164	1873-4464		DESALINATION	Desalination	JUN 1	2015	365						381	388		10.1016/j.desal.2015.03.005		8	Engineering, Chemical; Water Resources	Engineering; Water Resources	CI1LF	WOS:000354505000040		
J	Ogawa, N				Ogawa, Naohiro			Demographic Change in Southeast Asia: Recent Histories and Future Directions	DEVELOPING ECONOMIES			English	Book Review									[Ogawa, Naohiro] Nihon Univ, Populat Res Inst, Tokyo, Japan	Ogawa, N (reprint author), Nihon Univ, Populat Res Inst, Tokyo, Japan.						Cho Lee-Jay, 1985, P INT S ROL AS PAC R; Lee R, 2011, POPULATION AGING AND THE GENERATIONAL ECONOMY: A GLOBAL PERSPECTIVE, P1; Ogawa Naohiro, 1993, HUMAN RESOURCES DEV; WILLIAMS L, 2012, DEMOGRAPHIC CHANGE S	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1533	1746-1049		DEV ECON	Dev. Econ.	JUN	2015	53	2					150	154		10.1111/deve.12074		5	Economics; Planning & Development	Business & Economics; Public Administration	CI3AV	WOS:000354620700005		
J	Nishizumi, H; Sakano, H				Nishizumi, Hirofumi; Sakano, Hitoshi			Developmental regulation of neural map formation in the mouse olfactory system	DEVELOPMENTAL NEUROBIOLOGY			English	Review						neural map; olfactory sensory neurons; axonal projection; receptor baseline activity; odorant receptors; cyclic AMP	ODORANT RECEPTOR GENES; PROTEIN-COUPLED RECEPTORS; SENSORY NEURONS; BETA-2-ADRENERGIC RECEPTOR; MICE DEFICIENT; AXON GUIDANCE; EXPRESSION; BULB; CHANNEL; CHOICE	In the mouse olfactory system, various odorants are detected by approximately 1000 different odorant receptors (ORs) expressed in the olfactory sensory neurons (OSNs). It is well established that each OSN expresses only one functional OR gene in a monoallelic manner. Furthermore, OSN axons expressing the same OR converge to a set of glomeruli in the olfactory bulb (OB). During embryonic development, a coarse map is formed by the combination of two genetically programmed processes. One is OR-independent axonal projection along the dorsal-ventral (D-V) axis, and the other is OR-dependent projection along the anterior-posterior (A-P) axis. D-V projection is regulated by the anatomical location of OSNs within the olfactory epithelium (OE), whereas A-P projection is instructed by expressed OR molecules using cyclic adenosine monophosphate (cAMP) signals. After birth, the map is further refined in an activity-dependent manner by its conversion from a continuous to a discrete map through segregation of glomerular structures. Here, we summarize recent progress from our laboratory in understanding neural map formation in the mouse olfactory system. (c) 2015 Wiley Periodicals, Inc. Develop Neurobiol 75: 594-607, 2015	[Nishizumi, Hirofumi] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan; [Sakano, Hitoshi] Univ Fukui, Fac Med Sci, Dept Brain Funct, Fukui 9101193, Japan	Sakano, H (reprint author), Univ Fukui, Fac Med Sci, Dept Brain Funct, Fukui 9101193, Japan.	sakano@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Contract grant sponsor: Grants in Aid and Specially Promoted Research Grants (Ministry of Education, Culture, Sports, Science and Technology of Japan).	Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Sakano H, 2010, NEURON, V67, P530, DOI 10.1016/j.neuron.2010.07.003; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Dalton RP, 2013, CELL, V155, P321, DOI 10.1016/j.cell.2013.09.033; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Rodriguez I, 2013, CELL, V155, P274, DOI 10.1016/j.cell.2013.09.032; Lyons DB, 2013, CELL, V154, P325, DOI 10.1016/j.cell.2013.06.039; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Nakashima A, 2013, CELL, V154, P1314, DOI 10.1016/j.cell.2013.08.033; Duggan CD, 2008, J NEUROSCI, V28, P5229, DOI 10.1523/JNEUROSCI.1134-08.2008; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Reisert J, 2010, J GEN PHYSIOL, V136, P529, DOI 10.1085/jgp.201010528; ASTIC L, 1987, BRAIN RES, V424, P144, DOI 10.1016/0006-8993(87)91204-2; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Takeuchi H, 2010, CELL, V141, P1056, DOI 10.1016/j.cell.2010.04.041; Serizawa S, 2000, NAT NEUROSCI, V3, P687; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Khan M, 2011, CELL, V147, P907, DOI 10.1016/j.cell.2011.09.049; Bailey MS, 1999, J COMP NEUROL, V415, P423; Tsuboi A, 2006, EUR J NEUROSCI, V23, P1436, DOI 10.1111/j.1460-9568.2006.04675.x; Michaloski JS, 2006, GENOME RES, V16, P1091, DOI 10.1101/gr.5185406; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Norlin EM, 2001, MOL CELL NEUROSCI, V18, P283, DOI 10.1006/mcne.2001.1019; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Cho JH, 2007, J NEUROSCI, V27, P9094, DOI 10.1523/JNEUROSCI.2217-07.2007; Eggan Kevin, 2004, Nature (London), V428, P44, DOI 10.1038/nature02375; Lemke G, 2005, ANNU REV CELL DEV BI, V21, P551, DOI 10.1146/annurev.cellbio.20.022403.093702; Markenscoff-Papadimitriou E, 2014, CELL, V159, P543, DOI 10.1016/j.cell.2014.09.033; Nguyen-Ba-Charvet KT, 2008, J NEUROSCI, V28, P4244, DOI 10.1523/JNEUROSCI.5671-07.2008; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; Rothman A, 2005, MOL CELL NEUROSCI, V28, P535, DOI 10.1016/j.mcn.2004.11.006; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; SATODA M, 1995, J NEUROSCI, V15, P942; SAVARESE TM, 1992, BIOCHEM J, V283, P1; Strotmann J, 2004, J NEUROSCI, V24, P7754, DOI 10.1523/JNEUROSCI.2588-04.2004; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8	73	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8451	1932-846X		DEV NEUROBIOL	Dev. Neurobiol.	JUN	2015	75	6			SI		594	607		10.1002/dneu.22268		14	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CI3GT	WOS:000354636500006		
J	Enkhtuvshin, B; Nagashima, S; Saito, N; Wakabayashi, T; Ando, A; Takahashi, M; Sakai, K; Yamamuro, D; Nagasaka, S; Tamemoto, H; Ishibashi, S				Enkhtuvshin, B.; Nagashima, S.; Saito, N.; Wakabayashi, T.; Ando, A.; Takahashi, M.; Sakai, K.; Yamamuro, D.; Nagasaka, S.; Tamemoto, H.; Ishibashi, S.			Successful pregnancy outcomes in a patient with type A insulin resistance syndrome	DIABETIC MEDICINE			English	Article							GESTATIONAL DIABETES-MELLITUS; RECEPTOR GENE; METFORMIN; WOMEN; COMBINATION; ANALOGS	BackgroundThe management of severe insulin resistance during pregnancy is challenging because of the increased risk of perinatal complications for both mother and fetus. We describe two consecutive pregnancies in a patient with severe insulin resistance caused by a mutation in the subunit of the insulin receptor. Case reportA non-obese Japanese woman was diagnosed as having diabetes mellitus during her first pregnancy at age 31years. She presented at 6weeks' gestation with a fasting plasma glucose concentration of 15.1mmol/l and an HbA(1c) level of 95mmol/mol (10.8%). Fasting insulin concentration was high at 68.8 U/ml, suggesting severe insulin resistance. Anti-insulin and insulin-receptor antibodies were both negative. Genetic analysis revealed an in-frame heterozygous deletion mutation (Leu(999)) in the insulin receptor gene. Despite large daily doses (up to 480 units per day) of insulin aspart and isophane, the patient's postprandial plasma glucose level exceeded 11.1mmol/l. In the patient's second pregnancy, the addition of metformin at a dose of 2250mg per day achieved tighter glycaemic control, with lower doses of insulin lispro and isophane (up to 174 units/day). Both newborns, who were found to carry the same mutation, were small for gestational age and developed transient hypoglycaemia after birth. ConclusionAdding metformin to the conventional insulin regimen effectively achieved tight glycaemic control with a lower dose of insulin. The mutation of the insulin receptor gene might underlie the intrauterine growth retardation of the newborns. To our knowledge, this is the first report of successful management of diabetes mellitus in a pregnant woman with type A insulin resistance syndrome.	[Enkhtuvshin, B.; Nagashima, S.; Saito, N.; Wakabayashi, T.; Ando, A.; Takahashi, M.; Sakai, K.; Yamamuro, D.; Nagasaka, S.; Ishibashi, S.] Jichi Med Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Shimotsuke, Tochigi, Japan; [Tamemoto, H.] Jichi Med Univ, Sch Med, Div Med Biochem, Dept Biochem, Shimotsuke, Tochigi, Japan	Ishibashi, S (reprint author), Jichi Med Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Shimotsuke, Tochigi, Japan.	ishibash@jichi.ac.jp					Pettitt DJ, 2003, DIABETES CARE, V26, P183, DOI 10.2337/diacare.26.1.183; Holt RIG, 2014, DIABETIC MED, V31, P282, DOI 10.1111/dme.12376; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345; TAYLOR SI, 1992, ENDOCR REV, V13, P566, DOI 10.1210/er.13.3.566; Rowan JA, 2008, NEW ENGL J MED, V358, P2003, DOI 10.1056/NEJMoa0707193; Strowig SM, 2002, DIABETES CARE, V25, P1691, DOI 10.2337/diacare.25.10.1691; Balani J, 2009, DIABETIC MED, V26, P798, DOI 10.1111/j.1464-5491.2009.02780.x; AWATA T, 1994, J CLIN ENDOCR METAB, V79, P1840, DOI 10.1210/jc.79.6.1840; CAMA A, 1993, J BIOL CHEM, V268, P8060; Jovanovic L, 2007, DIABETES CARE, V30, pS220, DOI 10.2337/dc07-s220; Lambert K, 2013, DIABETES OBES METAB, V15, P888, DOI 10.1111/dom.12098; Mecacci F, 2003, EUR J OBSTET GYN R B, V111, P19, DOI 10.1016/S0301-2115(03)00157-X; Suliman SGL, 2009, DIABETES, V58, P2954, DOI 10.2337/db09-0787; Vambergue A, 2006, HUM REPROD, V21, P1274, DOI 10.1093/humrep/dei455; Wong T, 2013, DIABETIC MED, V30, P468, DOI 10.1111/dme.12110; Wulffele MG, 2002, DIABETES CARE, V25, P2133, DOI 10.2337/diacare.25.12.2133	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-3071	1464-5491		DIABETIC MED	Diabetic Med.	JUN	2015	32	6					E16	E19		10.1111/dme.12659		4	Endocrinology & Metabolism	Endocrinology & Metabolism	CI3HE	WOS:000354637600001		
J	Tran, HH; Ehsani, S; Shibayama, K; Matsui, M; Suzuki, S; Nguyen, MB; Tran, DN; Tran, VP; Tran, DL; Nguyen, HT; Dang, DA; Trinh, HS; Nguyen, TH; Wertheim, HFL				Tran, H. H.; Ehsani, S.; Shibayama, K.; Matsui, M.; Suzuki, S.; Nguyen, M. B.; Tran, D. N.; Tran, V. P.; Tran, D. L.; Nguyen, H. T.; Dang, D. A.; Trinh, H. S.; Nguyen, T. H.; Wertheim, H. F. L.			Common isolation of New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae in a large surgical hospital in Vietnam	EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES			English	Article							KLEBSIELLA-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; MULTIPLEX PCR; NDM-1; ACINETOBACTER; EMERGENCE; PLASMIDS; GENES; EPIDEMIOLOGY; ENVIRONMENT	This study sought to monitor the presence of carbapenem-resistant Enterobacteriaceae (CRE) and the proportion New Delhi metallo-beta-lactamase 1 (NDM-1)-producing bacteria between August 2010 and December 2012 in a surgical hospital in Vietnam. We identified 47 CRE strains from a total of 4,096 Enterobacteriaceae isolates (1.1 %) that were NDM-1-positive from 45 patients admitted to 11 different departments, with the majority being from the urology department. The NDM-1 gene was found in seven different species. Genotyping revealed limited clonality of NDM-1-positive isolates. Most of the isolates carried the NDM-1 gene on a plasmid and 17.8 % (8/45) of those were readily transferable. We found five patients at admission and one patient at discharge with NDM-1-positive bacteria in their stool. From 200 screening environmental hospital samples, five were confirmed to be NDM-1-positive and included Acinetobacter species (n = 3) and Enterobacter aerogenes (n = 2). The results reveal that NDM-1-producing Enterobacteriaceae are commonly isolated in patients admitted to a Vietnamese surgical hospital and are also detected in the hospital environment.	[Tran, H. H.; Nguyen, M. B.; Tran, D. N.; Tran, V. P.; Tran, D. L.; Nguyen, H. T.; Dang, D. A.; Nguyen, T. H.] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Ehsani, S.] Inst Pasteur, Paris, France; [Shibayama, K.; Matsui, M.; Suzuki, S.] Natl Inst Infect Dis, Tokyo, Japan; [Trinh, H. S.] Viet Duc Hosp, Hanoi, Vietnam; [Wertheim, H. F. L.] Oxford Univ Clin Res Unit, Wellcome Trust Major Overseas Program, Hanoi, Vietnam; [Wertheim, H. F. L.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	Tran, HH (reprint author), Natl Inst Hyg & Epidemiol, Yersin St 1, Hanoi, Vietnam.	Trhuyhoang1791@gmail.com			National Foundation for Science and Technology Development (NAFOSTED), Vietnam [MS106.03-2012.44]; Wellcome Trust, UK; Global Antibiotic Resistance Partnership, USA; Ministry of Health, Labor and Welfare, the Government of Japan [H23-Shinkou-shitei-020]	This work was supported by a grant from the National Foundation for Science and Technology Development (NAFOSTED; MS106.03-2012.44), Vietnam; the Wellcome Trust, UK; the Global Antibiotic Resistance Partnership, USA; and Grant-in-Aid of Ministry of Health, Labor and Welfare, the Government of Japan (H23-Shinkou-shitei-020).	Batchelor M, 2005, ANTIMICROB AGENTS CH, V49, P1319, DOI 10.1128/AAC.49.4.1319-1322.2005; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Poirel L, 2010, LANCET INFECT DIS, V10, P832, DOI 10.1016/S1473-3099(10)70279-6; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V59, P321, DOI 10.1093/jac/dkl481; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Bratu S, 2005, ANTIMICROB AGENTS CH, V49, P3018, DOI 10.1128/AAC.49.7.3018-3020.2005; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Fiett J, 2014, ANTIMICROB AGENTS CH, V58, P1203, DOI 10.1128/AAC.01197-13; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Isozumi R, 2012, EMERG INFECT DIS, V18, P1383, DOI 10.3201/eid1808.111816; Toleman MA, 2012, ANTIMICROB AGENTS CH, V56, P2773, DOI 10.1128/AAC.06297-11; HARDIN G, 1968, SCIENCE, V162, P1243; Hoang TH, 2013, J CLIN MICROBIOL, V51, P373, DOI 10.1128/JCM.02322-12; Rudholm N, 2002, J HEALTH ECON, V21, P1071, DOI 10.1016/S0167-6296(02)00053-X; Bogaerts P, 2013, J ANTIMICROB CHEMOTH, V68, P2414, DOI 10.1093/jac/dkt201; Bonnin RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034752; Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI; Clinical and Laboratory Standards Institute (CLSI), 2010, M100S20 CLSI; Dao TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091999; den Heijer CDJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049909; Hishinuma A, 2013, J ANTIMICROB CHEMOTH, V68, P2415, DOI 10.1093/jac/dkt190; Nga do T. T, 2014, BMC PHARMACOL TOXICO, V15, P6; Nguyen Kinh Van, 2013, BMC Public Health, V13, P1158, DOI 10.1186/1471-2458-13-1158; Walsh TR, 2011, EXPERT REV ANTI-INFE, V9, P137, DOI [10.1586/eri.10.159, 10.1586/ERI.10.159]; Walsh TR, 2011, CAN MED ASSOC J, V183, P1240, DOI 10.1503/cmaj.111100; Weill FX, 2004, J CLIN MICROBIOL, V42, P2432, DOI 10.1128/JCM.42.6.2432-2437.2004; Zhang CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064857	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0934-9723	1435-4373		EUR J CLIN MICROBIOL	Eur. J. Clin. Microbiol. Infect. Dis.	JUN	2015	34	6					1247	1254		10.1007/s10096-015-2345-6		8	Infectious Diseases; Microbiology	Infectious Diseases; Microbiology	CH7DF	WOS:000354195100024		
J	Kamata, Y; Minota, S				Kamata, Yasuyuki; Minota, Seiji			No increase in synovial fluid level of matrix metalloproteinase-3 by systemic administration of glucocorticoids in rheumatoid arthritis	EUROPEAN JOURNAL OF INTERNAL MEDICINE			English	Letter						Matrix metalloproteinase-3; Rheumatoid arthritis; Synovial fluid; Synovitis; Systemic glucocorticoids	FIBROBLASTS; STROMELYSIN		[Kamata, Yasuyuki; Minota, Seiji] Jichi Med Univ, Div Rheumatol & Clin Immunol, Shimotsuke, Tochigi 3290498, Japan	Kamata, Y (reprint author), Jichi Med Univ, Div Rheumatol & Clin Immunol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	y.kamata@jichi.ac.jp; sminota@jichi.ac.jp					OKADA Y, 1986, J BIOL CHEM, V261, P14245; MACNAUL KL, 1990, J BIOL CHEM, V265, P17238; OKADA Y, 1989, ANN RHEUM DIS, V48, P645, DOI 10.1136/ard.48.8.645; Ribbens C, 2002, ANN RHEUM DIS, V61, P161, DOI 10.1136/ard.61.2.161; TAYLOR DJ, 1994, ANN RHEUM DIS, V53, P768, DOI 10.1136/ard.53.11.768	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0953-6205	1879-0828		EUR J INTERN MED	Eur. J. Intern. Med.	JUN	2015	26	5					371	372		10.1016/j.ejim.2015.03.006		2	Medicine, General & Internal	General & Internal Medicine	CI2KR	WOS:000354577000016		
J	Tanaka, Y; Ueda, Y; Sano, A				Tanaka, Yoshihiro; Ueda, Yuichiro; Sano, Akihito			Effect of skin-transmitted vibration enhancement on vibrotactile perception	EXPERIMENTAL BRAIN RESEARCH			English	Article						Skin-transmitted vibration; Tactile enhancement; Detection threshold; Discrimination threshold; Vibrotactile stimulus	DISCRIMINATION; ROUGHNESS; FREQUENCY; TOUCH; AFFERENTS; SENSATION; FINGERTIP; AMPLITUDE; STIMULUS; HAND	Vibration on skin elicited by the mechanical interaction of touch between the skin and an object propagates to skin far from the point of contact. This paper investigates the effect of skin-transmitted vibration on vibrotactile perception. To enhance the transmission of high-frequency vibration on the skin, stiff tape was attached to the skin so that the tape covered the bottom surface of the index finger from the periphery of the distal interphalangeal joint to the metacarpophalangeal joint. Two psychophysical experiments with high-frequency vibrotactile stimuli of 250 Hz were conducted. In the psychophysical experiments, discrimination and detection thresholds were estimated and compared between conditions of the presence or the absence of the tape (normal bare finger). A method of limits was applied for the detection threshold estimation, and the discrimination task using a reference stimulus and six test stimuli with different amplitudes was applied for the discrimination threshold estimation. The stimulation was given to bare fingertips of participants. Result showed that the detection threshold was enhanced by attaching the tape, and the discrimination threshold enhancement by attaching the tape was confirmed for participants who have relatively large discrimination threshold under normal bare finger. Then, skin-transmitted vibration was measured with an accelerometer with the psychophysical experiments. Result showed that the skin-transmitted vibration when the tape was attached to the skin was larger than that when normal bare skin. There is a correlation between the increase in skin-transmitted vibration and the enhancement of the discrimination threshold.	[Tanaka, Yoshihiro; Sano, Akihito] Nagoya Inst Technol, Grad Sch Engn, Dept Engn Phys Elect & Mech, Showa Ku, Nagoya, Aichi 4668555, Japan; [Tanaka, Yoshihiro] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ueda, Yuichiro] Nagoya Inst Technol, Grad Sch Engn, Dept Comp Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan	Tanaka, Y (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Engn Phys Elect & Mech, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	tanaka.yoshihiro@nitech.ac.jp			JST, PRESTO; JSPS [22686026]	This research was funded in part by grants from the JST, PRESTO, and the JSPS Grant-in-Aid for Young Scientists (A) (No. 22686026).	Quek ZF, 2013, 2013 WORLD HAPTICS CONFERENCE (WHC), P467; Bensmaia S, 2005, PERCEPT PSYCHOPHYS, V67, P842, DOI 10.3758/BF03193537; CAUNA N, 1954, ANAT REC, V119, P449, DOI 10.1002/ar.1091190405; Libouton X, 2012, BEHAV BRAIN RES, V229, P273, DOI 10.1016/j.bbr.2012.01.018; Collins JJ, 1997, PHYS REV E, V56, P923, DOI 10.1103/PhysRevE.56.923; VERRILLO RT, 1963, J ACOUST SOC AM, V35, P1962, DOI 10.1121/1.1918868; LEDERMAN SJ, 1972, PERCEPT PSYCHOPHYS, V12, P401, DOI 10.3758/BF03205850; VALLBO AB, 1984, HUM NEUROBIOL, V3, P3; Scheibert J, 2009, SCIENCE, V323, P1503, DOI 10.1126/science.1166467; DELLON ES, 1995, J HAND SURG-BRIT EUR, V20B, P44, DOI 10.1016/S0266-7681(05)80015-4; Bensmaia SJ, 2000, J ACOUST SOC AM, V108, P1236, DOI 10.1121/1.1288937; Coren S., 1993, LEFT HANDER SYNDROME; CRAIG JC, 1974, PERCEPT PSYCHOPHYS, V15, P123, DOI 10.3758/BF03205839; CRAIG JC, 1972, PERCEPT PSYCHOPHYS, V11, P150, DOI 10.3758/BF03210362; Dandekar K, 2003, J BIOMECH ENG-T ASME, V118, P48; Delhaye B, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00037; Fujita K., 2001, P 5 WORLD MULT SYST, P78; Gescheider GA, 2001, SOMATOSENS MOT RES, V18, P191; Guest S, 2002, EXP BRAIN RES, V146, P161, DOI 10.1007/s00221-002-1164-z; HORCH K, 1991, J ACOUST SOC AM, V89, P2827, DOI 10.1121/1.400688; Israr A, 2006, J ACOUST SOC AM, V120, P2789, DOI 10.1121/1.2354022; Jeong HY, 2008, IEEE ENG MED BIO, P2409, DOI 10.1109/IEMBS.2008.4649685; Jeong HY, 2008, P 2008 INT C ROB BIO, P1206; Kahrimanovic M, 2010, LECT NOTES COMPUT SC, V6191, P17, DOI 10.1007/978-3-642-14064-8_3; Kandel E R, 2000, PRINCIPLES NEURAL SC; Kikuuwe R., 2005, ACM T APPL PERCEPT, V2, P46, DOI DOI 10.1145/1048687.1048691; LUNDSTROM R, 1984, J BIOMECH, V17, P137, DOI 10.1016/0021-9290(84)90131-3; Maeno T, 1998, JSME INT J C-MECH SY, V41, P94; Rinker MA, 1998, J ACOUST SOC AM, V104, P453, DOI 10.1121/1.423249; Tanaka Y, 2010, P 1 INT C APPL BION; Tanaka Y., 2012, LNCS, V7283, P169, DOI DOI 10.1007/978-3-642-31404-9_	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	JUN	2015	233	6					1721	1731		10.1007/s00221-015-4246-4		11	Neurosciences	Neurosciences & Neurology	CI4OR	WOS:000354731200005		
J	Hagio, S; Kouzaki, M				Hagio, Shota; Kouzaki, Motoki			Recruitment of muscle synergies is associated with endpoint force fluctuations during multi-directional isometric contractions	EXPERIMENTAL BRAIN RESEARCH			English	Article						Degree of freedom; Electromyogram; Nonnegative matrix factorization; Motor control; Force variability	SIGNAL-DEPENDENT NOISE; POSTURAL TASK; SPINAL-CORD; HUMANS; COACTIVATION; CONSTRUCTION; COMBINATIONS; PRIMITIVES; BEHAVIORS; MOVEMENTS	It has long been assumed that the human central nervous system uses flexible combinations of several muscle synergies to effortlessly and efficiently control redundant movements. However, whether muscle synergies exist in the neural circuit remains controversial, and it is critical to examine the association between the recruitment pattern of synergies and motor output. In this study, we examined the relationship between the activation of muscle synergies and endpoint force fluctuations in the presence of signal-dependent noise. Subjects performed multi-directional isometric force generations around the right ankle on the sagittal plane. We then extracted muscle synergies from measured electromyogram (EMG) data using nonnegative matrix factorization. As a result, the sum of the activation of muscle synergies was correlated with the endpoint force variability from the desired directions. Furthermore, we determined that the activation trace of each synergy reflected the endpoint force fluctuations using cross-correlation analysis. Therefore, these results suggest that muscle synergies statistically calculated from EMG data should be related to the motor output.	[Hagio, Shota] Japan Soc Promot Sci, Tokyo, Japan; [Hagio, Shota; Kouzaki, Motoki] Kyoto Univ, Grad Sch Human & Environm Studies, Neurophysiol Lab, Sakyo Ku, Kyoto 6068501, Japan	Kouzaki, M (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Neurophysiol Lab, Sakyo Ku, Yoshida Nihonmatsu Cho, Kyoto 6068501, Japan.	kouzaki.motoki.4x@kyoto-u.ac.jp			Descente and Ishimoto Memorial Foundation for the Promotion of Sports Science	This work was supported, in part, by a grant from the Descente and Ishimoto Memorial Foundation for the Promotion of Sports Science (M. Kouzaki).	Hart CB, 2010, J NEUROSCI, V30, P1322, DOI 10.1523/JNEUROSCI.5894-08.2010; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.00985.2001; Roh J, 2013, J NEUROPHYSIOL, V109, P768, DOI 10.1152/jn.00670.2012; Torres-Oviedo G, 2006, J NEUROPHYSIOL, V96, P1530, DOI 10.1152/jn.00810.2005; Kouzaki M, 2002, J APPL PHYSIOL, V93, P675, DOI 10.1152/japplphysiol.00764.2001; Kurtzer I, 2006, J NEUROPHYSIOL, V95, P493; d'Avella A, 2008, J NEUROPHYSIOL, V100, P1433, DOI 10.1152/jn.01377.2007; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; Lee DD, 1999, NATURE, V401, P788; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Kutch JJ, 2008, J NEUROPHYSIOL, V100, P2455, DOI 10.1152/jn.90274.2008; Takei T, 2010, J NEUROSCI, V30, P17041, DOI 10.1523/JNEUROSCI.4297-10.2010; Tresch MC, 1999, NAT NEUROSCI, V2, P162; Ting LH, 2005, J NEUROPHYSIOL, V93, P609, DOI 10.1152/jn.00681.2004; Tresch MC, 2009, CURR OPIN NEUROBIOL, V19, P601, DOI 10.1016/j.conb.2009.09.002; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; Roh J, 2012, J NEUROPHYSIOL, V107, P2123, DOI 10.1152/jn.00173.2011; Torres-Oviedo G, 2010, J NEUROPHYSIOL, V103, P3084, DOI 10.1152/jn.00960.2009; Chvatal SA, 2011, J NEUROPHYSIOL, V106, P999, DOI 10.1152/jn.00549.2010; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hart CB, 2004, J NEUROSCI, V24, P5269, DOI 10.1523/JNEUROSCI.5626-03.2004; Haruno M, 2005, J NEUROPHYSIOL, V94, P4244, DOI 10.1152/jn.00404.2005; Masani K, 2003, J NEUROPHYSIOL, V90, P3774, DOI 10.1152/jn.00730.2002; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; Berger DJ, 2014, FRONT COMPUT NEUROSC, V8, P1; Bernstein N, 1967, COORDINATION REGULAT; Bizzi E, 2013, FRONT COMPT NEUROSCI, V7, P1, DOI DOI 10.3389/FNC0M.2013.00051; Hagio S, 2012, J BIOMECH, V45, P179, DOI 10.1016/j.jbiomech.2011.10.012; Hagio S, 2014, J NEUROPHYSIOL, V112, P316, DOI 10.1152/jn.00109.2014; Imagawa H, 2013, J ELECTROMYOGR KINES, V23, P430, DOI 10.1016/j.jelekin.2012.11.003; JACOBS R, 1992, J PHYSIOL-LONDON, V457, P611; Kutch JJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002434; VOS EJ, 1990, EUR J APPL PHYSIOL O, V60, P467, DOI 10.1007/BF00705038; ZAR J. H., 1999, BIOSTATISTICAL ANAL	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	JUN	2015	233	6					1811	1823		10.1007/s00221-015-4253-5		13	Neurosciences	Neurosciences & Neurology	CI4OR	WOS:000354731200012		
J	Seya, Y; Mori, S				Seya, Yasuhiro; Mori, Shuji			Tradeoff between manual response speed and pursuit accuracy revealed by a deadline procedure	EXPERIMENTAL BRAIN RESEARCH			English	Article						Smooth pursuit; Reaction time; Tradeoff; Deadline procedure; Attentional resource	PERIPHERAL VISUAL-FIELD; SMOOTH EYE-MOVEMENT; HUMAN REACTION-TIME; CORTICAL AREAS MT; SPATIAL ATTENTION; MOTION; MST; ALLOCATION; VOLUNTARY; TARGET	To examine the tradeoff between manual reaction times (RTs) and smooth pursuit accuracy, we manipulated manual RTs to a visual target presented during pursuit by using a deadline procedure that required different response speeds to a target (300, 400, or 500 ms). Participants attempted to pursue a moving row of circles as accurately as possible, while responding to a target within a preset time. Stimulus velocity and target position were manipulated. As the preset time became shorter, participants responded with faster manual RTs and larger pursuit velocity errors, irrespective of the stimulus velocity, indicating a tradeoff between manual RTs and pursuit accuracy. Pursuit velocity errors were also larger after target onset. These results not only suggest that attentional resources as well as spatial shifts of attention play an important role in maintaining accurate pursuit, but also support the notion that a manual RT task is useful for revealing the operation of attention during pursuit.	[Seya, Yasuhiro] Ritsumeikan Univ, Dept Human & Comp Intelligence, Kusatsu, Shiga 5258577, Japan; [Mori, Shuji] Kyushu Univ, Fac Informat Sci & Elect Engn, Dept Informat, Intelligent Sci Div, Fukuoka 812, Japan	Seya, Y (reprint author), Ritsumeikan Univ, Dept Human & Comp Intelligence, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan.	yseya@fc.ritsumei.ac.jp			 [25870916];  [25240023]	The research was supported by Grants-in-Aid for Young Scientists (B) 25870916 to Y. S. and for Scientific Research (A) 25240023 to S. M.	YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P121, DOI 10.1037//0096-1523.16.1.121; Seya Y, 2015, ATTEN PERCEPT PSYCHO, V77, P220, DOI 10.3758/s13414-014-0734-z; KHURANA B, 1987, VISION RES, V27, P1603, DOI 10.1016/0042-6989(87)90168-4; KOWLER E, 1984, VISION RES, V24, P1789, DOI 10.1016/0042-6989(84)90010-5; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; KELLER EL, 1991, NEUROSCI RES, V11, P79, DOI 10.1016/0168-0102(91)90048-4; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Ilg UJ, 1997, PROG NEUROBIOL, V53, P293, DOI 10.1016/S0301-0082(97)00039-7; Lovejoy LP, 2009, VISION RES, V49, P1275, DOI 10.1016/j.visres.2009.01.011; Brown GS, 2005, BEHAV RES METHODS, V37, P436, DOI 10.3758/BF03192712; Kerzel D, 2008, VISION RES, V48, P958, DOI 10.1016/j.visres.2008.01.015; Brown GS, 2005, J EXP ANAL BEHAV, V83, P119, DOI 10.1901/jeab.2005.94-03; Chen Y, 2002, PROG BRAIN RES, V140, P255; PEW RW, 1969, ACTA PSYCHOL, V30, P16, DOI 10.1016/0001-6918(69)90035-3; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Van Donkelaar P, 2002, PROG BRAIN RES, V140, P267; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783; DURSTELER MR, 1988, J NEUROPHYSIOL, V60, P940; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; Baumann O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007110; Groh JM, 1997, J NEUROSCI, V17, P4312; Hutton SB, 2005, EXP BRAIN RES, V163, P306, DOI 10.1007/s00221-004-2171-z; Kathmann N, 1999, PSYCHOPHYSIOLOGY, V36, P158, DOI 10.1017/S0048577299981167; Kerzel D, 2009, BEHAV BRAIN RES, V201, P66, DOI 10.1016/j.bbr.2009.01.032; Lindner A, 2006, VISION RES, V46, P761, DOI 10.1016/j.visres.2005.09.033; Lisberger SG, 1997, J NEUROSCI, V17, P7490; Liston D, 2005, J VISION, V5, P678, DOI 10.1167/5.9.3; NEWSOME WT, 1985, J NEUROSCI, V5, P825; OSAKA N, 1976, JPN PSYCHOL RES, V18, P183; OSAKA N, 1978, NEUROPSYCHOLOGIA, V16, P299, DOI 10.1016/0028-3932(78)90023-4; Pachella R. G., 1974, HUMAN INFORMATION PR, P41; PACHELLA RG, 1969, J EXP PSYCHOL, V81, P7, DOI 10.1037/h0027431; RAINS JD, 1963, VISION RES, V3, P239, DOI 10.1016/0042-6989(63)90057-9; Recanzone GH, 1999, J NEUROPHYSIOL, V82, P1710; Schwarz U, 1999, NEUROREPORT, V10, P2477, DOI 10.1097/00001756-199908200-00008; Seya Y, 2007, MOTOR CONTROL, V11, P109; Seya Y, 2012, ATTEN PERCEPT PSYCHO, V74, P493, DOI 10.3758/s13414-011-0247-y; Seya Y, 2012, PERCEPTION, V41, P517, DOI 10.1068/p7048; VANGELDER P, 1995, VISION RES, V35, P667, DOI 10.1016/0042-6989(94)00161-E	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	JUN	2015	233	6					1845	1854		10.1007/s00221-015-4256-2		10	Neurosciences	Neurosciences & Neurology	CI4OR	WOS:000354731200015		
J	Nakamura, M; Morita, A; Seite, S; Haarmann-Stemmann, T; Grether-Beck, S; Krutmann, J				Nakamura, Motoki; Morita, Akimichi; Seite, Sophie; Haarmann-Stemmann, Thomas; Grether-Beck, Susanne; Krutmann, Jean			Environment-induced lentigines: formation of solar lentigines beyond ultraviolet radiation	EXPERIMENTAL DERMATOLOGY			English	Editorial Material						air pollution; aryl hydrocarbon receptor; lentigo; skin ageing; ultraviolet radiation	ARYL-HYDROCARBON RECEPTOR; GROWTH-FACTOR; HUMAN MELANOCYTES; SIGNAL-TRANSDUCTION; HUMAN KERATINOCYTES; SUN EXPOSURE; HUMAN SKIN; HYPERPIGMENTATION; PIGMENTATION; MECHANISM	There is no doubt that ultraviolet radiation (UVR) contributes to the generation of acquired lentigines in human skin, as indicated by the term solar lentigo. A growing number of recent epidemiological and mechanistic studies, however, strongly suggest that in addition to UVR, other environmental factors contribute to lentigines' formation as well. We therefore here introduce the term environment-induced lentigo' (EIL) to refer to acquired pigment spots of human skin. In this view point, we (i) summarize the existing evidence to support a role of environmental toxicants other than UVR in the pathogenesis of EILs, (ii) we argue that activation of aryl hydrocarbon receptor (AHR) signalling by UVR and environmental toxicants is critically involved in triggering and sustaining a crosstalk between melanocytes, keratinocytes and fibroblasts, which then causes the development and persistence of EILs in human skin, and (iii) we discuss clinical implications for the prevention and treatment of EILs resulting from this concept.	[Nakamura, Motoki; Haarmann-Stemmann, Thomas; Grether-Beck, Susanne; Krutmann, Jean] IUF Leibniz Res Inst Environm Med, D-40225 Dusseldorf, Germany; [Nakamura, Motoki; Morita, Akimichi] Nagoya City Univ, Dept Environm & Geriatr Dermatol, Nagoya, Aichi, Japan; [Seite, Sophie] LOreal, R&D, Asnieres, France	Krutmann, J (reprint author), IUF Leibniz Res Inst Environm Med, Aufm Hennekamp 50, D-40225 Dusseldorf, Germany.	jean.krutmann@iuf-duesseldorf.de					Celia C, 2012, BIOMED MICRODEVICES, V14, P119, DOI 10.1007/s10544-011-9590-y; Hakozaki T, 2002, BRIT J DERMATOL, V147, P20, DOI 10.1046/j.1365-2133.2002.04834.x; Abel J, 2010, BIOL CHEM, V391, P1235, DOI 10.1515/BC.2010.128; Scott G, 2004, J INVEST DERMATOL, V122, P1214, DOI 10.1111/j.0022-202X.2004.22516.x; Kadono S, 2001, J INVEST DERMATOL, V116, P571, DOI 10.1046/j.1523-1747.2001.01296.x; Nouveau-Richard S, 2005, J DERMATOL SCI, V40, P187, DOI 10.1016/j.jdermsci.2005.06.006; Tigges J, 2014, J INVEST DERMATOL, V134, P556, DOI 10.1038/jid.2013.362; Hattori H, 2004, J INVEST DERMATOL, V122, P1256, DOI 10.1111/j.0022-202X.2004.22503.x; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; Wakamatsu K, 1997, PIGM CELL RES, V10, P288, DOI 10.1111/j.1600-0749.1997.tb00688.x; Krutmann J, 2014, J DERMATOL SCI, V76, P163, DOI 10.1016/j.jdermsci.2014.08.008; Chen NN, 2010, EXP DERMATOL, V19, P865, DOI 10.1111/j.1600-0625.2009.00957.x; Luecke S, 2010, PIGM CELL MELANOMA R, V23, P828, DOI 10.1111/j.1755-148X.2010.00762.x; Ando H, 2010, INT J MOL SCI, V11, P2566, DOI 10.3390/ijms11062566; Yamada T, 2013, J INVEST DERMATOL, V133, P2753, DOI 10.1038/jid.2013.235; Monestier S, 2006, BRIT J DERMATOL, V154, P438, DOI 10.1111/j.1365-2133.2005.06996.x; HALABAN R, 1988, J CELL BIOL, V107, P1611, DOI 10.1083/jcb.107.4.1611; MATSUMOTO K, 1991, BIOCHEM BIOPH RES CO, V176, P45, DOI 10.1016/0006-291X(91)90887-D; Esser C, 2013, SEMIN IMMUNOPATHOL, V35, P677, DOI 10.1007/s00281-013-0394-4; Vierkotter A, 2010, J INVEST DERMATOL, V130, P2719, DOI 10.1038/jid.2010.204; Lin CB, 2010, J DERMATOL SCI, V59, P91, DOI 10.1016/j.jdermsci.2010.06.006; Frauenstein K, 2013, CELL DEATH DIFFER, V20, P1425, DOI 10.1038/cdd.2013.102; Nakamura M, 2013, EXP DERMATOL, V22, P556, DOI 10.1111/exd.12170; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Grichnik JM, 1998, J INVEST DERMATOL, V111, P233, DOI 10.1046/j.1523-1747.1998.00272.x; Wincent E, 2009, BIOORGAN MED CHEM, V17, P1648, DOI 10.1016/j.bmc.2008.12.072; Bastiaens M, 2004, PIGM CELL RES, V17, P225, DOI 10.1111/j.1600-0749.2004.00131.x; Berneburg M, 2004, J INVEST DERMATOL, V122, P1277, DOI 10.1111/j.0022-202X.2004.22502.x; Derancourt C, 2007, DERMATOLOGY, V214, P25, DOI 10.1159/000096909; Diani-Moore S, 2011, CHEM-BIOL INTERACT, V193, P119, DOI 10.1016/j.cbi.2011.05.010; DiMeglio P, 2014, IMMUNITY, V19, P989; Ezzedine K, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12186; Henry EC, 2010, TOXICOL SCI, V114, P90, DOI 10.1093/toxsci/kfp285; Huls A, 2015, J INVEST DERMATOL S1, V135; Imokawa G, 1996, BIOCHEM J, V313, P625; Jux B, 2010, J INVEST DERMATOL, V131, P203; Kovacs D, 2010, BRIT J DERMATOL, V163, P1020, DOI 10.1111/j.1365-2133.2010.09946.x; Navarrete-Solis J, 2011, DERMATOL RES PRACT, V2011; Ortonne J P, 1990, BR J DERMATOL S35, V122, P22; Ortonne JP, 2006, J AM ACAD DERMATOL, V54, pS262, DOI 10.1016/j.jaad.2005.12.043; Perner D, 2011, J DERMATOL SCI, V62, P138, DOI 10.1016/j.jdermsci.2011.02.010; Praetorius C, 2014, PIGM CELL MELANOMA R, V27, P339, DOI 10.1111/pcmr.12232; Rannug U, 1995, CHEM BIOL, V2, P841, DOI 10.1016/1074-5521(95)90090-X; Salducci M, 2014, PIGM CELL MELANOMA R, V27, P502, DOI 10.1111/pcmr.12234; Tigges J, 2013, J INVEST DERMATOL, V133, P87, DOI 10.1038/jid.2012.259; Tse TW, 2013, J COSMET DERMATOL-US, V12, P57, DOI 10.1111/jocd.12026; Vierkotter A, 2012, J INVEST DERMATOL, V132, P733, DOI 10.1038/jid.2011.350; Waldera-Lupa D M, 2004, J INVEST DERMATOL S1, V135; YADA Y, 1991, J BIOL CHEM, V266, P18352; Yamada T, 2014, EXP DERMATOL, V23, P652, DOI 10.1111/exd.12496	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	JUN	2015	24	6					407	411		10.1111/exd.12690		5	Dermatology	Dermatology	CI2FX	WOS:000354562100002		
J	Karuppagounder, V; Arumugam, S; Thandavarayan, RA; Pitchaimani, V; Sreedhar, R; Afrin, R; Harima, M; Suzuki, H; Nomoto, M; Miyashita, S; Suzuki, K; Nakamura, M; Watanabe, K				Karuppagounder, Vengadeshprabhu; Arumugam, Somasundaram; Thandavarayan, Rajarajan A.; Pitchaimani, Vigneshwaran; Sreedhar, Remya; Afrin, Rejina; Harima, Meilei; Suzuki, Hiroshi; Nomoto, Mayumi; Miyashita, Shizuka; Suzuki, Kenji; Nakamura, Masahiko; Watanabe, Kenichi			Modulation of HMGB1 translocation and RAGE/NFB cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice	EXPERIMENTAL DERMATOLOGY			English	Article						cytokine; high-mobility group box protein 1; nuclear factor kappa B; quercetin; receptor for advanced glycation products	NF-KAPPA-B; GROUP BOX-1 PROTEIN; INFLAMMATION; ACTIVATION; PATHWAY; CELLS; INHIBITION; EXPRESSION; RELEASE; IDENTIFICATION	Quercetin, glycosylated form of flavonoid compound, has potent antioxidant and anti-inflammatory properties. In this study, we have investigated the effects of quercetin on skin lesion, high-mobility group box (HMGB)1 cascade signalling and inflammation in atopic dermatitis (AD) mouse model. AD-like lesion was induced by the application of house dust mite extract to the dorsal skin of NC/Nga transgenic mouse. After AD induction, quercetin (50mg/kg, p.o) was administered daily for 2weeks. We evaluated dermatitis severity, histopathological changes and changes in protein expression by Western blotting for HMGB1, receptor for advanced glycation end products (RAGE), toll-like receptor (TLR)4, nuclear factor (NF)B, nuclear factor erythroid-2-related factor (Nrf)2, kelch-like ECH-associated protein (Keap)1, extracellular signal-regulated kinase (ERK)1/2, cyclooxygenase (COX)2, tumor necrosis factor (TNF), interleukin (IL)-1, IL-2R and other inflammatory markers in the skin of AD mice. In addition, serum levels of T helper (Th) cytokines (interferon (IFN), IL-4) were measured by enzyme-linked immunosorbent assay. Quercetin treatment attenuated the development of AD-like skin lesions. Histological analysis showed that quercetin inhibited hyperkeratosis, parakeratosis, acanthosis, mast cells and infiltration of inflammatory cells. Furthermore, quercetin treatment downregulated cytoplasmic HMGB1, RAGE, nuclear p-NFB, p-ERK1/2, COX2, TNF, IL-1, IL-2R, IFN and IL-4 and upregulated nuclear Nrf2. Our data demonstrated that the HMGB1/RAGE/NFB signalling might play an important role in skin inflammation, and quercetin treatment could be a promising agent for AD by modulating the HMGB1/RAGE/NFB signalling and induction of Nrf2 protein.	[Karuppagounder, Vengadeshprabhu; Arumugam, Somasundaram; Thandavarayan, Rajarajan A.; Pitchaimani, Vigneshwaran; Sreedhar, Remya; Afrin, Rejina; Harima, Meilei; Suzuki, Hiroshi; Nomoto, Mayumi; Miyashita, Shizuka; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Niigata 9568603, Japan; [Thandavarayan, Rajarajan A.] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX USA; [Suzuki, Kenji] Niigata Univ, Grad Sch Med & Dent Sci, Dept Gastroenterol, Niigata, Japan; [Nakamura, Masahiko] Yamanashi Prefectural Cent Hosp, Dept Cardiol, Kofu, Yamanashi, Japan	Watanabe, K (reprint author), Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Akiha Ku, 265-1 Higashijima, Niigata 9568603, Japan.	watanabe@nupals.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23602012]; Promotion and Mutual Aid Corporation for Private Schools, Japan [26460239]	This research was supported by Ministry of Education, Culture, Sports, Science and Technology of Japan and by a grant from the Promotion and Mutual Aid Corporation for Private Schools, Japan (23602012 and 26460239), respectively.	HOLLMAN PCH, 1995, AM J CLIN NUTR, V62, P1276; Strozyk EA, 2014, EXP DERMATOL, V23, P670, DOI 10.1111/exd.12505; Makarov SS, 2000, MOL MED TODAY, V6, P441, DOI 10.1016/S1357-4310(00)01814-1; Kimata M, 2000, CLIN EXP ALLERGY, V30, P501, DOI 10.1046/j.1365-2222.2000.00768.x; Nogueira-Machado JA, 2011, EXPERT OPIN THER TAR, V15, P1023, DOI 10.1517/14728222.2011.575360; Ding M, 2010, INT J ONCOL, V36, P59, DOI 10.3892/ijo_00000475; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P99, DOI 10.1016/j.anai.2009.10.002; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; Karuppagounder V, 2014, INT IMMUNOPHARMACOL, V23, P617, DOI 10.1016/j.intimp.2014.10.014; Huang WC, 2010, CYTOKINE, V51, P119, DOI 10.1016/j.cyto.2010.02.021; Arumugam S, 2014, EXP MOL PATHOL, V97, P137, DOI 10.1016/j.yexmp.2014.06.007; He Q, 2012, ASIAN PAC J CANCER P, V13, P1365, DOI 10.7314/APJCP.2012.13.4.1365; Castangia I, 2014, ACTA BIOMATER, V10, P1292, DOI 10.1016/j.actbio.2013.11.005; Tadie JM, 2012, MOL MED, V18, P659, DOI 10.2119/molmed.2011.00401; Kawahara KI, 2009, INT J MOL MED, V23, P615, DOI 10.3892/ijmm_00000172; Marcolin E, 2012, J NUTR, V142, P1821, DOI 10.3945/jn.112.165274; Miyamoto N, 2011, INVEST OPHTH VIS SCI, V52, P1055, DOI 10.1167/iovs.10-5777; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Feng L, 2013, INT IMMUNOPHARMACOL, V15, P206, DOI 10.1016/j.intimp.2012.11.015; Ipaktchi K, 2006, SHOCK, V26, P201, DOI 10.1097/01.shk.0000225739.13796.f2; Tang DL, 2009, AM J RESP CELL MOL, V41, P651, DOI 10.1165/rcmb.2008-0119OC; Jung MK, 2010, J INVEST DERMATOL, V130, P1459, DOI 10.1038/jid.2009.401; Thandavarayan RA, 2010, FREE RADICAL BIO MED, V49, P1422, DOI 10.1016/j.freeradbiomed.2010.08.005; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Riehl A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-537; Gounder V K, 2013, INT IMMUNOPHARMACOL, V18, P282; Lim H S, 2012, EVID-BASED COMPL ALT, V2012; Ma Z S, 2004, INT J ONCOL, V24, P1297; Palsamy P, 2011, BIOCHIM BIOPHYS ACTA, V12, P719; Schaper F, 2014, MOL MED, V20, P72, DOI 10.2119/molmed.2014.00019; Soetikno V, 2013, MOL NUTR FOOD RES, V57, P1649, DOI 10.1002/mnfr.201200540; Thomsen S F, 2014, ISRN ALLERGY, V2014, P1; Tsuji G, 2012, J INVEST DERMATOL, V132, P59, DOI 10.1038/jid.2011.194; Udompataikul M, 2012, J DRUGS DERMATOL, V11, P366; Voll RE, 2008, ISR MED ASSOC J, V10, P26; Weng H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-311; Weng ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033805	40	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	JUN	2015	24	6					418	423		10.1111/exd.12685		6	Dermatology	Dermatology	CI2FX	WOS:000354562100006		
J	Kanemaru, K; Matsuyuki, A; Nakamura, Y; Fukami, K				Kanemaru, Kaori; Matsuyuki, Ayano; Nakamura, Yoshikazu; Fukami, Kiyoko			Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice	EXPERIMENTAL DERMATOLOGY			English	Article						animal model; epidermal hyperplasia; obesity; psoriasis	BODY-MASS INDEX; FREE FATTY-ACIDS; DELTA T-CELLS; SKIN INFLAMMATION; INSULIN-RESISTANCE; EPITHELIAL-CELLS; SERUM LEPTIN; RECEPTOR; EXPRESSION; IMPACT	Psoriasis is a chronic inflammatory skin disorder that is accompanied by an imbalance between the proliferation and differentiation of keratinocytes. A number of studies have suggested an association between obesity and severe psoriasis; however, it remains to be clarified whether obesity exacerbates psoriasis. To address this unsolved question, we induced psoriasiform dermatitis in mouse models for obesity. We found that obesity exaggerated the severity of psoriasiform dermatitis induced by topical application of the Toll-like receptor (TLR) 7 agonist, imiquimod. Ear swelling and epidermal hyperplasia were more prominent in the obese mice than in the control mice. When compared to imiquimod-treated control mice, imiquimod-treated obese mice expressed higher levels of psoriasis mediators, interleukin-17A (IL-17A) and IL-22 in the skin. Food intake restriction partially abrogated enhanced ear swelling and cytokine overproduction in obese mice. Furthermore, the obesity environment and imiquimod treatment synergistically induced an IL-17A downstream molecule, regenerating islet-derived 3 (Reg3), which is a critical molecule for psoriatic epidermal hyperplasia. Palmitic acid, one of the fatty acids released by subcutaneous adipocytes, increased the expression of REG3A (a human homologue of mouse Reg3) in both the HaCaT keratinocyte cell line and normal human keratinocytes. Taken together, these results strongly suggest that obesity exacerbates psoriasiform dermatitis in mice by upregulating IL-17A, IL-22 and Reg3.	[Kanemaru, Kaori; Matsuyuki, Ayano; Nakamura, Yoshikazu; Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Genome & Biosignals, Hachioji, Tokyo 19203, Japan; [Kanemaru, Kaori; Nakamura, Yoshikazu; Fukami, Kiyoko] CREST JST, Saitama, Japan	Nakamura, Y (reprint author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Genome & Biosignals, 1432-1 Horinouchi, Hachioji, Tokyo 19203, Japan.	ynakamur@toyaku.ac.jp			Funding Program for Next Generation World-Leading Researchers; Uehara Memorial Foundation; Ono Medical Research Foundation; Kowa Life Science Foundation	We thank Ms. Y. Horibe for her technical assistance. This work was supported by the Funding Program for Next Generation World-Leading Researchers to KF, as well as a Grant-in-Aid for Scientific Research (C), Uehara Memorial Foundation, Ono Medical Research Foundation and The Kowa Life Science Foundation to YN.	Wang Y, 2008, BRIT J DERMATOL, V158, P1134, DOI 10.1111/j.1365-2133.2008.08456.x; Naldi L, 2005, J INVEST DERMATOL, V125, P61, DOI 10.1111/j.0022-202X.2005.23681.x; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Cohen AD, 2008, DERMATOLOGY, V216, P152, DOI 10.1159/000111512; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Naldi L, 2014, BRIT J DERMATOL, V170, P634, DOI 10.1111/bjd.12735; Boehncke S, 2007, BRIT J DERMATOL, V157, P1249, DOI 10.1111/j.1365-2133.2007.08190.x; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Naldi L, 2008, DERMATOLOGY, V217, P365, DOI 10.1159/000156599; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Jensen P, 2013, JAMA DERMATOL, V149, P795, DOI 10.1001/jamadermatol.2013.722; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Altavilla D, 2001, DIABETES, V50, P667, DOI 10.2337/diabetes.50.3.667; Cerman AA, 2008, BRIT J DERMATOL, V159, P820, DOI 10.1111/j.1365-2133.2008.08742.x; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Albanesi C, 2007, CLIN DERMATOL, V25, P581, DOI 10.1016/j.clindermatol.2007.08.013; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; MacLeod AS, 2013, J CLIN INVEST, V123, P4364, DOI 10.1172/JCI70064; Boehncke WH, 2011, EXP DERMATOL, V20, P303, DOI 10.1111/j.1600-0625.2011.01261.x; Lai YP, 2012, IMMUNITY, V37, P74, DOI 10.1016/j.immuni.2012.04.010; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; Johansen C, 2009, BRIT J DERMATOL, V160, P319, DOI 10.1111/j.1365-2133.2008.08902.x; Kwan HY, 2014, J BIOL CHEM, V289, P30525, DOI 10.1074/jbc.M114.593210; Gerdes S, 2014, EXP DERMATOL, V23, P438, DOI 10.1111/exd.12413; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Nakajima K, 2011, J IMMUNOL, V186, P4481, DOI 10.4049/jimmunol.1000148; Johnston A, 2013, J IMMUNOL, V190, P2252, DOI 10.4049/jimmunol.1201505; Heidenreich R, 2009, INT J EXP PATHOL, V90, P232, DOI 10.1111/j.1365-2613.2009.00669.x; DisCesare A, 2009, J INVEST DERMATOL, V129, P1339; Ezure T, 2011, J INVEST DERMATOL, V131, P2004, DOI 10.1038/jid.2011.145; Fry L, 2015, EXP DERMATOL, V24, P241, DOI 10.1111/exd.12572; Gerdes S, 2012, EXP DERMATOL, V21, P43, DOI 10.1111/j.1600-0625.2011.01402.x; Ghanaat-Pour H, 2011, METABOLOMICS, V1, P102, DOI [DOI 10.4172/2153-0769.1000102, 10. 4172/ 2153- 0769. 1000102]; Gottlieb A B, 2009, AM J MED, V122; Guida B, 2010, J EUR ACAD DERMATOL, V24, P191, DOI 10.1111/j.1468-3083.2009.03503.x; Huang L, 2000, Cell Res, V10, P81, DOI 10.1038/sj.cr.7290038; Im E, 2012, J INTERF CYTOK RES, V32, P583, DOI 10.1089/jir.2012.0053; Peck Y, 2002, NEW ENGL J MED, V347, P1151; Stahle M, 2015, EXP DERMATOL, V24, P181, DOI 10.1111/exd.12612; Taylor KR, 2011, J INVEST DERMATOL, V131, P2409, DOI 10.1038/jid.2011.241; Taylor KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011422; VansBelle A. B., 2012, J IMMUNOL, V188, P462; Xue K, 2013, EXP DERMATOL, V22, P406, DOI 10.1111/exd.12162; Yanaba K, 2014, ARCH DERMATOL RES, V306, P921, DOI 10.1007/s00403-014-1495-1	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	JUN	2015	24	6					436	442		10.1111/exd.12691		7	Dermatology	Dermatology	CI2FX	WOS:000354562100009		
J	Katoh, M				Katoh, Masaru			Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine	EXPERT REVIEW OF PROTEOMICS			English	Review						acute myeloid leukemia; cardiovascular development; colorectal cancer; Forkhead-box transcription factor; hepatocellular carcinoma; melanoma; microsatellite instability; myelodysplastic syndrome; ovarian cancer; pancreatic cancer	ADDITIONAL-SEX-COMBS; NUCLEAR RECEPTOR SUPERFAMILY; PROTEIN-PROTEIN INTERACTIONS; ACUTE MYELOID-LEUKEMIA; BOHRING-OPITZ SYNDROME; GENE IN-SILICO; PHD FINGER; MYELODYSPLASTIC SYNDROMES; MASS-SPECTROMETRY; BREAST-CANCER	ASXL1, ASXL2 and ASXL3 are epigenetic scaffolds for BAP1, EZH2, NCOA1, nuclear receptors and WTIP. Here, functional proteomics of the ASXL family members are reviewed with emphasis on mutation spectra, the ASXM2 domain and the plant homeodomain (PHD) finger. Copy number gains of ASXL1 occur in chromosome 20q11.2 duplication syndrome and cervical cancer. Truncation mutations of ASXLs occur in autism, Bohring-Opitz and related syndromes, hematological malignancies and solid tumors, such as prostate cancer, breast cancer and high-grade glioma, which are gain-or loss-of-function mutations. The ASXM2 domain is a binding module for androgen receptor and estrogen receptor a, while the PHD finger is a ligand of WTIP LIM domains and a putative chromatin-binding module. Phylogenetic analyses of 139 human PHD fingers revealed that ASXL PHD fingers cluster with those of BPTF, DIDO, ING1, KDM5A (JARID1A), KMT2E (MLL5), PHF2, PHF8 and PHF23. The cell context-dependent epigenetic code of ASXLs should be deciphered to develop therapeutics for human diseases.	Natl Canc Ctr Japan, Dept Om Network, Tokyo 1040045, Japan	Katoh, M (reprint author), Natl Canc Ctr Japan, Dept Om Network, 5-1-1 Tsukiji Chuo Ward, Tokyo 1040045, Japan.	mkatoh-kkr@umin.ac.jp			Masaru Katoh's Fund	This study was supported in part by a grant-in-aid for the Knowledgebase Project from the Masaru Katoh's Fund. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Agyeman A, 2014, ONCOTARGET, V5, P4492; Tan JZ, 2014, ACTA PHARMACOL SIN, V35, P161, DOI 10.1038/aps.2013.161; Park UH, 2011, J BIOL CHEM, V286, P1354, DOI 10.1074/jbc.M110.177816; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Chu CH, 2014, J MED CHEM, V57, P5975, DOI 10.1021/jm500249n; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Hoischen A, 2011, NAT GENET, V43, P729, DOI 10.1038/ng.868; Inoue D, 2013, J CLIN INVEST, V123, P4627, DOI 10.1172/JCI70739; Irvine DA, 2012, BLOOD, V119, P2196, DOI 10.1182/blood-2011-10-383752; Klein BJ, 2014, CELL REP, V6, P325, DOI 10.1016/j.celrep.2013.12.021; Wagner EK, 2012, BIOCHEMISTRY-US, V51, P8293, DOI 10.1021/bi3009278; Sinclair DAR, 1998, DEVELOPMENT, V125, P1207; Liu ZH, 2014, J BIOL CHEM, V289, P10069, DOI 10.1074/jbc.M113.535351; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Katoh M, 2014, MED RES REV, V34, P280, DOI 10.1002/med.21288; Liu L, 2012, J STRUCT BIOL, V180, P165, DOI 10.1016/j.jsb.2012.06.014; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Angrand PO, 2001, GENOMICS, V74, P79, DOI 10.1006/geno.2001.6524; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Nakahata S, 2009, GENE CHROMOSOME CANC, V48, P768, DOI 10.1002/gcc.20681; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Park UH, 2014, BIOCHEM BIOPH RES CO, V443, P489, DOI 10.1016/j.bbrc.2013.11.124; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Tan L, 2014, P NATL ACAD SCI USA, V111, pE4869, DOI 10.1073/pnas.1403438111; Fisher CL, 2003, GENE, V306, P115, DOI 10.1016/S0378-1119(03)00430-X; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Ali M, 2014, BBA-MOL CELL RES, V1843, P366, DOI 10.1016/j.bbamcr.2013.11.016; Khan FF, 2014, BIOCHEM BIOPH RES CO, V451, P101, DOI 10.1016/j.bbrc.2014.07.080; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Bonisch C, 2008, EXPERT REV PROTEOMIC, V5, P105, DOI 10.1586/14789450.5.1.105; Katoh M, 2004, INT J ONCOL, V24, P1623; Abdel-Wahab O, 2012, CANCER CELL, V22, P180, DOI 10.1016/j.ccr.2012.06.032; Li YY, 2012, ACTA BIOCH BIOPH SIN, V44, P28, DOI 10.1093/abbs/gmr117; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Katoh M, 2003, INT J ONCOL, V23, P845; Balbas-Martinez C, 2013, NAT GENET, V45, P1464, DOI 10.1038/ng.2799; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609; Hervouet E, 2013, EPIGENETICS-US, V8, P237, DOI 10.4161/epi.23790; Metzeler KH, 2011, BLOOD, V118, P6920, DOI 10.1182/blood-2011-08-368225; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Wen H, 2010, J BIOL CHEM, V285, P9322, DOI 10.1074/jbc.C109.097667; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; White AE, 2012, SCIENCE, V337, P1463, DOI 10.1126/science.1228463; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Gough SM, 2014, CANCER DISCOV, V4, P564, DOI 10.1158/2159-8290.CD-13-0419; Katoh M, 2013, BRIT J CANCER, V109, P299, DOI 10.1038/bjc.2013.281; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Rose NR, 2010, J MED CHEM, V53, P1810, DOI 10.1021/jm901680b; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Cho YS, 2006, J BIOL CHEM, V281, P17588, DOI 10.1074/jbc.M512616200; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Johansson C, 2014, EPIGENOMICS-UK, V6, P89, DOI 10.2217/epi.13.79; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Evans RM, 2005, MOL ENDOCRINOL, V19, P1429, DOI 10.1210/me.2005-0046; Simhadri C, 2014, J MED CHEM, V57, P2874, DOI 10.1021/jm401487x; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Katoh Y, 2009, CURR MOL MED, V9, P873; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Berry WL, 2013, CANCER RES, V73, P2936, DOI 10.1158/0008-5472.CAN-12-4300; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Katoh M, 2004, INT J ONCOL, V24, P1617; Aravind L, 2012, CELL CYCLE, V11, P119, DOI 10.4161/cc.11.1.18475; Avila M, 2013, AM J MED GENET A, V161A, P1594, DOI 10.1002/ajmg.a.35970; Bainbridge MN, 2013, GENOME MED, V5, DOI 10.1186/gm415; Baskind HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004750; Boulay G, 2011, BIOCHEM J, V434, P333, DOI 10.1042/BJ20100944; Bravo GM, 2014, BRIT J HAEMATOL, V166, P646, DOI 10.1111/bjh.12957; Brezinova J, 2014, BRIT J HAEMATOL, V164, P153, DOI 10.1111/bjh.12586; Cazzola M, 2013, BLOOD, V122, P4021, DOI 10.1182/blood-2013-09-381665; Chinen Y, 2014, GENE CHROMOSOME CANC, V53, P299, DOI 10.1002/gcc.22140; Deb G, 2013, EPIGENETICS-US, V8, P464, DOI 10.4161/epi.24532; Di Costanzo A, 2014, ARCH TOXICOL, V88, P1651, DOI 10.1007/s00204-014-1315-6; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Gadaleta RM, 2014, J MOL ENDOCRINOL, V52, pR137, DOI 10.1530/JME-13-0170; Gatchalian J, 2013, CELL REP, V4, P148, DOI 10.1016/j.celrep.2013.06.014; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Gelsi-Boyer V, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-12; Giri NC, 2013, BIOCHEMISTRY-US, V52, P4168, DOI 10.1021/bi400274v; Han Y, 2013, EPIGENOMICS, V5, P1; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Kanchi KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4156; Katoh Masaru, 2014, Front Cell Dev Biol, V2, P61, DOI 10.3389/fcell.2014.00061; Katoh Masaru, 2013, Front Cell Dev Biol, V1, P1, DOI 10.3389/fcell.2013.00001; Klein T, 2013, ACS MED CHEM LETT, V5, P166; Kwa FAA, 2014, DRUG DISCOV TODAY, V19, P1387, DOI 10.1016/j.drudis.2014.03.026; Labbe RM, 2014, AM J TRANSL RES, V6, P1; Lai HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073983; Lemak A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077020; Leurs U, 2014, ACS CHEM BIOL, V9, P2131, DOI 10.1021/cb500374f; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; McGinley AL, 2014, GENESIS, V52, P671, DOI 10.1002/dvg.22793; Mehdipour P, 2015, FEBS J; Metzeler KH, 2014, BLOOD, V124, P1382, DOI 10.1182/blood-2014-07-586073; Micol JB, 2014, BLOOD, V124, P1445, DOI 10.1182/blood-2014-04-571018; Moore JT, 2006, CHEMMEDCHEM, V1, P504, DOI 10.1002/cmdc.200600006; Russell B, 2013, GENOME MED, V5, DOI 10.1186/gm420; Simo-Riudalbas L, 2014, HUM GENET, V133, P713, DOI 10.1007/s00439-013-1373-5; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Trelle MB, 2007, EXPERT REV PROTEOMIC, V4, P491, DOI 10.1586/14789450.4.4.491; Williams DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016012; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Zhang Y, 2014, BIOCHEM BIOPH RES CO, V453, P172, DOI 10.1016/j.bbrc.2014.09.092	126	0	0	EXPERT REVIEWS	LONDON	UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND	1478-9450	1744-8387		EXPERT REV PROTEOMIC	Expert Rev. Proteomics	JUN	2015	12	3					317	328		10.1586/14789450.2015.1033409		12	Biochemical Research Methods	Biochemistry & Molecular Biology	CI2WZ	WOS:000354610000009		
J	Quynh, NT; Hikima, J; Kim, Y; Fagutao, FF; Kim, MS; Aoki, T; Jung, TS				Nhu Truong Quynh; Hikima, Jun-ichi; Kim, Young-rim; Fagutao, Fernand F.; Kim, Mee Sun; Aoki, Takashi; Jung, Tae Sung			The cytosolic sensor, DDX41, activates antiviral and inflammatory immunity in response to stimulation with double-stranded DNA adherent cells of the olive flounder, Paralichthys olivaceus	FISH & SHELLFISH IMMUNOLOGY			English	Article						DDX41; DExD/H-box helicases; Innate immunity; Bacterial cyclic dinucleotides	RIG-I; INTRACELLULAR DNA; DENDRITIC CELLS; RNA; RECOGNITION; IDENTIFICATION; CONSERVATION; RECEPTORS; INFECTION; HELICASES	DDX41, a receptor belonging to the DExD family, functions as a DNA sensor in the mammalian cytoplasm and mediates the antiviral response in host cells. Here, the olive flounder DDX41 was found to have 2267-bp long and encodes a putative protein of 614 amino acid residues. The olive flounder DDX41 mRNA was presented in all tested tissues, and was distinctly expressed in fish naturally infected with LCDV. High expression levels were observed in the heart, liver, kidney and stomach. Furthermore, the olive flounder DDX41 mRNA expression increased significantly in adherent (monocyte-like) cells folloWing stimulation with a DNA virus. Reporter assays showed that the transcriptional activity of the IFN-I promoter was enhanced in DDX41-overexpressing HINAE cells treated with C-di-GMP (dinucleotides). Overexpression of DDX41 also induced the antiviral and inflammatory cytokine gene expression through cytoplasmic C-di-GMP treatment. These results suggest that DDX41 functions as a cytosolic DNA sensor that is capable of inducing antiviral activity and inflammatory responses in the olive flounder. (c) 2015 Elsevier Ltd. All rights reserved.	[Nhu Truong Quynh; Kim, Young-rim; Fagutao, Fernand F.; Jung, Tae Sung] Gyeongsang Natl Univ, Coll Vet Med, Inst Anim Med, Lab Aquat Anim Dis, Jinju 660701, South Korea; [Hikima, Jun-ichi] Miyazaki Univ, Fac Agr, Dept Biochem & Appl Biosci, Miyazaki 8892192, Japan; [Aoki, Takashi] Waseda Univ, Consolidated Res Inst Adv Sci & Med Care, Shinjuku Ku, Tokyo 1620041, Japan; [Kim, Mee Sun] BluGen Korea, Busan, South Korea	Aoki, T (reprint author), Waseda Univ, Consolidated Res Inst Adv Sci & Med Care, Shinjuku Ku, 513 Wasedatsurumaki Cho, Tokyo 1620041, Japan.	aokitaka@aoni.waseda.jp; jungts@gsnu.ac.kr			Ministry of Agriculture, Food and Rural Affairs, Ministry of Oceans and Fisheries, Rural Development Administration and Korea Forest Service [213004041SB320]; Korea Research Foundation - Korean Government [NRF-2014 R1A2A1A01003404]	This research (213004041SB320) was supported by the Ministry of Agriculture, Food and Rural Affairs, Ministry of Oceans and Fisheries, Rural Development Administration and Korea Forest Service; and by the Korea Research Foundation grant funded by the Korean Government (NRF-2014 R1A2A1A01003404).	Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027; Rajendran KV, 2012, DEV COMP IMMUNOL, V37, P381, DOI 10.1016/j.dci.2012.02.004; Ohtani M, 2010, J IMMUNOL, V185, P7507, DOI 10.4049/jimmunol.1001850; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Horan KA, 2013, J IMMUNOL, V190, P2311, DOI 10.4049/jimmunol.1202749; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Zhang ZQ, 2013, NAT IMMUNOL, V14, P172, DOI 10.1038/ni.2492; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Stein SC, 2012, J VIROL, V86, P4527, DOI 10.1128/JVI.07071-11; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Aoki T, 2013, FISH SHELLFISH IMMUN, V35, P1689, DOI 10.1016/j.fsi.2013.02.005; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Bowie AG, 2012, NAT IMMUNOL, V13, P1137, DOI 10.1038/ni.2469; Hikima J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051522; Kim YR, 2011, COMP IMMUNOL MICROB, V34, P237, DOI 10.1016/j.cimid.2010.11.007; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Sugamata R, 2009, J IMMUNOL, V182, P6799, DOI 10.4049/jimmunol.0803371; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	26	0	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1050-4648	1095-9947		FISH SHELLFISH IMMUN	Fish Shellfish Immunol.	JUN	2015	44	2					576	583		10.1016/j.fsi.2015.03.008		8	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	CI2NH	WOS:000354583800022		
J	Mudaca, JD; Tsuchiya, T; Yamada, M; Onwona-Agyeman, S				Mudaca, Joao Daniel; Tsuchiya, Toshiyuki; Yamada, Masaaki; Onwona-Agyeman, Siaw			Household participation in Payments for Ecosystem Services: A case study from Mozambique	FOREST POLICY AND ECONOMICS			English	Article						Payments for Ecosystem Services; Factor analysis; Multinomial logistic regression; N'hambita community	INFLUENCING PEOPLES PARTICIPATION; ENVIRONMENTAL SERVICES; FARMERS PARTICIPATION; FOREST MANAGEMENT; PROTECTED AREAS; LATIN-AMERICA; COSTA-RICA; CONSERVATION; PROGRAMS; ADOPTION	The success of the PES programme in developing countries depends on the active participation and contribution of rural households. This paper investigates the factors influencing rural households' derision to participate in the PES programme in the N'hambita Community in Sofala Province, Mozambique, based on data collected through a survey of 115 households, using factor analysis and multiple regressions. Factor analysis has shown that the main factors influencing the household decision to participate in the programme are latent variables labelled as economic benefits, followed by social inclusion and forest conservation accounting, with 31%, 19% and 14% of the total variance respectively. Multinomial logistic regression demonstrates that the gender, marital status, household age, the educational level of the head, land area, distance from the project centre and source of income are important variables in explaining the level of participation of the three factors. (C) 2015 Elsevier B.V. All rights reserved.	[Mudaca, Joao Daniel; Tsuchiya, Toshiyuki] Tokyo Univ Agr & Technol, United Grad Sch, Tokyo, Japan; [Yamada, Masaaki; Onwona-Agyeman, Siaw] Tokyo Univ Agr & Technol, Grad Sch, Tokyo, Japan	Mudaca, JD (reprint author), Tokyo Univ Agr & Technol, United Grad Sch, Tokyo, Japan.	jmudaca@hotmail.com	YAMADA, Masaaki/G-1089-2013	YAMADA, Masaaki/0000-0002-1346-9938			Deressa TT, 2009, GLOBAL ENVIRON CHANG, V19, P248, DOI 10.1016/j.gloenvcha.2009.01.002; Walker SM, 2004, FOREST ECOL MANAG, V203, P345, DOI 10.1016/j.foreco.2004.08.004; Clements T, 2010, ECOL ECON, V69, P1283, DOI 10.1016/j.ecolecon.2009.11.010; Lopa D, 2012, ORYX, V46, P34, DOI 10.1017/S0030605311001335; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Ferraro PJ, 2002, SCIENCE, V298, P1718, DOI 10.1126/science.1078104; Dolisca F, 2006, FOREST ECOL MANAG, V236, P324, DOI 10.1016/j.foreco.2006.09.017; Grieg-Gran M, 2005, WORLD DEV, V33, P1511, DOI 10.1016/j.worlddev.2005.05.002; Knowler D, 2007, FOOD POLICY, V32, P25, DOI 10.1016/j.foodpol.2006.01.003; NEWMARK WD, 1993, BIOL CONSERV, V63, P177, DOI 10.1016/0006-3207(93)90507-W; Atmis E, 2007, ECOL ECON, V60, P787, DOI 10.1016/j.ecolecon.2006.02.016; Corbera E, 2007, GLOBAL ENVIRON CHANG, V17, P365, DOI 10.1016/j.gloenvcha.2006.12.005; Defrancesco E, 2008, J AGR ECON, V59, P114, DOI 10.1111/j.1477-9552.2007.00134.x; Zbinden S, 2005, WORLD DEV, V33, P255, DOI 10.1016/j.worlddev.2004.07.012; Lise W, 2000, ECOL ECON, V34, P379, DOI 10.1016/S0921-8009(00)00182-8; Falconer K, 2000, J RURAL STUD, V16, P379, DOI 10.1016/S0743-0167(99)00066-2; Mercer DE, 2004, AGROFOREST SYST, V61-2, P311, DOI 10.1023/B:AGFO.0000029007.85754.70; Pagiola S, 2005, WORLD DEV, V33, P237, DOI 10.1016/j.worlddev.2004.07.011; Pattanayak SK, 2010, REV ENV ECON POLICY, V4, P254, DOI 10.1093/reep/req006; Wunder S, 2008, ENVIRON DEV ECON, V13, P279, DOI 10.1017/S1355770X08004282; Baumgart-Getz A, 2012, J ENVIRON MANAGE, V96, P17, DOI 10.1016/j.jenvman.2011.10.006; Pagiola S, 2008, ECOL ECON, V65, P712, DOI 10.1016/j.ecolecon.2007.07.033; Pretty J, 2004, CONSERV BIOL, V18, P631, DOI 10.1111/j.1523-1739.2004.00126.x; Olli E, 2001, ENVIRON BEHAV, V33, P181, DOI 10.1177/0013916501332002; Kosoy N, 2008, GEOFORUM, V39, P2073, DOI 10.1016/j.geoforum.2008.08.007; Palmer C, 2012, LAND USE POLICY, V29, P83, DOI 10.1016/j.landusepol.2011.05.007; Toma L, 2007, J ENVIRON MANAGE, V83, P145, DOI 10.1016/j.jenvman.2006.02.004; Atmis E, 2009, FOREST POLICY ECON, V11, P102, DOI 10.1016/j.forpol.2008.10.002; Baden S., 2000, GENDER DEV CONCEPTS; Britt C., 1998, TREES PEOPLE, V35, P4; BROTHERTON I, 1989, J RURAL STUD, V5, P299, DOI 10.1016/0743-0167(89)90008-9; CHAMBERS RG, 1983, AM J AGR ECON, V65, P120, DOI 10.2307/1240346; Coulibaly-Lingani P, 2011, FOREST POLICY ECON, V13, P292, DOI 10.1016/j.forpol.2011.02.005; Damianos D., 2002, British Food Journal, V104, P261, DOI 10.1108/00070700210425705; Grace J., 2008, MIOMBO COMMUNITY LAN; Greene W. H., 2000, ECONOMETRIC ANAL; Hanlon J., 2008, DO BICYCLES EQUAL DE; Hegde R., 2008, MANAGING MIOMBO WOOD; Herd A., 2007, THESIS U EDINBURGH U; Jindal R., 2012, WORLD DEV; Kabii T, 2006, ENVIRON CONSERV, V33, P11, DOI 10.1017/S0376892906002761; Landell-Mills N., 2002, SILVER BULLET FOOLS; Lee D.R., 1985, J AGR RESOUR ECON, V14, P193; Lee E, 2009, PAYMENTS ENV SERVICE; Miranda M., 2004, SOCIAL IMPACT PAYMEN; Nkamleu G.B., 2005, SMALL SCALE FOR EC M, V4; Pattanayak Subhrendu K., 2003, Agroforestry Systems, V57, P173, DOI 10.1023/A:1024809108210; Porras I., 2008, ALL GLITTERS REV PAY; Sengupta S., 2003, DEV MARKETS WATERSHE; Tachbanick B.G., 1996, USING MULTIVARIATE S; Tinley K.L., 1997, FRAMEWORK GORONGOSA, P184; University of Edinburgh, 2008, MIOMB COMM LAND US C	52	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9341	1872-7050		FOREST POLICY ECON	Forest Policy Econ.	JUN	2015	55						21	27		10.1016/j.forpol.2015.03.002		7	Forestry	Forestry	CI2NM	WOS:000354584300003		
J	Ebi, M; Shimura, T; Yamada, T; Mizushima, T; Itoh, K; Tsukamoto, H; Tsuchida, K; Hirata, Y; Murakami, K; Kanie, H; Nomura, S; Iwasaki, H; Kitagawa, M; Takahashi, S; Joh, T				Ebi, Masahide; Shimura, Takaya; Yamada, Tomonori; Mizushima, Takashi; Itoh, Keisuke; Tsukamoto, Hironobu; Tsuchida, Kenji; Hirata, Yoshikazu; Murakami, Kenji; Kanie, Hiroshi; Nomura, Satoshi; Iwasaki, Hiroyasu; Kitagawa, Mika; Takahashi, Satoru; Joh, Takashi			Multicenter, prospective trial of white-light imaging alone versus white-light imaging followed by magnifying endoscopy with narrow-band imaging for the real-time imaging and diagnosis of invasion depth in superficial esophageal squamous cell carcinoma	GASTROINTESTINAL ENDOSCOPY			English	Article							SUBMUCOSAL DISSECTION; MUCOSAL RESECTION; CANCER; ULTRASONOGRAPHY; ACCURACY; FEATURES; OUTCOMES; JAPAN; PHASE	Background: Magnifying endoscopy with narrow-band imaging (ME-NBI) has been used to estimate the invasion depth of superficial esophageal squamous cell carcinoma (SESCC), but the real diagnostic power of ME-NBI remains unclear because of few prospective studies. Objectives: To evaluate whether ME-NBI adds additional information to white-light imaging (WLI) for the diagnosis of invasion depth of SESCC. Design: Multicenter, prospective trial using real-time imaging and diagnosis. Setting: Seven Japanese institutions. Patients: Fifty-five patients with SESCC were enrolled from June 2011 to October 2013, and the results for 49 lesions were analyzed. Interventions: Patients underwent primary WLI followed by ME-NBI, and reports of primary WLI (WLI alone) were completed before secondary ME-NBI (WLI followed by ME-NBI). To standardize diagnosis among examiners, this trial was started after achievement of a mean kappa value >= .6 among 11 participating endoscopists. Main Outcome Measurements: Diagnosis of invasion depth by each tool was divided into cancer limited to the epithelium and the lamina propria mucosa and cancer invading beyond the muscularis mucosae (>= T1a-MM) and then collated with the final pathologic diagnosis by an independent pathologist blinded to the clinical data. Results: The accuracy of invasion depth in WLI alone and WLI followed by ME-NBI was 71.4% and 65.3% (P = .375), respectively. Sensitivity for >= T1a-MM was 61.1% for both groups (P = 1.000), and specificity for >= T1a-MM was 77.4% for WLI alone and 67.7% for WLI followed by ME-NBI (P = .375). Limitation: Open-label trial. Conclusions: ME-NBI showed no additional benefit to WLI for diagnosis of invasion depth of SESCC.	[Ebi, Masahide; Shimura, Takaya; Tsukamoto, Hironobu; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi 4678601, Japan; [Takahashi, Satoru] Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Nagoya, Aichi 4678601, Japan; [Shimura, Takaya] Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Shimura, Takaya] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Shimura, Takaya] Boston Childrens Hosp, Boston, MA USA; [Yamada, Tomonori; Kanie, Hiroshi; Nomura, Satoshi] Japanese Red Cross Nagoya Daini Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Mizushima, Takashi; Iwasaki, Hiroyasu] Gifu Prefectural Tajimi Hosp, Dept Gastroenterol, Tajimi, Japan; [Itoh, Keisuke; Kitagawa, Mika] Nagoya City East Med Ctr, Dept Gastroenterol, Nagoya, Aichi, Japan; [Tsuchida, Kenji] Nagoya City West Med Ctr, Dept Gastroenterol, Nagoya, Aichi, Japan; [Hirata, Yoshikazu] Kasugai Municipal Hosp, Dept Gastroenterol, Kasugai, Aichi, Japan; [Murakami, Kenji] Nagoya Mem Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan	Shimura, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.						Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Muto M, 2010, J CLIN ONCOL, V28, P1566, DOI 10.1200/JCO.2009.25.4680; Yoshida T, 2004, GASTROINTEST ENDOSC, V59, P288, DOI 10.1016/S0016-5107(03)02532-X; Kodama M, 1998, SURGERY, V123, P432, DOI 10.1016/S0039-6060(98)70165-5; Ishihara R, 2008, GASTROINTEST ENDOSC, V68, P1066, DOI 10.1016/j.gie.2008.03.1114; Bailey SH, 2003, ANN THORAC SURG, V75, P217, DOI 10.1016/S0003-4975(02)04368-0; Higuchi K, 2013, GASTROINTEST ENDOSC, V78, P704, DOI 10.1016/j.gie.2013.04.182; Bossuyt PM, 2003, ANN INTERN MED, V138, P40; Kumagai Y, 2002, LANCET ONCOL, V3, P604, DOI 10.1016/S1470-2045(02)00874-4; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Gono K, 2004, J BIOMED OPT, V9, P568, DOI 10.1117/1.1695563; Eguchi T, 2006, MODERN PATHOL, V19, P475, DOI 10.1038/modpathol.3800557; Fujita H, 2001, WORLD J SURG, V25, P424; Goda K, 2009, DIS ESOPHAGUS, V22, P453, DOI 10.1111/j.1442-2050.2009.00942.x; Takubo K, 2007, HISTOPATHOLOGY, V51, P733, DOI 10.1111/j.1365-2559.2007.02766.x; Araki K, 2002, CANCER, V94, P570, DOI 10.1002/cncr.10190; Arima M, 2005, ESOPHAGUS, V2, P191, DOI DOI 10.1007/S10388-005-0060-6; Ebi M, 2012, DIGEST LIVER DIS, V44, P940, DOI 10.1016/j.dld.2012.05.007; Hasegawa N, 1996, GASTROINTEST ENDOSC, V44, P388, DOI 10.1016/S0016-5107(96)70086-X; Inoue H, 2000, DIG ENDOSC S, V13, P40; Kanzaki H, 2013, AM J GASTROENTEROL, V108, P1293, DOI 10.1038/ajg.2013.161; Kumagai Y, 2002, ENDOSCOPY, V34, P369, DOI 10.1055/s-2002-25285; Makuuchi H, 2001, Gastrointest Endosc Clin N Am, V11, P445; Minami H, 2014, DIGESTION, V89, P6, DOI 10.1159/000356200; Muto M, 2004, CANCER, V101, P1375, DOI 10.1002/cncr.20482; Oyama Tsuneo, 2005, Clin Gastroenterol Hepatol, V3, pS67, DOI 10.1016/S1542-3565(05)00291-0; Shimura T, 2007, J GASTROEN HEPATOL, V22, P821, DOI 10.1111/j.1440-1746.2006.04505.x; Shimura T, 2014, CLIN GASTROENTEROL H, V12, P662, DOI 10.1016/j.cgh.2013.06.022; TOH Y, 1993, HEPATO-GASTROENTEROL, V40, P212; Workshop. PitP, 2003, GASTROINTEST ENDOS S, V58, pS3	30	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JUN	2015	81	6					1355	+		10.1016/j.gie.2014.11.015		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CI2EW	WOS:000354558800008		
J	Onimaru, M; Inoue, H; Ikeda, H; Sato, C; Sato, H; Phalanusitthepha, C; Santi, EG; Grimes, KL; Ito, H; Kudo, S				Onimaru, Manabu; Inoue, Haruhiro; Ikeda, Haruo; Sato, Chiaki; Sato, Hiroki; Phalanusitthepha, Chainarong; Santi, Esperanza Grace; Grimes, Kevin L.; Ito, Hiroaki; Kudo, Shin-ei			Greater curvature myotomy is a safe and effective modified technique in per-oral endoscopic myotomy (with videos)	GASTROINTESTINAL ENDOSCOPY			English	Article							HELLER MYOTOMY; ESOPHAGEAL ACHALASIA; ESOPHAGOGASTRIC JUNCTION; SURGICAL-TREATMENT; POEM	Background: Per-oral endoscopic myotomy (POEM) for achalasia with esophagocardiomyotomy in the lesser curvature (LC myotomy) is now established and accepted widely. However, in some cases LC myotomy is precluded by previous procedures, such as Heller myotomy, or by other anatomic considerations that obscure the normal dissection planes. It may also be difficult to identify the esophagogastric junction (EGJ), which can result in an incomplete gastric myotomy and poor rates of symptom relief. On the other hand, the angle of His is always located in the greater curvature of the stomach and serves as a consistent, definite landmark of the gastric side. Objective: To evaluate esophagocardiomyotomy in the greater curvature (GC myotomy) as an alternative POEM technique in cases where a prior LC myotomy or supervening anatomic constraints make identification of the EGJ technically challenging. Design: Prospective. Setting: Single-center study. Patients: Twenty-one achalasia patients who received POEM with GC myotomy. Interventions: POEM. Main Outcome Measurements: Efficacy and safety of GC myotomy measured in terms of reduction in lower esophageal sphincter (LES) pressures, improvement in Eckardt scores, and development of intraoperative or postoperative adverse events. Results: Identification of the EGJ was achieved in all cases, resulting in a mean gastric myotomy length of 2.6 +/- 1.1 cm. Mean LES pressure and Eckardt symptom scores decreased significantly (21.2 +/- 7.3 vs 10.5 +/- 2.7 mm Hg, 5 [2-8] vs 1 [0-5], respectively) (P < .01). Endoscopic evidence of gastroesophageal reflux was identified in 52% of patients (11/21) postmyotomy; however, only 9.5% (2/11) were symptomatic, and these patients were successfully controlled with proton pump inhibitors. No severe adverse events were encountered. Limitations: Single center. Conclusions: GC myotomy is a promising, safe modification of the POEM technique and may be especially useful in cases of redo POEM, POEM post-Heller myotomy, or when the EGJ is difficult to recognize because of supervening anatomic constraints.	[Onimaru, Manabu; Inoue, Haruhiro; Ikeda, Haruo; Sato, Chiaki; Phalanusitthepha, Chainarong; Grimes, Kevin L.; Ito, Hiroaki] Showa Univ, Koto Toyosu Hosp, Ctr Digest Dis, Koto Ku, Tokyo 1358577, Japan; [Sato, Hiroki; Kudo, Shin-ei] Showa Univ, Northern Yokohama Hosp, Ctr Digest Dis, Yokohama, Kanagawa, Japan; [Santi, Esperanza Grace] De La Salle Univ, Sect Gastroenterol & Digest Endoscopy, Cavite, Philippines	Onimaru, M (reprint author), Showa Univ, Koto Toyosu Hosp, Ctr Digest Dis, Koto Ku, Toyosu 5-1-38, Tokyo 1358577, Japan.						Swanstrom LL, 2012, ANN SURG, V256, P659, DOI 10.1097/SLA.0b013e31826b5212; Onimaru M, 2013, J AM COLL SURGEONS, V217, P598, DOI 10.1016/j.jamcollsurg.2013.05.025; Inoue H, 2010, ENDOSCOPY, V42, P265, DOI 10.1055/s-0029-1244080; Francis DL, 2010, GASTROENTEROLOGY, V139, P369, DOI 10.1053/j.gastro.2010.06.024; von Renteln D, 2013, GASTROENTEROLOGY, V145, P309, DOI 10.1053/j.gastro.2013.04.057; Rieder E, 2013, SURG ENDOSC, V27, P400, DOI 10.1007/s00464-012-2484-0; Teitelbaum EN, 2013, SURG ENDOSC, V27, P4547, DOI 10.1007/s00464-013-3121-2; Sharata A, 2013, J GASTROINTEST SURG, V17, P1188, DOI 10.1007/s11605-013-2193-6; Pasricha PJ, 2007, ENDOSCOPY, V39, P761, DOI 10.1055/s-2007-966764; PAYNE WS, 1989, ANN THORAC SURG, V48, P876; Chiu PWY, 2013, GASTROINTEST ENDOSC, V77, P29, DOI 10.1016/j.gie.2012.08.018; Minami H, 2014, DIGEST ENDOSC, V26, P43, DOI 10.1111/den.12086; Vigneswaran Y, 2014, J GASTROINTEST SURG, V18, P1071, DOI 10.1007/s11605-014-2496-2; Stefanidis D, 2012, SURG ENDOSC, V26, P296, DOI 10.1007/s00464-011-2017-2; Simic AP, 2010, J GASTROINTEST SURG, V14, P587, DOI 10.1007/s11605-009-1135-9; Hungness ES, 2013, J GASTROINTEST SURG, V17, P228, DOI 10.1007/s11605-012-2030-3; Eleftheriadis N, 2012, THER CLIN RISK MANAG, V8, P329, DOI 10.2147/TCRM.S32666; Maselli R, 2012, ENDOSCOPY, V44, pE285, DOI 10.1055/s-0032-1309924; Costamagna G, 2012, DIGEST LIVER DIS, V44, P827, DOI 10.1016/j.dld.2012.04.003; Eckardt V F, 2001, Gastrointest Endosc Clin N Am, V11, P281; Eleftheriadis N, 2013, GASTROINTEST ENDOSC, V78, P676, DOI 10.1016/j.gie.2013.07.018; Japan Society of Esophageal Diseases, 2012, DESCR RUL ACH ES, V4th; Kahrilas PJ, 1997, GASTROENTEROL CLIN N, V26, P467, DOI 10.1016/S0889-8553(05)70307-1; Khashab MA, 2013, GASTROINTEST ENDOSC, V77, P119, DOI 10.1016/j.gie.2012.09.011; Korn O, 2000, J GASTROINTEST SURG, V4, P398, DOI 10.1016/S1091-255X(00)80019-0; Lee Byung Hoo, 2013, Clin Endosc, V46, P161, DOI 10.5946/ce.2013.46.2.161; Lyass S, 2003, SURG ENDOSC, V17, P554, DOI 10.1007/s00464-002-8604-5; Minami H, 2014, ENDOSCOPY, V46, pE79, DOI 10.1055/s-0032-1309922; Orlando RC, 2001, AM J MED, V111, P174, DOI 10.1016/S0002-9343(01)00828-2; Paterson W G, 2001, Chest Surg Clin N Am, V11, P473; Pescarus Radu, 2014, Curr Gastroenterol Rep, V16, P369, DOI 10.1007/s11894-013-0369-6; Pellegrini CA, 2004, ANN SURG, V240, P412; Richards William O, 2004, Ann Surg, V240, P405, DOI 10.1097/01.sla.0000136940.32255.51; Richter Joel E, 2010, J Neurogastroenterol Motil, V16, P232, DOI 10.5056/jnm.2010.16.3.232; SHIMI S, 1991, Journal of the Royal College of Surgeons of Edinburgh, V36, P152; Yang D, 2013, DIAGN THER ENDOSC, V2013, DOI [10.1155/2013/389596, DOI 10.1155/2013/389596]	36	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JUN	2015	81	6					1370	1377		10.1016/j.gie.2014.11.014		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CI2EW	WOS:000354558800010		
J	Ikeura, T; Takaoka, M; Uchida, K; Shimatani, M; Miyoshi, H; Kato, K; Ohe, C; Uemura, Y; Kaibori, M; Kwon, AH; Okazaki, K				Ikeura, Tsukasa; Takaoka, Makoto; Uchida, Kazushige; Shimatani, Masaaki; Miyoshi, Hideaki; Kato, Kota; Ohe, Chisato; Uemura, Yoshiko; Kaibori, Masaki; Kwon, A-Hon; Okazaki, Kazuichi			Fluorescence cytology with 5-aminolevulinic acid in EUS-guided FNA as a method for differentiating between malignant and benign lesions	GASTROINTESTINAL ENDOSCOPY			English	Article							FINE-NEEDLE-ASPIRATION; SOLID PANCREATIC MASSES; INVASIVE BLADDER-CANCER; PHOTODYNAMIC THERAPY; DIAGNOSTIC-ACCURACY; FOLLOW-UP; TUMORS; LYMPHADENOPATHY; 22-GAUGE; UTILITY	Background: EUS-guided FNA (EUS-FNA) has been increasingly performed to obtain specimens for the pathological evaluation of patients with GI and pancreaticobiliary masses as well as lymphadenopathies of unknown origin. Photodynamic diagnosis by using 5-aminolebulinic acid (ALA) has been reported to be useful for enabling the visual differentiation between malignant and normal tissue in various cancers. Objective: To evaluate the diagnostic accuracy of fluorescence cytology with ALA in EUS-FNA. Design: A prospective study. Setting: A single center. Patients: A total of 28 consecutive patients who underwent EUS-FNA for the pathological diagnosis of a pancreaticobiliary mass lesion or intra-abdominal lymphadenopathy of unknown origin. Interventions: Patients were orally administered ALA 3 to 6 hours before EUS-FNA. The sample was obtained via EUS-FNA for fluorescence cytology and conventional cytology. A single gastroenterologist performed the fluorescence cytology by using fluorescence microscopy after the procedure, independently of the conventional cytology by pathologists. Main Outcome Measurements: The accuracy of fluorescence cytology with ALA in the differentiation between benign and malignant lesions by comparing the results of fluorescence cytology with the final diagnosis. Results: Of the 28 patients included in the study, 22 were considered as having malignant lesions and 6 patients as having benign lesions. Fluorescence cytology could correctly discriminate between benign and malignant lesions in all patients. Therefore, both the sensitivity and specificity of fluorescence cytology were 100% in our study. Limitations: Fluorescence cytology was performed by only 1 gastroenterologist with a small number of patients. Conclusion: Fluorescence cytology with ALA in EUS-FNA may be an effective and simple method for differentiating between benign and malignant lesions.	[Ikeura, Tsukasa; Takaoka, Makoto; Uchida, Kazushige; Shimatani, Masaaki; Miyoshi, Hideaki; Kato, Kota; Ohe, Chisato; Okazaki, Kazuichi] Kansai Med Univ, Dept Internal Med 3, Hirakata, Osaka 5731191, Japan; [Ohe, Chisato; Uemura, Yoshiko] Kansai Med Univ, Dept Pathol, Hirakata Hosp, Hirakata, Osaka 5731191, Japan; [Kaibori, Masaki; Kwon, A-Hon] Kansai Med Univ, Dept Surg, Hirakata, Osaka 5731191, Japan	Ikeura, T (reprint author), Kansai Med Univ, Dept Internal Med 3, 2-5-1 Shinmachi, Hirakata, Osaka 5731191, Japan.				MEXT-Supported Program for the Strategic Research Foundation at Private Universities	All authors disclosed no financial relationships relevant to this article. This study was supported in part by MEXT-Supported Program for the Strategic Research Foundation at Private Universities.	Eloubeidi MA, 2006, GASTROINTEST ENDOSC, V63, P622, DOI 10.1016/j.gie.2005.05.024; Kanno A, 2012, GASTROINTEST ENDOSC, V76, P594, DOI 10.1016/j.gie.2012.05.014; Yusuf TE, 2009, ENDOSCOPY, V41, P445, DOI 10.1055/s-0029-1214643; Zhao BZ, 2010, EXPERT REV ANTICANC, V10, P1797, DOI [10.1586/era.10.154, 10.1586/ERA.10.154]; Bown SG, 2002, GUT, V50, P549, DOI 10.1136/gut.50.4.549; Mayinger B, 2001, GASTROINTEST ENDOSC, V54, P572, DOI 10.1067/mge.2001.118642; Liu Y, 2014, J BREAST CANCER, V17, P161, DOI 10.4048/jbc.2014.17.2.161; Okubo K, 2004, J GASTROENTEROL, V39, P747, DOI 10.1007/s00535-004-1383-0; Witjes JA, 2010, EUR UROL, V57, P607, DOI 10.1016/j.eururo.2010.01.025; Ishizuka M, 2011, INT IMMUNOPHARMACOL, V11, P358, DOI 10.1016/j.intimp.2010.11.029; Iglesias-Garcia J, 2011, AM J GASTROENTEROL, V106, P1705, DOI 10.1038/ajg.2011.119; Huggett MT, 2014, BRIT J CANCER, V110, P1698, DOI 10.1038/bjc.2014.95; Hartwig W, 2009, BRIT J SURG, V96, P5, DOI 10.1002/bjs.6407; Chang KJ, 1997, GASTROINTEST ENDOSC, V45, P387, DOI 10.1016/S0016-5107(97)70149-4; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Catalano MF, 2002, GASTROINTEST ENDOSC, V55, P863, DOI 10.1067/mge.2002.124637; Inoue K, 2012, CANCER-AM CANCER SOC, V118, P1062, DOI 10.1002/cncr.26378; Korenblit J, 2012, J INTERV GASTROENTER, V2, P172; LOH CS, 1994, ENDOSCOPY, V26, P243, DOI 10.1055/s-2007-1008952; Nasuti JF, 2002, DIAGN CYTOPATHOL, V27, P1, DOI 10.1002/dc.10065; Pytel A, 2002, UROLOGY, V59, P216, DOI 10.1016/S0090-4295(01)01528-X; Raut CP, 2003, J GASTROINTEST SURG, V7, P118, DOI 10.1016/S1091-255X(02)00150-6; Raut CP, 2003, J GASTROINTEST SURG, V7, P27; Tauber S, 2003, UROLOGY, V61, P1067, DOI 10.1016/S0090-4295(02)02554-2; Yasuda I, 2006, ENDOSCOPY, V38, P919, DOI 10.1055/s-2006-944665	25	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JUN	2015	81	6					1457	1462		10.1016/j.gie.2015.01.031		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CI2EW	WOS:000354558800023		
J	Tonozuka, R; Itoi, T; Tsuchiya, T; Sofuni, A; Ishii, K; Ikeuchi, N; Umeda, J; Tanaka, R; Mukai, S; Gotoda, T; Moriyasu, F				Tonozuka, Ryosuke; Itoi, Takao; Tsuchiya, Takayoshi; Sofuni, Atsushi; Ishii, Kentaro; Ikeuchi, Nobuhito; Umeda, Junko; Tanaka, Reina; Mukai, Shuntaro; Gotoda, Takuji; Moriyasu, Fuminori			EUS-guided drainage of hepatic abscess and infected biloma using short and long metal stents	GASTROINTESTINAL ENDOSCOPY			English	Article							LIVER-ABSCESS; MANAGEMENT	Background: Currently, few reports exist on EUS-guided hepatic abscess drainage (EUS-HAD) and EUS-guided biloma drainage (EUS-BLD) using a metal stent. Objective: We evaluated the technical success rate and efficacy of EUS-HAD and EUS-BLD for patients with hepatic abscess (HA) and infected biloma. Design: Retrospective case series. Setting: Single tertiary referral medical center. Patients: We evaluated 7 HA and 6 infected biloma patients who were treated between August 2013 and August 2014 at Tokyo Medical University Hospital. Interventions: EUS-HAD or EUS-BLD using a short (length, 2 or 3 cm) or long (length, 6 or 8 cm) self-expandable fully covered metal stent. Main Outcome Measurements: Technical success, clinical success, and adverse event. Results: The overall technical success rate was 100% in both EUS-HAD and EUS-BLD. The clinical success rates of EUS-HAD and EUS-BLD at the first session were 71.4% and 83.3%, respectively. Direct endoscopic necrosectomy was required in 1 case each of HA and infected biloma. The final clinical success rate was 100%. There were no procedure-related adverse events or cases of recurrence during the follow-up period (median, 83.5 days; range, 24-396 days). Limitations: Small sample size and no control group. Conclusions: EUS-HAD and EUS-BLD using a metal stent can be performed safely and effectively for HA and infected biloma.	[Tonozuka, Ryosuke; Itoi, Takao; Tsuchiya, Takayoshi; Sofuni, Atsushi; Ishii, Kentaro; Ikeuchi, Nobuhito; Umeda, Junko; Tanaka, Reina; Mukai, Shuntaro; Gotoda, Takuji; Moriyasu, Fuminori] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1600023, Japan	Itoi, T (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	itoi@tokyo-med.ac.jp					Alcaide Noelia, 2013, Gastrointest Endosc, V78, P941, DOI 10.1016/j.gie.2013.07.034; Ang TL, 2009, ENDOSCOPY, V41, pE21, DOI 10.1055/s-0028-1103468; Noh SH, 2010, GASTROINTEST ENDOSC, V71, P1314, DOI 10.1016/j.gie.2009.12.045; Cozzi G, 2006, CARDIOVASC INTER RAD, V29, P380, DOI 10.1007/s00270-005-0102-4; BERTEL CK, 1986, ARCH SURG-CHICAGO, V121, P554; Piraka C, 2009, GASTROINTEST ENDOSC, V70, P786, DOI 10.1016/j.gie.2009.04.049; Seewald S, 2005, GASTROINTEST ENDOSC, V61, P495, DOI 10.1016/S0016-5107(04)02848-2; Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P446, DOI 10.1016/j.gie.2009.10.027; Barakate MS, 1999, AUST NZ J SURG, V69, P205, DOI 10.1046/j.1440-1622.1999.01523.x; Baron TH, 2006, ENDOSCOPY, V38, P436, DOI 10.1055/s-2006-925174; Itoi T, 2014, J HEPATO-BIL-PAN SCI, V21, pE4, DOI 10.1002/jhbp.43; Itoi T, 2011, DIGEST ENDOSC, V23, P158, DOI 10.1111/j.1443-1661.2011.01115.x; Itoi T, 2013, DIGEST ENDOSC, V25, P241, DOI 10.1111/den.12048; Keohane J, 2011, J INTERV GASTROENTER, V1, P139; Mukai S, 2015, J GASTROENTEROL, V50, P211, DOI 10.1007/s00535-014-0957-8; Ponnudurai R, 2006, ENDOSCOPY, V38, P199, DOI 10.1055/s-2006-925143; Prachayakul V, 2012, J INTERV GASTROENETO, V2, P202; Quinn S F, 1992, Surg Laparosc Endosc, V2, P279; Shami VM, 2008, GASTROINTEST ENDOSC, V67, P136, DOI 10.1016/j.gie.2007.07.040	19	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JUN	2015	81	6					1463	1469		10.1016/j.gie.2015.01.023		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CI2EW	WOS:000354558800024		
J	Fujibayashi, S; Goto, T; Sasajima, J; Utsumi, T; Dokoshi, T; Sakatani, A; Tanaka, K; Nomura, Y; Ueno, N; Kashima, S; Inaba, Y; Moriichi, K; Fujiya, M; Kohgo, Y				Fujibayashi, Shugo; Goto, Takuma; Sasajima, Junpei; Utsumi, Tatsuya; Dokoshi, Tatsuya; Sakatani, Aki; Tanaka, Kazuyuki; Nomura, Yoshiki; Ueno, Nobuhiro; Kashima, Shin; Inaba, Yuhei; Moriichi, Kentaro; Fujiya, Mikihiro; Kohgo, Yutaka			Intraductal cholangioscopic visualization of moving Fasciola hepatica	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Fujibayashi, Shugo; Goto, Takuma; Sasajima, Junpei; Utsumi, Tatsuya; Dokoshi, Tatsuya; Sakatani, Aki; Tanaka, Kazuyuki; Nomura, Yoshiki; Ueno, Nobuhiro; Kashima, Shin; Inaba, Yuhei; Moriichi, Kentaro; Fujiya, Mikihiro; Kohgo, Yutaka] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido, Japan	Fujibayashi, S (reprint author), Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JUN	2015	81	6					1485	1486		10.1016/j.gie.2014.12.014		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CI2EW	WOS:000354558800036		
J	Mukai, S; Itoi, T; Kamada, K; Tanaka, R; Ishii, K				Mukai, Shuntaro; Itoi, Takao; Kamada, Kentaro; Tanaka, Reina; Ishii, Kentaro			Successful extraction of a carelessly impacted bile duct stone using sphincterotome	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Mukai, Shuntaro; Itoi, Takao; Kamada, Kentaro; Tanaka, Reina; Ishii, Kentaro] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan	Mukai, S (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	JUN	2015	81	6					1486	1487		10.1016/j.gie.2014.12.041		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CI2EW	WOS:000354558800037		
J	Geva, R; Vecchione, L; Kalogeras, KT; Jensen, BV; Lenz, HJ; Yoshino, T; Paez, D; Montagut, C; Souglakos, J; Cappuzzo, F; Cervantes, A; Frattini, M; Fountzilas, G; Johansen, JS; Hogdall, EV; Zhang, W; Yang, DY; Yamazaki, K; Nishina, T; Papamichael, D; Vincenzi, B; Macarulla, T; Loupakis, F; De Schutter, J; Spindler, KLG; Pfeiffer, P; Ciardiello, F; Piessevaux, H; Tejpar, S				Geva, Ravit; Vecchione, Loredana; Kalogeras, Konstantinos T.; Jensen, Benny Vittrup; Lenz, Heinz-Josef; Yoshino, Takayuki; Paez, David; Montagut, Clara; Souglakos, John; Cappuzzo, Federico; Cervantes, Andres; Frattini, Milo; Fountzilas, George; Johansen, Julia S.; Hogdall, Estrid Vilma; Zhang, Wu; Yang, Dongyun; Yamazaki, Kentaro; Nishina, Tomohiro; Papamichael, Demetris; Vincenzi, Bruno; Macarulla, Teresa; Loupakis, Fotios; De Schutter, Jef; Spindler, Karen Lise Garm; Pfeiffer, Per; Ciardiello, Fortunato; Piessevaux, Hubert; Tejpar, Sabine			FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study	GUT			English	Article						Antibody Targeted Therapy; Colorectal Cancer; Genetic Polymorphisms; Immune Response	GROWTH-FACTOR-RECEPTOR; SINGLE-AGENT CETUXIMAB; B-CELL LYMPHOMA; PLUS IRINOTECAN; BREAST-CANCER; FOLLICULAR LYMPHOMA; PREDICT RESPONSE; KRAS MUTATIONS; K-RAS; THERAPY	Objective We aimed to better clarify the role of germline variants of the FCG2 receptor, FCGR2A-H131R and FCGR3A-V158F, on the therapeutic efficacy of cetuximab in metastatic colorectal cancer (mCRC). A large cohort with sufficient statistical power was assembled. Design To show a HR advantage of 0.6 in progression-free survival (PFS) for FCGR2A-HH versus the rest and FCGR3A-VV versus the rest, with an 80% power, 80 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) wild-type (KRAS-WT) and 52 KRAS-WT patients are required, respectively. This leads to a total sample size of 952 and 619 patients, respectively. Samples were collected from 1123 mCRC patients from 15 European centres treated with cetuximab alone or in combination with chemotherapy. Fc gamma receptor (FCGR) status was centrally genotyped. Two additional externally genotyped series were included. Results Incidences of FCGR2A-HH and FCGR3A-VV in KRAS-WT patients were 220/660 (33%) and 109/676 (16.1%) respectively. There was no difference in median PFS (mPFS) for KRAS-WT patients with FCGR2A-HH (22.0weeks; 95% CI18.8 to 25.2) versus non-HH (22.0weeks; 95% CI 19.4 to 24.6) or for FCGR3A-VV (16.4weeks; 95% CI 13.0 to 19.8) versus non-VV (23weeks; 95% CI 21.1 to 24.9) (p=0.06). Median overall survival, response rate and disease control rate assessments showed no benefit for either HH or VV. Conclusions No differences in mPFS were found between the FCGR polymorphisms HH and the others and VV versus the others in KRAS-WT mCRC patients refractory to irinotecan, oxaliplatin and 5-fluorouracil treated with cetuximab. We cannot confirm the effects of other IgG1 antibodies, which may be weaker than previously suggested. Other markers may be needed to study the actual host antibody response to cetuximab.	[Geva, Ravit] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Oncol, IL-69978 Tel Aviv, Israel; [Vecchione, Loredana; De Schutter, Jef; Tejpar, Sabine] Univ Hosp Gasthuisberg, Lab Mol Digest Oncol, B-3000 Leuven, Belgium; [Kalogeras, Konstantinos T.; Fountzilas, George] Hellen Cooperat Oncol Grp HeCOG, Athens, Greece; [Jensen, Benny Vittrup; Johansen, Julia S.] Herlev Hosp, Copenhagen, Denmark; [Lenz, Heinz-Josef; Zhang, Wu; Yang, Dongyun] USC Norris Comprehens Canc Ctr & Hosp, Los Angeles, CA USA; [Yoshino, Takayuki] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan; [Paez, David] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Montagut, Clara] Univ Hosp del Mar IMIM, Dept Oncol, Barcelona, Spain; [Souglakos, John] Univ Crete, Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece; [Souglakos, John] Univ Crete, Tumor Cell Biol Lab, Sch Med, Iraklion, Greece; [Cappuzzo, Federico] Osped Civile Livorno, Livorno, Italy; [Cervantes, Andres] Univ Valencia, INCLIVA, Dept Hematol & Med Oncol, Valencia, Spain; [Frattini, Milo] Inst Pathol, Lab Mol Pathol, Locarno, Switzerland; [Hogdall, Estrid Vilma] Herlev Univ Hosp, Dept Pathol, Copenhagen, Denmark; [Yamazaki, Kentaro] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan; [Nishina, Tomohiro] Shikoku Canc Ctr, Natl Hosp Org, Dept Gastrointestinal Med Oncol, Matsuyama, Ehime, Japan; [Papamichael, Demetris] BO Cyprus Oncol Ctr, Nicosia, Cyprus; [Vincenzi, Bruno] Univ Campus Biomed, Rome, Italy; [Macarulla, Teresa] Hosp Valle De Hebron, Barcelona, Spain; [Loupakis, Fotios] Azienda Osped Univ Pisana, Ist Toscano, UO Oncol Med 2, Pisa, Italy; [Spindler, Karen Lise Garm] Vejle Hosp, Dept Oncol, Vejle, Denmark; [Pfeiffer, Per] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark; [Ciardiello, Fortunato] Univ Naples 2, Dept Expt & Clin Med, Div Med Oncol, Naples, Italy; [Piessevaux, Hubert] Clin Univ St Luc, B-1200 Brussels, Belgium	Tejpar, S (reprint author), Univ Hosp Gasthuisberg, Lab Mol Digest Oncol, Herestr 49, B-3000 Leuven, Belgium.	sabine.tejpar@uzleuven.be	Loupakis, Fotios/I-7243-2012; 	Ciardiello, Fortunato/0000-0002-3369-4841	ESMO fellowship for Translational Research; Ministry of Health, Labour and Welfare of Japan [21 S4-5]; Associazione italiana per la ricerca sul cancro (AIRC); Ministero dell'Istruzione, dell'Universita della Ricerca (MIUR); progetti di ricerca di interesse nazionale (PRIN); Instituto de Salud Carlos III [FIS/1101711]; Belgian Federation against Cancer (Stichting tegen Kanker); Belgian National Cancer Plan (Nationaal Kankerplan);  [PI12/00989];  [AECC 11964]	LV is supported by an ESMO fellowship for Translational Research. TY is supported by the Grant-in-Aid for Cancer Research (21 S4-5) from the Ministry of Health, Labour and Welfare of Japan. FC is sponsored by a grant from Associazione italiana per la ricerca sul cancro (AIRC) and from Ministero dell'Istruzione, dell'Universita della Ricerca (MIUR) and progetti di ricerca di interesse nazionale (PRIN). DP is supported by the Instituto de Salud Carlos III (FIS/1101711). CMV is supported by PI12/00989 and AECC 11964. ST is a Senior Clinical Investigator of the Fund for Scientific Research Flanders (FWO-Vlaanderen) and has received research grants from the Belgian Federation against Cancer (Stichting tegen Kanker) and from the Belgian National Cancer Plan (Nationaal Kankerplan).	Ahn J, 2010, J CLIN ONCOL, V28; Itoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3; Lurje G, 2008, CLIN CANCER RES, V14, P7884, DOI 10.1158/1078-0432.CCR-07-5165; Tsuchida Y, 2001, MED PEDIATR ONCOL, V37, P1, DOI 10.1002/mpo.1154; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Jiang XM, 1996, J IMMUNOL METHODS, V199, P55, DOI 10.1016/S0022-1759(96)00164-0; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; van Sorge NM, 2003, TISSUE ANTIGENS, V61, P189, DOI 10.1034/j.1399-0039.2003.00037.x; Graziano F, 2008, J CLIN ONCOL, V26, P1427, DOI 10.1200/JCO.2007.12.4602; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Hurvitz SA, 2012, CLIN CANCER RES, V18, P3478, DOI 10.1158/1078-0432.CCR-11-2294; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Zhang W, 2007, J CLIN ONCOL, V25, P3712, DOI 10.1200/JCO.2006.08.8021; Pander J, 2010, EUR J CANCER, V46, P1829, DOI 10.1016/j.ejca.2010.03.017; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kim DH, 2006, BLOOD, V108, P2720, DOI 10.1182/blood-2006-01-009480; Ahlgrimm M, 2011, BLOOD, V118, P4657, DOI 10.1182/blood-2011-04-346411; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Tamura K, 2011, ANN ONCOL, V22, P1302, DOI 10.1093/annonc/mdq585; Paez D, 2010, CANCER SCI, V101, P2048, DOI 10.1111/j.1349-7006.2010.01621.x; ROBERTSON MJ, 1990, BLOOD, V76, P2421; Leppers-van de Straat FGJ, 2000, J IMMUNOL METHODS, V242, P127, DOI 10.1016/S0022-1759(00)00240-4; Mendelsohn J, 2001, ENDOCR-RELAT CANCER, V8, P3, DOI 10.1677/erc.0.0080003; Persky DO, 2012, HAEMATOL-HEMATOL J, V97, P937, DOI 10.3324/haematol.2011.050419	28	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	JUN	2015	64	6					921	928		10.1136/gutjnl-2014-307234		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH9TT	WOS:000354380000012		
J	Cendrowski, J; Lobo, VJSA; Sendler, M; Salas, A; Kuhn, JP; Molero, X; Fukunaga, R; Mayerle, J; Lerch, MM; Real, FX				Cendrowski, Jaroslaw; Sanchez-Arevalo Lobo, Victor J.; Sendler, Matthias; Salas, Antonio; Kuehn, Jens-Peter; Molero, Xavier; Fukunaga, Rikiro; Mayerle, Julia; Lerch, Markus M.; Real, Francisco X.			Mnk1 is a novel acinar cell-specific kinase required for exocrine pancreatic secretion and response to pancreatitis in mice	GUT			English	Article						Pancreatic Function; Pancreatitis; Pancreatic Secretion; Cell Signalling	ACTIVATED PROTEIN-KINASE; HEAT-SHOCK PROTEINS; MAP KINASE; TRYPSINOGEN ACTIVATION; EXPRESSION; INDUCTION; PHOSPHORYLATION; SUPPRESSOR; PREMATURE; DISEASE	Objective Pancreatic acinar cell maturation is dependent on the activity of the pancreas transcription factor 1 (PTF1) complex. Induction of pancreatitis leads to MAP kinase activation and transient suppression of the acinar differentiation programme. We investigated the role of MAP kinase-interacting kinase 1 (Mnk1) in mouse exocrine pancreas development and in the response to secretagogue-induced pancreatitis. Design Mnk1 expression was analysed using immunohistochemistry, RT-qPCR and western blotting. Ptf1a binding to Mnk1 was assessed by chromatin immunoprecipitation and qPCR. Acute pancreatitis was induced in wild type and Mnk1(-/-) mice by 7h intraperitoneal injections of caerulein. In vitro amylase secretion and trypsinogen activation were assessed using freshly isolated acinar cells. In vivo secretion was quantified by secretin-stimulated MRI. Results Mnk1 is expressed at the highest levels in pancreatic acinar cells and is a direct PTF1 target. Mnk1 is activated upon induction of pancreatitis and is indispensable for eIF4E phosphorylation. The pancreas of Mnk1(-/-) mice is histologically normal. Digestive enzyme content is significantly increased and c-Myc and Ccnd1 levels are reduced in Mnk1(-/-) mice. Upon induction of acute pancreatitis, Mnk1(-/-) mice show impaired eIF4E phosphorylation, activation of c-Myc and downregulation of zymogen content. Acinar cells show defective relocalisation of digestive enzymes, polarity defects and impaired secretory response in vitro and in vivo. Conclusions Mnk1 is a novel pancreatic acinar cell-specific stress response kinase that regulates digestive enzyme abundance and eIF4E phosphorylation. It is required for the physiological secretory response of acinar cells and for the homeostatic response to caerulein administration during acute pancreatitis.	[Cendrowski, Jaroslaw; Sanchez-Arevalo Lobo, Victor J.; Real, Francisco X.] Spanish Natl Canc Res Ctr CNIO, Epithelial Carcinogenesis Grp, Madrid, Spain; [Sendler, Matthias; Mayerle, Julia; Lerch, Markus M.] Ernst Moritz Arndt Univ Greifswald, Univ Med, Dept Med A, Greifswald, Germany; [Salas, Antonio] Hosp Mutua Terrassa, Serv Anat Patol, Barcelona, Spain; [Kuehn, Jens-Peter] Ernst Moritz Arndt Univ Greifswald, Univ Med, Inst Radiol, Greifswald, Germany; [Molero, Xavier] Univ Autonoma Barcelona, CIBEREHD, Inst Recerca VHIR, Hosp Univ Vall dHebron,Exocrine Pancreas Res Unit, E-08193 Barcelona, Spain; [Fukunaga, Rikiro] Osaka Univ Pharmaceut Sci, Osaka 580, Japan; [Real, Francisco X.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain	Real, FX (reprint author), CNIO, Canc Cell Biol Programme, Melchor Fernandez Almagro 3, Madrid 28029, Spain.	preal@cnio.es	Real, Francisco X/H-5275-2015; Sanchez-Arevalo Lobo, Victor Javier/H-1069-2011	Real, Francisco X/0000-0001-9501-498X; Sanchez-Arevalo Lobo, Victor Javier/0000-0002-4561-1505	Ministerio de Economia y Competitividad [SAF2007-60860, SAF2011-29530]; Fondo de Investigacion Sanitaria (Madrid, Spain) [PI11/01542]; Deutsche Krebshilfe/Dr Mildred-Scheel-Stiftung [109102]; Deutsche Forschungsgemeinschaft [DFG GRK840-D2/E3/E4, MA 4115/1-2/3]; Federal Ministry of Education and Research [BMBF GANI-MED 03IS2061A, BMBF 0314107, 01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012]; European Union (EPC-TM-Net); European Union [EU-FP7-REGPOT-2010-1]; "La Caixa" International PhD Programme Fellowship; Ministerio de Economia y Competitividad (ONCOBIO Consolider)	This work was supported, in part, by grants from Ministerio de Economia y Competitividad (SAF2007-60860, SAF2011-29530 and ONCOBIO Consolider), Fondo de Investigacion Sanitaria (PI11/01542) (Madrid, Spain), Deutsche Krebshilfe/Dr Mildred-Scheel-Stiftung (109102), Deutsche Forschungsgemeinschaft (DFG GRK840-D2/E3/E4, MA 4115/1-2/3), Federal Ministry of Education and Research (BMBF GANI-MED 03IS2061A and BMBF 0314107, 01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012), and the European Union (EPC-TM-Net and EU-FP7-REGPOT-2010-1). JC was supported by a "La Caixa" International PhD Programme Fellowship.	Masui T, 2007, GENE DEV, V21, P2629, DOI 10.1101/gad.1575207; Kruger B, 1998, LAB INVEST, V78, P763; Rooman I, 2012, GUT, V61, P449, DOI 10.1136/gut.2010.235804; Williams JA, 2013, PANCREAS, V42, P905, DOI 10.1097/MPA.0b013e31828fddc3; Ueda T, 2010, P NATL ACAD SCI USA, V107, P13984, DOI 10.1073/pnas.1008136107; Mayerle J, 2005, GASTROENTEROLOGY, V129, P1251, DOI 10.1053/j.gastro.2005.08.002; Witt H, 2013, NAT GENET, V45, P1216, DOI 10.1038/ng.2730; Houbracken I, 2011, GASTROENTEROLOGY, V141, P731, DOI 10.1053/j.gastro.2011.04.050; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/mcb.247.15.6539-6549.2004; Sendler M, 2013, GUT, V62, P430, DOI 10.1136/gutjnl-2011-300771; Mensel B, 2014, AM J ROENTGENOL, V202, P102, DOI 10.2214/AJR.12.10271; Vasseur S, 2004, J BIOL CHEM, V279, P7199, DOI 10.1074/jbc.M309152200; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Flandez M, 2014, GUT, V63, P647, DOI 10.1136/gutjnl-2012-304381; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; CASE RM, 1978, BIOL REV, V53, P211, DOI 10.1111/j.1469-185X.1978.tb01437.x; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Saluja AK, 2007, ANNU REV PHYSIOL, V69, P249, DOI 10.1146/annurev.physiol.69.031905.161253; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Bhagat L, 2000, J CLIN INVEST, V106, P81, DOI 10.1172/JCI8706; Ethridge RT, 2000, PANCREAS, V21, P248, DOI 10.1097/00006676-200010000-00005; Grady T, 1998, AM J PHYSIOL-GASTR L, V275, pG1010; Grady T, 1996, BIOCHEM BIOPH RES CO, V227, P1, DOI 10.1006/bbrc.1996.1458; Halangk W, 2002, AM J PHYSIOL-GASTR L, V282, pG367; Imamura T, 2002, J BIOL CHEM, V277, P50725, DOI 10.1074/jbc.M204159200; Joshi S, 2011, J BIOL CHEM, V286, P6017, DOI 10.1074/jbc.M110.197921; Kidd D, 1997, J CELL SCI, V110, P209; DELAPORTE PL, 1991, PANCREAS, V6, P298, DOI 10.1097/00006676-199105000-00007; Molero X, 2007, EUR J CLIN INVEST, V37, P791, DOI 10.1111/j.1365-2362.2007.01856.x; Molero X, 2012, GUT, V61, P1187, DOI 10.1136/gutjnl-2011-300360; Pandol SJ, 2010, EXOCRINE PANCREAS; Rowlett RM, 2008, AM J PHYSIOL-GASTR L, V294, pG452, DOI 10.1152/ajpgi.00077.2007; Sans MD, 2002, J GASTROINTEST CANC, V31, P107; Schafer C, 2000, J GASTROENTEROL, V35, P1; Schnekenburger J, 2009, CELL MOL LIFE SCI, V66, P2525, DOI 10.1007/s00018-009-0052-0; Schramek H, 2002, NEWS PHYSIOL SCI, V17, P62, DOI 10.1152/nips.01365.2001; Shi Y, 2012, ONCOGENE, V32, P190; Tashiro M, 2001, GUT, V49, P241, DOI 10.1136/gut.49.2.241; Wagner ACC, 1999, DIGESTION, V60, P41, DOI 10.1159/000007587; WEBER CK, 1995, PANCREAS, V10, P360, DOI 10.1097/00006676-199505000-00007; Wheater MJ, 2010, CANCER BIOL THER, V10, P728, DOI 10.4161/cbt.10.7.12965; Williams JA, 2010, ISOLATION RODENT PAN	44	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	JUN	2015	64	6					937	947		10.1136/gutjnl-2013-306068		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH9TT	WOS:000354380000014		
J	Sugiyama, M; Hasebe, T; Shimada, H; Takeuchi, H; Shimizu, K; Shimizu, M; Yasuda, M; Ueda, S; Shigekawa, T; Osaki, A; Saeki, T				Sugiyama, Michiko; Hasebe, Takahiro; Shimada, Hiroko; Takeuchi, Hideki; Shimizu, Kyoko; Shimizu, Michio; Yasuda, Masanori; Ueda, Shigeto; Shigekawa, Takashi; Osaki, Akihiko; Saeki, Toshiaki			Grading system for blood vessel tumor emboli of invasive ductal carcinoma of the breast	HUMAN PATHOLOGY			English	Article						Breast; Blood vessel; Mitosis; Apoptosis; MIB-1; Caspase 3	PERITUMORAL VASCULAR INVASION; LONG-TERM SURVIVAL; HEPATOCELLULAR-CARCINOMA; PROGNOSTIC-SIGNIFICANCE; POOR-PROGNOSIS; FIBROTIC FOCUS; CELLS EXHIBIT; CANCER; MICROENVIRONMENT; METASTASIS	We previously reported that the number of mitotic and apoptotic figures in tumor cells in blood vessel tumor emboli had the greatest significant power for the accurate prediction of the outcome of patients with invasive ductal carcinoma of the breast. The purpose of the present study was to devise a grading system for blood vessel tumor emboli based on the mitotic and apoptotic figures of tumor cells in blood vessel tumor emboli, enabling accurate prediction of the outcome of patients with invasive ductal carcinoma of the breast We classified 263 invasive ductal carcinomas into the following 3 grades according to the numbers of mitotic and apoptotic figures in tumor cells located in blood vessels within 1 high-power field: grade 0, no blood vessel invasion; grade 1, absence of mitotic figures and presence of any number of apoptotic figures, or 1 mitotic figure and 0 to 2 apoptotic figures; and grade 2, 1 mitotic figure and 3 or more apoptotic figures, or 2 or more mitotic figures and 1 or more apoptotic figures. Multivariate analyses with well-known prognostic factors demonstrated that grade 2 blood vessel tumor emboli significantly increased the hazard ratios for tumor recurrence independent of the nodal status, pathological TNM stage, hormone receptor status, or HER2 status. The presently reported grading system for blood vessel tumor emboli is the strongest histologic factor for accurate prediction of the outcome of patients with invasive ductal carcinoma of the breast (C) 2015 Elsevier Inc. All rights reserved.	[Sugiyama, Michiko; Hasebe, Takahiro; Shimada, Hiroko; Shimizu, Michio; Yasuda, Masanori] Saitama Med Univ, Int Med Ctr, Dept Pathol, Hidaka City, Saitama 3501298, Japan; [Sugiyama, Michiko; Shimada, Hiroko; Shimizu, Kyoko; Ueda, Shigeto; Shigekawa, Takashi; Osaki, Akihiko; Saeki, Toshiaki] Saitama Med Univ, Int Med Ctr, Dept Breast Oncol, Hidaka City, Saitama 3501298, Japan; [Takeuchi, Hideki] Saitama Med Univ Hosp, Dept Breast Oncol, Saitama 3500495, Japan	Sugiyama, M (reprint author), Saitama Med Univ, Int Med Ctr, Dept Pathol, 1397-1 Yamane, Hidaka City, Saitama 3501298, Japan.	michikos612@gmail.com; thasebe@saitama-med.ac.jp; tsaeki@saitama-med.ac.jp			Japan Society for the Promotion of Science, Japan [24590439]	This study was supported in part by a Grant-in.-Aid for Scientific Research (KAKENHI) (C) (24590439) from the Japan Society for the Promotion of Science, Japan.	Ding T, 2011, CANCER-AM CANCER SOC, V117, P4878, DOI 10.1002/cncr.26137; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Fackler MJ, 2014, CANCER RES, V74, P2160, DOI 10.1158/0008-5472.CAN-13-3392; Steinert G, 2014, CANCER RES, V74, P1694, DOI 10.1158/0008-5472.CAN-13-1885; Munzone E, 2014, BREAST CANCER RES TR, V146, P573, DOI 10.1007/s10549-014-3043-2; DAWSON PJ, 1986, HUM PATHOL, V17, P1015, DOI 10.1016/S0046-8177(86)80085-5; Kaseda K, 2013, CANCER SCI, V104, P1262, DOI 10.1111/cas.12219; ROSEN PP, 1989, J CLIN ONCOL, V7, P1239; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Mohammed RAA, 2011, MODERN PATHOL, V24, P774, DOI 10.1038/modpathol.2011.4; Sabatier R, 2011, EUR J CANCER, V47, P1537, DOI 10.1016/j.ejca.2011.02.002; Pavese JM, 2014, CANCER LETT, V352, P179, DOI 10.1016/j.canlet.2014.06.012; Sun YF, 2013, HEPATOLOGY, V57, P1458, DOI 10.1002/hep.26151; Hasebe T, 2002, MODERN PATHOL, V15, P502, DOI 10.1038/modpathol.3880555; de Jong JS, 2000, BRIT J CANCER, V82, P368; Enuma H, 2011, J CLIN ONCOL, V20, P1564; Grobel A, 2013, CLIN CANCER RES, V20, P425; Hasebe T, 2003, CANCER SCI, V94, P158, DOI 10.1111/j.1349-7006.2003.tb01413.x; Hasebe T, 2008, HUM PATHOL, V39, P427, DOI 10.1016/j.humpath.2007.07.016; Hasebe T, 2011, AM J SURG PATHOL, V35, P1484, DOI 10.1097/PAS.0b013e318224ca28; Hasebe T, 2005, HUM PATHOL, V36, P655, DOI 10.1016/j.humpath.2005.04.004; Hasebe T, 2010, MODERN PATHOL, V23, P581, DOI 10.1038/modpathol.2010.3; Hasebe T, 1996, JPN J CANCER RES, V87, P385; Hasebe T, 2010, HUM PATHOL, V41, P706, DOI 10.1016/j.humpath.2009.10.015; Kato T, 2000, BRIT J CANCER, V82, P404, DOI 10.1054/bjoc.1999.0934; LAURIA R, 1995, CANCER, V76, P1772, DOI 10.1002/1097-0142(19951115)76:10<1772::AID-CNCR2820761014>3.0.CO;2-O; Sobin LH, 2009, INT UNION CANC TNM C, V7th, P181; Viale G, 2010, ANN ONCOL, V21, P245, DOI 10.1093/annonc/mdp317; WEIGAND RA, 1982, CANCER, V50, P962, DOI 10.1002/1097-0142(19820901)50:5<962::AID-CNCR2820500526>3.0.CO;2-X; Wiens AL, 2014, ARCH PATHOL LAB MED, V138, P175, DOI 10.5858/arpa.2012-0541-OA; Yu HK, 2013, CLIN CANCER RES, V19, P5340, DOI 10.1158/1078-0432.CCR-12-3685; Zhang QB, 2010, INT J CANCER, V126, P2534, DOI 10.1002/ijc.24979	33	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	JUN	2015	46	6					906	916		10.1016/j.humpath.2015.03.001		11	Pathology	Pathology	CI2QY	WOS:000354593300014		
J	Nagashima, H; Yamaoka, Y				Nagashima, Hiroyuki; Yamaoka, Yoshio			Helicobacter pylori dupA and smoking are associated with increased Levels of interleukin-8 in gastric mucosa in Iraq-reply	HUMAN PATHOLOGY			English	Letter									[Nagashima, Hiroyuki] Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu 8795593, Japan; Michael E DeBakey VA Med Ctr, Dept Med Gastroenterol, Houston, TX 77030 USA; Baylor Coll Med, Houston, TX 77030 USA	Nagashima, H (reprint author), Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu 8795593, Japan.	yyamaoka@oita-u.ac.jp					Jung SW, 2012, INFECT IMMUN, V80, P381, DOI 10.1128/IAI.05472-11; Lu H, 2005, GASTROENTEROLOGY, V128, P833, DOI 10.1053/j.gastro.2005.01.009	2	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	JUN	2015	46	6					931	931		10.1016/j.humpath.2015.01.022		1	Pathology	Pathology	CI2QY	WOS:000354593300019		
J	Kario, K				Kario, Kazuomi			Prognosis in Relation to Blood Pressure Variability Pro Side of the Argument	HYPERTENSION			English	Article							JAPANESE HYPERTENSIVE PATIENTS; MORNING SURGE; CARDIOVASCULAR OUTCOMES; CEREBROVASCULAR-DISEASE; ARTERIAL STIFFNESS; RISK-FACTOR; HEART-RATE; STROKE; HOME; PREDICTOR		Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi 3290498, Japan	Kario, K (reprint author), Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	kkario@jichi.ac.jp			Novartis; Teijin; Takeda	Dr Kario received Research Grant from Novartis, Teijin, and Takeda; Speakers Bureau from Takeda, Mochida, Sumitomo Dainippon Pharma, and Daiichi Sankyo.	MULLER JE, 1989, CIRCULATION, V79, P733; Kario K, 2014, HYPERTENSION, V64, P989, DOI 10.1161/HYPERTENSIONAHA.114.04262; Kikuya M, 2008, HYPERTENSION, V52, P1045, DOI 10.1161/HYPERTENSIONAHA.107.104620; Johansson JK, 2012, HYPERTENSION, V59, P212, DOI 10.1161/HYPERTENSIONAHA.111.178657; Metoki H, 2006, HYPERTENSION, V47, P149, DOI 10.1161/01.HYP.0000198541.12640.0f; Kario K, 2006, HYPERTENS RES, V29, P581, DOI 10.1291/hypres.29.581; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Li Y, 2010, HYPERTENSION, V55, P1040, DOI 10.1161/HYPERTENSIONAHA.109.137273; Nagai M, 2014, ATHEROSCLEROSIS, V233, P19, DOI 10.1016/j.atherosclerosis.2013.11.071; Israel S, 2011, AM J HYPERTENS, V24, P796, DOI 10.1038/ajh.2011.58; Kario K, 2013, NAT REV NEPHROL, V9, P726, DOI 10.1038/nrneph.2013.224; Okada Y, 2013, AM J PHYSIOL-HEART C, V305, pH793, DOI 10.1152/ajpheart.00254.2013; Kario K, 2001, HYPERTENSION, V38, P852, DOI 10.1161/hy1001.092640; Verdecchia P, 2012, HYPERTENSION, V60, P34, DOI 10.1161/HYPERTENSIONAHA.112.191858; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Pierdomenico SD, 2014, AM J HYPERTENS, V27, P564, DOI 10.1093/ajh/hpt170; Kario K, 2013, HYPERTENS RES, V36, P478, DOI 10.1038/hr.2013.19; Mitchell GF, 2011, BRAIN, V134, P3398, DOI 10.1093/brain/awr253; Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1; Ito S, 2009, HYPERTENS RES, V32, P115, DOI 10.1038/hr.2008.27; Yoda K, 2014, DIABETES CARE, V37, P644, DOI 10.2337/dc13-1102; Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149; Stergiou GS, 2008, HYPERTENS RES, V31, P1589, DOI 10.1291/hypres.31.1589; Matsui Y, 2011, HYPERTENSION, V57, P1087, DOI 10.1161/HYPERTENSIONAHA.111.171645; Bombelli M, 2014, HYPERTENSION, V64, P943, DOI 10.1161/HYPERTENSIONAHA.114.03675; Caliskan M, 2014, J AM SOC HYPERTENS, V8, P652, DOI 10.1016/j.jash.2014.05.010; Head GA, 2010, AM J HYPERTENS, V23, P1074, DOI 10.1038/ajh.2010.126; Kaneda R, 2005, AM J HYPERTENS, V18, P1528, DOI 10.1016/j.amjhyper.2005.06.015; Kario K, 2011, EUR HEART J, V32, P574, DOI 10.1093/eurheartj/ehq444; Kario K, 2010, J HYPERTENS, V28, P1574, DOI 10.1097/HJH.0b013e3283395267; Kario K, 2011, J HYPERTENS, V29, P2433, DOI 10.1097/HJH.0b013e32834cf1c0; Kario K, 2015, J CLIN HYPERTENS, V17, P328, DOI 10.1111/jch.12505; Kario K, 2015, ESSENTIAL MANUAL 24, P1; Kario K, 2004, AM J HYPERTENS, V17, P668, DOI 10.1016/j.amjhyper.2004.04.001; Marfella R, 2005, AM J HYPERTENS, V18, P308, DOI 10.1016/j.amjhyper.2004.09.013; Parati G, 2008, AM J HYPERTENS, V21, P123, DOI 10.1038/ajh.2007.27; Parati G, 2008, AM J HYPERTENS, V21, P127, DOI [10.1038/ajh.2007.27, DOI 10.1038/AJH.2007.27]; Sheppard JP, 2015, AM J HYPERTENS, V28, P30, DOI 10.1093/ajh/hpu104; Turak O, 2014, J CLIN HYPERTENS, V16, P530, DOI 10.1111/jch.12359; Yano Y, 2009, AM J HYPERTENS, V22, P1177, DOI 10.1038/ajh.2009.162	40	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	JUN	2015	65	6					1163	1169		10.1161/HYPERTENSIONAHA.115.04800		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CH9OJ	WOS:000354364900007		
J	Asayama, K; Wei, FF; Hara, A; Hansen, TW; Li, Y; Staessen, JA				Asayama, Kei; Wei, Fang-Fei; Hara, Azusa; Hansen, Tine W.; Li, Yan; Staessen, Jan A.			Prognosis in Relation to Blood Pressure Variability Con Side of the Argument	HYPERTENSION			English	Article							TO-VISIT VARIABILITY; TARGET-ORGAN DAMAGE; ISOLATED SYSTOLIC HYPERTENSION; ALL-CAUSE MORTALITY; OLDER PATIENTS; EPISODIC HYPERTENSION; CARDIOVASCULAR RISK; MORNING SURGE; HEART-RATE; POPULATION		[Wei, Fang-Fei; Hara, Azusa; Staessen, Jan A.] Univ Leuven, KU Leuven Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, Studies Coordinating Ctr, BE-3000 Leuven, Belgium; [Asayama, Kei] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 980, Japan; [Asayama, Kei] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Hansen, Tine W.] Gentofte & Res Ctr Prevent & Hlth, Steno Diabet Ctr, Copenhagen, Denmark; [Li, Yan] Shanghai Jiao Tong Univ, Sch Med, Ctr Epidemiol Studies & Clin Trials,Ruijin Hosp, Shanghai Inst Hypertens,Shanghai Key Lab Hyperten, Shanghai 200030, Peoples R China; [Li, Yan] Shanghai Jiao Tong Univ, Sch Med, Ctr Vasc Evaluat,Ruijin Hosp, Shanghai Inst Hypertens,Shanghai Key Lab Hyperten, Shanghai 200030, Peoples R China; [Staessen, Jan A.] Maastricht Univ, VitaK Res & Dev, NL-6200 MD Maastricht, Netherlands	Staessen, JA (reprint author), Univ Leuven, KU Leuven Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, Kapucijnenvoer 35, BE-3000 Leuven, Belgium.	jan.staessen@med.kuleuven.be	Staessen, Jan/A-1065-2011	Staessen, Jan/0000-0002-3026-1637	European Union [HEALTH-F7-2011-278249 EU-MASCARA, HEALTH-F7-305507 HOMAGE]; European Union (European Research Council) [294713 EPLORE]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium [G.0881.13, G.0880.13]	The European Union (HEALTH-F7-2011-278249 EU-MASCARA, HEALTH-F7-305507 HOMAGE and the European Research Council Advanced Researcher Grant 294713 EPLORE) and the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0881.13 and G.0880.13) currently support the Studies Coordinating Centre (Leuven, Belgium).	Hansen TW, 2005, HYPERTENSION, V45, P499, DOI 10.1161/01.HYP.0000160402.39597.3b; Wolk R, 2005, CURR PROB CARDIOLOGY, V30, P625, DOI 10.1016/j.cpcardiol.2005.07.002; Tatasciore A, 2007, HYPERTENSION, V50, P325, DOI 10.1161/HYPERTENSIONAHA.107.090084; Johansson JK, 2012, HYPERTENSION, V59, P212, DOI 10.1161/HYPERTENSIONAHA.111.178657; Metoki H, 2006, HYPERTENSION, V47, P149, DOI 10.1161/01.HYP.0000198541.12640.0f; Asayama K, 2014, HYPERTENSION, V64, P935, DOI 10.1161/HYPERTENSIONAHA.114.03614; Wei FF, 2014, HYPERTENSION, V63, P790, DOI 10.1161/HYPERTENSIONAHA.113.02681; Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273; Mancia G, 2006, HYPERTENSION, V47, P846, DOI 10.1161/01.HYP.0000215363.69793.bb; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Li Y, 2010, HYPERTENSION, V55, P1040, DOI 10.1161/HYPERTENSIONAHA.109.137273; Ingelsson E, 2006, JAMA-J AM MED ASSOC, V295, P2859, DOI 10.1001/jama.295.24.2859; Schutte R, 2012, HYPERTENSION, V60, P1138, DOI 10.1161/HYPERTENSIONAHA.112.202143; Mena L, 2005, J HYPERTENS, V23, P505, DOI 10.1097/01.hjh.0000160205.81652.5a; Ohkubo T, 2002, J HYPERTENS, V20, P2183, DOI 10.1097/00004872-200211000-00017; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; OBRIEN E, 1988, LANCET, V2, P397; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Kilpatrick ES, 2010, DIABETES CARE, V33, P2442, DOI 10.2337/dc10-1000; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Bilo G, 2007, J HYPERTENS, V25, P2058; Ben-Dov IZ, 2007, HYPERTENSION, V49, P1235, DOI 10.1161/HYPERTENSIONAHA.107.087262; Kikuya M, 2000, HYPERTENSION, V36, P901; Kario K, 2001, HYPERTENSION, V38, P852, DOI 10.1161/hy1001.092640; Verdecchia P, 2012, HYPERTENSION, V60, P34, DOI 10.1161/HYPERTENSIONAHA.112.191858; Hsieh YT, 2012, EUR J CLIN INVEST, V42, P245, DOI 10.1111/j.1365-2362.2011.02574.x; Muntner P, 2011, HYPERTENSION, V57, P160, DOI 10.1161/HYPERTENSIONAHA.110.162255; Gosse P, 2004, J HYPERTENS, V22, P1113, DOI 10.1097/01.hjh.0000125396.50839.3a; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Wizner B, 2008, J HYPERTENS, V26, P1328, DOI 10.1097/HJH.0b013e3283013b59; Kuo TBJ, 2014, SLEEP MED, V15, P986, DOI 10.1016/j.sleep.2014.03.022; Fan HQ, 2010, J HYPERTENS, V28, P2036, DOI 10.1097/HJH.0b013e32833b49fe; Boggia J, 2007, LANCET, V370, P1219, DOI 10.1016/S0140-6736(07)61538-4; de la Sierra A, 2009, HYPERTENSION, V53, P466, DOI 10.1161/HYPERTENSIONAHA.108.124008; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Shimbo D, 2012, HYPERTENSION, V60, P625, DOI 10.1161/HYPERTENSIONAHA.112.193094; Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1; Schwartz GL, 2007, HYPERTENSION, V49, P1228, DOI 10.1161/HYPERTENSIONAHA.106.078691; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; VERDECCHIA P, 1994, HYPERTENSION, V24, P793; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Matsui Y, 2011, HYPERTENSION, V57, P1087, DOI 10.1161/HYPERTENSIONAHA.111.171645; Bombelli M, 2014, HYPERTENSION, V64, P943, DOI 10.1161/HYPERTENSIONAHA.114.03675; Brunelli SM, 2008, AM J KIDNEY DIS, V52, P716, DOI 10.1053/j.ajkd.2008.04.032; CLEMENT DL, 1979, CLIN SCI, V57, pS217; Grove JS, 1997, AM J EPIDEMIOL, V145, P771; Hansen TW, 2010, HYPERTENSION, V55, P1049, DOI 10.1161/HYPERTENSIONAHA.109.140798; Hara A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103169; Hickson DA, 2011, AM J HYPERTENS, V24, P1015, DOI 10.1038/ajh.2011.98; Levitan EB, 2013, J HUM HYPERTENS, V27, P589, DOI 10.1038/jhh.2013.19; MANCIA G, 1980, CLIN SCI, V59, pS401; Muntner P, 2013, BLOOD PRESS MONIT, V18, P232, DOI 10.1097/MBP.0b013e3283624b24; PARATI G, 1987, J HYPERTENS, V5, P93, DOI 10.1097/00004872-198702000-00013; Pierdomenico SD, 2006, AM J HYPERTENS, V19, P991, DOI 10.1016/j.amhhyper.2006.03.009; Rossignol P, 2012, HYPERTENSION, V60, P339, DOI 10.1161/HYPERTENSIONAHA.111.190397; Staessen JA, 1997, JAMA-J AM MED ASSOC, V278, P1065, DOI 10.1001/jama.278.13.1065; Staessen JA, 1999, HYPERTENSION, V33, P1476; Stergiou GS, 2008, HYPERTENS RES, V31, P1859, DOI 10.1291/hypres.31.1859; Tozawa M, 1999, NEPHROL DIAL TRANSPL, V14, P1976, DOI 10.1093/ndt/14.8.1976; White WB, 2014, J AM SOC HYPERTENS, V8, P939, DOI 10.1016/j.jash.2014.10.005	61	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	JUN	2015	65	6					1170	1179		10.1161/HYPERTENSIONAHA.115.04808		10	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CH9OJ	WOS:000354364900008		
J	Mao, YJ; Tokudome, T; Kishimoto, I; Otani, K; Nishimura, H; Yamaguchi, O; Otsu, K; Miyazato, M; Kangawa, K				Mao, Yuanjie; Tokudome, Takeshi; Kishimoto, Ichiro; Otani, Kentaro; Nishimura, Hirohito; Yamaguchi, Osamu; Otsu, Kinya; Miyazato, Mikiya; Kangawa, Kenji			Endogenous Ghrelin Attenuates Pressure Overload-Induced Cardiac Hypertrophy via a Cholinergic Anti-Inflammatory Pathway	HYPERTENSION			English	Article						cardiomegaly; ghrelin; inflammation; mice, knockout	LEFT-VENTRICULAR HYPERTROPHY; HEART-RATE-VARIABILITY; TUMOR-NECROSIS-FACTOR; MYOCARDIAL-INFARCTION; VAGUS NERVE; SYMPATHETIC ACTIVITY; MICE; ACTIVATION; RECEPTOR; RATS	Cardiac hypertrophy, which is commonly caused by hypertension, is a major risk factor for heart failure and sudden death. Endogenous ghrelin has been shown to exert a beneficial effect on cardiac dysfunction and postinfarction remodeling via modulation of the autonomic nervous system. However, ghrelin's ability to attenuate cardiac hypertrophy and its potential mechanism of action are unknown. In this study, cardiac hypertrophy was induced by transverse aortic constriction in ghrelin knockout mice and their wild-type littermates. After 12 weeks, the ghrelin knockout mice showed significantly increased cardiac hypertrophy compared with wild-type mice, as evidenced by their significantly greater heart weight/tibial length ratios (9.2 +/- 1.9 versus 7.9 +/- 0.8 mg/mm), left ventricular anterior wall thickness (1.3 +/- 0.2 versus 1.0 +/- 0.2 mm), and posterior wall thickness (1.1 +/- 0.3 versus 0.9 +/- 0.1 mm). Furthermore, compared with wild-type mice, ghrelin knockout mice showed suppression of the cholinergic anti-inflammatory pathway, as indicated by reduced parasympathetic nerve activity and higher plasma interleukin-1 beta and interleukin-6 levels. The administration of either nicotine or ghrelin activated the cholinergic anti-inflammatory pathway and attenuated cardiac hypertrophy in ghrelin knockout mice. In conclusion, our results show that endogenous ghrelin plays a crucial role in the progression of pressure overload-induced cardiac hypertrophy via a mechanism that involves the activation of the cholinergic anti-inflammatory pathway.	[Mao, Yuanjie; Tokudome, Takeshi; Kishimoto, Ichiro; Nishimura, Hirohito; Miyazato, Mikiya; Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biochem, Suita, Osaka 5658565, Japan; [Otani, Kentaro] Osaka Univ, Dept Regenerat Med & Tissue Engn, Natl Cerebral & Cardiovasc Ctr Res Inst, Suita, Osaka, Japan; [Yamaguchi, Osamu] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka, Japan; [Otsu, Kinya] Kings Coll London, Cardiovasc Div, British Heart Fdn Ctr, London WC2R 2LS, England	Kishimoto, I (reprint author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biochem, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	kishimot@hsp.ncvc.go.jp	Mao, Yuanjie/G-2020-2015	Mao, Yuanjie/0000-0002-4196-7133	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Daiwa Securities Health Foundation; Senri Life Science Foundation; Alumni Association of Faculty of Medicine, Kagawa University [26-1]	This study was supported by research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Takeda Science Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Daiwa Securities Health Foundation, and the Senri Life Science Foundation, Alumni Association of Faculty of Medicine, Kagawa University, no. 26-1.	Honsho S, 2009, CIRC RES, V105, P1149, DOI 10.1161/CIRCRESAHA.109.208199; Cheyuo C, 2011, SHOCK, V35, P258, DOI 10.1097/SHK.0b013e3181f48a37; Shimizu S, 2011, AUTON NEUROSCI-BASIC, V162, P60, DOI 10.1016/j.autneu.2011.04.001; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Leib C, 2011, CIRC RES, V109, P130, DOI 10.1161/CIRCRESAHA.111.245563; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Borovikova LV, 2000, NATURE, V405, P458; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jcm.20040463; Wu RQ, 2007, ANN SURG, V245, P480, DOI 10.1097/01.sla.0000251614.42290.ed; Coles B, 2007, AM J PATHOL, V171, P315, DOI 10.2353/ajpath.2007.061078; Schlaich MP, 2003, CIRCULATION, V108, P560, DOI 10.1161/01.CIR.0000081775.72651.B6; Huda MSB, 2010, CLIN ENDOCRINOL, V73, P678, DOI 10.1111/j.1365-2265.2010.03865.x; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Vakili BA, 2001, AM HEART J, V141, P334, DOI 10.1067/mhj.2001.113218; HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862; Mao YJ, 2013, ENDOCRINOLOGY, V154, P1854, DOI 10.1210/en.2012-2132; Wilund KR, 2009, BIOCHEM BIOPH RES CO, V390, P148, DOI 10.1016/j.bbrc.2009.09.088; Rajan D, 2012, SURGERY, V151, P37, DOI 10.1016/j.surg.2011.06.027; Mabley JG, 2002, J PHARMACOL EXP THER, V300, P876, DOI 10.1124/jpet.300.3.876; Nakano M, 1998, CIRCULATION, V97, P1392; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Mao YJ, 2012, ENDOCRINOLOGY, V153, P3426, DOI 10.1210/en.2012-1065; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Hofer S, 2008, CRIT CARE MED, V36, P404, DOI 10.1097/01.CCM.0B013E31816208B3; Li DJ, 2011, HYPERTENSION, V57, P298, DOI 10.1161/HYPERTENSIONAHA.110.160077; Prabhu SD, 2004, CIRC RES, V95, P1140, DOI 10.1161/01.RES.0000150734.79804.92; de la Cour CD, 2005, GUT, V54, P907, DOI 10.1136/gut.2004.058578; Du XJ, 2004, CARDIOVASC RES, V63, P510, DOI 10.1016/j.cardiores.2004.03.027; Higashikuni Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000267; Li Y, 2006, AM J PHYSIOL-GASTR L, V290, pG1350, DOI 10.1152/ajpgi.00493.2005; Mao YJ, 2014, HYPERTENSION, V64, P450, DOI 10.1161/HYPERTENSIONAHA.114.03726; Nishiue T, 1999, J ELECTROCARDIOL, V32, P263, DOI 10.1016/S1053-0770(99)90066-6; PULLAN RD, 1994, NEW ENGL J MED, V330, P811, DOI 10.1056/NEJM199403243301202; Sato N, 2003, JPN J PHYSIOL, V53, P443, DOI 10.2170/jjphysiol.53.443; Soeki T, 2008, AM J PHYSIOL-HEART C, V294, pH426, DOI 10.1152/ajpheart.00643.2007; Thireau J, 2008, EXP PHYSIOL, V93, P83, DOI 10.1113/expphysiol.2007.040733; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703	38	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	JUN	2015	65	6					1238	1244		10.1161/HYPERTENSIONAHA.114.04864		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CH9OJ	WOS:000354364900017		
J	Iriyama, T; Wang, W; Parchim, NF; Song, AR; Blackwell, SC; Sibai, BM; Kellems, RE; Xia, Y				Iriyama, Takayuki; Wang, Wei; Parchim, Nicholas F.; Song, Anren; Blackwell, Sean C.; Sibai, Baha M.; Kellems, Rodney E.; Xia, Yang			Hypoxia-Independent Upregulation of Placental Hypoxia Inducible Factor-1 alpha Gene Expression Contributes to the Pathogenesis of Preeclampsia	HYPERTENSION			English	Article						hypoxia inducible factor-1 alpha; preeclampsia; tumor necrosis factor superfamily member 14	RECEPTOR AGONISTIC AUTOANTIBODIES; NECROSIS-FACTOR-ALPHA; TRANSCRIPTION FACTORS; HYPERTENSION; INDUCTION; PREGNANCY; CELLS; INTERLEUKIN-1-BETA; MECHANISMS; PATHWAY	Accumulation of hypoxia inducible factor-1 alpha (HIF-1 alpha) is commonly an acute and beneficial response to hypoxia, whereas chronically elevated HIF-1 alpha is associated with multiple disease conditions, including preeclampsia, a serious hypertensive disease of pregnancy. However, the molecular basis underlying the persistent elevation of placental HIF-1 alpha in preeclampsia and its role in the pathogenesis of preeclampsia are poorly understood. Here we report that Hif-1 alpha mRNA and HIF-1 alpha protein were elevated in the placentas of pregnant mice infused with angiotensin II type I receptor agonistic autoantibody, a pathogenic factor in preeclampsia. Knockdown of placental Hif-1 alpha mRNA by specific siRNA significantly attenuated hallmark features of preeclampsia induced by angiotensin II type I receptor agonistic autoantibody in pregnant mice, including hypertension, proteinuria, kidney damage, impaired placental vasculature, and elevated maternal circulating soluble fms-like tyrosine kinase-1 levels. Next, we discovered that Hif-1 alpha mRNA levels and HIF-1 alpha protein levels were induced in an independent preeclampsia model with infusion of the inflammatory cytokine tumor necrosis factor superfamily member 14 (LIGHT). SiRNA knockdown experiments also demonstrated that elevated HIF-1 alpha contributed to LIGHT-induced preeclampsia features. Translational studies with human placentas showed that angiotensin II type I receptor agonistic autoantibody or LIGHT is capable of inducing HIF-1 alpha in a hypoxia-independent manner. Moreover, increased HIF-1 alpha was found to be responsible for angiotensin II type I receptor agonistic autoantibody or LIGHT-induced elevation of Flt-1 gene expression and production of soluble fms-like tyrosine kinase-1 in human villous explants. Overall, we demonstrated that hypoxia-independent stimulation of HIF-1 alpha gene expression in the placenta is a common pathogenic mechanism promoting disease progression. Our findings reveal new insight to preeclampsia and highlight novel therapeutic possibilities for the disease.	[Iriyama, Takayuki; Wang, Wei; Parchim, Nicholas F.; Song, Anren; Kellems, Rodney E.; Xia, Yang] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Blackwell, Sean C.; Sibai, Baha M.] Univ Texas Med Sch Houston, Dept Obstet Gynecol & Reprod Sci, Houston, TX 77030 USA; [Parchim, Nicholas F.; Kellems, Rodney E.; Xia, Yang] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Grad Program Biochem & Mol Biol, Houston, TX 77030 USA; [Wang, Wei; Xia, Yang] Cent S Univ, Dept Nephrol, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Iriyama, Takayuki] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan	Xia, Y (reprint author), Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	yang.xia@uth.tmc.edu			National Institutes of Health [HL119549, RC4HD067977, HD34130]; China National Science Foundation [81228004]	This work was supported by National Institutes of Health Grants HL119549 (to Y. Xia), RC4HD067977 and HD34130 (to Y. Xia and R.E. Kellems), and by China National Science Foundation Grant 81228004 (to Y. Xia).	van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Hellwig-Burgel T, 1999, BLOOD, V94, P1561; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Xia Y, 2013, CIRC RES, V113, P78, DOI 10.1161/CIRCRESAHA.113.300752; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Parrish MR, 2010, AM J HYPERTENS, V23, P911, DOI 10.1038/ajh.2010.70; Rajakumar A, 2004, PLACENTA, V25, P763, DOI 10.1016/j.placenta.2004.02.011; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Kuschel A, 2012, J CELL PHYSIOL, V227, P514, DOI 10.1002/jcp.22798; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856; Ramadori P, 2010, LAB INVEST, V90, P1306, DOI 10.1038/labinvest.2010.85; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Pringle KG, 2010, HUM REPROD UPDATE, V16, P415, DOI 10.1093/humupd/dmp046; Wenzel K, 2011, HYPERTENSION, V58, P77, DOI 10.1161/HYPERTENSIONAHA.111.171348; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; LaMarca BD, 2007, CURR HYPERTENS REP, V9, P480, DOI 10.1007/s11906-007-0088-1; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; Richard DE, 2000, J BIOL CHEM, V275, P26765; Chen TH, 2005, ANN NY ACAD SCI, V1042, P286, DOI 10.1196/annals.1338.051; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Poth JM, 2013, J MOL MED, V91, P183, DOI 10.1007/s00109-012-0988-7; Qian D, 2004, BIOL REPROD, V70, P1822, DOI 10.1095/biolreprod.103.025031; Wang W, 2014, HYPERTENSION, V63, P595, DOI 10.1161/HYPERTENSIONAHA.113.02458	26	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	JUN	2015	65	6					1307	1315		10.1161/HYPERTENSIONAHA.115.05314		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CH9OJ	WOS:000354364900026		
J	Kameoka, H; Yoshizato, K; Ishihara, T; Kadowaki, K; Ohishi, Y; Kashino, K				Kameoka, Hirokazu; Yoshizato, Kota; Ishihara, Tatsuma; Kadowaki, Kento; Ohishi, Yasunori; Kashino, Kunio			Generative Modeling of Voice Fundamental Frequency Contours	IEEE-ACM TRANSACTIONS ON AUDIO SPEECH AND LANGUAGE PROCESSING			English	Article						Expectation-maximization algorithm; Fujisaki model; prosody; voice fundamental frequency contour	AUTOMATIC EXTRACTION; EM ALGORITHM; PARAMETERS; SPEECH	This paper introduces a generative model of voice fundamental frequency (F-0) contours that allows us to extract prosodic features from raw speech data. The present F-0 contour model is formulated by translating the Fujisaki model, a well-founded mathematical model representing the control mechanism of vocal fold vibration, into a probabilistic model described as a discrete-time stochastic process. There are two motivations behind this formulation. One is to derive a general parameter estimation framework for the Fujisaki model that allows the introduction of powerful statistical methods. The other is to construct an automatically trainable version of the Fujisaki model that we can incorporate into statistical-model-based text-to-speech synthesizers in such a way that the Fujisaki-model parameters can be learned from a speech corpus in a unified manner. It could also be useful for other speech applications such as emotion recognition, speaker identification, speech conversion and dialogue systems, in which prosodic information plays a significant role. We quantitatively evaluated the performance of the proposed Fujisaki model parameter extractor using real speech data. Experimental results revealed that our method was superior to a state-of-the-art Fujisaki model parameter extractor.	[Kameoka, Hirokazu; Yoshizato, Kota; Ishihara, Tatsuma; Kadowaki, Kento] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo 1138656, Japan; [Kameoka, Hirokazu; Ohishi, Yasunori; Kashino, Kunio] NTT Corp, NTT Commun Sci Labs, Tokyo 2430198, Japan	Kameoka, H (reprint author), Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo 1138656, Japan.	kameoka@hil.t.u-tokyo.ac.jp; yoshizato@hil.t.u-tokyo.ac.jp; ishihara@hil.t.u-tokyo.ac.jp; kadowaki@hil.t.u-tokyo.ac.jp; ohishi.yasunori@lab.ntt.co.jp; kashino.kunio@lab.ntt.co.jp			JSPS KAKENHI [26730100, 26280060]	This work was supported by the JSPS KAKENHI under Grants 26730100 and 26280060. Earlier versions of this work were presented at SAPA 2010 [1], Speech Prosody 2012 [2], Interspeech 2012 [3], and Interspeech 2013 [4] as workshop/conference papers. The associate editor coordinating the review of this manuscript and approving it for publication was Dr. Nobutaka Ono.	FEDER M, 1988, IEEE T ACOUST SPEECH, V36, P477, DOI 10.1109/29.1552; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1; Ferguson J., 1980, P S APPL HIDD MARK M, P143; Fujisaki H., 1994, P 1994 INT C SPOK LA, V1, P355; Fujisaki H., 2004, P 7 INT C SIGN PROC, V1, P655, DOI 10.1109/ICOSP.2004.1452748; Fujisaka H., 1984, Journal of the Acoustical Society of Japan (E), V5; Fujisaki H, 1988, VOCAL PHYSL VOICE PR; Fujisaki H., 1995, P EUROSPEECH 95, V2, P985; Fujisaki H., 1993, P IEEE INT C AC SPEE, P211; Fujisaki H, 2003, P EUR 2003 GEN SWITZ, V3, P2317; Kadowaki K., 2014, P 15 ANN C INT SPEEC, P2322; Kameoka H., 2010, P ISCA TUT RES WORKS, P43; Kameoka H., 2007, THESIS U TOKYO TOKYO; Kameoka H, 2009, INT CONF ACOUST SPEE, P45, DOI 10.1109/ICASSP.2009.4959516; Kameoka H., 2013, P INTERSPEECH2013, P1826; Kurematsu A., 1999, SPEECH COMMUN, V27, P187; Levinson S., 1986, ACOUSTICS SPEECH SIG, V11, P1241; Mixdorff H., 1994, P 1994 INT C SPOK LA, V4, P2231; MIXDORFF H, 2000, ACOUST SPEECH SIG PR, P1281; NARUSAWA S, 2002, ACOUST SPEECH SIG PR, P509; Pfitzinger H. R., 2009, P INTERSPEECH, P2455; Rossi P. S., 2003, P IEEE INT C AC SPEE, P520; Rossi P. S., 2002, P SPEECH PROSODY AIX, P615; Russell M., 1985, ACOUSTICS SPEECH SIG, V10, P5; Wang C., 2000, P 6 INT C SPOK LANG, V3, P326; Yoshizato K., 2012, P 13 ANN C INT SPEEC; Yoshizato K, 2012, PROCEEDINGS OF THE 6TH INTERNATIONAL CONFERENCE ON SPEECH PROSODY, VOLS I AND II, P175	27	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2329-9290			IEEE-ACM T AUDIO SPE	IEEE-ACM Trans. Audio Speech Lang.	JUN	2015	23	6					1042	1053		10.1109/TASLP.2015.2418576		12	Acoustics; Engineering, Electrical & Electronic	Acoustics; Engineering	CI1WQ	WOS:000354536200008		
J	Han, XH; Chen, YW; Xu, G				Han, Xian-Hua; Chen, Yen-Wei; Xu, Gang			High-Order Statistics of Weber Local Descriptors for Image Representation	IEEE TRANSACTIONS ON CYBERNETICS			English	Article						High-order statistics; local descriptor; microstructure; parametric model; Weber's Law	TEXTURE CLASSIFICATION; SCALE; FEATURES; KERNELS	Highly discriminant visual features play a key role in different image classification applications. This study aims to realize a method for extracting highly-discriminant features from images by exploring a robust local descriptor inspired by Weber's law. The investigated local descriptor is based on the fact that human perception for distinguishing a pattern depends not only on the absolute intensity of the stimulus but also on the relative variance of the stimulus. Therefore, we firstly transform the original stimulus (the images in our study) into a differential excitation-domain according to Weber's law, and then explore a local patch, called micro-Texton, in the transformed domain as Weber local descriptor (WLD). Furthermore, we propose to employ a parametric probability process to model the Weber local descriptors, and extract the higher-order statistics to the model parameters for image representation. The proposed strategy can adaptively characterize the WLD space using generative probability model, and then learn the parameters for better fitting the training space, which would lead to more discriminant representation for images. In order to validate the efficiency of the proposed strategy, we apply three different image classification applications including texture, food images and HEp-2 cell pattern recognition, which validates that our proposed strategy has advantages over the state-of-the-art approaches.	[Han, Xian-Hua; Chen, Yen-Wei; Xu, Gang] Ritsumeikan Univ, Coll Informat Sci & Engn, Kasatsu 5258577, Japan	Han, XH (reprint author), Ritsumeikan Univ, Coll Informat Sci & Engn, Kasatsu 5258577, Japan.	hanxhua@fc.ritsumei.ac.jp			Japanese MEXT [24700179, 2430076, 24103710]	This work was supported by the Grant-in Aid for Scientific Research from the Japanese MEXT under Grant 24700179, Grant 2430076, and Grant 24103710. This paper was recommended by Associate Editor J. Basak.	Aitnouri E., 1999, Neural, Parallel & Scientific Computations, V7; Amari S.-I., 2000, TRANSLATIONS MATH MO, V191; Zhang J, 2007, INT J COMPUT VISION, V73, P213, DOI 10.1007/s11263-006-9794-4; Jegou H, 2010, INT J COMPUT VISION, V87, P316, DOI 10.1007/s11263-009-0285-2; Chen J, 2010, IEEE T PATTERN ANAL, V32, P1705, DOI 10.1109/TPAMI.2009.155; Crosier M, 2010, INT J COMPUT VISION, V88, P447, DOI 10.1007/s11263-009-0315-0; Lazebnik S, 2005, IEEE T PATTERN ANAL, V27, P1265, DOI 10.1109/TPAMI.2005.151; Varma M, 2005, INT J COMPUT VISION, V62, P61, DOI 10.1007/s11263-005-4635-4; Wang XY, 2009, IEEE I CONF COMP VIS, P32, DOI 10.1109/ICCV.2009.5459207; Yang JC, 2009, PROC CVPR IEEE, P1794; Xu L, 1996, NEURAL COMPUT, V8, P129, DOI 10.1162/neco.1996.8.1.129; Chen M, 2009, 2009 16TH IEEE INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOLS 1-6, P289, DOI 10.1109/ICIP.2009.5413511; Wang JJ, 2010, PROC CVPR IEEE, P3360, DOI 10.1109/CVPR.2010.5540018; Varma M, 2003, PROC CVPR IEEE, P691; Liu LQ, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV), P2486; Xu Y, 2010, PROC CVPR IEEE, P161, DOI 10.1109/CVPR.2010.5540217; Aran O, 2010, PATTERN RECOGN, V43, P1776, DOI 10.1016/j.patcog.2009.12.002; Caputo B, 2005, IEEE I CONF COMP VIS, P1597; Yang S, 2010, PROC CVPR IEEE, P2249, DOI 10.1109/CVPR.2010.5539907; Dalal N, 2005, PROC CVPR IEEE, P886; Shen JH, 2003, PHYSICA D, V175, P241, DOI 10.1016/S0167-2789(02)00734-0; Jegou H, 2008, LECT NOTES COMPUT SC, V5302, P304, DOI 10.1007/978-3-540-88682-2_24; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Chang JH, 2002, IMAGE VISION COMPUT, V20, P203, DOI 10.1016/S0262-8856(01)00095-6; Christopher B., 2006, PATTERN RECOGNITION; Dempster AP, 1997, J ROYAL STAT SOC B, V39, P1; Dick U, 2006, LECT NOTES COMPUT SC, V4212, P114; Dinov I., 2008, STAT ONLINE COMP AUG; Gong DY, 2011, 2011 FIRST ASIAN CONFERENCE ON PATTERN RECOGNITION (ACPR), P589; Han XH, 2012, IEEE T IMAGE PROCESS, V21, P1314, DOI 10.1109/TIP.2011.2168417; Harris C., 1998, P 4 ALV VIS C, P147; Heikkila M, 2006, IEEE T PATTERN ANAL, V28, P657, DOI 10.1109/TPAMI.2006.68; Hobson P., 2013, P 20 IEEE INT C IM P, P2; Jaakkola TS, 1999, ADV NEUR IN, V11, P487; Jegou H, 2009, IEEE I CONF COMP VIS, P2357, DOI 10.1109/ICCV.2009.5459419; Ke Y., 2004, P IEEE INT C COMP VI, P505; Kertesz C., 2011, INT J SIGNAL PROCESS, V4, P51; Lazebnik S., 2006, P IEEE C COMP VIS PA, V2, P2169, DOI DOI 10.1109/CVPR.2006.68; Lowe D., 1999, P INT C COMP VIS, V2, P1150, DOI DOI 10.1109/ICCV.1999.790410; Nello C., 2000, INTRO SUPPORT VECTOR; Nister D, 2006, IEEE COMP SOC C COMP, V2, P2161, DOI DOI 10.1109/CVPR.2006.264; Philbin J., 2008, P IEEE C COMP VIS PA, P1; Sharma G, 2012, LECT NOTES COMPUT SC, V7578, P1, DOI 10.1007/978-3-642-33786-4_1; Shen JH, 2006, APPL MATH OPT, V53, P331, DOI 10.1007/s00245-005-0850-1; Sivic J., 2003, P 9 IEEE C COMP VIS, V2, P1470, DOI DOI 10.1109/ICCV.2003.1238663	46	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2267	2168-2275		IEEE T CYBERNETICS	IEEE T. Cybern.	JUN	2015	45	6					1180	1193		10.1109/TCYB.2014.2346793		14	Computer Science, Artificial Intelligence; Computer Science, Cybernetics	Computer Science	CI1VC	WOS:000354532000007		
J	Okawa, M; Yoshida, K				Okawa, Manabu; Yoshida, Kenichi			Text and User Generic Model for Writer Verification Using Combined Pen Pressure Information From Ink Intensity and Indented Writing on Paper	IEEE TRANSACTIONS ON HUMAN-MACHINE SYSTEMS			English	Article						Biometrics; cost-sensitive learning; dissimilarity representation; pen pressure; pseudodynamic approach; text-independent approach; writer-independent approach; writer verification	LINE SIGNATURE VERIFICATION; HANDWRITING RECOGNITION; FEATURES; ONLINE; IMAGE	Writer verification is a method to specify an authentic writer from handwriting. Automated writer verification methods are required for various applications (e.g., credit cards, checks, and passports). However, there is room for improvement in the performance of such methods compared with the performance of human beings, for example, forensic document examiners. Because automated writer verification systems do not always return correct results under any circumstances, which can lead to grave consequences, further research is required to improve the performance of such methods. Furthermore, problems caused by limited samples must be solved for real applications. To improve verification accuracy with limited samples, we propose a text and user generic model for writer verification that uses a combination of pen pressure information from ink intensity and writing indentations obtained by a multiband image scanner. We introduce a writer-specific dissimilarity representation to consider individual handwriting characteristics that affect model performance. Experimental results obtained using handwriting samples collected from 54 volunteers are reported. The results show a decrease in error rate compared with conventional methods from 10.0% to 4.0%.	[Okawa, Manabu] Metropolitan Police Dept, Criminal Invest Lab, Tokyo 1008929, Japan; [Yoshida, Kenichi] Univ Tsukuba, Grad Sch Business Sci, Tokyo 1120012, Japan	Okawa, M (reprint author), Metropolitan Police Dept, Criminal Invest Lab, Tokyo 1008929, Japan.	m_okawa.lab1@m.ieice.org; yoshida@gssm.otsuka.tsukuba.ac.jp			JSPS KAKENHI [26919004, 25280114]	This work was supported in part by JSPS KAKENHI Grant 26919004 and Grant 25280114.	Impedovo D, 2008, IEEE T SYST MAN CY C, V38, P609, DOI 10.1109/TSMCC.2008.923866; Kumar R, 2012, PATTERN RECOGN LETT, V33, P301, DOI 10.1016/j.patrec.2011.10.009; Unar JA, 2014, PATTERN RECOGN, V47, P2673, DOI 10.1016/j.patcog.2014.01.016; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62; Kimura F, 1997, PATTERN RECOGN, V30, P1329, DOI 10.1016/S0031-3203(96)00153-7; Ferrer MA, 2012, IEEE T INF FOREN SEC, V7, P966, DOI 10.1109/TIFS.2012.2190281; Impedovo S, 2014, PATTERN RECOGN, V47, P916, DOI 10.1016/j.patcog.2013.05.027; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Jabid T, 2010, ETRI J, V32, P784, DOI 10.4218/etrij.10.1510.0132; Srihari SN, 2002, J FORENSIC SCI, V47, P856; Bertolini D, 2010, PATTERN RECOGN, V43, P387, DOI 10.1016/j.patcog.2009.05.009; Bulacu M, 2007, IEEE T PATTERN ANAL, V29, P701, DOI 10.1109/TPAMI.2007.1009; Coetzer J., 2012, P SOC PHOTO-OPT INS, V8297; Djeddi C, 2013, PATTERN RECOGN LETT, V34, P1196, DOI 10.1016/j.patrec.2013.03.020; Ellen D., 2005, SCI EXAMINATION DOCU, V3rd; FRANKE K, 2008, P 2 INT WORKSH COMP, V5158, P204; Furukawa T, 2011, LECT NOTES COMPUT SC, V6540, P114; Jain AK, 2006, IEEE T INF FOREN SEC, V1, P125, DOI 10.1109/TIFS.2006.873653; Jane L., 2014, FORENSIC DOCUMENT EX, V1st; Kubat M., 1997, P 14 INT C MACH LEAR, V97, P179; Li X., 2008, P 11 INT C FRONT HAN; Malik M. I., 2013, P 16 INT GRAPH SOC C, P9; Muramatsu Daigo, 2009, Proceedings of the 2009 IEEE International Conference on Systems, Man and Cybernetics. SMC 2009, DOI 10.1109/ICSMC.2009.5346689; Narita R, 2011, PROC INT CONF DOC, P824, DOI 10.1109/ICDAR.2011.169; Nguyen V., 2010, P 9 IAPR INT WORKSH, P463, DOI 10.1145/1815330.1815390; Okawa M., 2013, P 13 IEEE INT C TECH, P375; Okawa M., 2013, P 16 INT GRAPH SOC C, P14; Okawa M, 2013, IET BIOMETRICS, V2, P199, DOI 10.1049/iet-bmt.2012.0068; OKAWA M, 2012, P 13 INT C FRONT HAN, P625; Parodi M, 2014, PATTERN RECOGN, V47, P128, DOI 10.1016/j.patcog.2013.06.026; Pkalska E., 2002, PATTERN RECOGN, V23, P943; Plamondon R, 2000, IEEE T PATTERN ANAL, V22, P63, DOI 10.1109/34.824821; Plamondon R, 1999, IEEE T IMAGE PROCESS, V8, P80, DOI 10.1109/83.736691; Platt JC, 2000, ADV NEUR IN, P61; Spagnolo GS, 2013, OPTIK, V124, P2155, DOI 10.1016/j.ijleo.2012.06.097; Srihari S, 2008, J FORENSIC SCI, V53, P430, DOI 10.1111/j.1556-4029.2008.00682.x; Srihari SN, 2014, PATTERN RECOGN, V47, P1083, DOI 10.1016/j.patcog.2013.09.032; Veropoulos K, 1999, P INT JOINT C ART IN, P55	38	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2291	2168-2305		IEEE T HUM-MACH SYST	IEEE T. Hum.-Mach. Syst.	JUN	2015	45	3					339	349		10.1109/THMS.2014.2380828		11	Computer Science, Artificial Intelligence; Computer Science, Cybernetics	Computer Science	CI1VG	WOS:000354532400006		
J	Asano, S; Okamoto, S; Yamada, Y				Asano, Shuhei; Okamoto, Shogo; Yamada, Yoji			Vibrotactile Stimulation to Increase and Decrease Texture Roughness	IEEE TRANSACTIONS ON HUMAN-MACHINE SYSTEMS			English	Article						Augmented reality; haptic device; mechanoreceptors; roughness; texture; vibrotactile stimulation	PERCEPTION; VIBRATION; MASKING; DISCRIMINATION; SURFACE	We have developed a texture display system that modifies the perceived roughness of textured surfaces via a voice coil actuator worn on the finger. To increase the roughness sensations, the vibrotactile stimuli from the actuator simulate the skin deformations that are activated when a wavy surface is scanned. Conversely, to decrease the roughness sensations of the textured surface, a high-frequency vibrotactile stimulus offsets the activity levels of tactile mechanoreceptors. This offset suppresses the perceived roughness of the surfaces being touched, with increase in the offset correlating with increase in the feeling of smoothness of the surfaces. We conducted an experiment in which we tested the effects of these two types of vibrotactile stimulation on grating roughness specimens, with subjective responses acquired from eight participants via the magnitude estimation method. The results obtained indicate that our method selectively increases and decreases the roughness felt. The intention is for the technique to be used to develop an augmented reality device for textures.	[Asano, Shuhei; Okamoto, Shogo; Yamada, Yoji] Nagoya Univ, Dept Mech Sci & Engn, Nagoya, Aichi 4648602, Japan	Asano, S (reprint author), Nagoya Univ, Dept Mech Sci & Engn, Nagoya, Aichi 4648602, Japan.	asano.shuhei@h.mbox.nagoya-u.ac.jp; okamoto-shogo@mech.nagoya-u.ac.jp; yamada-yoji@mech.nagoya-u.ac.jp			KAKENHI Shitsukan [25135717]; MIC SCOPE [142106003]	This work was supported in part by KAKENHI Shitsukan (25135717) and MIC SCOPE (142106003).	Abraham S., 1964, ANAL CHEM, V36, P1627; Enriquez M, 2008, BRAIN RES BULL, V75, P761, DOI 10.1016/j.brainresbull.2008.01.018; Okamura AM, 1998, IEEE INT CONF ROBOT, P674; WATANABE T, 1995, IEEE INT CONF ROBOT, P1134, DOI 10.1109/ROBOT.1995.525433; Chubb EC, 2010, IEEE T HAPTICS, V3, P189, DOI [10.1109/TOH.2010.7, 10.1109/ToH.2010.7]; SRINIVASAN MA, 1995, J NEUROPHYSIOL, V73, P88; Yoshioka T, 2001, J NEUROSCI, V21, P6905; Hollins M, 2001, SOMATOSENS MOT RES, V18, P253; Asano S, 2013, IEEE SYS MAN CYBERN, P510, DOI 10.1109/SMC.2013.93; Asano S., 2012, P 2012 IEEE INT S RO, P1001; Bau O, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185585; Biet M., 2007, P JOINT EUROHAPTICS, P385; Gescheider GA, 2005, SOMATOSENS MOT RES, V22, P127, DOI 10.1080/08990220500262018; Gescheider GA, 1995, J ACOUST SOC AM, V98, P3195, DOI 10.1121/1.413809; GESCHEIDER GA, 1982, J ACOUST SOC AM, V72, P1421, DOI 10.1121/1.388449; Guest S, 2002, EXP BRAIN RES, V146, P161, DOI 10.1007/s00221-002-1164-z; Hollins M, 2000, PERCEPTION, V29, P1455, DOI 10.1068/p3044; Imanaka K, 2002, HUM MOVEMENT SCI, V21, P541, DOI 10.1016/S0167-9457(02)00175-6; Konyo M., 2005, P IEEE RSJ INT C INT, P3965; Konyo M., 2008, HAPTICS PERCEPTION D; Niwa M., 2010, HAPTICS GENERATING P; Ochiai Y., 2014, HAPTICS NEUROSCIENCE; Suzuki Y, 2008, BRAIN RES, V1242, P87, DOI 10.1016/j.brainres.2008.06.104; VERRILLO RT, 1985, J ACOUST SOC AM, V77, P225, DOI 10.1121/1.392263; Winfield L., 2007, P 2 JOINT EUROHAPTIC, P421	25	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2291	2168-2305		IEEE T HUM-MACH SYST	IEEE T. Hum.-Mach. Syst.	JUN	2015	45	3					393	398		10.1109/THMS.2014.2376519		6	Computer Science, Artificial Intelligence; Computer Science, Cybernetics	Computer Science	CI1VG	WOS:000354532400011		
J	Kim, S; Kang, FS				Kim, Seonghye; Kang, Feel-Soon			Multifunctional Onboard Battery Charger for Plug-in Electric Vehicles	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS			English	Article						AC-to-DC converters; battery; dc-to-dc converters; dc-to-ac inverters; low-voltage dc-to-dc converter (LDC); onboard charger (OBC); plug-in electric vehicle (PEV); power factor correction (PFC)	DC/DC CONVERTER; DC-CONVERTER; VOLTAGE; SYSTEM; PHEV	This paper presents a multifunctional onboard battery charger for plug-in electric vehicles (PEVs). The proposed battery charger consists of three H-bridge modules including a selective switch, a high-frequency transformer, and inductors. The first duty of the proposed charger is to charge the propulsion battery when PEV connects to the ac grid [onboard charger (OBC)]. In this case, the proposed charger plays a role in ac-to-dc converting with power factor correction. Occasionally, the propulsion battery can supply surplus energy to the grid [vehicle to grid (V2G)]. In this second task, the proposed charger acts as an inverter. The third role is to charge the auxiliary battery via the propulsion battery when PEV is in a driving state [low-voltage dc-to-dc converter (LDC)]. In this case, the proposed charger acts as a step-down converter. In conventional PEVs, the aforementioned functions are done by an OBC and an LDC separately. The proposed charger can implement the three tasks by sharing switches and inductors in an all-in-one system. Thus, the proposed approach can realize a small and light design of the EV battery charger, resulting in the improvement of fuel efficiency. After theoretical analysis, we carry out simulations and experiments using a prototype to verify the validity of the proposed approach.	[Kim, Seonghye] Hanbat Natl Univ, Dept Control Instrumentat Engn, Taejon 305719, South Korea; [Kang, Feel-Soon] Hanbat Natl Univ, Dept Elect & Control Engn, Taejon 305719, South Korea	Kim, S (reprint author), Keio Univ, Yokohama, Kanagawa 2238522, Japan.	feelsoon@hanbat.ac.kr			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2012R1A1A2006120]	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012R1A1A2006120).	Lee JY, 2014, IEEE T IND ELECTRON, V61, P1243, DOI 10.1109/TIE.2013.2262749; Yilmaz M, 2013, IEEE T POWER ELECTR, V28, P2151, DOI 10.1109/TPEL.2012.2212917; Ortuzar M, 2007, IEEE T IND ELECTRON, V54, P2147, DOI 10.1109/TIE.2007.894713; Chen BY, 2012, IEEE T IND ELECTRON, V59, P1545, DOI 10.1109/TIE.2011.2167115; Kuperman A, 2013, IEEE T IND ELECTRON, V60, P5391, DOI 10.1109/TIE.2012.2233695; Haghbin S, 2011, IEEE T VEH TECHNOL, V60, P4115, DOI 10.1109/TVT.2011.2162258; van Hoek H, 2013, IEEE T POWER ELECTR, V28, P5499, DOI 10.1109/TPEL.2013.2251905; Khaligh A, 2012, IEEE T VEH TECHNOL, V61, P3475, DOI 10.1109/TVT.2012.2213104; Lee JY, 2014, IEEE T IND ELECTRON, V61, P1784, DOI 10.1109/TIE.2013.2263775; Lee YJ, 2009, IEEE T VEH TECHNOL, V58, P3970, DOI 10.1109/TVT.2009.2028070; Gautam DS, 2012, IEEE T VEH TECHNOL, V61, P3466, DOI 10.1109/TVT.2012.2210259; Gautam DS, 2013, IEEE T POWER ELECTR, V28, P5728, DOI 10.1109/TPEL.2013.2249671; Pahlevaninezhad M, 2012, IEEE T IND ELECTRON, V59, P920, DOI 10.1109/TIE.2011.2161063; Lee IO, 2014, IEEE T IND ELECTRON, V61, P3978, DOI 10.1109/TIE.2013.2282608; Chae H. J., 2011, P INT C POW EL SHILL, P2717; Chae HJ, 2010, ELECTRON LETT, V46, P1691, DOI 10.1049/el.2010.2710; Chen H.-T., 2011, P IEEE VEH POW PROP, P1, DOI DOI 10.1145/2029932.2029934; Dusmez S, 2013, IEEE T POWER ELECTR, V28, P5690, DOI 10.1109/TPEL.2012.2233763; Erb D. C., 2010, P IEEE VEH POW PROP, P1; Huiping Y., 2011, P PESA, P1; Jeomgoo Kim, 2010, P IEEE CUST INT CIRC, P1; Jones WD, 2005, IEEE SPECTRUM, V42, P10, DOI 10.1109/MSPEC.2005.1502520; Kim H, 2008, 2008 IEEE INTERNATIONAL CONFERENCE ON SUSTAINABLE ENERGY TECHNOLOGIES (ICSET), VOLS 1 AND 2, P1070; Kim S, 2014, INT CONF POW ELECTR, P2260; Lee JY, 2013, INT C POWER ELECT DR, P286; Pinto JG, 2014, IEEE T VEH TECHNOL, V63, P1104, DOI 10.1109/TVT.2013.2283531; Uno M, 2013, IEEE T IND ELECTRON, V60, P3227, DOI 10.1109/TIE.2012.2203776; Yoo KM, 2013, IEEE T IND ELECTRON, V60, P3136, DOI 10.1109/TIE.2012.2202361	28	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0046	1557-9948		IEEE T IND ELECTRON	IEEE Trans. Ind. Electron.	JUN	2015	62	6					3460	3472		10.1109/TIE.2014.2376878		13	Automation & Control Systems; Engineering, Electrical & Electronic; Instruments & Instrumentation	Automation & Control Systems; Engineering; Instruments & Instrumentation	CI0UJ	WOS:000354453600014		
J	Tang, ZY; Wang, ZR; Li, P; Guo, S; Liao, XF; Jin, H				Tang, Zaiyang; Wang, Zirui; Li, Peng; Guo, Song; Liao, Xiaofei; Jin, Hai			An Application Layer Protocol for Energy-Efficient Bandwidth Aggregation with Guaranteed Quality-of-Experience	IEEE TRANSACTIONS ON PARALLEL AND DISTRIBUTED SYSTEMS			English	Article						Application layer protocol; bandwidth aggregation; quality-of-experience; energy efficiency	HETEROGENEOUS WIRELESS NETWORKS	WiFi and cellular networks are pervasively provided for mobile Internet access. Although most existing mobile devices are equipped with both WiFi and cellular network interfaces, concurrent data transmissions over these interfaces for improved throughput are not provided. In this paper, a bandwidth aggregation prototype, named Application Layer Protocol based Aggregation (ALP-A), is developed for easy use by simply installing an application in mobile devices without modifying their operating systems or drivers. It provides desired quality-of-experience (QoE), i.e., acceptable response delay to users, learned from application characteristics and users behaviors. Furthermore, we propose an online algorithm of traffic scheduling over WiFi and cellular interfaces with the objective of minimizing energy consumption while guaranteeing the QoE. Over the prototype implemented on Andriod-based smartphones, we conduct extensive experiments to show that ALP-A outperforms existing schemes significantly.	[Tang, Zaiyang; Wang, Zirui; Liao, Xiaofei; Jin, Hai] Huazhong Univ Sci & Technol, Sch Comp Sci & Technol, Serv Comp Technol & Syst Lab, Cluster & Grid Comp Lab, Wuhan 430074, Hubei, Peoples R China; [Li, Peng; Guo, Song] Univ Aizu, Sch Comp Sci & Engn, Aizu Wakamatsu, Fukushima, Japan	Tang, ZY (reprint author), Huazhong Univ Sci & Technol, Sch Comp Sci & Technol, Serv Comp Technol & Syst Lab, Cluster & Grid Comp Lab, Wuhan 430074, Hubei, Peoples R China.	tangzaiyang@hust.edu.cn; m201172464@hust.edu.cn; pengli@u-aizu.ac.jp; sguo@u-aizu.ac.jp; xfliao@hust.edu.cn; hjin@hust.edu.cn			China National Natural Science Foundation [61272408, 61322210]; National High-Tech Research and Development Program of China (863 Program) [2012AA010905]; Ministry of Education of China [20130142110048]	This paper was partially supported by China National Natural Science Foundation under Grant No. 61272408, 61322210, National High-Tech Research and Development Program of China (863 Program) under Grant No. 2012AA010905, and the Doctoral Fund of Ministry of Education of China under Grant No. 20130142110048.	Adhari H., 2012, SCTP SOCKET IN PRESS; Allcock W., 2003, GLOB GRID FORUMGFD R, V20, P1; Allman Mark, 1996, P 1 INT WORKSH SAT B, P1; Ziouva E, 2002, COMPUT COMMUN, V25, P313, DOI 10.1016/S0140-3664(01)00369-3; Iyengar JR, 2006, IEEE ACM T NETWORK, V14, P951, DOI [10.1109/TNET.2006.882843, 10.1109/TNET.2006.882943]; Yousaf M, 2012, WIRELESS PERS COMMUN, V66, P57, DOI 10.1007/s11277-011-0326-3; Chen SY, 2013, 2013 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE (WCNC), P1291; [Anonymous], 2006, 3GPPTR37804; Hsieh HY, 2005, WIREL NETW, V11, P99, DOI 10.1007/s11276-004-4749-6; Liu X, 2003, COMPUT NETW, V41, P451, DOI 10.1016/S1389-1286(02)00401-2; Chebrolu K, 2006, IEEE T MOBILE COMPUT, V5, P388, DOI 10.1109/TMC.2006.1599407; Balasubramanian N, 2009, IMC'09: PROCEEDINGS OF THE 2009 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P280; Ramaboli AL, 2012, J NETW COMPUT APPL, V35, P1674, DOI 10.1016/j.jnca.2012.05.015; Chebrolu K, 2005, WIREL NETW, V11, P637, DOI 10.1007/s11276-005-3518-5; Koudouridis GP, 2005, IEEE VTS VEH TECHNOL, P235; Bazzi A., 2008, EURASIP J ADV SIG PR, V2008, P1, DOI 10.1155/2008/763264; Bellavista P, 2012, ACM COMPUT SURV, V44, DOI 10.1145/2333112.2333119; Chowdhury MZ, 2009, 11TH INTERNATIONAL CONFERENCE ON ADVANCED COMMUNICATION TECHNOLOGY, VOLS I-III, PROCEEDINGS,, P795; Evensen K., 2011, P 2 ANN ACM C MULT S, P57, DOI 10.1145/1943552.1943560; Ford A., 2011, INTERNET ENG TASK FO, V6182, P2070; Harjula E., 2009, P IEEE CONS COMM NET, P280; Hsieh HY, 2004, MOBILE NETW APPL, V9, P363, DOI 10.1023/B:MONE.0000031604.71054.b3; Huang Junxian, 2012, P 10 INT C MOB SYST, P225, DOI DOI 10.1145/2307636.2307658; Kaspar D., 2010, P IEEE ICC, P1; Koudouridis G. P., 2005, P WIR WORLD RES FOR, P1; Mahkoum H., 2009, P IEEE WCNC 2009, P1; Miu A., 2003, P IEEE INT C MULT EX, P441; Paasch C., 2012, P ACM SIGCOMM WORKSH, P31; Sachs J., 2003, P IEEE INT C COMM, V2, P834; Sivakumar Harimath, 2000, P 2000 ACM IEEE C SU, V2000, P1; Zhang Yansheng, 2009, Proceedings of the 2009 9th International Conference on Electronic Measurement & Instruments (ICEMI 2009), DOI [10.1109/ICEMI.2009.5274852, 10.1109/ICEMI.2009.5274829]	31	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1045-9219	1558-2183		IEEE T PARALL DISTR	IEEE Trans. Parallel Distrib. Syst.	JUN	2015	26	6					1538	1546		10.1109/TPDS.2014.2328586		9	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CI1SY	WOS:000354526000004		
J	Carapito, R; Shahram, F; Michel, S; Le Gentil, M; Radosavljevic, M; Meguro, A; Abdollahi, BS; Inoko, H; Ota, M; Davatchi, F; Bahram, S				Carapito, Raphael; Shahram, Farhad; Michel, Sandra; Le Gentil, Marion; Radosavljevic, Mirjana; Meguro, Akira; Abdollahi, Bahar Sadeghi; Inoko, Hidetoshi; Ota, Masao; Davatchi, Fereydoun; Bahram, Seiamak			On the genetics of the Silk Route: association analysis of HLA, IL10, and IL23R-IL12RB2 regions with Behcet's disease in an Iranian population	IMMUNOGENETICS			English	Article						Behcet'sdisease; Silk Route; Iranian population; HLA; IL10; IL23R-IL12RB2	GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; MHC	Despite that the association of Behcet's disease (BD) with the HLA-B5 was first established in the 1970s, a number of recent genome-wide association studies have both confirmed and furthered this association-in various populations-to individual SNPs both inside and outside the HLA. The former include HLA-B, MICA, and HLA-A, while the latter encompass IL10 and IL23R-IL12RB2 regions. The present study examined whether some of these SNPs could be replicated in an Iranian population, where the prevalence of disease is amply documented. Eight SNPs were selected and tested in 552 patients and 417 controls. These were rs7539328, rs12119179, rs1495965, rs1518111, and rs1800871 in IL10 and IL23R-IL12RB2 regions and rs114854070, rs12525170, and rs76546355 (formerly rs116799036) in the HLA locus. The well-known BD-associated genes HLA-B and MICA were independently genotyped. Although we were not able to formally replicate the association with IL10 and IL23R-IL12RB2, we do report that BD in Iran is strongly associated with HLA-B*51, MICA-A6, and the three HLA-linked SNPs (odds ratio (OR)=3.38, P=6.21x 10(-14); OR=2.08, P=1.58x10(-13); and OR=1.67-4.05, P=1.45x10(-04) to 4.79x10(-34), respectively). Our data further indicate that the robust HLA-B/MICA association may be explained by a single variant (rs76546355) between the two genes. Overall, these data contribute to a better appraisal of the intriguing linkage between BD and the ancient Silk Route, spanning from the Mediterranean shores to Japan.	[Carapito, Raphael; Michel, Sandra; Le Gentil, Marion; Radosavljevic, Mirjana; Bahram, Seiamak] Univ Strasbourg, Plateforme GENOMAX,Lab ImmunoRhumatol Mol, LabEx TRANSPLANTEX,Ctr Rech Immunol & Hematol, Fac Med,INSERM,UMR S1109, Strasbourg, France; [Carapito, Raphael; Michel, Sandra; Le Gentil, Marion; Radosavljevic, Mirjana; Inoko, Hidetoshi; Ota, Masao; Bahram, Seiamak] INSERM, Franco Japanese Nextgen HLA Lab FJ HLA, LIA, Strasbourg, France; [Carapito, Raphael; Michel, Sandra; Le Gentil, Marion; Radosavljevic, Mirjana; Inoko, Hidetoshi; Ota, Masao; Bahram, Seiamak] INSERM, Franco Japanese Nextgen HLA Lab FJ HLA, LIA, Nagano, Japan; [Shahram, Farhad; Abdollahi, Bahar Sadeghi; Davatchi, Fereydoun] Univ Tehran Med Sci, Shariati Hosp, Behcets Dis Unit, Rheumatol Res Ctr, Tehran 14114, Iran; [Meguro, Akira] Yokohama City Univ, Sch Med, Dept Ophthalmol, Yokohama, Kanagawa 232, Japan; [Inoko, Hidetoshi] Tokai Univ, Sch Med, Dept Mol Life Sci, Div Mol Med Sci & Mol Med, Isehara, Kanagawa 25911, Japan; [Ota, Masao] Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 390, Japan; [Carapito, Raphael; Michel, Sandra; Le Gentil, Marion; Radosavljevic, Mirjana; Bahram, Seiamak] Univ Strasbourg, Ctr Rech Immunol & Hematol, Fac Med, FMTS, F-67085 Strasbourg, France	Carapito, R (reprint author), Univ Strasbourg, Plateforme GENOMAX,Lab ImmunoRhumatol Mol, LabEx TRANSPLANTEX,Ctr Rech Immunol & Hematol, Fac Med,INSERM,UMR S1109, Strasbourg, France.	carapito@unistra.fr; siamak@unistra.fr			Rheumatology Research Center (Tehran University of Medical Sciences); French association for Behcet's disease; Strasbourg High Throughput Next Generation Sequencing facility (GENOMAX); INSERM [UMR_S 1109]; Partenariat Hubert Curien GUNDISHAPUR by the ministeres des Affaires etrangeres et du developpement international (MAEDI); Enseignement superieur et de la Recherche (MESR); INSERM Franco-Japanese Nextgen HLA laboratory (FJ-HLA); Laboratoire International Associe (LIA); Institut Universitaire de France (IUF)	This study was supported by the Rheumatology Research Center (Tehran University of Medical Sciences), the French association for Behcet's disease, the Strasbourg High Throughput Next Generation Sequencing facility (GENOMAX), INSERM UMR_S 1109 and Partenariat Hubert Curien GUNDISHAPUR by the ministeres des Affaires etrangeres et du developpement international (MAEDI) and Enseignement superieur et de la Recherche (MESR), the INSERM Franco-Japanese Nextgen HLA laboratory (FJ-HLA), Laboratoire International Associe (LIA), and the Institut Universitaire de France (IUF).	Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Gul A, 2000, ANN RHEUM DIS, V59, P622, DOI 10.1136/ard.59.8.622; Mizuki N, 1997, P NATL ACAD SCI USA, V94, P1298, DOI 10.1073/pnas.94.4.1298; Hughes T, 2013, NAT GENET, V45, P319, DOI 10.1038/ng.2551; Meguro A, 2010, ANN RHEUM DIS, V69, P747, DOI 10.1136/ard.2009.108571; Davatchi F, 2010, INT J RHEUM DIS, V13, P367, DOI 10.1111/j.1756-185X.2010.01549.x; Zouboulis CC, 1999, ANN MED INTERNE, V150, P488; Xavier JM, 2012, ARTHRITIS RHEUM-US, V64, P2761, DOI 10.1002/art.34437; Behcet H, 2010, CLIN EXP RHEUMATOL, V28, pS2; Davatchi F, 2008, ARCH IRAN MED, V11, P207, DOI 08112/AIM.0016; HAYASAKA S, 1994, GRAEF ARCH CLIN EXP, V232, P589, DOI 10.1007/BF00193118; HEIN J, 1995, TISSUE ANTIGENS, V45, P27, DOI 10.1111/j.1399-0039.1995.tb02411.x; INTERNATIONAL TEAM FOR THE REVISION OF THE INTERNATIONAL CRITERIA FOR BEHCET'S D, 2014, J EUR ACAD DERMATOL, V28, P338; Kauz R, 2010, ASPECTS MARITIME SIL; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; OHNO S, 1978, JAMA-J AM MED ASSOC, V240, P529	17	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0093-7711	1432-1211		IMMUNOGENETICS	Immunogenetics	JUN	2015	67	5-6					289	293		10.1007/s00251-015-0841-6		5	Genetics & Heredity; Immunology	Genetics & Heredity; Immunology	CI4MO	WOS:000354723900004		
J	Sawamura, Y; Kishida, K; Kimura, M				Sawamura, Yasuo; Kishida, Kiyoshi; Kimura, Makoto			Centrifuge Model Test and FEM Analysis of Dynamic Interactive Behavior between Embankments and Installed Culverts in Multiarch Culvert Embankments	INTERNATIONAL JOURNAL OF GEOMECHANICS			English	Article						Centrifuge models; Finite element method; Soil-structure interactions; Embankments; Culverts; Centrifuge model test; Finite-element method (FEM) analysis; Dynamic interaction between soil and structure; Embankment; Precast arch culvert	PILE FOUNDATION; CONCRETE	A multiarch culvert embankment is a new type of filling structure for which several precast arch culverts are installed continuously in the direction of the road extension. The key points in the design are to estimate the practical, optimal spacing between installed arch culverts and to clarify the interactive seismic behavior of the filling material and the culvert structure. In the current study, first, dynamic centrifuge model tests and a numerical analysis were carried out to clarify the basal earthquake behavior of the structure and verify the numerical approach. Then, the full-scale numerical analysis was performed to investigate the influence of spacing between multiarch culverts and the mechanical behavior under seismic conditions. From the results, it is confirmed that when the unit spacing is narrow, the whole rigidity of the ground and the arch culvert increases relatively. This is because the volume in the fill part, where the rigidity is small, decreases comparatively. Hence, the section force and the deformation are controlled.	[Sawamura, Yasuo; Kimura, Makoto] Kyoto Univ, Dept Civil & Earth Resources Engn, Nishikyo Ku, Kyoto 6158540, Japan; [Kishida, Kiyoshi] Kyoto Univ, Dept Urban Management, Nishikyo Ku, Kyoto 6158540, Japan	Sawamura, Y (reprint author), Kyoto Univ, Dept Civil & Earth Resources Engn, Nishikyo Ku, C1 Kyoto Daigaku Katsura, Kyoto 6158540, Japan.	sawamura.yasuo.34a@st.kyoto-u.ac.jp					Adachi T., 2001, P REG C GEOT ASP UND, P151; Danno K, 2009, SOILS FOUND, V49, P941, DOI 10.3208/sandf.49.941; Brennan AJ, 2005, J GEOTECH GEOENVIRON, V131, P1488, DOI 10.1061/(ASCE)1090-0241(2005)131:12(1488); Nakai T, 2004, SOILS FOUND, V44, P53; Arai T., 2011, P 24 KKCNN S CIV ENG, P353; Byrne P. M., 1996, 1541 TRANSP RES BOAR, V1541, P133; Cui Y., 2010, P GEOSHANGHAI 2010 D, P307; Hwang J. H., 2007, P 20 KKCNN S CIV ENG, P346; Hwang J. H., 2006, TUNN UNDERGR SP TECH, V21, P22; Kimura M., 2000, SOILS FOUND, V40, P113; LAI SS, 1984, J STRUCT ENG-ASCE, V110, P2563; Li K. N., 1999, ANN M HIR ST 2, P573; Murakami Y., 2008, JSCE J, V64, P282; Wood J. H., 2000, P 12 WORLD C EARTHQ; Xia Zhi-fan, 2010, Journal of Shanghai Jiaotong University (English Edition), V15, DOI 10.1007/s12204-010-1003-5; Ye B, 2007, SOILS FOUND, V47, P547, DOI 10.3208/sandf.47.547; Zhang F, 2002, SOILS FOUND, V42, P77; Zhang F., 2010, P 9 WORLD C COMP MEC, V10; Zoghi M, 2006, J PERFORM CONSTR FAC, V20, P244, DOI 10.1061/(ASCE)0887-3828(2006)20:3(244)	19	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1532-3641	1943-5622		INT J GEOMECH	Int. J. Geomech.	JUN	2015	15	3							04014050	10.1061/(ASCE)GM.1943-5622.0000361		12	Engineering, Geological	Engineering	CI1YX	WOS:000354542300002		
J	Chang, WL; Zeng, DZ; Chen, RC; Guo, S				Chang, Wei-Lun; Zeng, Deze; Chen, Rung-Ching; Guo, Song			An artificial bee colony algorithm for data collection path planning in sparse wireless sensor networks	INTERNATIONAL JOURNAL OF MACHINE LEARNING AND CYBERNETICS			English	Article						Sparse wireless sensor network; Artificial bee colony algorithm; Traveling salesman problem with neighborhoods	TRAVELING-SALESMAN PROBLEM; APPROXIMATION ALGORITHMS; TSP; NEIGHBORHOODS	In sparse wireless sensor networks, a mobile robot is usually exploited to collect the sensing data. Each sensor has a limited transmission range and the mobile robot must get into the coverage of each sensor node to obtain the sensing data. To minimize the energy consumption on the traveling of the mobile robot, it is significant to plan a data collection path with the minimum length to complete the data collection task. In this paper, we observe that this problem can be formulated as traveling salesman problem with neighborhoods, which is known to be NP-hard. To address this problem, we apply the concept of artificial bee colony (ABC) and design an ABC-based path planning algorithm. Simulation results validate the correctness and high efficiency of our proposal.	[Chang, Wei-Lun; Zeng, Deze; Guo, Song] Univ Aizu, Sch Comp Sci & Engn, Aizu Wakamatsu, Fukushima, Japan; [Chang, Wei-Lun; Chen, Rung-Ching] Choayang Univ Technol, Dept Informat Management, Taichung, Taiwan	Guo, S (reprint author), Univ Aizu, Sch Comp Sci & Engn, Aizu Wakamatsu, Fukushima, Japan.	m5162105@u-aizu.ac.jp; d8112106@u-aizu.ac.jp; crching@cyut.edu.tw; sguo@u-aizu.ac.jp					LIN S, 1973, OPER RES, V21, P498, DOI 10.1287/opre.21.2.498; LITTLE JDC, 1963, OPER RES, V11, P972, DOI 10.1287/opre.11.6.972; Karaboga D, 2008, APPL SOFT COMPUT, V8, P687, DOI 10.1016/j.asoc.2007.05.007; Gao WF, 2012, COMPUT OPER RES, V39, P687, DOI 10.1016/j.cor.2011.06.007; Chiu KM, 2011, 2011 IEEE WORKSHOP ON MERGING FIELDS OF COMPUTATIONAL INTELLIGENCE AND SENSOR TECHNOLOGY (COMPSENS), P42; Gentilini I, 2013, OPTIM METHOD SOFTW, V28, P364, DOI 10.1080/10556788.2011.648932; de Berg M, 2005, J ALGORITHMS, V57, P22, DOI 10.1016/j.jalgor.2005.01.010; Safra S, 2006, COMPUT COMPLEX, V14, P281, DOI 10.1007/s00037-005-0200-3; Elbassioni K, 2005, LECT NOTES COMPUT SC, V3580, P1115; Yuan B, 2007, IEEE T KNOWL DATA EN, V19, P1252, DOI [10.1109/TKDE.2007.1062, 10.1109/TKDE.2007.1062.]; Yick J, 2008, COMPUT NETW, V52, P2292, DOI 10.1016/j.comnet.2008.04.002; ARKIN EM, 1994, DISCRETE APPL MATH, V55, P197, DOI 10.1016/0166-218X(94)90008-6; Comarela G, 2011, P 13 ANN C COMP GEN, P599; Dorigo M., 1997, IEEE Transactions on Evolutionary Computation, V1, DOI 10.1109/4235.585892; Dorigo M, 2004, ANT COLONY OPTIMIZATION, P1, DOI 10.1007/b99492; Karakoyunlu D., 2010, P IEEE INT WORKSH IN, P1, DOI 10.1109/NEBC.2010.5458173; Li L, 2011, P 7 INT C INT COMP B, P566, DOI [10.1007/978-3-642-24553-4_75, DOI 10.1007/978-3-642-24553-4_75]; Papadimitriou C, 1997, EUCLIDEAN TRAVELING, V4, P237; Tekdas O, 2009, COMPUT NETW, V16, P22	19	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1868-8071	1868-808X		INT J MACH LEARN CYB	Int. J. Mach. Learn. Cybern.	JUN	2015	6	3					375	383		10.1007/s13042-013-0195-z		9	Computer Science, Artificial Intelligence	Computer Science	CH9YB	WOS:000354391500003		
J	Lukac, M; Kameyama, M				Lukac, Martin; Kameyama, Michitaka			An algorithm selection based platform for image understanding using high-level symbolic feedback and machine learning	INTERNATIONAL JOURNAL OF MACHINE LEARNING AND CYBERNETICS			English	Article						Image processing; Contour extraction; Algorithm selection; Bayesian networks	OBJECT RECOGNITION; SEGMENTATION; VISION; MODELS; SCENE	Natural image processing and understanding encompasses hundreds of different algorithms. Each algorithm generates best results for a particular set of input features and configurations of the objects/regions in the input image (environment). To obtain the best possible result of processing in a reliable manner, we propose an algorithm selection approach that selects the best algorithm for a each input image. The proposed algorithm selection starts by first selecting an algorithm using low level features such as color intensity, histograms, spectral coefficients or so and a user given context if available. The resulting high-level image description is analyzed for logical inconsistencies (contradictions) and image regions that must be processed using a different algorithm are selected. The high-level description and the optional user-given context are used by a Bayesian Network to estimate the cause of the error in the processing. The same Bayesian Network also generates new candidate algorithm for each region containing the contradiction in an iterative manner. This iterative selection stops when the high-level inconsistencies are all resolved or no more different algorithms can be selected. We also show that when inconsistencies can be detected, our framework is able to improve high-level description when compared with single algorithms. In order for such complex and iterative processing being computationally tractable we also introduce a hardware platform based on reconfigurable VLSI that is well suited as the platform of the proposed approach. We show that the algorithm selected approach is ideally suited for either a hybrid type VLSI processor or for a Logic-In-Memory processing platform.	[Lukac, Martin; Kameyama, Michitaka] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan	Lukac, M (reprint author), Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan.	lukacm@ecei.tohoku.ac.jp; kameyama@ecei.tohoku.ac.jp					Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; Kosecka J, 2005, COMPUT VIS IMAGE UND, V100, P274, DOI 10.1016/j.cviu.2005.04.005; BROOKS RA, 1981, ARTIF INTELL, V17, P285, DOI 10.1016/0004-3702(81)90028-X; Bao SY, 2011, IMAGE VISION COMPUT, V29, P569, DOI 10.1016/j.imavis.2011.08.001; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888; Carreira J, 2012, INT J COMPUT VISION, V98, P243, DOI 10.1007/s11263-011-0507-2; Arbelaez P, 2011, IEEE T PATTERN ANAL, V33, P898, DOI 10.1109/TPAMI.2010.161; Neumann B, 2008, IMAGE VISION COMPUT, V26, P82, DOI 10.1016/j.imavis.2007.08.013; Krivic J, 2004, COMPUT VIS IMAGE UND, V95, P105, DOI 10.1016/j.cviu.2003.11.002; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Arbelaez P, 2012, INT C COMP VIS PATT; Boykov Y, 1998, INT C COMP VIS PATT; Brox T, 2011, IEEE INT C COMP VIS; Chau CP, 2004, COMPUT VIS IMAGE UND, V96, P1, DOI 10.1016/j.cviu.2004.04.005; Datta M, 2012, INT J COMPUT VISION, V116; Donoser M, 2009, P INT C COMP VIS; Donoser M, 2007, P C COMPVIS PATT REC; Felzenszwalb Pedro F., 2010, IEEE T PATTERN ANAL, V32; Ferryman J, 2005, P 18 AUSTR JOINT C A; Heitz G, 2008, NEURAL INFORM PROCES; Hoiem D, 2008, P COMP VIS PATT REC; Hotz L, 2005, SCENE INTERPRETATION; Ion A, 2011, 25 C NEUR INF PROC S; Kembhavi A, 2010, LECT NOTES COMPUT SC, V6312, P693, DOI 10.1007/978-3-642-15552-9_50; Kolmogorov V, 2007, P INT C COMP VIS; Ladicky L, 2010, P 11 EUR C COMP VIS; Lam CP, 1997, COMPUT VIS IMAGE UND, V68, P209, DOI 10.1006/cviu.1997.0554; Leibe B, 2008, INT J COMPUT VISION, V77, P259, DOI 10.1007/s11263-007-0095-3; Li L-J, 2009, COMPUTER VISION PATT; Lukac M., 2013, IADIS TPMC; Lukac M., 2012, INTERDISCIP INF SCI, V18, P123, DOI DOI 10.4036/iis.2012.123; Lukac M., 2011, FACTA U, V24, P403; Lukac M, 2013, SPIE INT ROBOTS COMP; Maire M, 2008, C VIS PATT REC; Malik J, 1999, INT C COMP VIS; Martin M., 2001, P 8 INT C COMP VIS J, V2, P416; MATSUYAMA T, 1987, IEEE T GEOSCI REMOTE, V25, P305, DOI 10.1109/TGRS.1987.289802; Olson D. L., 2008, ADV DATA MINING TECH; Peng B, 2008, P BRIT C COMP VIS 20; Perera AGA, 2006, C COMP VIS PATT REC; Price B, 2010, P INT C COMP VIS PAT; Rice J, 1976, ADV COMPUT, V15, P65118; Takemoto S, 2009, 9 INT C INT SYST DES; Yong X., 2003, P PAN SYDN AR WORKSH	44	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1868-8071	1868-808X		INT J MACH LEARN CYB	Int. J. Mach. Learn. Cybern.	JUN	2015	6	3					417	434		10.1007/s13042-013-0197-x		18	Computer Science, Artificial Intelligence	Computer Science	CH9YB	WOS:000354391500007		
J	Mansour, MH; Kawahara, A; Sadatomi, M				Mansour, Mohamed H.; Kawahara, Akimaro; Sadatomi, Michio			Experimental investigation of gas-non-Newtonian liquid two-phase flows from T-junction mixer in rectangular microchannel	INTERNATIONAL JOURNAL OF MULTIPHASE FLOW			English	Article						Gas-liquid two-phase flow; Microchannel; Non-Newtonian fluid; Void fraction; Pressure drop	AIR-WATER; BUBBLES; BEHAVIOR; PATTERN; TUBES; PIPE	In this study, gas-non Newtonian liquid two-phase flows in a horizontal rectangular microchannel have been investigated. The rectangular microchannel has a hydraulic diameter of 0.235 mm, and a width and depth of 0.24 mm and 0.23 mm, respectively. A T-junction-type gas-liquid mixer was used to introduce gas and liquid in the channel. Polyacrylamide aqueous solutions with different mass concentration, which exhibits pseudo plastic with viscoelasticity, were used as non-Newtonian liquids, while the nitrogen gas was used as the test gas. The flow pattern, the bubble length, the liquid slug length, the bubble velocity and frictional pressure drop in two-phase flow were measured. Each experimental data are compared to those for nitrogen gas-water two-phase flow. From the comparison, rheological properties of polyacrylamide solutions are found to significantly affect flow parameters measured. In addition, two-phase frictional pressure drop could be correlated by using Lockhart-Martinelli method with a newly developed two-phase friction multiplier as function of void fraction and rheological flow index. (C) 2015 Elsevier Ltd. All rights reserved.	[Mansour, Mohamed H.] Mansoura Univ, Dept Power Mech Engn, Mansoura, Egypt; [Kawahara, Akimaro; Sadatomi, Michio] Kumamoto Univ, Dept Mech Syst Engn, Chuo Ku, Kumamoto 8608555, Japan	Kawahara, A (reprint author), Kumamoto Univ, Dept Mech Syst Engn, Chuo Ku, Kurokami 2-39-1, Kumamoto 8608555, Japan.	akimaro@mech.kumamoto-u.ac.jp			Egyptian Government; KAKENHI [26420118]	The authors wish to express their gratitude to Mr. W. Z. Law and Mr. S. Kawazoe for his cooperation in this experiment. The authors are grateful to the Egyptian Government for sponsoring M. H. Mansour. The present study was partially supported by KAKENHI (26420118).	Agostini B, 2008, INT J MULTIPHAS FLOW, V34, P590, DOI 10.1016/j.ijmultiphaseflow.2007.07.007; Ali M. I., 1994, CAN J CHEM ENG, V71, P1411; Fu TT, 2011, MICROFLUID NANOFLUID, V10, P1135, DOI 10.1007/s10404-010-0741-x; Garstecki P, 2006, LAB CHIP, V6, P437, DOI 10.1039/b510841a; KOZICKI W, 1966, CHEM ENG SCI, V21, P665, DOI 10.1016/0009-2509(66)80016-7; Kawahara A, 2009, INT J HEAT FLUID FL, V30, P831, DOI 10.1016/j.ijheatfluidflow.2009.02.017; Kawahara A, 2002, INT J MULTIPHAS FLOW, V28, P1411, DOI 10.1016/S0301-9322(02)00037-X; LOCKHART RW, 1949, CHEM ENG PROG, V45, P39; Fu TT, 2011, CHEM ENG PROCESS, V50, P438, DOI 10.1016/j.cep.2011.03.002; Yang CY, 2001, INT J MULTIPHAS FLOW, V27, P1163, DOI 10.1016/S0301-9322(00)00070-7; Armand A.A., 1946, IZV VSESOYUZNOGO TEP, V1, P16; BOGER DV, 1977, RHEOL ACTA, V16, P322, DOI 10.1007/BF01523743; Bohm L, 2014, INT J MULTIPHAS FLOW, V65, P11, DOI 10.1016/j.ijmultiphaseflow.2014.05.001; Butterworth D., 1975, International Journal of Multiphase Flow, V1, DOI 10.1016/0301-9322(75)90038-5; CHHABRA RP, 1984, CHEM ENG RES DES, V62, P22; Chisholm D., 1983, 2 PHASE FLOW PIPELIN; FAROOQI SI, 1982, T I CHEM ENG-LOND, V60, P292; FAROOQI SI, 1980, T I CHEM ENG-LOND, V58, P116; Kawahara A., 2005, P 3 INT C MICR MIN; Kawahara Akimaro, 2012, Multiphase Science and Technology, V24; Kawahara A, 2011, HEAT TRANSFER ENG, V32, P585, DOI 10.1080/01457632.2010.509752; Mahjoob M. R., 2009, IRAN J CHEM ENG, V6, P44; Mishima K, 1996, INT J MULTIPHAS FLOW, V22, P703, DOI 10.1016/0301-9322(96)00010-9; Santos R. M., 2011, CENT EUR J ENG, V36, P314; Santos R. M., 2010, INT J MULTIPHAS FLOW, V1, P341; Shah RK, 1978, LAMINAR FLOW FORCED; Sousa G. R., 2004, J FLUID MECH, V511, P217; Sousa RG, 2006, J NON-NEWTON FLUID, V135, P16, DOI 10.1016/j.jnnfm.2005.12.007; van Steijn V, 2007, CHEM ENG SCI, V62, P7505, DOI 10.1016/j.ces.2007.08.068; Tang GH, 2012, J NON-NEWTON FLUID, V173, P21, DOI 10.1016/j.jnnfm.2012.02.001; van Steijn V, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.214501; Yang ZC, 2010, INT J MULTIPHAS FLOW, V36, P60, DOI 10.1016/j.ijmultiphaseflow.2009.07.011; Zuber N., 1965, T ASME, V87, P453	33	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0301-9322	1879-3533		INT J MULTIPHAS FLOW	Int. J. Multiph. Flow	JUN	2015	72						263	274		10.1016/j.ijmultiphaseflow.2015.02.019		12	Mechanics	Mechanics	CI2NO	WOS:000354584500023		
J	Arima, T; Ruggeri, T; Sugiyama, M; Taniguchi, S				Arima, Takashi; Ruggeri, Tommaso; Sugiyama, Masaru; Taniguchi, Shigeru			Non-linear extended thermodynamics of real gases with 6 fields	INTERNATIONAL JOURNAL OF NON-LINEAR MECHANICS			English	Article						Extended thermodynamics; Non-equilibrium thermodynamics of gases; Meixner's theory; Dynamic pressure	RAREFIED POLYATOMIC GASES; VANISHING SHEAR VISCOSITY; INTERNAL VARIABLES; ENTROPY PRINCIPLE; COMPRESSIBLE FLUIDS; NONEQUILIBRIUM; TEMPERATURE; EQUATIONS; STATE	We establish extended thermodynamics (ET) of real gases with 6 independent fields, i.e., the mass density, the velocity, the temperature and the dynamic pressure, without adopting the near-equilibrium approximation. We prove its compatibility with the universal principles (the entropy principle, the Galilean invariance and the stability), and obtain the symmetric hyperbolic system with respect to the main field. In near-equilibrium we recover the previous results. The correspondence between the ET 6-field theory and Meixner's theory of relaxation processes is discovered. The internal variable and the non-equilibrium temperature in Meixner's theory are expressed in terms of the quantities of the ET 6-field theory, in particular, the dynamic pressure. As an example, we present the cases of a rarefied polyatomic gas and study the monatomic-gas limit where the system converges to the Euler system of a perfect fluid. (C) 2015 Elsevier Ltd. All rights reserved.	[Arima, Takashi] Kanagawa Univ, Fac Engn, Dept Mech Engn, Yokohama, Kanagawa 2218686, Japan; [Ruggeri, Tommaso] Univ Bologna, Dept Math, Bologna, Italy; [Sugiyama, Masaru] Nagoya Inst Technol, Grad Sch Engn, Nagoya, Aichi 4668555, Japan; [Taniguchi, Shigeru] Kitakyushu Natl Coll Technol, Dept Control & Informat Syst Engn, Kitakyushu, Fukuoka 8020985, Japan	Ruggeri, T (reprint author), Univ Bologna, Dept Math, Bologna, Italy.	arima@kanagawa-u.ac.jp; tommaso.ruggeri@unibo.it; sugiyama@nitech.ac.jp; taniguchi.shigeru@kct.ac.jp		Ruggeri, Tommaso/0000-0002-7588-2074	Japan Society of Promotion of Science (JSPS) [24760055, 25390150]; National Group of Mathematical Physics GNFM-INdAM; University of Bologna FARB Project Extended Thermodynamics of Non-Equilibrium Processes from Macro- to Nano-Scale	This work was partially supported by Japan Society of Promotion of Science (JSPS) No. 24760055 (S.T.) and No. 25390150 (M.S.) and by National Group of Mathematical Physics GNFM-INdAM and by University of Bologna: FARB 2012 Project Extended Thermodynamics of Non-Equilibrium Processes from Macro- to Nano-Scale (T.R.).	Arima T, 2014, ANN PHYS-NEW YORK, V345, P111, DOI 10.1016/j.aop.2014.03.011; Taniguchi S, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.013025; Arima T, 2013, PHYS LETT A, V377, P2136, DOI 10.1016/j.physleta.2013.06.035; Boillat G, 1997, ARCH RATION MECH AN, V137, P305, DOI 10.1007/s002050050030; Arima T, 2013, CONTINUUM MECH THERM, V25, P727, DOI 10.1007/s00161-012-0271-8; Pavic M, 2013, PHYSICA A, V392, P1302, DOI 10.1016/j.physa.2012.12.006; Arima T, 2014, MECCANICA, V49, P2181, DOI 10.1007/s11012-014-9886-0; MAUGIN GA, 1994, J NON-EQUIL THERMODY, V19, P217, DOI 10.1515/jnet.1994.19.3.217; IKENBERRY E, 1956, J RATION MECH ANAL, V5, P1; Arima T, 2012, CONTINUUM MECH THERM, V24, P271, DOI 10.1007/s00161-011-0213-x; Taniguchi S, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4861368; LIU IS, 1972, ARCH RATION MECH AN, V46, P131; Shelukhin V, 2000, J DIFFER EQUATIONS, V167, P73, DOI 10.1006/jdeq.2000.3773; Casas-Vazquez J, 2003, REP PROG PHYS, V66, P1937, DOI 10.1088/0034-4885/66/11/R03; Van P, 2008, J NON-EQUIL THERMODY, V33, P235, DOI 10.1515/JNETDY.2008.010; Frid H, 2000, SIAM J MATH ANAL, V31, P1144, DOI 10.1137/S003614109834394X; Arima T, 2012, PHYS LETT A, V376, P2799, DOI 10.1016/j.physleta.2012.08.030; Cimmelli VA, 2014, ENTROPY-SWITZ, V16, P1756, DOI 10.3390/e16031756; Arima T., 2013, P 34 S ULTR EL, V4, P15; Arima T, 2014, ACTA APPL MATH, V132, P15, DOI 10.1007/s10440-014-9888-x; Barbera E, 1999, MECCANICA, V34, P103, DOI 10.1023/A:1004503318075; BOILLAT G, 1974, CR ACAD SCI A MATH, V278, P909; CASASVAZQUEZ J, 1994, PHYS REV E, V49, P1040, DOI 10.1103/PhysRevE.49.1040; Chapman S., 1970, MATH THEORY NONUNIFO; de Groot S.R, 1984, NONEQUILIBRIUM THERM; Godunov S., 1961, SOV MATH, V2, P947; GORDON RG, 1968, ANNU REV PHYS CHEM, V19, P215, DOI 10.1146/annurev.pc.19.100168.001243; Grad H., 1949, PURE APPL MATH, V2, P331; COLEMAN BD, 1967, J CHEM PHYS, V47, P597, DOI 10.1063/1.1711937; Leontovich M.A., 1983, INTRO THERMODYNAMICS; MAUGIN GA, 1994, J NON-EQUIL THERMODY, V19, P250, DOI 10.1515/jnet.1994.19.3.250; Meixner J., 1943, Annalen der Physik, V43; MEIXNER J, 1952, ACUSTICA, V2, P101; Muller I., 1998, RATIONAL EXTENDED TH; Nagnibeda E, 2009, HEAT MASS TRANSF, P1; Pennisi S., 2006, RIC MAT, V55, P159, DOI 10.1007/s11587-006-0019-5; Pottier N., 2010, NONEQUILIBRIUM STAT; Ruggeri T, 2014, ACTA APPL MATH, V132, P527, DOI 10.1007/s10440-014-9923-y; Ruggeri T., 1981, Annales de l'Institut Henri Poincare, Section A (Physique Theorique), V34; Ruggeri T., 1989, Continuum Mechanics and Thermodynamics, V1, DOI 10.1007/BF01125883; Ruggeri T, 2004, Q APPL MATH, V62, P163; Secchi P., 1983, REND SEM PADOVA, V70, P73; Taniguchi S, 2014, ACTA APPL MATH, V132, P583, DOI 10.1007/s10440-014-9931-y; Vincenti W., 1965, INTRO PHYS GAS DYNAM; Zel'dovich Y. B., 2002, PHYS SHOCK WAVES HIG; Zubarev D.N., 1974, NONEQUILIBRIUM STAT	46	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7462	1878-5638		INT J NONLIN MECH	Int. J. Non-Linear Mech.	JUN	2015	72						6	15		10.1016/j.ijnonlinmec.2015.02.005		10	Mechanics	Mechanics	CI2RG	WOS:000354594100002		
J	Prieto-Granada, CN; Inagaki, H; Mueller, J				Prieto-Granada, Carlos N.; Inagaki, Hiroshi; Mueller, James			Thymic Mucoepidermoid Carcinoma: Report of a Case With CTRC1/3-MALM2 Molecular Studies	INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY			English	Article						thymic mucoepidermoid carcinoma; CRTC1-MAML2; CRTC3-MAML2; reverse transcriptase polymerase chain reaction; fluorescence in situ hybridization	CRTC3-MAML2 FUSION TRANSCRIPT; TORC1-MAML2 GENE FUSION; CLEAR-CELL HIDRADENOMA; 3RD TUMOR TYPE; WARTHINS TUMOR; CLINICOPATHOLOGICAL SIGNIFICANCE; SALIVARY-GLANDS; CRTC1-MAML2; TRANSLOCATION; REARRANGEMENT	Thymic mucoepidermoid carcinoma (TMEC) is a vanishingly rare entity that usually presents as low to intermediate grade MEC and carries a better prognosis when compared with other poorly differentiated thymic carcinomas. The recently described fusions, t(11;19)(q21;p13) CREB (cAMP response element-binding protein)-regulated transcription coactivator 1 and MAML2, mastermind-like gene 2 (CRTC1-MAML2) and t(11:15)(q21;q26) CRTC3-MAML2 characterize a considerable proportion of MEC examples arising from a variety of anatomical sites. Recent data point out that the aberrant proteins produced by this fusion drive oncogenesis by disrupting the cAMP/CREB and NOTCH1 pathways. To date, only 2 TMEC cases have been reported to have MAML2 rearrangements, a feature that was found to be absent in TMEC mimics. These findings led the authors to recommend this test as a diagnostic tool in the differential diagnosis for thymic carcinoma. Herein, we present a case of TMEC arising in a 58-year-old woman, which was predominantly cystic with intracystic papillary formations composed of a mixture of mucinous cells and intermediate/epidermoid eosinophilic cells. This case was negative for CTCR1-MAML2 and CTCR3-MAML2 fusion transcripts by reverse transcriptase polymerase chain reaction and lacked a MAML2 rearrangement by fluorescence in situ hybridization. We report a CTCR1/3-MAML2 fusion and MAML2 rearrangement-negative TMEC, indicating that a different molecular pathway must be involved in the generation of these tumors. The possibility of fusion-negative TMEC should be taken into consideration in the differential diagnosis of a thymic carcinoma.	[Prieto-Granada, Carlos N.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Inagaki, Hiroshi] Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Mueller, James] Tufts Univ, Sch Med, Baystate Med Ctr, Springfield, MA 01199 USA	Prieto-Granada, CN (reprint author), H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, 12902 USF Magnolia Dr, Tampa, FL 33612 USA.	carlos.prietogranada@moffitt.org					Amelio AL, 2014, P NATL ACAD SCI USA, V111, pE3260, DOI 10.1073/pnas.1319176111; Jee KJ, 2013, MODERN PATHOL, V26, P213, DOI 10.1038/modpathol.2012.154; STEWART FW, 1945, ANN SURG, V122, P820, DOI 10.1097/00000658-194511000-00005; Chan ES, 2013, PATHOLOGY, V45, P698, DOI 10.1097/PAT.0000000000000014; Enlund F, 2004, EXP CELL RES, V292, P21, DOI 10.1016/j.yexcr.2003.09.007; SUSTER S, 1991, CANCER, V67, P1025, DOI 10.1002/1097-0142(19910215)67:4<1025::AID-CNCR2820670427>3.0.CO;2-F; Kazakov DV, 2007, AM J DERMATOPATH, V29, P457; MARK J, 1989, ANTICANCER RES, V9, P1565; BULLERDIEK J, 1988, CANCER GENET CYTOGEN, V35, P129, DOI 10.1016/0165-4608(88)90131-8; Bell D, 2008, GENE CHROMOSOME CANC, V47, P309, DOI 10.1002/gcc.20534; Garcia JJ, 2011, HUM PATHOL, V42, P2001, DOI 10.1016/j.humpath.2011.02.028; Noda H, 2013, CANCER SCI, V104, P85, DOI 10.1111/cas.12039; Okabe M, 2006, CLIN CANCER RES, V12, P3902, DOI 10.1158/1078-0432.CCR-05-2376; Goode RK, 1998, CANCER, V82, P1217, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1217::AID-CNCR2>3.0.CO;2-C; MASAOKA A, 1981, CANCER, V48, P2485, DOI 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R; Fehr A, 2008, GENE CHROMOSOME CANC, V47, P203, DOI 10.1002/gec.20522; Brandwein MS, 2001, AM J SURG PATHOL, V25, P835, DOI 10.1097/00000478-200107000-00001; Okumura Y, 2011, HISTOPATHOLOGY, V59, P90, DOI 10.1111/j.1365-2559.2011.03890.x; Miyabe S, 2009, J ORAL MAXIL SURG, V67, P1432, DOI 10.1016/j.joms.2009.03.021; Winnes M, 2007, GENE CHROMOSOME CANC, V46, P559, DOI 10.1002/gcc.20440; Coxon A, 2005, CANCER RES, V65, P7137, DOI 10.1158/0008-5472.CAN-05-1125; Roden AC, 2013, HUM PATHOL, V44, P2799, DOI 10.1016/j.humpath.2013.07.031; Lennerz JKM, 2009, AM J SURG PATHOL, V33, P835, DOI 10.1097/PAS.0b013e318190cf5b; Fehr A, 2008, CANCER GENET CYTOGEN, V180, P135, DOI 10.1016/j.cancergencyto.2007.10.007; Tirado Y, 2007, GENE CHROMOSOME CANC, V46, P708, DOI 10.1002/gcc.20458; Seethala RR, 2010, AM J SURG PATHOL, V34, P1106, DOI 10.1097/PAS.0b013e3181de3021; Achcar RDD, 2009, HUM PATHOL, V40, P854, DOI 10.1016/j.humpath.2008.11.007; Xia HJ, 2011, HUM PATHOL, V42, P1297, DOI 10.1016/j.humpath.2010.11.022; Clauditz TS, 2012, DIAGN MOL PATHOL, V21, P134, DOI 10.1097/PDM.0b013e318255552c; Wu LZ, 2005, EMBO J, V24, P2391, DOI 10.1038/sj.emboj.7600719; O'Neill ID, 2009, ORAL ONCOL, V45, P2, DOI 10.1016/j.oraloncology.2008.03.012; Nakayama T, 2009, MODERN PATHOL, V22, P1575, DOI 10.1038/modpathol.2009.126; Argyris PP, 2015, HISTOPATHOLOGY, V66, P791, DOI 10.1111/his.12526; Behboudi A, 2005, GENE CHROMOSOME CANC, V43, P202, DOI 10.1002/gcc.20168; Bishop Justin A, 2014, Head Neck Pathol, V8, P287, DOI 10.1007/s12105-014-0534-8; El-Naggar AK, 2006, ADV ANAT PATHOL, V13, P80, DOI 10.1097/01.pap.0000213000.79866.bd; Lennerz JKM, 2009, BRIT J DERMATOL, V161, P925, DOI 10.1111/j.1365-2133.2009.09200.x; MARK J, 1990, CANCER GENET CYTOGEN, V46, P35, DOI 10.1016/0165-4608(90)90006-V; Martins C, 1997, ORAL ONCOL, V33, P344; Nonaka D, 2004, AM J SURG PATHOL, V28, P1526, DOI 10.1097/01.pas.0000137999.23780.2a; Roden AC, 2013, EUR J CARDIO-THORAC, V43, P1131, DOI 10.1093/ejcts/ezs529; Roden AC, 2014, MODERN PATHOL, V27, P1479, DOI 10.1038/modpathol.2014.72; Skalova A, 2013, AM J SURG PATHOL, V37, P1743, DOI 10.1097/PAS.0000000000000065; SNOVER DC, 1982, AM J SURG PATHOL, V6, P451, DOI 10.1097/00000478-198207000-00007; TANAKA M, 1982, ACTA PATHOL JAPON, V32, P703; Yamada S, 2012, HUM PATHOL, V43, P1322, DOI 10.1016/j.humpath.2011.10.013; Yasuda Manabu, 2006, Jpn J Thorac Cardiovasc Surg, V54, P23, DOI 10.1007/BF02743780	47	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1066-8969	1940-2465		INT J SURG PATHOL	Int. J. Surg. Pathol.	JUN	2015	23	4					277	283		10.1177/1066896915576959		7	Pathology; Surgery	Pathology; Surgery	CI0EA	WOS:000354407700003		
J	Shafait, F; Karatzas, D; Uchida, S; Iwamura, M				Shafait, Faisal; Karatzas, Dimosthenis; Uchida, Seiichi; Iwamura, Masakazu			Special Issue: Robust Reading Preface	INTERNATIONAL JOURNAL ON DOCUMENT ANALYSIS AND RECOGNITION			English	Editorial Material									[Shafait, Faisal] Natl Univ Sci & Technol, Islamabad, Pakistan; [Karatzas, Dimosthenis] Univ Autonoma Barcelona, Comp Vis Ctr, E-08193 Barcelona, Spain; [Uchida, Seiichi] Kyushu Univ, Fukuoka 812, Japan; [Iwamura, Masakazu] Osaka Prefecture Univ, Osaka, Japan	Shafait, F (reprint author), Natl Univ Sci & Technol, Islamabad, Pakistan.	faisal.shafait@seecs.edu.pk; dimos@cvc.uab.es; uchida@ait.kyushu-u.ac.jp; masa@cs.osakafu-u.ac.jp						0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1433-2833	1433-2825		INT J DOC ANAL RECOG	Int. J. Doc. Anal. Recognit.	JUN	2015	18	2			SI		109	110		10.1007/s10032-015-0244-0		2	Computer Science, Artificial Intelligence	Computer Science	CI0FX	WOS:000354413300001		
J	Kimura, H; Ikeda, T; Nakayama, H; Sakai, Y; Fujii, T				Kimura, Hiroshi; Ikeda, Takashi; Nakayama, Hidenari; Sakai, Yasuyuki; Fujii, Teruo			An On-Chip Small Intestine-Liver Model for Pharmacokinetic Studies	JALA			English	Article						lab-on-a-chip; microtechnology; microfluidics; ADME	MICROFLUIDIC SYSTEM; PERFUSION CULTURE; HUMAN HEPATOCYTES; HEPG2 CELLS; ABSORPTION; TISSUE; LEVEL; CYCLOPHOSPHAMIDE; BIOREACTOR; IRINOTECAN	Testing of drug effects and cytotoxicity by using cultured cells has been widely performed as an alternative to animal testing. However, the estimation of pharmacokinetics by conventional cell-based assay methods is difficult because of the inability to evaluate multiorgan effects. An important challenge in the field is to mimic the organ-to-organ network in the human body by using a microfluidic network connecting small-scale tissues based on recently emerging MicroTAS (Micro Total Analysis Systems) technology for prediction of pharmacokinetics. Here, we describe an on-chip small intestine-liver coupled model for pharmacokinetic studies. To construct an in vitro pharmacokinetic model that appropriately models in vivo conditions, physiological parameters such as the structure of internal circulation, volume ratios of each organ, and blood flow ratio of the portal vein to the hepatic artery were mimicked using microfluidic networks. To demonstrate interactions between organs in vitro in pharmacokinetic studies, Caco-2, HepG2, and A549 cell cultures were used as organ models of the small intestine, liver, and lung, respectively, and connected to each other through a microporous membrane and microchannels to prepare a simple model of a physiological organ-to-organ network. The on-chip organ model assay using three types of substrateepirubicine (EPI), irinotecan (CPT-11), and cyclophosphamide (CPA)were conducted to model the effects of orally administered or biologically active anticancer drugs. The result suggested that the device can replicate physiological phenomena such as activity of the anticancer drugs on the target cells. This microfluidic device can thus be used as an in vitro organ model to predict the pharmacokinetics of drugs in the human body and may thus provide not only an alternative to animal testing but also a method of obtaining parameters for in silico models of physiologically based pharmacokinetics.	[Kimura, Hiroshi; Ikeda, Takashi; Nakayama, Hidenari; Sakai, Yasuyuki; Fujii, Teruo] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; [Kimura, Hiroshi] Tokai Univ, Dept Mech Engn, Kanagawa 2591100, Japan; [Kimura, Hiroshi; Sakai, Yasuyuki; Fujii, Teruo] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Fujii, T (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	tfujii@iis.u-tokyo.ac.jp			JSPS KAKENHI; JST CREST	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by JSPS KAKENHI Grant-in-Aid for Young Scientists (B) and JST CREST.	Baudoin R, 2007, TOXICOL IN VITRO, V21, P535, DOI 10.1016/j.tiv.2006.11.004; Kimura H, 2008, LAB CHIP, V8, P741, DOI 10.1039/b717091b; Huh D, 2007, P NATL ACAD SCI USA, V104, P18886, DOI 10.1073/pnas.0610868104; WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222; Puleo CM, 2009, LAB CHIP, V9, P3221, DOI 10.1039/b908332d; Sung JH, 2009, LAB CHIP, V9, P1385, DOI 10.1039/b901377f; Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143; Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h; Imura Y, 2010, ANAL CHEM, V82, P9983, DOI 10.1021/ac100806x; Westerink WMA, 2007, TOXICOL IN VITRO, V21, P1581, DOI 10.1016/j.tiv.2007.05.014; Tilles AW, 2001, BIOTECHNOL BIOENG, V73, P379, DOI 10.1002/bit.1071; Okumura M, 2011, BIOCHEM PHARMACOL, V82, P1720, DOI 10.1016/j.bcp.2011.07.095; Humerickhouse R, 2000, CANCER RES, V60, P1189; Eisenbrand G, 2002, FOOD CHEM TOXICOL, V40, P193, DOI 10.1016/S0278-6915(01)00118-1; Baker M, 2011, NATURE, V471, P661, DOI 10.1038/471661a; Inamdar NK, 2011, CURR OPIN BIOTECH, V22, P681, DOI 10.1016/j.copbio.2011.05.512; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Kane BJ, 2006, ANAL CHEM, V78, P4291, DOI 10.1021/ac051856v; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Sung JH, 2010, LAB CHIP, V10, P446, DOI 10.1039/b917763a; Nakao Y, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3580753; Ocker M, 2005, J CANCER RES CLIN, V131, P385, DOI 10.1007/s00432-004-0664-6; Lee PJ, 2007, BIOTECHNOL BIOENG, V97, P1340, DOI 10.1002/bit.21360; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Barthe L, 1999, FUND CLIN PHARMACOL, V13, P154; Imura Y, 2009, ANAL SCI, V25, P1403; Choi SH, 2004, TOXICOL IN VITRO, V18, P393, DOI 10.1016/j.tiv.2003.09.010; Fleming RA, 1997, PHARMACOTHERAPY, V17, pS146; Imura Y, 2013, ANAL CHEM, V85, P1683, DOI 10.1021/ac302938q; Kimura H., 2007, J ROBOT MECHATRON, V19, P550; Kimura H., 2010, J ROBOT MECHATRONICS, V22, P594; Leclerc E, 2004, BIOCHEM ENG J, V20, P143, DOI 10.1016/j.bej.2003.09.010; Martin P, 2008, BRIT J PHARMACOL, V153, P805, DOI 10.1038/sj.bjp.0707601; Maruichi T, 2010, BIOCHEM PHARMACOL, V79, P288, DOI 10.1016/j.bcp.2009.08.019; MIRKES PE, 1985, TERATOGEN CARCIN MUT, V5, P75, DOI 10.1002/tcm.1770050202; Roig-Perez S, 2005, J MEMBRANE BIOL, V204, P85, DOI 10.1007/s00232-005-0750-y; Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756; Sung JH, 2013, LAB CHIP, V13, P1201, DOI 10.1039/c3lc41017j; TWELVES CJ, 1992, BRIT J CANCER, V66, P765, DOI 10.1038/bjc.1992.353; Xu H, 2012, BIOMED MICRODEVICES, V14, P409, DOI 10.1007/s10544-011-9617-4; Yanagida A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067541; YANAGITA T, 1975, PHARMACOL REV, V27, P503	42	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2211-0682	1540-2452		JALA-J LAB AUTOM	JALA	JUN	2015	20	3			SI		265	273		10.1177/2211068214557812		9	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CI2FW	WOS:000354562000005		
J	Suzuki, Y; Kubota, H; Sato'o, Y; Ono, HK; Kato, R; Sadamasu, K; Kai, A; Kamata, Y				Suzuki, Y.; Kubota, H.; Sato'o, Y.; Ono, H. K.; Kato, R.; Sadamasu, K.; Kai, A.; Kamata, Y.			Identification and characterization of novel Staphylococcus aureus pathogenicity islands encoding staphylococcal enterotoxins originating from staphylococcal food poisoning isolates	JOURNAL OF APPLIED MICROBIOLOGY			English	Article						replication initiator; replication origin; staphylococcal enterotoxin; Staphylococcus aureus; Staphylococcus aureus pathogenicity island	COMPREHENSIVE ANALYSIS; HELICASE ACTIVITY; TOXIN; PURIFICATION; REPLICATION; EVOLUTION; OUTBREAKS; ELEMENTS; PLASMID; GENES	AimsHorizontal transfer of Staphylococcus aureus pathogenicity islands (SaPIs) plays an important role in acquiring pathogenicity. This study aimed to identify novel SaPIs encoding staphylococcal enterotoxins (SEs) and to characterize their SE productivity and replication process. Methods and ResultsFour novel SaPIs (SaPITokyo12413, SaPITokyo11212, SaPITokyo12571 and SaPITokyo12381) were determined using the SaPI scanning method. These SaPIs were composed of mosaic structures containing reported sequences. Four strains harbouring novel SaPIs produced significant amounts of SEs to cause staphylococcal food poisoning (SFP). With focus on the interaction between the replication initiator protein (Rep) and the replication origin (ori sites) that are proposed to be important for the replication of SaPIs, each Rep was prepared and their two functions were confirmed: binding activity to ori sites and helicase activity. These activities were present in the Reps of SaPITokyo11212, SaPITokyo12571 and SaPITokyo12381, but were both absent in the Rep of SaPITokyo12413. ConclusionsAll four novel SaPIs could give sufficient toxicity to Staph.aureus to cause SFP. However, SaPITokyo12413 may be restricted in its replication capacity, suggesting that it lacks transfer ability unlike the other SaPIs. Significance and Impact of the StudyThis is the first report to identify four novel SE-encoding SaPIs and to examine their toxicity and replication capacity. Because SaPIs deeply participate in SE acquisition, it is important to elucidate their characteristics for understanding Staph.aureus virulence and speculating regarding its evolution as a pathogen.	[Suzuki, Y.; Kamata, Y.] Iwate Univ, Fac Agr, Dept Vet Med, Morioka, Iwate 020, Japan; [Suzuki, Y.; Kamata, Y.] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan; [Suzuki, Y.; Kubota, H.; Kato, R.; Sadamasu, K.; Kai, A.] Tokyo Metropolitan Inst Publ Hlth, Dept Microbiol, Shinjuku Ku, Tokyo 1690073, Japan; [Sato'o, Y.] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Bacteriol, Hiroshima, Hiroshima, Japan; [Ono, H. K.] Hirosaki Univ, Grad Sch Med, Dept Microbiol & Immunol, Hirosaki, Aomori, Japan	Suzuki, Y (reprint author), Tokyo Metropolitan Inst Publ Hlth, Dept Microbiol, Shinjuku Ku, 3-24-1 Hyakunin Cho, Tokyo 1690073, Japan.	Yasunori_1_Suzuki@member.metro.tokyo.jp					Ubeda C, 2007, P NATL ACAD SCI USA, V104, P14182, DOI 10.1073/pnas.0705994104; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16; Sato'o Y, 2014, J CLIN MICROBIOL, V52, P2637, DOI 10.1128/JCM.00661-14; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Sato'o Y, 2013, MICROBIOL IMMUNOL, V57, P91, DOI 10.1111/1348-0421.12007; Omoe K, 2005, FEMS MICROBIOL LETT, V246, P191, DOI 10.1016/j.femsle.2005.04.007; Omoe K, 2002, J CLIN MICROBIOL, V40, P857, DOI 10.1128/JCM.40.3.857-862.2002; RAJ HD, 1969, J BACTERIOL, V98, P833; Tani H, 2010, BIOCHEM BIOPH RES CO, V393, P131, DOI 10.1016/j.bbrc.2010.01.100; Novick RP, 2003, PLASMID, V49, P93, DOI 10.1016/S0147-619X(02)00157-9; Omoe K, 2013, INFECT IMMUN, V81, P3627, DOI 10.1128/IAI.00550-13; Balaban N, 2000, INT J FOOD MICROBIOL, V61, P1, DOI 10.1016/S0168-1605(00)00377-9; Malachowa N, 2010, CELL MOL LIFE SCI, V67, P3057, DOI 10.1007/s00018-010-0389-4; Argudin MA, 2010, TOXINS, V2, P1751, DOI 10.3390/toxins2071751; Omoe K, 2005, INFECT IMMUN, V73, P5540, DOI 10.1128/IAI.73.9.5540.5546.2005; Ubeda C, 2012, PLASMID, V67, P183, DOI 10.1016/j.plasmid.2012.01.006; EVENSON ML, 1988, INT J FOOD MICROBIOL, V7, P311, DOI 10.1016/0168-1605(88)90057-8; Ubeda C, 2008, MOL MICROBIOL, V67, P493; Schelin J, 2011, VIRULENCE, V2, P580, DOI 10.4161/viru.2.6.18122; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Masuda S, 2007, J MOL BIOL, V368, P1223, DOI 10.1016/j.jmb.2007.02.087; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Maki H, 1997, J BACTERIOL, V179, P6944; Hu DL, 2003, INFECT IMMUN, V71, P567, DOI 10.1128/IAI.71.1.567-570.2003; Boguszewska-Chachulska AM, 2004, FEBS LETT, V567, P253, DOI 10.1016/j.febslet.2004.04.072; BORJA CR, 1972, J BIOL CHEM, V247, P2456; BORJA CR, 1967, BIOCHEMISTRY-US, V6, P1467, DOI 10.1021/bi00857a032; Briani F, 2001, PLASMID, V45, P1, DOI 10.1006/plas.2000.1497; Hennig S, 2010, J BACTERIOL, V192, P4153, DOI 10.1128/JB.00226-10; IGARASHI H, 1972, JPN J MICROBIOL, V16, P483; Novick Richard P, 2007, Chem Immunol Allergy, V93, P42; Suzuki Y, 2014, MICROBIOL IMMUNOL, V58, P570, DOI 10.1111/1348-0421.12188; Yarwood JM, 2002, J BIOL CHEM, V277, P13138, DOI 10.1074/jbc.M111661200	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1364-5072	1365-2672		J APPL MICROBIOL	J. Appl. Microbiol.	JUN	2015	118	6					1507	1520		10.1111/jam.12786		14	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CI2IT	WOS:000354570600025		
J	Yamaki, S; Kawai, Y; Yamazaki, K				Yamaki, S.; Kawai, Y.; Yamazaki, K.			Characterization of a novel bacteriophage, Phda1, infecting the histamine-producing Photobacterium damselae subsp damselae	JOURNAL OF APPLIED MICROBIOLOGY			English	Article						bacteriophage; histamine poisoning; Myoviridae; phage therapy; Photobacterium damselae subsp; damselae	ESCHERICHIA-COLI O157-H7; DIVALENT-CATIONS; VIBRIO-DAMSELA; PHAGE COCKTAIL; FISH; EFFICACY; ACCUMULATION; CALCIUM; CAPSULE	AimsPhotobacterium damselae subsp. damselae is a potent histamine-producing micro-organism. The aim of this study was to isolate and characterize a bacteriophage Phda1 that infected P.damselae subsp. damselae to inhibit its growth and histamine accumulation. Methods and ResultsPhda1 was isolated from a raw oyster, and the host range, morphology and the bacteriophage genome size were analysed. Phda1 formed a clear plaque only against P.damselae subsp. damselae JCM8969 among five Gram-positive and 32 Gram-negative bacterial strains tested. Phda1 belongs to the family Myoviridae, and its genome size was estimated as 352-395kb. According to the one-step growth curve analysis, the latent period, rise period and burst size of Phda1 were 60min, 50min and 19plaque-forming units per infected cell, respectively. Divalent cations, especially Ca2+ and Mg2+, strongly improved Phda1 adsorption to the host cells and its propagation. Phda1 treatment delayed the growth and histamine production of P.damselae subsp. damselae in an invitro challenge test. ConclusionsThe bacteriophage Phda1 might serve as a potential antimicrobial agent to inhibit the histamine poisoning caused by P.damselae subsp. damselae. Significance and Impact of the StudyThis is the first description of a bacteriophage specifically infecting P.damselae subsp. damselae and its potential applications. Bacteriophage therapy could prove useful in the prevention of histamine poisoning.	[Yamaki, S.; Kawai, Y.; Yamazaki, K.] Hokkaido Univ, Lab Marine Food Sci & Technol, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan	Yamazaki, K (reprint author), Hokkaido Univ, Lab Marine Food Sci & Technol, Fac Fisheries Sci, 3-1-1 Minato, Hakodate, Hokkaido 0418611, Japan.	yamasaki@fish.hokudai.ac.jp			JSPS KAKENHI Grant [26450278]	This work was supported by JSPS KAKENHI Grant Number 26450278.	Lu TK, 2011, CURR OPIN MICROBIOL, V14, P524, DOI 10.1016/j.mib.2011.07.028; Bandara N, 2012, FOOD MICROBIOL, V31, P9, DOI 10.1016/j.fm.2012.02.003; Stenholm AR, 2008, APPL ENVIRON MICROB, V74, P4070, DOI 10.1128/AEM.00428-08; O'Flaherty S, 2009, FEMS MICROBIOL REV, V33, P801, DOI 10.1111/j.1574-6976.2009.00176.x; O'Flynn G, 2004, APPL ENVIRON MICROB, V70, P3417, DOI 10.1128/AEM.70.6.3417-3424.2004; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Chibeu A, 2013, INT J FOOD MICROBIOL, V167, P208, DOI 10.1016/j.ijfoodmicro.2013.08.018; Rodtong S, 2005, FOOD MICROBIOL, V22, P475, DOI 10.1016/j.fm.2004.08.009; Tanji Y, 2004, APPL MICROBIOL BIOT, V64, P270, DOI 10.1007/s00253-003-1438-9; Park M, 2012, APPL ENVIRON MICROB, V78, P58, DOI 10.1128/AEM.06231-11; Kanki M, 2007, APPL ENVIRON MICROB, V73, P1467, DOI 10.1128/AEM.01907-06; Kutateladze M, 2010, TRENDS BIOTECHNOL, V28, P591, DOI 10.1016/j.tibtech.2010.08.001; Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09; PUCK TT, 1951, J EXP MED, V93, P65; ROUNTREE PM, 1951, J GEN MICROBIOL, V5, P673; Nakakoshi M, 2011, J ELECTRON MICROSC, V60, P401, DOI 10.1093/jmicro/dfr084; Bermejo A., 2003, Journal of Food Processing and Preservation, V26, P401, DOI 10.1111/j.1745-4549.2003.tb00493.x; Born Y, 2014, ENVIRON MICROBIOL, V16, P2168, DOI 10.1111/1462-2920.12212; Carvalho C, 2010, LETT APPL MICROBIOL, V50, P192, DOI 10.1111/j.1472-765X.2009.02774.x; Carvalho CM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-232; Chhibber S, 2014, J BASIC MICROB, V54, P775, DOI 10.1002/jobm.201300051; D'Aloia A, 2011, CARDIOVASC TOXICOL, V11, P280, DOI 10.1007/s12012-011-9115-1; Ferrario C., 2012, J FOOD SCI, V77, P115; Gupta R, 2011, CURR MICROBIOL, V62, P255, DOI 10.1007/s00284-010-9699-x; Hidaka T., 1978, MEM FAC FISH KAGOSHI, V27, P79; Kanki M, 2004, INT J FOOD MICROBIOL, V92, P79, DOI 10.1016/j.ijfoodmicro.2003.08.019; Kimura B, 2009, J APPL MICROBIOL, V107, P485, DOI 10.1111/j.1365-2672.2009.04223.x; LANDRY EF, 1980, J GEN VIROL, V51, P125, DOI 10.1099/0022-1317-51-1-125; LOVE M, 1981, SCIENCE, V214, P1139, DOI 10.1126/science.214.4525.1139; Magarinos B, 1996, MICROB PATHOGENESIS, V21, P289, DOI 10.1006/mpat.1996.0062; METT CL, 1982, J CHROMATOGR, V235, P536, DOI 10.1016/S0021-9673(00)85921-X; Pedersen K, 1997, APPL ENVIRON MICROB, V63, P3711; POTTER NN, 1953, J BACTERIOL, V66, P508; ROUNTREE PM, 1955, J GEN MICROBIOL, V12, P275; SanchezGuerrero IM, 1997, J ALLERGY CLIN IMMUN, V100, P433, DOI 10.1016/S0091-6749(97)70263-X; Scholl D, 2005, APPL ENVIRON MICROB, V71, P4872, DOI 10.1128/AEM.71.8.4872-4874.2005; Yamaki S, 2014, FEMS MICROBIOL LETT, V359, P166, DOI 10.1111/1574-6968.12560	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1364-5072	1365-2672		J APPL MICROBIOL	J. Appl. Microbiol.	JUN	2015	118	6					1541	1550		10.1111/jam.12809		10	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CI2IT	WOS:000354570600028		
J	Fukui, M; Shimakawa, S; Nomura, S; Ohba, C; Kashiwagi, M; Miyamoto, R; Tanabe, T; Azumagawa, K; Tamai, H				Fukui, Miho; Shimakawa, Shuichi; Nomura, Shohei; Ohba, Chizu; Kashiwagi, Mitsuru; Miyamoto, Ryohei; Tanabe, Takuya; Azumagawa, Kohji; Tamai, Hiroshi			Serum N-Terminal Pro-B-Type Natriuretic Peptide (NTproBNP) Levels Are Elevated During the Acute Phase of Acute Encephalopathy-Associated Virus Infection	JOURNAL OF CHILD NEUROLOGY			English	Article						encephalopathy; febrile seizure; N-terminal pro-B-type natriuretic peptide (NTproBNP)	CHILDREN; DIAGNOSIS; SECRETION	Acute virus-associated encephalopathy induces seizures. Serum N-terminal pro-B-type natriuretic peptide (NTproBNP) levels are elevated following febrile and afebrile seizures. However, the role of NTproBNP in acute virus-associated encephalopathy pathology is unknown. We enrolled 10 patients with acute virus-associated encephalopathy and convulsions (E group: 7 boys, 3 girls; median age, 3.10 +/- 1.92 years) and 130 patients with febrile seizure (FS group: 80 boys, 50 girls; median age, 3.23 +/- 2.44 years). The E group had significantly higher NTproBNP levels (345 +/- 141 pg/mL) compared with the FS group (166 +/- 228 pg/mL) (P < .0005). Furthermore, subjects with prolonged seizure within the E group had significantly higher NTproBNP levels (303 +/- 107 pg/mL) compared with subjects with prolonged seizure within the FS group (134 +/- 100 pg/mL) (P < .005). Our findings suggest that serum NTproBNP levels are increased during the acute phase of acute virus-associated encephalopathy associated with convulsion.	[Fukui, Miho; Shimakawa, Shuichi; Nomura, Shohei; Tamai, Hiroshi] Osaka Med Coll, Dept Pediat, Takatsuki, Osaka 5698686, Japan; [Ohba, Chizu; Kashiwagi, Mitsuru] Hirakata Municipal Hosp, Dept Pediat, Osaka, Japan; [Miyamoto, Ryohei] Saiseikai Ibaragi Hosp, Dept Pediat, Osaka, Japan; [Tanabe, Takuya] Tanabe Childrens Clin, Dept Pediat Neurol, Osaka, Japan; [Azumagawa, Kohji] Seikeikai Hosp, Dept Pediat, Osaka, Japan	Shimakawa, S (reprint author), Osaka Med Coll, Dept Pediat, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	ZVQ10523@nifty.com					Berendes E, 1997, LANCET, V349, P245, DOI 10.1016/S0140-6736(96)08093-2; Ouanes I, 2012, RESPIROLOGY, V17, P660, DOI 10.1111/j.1440-1843.2012.02153.x; Sugimoto M, 2010, CIRC J, V74, P998, DOI 10.1253/circj.CJ-09-0535; Dyken PR, 1994, PEDIAT NEUROLOGY PRI, P657; Fukumoto Y, 2007, BRAIN DEV-JPN, V29, P425, DOI 10.1016/j.braindev.2006.12.005; Johns Martin Christopher, 2008, Am J Cardiol, V101, P76, DOI 10.1016/j.amjcard.2007.11.028; Kirchhoff C, 2006, J NEUROTRAUM, V23, P943, DOI 10.1089/neu.2006.23.943; Norozi K, 2009, PEDIATR INT, V51, P283, DOI 10.1111/j.1442-200X.2008.02710.x; Rauchenzauner M, 2007, EPILEPSIA, V48, P101, DOI 10.1111/j.1528-1167.2006.00837.x; Sviri GE, 2003, ACTA NEUROCHIR, V145, P851, DOI 10.1007/s00701-003-0101-7; Weil ML, 1995, TXB CHILD NEUROLOGY, P418; Yao Dengfu, 2003, Journal of Medical Investigation, V50, P1	12	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JUN	2015	30	7					823	827		10.1177/0883073814543304		5	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CI2AM	WOS:000354546700001		
J	Miyake, F; Kuroda, Y; Naruto, T; Ohashi, I; Takano, K; Kurosawa, K				Miyake, Fuyu; Kuroda, Yukiko; Naruto, Takuya; Ohashi, Ikuko; Takano, Kyoko; Kurosawa, Kenji			West Syndrome in a Patient With Schinzel-Giedion Syndrome	JOURNAL OF CHILD NEUROLOGY			English	Article						epilepsy; SET binding protein 1 (SETBP1); adrenocorticotropic hormone (ACTH)	SETBP1 MUTATIONS; FEATURES	Schinzel-Giedion syndrome is a rare recognizable malformation syndrome defined by characteristic facial features, profound developmental delay, severe growth failure, and multiple congenital anomalies. The causative gene of Schinzel-Giedion syndrome, SETBP1, has been identified, but limited cases have been confirmed by molecular analysis. We present a 9-month-old girl affected by West syndrome with Schinzel-Giedion syndrome. Congenital severe hydronephrosis, typical facial features, and multiple anomalies suggested a clinical diagnosis of Schinzel-Giedion syndrome. Hypsarrhythmia occurred at 7 months of age and was temporarily controlled by adrenocorticotropic hormone (ACTH) therapy during 5 weeks. SETBP1 mutational analysis showed the presence of a recurrent mutation, p.Ile871Thr. The implications in management of Schinzel-Giedion syndrome are discussed.	[Miyake, Fuyu; Kuroda, Yukiko; Naruto, Takuya; Ohashi, Ikuko; Kurosawa, Kenji] Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa 2328555, Japan; [Takano, Kyoko] Kanagawa Childrens Med Ctr, Div Neurol, Yokohama, Kanagawa 2328555, Japan	Kurosawa, K (reprint author), Kanagawa Childrens Med Ctr, Div Med Genet, Minami Ku, 2-138-4 Mutsukawa, Yokohama, Kanagawa 2328555, Japan.	kkurosawa@kcmc.jp			Ministry of Health, Labour and Welfare, Japan	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported in part by a Grant-in-aid from the Ministry of Health, Labour and Welfare, Japan.	Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Sakaguchi H, 2013, NAT GENET, V45, P937, DOI 10.1038/ng.2698; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Makishima H, 2013, NAT GENET, V45, P942, DOI 10.1038/ng.2696; Grosso S, 2003, BRAIN DEV-JPN, V25, P294, DOI 10.1016/S0387-7604(02)00232-2; Ko JM, 2013, CHILD NERV SYST, V29, P525, DOI 10.1007/s00381-013-2047-2; Lehman AM, 2008, AM J MED GENET A, V146A, P1299, DOI 10.1002/ajmg.a.32277; Lestner JM, 2012, CLIN DYSMORPHOL, V21, P152, DOI 10.1097/MCD.0b013e3283518f1e; McPherson E, 1998, AM J MED GENET, V79, P62, DOI 10.1002/(SICI)1096-8628(19980827)79:1<62::AID-AJMG13>3.3.CO;2-I; SCHINZEL A, 1978, AM J MED GENET, V1, P361, DOI 10.1002/ajmg.1320010402; Shah AM, 1999, AM J MED GENET, V82, P344, DOI 10.1002/(SICI)1096-8628(19990212)82:4<344::AID-AJMG13>3.0.CO;2-H; Suphapeetiporn K, 2011, CLIN GENET, V79, P391, DOI 10.1111/j.1399-0004.2010.01552.x; Touge H, 2001, INT J UROL, V8, P237, DOI 10.1046/j.1442-2042.2001.00291.x; Watanabe S, 2013, BRAIN DEV, V34, P151	14	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JUN	2015	30	7					932	936		10.1177/0883073814541468		5	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CI2AM	WOS:000354546700017		
J	Fujikawa, M; Kishimoto, Y; Kakisaka, Y; Jin, K; Kato, K; Iwasaki, M; Nakasato, N				Fujikawa, Mayu; Kishimoto, Yuri; Kakisaka, Yosuke; Jin, Kazutaka; Kato, Kazuhiro; Iwasaki, Masaki; Nakasato, Nobukazu			Obsessive-Compulsive Behavior Induced by Levetiracetam	JOURNAL OF CHILD NEUROLOGY			English	Article						obsessive-compulsive behavior; levetiracetam; glutamate	DISORDER	A novel antiepileptic drug, levetiracetam, has been reported to cause several psychiatric adverse effects in spite of its effectiveness on epilepsy. However, a possible relationship between levetiracetam and obsessive-compulsive behavior has only been reported in a few studies with adult epilepsy patients. We treated a pediatric patient with epilepsy without past or family history of psychiatric disorder. Levetiracetam was started to control generalized tonic-clonic seizure. Two months after initiation of levetiracetam with favorable seizure control, she started to show an obsessive-compulsive behavior such as repetitive checking of her back, pants, and chair. Based on the course of its appearance, levetiracetam administration was identified as a possible cause. After termination of levetiracetam, her obsessive-compulsive behavior completely disappeared with reappearance of seizures. This case provides clear evidence that levetiracetam may cause obsessive-compulsive behavior even in a pediatric epilepsy patient without psychiatric background, possibly mediated by modulation of the glutamate system by levetiracetam.	[Fujikawa, Mayu; Kishimoto, Yuri; Kakisaka, Yosuke; Jin, Kazutaka; Nakasato, Nobukazu] Tohoku Univ, Sch Med, Dept Epileptol, Sendai, Miyagi 9808575, Japan; [Kato, Kazuhiro] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 9808575, Japan; [Iwasaki, Masaki] Tohoku Univ, Sch Med, Dept Neurosurg, Sendai, Miyagi 9808575, Japan	Kakisaka, Y (reprint author), Tohoku Univ, Sch Med, Dept Epileptol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kakisuke@mui.biglobe.ne.jp		Iwasaki, Masaki/0000-0002-4204-7144			American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Phillips KA, 2009, CNS SPECTRUMS, V14, P252; Rosenberg DR, 1998, BIOL PSYCHIAT, V43, P623, DOI 10.1016/S0006-3223(97)00443-5; Dinkelacker V, 2003, EPILEPSY BEHAV, V4, P537, DOI 10.1016/j.yebeh.2003.07.008; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Scahill L, 1997, J AM ACAD CHILD PSY, V36, P844, DOI 10.1097/00004583-199706000-00023; Rosenberg DR, 2004, J AM ACAD CHILD PSY, V43, P1146, DOI 10.1097/01.chi.0000132812.44664.2d; Helmstaedter C, 2008, Epilepsy Behav, V13, P535, DOI 10.1016/j.yebeh.2008.05.012; Hurtado B, 2006, EPILEPSY BEHAV, V8, P588, DOI 10.1016/j.yebeh.2006.01.003; MacMaster FP, 2008, J AM ACAD CHILD PSY, V47, P1262, DOI 10.1097/CHI.0b013e318185d2be; Sherer M, 2008, MENT HLTH ASPECT DEV, V11, P1; Wang HR, 2014, PSYCHIAT CLIN NEUROS, V68, P723, DOI 10.1111/pcn.12186; Whiteside SP, 2006, PSYCHIAT RES-NEUROIM, V146, P137, DOI 10.1016/j.psychresns.2005.12.006	13	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JUN	2015	30	7					942	944		10.1177/0883073814541471		3	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CI2AM	WOS:000354546700019		
J	Takekita, Y; Fabbri, C; Kato, M; Nonen, S; Sakai, S; Sunada, N; Koshikawa, Y; Wakeno, M; Okugawa, G; Kinoshita, T; Serretti, A				Takekita, Yoshiteru; Fabbri, Chiara; Kato, Masaki; Nonen, Shinpei; Sakai, Shiho; Sunada, Naotaka; Koshikawa, Yosuke; Wakeno, Masataka; Okugawa, Gaku; Kinoshita, Toshihiko; Serretti, Alessandro			HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia	JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY			English	Article						HTR1A; 5-HT1A receptor partial agonism; schizophrenia; antipsychotics; efficacy	SOCIAL-INTERACTION DEFICITS; MAJOR DEPRESSIVE DISORDER; ATYPICAL ANTIPSYCHOTICS; PREFRONTAL CORTEX; SYMPTOM RESPONSE; DOUBLE-BLIND; SEROTONIN; ARIPIPRAZOLE; TANDOSPIRONE; RISPERIDONE	Individual differences in serotonin 1A (5-HT1A) receptor may result in variable response to antipsychotics with 5-HT1A receptor partial agonism. We investigated the relationship between 5-HT1A receptor gene (HTR1A) single nucleotide polymorphisms (SNPs) and efficacy of antipsychotics with 5-HT1A receptor partial agonism in Japanese patients with schizophrenia. Perospirone or aripiprazole was administered to 100 patients with schizophrenia in a randomized controlled study. Candidate SNPs were rs6295 (which affects HTR1A expression and function), rs1364043, rs878567, and rs10042486. Efficacy atweek 12 of treatment was evaluated using the Positive and Negative Syndrome Scale (PANSS) 5-factor subscales (excitement/hostility, depression/anxiety, cognition, positive, and negative). Rs1364043 T allele was correlated with the percent change in the PANSS 5-factor negative score (P < 0.01). Haplotype analysis showed that the rs10042486-rs6295-rs1364043 T-C-G haplotype was correlated with worse negative score improvement (haplotype frequency, 0.675; P = 0.014), and the relatively rare T-G-T haplotype correlated with better efficacy (haplotype frequency, 0.05; P = 0.031). This is the first study to show that rs10042486-rs6295-rs1364043 HTR1A variants may be correlated with the improvement of the PANSS 5-factor negative score during treatment with 5-HT1A partial agonist antipsychotics. Studies with larger sample sizes and in different ethnic groups are warranted.	[Takekita, Yoshiteru; Fabbri, Chiara; Serretti, Alessandro] Univ Bologna, Dept Biomed & NeuroMotor Sci, I-40123 Bologna, Italy; [Takekita, Yoshiteru; Kato, Masaki; Sakai, Shiho; Sunada, Naotaka; Koshikawa, Yosuke; Wakeno, Masataka; Okugawa, Gaku; Kinoshita, Toshihiko] Kansai Med Univ, Dept Neuropsychiat, Osaka, Japan; [Nonen, Shinpei] Hyogo Univ Hlth Sci, Dept Pharm, Kobe, Hyogo, Japan	Takekita, Y (reprint author), Univ Bologna, Dept Biomed & NeuroMotor Sci, Viale Carlo Pepoli 5, I-40123 Bologna, Italy.	takekity@takii.kmu.ac.jp			Japan Society for the Promotion of Science (JSPS) [23791357, 25861034, 23591684]; Takeda Pharmaceutical	Dr Takekita has received grant funding from Grant-in-Aid for Young Scientists (B) (Grant Nos. 23791357 and 25861034) from Japan Society for the Promotion of Science (JSPS) and speaker's honoraria from Dainippon-Sumitomo Pharma, Otsuka, Meiji-Seika Pharma, Janssen Pharmaceutical, Daiichi-Sankyo Company, Takeda Pharmaceutical, Eli Lilly, Novartis, MSD K.K., and Ono Pharmaceutical within the past 3 years. Dr Kato has received grant funding from Grant-in-Aid for Scientific Research (C) (Grant No. 23591684) from Japan Society for the Promotion of Science (JSPS) and speaker's honoraria from Dainippon-Sumitomo Pharma and Otsuka within the past 3 years. Dr Sunada has received speaker's honoraria from Mochida Pharmaceutical and Eisai within the past 3 years. Dr Okugawa received consulting fee from Takeda Pharmaceutical. Dr Kinoshita has received speaker's honoraria from Dainippon-Sumitomo Pharma, Otsuka, Meiji-Seika Pharma, Janssen Pharmaceutical, Daiichi-Sankyo Company, Takeda Pharmaceutical, Eli Lilly, MSD K.K. Shionogi, Astellas Pharma, Eisai, GlaxoSmithKline, and Ono Pharmaceutical. Dr Serretti is or has been consultant/speaker for Abbott, Abbvie, Angelini, Astra Zeneca, Clinical Data, Boheringer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Innovapharma, Italfarmaco, Janssen, Lundbeck, Naurex, Pfizer, Polipharma, Sanofi, and Servier. The other authors declare no conflicts of interest.	Albert PR, 2012, PHILOS T R SOC B, V367, P2402, DOI 10.1098/rstb.2011.0376; Burnet PWJ, 1996, NEUROPSYCHOPHARMACOL, V15, P442, DOI 10.1016/S0893-133X(96)00053-X; Tauscher J, 2002, ARCH GEN PSYCHIAT, V59, P514, DOI 10.1001/archpsyc.59.6.514; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Villafuerte SM, 2009, PSYCHIAT GENET, V19, P281, DOI 10.1097/YPG.0b013e32832a506e; Horiguchi M, 2012, PSYCHOPHARMACOLOGY, V221, P205, DOI 10.1007/s00213-011-2561-4; Kapur S, 2001, AM J PSYCHIAT, V158, P360, DOI 10.1176/appi.ajp.158.3.360; Sirota P, 2001, J CLIN PSYCHOPHARM, V21, P454, DOI 10.1097/00004714-200108000-00015; Varnas K, 2004, HUM BRAIN MAPP, V22, P246, DOI 10.1002/hbm.20035; [Anonymous], 2013, G POW COMP PROGR VER; Reynolds GP, 2006, AM J PSYCHIAT, V163, P1826, DOI 10.1176/appi.ajp.163.10.1826; Czesak M, 2006, J NEUROSCI, V26, P1864, DOI 10.1523/JNEUROSCI.2643-05.2006; Sumiyoshi T, 2001, AM J PSYCHIAT, V158, P1722, DOI 10.1176/appi.ajp.158.10.1722; Fabbri C, 2013, AM J MED GENET B, V162, P487, DOI 10.1002/ajmg.b.32184; Boulay D, 2004, NEUROPHARMACOLOGY, V46, P1121, DOI 10.1016/j.neuropharm.2004.02.008; Crisafulli C, 2012, EUR ARCH PSY CLIN N, V262, P199, DOI 10.1007/s00406-011-0278-3; Bortolozzi A, 2010, INT J NEUROPSYCHOPH, V13, P1299, DOI 10.1017/S146114571000009X; Sumiyoshi T, 1996, BRAIN RES, V708, P209, DOI 10.1016/0006-8993(95)01361-X; Newman-Tancredi A, 2010, CURR OPIN INVEST DR, V11, P802; Huang M, 2014, J NEUROCHEM, V128, P938, DOI 10.1111/jnc.12512; Czesak M, 2012, J BIOL CHEM, V287, P6615, DOI 10.1074/jbc.M111.293027; [Anonymous], 2008, HAPL COMP PROGR VERS; Pae CU, 2009, EUR NEUROPSYCHOPHARM, V19, P562, DOI 10.1016/j.euroneuro.2009.04.002; Slot LAB, 2005, NEUROPHARMACOLOGY, V49, P996, DOI 10.1016/j.neuropharm.2005.05.013; Aznar S, 2003, BRAIN RES, V959, P58, DOI 10.1016/S0006-8993(02)03727-7; Sumiyoshi T, 2001, BIOL PSYCHIAT, V49, P861, DOI 10.1016/S0006-3223(00)01025-8; Newman-Tancredi A, 2011, PSYCHOPHARMACOLOGY, V216, P451, DOI 10.1007/s00213-011-2247-y; Diaz-Mataix L, 2005, J NEUROSCI, V25, P10831, DOI 10.1523/JNEUROSCI.2999-05.2005; Madjid N, 2006, J PHARMACOL EXP THER, V316, P581, DOI 10.1124/jpet.105.092262; Lerond J, 2013, J CLIN PSYCHOPHARM, V33, P84, DOI 10.1097/JCP.0b013e31827b97a6; Jordan S, 2002, EUR J PHARMACOL, V441, P137, DOI 10.1016/S0014-2999(02)01532-7; Albert PR, 2004, NEUROSCIENTIST, V10, P575, DOI 10.1177/1073858404267382; Casey DE, 2003, PSYCHOPHARMACOLOGY, V166, P391, DOI 10.1007/s00213-002-1344-3; Citrome L, 2011, SCHIZOPHR RES, V131, P75, DOI 10.1016/j.schres.2011.05.018; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Sumiyoshi T, 2007, SCHIZOPHR RES, V95, P158, DOI 10.1016/j.schres.2007.06.008; Ichikawa J, 2001, J NEUROCHEM, V76, P1521, DOI 10.1046/j.1471-4159.2001.00154.x; Arranz MJ, 2007, MOL PSYCHIATR, V12, P707, DOI 10.1038/sj.mp.4002009; Lemonde S, 2003, J NEUROSCI, V23, P8788; [Anonymous], 2014, NUCLEOTIDE DATABASE; Celada Pau, 2013, Front Integr Neurosci, V7, P25, DOI 10.3389/fnint.2013.00025; Chiesa A, 2013, GENET TEST MOL BIOMA, V17, P504, DOI 10.1089/gtmb.2012.0484; Cohen J., 1988, STAT POWER ANAL BEHA; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Di Matteo M, 2000, BRAIN RES, V865, P85; Fagiolini A, 2010, EXPERT OPIN PHARMACO, V11, P2199, DOI 10.1517/14656566.2010.507630; Ghaleiha A, 2010, J CLIN PSYCHOPHARM, V30, P678, DOI 10.1097/JCP.0b013e3181fa8720; HASHIMOTO T, 1991, LIFE SCI, V48, P355, DOI 10.1016/0024-3205(91)90556-Q; HOLLISTER LE, 1994, J CLIN PSYCHOPHARM, V14, P50; Inagaki A, 2006, JPN J CLIN PSYCHOPHA, V9, P249; Jacobsen KX, 2008, MOL CELL NEUROSCI, V38, P349, DOI 10.1016/j.mcn.2008.03.007; Kato M, 2009, AM J MED GENET B, V150B, P115, DOI 10.1002/ajmg.b.30783; LINDENMAYER JP, 1995, SCHIZOPHR RES, V14, P229, DOI 10.1016/0920-9964(94)00041-6; Mossner R, 2009, PHARMACOGENET GENOM, V19, P91, DOI 10.1097/FPC.0b013e328311a917; Murasaki M, 2008, JPN J CLIN PSYCHOPHA, V11, P845; Odagaki Y, 2007, CLIN EXP PHARMACOL P, V34, P462, DOI 10.1111/j.1440-1681.2007.04595.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Silver H, 2004, EXPERT OPIN PHARMACO, V5, P2053, DOI 10.1517/14656566.5.10.2053; Sumiyoshi T, 2000, J CLIN PSYCHOPHARM, V20, P386, DOI 10.1097/00004714-200006000-00019; Sumiyoshi T, 2010, ADV THER, V27, P307, DOI 10.1007/s12325-010-0035-4; Takekita Y, 2013, PROG NEURO-PSYCHOPH, V40, P110, DOI 10.1016/j.pnpbp.2012.09.010; VARRAULT A, 1992, MOL PHARMACOL, V41, P999; Wang L, 2008, J PSYCHOPHARMACOL, V22, P904, DOI 10.1177/0269881107081522; Wu S, 1999, PSYCHIATR GENET, V9, P105, DOI 10.1097/00041444-199906000-00010; Zhao XF, 2012, PSYCHIAT GENET, V22, P261, DOI 10.1097/YPG.0b013e32834dc44c	65	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-0749	1533-712X		J CLIN PSYCHOPHARM	J. Clin. Psychopharmacol.	JUN	2015	35	3					220	227		10.1097/JCP.0000000000000304		8	Pharmacology & Pharmacy; Psychiatry	Pharmacology & Pharmacy; Psychiatry	CH1XS	WOS:000353817400003		
J	Lee, J; Fervaha, G; Takeuchi, H; Powell, V; Remington, G				Lee, Jimmy; Fervaha, Gagan; Takeuchi, Hiroyoshi; Powell, Valerie; Remington, Gary			Positive Symptoms Are Associated With Clinicians' Global Impression in Treatment-Resistant Schizophrenia	JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY			English	Article						Brief Psychiatric Rating Scale (BPRS); Clinical Global Impression-Severity (CGI-S); Clinical Global Impression-Improvement (CGI-I); Treatment-resistant schizophrenia, clozapine	PSYCHIATRIC RATING-SCALE; NEGATIVE SYNDROME SCALE; EQUIPERCENTILE LINKING; CGI-S; PANSS; CLOZAPINE; SEVERITY; BPRS	Previous investigations on the relationship between global rating measures and symptoms have not considered the additional role of functioning. In this naturalistic study, we examined the relationship between symptom domains and functioning on Clinical Global Impression scales for severity (CGI-S) and improvement (CGI-I) in a sample of patients with schizophrenia assessed to be treatment resistant. Participants were patients with a diagnosis of schizophrenia or schizoaffective disorder who failed 2 prior antipsychotic trials and were considered candidates for clozapine. They were assessed on the 18-item Brief Psychiatric rating Scale (BPRS), Social Occupational Functioning Assessment Scale (SOFAS), and CGI-S at baseline. A subset of patients was followed up at 6 weeks after initiation of clozapine and assessed on the CGI-I. The independent effects of symptom domains and functioning on the CGI scales were examined viamultivariate regression models. Brief Psychiatric rating Scale positive factor (P < 0.001) and SOFAS (P < 0.001) scores were significant determinants of CGI-S at baseline. Multivariate models suggested that relative change measures had a better fit for the CGI-I compared to absolute change measures (R-2 = 0.72 vs R-2 = 0.61, respectively). Improvements in BPRS positive (P < 0.001) and affect (P = 0.002) factors and SOFAS (P = 0.030) scores were significant determinants of CGI-I. Ratings of 1 and 2 on the CGI-I corresponded to a mean relative change in the BPRS total of 65% and 41%, respectively. Positive symptoms were a key determinant of clinicians' impression of severity and improvement in this study. Although psychosocial functioning played a large part in determining severity, it was not as significant in the assessment of improvement.	[Lee, Jimmy] Inst Mental Hlth, Dept Gen Psychiat 1, New York, NY USA; [Lee, Jimmy] Duke NUS Grad Med Sch, Off Clin Sci, Singapore, Singapore; [Lee, Jimmy; Fervaha, Gagan; Takeuchi, Hiroyoshi; Powell, Valerie; Remington, Gary] Ctr Addict & Mental Hlth, Schizophrenia Div, Toronto, ON M5T 1R8, Canada; [Fervaha, Gagan; Remington, Gary] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Takeuchi, Hiroyoshi] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Remington, Gary] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	Lee, J (reprint author), Ctr Addict & Mental Hlth, Schizophrenia Div, 250 Coll St, Toronto, ON M5T 1R8, Canada.	jimmy_lee@imh.com.sg			Roche; Singapore Ministry of Health's National Medical Research Council [NMRC/TA/002/2012]; Canadian Institutes of Health Research; CAMH Foundation; Japanese Society of Clinical Neuropsychopharmacology; Astellas Foundation for Research on Metabolic Disorders; Novartis Canada; Canadian Diabetes Association; Hoffman-La Roche; Laboratorios Farmaceuticos Rovi; Medicure; Neurocrine Biosciences; Research Hospital Fund-Canada Foundation for Innovation; Schizophrenia Society of Ontario	Dr Lee has received a consulting fee from Roche and is currently supported by the Singapore Ministry of Health's National Medical Research Council under its Transition Award (Grant No. NMRC/TA/002/2012). Dr Takeuchi has received fellowship grants from the Canadian Institutes of Health Research, CAMH Foundation, the Japanese Society of Clinical Neuropsychopharmacology, and Astellas Foundation for Research on Metabolic Disorders, and manuscript fees from Dainippon Sumitomo Pharma within the past 5 years. Ms Powell has received an honorarium from Novartis Canada. Dr Remington has received research support, consulting fees, or speaker's fees from the Canadian Diabetes Association, the Canadian Institutes of Health Research, Hoffman-La Roche, Laboratorios Farmaceuticos Rovi, Medicure, Neurocrine Biosciences, Novartis Canada, Research Hospital Fund-Canada Foundation for Innovation, and the Schizophrenia Society of Ontario. The other authors have no competing interests to disclose.	Shafer A, 2005, PSYCHOL ASSESSMENT, V17, P324, DOI 10.1037/1040-3590.17.3.324; Levine SZ, 2008, SCHIZOPHR RES, V98, P318, DOI 10.1016/j.schres.2007.09.006; Targum SD, 2008, HUM PSYCHOPHARM CLIN, V23, P629, DOI 10.1002/hup.966; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Leucht S, 2005, BRIT J PSYCHIAT, V187, P366, DOI 10.1192/bjp.187.4.366; Frogley C, 2012, INT J NEUROPSYCHOPH, V15, P1351, DOI 10.1017/S146114571100201X; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Goldman M, 1999, COMPR PSYCHIAT, V40, P458, DOI 10.1016/S0010-440X(99)90090-1; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Hermes EDA, 2012, J CLIN PSYCHIAT, V73, P526, DOI 10.4088/JCP.11m07162; Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82; Leucht S, 2006, NEUROPSYCHOPHARMACOL, V31, P2318, DOI 10.1038/sj.npp.1301147; Rabinowitz J, 2006, J CLIN PSYCHOPHARM, V26, P303, DOI 10.1097/01.jcp.0000218407.10362.6e; Schennach-Wolff R, 2010, J CLIN PSYCHOPHARM, V30, P726, DOI 10.1097/JCP.0b013e3181faf39b; Leucht S, 2005, SCHIZOPHR RES, V79, P231, DOI 10.1016/j.schres.2005.04.008; Buchanan Robert W, 2010, Schizophr Bull, V36, P71, DOI 10.1093/schbul/sbp116; Citrome L, 2014, J CLIN PSYCHIAT, V75, P21, DOI 10.4088/JCP.13049su1c.04; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Eckert SL, 1996, PSYCHIAT RES, V63, P67, DOI 10.1016/0165-1781(96)02870-3; Essock SM, 1996, SCHIZOPHRENIA BULL, V22, P15; Fervaha G, 2014, J CLIN PSYCHIAT; Guy W., 1976, DHEW PUBL, VADM 76-338, P218; Lee J, 2014, EUR NEUROPSYCHOPHARM, V24, P1622, DOI 10.1016/j.euroneuro.2014.08.003; Leucht S, 2012, EUR NEUROPSYCHOPHARM, V22, P501, DOI 10.1016/j.euroneuro.2011.11.007; Leucht S, 2009, ACTA PSYCHIAT SCAND, V119, P7, DOI 10.1111/j.1600-0447.2008.01308.x; Leucht S, 2013, EUR NEUROPSYCHOPHARM, V23, P956, DOI 10.1016/j.euroneuro.2012.11.004; Nierenberg Andrew A., 2001, Journal of Clinical Psychiatry, V62, P5; Overall JE, 1974, BRIEF PSYCHIAT RATIN; Rabinowitz J, 2010, J CLIN PSYCHOPHARM, V30, P478, DOI 10.1097/JCP.0b013e3181e7145f; Remington GJ, 1996, CAN J PSYCHIAT, V41, P161	30	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-0749	1533-712X		J CLIN PSYCHOPHARM	J. Clin. Psychopharmacol.	JUN	2015	35	3					237	241		10.1097/JCP.0000000000000310		5	Pharmacology & Pharmacy; Psychiatry	Pharmacology & Pharmacy; Psychiatry	CH1XS	WOS:000353817400005		
J	Ota, T; Miura, I; Kanno-Nozaki, K; Hoshino, H; Horikoshi, S; Fujimori, H; Kanno, T; Mashiko, H; Yabe, H				Ota, Takafumi; Miura, Itaru; Kanno-Nozaki, Keiko; Hoshino, Hiroshi; Horikoshi, Sho; Fujimori, Haruo; Kanno, Tomoyuki; Mashiko, Hirobumi; Yabe, Hirooki			Effects of Shakuyaku-Kanzo-to on Extrapyramidal Symptoms During Antipsychotic Treatment A Randomized, Open-Label Study	JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY			English	Article						antipsychotics; shakuyaku-kanzo-to; extrapyramidal symptoms; homovanillic acid	PLASMA; HYPERPROLACTINEMIA; SCHIZOPHRENIA; METABOLITES; OLANZAPINE	Extrapyramidal symptoms (EPS) are common adverse effects of antipsychotic treatment. This study examined the effects of the traditional Japanese herbal medicine (kampo) shakuyaku-kanzo-to on EPS during antipsychotic treatment. Twenty-two Japanese patients with psychiatric disorderswho had developed EPS during antipsychotic treatment were randomly allocated to receive either shakuyaku-kanzo-to (7.5 g/d) or biperiden (3 mg/d) for 2 weeks. Extrapyramidal symptoms were evaluated using the Drug-Induced Extrapyramidal Symptom Scale (DIEPSS) and the Barnes Akathisia Rating Scale. Plasma levels of the monoamine metabolite homovanillic acid and serum prolactin levels were measured to investigate the mechanisms of action of shakuyaku-kanzo-to. Twenty of the 22 patients completed the study (10 patients in the shakuyaku-kanzo-to group and 10 patients in the biperiden group). There was a time effect on the Drug-Induced Extrapyramidal Symptom Scale total score (P < 0.01), suggesting that both shakuyaku-kanzo-to and biperiden decreased EPS. Notably, there was a time X drug interaction in dystonia, suggesting that shakuyaku-kanzo-to had a greater effect on dystonia compared with biperiden. No significant changes were observed in plasma homovanillic acid or serum prolactin levels after 2 weeks of treatment in either group. The effects of shakuyaku-kanzo-to on abnormal muscle tonus and dopamine D2 receptors may have contributed to improve EPS. These results suggest that shakuyaku-kanzo-to may be useful in decreasing EPS, especially dystonia, in patients undergoing treatment with antipsychotic agents.	[Ota, Takafumi; Miura, Itaru; Kanno-Nozaki, Keiko; Hoshino, Hiroshi; Horikoshi, Sho; Mashiko, Hirobumi; Yabe, Hirooki] Fukushima Med Univ, Sch Med, Dept Neuropsychiat, Fukushima 9601295, Japan; [Fujimori, Haruo; Kanno, Tomoyuki] Fukushima Red Cross Hosp, Fukushima, Japan	Miura, I (reprint author), Fukushima Med Univ, Sch Med, Dept Neuropsychiat, 1 Hikarigaoka, Fukushima 9601295, Japan.	itaru@fmu.ac.jp			Eli Lilly Fellowship for Clinical Psychopharmacology	Dr Ota has no disclosures to declare. Dr Miura has received speaker's honoraria from Dainippon Sumitomo, Janssen, Meiji Seika, Otsuka, and Yoshitomi. He has received grant support from the Eli Lilly Fellowship for Clinical Psychopharmacology. Drs Kanno-Nozaki, Hoshino, Horikoshi, Fujimori, Kanno, Mashiko, and Yabe have no disclosures to declare.	American Psychiatric Association, 2004, PRACT GUID TREATM PA, V2nd, P86; Lee KK, 2013, J ETHNOPHARMACOL, V145, P286, DOI 10.1016/j.jep.2012.11.005; Hyodo T, 2006, NEPHRON CLIN PRACT, V104, pC28, DOI 10.1159/000093256; Miura I, 2012, J CLIN PSYCHOPHARM, V32, P106, DOI 10.1097/JCP.0b013e31823f87ac; GERHARDT GA, 1986, ANAL CHEM, V58, P2879, DOI 10.1021/ac00126a067; Homma M, 2006, YAKUGAKU ZASSHI, V126, P973, DOI 10.1248/yakushi.126.973; Hori H, 2013, J CLIN PSYCHOPHARM, V33, P122, DOI 10.1097/01.jcp.0000426177.36207.da; Ilyina Rosa Yu, 2013, Int J Risk Saf Med, V25, P95, DOI 10.3233/JRS-130584; Inada T, 2003, INT CLIN PSYCHOPHARM, V18, P39, DOI 10.1097/01.yic.0000047781.24295.77; Kelley ME, 1999, NEUROPSYCHOPHARMACOL, V20, P603, DOI 10.1016/S0893-133X(98)00094-3; Kimura M, 2011, SCI KAMPO MED, V35, P58; Kimura M, 1992, TAISYA, V29, P9; Kumada T, 1999, J CLIN THER MED, V15, P499; Sasaki I, 2005, SCI KANPO MED, V29, P18; Yamada K, 1999, J CLIN PSYCHOPHARM, V19, P380, DOI 10.1097/00004714-199908000-00018; Yamada K, 1997, J CLIN PSYCHOPHARM, V17, P234, DOI 10.1097/00004714-199706000-00025	16	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-0749	1533-712X		J CLIN PSYCHOPHARM	J. Clin. Psychopharmacol.	JUN	2015	35	3					304	307		10.1097/JCP.0000000000000312		4	Pharmacology & Pharmacy; Psychiatry	Pharmacology & Pharmacy; Psychiatry	CH1XS	WOS:000353817400014		
J	Miura, I; Kanno-Nozaki, K; Hino, M; Horikoshi, S; Ota, T; Mashiko, H; Niwa, SI; Yabe, H				Miura, Itaru; Kanno-Nozaki, Keiko; Hino, Mizuki; Horikoshi, Sho; Ota, Takafumi; Mashiko, Hirobumi; Niwa, Shin-Ichi; Yabe, Hirooki			Influence of-141C Ins/Del Polymorphism in DRD2 Gene on Clinical Symptoms and Plasma Homovanillic Acid Levels in the Treatment of Schizophrenia With Aripiprazole	JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY			English	Letter							DOPAMINE D2 RECEPTOR		[Miura, Itaru; Kanno-Nozaki, Keiko; Hino, Mizuki; Horikoshi, Sho; Ota, Takafumi; Mashiko, Hirobumi; Niwa, Shin-Ichi; Yabe, Hirooki] Fukushima Med Univ, Sch Med, Dept Neuropsychiat, Fukushima, Japan; [Niwa, Shin-Ichi] Fukushima Med Univ, Aizu Med Ctr, Dept Neuropsychiat, Aizu Wakamatsu, Fukushima, Japan	Miura, I (reprint author), Fukushima Med Univ, Sch Med, Dept Neuropsychiat, Fukushima, Japan.	itaru@fmu.ac.jp					Zhang JP, 2010, AM J PSYCHIAT, V167, P763, DOI 10.1176/appi.ajp.2009.09040598; Arinami T, 1997, HUM MOL GENET, V6, P577, DOI 10.1093/hmg/6.4.577; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Miura I, 2012, J CLIN PSYCHOPHARM, V32, P106, DOI 10.1097/JCP.0b013e31823f87ac; Dolzan V, 2007, AM J MED GENET B, V144B, P809, DOI 10.1002/ajmg.b.30544; Shen YC, 2009, J PSYCHIATR RES, V43, P600, DOI 10.1016/j.jpsychires.2008.09.005; Himei A, 2002, PSYCHIAT CLIN NEUROS, V56, P97, DOI 10.1046/j.1440-1819.2002.00935.x; Nagai G, 2012, PSYCHIAT CLIN NEUROS, V66, P518, DOI 10.1111/j.1440-1819.2012.02391.x; Ujike H, 2009, PROG NEURO-PSYCHOPH, V33, P625, DOI 10.1016/j.pnpbp.2009.02.019; Zahari Z, 2011, PSYCHIAT GENET, V21, P183, DOI 10.1097/YPG.0b013e3283437250	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-0749	1533-712X		J CLIN PSYCHOPHARM	J. Clin. Psychopharmacol.	JUN	2015	35	3					333	334				2	Pharmacology & Pharmacy; Psychiatry	Pharmacology & Pharmacy; Psychiatry	CH1XS	WOS:000353817400020		
J	Amin, AFMS; Bhuiyan, AR; Hossain, T; Okui, Y				Amin, A. F. M. S.; Bhuiyan, A. R.; Hossain, T.; Okui, Y.			Nonlinear Viscosity Law in Finite-Element Analysis of High Damping Rubber Bearings and Expansion Joints	JOURNAL OF ENGINEERING MECHANICS			English	Article						High damping rubber; Nonlinear viscosity law; Finite-element implementation; Isolation bearing; Expansion joints	PARAMETER-IDENTIFICATION; NUMERICAL VERIFICATION; CONSTITUTIVE MODEL; DEFORMATION; VISCOELASTICITY; COMPRESSION; IMPLEMENTATION; EQUATIONS; BEHAVIOR; DAMAGE	A simple computational strategy for finite-element implementation of a finite-strain viscohyperelasticity model for rubber-like materials was developed. The constitutive model has had a strong physical significance because of the explicit consideration of the nonlinear dependence of viscosity through internal variables (e.g., past maximum overstress and current deformation). To simulate the stress-strain response for particular one-dimensional boundary value problems, a scheme for solving the first-order differential equation representing the viscosity-induced strain-rate effect of rubber was proposed. The scheme was successful in reproducing experimental results obtained from high-damping rubber specimens. In addition, the wider applicability of the proposed strategy in simulation was tested by verifying the numerical results with independent experiments on full-scale high-damping rubber bearings with different geometries and loading rates. The effect of shape factor on bearing responses was examined through numerical examples obtained from different finite-element models subjected to the same load and loading rate. Finally, the proposed computational strategy was applied to locate the regions of stress concentrations in steel plate laminated rubber expansion joints used widely to transfer reactions at central-hinge locations on balanced cantilever highway bridges. (C) 2014 American Society of Civil Engineers.	[Amin, A. F. M. S.] Bangladesh Univ Engn & Technol, Dept Civil Engn, Dhaka 1000, Bangladesh; [Bhuiyan, A. R.] Chittagong Univ Engn & Technol, Dept Civil Engn, Chittagong 4349, Bangladesh; [Hossain, T.] Dhaka Univ Engn & Technol, Dept Civil Engn, Gazipur 1700, Bangladesh; [Okui, Y.] Saitama Univ, Dept Civil & Environm Engn, Sakura Ku, Saitama 3388570, Japan	Amin, AFMS (reprint author), Bangladesh Univ Engn & Technol, Dept Civil Engn, Dhaka 1000, Bangladesh.	samin@ce.buet.ac.bd			Japanese Ministry of Education, Science, Sports and Culture [12650457]	The authors are very grateful to Professor H. Horii, Department of Civil Engineering, University of Tokyo, Japan, for his valuable comments and suggestions and particularly for allowing the use of the experimental facilities of his laboratory to carry out the mechanical tests in the investigation. The authors gratefully acknowledge the kind cooperation extended by the Yokohama Rubber Co. in providing test specimens. The authors also sincerely appreciate the funding provided by the Japanese Ministry of Education, Science, Sports and Culture as Grant-in-Aid for Scientific Research (C) (No. 12650457) to carry out this research.	Amin A. F. M. S, 2001, THESIS SAITAMA U SAI; Amin AFMS, 2006, J ENG MECH-ASCE, V132, P54, DOI 10.1061/(ASCE)0733-9399(2006)132:1(54); LUBLINER J, 1973, ACTA MECH, V17, P109, DOI 10.1007/BF01260883; Bergstrom JS, 1998, J MECH PHYS SOLIDS, V46, P931, DOI 10.1016/S0022-5096(97)00075-6; SIMO JC, 1991, COMPUT METHOD APPL M, V85, P273, DOI 10.1016/0045-7825(91)90100-K; [Anonymous], FEAP 8 1 COMP SOFTW; Bhuiyan AR, 2009, INT J SOLIDS STRUCT, V46, P1778, DOI 10.1016/j.ijsolstr.2009.01.005; Dal H, 2009, COMPUT MECH, V44, P809, DOI 10.1007/s00466-009-0407-2; Amin AFMS, 2002, MECH MATER, V34, P75, DOI 10.1016/S0167-6636(01)00102-8; Amin AFMS, 2006, INT J PLASTICITY, V22, P1610, DOI 10.1016/j.ijplas.2005.09.005; Miehe C, 2000, J MECH PHYS SOLIDS, V48, P323, DOI 10.1016/S0022-5096(99)00017-4; Haupt P, 2001, ARCH APPL MECH, V71, P89, DOI 10.1007/s004190000102; Mooney M, 1940, J APPL PHYS, V11, P582, DOI 10.1063/1.1712836; LUBLINER J, 1985, MECH RES COMMUN, V12, P93, DOI 10.1016/0093-6413(85)90075-8; Bhuiyan A. R., 2007, P 5 EUR C CONST MOD, P274; Hasanpour K, 2008, COMPUT STRUCT, V86, P1643, DOI 10.1016/j.compstruc.2008.01.004; Hasanpour K, 2009, INT J PLASTICITY, V25, P1154, DOI 10.1016/j.ijplas.2008.06.012; Hossain T, 2007, THESIS BANGLADESH U; Huber N, 2000, MECH MATER, V32, P1, DOI 10.1016/S0167-6636(99)00045-9; Imbimbo M, 1998, COMPUT STRUCT, V68, P31, DOI 10.1016/S0045-7949(98)00038-8; Johlitz M, 2007, J MATER SCI, V42, P9894, DOI 10.1007/s10853-006-1479-4; Johlitz M, 2008, J MATER SCI, V43, P4768, DOI 10.1007/s10853-008-2674-2; Kelly J. M, 1997, EARTHQUAKE RESISTANT; Lion A, 1996, CONTINUUM MECH THERM, V8, P153; Matsuda A, 2004, J PRESS VESS-T ASME, V126, P134, DOI 10.1115/1.1636784; Noll W., 2004, NONLINEAR FIELD THEO; RIVLIN RS, 1951, PHILOS TR R SOC S-A, V243, P251, DOI 10.1098/rsta.1951.0004; Shariff MHBM, 2000, RUBBER CHEM TECHNOL, V73, P1, DOI 10.5254/1.3547576; SIMO JC, 1987, COMPUT METHOD APPL M, V60, P153, DOI 10.1016/0045-7825(87)90107-1; SIMO JC, 1985, COMPUT METHOD APPL M, V51, P177, DOI 10.1016/0045-7825(85)90033-7; Spathis G, 2008, J MATER SCI, V43, P2046, DOI 10.1007/s10853-007-2428-6; Spuler T., 2010, P IABSE JSCE JOINT C, P275; Taylor R. L., 2006, FEAP FINITE ELEMENT; Treloar LRG, 1944, T FARADAY SOC, V40, P0059, DOI 10.1039/tf9444000059; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	35	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-9399	1943-7889		J ENG MECH	J. Eng. Mech.	JUN	2015	141	6							04014169	10.1061/(ASCE)EM.1943-7889.0000888		11	Engineering, Mechanical	Engineering	CI2CD	WOS:000354551500009		
J	Rayamajhi, D; Tamura, S; Khosravi, M; Boulanger, RW; Wilson, DW; Ashford, SA; Olgun, CG				Rayamajhi, Deepak; Tamura, Shuji; Khosravi, Mohammad; Boulanger, Ross W.; Wilson, Daniel W.; Ashford, Scott A.; Olgun, C. Guney			Dynamic Centrifuge Tests to Evaluate Reinforcing Mechanisms of Soil-Cement Columns in Liquefiable Sand	JOURNAL OF GEOTECHNICAL AND GEOENVIRONMENTAL ENGINEERING			English	Article						Earthquake engineering; Ground improvement; Liquefaction; Deep soil mixing; Soil-cement columns; Centrifuge testing	STONE COLUMNS; LIQUEFACTION; MITIGATION	Four centrifuge tests were performed to investigate the reinforcing mechanisms of soil-cement columns in liquefiable sand. Two unimproved baseline models and two models improved with soil-cement columns were subjected to sine sweep and earthquake base motions of varying intensities to observe acceleration, pore pressure, lateral displacement, and settlement responses. The dynamic records were processed to derive the effective natural frequency of the profiles and to obtain the dynamic stress-strain responses for unimproved and improved soil. It was found that the shear reinforcement mechanisms of columns was not effective in reducing cyclic stress ratios in the treated soil; liquefaction triggering occurred nearly at same time for both unimproved and improved soil cases and the magnitude of the resulting soil settlement was not significantly reduced. When the bases of the columns were free to rotate, the columns rocked within the soil and produced negligible shear stiffening of the soil profile. When the bases of the columns were fixed against rocking, the columns deformed primarily in shear and flexure but the observed increase in natural frequency of the improved profile was much smaller than predicted by assuming shear strain compatibility between the columns and soil. Design equations that account for shear strain incompatibility are shown to give reasonable estimates for the observed natural frequency of the improved soil profile, and these equations suggest that the associated reduction in cyclic shear stress in the improved soil is small. The soil-cement columns did, however, remain intact and would have provided a means for supporting overlying structures even after liquefaction was triggering in the soil. (C) 2015 American Society of Civil Engineers.	[Rayamajhi, Deepak] Oregon State Univ, Sch Civil & Construct Engn, Corvallis, OR 97331 USA; [Tamura, Shuji] Tokyo Inst Technol, Dept Architecture & Bldg Engn, Meguro Ku, Tokyo 1528550, Japan; [Khosravi, Mohammad; Olgun, C. Guney] Virginia Tech, Dept Civil & Environm Engn, Blacksburg, VA 24061 USA; [Boulanger, Ross W.] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA; [Wilson, Daniel W.] Univ Calif Davis, Dept Civil & Environm Engn, Ctr Geotech Modeling, Davis, CA 95616 USA; [Ashford, Scott A.] Oregon State Univ, Coll Engn, Corvallis, OR 97331 USA	Rayamajhi, D (reprint author), Oregon State Univ, Sch Civil & Construct Engn, 220 Owen Hall, Corvallis, OR 97331 USA.	rayamajd@onid.orst.edu; tamura.s.aj@m.titech.ac.jp; khosravi@vt.edu; rwboulanger@ucdavis.edu; dxwilson@ucdavis.edu; scott.ashford@oregonstate.edu; colgun@vt.edu			Oregon Transportation Research and Education Consortium (OTREC); Oregon Department of Transportation (ODOT); Pacific Earthquake Engineering Research Center (PEER); Japan Society for the Promotion of Science (JSPS); Disaster Prevention Research Institute (DPRI), Kyoto University; National Science Foundation (NSF) through the George E. Brown, Jr. Network for Earthquake Engineering Simulation (NEEScomm) [CMMI-1208117]	Support for this research was provided by the Oregon Transportation Research and Education Consortium (OTREC), Oregon Department of Transportation (ODOT), Pacific Earthquake Engineering Research Center (PEER), Japan Society for the Promotion of Science (JSPS), Disaster Prevention Research Institute (DPRI), Kyoto University, and National Science Foundation (NSF) through the George E. Brown, Jr. Network for Earthquake Engineering Simulation (NEEScomm) under Grant No. CMMI-1208117. The staff at the Center for Geotechnical Modeling at UC Davis assisted with development of model preparation methods. All of the support and assistance are greatly appreciated.	Adalier K, 2004, ENG GEOL, V72, P275, DOI 10.1016/j.enggeo.2003.11.001; Adalier K, 2003, SOIL DYN EARTHQ ENG, V23, P571, DOI 10.1016/S0267-7261(03)00070-8; Martin JR, 2004, J GEOTECH GEOENVIRON, V130, P561, DOI 10.1016/(ASCE)1090-0241(2004)130:6(561); Brandenberg SJ, 2010, J GEOTECH GEOENVIRON, V136, P854, DOI 10.1061/(ASCE)GT.1943-5606.0000277; Arulmoli K., 1992, VELACS VERIFICATION; Baez J. I., 1995, THESIS U SO CALIFORN; Dashti S, 2009, THESIS U CALIFORNIA; Durgunoglu H. T., 2006, US 8 NAT C EARTHQ EN; FIEGEL GL, 1994, CENTRIFUGE 94, P145; GEER (Geotechnical Extreme Events Reconnaissance), 2011, GEOT REC 2011 CHRIST; GEER (Geotechnical Extreme Events Reconnaissance), 2010, GEOT ENG REC 2010 HA; GEER (Geotechnical Extreme Events Reconnaissance), 2011, GEOT QUICK REP KANT; Goughnour R. R., 1998, P 2 INT C GROUND IMP, P157; Green R. A., 2008, GEOTECHNICAL EARTHQU; Gueguin Maxime, 2013, International Journal for Numerical and Analytical Methods in Geomechanics, V37, DOI 10.1002/nag.2183; Kamai R., 2010, MESOSCALE SHEAR PHYS, P219; Mitchell J. K., 2008, RES PRACTICE GEOTECH, P433; Olgun C. G., 2008, GEOTECHNICAL EARTHQU; RAYAMAJHI D, 2014, J GEOTECH GEOENVIRON, V140, DOI DOI 10.1061/(ASCE)GT.1943-5606.0000970; Rayamajhi D., 2012, P GEOC 2012 STAT ART, P1908; Rayamajhi D., 2014, REINFORCING EFFECTS; Schofield A. N., 1981, P INT C RECENT ADV G, P1081	22	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1090-0241	1943-5606		J GEOTECH GEOENVIRON	J. Geotech. Geoenviron. Eng.	JUN	2015	141	6							04015015	10.1061/(ASCE)GT.1943-5606.0001298		12	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CI2AJ	WOS:000354546400001		
J	Sato, M; Muraoka, K				Sato, Masayuki; Muraoka, Koji			Flight Controller Design and Demonstration of Quad-Tilt-Wing Unmanned Aerial Vehicle	JOURNAL OF GUIDANCE CONTROL AND DYNAMICS			English	Article; Proceedings Paper	AIAA Guidance, Navigation, and Control (GNC) Conference / AIAA Infotech at Aerospace Conference	AUG 19-22, 2013	Boston, MA	AIAA				This paper concerns the flight controller design of aircraft that has significant changes in aerodynamic characteristics and addresses the flight controller design of a quad-tilt-wing unmanned aerial vehicle that has vertical takeoff and landing as well as high-speed cruise capabilities. The quad-tilt-wing unmanned aerial vehicle has a tandem wing that tilts between vertical to horizontal positions. This configuration change significantly alters its aerodynamic characteristics, and therefore requires a gain-scheduled flight controller. The gain-scheduled flight controller, which consists of a gain-scheduled stability augmentation system, a gain-scheduled control augmentation system, and a gain-scheduled turn coordinator, is also required to be robust against modeling errors because the motion dynamics of the quad-tilt-wing unmanned aerial vehicle are inherently unstable at almost all wing tilt angles and the precise aerodynamic characteristics are not available. To this end, this paper proposes a design method for structured gain-scheduled flight controllers by combining a conventional gain-scheduled controller design method and multiple-model approach to satisfy the robustness requirement, and it designs a gain-scheduled flight controller for the quad-tilt-wing unmanned aerial vehicle. The effectiveness of the method is demonstrated by flight tests during which the quad-tilt-wing unmanned aerial vehicle successfully achieved full conversion flight: that is, vertical takeoff, accelerating transition, high-speed cruise, decelerating transition, and vertical landing, as well as super-short takeoff.	[Sato, Masayuki; Muraoka, Koji] Japan Aerosp Explorat Agcy, Flight Res Ctr, Mitaka, Tokyo 1810015, Japan	Sato, M (reprint author), Japan Aerosp Explorat Agcy, Flight Res Ctr, Mitaka, Tokyo 1810015, Japan.						Ackermann J., 1985, LECT NOTES CONTROL I, V70, P108, DOI DOI 10.1007/BFB0007282; Ahn O. S., 2010, 27 C INT COUNC AER S; Cetinsoy E, 2012, MECHATRONICS, V22, P723, DOI 10.1016/j.mechatronics.2012.03.003; [Anonymous], 2005, UNM AIRCR SYST ROADM; BECKER G, 1994, SYST CONTROL LETT, V23, P205, DOI 10.1016/0167-6911(94)90006-X; Cox T.H., 2004, CIVIL UAV CAPABILITY; Daly M, 2011, JANES UNMANNED AERIA; Maisel M. D., 2000, TRSP20004517 NASA; MIYAZAWA Y, 1992, J GUID CONTROL DYNAM, V15, P785, DOI 10.2514/3.20908; Zope R, 2012, CONTROL OF LINEAR PARAMETER VARYING SYSTEMS WITH APPLICATIONS, P279, DOI 10.1007/978-1-4614-1833-7_11; Muraoka K., 2009, AIAA INF AER C, DOI [10.2514/6.2009-1834, DOI 10.2514/6.2009-1834]; Muraoka K., 2012, 28 C INT COUNC AER S; Nonami K, 2010, AUTONOMOUS FLYING ROBOTS: UNMANNED AERIAL VEHICLES AND MICRO AERIAL VEHICLES, P77, DOI 10.1007/978-4-431-53856-1_4; Rutherford J., 1992, AIAA AIRCR DES SYST, DOI [10.2514/6.1992-4237, DOI 10.2514/6.1992-4237]; Sato M., 2013, P AM CONTR C DAYT OH, P6845; Sato M., 2013, AIAA GUID NAV CONTR, DOI [10.2514/6.2013-5100, DOI 10.2514/6.2013-5100]; Sename O., 2013, LECT NOTES CONTROL I, V437; White A. P., SPRINGER BRIEFS ELEC	18	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0731-5090	1533-3884		J GUID CONTROL DYNAM	J. Guid. Control Dyn.	JUN	2015	38	6					1071	1082		10.2514/1.G000263		12	Engineering, Aerospace; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI2ZC	WOS:000354615900008		
J	Ferenci, P; Asselah, T; Foster, GR; Zeuzem, S; Sarrazin, C; Moreno, C; Ouzan, D; Maevskaya, M; Calinas, F; Morano, LE; Crespo, J; Dufour, JF; Bourliere, M; Agarwal, K; Forton, D; Schuchmann, M; Zehnter, E; Nishiguchi, S; Omata, M; Kukolj, G; Datsenko, Y; Garcia, M; Scherer, J; Quinson, AM; Stern, JO				Ferenci, Peter; Asselah, Tarik; Foster, Graham R.; Zeuzem, Stefan; Sarrazin, Christoph; Moreno, Christophe; Ouzan, Denis; Maevskaya, Marina; Calinas, Filipe; Morano, Luis E.; Crespo, Javier; Dufour, Jean-Francois; Bourliere, Marc; Agarwal, Kosh; Forton, Daniel; Schuchmann, Marcus; Zehnter, Elmar; Nishiguchi, Shuhei; Omata, Masao; Kukolj, George; Datsenko, Yakov; Garcia, Miguel; Scherer, Joseph; Quinson, Anne-Marie; Stern, Jerry O.		STARTVerso1 Study Grp	STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection	JOURNAL OF HEPATOLOGY			English	Article						NS3/4A protease inhibitor; SVR12; Early treatment success; DAA; Clinical trial; Phase 3	CHRONIC HEPATITIS-C; TREATMENT-NAIVE PATIENTS; SUSTAINED VIROLOGICAL RESPONSE; LIVER FIBROSIS; TRANSIENT ELASTOGRAPHY; TRIPLE THERAPY; PHASE-3 TRIAL; DOUBLE-BLIND; BI 201335; ALPHA 2A	Background & Aims: The efficacy and tolerability of faldaprevir, a potent hepatitis C virus (HCV) NS3/4A protease inhibitor, plus peginterferon (PegIFN) and ribavirin (RBV) was assessed in a double- blind, placebo-controlled phase 3 study of treatment-naive patients with HCV genotype-1 infection. Methods: Patients were randomly assigned (1: 2: 2) to PegIFN/RBV plus: placebo (arm 1, n = 132) for 24 weeks; faldaprevir (120 mg, once daily) for 12 or 24 weeks (arm 2, n = 259); or faldaprevir (240 mg, once daily) for 12 weeks (arm 3, n = 261). In arms 2 and 3, patients with early treatment success (HCV-RNA < 25 IU/ml at week 4 and undetectable at week 8) stopped all treatment at week 24. Other patients received PegIFN/RBV until week 48 unless they met futility criteria. The primary endpoint was sustained virologic response 12 weeks post-treatment (SVR12). Results: SVR12 was achieved by 52%, 79%, and 80% of patients in arms 1, 2, and 3, respectively (estimated difference for arms 2 and 3 vs. arm 1: 27%, 95% confidence interval 17%-36%; and 29%, 95% confidence interval, 19%-38%, respectively; p < 0.0001 for both). Early treatment success was achieved by 87% (arm 2) and 89% (arm 3) of patients, of whom 86% and 89% achieved SVR12. Adverse event rates were similar among groups; few adverse events led to discontinuation of all regimen components. Conclusions: Faldaprevir plus PegIFN/RBV significantly increased SVR12, compared with PegIFN/RBV, in treatment-naive patients with HCV genotype-1 infection. No differences were seen in responses of patients given faldaprevir once daily at 120 or 240 mg. (C) 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[Ferenci, Peter] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, A-1090 Vienna, Austria; [Asselah, Tarik] Univ Paris Diderot, Hop Beaujon, AP HP, Dept Hepatol, Clichy, France; [Asselah, Tarik] INSERM, CRB3, Clichy, France; [Foster, Graham R.] Univ London, Barts & London Sch Med & Dent, Dept Hepatol, London, England; [Zeuzem, Stefan; Sarrazin, Christoph] JW Goethe Univ Hosp, Dept Internal Med, Frankfurt, Germany; [Moreno, Christophe] Univ Libre Bruxelles, Hop Univ Erasme, Dept Gastroenterol Hepatopancreatol & Digest Onco, Brussels, Belgium; [Ouzan, Denis] Inst Arnault Tzanck, Dept Hepatogastroenterol, St Laurent Du Var, France; [Maevskaya, Marina] First Moscow State Med Univ, Hepatol Dept, Moscow, Russia; [Calinas, Filipe] Ctr Hosp Lisboa Cent, Gastroenterol Serv, Lisbon, Portugal; [Morano, Luis E.] Hosp Meixoeiro, Depnt Internal Med Infect Dis, Vigo, Spain; [Crespo, Javier] Hosp Univ Marques de Valdecilla, Dept Gastroenterol & Hepatol, Santander, Spain; [Dufour, Jean-Francois] Univ Clin Visceral Surg & Med, Dept Hepatol, Bern, Switzerland; [Bourliere, Marc] Hop St Joseph, Dept Hepatogastroenterol, Marseille, France; [Agarwal, Kosh] Kings Coll Hosp London, Inst Liver Studies, London, England; [Forton, Daniel] St George Hosp, Dept Gastroenterol & Hepatol, London, England; [Schuchmann, Marcus] Univ Hosp Mainz, Dept Med 1, Mainz, Germany; [Zehnter, Elmar] Schwerpunktpraxis Hepatol, Gastroenterol Practice, Dortmund, Germany; [Nishiguchi, Shuhei] Hyogo Coll Med, Dept Internal Med, Nishinomiya, Hyogo, Japan; [Omata, Masao] Yamanishi Cent & Kita Hosp, Dept Gastroenterol, Yamanishi, Japan; [Kukolj, George; Garcia, Miguel; Scherer, Joseph; Quinson, Anne-Marie; Stern, Jerry O.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Datsenko, Yakov] Boehringer Ingelheim Pharmaceut GmbH & Co KG, Biberach, Germany	Ferenci, P (reprint author), Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	peter.ferenci@meduniwien.ac.at			Boehringer Ingelheim Pharmaceuticals, GmbH Co. KG	Boehringer Ingelheim Pharmaceuticals, GmbH & Co. KG.	AASLD/IDSA/IAS-USA, REC TEST MAN TREAT H; Nishiguchi S, 2014, LIVER INT, V34, P78, DOI 10.1111/liv.12254; White PW, 2010, ANTIMICROB AGENTS CH, V54, P4611, DOI 10.1128/AAC.00787-10; Sulkowski MS, 2013, HEPATOLOGY, V57, P2143, DOI 10.1002/hep.26276; Chen JM, 2013, GASTROENTEROLOGY, V144, P1450, DOI 10.1053/j.gastro.2013.02.039; Ferenci P, 2014, HEPATOL INT, V8, P83, DOI 10.1007/s12072-013-9484-6; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Forns X, 2014, GASTROENTEROLOGY, V146, P1669, DOI 10.1053/j.gastro.2014.02.051; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Hezode C, 2013, J HEPATOL, V59, P434, DOI 10.1016/j.jhep.2013.04.035; Jacobson IM, 2014, LANCET, V384, P403, DOI 10.1016/S0140-6736(14)60494-3; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Manns MP, 2011, J HEPATOL, V54, P1114, DOI 10.1016/j.jhep.2010.08.040; Manns M, 2014, LANCET, V384, P414, DOI 10.1016/S0140-6736(14)60538-9; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Llinas-Brunet M, 2010, J MED CHEM, V53, P6466, DOI 10.1021/jm100690x; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Dieterich D, 2014, ANTIMICROB AGENTS CH, V58, P3429, DOI 10.1128/AAC.02497-13; Ferenci P, 2014, GUT, V63, P1033, DOI 10.1136/gutjnl-2013-306480; HCV Phenotype Working Group HCV Drug Development Advisory Group, 2012, ANN FORUM COLLAB HIV, V14, P1; Huisman MT, 2010, HEPATOLOGY, V52, p123A; Jacobson IM, 2013, HEPATOLOGY AASLD, V58; Janssen Cilag International NV, 2013, INCIVO TEL SUMM PROD; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Merck & Co. Inc, 2013, VICTRELIS BOC SUMM P; Merck & Co. Inc, 2014, VICTRELIS BOC HIGHL; Sabo JP, 2013, 2013 C RETR OPP INF; Sane RS, 2014, J PHARMACOL EXP THER, V351, P403, DOI 10.1124/jpet.114.218081; Sulkowski MS, 2013, HEPATOLOGY, V57, P2155, DOI 10.1002/hep.26386; US Food and Drug Administration (FDA), 2012, INC TEL COMB DRUGS P; US Food and Drug Administration (FDA), 2009, DIV AIDS TABL GRAD S; Vertex Pharmaceuticals Incorporated, 2013, INCIVEK TEL HIGHL US; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557	38	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	JUN	2015	62	6					1246	1255		10.1016/j.jhep.2014.12.024		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CI2KA	WOS:000354574800006		
J	Abd Elbasit, MAM; Ojha, CSP; Ahmed, Z; Yasuda, H; Salmi, A; Ahmed, F				Abd Elbasit, M. A. M.; Ojha, C. S. P.; Ahmed, Z.; Yasuda, H.; Salmi, A.; Ahmed, F.			Rain Microstructure and Erosivity Relationships under Pressurized Rainfall Simulator	JOURNAL OF HYDROLOGIC ENGINEERING			English	Article						Drop size distribution; Erosivity; Piezoelectric transducer; Soil erosion; Rainfall energy	KINETIC-ENERGY RELATIONSHIPS; PIEZOELECTRIC TRANSDUCERS; SOIL SPLASH; INTENSITY; SIZE; CALIBRATION; EROSION; IMPACT	Rain simulators have been used extensively in order to assess the interaction between rainfall and land surface. The main objective of a rain simulator is to produce rain with characteristics similar to natural rainfall at a certain geographical location. This paper investigates the microstructural characteristics of rainfall generated by a pressurized simulation system and their impact on rainfall erosivity in comparison with natural rainfall for different environments. The simulated raindrop characteristics have been measured using two piezoelectric transducers to investigate the rainfall kinetic energy and drop size distribution. The pressurized simulation system was able to generate rain with different intensities and the relationship between the pressure and rainfall intensity was statistically significant. On the other hand, the time-based rainfall kinetic energy was increasing linearly with rainfall intensity. The pressurized rain simulator showed low volume-based kinetic energy (KEc) and the trend was different from that observed under natural rainfall. The average percentage of small raindrops (<2mm) was more than 98%, and the average median drop size was 1.4mm.	[Abd Elbasit, M. A. M.] Univ Johannesburg, Dept Geog Environm Management & Energy Studies, ZA-2006 Johannesburg, South Africa; [Ojha, C. S. P.] Indian Inst Technol, Dept Civil Engn, Roorkee 247667, Uttar Pradesh, India; [Ahmed, Z.] Univ Haripur, Soil & Environm Sci Sect, Dept Agr, Haripur 22620, Pakistan; [Yasuda, H.] Tottori Univ, Arid Land Res Ctr, Tottori 1390, Japan; [Salmi, A.] Gradient Lab Ltd, FI-06150 Porvoo, Finland; [Ahmed, F.] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, ZA-2050 Johannesburg, South Africa	Abd Elbasit, MAM (reprint author), Univ Johannesburg, Dept Geog Environm Management & Energy Studies, ZA-2006 Johannesburg, South Africa.	abdelbasit@uj.ac.za					Abd Elbasit MAM, 2011, HYDROLOG SCI J, V56, P187, DOI 10.1080/02626667.2010.546359; ALDURRAH MM, 1982, SOIL SCI SOC AM J, V46, P1086; Amu-Mensah F. K., 2013, INT J WATER RESOU EN, V5, P426, DOI [10. 5897/IJWREE2012. 0398, DOI 10.5897/IJWREE2012.0398]; Esteves M, 2000, EARTH SURF PROC LAND, V25, P681, DOI 10.1002/1096-9837(200007)25:7<681::AID-ESP124>3.3.CO;2-#; Abd Elbasit MAM, 2010, EARTH SURF PROC LAND, V35, P466, DOI 10.1002/esp.1935; Mouzai L, 2003, J HYDRAUL RES, V41, P61; PALL R, 1983, CAN AGR ENG, V25, P181; MARSHALL JS, 1948, J METEOROL, V5, P165, DOI 10.1175/1520-0469(1948)005<0165:TDORWS>2.0.CO;2; Laws JO, 1943, EOS T AM GEOPHYS UN, V24, P452; Salles C, 2000, HYDROL PROCESS, V14, P271, DOI 10.1002/(SICI)1099-1085(20000215)14:2<271::AID-HYP925>3.0.CO;2-J; Dunkerley D, 2012, HYDROL PROCESS, V26, P2211, DOI 10.1002/hyp.8317; de Lima JLMP, 2002, CATENA, V46, P221, DOI 10.1016/S0341-8162(01)00171-0; HALL MJ, 1970, WATER RESOUR RES, V6, P1104, DOI 10.1029/WR006i004p01104; Grismer M, 2012, CALIF AGR, V66, P102, DOI 10.3733/ca.v066n03p102; Dunkerley D, 2008, HYDROL PROCESS, V22, P4415, DOI 10.1002/hyp.7045; Iserloh T, 2013, CATENA, V110, P100, DOI 10.1016/j.catena.2013.05.013; Jayawardena AW, 2000, HYDROL PROCESS, V14, P1069, DOI 10.1002/(SICI)1099-1085(20000430)14:6<1069::AID-HYP997>3.0.CO;2-Q; van Dijk AIJM, 2002, J HYDROL, V261, P1, DOI 10.1016/S0022-1694(02)00020-3; Armstrong A, 2009, EARTH SURF PROC LAND, V34, P1310, DOI 10.1002/esp.1810; Bowyer-Bower T. A. S., 1989, SOIL TECHNOL, V2, P1, DOI DOI 10.1016/S0933-3630(89)80002-9; BRADFORD JM, 1986, SOIL SCI SOC AM J, V50, P1547; CARTER CE, 1974, T ASAE, V17, P1033; Christiansen J. E., 1942, IRRIGATION SPRINKLIN; Epema GF, 1983, CATENA S, V4, P1; Foster IDL, 2000, EARTH SURF PROC LAND, V25, P691, DOI 10.1002/1096-9837(200007)25:7<691::AID-ESP125>3.3.CO;2-W; Hall M.J., 1970, T ASAE, V41, P33; HUDSON N. W., 1963, RHODESIAN JOUR AGRIC RES, V1, P6; KINNELL PIA, 1981, SOIL SCI SOC AM J, V45, P153; Kinnell PIA, 2005, SOIL SCI SOC AM J, V69, P902, DOI 10.2136/sssaj2004.0273; Sanchez-Moreno F., 2012, J HYDROL, P454, DOI [10.1016/j.jhydrol.2012.06.007, DOI 10.1016/J.JHYDROL.2012.06.007]; Sempere Torres D., 1994, J APPL METEOROL, V33, P1494, DOI 10.1175/1520-0450(1994)0331494:AGFFRS2.0.CO;2; Williams J, 1998, PARIS REV, P14; Wischmeier W. H., 1978, AGR HDB, V537; Yu B, 2003, EARTH SURF PROC LAND, V28, P1483, DOI 10.1002/esp.1001; Zanchi C., 1980, Assessment of Erosion., P133	35	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1084-0699	1943-5584		J HYDROL ENG	J. Hydrol. Eng.	JUN	2015	20	6			SI				C6015001	10.1061/(ASCE)HE.1943-5584.0001140		6	Engineering, Civil; Environmental Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Water Resources	CI2AU	WOS:000354547700022		
J	Higuchi, K; Chigira, M; Lee, DH; Wu, JH				Higuchi, Kohei; Chigira, Masahiro; Lee, Der-Her; Wu, Jian-Hong			Rapid Weathering and Erosion of Mudstone Induced by Saltwater Migration near a Slope Surface	JOURNAL OF HYDROLOGIC ENGINEERING			English	Article						Badlands; Mudstone; Weathering; Erosion; Salt water; In situ monitoring	SOIL-WATER CONTENT; BADLAND; SPAIN	Barren badlands lacking vegetation and consisting of sharp-edged ridges and v-shaped gullies are widely formed by rapid incision on silt-clay fine sediments, especially in weakly consolidated mudstones around the world. The development of these badlands has been explained in terms of the repeated drying and wetting of rocks, and high salt contents in pore water. Water contents and salt concentration were monitored, for the first time, by measuring dielectric permittivity and pore water electrical conductivity (EC) beneath a badland slope in southern Taiwan. The rock slope is composed of Plio-Pleistocene marine mudstone and has a subtropical climate with distinct dry and wet seasons. The monitoring revealed that salt water at depth migrated to the slope surface in the dry season and deposited salt in desiccation cracks. During the following rainy season, rainwater dissolved the salts, diluted pore water near the slope surface, and closed desiccation cracks, consequently slowing the downward movement of water. The combined wetting of rocks and dilution of pore water near the slope surface deteriorated the rock and dispersed rock-forming grains, ultimately leading to erosion rates as high as 9cm during a single rainy season. Subsequent drying near the slope surface and the movement of salt water from depth led to the renewal of the cycle during the following dry season.	[Higuchi, Kohei] Univ Tokyo, Grad Sch Frontier Sci, Dept Environm Syst, Kashiwa, Chiba 2778563, Japan; [Higuchi, Kohei; Lee, Der-Her; Wu, Jian-Hong] Natl Cheng Kung Univ, Dept Civil Engn, Tainan 70101, Taiwan; [Chigira, Masahiro] Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan	Higuchi, K (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Environm Syst, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778563, Japan.	khiguchi@geoenv.k.u-tokyo.ac.jp; chigira@slope.dpri.kyoto-u.ac.jp; derher@mail.ncku.edu.tw; jhwu@mail.ncku.edu.tw					Alexander D. E., 1982, BADLAND GEOMORPHOLOG, V64, P71; DIRKSEN C, 1993, SOIL SCI SOC AM J, V57, P660; Hilhorst MA, 2000, SOIL SCI SOC AM J, V64, P1922; Faulkner H, 2004, EARTH SURF PROC LAND, V29, P1143, DOI 10.1002/esp.1109; Kasanin-Grubin M, 2007, CATENA, V70, P68, DOI 10.1016/j.catena.2006.08.001; TOPP GC, 1980, WATER RESOUR RES, V16, P574, DOI 10.1029/WR016i003p00574; Bouma NA, 2000, CATENA, V40, P147, DOI 10.1016/S0341-8162(99)00046-6; Campbell G. S., 1985, DEV SOIL SCI, P40; Campbell I., 1989, ARID ZONE GEOMORPHOL, P159; Canton Y, 2001, CATENA, V44, P111, DOI 10.1016/S0341-8162(00)00153-3; Chou J. T., 1971, PETROL GEOL TAIWAN, V8, P187; Higuchi K, 2013, CATENA, V106, P68, DOI 10.1016/j.catena.2012.11.005; Kiho K., 1999, J JPN SOC ENG GEOLOG, V40, P260, DOI 10.5110/jjseg.40.260; Lee D. H., 2007, J GEOENG, V2, P81; Nakata E., 2009, J GEOGR, V118, P511, DOI [10.5026/jgeography.118.511, DOI 10.5026/JGEOGRAPHY.118.511]; SCHUMM SA, 1956, AM J SCI, V254, P693; Sherard J. L., 1976, Journal of the Geotechnical Engineering Division, ASCE, V102, P287	17	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1084-0699	1943-5584		J HYDROL ENG	J. Hydrol. Eng.	JUN	2015	20	6			SI				C6014004	10.1061/(ASCE)HE.1943-5584.0001105		5	Engineering, Civil; Environmental Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Water Resources	CI2AU	WOS:000354547700016		
J	Yang, HC; Wang, GQ; Jiang, H; Fang, HY; Ishidaira, H				Yang, Huicai; Wang, Guoqiang; Jiang, Hong; Fang, Huaiyang; Ishidaira, Hiroshi			Integrated Modeling Approach to the Response of Soil Erosion and Sediment Export to Land-Use Change at the Basin Scale	JOURNAL OF HYDROLOGIC ENGINEERING			English	Article						Soil erosion; Land use; Rainfall; Simulation; Sediment transport; Soil erosion; Land-use change; Rainfall simulation; Yamanashi hydrological model	MEKONG RIVER-BASIN; DISTRIBUTED HYDROLOGICAL MODEL; INDIVIDUAL RAINSTORMS; YIELD; RUNOFF; SIMULATION; CHINA; CATCHMENTS; TOPMODEL; IMPACT	Land use determines the erodibility and hydrological structure of land units. Grid-based modeling is an effective approach for handling the spatial heterogeneity of basin characteristics, such as land use, soil, rainfall, and topographical information. The reliability of simulation results from erosion models is circumscribed by considerable spatial variation of numerous parameters. In this study, a grid-based distributed soil erosion and sediment transport model was used in conjunction with a laboratory rainfall simulation experiment to determine the impact of land-use changes on soil erosion and sediment yield in a river basin during individual storms. Land-use changes in Lushi Basin, primarily in Henan, China, were analyzed by comparing historical land use maps from 1990 and 1995. By comparing the responses of four selected storms that were simulated under conditions indicated by these two land-use maps, the average erosion rates were found to increase from 1989 to 1996. The increase in the average erosion rates followed land-use changes, particularly the transformation of forest to farmland. The results indicated that land-use change has a significant effect on regional soil erosion and sediment supply.	[Yang, Huicai; Wang, Guoqiang] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Jiang, Hong] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing 210042, Jiangsu, Peoples R China; [Fang, Huaiyang] Minist Environm Protect, South China Inst Environm Sci, Guangzhou 510655, Guangdong, Peoples R China; [Ishidaira, Hiroshi] Univ Yamanashi, Dept Civil & Environm Engn, Kofu, Yamanashi 4008511, Japan	Wang, GQ (reprint author), Beijing Normal Univ, Coll Water Sci, 19 Xinjiekouwai St, Beijing 100875, Peoples R China.	wanggq@bnu.edu.cn			National Natural Science Foundation of China [41001155]; Program for New Century Excellent Talents in University [NCET-12-0058]; Fundamental Research Funds for the Central Universities [2012LZD10]	This research is supported by the National Natural Science Foundation of China (Grant No. 41001155), Program for New Century Excellent Talents in University (Grant No. NCET-12-0058) and Fundamental Research Funds for the Central Universities (Grant No. 2012LZD10).	Kiem AS, 2008, HYDROL PROCESS, V22, P1382, DOI 10.1002/hyp.6947; LUDWIG B, 1995, CATENA, V25, P227, DOI 10.1016/0341-8162(95)00012-H; Wang GQ, 2012, HYDROL PROCESS, V26, P3579, DOI 10.1002/hyp.9193; Romkens MJM, 2002, CATENA, V46, P103, DOI 10.1016/S0341-8162(01)00161-8; FAVISMORTLOCK D, 1995, CATENA, V25, P365, DOI 10.1016/0341-8162(95)00018-N; FU B, 1994, LAND DEGRAD REHABIL, V5, P33, DOI 10.1002/ldr.3400050105; Jordan G, 2005, AGR ECOSYST ENVIRON, V108, P119, DOI 10.1016/j.agee.2005.01.013; BINGNER RL, 1989, T ASAE, V32, P529; Kinnell PIA, 1997, AUST J SOIL RES, V35, P1, DOI 10.1071/S95085; BEASLEY DB, 1980, T ASAE, V23, P938; Morgan RPC, 1998, EARTH SURF PROC LAND, V23, P527, DOI 10.1002/(SICI)1096-9837(199806)23:6<527::AID-ESP868>3.0.CO;2-5; Desmet PJJ, 1996, J SOIL WATER CONSERV, V51, P427; Takeuchi K, 2008, HYDROL PROCESS, V22, P3236, DOI 10.1002/hyp.6910; LI G, 1995, HYDROL PROCESS, V9, P227, DOI 10.1002/hyp.3360090208; Zhou MC, 2006, J HYDROL, V327, P151, DOI 10.1016/j.jhydrol.2005.11.013; Beven K. J., 1979, HYDROL SCI B, V24, P43, DOI DOI 10.1080/02626667909491834; Bissonnais Y. L., 1998, SOIL TILL RES, V46, P69, DOI 10.1016/S0167-1987(98)80109-8SOTRD50167-1987; BRYAN RB, 1989, EARTH SURF PROCESSES, V14, P211, DOI 10.1002/esp.3290140304; China Soil Scientific Database Institute of Soil Science Chinese Academy of Sciences, 2008, DAT PROF SOIL SPAT D; Climatic Data Center, 2014, DAT PROF RAIN GAUG S; Daniel G. Y., 2003, USERS GUIDE REV UNIV; Flanagan D. C., 1995, 10 NSERL USDA ARS NA; Foster G. R., 1982, ASAE MONOGRAPH, V5, P295; Georgievsky M., 2006, ANN J HYDRAUL ENG JS, V50, P49, DOI [10.2208/prohe.50.49, DOI 10.2208/PROHE.50.49]; Hao FH, 2004, IAHS-AISH P, V289, P157; Hapuarachchi HAP, 2008, HYDROL PROCESS, V22, P1246, DOI 10.1002/hyp.6934; Houben P, 2006, CATENA, V66, P42, DOI 10.1016/j.catena.2005.07.009; Jiang D., 1997, SOIL EROSION CONTROL; Li Y., 2013, PHYSICAL GEOGR, V27, P109, DOI [10.2747/0272-3646.27.2.1090272-3646, DOI 10.2747/0272-3646.27.2.1090272-3646]; Liu X. D., 1999, B SOIL WATER CONSERV, V19, P57; Magome J., 2002, J HYDROSCI HYDRAUL E, V20, P49; Nash J. E., 1970, J HYDROL, V10, P282, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; NEARING MA, 1989, T ASAE, V32, P919; Ni JR, 2008, GEOMORPHOLOGY, V93, P233, DOI 10.1016/j.geomorph.2007.02.015; PHILIP J. R., 1957, SOIL SCI, V83, P435; Philips J. D., 1992, Overland flow: hydraulics and erosion mechanics., P177; [邱扬 Qiu Yang], 2002, [水土保持学报, Journal of soil and water conservation], V16, P108; Renard KG, 1997, AGR HDB; SHERMAN LK, 1943, T AM GEOPHYS UNION, V24, P465, DOI DOI 10.1029/TR024I002P00465; Singh RK, 2012, WATER RESOUR MANAG, V26, P643, DOI 10.1007/s11269-011-9937-4; Sivapalan M., 1986, SCALE PROBLEMS HYDRO, V6, P81; Takeuchi K, 1999, HYDROLOG SCI J, V44, P633, DOI 10.1080/02626669909492258; Toy J.T., 2002, SOIL EROSION PROCESS; Wang GQ, 2009, WATER RESOUR MANAG, V23, P1447, DOI 10.1007/s11269-008-9335-8; Wang GQ, 2007, J GEOGR SCI, V17, P73, DOI 10.1007/s11442-007-0073-2; Wang Jun, 2005, Journal of Geographical Sciences, V15, P396, DOI 10.1360/gs050402; Wischmeier W. H., 1978, USDA AGR RES SERVICE, V537; Yoshimura C, 2009, SCI TOTAL ENVIRON, V407, P5356, DOI 10.1016/j.scitotenv.2009.06.026; Zheng F, 1998, ACT GEOGRAPHIC SINIC, V53, P422	49	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1084-0699	1943-5584		J HYDROL ENG	J. Hydrol. Eng.	JUN	2015	20	6			SI				C4014003	10.1061/(ASCE)HE.1943-5584.0001037		13	Engineering, Civil; Environmental Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Water Resources	CI2AU	WOS:000354547700003		
J	Mayor, P; Takeshita, RSC; Coutinho, LN; Sanchez, N; Galvez, H; Ique, C; Ruiz, JC; Monteiro, FOB				Mayor, Pedro; Takeshita, Rafaela Sayuri Cicalise; Coutinho, Leandro Nassar; Sanchez, Nofre; Galvez, Hugo; Ique, Carlos; Ruiz, Julio Cesar; Monteiro, Frederico Ozanan Barros			Functional morphology of the tubular genital organs in the female owl monkey (Aotus spp.)	JOURNAL OF MEDICAL PRIMATOLOGY			English	Article						Aotus; female; owl monkey; reproduction; tubular genital organs	ARGENTINEAN CHACO; ATELES-GEOFFROYI; AZARAI-INFULATUS; TAYASSU-TAJACU; UTERINE GLANDS; WILD; PLACENTA; ULTRASOUND; EPITHELIUM; DIAGNOSIS	BackgroundStudies on reproductive morphology are important to understand the reproductive cycle of non-human primates. MethodsThis study describes the functional morphology of the adult female tubular genital organs in 41 Aotus (12.86.8years old, ranging from 3 to 25years), with respect to reproductive status and number of parturitions. ResultsIn females with developing embryos, endometrial glands showed a higher secretion than other females, and the embryo implantation occupied this secretive endometrium. Changes in the thickening, number of layers, and keratinization in the vaginal epithelium suggest that vaginal cytology may be an indicator of the estrous cycle. Non-pregnant multiparous females had a larger uterine body than nulliparous females. Number of parturitions and reproductive state had an impact on tubular genital organs in female owl monkeys. ConclusionsThese results can be useful for the development of biotechnologies of reproduction and for improvement of the management of this species.	[Mayor, Pedro] Univ Autonoma Barcelona, Dept Anim Hlth & Anat, Fac Vet, E-08193 Barcelona, Spain; [Mayor, Pedro] Yavari Conservac & Uso Sostenible, YAVACUS, Iquitos, Peru; [Takeshita, Rafaela Sayuri Cicalise] Kyoto Univ, Primate Res Inst, Dept Ecol & Social Behav, Inuyama, Aichi 484, Japan; [Coutinho, Leandro Nassar; Monteiro, Frederico Ozanan Barros] Univ Fed Rural Amazonia, Postgrad Program Anim Hlth & Prod Amazonia, Belem, Para, Brazil; [Sanchez, Nofre; Galvez, Hugo; Ique, Carlos] Univ Nacl Mayor San Marcos, Inst Vet Invest Trop & Altura, Iquitos, Peru; [Ruiz, Julio Cesar; Monteiro, Frederico Ozanan Barros] Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Bastrop, TX USA	Mayor, P (reprint author), Univ Autonoma Barcelona, Dept Anim Hlth & Anat, E-08193 Bellaterra, Spain.	mayorpedro@hotmail.com	Mayor, Pedro/D-6359-2015	Monteiro, Frederico/0000-0002-1406-9979; Mayor, Pedro/0000-0001-5297-792X	Veterinary Faculty of the Universidad Nacional Mayor de San Marcos (CON/CON) [20]	This project was supported by the Veterinary Faculty of the Universidad Nacional Mayor de San Marcos (CON/CON 2014, n 20). The authors have no conflict of interest to declare. We are especially thankful for the institutional support provided by the Instituto de Investigaciones de Tropico y de Altura and the Veterinary Faculty of the Universidad Nacional Mayor de San Marcos. We thank Dr. Anita Stone, Ph.D. (Eastern Michigan University) for reviewing this manuscript.	Cooke PS, 2013, MOL HUM REPROD, V19, P547, DOI 10.1093/molehr/gat031; [Anonymous], 1994, NOMINA EMBRYOLOGICAL; Andrabi SMH, 2007, ANIM REPROD SCI, V99, P223, DOI 10.1016/j.anireprosci.2006.07.002; Gray CA, 2001, BIOL REPROD, V65, P1311, DOI 10.1095/biolreprod65.5.1311; Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103; Fernandez-Duque E, 2002, AM J PRIMATOL, V57, P219, DOI 10.1002/ajp.10045; Beattie J, 1927, P ZOOL SOC LOND, V1927, P593; BENIRSCHKE K, 1982, BIOL REPROD, V26, P29, DOI 10.1095/biolreprod26.1.29; Bodmer R, 2004, PEOPLE NATURE WILDLI, P199; Boyd JD, 1944, J ANAT, V78, P5; CLAVER J A, 1984, Primates, V25, P110, DOI 10.1007/BF02382301; CONRAD SH, 1989, J MED PRIMATOL, V18, P143; Coutinho LN, 2011, J MED PRIMATOL, V40, P310, DOI 10.1111/j.1600-0684.2011.00476.x; Dixson AF, 1998, PRIMATES SEXUALITY C; Dixson Allen F., 1994, P113; ENDERS ROBERT K., 1952, PROC AMER PHIL SOC, V96, P691; Mayor P, 2006, GEN COMP ENDOCR, V147, P268, DOI 10.1016/j.ygcen.2006.01.010; Fernandez-Duque E., 2012, International Zoo Yearbook, V46, P80, DOI 10.1111/j.1748-1090.2011.00156.x; Fernandez-Duque E, 2011, FOLIA PRIMATOL, V82, P143, DOI 10.1159/000333081; Fernandez-Duque E, 2002, INT J PRIMATOL, V23, P639, DOI 10.1023/A:1014929902923; Gluckman TL, 2004, CONTEMP TOP LAB ANIM, V43, P28; Goodman L, 1935, ANAT REC, V61, P379, DOI 10.1002/ar.1090610402; GURPIDE E, 1981, J CLIN ENDOCR METAB, V52, P252; HERTIG AT, 1976, LAB ANIM SCI, V26, P1041; IUCN [International Union for Conservation of Nature], 2013, IUCN RED LIST THREAT; Jori F, 2002, J ZOOL, V256, P35, DOI 10.1017/S0952836902000055; Lindsey L, 1999, ENCY REPROD, P79; Mayor P, 2012, AM J PRIMATOL, V74, P1006, DOI 10.1002/ajp.22051; Mayor P, 2013, AM J PRIMATOL, V75, P545, DOI 10.1002/ajp.22132; Mayor P, 2006, RES VET SCI, V81, P246, DOI 10.1016/j.rvsc.2005.12.003; MILLER PW, 1985, PLACENTA, V6, P423, DOI 10.1016/S0143-4004(85)80019-9; Monteiro FOB, 2009, INT J PRIMATOL, V30, P327, DOI 10.1007/s10764-009-9346-1; Monteiro FOB, 2006, J MED PRIMATOL, V35, P123, DOI 10.1111/j.1600-0684.2006.00155.x; Mossman HW, 1987, VERTEBRATE FETAL MEM; Pissinatti L, 2008, ARQ BRAS MED VET ZOO, V60, P1472, DOI 10.1590/S0102-09352008000600025; Priedkalns J., 1987, Textbook of veterinary histology, P313; Ramos PG, 2009, REV MED-U NAVARRA, V53, P14; ROSS R, 1967, J CELL BIOL, V32, P155, DOI 10.1083/jcb.32.1.155; Tanaka T, 2009, INT J MOL MED, V23, P173, DOI 10.3892/ijmm_00000114; Tempkin BB, 2004, SONOGRAPHY INTRO NOR, P325; Veras MM, 2009, AM J PRIMATOL, V71, P145, DOI 10.1002/ajp.20633; Wislocki G. B., 1932, Contributions to Embryology Carnegie Institution, V23, P163; WISLOCKI GEORGE B., 1930, CARNEGIE INST WASHINGTON [PUBL 414] CONTR EMBRYOL, V22, P173; YOUNG A, 1972, J HUM EVOL, V1, P345, DOI 10.1016/0047-2484(72)90111-X	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0047-2565	1600-0684		J MED PRIMATOL	J. Med. Primatol.	JUN	2015	44	3					158	167		10.1111/jmp.12169		10	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CI0AU	WOS:000354398800005		
J	Okochi, M; Ueda, K; Okochi, H				Okochi, Masayuki; Ueda, Kazuki; Okochi, Hiromi			Hemi-Bernard Method: Straightforward Reconstruction of Lower Lip After Malignant Tumor Resection	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							FUNCTIONAL RECONSTRUCTION; FLAP; DEFECTS	The Bernard method is a straightforward method for reconstructing lower lip defects after tumor resection. However, this method is difficult to apply when the defect is located on the unilateral side of the lower lip. This report describes the reconstruction of unilateral lower lip defects using a modified Bernard method, which is referred to as the hemi-Bernard method. Three patients (2 male and 1 female; mean defect, 55%) underwent reconstruction using the hemi-Bernard method after lower lip malignant tumor resection. No infection or flap necrosis occurred, and none of the 3 patients had difficulty with oral ingestion. Movement of the orbicularis oris muscle was retained in all patients. The hemi-Bernard method is straightforward and has several advantages, including extension of lower lip length. This method could be useful for reconstructing full-thickness defects located on the unilateral side of the lower lip. (C) 2015 American Association of Oral and Maxillofacial Surgeons	[Okochi, Masayuki; Ueda, Kazuki; Okochi, Hiromi] Fukushima Med Univ, Dept Plast & Reconstruct Surg, Fukushima 9601295, Japan	Okochi, M (reprint author), Fukushima Med Univ, Dept Plast & Reconstruct Surg, 1 Hikarigaoka, Fukushima 9601295, Japan.	oktms-okt@umin.ac.jp					Bayramicli M, 1997, PLAST RECONSTR SURG, V100, P1682, DOI 10.1097/00006534-199712000-00006; Bernard C, 1853, B MEM SOC CHIR PARIS, V3, P357; BOWERS DG, 1971, PLAST RECONSTR SURG, V47, P209, DOI 10.1097/00006534-197103000-00001; Fang QG, 2014, J ORAL MAXILLOFAC SU, V72; FREEMAN B S, 1958, Plast Reconstr Surg Transplant Bull, V21, P453; FRIES R, 1971, CHIR PLAST, V1, P45, DOI 10.1007/BF00289777; Gillies H, 1977, PRINCIPLE ART PLASTI, P507; Hamahata A, 2012, ANN PLAST SURG, V70, P654; KARAPAND.M, 1974, BRIT J PLAST SURG, V27, P93, DOI 10.1016/0007-1226(74)90068-X; McGregor LA, 1983, BR J PLAST SURG, V36, P40; MEYER R, 1973, CHIR PLAST, V2, P1, DOI 10.1007/BF00280912; Minagawa T, 2011, J ORAL MAXIL SURG, V69, pE256, DOI 10.1016/j.joms.2011.01.007; NAKAJIMA T, 1984, BRIT J PLAST SURG, V37, P52, DOI 10.1016/0007-1226(84)90042-0; Ono I, 2006, PLAST RECONSTR SURG, V117, p133E, DOI 10.1097/01.prs.0000225465.90827.7f; Tetik G, 2014, J ORAL MAXIL SURG, V72, P1841, DOI 10.1016/j.joms.2014.03.019; WEBSTER R C, 1960, Plast Reconstr Surg Transplant Bull, V25, P360, DOI 10.1097/00006534-196004000-00007; Ye WM, 2014, J ORAL MAXIL SURG, V72, P2077, DOI 10.1016/j.joms.2014.04.014; Yotsuyanagi T, 1999, PLAST RECONSTR SURG, V103, P850, DOI 10.1097/00006534-199903000-00011	18	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	JUN	2015	73	6							1232.e1	10.1016/j.joms.2014.12.025		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CI2LA	WOS:000354577900038		
J	Miura, K; Yoshida, M; Asahina, I				Miura, Kei-ichiro; Yoshida, Masashi; Asahina, Izumi			Secondary Bone Grafting With Simultaneous Auto-Tooth Transplantation to the Alveolar Cleft	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							PLATELET-RICH PLASMA; LONGITUDINAL COHORT; PERMANENT DENTITION; SINUS AUGMENTATION; AUTOGENOUS BONE; DENTAL IMPLANTS; GROWTH-FACTOR; PALATE; LIP; PREMOLAR	One of the most important purposes of secondary bone grafting of the alveolar cleft is to stabilize the maxillary alveolar arch with completion of the dental arch. We report a case of secondary bone grafting with simultaneous auto-tooth transplantation to the alveolar cleft, using particulate cancellous bone and marrow (PCBM) combined with platelet-rich plasma (PRP), which contains many growth factors. The patient was born with a bilateral cleft lip and left buccal-localized cleft alveolus. We performed bone grafting to the cleft using PCBM with PRP and transplantation of the supernumerary tooth under general anesthesia when the patient was aged 11 years, 10 months. The postoperative course was uneventful and without any complications. The orthodontic treatment was nearly complete 10 months after the operation. The transplanted tooth was stable, and a normal gingival contour was attained during the 2-year follow-up period. The case was successful in achieving a stable occlusal condition within a short period. We suggest secondary bone grafting with simultaneous auto-tooth transplantation as an option for alveolar cleft treatment. (C) 2015 American Association of Oral and Maxillofacial Surgeons	[Miura, Kei-ichiro; Asahina, Izumi] Nagasaki Univ, Grad Sch Biomed Sci, Unit Translat Med, Dept Regenerat Oral Surg, Nagasaki 8528588, Japan; [Miura, Kei-ichiro; Yoshida, Masashi] Imakiire Gen Hosp, Dept Oral Surg, Kagoshima, Japan	Asahina, I (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Unit Translat Med, Dept Regenerat Oral Surg, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	asahina@nagasaki-u.ac.jp					PIERCE GF, 1992, AM J PATHOL, V140, P1375; Lee C, 2009, INT J ORAL MAX SURG, V38, P117, DOI 10.1016/j.ijom.2008.11.019; Aizenbud D, 2013, J CRANIO MAXILL SURG, V41, P371, DOI 10.1016/j.jcms.2012.10.020; Oyama T, 2004, J ORAL MAXIL SURG, V62, P555, DOI 10.1016/j.joms.2003.08.023; Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4; Wermker K, 2014, INT J ORAL MAX IMPL, V29, P384, DOI 10.11607/jomi.3303; Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003; Freitas JAD, 2012, J APPL ORAL SCI, V20, P268, DOI 10.1590/S1678-77572012000200024; Giudice G, 2007, PLAST RECONSTR SURG, V119, P2206, DOI 10.1097/01.prs.0000260709.90237.ae; Hartel J, 1999, J CRANIO MAXILL SURG, V27, P354, DOI 10.1054/jcms.2000.0096; Hermann NV, 2012, DENT TRAUMATOL, V28, P386, DOI 10.1111/j.1600-9657.2012.01165.x; Hermann NV, 2012, DENT TRAUMATOL, V28, P394, DOI 10.1111/edt.12000; Klongnoi B, 2006, CLIN ORAL IMPLAN RES, V17, P312, DOI 10.1111/j.1600-0501.2005.01215.x; Klongnoi B, 2006, J CLIN PERIODONTOL, V33, P500, DOI 10.1111/j.1600-051X.2006.00938.x; Long RE, 1996, CLEFT PALATE-CRAN J, V33, P225, DOI 10.1597/1545-1569(1996)033<0225:EOCPIT>2.3.CO;2; Luvizuto ER, 2013, DENT TRAUMATOL, V29, P483, DOI 10.1111/j.1600-9657.2012.01163.x; Peamkaroonrath C, 2008, AUST ORTHOD J, V24, P149; Reisberg DJ, 2000, CLEFT PALATE-CRAN J, V37, P534, DOI 10.1597/1545-1569(2000)037<0534:DAPCFP>2.0.CO;2; Rullo R, 2007, Minerva Stomatol, V56, P63	19	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	JUN	2015	73	6					1050	1057		10.1016/j.joms.2015.01.004		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CI2LA	WOS:000354577900015		
J	Sago, T; Harano, N; Chogyoji, Y; Nunomaki, M; Shiiba, S; Watanabe, S				Sago, Teppei; Harano, Nozomu; Chogyoji, Yuki; Nunomaki, Masahito; Shiiba, Shunji; Watanabe, Seiji			A Nasal High-Flow System Prevents Hypoxia in Dental Patients Under Intravenous Sedation	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							UPPER AIRWAY COLLAPSIBILITY; MIDAZOLAM SEDATION; PROPOFOL; VENTILATION; ANESTHESIA; THERAPY; HEAD	Purpose: Hypoxia is a major complication in dental patients under intravenous sedation (IVS). A nasal high-flow (NHF) system has been reported to achieve effective oxygenation in patients with sleep apnea syndrome. This study investigated the ability of the NHF system to prevent hypoxia in dental patients under IVS. Materials andMethods: Thirty patients scheduled for dental treatment under IVS were enrolled. Patients were randomly divided into 3 groups: patients spontaneously breathing oxygen at 5 L/minute through a nasal cannula (NC5 group), patients administered oxygen at 30 L/minute through the NHF system, and patients administered oxygen at 50 L/minute through the NHF system. Hypnosis was induced by bolus administration of midazolam (0.05 mg/kg) followed by continuous administration of propofol (target blood concentration, 1.2 to 2 mg/mL). Noninvasive blood pressure, peripheral capillary oxygen saturation (SpO(2)), heart rate, and bispectral index values were recorded every 2.5 minutes before the induction of anesthesia. Interventions, such as jaw lifting, were recorded during IVS and arterial blood gas analysis was performed at the end of sedation. Patient and surgeon satisfaction with IVS was evaluated by interview. Results: Minimum SpO2 was lowest in and surgeons were least satisfied with the NC5 group. In addition, interventions were required most frequently in the NC5 group (P<.05). Compared with the NC5 group, use of the NHF system improved partial pressures of oxygen and carbon dioxide in dental patients under IVS (P <.05). Conclusions: These results suggest that use of the NHF system can prevent hypoxia in dental patients under IVS. Further studies are necessary to determine the appropriate flow rate and indications for NHF in obese patients.	[Sago, Teppei; Harano, Nozomu; Chogyoji, Yuki; Nunomaki, Masahito; Shiiba, Shunji; Watanabe, Seiji] Kyushu Dent Univ, Dept Dent Anesthesiol, Kitakyushu, Fukuoka 8038580, Japan	Sago, T (reprint author), Kyushu Dent Univ, Dept Dent Anesthesiol, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	r07sagou@fa.kyu-dent.ac.jp					McGinley B, 2009, PEDIATRICS, V124, P179, DOI 10.1542/peds.2008-2824; Roca O, 2010, RESP CARE, V55, P408; Tuggey JM, 2007, RESP MED, V101, P1874, DOI 10.1016/j.rmed.2007.05.005; Braunlich J, 2013, RESPIRATION, V85, P319, DOI 10.1159/000342027; Dysart K, 2009, RESP MED, V103, P1400, DOI 10.1016/j.rmed.2009.04.007; Parke R, 2009, BRIT J ANAESTH, V103, P886, DOI 10.1093/bja/aep280; Win NN, 2005, ANESTH ANALG, V101, P97, DOI 10.1213/01.ANE.0000156204.89879.5C; Hillman DR, 2009, ANESTHESIOLOGY, V111, P63, DOI 10.1097/ALN.0b013e3181a7ec68; Brian M, 2007, AM J RESP CRIT CARE, V176, P194; Groves Nicole, 2007, Aust Crit Care, V20, P126, DOI 10.1016/j.aucc.2007.08.001; Hamamoto H, 2013, J ORAL MAXILLOFAC SU, V71, pe158; Ikeda H, 2006, J CLIN ANESTH, V18, P185, DOI 10.1016/j.jclinane.2005.08.010; Kawauchi Y, 2000, CAN J ANAESTH, V47, P215; Kobayashi M, 2011, ANESTHESIOLOGY, V115, P273, DOI 10.1097/ALN.0b013e318223ba6d; Kopelman E, 2003, J PERINATOL, V23, P94; Niwa Hitoshi, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V102, pe1, DOI 10.1016/j.tripleo.2006.03.014; Reber A, 1999, ANESTHESIOLOGY, V90, P1617, DOI 10.1097/00000542-199906000-00018; Sivieri EM, 2013, PEDIATR PULM, V48, P506, DOI 10.1002/ppul.22636	18	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	JUN	2015	73	6					1058	1064		10.1016/j.joms.2014.12.020		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CI2LA	WOS:000354577900016		
J	Abukawa, H; Matsuo, A; Watanabe, M; Kono, M; Satomi, T; Chikazu, D				Abukawa, Harutsugi; Matsuo, Akira; Watanabe, Masato; Kono, Michihide; Satomi, Takafumi; Chikazu, Daichi			A Randomized Trial to Identify the Most Effective Dose of Remifentanil During Le Fort I Osteotomy	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							HYPOTENSIVE ANESTHESIA; ORTHOGNATHIC SURGERY; STRESS; RESPONSES; RECOVERY; FENTANYL; PROFILE	Purpose: The Le Fort I osteotomy (L-I) requires extensive dissection and manipulation of tissue, causing hemodynamic instability and an undesirable postoperative stress response. This study aimed to clarify the most effective dose of remifentanil during L-I. Materials and Methods: This study was designed as a prospective, randomized, controlled doubleblinded study. Patients (American Society of Anesthesiologists physical status I to II) undergoing L-I were randomly assigned to receive anesthesia with propofol and remifentanil under 3 remifentanil dose conditions: 0.25 mu g/kg/minute (group 1), 0.5 mu g/kg/minute (group 2), and 0.75 mu g/kg/minute (group 3). All patients underwent L-I with propofol and remifentanil target-controlled anesthesia. The study endpoints were mean arterial pressure (MAP) and heart rate. Data were recorded before L-I (20-minute period before surgery), during L-I (from the beginning of surgery to downfracture), and after L-I (20-minute period after downfracture). Average age, gender, average body mass index, aimed maxillary position, average bispectral index, average surgery time, and average blood loss also were examined. Data were analyzed using the Bartlett test and then 1-way analysis of variance with the Bonferroni multiple comparison test. Results: Data were obtained from 20 patients (9 men, 11 women). The average operating times for groups 1, 2, and 3 were 53.1, 46.7, and 49 minutes, respectively. The age range was 18 to 46 years (average, 26.05 yr). The rate of MAP increase from before to during L-I in group 1 was 10.8% (n = 7). The rate of MAP increase from before to during L-I in group 3 was 2.1% (n = 6). Group 3 showed a significantly lower rate of MAP increase during and after L-I compared with group 1 (P <.05). Conclusion: Remifentanil administration at 0.75 mg/kg/minute stabilized hemodynamics during L-I without major side effects. Results indicated that the standard index of remifentanil administration during L-I should be 0.75 mu g/kg/minute when using oxygen, propofol, and remifentanil for general anesthesia. (C) 2015 American Association of Oral and Maxillofacial Surgeons	[Abukawa, Harutsugi; Matsuo, Akira; Watanabe, Masato; Kono, Michihide; Satomi, Takafumi; Chikazu, Daichi] Tokyo Med Univ, Dept Oral & Maxillofacial Surg, Tokyo 1600023, Japan	Abukawa, H (reprint author), Tokyo Med Univ, Dept Oral & Maxillofacial Surg, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	habukawa@tokyo-med.ac.jp					Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Degoute CS, 2001, CAN J ANAESTH, V48, P20; Twersky RS, 2001, J CLIN ANESTH, V13, P407, DOI 10.1016/S0952-8180(01)00292-6; Caverni V, 2005, J CRANIOFAC SURG, V16, P531, DOI 10.1097/01.SCS.0000159084.60049.E6; Guy J, 1997, ANESTHESIOLOGY, V86, P514, DOI 10.1097/00000542-199703000-00002; Huiku M, 2007, BRIT J ANAESTH, V98, P447, DOI 10.1093/bja/aem004; Dolman RM, 2000, J ORAL MAXIL SURG, V58, P834, DOI 10.1053/joms.2000.8194; Elliott P, 2000, ANESTH ANALG, V91, P58, DOI 10.1097/00000539-200007000-00011; Nakada T, 2010, J ANESTH, V24, P832, DOI 10.1007/s00540-010-1006-2; Noma T, 1998, ORAL SURG ORAL MED O, V86, P511, DOI 10.1016/S1079-2104(98)90338-9; Nooh N, 2013, INT J ORAL MAX SURG, V42, P988, DOI 10.1016/j.ijom.2013.02.001; Purdham R S, 1996, CRNA, V7, P33; Stajcic Z, 1997, BRIT J ORAL MAX SURG, V35, P328, DOI 10.1016/S0266-4356(97)90405-8	13	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	JUN	2015	73	6					1073	1077		10.1016/j.joms.2014.12.035		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CI2LA	WOS:000354577900018		
J	Yano, M; Tateyama, Y; Sakamoto, T				Yano, Masataka; Tateyama, Yuki; Sakamoto, Tsutomu			Processing of Japanese Cleft Constructions in Context: Evidence from Event-Related Brain Potentials	JOURNAL OF PSYCHOLINGUISTIC RESEARCH			English	Article						Japanese; Sentence comprehension; Cleft constructions; Gap-filler dependency; Event-related brain potentials (ERPs)	DEPENDENCIES; MEMORY; ERP	Numerous studies have found "subject gap preference" in relative clauses and cleft constructions in English, French, and other languages. In contrast, previous studies have reported "object gap preference" in cleft constructions in Japanese. However, the effect of integrating a filler and its gap may be influenced by the effect of transitional probabilities, so previous studies confounded these two factors. This study explores processing asymmetries in Japanese cleft constructions by conducting an event-related brain potential experiment by controlling transitional probabilities. The results demonstrate that the subject gap preference in Japanese is well aligned with that observed in other languages, suggesting that subject gap preference is a universal aspect of language comprehension.	[Yano, Masataka; Tateyama, Yuki] Kyushu Univ, Grad Sch Humanities, Higashi Ku, Fukuoka 812, Japan; [Yano, Masataka; Tateyama, Yuki] Japan Soc Promot Sci, Tokyo, Japan; [Sakamoto, Tsutomu] Kyushu Univ, Fac Humanities, Fukuoka 812, Japan	Yano, M (reprint author), Kyushu Univ, Grad Sch Humanities, Higashi Ku, 6-19-1 Hakozaki, Fukuoka 812, Japan.	masayano@kyudai.jp			Japan Society for the Promotion of Science [25.4854, 25244018]	This study was supported by a Grant-in-Aid for Scientific Research (#25.4854, PI: Masataka Yano) and a Grant-in-Aid for Scientific Research (A) (#25244018, PI: Tsutomu Sakamoto) from the Japan Society for the Promotion of Science. We are grateful to anonymous reviewers for their valuable comments. We also would like to thank Maiko Yano and Kojin Kuwahara for assistance with data collection and analysis.	Phillips C, 2005, COGNITIVE BRAIN RES, V22, P407, DOI 10.1016/j.cogbrainres.2004.09.012; Ueno M, 2008, LANG COGNITIVE PROC, V23, P646, DOI 10.1080/01690960701653501; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Fiebach CJ, 2001, J PSYCHOLINGUIST RES, V30, P321, DOI 10.1023/A:1010447102554; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gibson E, 1998, COGNITION, V68, P1, DOI 10.1016/S0010-0277(98)00034-1; Ferreira F, 2003, COGNITIVE PSYCHOL, V47, P164, DOI 10.1016/S0010-0285(03)00005-7; Gordon PC, 2001, J EXP PSYCHOL LEARN, V27, P1411, DOI 10.1037//0278-7393.27.6.1411; Gibson E, 2000, IMAGE, LANGUAGE, BRAIN, P95; Hiraiwa K, 2012, SYNTAX-UK, V15, P142, DOI 10.1111/j.1467-9612.2011.00164.x; Ishizuka T., 2006, 19 ANN CUNY C HUM SE; Jasper H. H., 1958, ELECTROENCEPHALOGRAP, V10, P371, DOI DOI 10.1016/0013-4694(58)90053-1; Kahraman B., 2011, P 12 TOK C PSYCH, P113; Kahraman B., 2011, WHY OBJECT CLEFTS AR, V111, P67; Miyamoto E., 2003, P WCCFL, V22, P342; O'Grady W., 1997, SYNTACTIC DEV; Thompson S. P., 2007, LANGUAGE LEARNING DE, V3, P1, DOI DOI 10.1080/154754407093	18	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6905	1573-6555		J PSYCHOLINGUIST RES	J. Psycholinguist. Res.	JUN	2015	44	3			SI		277	286		10.1007/s10936-014-9294-6		10	Linguistics; Psychology, Experimental	Linguistics; Psychology	CI3FY	WOS:000354634300005		
J	Minai, U; Isobe, M; Okabe, R				Minai, Utako; Isobe, Miwa; Okabe, Reiko			Acquisition and Use of Linguistic Knowledge: Scrambling in Child Japanese as a Test Case	JOURNAL OF PSYCHOLINGUISTIC RESEARCH			English	Article						Scrambling; Prosody; Child Japanese	COMPREHENSION; STRESS	The current study investigates preschool-age children's comprehension of scrambled sentences in Japanese. While scrambling has been known to be challenging for children, biasing them to exhibit non-adult-like interpretations (e.g., Hayashibe in Descr Appl Linguist 8:1-18, 1975; Sano in Descr Appl Linguist 10:213-233, 1977; Suzuki in Jpn J Educ Psychol 25(3):56-61, 1977), children are able to interpret scrambled sentences in an adult-like way when the pragmatics is enriched in the experiments (Otsu in Acquisition studies in generative grammar, John Benjamins, Amsterdam, pp 253-264, 1994). These findings suggest that children's difficulty in comprehending scrambling may be due to processing difficulties (Suzuki in J Psycholinguist Res 42(2), 119-137, 2013), such as the Lexical-ordering Strategy bias (Bever in Cognition and language development, Wiley, New York, pp 279-352, 1970), rather than their lack of the linguistic knowledge of scrambling. The current study revealed that children are indeed able to utilize prosodic information to interpret scrambled sentences in an adult-like way. Our findings provide converging evidence in favor of the proposal that children's grammatical knowledge of scrambling is intact, although they are more vulnerable than adults to processing difficulties that hinder their ability to successfully interpret scrambled sentences.	[Minai, Utako] Univ Kansas, Dept Linguist, Lawrence, KS 66045 USA; [Isobe, Miwa] Tokyo Univ Arts, Training Ctr Foreign Languages & Dict, Taito Ku, Tokyo, Japan; [Okabe, Reiko] Nihon Univ, Coll Law, Chiyoda Ku, Tokyo, Japan	Minai, U (reprint author), Univ Kansas, Dept Linguist, 1541 Lilac Lane,Blake Hall Room 427, Lawrence, KS 66045 USA.	minai@ku.edu					Aoshima S, 2004, J MEM LANG, V51, P23, DOI 10.1016/j.jml.2004.03.001; SLOBIN DI, 1982, COGNITION, V12, P229, DOI 10.1016/0010-0277(82)90033-6; Tamaoka K, 2005, J PSYCHOLINGUIST RES, V34, P281, DOI 10.1007/s10936-005-3641-6; MATSUMOTO Y, 1993, LINGUISTICS, V31, P667, DOI 10.1515/ling.1993.31.4.667; Bever Thomas, 1970, COGNITION DEV LANGUA, P279; Boersma P., 2014, PRAAT DOING PHONETIC; CHUJO K, 1983, JPN J PSYCHOL, V54, P250; CUTLER A, 1987, J CHILD LANG, V14, P145; Dahan D, 1996, LANG SPEECH, V39, P341; Grassmann S, 2010, J PRAGMATICS, V42, P3098, DOI 10.1016/j.pragma.2010.04.019; Gualmini A., 2003, P 25 PENN LING C, P87; Hale Ken, 1980, MIT WORKING PAPERS L, V2, P185; Hayashibe H., 1975, DESCRIPTIVE APPLIED, V8, P1; Hoji H., 1985, THESIS U WASHINGTON; Ito K, 2012, J MEM LANG, V66, P265, DOI 10.1016/j.jml.2011.09.002; Ito K., 2009, LANGUAGE LINGUISTICS, V3, P90; Kuroda S.-Y., 1980, NICHI EI HIKAKU KOZA, P23; Lidz J., 2011, P 12 TOK C PSYCH TOK, P17; MARATSOS MP, 1973, J PSYCHOLINGUIST RES, V2, P1, DOI 10.1007/BF01067108; Masunaga K., 1983, P 13 INT C LING, P455; Mazuka R., 2002, SENTENCE PROCESSING, P131; Mazuka R., 2009, LANGUAGE LINGUISTICS, V3, P59, DOI [10.1111/j.1749-818X.2008.00102.x, DOI 10.1111/J.1749-818X.2008.00102.X]; Miller K., 2005, BOST U C LANG DEV BU, P389; Minai U, 2012, J CHILD LANG, V39, P919, DOI 10.1017/S0305000911000316; Miyagawa S., 1980, THESIS U ARIZONA; Miyamoto E. T., 2004, LANGUAGE LINGUISTICS, V5, P153; Murasugi K, 2005, STUD GENERAT GRAMM, V69, P221; Otsu Y., 1994, ACQUISITION STUDIES, P253; Pierrehumbert J, 1988, JAPANESE TONE STRUCT; Saito Mamuro, 1985, THESIS MIT; Sano K., 1977, DESCRIPTIVE APPL LIN, V10, P213; Sano T., 2007, BUCLD 31 ONL P SUPPL; SOLAN L, 1980, J SPEECH HEAR RES, V23, P688; Suzuki S., 1977, JAPANESE J ED PSYCHO, V25, P56; Suzuki T, 2013, J PSYCHOLINGUIST RES, V42, P119, DOI 10.1007/s10936-012-9201-y	35	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6905	1573-6555		J PSYCHOLINGUIST RES	J. Psycholinguist. Res.	JUN	2015	44	3			SI		287	307		10.1007/s10936-014-9347-x		21	Linguistics; Psychology, Experimental	Linguistics; Psychology	CI3FY	WOS:000354634300006		
J	Taniguchi, N; Suenaga, N; Oizumi, N; Miyoshi, N; Yamaguchi, H; Inoue, K; Chosa, E				Taniguchi, Noboru; Suenaga, Naoki; Oizumi, Naomi; Miyoshi, Naoki; Yamaguchi, Hiroshi; Inoue, Kazuya; Chosa, Etsuo			Bone marrow stimulation at the footprint of arthroscopic surface-holding repair advances cuff repair integrity	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Bone marrow stimulation; mesenchymal stem cells; biologic healing; arthroscopic rotator cuff repair; surface-holding technique; cuff repair integrity	CONTRAST-ENHANCED ULTRASOUND; ROTATOR-CUFF; STRUCTURAL FAILURE; TEARS; FIXATION; TENDON; RECONSTRUCTION; SUTURE; CELLS	Background: Bone marrow stimulation (BMS) at the footprint of arthroscopic rotator cuff repair has not been fully evaluated according to the preoperative tear size and surgical technique. In this study, we investigated the effect of BMS on cuff repair integrity after an arthroscopic surface-holding (ASH) repair. Materials and methods: A total of 111 patients (mean age, 64.5 years) with chronic rotator cuff tears who underwent treatment by the ASH method with BMS by drilling of multiple holes at the footprint (67 shoulders) or without BMS (44 shoulders) were studied, and all patients were observed prospectively. Sugaya's classification was used to evaluate cuff integrity by postoperative magnetic resonance imaging, with types IV and V classified as rotator cuff retears. Results: The mean scores for cuff integrity were 2.2 +/- 0.2 and 1.7 +/- 0.2 in the non-BMS and BMS groups, respectively. The mean scores were similar between the 2 groups for medium tears; however, scores for large-massive tears were significantly lower in the BMS group. The overall retear rate was 23.9% in the non-BMS group and 9.1% in the BMS group, and the distribution of repair types differed significantly. For large-massive tears, the retear rate was much higher in the non-BMS group (28.6%) than in the BMS group (4.5%), although the rates for medium tears were comparable between the 2 groups. Conclusions: These findings demonstrate that applying BMS to the footprint during ASH repair results in improved cuff repair integrity, particularly in large-massive tears, and suggest the importance of biologic treatment for rotator cuff healing after arthroscopic rotator cuff repair. (C) 2015 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Taniguchi, Noboru; Chosa, Etsuo] Miyazaki Univ, Dept Orthopaed Surg, Kiyotake, Miyazaki 8891692, Japan; [Taniguchi, Noboru] Tokyo Med Univ, Inst Med Sci, Tokyo 1608402, Japan; [Suenaga, Naoki; Oizumi, Naomi] Hokushin Orthopaed Hosp, Upper Extrem Ctr Joint Replacement & Endoscop Sur, Sapporo, Hokkaido, Japan; [Miyoshi, Naoki] Asahikawa Med Univ, Dept Orthopaed Surg, Asahikawa, Hokkaido, Japan; [Yamaguchi, Hiroshi] Rehabil Clin Yamaguchi, Naha, Japan; [Inoue, Kazuya] Nara Med Univ, Dept Orthopaed Surg, Kashihara, Nara 634, Japan	Taniguchi, N (reprint author), Miyazaki Univ, Dept Orthopaed Surg, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan.	nobutanigu@gmail.com					Sugaya H, 2007, J BONE JOINT SURG AM, V89A, P953, DOI 10.2106/JBJS.F.00512; Funakoshi T, 2008, J SHOULDER ELB SURG, V17, P986, DOI [10.1016/j.jse.2008.06.002, 10.1016/i.jse.2008.06.002]; Jost B, 2006, J BONE JOINT SURG AM, V88A, P472, DOI 10.2106/JBJS.E.00003; Steadman JR, 1999, ORTHOPADE, V28, P26; Funakoshi T, 2010, AM J SPORT MED, V38, P2464, DOI 10.1177/0363546510375536; Kluger R, 2011, AM J SPORT MED, V39, P2071, DOI 10.1177/0363546511406395; Boileau P, 2005, J BONE JOINT SURG AM, V87A, P1229, DOI 10.2106/JBJS.D.02035; ELLMAN H, 1986, J BONE JOINT SURG AM, V68A, P1136; CHAKRAVARTY K, 1993, J RHEUMATOL, V20, P1359; Yamaguchi H, 2011, J ORTHOP SCI, V16, P398, DOI 10.1007/s00776-011-0092-9; Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219; Apreleva M, 2002, ARTHROSCOPY, V18, P519, DOI 10.1053/jars.2002.32930; Ju YJ, 2008, CELL TISSUE RES, V332, P469, DOI 10.1007/s00441-008-0610-z; DEORIO JK, 1984, J BONE JOINT SURG AM, V66A, P563; Kida Y, 2013, J SHOULDER ELB SURG, V22, P197, DOI 10.1016/j.jse.2012.02.007; Jost B, 2000, J BONE JOINT SURG AM, V82A, P304; Jo CH, 2013, AM J SPORT MED, V41, P2650, DOI 10.1177/0363546513499138; Benjamin M, 1997, HISTOL HISTOPATHOL, V12, P1135; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Huijsmans PE, 2007, J BONE JOINT SURG AM, V89A, P1248, DOI 10.2106/JBJS.E.00743; Barber FA, 1997, ARTHROSCOPY, V13, P340, DOI 10.1016/S0749-8063(97)90031-1; Ellman H, 1987, Arthroscopy, V3, P173, DOI 10.1016/S0749-8063(87)80061-0; Funakoshi T, 2011, AM J SPORT MED, V39, P2640, DOI 10.1177/0363546511420077; GOUTALLIER D, 1994, CLIN ORTHOP RELAT R, P78; Memon AR, 2012, ADV ORTHOP, V2012; Meyer DC, 2004, J SHOULDER ELB SURG, V13, P333, DOI 10.1016/j.jse.2003.12.016; Milano G, 2013, ARTHROSCOPY, V29, P802, DOI 10.1016/j.arthro.2013.01.019; Park MC, 2005, AM J SPORT MED, V33, P1154, DOI 10.1177/0363546504273053; Snyder JS, 2009, TECH SHOULDER ELBOW, V10, P130; Taniguchi N, 2014, J SHOULDER ELB SURG, V23, P620, DOI 10.1016/j.jse.2014.01.007; Warner JJP, 2005, ARTHROSCOPY, V21, P328, DOI 10.1016/j.arthro.2004.11.006; Yamaguchi H, 2012, ADV ORTHOP, V2012	32	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	JUN	2015	24	6					860	866		10.1016/j.jse.2014.09.031		7	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CI1ID	WOS:000354496300010		
J	Fujibuchi, T; Matsumoto, S; Shimoji, T; Ae, K; Tanizawa, T; Gokita, T; Hayakawa, K				Fujibuchi, Taketsugu; Matsumoto, Seiichi; Shimoji, Takashi; Ae, Keisuke; Tanizawa, Taisuke; Gokita, Tabu; Hayakawa, Keiko			New endoprosthesis suspension method with polypropylene monofilament knitted mesh after resection of bone tumors in proximal humerus	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Bone tumor; shoulder joint; endoprosthesis; artificial mesh	PROSTHESIS COMPOSITE RECONSTRUCTION; WIDE RESECTION; EXTREMITY TUMORS; REPLACEMENT; ALLOGRAFT; SHOULDER; ARTHROPLASTY; EXCISION; PART	Background: Endoprosthetic reconstruction of the proximal humerus is one of the standard procedures after resection of tumors of the proximal humerus and has been considered a reliable method to reconstruct the proximal humerus in recent reports. However, instability of the shoulder joint caused by loss of the rotator cuff and deltoid muscle function is often observed after such an endoprosthetic reconstruction. Methods: We performed the endoprosthesis suspension method with polypropylene monofilament knitted mesh. This suspension method, by which the endoprosthesis is suspended from the bone structure, was used after resection of tumors in 9 patients. We assessed postoperative stability of the shoulder joint by comparing these patients with 12 patients who underwent the conventional surgical technique, by which the mesh-wrapped endoprosthesis is attached only to soft tissue. Results: In radiographic and physical evaluation, 4 of the 12 patients in the soft tissue reconstruction group showed shoulder joint instability. No patient in the suspension method group showed subluxation of the humeral prosthesis. The mean shoulder flexion was 35 degrees and 65 degrees and the mean shoulder abduction was 40 degrees and 40 degrees for the soft tissue reconstruction group and the suspension method group, respectively. Discussion: Shoulder joint subluxation sometimes occurs because of elongation of the attached soft tissue in the conventional reconstruction with mesh, whereas no shoulder joint subluxation occurs after endoprosthetic reconstruction in the suspension method because the bone structure has no leeway for elongation. Excellent stability of our new method enables exercise of the surgical shoulder at an early stage, leading to improved range of shoulder joint motion.	[Fujibuchi, Taketsugu; Matsumoto, Seiichi; Shimoji, Takashi; Ae, Keisuke; Tanizawa, Taisuke; Gokita, Tabu; Hayakawa, Keiko] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Orthopaed Oncol, Koto Ku, Tokyo, Japan	Fujibuchi, T (reprint author), Ehime Univ, Grad Sch Med, Dept Bone & Joint Surg, Toon, Ehime 7910295, Japan.	buchi@m.ehime-u.ac.jp					Abdeen A, 2009, J BONE JOINT SURG AM, V91A, P2406, DOI 10.2106/JBJS.H.00815; Potter BK, 2009, CLIN ORTHOP RELAT R, V467, P1035, DOI 10.1007/s11999-008-0531-x; Ozaki T, 1999, INT ORTHOP, V23, P182, DOI 10.1007/s002640050342; Boileau P, 2006, J BONE JOINT SURG BR, V88B, P562, DOI 10.1302/0301-620X.88B5.16466; Marulanda GA, 2010, CLIN ORTHOP RELAT R, V468, P2896, DOI 10.1007/s11999-010-1418-1; Masterson EL, 1998, J ARTHROPLASTY, V13, P860, DOI 10.1016/S0883-5403(98)90190-5; van de Sande MAJ, 2011, INT ORTHOP, V35, P1375, DOI 10.1007/s00264-010-1152-z; SALZER M, 1979, ARCH ORTHOP TRAUM SU, V93, P169, DOI 10.1007/BF00523668; Kumar D, 2003, J BONE JOINT SURG BR, V85B, P717, DOI 10.1302/0301-620X.85B5.13838; De Wilde L, 2011, CLIN ORTHOP RELAT R, V469, P2489, DOI 10.1007/s11999-010-1758-x; Asavamongkolkul A, 1999, CLIN ORTHOP RELAT R, P207; Black AW, 2007, J SHOULDER ELB SURG, V16, P525, DOI 10.1016/j.jse.2006.12.006; Campanacci M, 1982, Ital J Orthop Traumatol, V8, P59; Cannon CP, 2009, J SHOULDER ELB SURG, V18, P705, DOI 10.1016/j.jse.2008.10.011; De Wilde Lieven, 2003, Acta Orthop Belg, V69, P495; GEBHARDT MC, 1990, J BONE JOINT SURG AM, V72A, P334; Getty PJ, 1999, J BONE JOINT SURG AM, V81A, P1138; Gosheger G, 2001, CLIN ORTHOP RELAT R, P264; Kitagawa Y, 2007, J Orthop Surg (Hong Kong), V15, P201; MALAWER MM, 1991, CLIN ORTHOP RELAT R, P33; Moran M, 2009, ARCH ORTHOP TRAUM SU, V129, P1339, DOI 10.1007/s00402-008-0752-1; Palumbo BT, 2011, CANCER CONTROL, V18, P160; Raiss P, 2010, EJSO-EUR J SURG ONC, V36, P371, DOI 10.1016/j.ejso.2009.11.001; Rodl RW, 2002, J BONE JOINT SURG BR, V84B, P1004, DOI 10.1302/0301-620X.84B7.12989; ROSS AC, 1987, J BONE JOINT SURG BR, V69, P656; Tsukushi S, 2006, CLIN ORTHOP RELAT R, P132, DOI 10.1097/01.blo.0000201169.80011.ff; Wittig JC, 2002, CLIN ORTHOP RELAT R, P156	27	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	JUN	2015	24	6					882	888		10.1016/j.jse.2014.10.011		7	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CI1ID	WOS:000354496300013		
J	Yamauchi, T; Hasegawa, S; Matsumura, A; Nakamura, M; Ibuki, S; Ichihashi, N				Yamauchi, Taishi; Hasegawa, Satoshi; Matsumura, Aoi; Nakamura, Masatoshi; Ibuki, Satoko; Ichihashi, Noriaki			The effect of trunk rotation during shoulder exercises on the activity of the scapular muscle and scapular kinematics	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Shoulder exercise; kinetic chain; trunk rotation; rehabilitation; scapular kinematics; muscle activation ratio	SCAPULOHUMERAL RHYTHM; IMPINGEMENT SYMPTOMS; REHABILITATION; MOTION; DYSKINESIS; TRAPEZIUS; ELEVATION; MOVEMENT; ARM	Background: In patients with shoulder disease, kinetic chain exercises including hip or trunk movement are recommended. However, the actual muscle activation and scapular kinematics of these exercises are not known. The purpose of this study was to examine the effect of trunk rotation on shoulder exercises that are devised to improve scapular function. Methods: Thirteen healthy young men participated in this study. Scaption, external rotation in the first and second positions, and prone scapular retraction at 45 degrees, 90 degrees, and 145 degrees of shoulder abduction were performed with and without trunk rotation. Electromyography was used to assess the scapular muscle activity of the upper trapezius (UT), middle trapezius (MT), lower trapezius (LT), and serratus anterior (SA), and electromagnetic motion capture was used to assess scapular motion. The muscle activity ratio, which is the activity of the UT to the MT, LT, and SA, was calculated. These data were compared between 2 conditions (with and without trunk rotation) for each exercise. Results: Adding trunk rotation to scaption, the first external rotation, and the second external rotation significantly increased scapular external rotation and posterior tilt, and all 3 exercises increased LT activation. In addition, trunk rotation with scapular retraction at 90 degrees and 145 degrees of shoulder abduction significantly decreased the UT/LT ratio. Conclusions: Our findings suggest that shoulder exercises with trunk rotation in this study may be effective in patients who have difficulty in enhancing LT activity and suppressing excessive activation of the UT or in cases in which a decreased scapular external rotation or posterior tilt is observed. (C) 2015 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Yamauchi, Taishi; Hasegawa, Satoshi; Nakamura, Masatoshi; Ibuki, Satoko; Ichihashi, Noriaki] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto 6068507, Japan; [Matsumura, Aoi] Kyoto Univ Hosp, Rehabil Unit, Kyoto 606, Japan; [Nakamura, Masatoshi] Japan Soc Promot Sci, Tokyo, Japan; [Nakamura, Masatoshi] Doshisha Univ, Fac Hlth & Sports Sci, Kyoto 602, Japan	Yamauchi, T (reprint author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	yamauchi.taishi.83z@st.kyoto-u.ac.jp					Kibler WB, 1998, AM J SPORT MED, V26, P325; Ludewig PM, 2000, PHYS THER, V80, P276; Boettcher CE, 2008, J ORTHOP RES, V26, P1591, DOI 10.1002/jor.20675; Karduna AR, 2001, J BIOMECH ENG-T ASME, V123, P184, DOI 10.1115/1.1351892; Mihata T, 2010, AM J SPORT MED, V38, P369, DOI 10.1177/0363546509346408; Bitter NL, 2007, J SHOULDER ELB SURG, V16, P563, DOI 10.1016/j.jse.2006.11.007; Kaplan LD, 2004, ARTHROSCOPY, V20, P701, DOI 10.1016/j.arthro.2004.06.006; Graichen H, 1999, AM J ROENTGENOL, V172, P1081; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Kibler WB, 2010, BRIT J SPORT MED, V44, P300, DOI 10.1136/bjsm.2009.058834; Wadsworth DJS, 1997, INT J SPORTS MED, V18, P618, DOI 10.1055/s-2007-972692; JOHNSON G, 1994, CLIN BIOMECH, V9, P44, DOI 10.1016/0268-0033(94)90057-4; Maenhout A, 2010, BRIT J SPORT MED, V44, P1010, DOI 10.1136/bjsm.2009.062810; Ludewig PM, 2009, J ORTHOP SPORT PHYS, V39, P90, DOI 10.2519/jospt.2009.2808; Cools AM, 2007, AM J SPORT MED, V35, P1744, DOI 10.1177/0363546507303560; Ludewig PM, 2011, MANUAL THER, V16, P33, DOI 10.1016/j.math.2010.08.004; De Luca CJ, 1997, J APPL BIOMECH, V13, P135; Struyf F, 2011, SCAND J MED SCI SPOR, V21, P352, DOI 10.1111/j.1600-0838.2010.01274.x; Cools AM, 2005, J ATHL TRAINING, V40, P104; McQuade KJ, 1998, J ORTHOP SPORT PHYS, V27, P125; Burkhart SS, 2003, ARTHROSCOPY, V19, P641, DOI 10.1016/S0749-8063(03)00389-X; Cools AM, 2004, BRIT J SPORT MED, V38, P64, DOI 10.1136/bjsm.2003.004952; Cricchio M, 2011, J HAND THER, V24, P322, DOI 10.1016/j.jht.2011.06.001; Crosbie J, 2008, CLIN BIOMECH, V23, P184, DOI 10.1016/j.clinbiomech.2007.09.012; Davidson P A, 1995, J Shoulder Elbow Surg, V4, P384, DOI 10.1016/S1058-2746(95)80023-9; Digiovine N M, 1992, J Shoulder Elbow Surg, V1, P15, DOI 10.1016/S1058-2746(09)80011-6; Glousman R, 1988, J BONE JOINT SURG AM, V70, P1428; Ha SM, 2012, PHYS THER SPORT, V13, P227, DOI 10.1016/j.ptsp.2011.11.002; Hermens H. J., 1999, EUROPEAN RECOMMENDAT; Kendall F. P., 2005, MUSCLES TESTING FUNC; Kibler W Ben, 2008, Am J Sports Med, V36, P1789, DOI 10.1177/0363546508316281; Kristof DM, 2013, J SCI MED SPORT, V16, P65; McCabe Robert A, 2007, N Am J Sports Phys Ther, V2, P34; Mottram SL, 2009, MANUAL THER, V14, P13, DOI 10.1016/j.math.2007.07.008; Nagai K, 2013, J ELECTROMYOGR KINES, V23, P679, DOI 10.1016/j.jelekin.2013.01.012; Oyama S, 2010, J ORTHOP SPORT PHYS, V40, P169, DOI 10.2519/jospt.2010.3018; Thigpen CA, 2006, AM J SPORT MED, V34, P644, DOI 10.1177/0363546505281797	37	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	JUN	2015	24	6					955	964		10.1016/j.jse.2014.10.010		10	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CI1ID	WOS:000354496300024		
J	Ito, K; Masuda, T; Komiya, A; Hioki, K				Ito, Kenichi; Masuda, Takahiko; Komiya, Asuka; Hioki, Koichi			Seeking help from close, same-sex friends: Relational costs for Japanese and personal costs for European Canadians	JOURNAL OF SOCIAL AND PERSONAL RELATIONSHIPS			English	Article						Closeness; cross-cultural differences; friendship; intersubjective perception; social support	SOCIAL SUPPORT; UNITED-STATES; DESCRIPTIVE NORMS; CULTURE; CONSEQUENCES; CONSENSUS; BEHAVIOR; SELF	Seeking help from close friends is beneficial for help seekers but also entails costs. Past research on social support suggested that East Asians were more likely than their North American counterparts to perceive relational costs (e.g., causing trouble for close friends), whereas North Americans tended to selectively perceive personal costs (e.g., admitting incompetence). We first collected European Canadian and Japanese people's everyday experiences of help-seeking behaviors. We then examined whether norms would mediate the relationship between perceptions of costs and expected closeness in friendship. For European Canadians, we found such meditating relationships only for personal costs; whereas for the Japanese, the relationships were observed for both personal and relational costs. Implications for social cognitive research and clinical research are discussed.	[Ito, Kenichi] Nanyang Technol Univ, Singapore 639798, Singapore; [Ito, Kenichi] Inst Asian Consumer Insight, Singapore, Singapore; [Masuda, Takahiko] Univ Alberta, Edmonton, AB T6G 2M7, Canada; [Komiya, Asuka] Univ Virginia, Charlottesville, VA 22903 USA; [Hioki, Koichi] Kobe Univ, Kobe, Hyogo, Japan	Ito, K (reprint author), Nanyang Technol Univ, Div Psychol, HSS 04-11,14 Nanyang Ave, Singapore 639798, Singapore.	kito@ntu.edu.sg			Institute on Asian Consumer Insight Start-Up Grant; SSHRC [410-2007-382, 410-2010-0720]	This research was supported in part by Institute on Asian Consumer Insight Start-Up Grant awarded to the author K.I. and SSHRC Standard Research Grants 410-2007-382 and 410-2010-0720, awarded to the author T.M.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Kim HS, 2008, AM PSYCHOL, V63, P518, DOI 10.1037/0003-066X; Kitayama S, 2006, J PERS SOC PSYCHOL, V91, P890, DOI 10.1037/0022-3514.91.5.890; Fischer R, 2009, J CROSS CULT PSYCHOL, V40, P187, DOI 10.1177/0022022109332738; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; Chiu CY, 2010, PERSPECT PSYCHOL SCI, V5, P482, DOI 10.1177/1745691610375562; Kim HS, 2006, PERS SOC PSYCHOL B, V32, P1595, DOI 10.1177/0146167206291991; DRUIAN PR, 1977, SOC BEHAV PERSONAL, V5, P33; Uchida Y, 2008, PERS SOC PSYCHOL B, V34, P741, DOI 10.1177/0146167208315157; Kitayama S, 1997, J PERS SOC PSYCHOL, V72, P1245, DOI 10.1037/0022-3514.72.6.1245; MARKS G, 1987, PSYCHOL BULL, V102, P72, DOI 10.1037//0033-2909.102.1.72; Cole T, 1996, J SOC PERS RELAT, V13, P57, DOI 10.1177/0265407596131004; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; PRENTICE DA, 1993, J PERS SOC PSYCHOL, V64, P243, DOI 10.1037/0022-3514.64.2.243; Shteynberg G, 2009, J CROSS CULT PSYCHOL, V40, P46, DOI 10.1177/0022022108326196; Taylor SE, 2004, J PERS SOC PSYCHOL, V87, P354, DOI 10.1037/0022-3514.87.3.354; Hamamura T, 2009, PERS SOC PSYCHOL B, V35, P454, DOI 10.1177/0146167208329512; Yamagishi T, 2008, PSYCHOL SCI, V19, P579, DOI 10.1111/j.1467-9280.2008.02126.x; Kashima Y, 2007, FRONT SOC PSYCHOL, P27; Maeda E, 2003, J SOC PERS RELAT, V20, P579, DOI 10.1177/02654075030205001; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185; Zou X, 2009, J PERS SOC PSYCHOL, V97, P579, DOI 10.1037/a0016399; Fehr B, 2004, J PERS SOC PSYCHOL, V86, P265, DOI 10.1037/0022-3514.86.2.265; Taylor SE, 2007, PSYCHOL SCI, V18, P831, DOI 10.1111/j.1467-9280.2007.01987.x; Morling B, 2002, PERS SOC PSYCHOL B, V28, P311, DOI 10.1177/0146167202286003; Sinclair S, 2005, J PERS SOC PSYCHOL, V89, P160, DOI 10.1037/0022-3514.89.2.160; Argyle M., 1984, J SOCIAL PERSONAL RE, V1, P211, DOI [10.1177/0265407584012005, DOI 10.1177/0265407584012005]; Burleson B. R., 1994, COMMUNICATION RELATI, P61; Clark M. S., 1983, NEW DIRECTIONS HELPI, V2, P205; Cohen D., 2007, HDB CULTURAL PSYCHOL, P196; DePaulo B., 1983, NEW DIRECTIONS HELPI, V2, P3; Dunn J., 2004, CHILDRENS FRIENDSHIP; FEHR B, 1988, J PERS SOC PSYCHOL, V55, P557, DOI 10.1037//0022-3514.55.4.557; Fehr B., 1996, FRIENDSHIP PROCESSES; Fischer R., 2009, INT J CROSS CULTURAL, V9, P25, DOI DOI 10.1177/1470595808101154; Fisher J. D., 1983, NEW DIRECTIONS HELPI, V1, P51; FISHER JD, 1978, PERS SOC PSYCHOL B, V4, P627, DOI 10.1177/014616727800400428; Fleiss JL, 2003, STAT METHODS RATES P; Hardin C. D., 1996, HDB MOTIVATION COGNI, P28; Hardin CD, 2001, COGNITIVE SOCIAL PSYCHOLOGY, P3; KON IS, 1978, J MARRIAGE FAM, V40, P143, DOI 10.2307/350615; Lee F, 2002, J APPL BEHAV SCI, V38, P17, DOI DOI 10.1177/0021886302381002; Maeda F, 1999, J PSYCHOSOM RES, V46, P525; Nadler A., 1983, NEW DIRECTIONS HELPI, V2, P303; OMEARA JD, 1989, SEX ROLES, V21, P525, DOI 10.1007/BF00289102; Tomasello M, 2009, WHY WE COOPERATE, P1; Uchida Y., 2012, JAPANESE J EXPT SOCI, V52, P63; WEREBE MJG, 1987, J ADOLESCENCE, V10, P269, DOI 10.1016/S0140-1971(87)80004-0	48	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0265-4075	1460-3608		J SOC PERS RELAT	J. Soc. Pers. Relatsh.	JUN	2015	32	4					529	554		10.1177/0265407514539780		26	Communication; Psychology, Social	Communication; Psychology	CI4MJ	WOS:000354723300007		
J	Naitoh, S; Okada, Y				Naitoh, Shunya; Okada, Yoshitaka			Efficiency Estimations for Multijunction and Intermediate Band Solar Cells Using Actual Measured Solar Spectra in Japan	JOURNAL OF SOLAR ENERGY ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							DETAILED BALANCE LIMIT	An intermediate band solar cell (IBSC) whose equivalent circuit is similar to a multijunction (MJ) solar cell but with an additional parallel diode connection is shown to be more robust to spectral variation than a series-connected MJ solar cell. We have calculated the limiting efficiencies of IBSC and MJ solar cells using the measured solar spectra in Japan. Even though the maximum efficiency of an IBSC is lower than a triple junction (3J) solar cell at airmass (AM)1.5, the IBSC would generate more annual electricity by 1% than 3J cell at 1 sun, if they had been optimized at AM1.5.	[Naitoh, Shunya; Okada, Yoshitaka] Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Naitoh, Shunya; Okada, Yoshitaka] Univ Tokyo, Res Ctr Adv Sci & Technol RCAST, Meguro Ku, Tokyo 1538904, Japan	Naitoh, S (reprint author), Univ Tokyo, Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	naito@mbe.rcast.u-tokyo.ac.jp; okada@mbe.rcast.u-tokyo.ac.jp			Japan Society for the Promotion of Science through Program for Leading Graduate Schools (MERIT)	The data of solar spectra and meteorological conditions are measured and provided by NEDO [14]. S. Naitoh was supported by Japan Society for the Promotion of Science through Program for Leading Graduate Schools (MERIT).	Yamaguchi M, 2006, SOL ENERG MAT SOL C, V90, P3068, DOI 10.1016/j.solmat.2006.06.028; Yoshida K, 2012, J APPL PHYS, V112, DOI 10.1063/1.4759134; Guter W, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3148341; King RR, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2734507; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; DEVOS A, 1980, J PHYS D APPL PHYS, V13, P839, DOI 10.1088/0022-3727/13/5/018; Marti A, 1996, SOL ENERG MAT SOL C, V43, P203, DOI 10.1016/0927-0248(96)00015-3; Dimroth F, 2007, MRS BULL, V32, P230, DOI 10.1557/mrs2007.27; Luque A, 1997, PHYS REV LETT, V78, P5014, DOI 10.1103/PhysRevLett.78.5014; NEDO, 2010, P07015 NEDO; Nelson J., 2003, PHYS SOLAR CELLS; NREL, 2003, G17303 NREL ASTM; Okada Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3533423; Trupke T, 2004, J APPL PHYS, V96, P2347, DOI 10.1063/1.1766091	14	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0199-6231	1528-8986		J SOL ENERG-T ASME	J. Sol. Energy Eng. Trans.-ASME	JUN	2015	137	3							034504	10.1115/1.4029382		4	Energy & Fuels; Engineering, Mechanical	Energy & Fuels; Engineering	CI2LB	WOS:000354578000024		
J	Okada, S; Uchida, T; Karasudani, T; Ohya, Y				Okada, Shinsuke; Uchida, Takanori; Karasudani, Takashi; Ohya, Yuji			Improvement in Solar Chimney Power Generation by Using a Diffuser Tower	JOURNAL OF SOLAR ENERGY ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						renewable energy; solar energy; wind energy; solar chimney; wind-lens	SHROUDED WIND TURBINE; FLANGED-DIFFUSER; FLOWS	The solar chimney prototype, operated in Spain from 1982 to 1989, verified the concept of the solar chimney. The power generation mechanism in this system is to turn the wind turbine placed inside a high rise cylindrical hollow tower by an induced thermal updraft. As long as the thermal updraft is induced inside the tower by the solar radiation, this system can produce electricity. The disadvantage of this system is the low power generation efficiency compared to other solar energy power generation systems. To overcome this disadvantage, we improved the mechanism in order to augment the velocity of the air which flows into the wind turbine. By applying a diffuser tower instead of a cylindrical one, the efficiency of the systems power generation is increased. The mechanism that we investigated was the effect of the diffuser on the solar chimney structure. The inner diameter of the tower expands as the height increases so that the static pressure recovery effect of the diffuser causes a low static pressure region to form at the bottom of the tower. This effect induces greater airflow within the tower. The laboratory experiment, as does the computational fluid dynamics (CFD) analysis of the laboratory sized model, shows that the proposed diffuser type tower induces a velocity approximately 1.38-1.44 times greater than the conventional cylindrical type. The wind power generation output is proportional to the cube of the incoming wind velocity into the wind turbine; therefore, approximately 2.6-3.0 times greater power output can be expected from using the diffuser type tower.	[Okada, Shinsuke] Kyushu Univ, Dept Aeronaut & Astronaut, Nishi Ku, Fukuoka 8190395, Japan; [Uchida, Takanori; Karasudani, Takashi; Ohya, Yuji] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan	Okada, S (reprint author), Kyushu Univ, Dept Aeronaut & Astronaut, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	shin_ok77@hotmail.com; takanori@riam.kyushu-u.ac.jp; karasu@riam.kyushu-u.ac.jp; ohya@riam.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015				Schlaich J, 2005, J SOL ENERG-T ASME, V127, P117, DOI 10.1115/1.1823493; Ohya Y, 2008, J WIND ENG IND AEROD, V96, P524, DOI 10.1016/j.jweia.2008.01.006; KIM J, 1985, J COMPUT PHYS, V59, P308, DOI 10.1016/0021-9991(85)90148-2; Ohya Y, 2010, ENERGIES, V3, P634, DOI 10.3390/en3040634; Fujiwara M., 1983, SOL ENERGY, V9, P24; Haaf W., 1984, International Journal of Solar Energy, V2, DOI 10.1080/01425918408909921; Haaf W., 1983, International Journal of Solar Energy, V2, DOI 10.1080/01425918308909911; Kajishima T., 1994, B JPN SOC MECH ENG B, V60, P3319; Kawamura T., 1986, Fluid Dynamics Research, V1, DOI 10.1016/0169-5983(86)90014-6; Ohya Y, 2008, J WIND ENG IND AEROD, V96, P2150, DOI 10.1016/j.jweia.2008.02.037; Okada S., 2006, P 19 NAT S WIND ENG, P145; Richards R., 1982, MOD POWER SYST, V1982, P21; Richards R., 1982, Electrical Review, V210; Richards R., 1981, MOD POWER SYST, V1981, P21; Schlaich J., 1995, THE SOLAR CHIMNEY; Toshimitsu K, 2008, J THERM SCI, V17, P375, DOI 10.1007/s11630-008-0375-4; Trieb F, 1997, SOL ENERGY, V59, P89, DOI 10.1016/S0038-092X(97)80946-2	17	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0199-6231	1528-8986		J SOL ENERG-T ASME	J. Sol. Energy Eng. Trans.-ASME	JUN	2015	137	3							031009	10.1115/1.4029377		8	Energy & Fuels; Engineering, Mechanical	Energy & Fuels; Engineering	CI2LB	WOS:000354578000009		
J	Sakai, T; Arakawa, K; Ogushi, M; Ishihara, T; Matsumoto, H; Okuyama, Y				Sakai, Takaaki; Arakawa, Keita; Ogushi, Masako; Ishihara, Tatsumi; Matsumoto, Hiroshige; Okuyama, Yuji			Atmosphere dependence of anode reaction of intermediate temperature steam electrolysis using perovskite type proton conductor	JOURNAL OF SOLID STATE ELECTROCHEMISTRY			English	Article						Steam electrolysis; Proton conducting oxide; Electrode reaction; Perovskite oxide	ZIRCONIA INTERFACES; HYDROGEN-PRODUCTION; SOLID ELECTROLYTES; PLATINUM-ELECTRODE; CELLS; PERFORMANCE; STRONTIUM; KINETICS; OXIDES; FUEL	The effect of oxygen partial pressure on anode reaction of steam electrolysis using SrZr0.5Ce0.4Y0.1O3-alpha (SZCY-541) proton conducting electrolyte was investigated by AC impedance measurement in this work. The anode reaction was enhanced by increasing oxygen partial pressure, and this result was opposite to the expectation from the conventional anode reaction (water splitting reaction). The increase in the electrode reaction conductivity with oxygen chemical potential was proportional to at 600 A degrees C and at higher oxygen partial pressure region of 700 and 800 A degrees C, suggesting the possibility that the enhancement is caused by the increase in hole concentration on the electrolyte surface near the anode.	[Sakai, Takaaki] Kyushu Univ, Ctr Mol Syst CMS, Nishi Ku, Fukuoka 8190395, Japan; [Sakai, Takaaki; Ogushi, Masako; Ishihara, Tatsumi] Kyushu Univ, Fac Engn, Dept Appl Chem, Nishi Ku, Fukuoka 8190395, Japan; [Arakawa, Keita] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Ishihara, Tatsumi; Matsumoto, Hiroshige] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan; [Okuyama, Yuji] Miyazaki Univ, Org Promot Tenure Track, Miyazaki 8892192, Japan	Sakai, T (reprint author), Kyushu Univ, Ctr Mol Syst CMS, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	t-sakai@cstf.kyushu-u.ac.jp					ACCORSI R, 1980, J ELECTROCHEM SOC, V127, P804, DOI 10.1149/1.2129761; Akoshima S, 2010, SOLID STATE IONICS, V181, P240, DOI 10.1016/j.ssi.2009.05.003; DOENITZ W, 1980, INT J HYDROGEN ENERG, V5, P55, DOI 10.1016/0360-3199(80)90114-7; IWAHARA H, 1993, SOLID STATE IONICS, V61, P65, DOI 10.1016/0167-2738(93)90335-Z; UCHIDA H, 1983, SOLID STATE IONICS, V11, P117, DOI 10.1016/0167-2738(83)90048-6; IWAHARA H, 1995, SOLID STATE IONICS, V77, P289, DOI 10.1016/0167-2738(95)00051-7; Kreuer KD, 1999, SOLID STATE IONICS, V125, P285, DOI 10.1016/S0167-2738(99)00188-5; IWAHARA H, 1981, SOLID STATE IONICS, V3-4, P359, DOI 10.1016/0167-2738(81)90113-2; MIZUSAKI J, 1987, SOLID STATE IONICS, V22, P323, DOI 10.1016/0167-2738(87)90150-0; He F, 2010, J POWER SOURCES, V195, P3359, DOI 10.1016/j.jpowsour.2009.12.079; BADWAL SPS, 1980, ELECTROCHIM ACTA, V25, P1115, DOI 10.1016/0013-4686(80)87108-8; IWAHARA H, 1982, J POWER SOURCES, V7, P293, DOI 10.1016/0378-7753(82)80018-9; IWAHARA H, 1983, SOLID STATE IONICS, V11, P109, DOI 10.1016/0167-2738(83)90047-4; Sakai T, 2009, IONICS, V15, P665, DOI 10.1007/s11581-009-0365-x; Sakai T, 2008, ELECTROCHIM ACTA, V53, P8172, DOI 10.1016/j.electacta.2008.06.013; Sakai T, 2009, INT J HYDROGEN ENERG, V34, P56, DOI 10.1016/j.ijhydene.2008.10.011; Sakai T, 2012, ELECTROCHIM ACTA, V75, P179, DOI 10.1016/j.electacta.2012.04.102	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1432-8488	1433-0768		J SOLID STATE ELECTR	J. Solid State Electrochem.	JUN	2015	19	6					1793	1798		10.1007/s10008-015-2808-9		6	Electrochemistry	Electrochemistry	CI3BP	WOS:000354622700023		
J	Tomai, T; Nakayasu, Y; Yanaka, M; Honma, I				Tomai, Takaaki; Nakayasu, Yuta; Yanaka, Miki; Honma, Itaru			Fabrication of CuInSe2 and Cu2ZnSnSe4 films from metal-oxide precursors and SeO2 using supercritical ethanol	JOURNAL OF SUPERCRITICAL FLUIDS			English	Article						Chalcogens; Green chemistry; Thin films; Supercritical fluids; Selenization	SOLAR-CELL; VAPOR SELENIZATION; THIN-FILMS; SELENIUM; DIOXIDE	In this study, we achieved the conversions of Cu-In and Cu-Zn-Sn oxide precursor films to CuInSe2 and Cu2ZnSnSe4 films, respectively, using SeO2 as a selenium source in supercritical ethanol (EtOH). EtOH enables sufficient supply of SeO2 to reaction field due to its high solubility. Moreover, EtOH in high temperature condition reacts with SeO2 to form diethylselenide, Et2Se, and elemental selenium, and shows self-oxidation to release hydrogen. These features of EtOH will contribute to the selenization for the fabrication of the metal-selenide film facilitates the fabrication of metal-selenide film with ideal band gap, even when both precursor film and selenium source are oxides. Supercritical-alcohol-assisted selenization will contribute to the development of the cost-effective non-vacuum fabrication process for metal-selenide in optical devices, such as solar cells. (C) 2015 Elsevier B.V. All rights reserved.	[Tomai, Takaaki; Nakayasu, Yuta; Yanaka, Miki; Honma, Itaru] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan	Tomai, T (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan.	tomai@tagen.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [25630353]	This work was financially supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 25630353.	Ahn A., 2010, APPL PHYS LETT, V97; Chichibu S, 1997, JPN J APPL PHYS 1, V36, P1703, DOI 10.1143/JJAP.36.1703; Cabanas A, 2003, CHEM MATER, V15, P2910, DOI 10.1021/cm021814c; Persson C, 2010, J APPL PHYS, V107, DOI 10.1063/1.3318468; Chen O, 2008, ANGEW CHEM INT EDIT, V47, P8638, DOI 10.1002/anie.200804266; Duchatelet A, 2013, SOL ENERG MAT SOL C, V119, P241, DOI 10.1016/j.solmat.2013.07.053; Wang W, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301465; Eckert CA, 1996, NATURE, V383, P313, DOI 10.1038/383313a0; Marudachalam M, 1995, APPL PHYS LETT, V67, P3978, DOI 10.1063/1.114424; NAKADA T, 1994, SOL ENERG MAT SOL C, V35, P209, DOI 10.1016/0927-0248(94)90142-2; Katagiri H, 1997, SOL ENERG MAT SOL C, V49, P407, DOI 10.1016/S0927-0248(97)00119-0; Washio T, 2012, J MATER CHEM, V22, P4021, DOI 10.1039/c2jm16454j; IWASA N, 1991, B CHEM SOC JPN, V64, P2619, DOI 10.1246/bcsj.64.2619; Todorov TK, 2010, ADV MATER, V22, pE156, DOI 10.1002/adma.200904155; Chichibu SF, 2002, J CRYST GROWTH, V243, P404, DOI 10.1016/S0022-0248(02)01558-0; GUPTA A, 1994, SOL ENERG MAT SOL C, V32, P137, DOI 10.1016/0927-0248(94)90299-2; Gustafsson AMK, 2014, WASTE MANAGE, V34, P1775, DOI 10.1016/j.wasman.2013.12.021; Lakshmikumar ST, 1996, J APPL PHYS, V79, P3585, DOI 10.1063/1.361411; Rockett A., 1991, J APPL PHYS, V70, P81; Shen HB, 2010, DALTON T, V39, P11432, DOI 10.1039/c0dt00709a; Tomai T, 2011, ACS APPL MATER INTER, V3, P3268, DOI 10.1021/am200899q; Tomai T, 2013, J SUPERCRIT FLUID, V83, P41, DOI 10.1016/j.supflu.2013.08.013; WAITKINS GR, 1945, CHEM REV, V36, P235, DOI 10.1021/cr60115a001	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0896-8446	1872-8162		J SUPERCRIT FLUID	J. Supercrit. Fluids	JUN	2015	101						48	53		10.1016/j.supflu.2015.03.003		6	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CI2MN	WOS:000354581800005		
J	Genda, Y; Kuroda, S; Ohta, S				Genda, Yuji; Kuroda, Sachiko; Ohta, Souichi			Does downsizing take a toll on retained staff? An analysis of increased working hours in the early 2000s in Japan	JOURNAL OF THE JAPANESE AND INTERNATIONAL ECONOMIES			English	Article						Hours worked; Employee adjustments; Japan's lost decades	GROSS JOB CREATION; LIFETIME EMPLOYMENT; PERFORMANCE PAY; UNITED-STATES; DESTRUCTION; TOURNAMENTS; TRENDS; FIRMS; MEN; US	Using several kinds of micro data from household, employee, and retrospective surveys, this study examines the increase in the working hours of regular male employees in Japan during the serious recession of the early 2000s. The most important finding of this study is that working hours tended to be long among regular male employees in firms with major employee adjustments. The results suggest that the existence of abundant fixed duties necessary to maintain the internal organization of a firm primarily account for the increase in working hours of male employees during the recession. J. Japanese Int. Economies 36 (2015) 1-24. The University of Tokyo, Institute of Social Science, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan; Waseda University, Faculty of Education and Integrated Arts and Sciences, 1-6-1 Nishiwaseda, Shinjuku-ku, Tokyo 169-8050, Japan; Keio University, Faculty of Economics, 2-15-45 Mita, Minato-ku, Tokyo 108-8345, Japan. (C) 2015 Elsevier Inc. All rights reserved.	[Genda, Yuji] Univ Tokyo, Inst Social Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kuroda, Sachiko] Waseda Univ, Fac Educ & Integrated Arts & Sci, Shinjuku Ku, Tokyo 1698050, Japan; [Ohta, Souichi] Keio Univ, Fac Econ, Minato Ku, Tokyo 1088345, Japan	Kuroda, S (reprint author), Waseda Univ, Fac Educ & Integrated Arts & Sci, Shinjuku Ku, 1-6-1 Nishiwaseda, Tokyo 1698050, Japan.	genda@iss.u-tokyo.ac.jp; s-kuroda@waseda.ac.jp; ohta@econ.keio.ac.jp			Japan Society for the Promotion of Science [22000001]; Japanese government (Japan Society for the Promotion of Science) [25380372]	A part of the data used in this study is taken from the Labor Force Survey housed at the on-site data center of the Statistical Research and Training Institute, Ministry of International Affairs and Communications, Japan. The authors gratefully acknowledge the MIAC for providing the precious data. The authors also extend their heartfelt gratitude to Professors Mitsuhiro Fukao (Keio University), Yoshio Higuchi (Keio University), Sebastien Lechevalier (L'Ecole des Hautes Etudes en Sciences Sociales), Takanobu Nakajima (Keio University), Thomas Piketty (Paris School of Economics), Isamu Yamamoto (Keio University), and participants of the Workshop at Keio University and the Paris School of Economics Lunch Seminar for their valuable comments. Any remaining errors are entirely our own. This research is supported by the Grant-in-Aid for Specially Promoted Research from the Japan Society for the Promotion of Science (grant number 22000001, academic project on Economic Analysis of Intergenerational Issues: Searching for Further Development) and the Japanese government's Grants-in-Aid for Scientific Research [C] (Japan Society for the Promotion of Science; Research No. 25380372).	Abraham K.G., 1989, J JAPANESE INT EC, V3, P500, DOI 10.1016/0889-1583(89)90015-4; Landers RM, 1996, AM ECON REV, V86, P329; Bell LA, 2001, LABOUR ECON, V8, P181, DOI 10.1016/S0927-5371(01)00030-6; Lazear EP, 2000, AM ECON REV, V90, P1346, DOI 10.1257/aer.90.5.1346; Kuhn P, 2008, J LABOR ECON, V26, P311, DOI 10.1086/533618; DeVaro J, 2006, RAND J ECON, V37, P521, DOI 10.1111/j.1756-2171.2006.tb00029.x; Kato T, 2001, J JPN INT ECON, V15, P489, DOI 10.1006/jjie.2001.0493; Ono H, 2010, J JPN INT ECON, V24, P1, DOI 10.1016/j.jjie.2009.11.003; HASHIMOTO M, 1985, AM ECON REV, V75, P721; Ohanian LE, 2012, J MONETARY ECON, V59, P40, DOI 10.1016/j.jmoneco.2011.11.005; LAZEAR EP, 1981, J POLIT ECON, V89, P841, DOI 10.1086/261010; Autor DH, 2003, Q J ECON, V118, P1279, DOI 10.1162/003355303322552801; Callcredit, 2009, WORK GIV AW 71M EV D; DAVIS SJ, 1992, Q J ECON, V107, P819, DOI 10.2307/2118365; DAVIS SJ, 1990, NBER MACROECON ANN, V5, P123, DOI 10.2307/3585137; Genda Y., 1998, WAGE DIFFERENTIALS I, P35; Genda Y., 2010, LABOR MARKET INCOME, P137; Genda Y, 1998, J JPN INT ECON, V12, P1, DOI 10.1006/jjie.1997.0392; Hamermesh D.H., 1993, LABOR DEMAND; MINCER J, 1988, J JAPANESE INT EC, V0002; Kambayashi R, 2008, CAN J ECON, V41, P1329; Kambayashi R., 2011, JAPANS BUBBLE DEFLAT; Koike K., 1988, UNDERSTANDING IND RE; Kuroda S, 2010, J JPN INT ECON, V24, P481, DOI 10.1016/j.jjie.2010.05.001; Lemieux T, 2009, Q J ECON, V124, P1; Liu Y, 2002, OCCUP ENVIRON MED, V59, P447, DOI 10.1136/oem.59.7.447; Rebick M., 2005, JAPANESE EMPLOYMENT; ROSEN S, 1986, AM ECON REV, V76, P701; TACHIBANAKI T, 1987, EUR ECON REV, V31, P647, DOI 10.1016/0014-2921(87)90086-9; Towers Watson, 2011, TOW WATS TAL MAN REW	30	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1583	1095-8681		J JPN INT ECON	J. Jpn. Inst. Econ.	JUN	2015	36						1	24		10.1016/j.jjie.2015.02.003		24	Economics; International Relations	Business & Economics; International Relations	CH6LA	WOS:000354146900001		
J	Iiboshi, H; Matsumae, T; Namba, R; Nishiyama, SI				Iiboshi, Hirokuni; Matsumae, Tatsuyoshi; Namba, Ryoichi; Nishiyama, Shin-Ichi			Estimating a DSGE model for Japan in a data-rich environment	JOURNAL OF THE JAPANESE AND INTERNATIONAL ECONOMIES			English	Article						DSGE; Business cycle; Data-rich estimation; Measurement error; MCMC; Bayesian estimation	MONETARY-POLICY; TECHNOLOGY SHOCKS; FLUCTUATIONS; INDETERMINACY; INFLATION; 1990S	A dynamic factor model (DFM), widely used in empirical research in macroeconomics, shows that common factors extracted from large panel data sets are key factors behind the fluctuations of primal macroeconomic series. Boivin and Giannoni (2006) and Kryshko (2011) combine a dynamic stochastic general equilibrium (DSGE) model with a DFM as a data-rich DSGE model, in which model variables are regarded as common factors derived from large data sets. Following Smets and Wouters (2003, 2007), we estimate a new Keynesian DSGE model for Japan between 1981Q1 and 1995Q4 in a data-rich environment with 55 macroeconomic indicators using Markov chain Monte Carlo (MCMC) methods. Using a simulation smoother developed by de Jong and Shephard (1995), unlike previous studies, we succeeded in sampling model variables and exogenous shocks used for analyzing sources of business cycles. We found that a data-rich DSGE model with an inappropriate data set or inaccurate specificities reduces efficiency even though the number of indicators is fulfilling. J. Japanese Int. Economies 36 (2015) 25-55. Graduate School of Social Sciences, Tokyo Metropolitan University, Japan; Economic and Social Research Institute, Cabinet Office, Japan; Graduate School of Economics and Management, Tohoku University, Japan. (C) 2015 Elsevier Inc. All rights reserved.	[Iiboshi, Hirokuni] Tokyo Metropolitan Univ, Grad Sch Social Sci, Tokyo, Japan; [Matsumae, Tatsuyoshi; Namba, Ryoichi] Econ & Social Res Inst, Cabinet Off, Tokyo, Japan; [Nishiyama, Shin-Ichi] Tohoku Univ, Grad Sch Econ & Management, Sendai, Miyagi 980, Japan	Iiboshi, H (reprint author), Tokyo Metropolitan Univ, Grad Sch Social Sci, Tokyo, Japan.	iiboshi@tmu.ac.jp; tatsuyoshi.matsumae@gmail.com; nishiyama@econ.tohoku.ac.jp		Nishiyama, Shin-Ichi/0000-0002-3287-3733			Del Negro M, 2007, J BUS ECON STAT, V25, P123, DOI 10.1198/073500107000000016; Stock JH, 2002, J AM STAT ASSOC, V97, P1167, DOI 10.1198/016214502388618960; Smets F, 2007, AM ECON REV, V97, P586, DOI 10.1257/aer.97.3.586; Lubik TA, 2004, AM ECON REV, V94, P190, DOI 10.1257/000282804322970760; DEJONG P, 1995, BIOMETRIKA, V82, P339; Stock JH, 2002, J BUS ECON STAT, V20, P147, DOI 10.1198/073500102317351921; Edge RM, 2010, BROOKINGS PAP ECO AC, P209; Bernanke BS, 2003, J MONETARY ECON, V50, P525, DOI 10.1016/S0304-3932(03)00024-2; Hayashi F, 2002, REV ECON DYNAM, V5, P206, DOI 10.1006/redy.2001.0149; Schorfheide F, 2000, J APPL ECONOM, V15, P645, DOI 10.1002/jae.582; Fisher JDM, 2006, J POLIT ECON, V114, P413, DOI 10.1086/505048; Gali J, 2001, EUR ECON REV, V45, P1237, DOI 10.1016/S0014-2921(00)00105-7; Justiniano A, 2008, AM ECON REV, V98, P604, DOI 10.1257/aer.98.3.604; Stock JH, 2007, J MONEY CREDIT BANK, V39, P3, DOI 10.1111/j.1538-4616.2007.00014.x; Bauwens L., 1999, BAYESIAN INFERENCE D; Bernanke BS, 2005, Q J ECON, V120, P387, DOI 10.1162/0033553053327452; Boivin J., 2006, NBER WORKING PAPERS, V12772; Boivin J., 2011, HDB MONETARY EC, V3, P369; CHIB S, 1994, J ECONOMETRICS, V64, P183, DOI 10.1016/0304-4076(94)90063-9; Cristiano L. J., 2005, J POLITICAL EC, V113, P1; Fueki T., 2010, 10E13 BANK JAP; Gamerman D., 2006, MARKOV CHAIN MONTE C; Geweke J., 1992, BAYESIAN STAT, V4; Hirose Y, 2012, PAC ECON REV, V17, P208, DOI 10.1111/j.1468-0106.2012.00580.x; Hirose Y, 2008, J MONEY CREDIT BANK, V40, P967, DOI 10.1111/j.1538-4616.2008.00143.x; Iiboshi H., 2014, ERSI WORKING PAPER S, V31; Iiboshi H., 2012, ERSI DISCUSSION PAPE, V292; Iiboshi H., 2006, ESTIMATED DYNA UNPUB; Jungbacker B., 2008, LIKELIHOOD BAS UNPUB; Justiniano A., 2008, POTENCIAL NATU UNPUB; Kaihatsu S, 2014, J JPN INT ECON, V34, P217, DOI 10.1016/j.jjie.2014.08.002; Kaihatsu S, 2014, REV ECON DYNAM, V17, P224, DOI 10.1016/j.red.2013.08.001; Kim C. J., 1999, STATE SPACE MODELS R; King R., 2000, 7534 NBER; Kryshko M., 2011, 216 IMF; Kumano Y, 2014, J JPN INT ECON, V34, P135, DOI 10.1016/j.jjie.2014.05.004; Levin A., 2005, NBER MACROECON ANNU, V20, P229; Matsumae T., 2011, J JAPANESE STAT SOC, V41, P83; Onatski A, 2010, J APPL ECONOMET, V25, P145, DOI 10.1002/jae.1131; Shorfheide F., 2010, INT J FORECASTING, V26, P348; Sims C. A., 2002, Computational Economics, V20, DOI 10.1023/A:1020517101123; Smets F, 2003, J EUR ECON ASSOC, V1, P1123, DOI 10.1162/154247603770383406; Stock J. H., 2005, 11467 NBER; Sugo T, 2008, J JPN INT ECON, V22, P476, DOI 10.1016/j.jjie.2007.09.002; Urasawa S, 2014, J JPN INT ECON, V34, P116, DOI 10.1016/j.jjie.2014.05.005	45	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1583	1095-8681		J JPN INT ECON	J. Jpn. Inst. Econ.	JUN	2015	36						25	55		10.1016/j.jjie.2015.02.001		31	Economics; International Relations	Business & Economics; International Relations	CH6LA	WOS:000354146900002		
J	Nutahara, K				Nutahara, Kengo			Laffer curves in Japan	JOURNAL OF THE JAPANESE AND INTERNATIONAL ECONOMIES			English	Article						Laffer curve; Fiscal policy; Labor tax; Capital tax; Consumption tax; Japan	GENERAL EQUILIBRIUM; CAPITAL INCOME; TAXATION; MODEL; TAX	This paper investigates the Laffer curves in Japan, based on a neoclassical growth model. It is found that while the labor tax rate is smaller than that at the peak of the Laffer curve, the capital tax rate is either very close to, or larger than, that at the peak of the Laffer curve. This problem is more serious when the consumption tax rate is high. It is also found that to maximize total tax revenue, the government should increase the labor tax rate but decrease the capital tax rate. J. Japanese Int. Economies 36 (2015) 56-72. Senshu University, Japan; University College London, United Kingdom; The Canon Institute for Global Studies, Japan. (C) 2015 Elsevier Inc. All rights reserved.	[Nutahara, Kengo] Senshu Univ, Tokyo, Japan; [Nutahara, Kengo] UCL, London WC1E 6BT, England; [Nutahara, Kengo] Canon Inst Global Studies, Tokyo, Japan	Nutahara, K (reprint author), 2-1-1 Higashimita,Tama Ku, Kawasaki, Kanagawa 2148580, Japan.	nutti@isc.senshu-u.ac.jp			 [24330094]	I would like to thank Hiroshi Gunji, Keiichiro Kobayashi, Masaru Inaba, and Daichi Shirai for comments and discussions. I'm also grateful to Shin-ichi Fukuda (Editor) and two anonymous referees for their helpful comments. This work is supported by a Grant-in-Aid for Scientific Research (B) (Grant Number 24330094).	CHAMLEY C, 1986, ECONOMETRICA, V54, P607, DOI 10.2307/1911310; Hayashi F, 2002, REV ECON DYNAM, V5, P206, DOI 10.1006/redy.2001.0149; Trabandt M, 2011, J MONETARY ECON, V58, P305, DOI 10.1016/j.jmoneco.2011.07.003; Braun R. A., 2006, 649 SFB HUMB U BERL; Braun R. A., 2013, SMALL POL C JAP FISC; Fujiwara I., 2005, MONETARY EC STUDIES, V23, P61; Gunji H, 2011, J JPN INT ECON, V25, P81, DOI 10.1016/j.jjie.2011.02.003; Hiraga K., 2011, KEIO KYOTO GLOBAL CO, VDP2011-021; Imrohoroglu S., 2013, 19431 NBER; JOINES DH, 1981, J BUS, V54, P191, DOI 10.1086/296129; JUDD KL, 1985, J PUBLIC ECON, V28, P59, DOI 10.1016/0047-2727(85)90020-9; Kobayashi K, 2006, JPN WORLD ECON, V18, P418, DOI 10.1016/j.japwor.2006.04.003; Miyazawa K., 2013, 13006E CIGS; Sugo T, 2008, J JPN INT ECON, V22, P476, DOI 10.1016/j.jjie.2007.09.002; Trabandt M., 2013, NBER CHAPTERS FISCAL, P211; WANNISKI J, 1978, PUBLIC INTEREST, P3; Uhlig H, 1996, EUR ECON REV, V40, P1521, DOI 10.1016/0014-2921(96)00032-3	17	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1583	1095-8681		J JPN INT ECON	J. Jpn. Inst. Econ.	JUN	2015	36						56	72		10.1016/j.jjie.2015.02.002		17	Economics; International Relations	Business & Economics; International Relations	CH6LA	WOS:000354146900003		
J	Tajika, T				Tajika, Tomoya			Japanese government and utilitarian behavior	JOURNAL OF THE JAPANESE AND INTERNATIONAL ECONOMIES			English	Article						Utilitarian social welfare; Subsidies to local governments; Local public finance; Vote value	PREFERENCES; EXPLORATION; TAXATION	When optimal policies for governments are studied in economics, social welfare functions are often used, but the functions are typically unobservable. This paper estimates the social welfare function of Japan's central government from FY 1955 to 2010. We assume that the central government determines its subsidies to the local governments of prefectures to maximize a social welfare function, which is assumed to be a weighted sum of the utility of a representative resident of each prefecture. The weight on each prefecture is estimated from the amounts of subsidies using the method developed by Iritani and Tamaoka (2005). Using regression analysis, we show that the weight on a prefecture is approximately equal to the prefecture's population. The correlation coefficient between weights and populations is 0.969. This implies that the social welfare function is approximately the (unweighted) sum of the utilities of all individuals in the entire country, that is, utilitarian with identical weights on all individuals Japanese Int. Economies 36 (2015) 90-107. Graduate School of Economics, Kobe University, 2-1 Rokkodaicho, Nada-ku, Kobe 657-8501, Japan; Japan Society for the Promotion of Science, 5-3-1 Kojimachi, Chiyoda-ku, Tokyo 102-0083, Japan. (C) 2014 Elsevier Inc. All rights reserved.	[Tajika, Tomoya] Kobe Univ, Grad Sch Econ, Nada Ku, Kobe, Hyogo 6578501, Japan; [Tajika, Tomoya] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan	Tajika, T (reprint author), Kobe Univ, Grad Sch Econ, Nada Ku, 2-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	tomoyatajika@gmail.com			JSPS KAKENHI [26-5350]	I am deeply grateful to Jun Iritani and Eiichi Miyagawa, who provided carefully considered feedback and valuable comments. I am also indebted to Takao Fujii, Shinpei Sano, Masayuki Tamaoka, Yoshikatsu Tatamitani, seminar participants at Kobe, and many others who commented on my works. Their comments significantly contributed to my work. I also thank anonymous referees of this journal for their careful reading and valuable comments, which greatly improved this paper. Any errors in this paper are my own. This paper is based on the author's undergraduate thesis at Kobe University and completed while the author is a research fellow of the Japan Society for the Promotion of Science (JSPS). This research is supported by JSPS KAKENHI Grant No. 26-5350.	AHMAD E, 1984, J PUBLIC ECON, V25, P259, DOI 10.1016/0047-2727(84)90057-4; Akai N., 2003, REFORM INTERGOVERNME; HENDERSON JM, 1968, REV ECON STAT, V50, P156, DOI 10.2307/1926191; BEHRMAN JR, 1987, AM ECON REV, V77, P37; Bargain O., 2010, LABOUR, V24, P141, DOI 10.1111/j.1467-9914.2010.00506.x; Bourguignon F, 2012, J ECON INEQUAL, V10, P75, DOI 10.1007/s10888-010-9153-0; BULLOCK DS, 1994, AM J AGR ECON, V76, P347, DOI 10.2307/1243648; CHRISTIANSEN V, 1978, J PUBLIC ECON, V10, P217, DOI 10.1016/0047-2727(78)90036-1; Council on Economic and Fiscal Policy, 2003, BAS POL EC FISC POL; Dewit A., 2002, SOCIAL SCI JAPAN J, V5, P159, DOI 10.1093/ssjj/05.2.159; Doi T., 1997, JAPAN CTR EC RES EC, V34, P180; Doi T, 2002, J JPN INT ECON, V16, P492, DOI 10.1006/jjie.2002.0518; Economic and Social Research Institute Cabinet Office Government of Japan, 1955, ANN REP PREF ACC ANN; Iqbal F., 2001, EVOLUTION SALIENT CH; Iritani J., 2005, GOV AUDIT REV, V12, P23; Local Public Finance Research Council, 1955, ANN REP LOC PUBL FIN; Mattos E., 2008, BRAZ REV EC, V28, P133; MIRRLEES JA, 1971, REV ECON STUD, V38, P175, DOI 10.2307/2296779; Mochida N., 2001, TAXES TRANSFERS JAPA; National Tax Agency Government of Japan, 1955, NAT TAX AG ANN STAT; LIANOS TP, 1988, J AGR ECON, V39, P61, DOI 10.1111/j.1477-9552.1988.tb00562.x; Saez E, 2002, Q J ECON, V117, P1039, DOI 10.1162/003355302760193959; Salhofer K, 2000, PUBLIC CHOICE, V102, P229, DOI 10.1023/A:1005024920319; Statistics Bureau of Japan, 2012, HIST STAT JAP; Statistics Bureau of Japan, 2011, POP CENS; Statistics Bureau of Japan, 2005, MAJ METR AR METR AR	26	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1583	1095-8681		J JPN INT ECON	J. Jpn. Inst. Econ.	JUN	2015	36						90	107		10.1016/j.jjie.2014.11.004		18	Economics; International Relations	Business & Economics; International Relations	CH6LA	WOS:000354146900005		
J	Kumar, NA; Dar, MA; Gul, R; Baek, JB				Kumar, Nanjundan Ashok; Dar, Mushtaq Ahmad; Gul, Rukhsana; Baek, Jong-Beom			Graphene and molybdenum disulfide hybrids: synthesis and applications	MATERIALS TODAY			English	Article							LITHIUM-ION BATTERIES; HYDROGEN EVOLUTION REACTION; TRANSITION-METAL DICHALCOGENIDES; SENSITIZED SOLAR-CELLS; LAYERED MOS2-GRAPHENE COMPOSITES; PERFORMANCE ANODE MATERIAL; FIELD-EFFECT TRANSISTORS; MOS2 NANOSHEETS; ASSISTED SYNTHESIS; ELECTROCHEMICAL PERFORMANCES	Graphene and related inorganic two-dimensional (2D) nanomaterials are an exceptional class of compounds with exotic properties that are technologically intriguing. While graphene itself is chemically inert and a gapless semimetal, its isostructural analog, molybdenum disulfide (MOS2) is chemically versatile with band gaps, thereby finding significant use in a myriad of applications. Although these 2D nanomaterials individually possess tremendous authority for various applications, the combination of these materials in the recent past has created a new paradigm in emerging applications. Here, we summarize the current state-of-the-art and progress over the past three years on the development of hybrids of these layered materials. We highlight their pivotal role in electrochemical energy storage, sensing, hydrogen generation by photochemical water splitting and electronic device applications such as field-effect transistors. Perspectives on the challenges and opportunities for the exploration of these 2D layered hybrid materials are put forward.	[Kumar, Nanjundan Ashok; Baek, Jong-Beom] Ulsan Natl Inst Sci & Technol, Low Dimens Carbon Mat Ctr, Sch Energy & Chem Engn, Ulsan 689798, South Korea; [Dar, Mushtaq Ahmad; Gul, Rukhsana] King Saud Univ, Adv Mfg Inst, Ctr Excellence Res Engn Mat, Riyadh, Saudi Arabia	Kumar, NA (reprint author), Kumamoto Univ, Dept Appl Chem & Biochem, Kumamoto 860, Japan.	ashoknanjundan@yahoo.com; jbbaek@unist.ac.kr	Baek, Jong-Beom/E-5883-2010		National Research Foundation (NRF) of Korea - Ministry of Education, Science and Technology (MEST); US Air Force Office of Scientific Research through the Asian Office of Aerospace RD (AFOSR-AOARD)	The authors acknowledge support of Basic Science Research, BK21 Plus, Mid-Career Researcher and Basic Research Laboratory (BRL) programs through the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science and Technology (MEST), and the US Air Force Office of Scientific Research through the Asian Office of Aerospace R&D (AFOSR-AOARD).	Bonaccorso F, 2012, MATER TODAY, V15, P564, DOI 10.1016/S1369-7021(13)70014-2; Kim MJ, 2014, ACS NANO, V8, P2820, DOI 10.1021/nn4066395; Pham VH, 2013, J POWER SOURCES, V244, P280, DOI 10.1016/j.jpowsour.2013.01.053; Yan Y, 2014, ACS CATAL, V4, P1693, DOI 10.1021/cs500070x; Peng X, 2014, CHEM SOC REV, V43, P3303, DOI 10.1039/c3cs60407a; Jung SM, 2014, ANGEW CHEM INT EDIT, V53, P2398, DOI 10.1002/anie.201310260; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; David L, 2014, ACS NANO, V8, P1759, DOI 10.1021/nn406156b; Li YG, 2011, J AM CHEM SOC, V133, P7296, DOI 10.1021/ja201269b; Chang K, 2014, ACS NANO, V8, P7078, DOI 10.1021/nn5019945; Yu LL, 2014, NANO LETT, V14, P3055, DOI 10.1021/nl404795z; Huang KJ, 2013, SENSOR ACTUAT B-CHEM, V178, P671, DOI 10.1016/j.snb.2013.01.028; Lin JY, 2013, CHEM COMMUN, V49, P1440, DOI 10.1039/c2cc38658e; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Chang K, 2011, CHEM COMMUN, V47, P4252, DOI 10.1039/c1cc10631g; Yoon J, 2013, SMALL, V9, P3295, DOI 10.1002/smll.201300134; Ma L, 2014, J POWER SOURCES, V264, P262, DOI 10.1016/j.jpowsour.2014.04.084; Ma CB, 2014, NANOSCALE, V6, P5624, DOI 10.1039/c3nr04975b; Rao CNR, 2013, ANGEW CHEM INT EDIT, V52, P13162, DOI 10.1002/anie.201301548; Wang Z, 2013, J MATER CHEM A, V1, P2202, DOI 10.1039/c2ta00598k; Yuan WJ, 2014, MATER TODAY, V17, P77, DOI 10.1016/j.mattod.2014.01.021; Yan Y, 2013, CHEM COMMUN, V49, P4884, DOI 10.1039/c3cc41031e; Chang K, 2011, ACS NANO, V5, P4720, DOI 10.1021/nn200659w; Cai BJ, 2014, ACS NANO, V8, P2632, DOI 10.1021/nn4063424; Finn DJ, 2014, J MATER CHEM C, V2, P925, DOI 10.1039/c3tc31993h; Liu N, 2014, ACS NANO, V8, P6902, DOI 10.1021/nn5016242; Xiang QJ, 2012, J AM CHEM SOC, V134, P6575, DOI 10.1021/ja302846n; Huang X, 2013, CHEM SOC REV, V42, P1934, DOI 10.1039/c2cs35387c; Hu YH, 2013, ECS J SOLID STATE SC, V2, pM3034, DOI 10.1149/2.007310jss; Bernardi M, 2013, NANO LETT, V13, P3664, DOI 10.1021/nl401544y; Kwak JY, 2014, NANO LETT, V14, P4511, DOI 10.1021/nl5015316; Myoung N, 2013, ACS NANO, V7, P7021, DOI 10.1021/nn402919d; Rao CNR, 2013, ACCOUNTS CHEM RES, V46, P149, DOI 10.1021/ar300033m; Loan PTK, 2014, ADV MATER, V26, P4838, DOI 10.1002/adma.201401084; Li JL, 2014, RSC ADV, V4, P9647, DOI 10.1039/c3ra46956e; Yu HL, 2013, CHEM-EUR J, V19, P5818, DOI 10.1002/chem.201300072; Yang J, 2014, J MATER CHEM A, V2, P5979, DOI 10.1039/c3ta14151a; Butler SZ, 2013, ACS NANO, V7, P2898, DOI 10.1021/nn400280c; Pumera M, 2014, J MATER CHEM A, V2, P8981, DOI 10.1039/c4ta00652f; Zheng XL, 2014, CHEM MATER, V26, P2344, DOI 10.1021/cm500347r; Kumar NA, 2014, CHEM COMMUN, V50, P6298, DOI 10.1039/c4cc01049c; Lin MY, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4893448; Yu WJ, 2013, NAT NANOTECHNOL, V8, P952, DOI [10.1038/nnano.2013.219, 10.1038/NNANO.2013.219]; Xiao J, 2011, ADV FUNCT MATER, V21, P2840, DOI 10.1002/adfm.201002752; Liao L, 2013, ADV FUNCT MATER, V23, P5326, DOI 10.1002/adfm.201300318; Shih CJ, 2014, ACS NANO, V8, P5790, DOI 10.1021/nn500676t; Matte HSSR, 2010, ANGEW CHEM INT EDIT, V49, P4059, DOI 10.1002/anie.201000009; Huang GC, 2013, SMALL, V9, P3693, DOI 10.1002/smll.201300415; Chang K, 2013, ADV ENERGY MATER, V3, P839, DOI 10.1002/aenm.201201108; Huang KJ, 2013, INT J HYDROGEN ENERG, V38, P14027, DOI 10.1016/j.ijhydene.2013.08.112; Cao XH, 2013, SMALL, V9, P3433, DOI 10.1002/smll.201202697; Zhou KG, 2011, ANGEW CHEM INT EDIT, V50, P10839, DOI 10.1002/anie.201105364; Zhou XS, 2013, CHEM COMMUN, V49, P1838, DOI 10.1039/c3cc38780a; Wang D, 2013, IND ENG CHEM RES, V52, P17882, DOI 10.1021/ie402441g; Yue GT, 2012, ELECTROCHIM ACTA, V85, P162, DOI 10.1016/j.electacta.2012.08.040; Zhou XF, 2014, J POWER SOURCES, V251, P264, DOI 10.1016/j.jpowsour.2013.11.060; Liu N, 2014, FUEL, V119, P163, DOI 10.1016/j.fuel.2013.11.045; Rao CNR, 2014, CHEM PHYS LETT, V609, P172, DOI 10.1016/j.cplett.2014.06.003; Song HY, 2014, BIOSENS BIOELECTRON, V56, P137, DOI 10.1016/j.bios.2014.01.014; Liu YM, 2014, ANAL METHODS-UK, V6, P4152, DOI 10.1039/c4ay00063c; Feng QL, 2014, SENSOR ACTUAT B-CHEM, V192, P1, DOI 10.1016/j.snb.2013.10.087; Chang K, 2011, J MATER CHEM, V21, P17175, DOI 10.1039/c1jm12942b; Zan R, 2013, ACS NANO, V7, P10167, DOI 10.1021/nn4044035; Hou Y, 2013, ADV MATER, V25, P6291, DOI 10.1002/adma.201303116; Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/nnano.2010.89, 10.1038/NNANO.2010.89]; Lin YC, 2014, ACS NANO, V8, P3715, DOI 10.1021/nn5003858; Roy T, 2014, ACS NANO, V8, P6259, DOI 10.1021/nn501723y; Roy K, 2013, NAT NANOTECHNOL, V8, P826, DOI [10.1038/nnano.2013.206, 10.1038/NNANO.2013.206]; Liu CJ, 2012, J MATER CHEM, V22, P21057, DOI 10.1039/c2jm33679k; Shi YM, 2012, NANO LETT, V12, P2784, DOI [10.1021/nl204562j, 10.1021/nl204562J]; Min SX, 2012, J PHYS CHEM C, V116, P25415, DOI 10.1021/jp3093786; Liu YC, 2014, J MATER CHEM A, V2, P13109, DOI 10.1039/c4ta01644k; Cao LJ, 2013, SMALL, V9, P2905, DOI 10.1002/smll.201203164; Guardia L, 2014, RSC ADV, V4, P14115, DOI 10.1039/c4ra00212a; Bertolazzi S, 2013, ACS NANO, V7, P3246, DOI 10.1021/nn3059136; Firmiano EGS, 2012, CHEM COMMUN, V48, P7687, DOI 10.1039/c2cc33397j; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Lin JY, 2013, MATER CHEM PHYS, V143, P53, DOI 10.1016/j.matchemphys.2013.08.010; Lee GH, 2013, ACS NANO, V7, P7931, DOI 10.1021/nn402954e; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Liu YT, 2013, CHEM COMMUN, V49, P10305, DOI 10.1039/c3cc45936e; Ganatra R, 2014, ACS NANO, V8, P4074, DOI 10.1021/nn405938z; Maitra U, 2013, ANGEW CHEM INT EDIT, V52, P13057, DOI 10.1002/anie.201306918; Chang YH, 2013, ADV MATER, V25, P756, DOI 10.1002/adma.201202920; Chen DY, 2014, MATER TODAY, V17, P184, DOI 10.1016/j.mattod.2014.04.001; Britnell L., 2012, SCIENCE, V335, P6071; da Silveira Firmiano E. G., 2014, ADV ENERGY MAT, V4; Demchenko AT, 1964, METALLURGIST, V8, P42, DOI 10.1007/BF01088077; Fu W, 2014, SCI REP-UK, V4, DOI 10.1038/srep04673; Huang ZY, 2014, CERAM INT, V40, P11971, DOI 10.1016/j.ceramint.2014.04.034; Jiang JW, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4891342; Lansdown A.R., 1999, TRIBOLOGY SERIES; Matte H.S.S.R., 2012, ALLA CHEM, V638, P2617; Nayak AP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4731; Roy K, 2013, SOLID STATE COMMUN, V175, P35, DOI 10.1016/j.ssc.2013.09.021; Stengl V, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-167; Tan Z, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4859655; Yuchen D., 2014, ELECT DEVICE LETT IE, V35, P599; Zhang WJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03826; Zheng J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3995	100	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1369-7021	1873-4103		MATER TODAY	Mater. Today	JUN	2015	18	5					286	298		10.1016/j.mattod.2015.01.016		13	Materials Science, Multidisciplinary	Materials Science	CH9YJ	WOS:000354392300018		
J	Wang, DF; Maeda, R				Wang, Dong F.; Maeda, Ryutaro			Analytical study on cantilever resonance type magnet-integrated sensor device for micro-magnetic field detection	MICROSYSTEM TECHNOLOGIES-MICRO-AND NANOSYSTEMS-INFORMATION STORAGE AND PROCESSING SYSTEMS			English	Article							ATTONEWTON FORCE DETECTION; DC ELECTRIC APPLIANCES; SYNCHRONIZED OSCILLATION; SILICON CANTILEVERS; RESONATORS; ELEMENTS; SYSTEM; NOISE	A beam-shaped cantilever resonance type magnetic sensor device has been proposed with a micro magnet. Two structural designs, named as design 1 and design 2, have been comparatively analyzed using ANSYS in order to obtain larger frequency shifts (higher magnetism sensitivity) due to the applied exterior magnetic field. The analytical results show that, in the range of 0-10 mT, the frequency shifts are small, while under 100 mT, a relatively larger frequency shift of about 30 Hz can be theoretically obtained. The power consumption of the proposed devices has been further theoretically studied for preliminary understanding. Using the well-known displacement equations, the estimated power consumption is around 0.21 mu W, which is very lower than that of the reported magnetic field sensors. This implies that it is possible to fabricate higher sensitive magnetic field sensor with lower power consumption.	[Wang, Dong F.] Jilin Univ, Coll Mech Sci & Engn, Micro Engn & Micro Syst Div, Changchun 130025, Peoples R China; [Wang, Dong F.; Maeda, Ryutaro] Natl Inst Adv Ind Sci & Technol, Res Ctr Ubiquitous MEMS & Micro Engn, Tsukuba, Ibaraki 3058564, Japan	Wang, DF (reprint author), Jilin Univ, Coll Mech Sci & Engn, Micro Engn & Micro Syst Div, Changchun 130025, Peoples R China.	dongfwang@jlu.edu.cn			MEMS/Nanotech Inter-University Networking (MIN); Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP)	This research is granted by the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP). This work is also managed and supported by MEMS/Nanotech Inter-University Networking (MIN) steered by the Research Center for Ubiquitous MEMS and Micro Engineering (UMEMSME), National Institute of Advanced Industrial Science and Technology (AIST). Authors would like to thank Dr. Toshihiro Itoh at National Institute of Advanced Industrial Science and Technology (AIST) and Dr. Peck Cheng Lim at Singapore Institute of Manufacturing Technology (SIMTech) for scientific discussions, and Mr. Daisuke Terasawa (presently with Canon Inc., Tokyo 146-8501, Japan) at Micro Engineering and Micro Systems Laboratory for experimental assistance. Special thanks are also given to Prof. Zhi Y. Mao at Zhejiang University (Hangzhou 310027, China), and Prof. Masayoshi Esashi at Tohoku University (Sendai 980-8579, Japan), for their continuous supports and profound encouragements.	Ono T, 2003, APPL PHYS LETT, V83, P1950, DOI 10.1063/1.1608485; Stowe TD, 1997, APPL PHYS LETT, V71, P288, DOI 10.1063/1.119522; Mamin HJ, 2001, APPL PHYS LETT, V79, P3358, DOI 10.1063/1.1418256; ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; Cleland AN, 2002, J APPL PHYS, V92, P2758, DOI 10.1063/1.1499745; Requa M. V., 2006, Applied Physics Letters, V88, DOI 10.1063/1.2216033; Naeli K, 2009, J APPL PHYS, V105, DOI 10.1063/1.3062204; Wang DF, 2004, NANOTECHNOLOGY, V15, P1851, DOI 10.1088/0957-4484/15/12/028; Zalalutdinov M, 2003, APPL PHYS LETT, V83, P3281, DOI 10.1063/1.1618363; Ekinci KL, 2004, J APPL PHYS, V95, P2682, DOI 10.1063/1.1642738; Lavrik NV, 2004, REV SCI INSTRUM, V75, P2229, DOI 10.1063/1.1763252; Wang DF, 2010, PROC IEEE MICR ELECT, P703; Leland ES, 2009, J MICROMECH MICROENG, V19, P6; Nakajima M, 2011, P 16 INT C SOL STAT, P1492; Ono T, 2003, IEEE SENSOR, P825, DOI 10.1109/ICSENS.2003.1279058; Ono T, 2003, APPL PHYS LETT, V83, P3189; Popovic RS, 2000, SENSOR ACTUAT A-PHYS, V85, P9, DOI 10.1016/S0924-4247(00)00323-X; Ripka P, 2004, J OPTOELECTRON ADV M, V6, P587; Shim S, 2007, SCIENCE, V316, P6; SMITS JG, 1991, IEEE T ULTRASON FERR, V38, P256, DOI 10.1109/58.79611; Spphian A, 2002, SENSOR ACTUAT A-PHYS, V101, P92; Wang DF, 2012, MICRO NANO LETT, V7, P188, DOI 10.1049/mnl.2011.0618; Wang DF, 2013, MICRO NANO LETT, V8, P858, DOI 10.1049/mnl.2013.0584; Wang DF, 2012, MICROSYST TECHNOL, V18, P1897, DOI 10.1007/s00542-012-1535-8; Wang DF, 2012, MICRO NANO LETT, V7, P717, DOI 10.1049/mnl.2012.0389; Wang DF, 2012, MICRO NANO LETT, V7, P68, DOI 10.1049/mnl.2011.0637; Wang DF, 2013, MEAS SCI TECHNOL, V24, P5; Wang DF, 2013, MICROSYST TECHNOL, V19, P923, DOI 10.1007/s00542-013-1749-4	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-7076	1432-1858		MICROSYST TECHNOL	Microsyst. Technol.	JUN	2015	21	6					1167	1172		10.1007/s00542-014-2167-y		6	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	CI1JK	WOS:000354500100002		
J	Wang, DF; Ishida, T; Maeda, R				Wang, Dong F.; Ishida, Takao; Maeda, Ryutaro			Self-alignment observation and conductivity evaluation in micro chips integration with square binding pattern	MICROSYSTEM TECHNOLOGIES-MICRO-AND NANOSYSTEMS-INFORMATION STORAGE AND PROCESSING SYSTEMS			English	Article							CAPILLARY FORCES	A "square" binding alignment pattern, with relatively higher energy barrier but four fully aligned orientations at four off-set angles of 0A degrees, 90A degrees, 180A degrees, and 270A degrees, has been analyzed by introducing a concept of the overlap ratio, compared to a "rectangular" one. Both the "square-pattern" micro-chips and the substrate with the "square-pattern" binding sites were fabricated using one-mask micromachining process, and the self-alignment in situ observation under three different off-set orientation angles of 35A degrees, 46A degrees, and 90A degrees was demonstrated using a high-speed video camera. Sequential images reveal a slow translational motion in the early stage followed by a faster rotational alignment. A novel technique has been further proposed for the conductivity evaluation by using three kinds of SAM films, i.e., C12, C18, and Terphenyl. The preliminary measurements indicate that, using the proposed novel structure, the Terphenyl film is believed to be desirable as a conductive SAM film for self-alignment of micro-chips.	[Wang, Dong F.] Jilin Univ, Sch Mech Sci & Engn, Micro Engn & Micro Syst Div, Changchun 130025, Peoples R China; [Wang, Dong F.; Maeda, Ryutaro] Natl Inst Adv Ind Sci & Technol, Res Ctr Ubiquitous MEMS & Micro Engn, Tsukuba, Ibaraki 3058564, Japan; [Ishida, Takao] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki 3058564, Japan	Wang, DF (reprint author), Natl Inst Adv Ind Sci & Technol, Res Ctr Ubiquitous MEMS & Micro Engn, Tsukuba, Ibaraki 3058564, Japan.	dfwang-ou@aist.go.jp			MEMS/Nanotech Inter-University Networking (MIN); Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP)	This research is granted by the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP). This work is also managed and supported by MEMS/Nanotech Inter-University Networking (MIN) steered by the Research Center for Ubiquitous MEMS and Micro Engineering (UMEMSME), National Institute of Advanced Industrial Science and Technology (AIST). Authors would like to thank Dr. Toshihiro Itoh at National Institute of Advanced Industrial Science, Technology (AIST) and Dr. Peck Cheng Lim at Singapore Institute of Manufacturing Technology (SIMTech) for scientific discussions, and Mr. Mengqing Liu (presently with Mitsubishi Heavy Industries, Ltd, Tokyo 108-8215, Japan) at Micro Engineering and Micro Systems Laboratory for experimental assistance. Special thanks are also given to Prof. Zhi Y. Mao at Zhejiang University (Hangzhou 310027, China), Prof. Masayoshi Esashi at Tohoku University (Sendai 98-08579, Japan), and Prof. Karl F. Bohringer at University of Washington (Seattle, WA 98195 USA) for their continuous supports and profound encouragements.	Terfort A, 1997, NATURE, V386, P162, DOI 10.1038/386162a0; Srinivasan U, 2002, IEEE J SEL TOP QUANT, V8, P4, DOI 10.1109/2944.991393; Jacobs HO, 2002, SCIENCE, V296, P323, DOI 10.1126/science.1069153; Srinivasan U, 2001, J MICROELECTROMECH S, V10, P17, DOI 10.1109/84.911087; Bohringer KF, 2003, J MICROMECH MICROENG, V13, pS1; Lin C, 2009, J MICROMECH MICROENG, V19, P1; Liu M, 2014, P 16 S DES TEST INT; Liu M, 2012, INT C EL MAT IUMRS I; Shiga S, 2011, TECHN DIG INT WORKSH, P49; Shiga S, 2010, 1 JAP CHIN KOR JOINT; Tasi CG, 2007, SENSOR ACTUAT A-PHYS, V139, P343; Wang DF, 2012, MICROSYST TECHNOL, V18, P1843, DOI 10.1007/s00542-012-1451-y	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-7076	1432-1858		MICROSYST TECHNOL	Microsyst. Technol.	JUN	2015	21	6					1203	1208		10.1007/s00542-014-2170-3		6	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	CI1JK	WOS:000354500100006		
J	Takamatsu, S; Yamashita, T; Itoh, T				Takamatsu, Seiichi; Yamashita, Takahiro; Itoh, Toshihiro			Meter-scale large area LED-embedded light fabric for the application of fabric ceilings in rooms	MICROSYSTEM TECHNOLOGIES-MICRO-AND NANOSYSTEMS-INFORMATION STORAGE AND PROCESSING SYSTEMS			English	Article							DEVICE PLACEMENT MACHINE; TOHOKU EARTHQUAKE; PACIFIC COAST; BUILDINGS; OPTIMIZATION; SYSTEM; OFFICE; DAMAGE; FORM	We have developed a meter-scale light emitting diode (LED)-embedded light fabric and its weaving machine for application to a light device for fabric ceilings, which have recently become desired for lightweight safe ceilings in Japan and other countries with frequent earthquakes. The LED fabric structure is 1.2-m-wide woven fabric that has 5-mm-wide LED chip-mounted printed circuit board (PCB) tapes as wefts. LEDs are mounted on the tape of PCBs with a reel-to-reel chip mounting system. Then, the LED-mounted tapes are woven with a developed automatic looming machine that aligns the weft with an accuracy of 0.9 mm, which is suitable for precise arrangement of LEDs and wiring to power supply. A 1.2 x 1.2 m LED-embedded light fabric weighing 320 g/m(2) was woven. The luminance of the LED fabric is 353 lx at a distance of 1 m, which is the luminance of conventional office lighting. The temperature increase of LEDs without a rigid cooling aluminum plate is only 5.8 A degrees C, and the LED fabric is flexible enough to sustain 1,000 bends down to a radius of 3 mm. This LED fabric and its weaving technology will lead to light devices that have lightweight, large area, and high flexibility for fabric ceilings, walls, and other large areas in homes and offices.	[Takamatsu, Seiichi; Yamashita, Takahiro; Itoh, Toshihiro] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058564, Japan	Takamatsu, S (reprint author), Natl Inst Adv Ind Sci & Technol, 1-2-1 Namiki, Tsukuba, Ibaraki 3058564, Japan.	seiichi-takamatsu@aist.go.jp					Aman MM, 2013, ENERG POLICY, V52, P482, DOI 10.1016/j.enpol.2012.09.068; Branas C, 2013, IEEE IND ELECTRON M, V7, P6, DOI 10.1109/MIE.2013.2280038; Magliulo G, 2012, B EARTHQ ENG, V10, P1819, DOI 10.1007/s10518-012-9383-6; Fraser S, 2013, B EARTHQ ENG, V11, P205, DOI 10.1007/s10518-012-9348-9; Dubois MC, 2011, ENERG BUILDINGS, V43, P2572, DOI 10.1016/j.enbuild.2011.07.001; Taguchi T, 2008, IEEJ T ELECTR ELECTR, V3, P21, DOI 10.1002/tee.20228; Cherenack K, 2010, ADV MATER, V22, P5178, DOI 10.1002/adma.201002159; Bletzinger KU, 2001, COMPUT STRUCT, V79, P2053, DOI 10.1016/S0045-7949(01)00052-9; Bridgens B, 2012, ENG STRUCT, V44, P1, DOI 10.1016/j.engstruct.2012.05.044; Takamatsu S, 2012, SENSOR ACTUAT A-PHYS, V184, P57, DOI 10.1016/j.sna.2012.06.031; Takewaki I, 2011, SOIL DYN EARTHQ ENG, V31, P1511, DOI 10.1016/j.soildyn.2011.06.001; Ayob M, 2008, EUR J OPER RES, V186, P893, DOI 10.1016/j.ejor.2007.03.042; Ayob M, 2009, INT J SYST SCI, V40, P553, DOI 10.1080/00207720902777964; Berger H, 1999, ENG STRUCT, V21, P669, DOI 10.1016/S0141-0296(98)00022-4; Byun J, 2013, IEEE T CONSUM ELECTR, V59, P70; Maxfield C, 2009, BEBOP TO THE BOOLEAN BOOGIE: AN UNCONVENTIONAL GUIDE TO ELECTRONICS, 3RD EDITION, P1, DOI 10.1016/B978-1-85617-507-4.00001-2; Motosaka M, 2012, SOILS FOUND, V52, P929, DOI 10.1016/j.sandf.2012.11.012; Normalu Barrisol SAS, 2014, BARR STRETCH CEIL WA; Ono K, 2012, ELECTR COMMUN JPN, V95, P54, DOI 10.1002/ecj.10395; Chan Y Sing, 2011, Journal of Semiconductors, V32, DOI 10.1088/1674-4926/32/1/014005; Takamatsu S, 2013, MICROSYST TECHNOL, DOI [10.1007/s00542-013-1925.6, DOI 10.1007/S00542-013-1925.6]	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-7076	1432-1858		MICROSYST TECHNOL	Microsyst. Technol.	JUN	2015	21	6					1209	1217		10.1007/s00542-014-2174-z		9	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	CI1JK	WOS:000354500100007		
J	Kambara, T; Shibata, R; Ohashi, K; Matsuo, K; Hiramatsu-Ito, M; Enomoto, T; Yuasa, D; Ito, M; Hayakawa, S; Ogawa, H; Aprahamian, T; Walsh, K; Murohara, T; Ouchi, N				Kambara, Takahiro; Shibata, Rei; Ohashi, Koji; Matsuo, Kazuhiro; Hiramatsu-Ito, Mizuho; Enomoto, Takashi; Yuasa, Daisuke; Ito, Masanori; Hayakawa, Satoko; Ogawa, Hayato; Aprahamian, Tamar; Walsh, Kenneth; Murohara, Toyoaki; Ouchi, Noriyuki			C1q/Tumor Necrosis Factor-Related Protein 9 Protects against Acute Myocardial Injury through an Adiponectin Receptor I-AMPK-Dependent Mechanism	MOLECULAR AND CELLULAR BIOLOGY			English	Article							FOLLISTATIN-LIKE 1; METABOLIC DYSFUNCTION; ISCHEMIA-REPERFUSION; ENDOTHELIAL-CELLS; KINASE; CTRP9; ADIPOKINES; INFARCTION; DISEASE; HEART	Obesity is a risk factor for cardiovascular disease. C1q/tumor necrosis factor-related protein 9 (CTRP9) is an adipokine that is downregulated by obesity. We investigated the role of CTRP9 in cardiac injury with loss-of-function genetic manipulations and defined the receptor-mediated signaling pathway downstream of this adipokine. CTRP9-knockout (CTRP9-KO) mice at the age of 12 weeks were indistinguishable from wild-type (WT) mice under basal conditions. CTRP9-KO mice had exacerbated contractile left ventricle dysfunction following intraperitoneal injection of lipopolysaccharide (LPS) compared to WT mice. Administration of LPS to CTRP9-KO mice also resulted in increased expression of proinflammatory cytokines and oxidative stress markers in the heart compared to WT mice. Likewise, CTRP9-KO mice showed increased myocardial infarct size and elevated expression of inflammatory mediators in ischemic heart following ischemia and reperfusion compared to WT mice. Treatment of cardiac myocytes with CTRP9 protein led to suppression of LPS-induced expression of proinflammatory genes, which was reversed by blockade of AMPK or ablation of adiponectin receptor I (AdipoR1). Systemic delivery of CTRP9 attenuated LPS-induced cardiac dysfunction in WT mice but not in muscle-specific transgenic mice expressing dominant-negative mutant form of AMPK or in AdipoR1-knockout mice. CTRP9 protects against acute cardiac damage in response to pathological stimuli by suppressing inflammatory reactions through AdipoR1/AMPK-dependent mechanisms.	[Kambara, Takahiro; Shibata, Rei; Matsuo, Kazuhiro; Hiramatsu-Ito, Mizuho; Enomoto, Takashi; Yuasa, Daisuke; Ito, Masanori; Hayakawa, Satoko; Ogawa, Hayato; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Mol Cardiovasc Med, Nagoya, Aichi 4648601, Japan; [Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Mol Cardiol, Boston, MA 02118 USA; [Aprahamian, Tamar] Boston Univ, Sch Med, Dept Med, Renal Sect, Boston, MA 02118 USA	Shibata, R (reprint author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan.	rshibata@med.nagoya-u.ac.jp; nouchi@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014		Takeda Science Foundation; AstraZeneca Research and Development grant; Kanae Foundation; Banyu Life Science Foundation International	This study was supported by Grant-in-Aid for Scientific Research and grants from Takeda Science Foundation and by a AstraZeneca Research and Development grant to N.O. R.S. was supported by a Grant-in-Aid for Scientific Research C, Banyu Life Science Foundation International, and Kanae Foundation.	O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Kambara T, 2012, J BIOL CHEM, V287, P18965, DOI 10.1074/jbc.M112.357939; Uemura Y, 2013, FASEB J, V27, P25, DOI 10.1096/fj.12-213744; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Wei ZK, 2014, AM J PHYSIOL-ENDOC M, V306, pE779, DOI 10.1152/ajpendo.00593.2013; Parker-Duffen JL, 2014, J BIOL CHEM, V289, P16200, DOI 10.1074/jbc.M114.548115; Peng TQ, 2005, CIRCULATION, V111, P1637, DOI 10.1161/01.CIR.0000160366.50210.E9; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Ogura Y, 2012, CIRCULATION, V126, P1728, DOI 10.1161/CIRCULATIONAHA.112.115089; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Hao EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069452; Hayakawa S, 2015, J AM SOC NEPHROL, V26, P636, DOI 10.1681/ASN.2014020210; Hwang YC, 2014, INT J OBESITY, V38, P1207, DOI 10.1038/ijo.2013.242; ORLANDER PR, 1994, DIABETES, V43, P897, DOI 10.2337/diabetes.43.7.897; Ouchi N, 2012, CIRCULATION, V125, P3066, DOI 10.1161/CIRCULATIONAHA.112.114181; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Shibata R, 2014, CYTOKINE GROWTH F R, V25, P483, DOI 10.1016/j.cytogfr.2014.07.005; Sun Y, 2013, CIRCULATION, V128, pS113, DOI 10.1161/CIRCULATIONAHA.112.000010; Watanabe Y, 2014, BIOMED RES INT, V2014; Wolk R, 2003, CIRCULATION, V108, P2206, DOI 10.1161/01.CIR.0000095270.85646.E8	28	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0270-7306	1098-5549		MOL CELL BIOL	Mol. Cell. Biol.	JUN	2015	35	12					2173	2185		10.1128/MCB.01518-14		13	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CI2ZX	WOS:000354618200011		
J	Permanasari, ED; Yasukawa, K; Kanaya, S				Permanasari, Etin-Diah; Yasukawa, Kiyoshi; Kanaya, Shigenori			Enzymatic Activities of RNase H Domains of HIV-1 Reverse Transcriptase with Substrate Binding Domains of Bacterial RNases H1 and H2	MOLECULAR BIOTECHNOLOGY			English	Article						RNase H; Substrate binding domain; Hybrid binding domain; HIV-1 reverse transcriptase; RNA/DNA hybrid; Stability; Thermotoga maritima; Bacillus stearothermophilus	RIBONUCLEASE-H; CRYSTAL-STRUCTURE; RNA/DNA HYBRID; BACILLUS-STEAROTHERMOPHILUS; SACCHAROMYCES-CEREVISIAE; THERMOTOGA-MARITIMA; GENOME INTEGRITY; DNA; IDENTIFICATION; RECOGNITION	Thermotoga maritima RNase H1 and Bacillus stearothermophilus RNase H2 have an N-terminal substrate binding domain, termed hybrid binding domain (TmaHBD), and N-terminal domain (BstNTD), respectively. HIV-1 reverse transcriptase (RT) is a heterodimer consisting of a P66 subunit and a P51 subunit. The P66 subunit contains a C-terminal RNase H domain, which exhibits RNase H activity either in the presence of Mg2+ or Mn2+ ions. The isolated RNase H domain of HIV-1 RT (RNHHIV) is inactive, possibly due to the lack of a substrate binding ability, disorder of a loop containing His539, and increased flexibility. To examine whether the activity of RNHHIV is restored by the attachment of TmaHBD or BstNTD to its N-terminus, two chimeric proteins, TmaHBD-RNHHIV and BstNTD-RNHHIV, were constructed and characterized. Both chimeric proteins bound to RNA/DNA hybrid more strongly than RNHHIV and exhibited enzymatic activity in the presence of Mn2+ ions. They did not exhibit activity or exhibited very weak activity in the presence of Mg2+ ions. These results indicate that TmaHBD and BstNTD function as an RNA/DNA hybrid binding tag, and greatly increase the substrate binding affinity and Mn2+-dependent activity of RNHHIV but do not restore the Mg2+-dependent activity of RNHHIV.	[Permanasari, Etin-Diah; Yasukawa, Kiyoshi; Kanaya, Shigenori] Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Suita, Osaka 5650871, Japan; [Permanasari, Etin-Diah; Yasukawa, Kiyoshi; Kanaya, Shigenori] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Sakyo Ku, Kyoto 6068502, Japan	Kanaya, S (reprint author), Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	kanaya@mls.eng.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24380055]	We thank Dr. Y. Koga and Dr. E. Kanaya for helpful discussions. This work was supported in part by the Grant (24380055) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; TISDALE M, 1991, J GEN VIROL, V72, P59, DOI 10.1099/0022-1317-72-1-59; Rychlik MP, 2010, MOL CELL, V40, P658, DOI 10.1016/j.molcel.2010.11.001; SMITH JS, 1994, J VIROL, V68, P5721; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI 10.1038/NCHEMBIO.424; EVANS DB, 1994, J BIOL CHEM, V269, P21741; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Jongruja N, 2010, FEBS J, V277, P4474, DOI 10.1111/j.1742-4658.2010.07834.x; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; Itaya M, 1999, J BACTERIOL, V181, P2118; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Permanasari ED, 2013, FEBS J, V280, P5065, DOI 10.1111/febs.12479; Kogoma T, 1998, RESEARCH IN, P39; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; Bohlayer WP, 2006, BIOCHEMISTRY-US, V45, P7628, DOI 10.1021/bi051770w; Rohman MS, 2008, FEBS J, V275, P4836, DOI 10.1111/j.1742-4658.2008.06622.x; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361; SMITH JS, 1993, J VIROL, V67, P4037; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Arudchandran A, 2000, GENES CELLS, V5, P789, DOI 10.1046/j.1365-2443.2000.00373.x; Reijns MAM, 2014, BIOCHEM SOC T, V42, P717, DOI 10.1042/BST20140079; DROLET M, 1995, P NATL ACAD SCI USA, V92, P3526, DOI 10.1073/pnas.92.8.3526; Hang JQ, 2004, BIOCHEM BIOPH RES CO, V317, P321, DOI 10.1016/j.bbrc.2004.03.061; Zuniga R, 2004, PROTEIN ENG DES SEL, V17, P581, DOI 10.1093/protein/gzh071; Konishi A, 2013, APPL BIOCHEM BIOTECH, V169, P77, DOI 10.1007/s12010-012-9953-8; Tadokoro T, 2009, FEBS J, V276, P1482, DOI 10.1111/j.1742-4658.2009.06907.x; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; BENARTZI H, 1992, P NATL ACAD SCI USA, V89, P927, DOI 10.1073/pnas.89.3.927; Champoux JJ, 2009, FEBS J, V276, P1506, DOI 10.1111/j.1742-4658.2009.06909.x; Farias RV, 2011, ANTIMICROB AGENTS CH, V55, P4735, DOI 10.1128/AAC.00658-11; Haruki M, 1997, J BIOL CHEM, V272, P22015, DOI 10.1074/jbc.272.35.22015; Le Grice SFJ, 2012, J BIOL CHEM, V287, P40850, DOI 10.1074/jbc.R112.389056; Chon H, 2006, J MOL BIOL, V356, P165, DOI 10.1016/j.jmb.2005.11.017; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; EVANS DB, 1991, J BIOL CHEM, V266, P20583; Christen MT, 2012, CHEM BIOL DRUG DES, V80, P706, DOI 10.1111/cbdd.12010; Corona A, 2014, ANTIMICROB AGENTS CH, V58, P6101, DOI 10.1128/AAC.03605-14; Figiel M, 2014, NUCLEIC ACIDS RES, V42, P9285, DOI 10.1093/nar/gku615; Goodwin T. W., 1946, BIOCHEM JOUR, V40, P628; Haruki M, 2002, FEBS LETT, V531, P204, DOI 10.1016/S0014-5793(02)03503-2; HOSTOMSKY Z, 1991, P NATL ACAD SCI USA, V88, P1148, DOI 10.1073/pnas.88.4.1148; Jongruja N, 2012, FEBS J, V279, P2737, DOI 10.1111/j.1742-4658.2012.08657.x; KECK JL, 1995, P NATL ACAD SCI USA, V92, P2740, DOI 10.1073/pnas.92.7.2740; McDonald JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003030; Miyashita S, 2011, FEBS LETT, V585, P2313, DOI 10.1016/j.febslet.2011.05.064; Nowotny M, 2008, EMBO J, V27, P1172, DOI 10.1038/emboj.2008.44; Ohtani N, 1999, BIOCHEMISTRY-US, V38, P605, DOI 10.1021/bi982207z; Ohtani N, 2000, J BIOCHEM-TOKYO, V127, P895; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; STAHL SJ, 1994, PROTEIN ENG, V7, P1103, DOI 10.1093/protein/7.9.1103	56	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1073-6085	1559-0305		MOL BIOTECHNOL	Mol. Biotechnol.	JUN	2015	57	6					526	538		10.1007/s12033-015-9846-5		13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CI0XE	WOS:000354462100005		
J	Iwai, M; Yamada, H; Ikemoto, T; Matsumoto, S; Fujiwara, D; Takenaka, S; Sakamoto, T				Iwai, Marin; Yamada, Hiroyuki; Ikemoto, Takeshi; Matsumoto, Shotaro; Fujiwara, Daisuke; Takenaka, Shigeo; Sakamoto, Tatsuji			Biochemical Characterization and Overexpression of an Endo-rhamnogalacturonan Lyase from Penicillium chrysogenum	MOLECULAR BIOTECHNOLOGY			English	Article						Penicillium chrysogenum; Endo-rhamnogalacturonan lyase; Polysaccharide lyase family 4; Nucleotide sequence; Overexpression	ASPERGILLUS-ACULEATUS; PLANT-CELL; RAMIFIED REGIONS; PECTIN; POLYSACCHARIDE; ENZYME; EXPRESSION; WALLS; DEGRADATION; ARABINANASE	Rhamnogalacturonan lyase (PcRGL4A) was purified from the culture supernatant of Penicillium chrysogenum 31B. PcRGL4A optimal activity occurred between pH 7-8 and at 40 A degrees C. Conserved Domain Search analysis identified PcRGL4A as a member of Polysaccharide Lyase family 4. PcRGL4A contains two conserved catalytic and four conserved substrate-binding residues as determined by X-ray crystallography of the Aspergillus aculeatus RG lyase. Recombinant PcRGL4A (rPcRGL4A) expressed in Escherichia coli demonstrated specific activity against rhamnogalacturonan (RG) but not homogalacturonan. Analysis of the RG reaction products by high-performance anion-exchange chromatography revealed that rPcRGL4A cleaved the substrate in an endo-manner and that the major final product was an RG tetrasaccharide with 4-deoxy-4,5-unsaturated galacturonic acid at the nonreducing end. Based on these results, PcRGL4A was classified as an endo-acting RG lyase (EC 4.2.2.23). Divalent cations were not essential for the enzymatic activity of rPcRGL4A, but addition of calcium ions to the reaction mixture increased enzymatic activity. rPcRGL4A demonstrated a preference for RG lacking galactose decoration.	[Iwai, Marin; Yamada, Hiroyuki; Ikemoto, Takeshi; Matsumoto, Shotaro; Sakamoto, Tatsuji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka 5998531, Japan; [Fujiwara, Daisuke] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Sakai, Osaka 5998531, Japan; [Takenaka, Shigeo] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Vet Sci, Izumisano, Osaka 5988531, Japan	Sakamoto, T (reprint author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka 5998531, Japan.	sakamoto@biochem.osakafu-u.ac.jp			JSPS KAKENHI [25450135]	This work was supported by JSPS KAKENHI Grant Number 25450135.	Thakur BR, 1997, CRIT REV FOOD SCI, V37, P47; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Ochiai A, 2007, J BIOL CHEM, V282, P37134, DOI 10.1074/jbc.M704663200; Voragen AGJ, 2009, STRUCT CHEM, V20, P263, DOI 10.1007/s11224-009-9442-z; Thomassen LV, 2011, APPL MICROBIOL BIOT, V90, P873, DOI 10.1007/s00253-011-3092-y; Wong D, 2008, PROTEIN J, V27, P30, DOI 10.1007/s10930-007-9105-0; Sakamoto T, 2011, APPL MICROBIOL BIOT, V90, P137, DOI 10.1007/s00253-010-2988-2; Sakamoto T, 2004, FEBS LETT, V560, P199, DOI 10.1016/S0014-5793(04)00106-1; Pages S, 2003, J BACTERIOL, V185, P4727, DOI 10.1128/JB.185.16.4726-4733.2003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mutter M, 1998, CARBOHYD RES, V311, P155, DOI 10.1016/S0008-6215(98)00188-8; Willats WGT, 2006, TRENDS FOOD SCI TECH, V17, P97, DOI 10.1016/j.tifs.2005.10.008; Jensen MH, 2010, J MOL BIOL, V404, P100, DOI 10.1016/j.jmb.2010.09.013; Ochiai A, 2007, APPL ENVIRON MICROB, V73, P3803, DOI 10.1128/AEM.00147-07; KOFOD LV, 1994, J BIOL CHEM, V269, P29182; Laatu M, 2003, J BACTERIOL, V185, P1642, DOI 10.1128/JB.185.5.1642-1649.2003; MCNEIL M, 1984, ANNU REV BIOCHEM, V53, P625; Sakamoto T, 2012, APPL MICROBIOL BIOT, V93, P1087, DOI 10.1007/s00253-011-3452-7; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Mutter M, 1996, PLANT PHYSIOL, V110, P73, DOI 10.1104/pp.110.1.73; McDonough MA, 2004, FEBS LETT, V565, P188, DOI 10.1016/j.febslet.2004.03.094; Onumpai C, 2011, APPL ENVIRON MICROB, V77, P5747, DOI 10.1128/AEM.00179-11; SCHOLS HA, 1990, CARBOHYD RES, V206, P105, DOI 10.1016/0008-6215(90)84010-R; Laerke HN, 2007, NUTR RES, V27, P152, DOI 10.1016/j.nutres.2007.01.003; THIBAULT JF, 1993, CARBOHYD RES, V238, P271, DOI 10.1016/0008-6215(93)87019-O; Yoshino-Yasuda S, 2012, FOOD SCI TECHNOL RES, V18, P901; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; ONeill MA, 1996, J BIOL CHEM, V271, P22923; Sakamoto T, 2001, APPL ENVIRON MICROB, V67, P3319, DOI 10.1128/AEM.67.7.3319-3321.2001; Mutter M, 1998, PLANT PHYSIOL, V117, P141, DOI 10.1104/pp.117.1.141; McKie VA, 2001, BIOCHEM J, V355, P167, DOI 10.1042/0264-6021:3550167; Silva IR, 2011, ENZYME MICROB TECH, V49, P160, DOI 10.1016/j.enzmictec.2011.04.015; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Bonnin E, 2014, APPL MICROBIOL BIOT, V98, P519, DOI 10.1007/s00253-013-5388-6; Marcet-Houben M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-646; Ochiai A, 2006, ACTA CRYSTALLOGR F, V62, P438, DOI 10.1107/S1744309106011894; Sakamoto T, 2013, APPL MICROBIOL BIOT, V97, P1121, DOI 10.1007/s00253-012-3978-3; Sakamoto T, 2003, BBA-GEN SUBJECTS, V1624, P70, DOI 10.1016/j.bbagen.2003.09.011; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shinozaki A, 2014, ENZYME MICROB TECH, V58-59, P80, DOI 10.1016/j.enzmictec.2014.03.005; TANABE H, 1984, AGR BIOL CHEM TOKYO, V48, P2113	41	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1073-6085	1559-0305		MOL BIOTECHNOL	Mol. Biotechnol.	JUN	2015	57	6					539	548		10.1007/s12033-015-9847-4		10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CI0XE	WOS:000354462100006		
J	Terao, T; Hirose, T				Terao, Tomio; Hirose, Tatsuro			Control of grain protein contents through SEMIDWARF1 mutant alleles: sd1 increases the grain protein content in Dee-geo-woo-gen but not in Reimei	MOLECULAR GENETICS AND GENOMICS			English	Article						Grain protein content; Nitrogen content; QTL; SD1; Semi-dwarfism; Rice (Oryza sativa L.)	QUANTITATIVE TRAIT LOCI; ORYZA-SATIVA L.; EATING-QUALITY; STORAGE PROTEINS; GREEN-REVOLUTION; LINE POPULATION; AMYLOSE CONTENT; QTL-ANALYSIS; COOKED RICE; PALATABILITY	A new possibility for genetic control of the protein content of rice grains was suggested by the allele differences of the SEMIDWARF1 (SD1) mutation. Two quantitative trait loci-qPROT1 and qPROT12-were found on chromosomes 1 and 12, respectively, using backcrossed inbred lines of Sasanishiki/Habataki//Sasanishiki///Sasanishiki. One of them, qPROT1, increased almost all grain proteins instead of only certain proteins in the recessive Habataki allele. Fine mapping of qPROT1 revealed that two gene candidates-Os01g0883800 and Os01g0883900-were included in this region. Os01g0883800 encoded Gibberellin 20 oxidase 2 as well as SD1, the dwarf gene used in the so-called 'Green Revolution'. Mutant analyses as well as sequencing analysis using the semi-dwarf mutant cultivars Dee-geo-woo-gen and Calrose 76 revealed that the sd1 mutant showed significantly higher grain protein contents than their corresponding wild-type cultivars, strongly suggesting that the high protein contents were caused by sd1 mutation. However, the sd1 mutant Reimei did not have high grain protein contents. It is possible to control the grain protein content and column length separately by selecting for sd1 alleles. From this finding, the genetic control of grain protein content, as well as the column length of rice cultivars, might be possible. This ability might be useful to improve rice nutrition, particularly in areas where the introduction of semi-dwarf cultivars is not advanced.	[Terao, Tomio; Hirose, Tatsuro] NARO Agr Res Ctr, Hokuriku Res Ctr, Niigata 9430193, Japan	Terao, T (reprint author), NARO Agr Res Ctr, Hokuriku Res Ctr, 1-2-1 Inada, Niigata 9430193, Japan.	terao@affrc.go.jp; dragon@affrc.go.jp			JSPS KAKENHI [24580030]	This work was partly supported by JSPS KAKENHI Grant Number 24580030. We are grateful to Mr. Tokuya Genba, Mr. Tuyoshi Kotake, Mr. Masanori Ichihashi, Mr. Shinobu Yuminamochi, Mr. Koushi Yazaki, Mr. Susumu Saitou, Mr. Ken-ichi Koide, Ms. Keiko Nozaki and Ms. Setsuko Hayashi for their excellent technical assistance.	Nelson JC, 1997, MOL BREEDING, V3, P239, DOI 10.1023/A:1009604312050; Ashikari M, 2002, BREEDING SCI, V52, P143, DOI 10.1270/jsbbs.52.143; Finnegan EJ, 1998, ANNU REV PLANT PHYS, V49, P223, DOI 10.1146/annurev.arplant.49.1.223; Wan XY, 2004, THEOR APPL GENET, V110, P71, DOI 10.1007/s00122-004-1744-3; WANG H, 1993, NUCLEIC ACIDS RES, V21, P4153, DOI 10.1093/nar/21.17.4153; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Joehanes R, 2008, BIOINFORMATICS, V24, P2788, DOI 10.1093/bioinformatics/btn523; Terao T, 2005, J SCI FOOD AGR, V85, P1861, DOI 10.1002/jsfa.2165; Asano K, 2007, BREEDING SCI, V57, P53, DOI 10.1270/jsbbs.57.53; Aluko G, 2004, THEOR APPL GENET, V109, P630, DOI 10.1007/s00122-004-1668-y; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Yoshida S, 2002, BREEDING SCI, V52, P309, DOI 10.1270/jsbbs.52.309; Zheng LN, 2011, J PLANT BIOL, V54, P321, DOI 10.1007/s12374-011-9170-y; Hu ZL, 2004, EUPHYTICA, V135, P47, DOI 10.1023/B:EUPH.0000009539.38916.32; IIDA S, 1993, THEOR APPL GENET, V87, P374, DOI 10.1007/BF01184926; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Jones D. B., 1941, 183 USDA; Kennedy G, 2003, SUSTAINABLE RICE PRO; Kikuchi F, 1985, B NATL I AGR SCI D, V36, P125; Kuroda M, 2010, BIOSCI BIOTECH BIOCH, V74, P2348, DOI 10.1271/bbb.100465; Liu XL, 2011, GENOME, V54, P64, DOI 10.1139/G10-070; MATSUE Y, 1994, JPN J CROP SCI, V63, P271; Matsue Y, 2001, PLANT PROD SCI, V4, P71; Matsue Y, 1997, JPN J CROP SCI, V66, P189; Miura K, 1991, HOKURIKU CROP SCI, V26, P52; Mohanty S, 2013, TRENDS GLOBAL RICE C; Murai M, 2002, BREEDING SCI, V52, P95, DOI 10.1270/jsbbs.52.95; Murai M., 2001, SABRAO Journal of Breeding and Genetics, V33, P21; Nagata K, 2002, BREEDING SCI, V52, P259, DOI 10.1270/jsbbs.52.259; Nelson B, 2008, FRONTIERS NBC NEWS; Song YJ, 2012, PLANT PROD SCI, V15, P253, DOI 10.1626/pps.15.253; Tan YF, 2001, THEOR APPL GENET, V103, P1037, DOI 10.1007/s001220100665; Terao T, 2010, THEOR APPL GENET, V120, P875, DOI 10.1007/s00122-009-1218-8; Ye GY, 2010, THEOR APPL GENET, V121, P741, DOI 10.1007/s00122-010-1345-2; Yun ByungWook, 2014, American Journal of Plant Sciences, V5, P1125; Zheng Z, 2012, J CEREAL SCI, V56, P153	41	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-4615	1617-4623		MOL GENET GENOMICS	Mol. Genet. Genomics	JUN	2015	290	3					939	954		10.1007/s00438-014-0965-7		16	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CI3CP	WOS:000354625500010		
J	Fukuda, A; Sugimoto, K; Ando, T; Yamamoto, T; Yano, M				Fukuda, Atsunori; Sugimoto, Kazuhiko; Ando, Tsuyu; Yamamoto, Toshio; Yano, Masahiro			Chromosomal locations of a gene underlying heat-accelerated brown spot formation and its suppressor genes in rice	MOLECULAR GENETICS AND GENOMICS			English	Article						Brown spot; Chromosome segment substitution line; Heat stress; Oryza sativa	LESION-MIMIC MUTANTS; SEGMENT SUBSTITUTION LINES; ENHANCED RESISTANCE; BACTERIAL-BLIGHT; CELL-DEATH; PLANTS; ENCODES; DEFENSE; PROTEIN; BLAST	Brown spots on mature leaves from the heading to ripening stages in rice are considered to be lesions induced by heat stress. However, there are few studies of lesions that are induced by heat stress rather than by pathogen infections. To understand the genetic background underlying such lesions, we used the chromosome segment substitution line (CSSL) SL518, derived from a distant cross between rice cultivars Koshihikari (japonica) and Nona Bokra (indica). We observed brown spots on mature leaf blades of the CSSL, although the parents barely showed any spots. Spot formation in SL518 was accelerated by high temperature, suggesting that the candidate gene for spot formation is related to heat stress response. Using progeny derived from a cross between SL518 and Koshihikari, we mapped the causative gene, BROWN-SPOTTED LEAF 1 (BSPL1), on chromosome 5. We speculated that one or more Nona Bokra genes suppress spot formation caused by BSPL1 and identified candidate genomic regions on chromosomes 2 and 9 using a cross between a near-isogenic line for BSPL1 and other CSSLs possessing Nona Bokra segments in the Koshihikari genetic background. In conclusion, our data support the concept that multiple genes are complementarily involved in brown spot formation induced by heat stress and will be useful for cloning of the novel gene(s) related to the spot formation.	[Fukuda, Atsunori; Sugimoto, Kazuhiko; Ando, Tsuyu; Yamamoto, Toshio; Yano, Masahiro] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Tsukuba, Ibaraki 3058602, Japan	Fukuda, A (reprint author), Natl Inst Agrobiol Sci, Agrogen Res Ctr, Kannondai 2-1-2, Tsukuba, Ibaraki 3058602, Japan.	fukuda@affrc.go.jp					Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171; Bomblies K, 2010, ANNU REV PLANT BIOL, V61, P109, DOI 10.1146/annurev-arplant-042809-112146; Endo M, 2009, PLANT CELL PHYSIOL, V50, P1911, DOI 10.1093/pcp/pcp135; Takai T, 2007, BREEDING SCI, V57, P257, DOI 10.1270/jsbbs.57.257; Matsubara K, 2007, THEOR APPL GENET, V115, P179, DOI 10.1007/s00122-007-0553-x; Yamamoto E, 2010, MOL GENET GENOMICS, V283, P305, DOI 10.1007/s00438-010-0514-y; Babu R, 2011, THEOR APPL GENET, V122, P831, DOI 10.1007/s00122-010-1490-7; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Yin ZC, 2000, MOL PLANT MICROBE IN, V13, P869, DOI 10.1094/MPMI.2000.13.8.869; Jiang CJ, 2010, MOL PLANT MICROBE IN, V23, P791, DOI 10.1094/MPMI-23-6-0791; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Mori M, 2007, PLANT MOL BIOL, V63, P847, DOI 10.1007/s11103-006-9130-y; Wu CJ, 2008, MOL GENET GENOMICS, V279, P605, DOI 10.1007/s00438-008-0337-2; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Mizobuchi R, 2002, PLANT SCI, V163, P345, DOI 10.1016/S0168-9452(02)00134-6; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Yamanouchi U, 2002, P NATL ACAD SCI USA, V99, P7530, DOI 10.1073/pnas.112209199; Yamakawa H, 2010, PLANT CELL PHYSIOL, V51, P795, DOI 10.1093/pcp/pcq034; Dobzhansky T., 1970, GENETICS EVOLUTIONAR, P311; Fukuoka S, 2010, RICE, V3, P131, DOI 10.1007/s12284-010-9044-9; Hoshikawa K, 1989, GROWING RICE PLANT, P229; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Iwata T., 1973, Proceedings, Crop Science Society of Japan, V42, P454; Kubo T, 2001, RICE GENET NEWSL, V18, P55; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Marzougui S, 2012, THEOR APPL GENET, V124, P893, DOI 10.1007/s00122-011-1753-y; Wang S, 2005, WINDOWS QTL CARTOGRA	28	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-4615	1617-4623		MOL GENET GENOMICS	Mol. Genet. Genomics	JUN	2015	290	3					1085	1094		10.1007/s00438-014-0975-5		10	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CI3CP	WOS:000354625500019		
J	Ramakrishnan, NK; Schepers, M; Luurtsema, G; Nyakas, CJ; Elsinga, PH; Ishiwata, K; Dierckx, RAJO; van Waarde, A				Ramakrishnan, Nisha K.; Schepers, Marianne; Luurtsema, Gert; Nyakas, Csaba J.; Elsinga, Philip H.; Ishiwata, Kiichi; Dierckx, Rudi A. J. O.; van Waarde, Aren			Cutamesine Overcomes REM Sleep Deprivation-Induced Memory Loss: Relationship to Sigma-1 Receptor Occupancy	MOLECULAR IMAGING AND BIOLOGY			English	Article						Sigma-1 receptor; Receptor occupancy; Cutamesine; REM sleep deprivation; Amnesia; Positron emission tomography; Passive avoidance	POSITRON-EMISSION-TOMOGRAPHY; SELECTIVE CHOLINERGIC LESION; COGNITIVE ENHANCER; RAT-BRAIN; BEHAVIORAL EVIDENCE; OBJECT RECOGNITION; INDUCED AMNESIA; MODULATING ROLE; IN-VIVO; SA4503	Rapid eye movement (REM) sleep deprivation (SD) decreases cerebral sigma-1 receptor expression and causes cognitive deficits. Sigma-1 agonists are cognitive enhancers. Here, we investigate the effect of cutamesine treatment in the REM SD model. Sigma-1 receptor occupancy (RO) in the rat brain by cutamesine was determined using 1-[2-(3,4-dimethoxyphenethyl)]-4-(3-phenylpropyl)piperazine ([C-11]SA4503) and positron emission tomography (PET), and tissue cutamesine levels were measured by ultra performance liquid chromatography (UPLC)-MS. RO was calculated from a Cunningham-Lassen plot, based on the total distribution volume of [C-11]SA4503 determined by Logan graphical analysis. Cognitive performance was assessed using the passive avoidance (PA) test. Cutamesine at a dose of 1.0 mg/kg reversed REM SD-induced cognitive deficit and occupied 92 % of the sigma-1 receptor population. A lower dose (0.3 mg/kg) occupied 88 % of the receptors but did not significantly improve cognition. The anti-amnesic effect of cutamesine in this animal model may be related to longer exposure at a higher dose and/or drug binding to secondary targets.	[Ramakrishnan, Nisha K.; Schepers, Marianne; Luurtsema, Gert; Elsinga, Philip H.; Dierckx, Rudi A. J. O.; van Waarde, Aren] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, NL-9713 GZ Groningen, Netherlands; [Nyakas, Csaba J.] Semmelweis Univ, Brain Physiol Res Unit, H-1085 Budapest, Hungary; [Ishiwata, Kiichi] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan	van Waarde, A (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	a.van.waarde@umcg.nl			Ubbo Emmius Bursary Position	During the period of this research, NKR was supported by university funding (Ubbo Emmius Bursary Position).	Ramakrishnan NK, 2014, PSYCHOPHARMACOLOGY, V231, P3997, DOI 10.1007/s00213-014-3533-2; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Senda T, 1996, EUR J PHARMACOL, V315, P1, DOI 10.1016/S0014-2999(96)00572-9; Ishikawa M, 2009, INT J NEUROPSYCHOPH, V12, P1127, DOI 10.1017/S1461145709990204; Ishikawa M, 2007, BIOL PSYCHIAT, V62, P878, DOI 10.1016/j.biopsych.2007.04.001; Rothman SM, 2013, BRAIN RES, V1529, P200, DOI 10.1016/j.brainres.2013.07.010; Hagewoud R, 2010, J SLEEP RES, V19, P280, DOI 10.1111/j.1365-2869.2009.00799.x; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Maurice T, 1997, EUR J PHARMACOL, V328, P9, DOI 10.1016/S0014-2999(97)83020-8; Cunningham VJ, 2010, J CEREBR BLOOD F MET, V30, P46, DOI 10.1038/jcbfm.2009.190; Palchykova S, 2006, NEUROBIOL LEARN MEM, V85, P263, DOI 10.1016/j.nlm.2005.11.005; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; Hashimoto K, 2007, NEUROPSYCHOPHARMACOL, V32, P514, DOI 10.1038/sj.npp.1301047; Matsuno K, 1996, EUR J PHARMACOL, V306, P271, DOI 10.1016/0014-2999(96)00201-4; Kawamura K, 2003, NUCL MED BIOL, V30, P273, DOI 10.1016/S0969-8051(02)00439-0; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Aleisa AM, 2011, NEUROSCI LETT, V499, P28, DOI 10.1016/j.neulet.2011.05.025; Naidoo N, 2009, SLEEP MED REV, V13, P195, DOI 10.1016/j.smrv.2009.01.001; Lever JR, 2006, SYNAPSE, V59, P350, DOI 10.1002/syn.20253; MAURICE T, 1994, BRAIN RES, V647, P44, DOI 10.1016/0006-8993(94)91397-8; Antonini V, 2011, J ALZHEIMERS DIS, V24, P569, DOI 10.3233/JAD-2011-101794; Antonini V, 2009, J NEUROCHEM, V109, P744, DOI 10.1111/j.1471-4159.2009.06000.x; Behensky AA, 2013, J PHARMACOL EXP THER, V347, P458, DOI 10.1124/jpet.113.208348; Colavito Valeria, 2013, Front Syst Neurosci, V7, P106, DOI 10.3389/fnsys.2013.00106; Esumi LA, 2011, BEHAV BRAIN RES, V221, P7, DOI 10.1016/j.bbr.2011.02.025; Ishiwata K, 2006, ANN NUCL MED, V20, P569; Julien-Dolbec C, 2002, BRIT J ANAESTH, V89, P287, DOI 10.1093/bja/aef182; LASSEN NA, 1995, J CEREBR BLOOD F MET, V15, P152; Lever JR, 2014, J PHARMACOL EXP THER, V351, P153, DOI 10.1124/jpet.114.216671; Matsuno K, 1997, BEHAV BRAIN RES, V83, P221, DOI 10.1016/S0166-4328(97)86074-3; Matsuno Kiyoshi, 1998, CNS Drug Reviews, V4, P1, DOI 10.1111/j.1527-3458.1998.tb00038.x; Maurice T, 1996, BRAIN RES, V733, P219, DOI 10.1016/0006-8993(96)00565-3; Maurice T, 2001, BRAIN RES, V898, P113, DOI 10.1016/S0006-8993(01)02152-7; MAURICE T, 1994, BRAIN RES, V647, P57, DOI 10.1016/0006-8993(94)91398-6; Maurice T, 1998, NEUROSCIENCE, V83, P413; Meunier J, 2006, BEHAV BRAIN RES, V166, P166, DOI 10.1016/j.bbr.2005.07.019; Noda A, 2001, NEUROPSYCHOPHARMACOL, V24, P451, DOI 10.1016/S0893-133X(00)00192-5; Ramakrishnan N, 2014, MOL IMAGING IN PRESS; Ramakrishnan NK, 2012, EUR J NUCL MED MOL I, V39, pS301; Senda T, 1998, PHARMACOL BIOCHEM BE, V59, P129, DOI 10.1016/S0091-3057(97)00385-7; Spira AP, 2013, JAMA NEUROL, V70, P1537, DOI 10.1001/jamaneurol.2013.4258; Xu ZQ, 2010, CELL BIOCHEM BIOPHYS, V58, P137, DOI 10.1007/s12013-010-9098-8; Zou LB, 1998, EUR J PHARMACOL, V355, P1, DOI 10.1016/S0014-2999(98)00464-6; Zvejniece L, 2014, BRIT J PHARMACOL, V171, P761, DOI 10.1111/bph.12506	44	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1536-1632	1860-2002		MOL IMAGING BIOL	Mol. Imaging. Biol.	JUN	2015	17	3					364	372		10.1007/s11307-014-0808-2		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH5TE	WOS:000354097400009		
J	Tatsumoto, M; Misawa, S; Kokubun, N; Sekiguchi, Y; Hirata, K; Kuwabara, S; Yuki, N				Tatsumoto, Muneto; Misawa, Sonoko; Kokubun, Norito; Sekiguchi, Yukari; Hirata, Koichi; Kuwabara, Satoshi; Yuki, Nobuhiro			Delayed facial weakness in Guillain-Barre and miller fisher syndromes	MUSCLE & NERVE			English	Article						acute inflammatory demyelinating polyneuropathy; acute motor axonal neuropathy; facial palsy; facial weakness; Guillain-Barre syndrome; Miller Fisher syndrome	CLINICAL-FEATURES; ANTIBODIES; SPECTRUM	Introduction: Dr. C. Miller Fisher described the appearance of unilateral facial palsy after resolution of ataxia in a patient with the eponymic Miller Fisher syndrome (MFS). However, there have been very few reports of delayed appearance of facial weakness in Guillain-Barre syndrome (GBS) and MFS when the other neurological signs reached nadir or started improving. Methods: In this study we reviewed the clinical and laboratory findings of consecutive patients with GBS (n=195) and MFS (n=68). Results: Delayed facial weakness occurred in 12 (6%) GBS and 4 (6%) MFS patients and was unilateral in 5 (42%) GBS and 2 (50%) MFS patients. In those patients with delayed facial weakness, neither limb weakness nor ataxia progressed, and facial weakness disappeared without immunotherapy. Conclusions: Because facial weakness can lead to further morbidity, it would be prudent for clinicians to warn patients of this possibility, although additional immunotherapy is usually not required. Muscle Nerve51: 811-814, 2015	[Tatsumoto, Muneto; Kokubun, Norito; Hirata, Koichi] Dokkyo Med Univ, Dept Neurol, Mibu, Tochigi, Japan; [Misawa, Sonoko; Sekiguchi, Yukari; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan; [Yuki, Nobuhiro] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Yuki, Nobuhiro] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Translat Med, Dept Med, Singapore 117599, Singapore	Yuki, N (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore.	mdcyuki@nus.edu.sg			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Singapore National Medical Research Council [IRG 10nov086, CSA/047/2012]; Yong Loo Lin School of Medicine [R-172-000-264-733]	This study was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S.K.); grants-in-aid from the Ministry of Health, Labor, and Welfare of Japan (to S.K.); the Singapore National Medical Research Council (IRG 10nov086 and CSA/047/2012 to N.Y.); and the Yong Loo Lin School of Medicine (R-172-000-264-733 to N.Y.).	HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597; Ito M, 2008, J NEUROL, V255, P674, DOI 10.1007/s00415-008-0775-0; Koga M, 2005, NEUROLOGY, V65, P1376, DOI 10.1212/01.wnl.0000176914.70893.14; HUGHES RAC, 1978, LANCET, V2, P750; Shahrizaila N, 2014, MUSCLE NERVE, V49, P558, DOI 10.1002/mus.23973; Chida K, 1998, J NEUROL NEUROSUR PS, V64, P399, DOI 10.1136/jnnp.64.3.399; Sekiguchi Y, 2012, J NEUROL NEUROSUR PS, V83, P23, DOI 10.1136/jnnp-2011-300309; Mori M, 2001, NEUROLOGY, V56, P1104; Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512; Kokubun N, 2010, BRAIN, V133, P2897, DOI 10.1093/brain/awq260; ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; Yuki N, 1997, J NEUROIMMUNOL, V74, P30, DOI 10.1016/S0165-5728(96)00201-9; Kimoto K, 2006, NEUROLOGY, V67, P1837, DOI 10.1212/01.wnl.0000244468.22377.6b; FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201; Mitsui Y, 2013, J NEUROL NEUROSURG P; ROPPER AH, 1992, NEW ENGL J MED, V326, P1130; Stevenson Mary L, 2010, J Med Case Rep, V4, P253, DOI 10.1186/1752-1947-4-253	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-639X	1097-4598		MUSCLE NERVE	Muscle Nerve	JUN	2015	51	6					811	814		10.1002/mus.24475		4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI1TG	WOS:000354526900003		
J	Coraci, D; Tsukamoto, H; Granata, G; Briani, C; Santilli, V; Padua, L				Coraci, Daniele; Tsukamoto, Hiroshi; Granata, Giuseppe; Briani, Chiara; Santilli, Valter; Padua, Luca			Fibular nerve damage in knee dislocation: Spectrum of ultrasound patterns	MUSCLE & NERVE			English	Article						fibular nerve; knee dislocation; peripheral nerve trauma; rehabilitation; ultrasound	PERONEAL NERVE; DIAGNOSIS; ANKLE; PALSY; FOOT; LEG	IntroductionAt least 25% of knee dislocations are associated with common fibular nerve injury. Diagnosis is usually based on clinical and neurophysiological findings. We assessed the role of nerve ultrasound in common fibular nerve injury. MethodsEight consecutive patients (6 men and 2 women, mean age 34 years) with knee luxation referred to our laboratory underwent clinical, neurophysiological, and ultrasound examination. ResultsIn all patients we observed a similar pattern: severe weakness (plegia or severe paresis); neurophysiological involvement of both fibular nerve branches; and ultrasound evidence of increased fibular nerve area with hypoechogenicity. On follow-up evaluation, 6 patients remained stable, and 2 patients improved. The greater the ultrasound fibular nerve enlargement, the worse the recovery. ConclusionsNerve ultrasound was confirmed to be a useful diagnostic/prognostic tool in traumatic nerve lesions. A prompt ultrasound examination of the fibular nerve should be considered after any case of knee dislocation. Muscle Nerve51: 859-863, 2015	[Coraci, Daniele; Santilli, Valter] Univ Roma La Sapienza, Dept Orthopaed Sci, Board Phys Med & Rehabil, I-00185 Rome, Italy; [Tsukamoto, Hiroshi] Teikyo Univ, Inst Neurol, Tokyo 173, Japan; [Granata, Giuseppe; Padua, Luca] Univ Cattolica Sacro Cuore, Inst Neurol, Rome, Italy; [Briani, Chiara] Univ Padua, Sci NPSRR, Dept Neurosci, Padua, Italy; [Santilli, Valter] Azienda Policlin Umberto I, Phys Med & Rehabil Unit, Rome, Italy; [Padua, Luca] Don Carlo Gnocchi Onlus Fdn, Milan, Italy	Coraci, D (reprint author), Univ Roma La Sapienza, Dept Orthopaed Sci, Board Phys Med & Rehabil, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	danielecoraci@aol.com		Santilli, Valter/0000-0002-2547-6801			Padua L, 2013, CLIN NEUROPHYSIOL, V124, P1237, DOI 10.1016/j.clinph.2012.10.024; Niall DM, 2005, J BONE JOINT SURG BR, V87B, P664, DOI 10.1302/0301-620X.87B5.15607; Padua L, 2007, CLIN NEUROPHYSIOL, V118, P1410, DOI 10.1016/j.clinph.2007.03.011; Allen JM, 2008, MAGN RESON IMAGING C, V16, P117, DOI 10.1016/j.mric.2008.02.006; Flanigan RM, 2011, FOOT ANKLE CLIN, V16, P255, DOI 10.1016/j.fcl.2011.01.006; Aprile I, 2000, NEUROL SCI, V21, P367, DOI 10.1007/s100720070052; Gruber H, 2005, AM J ROENTGENOL, V185, P1119, DOI 10.2214/AJR.04.1050; Liotta G, 2010, MUSCLE NERVE, V41, P287, DOI 10.1002/mus.21580; Stewart John D, 2008, Pract Neurol, V8, P158, DOI 10.1136/jnnp.2008.149393; Vasudevan JM, 2011, PM&R, V3, P274, DOI 10.1016/j.pmrj.2010.09.014	10	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-639X	1097-4598		MUSCLE NERVE	Muscle Nerve	JUN	2015	51	6					859	863		10.1002/mus.24472		5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI1TG	WOS:000354526900010		
J	Hayashi, K; Iwasa, K; Morinaga, A; Ono, K; Yamada, M				Hayashi, Koji; Iwasa, Kazuo; Morinaga, Akiyoshi; Ono, Kenjiro; Yamada, Masahito			Exacerbation of myasthenia gravis by intravenous peramivir	MUSCLE & NERVE			English	Letter									[Hayashi, Koji; Iwasa, Kazuo; Morinaga, Akiyoshi; Ono, Kenjiro; Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan	Hayashi, K (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan.							0	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-639X	1097-4598		MUSCLE NERVE	Muscle Nerve	JUN	2015	51	6					935	936		10.1002/mus.24594		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI1TG	WOS:000354526900025		
J	Tanaka, M; Komi, Y				Tanaka, Motomasa; Komi, Yusuke			Layers of structure and function in protein aggregation	NATURE CHEMICAL BIOLOGY			English	Article							ENVIRONMENTAL-STRESS; AMYLOID FIBRILS; PRION; OLIGOMERS; DISEASES; BETA; YEAST; NEURODEGENERATION; SEGREGATION; CELLS	Protein aggregation is a central hallmark of many neurodegenerative disorders, but the relationship of aggregate structural diversity to the resultant cellular cytotoxicity and phenotypic diversity has remained obscure. Recent advances in understanding the mechanisms of protein aggregation and their physiological consequences have been achieved through chemical biology approaches, such as rationally designed protein modifications and chemical probes, providing crucial mechanistic insights and promise for therapeutic strategies for brain disorders.	[Tanaka, Motomasa; Komi, Yusuke] RIKEN, Brain Sci Inst, Wako, Saitama, Japan	Tanaka, M (reprint author), RIKEN, Brain Sci Inst, Wako, Saitama, Japan.	motomasa@brain.riken.jp			Japan Society for the Promotion of Science [LS129]; Ministry of Health, Labour, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [25830025]	We thank the collaborators that have contributed to our work in this research area. In our work, the funding was provided by the Next program (LS129; M.T.) from the Japan Society for the Promotion of Science, Grants-in-Aid from the Ministry of Health, Labour, and Welfare, Japan (the Research Committee of Prion Disease and Slow Virus Infection; M.T.) and from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT; Young Scientist (B) 25830025; Y.K.), Japan.	Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Jackrel ME, 2014, CELL, V156, P170, DOI 10.1016/j.cell.2013.11.047; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Perchiacca JM, 2012, P NATL ACAD SCI USA, V109, P84, DOI 10.1073/pnas.1111232108; Karamanos TK, 2014, MOL CELL, V55, P214, DOI 10.1016/j.molcel.2014.05.026; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Zhou CK, 2014, CELL, V159, P530, DOI 10.1016/j.cell.2014.09.026; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Woods LA, 2011, NAT CHEM BIOL, V7, P730, DOI [10.1038/nchembio.635, 10.1038/NCHEMBIO.635]; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Jarosz DF, 2014, CELL, V158, P1072, DOI 10.1016/j.cell.2014.07.024; Zhou CK, 2011, CELL, V147, P1186, DOI 10.1016/j.cell.2011.11.002; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Suzuki G, 2012, SCIENCE, V336, P355, DOI 10.1126/science.1219491; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/nchembio.283, 10.1038/NCHEMBIO.283]; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294	27	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2015	11	6					373	377				5	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI1XW	WOS:000354539400003		
J	Bertozzi, CR; Stockwell, BR; Kubicek, S; Dickinson, BC; Chang, CJ; Schultz, C; Silver, PA; Gestwicki, JE; Chiosis, G; Chattopadhyay, A; Butcher, RA; Park, SB; Shoichet, BK; Flitsch, SL; Zhang, J; Liu, DR; Ohnishi, Y; Weerapana, E; Williams, AH; He, C; Moroni, A; Thiel, G; Chang, YT; Waldmann, H; Bogyo, M; Oddershede, LB; Christopoulos, A; Imperiali, B; Ehrlich, H; Chen, X; Prescher, JA				Bertozzi, Carolyn R.; Stockwell, Brent R.; Kubicek, Stefan; Dickinson, Bryan C.; Chang, Christopher J.; Schultz, Carsten; Silver, Pamela A.; Gestwicki, Jason E.; Chiosis, Gabriela; Chattopadhyay, Amitabha; Butcher, Rebecca A.; Park, Seung Bum; Shoichet, Brian K.; Flitsch, Sabine L.; Zhang, Jin; Liu, David R.; Ohnishi, Yasuo; Weerapana, Eranthie; Williams, Allison H.; He, Chuan; Moroni, Anna; Thiel, Gerhard; Chang, Young-Tae; Waldmann, Herbert; Bogyo, Matthew; Oddershede, Lene B.; Christopoulos, Arthur; Imperiali, Barbara; Ehrlich, Hermann; Chen, Xing; Prescher, Jennifer A.			Voices of chemical biology	NATURE CHEMICAL BIOLOGY			English	Editorial Material									[Bertozzi, Carolyn R.] Stanford Univ, Palo Alto, CA 94304 USA; [Stockwell, Brent R.] Columbia Univ, New York, NY USA; [Kubicek, Stefan] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Dickinson, Bryan C.] Univ Chicago, Chicago, IL 60637 USA; [Chang, Christopher J.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Chang, Christopher J.] HHMI, Berkeley, CA USA; [Schultz, Carsten] European Mol Biol Lab, D-69012 Heidelberg, Germany; [Silver, Pamela A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gestwicki, Jason E.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Chiosis, Gabriela] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Chattopadhyay, Amitabha] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Butcher, Rebecca A.] Univ Florida, Gainesville, FL USA; [Park, Seung Bum] Seoul Natl Univ, Seoul, South Korea; [Shoichet, Brian K.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Flitsch, Sabine L.] Univ Manchester, Manchester, Lancs, England; [Zhang, Jin] Johns Hopkins Univ, Baltimore, MD USA; [Liu, David R.] Harvard Univ, Cambridge, MA 02138 USA; [Ohnishi, Yasuo] Univ Tokyo, Tokyo, Japan; [Weerapana, Eranthie] Boston Coll, Chestnut Hill, MA 02167 USA; [Williams, Allison H.] Inst Pasteur, Paris, France; [He, Chuan] Univ Chicago, Chicago, IL 60637 USA; [Moroni, Anna] Univ Milan, Milan, Italy; [Thiel, Gerhard] Tech Univ Darmstadt, Darmstadt, Germany; [Chang, Young-Tae] Natl Univ Singapore, Singapore 117548, Singapore; [Waldmann, Herbert] Max Planck Inst Mol Physiol, D-44139 Dortmund, Germany; [Bogyo, Matthew] Stanford Univ, Palo Alto, CA 94304 USA; [Oddershede, Lene B.] Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Christopoulos, Arthur] Monash Univ, Parkville, Vic, Australia; [Imperiali, Barbara] MIT, Cambridge, MA 02139 USA; [Ehrlich, Hermann] Tech Univ Bergakad Freiberg, D-09596 Freiberg, Germany; [Chen, Xing] Peking Univ, Beijing 100871, Peoples R China; [Prescher, Jennifer A.] Univ Calif Irvine, Irvine, CA USA	Bertozzi, CR (reprint author), Stanford Univ, Palo Alto, CA 94304 USA.		moroni, anna/H-2097-2014; Chang, Young-Tae/B-2780-2010	moroni, anna/0000-0002-1860-406X; Chang, Young-Tae/0000-0002-1927-3688				0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2015	11	6					378	379				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI1XW	WOS:000354539400004		
J	Hoshino, O				Hoshino, Osamu			Regulation of Local Ambient GABA Levels via Transporter-Mediated GABA Import and Export for Subliminal Learning	NEURAL COMPUTATION			English	Article							RAT FRONTAL-CORTEX; CAT VISUAL-CORTEX; NEURONAL-ACTIVITY; PERCEPTION; PLASTICITY; SUBTHRESHOLD; INHIBITION; POTENTIALS; REVERSAL; MARKERS	Perception of supraliminal stimuli might in general be reflected in bursts of action potentials (spikes), and their memory traces could be formed through spike-timing-dependent plasticity (STDP). Memory traces for subliminal stimuli might be formed in a different manner, because subliminal stimulation evokes a fraction (but not a burst) of spikes. Simulations of a cortical neural network model showed that a subliminal stimulus that was too brief (10 msec) to perceive transiently (more than about 500 msec) depolarized stimulus-relevant principal cells and hyperpolarized stimulus-irrelevant principal cells in a subthreshold manner. This led to a small increase or decrease in ongoing-spontaneous spiking activity frequency (less than 1 Hz). Synaptic modification based on STDP during this period effectively enhanced relevant synaptic weights, by which subliminal learning was improved. GABA transporters on GABAergic interneurons modulated local levels of ambient GABA. Ambient GABA molecules acted on extrasynaptic receptors, provided principal cells with tonic inhibitory currents, and contributed to achieving the subthreshold neuronal state. We suggest that ongoing-spontaneous synaptic alteration through STDP following subliminal stimulation may be a possible neuronal mechanism for leaving its memory trace in cortical circuitry. Regulation of local ambient GABA levels by transporter-mediated GABA import and export may be crucial for subliminal learning.	Ibaraki Univ, Dept Intelligent Syst Engn, Hitachi, Ibaraki 3168511, Japan	Hoshino, O (reprint author), Ibaraki Univ, Dept Intelligent Syst Engn, Hitachi, Ibaraki 3168511, Japan.	hoshino@mx.ibaraki.ac.jp					Shevrin H, 2001, INT J PSYCHOPHYSIOL, V42, P209, DOI 10.1016/S0167-8760(01)00165-9; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Hoshino O, 2007, NEURAL COMPUT, V19, P3310, DOI 10.1162/neco.2007.19.12.3310; Young JM, 2007, NAT NEUROSCI, V10, P887, DOI 10.1038/nn1913; Hoshino O, 2014, NEURAL COMPUT, V26, P1362, DOI 10.1162/NECO_a_00606; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Kahn I, 2013, BRAIN RES, V1511, P33, DOI 10.1016/j.brainres.2013.03.011; KISVARDAY ZF, 1994, EUR J NEUROSCI, V6, P1619, DOI 10.1111/j.1460-9568.1994.tb00553.x; Eysel UT, 1998, NEUROSCIENCE, V84, P25, DOI 10.1016/S0306-4522(97)00378-3; Hoshino O, 2009, NEURAL COMPUT, V21, P1683, DOI 10.1162/neco.2009.05-08-778; Wu YM, 2003, J NEUROPHYSIOL, V89, P2021, DOI 10.1152/jn.00856.2002; Hoshino O, 2010, NEURAL COMPUT, V22, P1358, DOI 10.1162/neco.2010.02-09-969; EYSEL UT, 1992, PROG BRAIN RES, V90, P407; Hoshino O, 2012, NEURAL COMPUT, V24, P2964, DOI 10.1162/NECO_a_00356; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Richerson GB, 2003, J NEUROPHYSIOL, V90, P1363, DOI 10.1152/jn.00317.2003; Hoshino O, 2013, NEURAL COMPUT, V25, P1164, DOI 10.1162/NECO_a_00431; Hoshino O, 2011, NEURAL COMPUT, V23, P958, DOI 10.1162/NECO_a_00096; Bi GQ, 1998, J NEUROSCI, V18, P10464; Bernat E, 2001, INT J PSYCHOPHYSIOL, V42, P11, DOI 10.1016/S0167-8760(01)00133-7; Grossberg S, 1999, SPATIAL VISION, V12, P163, DOI 10.1163/156856899X00102; Wu YM, 2007, NEURON, V56, P851, DOI 10.1016/j.neuron.2007.10.021; Hoshino O, 2011, NEURAL COMPUT, V23, P3205, DOI 10.1162/NECO_a_00211; Maya-Vetencourt JF, 2012, NEURAL PLAST, DOI 10.1155/2012/250421; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Massie A, 2003, BRAIN RES, V976, P100, DOI 10.1016/S0006-8993(03)02717-3; Hoshino O, 2007, NEURAL COMPUT, V19, P351, DOI 10.1162/neco.2007.19.2.351; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Arckens L, 2000, EUR J NEUROSCI, V12, P4222, DOI 10.1046/j.0953-816X.2000.01328.x; Hoshino O, 2008, NEURAL COMPUT, V20, P3055, DOI 10.1162/neco.2008.08-07-589; Brazdil M, 1998, ELECTROEN CLIN NEURO, V107, P64, DOI 10.1016/S0013-4694(98)00038-8; Gilbert CD, 1996, CURR OPIN NEUROBIOL, V6, P269, DOI 10.1016/S0959-4388(96)80083-3; GILBERT CD, 1994, CURR BIOL, V4, P627, DOI 10.1016/S0960-9822(00)00138-X; Hirst W., 1997, COGNITIVE NEUROSCIEN, P1307; Hoshino O, 2013, NEURAL COMPUT, V25, P3235, DOI 10.1162/NECO_a_00519; Kern MK, 2002, GASTROENTEROLOGY, V122, P290, DOI 10.1053/gast.2002.30989; Richerson George B, 2004, Epilepsy Curr, V4, P239, DOI 10.1111/j.1535-7597.2004.46008.x; Sillito A. M., 1984, CEREB CORTEX, P91; Stemmler M., 2000, OSCILLATIONS NEURAL, P79; Vaina LM, 1998, P NATL ACAD SCI USA, V95, P12657, DOI 10.1073/pnas.95.21.12657; Yost WA, 1994, FUNDAMENTALS HEARING	44	2	2	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0899-7667	1530-888X		NEURAL COMPUT	Neural Comput.	JUN	2015	27	6					1223	1251		10.1162/NECO_a_00733		29	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CI3MP	WOS:000354652200003		
J	Lv, SG				Lv, Shao-Gao			Refined Generalization Bounds of Gradient Learning over Reproducing Kernel Hilbert Spaces	NEURAL COMPUTATION			English	Article							VARIABLE SELECTION; REGRESSION; RANKING; MODELS	Gradient learning (GL), initially proposed by Mukherjee and Zhou (2006) has been proved to be a powerful tool for conducting variable selection and dimensional reduction simultaneously. This approach presents a nonparametric version of a gradient estimator with positive definite kernels without estimating the true function itself, so that the proposed version has wide applicability and allows for complex effects between predictors. In terms of theory, however, existing generalization bounds for GL depend on capacity-independent techniques, and the capacity of kernel classes cannot be characterized completely. Thus, this letter considers GL estimators that minimize the empirical convex risk. We prove generalization bounds for such estimators with rates that are faster than previous results. Moreover, we provide a novel upper bound for Rademacher chaos complexity of order two, which also plays an important role in general pairwise-type estimations, including ranking and score problems.	[Lv, Shao-Gao] Southwestern Univ Finance & Econ, Sch Stat, Chengdu, Peoples R China; [Lv, Shao-Gao] Inst Stat Math, Tachikawa, Tokyo 1908562, Japan	Lv, SG (reprint author), Southwestern Univ Finance & Econ, Sch Stat, Chengdu, Peoples R China.	lvsg716@swufe.edu.cn			National Natural Science Foundation of China [11301421]; Fundamental Research Funds for the Central Universities of China [JBK141111, 14TD0046, JBK140210]; MEXT [25120012]	I thank the anonymous reviewers for their helpful comments. My research is supported partially by the National Natural Science Foundation of China (grant 11301421), and Fundamental Research Funds for the Central Universities of China (grants JBK141111, 14TD0046, and JBK140210). My research is also supported partially by MEXT Grant-in-Aid for Scientific Research on Innovative Areas of Japan (grant 25120012).	BREIMAN L, 1995, TECHNOMETRICS, V37, P373, DOI 10.2307/1269730; Donoho DL, 2003, P NATL ACAD SCI USA, V100, P5591, DOI 10.1073/pnas.1031596100; Ravikumar P, 2009, J ROY STAT SOC B, V71, P1009; Meier L, 2009, ANN STAT, V37, P3779, DOI 10.1214/09-AOS692; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Li LX, 2005, J ROY STAT SOC B, V67, P285, DOI 10.1111/j.1467-9868.2005.00502.x; Bartlett PL, 2005, ANN STAT, V33, P1497, DOI 10.1214/009053605000000282; Lin Y, 2006, ANN STAT, V34, P2272, DOI 10.1214/009053606000000722; Rejchel W, 2012, J MACH LEARN RES, V13, P1373; Mukherjee S, 2006, J MACH LEARN RES, V7, P519; Smale S, 2009, CONSTR APPROX, V30, P311, DOI 10.1007/s00365-009-9070-2; Arcones A., 1993, ANN PROBAB, V21, P1494; Clemencon S, 2008, ANN STAT, V36, P844, DOI 10.1214/009052607000000910; COX DR, 1974, ROY STAT SOC C-APP, V23, P51; Cucker F., 2001, B AM MATH SOC, V39, P1, DOI 10.1090/S0273-0979-01-00923-5; Efron B, 2004, ANN STAT, V32, P407; Feng Y. L., 2014, ROBUST GRADIENT LEAR; Guo X, 2012, APPL COMPUT HARMON A, V32, P389, DOI 10.1016/j.acha.2011.07.005; Guo X, 2010, J APPROX THEORY, V162, P1919, DOI 10.1016/j.jat.2010.05.004; Hu T, 2013, J MACH LEARN RES, V14, P377; Lei YW, 2014, NEURAL COMPUT, V26, P739, DOI 10.1162/NECO_a_00566; Li H, 2014, NEURAL COMPUT, V26, P2896, DOI 10.1162/NECO_a_00674; Mendelson S., 2002, P COLT, P29; Mukherjee S, 2006, J MACH LEARN RES, V7, P2481; Mukherjee S, 2010, BERNOULLI, V16, P181, DOI 10.3150/09-BEJ206; Pena V. H., 1999, DECOUPLING DEPENDENC; Steinwart I., 2009, P 22 ANN C LEARN THE; Steinwart I, 2008, INFORM SCI STAT, P1; van der Vaart A. W., 1996, WEAK CONVERGENCE EMP; Wu QA, 2010, J MACH LEARN RES, V11, P2175; Xia Y. C., 2002, J R STAT SOC B, V64, P360; Ye GB, 2012, MACH LEARN, V87, P303, DOI 10.1007/s10994-012-5284-9; Ying Y. M., 2008, P 22 ANN C LEARN THE; Ying Y. M., 2009, P 22 ANN C LEARN THE	34	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0899-7667	1530-888X		NEURAL COMPUT	Neural Comput.	JUN	2015	27	6					1294	1320		10.1162/NECO_a_00739		27	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CI3MP	WOS:000354652200005		
J	Noguchi, H; Kimura, A; Murao, N; Matsuda, T; Namihira, M; Nakashima, K				Noguchi, Hirofumi; Kimura, Ayaka; Murao, Naoya; Matsuda, Taito; Namihira, Masakazu; Nakashima, Kinichi			Expression of DNMT1 in neural stem/precursor cells is critical for survival of newly generated neurons in the adult hippocampus	NEUROSCIENCE RESEARCH			English	Article						DNA methyltransferase 1; Adult neurogenesis; DNA methylation; Neuronal survival; Neural stem cells	NEWLY BORN NEURONS; DNA METHYLATION; STEM-CELLS; MAMMALIAN BRAIN; DENTATE GYRUS; EPIGENETIC REGULATION; NEUROGENESIS; DIFFERENTIATION; HUNTINGTIN; FOREBRAIN	Adult neurogenesis persists throughout life in the dentate gyrus (DG) of the hippocampus, and its importance has been highlighted in hippocampus-dependent learning and memory. Adult neurogenesis consists of multiple processes: maintenance and neuronal differentiation of neural stem/precursor cells (NS/PCs), followed by survival and maturation of newborn neurons and their integration into existing neuronal circuitry. However, the mechanisms that govern these processes remain largely unclear. Here we show that DNA methyltransferase 1 (DNMT1), an enzyme responsible for the maintenance of DNA methylation, is highly expressed in proliferative cells in the adult DG and plays an important role in the survival of newly generated neurons. Deletion of Dnmtl in adult NS/PCs (aNS/PCs) did not affect the proliferation and differentiation of aNS/PCs per se. However, it resulted in a decrease of newly generated mature neurons, probably due to gradual cell death after aNS/PCs differentiated into neurons in the hippocampus. Interestingly, loss of DNMT1 in post-mitotic neurons did not influence their survival. Taken together, these findings suggest that the presence of DNMT1 in aNS/PCs is crucial for the survival of newly generated neurons, but is dispensable once they accomplish neuronal differentiation in the adult hippocampus. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Noguchi, Hirofumi; Kimura, Ayaka; Murao, Naoya; Matsuda, Taito; Nakashima, Kinichi] Kyushu Univ, Grad Sch Med Sci, Stem Cell Biol & Med, Fukuoka 8128582, Japan; [Noguchi, Hirofumi; Murao, Naoya] Nara Inst Sci & Technol, Grad Sch Biol Sci, Lab Gene Regulat Res, Nara 6300101, Japan; [Namihira, Masakazu] AIST, Biomed Res Inst, Mol Neurophysiol Grp, Ibaraki, Japan	Nakashima, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Stem Cell Biol & Med, Fukuoka 8128582, Japan.	kin1@scb.med.kyushu-u.ac.jp			Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency; JSPS [13J09870]	We thank Y. Bessho, T. Matsui, Y. Nakahata, T. Imamura and S. Katada for valuable discussions and M.E. Greenberg and Z. Zhou for sharing reagents. We are grateful to R. Jaenisch for Dnmt1<SUP>flox</SUP> mice, R. Kageyama for Nestin-CreER<SUP>T2</SUP> mice. We also appreciate the members of our laboratories, in particular T. Sanosaka and B. Juliandi for technical help and suggestions, A.M.D. Adefuin and M.C. Sanosaka for writing this manuscript and experimental support and C. Soldati for establishment of adult NS/PCs. We would like to thank I. Smith for helpful comments and grammatical corrections on the manuscript. Furthermore, we are very grateful to M. Tano and Y. Nakagawa for their excellent secretarial assistance. We appreciate the technical assistance from The Research Support Center, Research Center for Human Disease Modeling, Kyushu University Graduate School of Medical Sciences. This work was funded by Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency. H.N. received funding from a Grant-in-Aid for JSPS Fellows (no. 13J09870).	Adefuin AMD, 2014, EPIGENOMICS-UK, V6, P637, DOI [10.2217/epi.14.53, 10.2217/EPI.14.53]; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Kimura H, 2003, NUCLEIC ACIDS RES, V31, P3101, DOI 10.1093/nar/gkg406; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Simon R, 2012, EMBO J, V31, P2922, DOI 10.1038/emboj.2012.142; Meehan RR, 2003, SEMIN CELL DEV BIOL, V14, P53, DOI 10.1016/S1084-9521(02)00137-4; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Seri B, 2001, J NEUROSCI, V21, P7153; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Covic M, 2010, HEREDITY, V105, P122, DOI 10.1038/hdy.2010.27; MuhChyi C, 2013, INT J DEV NEUROSCI, V31, P424, DOI 10.1016/j.ijdevneu.2013.02.006; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Namihira M, 2013, CURR OPIN NEUROBIOL, V23, P921, DOI 10.1016/j.conb.2013.06.002; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Fan GP, 2001, J NEUROSCI, V21, P788; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; Hutnick LK, 2009, HUM MOL GENET, V18, P2875, DOI 10.1093/hmg/ddp222; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Choi SA, 2006, FEBS LETT, V580, P5275, DOI 10.1016/j.febslet.2006.08.076; Clements EG, 2012, NUCLEIC ACIDS RES, V40, P4334, DOI 10.1093/nar/gks031; Espada J, 2012, EPIGENETICS-US, V7, P115, DOI 10.4161/epi.7.2.18756; Espada J, 2011, NUCLEIC ACIDS RES, V39, P9194, DOI 10.1093/nar/gkr658; Georgia S, 2013, GENE DEV, V27, P372, DOI 10.1101/gad.207001.112; Hackam AS, 2000, J BIOL CHEM, V275, P41299, DOI 10.1074/jbc.M008408200; Imayoshi I, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00064; McCabe MT, 2005, CANCER RES, V65, P3624, DOI 10.1158/0008-5472.CAN-04-2158; Metzler M, 2007, J NEUROSCI, V27, P2298, DOI 10.1523/JNEUROSCI.5175-06.2007; Murao N., 2014, NEUROGENESIS, V1, P1; Rhee KD, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.165; So AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019503; Zeron MM, 2004, MOL CELL NEUROSCI, V25, P469, DOI 10.1016/j.mcn.2003.11.014	58	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	JUN	2015	95						1	11		10.1016/j.neures.2015.01.014		11	Neurosciences	Neurosciences & Neurology	CI2MH	WOS:000354581200001		
J	Avriyanti, E; Atik, N; Kunii, M; Furumoto, N; Iwano, T; Yoshimura, S; Harada, R; Harada, A				Avriyanti, Erda; Atik, Nur; Kunii, Masataka; Furumoto, Naomi; Iwano, Tomohiko; Yoshimura, Shin-ichiro; Harada, Reiko; Harada, Akihiro			Functional redundancy of protein kinase D1 and protein kinase D2 in neuronal polarity	NEUROSCIENCE RESEARCH			English	Article						Protein kinase D; Functional redundancy; Neuronal polarity; Knockout mouse	CELL POLARITY; ESTABLISHMENT; TRAFFICKING; SUBSTRATE; MEMBRANE; AXONS; PKD	Mammalian protein kinase D (PKD) isoforms have been proposed to regulate diverse biological processes, including the establishment and maintenance of neuronal polarity. To investigate the function of PKD in neuronal polarization in vivo, we generated PKD knockout (KO) mice. Here, we show that the brain, particularly the hippocampus, of both PKD1 KO and PKD2 KO mice was similar to that of control animals. Neurite length in cultured PICD1 KO and PKD2 KO hippocampal neurons was similar to that of wild-type neurons. However, hippocampal neurons deficient in both PKD1 and PKD2 genes showed a reduction in axonal elongation and an increase in the percentage of neurons with multiple axons relative to control neurons. These results reveal that whereas PKD1 and PKD2 are essential for neuronal polarity, there exists a functional redundancy between the two proteins. (C) 2015 The Authors. Published by Elsevier Ireland Ltd.	[Avriyanti, Erda; Atik, Nur; Kunii, Masataka; Iwano, Tomohiko; Yoshimura, Shin-ichiro; Harada, Reiko; Harada, Akihiro] Osaka Univ, Dept Cell Biol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Furumoto, Naomi; Harada, Akihiro] Gunma Univ, Inst Mol & Cellular Regulat, Dept Cellular & Mol Biol, Lab Mol Traff, Maebashi, Gumma 3718512, Japan; [Harada, Reiko] Takarazuka Univ Med & Hlth Care, Dept Judo Therapy, Takarazuka, Hyogo 6660162, Japan; [Atik, Nur] Padjadjaran State Univ, Fac Med, Dept Anat & Cell Biol, Bandung, Indonesia	Harada, A (reprint author), Osaka Univ, Dept Cell Biol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	aharada@acb.med.osaka-u.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [24390046]	We thank A. Watanabe, A. Izumi, M. Natsume, H. Togawa, and A. Goto for technical assistance. This work was supported by the Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (KAKENHI no. 24390046) to A.H.	Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; Bisbal M, 2008, J NEUROSCI, V28, P9297, DOI 10.1523/JNEUROSCI.1879-08.2008; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Yin DM, 2008, J NEUROSCI, V28, P8832, DOI 10.1523/JNEUROSCI.1291-08.2008; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Mori T, 2007, J BIOL CHEM, V282, P19884, DOI 10.1074/jbc.M700770200; Atik N, 2014, CELL STRUCT FUNCT, V39, P61; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.neuro.17.1.267; Higuero AM, 2010, J BIOL CHEM, V285, P1343, DOI 10.1074/jbc.M109.024703; Li G, 2014, NEUROSCI BULL, V30, P497, DOI 10.1007/s12264-013-1403-2; Sato M, 2011, TRAFFIC, V12, P1383, DOI 10.1111/j.1600-0854.2011.01247.x; Tahirovic S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001644	17	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	JUN	2015	95						12	20		10.1016/j.neures.2015.01.007		9	Neurosciences	Neurosciences & Neurology	CI2MH	WOS:000354581200002		
J	Watada, Y; Yamashita, D; Toyoda, M; Tsuchiya, K; Hida, N; Tanimoto, A; Ogawa, K; Kanzaki, S; Umezawa, A				Watada, Yukiko; Yamashita, Daisuke; Toyoda, Masashi; Tsuchiya, Kohei; Hida, Naoko; Tanimoto, Akihiro; Ogawa, Kaoru; Kanzaki, Sho; Umezawa, Akihiro			Magnetic resonance monitoring of superparamagnetic iron oxide (SPIO)-labeled stem cells transplanted into the inner ear	NEUROSCIENCE RESEARCH			English	Article						Cochlea; Transplantation; Mesenchymal stem cells; Superparamagnetic iron oxide; Magnetic resonance imaging; Guinea pigs	MARROW STROMAL CELLS; IN-VIVO; MAMMALIAN COCHLEA; TRANSFECTION AGENT; LIFE-SPAN; DIFFERENTIATION; TRACKING; NANOPARTICLES; MACROPHAGES; METABOLISM	In the field of regenerative medicine, cell transplantation or cell-based therapies for inner ear defects are considered to be promising candidates for a therapeutic strategy. In this paper, we report on a study that examined the use of magnetic resonance imaging (MRI) to monitor stem cells transplanted into the cochlea labeled with superparamagnetic iron oxide (SPIO), a contrast agent commonly used with MRI. First, we demonstrated in vitro that stem cells efficiently took up SPIO particles. This was confirmed by Prussian blue staining and TEM. In MRI studies, T2 relaxation times of SPIO-labeled cells decreased in a dose-dependent manner. Next, we transplanted SPIO-labeled cells directly into the cochlea in vivo and then performed MRI 1 h, 2 weeks, and 4 weeks after transplantation. The images were evaluated objectively by measuring signal intensity (SI). SI within the ears receiving transplants was significantly lower (P < 0.05) than that of control sides at the 1-h assessment. This novel method will be helpful for evaluating stem cell therapies, which represents a new strategy for inner ear regeneration. To the best of our knowledge, this study is the first to demonstrate that local transplantation of labeled stem cells into the inner ear can be visualized in vivo via MRI. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Watada, Yukiko; Yamashita, Daisuke; Ogawa, Kaoru; Kanzaki, Sho] Keio Univ, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Tokyo 1608582, Japan; [Yamashita, Daisuke] Kobe Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kobe, Hyogo, Japan; [Toyoda, Masashi; Tsuchiya, Kohei; Hida, Naoko; Umezawa, Akihiro] Natl Inst Child Hlth & Dev, Dept Dept Reprod Biol, Tokyo, Japan; [Toyoda, Masashi; Hida, Naoko] Metropolitan Inst Gerontol, Res Team Vasc Med, Tokyo, Japan; [Tanimoto, Akihiro] Keio Univ, Sch Med, Dept Diagnost Radiol, Tokyo, Japan	Kanzaki, S (reprint author), Keio Univ, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	skan@a7.keio.jp			Ministry of Health, Labor, and Welfare in Japan [H16-008OK]; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [23592482]	We thank Dr. Kunio Mizutari for helping with the optimization of data acquisition. This work was supported by grants from the Ministry of Health, Labor, and Welfare in Japan (H16-008OK) and Grant-in-Aid for Scientific Research (C) (No. 23592482 to D.Y) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT).	Amsalem Y., 2007, CIRCULATION, V116, P138; Cotanche DA, 2010, HEARING RES, V266, P18, DOI 10.1016/j.heares.2010.04.012; Farrell E, 2008, BIOCHEM BIOPH RES CO, V369, P1076, DOI 10.1016/j.bbrc.2008.02.159; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Sykova E, 2007, PROG BRAIN RES, V161, P367, DOI 10.1016/S0079-6123(06)61026-1; Hsiao JK, 2007, MAGN RESON MED, V58, P717, DOI 10.1002/mrm.21377; Coleman B, 2006, CELL TRANSPLANT, V15, P369, DOI 10.3727/000000006783981819; Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Groves AK, 2010, EXP BIOL MED, V235, P434, DOI 10.1258/ebm.2009.009281; Matuszewski L, 2005, RADIOLOGY, V235, P155, DOI 10.1148/radiol.2351040094; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Hirose K, 2005, J COMP NEUROL, V489, P180, DOI 10.1002/cne.20619; Hu ZQ, 2005, EXP CELL RES, V302, P40, DOI 10.1016/j.yexer.2004.08.023; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005; Meyer AK, 2010, J NEUROL SCI, V289, P93, DOI 10.1016/j.jns.2009.08.024; Backhouse S, 2008, EXP NEUROL, V214, P193, DOI 10.1016/j.expneurol.2008.08.002; Bogaerts S, 2008, J NEUROSCI METH, V168, P156, DOI 10.1016/j.jneumeth.2007.09.016; Cicchetti F, 2007, CONTRAST MEDIA MOL I, V2, P130, DOI 10.1002/cmmi.138; Geraerts M, 2009, ADV BIOCHEM ENG BIOT, V114, P1, DOI 10.1007/10_2008_21; Guo J, 2011, APPL BIOCHEM BIOTECH, V163, P636, DOI 10.1007/s12010-010-9069-y; Hildebrand MS, 2005, JARO-J ASSOC RES OTO, V6, P341, DOI 10.1007/s10162-005-0012-9; Jeon SJ, 2007, MOL CELL NEUROSCI, V34, P59, DOI 10.1016/j.mcn.2006.10.003; Kamiya K, 2007, AM J PATHOL, V171, P214, DOI 10.2353/ajpath.2007.060948; Kanzaki S, 2007, AUDIOL NEURO-OTOL, V12, P119, DOI 10.1159/000097798; Kiessling Fabian, 2008, V185, P305; Okano T, 2008, J NEUROSCI RES, V86, P1758, DOI 10.1002/jnr.21625; Peng C., 2011, INT J CARDIOL, V162, P158; Sato E, 2008, J COMP NEUROL, V506, P930, DOI 10.1002/cne.21583; Takeda Y, 2004, J GENE MED, V6, P833, DOI 10.1002/jgm.583; Warchol ME, 1997, J NEUROBIOL, V33, P724, DOI 10.1002/(SICI)1097-4695(19971120)33:6<724::AID-NEU2>3.0.CO;2-B	32	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	JUN	2015	95						21	26		10.1016/j.neures.2015.01.010		6	Neurosciences	Neurosciences & Neurology	CI2MH	WOS:000354581200003		
J	Ichijo, H; Hamada, M; Takahashi, S; Kobayashi, M; Nagai, T; Toyama, T; Kawaguchi, M				Ichijo, Hiroyuki; Hamada, Michito; Takahashi, Satoru; Kobayashi, Makoto; Nagai, Takeharu; Toyama, Tomoko; Kawaguchi, Masahumi			Lateralization, maturation, and anteroposterior topography in the lateral habenula revealed by ZIF268/EGR1 immunoreactivity and labeling history of neuronal activity	NEUROSCIENCE RESEARCH			English	Article						Habenula; Fasciculus retroflexus; Asymmetry; Immediate-early gene; Stress	IN-VIVO; HELPLESS BEHAVIOR; MIDBRAIN TARGET; GENE-EXPRESSION; NEURAL CIRCUITS; RAT-BRAIN; C-FOS; ZEBRAFISH; EXPERIENCE; NUCLEI	We report habenular lateralization in a simple transgenic mouse model used for labeling a facet of neuronal activity history. A transgenic construct comprised of a ziP68/egrl immediate-early gene promoter and a gene for normal Venus fluorescent protein with a membrane tag converted promoter activity into long-life fluorescent proteins, which was thought to describe a facet of neuronal activity history by summing neuronal activity. In addition to mapping the immediate-early gene-immunopositive cells, this method helped demonstrate the functionality of the lateral habenular nucleus (LHb). During postnatal development, the LHb was activated between postnatal days 10 and 16. The water-immersion restraint stress also activated the LHb over a similar period. LHb activation was functionally lateralized, but had no directional bias at the population level. Moreover, the posterior LHb was activated in the early stage after the stress, while the anterior LHb was activated in the later stage. Our results indicate lateralization, maturation, and anteroposterior topography of the LHb during postnatal development and the stress response. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Ichijo, Hiroyuki; Kawaguchi, Masahumi] Toyama Univ, Dept Anat, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Ichijo, Hiroyuki; Hamada, Michito; Takahashi, Satoru; Toyama, Tomoko] Univ Tsukuba, Fac Med, Div Biomed Sci, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan; [Takahashi, Satoru] Univ Tsukuba, Fac Med, Div Biomed Sci, Lab Anim Resource Ctr, Tsukuba, Ibaraki 3058575, Japan; [Kobayashi, Makoto] Univ Tsukuba, Fac Med, Div Biomed Sci, Dept Mol & Dev Biol, Tsukuba, Ibaraki 3058575, Japan; [Nagai, Takeharu] Osaka Univ, Inst Sci & Ind Res, Ibaraki 5670047, Japan	Ichijo, H (reprint author), Toyama Univ, Dept Anat, Grad Sch Med & Pharmaceut Sci, Sugitani 2630, Toyama 9300194, Japan.	ichijo@med.u-toyama.ac.jp	Kobayashi, Makoto/B-2537-2008		Ministry of Education, Culture, Sports, Science, and Technology, Japan [21220009, 26640009, 13210021]; Tamura Science and Technology Foundation	We thank Dr. Y. Takeuchi for the discussion and Profs. H. Nishijo, and H. Mori for critically reading the manuscript. H.I. designed the project, constructed the transgenes, performed in vitro experiments, experiments on the transgenic mice, and wrote the manuscript. T.T. and M.K. performed the experiments on the transgenic mice. T.N. constructed the transgenes and performed the in vitro experiments. M.K. constructed the transgenes. M.H. and S.T. generated the transgenic mice. All authors discussed the results and commented on the manuscript. This work was supported by Grants-in-Aids for the 21st Century COE Program, Scientific Research on Priority Areas (C)-Advanced Brain Science Project (13210021), Scientific Research (S) (21220009), Challenging Exploratory Research (26640009) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and Grants-in-Aid from Tamura Science and Technology Foundation.	HERKENHAM M, 1977, J COMP NEUROL, V173, P123, DOI 10.1002/cne.901730107; Andres KH, 1999, J COMP NEUROL, V407, P130, DOI 10.1002/(SICI)1096-9861(19990428)407:1<130::AID-CNE10>3.0.CO;2-8; Barth AL, 2007, CURR OPIN NEUROBIOL, V17, P567, DOI 10.1016/j.conb.2007.10.003; Eguchi M, 2009, NEUROIMAGE, V44, P1274, DOI 10.1016/j.neuroimage.2008.10.046; Wilson Y, 2002, P NATL ACAD SCI USA, V99, P3252, DOI 10.1073/pnas.042701199; Miyashita T, 2009, J NEUROSCI, V29, P898, DOI 10.1523/JNEUROSCI.4588-08.2009; Stein I, 1998, MOL CELL BIOL, V18, P3112; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Aizawa H, 2012, J COMP NEUROL, V520, P4051, DOI 10.1002/cne.23167; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Okamoto H, 2012, DEV NEUROBIOL, V72, P386, DOI 10.1002/dneu.20913; Hooks BM, 2007, NEURON, V56, P312, DOI 10.1016/j.neuron.2007.10.003; Shumake J, 2003, BRAIN RES, V963, P274, DOI 10.1016/S0006-8993(02)04048-9; Lee A, 2010, CURR BIOL, V20, P2211, DOI 10.1016/j.cub.2010.11.025; Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Yamaguchi T, 2013, NEURON, V78, P537, DOI 10.1016/j.neuron.2013.02.035; WIRTSHAFTER D, 1994, BRAIN RES, V633, P21, DOI 10.1016/0006-8993(94)91517-2; BECK CHM, 1995, J NEUROSCI, V15, P709; Kim U, 2005, J COMP NEUROL, V483, P236, DOI 10.1002/cne.20410; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Concha ML, 2012, NAT REV NEUROSCI, V13, P832, DOI 10.1038/nrn3371; Aizawa H, 2007, DEV CELL, V12, P87, DOI 10.1016/j.devcel.2006.10.004; Arni S, 1998, J BIOL CHEM, V273, P28478, DOI 10.1074/jbc.273.43.28478; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Geisler S, 2003, J COMP NEUROL, V458, P78, DOI 10.1002/cne.10566; SANES DH, 1985, J NEUROSCI, V5, P1152; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046; Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; Kawashima T, 2013, NAT METHODS, V10, P889, DOI [10.1038/nmeth.2559, 10.1038/NMETH.2559]; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Bianco IH, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-9; Ichijo H, 1999, DEV BRAIN RES, V117, P199, DOI 10.1016/S0165-3806(99)00126-1; Ichijo H., 2014, ANAT SCI INT; Man PS, 2007, GENE EXPR PATTERNS, V7, P872, DOI 10.1016/j.modgep.2007.06.006; Mathuru Ajay S, 2013, Front Neural Circuits, V7, P99, DOI 10.3389/fncir.2013.00099; Miyata S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019859; Palmer A.R, 1994, DEV INSTABILITY ITS, P335; SAFFEN DW, 1988, P NATL ACAD SCI USA, V85, P7795, DOI 10.1073/pnas.85.20.7795; SAKAMOTO KM, 1991, ONCOGENE, V6, P867; Shnerson A, 1981, Brain Res, V254, P77; Slade JP, 2002, NEUROREPORT, V13, P671, DOI 10.1097/00001756-200204160-00027; WORLEY PF, 1993, J NEUROSCI, V13, P4776; Zangenehpour S, 2002, MOL BRAIN RES, V109, P221, DOI 10.1016/S0169-328X(02)00556-9	50	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	JUN	2015	95						27	37		10.1016/j.neures.2015.01.005		11	Neurosciences	Neurosciences & Neurology	CI2MH	WOS:000354581200004		
J	Yamaguchi, K				Yamaguchi, Ken'ichi			Evaluation for roles of neurosteroids in modulating forebrain mechanisms controlling vasopressin secretion and related phenomena in conscious rats	NEUROSCIENCE RESEARCH			English	Article						Anteroventral third ventricular; region (AV3V); Antidiuretic hormone; Gamma aminobutyric acid; Hyperosmolality; Hypovolemia; Neurosteroid	ESTROGEN-RECEPTOR-BETA; MEDIAN PREOPTIC NUCLEUS; CENTRAL-NERVOUS-SYSTEM; SUBFORNICAL ORGAN; GABA(A) RECEPTOR; LAMINA TERMINALIS; PARAVENTRICULAR NUCLEUS; STEROID-HORMONES; SOLITARY TRACT; MESSENGER-RNA	Anteroventral third ventricular region (AV3V) that regulates autonomic functions through a GABAergic mechanism possesses neuroactive steroid (NS)-synthesizing ability. Although NS can exert effects by acting on a certain type of GABA(A)-receptor (R), it is not clear whether NS may operate to modulate AV3V GABAergic activity for controlling autonomic functions. This study aimed to investigate the issue. AV3V infusion with a GABA(A) antagonist bicuculline increased plasma vasopressin (AVP), glucose, blood pressure (BP), and heart rate in rats. These events were abolished by preinjecting its agonist muscimol, whereas the infusion with allopregnanolone, a NS capable of potentiating GABA(A)-R function, affected none of the variables in the absence or presence of such bicuculline actions. Similarly, AV3V infusion with pregnanolone sulfate, a NS capable of antagonizing GABA(A)-R, produced no effect on those variables. AV3V infusion with muscimol was effective in inhibiting the responses of plasma AVP or glucose, or BP to an osmotic loading or bleeding. However, AV3V infusion with aminoglutethimide, a NS synthesis inhibitor, did not affect any of the variables in the absence or presence of those stimuli. These results suggest that NS may not cause acute effects on the AV3V GABAergic mechanism involved in regulating AVP release and other autonomic function. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Yamaguchi, Ken'ichi] Niigata Univ, Dept Homeostat Regulat & Dev, Grad Sch Med & Dent Sci, Niigata, Niigata 9518510, Japan	Yamaguchi, K (reprint author), Niigata Univ, Dept Homeostat Regulat & Dev, Grad Sch Med & Dent Sci, Chuo Ku, Asahimachi Dori 1-757, Niigata, Niigata 9518510, Japan.	kenbo@med.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [21590252]	The author thanks Drs. Kanemitsu Yamaya (Oyokyo Kidney Institute, Hirosaki), Takaho Yamada (Niigata University, Niigata), and Mamoru Koike (Kido Hospital, Niigata) for assistance and advice. This work was supported by a Grant-in-Aid for Scientific Research (C) (Project No. 21590252) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to KY.	Akaishi T, 1996, NEUROSCI LETT, V202, P153, DOI 10.1016/0304-3940(95)12228-1; AKWA Y, 1991, J STEROID BIOCHEM, V40, P71, DOI 10.1016/0960-0760(91)90169-6; Akwa Y, 1999, BEHAV BRAIN RES, V106, P119, DOI 10.1016/S0166-4328(99)00101-1; Somponpun SJ, 2004, AM J PHYSIOL-REG I, V287, pR661, DOI 10.1152/ajpregu.00136.2004; PUIA G, 1990, NEURON, V4, P759, DOI 10.1016/0896-6273(90)90202-Q; YANG CR, 1994, J PHYSIOL-LONDON, V477, P59; Pinna G, 2008, NEUROCHEM RES, V33, P1990, DOI 10.1007/s11064-008-9718-5; MAJEWSKA MD, 1988, NEUROSCI LETT, V90, P279, DOI 10.1016/0304-3940(88)90202-9; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; Sasso O, 2010, EUR NEUROPSYCHOPHARM, V20, P195, DOI 10.1016/j.euroneuro.2009.09.003; LEHMANN A, 1989, J NEUROCHEM, V53, P525, DOI 10.1111/j.1471-4159.1989.tb07365.x; MYERS RD, 1966, PHYSIOL BEHAV, V1, P171, DOI 10.1016/0031-9384(66)90064-3; Nunn N, 2011, CURR NEUROPHARMACOL, V9, P262, DOI 10.2174/157015911795596531; BOWERY NG, 1993, ANNU REV PHARMACOL, V33, P109; Mitchell EA, 2008, NEUROCHEM INT, V52, P588, DOI 10.1016/j.neuint.2007.10.007; Zinder O, 1999, ACTA PHYSIOL SCAND, V167, P181; Somponpun SJ, 2004, J NEUROENDOCRINOL, V16, P544, DOI 10.1111/j.1365-2826.2004.01200.x; Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1; McKinley MJ, 2003, ADV ANAT EMBRYOL CEL, V172, P1; Sakamoto H, 2001, J NEUROSCI, V21, P6221; Barnard EA, 1998, PHARMACOL REV, V50, P291; Kimoto T, 2001, ENDOCRINOLOGY, V142, P3578, DOI 10.1210/en.142.8.3578; Puia G, 2003, NEUROPHARMACOLOGY, V44, P49, DOI 10.1016/S0028-3908(02)00341-6; Tanaka M, 2012, NEUROPHARMACOLOGY, V62, P2373, DOI 10.1016/j.neuropharm.2012.02.007; Sladek CD, 2008, FRONT NEUROENDOCRIN, V29, P114, DOI 10.1016/j.yfrne.2007.08.005; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Agis-Balboa RC, 2006, P NATL ACAD SCI USA, V103, P14602, DOI 10.1073/pnas.0606544103; SAPER CB, 1983, BRAIN RES, V288, P21, DOI 10.1016/0006-8993(83)90078-1; CHENEY DL, 1995, J NEUROSCI, V15, P4641; Somponpun SJ, 2003, J NEUROSCI, V23, P4261; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Agis-Balboa RC, 2007, P NATL ACAD SCI USA, V104, P18736, DOI 10.1073/pnas.0709419104; Shibuya K, 2003, BBA-GEN SUBJECTS, V1619, P301, DOI 10.1016/S0304-4165(02)00489-0; HARRISON NL, 1987, J PHARMACOL EXP THER, V241, P346; Mody I, 2008, NEUROCHEM INT, V52, P60, DOI 10.1016/j.neuint.2007.07.010; BEALER SL, 1983, AM J PHYSIOL, V245, pR901; BRIAND R, 1989, AM J PHYSIOL, V257, pR317; CIRIELLO J, 1984, BRAIN RES, V292, P221, DOI 10.1016/0006-8993(84)90758-3; Cooper J.R., 2003, BIOCH BASIS NEUROPHA; Czlonkowska AI, 2000, PHARMACOL BIOCHEM BE, V67, P345, DOI 10.1016/S0091-3057(00)00369-5; FEUERSTEIN G, 1984, AM J PHYSIOL, V246, pR551; FOSTER AB, 1983, J MED CHEM, V26, P50, DOI 10.1021/jm00355a011; Greenstein B., 2000, COLOR ATLAS NEUROSCI; Grob M, 2003, NEUROSCIENCE, V122, P247, DOI 10.1016/S0306-4522(03)00608-0; Haage D, 2002, BRAIN RES, V958, P405, DOI 10.1016/S0006-8993(02)03704-6; HEAD GA, 1987, AM J PHYSIOL, V253, pH1012; HORN T, 1995, J NEUROCHEM, V64, P1632; IITAKE K, 1986, AM J PHYSIOL, V251, pE146; IWASAKI Y, 1993, J CLIN INVEST, V92, P2230, DOI 10.1172/JCI116826; JOHNSON AK, 1985, BRAIN RES BULL, V15, P595, DOI 10.1016/0361-9230(85)90209-6; KANNAN H, 1986, BRAIN RES, V376, P342, DOI 10.1016/0006-8993(86)90197-6; Kawata M, 1995, NEUROSCI RES, V24, P1, DOI 10.1016/0168-0102(96)81278-8; KNEPEL W, 1980, PFLUG ARCH EUR J PHY, V388, P177, DOI 10.1007/BF00584125; Kolaj M, 2004, J NEUROPHYSIOL, V92, P111, DOI 10.1152/jn.00014.2004; LEGOASCOGNE C, 1987, SCIENCE, V237, P1212, DOI 10.1126/science.3306919; Li X, 1997, NEUROENDOCRINOLOGY, V66, P63, DOI 10.1159/000127221; MAJEWSKA MD, 1989, PHARMACOL BIOCHEM BE, V33, P701, DOI 10.1016/0091-3057(89)90410-3; Matsumoto K, 2007, STRESS, V10, P3, DOI 10.1080/10253890701200997; MCEWEN BS, 1991, TRENDS PHARMACOL SCI, V12, P141, DOI 10.1016/0165-6147(91)90531-V; MIENVILLE JM, 1989, BRAIN RES, V489, P190, DOI 10.1016/0006-8993(89)90024-3; MYERS RD, 1971, PHYSIOL BEHAV, V7, P743, DOI 10.1016/0031-9384(71)90143-0; NISSEN R, 1994, J PHYSIOL-LONDON, V479, P207; Paxinos G, 1998, RAT BRAIN STEREOTAXI; Pinna G, 2000, NEUROPHARMACOLOGY, V39, P440, DOI 10.1016/S0028-3908(99)00149-5; PUIA G, 1991, MOL PHARMACOL, V39, P691; RENZI A, 1993, J DENT RES, V72, P1481, DOI 10.1177/00220345930720110401; Rodovalho GV, 2006, NEUROCHEM RES, V31, P259, DOI 10.1007/s11064-005-9015-5; Sasso O, 2012, PAIN, V153, P33, DOI 10.1016/j.pain.2011.08.010; Segra T., 1989, BRAIN RES, V499, P53; Shughrue PJ, 1996, STEROIDS, V61, P678, DOI 10.1016/S0039-128X(96)00222-X; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Sladek CD, 2000, EXP PHYSIOL, V85, p171S, DOI 10.1111/j.1469-445X.2000.tb00021.x; Steil B.M., 2003, P NATL ACAD SCI USA, V100, P14439; TANAKA J, 1988, NEUROSCI LETT, V89, P152, DOI 10.1016/0304-3940(88)90372-2; TANAKA J, 1992, NEUROREPORT, V3, P946, DOI 10.1097/00001756-199210000-00033; Tsutsui K, 1999, INT J MOL MED, V4, P49; Tsutsui K., 2003, JAP J REPROD ENDOCRI, V8, P19; Uchida S, 2002, AM J PHYSIOL-ENDOC M, V283, pE1257, DOI 10.1152/ajpendo.00049.2002; Ushigome A, 2004, NEUROCHEM INT, V44, P139, DOI 10.1016/S0197-0186(03)00134-7; USUI M, 1995, BRAIN RES, V678, P10; Vizi ES, 2006, CURR TOP MED CHEM, V6, P941, DOI 10.2174/156802606777323782; Yamaguchi K, 2006, BRAIN RES BULL, V71, P183, DOI 10.1016/j.brainresbull.2006.09.002; Yamaguchi K, 2008, BRAIN RES BULL, V77, P61, DOI 10.1016/j.brainresbull.2008.04.009; YAMAGUCHI K, 1981, ACTA ENDOCRINOL-COP, V97, P137; Yamaguchi K, 1998, EUR J ENDOCRINOL, V138, P206, DOI 10.1530/eje.0.1380206; YAMAGUCHI KI, 1985, AM J PHYSIOL, V248, pR249; Yamaguchi K, 2011, ENDOCR J, V58, P559; YURI K, 1994, NEUROSCI RES, V21, P135, DOI 10.1016/0168-0102(94)90155-4; ZARDETTOSMITH AM, 1987, NEUROSCI LETT, V80, P163, DOI 10.1016/0304-3940(87)90647-1	90	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	JUN	2015	95						38	50		10.1016/j.neures.2015.01.002		13	Neurosciences	Neurosciences & Neurology	CI2MH	WOS:000354581200005		
J	Iwasaki, S; Sakaguchi, T; Ikegaya, Y				Iwasaki, Satoshi; Sakaguchi, Tetsuya; Ikegaya, Yuji			Brief fear preexposure facilitates subsequent fear conditioning	NEUROSCIENCE RESEARCH			English	Article						Fear conditioning; Post traumatic stress disorder; N-methyl-D-aspartate receptor; Trauma; Mouse	POSTTRAUMATIC-STRESS-DISORDER; D-ASPARTATE RECEPTOR; BASOLATERAL AMYGDALA; ANIMAL-MODEL; ACQUISITION; EXPRESSION; RATS; CORTICOSTERONE; METAANALYSIS; ENHANCEMENT	Post-traumatic stress disorder (PTSD) is an anxiety disorder that occurs following an unexpected exposure to a severe psychological event. A history of a brief trauma is reported to affect a risk for future PTSD development; however, little is known about the mechanisms by which a previous trauma exposure drives the sensitivity to a late-coming trauma. Using a mouse PTSD model, we found that a prior foot shock enhances contextual fear conditioning. This shock-induced facilitation of fear conditioning (i.e., priming effect) persisted for 7 days and was prevented by MK801, an N-methyl-D-aspartate receptor antagonist. Other types of trauma, such as forced swimming or tail pinch, did not induce a priming effect on fear conditioning. Thus, a trauma is unlikely generalized to modify the sensitivity to other traumatic experiences. The behavioral procedure employed in this study may be a useful tool to elucidate the etiology of PTSD. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Iwasaki, Satoshi; Sakaguchi, Tetsuya; Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Ikegaya, Yuji] Ctr Informat & Neural Networks, Suita, Osaka 5650835, Japan	Ikegaya, Y (reprint author), Univ Tokyo, Chem Pharmacol Lab, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ikegaya@mol.f.u-tokyo.ac.jp			 [22115003];  [25119004];  [26250003]	This work was supported by supported by Grants-in-Aid for Science Research on Innovative Areas (22115003; 25119004; 26250003).	Al-Amin HA, 2003, BRAIN RES, V981, P99, DOI 10.1016/S0006-8993(03)02988-3; Anisman H, 1998, Stress, V2, P209; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Cordero MI, 2003, HORM BEHAV, V44, P338, DOI 10.1016/S0018-506X(03)00160-0; Rau V, 2009, STRESS, V12, P125, DOI 10.1080/10253890802137320; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; CAMPEAU S, 1992, BEHAV NEUROSCI, V106, P569, DOI 10.1037/0735-7044.106.3.569; Schmidt AP, 2009, PHARMACOL BIOCHEM BE, V91, P549, DOI 10.1016/j.pbb.2008.09.009; Gould TJ, 2002, BEHAV PHARMACOL, V13, P287; Rau V, 2005, NEUROSCI BIOBEHAV R, V29, P1207, DOI 10.1016/j.neubiorev.2005.04.010; Fisher K, 2000, J PAIN SYMPTOM MANAG, V20, P358, DOI 10.1016/S0885-3924(00)00213-X; Manzanares PAR, 2005, J NEUROSCI, V25, P8725, DOI 10.1523/JNEUROSCI.2260-05.2005; Duvarci S, 2007, J NEUROSCI, V27, P4482, DOI 10.1523/JNEUROSCI.0680-07.2007; SHORS TJ, 1992, SCIENCE, V257, P537, DOI 10.1126/science.1636089; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Ishikawa D, 2014, J NEUROSCI, V34, P5044, DOI 10.1523/JNEUROSCI.5298-13.2014; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; SHANKS N, 1990, PHARMACOL BIOCHEM BE, V36, P515, DOI 10.1016/0091-3057(90)90249-H; FANSELOW MS, 1979, J COMP PHYSIOL PSYCH, V93, P736, DOI 10.1037/h0077609; DSM-V, 2013, DIAGN STAT MAN VERS; Goosens KA, 2004, EUR J NEUROSCI, V20, P537, DOI 10.1111/j.1460-9568.2004.03513.x; Kumakura K, 2010, NEUROSCI RES, V66, P313, DOI 10.1016/j.neures.2009.12.003; Landeira-Fernandez J, 2006, BEHAV NEUROSCI, V120, P873, DOI 10.1037/0735-7044.120.4.873; Sakaguchi T, 2012, NEUROREPORT, V23, P457, DOI 10.1097/WNR.0b013e32835375b6	25	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	JUN	2015	95						66	73		10.1016/j.neures.2015.02.001		8	Neurosciences	Neurosciences & Neurology	CI2MH	WOS:000354581200008		
J	Tabu, H; Aso, T; Matsuhashi, M; Ueki, Y; Takahashi, R; Fukuyama, H; Shibasaki, H; Mima, T				Tabu, Hayato; Aso, Toshihiko; Matsuhashi, Masao; Ueki, Yoshino; Takahashi, Ryosuke; Fukuyama, Hidenao; Shibasaki, Hiroshi; Mima, Tatsuya			Parkinson's disease patients showed delayed awareness of motor intention	NEUROSCIENCE RESEARCH			English	Article						Parkinson disease; Motor intention; Libet clock task	EVENT-RELATED FMRI; TEMPORAL DISCRIMINATION; CORTEX; MOVEMENT; READINESS; LEVODOPA; PET; POTENTIALS; PREMOTOR; INPUTS	Although dopamine plays an important role for motor control and modulates the frontal function via basal ganglia-thalamo-cortical loop, it is not known whether dopamine can affect the awareness of motor intention or not. To test this hypothesis, we applied Libet's clock paradigm to Parkinson's disease (PD) patients. Thirteen PD patients and 13 age-matched, healthy controls took part in the experiment which consisted of three judgment paradigms: W, M and S judgment. In W and M judgments, subjects were asked to press the key at self-willed timing. In W judgment, subjects reported the location of the clock's hand when they became aware of the intention (W-time). In M judgment, subjects reported the time when they became aware of the actual movement (M-time). In S judgment, subjects reported the time of the electrical stimulation given to their hand (S-time). W-time was significantly shorter in PD patients than in healthy control subjects while M-time and S-time were not different between the two groups. Delayed awareness of motor intention but not of action in PD patients might be related to dopamine depletion in those patients. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Tabu, Hayato] Kitano Res Ctr Mental Neurol Sensory & Motor Orga, Osaka 5308480, Japan; [Tabu, Hayato; Aso, Toshihiko; Matsuhashi, Masao; Ueki, Yoshino; Fukuyama, Hidenao; Shibasaki, Hiroshi; Mima, Tatsuya] Kyoto Univ, Human Brain Res Ctr, Grad Sch Med, Kyoto 6068507, Japan; [Tabu, Hayato; Takahashi, Ryosuke; Shibasaki, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto 6068507, Japan; [Ueki, Yoshino] Nagoya City Univ, Grad Sch Med Sci, Dept Neurol & Neurosci, Nagoya, Aichi 4678602, Japan; [Shibasaki, Hiroshi] Kyoto Univ, Emeritus Prof Dept Neurol, Grad Sch Med, Kyoto 6068507, Japan	Mima, T (reprint author), Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Sakyo Ku, Kawahara Cho 54, Kyoto 6068507, Japan.	mima@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science [24300192]	This study was partly supported by Grant-in-Aid for Scientific Research (B) 24300192 (to T.M.) from the Japan Society for the Promotion of Science.	HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; Samuel M, 1997, BRAIN, V120, P963, DOI 10.1093/brain/120.6.963; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; DEECKE L, 1978, BRAIN RES, V159, P473, DOI 10.1016/0006-8993(78)90561-9; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; ARTIEDA J, 1992, BRAIN, V115, P199, DOI 10.1093/brain/115.1.199; Shibasaki H, 2012, CLIN NEUROPHYSIOL, V123, P229, DOI 10.1016/j.clinph.2011.07.042; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; Fox SH, 2009, MOVEMENT DISORD, V24, P1255, DOI 10.1002/mds.22473; Sirigu A, 2004, NAT NEUROSCI, V7, P80, DOI 10.1038/nn1160; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Cunnington R, 2003, NEUROIMAGE, V20, P404, DOI 10.1016/S1053-8119(03)00291-X; Buhmann C, 2003, BRAIN, V126, P451, DOI 10.1093/brain/awg033; SCHELL GR, 1984, J NEUROSCI, V4, P539; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047; DICK JPR, 1989, BRAIN, V112, P233, DOI 10.1093/brain/112.1.233; Kehagia AA, 2010, LANCET NEUROL, V9, P1200, DOI 10.1016/S1474-4422(10)70212-X; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Brooks DJ, 2010, MOVEMENT DISORD, V25, pS83, DOI 10.1002/mds.22720; DICK JPR, 1987, ELECTROEN CLIN NEURO, V66, P263, DOI 10.1016/0013-4694(87)90075-7; Fiorio M, 2007, NEUROSCI LETT, V417, P312, DOI 10.1016/j.neulet.2007.02.050; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; LIBET B, 1982, ELECTROEN CLIN NEURO, V54, P322, DOI 10.1016/0013-4694(82)90181-X; ROUILLER EM, 1994, J COMP NEUROL, V345, P185, DOI 10.1002/cne.903450204; Sakai ST, 1999, ANAT EMBRYOL, V199, P9, DOI 10.1007/s004290050204; Tinaz S., 2010, MOVEMENT DISORD, V26, P436; Torta DME, 2010, J NEUROL, V257, P1356, DOI 10.1007/s00415-010-5532-5; WIESENDANGER R, 1985, EXP BRAIN RES, V59, P91; Zgaljardic Dennis J, 2003, Cogn Behav Neurol, V16, P193, DOI 10.1097/00146965-200312000-00001	36	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	JUN	2015	95						74	77		10.1016/j.neures.2015.01.012		4	Neurosciences	Neurosciences & Neurology	CI2MH	WOS:000354581200009		
J	Kobayashi, M; Nishii, R; Shikano, N; Flores, LG; Mizutani, A; Ogai, K; Sugama, J; Nagamachi, S; Kawai, K				Kobayashi, Masato; Nishii, Ryuichi; Shikano, Naoto; Flores, Leo G.; Mizutani, Asuka; Ogai, Kazuhiro; Sugama, Jyunko; Nagamachi, Shigeki; Kawai, Keiichi			Development of radioiodine-labeled 4-hydroxyphenylcysteamine for specific diagnosis of malignant melanoma	NUCLEAR MEDICINE AND BIOLOGY			English	Article						Malignant melanoma; Radioiodine; SPECT imaging; Tyrosinase; 4-hydroxyphenylcysteamine	IN-VITRO; 4-S-CYSTEAMINYLPHENOL; TRANSPORT; CELLS; TYROSINASE; MECHANISM; ANALOGS	Introduction: A specific diagnosis for melanoma is strongly desired because malignant melanoma has poor prognosis. In a previous study, although radioiodine-125-labeled 4-hydroxyphenyl-L-cysteine (I-125-L-PC) was found to have good substrate affinity for tyrosinase enzyme in the melanin metabolic pathway, 1231131 I-L-PC had insufficient substrate affinity for tyrosinase to diagnose melanoma. In this study, we synthesized 4-hydroxyphenylcysteamine (4-PCA) and developed a novel radioiodine-125-labeled 4-hydroxyphenylcysteamine (I-125-PCA) to increase affinity for the melanin biosynthesis pathway. Methods: 4-PCA was separated with 2-hydroxyphenylcysteamine (2-PCA), which is an isomer of 4-PCA, and was examined using melting point, proton nuclear magnetic resonance, mass spectrometry and elemental analysis. I-125-PCA was prepared using the chloramine-T method under no-carrier added conditions. We performed biodistribution experiments using B16 melanoma-bearing mice using I-125-PCA, I-125-L-pc, I-125-alpha-methyl-L-tyrosine, I-123-m-iodobenzylguanidine and Ga-67-citrate. In vitro assay was performed with B16 melanoma cells, and affinity for tyrosinase, DNA polymerase and amino acid transport was evaluated using phenylthiourea, thymidine, ouabine and L-tyrosine inhibitor. In addition, partition coefficients of I-125-PCA were evaluated. Results: In the synthesis of 4-PCA, analysis values did not differ between calculated and reported values, and 4-PCA was separated from 2-PCA at high purity. In biodistribution experiments, I-125-PCA was accumulated and retained in B16 melanoma cells when compared with 125I-L-PC. I-125-PCA showed the highest values at 60 min after radiotracer injection in melanoma-to-muscle ratios, melanoma-to-blood ratios and melanoma-to-skin ratios. Accumulation of I-125-PCA was significantly inhibited by phenylthiourea and thymidine. Partition coefficients of I-125-PCA were lower than those of N-isopropyl-p-[I-123]iodoamphetamine and were not significantly different from 125I-L-PC. Conclusions: I-125-PCA is a better substrate for tyrosinase and DNA polymerase and has higher uptake and longer retention in B16 melanoma cells when compared with 125I-L-PC. Therefore, I-123/131-PCA has good potential for diagnosis for malignant melanoma. Advance in Knowledge: I-125-PCA will be a specific diagnosis tool for malignant melanoma. Implications for Patient Care: I-123/131-PCA has good potential for the diagnosis of malignant melanoma when compared with other SPECT tracers, as well as anti-melanoma chemotherapeutic drugs. (C) 2015 Elsevier Inc. All rights reserved.	[Kobayashi, Masato; Ogai, Kazuhiro; Sugama, Jyunko] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Wellness Promot Sci Ctr, Kanazawa, Ishikawa 9200942, Japan; [Nishii, Ryuichi; Nagamachi, Shigeki] Miyazaki Univ, Dept Radiol, Fac Med, Miyazaki, Miyazaki 8891692, Japan; [Shikano, Naoto] Ibaraki Prefectural Univ Hlth Sci, Dept Radiol Sci, Ibaraki, Japan; [Flores, Leo G.; Kawai, Keiichi] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA; [Mizutani, Asuka] Kanazawa Univ, Sch Hlth Sci, Coll Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan	Kobayashi, M (reprint author), Miyazaki Univ, Dept Radiol, Fac Med, 5200 Kihara,Kiyotake Cho, Miyazaki, Miyazaki 8891692, Japan.	kobayasi@mhs.mp.kanazawa-u.ac.jp			Japan Society for the Promotion of Science [24601008, 24659558]; Nakayama Foundation for Human Science	This study was partly funded by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (24601008, 24659558) and the Nakayama Foundation for Human Science.	ALENA F, 1994, CANCER RES, V54, P2661; Bastiaannet E, 2009, J CLIN ONCOL, V27, P4774, DOI 10.1200/JCO.2008.20.1822; Gili A, 2000, MELANOMA RES, V10, P9, DOI 10.1097/00008390-200010010-00002; ITO S, 1981, J MED CHEM, V24, P673, DOI 10.1021/jm00138a006; ITO S, 1987, BIOCHEM PHARMACOL, V36, P2007; JIMBOW K, 1993, J INVEST DERMATOL, V100, pS231, DOI 10.1038/jid.1993.41; JIMBOW K, 1989, PIGM CELL RES, V2, P34, DOI 10.1111/j.1600-0749.1989.tb00155.x; KAWAI K, 1991, J NUCL MED, V32, P819; KLOSTER G, 1982, INT J NUCL MED BIOL, V9, P259, DOI 10.1016/0047-0740(82)90086-9; Kobayashi M, 2012, NUCL MED BIOL, V39, P1213, DOI 10.1016/j.nucmedbio.2012.06.006; MIURA S, 1987, ARCH DERMATOL RES, V279, P219, DOI 10.1007/BF00417318; Nishii R, 2003, NUCL MED COMMUN, V24, P575, DOI 10.1097/01.mnh.0000071254.54690.86; OSEIBONSU A, 1989, EUR J NUCL MED, V15, P629; PANKOVICH JM, 1990, PIGM CELL RES, V3, P146, DOI 10.1111/j.1600-0749.1990.tb00279.x; PANKOVICH JM, 1991, BIOCHEM J, V280, P721; PAWELEK JM, 1976, J INVEST DERMATOL, V66, P201, DOI 10.1111/1523-1747.ep12482134; Tandon M, 1998, BIOCHEM PHARMACOL, V55, P2023, DOI 10.1016/S0006-2952(98)00090-2; YAMADA I, 1991, BRIT J CANCER, V63, P187, DOI 10.1038/bjc.1991.46	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0969-8051	1872-9614		NUCL MED BIOL	Nucl. Med. Biol.	JUN	2015	42	6					536	540		10.1016/j.nucmedbio.2015.02.004		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI3QM	WOS:000354662500004		
J	Nozawa, A; Rivandi, AH; Kanematsu, M; Hoshi, H; Piccioni, D; Kesari, S; Hoh, CK				Nozawa, Asae; Rivandi, Ali Hosseini; Kanematsu, Masayuki; Hoshi, Hiroaki; Piccioni, David; Kesari, Santosh; Hoh, Carl K.			Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes	NUCLEAR MEDICINE COMMUNICATIONS			English	Article						fluorine-18 fluorodeoxyglucose; glucose-corrected standardized uptake value; high-grade glioma; PET	F-18-FDG PET; BRAIN-TUMORS; FDG-PET; ADJUVANT TEMOZOLOMIDE; RECURRENCE; PERFUSION; HISTOPATHOLOGY; GLIOBLASTOMA; RADIOTHERAPY; DELINEATION	BackgroundStandardized uptake values (SUVs) of fluorine-18 fluorodeoxyglucose PET (F-18-FDG PET) are used widely to differentiate residual or recurrent high-grade gliomas from post-treatment changes in patients with brain tumors. The aim of this study is to assess the accuracy of SUV corrected by blood glucose level (SUVgluc) compared with various quantitative methods in this role.Materials and methodsIn 55 patients with dynamic F-18-FDG PET scans, there were 97 glioma lesions: glioblastoma (n=60), grade III gliomas (n=22), grade III or IV gliomas (n=6), grade I/II (n=7), and prebiopsy lesions (n=2). The final actual diagnosis was made on the basis of pathology (n=33) and clinical outcome (n=64). Dynamic F-18-FDG PET scans were processed to generate parametric images of SUVgluc, SUVmax, and glucose metabolic rate (GMR). Lesion to cerebellum ratios (SUVRc) and contralateral white matter ratios (SUVRw) were also measured. The SUVgluc was calculated as SUV(max)xblood glucose level/100.ResultsUsing the thresholds of SUVmax>4.6, SUVRc>0.9, SUVRw>1.8, SUVgluc>4.3, and GMR>12.2mol/min/100g to represent positivity for viable tumors, the accuracies were the same for the SUVgluc and SUVRw (80%) and were higher than the conventional SUVmax (72%). The area under the receiver operating characteristic curve for the SUVgluc (0.8933) was better than that for the SUVmax (0.8266) (P<0.01) and was similar to those of the GMR (0.8622), SUVRc (0.8606), and SUVRw (0.8981).ConclusionThese results suggest that SUVgluc may aid in the differentiation of residual or recurrent high-grade tumor from post-treatment changes in patients with abnormal blood glucose levels. The simplicity of the SUVgluc avoids the complexity of kinetic analysis or the requirement of a reference tissue.	[Nozawa, Asae; Rivandi, Ali Hosseini; Hoh, Carl K.] Univ Calif San Diego, Dept Radiol, La Jolla, CA USA; [Piccioni, David; Kesari, Santosh] Univ Calif San Diego, Dept Neurosci, La Jolla, CA USA; [Piccioni, David; Kesari, Santosh] UC San Diego Hlth Syst, Translat Neurooncol Labs, Moores Canc Ctr, La Jolla, CA USA; [Nozawa, Asae] Gifu Univ, Dept Diagnost Radiol, Gifu Prefectural Gen Med Ctr, Gifu, Japan; [Nozawa, Asae; Kanematsu, Masayuki; Hoshi, Hiroaki] Gifu Univ, Dept Radiol, Gifu, Japan	Hoh, CK (reprint author), Univ Calif San Diego, Med Ctr, 200W Arbor Dr, San Diego, CA 92103 USA.	ckhoh@ucsd.edu			Wagner Torizuka Fellowship Program; Gifu Prefectural General Medical Center; National Institutes of Health [NIH3P30CA023100-25S8]; UC San Diego Brain Cancer Research Funds	This research was supported in part by the Wagner Torizuka Fellowship Program and Gifu Prefectural General Medical Center to A. Nozawa and by grants from National Institutes of Health (NIH3P30CA023100-25S8) and from UC San Diego Brain Cancer Research Funds to S. Kesari.	Bobek-Billewicz B, 2010, FOLIA NEUROPATHOL, V48, P81; Barajas RF, 2009, RADIOLOGY, V253, P486, DOI 10.1148/radiol.2532090007; DELBEKE D, 1995, RADIOLOGY, V195, P47; ISHIZU K, 1994, J NUCL MED, V35, P1104; Dhermain FG, 2010, LANCET NEUROL, V9, P906, DOI 10.1016/S1474-4422(10)70181-2; Hustinx R, 1999, EUR J NUCL MED, V26, P1501, DOI 10.1007/s002590050487; Fink J, 2011, CURR TREAT OPTION ON, V12, P240, DOI 10.1007/s11864-011-0157-1; Barker FG, 1997, CANCER, V79, P115, DOI 10.1002/(SICI)1097-0142(19970101)79:1<115::AID-CNCR17>3.0.CO;2-7; Kosaka N, 2008, AM J ROENTGENOL, V190, pW365, DOI 10.2214/AJR.07.2660; Brandsma D, 2009, CURR OPIN NEUROL, V22, P633, DOI 10.1097/WCO.0b013e328332363e; Goldman S, 1996, CANCER, V78, P1098, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1098::AID-CNCR21>3.3.CO;2-A; Varrone A, 2009, EUR J NUCL MED MOL I, V36, P2103, DOI 10.1007/s00259-009-1264-0; Prieto E, 2011, J NUCL MED, V52, P865, DOI 10.2967/jnumed.110.085324; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Hu LS, 2009, AM J NEURORADIOL, V30, P552, DOI 10.3174/ajnr.A1377; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; Yang I, 2010, NEUROSURG CLIN N AM, V21, P181, DOI 10.1016/j.nec.2009.08.003; Kim YH, 2010, CLIN NEUROL NEUROSUR, V112, P758, DOI 10.1016/j.clineuro.2010.06.005; Habibollahi P, 2013, J NUCL MED, V54, P252, DOI 10.2967/jnumed.112.107011; Soritau O, 2011, J BUON, V16, P282; Bahar Dasgeb ES, 2007, J NUCL MED S2, V48, p184P; Boellaard R, 2009, J NUCL MED S1, V50, P11, DOI DOI 10.2967/JNUMED.108.057182; Britz-Cunningham SH, 2008, CLIN NUCL MED, V33, P681, DOI 10.1097/RLU.0b013e318184b435; Gao LB, 2013, NEUROREPORT, V24, P504, DOI 10.1097/WNR.0b013e32836277fb; Kimura N, 2009, NUCL MED COMMUN, V30, P602, DOI 10.1097/MNM.0b013e32832e1c7d; Lee SM, 2011, CLIN NUCL MED, V36, P331, DOI 10.1097/RLU.0b013e31820a9eea; Nozawa A, 2013, EUR J NUCL MED MOL I, V40, P997, DOI 10.1007/s00259-013-2396-9; Schiepers C, 1999, P SOC PHOTO-OPT INS, V3661, P1343, DOI 10.1117/12.348532; Tezcan Y, 2011, RADIOL ONCOL, V45, P213, DOI 10.2478/v10019-011-0019-2; Wu H, 2001, EUR J NUCL MED, V28, P704, DOI 10.1007/s002590100511; Wu Hsiao-Ming, 2003, Mol Imaging Biol, V5, P32, DOI 10.1016/S1536-1632(02)00122-1	31	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0143-3636	1473-5628		NUCL MED COMMUN	Nucl. Med. Commun.	JUN	2015	36	6					573	581		10.1097/MNM.0000000000000288		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH8RQ	WOS:000354304200005		
J	Kubota, S; Inaba, Y; Kobayashi, N; Tateishi, U; Ike, H; Inoue, T; Saito, T				Kubota, So; Inaba, Yutaka; Kobayashi, Naomi; Tateishi, Ukihide; Ike, Hiroyuki; Inoue, Tomio; Saito, Tomoyuki			Prediction of femoral head collapse in osteonecrosis using F-18-fluoride positron emission tomography	NUCLEAR MEDICINE COMMUNICATIONS			English	Article						F-18-fluoride positron emission tomography; femoral head collapse; osteonecrosis; prediction	TRANSTROCHANTERIC ROTATIONAL OSTEOTOMY; NONTRAUMATIC OSTEONECROSIS; BONE-SCINTIGRAPHY; NECROSIS; LESION; MRI; HIP; PET	ObjectiveWe investigated the usefulness of F-18-fluoride PET as a predictor of femoral head collapse in patients with osteonecrosis (ON) before radiographic changes occur.Patients and methodsSixty-six hips of 42 patients diagnosed with ON of the femoral head were included in this study. We evaluated the relationship between the maximum standardized uptake value (SUVmax) in F-18-fluoride PET and the Ficat classification. We evaluated the relationship between SUVmax and the presence of femoral head collapse on plain radiography at 12 months after F-18-fluoride PET in 23 hips of 18 patients with Ficat classification stage 1 or 2. A receiver operating characteristic analysis was carried out to calculate the cut-off SUVmax for the prediction of femoral head collapse. We analyzed the relationship between SUVmax and femoral head collapse on plain radiography in the 23 hips using a logistic regression model.ResultsSUV(max) increased according to the progression of the Ficat classification stage. The mean SUVmax was 12.35.9 in the collapse group and 4.9 +/- 1.3 in the noncollapse group (P<0.01). The cut-off SUVmax of 6.45 (sensitivity: 0.80, specificity: 0.92) was used for the prediction of femoral head collapse. In the univariate analysis, SUVmax, type classification, and ring sign were related significantly to femoral head collapse.ConclusionWe showed that the quantitative assessment of SUVmax in F-18-fluoride PET was useful to predict femoral head collapse in ON. F-18-Fluoride PET might reflect accelerated bone metabolism because of microcollapse of the femoral head, which is undetectable on plain radiography.	[Kubota, So; Inaba, Yutaka; Kobayashi, Naomi; Ike, Hiroyuki] Yokohama City Univ, Dept Orthopaed Surg, Yokohama, Kanagawa 2360004, Japan; [Tateishi, Ukihide; Inoue, Tomio] Yokohama City Univ, Dept Radiol, Yokohama, Kanagawa 2360004, Japan	Inaba, Y (reprint author), Yokohama City Univ, Dept Orthopaed Surg, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	yute0131@med.yokohama-cu.ac.jp					Alavi A, 2004, SEMIN NUCL MED, V34, P56, DOI 10.1053/j.semnuclmed.2003.09.007; FICAT RP, 1985, J BONE JOINT SURG BR, V67, P3; Sedonja I, 2007, ANN NUCL MED, V21, P167, DOI 10.1007/s12149-007-0001-7; Kubo T, 1997, MAGN RESON IMAGING, V15, P1017, DOI 10.1016/S0730-725X(97)00159-8; Ha YC, 2006, J BONE JOINT SURG AM, V88A, P35, DOI 10.2106/JBJS.F.00535; Dasa V, 2008, CLIN ORTHOP RELAT R, V466, P1081, DOI 10.1007/s11999-008-0219-2; Ryu JS, 2002, J NUCL MED, V43, P1006; Min BW, 2008, CLIN ORTHOP RELAT R, V466, P1087, DOI 10.1007/s11999-008-0191-x; Aratake M, 2009, KNEE SURG SPORT TR A, V17, P53, DOI 10.1007/s00167-008-0641-8; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Even-Sapir E, 2007, SEMIN NUCL MED, V37, P462, DOI 10.1053/j.semnuclmed.2007.07.002; Kobayashi N, 2013, CLIN NUCL MED, V38, pE379, DOI 10.1097/RLU.0b013e31828d30c0; Nishii T, 2002, J ORTHOPAED RES, V20, P130, DOI 10.1016/S0736-0266(01)00063-8; Sugano N, 1999, J BONE JOINT SURG BR, V81B, P590, DOI 10.1302/0301-620X.81B4.9393; Even-Sapir E, 2007, SEMIN MUSCULOSKEL R, V11, P312, DOI 10.1055/s-2008-1060334; Iwasada S, 1999, SKELETAL RADIOL, V28, P251; MANKIN HJ, 1992, NEW ENGL J MED, V326, P1473; Merle DAubigne R, 1965, J BONE JOINT SURG  B, V47, P612; Nakai T, 2000, J BONE JOINT SURG AM, V82A, P1421; Plenk H, 2001, CLIN ORTHOP RELAT R, P42; Schiepers C, 1998, ARCH ORTHOP TRAUM SU, V118, P131, DOI 10.1007/s004020050332; SUGANO N, 1994, CLIN ORTHOPAEDICS, V305, P190; Sugano Nobuhiko, 2002, J Orthop Sci, V7, P601, DOI 10.1007/s007760200108; Tingart M, 2008, CALCIFIED TISSUE INT, V82, P300, DOI 10.1007/s00223-008-9111-z	24	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0143-3636	1473-5628		NUCL MED COMMUN	Nucl. Med. Commun.	JUN	2015	36	6					596	603		10.1097/MNM.0000000000000284		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH8RQ	WOS:000354304200008		
J	Kitamura, H; Kono, Y; Murano, T; Hiroi, K; Ihara, K; Aso, T; Inoue, K; Fukushi, M				Kitamura, Hideaki; Kono, Yuzuru; Murano, Takeshi; Hiroi, Kenta; Ihara, Kanyu; Aso, Tomohiko; Inoue, Kazumasa; Fukushi, Masahiro			Estimation of radioactivity in single-photon emission computed tomography for sentinel lymph node biopsy in a torso phantom study	NUCLEAR MEDICINE COMMUNICATIONS			English	Article						quantification; sentinel lymph node; single-photon emission computed tomography; total radioactivity	EXPECTATION MAXIMIZATION; SPECT/CT; MELANOMA; ATTENUATION; ACCURACY	ObjectiveThe number of lymph nodes to be removed is determined from residual counts. Advance estimation of residual radioactivity in lymphatic nodes before a biopsy is useful for reducing surgical operation time. The purpose of this study was to estimate the total radioactivity of a small hotspot in single-photon emission computed tomography (SPECT) of a torso phantom.MethodsA cross-calibration study was performed to convert counts in SPECT images to radioactivity. A simulation study was performed to estimate the size of the volume of interest (VOI) covering a hotspot corrupted with full-width at half-maximum between 8 and 16mm. The estimation of total radioactivity was validated in a torso phantom study using small sources.ResultsTrue radioactivity was approximately equal to integrated values of hotspots using the VOI with a diameter of 40mm in our simulation study. The difference was less than 18% in cases of more than 9.4kBq.ConclusionThe total radioactivity in small sources simulating a typical sentinel node was estimated from SPECT images using a VOI of 40mm in a torso phantom study. Because the difference from actual values was less than 10% on average when radioactivities were more than 9.4kBq, the total radioactivity of a lymph node can be estimated in a clinical examination.	[Kitamura, Hideaki; Kono, Yuzuru; Murano, Takeshi; Hiroi, Kenta; Ihara, Kanyu; Aso, Tomohiko] Natl Canc Ctr, Diagnost Radiol Div, Tokyo 1040045, Japan; [Inoue, Kazumasa; Fukushi, Masahiro] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Tokyo 158, Japan	Kitamura, H (reprint author), Natl Canc Ctr, Diagnost Radiol Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	hikitamu@ncc.go.jp			Foundation for Promotion of Cancer Research	This work was partially supported by Foundation for Promotion of Cancer Research.	Mariani G, 2002, J NUCL MED, V43, P811; Vermeeren L, 2011, HEAD NECK-J SCI SPEC, V33, P1, DOI 10.1002/hed.21392; Zaidi H, 2003, J NUCL MED, V44, P291; Ritt P, 2011, EUR J NUCL MED MOL I, V38, P69, DOI 10.1007/s00259-011-1770-8; Wong SL, 2012, J CLIN ONCOL, V30, P2912, DOI 10.1200/JCO.2011.40.3519; Willowson K, 2008, PHYS MED BIOL, V53, P3099, DOI 10.1088/0031-9155/53/12/002; Kapteijn BAE, 1997, J NUCL MED, V38, P362; Zeintl J, 2010, J NUCL MED, V51, P921, DOI 10.2967/jnumed.109.071571; Shcherbinin S, 2008, PHYS MED BIOL, V53, P4595, DOI 10.1088/0031-9155/53/17/009; Seo Y, 2008, SEMIN NUCL MED, V38, P177, DOI 10.1053/j.semnuclmed.2008.01.001; Vermeeren L, 2010, J SURG ONCOL, V101, P184, DOI 10.1002/jso.21439; Dickinson RL, 2011, INT J MOL IMAGING, V2011; Gantet P, 2006, MED PHYS, V33, P52, DOI 10.1118/1.2135908; McMasters KM, 2001, ANN SURG ONCOL, V8, P192, DOI 10.1245/aso.2001.8.3.192; Patton James A, 2008, J Nucl Med Technol, V36, P1, DOI 10.2967/jnmt.107.046839; Ralph AB, 2012, CORRECTION TECHNIQUE, P51; Shon Ho, 2008, NUCL MED COMMUN, V29, P847; van der Ploeg IMC, 2007, J NUCL MED, V48, P1756, DOI 10.2967/jnumed.107.043372; Wagner T, 2013, NUCL MED COMMUN, V34, P191, DOI 10.1097/MNM.0b013e32835c5a24	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0143-3636	1473-5628		NUCL MED COMMUN	Nucl. Med. Commun.	JUN	2015	36	6					646	650		10.1097/MNM.0000000000000294		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH8RQ	WOS:000354304200015		
J	Suzuki, T; Muramatsu, T; Morioka, K; Goda, T; Mochizuki, K				Suzuki, Takuji; Muramatsu, Takeshi; Morioka, Kousuke; Goda, Toshinao; Mochizuki, Kazuki			ChREBP binding and histone modifications modulate hepatic expression of the Fasn gene in a metabolic syndrome rat model	NUTRITION			English	Article						Insulin resistance; Histone modifications; ChREBP; Lipogenesis; Liver	SHR/NDMC-CP RATS; FATTY-ACID SYNTHASE; INSULIN-RESISTANCE; POSTTRANSCRIPTIONAL REGULATION; SKELETAL-MUSCLE; NERVOUS-SYSTEM; KOLETSKY RATS; MESSENGER-RNA; DIABETIC MICE; GLUCOSE	Objective: Although the expression of hepatic lipogenic genes is enhanced in insulin resistance, the underlying mechanism is unclear. To reveal the details, the aim of this study was to investigate whether the expression of hepatic lipogenic genes are mediated by epigenetic regulation and specific transcription factors in an insulin resistance model of rats. Methods: Using a rat model of insulin resistance (SHR/NDmc-cp), we investigated the relationship between hepatic expression of the lipogenic gene fatty-acid synthase (Fasn), binding of the transcription factor carbohydrate-responsive element-binding protein (ChREBP) to the Fasn gene, and histone modifications in the region of the Fasn gene by real-time reverse transcriptase polymerase chain reaction, immunoblotting, and chromatin immuno precipitation assay. Results: Compared with control rats, Fasn mRNA expression and protein levels were higher in the livers of SHR/NDmc-cp rats, as were protein expression levels and Fasn binding of ChREBP and RNA polymerase II. Moreover, compared with the livers of control rats, levels of mono-methylated histone H3 lysine (K) 4 and acetylated histone H4 were higher in the promoter/enhancer region of the Fasn gene in the livers of SHR/NDmc-cp rats. Levels of trimethylated histone H3K4 and acetylated histone H3 were higher in the transcribed region. Conclusion: The results of this study indicate that expression of the Fasn gene in the livers of insulin-resistant rats is associated with increased H3K4 methylation, increased histone H3 acetylation, and increased H4 acetylation, and also, binding levels of ChREBP to promoter/enhancer region of Fasn gene is involved in the Fasn gene expression caused by hyperglycemia. (C) 2015 Elsevier Inc. All rights reserved.	[Suzuki, Takuji; Muramatsu, Takeshi; Morioka, Kousuke; Goda, Toshinao; Mochizuki, Kazuki] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Nutr Physiol, Global COE Program, Shizuoka 4228526, Japan; [Suzuki, Takuji] Yamagata Univ, Fac Educ Art & Sci, Food Environm Design Course, Yamagata 990, Japan; [Mochizuki, Kazuki] Univ Yamanashi, Fac Life & Environm Sci, Lab Food & Nutr Sci, Kofu, Yamanashi, Japan	Mochizuki, K (reprint author), Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Nutr Physiol, Global COE Program, Shizuoka 4228526, Japan.	Mochizukik@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26282023]; Takeda Science Foundation	This work was supported by a Grant-in-Aid for Young Scientists from the Ministry of Education, Culture, Sports, Science and Technology of Japan (26282023), and the Takeda Science Foundation. TS wrote the manuscript and conducted the all experiments. TM and KM contributed to the experiments and rearing of animals. TG contributed as experiment adviser. KM organized this study as corresponding author.	El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Chen WL, 2011, EUR J PHARMACOL, V671, P107, DOI 10.1016/j.ejphar.2011.09.029; Matsuzaka T, 2004, DIABETES, V53, P560, DOI 10.2337/diabetes.53.3.560; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Rahmouni K, 2003, HYPERTENSION, V41, P763, DOI 10.1161/01.HYP.0000048342.54392.40; Suzuki T, 2011, BIOCHEM J, V435, P43, DOI 10.1042/BJ20101987; Hiraoka J, 1997, BIOCHEM BIOPH RES CO, V231, P582, DOI 10.1006/bbrc.1997.6145; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Rufo C, 2001, J BIOL CHEM, V276, P21969, DOI 10.1074/jbc.M100461200; Miao F, 2007, J BIOL CHEM, V282, P13854, DOI 10.1074/jbc.M609446200; Nangaku M, 2003, J AM SOC NEPHROL, V14, P1212, DOI 10.1097/01.ASN.0000062961.76776.C1; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEMON RA, 1994, HORM METAB RES, V26, P85, DOI 10.1055/s-2007-1000778; Hariya N, 2014, J NUTR SCI VITAMINOL, V60, P52; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; SHIH HM, 1995, J BIOL CHEM, V270, P21991; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Correia MLG, 2001, HYPERTENSION, V37, P936; Davy KP, 2009, NEUROSCI BIOBEHAV R, V33, P116, DOI 10.1016/j.neubiorev.2008.05.024; KATSURADA A, 1990, EUR J BIOCHEM, V190, P435, DOI 10.1111/j.1432-1033.1990.tb15593.x; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; NACHIAPPAN V, 1994, SHOCK, V1, P123, DOI 10.1097/00024382-199402000-00007; HAFFNER SM, 1992, DIABETES, V41, P715, DOI 10.2337/diabetes.41.6.715; BOLLI G, 1982, J CLIN ENDOCR METAB, V54, P447; BRASS EP, 1994, BIOCHEM J, V301, P193; Campese VM, 2000, J NEPHROL, V13, P221; da Silva XG, 2006, J LIPID RES, V47, P2482; Gorter PM, 2004, ATHEROSCLEROSIS, V173, P363, DOI 10.1016/j.atherosclerosis.2003.12.033; Han CC, 2009, J EXP BIOL, V212, P1553, DOI 10.1242/jeb.022210; Harikai N, 2007, METABOLISM, V56, P847, DOI 10.1016/j.metabol.2007.01.016; Hariya N, 2015, J NUTR SCI VITAMINOL, V61, P28, DOI 10.3177/jnsv.61.28; Honma K, 2007, BIOCHEM BIOPH RES CO, V357, P1124, DOI 10.1016/j.bbrc.2007.04.070; Inoue S, 2011, J NUTR SCI VITAMINOL, V57, P162, DOI 10.3177/jnsv.57.162; Ishizuka T, 1998, J NUTR, V128, P2299; KATSURADA A, 1990, EUR J BIOCHEM, V190, P427, DOI 10.1111/j.1432-1033.1990.tb15592.x; Kim TS, 1996, J NUTR, V126, P611; Lee YS, 2007, DIABETES, V56, P1671, DOI 10.2337/db06-1182; Iizuka K, 2009, FEBS LETT, V583, P2882, DOI 10.1016/j.febslet.2009.07.053; Musri MM, 2006, J BIOL CHEM, V281, P17180, DOI 10.1074/jbc.M601295200; Shimada M, 2013, J NUTR BIOCHEM, V24, P606, DOI 10.1016/j.jnutbio.2012.03.006; Suzuki T, 2009, BBA-GEN SUBJECTS, V1790, P1624, DOI 10.1016/j.bbagen.2009.08.004; TRISCARI J, 1981, METABOLISM, V30, P1135, DOI 10.1016/0026-0495(81)90060-3; Velasque M T, 2001, Int J Exp Diabetes Res, V2, P217, DOI 10.1155/EDR.2001.217; Warne JP, 2011, CELL METAB, V14, P791, DOI 10.1016/j.cmet.2011.11.001; Yoshinaga Y, 2012, BIOCHEM BIOPH RES CO, V419, P605, DOI 10.1016/j.bbrc.2012.02.043	51	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	JUN	2015	31	6					877	883		10.1016/j.nut.2015.01.005		7	Nutrition & Dietetics	Nutrition & Dietetics	CH9GB	WOS:000354342900016		
J	Yoneda, M; Hasegawa, T; Sato, K				Yoneda, Masashi; Hasegawa, Takenao; Sato, Ken			Vitamin E therapy for NAFLD/NASH	NUTRITION			English	Letter							FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; SUPPLEMENTATION; PATHOGENESIS		[Yoneda, Masashi; Sato, Ken] Aichi Med Univ, Dept Internal Med, Div Gastroenterol, Nagakute, Aichi, Japan; [Hasegawa, Takenao] Oketo Red Cross Hosp, Dept Internal Med, Oketo, Japan	Yoneda, M (reprint author), Aichi Med Univ, Dept Internal Med, Div Gastroenterol, Nagakute, Aichi, Japan.						Ji HF, 2014, NUTRITION, V30, P986, DOI 10.1016/j.nut.2014.01.016; BACON BR, 1994, GASTROENTEROLOGY, V107, P1103; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Day CP, 2002, BEST PRACT RES CL GA, V16, P663, DOI 10.1053/bega.2002.0333; Levene AP, 2012, HISTOPATHOLOGY, V61, P141, DOI 10.1111/j.1365-2559.2011.04145.x; Lavine JE, 2011, JAMA-J AM MED ASSOC, V305, P1659, DOI 10.1001/jama.2011.520; Hasegawa T, 2001, ALIMENT PHARM THERAP, V15, P1667, DOI 10.1046/j.1365-2036.2001.01083.x; PAROLA M, 1992, FEBS LETT, V308, P267, DOI 10.1016/0014-5793(92)81290-3; Poli G, 1985, FREE RADICALS LIVER, P207	11	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	JUN	2015	31	6					898	899		10.1016/j.nut.2014.08.007		2	Nutrition & Dietetics	Nutrition & Dietetics	CH9GB	WOS:000354342900020		
J	Saito, K; Kihara, M; Shimizu, T; Yoneda, K; Kurashima, T				Saito, Kotaro; Kihara, Mitsuru; Shimizu, Tomoya; Yoneda, Keisuke; Kurashima, Toshio			High reliability solid refractive index matching materials for field installable connections in FTTH network	OPTICAL FIBER TECHNOLOGY			English	Article						Field installable connection; Solid refractive index matching materials; Long-term reliability environmental tests; Accelerated aging tests	ACCESS	We performed environmental and accelerated aging tests to ensure the long-term reliability of solid type refractive index matching material at a splice point. Stable optical characteristics were confirmed in environmental tests based on an IEC standard. In an accelerated aging test at 140 degrees C, which is very much higher than the specification test temperature, the index matching material itself and spliced fibers passing through it had steady optical characteristics. Then we performed an accelerated aging test on an index matching material attached to a built-in fiber before splicing it in the worst condition, which is different from the normal use configuration. As a result, we confirmed that the repeated insertion and removal of fiber for splicing resulted in failure. We consider that the repetition of adhesion between index matching material and fibers causes the splice to degrade. With this result, we used the Arrhenius model to estimate a median lifetime of about 68 years in a high temperature environment of 60 degrees C. Thus solid type index matching material at a splice point is highly reliable over long periods under normal conditions of use. (C) 2015 Elsevier Inc. All rights reserved.	[Saito, Kotaro; Kihara, Mitsuru; Shimizu, Tomoya; Yoneda, Keisuke; Kurashima, Toshio] NTT Corp, Access Network Serv Syst Labs, Tsukuba, Ibaraki 3050805, Japan	Saito, K (reprint author), NTT Corp, Access Network Serv Syst Labs, 1-7-1 Hanabatake, Tsukuba, Ibaraki 3050805, Japan.	saitou.koutarou@lab.ntt.co.jp					Abe Y, 2009, IEEE PHOTONIC TECH L, V21, P194, DOI 10.1109/LPT.2008.2009881; [Anonymous], 2011, 608741 IEC; [Anonymous], 2009, ITU T RECOMMENDATION; Shinohara H, 2005, IEEE COMMUN MAG, V43, P72, DOI 10.1109/MCOM.2005.1509970; Aoyama H., 2005, NTT TECHNICAL REV, V3, P33; Aozasa S., 2010, P IWCS 10, P126; Hanafusa H, 1998, MATER RES SOC SYMP P, V531, P349; JIS K, 2012, K6253 JIS, P6253; JIS Z, 2009, Z0237 JIS, V0237; KECK DB, 1989, J LIGHTWAVE TECHNOL, V7, P1623, DOI 10.1109/50.45881; Kuramoto K., 2012, P IWCS 12, P513; Nakajima K., 2009, P 58 INT WIR CABL S, P264; Saito K, 2014, J LIGHTWAVE TECHNOL, V32, P344, DOI 10.1109/JLT.2013.2292871; Saito K, 2012, J LIGHTWAVE TECHNOL, V30, P267, DOI 10.1109/JLT.2011.2179009; Sankawa I., 1984, IEICE B, V67, P1423; Takaya M, 2000, IEEE TRANS ADV PACK, V23, P36, DOI 10.1109/6040.826760; Watanabe H, 2010, IEICE T ELECTRON, VE93C, P1180, DOI 10.1587/transele.E93.C.1180	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1068-5200	1095-9912		OPT FIBER TECHNOL	Opt. Fiber Technol.	JUN	2015	23						18	23		10.1016/j.yofte.2015.01.021		6	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CH4TM	WOS:000354025800003		
J	Saito, K; Matsui, T; Nakajima, K; Kurashima, T				Saito, Kotaro; Matsui, Takashi; Nakajima, Kazuhide; Kurashima, Toshio			Multi-core fiber connector using V-groove ferrule	OPTICAL FIBER TECHNOLOGY			English	Article						Multi-core fiber; Optical connector; Rotational angle alignment		We propose a novel connector for a multi-core fiber (MCF) that employs a V-groove ferrule. The proposed connector achieves rotational angle alignment by the insertion of a V-groove ferrule into a split sleeve with a pin. The proposed mechanism enables us to align cores directly in MCF not only in the vertical, horizontal and longitudinal directions but also in the rotational direction. With the proposed technique there is no need to control the clearance of the connector components because the rotational axis of the plug is directly aligned with the adaptor when we fit the pin into the V-groove. Moreover, the floating structure can remain unchanged since currently available connector parts can be employed. We show that this technique can precisely align the rotational angle for MCF with an arbitrary core structure. We also show that a more stable connection can be realized if we take account of the tolerance of the V-groove and pin. (C) 2015 Elsevier Inc. All rights reserved.	[Saito, Kotaro; Matsui, Takashi; Nakajima, Kazuhide; Kurashima, Toshio] NTT Corp, Access Network Serv Syst Labs, Tsukuba, Ibaraki, Japan	Saito, K (reprint author), NTT Corp, Access Network Serv Syst Labs, 1-7-1 Hanabatake, Tsukuba, Ibaraki, Japan.	saitou.koutarou@lab.ntt.co.jp					Winzer PJ, 2012, IEEE PHOTONICS J, V4, P647, DOI 10.1109/JPHOT.2012.2189379; Nagase R., 2012, P 61 IWCS, P823; Nakajima K., 2012, P OECC2012; Shimakawa O., 2013, P OFC2013; Shimakawa O., 2013, OFT201271 IEICE, P11; SUZUKI N, 1979, ELECTRON LETT, V15, P809; Watanabe K., 2012, P OECC2012; Winzer P.J., 2013, P ECOC 2013	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1068-5200	1095-9912		OPT FIBER TECHNOL	Opt. Fiber Technol.	JUN	2015	23						24	29		10.1016/j.yofte.2015.01.019		6	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CH4TM	WOS:000354025800004		
J	Saito, K; Kihara, M; Shimizu, T; Kurashima, T				Saito, Kotaro; Kihara, Mitsuru; Shimizu, Tomoya; Kurashima, Toshio			Easy and safe coated optical fiber direct connection without handling bare optical fiber	OPTICAL FIBER TECHNOLOGY			English	Article						Field installable splicing technique; Coated optical fiber; Optical fiber cleaving technique; Coating removal	ACCESS NETWORKS; SPLICES	We propose a novel field installable splicing technique for the direct connection of 250 mu m diameter coated optical fiber that does not require bare optical fiber to be handled. Our proposed technique can realize a low insertion loss over a wide field installation temperature range of -10-40 degrees C. The keys to coated optical fiber direct connection are a cleaving technique and a technique for removing coated optical fiber. As the cleaving technique, we employed a method where the fiber is stretched and then a blade is pushed perpendicularly against the stretched fiber. As a result we confirmed that fiber endfaces cleaved at -10-40 degrees C were all mirror endfaces. With the removal technique, the coating is removed inside the connecting component by incorporating a circular cone shaped coating removal part. A mechanical splice based on these techniques successfully achieved a low insertion loss of less than 0.11 dB and a return loss of more than 50 dB at -10, 20, and 40 degrees C. In addition, the temperature cycle characteristics were stable over a wide temperature range of -40-75 degrees C. (C) 2015 Elsevier Inc. All rights reserved.	[Saito, Kotaro; Kihara, Mitsuru; Shimizu, Tomoya; Kurashima, Toshio] NTT Corp, Access Network Serv Syst Labs, Tsukuba, Ibaraki 3050805, Japan	Saito, K (reprint author), NTT Corp, Access Network Serv Syst Labs, 1-7-1 Hanabatake, Tsukuba, Ibaraki 3050805, Japan.	saitou.koutarou@lab.ntt.co.jp					[Anonymous], 2010, 60793132 IEC; MARCUSE D, 1977, AT&T TECH J, V56, P703; [Anonymous], 2012, 60793250 IEC; SUGITA E, 1989, J LIGHTWAVE TECHNOL, V7, P1689, DOI 10.1109/50.45890; Shinohara H, 2005, IEEE COMMUN MAG, V43, P72, DOI 10.1109/MCOM.2005.1509970; GLOGE D, 1973, AT&T TECH J, V52, P1579; Hogari K, 2010, IEICE T ELECTRON, VE93C, P1172, DOI 10.1587/transele.E93.C.1172; KECK DB, 1989, J LIGHTWAVE TECHNOL, V7, P1623, DOI 10.1109/50.45881; Kihara M, 2013, OPT FIBER TECHNOL, V19, P269, DOI 10.1016/j.yofte.2013.02.007; NAGASE R, 1991, IEEE PHOTONIC TECH L, V3, P1045, DOI 10.1109/68.97857; Nakajima T., 2006, P 55 IWCS FOC, P439; SATAKE T, 1986, J LIGHTWAVE TECHNOL, V4, P1232, DOI 10.1109/JLT.1986.1074860; Son H., 2007, P EUR C OPT COMM 200, V2007, pP008; Timoshenko S., 1956, STRENGTH MAT 2, V3rd, P145	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1068-5200	1095-9912		OPT FIBER TECHNOL	Opt. Fiber Technol.	JUN	2015	23						30	36		10.1016/j.yofte.2015.01.018		7	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CH4TM	WOS:000354025800005		
J	Yokota, H; Ushiroda, K; Inoue, N; Imai, Y; Sasaki, Y				Yokota, Hirohisa; Ushiroda, Kosuke; Inoue, Naoya; Imai, Yoh; Sasaki, Yutaka			Fabrication of photonic crystal fiber optical attenuators with air hole diameter control using CO2 laser irradiation technique	OPTICAL FIBER TECHNOLOGY			English	Article						Photonic crystal fiber; Optical attenuator; Confinement loss; Mode field diameter mismatch loss; Cladding mode; CO2 laser irradiation		Photonic crystal fiber (PCF) optical attenuators with air hole diameter control were fabricated by PCF fusion using CO2 laser irradiation technique. The diameters of air holes in the PCF cross-section were equally decreased by laser irradiation with a PCF rotation. We demonstrated that the air hole diameter or the air hole diameter ratio to pitch could be adjusted by the irradiated laser power. It was clarified that the larger attenuation could be obtained for the smaller air hole diameter ratio to pitch. The attenuation was controlled from 5 dB to 20 dB at 1550 nm-wavelength for the air hole diameter ratio to pitch from 0.35 to 0.225, where the length of air hole diameter controlled region was 10 mm. It was also clarified that the fabricated PCF optical attenuators exhibited good wavelength independent characteristics for 980 nm-, 1310 nm-, and 1550 nm-wavelengths. (C) 2015 Elsevier Inc. All rights reserved.	[Yokota, Hirohisa; Ushiroda, Kosuke; Inoue, Naoya; Imai, Yoh; Sasaki, Yutaka] Ibaraki Univ, Grad Sch Sci & Engn, Hitachi, Ibaraki 3168511, Japan	Yokota, H (reprint author), Ibaraki Univ, Grad Sch Sci & Engn, 4-12-1 Nakanarusawa, Hitachi, Ibaraki 3168511, Japan.	hirohisa@mx.ibaraki.ac.jp			Japan Society for the Promotion of Science (JSPS) [24560395]	This work was supported by Grants-in-Aid for Scientific Research (24560395) of Japan Society for the Promotion of Science (JSPS).	Agrawal G. P., 2002, FIBER OPTIC COMMUNIC; Agrawal G. P., 2001, NONLINEAR FIBER OPTI; MARCUSE D, 1977, AT&T TECH J, V56, P703; White TP, 2001, OPT LETT, V26, P1660, DOI 10.1364/OL.26.001660; Ranka JK, 2000, OPT LETT, V25, P25, DOI 10.1364/OL.25.000025; Russell P, 2003, SCIENCE, V299, P358, DOI 10.1126/science.1079280; Tajima K, 2004, J LIGHTWAVE TECHNOL, V22, P7, DOI 10.1109/JLT.2003.822143; Birks TA, 1997, OPT LETT, V22, P961, DOI 10.1364/OL.22.000961; Kashyap R, 2013, OPT EXPRESS, V21, P6422, DOI 10.1364/OE.21.006422; Kubota H, 2004, IEEE PHOTONIC TECH L, V16, P182, DOI 10.1109/LPT.2003.819415; He Z., 2010, OPT EXPRESS, V18, P507; Kosmba M., 2004, OPT LETT, V29, P1739; Nakajima K, 2005, J LIGHTWAVE TECHNOL, V23, P7, DOI 10.1109/JLT.2004.840052; Park HC, 2007, OPT EXPRESS, V15, P15154, DOI 10.1364/OE.15.015154; Stevenson M, 2005, ELECTRON LETT, V41, P1167, DOI 10.1049/el:20052649; Takeuchi Y, 1997, ELECTRON LETT, V33, P1245, DOI 10.1049/el:19970821; YAMAUCHI J, 1991, ELECTRON LETT, V27, P1663, DOI 10.1049/el:19911039; Yokota H, 2008, IEICE T ELECTRON, VE91C, P1136, DOI [10.1093/ietele/e91-c.7.1136, 10.1093/ietele/e9l-c.7.1136]	18	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1068-5200	1095-9912		OPT FIBER TECHNOL	Opt. Fiber Technol.	JUN	2015	23						37	41		10.1016/j.yofte.2015.01.017		5	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CH4TM	WOS:000354025800006		
J	Kida, M; Maki, K; Takata, A; Kato, T; Tsuda, K; Hayakawa, K; Sugiyama, Y; Fujitake, N				Kida, Morimaru; Maki, Kenzo; Takata, Akihiro; Kato, Taku; Tsuda, Kumiko; Hayakawa, Kazuhide; Sugiyama, Yuko; Fujitake, Nobuhide			Quantitative monitoring of aquatic humic substances in Lake Biwa, Japan, using the DAX-8 batch method based on carbon concentrations	ORGANIC GEOCHEMISTRY			English	Article						Dissolved organic matter (DOM); Refractory organic matter (ROM); Natural organic matter (NOM); Quantitative analysis; Abundance; Clear water	DISSOLVED ORGANIC-MATTER; MARINE-PHYTOPLANKTON; PRIMARY PRODUCTIVITY; CLIMATE-CHANGE; GREAT-LAKES; DYNAMICS; WATERS; FLUORESCENCE; CONSUMPTION; TANGANYIKA	Aquatic humic substances (AHS) have been intensively studied because they have a number of significant biogeochemical functions in water chemistry. In order to evaluate such functions, which are regulated by their quantity and quality, a quantitative understanding of AHS is necessary. This study shows the seasonal and vertical changes in the AHS concentration in Lake Biwa, the largest monomictic lake in Japan, over 4 years. The concentration of dissolved organic matter carbon (DOM-C) and AHS carbon (AHS-C) ranged from 0.85-1.6 mg C/l and 0.32-0.71 mg C/l, respectively. The percentages of AHS-C in the DOM-C ranged from 32% to 65%. At all depths, the DOM-C decreased and the AHS-C slightly increased or remained at nearly the same level, suggesting that the quality of the water may have changed mainly due to changes in the composition of the organic matter. Although the AHS-C to DOM-C ratio fluctuated and had no seasonal tendency, the average AHS-C ratio increased during the 4 year monitoring period. Because AHS can influence the entire food web starting with phytoplankton, unraveling the mechanism by which they accumulate remains an important goal. (C) 2015 Elsevier Ltd. All rights reserved.	[Kida, Morimaru; Maki, Kenzo; Takata, Akihiro; Kato, Taku; Fujitake, Nobuhide] Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Tsuda, Kumiko] Kobe Univ, Grad Sch Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Hayakawa, Kazuhide] Lake Biwa Environm Res Inst, Otsu, Shiga 5200022, Japan; [Sugiyama, Yuko] Univ Hyogo, Sch Human Sci & Environm, Nishi Ku, Kobe, Hyogo 6512197, Japan	Fujitake, N (reprint author), Kobe Univ, Grad Sch Agr Sci, Nada Ku, Rokkodai 1, Kobe, Hyogo 6578501, Japan.	fujitake@kobe-u.ac.jp			 [C-24510044]	This work was supported by a Grant-in-Aid for Scientific Research (C-24510044, 2012-2014).	Alin S.R., 2007, GLOBAL BIOGEOCHEMICA, V21; Sugiyama Y, 2005, LIMNOLOGY, V6, P161, DOI 10.1007/s10201-005-0155-8; Williamson CE, 2009, LIMNOL OCEANOGR, V54, P2273, DOI 10.4319/lo.2009.54.6_part_2.2273; Turner GF, 2001, MOL ECOL, V10, P793, DOI 10.1046/j.1365-294x.2001.01200.x; BARON J, 1991, BIOGEOCHEMISTRY, V15, P89; Nakano T, 2008, SCI TOTAL ENVIRON, V389, P132, DOI 10.1016/j.scitotenv.2007.08.042; Nelson NB, 2004, MAR CHEM, V89, P273, DOI 10.1016/j.marchem.2004.02.017; JUDE DJ, 1992, J GREAT LAKES RES, V18, P651; Zhang YL, 2009, WATER RES, V43, P4685, DOI 10.1016/j.watres.2009.07.024; Li W, 2008, LIMNOLOGY, V9, P163, DOI 10.1007/s10201-008-0241-9; Sakai Y, 2013, LIMNOLOGY, V14, P167, DOI 10.1007/s10201-012-0394-4; Mostofa KMG, 2005, LIMNOLOGY, V6, P101, DOI 10.1007/s1201-005-0149-6; Magnuson JJ, 1997, HYDROL PROCESS, V11, P825; Rochelle-Newall EJ, 2002, MAR CHEM, V77, P7, DOI 10.1016/S0304-4203(01)00072-X; Itoh N, 2010, ORG GEOCHEM, V41, P845, DOI 10.1016/j.orggeochem.2010.04.002; MAGUE TH, 1980, LIMNOL OCEANOGR, V25, P262; O'Reilly CM, 2003, NATURE, V424, P766, DOI 10.1038/nature01833; Kim C, 2006, LIMNOL OCEANOGR, V51, P70; Guillemette F, 2012, ENVIRON MICROBIOL, V14, P1432, DOI 10.1111/j.1462-2920.2012.02728.x; Thottathil SD, 2013, LIMNOL OCEANOGR, V58, P2262, DOI 10.4319/lo.2013.58.6.2262; Sobek S, 2007, LIMNOL OCEANOGR, V52, P1208; Tsuda K, 2012, ANAL SCI, V28, P1017; Romera-Castillo C, 2011, APPL ENVIRON MICROB, V77, P7490, DOI 10.1128/AEM.00200-11; Aoki S, 2004, ANAL SCI, V20, P159, DOI 10.2116/analsci.20.159; BONAN GB, 1995, J CLIMATE, V8, P2691, DOI 10.1175/1520-0442(1995)008<2691:SOAGST>2.0.CO;2; Fujitake N, 2009, HUMIC SUBSTANCES RES, V5-6, P45; Fujitake N., 2011, LIMNOLOGY, V13, P45; Hayakawa K, 2004, ORG GEOCHEM, V35, P169, DOI 10.1016/j.orggeochem.2003.09.002; Hosono T, 2007, SCI TOTAL ENVIRON, V384, P342, DOI 10.1016/j.scitotenv.2007.05.033; Imai Akio, 1998, Japanese Journal of Limnology, V59, P53; International Lake Environment Committee (ILEC), 1993, DAT BOOK WORLD LAK E, V1; Maki K., 2009, LIMNOLOGY, V11; Molsa H, 1999, HYDROBIOLOGIA, V407, P1, DOI 10.1023/A:1003712708969; Mostofa KMG, 2007, GEOCHEM J, V41, P323; Nagao S, 2007, NUCL INSTRUM METH B, V259, P552, DOI 10.1016/j.nimb.2007.01.199; NORRMAN B, 1995, LIMNOL OCEANOGR, V40, P898; Nozaki K, 2001, FRESHWATER BIOL, V46, P587, DOI 10.1046/j.1365-2427.2001.00696.x; Ohara S, 2009, BUNSEKI KAGAKU, V58, P231; Ohte N., 2010, WATER RESOURCES RES, V46; Okamura H, 2002, ENVIRON POLLUT, V117, P411, DOI 10.1016/S0269-7491(01)00196-8; Shiga Prefecture, 2013, KANK, P45; Steinberg CEW, 2003, ECOLOGY HUMIC SUBSTA; Thurman EM., 1985, ORGANIC GEOCHEMISTRY, P273; Urabe J, 1999, ECOL RES, V14, P233, DOI 10.1046/j.1440-1703.1999.143300.x; Urban-Rich J, 2006, J EXP MAR BIOL ECOL, V332, P96, DOI 10.1016/j.jembe.2005.11.023; Wetzel R. G., 2001, LIMNOLOGY LAKE RIVER; Yamada E, 2012, ANAL SCI, V28, P675	47	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0146-6380			ORG GEOCHEM	Org. Geochem.	JUN-JUL	2015	83-84						153	157		10.1016/j.orggeochem.2015.03.015		5	Geochemistry & Geophysics	Geochemistry & Geophysics	CI2DQ	WOS:000354555600014		
J	Watanabe, K; Hashimoto, I; Ibuki, K; Okabe, M; Kaneda, H; Ichida, F				Watanabe, Kazuhiro; Hashimoto, Ikuo; Ibuki, Keijiro; Okabe, Mako; Kaneda, Hisashi; Ichida, Fukiko			Evaluation of Right Ventricular Function Using Single-Beat Three-Dimensional Echocardiography in Neonate	PEDIATRIC CARDIOLOGY			English	Article						Right ventricle; Echocardiography; Neonate; Cardiac function	CARDIAC MAGNETIC-RESONANCE; PLANE SYSTOLIC EXCURSION; NON-INVASIVE EVALUATION; 3D ECHOCARDIOGRAPHY; EJECTION FRACTION; ANIMAL-MODEL; PULMONARY; VOLUME; VALIDATION; FLOW	Aim of our study was to evaluate right ventricular (RV) systolic function in neonate using newly developed single-beat three-dimensional echocardiography (sb3DE). We enrolled 15 healthy or premature neonates (0-53 days after birth). We scanned one beat full volume using Siemens ACUSON SC2000 (Siemens AG) echocardiography with 4Z1c full-volume transducer without ECG gating. RV end-diastolic volume (RVEDV) and RV end-systolic volume (RVESV) were computed with special software dedicated to analysis for RV volume. RV ejection fraction (RVEF) and RV stroke volume (3D-RVSV) were calculated. And RV stroke volume was also determined from the recordings of ejection blood flow velocity and diameter at the level of the pulmonary orifice in RV outflow tract (Doppler-RVSV). Tricuspid annular plane systolic excursion (TAPSE) was also measured by 2D echocardiography. RVEDV ranged from 5.1 to 10.7 ml (average 7.5 ml), RVESV ranged from 2.3 to 5.8 ml (average 3.9 ml). There was a good correlation between 3D-RVSV and Doppler-RVSV (r = 0.77). Bland-Altman plot revealed that 3D-RVSV became underestimation of an average of 1.78 ml compared to Doppler-RVSV. And TAPSE positively correlated with 3D-RVEF (r = 0.58, P = 0.038). Newly developed sb3DE enables us to perform three-dimensional acquisition of RV volume without ECG gating even in neonate. However, 3D-RVSV currently tends to be underestimated in neonatal measurement.	[Watanabe, Kazuhiro; Hashimoto, Ikuo; Okabe, Mako; Kaneda, Hisashi] Toyama City Hosp, Dept Pediat, Toyama, Toyama, Japan; [Ibuki, Keijiro; Ichida, Fukiko] Toyama Univ, Dept Pediat, Toyama 930, Japan	Hashimoto, I (reprint author), Toyama City Hosp, Dept Pediat, 2-1 Hokubu Mach, Toyama, Toyama, Japan.	i.hashimoto@icloud.com					Shibayama K, 2013, J CARDIOL, V61, P281, DOI 10.1016/j.jjcc.2012.11.005; KITABATAKE A, 1983, CIRCULATION, V68, P302; Shiota T, 1998, CIRCULATION, V97, P1897; Speiser U, 2012, BRIT J RADIOL, V85, pE716, DOI 10.1259/bjr/50238360; Koestenberger M, 2009, J AM SOC ECHOCARDIOG, V22, P715, DOI 10.1016/j.echo.2009.03.026; KITABATAKE A, 1984, CIRCULATION, V69, P73; Kjaergaard J, 2006, EUR J ECHOCARDIOGR, V7, P430, DOI 10.1016/j.euje.2005.10.009; BLAND JM, 1986, LANCET, V1, P307; Hashimoto I, 2014, CIRC J, V78, P1967, DOI 10.1253/circj.CJ-14-0083; Li J, 1999, CURR OPIN CARDIOL, V14, P53, DOI 10.1097/00001573-199901000-00009; Macron L, 2010, CIRC-CARDIOVASC IMAG, V3, P450, DOI 10.1161/CIRCIMAGING.109.925966; Mori Y, 2001, J AM COLL CARDIOL, V37, P632, DOI 10.1016/S0735-1097(00)01106-2; Ren B, 2013, INT J CARDIOVAS IMAG, V30, P287; Schattke S, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-6; Shiota T, 2009, CURR OPIN CARDIOL, V24, P410, DOI 10.1097/HCO.0b013e32832cf8f6	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	JUN	2015	36	5					918	924		10.1007/s00246-015-1095-7		7	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CI1CC	WOS:000354477000005		
J	Hashimoto, I; Watanabe, K; Okabe, M; Kaneda, H				Hashimoto, Ikuo; Watanabe, Kazuhiro; Okabe, Mako; Kaneda, Hisashi			Impairment of Left Ventricular Longitudinal Contraction is Associated with Serum Brain Natriuretic Peptide Concentration in Patients with Acute-Phase Kawasaki Disease	PEDIATRIC CARDIOLOGY			English	Article						Kawasaki disease; Left ventricular function; Brain natriuretic peptide	PLANE SYSTOLIC EXCURSION; EJECTION FRACTION; HEALTHY-CHILDREN; PRO-BNP; ECHOCARDIOGRAPHY; IMMUNOGLOBULIN; LESIONS; MARKER; STRAIN; RISK	It is well known that brain natriuretic peptide (BNP) is elevated in the acute phase of Kawasaki disease (KD). We hypothesized that mitral annular plane systolic excursion (MAPSE) could identify LV dysfunction in the acute phase of KD. Fifty patients with KD were enrolled in this study. BNP sampling and an echocardiographic study were performed just before and after intravenous immunoglobulin administration. MAPSE was measured in M-mode in the apical four-chamber view. The %MAPSE was calculated as the MAPSE measured in the acute phase divided by that measured in the convalescent phase. We compared the acute and the convalescent phases of KD. The values of the MAPSE were significantly reduced (45 out of 50 patients) during the acute phase and immediately recovered in the convalescent phase (10.0 +/- A 1.9 vs. 12.7 +/- A 1.9 mm, P < 0.0001). Of the parameters tested, %MAPSE was the only echocardiographic parameter that was associated with Log-BNP. Additionally, %MAPSE had a significant negative correlation with Log-BNP (r = -0.45, P < 0.0039). Longitudinal LV contraction is impaired in the acute phase of KD, but it immediately recovers in the convalescent phase. Measuring the longitudinal LV contractility should be essential for evaluating LV function in the acute phase of KD, and MAPSE is useful for this evaluation.	[Hashimoto, Ikuo; Watanabe, Kazuhiro; Okabe, Mako; Kaneda, Hisashi] Toyama City Hosp, Dept Pediat, Toyama, Toyama, Japan	Hashimoto, I (reprint author), Toyama City Hosp, Dept Pediat, 2-1 Hokubu Machi, Toyama, Toyama, Japan.	i.hashimoto@icloud.com					Cho SY, 2011, ANN CLIN LAB SCI, V41, P360; Suzuki H, 1996, EUR J PEDIATR, V155, P291; Koteda Y, 2009, J CARDIOL, V54, P45, DOI 10.1016/j.jjcc.2009.03.005; Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x; Kurotobi S, 2005, PEDIATR CARDIOL, V26, P425, DOI 10.1007/s00246-004-0812-4; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Tanaka T, 2004, J INT MED RES, V32, P57; POMBO JF, 1971, CIRCULATION, V43, P480; Takeuchi D, 2007, CIRC J, V71, P357, DOI 10.1253/circj.71.357; KITABATAKE A, 1984, CIRCULATION, V69, P73; Dahdah N, 2009, PEDIATR CARDIOL, V30, P810, DOI 10.1007/s00246-009-9441-2; Poterucha JT, 2012, J AM SOC ECHOCARDIOG, V25, P733, DOI 10.1016/j.echo.2012.04.007; Kaneko K, 2011, PEDIATR CARDIOL, V32, P1106, DOI 10.1007/s00246-011-9986-8; McCrindle BW, 2007, CIRCULATION, V116, P174, DOI 10.1161/CIRCULATIONAHA.107.690875; Bang Sunhee, 2011, Korean J Pediatr, V54, P340, DOI 10.3345/kjp.2011.54.8.340; Bergenzaun L, 2013, CARDIOVASC ULTRASOUN, V11, DOI 10.1186/1476-7120-11-16; Harada Kensuke, 1991, Acta Paediatrica Japonica, V33, P805; Harada M, 2012, HISTOPATHOLOGY, V61, P1156, DOI 10.1111/j.1365-2559.2012.04332.x; Hashimoto I, 2014, CIRC J, V78, P1967, DOI 10.1253/circj.CJ-14-0083; Iwashima S, 2013, WORLD J PEDIATR, V9, P239, DOI 10.1007/s12519-013-0402-8; Kawamura T, 2000, PEDIATR INT, V42, P241, DOI 10.1046/j.1442-200x.2000.01225.x; Kishimoto S, 2011, PEDIATR INT, V53, P736, DOI 10.1111/j.1442-200X.2011.03351.x; Koestenberger M, 2012, AM HEART J, V164, P125, DOI 10.1016/j.ahj.2012.05.004; Lisi M, 2012, INT J CARDIOL, V157, P212, DOI 10.1016/j.ijcard.2010.12.054; Matos J, 2012, J AM SOC ECHOCARDIOG, V25, P969, DOI 10.1016/j.echo.2012.06.011; Matsubara T, 1991, Arerugi, V40, P147; McCandless RT, 2013, EUR HEART J-CARD IMG, V14, P1061, DOI 10.1093/ehjci/jet041; Ogawa T, 2012, BIOMARKERS, V17, P140, DOI 10.3109/1354750X.2011.643487; SATO N, 1993, J PEDIATR-US, V122, P198, DOI 10.1016/S0022-3476(06)80113-7; TEICHHOL.LE, 1974, NEW ENGL J MED, V291, P1220, DOI 10.1056/NEJM197412052912304; Torrent-Guasp F, 2001, Semin Thorac Cardiovasc Surg, V13, P301; Yoshimura K, 2013, J PEDIATR-US, V162, P1205, DOI 10.1016/j.jpeds.2012.11.026; Yu JJ, 2010, PEDIATR CARDIOL, V31, P807, DOI 10.1007/s00246-010-9708-7	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	JUN	2015	36	5					979	986		10.1007/s00246-015-1108-6		8	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CI1CC	WOS:000354477000013		
J	Chen, J; Choi, MS; Mizoguchi, A; Veenstra, JA; Kang, K; Kim, YJ; Kwon, JY				Chen, Ji; Choi, Min Sung; Mizoguchi, Akira; Veenstra, Jan A.; Kang, KyeongJin; Kim, Young-Joon; Kwon, Jae Young			Isoform-specific expression of the neuropeptide orcokinin in Drosophila melanogaster	PEPTIDES			English	Article						Orcokinin; Neuropeptide; Drosophila melanogaster	COCKROACH LEUCOPHAEA-MADERAE; NERVOUS-SYSTEM; NEURONS; INSECTS; BRAIN; PEPTIDES; RECEPTOR; IDENTIFICATION; GENOME; GENES	Orcokinins are neuropeptides that have been identified in diverse arthropods. In some species, an orcokinin gene encodes two isoforms of mature orcokinin peptide through alternative mRNA splicing. The existence of two orcokinin isoforms was predicted in Drosophila melanogaster as well, but the expression pattern of both isoforms has not been characterized. Here, we use in situ hybridization, antibody staining, and enhancer fusion GAL4 transgenic flies to examine the expression patterns of the A and B forms of orcokinin, and provide evidence that they are expressed differentially in the central nervous system (CNS) and the intestinal enteroendocrine system. The orcokinin A isoform is mainly expressed in the CNS of both larvae and adults. The A form is expressed in 5 pairs of neurons in abdominal neuromeres 1-5 of the larval CNS. In the adult brain, the A form is expressed in one pair of neurons in the posteriorlateral protocerebrum, and an additional four pairs of neurons located near the basement of the accessory medulla. Orcokinin A expression is also observed in two pairs of neurons in the ventral nerve cord (VNC). The orcokinin B form is mainly expressed in intestinal enteroendocrine cells in the larva and adult, with additional expression in one unpaired neuron in the adult abdominal ganglion. Together, our results provide elucidation of the existence and differential expression of the two orcokinin isoforms in the Drosophila brain and gut, setting the stage for future functional studies of orcokinins utilizing the genetically amenable fly model. (C) 2015 Elsevier Inc. All rights reserved.	[Chen, Ji; Choi, Min Sung; Kwon, Jae Young] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Mizoguchi, Akira] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Veenstra, Jan A.] Univ Bordeaux, INCIA UMR CNRS 5287, F-33405 Talence, France; [Kang, KyeongJin] Sungkyunkwan Univ, Sch Med, Dept Anat & Cell Biol, Samsung Biomed Res Inst, Suwon 440746, South Korea; [Kim, Young-Joon] Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju 500712, South Korea	Kim, YJ (reprint author), Gwangju Inst Sci & Technol, Sch Life Sci, 261 Cheomdan Gwagiro, Gwangju 500712, South Korea.	kimyj@gist.ac.kr; jykwon@skku.edu			Basic Science Research Programs through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea [NRF-2010-0010597, NRF-2013R1A1A2061120, NRF-2013R1A1A2010475]	We would like to thank Barry J. Dickson (Janelia Farm Research Campus) for reagents. The Developmental Studies Hybridoma Bank (University of Iowa) provided the anti-Prospero antibody. This research was supported by Basic Science Research Programs through the National Research Foundation of Korea (NRF) funded by Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea (NRF-2010-0010597 U.Y.K), NRF-2013R1A1A2061120 U.Y.K), NRF-2013R1A1A2010475 (Y.-J.K.)).	Sterkel M, 2012, INSECT BIOCHEM MOLEC, V42, P466, DOI 10.1016/j.ibmb.2012.03.003; Hofer S, 2006, CELL TISSUE RES, V325, P589, DOI 10.1007/s00441-006-0155-y; Liu F, 2006, MOL CELL PROTEOMICS, V5, P510, DOI 10.1074/mcp.M400114-MCP200; Hofer S, 2005, J COMP NEUROL, V490, P57, DOI 10.1002/cne.20650; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; Park JH, 2011, MOL CELLS, V32, P375, DOI 10.1007/s10059-011-0128-1; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Hofer S, 2006, J EXP BIOL, V209, P2794, DOI 10.1242/jeb.02307; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Clynen E, 2009, INSECT BIOCHEM MOLEC, V39, P491, DOI 10.1016/j.ibmb.2009.06.001; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; Pascual N, 2004, INSECT BIOCHEM MOLEC, V34, P1141, DOI 10.1016/j.ibmb.2004.07.005; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Hummon AB, 2006, MASS SPECTROM REV, V25, P77, DOI 10.1002/mas.20055; Ons S, 2009, PROTEOMICS, V9, P788, DOI 10.1002/pmic.200800499; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Jung SH, 2014, FEBS LETT, V588, P2037, DOI 10.1016/j.febslet.2014.04.028; STANGIER J, 1992, PEPTIDES, V13, P859, DOI 10.1016/0196-9781(92)90041-Z; Veenstra JA, 2014, CELL TISSUE RES, V357, P607, DOI 10.1007/s00441-014-1880-2; Christie AE, 2008, GEN COMP ENDOCR, V159, P67, DOI 10.1016/j.ygcen.2008.07.022; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; CHEN YT, 1994, CELL TISSUE RES, V276, P69, DOI 10.1007/BF00354786; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Huybrechts J, 2010, INSECT MOL BIOL, V19, P87, DOI 10.1111/j.1365-2583.2009.00951.x; Yamanaka N, 2011, J COMP NEUROL, V519, P238, DOI 10.1002/cne.22517; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Park JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029022; Soehler S, 2011, CELL TISSUE RES, V343, P559, DOI 10.1007/s00441-010-1091-4; Strand F. L., 1999, NEUROPEPTIDES REGULA	32	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	JUN	2015	68						50	57		10.1016/j.peptides.2015.01.002		8	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CI2JF	WOS:000354572200008		
J	Morishita, F; Furukawa, Y; Kodani, Y; Minakata, H; Horiguchi, T; Matsushima, O				Morishita, Fumihiro; Furukawa, Yasuo; Kodani, Yu; Minakata, Hiroyuki; Horiguchi, Toshihiro; Matsushima, Osamu			Molecular cloning of precursors for TEP-1 and TEP-2: The GGNG peptide-related peptides of a prosobranch gastropod, Thais clavigera	PEPTIDES			English	Article						In situ hybridization; RT-PCR; Neuropeptide; Precursor; cDNA-library; Mollusk	NEUROPEPTIDES; MOLLUSKS; IMPOSEX; GENES; SEA	TEP (Thais excitatory peptide)-1 and TEP-2 are molluscan counterparts of annelidan GGNG-peptides, identified in a neogastropod, Thais clavigera (Morishita et al., 2006). We have cloned two cDNAs encoding TEP-1 and TEP-2 precursor protein, respectively, by the standard molecular cloning techniques. Predicted TEP-1 precursor protein consists of 161 amino acids, while predicted TEP-2 precursor protein has 118 amino acids. Only a single copy of TEP was found on the respective precursor. The semi-quantitative RT-PCR showed that expression of TEP-1 was high in sub-esophageal, pleural, pedal and visceral ganglia, while it was low in supra-esophageal ganglion. By contrast, expression level of TEP-2 was high in pedal and visceral ganglia. In situ hybridization visualized different subsets of TEP-1 and TEP-2 expressing neurons in Thais ganglia. For example, supra-esophageal ganglion contained many TEP-2 expressing neuron, but not TEP-1 expressing ones. These results suggest that expression of TEP-1 and TEP-2 is differently regulated in the Thais ganglia. (C) 2014 Elsevier Inc. All rights reserved.	[Morishita, Fumihiro] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Higashihiroshima, Hiroshima 7398526, Japan; [Furukawa, Yasuo; Kodani, Yu] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Div Human Sci, Higashihiroshima, Hiroshima 7398521, Japan; [Minakata, Hiroyuki] Suntory Fdn Life Sci, Shimamoto, Osaka 6288503, Japan; [Horiguchi, Toshihiro] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Matsushima, Osamu] Hiroshima Inst Technol, Fac Environm Studies, Dept Global Environm Studies, Saeki Ku, Hiroshima 7315193, Japan	Morishita, F (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, 1-3-1 Kagamiyama, Higashihiroshima, Hiroshima 7398526, Japan.	fumi425@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [16570063, 21248026]; Sumitomo Foundation [053480]	Authors thank Professor Emeritus Hitoshi Michibata and Dr. Tatsuya Ueki at Hiroshima University for their kind support and encouragement to this work. We also thank Dr. Nobuo Yamaguchi at Mukaishima Marine Biological Laboratory, Hiroshima University for collecting animals. Liquid nitrogen used in this study was supplied by the Cryogenic and Instrumental Analysis Division of Natural Science Center for Basic Research and Development (NSCBRD). Nucleotide sequence was analyzed by Gene Science Division of NSCBRD. This work was financially supported by the grant-in-aid from the Japan Society for the Promotion of Science to F.M (No. 16570063) and to T.H. (No. 21248026) and that from the Sumitomo Foundation (No. 053480) to F.M.	Veenstra JA, 2010, GEN COMP ENDOCR, V167, P86, DOI 10.1016/j.ygcen.2010.02.010; NASSEL DR, 1993, CELL TISSUE RES, V273, P1, DOI 10.1007/BF00304608; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Bouchet P, 2005, MALACOLOGIA, V47, P1; Koshimizu TA, 2012, PHYSIOL REV, V92, P1813, DOI 10.1152/physrev.00035.2011; Horiguchi Toshihiro, 2006, Environmental Sciences, V13, P77; Oehlmann J, 2007, ECOTOXICOLOGY, V16, P29, DOI 10.1007/s10646-006-0109-x; Chase R, 2002, BEHAV ITS NEURAL CON; Fretter V., 1962, BRIT PROSOBRANCH MOL; Geraerts WPM, 1988, NEUROHORMONES INVERT, P261, DOI 10.1017/CBO9780511752230.015; Horiguchi T, 1998, SCI TOTAL ENVIRON, V214, P65, DOI 10.1016/S0048-9697(98)00053-9; Horiuchi Y, 2008, PEPT SCI, V2007, P273; Kawano T, 1995, PEPT CHEM, V1996, P311; Koene JM, 2000, J EXP BIOL, V203, P1071; Matsushima O, 2002, PEPTIDES, V23, P1379, DOI 10.1016/S0196-9781(02)00075-X; Minakata H, 1999, BIOSCI BIOTECH BIOCH, V63, P443, DOI 10.1271/bbb.63.443; Minakata H, 1997, FEBS LETT, V410, P437, DOI 10.1016/S0014-5793(97)00567-X; Morishita F, 2006, PEPTIDES, V27, P483, DOI 10.1016/j.peptides.2005.06.026; Morishita F, 2006, INVERTEBRATE NEUROPE, P37; Morishita F, 2012, PEPTIDES, V38, P291, DOI 10.1016/j.peptides.2012.08.025; Muneoka Y, 2000, ACTA BIOL HUNG, V51, P111; OUMI T, 1995, BIOCHEM BIOPH RES CO, V216, P1072, DOI 10.1006/bbrc.1995.2730; Thibonnier M, 2001, ANNU REV PHARMACOL, V41, P175, DOI 10.1146/annurev.pharmtox.41.1.175; WATSON WH, 1992, J NEUROBIOL, V23, P173, DOI 10.1002/neu.480230208	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	JUN	2015	68						72	82		10.1016/j.peptides.2014.10.009		11	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CI2JF	WOS:000354572200011		
J	Niones, JM; Inukai, Y; Suralta, RR; Yamauchi, A				Niones, Jonathan M.; Inukai, Yoshiaki; Suralta, Roel R.; Yamauchi, Akira			QTL associated with lateral root plasticity in response to soil moisture fluctuation stress in rice	PLANT AND SOIL			English	Article						Chromosome segment substitution lines (CSSL); Drought; Lateral roots; Quantitative trait loci (QTL); Root plasticity; Waterlogging	QUANTITATIVE TRAIT LOCI; DRY-MATTER PRODUCTION; SEGMENT SUBSTITUTION LINES; FED LOWLAND RICE; ORYZA-SATIVA L.; MAPPING QTLS; AERENCHYMA DEVELOPMENT; GENOTYPIC VARIATION; DROUGHT AVOIDANCE; MOLECULAR MARKERS	Background Lateral root (LR) plasticity is a key trait that plays a significant role in plant adaptation to fluctuating soil moisture stressed environments. We previously had demonstrated that promoted LR production (LR plasticity) contributed to the maintenance in shoot dry matter production and grain yield under soil moisture fluctuation (SMF) stress. Aim To identify quantitative trait loci (QTLs) associated with LR plasticity under SMF condition and their contributions to shoot dry matter production. Methods F-2 lines derived from Nipponbare x chromosome segment substituted line number 47 (Nipponbare/Kasalath) backcrosses were used to analyze ten substituted chromosome regions with 'Kasalath' allele that are associated with root plasticity under SMF stress. Results We mapped two closely linked QTLs on chromosome 12 region namely qTLRN-12 at seedling stage and qLLRN-12 at vegetative stage. Under SMF conditions, qTLRN-12 found at the flanking markers between TG154 and RM247 is responsible for the plasticity in total LR number while qLLRN-12 detected at the flanking markers between RM6296 and TG156 is associated with plasticity in L-type LR production. Kasalath genome contributed the corresponding alleles for increasing the mentioned root traits that resulted in a significant increase in shoot dry matter production under SMF stress. Conclusion We identified two QTLs associated with LR plasticity on chromosome 12 which significantly contributed to the greater root system development and maintenance of total dry matter production under SMF stress.	[Niones, Jonathan M.; Suralta, Roel R.] Philippine Rice Res Inst, Sci City Of Munoz 3119, Nueva Ecija, Philippines; [Inukai, Yoshiaki] Nagoya Univ, Int Cooperat Ctr Agr Educ, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Suralta, Roel R.; Yamauchi, Akira] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Yamauchi, A (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	ayama@agr.nagoya-u.ac.jp			Japan Society for the Promotion of Science [26292012]	We would like to thank the following: Dr. Abdelbagi M. Ismail of International Rice Research Institute for his critical review and useful comments on our manuscript, Drs. Ma. Rosalyn Angeles-Shim (Nagoya University, Japan) and Jennifer T. Niones (Philippine Rice Research Institute) for reviewing and technical editing, and Ms. Ev A. Parac (Philippine Rice Research Institute) for the English editing. This research was supported by Grant-Aid for Scientific Research (No. 26292012) from the Japan Society for the Promotion of Science, and contributed to the Generation Challenge Project under the Consultative Group for International Agricultural Research on "Targeting drought avoidance root traits to enhance rice productivity under water-limited environments".	Ali ML, 2000, THEOR APPL GENET, V101, P756, DOI 10.1007/s001220051541; Henry A, 2011, FIELD CROP RES, V120, P205, DOI 10.1016/j.fcr.2010.10.003; Yadav R, 1997, THEOR APPL GENET, V94, P619, DOI 10.1007/s001220050459; Kamoshita A, 2004, PLANT PROD SCI, V7, P406, DOI 10.1626/pps.7.406; Kamoshita A, 2002, THEOR APPL GENET, V104, P880, DOI 10.1007/s00122-001-0837-5; Courtois B, 2009, RICE, V2, P115, DOI 10.1007/s12284-009-9028-9; Siopongco JDLC, 2006, PLANT PROD SCI, V9, P141, DOI 10.1626/pps.9.141; Gowda VRP, 2011, FIELD CROP RES, V122, P1, DOI 10.1016/j.fcr.2011.03.001; Wiengweera A, 1997, ANN BOT-LONDON, V80, P115, DOI 10.1006/anbo.1996.0405; Joehanes R, 2008, BIOINFORMATICS, V24, P2788, DOI 10.1093/bioinformatics/btn523; Paterson AH, 2003, THEOR APPL GENET, V106, P384, DOI 10.1007/s00122-002-1025-y; Qu YY, 2008, GENETICA, V133, P187, DOI 10.1007/s10709-007-9199-5; LANDER ES, 1989, GENETICS, V121, P185; OTOOLE JC, 1987, ADV AGRON, V41, P91, DOI 10.1016/S0065-2113(08)60803-2; YAMAUCHI A, 1987, JPN J CROP SCI, V56, P608; Kamoshita A, 2002, CROP SCI, V42, P255; Kano M, 2011, PLANT SOIL, V342, P117, DOI 10.1007/s11104-010-0675-9; Babu RC, 2003, CROP SCI, V43, P1457; Banoc Dionisio M., 2000, Plant Production Science, V3, P335; Boling A, 2004, FIELD CROP RES, V90, P351, DOI 10.1019/j.fcr.2004.04.005; CHAMPOUX MC, 1995, THEOR APPL GENET, V90, P969, DOI 10.1007/BF00222910; Courdert Y, 2010, TRENDS PLANT SCI, V15, P219; Gramene, 2005, GRAM PROJ 2005; Horii H, 2006, PLANT BREEDING, V125, P198, DOI 10.1111/j.1439-0523.2006.01124.x; Huang G, 2004, PLANT SOIL, V263, P229, DOI 10.1023/B:PLSO.0000047736.66712.c6; Ito K, 2006, PHYSIOL PLANTARUM, V127, P260, DOI 10.1111/j.1399-3054.2006.00657.x; Kamoshita Akihiko, 2000, Plant Production Science, V3, P189; KANG SY, 1994, JPN J CROP SCI, V63, P118; KANO-NAKATA M, 2011, PLANT PROD SCI, V14, P329; Kato Y, 2011, FIELD CROP RES, V123, P130, DOI 10.1016/j.fcr.2011.05.009; Kimura K, 2001, PLANT SOIL, V234, P37, DOI 10.1023/A:1010501905868; Kimura K, 1999, PLANT SOIL, V216, P117, DOI 10.1023/A:1004778925316; Kobata T, 1996, JPN J CROP SCI, V65, P652; KONO Y, 1987, JPN J CROP SCI, V56, P597; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; MacMillan K, 2006, THEOR APPL GENET, V113, P953, DOI 10.1007/s00122-006-0357-4; Niones JM, 2013, PLANT PROD SCI, V16, P205, DOI 10.1626/pps.16.205; Niones JM, 2012, PLANT SOIL, V359, P107, DOI 10.1007/s11104-012-1178-7; Ober ES, 2003, J EXP BOT, V54, P813, DOI 10.1093/jxb/erg060; Ogawa A, 2005, PLANT PROD SCI, V8, P73; Price AH, 2002, FIELD CROP RES, V76, P25, DOI 10.1016/S0378-4290(02)00010-2; Rebouillat J, 2009, RICE, V2, P15, DOI 10.1007/s12284-008-9016-5; RGP, 2000, RIC GEN PROJ NAT I A; Siopongco JDLC, 2005, PLANT PROD SCI, V8, P497, DOI 10.1626/pps.8.497; Suralta RR, 2008, ENVIRON EXP BOT, V64, P75, DOI 10.1016/j.envexpbot.2008.01.004; Suralta RR, 2008, PLANT PROD SCI, V11, P457, DOI 10.1626/pps.11.457; Suralta RR, 2008, PLANT PROD SCI, V11, P324, DOI 10.1626/pps.11.324; Wang H, 2005, RICE IS LIFE SCI PER, P464; Wang H, 2009, ENVIRON EXP BOT, V65, P338, DOI 10.1016/j.envexpbot.2008.10.002; Wang H., 2006, PLANT ENV INTERACTIO, P271, DOI 10.1201/9781420019346.ch10; Yadav Sudhir, 2011, Field Crops Research, V120, DOI 10.1016/j.fcr.2010.09.003; Yamauchi A., 1996, ROOTS NITROGEN CROPP, P211; Zhang WP, 2001, THEOR APPL GENET, V103, P118, DOI 10.1007/s001220100561; Zheng Bing-Song, 2006, Acta Genetica Sinica, V33, P141, DOI 10.1016/S0379-4172(06)60033-4; Zheng BS, 2003, THEOR APPL GENET, V107, P1505, DOI 10.1007/s00122-003-1390-1; Zheng K, 1995, PCR BASED MARKER ASS, P1	56	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0032-079X	1573-5036		PLANT SOIL	Plant Soil	JUN	2015	391	1-2					63	75		10.1007/s11104-015-2404-x		13	Agronomy; Plant Sciences; Soil Science	Agriculture; Plant Sciences	CH7DZ	WOS:000354197100005		
J	Gong, X; Guo, CH; Terachi, T; Cai, HS; Yu, DS				Gong, Xun; Guo, Changhong; Terachi, Toru; Cai, Hongsheng; Yu, Diansi			Tobacco PIC1 Mediates Iron Transport and Regulates Chloroplast Development	PLANT MOLECULAR BIOLOGY REPORTER			English	Article						Tobacco; Chloroplast; NtPIC1; Iron transporter; RNA interference	INNER ENVELOPE MEMBRANE; AMINO-ACID-SEQUENCE; ARABIDOPSIS-THALIANA; METAL TRANSPORTER; DIFFERENTIAL REGULATION; TRANSGENIC TOBACCO; CIRCADIAN CLOCK; HIGHER-PLANTS; HOMEOSTASIS; EXPRESSION	Iron is an essential element for plant growth and development, playing important roles in a variety of cellular activities including cell respiration, chlorophyll biosynthesis, and DNA synthesis. In chloroplasts, iron is essential for photosynthetic electron transport and functions as a cofactor for superoxide dismutases. Thus, iron homeostasis is critical for chloroplast and plant development. To better understand the mechanisms by which iron is transported into chloroplasts, we cloned and characterized the Nicotiana tabacum homolog of AtPIC1, which is a chloroplast iron transporter in Arabidopsis thaliana. NtPIC1 was expressed in many tissues of the tobacco plant, and the encoded protein was localized to the chloroplast envelope. Southern blotting indicated that there is a single copy of NtPIC1 in the tobacco genome. Moreover, yeast complementation assays suggested that NtPIC1 transports iron. We used RNA interference to downregulate NtPIC1 in transgenic plants, which resulted in albinism, dwarfism, iron-deficient chloroplasts, and chloroplast that exhibited ultrastructural defects. NtPIC1 overexpression resulted in deep-green leaves, elevated levels of chlorophyll, more densely packed chloroplasts, and the accumulation of iron and starch grains within chloroplasts. In addition, NtPIC1 influenced the expression of genes involved in iron transport, iron storage, iron oxidative stress, and the biogenesis of iron-sulfur proteins. These results suggest that NtPIC1 transports iron into chloroplasts, regulates iron homeostasis, and influences plant development.	[Gong, Xun; Guo, Changhong; Cai, Hongsheng; Yu, Diansi] Harbin Normal Univ, Coll Life Sci & Technol, Key Lab Mol Cytogenet & Genet Breeding Heilongjia, Harbin 150025, Peoples R China; [Terachi, Toru] Kyoto Sangyo Univ, Dept Bioresource & Environm Sci, Fac Life Sci, Kyoto 6038555, Japan	Guo, CH (reprint author), Harbin Normal Univ, Coll Life Sci & Technol, Key Lab Mol Cytogenet & Genet Breeding Heilongjia, Harbin 150025, Peoples R China.	kaku_2008@163.com			MOST 863 project [2013AA102607-5]; Graduate Innovation Fund of Harbin Normal University [HSDBSCX2012-05]; Natural Science Foundation of Heilongjiang Province of China [C201308C0601]	We thank Dr. Mikio Nozoe (Faculty of Engineering, Kyoto Sangyo University, Japan) for helping to clone NtPIC1. We also thank Dr. Yao Guang Liu (South China Agricultural University, China) for kindly providing the pRNAi vector, Prof. Shaojian Zheng (Zhejiang University) for providing the yeast strain BY4741, and Prof. Yuanmei Zuo (China Agricultural University) for providing the yeast strain DEY1453. This work was supported by MOST 863 project (2013AA102607-5), and the Graduate Innovation Fund of Harbin Normal University (HSDBSCX2012-05) and Natural Science Foundation of Heilongjiang Province of China (C201308C0601).	Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Nouet C, 2011, TRENDS PLANT SCI, V16, P395, DOI 10.1016/j.tplants.2011.03.005; Morrissey J, 2009, CHEM REV, V109, P4553, DOI 10.1021/cr900112r; Varotto C, 2002, PLANT J, V31, P589, DOI 10.1046/j.1365-313X.2002.01381.x; TERRY N, 1986, J PLANT NUTR, V9, P609, DOI 10.1080/01904168609363470; Briat JF, 2007, CURR OPIN PLANT BIOL, V10, P276, DOI 10.1016/j.pbi.2007.04.003; Dellagi A, 2005, PLANT J, V43, P262, DOI 10.1111/j.1365-313X.2005.02451.x; Mori S, 1999, CURR OPIN PLANT BIOL, V2, P250, DOI 10.1016/S1369-5266(99)80043-0; CRICHTON RR, 1992, BIOCHEMISTRY-US, V31, P11255, DOI 10.1021/bi00161a001; Duy D, 2007, PLANT CELL, V19, P986, DOI 10.1105/tpc.106.047407; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; GUERINOT ML, 1994, PLANT PHYSIOL, V104, P815; Kim SA, 2007, FEBS LETT, V581, P2273, DOI 10.1016/j.febslet.2007.04.043; Teng YS, 2006, PLANT CELL, V18, P2247, DOI 10.1105/tpc.106.044305; HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y; JOHNSTON M, 1984, AUST J PLANT PHYSIOL, V11, P325; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Divol F, 2013, PLANT CELL, V25, P1040, DOI 10.1105/tpc.112.107672; Xiong HC, 2012, J EXP BOT, V63, P4437, DOI 10.1093/jxb/ers117; Henriques R, 2002, PLANT MOL BIOL, V50, P587, DOI 10.1023/A:1019942200164; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARSCHNER H, 1986, J PLANT NUTR, V9, P695, DOI 10.1080/01904168609363475; Briat JF, 1997, TRENDS PLANT SCI, V2, P187, DOI 10.1016/S1360-1385(97)85225-9; Zhang Y, 2011, BBA-BIOENERGETICS, V1807, P391, DOI 10.1016/j.bbabio.2011.01.006; Hell R, 2003, PLANTA, V216, P541, DOI 10.1007/s00425-002-0920-4; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Salome PA, 2013, EMBO J, V32, P511, DOI 10.1038/emboj.2012.330; Conte S, 2009, PLANT PHYSIOL, V151, P559, DOI 10.1104/pp.109.143487; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Philippar K, 2007, P NATL ACAD SCI USA, V104, P678, DOI 10.1073/pnas.0610062104; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Watson JM, 2005, FEBS LETT, V579, P5982, DOI 10.1016/j.febslet.2005.08.014; Stephan UW, 1996, BIOMETALS, V9, P84; Palmer CM, 2009, NAT CHEM BIOL, V5, P333, DOI 10.1038/nchembio.166; Curie C, 2000, BIOCHEM J, V347, P749, DOI 10.1042/0264-6021:3470749; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; HORSCH RB, 1985, SCIENCE, V227, P1229; Bereczky Z, 2003, J BIOL CHEM, V278, P24697, DOI 10.1074/jbc.M301365200; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Takahashi R, 2011, J EXP BOT, V62, P4843, DOI 10.1093/jxb/err136; Cornah JE, 2003, TRENDS PLANT SCI, V8, P224, DOI 10.1016/S1360-1385(03)00064-6; Hodoshima H, 2007, PHYSIOL PLANTARUM, V129, P622, DOI 10.1111/j.1399-3054.2006.00825.x; Blanco NE, 2011, PLANT J, V65, P922, DOI 10.1111/j.1365-313X.2010.04479.x; Briat JF, 2010, ANN BOT-LONDON, V105, P811, DOI 10.1093/aob/mcp128; Bughio N, 1997, PLANT CELL PHYSIOL, V38, P101; CALVIN M, 1976, PHOTOCHEM PHOTOBIOL, V23, P425, DOI 10.1111/j.1751-1097.1976.tb07276.x; Castagna A., 2009, V44, P205; DIX DR, 1994, J BIOL CHEM, V269, P26092; Duan C, 1994, J YUNNAN U, V16, P258; Duy D, 2011, PLANT PHYSIOL, V155, P1709, DOI 10.1104/pp.110.170233; Jiang TB, 2005, J INTEGR PLANT BIOL, V47, P477, DOI 10.1111/j.1744-7909.2005.00044.x; Jukes TH, 1995, PHOTOSYNTH RES, V46, P13, DOI 10.1007/BF00020410; Kikuchi S, 2009, PLANT CELL, V21, P1781, DOI 10.1105/tpc.108.063552; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Kumar V, 2013, MOL BIOTECHNOL, V53, P118, DOI 10.1007/s12033-012-9495-x; LOBREAUX S, 1992, BIOCHEM J, V288, P931; Rochaix JD, 2005, DISCOVERIES PHOTOSYN, P1047; Shimoni-Shor E, 2010, PLANT CELL ENVIRON, V33, P1029, DOI 10.1111/j.1365-3040.2010.02124.x; Shingles R, 2001, ANAL BIOCHEM, V296, P106, DOI 10.1006/abio.2001.5209; Tognetti VB, 2007, P NATL ACAD SCI USA, V104, P11495, DOI 10.1073/pnas.0704553104; Vigani G, 2013, TRENDS PLANT SCI, V18, P305, DOI 10.1016/j.tplants.2013.01.006; Wilson GT, 2013, EMBO J, V32, P490, DOI 10.1038/emboj.2013.14	67	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0735-9640	1572-9818		PLANT MOL BIOL REP	Plant Mol. Biol. Rep.	JUN	2015	33	3					401	413		10.1007/s11105-014-0758-5		13	Biochemical Research Methods; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CI1HV	WOS:000354495500006		
J	Kato-Minoura, T; Karino, K; Akimoto, N; Yoshiga, N; Ehara, M; Aoki, S				Kato-Minoura, Takako; Karino, Kumiko; Akimoto, Nobuyuki; Yoshiga, Norito; Ehara, Mika; Aoki, Seishiro			Phylogenetic analysis of NAP, an unconventional actin of the Volvocales	PLANT SYSTEMATICS AND EVOLUTION			English	Article						Volvocales; Divergent actin	MAXIMUM-LIKELIHOOD; VOLVOX-CARTERI; ENCODING GENE; CHLAMYDOMONAS; EVOLUTION; SEQUENCE; ALIGNMENT; PROTEIN; COMPLEXITY; SELECTION	The unicellular green alga Chlamydomonas reinhardtii has two actin genes, one encoding a conventional actin and the other an unconventional actin called novel actin-like protein (NAP). These actins apparently differ in their ability to polymerize, but their specific functions in the cell are unknown. To understand their evolutionary relationship, we investigated the molecular phylogeny of the actin/NAP family in Volvocales, using fully identified sequences (Chlamydomonas moewusii, Gonium pectorale, and Volvox carteri) and newly determined partial sequences (Eudorina elegans, and Volvulina steinii). Although the origin of the NAP clade remains ambiguous, the inferred phylogenetic trees strongly support the monophyly of NAP genes and show that only the genomes of volvocine species contain NAP genes. The nonsynonymous substitution rate of the NAP gene is, in consistence with its long branch length in the phylogeny, relatively high compared with that of the actin gene. NAP is thus apparently unique to volvocine species and most likely performs a cellular function with fewer constraints.	[Kato-Minoura, Takako; Karino, Kumiko; Akimoto, Nobuyuki; Yoshiga, Norito; Ehara, Mika] Chuo Univ, Dept Biol Sci, Fac Sci & Engn, Bunkyo Ku, Tokyo 1128551, Japan; [Aoki, Seishiro] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Meguro Ku, Tokyo 1538902, Japan	Kato-Minoura, T (reprint author), Chuo Univ, Dept Biol Sci, Fac Sci & Engn, Bunkyo Ku, Kasuga 1-13-27, Tokyo 1128551, Japan.	minoura@bio.chuo-u.ac.jp			Chuo University	This work was supported by grants from Chuo University (Joint Research Grant and Grant for Special Research). The authors express gratitude to Drs. T. Hamaji, H. Nozaki, and A. Fujiyama for the sequence information of G. pectorale actin and NAP; Mses. Y. Kakiyama and Y. Ohto for their assistance with the experiments; Mr. T. Naito for sequencing of G. pectorale NAP cDNA; Dr. N Ueki for maintaining volvocine strains; and Dr. R. Kamiya for his critical reading of the manuscript.	Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2000, MOL BIOL EVOL, V17, P32; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; An SS, 1999, MOL BIOL EVOL, V16, P275; Herron MD, 2008, EVOLUTION, V62, P436, DOI 10.1111/j.1558-5646.2007.00304.x; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Neiman M, 2010, MOL BIOL EVOL, V27, P954, DOI 10.1093/molbev/msp300; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Uchiyama I, 2003, NUCLEIC ACIDS RES, V31, P58, DOI 10.1093/nar/gkg109; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Aoki S, 2013, MOL BIOL EVOL, V30, P2494, DOI 10.1093/molbev/mst153; Arbiza L, 2006, PLOS COMPUT BIOL, V2, P288, DOI 10.1371/journal.pcbi.0020038; Barton N. H., 2007, EVOLUTION; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; CRESNAR B, 1990, CURR GENET, V18, P337, DOI 10.1007/BF00318215; Kasai F., 2009, JPN J PHYCOL S, V57, P1; Kato-Minoura T, 2011, BIOCHEM BIOPH RES CO, V412, P723, DOI 10.1016/j.bbrc.2011.08.040; KatoMinoura T, 1997, J CELL BIOL, V137, P649, DOI 10.1083/jcb.137.3.649; Kato-Minoura T, 1998, BIOCHEM BIOPH RES CO, V251, P71, DOI 10.1006/bbrc.1998.9373; Kato-Minoura T, 2003, J MOL EVOL, V57, P555, DOI 10.1007/s00239-003-2509-3; Kwan AL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-210; Lee VD, 1997, GENE, V197, P153, DOI 10.1016/S0378-1119(97)00254-0; Sheterline P, 1999, ACTIN, V4th; Sugase Y, 1996, GENE, V168, P117, DOI 10.1016/0378-1119(95)00711-3; WEBER K, 1994, EMBO J, V13, P1280; ZAKUT R, 1982, NATURE, V298, P857, DOI 10.1038/298857a0; Zhou LM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp319	31	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0378-2697	1615-6110		PLANT SYST EVOL	Plant Syst. Evol.	JUN	2015	301	6					1725	1733		10.1007/s00606-014-1187-5		9	Plant Sciences; Evolutionary Biology	Plant Sciences; Evolutionary Biology	CH7VE	WOS:000354243900013		
J	Kawahara, S; Shioyama, S; Nuorn, C; Fukuhara, L; Ishii, H; Yamamoto, Y; Takenaka, K				Kawahara, Seiichi; Shioyama, Shintaro; Nuorn, Choothong; Fukuhara, Lina; Ishii, Hiroyuki; Yamamoto, Yoshimasa; Takenaka, Katsuhiko			Preparation and properties of phenyl-modified natural rubber	POLYMERS FOR ADVANCED TECHNOLOGIES			English	Article						natural rubber; Suzuki-Miyaura cross-coupling reaction; NMR	AMORPHOUS POLYSTYRENE; N-BROMOSUCCINIMIDE; SOLID POLYMERS; DEUTERON NMR; T-G; UREA; RELAXATIONS; TEMPERATURE; PROTEINS; DYNAMICS	We prepared phenyl-modified natural rubber using a two-step process. In the first step, natural rubber was brominated using N-bromosuccinimide in a dichloromethane solution of natural rubber. The amount of N-bromosuccinimide controlled the bromine content. In the second step, a Suzuki-Miyaura cross-coupling reaction of the brominated natural rubber with phenyl boronic acid in the presence of a palladium catalyst replaced the bromine atoms with phenyl groups. H-1-nuclear magnetic resonance and C-13-nuclear magnetic resonance measurements characterized the products. The signals around 7ppm in the H-1-nuclear magnetic resonance spectra of the products were assigned to the phenyl protons, and based on the assigned signals, the estimated conversion of the cross-coupling reaction under mild conditions was more than 70mol%. The amount of phenyl groups present affected both the loss tangent and the glass transition temperature of natural rubber, which increases from -62 degrees C to -30 degrees C. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Kawahara, Seiichi; Shioyama, Shintaro; Nuorn, Choothong; Takenaka, Katsuhiko] Nagaoka Univ Technol, Dept Mat Sci & Technol, Nagaoka, Niigata 9402188, Japan; [Fukuhara, Lina; Ishii, Hiroyuki; Yamamoto, Yoshimasa] Tokyo Natl Coll Technol, Dept Chem Sci & Engn, Hachioji, Tokyo 1930997, Japan	Kawahara, S (reprint author), Nagaoka Univ Technol, Dept Mat Sci & Technol, 1603-1 Kamitomioka Cho, Nagaoka, Niigata 9402188, Japan.	kawahara@mst.nagaokaut.ac.jp			Japan Society for the Promotion of Science [21655080, 223501000]; JST-JICA SATREPS	This work was supported partly by a Grant-in-Aid (21655080) for Challenging Exploratory Research and a Grant-in-Aid (223501000) for Scientific Research (B) from the Japan Society for the Promotion of Science and JST-JICA SATREPS.	Chaikumpollert O, 2012, COLLOID POLYM SCI, V290, P331, DOI 10.1007/s00396-011-2549-y; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Kawahara S, 2003, POLYMER, V44, P4527, DOI 10.1016/S0032-3861(03)00415-4; Kanaya T, 1996, J CHEM PHYS, V104, P3841, DOI 10.1063/1.471037; Tanaka Y, 1996, PHYTOCHEMISTRY, V41, P1501, DOI 10.1016/0031-9422(95)00817-9; Klinklai W, 2004, SOLID STATE IONICS, V168, P131, DOI 10.1016/j.ssi.2003.12.024; SPIESS HW, 1983, COLLOID POLYM SCI, V261, P193, DOI 10.1007/BF01469664; Heropoulos GA, 2007, TETRAHEDRON LETT, V48, P3247, DOI 10.1016/j.tetlet.2007.03.023; DJERASSI C, 1948, CHEM REV, V43, P271, DOI 10.1021/cr60135a004; Jereb M, 2009, HELV CHIM ACTA, V92, P555; Kawahara S, 2004, POLYM ADVAN TECHNOL, V15, P181, DOI 10.1002/pat.465; Zhao J, 2001, RUBBER CHEM TECHNOL, V74, P409, DOI 10.5254/1.3547645; Halasa AF, 2005, POLYMER, V46, P4166, DOI 10.1016/j.polymer.2005.02.063; SCHAEFER J, 1984, MACROMOLECULES, V17, P1107, DOI 10.1021/ma00136a001; TANAKA Y, 1971, J POLYM SCI A2, V9, P43, DOI 10.1002/pol.1971.160090104; BRADBURY JH, 1987, POLYMER, V28, P1098, DOI 10.1016/0032-3861(87)90249-7; Chaikumpollert O, 2012, POLYM ADVAN TECHNOL, V23, P825, DOI 10.1002/pat.1965; CHU CY, 1987, RUBBER CHEM TECHNOL, V60, P636, DOI 10.5254/1.3536147; KANAYA T, 1995, PHYSICA B, V213, P502, DOI 10.1016/0921-4526(95)00193-D; KAWAGUCHI T, 1995, PHYSICA B, V213, P510, DOI 10.1016/0921-4526(95)00195-F; Kawahara S, 2006, J POLYM SCI POL CHEM, V44, P1561, DOI 10.1002/pola.21282; Klinklai W, 2004, J APPL POLYM SCI, V93, P555, DOI 10.1002/app.20463; Larock R. C., 1989, COMPREHENSIVE ORGANI; Manroshan S, 2009, J RUBBER RES, V12, P1; Nechvatal A., 1972, ADV FREE RADICAL CHE, V4, P175; Oda M, 1996, ORG SYNTH, V73, P240; Smith M. B., 2007, MARCHS ADV ORGANIC C; SPIESS HW, 1983, J MOL STRUCT, V111, P119, DOI 10.1016/0022-2860(83)85107-2; Suzuki M., 2009, NIPPON GOMU KYOKAISH, V82, P241; Takenaka K, 2012, J POLYM SCI POL CHEM, V50, P659, DOI 10.1002/pola.25075; Wohl A, 1919, BER DTSCH CHEM GES, V52, P51, DOI 10.1002/cber.19190520109; Yamamoto Y, 2010, J POLYM SCI POL CHEM, V48, P2418, DOI 10.1002/pola.24011; Yamamoto Y, 2008, J APPL POLYM SCI, V107, P2329, DOI 10.1002/app.27236; YANO O, 1971, J POLYM SCI A2, V9, P669, DOI 10.1002/pol.1971.160090409; Ziegler K, 1942, LIEBIGS ANN CHEM, V551, P1	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7147	1099-1581		POLYM ADVAN TECHNOL	Polym. Adv. Technol.	JUN	2015	26	6					546	554		10.1002/pat.3482		9	Polymer Science	Polymer Science	CI3HT	WOS:000354639300002		
J	Adachi, K; Toyomura, S; Miyakuni, Y; Yamazaki, S; Honda, K; Hirano, T				Adachi, Kenta; Toyomura, Shoko; Miyakuni, Yuko; Yamazaki, Suzuko; Honda, Kensuke; Hirano, Tomoyuki			Dioxomolybdenum(VI) and dioxotungsten(VI) complexes: efficient catalytic activity for crosslinking reaction in ethylene-vinyl acetate copolymer/alkoxysilane composites	POLYMERS FOR ADVANCED TECHNOLOGIES			English	Article						dioxomolybdenum(VI); dioxotungsten(VI); ethylene-vinyl acetate copolymer; alkoxysilane; transesterification	PROPYLENE COPOLYMER SYSTEM; ORGANOTIN COMPOUNDS; SOLUBILITY PARAMETERS; WATER; GEL; NMR; SPECTROSCOPY; DIBUTYLTIN; TEOS; MOLYBDENUM	The catalytic performances of several bis(acetylacetonato)metal complexes [Cu(acac)(2), Zn(acac)(2), TiO(acac)(2), VO(acac)(2), MoO2(acac)(2), and WO2(acac)(2)] were investigated for the crosslinking reaction via transesterifications in the ethylene-vinyl acetate copolymer/tetraethoxysilane (EVA/TEOS) composite system by means of dynamic attenuated total reflectance Fourier transform infrared, solvent swelling, and solid-state Si-29 cross polarization/magic angle spinning nuclear magnetic resonance techniques. Results of the kinetic examination revealed that MoO2(acac)(2) and WO2(acac)(2) exhibited a higher catalytic activity than di-n-butyltin(IV) oxide, which is a catalyst most commonly used for the transesterification process in polymer system, but has a toxic effect on the environmental health. And furthermore, the crosslink density and final siloxane network structure of crosslinked EVA/TEOS composites are found to be greatly correlated with the catalyst used. On the basis of the S(N)2-Si pathway, a plausible catalytic mechanism of MoO2(acac)(2) and WO2(acac)(2) was proposed for the crosslinking reaction via transesterifications of the vinyl acetate moieties in EVA backbone with the ethoxysilane groups in one TEOS molecule. The findings in this study may fill the blank in the high performance and environmentally friendly catalyst in the field of the crosslinking reactions in polymer system and provide useful clue for other transesterifications. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Adachi, Kenta; Miyakuni, Yuko; Yamazaki, Suzuko; Honda, Kensuke] Yamaguchi Univ, Grad Sch Sci & Engn, Dept Environm Sci & Engn, Yamaguchi 7538512, Japan; [Toyomura, Shoko] Yamaguchi Univ, Fac Sci, Dept Biol & Chem, Yamaguchi 7538512, Japan; [Hirano, Tomoyuki] MORESCO, Frontier Res & Dev Dept, Kobe, Hyogo 6500047, Japan	Adachi, K (reprint author), Yamaguchi Univ, Grad Sch Sci & Engn, Dept Environm Sci & Engn, Yamaguchi 7538512, Japan.	k-adachi@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24750069]	This study was partially supported by the Scientific Research of the Grant-in-Aid for Young Scientists (B) (No. 24750069) from Japan Society for the Promotion of Science (JSPS). The author (K. A.) thanks Dr. Paul H. Kasai (MORESCO) and Dr. Katsuhiko Nakamae (Synchrotron Radiation Nanotechnology Laboratory) for their helpful supports and advices and for fruitful discussions.	Adachi K, 2008, IND ENG CHEM RES, V47, P1812, DOI 10.1021/ie0708069; Adachi K, 2010, POLYM INT, V59, P510, DOI 10.1002/pi.2729; Adachi K, 2011, POLYM ENG SCI, V51, P632, DOI 10.1002/pen.21856; Adachi K, 2009, J SOL-GEL SCI TECHN, V49, P186, DOI 10.1007/s10971-008-1857-2; Al-Malaika S., 1997, REACTIVE MODIFIERS P; Liu HC, 2003, J CATAL, V217, P222, DOI 10.1016/S0021-9517(03)00025-3; Hirschl C, 2013, SOL ENERG MAT SOL C, V116, P203, DOI 10.1016/j.solmat.2013.04.022; Czanderna AW, 1996, SOL ENERG MAT SOL C, V43, P101, DOI 10.1016/0927-0248(95)00150-6; FALLER JW, 1991, J AM CHEM SOC, V113, P1579, DOI 10.1021/ja00005a021; Bounor-Legare V, 2004, POLYMER, V45, P1485, DOI 10.1016/j.polymer.2003.12.027; Hulsmann P, 2014, PROG PHOTOVOLTAICS, V22, P415, DOI 10.1002/pip.2273; PEETERS MPJ, 1995, J NON-CRYST SOLIDS, V189, P77, DOI 10.1016/0022-3093(95)00248-0; Adachi K, 2008, EUR POLYM J, V44, P542, DOI 10.1016/j.eurpolymj.2007.11.033; Kannan K, 1999, ENVIRON SCI TECHNOL, V33, P1776, DOI 10.1021/es990011w; Whalen MM, 1999, ENVIRON RES, V81, P108, DOI 10.1006/enrs.1999.3968; Adachi K, 2007, MACROMOL REACT ENG, V1, P313, DOI 10.1002/mren.200600044; Cledon M, 2006, J MAR BIOL ASSOC UK, V86, P751, DOI 10.1017/S002531540601366X; GLASER RH, 1989, J NON-CRYST SOLIDS, V113, P73, DOI 10.1016/0022-3093(89)90320-7; BOYER IJ, 1989, TOXICOLOGY, V55, P253, DOI 10.1016/0300-483X(89)90018-8; Bianchi O, 2011, POLYM TEST, V30, P616, DOI 10.1016/j.polymertesting.2011.05.001; SHAIKH AAG, 1992, IND ENG CHEM RES, V31, P1167, DOI 10.1021/ie00004a028; KOENHEN DM, 1975, J APPL POLYM SCI, V19, P1163, DOI 10.1002/app.1975.070190423; BARTON AFM, 1985, PURE APPL CHEM, V57, P905, DOI 10.1351/pac198557070905; Barton A.F.M., 1983, HDB SOLUBILITY PARAM; BONETTI J, 1994, J ORGANOMET CHEM, V481, P7, DOI 10.1016/0022-328X(94)85003-8; Bounor-Legare V., 2004, Polymer International, V53, DOI 10.1002/pi.1424; Bounor-Legare V, 2002, POLYMER, V43, P6085, DOI 10.1016/S0032-3861(02)00364-6; Brandup J., 1999, POLYM HDB; BRUNET F, 1993, J NON-CRYST SOLIDS, V163, P211, DOI 10.1016/0022-3093(93)91298-H; Drobny J.G., 2014, HDB THERMOPLASTIC EL; Fent Karl, 1996, Critical Reviews in Toxicology, V26, P1, DOI 10.1080/1040844041696481; Innocenzi P, 2003, J NON-CRYST SOLIDS, V316, P309, DOI 10.1016/S0022-3093(02)01637-X; Isarankura S., 2008, J APPL POLYM SCI, V107, P3853; Koene B., 2012, PCT international application, Patent No. [WO 2012024005, 2012024005]; Kricheldorf H., 2003, POLYCONDENSATION HIS; Laakso R., 2008, HDB SPECIALTY ELASTO; Litvinov V., 2002, SPECTROSCOPY RUBBER; Liu R, 2013, J SOL-GEL SCI TECHN, V68, P19, DOI 10.1007/s10971-013-3129-z; Llauroa M. -F., 2006, CR CHIM, V11-12, P1363; MATOS MC, 1992, J NON-CRYST SOLIDS, V147, P232, DOI 10.1016/S0022-3093(05)80622-2; Mendez-Vivar J, 2006, J SOL-GEL SCI TECHN, V38, P159, DOI 10.1007/s10971-006-6351-0; Mundy WR, 2006, NEUROTOXICOLOGY, V27, P71, DOI 10.1016/j.neuro.2005.07.007; NARKIS M, 1985, POLYM ENG SCI, V25, P857, DOI 10.1002/pen.760251311; Otera J, 2004, ACCOUNTS CHEM RES, V37, P288, DOI 10.1021/ar030146d; Salazar-Hernandez C, 2009, J SOL-GEL SCI TECHN, V49, P301, DOI 10.1007/s10971-008-1879-9; Scheirs J., 2003, MODERN POLYESTERS CH; Shieh YT, 2001, J APPL POLYM SCI, V81, P186, DOI 10.1002/app.1428; Shifeng W., 2004, J APPL POLYM SCI, V91, P1571; Silverstein R. M., 1991, SPECTROMETRIC IDENTI; SOPTRAJA.B, 1968, SPECTROCHIM ACTA A-M, VA 24, P1617, DOI 10.1016/0584-8539(68)80210-7; Vasile C., 2000, HDB POLYOLEFINS; Verbois A, 2004, POLYM INT, V53, P523, DOI 10.1002/pi.1428; White J. L., 2004, POLYOLEFINS PROCESSI; Wolff F, 2012, RHEOL ACTA, V51, P71, DOI 10.1007/s00397-011-0585-7	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7147	1099-1581		POLYM ADVAN TECHNOL	Polym. Adv. Technol.	JUN	2015	26	6					597	605		10.1002/pat.3491		9	Polymer Science	Polymer Science	CI3HT	WOS:000354639300009		
J	Miyata, A; Iwamoto, K; Kawano, N; Kohmura, K; Yamamoto, M; Aleksic, B; Ebe, K; Noda, A; Noda, Y; Iritani, S; Ozaki, N				Miyata, Akemi; Iwamoto, Kunihiro; Kawano, Naoko; Kohmura, Kunihiro; Yamamoto, Maeri; Aleksic, Branko; Ebe, Kazutoshi; Noda, Akiko; Noda, Yukihiro; Iritani, Shuji; Ozaki, Norio			The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers	PSYCHOPHARMACOLOGY			English	Article						Hypnotics; Ramelteon; Triazolam; Driving performance; Cognitive function; Body sway	DORSOLATERAL PREFRONTAL CORTEX; CHRONIC PRIMARY INSOMNIA; SHORT-SLEEP DURATION; PSYCHOMOTOR PERFORMANCE; POSTURAL SWAY; SUSTAINED ATTENTION; TRANSIENT INSOMNIA; RECEPTOR AGONIST; CONTROLLED TRIAL; ABUSE LIABILITY	Hypnotics are widely used to treat insomnia but adverse effects of different hypnotics, especially benzodiazepine receptor agonists, are getting more attention lately. The effects of novel hypnotics have not been fully examined. This study aims to assess the effects of two hypnotics, ramelteon and triazolam, on driving performance, cognitive function, and equilibrium function. In this double-blinded, three-way crossover trial, 17 healthy males received acute doses of 8 mg ramelteon, 0.125 mg triazolam, and placebo. The subjects were administered three driving tasks-road-tracking, car-following, and harsh-braking-using a driving simulator and three cognitive tasks-Continuous Performance Test, N-back Test, and Trail-Making Test-at baseline and at 1 and 4 h post-dosing. The Stanford Sleepiness Scale scores and computerized posturography were also assessed. In the driving simulations, ramelteon and triazolam increased the number of subjects who slid off the road. Triazolam increased the standard deviation of lateral position compared to ramelteon and placebo at 1 h post-dosing. Ramelteon and triazolam significantly increased the time to complete of Trail-Making Test part A and the environmental area in posturography compared to placebo at 1 and 4 h post-dosing. Ramelteon and triazolam significantly increased subjective sleepiness compared to placebo at 1 h post-dosing. Ramelteon may affect road-tracking performance, visual attention and/or psychomotor speed measured by Trail-Making Test part A, and body balance in acute dosing. Lower dose of triazolam also impaired performance worse than ramelteon. Physicians should consider risks and benefits when prescribing both drugs, especially in the initial period of administration.	[Miyata, Akemi; Iwamoto, Kunihiro; Kawano, Naoko; Kohmura, Kunihiro; Yamamoto, Maeri; Aleksic, Branko; Iritani, Shuji; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Showa Ku, Nagoya, Aichi 4668550, Japan; [Ebe, Kazutoshi] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi, Japan; [Noda, Akiko] Chubu Univ, Dept Biomed Sci, Kasugai, Aichi 487, Japan; [Noda, Yukihiro] Meijo Univ, Grad Sch Pharm, Div Clin Sci & Neuropsychopharmacol, Nagoya, Aichi, Japan	Iwamoto, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Psychiat, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	iwamoto@med.nagoya-u.ac.jp	Aleksic, Branko/G-1540-2011; Ozaki, Norio/M-8908-2014; IWAMOTO, Kunihiro/M-8857-2014	Aleksic, Branko/0000-0001-8982-4580; Ozaki, Norio/0000-0002-7360-4898; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Center of Innovation Program from Japan Science and Technology Agency, JST; NEXCO Group Companies'; General Insurance Association of Japan; Daiwa Syoken Health Foundation; Mitsui-Sumitomo Wellness Foundation; Japan Foundation for Neuroscience and Mental Health	We sincerely thank the healthy volunteers for participating in our study. This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Ministry of Health, Labor and Welfare of Japan; the Center of Innovation Program from Japan Science and Technology Agency, JST; NEXCO Group Companies' Support Fund to Disaster Prevention Measures on Expressways; the General Insurance Association of Japan; the Daiwa Syoken Health Foundation; the Mitsui-Sumitomo Wellness Foundation; and the Japan Foundation for Neuroscience and Mental Health.	Erman M, 2006, SLEEP MED, V7, P17, DOI 10.1016/j.sleep.2005.09.004; Roehrs T, 2001, SLEEP MED, V2, P323, DOI 10.1016/S1389-9457(00)00067-8; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Mets MAJ, 2010, SLEEP MED REV, V14, P259, DOI 10.1016/j.smrv.2009.10.008; Shahly V, 2012, ARCH GEN PSYCHIAT, V69, P1054, DOI 10.1001/archgenpsychiatry.2011.2188; Vermeeren A, 2004, CNS DRUGS, V18, P297, DOI 10.2165/00023210-200418050-00003; Morin CM, 2009, ARCH INTERN MED, V169, P447, DOI 10.1001/archinternmed.2008.610; Vgontzas AN, 2010, SLEEP, V33, P1159; Vgontzas AN, 2009, DIABETES CARE, V32, P1980, DOI 10.2337/dc09-0284; Zammit G, 2009, SLEEP MED, V10, P55, DOI 10.1016/j.sleep.2008.04.010; Fava M, 2006, BIOL PSYCHIAT, V59, P1052, DOI 10.1016/j.biopsych.2006.01.016; CORNBLATT BA, 1988, PSYCHIAT RES, V26, P223, DOI 10.1016/0165-1781(88)90076-5; Demakis GJ, 2004, J CLIN EXP NEUROPSYC, V26, P441, DOI 10.1080/13803390490510149; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Hatta K, 2014, JAMA PSYCHIAT, V71, P397, DOI 10.1001/jamapsychiatry.2013.3320; Leufkens TRM, 2009, J CLIN PSYCHOPHARM, V29, P432, DOI 10.1097/JCP.0b013e3181b57b43; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Gustavsen I, 2008, SLEEP MED, V9, P818, DOI 10.1016/j.sleep.2007.11.011; Hall MH, 2008, SLEEP, V31, P635; Calem M, 2012, SLEEP, V35, P377, DOI 10.5665/sleep.1700; Johnson MW, 2006, ARCH GEN PSYCHIAT, V63, P1149, DOI 10.1001/archpsyc.63.10.1149; Kato K, 2005, NEUROPHARMACOLOGY, V48, P301, DOI 10.1016/j.neuropharm.2004.09.007; Otmani S, 2012, HUM PSYCHOPHARM CLIN, V27, P270, DOI 10.1002/hup.2219; OHANLON JF, 1982, SCIENCE, V217, P79, DOI 10.1126/science.7089544; Leufkens TRM, 2009, J SLEEP RES, V18, P387, DOI 10.1111/j.1365-2869.2009.00746.x; Verster JC, 2004, SLEEP MED REV, V8, P309, DOI 10.1016/j.smrv.2004.02.001; Stewart SA, 2005, J CLIN PSYCHIAT, V66, P9; Clay E, 2013, EUR J CLIN PHARMACOL, V69, P1, DOI 10.1007/s00228-012-1424-1; Karim A, 2006, J CLIN PHARMACOL, V46, P140, DOI 10.1177/0091270005283461; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Staner L, 2005, PSYCHOPHARMACOLOGY, V181, P790, DOI 10.1007/s00213-005-0082-8; Fujimoto C, 2009, CLIN NEUROPHYSIOL, V120, P1408, DOI 10.1016/j.clinph.2009.05.002; Chang CM, 2013, BRIT J CLIN PHARMACO, V75, P1125, DOI 10.1111/j.1365-2125.2012.04410.x; Ohayon MM, 2002, J CLIN PSYCHIAT, V63, P817; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Mayer G, 2009, SLEEP, V32, P351; Vgontzas AN, 2009, SLEEP, V32, P491; Vermeeren A, 2002, SLEEP, V25, P224; Roth T, 2011, BIOL PSYCHIAT, V69, P592, DOI 10.1016/j.biopsych.2010.10.023; Callicott JH, 2003, AM J PSYCHIAT, V160, P709, DOI 10.1176/appi.ajp.160.4.709; Roth T, 2005, SLEEP, V28, P303; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Mets MAJ, 2011, SLEEP, V34, P1327, DOI 10.5665/SLEEP.1272; Ishizaki K, 2002, PSYCHIAT CLIN NEUROS, V56, P85, DOI 10.1046/j.1440-1819.2002.00933.x; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; Bocca ML, 2011, PSYCHOPHARMACOLOGY, V214, P699, DOI 10.1007/s00213-010-2075-5; Botteman MF, 2007, CNS DRUGS, V21, P319, DOI 10.2165/00023210-200721040-00005; Carter CS, 1998, PROG NEURO-PSYCHOPH, V22, P279, DOI 10.1016/S0278-5846(98)00004-9; Carter LP, 2007, J PHARMACOL EXP THER, V322, P749, DOI 10.1124/jpet.107.119693; Cohen DA, 2010, J CLIN SLEEP MED, V6, P565; Farkas RH, 2013, NEW ENGL J MED, V369, P689, DOI 10.1056/NEJMp1307972; Hallam KT, 2003, HUM PSYCHOPHARM CLIN, V18, P619, DOI 10.1002/hup.542; Huang YL, 2012, SLEEP MED, V13, P263, DOI 10.1016/j.sleep.2011.07.016; Iwamoto K, 2013, HUM PSYCHOPHARM CLIN, V28, P523, DOI 10.1002/hup.2327; Iwamoto K, 2008, HUM PSYCHOPHARM CLIN, V23, P399, DOI 10.1002/hup.939; JOHNSON DN, 1995, PSYCHOPHARMACOLOGY, V121, P145, DOI 10.1007/BF02245623; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V309, P645, DOI 10.1001/jama.2013.323; Kyriacou CP, 2010, TRENDS COGN SCI, V14, P259, DOI 10.1016/j.tics.2010.03.007; LAURELL H, 1986, ACTA PHARMACOL TOX, V58, P182; Lim J, 2013, INT PSYCHOGERIATR, V25, P1543, DOI 10.1017/S1041610213000689; LUSTMAN PJ, 1995, DIABETES CARE, V18, P1133, DOI 10.2337/diacare.18.8.1133; McKean Andrew, 2011, N Z Med J, V124, P108; Mintzer MZ, 1999, PSYCHOPHARMACOLOGY, V144, P8, DOI 10.1007/s002130050971; Mintzer MZ, 2006, PSYCHOPHARMACOLOGY, V188, P445, DOI 10.1007/s00213-006-0446-8; Nakamura M, 2005, ORL J OTO-RHINO-LARY, V67, P106, DOI 10.1159/000084998; Nakano T, 2001, PSYCHIAT CLIN NEUROS, V55, P277, DOI 10.1046/j.1440-1819.2001.00858.x; National Highway Traffic Safety Administration, 2013, TRAFF SAF FACTS 2011; National Police Agency Transportation Authority, 2013, GEN STAT TRAFF ACC D; NIKAIDO AM, 1987, PSYCHOPHARMACOLOGY, V92, P459; OHANLON JF, 1984, BRIT J CLIN PHARMACO, V18, pS121; Pandi-Perumal SR, 2007, NAT CLIN PRACT NEURO, V3, P221, DOI 10.1038/ncpneuro0467; ROACHE JD, 1993, J CLIN PSYCHOPHARM, V13, P3; ROBIN DW, 1991, CLIN PHARMACOL THER, V49, P581; RUSH CR, 1993, PSYCHOPHARMACOLOGY, V112, P407, DOI 10.1007/BF02244887; Rush CR, 1996, J CLIN PSYCHOPHARM, V16, P146, DOI 10.1097/00004714-199604000-00007; Rush CR, 1997, PSYCHOPHARMACOLOGY, V131, P9, DOI 10.1007/s002130050259; Rush CR, 1999, PSYCHOPHARMACOLOGY, V144, P220, DOI 10.1007/s002130050997; Sack RL, 2010, NEW ENGL J MED, V362, P440, DOI 10.1056/NEJMcp0909838; Sasada K, 2013, HUM PSYCHOPHARM CLIN, V28, P281, DOI 10.1002/hup.2321; Spreen OSE, 1998, COMP NEUR TESTS NORM, V2nd; TADA K, 1994, NEUROPSYCHOBIOLOGY, V29, P17, DOI 10.1159/000119057; Takahashi M, 2010, HUM PSYCHOPHARM CLIN, V25, P260, DOI 10.1002/hup.1105; Troy SM, 2000, J CLIN PSYCHOPHARM, V20, P328, DOI 10.1097/00004714-200006000-00007; Uchiyama Y, 2003, NEUROSCI LETT, V352, P199, DOI 10.1016/S0304-3940(03)01069-3; Verster JC, 2013, PSYCHOPHARMACOLOGY B, V231, P283; Zammit G, 2009, J CLIN SLEEP MED, V5, P34; Zee PC, 2010, SLEEP MED, V11, P525, DOI 10.1016/j.sleep.2010.03.010	87	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	JUN	2015	232	12					2127	2137		10.1007/s00213-014-3843-4		11	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CI1DG	WOS:000354481000009		
J	Ago, Y; Condro, MC; Tan, YV; Ghiani, CA; Colwell, CS; Cushman, JD; Fanselow, MS; Hashimoto, H; Waschek, JA				Ago, Yukio; Condro, Michael C.; Tan, Yossan-Var; Ghiani, Cristina A.; Colwell, Christopher S.; Cushman, Jesse D.; Fanselow, Michael S.; Hashimoto, Hitoshi; Waschek, James A.			Reductions in synaptic proteins and selective alteration of prepulse inhibition in male C57BL/6 mice after postnatal administration of a VIP receptor (VIPR2) agonist	PSYCHOPHARMACOLOGY			English	Article						VPAC2 receptor (VIPR2); Schizophrenia; Prepulse inhibition; PSD-95; Synaptophysin; Mouse	CYCLASE-ACTIVATING POLYPEPTIDE; VASOACTIVE-INTESTINAL-PEPTIDE; LONG-TERM POTENTIATION; SUPRACHIASMATIC NUCLEI; PREFRONTAL CORTEX; GENE-EXPRESSION; CEREBRAL-CORTEX; DENTATE GYRUS; MUTANT MICE; SCHIZOPHRENIA	An abundance of genetic and epidemiologic evidence as well as longitudinal neuroimaging data point to developmental origins for schizophrenia and other mental health disorders. Recent clinical studies indicate that microduplications of VIPR2, encoding the vasoactive intestinal peptide (VIP) receptor VPAC2, confer significant risk for schizophrenia and autism spectrum disorder. Lymphocytes from patients with these mutations exhibited higher VIPR2 gene expression and VIP responsiveness (cAMP induction), but mechanisms by which overactive VPAC2 signaling may lead to these psychiatric disorders are unknown. We subcutaneously administered the highly selective VPAC2 receptor agonist Ro 25-1553 to C57BL/6 mice from postnatal day 1 (P1) to P14 to determine if overactivation of VPAC2 receptor signaling during postnatal brain maturation affects synaptogenesis and selected behaviors. Western blot analyses on P21 revealed significant reductions of synaptophysin and postsynaptic density protein 95 (PSD-95) in the prefrontal cortex, but not in the hippocampus in Ro 25-1553-treated mice. The same postnatally restricted treatment resulted in a disruption in prepulse inhibition of the acoustic startle measured in adult mice. No effects were observed in open-field locomotor activity, sociability in the three-chamber social interaction test, or fear conditioning or extinction. Overactivation of the VPAC2 receptor in the postnatal mouse results in a reduction in synaptic proteins in the prefrontal cortex and selective alterations in prepulse inhibition. These findings suggest that the VIPR2-linkage to mental health disorders may be due in part to overactive VPAC2 receptor signaling during a critical time of synaptic maturation.	[Ago, Yukio; Condro, Michael C.; Ghiani, Cristina A.; Fanselow, Michael S.; Waschek, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Ago, Yukio] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Med Pharmacol, Suita, Osaka 5650871, Japan; [Tan, Yossan-Var] Univ Rouen, INSERM Unite Mixte Rech U905 IRIB, F-76183 Rouen, France; [Colwell, Christopher S.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Lab Circadian & Sleep Med, Los Angeles, CA 90095 USA; [Cushman, Jesse D.; Fanselow, Michael S.] Univ Calif Los Angeles, Brain Res Inst, Dept Psychol, Los Angeles, CA 90095 USA; [Hashimoto, Hitoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka 5650871, Japan	Waschek, JA (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, 635 Charles E Young Dr South, Los Angeles, CA 90095 USA.	jwaschek@mednet.ucla.edu			Simons Foundation; Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (Japan) [S2603]; National Institutes of Health [MH098506, HD04612]	We thank Dr. Felix E. Schweizer (UCLA) and Dr. Thomas J. O'Dell (UCLA) for their kind gifts of anti-synaptophysin and anti-PSD-95 antibodies, respectively. This study was supported in part by grants from Simons Foundation, Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (Grant No. S2603, Japan) and National Institutes of Health (MH098506 and HD04612).	Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Yuan JM, 2014, SCHIZOPHR RES, V156, P66, DOI 10.1016/j.schres.2014.04.004; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Matsuyama S, 2003, NEUROREPORT, V14, P2095, DOI 10.1097/01.wnr.0000090953.15465.5a; Karson CN, 1999, MOL PSYCHIATR, V4, P39, DOI 10.1038/sj.mp.4000459; Ghiani CA, 2001, J NEUROSCI, V21, P1274; Glantz LA, 1997, ARCH GEN PSYCHIAT, V54, P943; Amann LC, 2010, BRAIN RES BULL, V83, P147, DOI 10.1016/j.brainresbull.2010.04.008; Nelson KB, 2001, ANN NEUROL, V49, P597, DOI 10.1002/ana.1024; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Swerdlow NR, 2006, ARCH GEN PSYCHIAT, V63, P1325, DOI 10.1001/archpsyc.63.12.1325; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; Nakamachi T, 2011, CURR PHARM DESIGN, V17, P973; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Allais A, 2007, EUR J NEUROSCI, V25, P2604, DOI 10.1111/j.1460-9568.2007.05535.x; O'Kusky JR, 2000, J NEUROSCI, V20, P8435; Ohnuma T, 2000, NEUROREPORT, V11, P3133, DOI 10.1097/00001756-200009280-00019; Zelikowsky M, 2013, BIOL PSYCHIAT, V73, P345, DOI 10.1016/j.biopsych.2012.08.006; Pascual R, 2006, ACTA NEUROBIOL EXP, V66, P7; Braff DL, 1999, AM J PSYCHIAT, V156, P596; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Holt DJ, 2009, BIOL PSYCHIAT, V65, P455, DOI 10.1016/j.biopsych.2008.09.017; Niewiadomski P, 2013, CELL SIGNAL, V25, P2222, DOI 10.1016/j.cellsig.2013.07.012; Hermes G, 2011, PHYSIOL BEHAV, V104, P354, DOI 10.1016/j.physbeh.2010.12.019; Kristiansen LV, 2006, MOL PSYCHIATR, V11, P737, DOI 10.1038/sj.mp.4001844; Otto C, 2001, J NEUROSCI, V21, P5520; Romero E, 2010, MOL PSYCHIATR, V15, P372, DOI 10.1038/mp.2008.44; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; Holt DJ, 2012, ARCH GEN PSYCHIAT, V69, P893, DOI 10.1001/archgenpsychiatry.2011.2310; Ye P, 2002, J NEUROSCI, V22, P6041; Feyder M, 2010, AM J PSYCHIAT, V167, P1508, DOI 10.1176/appi.ajp.2010.10040484; Walf AA, 2009, BEHAV BRAIN RES, V196, P254, DOI 10.1016/j.bbr.2008.09.016; Gale GD, 2009, MOL PSYCHIATR, V14, P631, DOI 10.1038/mp.2008.4; Suh JH, 2001, NAT NEUROSCI, V4, P123, DOI 10.1038/83936; Eastwood SL, 2000, BRIT J PSYCHIAT, V176, P236, DOI 10.1192/bjp.176.3.236; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Charitidi K, 2012, ENDOCRINOLOGY, V153, P4412, DOI 10.1210/en.2012-1416; Council NR, 1996, GUIDE CARE USE LAB A; Falluel-Morel A, 2007, J NEUROENDOCRINOL, V19, P321, DOI 10.1111/j.1365-2826.2007.01537.x; Faludi Gábor, 2011, Int J Dev Neurosci, V29, P305, DOI 10.1016/j.ijdevneu.2011.02.013; Girard BM, 2004, REGUL PEPTIDES, V123, P107, DOI 10.1016/j.regpep.2004.05.024; Gourlet P, 1997, PEPTIDES, V18, P403, DOI 10.1016/S0196-9781(96)00322-1; Hanks AN, 2013, BEHAV BRAIN RES, V252, P405, DOI 10.1016/j.bbr.2013.06.017; Harmar AJ, 2003, J NEUROENDOCRINOL, V15, P335, DOI 10.1046/j.1365-2826.2003.01005.x; Harmar AJ, 1998, PHARMACOL REV, V50, P265; Hattori T, 2007, MOL PSYCHIATR, V12, P398, DOI 10.1038/sj.mp.4001945; Itri J, 2003, J NEUROPHYSIOL, V90, P1589, DOI 10.1152/jn.00332.2003; Jacobs NS, 2010, J NEUROSCI METH, V190, P235, DOI 10.1016/j.jneumeth.2010.04.029; Pakhotin P, 2006, PFLUG ARCH EUR J PHY, V452, P7, DOI 10.1007/s00424-005-0003-z; Reglodi D, 2003, BEHAV BRAIN RES, V140, P131, DOI 10.1016/S0166-4328(02)00289-9; Waschek JA, 1996, J NEUROCHEM, V66, P1762; Waschek JA, 1996, ANN NY ACAD SCI, V805, P290; Yamada K, 2010, PLOS ONE, V5, pe8596; Zupan V, 2000, PEDIATR RES, V47, P53, DOI 10.1203/00006450-200001000-00012	57	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	JUN	2015	232	12					2181	2189		10.1007/s00213-014-3848-z		9	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CI1DG	WOS:000354481000014		
J	Peltokorpi, V; Hasu, M				Peltokorpi, Vesa; Hasu, Mervi			Moderating effects of transformational leadership between external team learning and research team performance outcomes	R & D MANAGEMENT			English	Article							ABSORPTIVE-CAPACITY; PRODUCT DEVELOPMENT; CLIMATE INVENTORY; PROJECT GROUPS; INNOVATION; KNOWLEDGE; WORK; METAANALYSIS; PERSPECTIVE; IMPROVEMENT	A growing body of empirical research examines the effects of external team learning on team performance. While previous studies suggest that external learning activities enhance team performance, the contingencies of such activities have received less research attention. This study examines the moderating effects of transformational team leadership between external team learning and two team performance outcomes: (1) accepted and published articles in peer-reviewed scientific journals, and (2) project occupancy rate. The study was conducted with 124 research teams. Supporting the hypotheses, the findings show that transformational leadership has a positive moderating effect between external team learning and both team performance outcomes.	[Peltokorpi, Vesa] Japan Adv Inst Sci & Technol, Nomi, Ishikawa 9231292, Japan; [Hasu, Mervi] Finnish Inst Occupat Hlth, Helsinki 00250, Finland	Peltokorpi, V (reprint author), Japan Adv Inst Sci & Technol, 1-1 Asahidai, Nomi, Ishikawa 9231292, Japan.	vesap@jaist.ac.jp; mervi.hasu@ttl.fi					Aiken L. S., 1991, MULTIPLE REGRESSION; Allen T., 1984, MANAGING FLOW TECHNO; ANCONA DG, 1990, ACAD MANAGE J, V33, P334, DOI 10.2307/256328; Yukl G, 2009, LEADERSHIP QUART, V20, P49, DOI 10.1016/j.leaqua.2008.11.006; Shin SJ, 2003, ACAD MANAGE J, V46, P703, DOI 10.2307/30040662; Tucker AL, 2007, MANAGE SCI, V53, P894, DOI 10.1287/mnsc.1060.0692; Marrone JA, 2007, ACAD MANAGE J, V50, P1423; Kessler EH, 2000, R&D MANAGE, V30, P213, DOI 10.1111/1467-9310.00172; Haas MR, 2005, STRATEGIC MANAGE J, V26, P1, DOI 10.1002/smj.429; JAMES LR, 1982, J APPL PSYCHOL, V67, P219, DOI 10.1037/0021-9010.67.2.219; Zellmer-Bruhn ME, 2003, MANAGE SCI, V49, P514, DOI 10.1287/mnsc.49.4.514.14423; Anderson NR, 1998, J ORGAN BEHAV, V19, P235, DOI 10.1002/(SICI)1099-1379(199805)19:3<235::AID-JOB837>3.3.CO;2-3; Elkins T, 2003, LEADERSHIP QUART, V14, P587, DOI 10.1016/S1048-9843(03)00053-5; Hulsheger UR, 2009, J APPL PSYCHOL, V94, P1128, DOI 10.1037/a0015978; Burke CS, 2006, LEADERSHIP QUART, V17, P288, DOI 10.1016/j.leaqua.2006.02.007; Kivimaki M, 1999, J OCCUP ORGAN PSYCH, V72, P241, DOI 10.1348/096317999166644; Maloney MM, 2010, SMALL GR RES, V41, P281, DOI 10.1177/1046496410363829; Nemanich LA, 2009, LEADERSHIP QUART, V20, P19, DOI 10.1016/j.leaqua.2008.11.002; Lane PJ, 1998, STRATEGIC MANAGE J, V19, P461, DOI 10.1002/(SICI)1097-0266(199805)19:5<461::AID-SMJ953>3.3.CO;2-C; Edmondson AC, 2007, ACAD MANAG ANN, V1, P269, DOI 10.1080/078559811; Judge TA, 2004, J APPL PSYCHOL, V89, P755, DOI 10.1037/0021-9010.89.5.755; Ryan JC, 2007, R&D MANAGE, V37, P345, DOI 10.1111/j.1467-9310.2007.00480.x; Edmondson AC, 2003, J MANAGE STUD, V40, P1419, DOI 10.1111/1467-6486.00386; Mumford MD, 2002, LEADERSHIP QUART, V13, P705, DOI 10.1016/S1048-9843(02)00158-3; Sarin S, 2003, DECISION SCI, V34, P707, DOI 10.1111/j.1540-5414.2003.02350.x; HENDERSON JC, 1992, MANAGE SCI, V38, P757, DOI 10.1287/mnsc.38.6.757; KATZ R, 1982, R&D MANAGE, V12, P7, DOI 10.1111/j.1467-9310.1982.tb00478.x; Drach-Zahavy A, 2001, GROUP DYN-THEOR RES, V5, P111, DOI 10.1037//1089-2699.5.2.111; KELLER RT, 1992, J MANAGE, V18, P489, DOI 10.1177/014920639201800304; Wong SS, 2004, ORGAN SCI, V15, P645, DOI 10.1287/orsc.1040.0080; Van der Vegt GS, 2003, ACAD MANAGE J, V46, P715, DOI 10.2307/30040663; Nembhard IM, 2006, J ORGAN BEHAV, V27, P941, DOI 10.1002/job.413; Zaccaro SJ, 2001, LEADERSHIP QUART, V12, P451, DOI 10.1016/S1048-9843(01)00093-5; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9101.88.5.879; ANCONA DG, 1992, ADMIN SCI QUART, V37, P634, DOI 10.2307/2393475; JAMES LR, 1984, J APPL PSYCHOL, V69, P85, DOI 10.1037/0021-9010.69.1.85; Vera D, 2004, ACAD MANAGE REV, V29, P222; Bresman H, 2010, ORGAN SCI, V21, P81, DOI 10.1287/orsc.1080.0413; Avolio B. J., 1999, FULL LEADERSHIP DEV; Avolio B. J., 1995, MULTIFACTOR LEADERSH; Bandura A., 1977, SOCIAL LEARNING THEO; Barling J, 1996, J APPL PSYCHOL, V81, P827, DOI 10.1037/0021-9010.81.6.827; Bass B. M., 1985, LEADERSHIP PERFORMAN; Bass B. M., 1998, TRANSFORMATIONAL LEA; Bliese P, 2000, MULTILEVEL THEORY RE, P349; Brewer M. B., 1986, J PERS SOC PSYCHOL, V50, P593; Brislin R., 1980, HDB CROSS CULTURAL P, V2, P349; Brooks A. K., 1994, HUMAN RESOURCE DEV Q, V5, P213, DOI 10.1002/hrdq.3920050303; Cameron AC, 1998, REGRESSION ANAL COUN; COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553; Edmondson Amy C., 2009, J PROD INNOVAT MANAG, V26, P123, DOI DOI 10.1111/J.1540-5885.2009.00341.X; GLICK WH, 1985, ACAD MANAGE REV, V10, P601, DOI 10.2307/258140; Hair J. F. Jr., 1998, MULTIVARIATE DATA AN; HAMBRICK DC, 1992, MANAGE SCI, V38, P1445, DOI 10.1287/mnsc.38.10.1445; Keller R. T., 1996, IEEE T ENG MANAGE, V42, P48; Nunnally J. C., 1978, PSYCHOMETRIC THEORY; Perkmann H., 2009, IND CORP CHANGE, V18, P1033; Roloff K. S., 2011, HDB ORG LEARNING KNO, P249; Schultz C, 2013, RES POLICY, V42, P1356, DOI 10.1016/j.respol.2013.04.008; Sole D, 2002, BRIT J MANAGE, V13, P17, DOI DOI 10.1111/1467-8551.13.S2.3; Yammarino F. J., 1990, MEASURES LEADERSHIP, P151; Zohar D, 2010, APPL PSYCHOL-INT REV, V59, P647, DOI 10.1111/j.1464-0597.2010.00421.x	63	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0033-6807	1467-9310		R&D MANAGE	R D Manage.	JUN	2015	45	3					304	316		10.1111/radm.12091		13	Business; Management	Business & Economics	CI1IR	WOS:000354497700005		
J	Nishimura, T				Nishimura, Takeshi			Optimal design of scoring auctions with multidimensional quality	REVIEW OF ECONOMIC DESIGN			English	Article						Scoring auction; Optimal auction design; Procurement	MULTIATTRIBUTE AUCTIONS; ECONOMIES; SCOPE; SCALE; COMPETITION; CONTRACTS; MECHANISM	This article studies the optimal design of scoring auctions used in public and private procurement. In this auction, each supplier's offer consists of both price and quality, and a supplier whose offer achieves the highest score wins. The environment we consider has the feature that quality is multidimensional, and the cost complementarity or cost substitutability among quality attributes significantly affects the form of a scoring rule which implements the buyer's optimal mechanism. Our results show that the optimal scoring rule can be additively separable in the quality attributes if the degree of cost substitutability between the attributes is nonpositive, and it cannot be additively separable if the degree is sufficiently high. An example shows how to compute the buyer's loss from using an additively separable scoring rule. We also investigate how the optimal scoring rule depends on the buyer's weight parameter on suppliers' profits and the number of suppliers.	Komazawa Univ, Dept Econ, Tokyo, Japan	Nishimura, T (reprint author), Komazawa Univ, Dept Econ, Tokyo, Japan.	tnishi@komazawa-u.ac.jp			JSPS KAKENHI [11J56302]	I am grateful to an editor and two referees for their invaluable suggestions and comments. I would also like to thank Reiko Aoki, Gary Biglaiser, Eric S. Chou, Makoto Hanazono, Hideshi Itoh, Atsushi Kajii, R. Vijay Krishna, Takashi Kunimoto, Kota Murayama, Jun Nakabayashi, Ichiro Obara, Akira Okada, Sergio Parreiras, Olivier Tercieux, Masanori Tsuruoka, Takashi Ui, and seminar participants at Kansai Game Theory Seminar, Game Theory Workshop 2012, Nagoya University, Osaka University, GAMES 2012, the 18th Decentralization Conference, the 6th Japan-Taiwan Contract Theory Conference, Asian Meeting of the Econometric Society 2012 for their thoughtful comments and suggestions. This work was supported by JSPS KAKENHI Grant Number 11J56302.	Bichler M, 2000, DECIS SUPPORT SYST, V29, P249, DOI 10.1016/S0167-9236(00)00075-0; Asker J, 2008, RAND J ECON, V39, P69, DOI 10.1111/j.0741-6261.2008.00004.x; Chen-Ritzo CH, 2005, MANAGE SCI, V51, P1753, DOI 10.1287/mnsc.1050.0433; MILGROM P, 1994, ECONOMETRICA, V62, P157, DOI 10.2307/2951479; Beil DR, 2003, MANAGE SCI, V49, P1529, DOI 10.1287/mnsc.49.11.1529.20588; Bloch H, 2001, REV IND ORGAN, V18, P219, DOI 10.1023/A:1007839802268; Asker J, 2010, RAND J ECON, V41, P1; David E, 2006, DECIS SUPPORT SYST, V42, P527, DOI 10.1016/j.dss.2005.02.007; Milgrom P, 2002, ECONOMETRICA, V70, P583, DOI 10.1111/1468-0262.00296; LAFFONT JJ, 1987, J POLIT ECON, V95, P921, DOI 10.1086/261496; Farsi M, 2007, J TRANSP ECON POLICY, V41, P345; Branco F, 1997, RAND J ECON, V28, P63, DOI 10.2307/2555940; CHE YK, 1993, RAND J ECON, V24, P668, DOI 10.2307/2555752; Dastidar KG, 2014, SCORING AUCTIONS NON; Fraquelli G, 2004, APPL ECON, V36, P2045, DOI 10.1080/0003684042000245543; Hanazono M, 2013, PROCUREMENT AUCTIONS; MCAFEE RP, 1987, RAND J ECON, V18, P296, DOI 10.2307/2555554; McMillan J, 2003, REINVENTING BAZAAR N; Milgrom Paul R., 2004, PUTTING AUCTION THEO; Molenaar KR, 2007, ALTERNATIVE PROJECT; Nishimura T, 2012, GLOBAL COE HI STAT D; OECD, 2012, SIZ PUBL PROC MARK; Ok EA, 2007, REAL AN EC APPL; PULLEY LB, 1992, REV ECON STAT, V74, P221, DOI 10.2307/2109653; RIORDAN MH, 1987, AM ECON REV, V77, P375; ROYDEN H. L., 2010, REAL ANAL; Topkis D. M., 1998, SUPERMODULARITY COMP; Wang MX, 2014, ECON LETT, V123, P352, DOI 10.1016/j.econlet.2014.03.021	28	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1434-4742	1434-4750		REV ECON DES	Rev. Econ. Des.	JUN	2015	19	2					117	143		10.1007/s10058-015-0169-6		27	Economics	Business & Economics	CI3DQ	WOS:000354628200002		
J	Arai, H; Hayashi, H; Takahashi, K; Koide, S; Sato, W; Hasegawa, M; Yamaguchi, Y; Aten, J; Ito, Y; Yuzawa, Y				Arai, Haruna; Hayashi, Hiroki; Takahashi, Kazuo; Koide, Shigehisa; Sato, Waichi; Hasegawa, Midori; Yamaguchi, Yutaka; Aten, Jan; Ito, Yasuhiko; Yuzawa, Yukio			Tubulointerstitial fibrosis in patients with IgG4-related kidney disease: pathological findings on repeat renal biopsy	RHEUMATOLOGY INTERNATIONAL			English	Article						IgG4-related kidney disease; Tubulointerstitial nephritis; Connective tissue growth factor; Corticosteroid therapy	TISSUE GROWTH-FACTOR; MEMBRANOUS NEPHROPATHY; SYSTEMIC-DISEASE; AUTOIMMUNE PANCREATITIS; SCLEROSING PANCREATITIS; DIAGNOSTIC-CRITERIA; RITUXIMAB THERAPY; TGF-BETA; NEPHRITIS; EXPRESSION	Renal parenchymal lesions in patients with IgG4-related kidney disease (IgG4-RKD) are characterized by tubulointerstitial nephritis with storiform fibrosis and infiltration by high numbers of IgG4-positive plasma cells. The aim of this study was to evaluate the clinical and pathological effects of corticosteroid therapy in patients with IgG4-RKD. Of six patients who were diagnosed with IgG4-RKD, four patients underwent re-biopsy at approximately 30-50 days after corticosteroid therapy was initiated. Based on the classification of Yamaguchi et al., the degree of tubulointerstitial fibrosis was classified before and after therapy. In addition, tubulointerstitial expression patterns of alpha-smooth muscle actin (alpha-SMA), collagen I, III, and IV protein, and connective tissue growth factor (CTGF) mRNA were examined. Histopathological findings before treatment showed alpha-SMA-positive myofibroblasts in the lesion, and CTGF mRNA-positive cells were found in the cellular infiltrate. Although corticosteroid therapy improved serum creatinine clinically, the stage of fibrosis advanced pathologically as evidenced by increased staining for collagen I and III. However, the number of IgG4-positive plasma cells decreased, and CTGF mRNA expression reduced. In other words, fibrosis had advanced from the time of extensive cell infiltration in patients with IgG4-RKD and inflammation was relieved by corticosteroid. A reduced number of positive CTGF mRNA expression cells in repeat biopsies indicated that the fibrosis process was terminated by corticosteroid therapy. We propose that corticosteroid therapy could terminate the pathway of active fibrosis, thereby inhibiting progression to renal dysfunction.	[Arai, Haruna; Hayashi, Hiroki; Takahashi, Kazuo; Koide, Shigehisa; Sato, Waichi; Hasegawa, Midori; Yuzawa, Yukio] Fujita Hlth Univ, Sch Med, Dept Nephrol, Toyoake, Aichi 4701192, Japan; [Yamaguchi, Yutaka] Yamaguchis Pathol Lab, Chiba, Japan; [Aten, Jan] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Ito, Yasuhiko] Nagoya Univ, Grad Sch Med, Dept Renal Replacement Therapy & Nephrol, Nagoya, Aichi 4648601, Japan	Hayashi, H (reprint author), Fujita Hlth Univ, Sch Med, Dept Nephrol, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	hhayashi@fujita-hu.ac.jp; yukio-y@fujita-hu.ac.jp			Ministry of Health, Labor and Welfare of Japan; JSPS KAKENHI [23790967, 22590886, 19590947]; Aichi Kidney Foundation	This study was supported by a Grant-in-Aid for Diabetic Nephropathy and Nephrosclerosis Research and for Progressive Renal Diseases Research, Research on Intractable Disease, from the Ministry of Health, Labor and Welfare of Japan. This work was also supported by JSPS KAKENHI Grant Numbers, 23790967, 22590886, and 19590947 and by the Aichi Kidney Foundation.	Mizushima I, 2012, MOD RHEUMATOL, V22, P859, DOI 10.1007/s10165-011-0589-2; Khosroshahi A, 2012, MEDICINE, V91, P57, DOI 10.1097/MD.0b013e3182431ef6; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Nishi S, 2011, CLIN EXP NEPHROL, V15, P810, DOI 10.1007/s10157-011-0526-x; Takeda S, 2004, NEPHROL DIAL TRANSPL, V19, P474, DOI 10.1093/ndt/gfg477; Ito K, 2013, CLIN NEPHROL, V79, P246, DOI 10.5414/CN107114; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Topazian M, 2008, CLIN GASTROENTEROL H, V6, P364, DOI 10.1016/j.cgh.2007.12.020; Watson SJW, 2006, AM J SURG PATHOL, V30, P1472, DOI 10.1097/01.pas.0000213308.43929.97; Kawano M, 2011, CLIN EXP NEPHROL, V15, P615, DOI 10.1007/s10157-011-0521-2; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Yamamoto M, 2005, AUTOIMMUN REV, V4, P195, DOI 10.1016/j.autrev.2004.10.005; RISDON RA, 1968, LANCET, V2, P363; Cravedi P, 2011, AM J KIDNEY DIS, V58, P272, DOI 10.1053/j.ajkd.2011.05.002; Saeki T, 2010, KIDNEY INT, V78, P1016, DOI 10.1038/ki.2010.271; Khosroshahi A, 2010, ARTHRITIS RHEUM-US, V62, P1755, DOI 10.1002/art.27435; Ito Y, 2010, AM J PHYSIOL-RENAL, V299, pF545, DOI 10.1152/ajprenal.00120.2009; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Raissian Y, 2011, J AM SOC NEPHROL, V22, P1343, DOI 10.1681/ASN.2011010062; Hamano H, 2002, LANCET, V359, P1403, DOI 10.1016/S0140-6736(02)08359-9; Blom IE, 2001, NEPHROL DIAL TRANSPL, V16, P1139, DOI 10.1093/ndt/16.6.1139; Bohle A, 1996, Kidney Int Suppl, V54, pS2; Fervenza FC, 2011, AM J KIDNEY DIS, V58, P320, DOI 10.1053/j.ajkd.2011.05.006; Palmisano A, 2010, CLIN NEPHROL, V74, P485; Saeki T, 2009, CLIN NEPHROL, V71, P173; Uchiyama-Tanaka Yoko, 2004, Am J Kidney Dis, V43, pe18, DOI 10.1053/j.ajkd.2003.12.006; Yamaguchi Y, 2011, HUM PATHOL, V43, P536, DOI 10.1016/j.humpath.2011.06.002; Yokoi H, 2002, AM J PHYSIOL-RENAL, V282, pF933, DOI 10.1152/ajprenal.00122.2001; Zaidan M, 2011, NEPHROL DIAL TRANSPL, V26, P2047, DOI 10.1093/ndt/gfr097	29	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0172-8172	1437-160X		RHEUMATOL INT	Rheumatol. Int.	JUN	2015	35	6					1093	1101		10.1007/s00296-014-3153-5		9	Rheumatology	Rheumatology	CI3AO	WOS:000354620000019		
J	Obara, K; Amoh, Y				Obara, Koya; Amoh, Yasuyuki			A case of Kikuchi's disease (histiocytic necrotizing lymphoadenitis) with histiocytic cutaneous involvement	RHEUMATOLOGY INTERNATIONAL			English	Letter							LYMPHADENITIS; SKIN		[Obara, Koya; Amoh, Yasuyuki] Kitasato Univ, Dept Dermatol, Sch Med, Sagamihara, Kanagawa 2520374, Japan	Obara, K (reprint author), Kitasato Univ, Dept Dermatol, Sch Med, I-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	obarakoya@yahoo.co.jp					KUO TT, 1990, AM J SURG PATHOL, V14, P872, DOI 10.1097/00000478-199009000-00009; Kim JH, 2010, HUM PATHOL, V41, P1245, DOI 10.1016/j.humpath.2010.02.002; KUO TT, 1995, AM J SURG PATHOL, V19, P798, DOI 10.1097/00000478-199507000-00008; Atwater AR, 2008, J AM ACAD DERMATOL, V59, P130, DOI 10.1016/j.jaad.2008.03.012; Kaur S, 2001, PEDIATR DERMATOL, V18, P403, DOI 10.1046/j.1525-1470.2001.01965.x; Kawai H, 1999, PEDIATR INT, V41, P323, DOI 10.1046/j.1442-200x.1999.01059.x; KIKUCHI M, 1972, Acta Haematologica Japonica, V35, P379; Kim KJ, 2003, CLIN EXP DERMATOL, V28, P142, DOI 10.1046/j.1365-2230.2003.01160.x; Roger M, 1999, ANN DERMATOL VENER, V126, P826; Yasukawa K, 2001, BRIT J DERMATOL, V144, P885, DOI 10.1046/j.1365-2133.2001.04151.x	10	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0172-8172	1437-160X		RHEUMATOL INT	Rheumatol. Int.	JUN	2015	35	6					1111	1113		10.1007/s00296-014-3184-y		3	Rheumatology	Rheumatology	CI3AO	WOS:000354620000022		
J	Nomura, Y; Kuramochi, R; Fukubayashi, T				Nomura, Y.; Kuramochi, R.; Fukubayashi, T.			Evaluation of hamstring muscle strength and morphology after anterior cruciate ligament reconstruction	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						Anterior cruciate ligament; semitendinosus; flexion torque; muscle volume; MRI	KNEE-FLEXION TORQUE; SEMITENDINOSUS TENDON; ACL RECONSTRUCTION; GRACILIS TENDONS; FLEXOR STRENGTH; REGENERATION; HARVEST; MRI; AUTOGRAFT; TIME	This study aimed to clarify the relationship between knee flexor strength and hamstring muscle morphology after anterior cruciate ligament (ACL) reconstruction using the semitendinosus (ST) tendon and to determine the causative factors of decreased knee flexor muscle strength. Fourteen male and ten female patients who resumed sports activities after surgery participated in the experiment. Isometric knee flexion torque was measured at 30 degrees, 45 degrees, 60 degrees, 90 degrees, and 105 degrees of knee flexion. Magnetic resonance imaging (MRI) was used to calculate ST muscle length and hamstring muscle volume, and to confirm the status of ST tendon regeneration. The correlation between the MRI findings and flexor strength was analyzed. Regenerated ST tendon was confirmed in 21 of the 24 patients, but muscle volume (87.6%) and muscle length (74.5%) of the ST in the operated limb were significantly smaller than those in the normal limb. The percentage of the knee flexion torque of the operated limb compared with that of the normal was apparently lower at 105 degrees (69.1%) and 90 degrees (68.6%) than at 60 degrees (84.4%). Tendon regeneration, ST muscle shortening, and ST muscle atrophy correlated with decreased knee flexion torque. These results indicated that preserving the morphology of the ST muscle-tendon complex is important.	[Nomura, Y.] Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Saitama 3591192, Japan; [Kuramochi, R.] Chukyo Univ, Sch Hlth & Sport Sci, Aichi, Japan; [Fukubayashi, T.] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama 3591192, Japan	Nomura, Y (reprint author), Waseda Univ, Grad Sch Sport Sci, 2-579-15 Mikajima, Tokorozawa, Saitama 3591192, Japan.	yumi.nmr@gmail.com					Ahlen M, 2012, AM J SPORT MED, V40, P1735, DOI 10.1177/0363546512449611; Okahashi K, 2006, KNEE SURG SPORT TR A, V14, P542, DOI 10.1007/s00167-006-0068-z; Kubota J, 2007, EUR J APPL PHYSIOL, V101, P713, DOI 10.1007/s00421-007-0549-x; Rispoli DM, 2001, ARTHROSCOPY, V17, P2, DOI 10.1053/jars.2001.19460; Tadokoro K, 2004, AM J SPORT MED, V32, P1644, DOI 10.1077/0363546504263152; Tashiro T, 2003, AM J SPORT MED, V31, P522, DOI 10.1177/31.4.522; Nishino A, 2006, MED SCI SPORT EXER, V38, P1895, DOI 10.1249/01.mss.0000230344.71623.51; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Makihara Y, 2006, KNEE SURG SPORT TR A, V14, P310, DOI 10.1007/s00167-005-0701-2; Eriksson K, 2001, ARTHROSCOPY, V17, P808; Nakamae A, 2005, J COMPUT ASSIST TOMO, V29, P241, DOI 10.1097/01.rct.0000153779.86663.92; Papandrea P, 2000, AM J SPORT MED, V28, P556; CROSS MJ, 1992, AM J SPORT MED, V20, P221, DOI 10.1177/036354659202000223; Eriksson K, 2001, ACTA ORTHOP SCAND, V72, P379, DOI 10.1080/000164701753542041; Eriksson K, 1999, KNEE SURG SPORT TR A, V7, P220, DOI 10.1007/s001670050152; Choi JY, 2012, AM J SPORT MED, V40, P152, DOI 10.1177/0363546511424134; Takeda Y, 2006, AM J SPORT MED, V34, P281, DOI 10.1177/0363546505279574; Cooley VJ, 2001, ARTHROSCOPY, V17, P795, DOI 10.1053/jars.2001.25244; DANIEL DM, 1994, AM J SPORT MED, V22, P632, DOI 10.1177/036354659402200511; Ferretti A, 2002, AM J SPORT MED, V30, P204; HERZOG W, 1993, J ANAT, V182, P213; Hioki S, 2003, KNEE SURG SPORT TR A, V11, P223, DOI 10.1007/s00167-003-0361-z; Noyes FR, 2005, AM J SPORT MED, V33, P197, DOI 10.1177/0363546504266484; Ohkoshi Y, 1998, ARTHROSCOPY, V145, P80; Rosenberg TD, 1997, SPORTS MED ARTHROSC, V5, P51; Rosenberg TD, 1997, ORTHOPEDICS, V20, P396; Simonian P T, 1997, Am J Knee Surg, V10, P54	27	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	JUN	2015	25	3					301	307		10.1111/sms.12205		7	Sport Sciences	Sport Sciences	CI2ID	WOS:000354568800008		
J	Penailillo, L; Blazevich, A; Numazawa, H; Nosaka, K				Penailillo, L.; Blazevich, A.; Numazawa, H.; Nosaka, K.			Rate of force development as a measure of muscle damage	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						Lengthening contractions; knee extensors; repeated bout effect; maximal voluntary contraction; eccentric cycling	EXERCISE-INDUCED MUSCLE; HUMAN SKELETAL-MUSCLE; ECCENTRIC EXERCISE; CONTRACTILE PROPERTIES; REPEATED BOUTS; ELBOW FLEXORS; STRENGTH LOSS; PERFORMANCE; ADAPTATION; TIME	This study tested the hypothesis that rate of force development (RFD) would be a more sensitive indirect marker of muscle damage than maximum voluntary isometric contraction (MVC) peak torque. Ten men performed one concentric cycling and two eccentric cycling (ECC1, ECC2) bouts for 30min at 60% of maximal concentric power output with 2 weeks between bouts. MVC peak torque, RFD, and vastus lateralis electromyogram amplitude and mean frequency were measured during a knee extensor MVC before, immediately after and 1-2 days after each bout. The magnitude of decrease in MVC peak torque after exercise was greater (P<0.05) for ECC1 (11-25%) than concentric cycling (2-12%) and ECC2 (0-16%). Peak RFD and RFD from 0-30ms, 0-50ms, 0-100ms, to 0-200ms decreased (P<0.05) immediately after all cycling bouts without significant differences between bouts, but RFD at 100-200ms interval (RFD100-200) decreased (P<0.05) at all time points after ECC1 (24-32%) and immediately after ECC2 (23%), but did not change after CONC. The magnitude of decrease in RFD100-200 was 7-19% greater than that of MVC peak torque after ECC1 (P<0.05). It is concluded that RFD100-200 is a more specific and sensitive indirect marker of eccentric exercise-induced muscle damage than MVC peak torque.	[Penailillo, L.; Blazevich, A.; Nosaka, K.] Edith Cowan Univ, Sch Exercise & Hlth Sci, Ctr Exercise & Sci Res CESSR, Joondalup, WA, Australia; [Penailillo, L.] Univ Finis Terrae, Sch Kinesiol, Exercise Sci Lab, Fac Med, Santiago 7501015, Chile; [Numazawa, H.] Rikkyo Univ, Dept Sports & Wellness, Saitama, Japan	Penailillo, L (reprint author), Univ Finis Terrae, Sch Kinesiol, 1509 Pedro de Valdivia Ave, Santiago 7501015, Chile.	lpenailillo@uft.cl					Mackey AL, 2011, FASEB J, V25, P1943, DOI 10.1096/fj.10-176487; Bojsen-Moller J, 2005, J APPL PHYSIOL, V99, P986, DOI 10.1152/japplphysiol.01305.2004; Chen TC, 2013, EUR J APPL PHYSIOL, V113, P1005, DOI 10.1007/s00421-012-2517-3; Aagaard P, 2003, EXERC SPORT SCI REV, V31, P61, DOI 10.1097/00003677-200304000-00002; Minshull C, 2012, J SPORT SCI, V30, P1015, DOI 10.1080/02640414.2012.682084; Thorlund JB, 2008, SCAND J MED SCI SPOR, V18, P462, DOI 10.1111/j.1600-0838.2007.00710.x; Warren GL, 1999, SPORTS MED, V27, P43, DOI 10.2165/00007256-199927010-00004; Chen TC, 2011, EUR J APPL PHYSIOL, V111, P211, DOI 10.1007/s00421-010-1648-7; NOSAKA K, 1995, MED SCI SPORT EXER, V27, P1263; Holtermann A, 2007, EUR J APPL PHYSIOL, V99, P605, DOI 10.1007/s00421-006-0380-9; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Buckthorpe MW, 2012, MUSCLE NERVE, V46, P566, DOI 10.1002/mus.23322; JONES DA, 1986, J PHYSIOL-LONDON, V375, P435; Behrens M, 2012, INT J SPORTS MED, V33, P600, DOI 10.1055/s-0032-1304642; Thorlund JB, 2009, INT J SPORTS MED, V30, P273, DOI 10.1055/s-0028-1104587; Harridge SDR, 1996, PFLUG ARCH EUR J PHY, V432, P913, DOI 10.1007/s004240050215; Brown SJ, 1997, J SPORT SCI, V15, P215, DOI 10.1080/026404197367498; PLAGENHOEF S, 1983, RES Q EXERCISE SPORT, V54, P169; Nosaka K, 1996, MED SCI SPORT EXER, V28, P953, DOI 10.1097/00005768-199608000-00003; CLARKSON PM, 1992, MED SCI SPORT EXER, V24, P512; FRIDEN J, 1983, INT J SPORTS MED, V4, P170, DOI 10.1055/s-2008-1026030; Hunter AM, 2012, J ELECTROMYOGR KINES, V22, P334, DOI 10.1016/j.jelekin.2012.01.009; Andersen LL, 2006, EUR J APPL PHYSIOL, V96, P46, DOI 10.1007/s00421-005-0070-z; Warren GL, 2002, J ORTHOP SPORT PHYS, V32, P58; Isner-Horobeti ME, 2013, SPORTS MED, V43, P483, DOI 10.1007/s40279-013-0052-y; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Paulsen G, 2009, J APPL PHYSIOL, V107, P570, DOI 10.1152/japplphysiol.00209.2009; Stupka N, 2001, J APPL PHYSIOL, V91, P1669; Tillin NA, 2010, MED SCI SPORT EXER, V42, P781, DOI 10.1249/MSS.0b013e3181be9c7e; LaStayo P, 2014, J APPL PHYSIOL, V116, P1426, DOI 10.1152/japplphysiol.00008.2013; Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Raastad T, 2010, MED SCI SPORT EXER, V42, P86, DOI 10.1249/MSS.0b013e3181ac7afa; Blazevich AJ, 2008, MUSCLE NERVE, V38, P1133, DOI 10.1002/mus.21021; Blazevich AJ, 2009, MUSCLE NERVE, V39, P512, DOI 10.1002/mus.21259; Buckthorpe MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057549; Chen TC, 2010, MED SCI SPORT EXER, V42, P1004, DOI 10.1249/MSS.0b013e3181c0a818; Crameri RM, 2007, J PHYSIOL-LONDON, V583, P365, DOI 10.1113/jphysiol.2007.128827; Edman KAP, 2007, J PHYSIOL-LONDON, V580, P1007, DOI 10.1113/jphysiol.2006.119982; Elmer SJ, 2010, MED SCI SPORT EXER, V42, P1723, DOI 10.1249/MSS.0b013e3181d60ead; HENNEMAN E, 1985, J EXP BIOL, V115, P105; Keenan KG, 2005, J APPL PHYSIOL, V98, P120, DOI 10.1152/japplphysiol.00894.2004; Linnamo V, 2000, J ELECTROMYOGR KINES, V10, P417, DOI 10.1016/S1050-6411(00)00029-8; Molina R, 2012, CLIN PHYSIOL FUNCT I, V32, P179, DOI 10.1111/j.1475-097X.2011.01074.x; Nosaka K, 2006, APPL PHYSIOL NUTR ME, V31, P313, DOI 10.1139/H06-005; Oliveira AS, 2013, EUR J APPL PHYSIOL, V113, P2301, DOI 10.1007/s00421-013-2660-5; Penailillo L, 2013, MED SCI SPORT EXER, V45, P1773, DOI 10.1249/MSS.0b013e31828f8a73; Philippou A, 2012, J MUSCLE RES CELL M, V33, P167, DOI 10.1007/s10974-012-9314-9; VIITASALO JT, 1978, EUR J APPL PHYSIOL O, V40, P7, DOI 10.1007/BF00420984; Vila-Cha C, 2012, EXP BRAIN RES, V216, P385, DOI 10.1007/s00221-011-2942-2; Warren G L, 2001, Exerc Sport Sci Rev, V29, P82, DOI 10.1097/00003677-200104000-00008; Zhou Y, 2011, J ELECTROMYOGR KINES, V21, P356, DOI 10.1016/j.jelekin.2010.09.009	51	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	JUN	2015	25	3					417	427		10.1111/sms.12241		11	Sport Sciences	Sport Sciences	CI2ID	WOS:000354568800026		
J	Suzuki, K; Fujiwara, H; Ohta, T				Suzuki, Keita; Fujiwara, Hajime; Ohta, Tohru			The evaluation of macroscopic and microscopic textures of sand grains using elliptic Fourier and principal component analysis: Implications for the discrimination of sedimentary environments	SEDIMENTOLOGY			English	Article						Elliptic Fourier; grain shape; principal component analysis; sedimentary environment discrimination	PARTICLE-SHAPE; QUANTITATIVE-EVALUATION; ROCK PARTICLES; DESCRIPTORS; ROUNDNESS; CLASSIFICATION; ANGULARITY; PROVENANCE; FORMS; SIZE	A method that integrates elliptic Fourier and principal component analysis is a new development in the analysis of the shapes of sand grains. However, conventional elliptic Fourier and principal component analysis based on the variance-covariance matrix of the elliptic Fourier results can determine only the form of sand grains, and fails to quantify fine-scale boundary smoothness of grains. In this study, sand grains from glacial, fluvial, foreshore and aeolian environments were analysed using both elliptic Fourier and principal component analysis and an extension of elliptic Fourier and principal component analysis based on the correlation matrix to extract information on grain form (macroscopic) and grain boundary smoothness (microscopic) separately. Conventional elliptic Fourier and principal component analysis based on the variance-covariance matrix produces macroscopic particle shape descriptors, such as the elongation index and bump indices. These indices indicate that sand grains exposed to subaqueous transportation (fluvial and foreshore) have forms that are more elongated than those exposed to subaerial transportation (aeolian dunes). However, elliptic Fourier and principal component analysis based on the correlation matrix is, in addition, able to extract microscopic particle features, which can be interpreted in terms of a boundary smoothness index. The boundary smoothness index indicates that the surfaces of glacial grains are the most rugged, whereas the surfaces of aeolian grains are the smoothest. On bivariate plots of the boundary smoothness and elongation indices, samples from fluvial, foreshore, aeolian and glacial environments cluster in discrete regions. In addition, the analysis reveals that glacial grains are exposed to different morphological maturation pathways than those from fluvial, foreshore and aeolian environments.	[Suzuki, Keita; Fujiwara, Hajime] Waseda Univ, Grad Sch Creat Sci & Engn, Shinjuku Ku, Tokyo 1698550, Japan; [Ohta, Tohru] Waseda Univ, Fac Educ & Integrated Arts & Sci, Shinjuku Ku, Tokyo 1698050, Japan	Suzuki, K (reprint author), Waseda Univ, Grad Sch Creat Sci & Engn, Shinjuku Ku, 3-4-1 Ohkubo, Tokyo 1698550, Japan.	dnvtk@moegi.waseda.jp	Ohta, Tohru/B-4379-2008	Ohta, Tohru/0000-0003-0641-3538			ROHLF FJ, 1984, SYST ZOOL, V33, P302, DOI 10.2307/2413076; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Wadell H, 1932, J GEOL, V40, P443; Jerolmack DJ, 2010, GEOLOGY, V38, P719, DOI 10.1130/G30922.1; Wentworth CK, 1919, J GEOL, V27, P507; DIEPENBROEK M, 1992, SEDIMENTOLOGY, V39, P411, DOI 10.1111/j.1365-3091.1992.tb02125.x; ANDERSON RS, 1986, GEOL SOC AM BULL, V97, P1270, DOI 10.1130/0016-7606(1986)97<1270:EPDTPE>2.0.CO;2; Tafesse S, 2013, SEDIMENTOLOGY, V60, P1100, DOI 10.1111/j.1365-3091.2012.01367.x; LEES G, 1964, SEDIMENTOLOGY, V3, P2, DOI 10.1111/j.1365-3091.1964.tb00271.x; Wadell H, 1933, J GEOL, V41, P310; Yoshioka Y, 2004, ANN BOT-LONDON, V94, P657, DOI 10.1093/aob/mch190; Blott SJ, 2008, SEDIMENTOLOGY, V55, P31, DOI 10.1111/j.1365-3091.2007.00892.x; PYE K, 1994, J SEDIMENT RES A, V64, P500; Barclay DR, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005993; Bernasconi SM, 2008, MINERAL MAG, V72, P19, DOI 10.1180/minmag.2008.072.1.19; Boggs S, 2009, PETROLOGY SEDIMENTAR; BOHRER R, 1967, J ROY STAT SOC B, V29, P110; BROWN PJ, 1980, J SEDIMENT PETROL, V50, P1095; Cox E. P., 1927, J PALEONTOL, V1, P179; DOWDESWELL JA, 1982, J SEDIMENT PETROL, V52, P1315; Ehrich R., 1980, J SEDIMENT PETROL, V50, P475; EHRLICH R, 1970, J SEDIMENT PETROL, V40, P205; Freeman H., 1974, Computing Surveys, V6; Hentschel ML, 2003, PART PART SYST CHAR, V20, P25, DOI 10.1002/ppsc.200390002; HUDSON CB, 1980, J SEDIMENT PETROL, V50, P1101; Iwata H, 1998, EUPHYTICA, V102, P143, DOI 10.1023/A:1018392531226; KEDDY PA, 1982, AQUAT BOT, V14, P41, DOI 10.1016/0304-3770(82)90085-7; KENNEDY SK, 1992, J SEDIMENT PETROL, V62, P842; Krumbein W.C., 1941, J SEDIMENT PETROL, V11, P64, DOI DOI 10.1306/D42690F3-2B26-11D7-8648000102C1865D; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Livsey DN, 2013, J SEDIMENT RES, V83, P52, DOI 10.2110/jsr.2013.5; LUCKMAN BH, 1988, ARCTIC ALPINE RES, V20, P40, DOI 10.2307/1551697; MAZZULLO J, 1987, J SEDIMENT PETROL, V57, P479; Rajaei M, 2014, TURK J ZOOL, V38, P42, DOI 10.3906/zoo-1207-9; Rogers J. W., 1963, J SEDIMENT PETROL, V33, P628; SCHWARCZ HP, 1969, SEDIMENTOLOGY, V13, P213, DOI 10.1111/j.1365-3091.1969.tb00170.x; SUZUKI K, 2013, J GEOL SOC JPN, V119, P205, DOI DOI 10.5575/geosoc.2012.0085; THOMAS MC, 1995, SEDIMENTOLOGY, V42, P635, DOI 10.1111/j.1365-3091.1995.tb00397.x; Tracey SR, 2006, FISH RES, V77, P138, DOI 10.1016/j.fishres.2005.10.013; Tysmans D., 2006, PART PART SYST CHAR, V23, P381, DOI 10.1002/ppsc.200500965; Yagishita K., 2000, MEMOIRS GEOLOGICAL S, V57, P19	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0037-0746	1365-3091		SEDIMENTOLOGY	Sedimentology	JUN	2015	62	4					1184	1197		10.1111/sed.12183		14	Geology	Geology	CI2GR	WOS:000354564200011		
J	Hokimoto, S; Akasaka, T; Tabata, N; Arima, Y; Tsujita, K; Sakamoto, K; Kaikita, K; Morita, K; Kumagae, N; Yamamoto, E; Oniki, K; Nakagawa, K; Ogawa, H				Hokimoto, Seiji; Akasaka, Tomonori; Tabata, Noriaki; Arima, Yuichiro; Tsujita, Kenichi; Sakamoto, Kenji; Kaikita, Koichi; Morita, Kazunori; Kumagae, Naoki; Yamamoto, Eiichiro; Oniki, Kentaro; Nakagawa, Kazuko; Ogawa, Hisao			Impact of esomeprazole on platelet reactivity and clinical outcome according to CYP2C19 genotype in coronary heart disease patients during dual antiplatelet therapy	THROMBOSIS RESEARCH			English	Article						Cardiovascular disease; Clopidogrel; Pharmacogenetics; Polymorphism; Platelets	PROTON-PUMP INHIBITORS; ASSOCIATION TASK-FORCE; ELEVATION MYOCARDIAL-INFARCTION; PRACTICE GUIDELINES; STENT IMPLANTATION; ADVERSE OUTCOMES; RANDOMIZED-TRIAL; CONCOMITANT USE; CLOPIDOGREL; RISK	Objectives: The aim of this study was to investigate the effect of CYP2C19 polymorphism and co-therapy with esomeprazole on the antiplatelet efficacy of clopidogrel. Background: The antiplatelet efficacy of clopidogrel depends on CYP2C19 polymorphismor the co-administration of some kind of proton pump inhibitor (PPI). Methods: CYP2C19 genotype and the residual platelet reactivity (RPR) were measured in 361 coronary heart disease patients (male, mean age 69 yrs), and the risk of cardiovascular events over a 3-month follow-up was assessed to evaluate the impact of co-administration of esomeprazole during dual antiplatelet therapy with aspirin and clopidogrel. Results: The values of RPR did not differ between esomeprazole and non-esomeprazole groups (4389 +/- 1112 versus 4079 +/- 1355 AU . min, P=0.103). RPR value was higher in intermediate metabolizers (IM) than in extensive metabolizers (EM) (4089 +/- 1252 versus 3697 +/- 1215 AU . min P = 0.012) and, similarly, higher in poor metabolizers (PM) than in IM(4884 +/- 1027 versus 4089 +/- 1252 AU . min, P < 0.001). There were no differences in RPR between esomeprazole and non-esomeprazole groups according to CYP2C19 genotype (EM, 3954 +/- 1192 versus 3645 +/- 1220 AU . min, P = 0.361; IM, 4401 +/- 1063 versus 4051 +/- 1271 AU . min, P = 0.293; PM, 4917 +/- 669 versus 4876 +/- 1099 AU . min, P = 0.907, respectively). There was also no difference in clinical outcomes between esomeprazole and non-esomeprazole groups in the three-month follow-up (0% versus 0.92%, P=0.487). Conclusions: These results suggest that concomitant use of esomeprazole with clopidogrel is not associated with reduced antiplatelet efficacy of clopidogrel or increased risk of cardiovascular events, irrespective of CYP2C19 genotype. (C) 2015 Elsevier Ltd. All rights reserved.	[Hokimoto, Seiji; Akasaka, Tomonori; Tabata, Noriaki; Arima, Yuichiro; Tsujita, Kenichi; Sakamoto, Kenji; Kaikita, Koichi; Yamamoto, Eiichiro; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan; [Morita, Kazunori; Kumagae, Naoki; Oniki, Kentaro; Nakagawa, Kazuko] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Div Pharmacol & Therapeut, Kumamoto 8608556, Japan; [Morita, Kazunori; Kumagae, Naoki; Oniki, Kentaro; Nakagawa, Kazuko] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Kumamoto 8608556, Japan	Hokimoto, S (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	shokimot@kumamoto-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology	This work was supported in part by grants-in-aid for scientific research from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419; Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001; Siller-Matula JM, 2009, AM HEART J, V157, P148, DOI 10.1016/j.ahj.2008.09.017; Kubota T, 1996, CLIN PHARMACOL THER, V60, P661, DOI 10.1016/S0009-9236(96)90214-3; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI 10.1016/j.jacc.2012.11.019; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Nikolsky E, 2009, J AM COLL CARDIOL, V54, P1293, DOI 10.1016/j.jacc.2009.07.019; Man M, 2010, J CLIN PHARMACOL, V50, P929, DOI 10.1177/0091270009355161; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Hokimoto S, 2014, THROMB RES, V133, P599, DOI 10.1016/j.thromres.2014.01.003; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Frelinger AL, 2013, J AM COLL CARDIOL, V61, P872, DOI 10.1016/j.jacc.2012.11.040; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Yamamoto K, 2011, J CARDIOL, V57, P194, DOI 10.1016/j.jjcc.2010.10.007; Sibbing D, 2009, THROMB HAEMOSTASIS, V101, P714, DOI 10.1160/TH08-12-0808; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Ray WA, 2010, ANN INTERN MED, V152, P337, DOI 10.7326/0003-4819-152-6-201003160-00003; Kimura T, 2010, CIRCULATION, V122, P52, DOI 10.1161/CIRCULATIONAHA.109.903955; Stockl KM, 2010, ARCH INTERN MED, V170, P704, DOI 10.1001/archinternmed.2010.34; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Huang CC, 2010, AM J CARDIOL, V105, P1705, DOI 10.1016/j.amjcard.2010.01.348; Suh JW, 2011, J AM COLL CARDIOL, V57, P280, DOI 10.1016/j.jacc.2010.08.631; Abraham NS, 2010, CIRCULATION, V122, P2619, DOI 10.1161/CIR.0b013e318202f701; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Hulot JS, 2010, J AM COLL CARDIOL, V56, P134, DOI 10.1016/j.jacc.2009.12.071; Jneid H, 2012, J AM COLL CARDIOL, V60, P645, DOI 10.1016/j.jacc.2012.06.004; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; El-Halabi MM, 2013, J CARDIOVASC PHARM, V62, P41, DOI 10.1097/FJC.0b013e31828ecf44; Food US, 2012, INT ES OM CLOP LAB C; Hochholzer W, 2006, J AM COLL CARDIOL, V48, P1742, DOI 10.1016/j.jacc.2006.06.065; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; McKeage K, 2008, DRUGS, V68, P1571, DOI 10.2165/00003495-200868110-00009; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Xie HG, 1999, PHARMACOGENETICS, V9, P539, DOI 10.1097/01213011-199910000-00001	40	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	JUN	2015	135	6					1081	1086		10.1016/j.thromres.2015.03.033		6	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CI1IN	WOS:000354497300009		
J	Akita, N; Ma, N; Okamoto, T; Asanuma, K; Yoshida, K; Nishioka, J; Shimaoka, M; Suzuki, K; Hayashi, T				Akita, Nobuyuki; Ma, Ning; Okamoto, Takayuki; Asanuma, Kunihiro; Yoshida, Kakunoshin; Nishioka, Junji; Shimaoka, Motomu; Suzuki, Koji; Hayashi, Tatsuya			Host protein C inhibitor inhibits tumor growth, but promotes tumor metastasis, which is closely correlated with hypercoagulability	THROMBOSIS RESEARCH			English	Article						Protein C inhibitor; Serine protease inhibitors; Neoplasm metastasis; Protein C; Thrombomodulin	PLASMINOGEN-ACTIVATOR; HEPARIN-BINDING; FACTOR-V; ANTIANGIOGENIC ACTIVITY; MOLECULAR-CLONING; HUMAN-PLASMA; IN-VIVO; ANGIOGENESIS; INACTIVATION; COAGULATION	Introduction: Protein C inhibitor (PCI), a member of the serine protease inhibitor family, is expressed in various human tissues, including liver and kidneys. In the plasma, PCI physiologically inhibits an anticoagulant serine protease, activated protein C (APC). PCI expressed by cancer cells suppresses tumor invasion by inhibiting urokinase-type plasminogen activator, and inhibits tumor growth and metastasis, which are independent of its protease-inhibitory activity. In the present study, we clarified the effects of host PCI on growth and metastasis of B16 melanoma (B16) cells by comparing between wild-type mice and mice transgenic for human PCI gene (hPCI-TG), which have a tissue distribution of PCI similar to that observed in humans. Materials and Methods: Growth of intracutaneously-injected B16 cells was evaluated by measuring the tumor volume, and metastatic behavior of intravenously-injected B16 cells by counting the number of metastatic lung nodules. Results: Growth of intracutaneously injected B16 cells was significantly faster in wild-typemice than in hPCI-TG mice; however, hPCI-TG mice developed more metastatic nodules of B16 cells in the lungs. Immunohistochemical analysis using anti-mouse fibrinogen antibody revealed more fibrin deposition in the lung in hPCI-TG mice than in wild-typemice. Furthermore, the more invasive behavior observed in hPCI-TG mice was reduced by rabbit anti-human PCI IgG, APC, or soluble TM administration for 3 consecutive days including the day that B16 cells were injected. Conclusions: Our results suggest that like PCI expressed in tumor cells, host PCI also inhibits tumor growth, but host PCI promotes tumor metastasis via its procoagulant properties. (C) 2015 Elsevier Ltd. All rights reserved.	[Akita, Nobuyuki] Suzuka Univ Med Sci, Fac Med Engn, Suzuka, Mie, Japan; [Ma, Ning] Suzuka Univ Med Sci, Fac Hlth Sci, Suzuka, Mie, Japan; [Okamoto, Takayuki; Shimaoka, Motomu] Mie Univ, Grad Sch Med, Dept Mol Pathobiol & Cell Adhes Biol, Tsu, Mie 514, Japan; [Asanuma, Kunihiro; Yoshida, Kakunoshin] Mie Univ, Grad Sch Med, Dept Orthoped Surg, Tsu, Mie 514, Japan; [Nishioka, Junji] Suzuka Univ Med Sci, Dept Clin Nutr, Suzuka, Mie, Japan; [Suzuki, Koji] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie, Japan; [Hayashi, Tatsuya] Mie Prefectural Coll Nursing, Dept Biochem, Tsu, Mie 5140116, Japan	Hayashi, T (reprint author), Mie Prefectural Coll Nursing, Dept Biochem, Tsu, Mie 5140116, Japan.	tatsuya.hayashi@mcn.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science (JPSP) [24790865]; Mie Prefectural College of Nursing	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology and the Japan Society for the Promotion of Science (JPSP) (No. 24790865), and by a grant from the Mie Prefectural College of Nursing.	Uhrin P, 2000, J CLIN INVEST, V106, P1531, DOI 10.1172/JCI10768; REZAIE AR, 1995, J BIOL CHEM, V270, P25336; MARLAR RA, 1980, J CLIN INVEST, V66, P1186, DOI 10.1172/JCI109952; Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791; SUZUKI K, 1984, J BIOCHEM-TOKYO, V95, P187; SHIMOMURA T, 1993, J BIOL CHEM, V268, P22927; Yee D, 2011, BIODRUGS, V25, P271, DOI 10.2165/11592720-000000000-00000; O'Reilly MS, 1999, SCIENCE, V285, P1926, DOI 10.1126/science.285.5435.1926; Stefansson S, 2001, J BIOL CHEM, V276, P8135, DOI 10.1074/jbc.M007609200; Landi L, 2013, CURR OPIN ONCOL, V25, P130, DOI 10.1097/CCO.0b013e32835daf37; Scagliotti GV, 2013, CANCER TREAT REV, V39, P793, DOI 10.1016/j.ctrv.2013.02.001; Marlar R A, 1981, Ann N Y Acad Sci, V370, P303, DOI 10.1111/j.1749-6632.1981.tb29743.x; Huang HH, 2004, INT J CANCER, V112, P1042, DOI 10.1002/ijc.20494; MEIJERS JCM, 1988, BIOCHEMISTRY-US, V27, P4231, DOI 10.1021/bi00412a005; Goetsch L, 2013, FRONT BIOSCI-LANDMRK, V18, P454, DOI 10.2741/4114; SUZUKI K, 1983, J BIOL CHEM, V258, P163; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Dahlback B, 2005, FEBS LETT, V579, P3310, DOI 10.1016/j.febslet.2005.03.001; LAURELL M, 1992, J CLIN INVEST, V89, P1094, DOI 10.1172/JCI115689; Gil-Bernabe AM, 2013, BRIT J HAEMATOL, V162, P433, DOI 10.1111/bjh.12381; STIEF TW, 1987, BIOL CHEM H-S, V368, P1427, DOI 10.1515/bchm3.1987.368.2.1427; Asanuma K, 2007, INT J CANCER, V1021, P555; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Fortenberry YM, 2011, J THROMB HAEMOST, V9, P861, DOI 10.1111/j.1538-7836.2011.04196.x; FRANCIS RB, 1984, THROMB HAEMOSTASIS, V52, P71; GEIGER M, 1989, BLOOD, V74, P722; Hayashi T, 2007, J THROMB HAEMOST, V5, P2507; Hayashi T, 2004, J THROMB HAEMOST, V2, P949, DOI 10.1111/j.1538-7836.2004.00733.x; KWAAN HC, 1992, CANCER METAST REV, V11, P291, DOI 10.1007/BF01307184; Miao RQ, 2003, AM J PHYSIOL-CELL PH, V284, pC1604, DOI 10.1152/ajpcell.00524.2002; MIYAZAWA K, 1993, J BIOL CHEM, V268, P10024; Neese LL, 1998, ARCH BIOCHEM BIOPHYS, V355, P101, DOI 10.1006/abbi.1998.0716; RADTKE KP, 1994, J CLIN INVEST, V94, P2117, DOI 10.1172/JCI117566; SHIRK RA, 1994, J BIOL CHEM, V269, P28690; Song Z, 2007, HISTOCHEM CELL BIOL, V128, P293, DOI 10.1007/s00418-007-0330-6; SUZUKI K, 1983, J BIOL CHEM, V258, P1914; Wakita T, 1998, FEBS LETT, V429, P146; Wakita T, 2004, INT J CANCER, V108, P516, DOI 10.1002/ijc.11594; WALKER FJ, 1980, J BIOL CHEM, V255, P5521; WALKER FJ, 1981, J BIOL CHEM, V256, P1128; Wang L, 2003, MOL THER, V8, P72, DOI 10.1016/S01525-0016(03)00128-X; ZechmeisterMachhart M, 1996, IMMUNOPHARMACOLOGY, V32, P96, DOI 10.1016/0162-3109(95)00062-3; Zhang WQ, 2005, BLOOD, V106, P1621, DOI 10.1182/blood-2005-02-0547	43	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	JUN	2015	135	6					1203	1208		10.1016/j.thromres.2015.03.026		6	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CI1IN	WOS:000354497300028		
J	Yamashita, T; Sato, T; Sakamoto, K; Ishii, H; Yamamoto, J				Yamashita, Tsutomu; Sato, Takumi; Sakamoto, Kumi; Ishii, Hiromitsu; Yamamoto, Junichiro			The free-radical scavenger edaravone accelerates thrombolysis with alteplase in an experimental thrombosis model	THROMBOSIS RESEARCH			English	Article						Thrombolysis; Alteplase; Edaravone; Tissue plasminogen activator; Stroke	ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; T-PA; EARLY MANAGEMENT; IN-VIVO; GUIDELINES; THERAPY; ASSOCIATION; COUNCIL; BRAIN	Background and Purpose: Reperfusion injury after thrombolytic therapy can have adverse neurologic effects. The free-radical scavenger edaravone is used in combination with the recombinant tissue plasminogen activator alteplase to treat acute ischemic stroke. However, basic investigations of this combination use remain inadequate. Here, we used an in vivo model to investigate the effects of edaravone on alteplase-induced thrombolysis. Methods: Thrombolysis was evaluated by using a He-Ne-laser-induced thrombosis model in rat mesenteric microvessels. Changes in thrombus volume were analyzed with the image analysis software Image-Pro Plus (Media Cybernetics, USA). There were three experimental groups (placebo, alteplase 0.6 mg/kg, alteplase 0.6 mg/kg + edaravone 10.5 mg/kg). Sequential changes (0 to 60 min) in thrombus volume were compared by using a relative optical density method that we had used previously. Results: In the placebo group, the thrombus volume at 60 min, reflecting the extent of thrombolysis, was 97.2% +/- 5.7% of the initial value. In the alteplase group, thrombus volume decreased to 70.7% +/- 4.1% (P < 0.01) after 20 min and 14.2% +/- 6.6% after 60 min. In the alteplase + edaravone group, thrombus volume decreased to 66.9% +/- 7.2% (P < 0.001) after 10 min and 10.9% +/- 2.3% after 60 min. Conclusions: These results support the hypothesis that edaravone accelerates thrombolysis by alteplase. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamashita, Tsutomu; Sato, Takumi; Sakamoto, Kumi; Ishii, Hiromitsu; Yamamoto, Junichiro] Kobe Gakuin Univ, Fac Nutr, Lab Med Technol, Kobe, Hyogo 6512180, Japan	Yamashita, T (reprint author), Kobe Gakuin Univ, Fac Nutr, Lab Med Technol, Nishi Ku, 518 Arise,Igawadani Cho, Kobe, Hyogo 6512180, Japan.	tsutomu@nutr.kobegakuin.ac.jp					Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Lapchak PA, 2010, EXPERT OPIN PHARMACO, V11, P1753, DOI 10.1517/14656566.2010.493558; Shinohara Y, 2009, CEREBROVASC DIS, V27, P485, DOI 10.1159/000210190; [Anonymous], 2006, LANCET, V368, P1548; Niego B, 2012, BLOOD, V119, P4752, DOI 10.1182/blood-2011-07-369512; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; Brott T, 1997, STROKE, V28, P2109; Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; Wang DZ, 2000, STROKE, V31, P77; Adams HP, 1996, STROKE, V27, P1711; Unno Y, 2010, CLIN DRUG INVEST, V30, P143, DOI 10.2165/11535500-000000000-00000; Brott T, 1997, STROKE, V28, P2119; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; Yamashita T, 2013, VASC PHARMACOL, V58, P134, DOI 10.1016/j.vph.2012.10.006; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Ingall Timothy, 2004, J Insur Med, V36, P143; Kimura K, 2012, J NEUROL SCI, V313, P132, DOI 10.1016/j.jns.2011.09.006; Micieli Giuseppe, 2009, Vasc Health Risk Manag, V5, P397; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Sakamoto Kumi, 2013, HEALTH, V5, P402; MARLER JR, 1995, NEW ENGL J MED, V333, P1581; Wada T, 2014, J NEUROL SCI, V345, P106, DOI 10.1016/j.jns.2014.07.018; Yamashita T, 2000, HAEMOSTASIS, V30, P321; Yamashita T, 2003, PATHOPHYSIOL HAEMO T, V33, P138, DOI 10.1159/000077822; Yamashita T, 2006, PLATELETS, V17, P201, DOI 10.1080/09537100500444063; Zhang WR, 2004, NEUROL RES, V26, P342, DOI 10.1179/016164104225014058	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	JUN	2015	135	6					1209	1213		10.1016/j.thromres.2015.04.011		5	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CI1IN	WOS:000354497300029		
J	Taniguchi, F; Morishita, E; Sekiya, A; Yamaguchi, D; Nomoto, H; Kobayashi, E; Takata, M; Kosugi, I; Takeuchi, N; Asakura, H; Ohtake, S				Taniguchi, Fumina; Morishita, Eriko; Sekiya, Akiko; Yamaguchi, Daisuke; Nomoto, Haruka; Kobayashi, Erina; Takata, Mao; Kosugi, Ikuko; Takeuchi, Nobuyasu; Asakura, Hidesaku; Ohtake, Shigeki			Late onset thrombosis in two Japanese patients with compound heterozygote protein S deficiency	THROMBOSIS RESEARCH			English	Letter							PREVALENCE		[Taniguchi, Fumina; Morishita, Eriko; Sekiya, Akiko; Yamaguchi, Daisuke; Nomoto, Haruka; Kobayashi, Erina; Takata, Mao; Ohtake, Shigeki] Kanazawa Univ, Grad Sch Med Sci, Dept Clin Lab Sci, Kanazawa, Ishikawa 9200942, Japan; [Morishita, Eriko; Ohtake, Shigeki] Kanazawa Univ Hosp, Dept Hematol, Kanazawa, Ishikawa, Japan; [Kosugi, Ikuko] Fukui Saiseikai Hosp, Fukui, Japan; [Takeuchi, Nobuyasu] Nasu Neurosurg Hosp, Nasushiobara, Tochigi, Japan; [Asakura, Hidesaku] Kanazawa Univ, Dept Hematol, Kanazawa, Ishikawa, Japan	Morishita, E (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Clin Lab Sci, 5-11-80 Kodatsuno Kanazawa, Kanazawa, Ishikawa 9200942, Japan.	eriko86@staff.kanazawa-u.ac.jp					Dykes AC, 2001, BRIT J HAEMATOL, V113, P636; HAYASHI T, 1994, BLOOD, V83, P683; DAHLBACK B, 1991, THROMB HAEMOSTASIS, V66, P49; Miyata T, 2009, THROMB RES, V124, P14, DOI 10.1016/j.thromres.2008.08.020; Gandrille S, 2000, THROMB HAEMOSTASIS, V84, P918; Hackeng TM, 2000, BIOCHEM J, V349, P757; Makris M, 2000, BLOOD, V95, P935; Sakata T, 2004, J THROMB HAEMOST, V2, P1012, DOI 10.1111/j.1538-7836.2004.00742.x; Villoutreix BO, 1997, J COMPUT AID MOL DES, V11, P293, DOI 10.1023/A:1007912929828	9	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	JUN	2015	135	6					1221	1223		10.1016/j.thromres.2015.03.023		3	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CI1IN	WOS:000354497300032		
J	Konoeda, C; Nakajima, J; Murakawa, T				Konoeda, Chihiro; Nakajima, Jun; Murakawa, Tomohiro			Fibroblasts of recipient origin contribute to airway fibrosis in murine tracheal transplantations	TRANSPLANT INTERNATIONAL			English	Letter							BRONCHIOLITIS OBLITERANS SYNDROME; LUNG TRANSPLANTATION; MESENCHYMAL TRANSITION; EPITHELIUM; ALLOTRANSPLANTATION		[Konoeda, Chihiro; Nakajima, Jun; Murakawa, Tomohiro] Univ Tokyo, Grad Sch Med, Dept Thorac Surg, Tokyo, Japan	Konoeda, C (reprint author), Univ Tokyo, Grad Sch Med, Dept Thorac Surg, Tokyo, Japan.	murakawa-tky@umin.ac.jp					Todd JL, 2011, CHEST, V140, P502, DOI 10.1378/chest.10-2838; Genden EM, 2003, AM J RESP CELL MOL, V28, P673, DOI 10.1165/rcmb.2002-0214OC; LaPar DJ, 2011, ANN THORAC SURG, V92, P470, DOI 10.1016/j.athoracsur.2011.04.065; Borthwick LA, 2009, THORAX, V64, P770, DOI 10.1136/thx.2008.104133; Fernandez FG, 2004, AM J TRANSPLANT, V4, P319, DOI 10.1111/j.1600-6143.2004.00333.x; HERTZ MI, 1993, AM J PATHOL, V142, P1945; Konoeda C, 2013, TRANSPL P, V45, P1797, DOI 10.1016/j.transproceed.2012.11.024; Mukaida T, 1998, ANN THORAC SURG, V66, P205, DOI 10.1016/S0003-4975(98)00154-4; Murakawa T, 2005, J IMMUNOL, V174, P3869; Walker N, 2011, AM J PATHOL, V178, P2461, DOI 10.1016/j.ajpath.2011.01.058	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0934-0874	1432-2277		TRANSPL INT	Transpl. Int.	JUN	2015	28	6			SI		761	763		10.1111/tri.12525		3	Surgery; Transplantation	Surgery; Transplantation	CI1IW	WOS:000354498200015		
J	Ogawa, K				Ogawa, Kazuharu			Mathematical consideration of the pipe model theory in woody plant species	TREES-STRUCTURE AND FUNCTION			English	Article						Allometry; Canopy structure; Initial slope; Non-rectangular hyperbola; Pipe model theory; Size dependency	SAPWOOD AREA RATIO; SCOTS PINE; FOLIAGE BIOMASS; LEAF-AREA; SIZE VARIABILITY; STAND DENSITY; COMPETITION; SYLVESTRIS; ORGANISMS; POSITION	Key message Using the pipe model theory, a quantitative relationship between leaves and non-green plant organs has been defined that depends on tree size. In the pipe model theory, the cumulative mass of leaves and the density of non-photosynthetic organs at depth (z) from the crown surface of a woody plant are defined as F(z) and C(z), respectively. In this study, the F(z)-C(z) relationship was approximated by a non-rectangular hyperbola for Abies veitchii, Chamaecyparis obtusa, Cryptomeria japonica and Larix leptolepis. The initial slope of the non-rectangular hyperbola, corresponding to the specific pipe length, varied among individual trees. The relationship between the initial slope and the square of the stem diameter at the crown base, which can be expressed as a power function with positive exponents, was species dependent. Based on the size dependence of the initial slope, the value of the allometric exponent describing the relationship between leaf mass and the square of the stem diameter at the crown base was theoretically shown to exceed unity. Empirically, the value of the allometric exponent usually exceeds two. However, in the allometric model developed here, the allometric exponent between the leaf mass and the square of the stem diameter at the crown base did not differ significantly from unity, indicating that the leaf mass was directly proportional to the stem cross-sectional area at the crown base.	Nagoya Univ, Grad Sch Bioagr Sci, Lab Forest Ecol & Physiol, Nagoya, Aichi 4648601, Japan	Ogawa, K (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Forest Ecol & Physiol, Nagoya, Aichi 4648601, Japan.	kazogawa@agr.nagoya-u.ac.jp					Makela A, 2006, ECOLOGY, V87, P2967, DOI 10.1890/0012-9658(2006)87[2967:CRIASI]2.0.CO;2; MAKELA A, 1995, CAN J FOREST RES, V25, P970, DOI 10.1139/x95-105; Makela A, 1998, CAN J FOREST RES, V28, P216, DOI 10.1139/cjfr-28-2-216; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; Enquist BJ, 2003, NATURE, V423, P639, DOI 10.1038/nature01671; WEINER J, 1986, OIKOS, V47, P211, DOI 10.2307/3566048; Enquist BJ, 2007, NATURE, V445, pE9, DOI 10.1038/nature05548; McDowell N, 2002, OECOLOGIA, V132, P12, DOI 10.1007/s00442-002-0904-x; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; MENCUCCINI M, 1995, TREE PHYSIOL, V15, P1; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Kershaw JA, 2000, FOREST SCI, V46, P86; Makela A, 1992, SCAND J FOREST RES, V7, P297, DOI 10.1080/02827589209382722; Berninger F, 1997, FUNCT ECOL, V11, P146, DOI 10.1046/j.1365-2435.1997.00067.x; JOHNSON IR, 1984, J THEOR BIOL, V107, P531, DOI 10.1016/S0022-5193(84)80131-9; Berninger F, 2005, CAN J FOREST RES, V35, P1294, DOI 10.1039/X05-055; Blackman FF, 1905, ANN BOT-LONDON, V19, P281; Chiba Y., 1988, Journal of the Japanese Forestry Society, V70, P245; Hagihara A, 1993, B NAGOYA U FOR, V12, P11; Hozumi K, 1981, SILVICULTURE LARIX, P89; KIKUZAWA K, 1988, ANN BOT-LONDON, V61, P727; Makela A, 2002, TREE PHYSIOL, V22, P891; Miyaura T, 1982, JPN FOR SOC, P11; Monsi M., 1953, JAPANESE J BOTANY, V14, P22; Ogawa K, 2003, FOREST ECOL MANAG, V174, P415; Ogawa K, 2007, SELF THINNING STAND, P141; Ogisu K, 1985, THESIS NAGOYA U NAGO; Press WH, 1992, NUMERICAL RECIPES C, P994; Schneider R, 2011, TREE PHYSIOL, V31, P22, DOI 10.1093/treephys/tpq104; SHELBURNE VB, 1993, FOREST ECOL MANAG, V58, P193, DOI 10.1016/0378-1127(93)90145-D; Shidei T, 1965, MATERIAL, V2, P223; Shidei T, 1965, MATERIAL, V1, P160; Shinozaki K., 1964, JAPANESE J ECOL, V14, P97; Shinozaki K., 1964, JAPANESE J ECOL, V14, P133; Sone K, 2009, J PLANT RES, V122, P41, DOI 10.1007/s10265-008-0177-5; Tanao T, 1981, THESIS NAGOYA U NAGO; Thornley J. H. M., 1976, Mathematical models in plant physiology.; Weiner J, 1988, PLANT POPULATION ECO, P59; WEINER J, 1988, AM J BOT, V75, P445, DOI 10.2307/2443991; Xue L, 1999, ECOL RES, V14, P49, DOI 10.1046/j.1440-1703.1999.141284.x; YAMAKURA T, 1987, Ecological Research, V2, P215, DOI 10.1007/BF02349775	43	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0931-1890	1432-2285		TREES-STRUCT FUNCT	Trees-Struct. Funct.	JUN	2015	29	3					695	704		10.1007/s00468-014-1147-2		10	Forestry	Forestry	CI1EF	WOS:000354484000007		
J	Guenard, B; Cardinal-De Casas, A; Dunn, R				Guenard, Benoit; Cardinal-De Casas, Adrianna; Dunn, Robert R.			High diversity in an urban habitat: are some animal assemblages resilient to long-term anthropogenic change?	URBAN ECOSYSTEMS			English	Article						Urban ecosystem; Long term study; Formicidae; Disturbance; Invasive species	HYMENOPTERA-FORMICIDAE; ANTS HYMENOPTERA; ALIEN PLANTS; INVASIONS; ECOSYSTEMS; IMPACTS; CONSEQUENCES; BIODIVERSITY; ARTHROPODS; EXPANSION	Urbanization is thought to lead to the loss of biodiversity both because of habitat disturbance and the increased abundance of invasive species. However, most studies of biodiversity in cities are conducted on a short time scale, usually less than 3 years, and so miss the long-term dynamics of communities inhabiting these ecosystems. Here we use a study performed in the early 70's on North Carolina State University (Raleigh, USA) as a baseline to evaluate the long term effects of disturbance and introduced species on native ant communities. Ant species were sampled almost 40 years later using a variety of sampling techniques in order to maximize species collection. Our results show that while the number of exotic species increased, including three major invasive ants, native ant species richness remained high. Furthermore, our survey was able to add several new records for the area considered, in comparison of the 70's study, for a total of 89 species known from NCSU campus. After comparison with other studies, our results represent one of the most species-rich urban environments monitored and thus open encouraging perspective on how urban ecosystems could contribute to the preservation of the biodiversity of small-bodies organisms such as ants.	[Guenard, Benoit] Grad Univ, Okinawa Inst Sci & Technol, Okinawa, Japan; [Guenard, Benoit; Cardinal-De Casas, Adrianna; Dunn, Robert R.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Guenard, Benoit; Cardinal-De Casas, Adrianna; Dunn, Robert R.] N Carolina State Univ, Keck Ctr Behav Biol, Raleigh, NC 27695 USA	Guenard, B (reprint author), Grad Univ, Okinawa Inst Sci & Technol, Okinawa, Japan.	zeroben@gmail.com			NASA Biodiversity Grant [ROSES-NNX09AK22G]; USGS grant; NSF-CAREER grant [09533390]	The authors would like to thank Neil McCoy, Katherine Driscoll, Matthew Drew for their help in collecting. We would like to thank Terry Nuhn for discussion about his collection. Thank you also to Alex Wild for authorizing the use of his pictures. Finally, we'd like to thank two anonymous reviewers for their comments on a previous version of the manuscript. The work of RRD and BG was supported by a NASA Biodiversity Grant (ROSES-NNX09AK22G), support from a USGS grant to the Climate Science Center and an NSF-CAREER grant (09533390).	PORTER SD, 1990, ECOLOGY, V71, P2095, DOI 10.2307/1938623; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolysis.33.010802.150444; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; [Anonymous], 2012, ZOOTAXA 1116; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Schlick-Steiner BC, 2006, MOL PHYLOGENET EVOL, V40, P259, DOI 10.1016/j.ympev.2006.03.005; Callcott AMA, 1996, FLA ENTOMOL, V79, P240, DOI 10.2307/3495821; Wetterer JK, 2009, SOCIOBIOLOGY, V54, P811; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Chytry M, 2008, ECOLOGY, V89, P1541, DOI 10.1890/07-0682.1; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Savard JPL, 2000, LANDSCAPE URBAN PLAN, V48, P131, DOI 10.1016/S0169-2046(00)00037-2; Tait CJ, 2005, ECOL APPL, V15, P346, DOI 10.1890/04-0920; Pysek P, 2010, GLOBAL ECOL BIOGEOGR, V19, P317, DOI 10.1111/j.1466-8238.2009.00514.x; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; REBELE F, 1994, GLOBAL ECOL BIOGEOGR, V4, P173, DOI 10.2307/2997649; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Dunn RR, 2006, CONSERV BIOL, V20, P1814, DOI 10.1111/j.1523-1739.2006.00533.x; Antonov IA, 2008, RUSS J ECOL+, V39, P454, DOI 10.1134/S106741360806012X; Bernard F, 1958, B SOC SCI NAT PHYS, V38, P131; Bestelmeyer Brandon T., 2000, P122; Bolger TD, 2000, ECOL APPL, V10, P1230; CARTER WILLIAM G., 1962, JOUR ELISHA MITCHELL SCI SOC, V78, P1; Dauber Jens, 1997, Naturschutz und Landschaftsplanung, V29, P303; Guenard B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011614; Elton CS, 1958, ECOLOGY INVASIONS AN; Epperson DM, 2010, AM MIDL NAT, V163, P54, DOI 10.1674/0003-0031-163.1.54; ESPADALER X, 1991, INSECT SOC, V38, P365, DOI 10.1007/BF01241872; Guenard B, 2012, P NATL ACAD SCI USA, V109, P7368, DOI 10.1073/pnas.1113867109; Herraiz JA, 2007, SOCIOBIOLOGY, V50, P449; JOHNSON C, 1987, J ENTOMOL SCI, V22, P358; King JR, 2008, P NATL ACAD SCI USA, V105, P20339, DOI 10.1073/pnas.0809423105; MacGown JA, 2007, FLA ENTOMOL, V90, P457, DOI 10.1653/0015-4040(2007)90[457:BPHFAE]2.0.CO;2; MacGown JA, 2010, P IMP FIR ANT C CHAR, P80; Martinez MJ, 2011, PAN-PAC ENTOMOL, V87, P47, DOI 10.3956/2011-03.1; Menke SB, 2011, URBAN ECOSYST, V14, P135, DOI 10.1007/s11252-010-0150-7; NUHN TP, 1979, AM MIDL NAT, V102, P353, DOI 10.2307/2424662; Nuhn TP, 1977, THESIS N CAROLINA U; Ordonez-Urbano C., 2008, Boletin de la SEA, V42, P321; Rizali A, 2008, HAYATI J BIOSCIENCES, V15, P77; Rowles AD, 2009, OECOLOGIA, V161, P161, DOI 10.1007/s00442-009-1368-z; Smith Marion R., 1946, PROC ENT SOC WASHINGTON, V48, P29; Rice ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056281; Ward Philip S., 2000, P99; Wheeler William Morton, 1910, Psyche Boston Mass, V17, DOI 10.1155/1910/92701; Yasuda M, 2009, LANDSCAPE URBAN PLAN, V92, P276, DOI 10.1016/j.landurbplan.2009.05.008	47	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1083-8155	1573-1642		URBAN ECOSYST	Urban Ecosyst.	JUN	2015	18	2					449	463		10.1007/s11252-014-0406-8		15	Biodiversity Conservation; Ecology; Environmental Sciences; Urban Studies	Biodiversity & Conservation; Environmental Sciences & Ecology; Urban Studies	CH9VZ	WOS:000354385800008		
J	Yoshida, H; Kudari, S; Hori, T; Sugiyama, M				Yoshida, Hiroo; Kudari, Shunsuke; Hori, Toshitaka; Sugiyama, Masahito			Distribution and geochemical behaviour of anionic surfactants determined as ethyl violet active substances in Lake Biwa, Japan	WATER AND ENVIRONMENT JOURNAL			English	Article						anionic surfactants; distribution; ethyl violet; geochemical behaviour; Lake Biwa	LINEAR ALKYLBENZENE SULFONATES; RIVER WATER; WASTE-WATER; LAS; BIODEGRADATION; ADSORPTION; SEDIMENTS	The distribution and geochemical behaviour of anionic surfactants (AS) determined as ethyl violet active substances (EVAS) were studied in Lake Biwa, Japan. We determined the vertical distributions of dissolved EVAS (DEVAS), suspended particulate EVAS (PEVAS), particulate organic carbon (POC) and the PEVAS/POC ratio. Statistical analyses conducted using plots of PEVAS versus POC and PEVAS/ Chlorophyll-a (Chl-a) versus POC/Chl-a revealed that the distributions of DEVAS and PEVAS were affected by the concentrations of freshly produced POC and aged POC and by the pH of the lake water. Adsorption and desorption of EVAS onto the POC phase were found to be important mechanisms regulating the distribution and environmental/geochemical behaviour of EVAS in the lake. The organic carbon-normalized particle-water-partitioning coefficient, K-oc, for EVAS was also estimated and compared with that for nonylphenol.	[Yoshida, Hiroo; Kudari, Shunsuke; Hori, Toshitaka; Sugiyama, Masahito] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan	Sugiyama, M (reprint author), Yoshida Nihonmatsu Cho,Sakyo Ku, Kyoto 6068501, Japan.	sugiyama.masahito.5s@kyoto-u.ac.jp			Japan Society for the Promotion of Science [12480150, 15651028]; Nippon Life Insurance Foundation	This study was partly supported by grants from the Japan Society for the Promotion of Science (12480150 and 15651028) and from the Nippon Life Insurance Foundation. The authors thank Mr. T. Koitabashi and Mr. T. Miyano from the Center for Ecological Research at Kyoto University for their assistance with collection of samples in Lake Biwa.	Ambe Y., 1972, JPN J LIMNOL, V33, P44; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343; TAKADA H, 1987, ENVIRON SCI TECHNOL, V21, P875, DOI 10.1021/es00163a005; Perales JA, 1999, INT BIODETER BIODEGR, V43, P155, DOI 10.1016/S0964-8305(99)00044-X; Harita Y, 2005, LIMNOL OCEANOGR, V50, P636; Sutterlin H, 2008, CHEMOSPHERE, V72, P479, DOI 10.1016/j.chemosphere.2008.03.008; Hirayama Y, 2006, J HEALTH SCI, V52, P228, DOI 10.1248/jhs.52.228; Sugiyama M, 2005, LIMNOLOGY, V6, P117, DOI 10.1002/s10201-005-0144-y; Ou ZQ, 1996, CHEMOSPHERE, V32, P827, DOI 10.1016/0045-6535(95)00350-9; Sun HF, 2003, J ENVIRON MONITOR, V5, P891, DOI 10.1039/b308988f; Doi J, 2002, ENVIRON TOXICOL CHEM, V21, P2617, DOI 10.1897/1551-5028(2002)021<2617:IOAOWT>2.0.CO;2; Dyer SD, 2003, CHEMOSPHERE, V52, P43, DOI 10.1016/S0045-6535(03)000269-8; Garcia MT, 2002, CHEMOSPHERE, V49, P279, DOI 10.1016/S0045-6535(02)00182-0; Gordon AK, 2009, SCI TOTAL ENVIRON, V407, P4465, DOI 10.1016/j.scitotenv.2009.04.023; Hampel M, 2009, ENVIRON MONIT ASSESS, V149, P151, DOI 10.1007/s10661-008-0190-0; Japan Ministry of the Environment, 2014, PRTR SUBST; Japan Standards Association, 1998, JAP IND STAND K0101; Japan Surfactant Industry Association, 1997, ANN REP JAP; Kimaro T., 2002, P INT C URB HYDR 21, P696; Kobayashi S., 1979, JPN J LIMNOL, V40, P29; Kobuke Y, 2004, WATER SCI TECHNOL, V50, P355; KOBUKE Y, 1981, Japanese Journal of Limnology, V42, P189; Kunimatsu T., 1988, MECH POLLUTION DISCH, P49; Lake Biwa Environmental Research Institute, 1986, DAT BOOK SHIG PREF E; Lake Biwa Research Institute and National Institute for Research Advancement, 1984, 513 LECS 84 OTS JAP, V513; Miura K, 2008, J OLEO SCI, V57, P161, DOI 10.5650/jos.57.161; MOTOMIZU S, 1982, ANAL CHEM, V54, P392, DOI 10.1021/ac00240a011; National Institute of Technology and Evaluation, 2005, LIN ALK SULF AC ITS, V1, P4; Soejima K., 1996, SAGA KEN KANKYO SENT, V11, P56; TEZUKA Y, 1985, Japanese Journal of Limnology, V46, P239; UCHIYAMA M, 1982, Japanese Journal of Limnology, V43, P39; Utsunomiya A, 1998, JPN J TOX ENV HEALTH, V44, P264; Vincent C. H., 1987, ENVIRON SCI TECHNOL, V21, P370; Yoshida H, 2009, WATER AIR SOIL POLL, V200, P267, DOI 10.1007/s11270-008-9910-x; YOSHIMURA K, 1984, Japanese Journal of Limnology, V45, P51; Yoshimura K., 1982, JAPAN J WATER POLLUT, V5, P19	36	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-6585	1747-6593		WATER ENVIRON J	Water Environ. J.	JUN	2015	29	2					221	227		10.1111/wej.12090		7	Environmental Sciences; Limnology; Water Resources	Environmental Sciences & Ecology; Marine & Freshwater Biology; Water Resources	CI2IM	WOS:000354569900008		
J	Yoshida, K; Tashiro, Y; May, T; Okabe, S				Yoshida, Keitaro; Tashiro, Yosuke; May, Thithiwat; Okabe, Satoshi			Impacts of hydrophilic colanic acid on bacterial attachment to microfiltration membranes and subsequent membrane biofouling	WATER RESEARCH			English	Article						Membrane fouling; Bacterial attachment; Colanic acid; Extracellular polymeric substances (EPS)	ESCHERICHIA-COLI K-12; MUNICIPAL WASTE-WATER; BIOFILM FORMATION; MICROBIAL PRODUCTS; BIOREACTORS; SURFACE; MBR; IDENTIFICATION; CHLOROFLEXI; PERFORMANCE	In order to examine the interactions between physicochemical properties of specific extracellular polymeric substances (BPS) and membrane biofouling, we investigated the impacts of hydrophilic colanic acid, as a model extracellular polysaccharide component, on initial bacterial attachment to different microfiltration (MF) membranes and membrane biofouling by using Escherichia coli strains producing different amounts of colanic acid. In a newly designed microtiter plate assay, the bacterial attachment by an E. coli strain RcsF, which produces massive amounts of colanic acid, decreased only to a hydrophobic membrane because the colanic acid made cell surfaces more hydrophilic, resulting in low cell attachment to hydrophobic membranes. The bench-scale cross-flow filtration tests followed by filtration resistance measurement revealed that RcsF(+) caused severe irreversible membrane fouling (i.e., pore-clogging), whereas less extracellular polysaccharide-producing strains caused moderate but reversible fouling to all membranes used in this study. Further cross-flow filtration tests indicated that colanic acid liberated in the bulk phase could rapidly penetrate pre-accumulated biomass layers (i.e., biofilms) and then directly clogged membrane pores. These results indicate that colanic acid, a hydrophilic extracellular polysaccharide, and possible polysaccharides with similar characteristics with colanic acid are considered as a major cause of severe irreversible membrane fouling (i.e., pore-clogging) regardless of biofilm formation (dynamic membrane). (C) 2015 Elsevier Ltd. All rights reserved.	[Yoshida, Keitaro; Tashiro, Yosuke; May, Thithiwat; Okabe, Satoshi] Hokkaido Univ, Fac Engn, Div Environm Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Tashiro, Yosuke] Shizuoka Univ, Grad Sch Engn, Dept Appl Chem & Biochem Engn, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan	Okabe, S (reprint author), Hokkaido Univ, Fac Engn, Div Environm Engn, Kita Ku, North 13,West 8, Sapporo, Hokkaido 0608628, Japan.	sokabe@eng.hokudai.ac.jp	Okabe, Satoshi/C-7014-2012		Japan Science and Technology Agency, CREST	This research was financially supported by the Japan Science and Technology Agency, CREST. We sincerely appreciate Y. Matsui (Hokkaido University) for technical assistance with the measurement of bacterial zeta potential and T. Anbo (Mitsubishi Rayon Co., Ltd.) for technical assistance with the crossflow microfiltration study.	Ni BJ, 2011, TRENDS BIOTECHNOL, V29, P454, DOI 10.1016/j.tibtech.2011.04.006; Prigent-Combaret C, 2000, ENVIRON MICROBIOL, V2, P450, DOI 10.1046/j.1462-2920.2000.00128.x; Le-Clech P, 2006, J MEMBRANE SCI, V284, P17, DOI 10.1016/j.memsci.2006.08.019; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Miura Y, 2007, ENVIRON SCI TECHNOL, V41, P632, DOI 10.1021/es0615371; Eshed L, 2008, APPL ENVIRON MICROB, V74, P7338, DOI 10.1128/AEM.00631-08; Hwang BK, 2008, ENVIRON SCI TECHNOL, V42, P3963, DOI 10.1021/es7029784; Pang CM, 2005, ENVIRON SCI TECHNOL, V39, P7541, DOI 10.1021/es050170h; Jinhua P, 2006, SEPAR SCI TECHNOL, V41, P1527, DOI 10.1080/01496390600683571; Hanna A, 2003, APPL ENVIRON MICROB, V69, P4474, DOI 10.1128/AEM.69.8.4474-4481.2003; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Miura Y, 2007, ENVIRON SCI TECHNOL, V41, P7787, DOI 10.1021/es071263x; Obadia B, 2007, J MOL BIOL, V367, P42, DOI 10.1016/j.jmb.2006.12.048; Chu HP, 2005, BIOTECHNOL BIOENG, V90, P323, DOI 10.1002/bit.20409; Ng HY, 2006, ENVIRON SCI TECHNOL, V40, P2706, DOI 10.1021/es0516155; Lee J, 2001, WATER RES, V35, P2435, DOI 10.1016/S0043-1354(00)00524-8; Drews A, 2010, J MEMBRANE SCI, V363, P1, DOI 10.1016/j.memsci.2010.06.046; DISCHE Z, 1948, J BIOL CHEM, V175, P595; Stevenson G, 1996, J BACTERIOL, V178, P4885; Herzberg M, 2009, ENVIRON SCI TECHNOL, V43, P7376, DOI 10.1021/es901095u; Metzger U, 2007, J MEMBRANE SCI, V301, P180, DOI 10.1016/j.memsci.2007.06.016; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; Meng FG, 2009, WATER RES, V43, P1489, DOI 10.1016/j.watres.2008.12.044; Lesjean B, 2005, WATER SCI TECHNOL, V51, P1; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; ROSENBERG M, 1984, FEMS MICROBIOL LETT, V22, P289; Miura Y, 2007, WATER RES, V41, P627, DOI 10.1016/j.watres.2006.11.005; Yun MA, 2006, WATER RES, V40, P45, DOI 10.1016/j.watres.2005.10.035; Chang IS, 2002, J ENVIRON ENG-ASCE, V128, P1018, DOI 10.1061/(ASCE)0733-9372(2002)128:11(1018); Chao YQ, 2011, LANGMUIR, V27, P11545, DOI 10.1021/la202534p; Dreszer C, 2013, J MEMBRANE SCI, V429, P436, DOI 10.1016/j.memsci.2012.11.030; Fan FS, 2006, WATER RES, V40, P205, DOI 10.1016/j.watres.2005.10.037; GAREGG PJ, 1971, ACTA CHEM SCAND, V25, P2103, DOI 10.3891/acta.chem.scand.25-2103; GERVAIS FG, 1992, J BACTERIOL, V174, P8016; Kimura K, 2012, WATER RES, V46, P5725, DOI 10.1016/j.watres.2012.08.004; May T, 2009, ANTIMICROB AGENTS CH, V53, P4628, DOI 10.1128/AAC.00454-09; May T, 2008, J BACTERIOL, V190, P7479, DOI 10.1128/JB.00823-08; Miura Y, 2008, ENVIRON SCI TECHNOL, V42, P7380, DOI 10.1021/es800566e; Ratto M, 2006, J IND MICROBIOL BIOT, V33, P359, DOI 10.1007/s10295-005-0064-1; van Loosdrecht M.C.M., 1978, APPL ENVIRON MICROB, V53, P1989; Zhou ZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042270	42	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0043-1354			WATER RES	Water Res.	JUN 1	2015	76						33	42		10.1016/j.watres.2015.02.045		10	Engineering, Environmental; Environmental Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Water Resources	CH9FN	WOS:000354341500004		
J	Simazaki, D; Kubota, R; Suzuki, T; Akiba, M; Nishimura, T; Kunikane, S				Simazaki, Dai; Kubota, Reiji; Suzuki, Toshinari; Akiba, Michihiro; Nishimura, Tetsuji; Kunikane, Shoichi			Occurrence of selected pharmaceuticals at drinking water purification plants in Japan and implications for human health	WATER RESEARCH			English	Article						Drinking water; Pharmaceutical; Therapeutic dose; Source water; Water treatment	ENDOCRINE DISRUPTING COMPOUNDS; RAY CONTRAST-MEDIA; SEWAGE-TREATMENT PLANTS; WASTE-WATER; AQUATIC ENVIRONMENT; VETERINARY ANTIBIOTICS; ACTIVATED-SLUDGE; REMOVAL; CHEMICALS; FATE	The present study was performed to determine the occurrence of 64 pharmaceuticals and metabolites in source water and finished water at 6 drinking water purification plants and 2 industrial water purification plants across Japan. The analytical methods employed were sample concentration using solid-phase extraction cartridges and instrumental analysis by liquid chromatography with tandem mass spectrometry (LC-MS/MS), liquid chromatography with mass spectrometry (LC/MS), or trimethylsilyl derivatization followed by gas chromatography with mass spectrometry (GC/MS). Thirty-seven of the 64 target substances were detected in the source water samples. The maximum concentrations in the source water were mostly below 50 ng/L except for 13 substances. In particular, residual concentrations of iopamidol (contrast agent) exceeded 1000 ng/L at most facilities. Most of the residual pharmaceuticals and metabolites in the source water samples were removed in the course of conventional and/or advanced drinking water treatments, except for 7 pharmaceuticals and 1 metabolite, i.e., amantadine, carbamazepine, diclofenac, epinastine, fenofibrate, ibuprofen, iopamidol, and oseltamivir acid. The removal ratios of the advanced water treatment processes including ozonation and granular activated carbon filtration were typically much higher than those of the conventional treatment processes. The margins of exposure estimated by the ratio of daily minimum therapeutic dose to daily intake via drinking water were substantial, and therefore the pharmacological and physiological impacts of ingesting those residual substances via drinking water would be negligible. (C) 2015 Elsevier Ltd. All rights reserved.	[Simazaki, Dai; Akiba, Michihiro; Kunikane, Shoichi] Natl Inst Publ Hlth, Dept Environm Hlth, Water Management Sect, Wako, Saitama 3510197, Japan; [Kubota, Reiji] Natl Inst Hlth Sci, Div Environm Chem, Setagaya Ku, Tokyo 1588501, Japan; [Suzuki, Toshinari] Tokyo Metropolitan Inst Publ Hlth, Div Pharmaceut & Environm Sci, Shinjuku Ku, Tokyo 1690073, Japan; [Nishimura, Tetsuji] Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, Tokyo 1648530, Japan	Simazaki, D (reprint author), Natl Inst Publ Hlth, Dept Environm Hlth, Water Management Sect, 2-3-6 Wako, Wako, Saitama 3510197, Japan.	simazaki@niph.go.jp			Ministry of the Environment, Japanese government	The authors are grateful to the Ministry of the Environment, Japanese government, for financial support for this study from April 2004 to March 2010.	Kummerer K, 2001, CHEMOSPHERE, V45, P957, DOI 10.1016/S0045-6535(01)00144-8; Yoon Y, 2006, J MEMBRANE SCI, V270, P88, DOI 10.1016/j.memsci.2005.06.045; Huber MM, 2003, ENVIRON SCI TECHNOL, V37, P1016, DOI 10.1021/es025896h; Managaki S, 2007, ENVIRON SCI TECHNOL, V41, P8004, DOI 10.1021/es0709021; Sui Q, 2010, WATER RES, V44, P417, DOI 10.1016/j.watres.2009.07.010; RICHARDSON ML, 1985, J PHARM PHARMACOL, V37, P1; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Hirsch R, 1999, SCI TOTAL ENVIRON, V225, P109, DOI 10.1016/S0048-9697(98)00337-4; Nakada N, 2006, WATER RES, V40, P3297, DOI 10.1016/j.watres.2006.06.039; Ternes TA, 1998, WATER RES, V32, P3245, DOI 10.1016/S0043-1354(98)00099-2; Hua WY, 2006, WATER RES, V40, P2259, DOI 10.1016/j.watres.2006.04.033; Phillips PJ, 2010, ENVIRON SCI TECHNOL, V44, P4910, DOI 10.1021/es100356f; Ternes TA, 2000, ENVIRON SCI TECHNOL, V34, P2741, DOI 10.1021/es991118m; Mons MN, 2013, WATER RES, V47, P1666, DOI 10.1016/j.watres.2012.12.025; Kim SD, 2007, WATER RES, V41, P1013, DOI 10.1016/j.watres.2006.06.034; Benotti MJ, 2009, ENVIRON SCI TECHNOL, V43, P597, DOI 10.1021/es801845a; Seitz W, 2006, ENVIRON CHEM, V3, P35, DOI 10.1071/EN05036; Kemper N, 2008, ECOL INDIC, V8, P1, DOI 10.1016/j.ecolind.2007.06.002; Westerhoff P, 2005, ENVIRON SCI TECHNOL, V39, P6649, DOI 10.1021/es0484799; Buser HR, 1998, ENVIRON SCI TECHNOL, V32, P3449, DOI 10.1021/es980301x; Kimura K, 2004, J MEMBRANE SCI, V245, P71, DOI 10.1016/j.memsci.2004.07.018; Ternes TA, 2002, ENVIRON SCI TECHNOL, V36, P3855, DOI 10.1021/es015757k; Ternes TA, 1999, SCI TOTAL ENVIRON, V225, P91, DOI 10.1016/S0048-9697(98)00335-0; Ternes TA, 2003, WATER RES, V37, P1976, DOI 10.1016/S0043-1354(02)00570-5; Jones OAH, 2001, ENVIRON TECHNOL, V22, P1383, DOI 10.1080/09593332208618186; Yamamoto H, 2009, WATER RES, V43, P351, DOI 10.1016/j.watres.2008.10.039; Buser HR, 1998, ENVIRON SCI TECHNOL, V32, P188, DOI 10.1021/es9705811; Balcioglu IA, 2003, CHEMOSPHERE, V50, P85; Drinking Water Inspectorate for England and Wales, 2007, DESK BAS REV CURR KN; Japan Pharmaceutical Information Center, 2004, IYAK PHARM INF DAT; Japan Water Works Association, 2013, WAT SUPPL JAP 2013; Matsushita T., 2011, P IWA MICR EC 2011 1; Ministry of Health Labour and Welfare, 2006, DOM STAT SURV TRENDS; Ministry of Land Infrastructure and Transportation, 2005, FRESHN RIV NAT; Sadezky A., 2010, REAL SITUATION OCCUR, P78; Schittko S, 2004, WATER SCI TECHNOL, V50, P261; Simazaki D, 2008, WATER SCI TECHNOL, V58, P1129, DOI 10.2166/wst.2008.472; Simazaki D., 2014, J WATER ENV TECH, V12, P277; Snyder S.A., 2008, TOXICOLOGICAL RELAVA, P91238; WHO, 2012, PHARM DRINK WAT	40	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0043-1354			WATER RES	Water Res.	JUN 1	2015	76						187	200		10.1016/j.watres.2015.02.059		14	Engineering, Environmental; Environmental Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Water Resources	CH9FN	WOS:000354341500018		
J	Juzova, K; Nakase, Y; Straka, J				Juzova, Katerina; Nakase, Yuta; Straka, Jakub			Host specialization and species diversity in the genus Stylops (Strepsiptera: Stylopidae), revealed by molecular phylogenetic analysis	ZOOLOGICAL JOURNAL OF THE LINNEAN SOCIETY			English	Article						Andrenidae; bee parasites; generalist parasites; host; parasite systems; phylogenetics; Stylopidae	EVIDENCE CONVERGE; DNA-SEQUENCES; INSECT ORDERS; EVOLUTION; MITOCHONDRIAL; HYMENOPTERA; AMPLIFICATION; SPECIFICITY; GENERALIST; ANDRENIDAE	Host specialization is an important ecological characteristic of parasitic species. The identification of the parasitic strategy of the genus Stylops (Strepsiptera; Stylopidae) is, however, ambiguous. According to the number of recognized species based on existing taxonomy, highly specialized and supergeneralistic species exist in this genus. Our research aims to clarify the concept of host specialization in the genus Stylops, in which all of the members are parasites of Andrena bees. Based on the phylogenetic analysis of the parasites (mostly females) and the mapping of hosts onto the phylogenetic tree, we tested three hypotheses of host specialization: (1) each species of the genus Stylops is associated with a single host species; (2) Stylops species are specialized to a group of closely related hosts; and (3) a single Stylops species is a generalist, parasitizing all host Andrena species in this particular region. Our evidence clearly shows a close relationship between the parasite and the host: one species of Stylops attacks one or a few host species of Andrena bees, usually from a single subgenus. Moreover, a moderate generalistic strategy is also likely in a few Stylops species. According to our results, the species diversity of the strepsipteran parasites of bees must be reconsidered. A single European species of Stylops should be divided into a higher number of valid species.(c) 2015 The Linnean Society of London	[Juzova, Katerina; Straka, Jakub] Charles Univ Prague, Fac Sci, Dept Zool, CR-12844 Prague 2, Czech Republic; [Nakase, Yuta] Natl Museum Nat & Sci, Tsukuba, Ibaraki 3050005, Japan	Straka, J (reprint author), Charles Univ Prague, Fac Sci, Dept Zool, Vinicna 7, CR-12844 Prague 2, Czech Republic.	jakub.straka@aculeataresearch.com	Straka, Jakub/A-7215-2012		Czech Science Foundation [P506/10/1466]; Grant Agency of Charles University in Prague [380411]; SVV project (Integrative Animal Biology) [SVV-2013-267201]	We thank all of the people who helped with the material acquisition, namely John Ascher, Jan Batelka, Lukas Blazej, Petr Bogusch, Katerina Cerna, Sam Droege, Libor Dvorak, Jiri Halada, Zdislava Kolinova, Jan Mateju, Michael Mikat, Joan Milam, Pavel Tyrner, and Eli Wyman. We also thank Jan Batelka, Jan Sobotnik, and the anonymous referees for their comments on the work. This project was supported by: the Czech Science Foundation, project no. P506/10/1466; the Grant Agency of Charles University in Prague, project no. 380411; and the SVV project (Integrative Animal Biology), no. SVV-2013-267201.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Kathirithamby J, 2003, P NATL ACAD SCI USA, V100, P7655, DOI 10.1073/pnas.1131999100; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.ecolsys.21.1.243; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Beutel RG, 2011, CLADISTICS, V27, P341, DOI 10.1111/j.1096-0031.2010.00338.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.ecolsys.19.1.207; Johnson KP, 2009, P R SOC B, V276, P3921, DOI 10.1098/rspb.2009.1174; NIXON KC, 1990, CLADISTICS, V6, P211, DOI 10.1111/j.1096-0031.1990.tb00541.x; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Stothard P, 2000, BIOTECHNIQUES, V28, P1102; Pohl H, 2008, ZOOLOGY, V111, P318, DOI 10.1016/j.zool.2007.06.008; de Queiroz K, 2005, P NATL ACAD SCI USA, V102, P6600, DOI 10.1073/pnas.0502030102; JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651; Steidle JLM, 2003, J CHEM ECOL, V29, P131, DOI 10.1023/A:1021932731350; KAWECKI TJ, 1994, AM NAT, V144, P833, DOI 10.1086/285709; Whiting MF, 1997, SYST BIOL, V46, P1; Niehuis O, 2012, CURR BIOL, V22, P1309, DOI 10.1016/j.cub.2012.05.018; Sasal P, 1999, J ANIM ECOL, V68, P437, DOI 10.1046/j.1365-2656.1999.00313.x; Gibbs J, 2009, ZOOTAXA, P1; Begon M., 2006, ECOLOGY INDIVIDUALS; BOHART RICHARD M., 1941, UNIV CALIFORNIA PUBL ENT, V7, P91; Brandenburg J., 1953, Zeitschrift fuer Parasitenkunde, V15, P457; Cvaka J, 2012, J CHEM ECOL, V38, P1483; FELSENSTEIN J, 1984, EVOLUTION, V38, P16, DOI 10.2307/2408542; Graham SP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007873; Habermannova J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064537; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Harris CM, 2012, J CHEM ECOL, V38, P340, DOI 10.1007/s10886-012-0095-9; Hayward A, 2011, MOL ECOL, V20, P1508, DOI 10.1111/j.1365-294X.2011.05010.x; HOFENEDER KARL, 1949, BROTERIA CIENC NAT, V18, P145; Huelsenbeck JP, 1998, SYST BIOL, V47, P519; Isaka Y, 2012, NEW ENTOMOLOGIST, V61, P15; Kathirithamby J, 2012, P ENTOMOL SOC WASH, V114, P464, DOI 10.4289/0013-8797.114.4.464; KATHIRITHAMBY J, 1984, ZOOL J LINN SOC-LOND, V82, P335, DOI 10.1111/j.1096-3642.1984.tb00647.x; Kathirithamby J, 2012, ZOOTAXA, P16; Kathirithamby J, 2009, ANNU REV ENTOMOL, V54, P227, DOI 10.1146/annurev.ento.54.110807.090525; KIFUNE T, 1991, Japanese Journal of Entomology, V59, P155; Kifune T, 1990, ESAKIA, V29, P97; Kifune T, 1985, ESAKIA, V23, P45; KINZELBACH R.K, 1971, MORPHOLOGISCHE BEFUN; Kinzelbach RK, 1978, FACHERFLUGLER STREPS; KRISTENSEN NP, 1981, ANNU REV ENTOMOL, V26, P135, DOI 10.1146/annurev.en.26.010181.001031; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Larkin LL, 2006, MOL PHYLOGENET EVOL, V38, P330, DOI 10.1016/j.ympev.2005.10.003; Linsley EG, 1957, U CALIF PUBL ENTOMOL, V11, P395; LUNA de CARVALHO E., 1974, EOS REV ESPANOLA ENT, V48, P301; Matsumoto Y, 2011, APPL ENTOMOL ZOOL, V46, P435, DOI 10.1007/s13355-011-0060-z; McKenna DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011887; McMahon DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021206; McMahon DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-603; Nakase Y, 2013, ZOOL SCI, V30, P331, DOI 10.2108/zsj.30.331; Perkins R. C. L., 1918, Entomologist's Monthly Magazine, V54; PIERCE W. D., 1911, P US NATL MUS, V40, P487, DOI DOI 10.5479/SI.00963801.1834.487; Pierce WD, 1909, B US NAT MUS, V66, P1; POHL H., 2013, ENTOMOLOGIA, V1, pe4; Rambaut A., 2007, TRACER V1 4, V4; Riek EF, 1970, INSECTS AUSTR, P622; Rozen S, 2000, Methods Mol Biol, V132, P365; Straka J, 2011, ETHOL ECOL EVOL, V23, P97, DOI 10.1080/03949370.2011.554880; Swofford D.L., 1998, PAUP PHYLOGENETIC AN; Tolasch T, 2012, J CHEM ECOL, V38, P1493, DOI 10.1007/s10886-012-0215-6; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1017/CBO9781139173179; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Zwickl DJ, 2006, THESIS U TEXAS AUSTI	69	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0024-4082	1096-3642		ZOOL J LINN SOC-LOND	Zool. J. Linn. Soc.	JUN	2015	174	2					228	243		10.1111/zoj.12233		16	Zoology	Zoology	CI1HR	WOS:000354495100002		
J	Iwai, T; Zhilinskii, B				Iwai, Toshihiro; Zhilinskii, Boris			Local Description of Band Rearrangements	ACTA APPLICANDAE MATHEMATICAE			English	Article						Energy band; Chern number; Dirac operator	DIABOLIC POINTS; ENERGY-BANDS; SYMMETRY	Rearrangement of rotation-vibration energy bands in isolated molecules within semi-quantum approach is characterized by delta-Chern invariants, each of which is associated to a locally approximated semi-quantum Hamiltonian valid in a small neighborhood of a degeneracy point for the initial semi-quantum Hamiltonian and also valid in a small neighborhood of a critical point corresponding to the crossing of the boundary between iso-Chern domains in the control parameter space. For a full quantum model, a locally approximated Hamiltonian is assumed to take the form of a Dirac operator together with a specific boundary condition. It is demonstrated that the crossing of the boundary along a path with a delta-Chern invariant equal to +/- 1 corresponds to the transfer of one quantum level from a subspaces of quantum states to the other subspace associated with respective positive and negative energy eigenvalues of the local Dirac Hamiltonian.	[Iwai, Toshihiro] Kyoto Univ, Kyoto 6068501, Japan; [Zhilinskii, Boris] Univ Littoral Cote dOpale, F-59140 Dunkerque, France	Zhilinskii, B (reprint author), Univ Littoral Cote dOpale, 189A Av M Schumann, F-59140 Dunkerque, France.	iwai.toshihiro.63u@st.kyoto-u.ac.jp; zhilin@univ-littoral.fr					von Neumann J, 1929, PHYS Z, V30, P467; Sadovskii D, 1999, PHYS LETT A, V256, P235, DOI 10.1016/S0375-9601(99)00229-7; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; ATIYAH MF, 1976, MATH PROC CAMBRIDGE, V79, P71, DOI 10.1017/S0305004100052105; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Arnold V. I., 1995, SELECTA MATH, V1, P1, DOI 10.1007/BF01614072; Asorey M., 2013, J HIGH ENERGY PHYS, V12, P073; BERRY MV, 1984, P ROY SOC LOND A MAT, V392, P45, DOI 10.1098/rspa.1984.0023; Faure F, 2002, PHYS LETT A, V302, P242, DOI 10.1016/S0375-9601(02)01171-4; Faure F, 2000, PHYS REV LETT, V85, P960, DOI 10.1103/PhysRevLett.85.960; Iwai T, 2012, ACTA APPL MATH, V120, P153, DOI 10.1007/s10440-012-9694-2; Iwai T, 2011, ANN PHYS-NEW YORK, V326, P3013, DOI 10.1016/j.aop.2011.07.002; Iwai T, 2013, PHYS LETT A, V377, P2481, DOI 10.1016/j.physleta.2013.07.043; Iwai T, 2014, THEOR CHEM ACC, V133, DOI 10.1007/s00214-014-1501-x; NASELL I, 1974, MATH COMPUT, V28, P253, DOI 10.2307/2005831; PAVLOVVEREVKIN VB, 1988, EUROPHYS LETT, V6, P573, DOI 10.1209/0295-5075/6/7/001; Prokhorova M, 2013, COMMUN MATH PHYS, V322, P385, DOI 10.1007/s00220-013-1701-6; SADOVSKII DA, 1993, PHYS REV A, V47, P2653, DOI 10.1103/PhysRevA.47.2653; Shapere A., 1989, GEOMETRIC PHASES PHY; Zhilinskii BI, 2001, PHYS REP, V341, P85, DOI 10.1016/S0370-1573(00)00089-2	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-8019	1572-9036		ACTA APPL MATH	Acta Appl. Math.	JUN	2015	137	1					97	121		10.1007/s10440-014-9992-y		25	Mathematics, Applied	Mathematics	CH6BH	WOS:000354120100007		
J	Shih, YR; Phadke, A; Yamaguchi, T; Kang, H; Inoue, N; Masuda, K; Varghese, S				Shih, Yu-Ru; Phadke, Ameya; Yamaguchi, Tomonori; Kang, Heemin; Inoue, Nozomu; Masuda, Koichi; Varghese, Shyni			Synthetic bone mimetic matrix-mediated in situ bone tissue formation through host cell recruitment	ACTA BIOMATERIALIA			English	Article						Biomimetic materials; Bone grafts; Posterolateral fusion; Spine; Biomineralization	MESENCHYMAL STEM-CELLS; BETA-TRICALCIUM PHOSPHATE; CALCIUM-PHOSPHATE; OSTEOGENIC DIFFERENTIATION; SPINAL-FUSION; POSTEROLATERAL FUSION; MINERAL COATINGS; GRAFT SUBSTITUTE; LUMBAR SPINE; MODEL	Advances in tissue engineering have offered new opportunities to restore anatomically and functionally compromised tissues. Although traditional tissue engineering approaches that utilize biomaterials and cells to create tissue constructs for implantation or biomaterials as a scaffold to deliver cells are promising, strategies that can activate endogenous cells to promote tissue repair are more clinically attractive. Here, we demonstrate that an engineered injectable matrix mimicking a calcium phosphate (CaP)-rich bone-specific microenvironment can recruit endogenous cells to form bone tissues in vivo. Comparison of matrix alone with that of bone marrow-soaked or bFGF-soaked matrix demonstrates similar extent of neo-bone formation and bridging of decorticated transverse processes in a posterolateral lumbar fusion rat model. Synthetic biomaterials that stimulate endogenous cells without the need for biologics to assist tissue repair could circumvent limitations associated with conventional tissue engineering approaches, including ex vivo cell processing and laborious efforts, thereby accelerating the translational aspects of regenerative medicine. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Shih, Yu-Ru; Phadke, Ameya; Kang, Heemin; Varghese, Shyni] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Yamaguchi, Tomonori; Masuda, Koichi] Univ Calif San Diego, Sch Med, Dept Orthopaed Surg, La Jolla, CA 92093 USA; [Yamaguchi, Tomonori; Inoue, Nozomu] Doshisha Univ, Grad Sch Life & Med Sci, Dept Biomed Engn, Kyoto 602, Japan	Varghese, S (reprint author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr,MC 0412, La Jolla, CA 92093 USA.	komasuda@ucsd.edu; svarghese@ucsd.edu			National Institutes of Health (NIH) [1 R01 AR063184-01A1]	The authors gratefully acknowledge the financial support from National Institutes of Health (NIH, Grant 1 R01 AR063184-01A1).	Acharya NK, 2008, J SPINAL DISORD TECH, V21, P106, DOI 10.1097/BSD.0b013e31805fea1f; Albrektsson T., 2001, EUR SPINE J, V10, P596; Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107; Nakamura Y, 2005, BONE, V36, P399, DOI 10.1016/j.bone.2004.11.010; Yuan HP, 1998, J MATER SCI-MATER M, V9, P717, DOI 10.1023/A:1008998817977; Rajaee SS, 2012, SPINE, V37, P67, DOI 10.1097/BRS.0b013e31820cccfb; Perez RA, 2013, J BIOMED MATER RES A, V101, P923, DOI 10.1002/jbm.a.34390; Kawai T, 2009, TISSUE ENG PT A, V15, P23, DOI 10.1089/ten.tea.2008.0141; LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g; DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Glassman SD, 2011, SPINE, V36, P1849, DOI 10.1097/BRS.0b013e3181d133d0; Barradas AMC, 2012, BIOMATERIALS, V33, P5696, DOI 10.1016/j.biomaterials.2012.04.021; Phadke A, 2013, EUR CELLS MATER, V25, P114; Barradas AMC, 2013, INTEGR BIOL-UK, V5, P920, DOI 10.1039/c3ib40027a; Chai YC, 2011, TISSUE ENG PT A, V17, P1083, DOI [10.1089/ten.TEA.2010.0160, 10.1089/ten.tea.2010.0160]; BODEN SD, 1995, SPINE, V20, P412, DOI 10.1097/00007632-199502001-00003; Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004; Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482; Alam MI, 2001, BIOMATERIALS, V22, P1643; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Pek YS, 2008, BIOMATERIALS, V29, P4300, DOI 10.1016/j.biomaterials.2008.07.030; Lee JS, 2011, ADV MATER, V23, P4279, DOI 10.1002/adma.201100060; Muller P, 2008, J CELL MOL MED, V12, P281, DOI 10.1111/j.1582-4934.2007.00103.x; Phadke A, 2010, BIOMACROMOLECULES, V11, P2060, DOI 10.1021/bm100425p; Kimoto T, 1998, J DENT RES, V77, P1965; Jenis LG, 2010, SPINE, V35, pE1058, DOI 10.1097/BRS.0b013e3181df196f; Bhatia SK, 2012, GREEN CHEM CHEM ENG, P149; Chai YC, 2012, TISSUE ENG PART C-ME, V18, P90, DOI [10.1089/ten.TEC.2011.0248, 10.1089/ten.tec.2011.0248]; Cheng L, 2012, APPL SURF SCI, P262; Faour O, 2011, INJURY, V42, pS87, DOI 10.1016/j.injury.2011.06.020; Hartman EHM, 2005, BIOMATERIALS, V26, P1829, DOI 10.1016/j.biomaterials.2004.06.016; Kabra H, 2015, ACS BIOMATER SCI ENG, V1, P7; Kai T, 2003, SPINE, V28, P1653, DOI 10.1097/00007632-200308010-00005; Kang HM, 2014, J MATER CHEM B, V2, P5676, DOI 10.1039/c4tb00714j; Kang H, 2014, ACTA BIOMATER; Lee YP, 2005, J SPINAL DISORD TECH, V18, P439, DOI 10.1097/01.bsd.0000175696.66049.f7; Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017; Liu YL, 2004, TISSUE ENG, V10, P101, DOI 10.1089/107632704322791745; Matsushita N, 2004, J BIOMED MATER RES A, V70A, P450, DOI 10.1002/jbm.a.30102; Midy V, 1998, J BIOMED MATER RES, V41, P405, DOI 10.1002/(SICI)1097-4636(19980905)41:3<405::AID-JBM10>3.0.CO;2-H; Nagai H, 1999, J VET MED SCI, V61, P869, DOI 10.1292/jvms.61.869; Ochia RS, 2006, SPINE, V31, P2073, DOI 10.1097/01.brs.0000231435.55842.9e; Okamoto S, 2012, TISSUE ENG PT A, V18, P157, DOI [10.1089/ten.TEA.2011.0283, 10.1089/ten.tea.2011.0283]; Phadke A, 2012, MACROMOL BIOSCI, V12, P1022, DOI 10.1002/mabi.201100289; Selye H, 1960, DEV GENES EVOL, V151, P572; Seyedjafari E, 2010, BIOMACROMOLECULES, V11, P3118, DOI 10.1021/bm1009238; Shih YRV, 2014, P NATL ACAD SCI USA, V111, P990, DOI 10.1073/pnas.1321717111; Suarez-Gonzalez D, 2012, ACTA BIOMATER, V8, P1117, DOI 10.1016/j.actbio.2011.11.028; Tay BKB, 1998, SPINE, V23, P2276, DOI 10.1097/00007632-199811010-00005; Yamaguchi T, 2014, TISSUE ENG C; Yee AJM, 2004, SPINE, V29, P1308, DOI 10.1097/01.BRS.0000127184.43765.61; Yoshida Tatsuya, 2009, J Orthop Surg Res, V4, P31, DOI 10.1186/1749-799X-4-31	53	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	JUN	2015	19						1	9		10.1016/j.actbio.2015.03.017		9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CH6NA	WOS:000354152100001		
J	Abdalkader, R; Kawakami, S; Unga, J; Suzuki, R; Maruyama, K; Yamashita, F; Hashida, M				Abdalkader, Rodi; Kawakami, Shigeru; Unga, Johan; Suzuki, Ryo; Maruyama, Kazuo; Yamashita, Fumiyoshi; Hashida, Mitsuru			Evaluation of the potential of doxorubicin loaded microbubbles as a theranostic modality using a murine tumor model	ACTA BIOMATERIALIA			English	Article						Cancer therapy; Doxorubicin loaded microbubbles; Theranostics; Ultrasound; Cavitation	MANNOSE-MODIFIED LIPOPLEXES; GENE DELIVERY; SOLID TUMORS; ULTRASOUND; THERAPY; CELLS; DRUG; PHOSPHOLIPIDS; INFLAMMATION; COMBINATION	In this study, a novel phospholipid-based microbubble formulation containing doxorubicin and perfluoropropane gas (DLMB) was developed. The DLMBs were prepared by mechanical agitation of a phospholipid dispersion in the presence of perfluoropropane (PFP) gas. An anionic phospholipid, distearoyl phosphatidylglycerol (DSPG) was selected to load doxorubicin in the microbubbles by means of electrostatic interaction. The particle size, zeta potential, echogenicity and stability of the DLMBs were measured. Drug loading was >= 92%. The potential of the DLMBs for use as a theranostic modality was evaluated in tumor bearing mice. Gas chromatography analysis of PFP showed significant enhancement of PFP retention when doxorubicin was used at concentrations of 10-82% equivalent to DSPG. The inhibitory effects on the proliferation of B16BL6 melanoma murine cells in vitro were enhanced using a combination of ultrasound (US) irradiation and DLMBs. Moreover, in vivo DLMBs in combination with (US) irradiation significantly inhibited the growth of B16BL6 melanoma tumor in mice. Additionally, US echo imaging showed high contrast enhancement of the DLMBs in the tumor vasculature. These results suggest that DLMBs could serve as US triggered carriers of doxorubicin as well as tumor imaging agents in cancer therapy. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Abdalkader, Rodi; Unga, Johan; Yamashita, Fumiyoshi; Hashida, Mitsuru] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Kawakami, Shigeru] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Suzuki, Ryo; Maruyama, Kazuo] Teikyo Univ, Fac Pharma Sci, Lab Drug & Gene Delivery, Tokyo, Japan; [Hashida, Mitsuru] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kyoto, Japan	Hashida, M (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan.	skawakam@nagasaki-u.ac.jp; hashidam@pharm.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Programs for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Uehara Memorial Foundation	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by the Programs for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) and by the Uehara Memorial Foundation.	Hashida M, 2005, CHEM PHARM BULL, V53, P871, DOI 10.1248/cpb.53.871; Niu CC, 2013, BIOMATERIALS, V34, P2307, DOI 10.1016/j.biomaterials.2012.12.003; Deng CX, 2004, ULTRASOUND MED BIOL, V30, P519, DOI 10.1016/j.ultrasmedbio.2004.01.005; Suzuki R, 2007, J CONTROL RELEASE, V117, P130, DOI 10.1016/j.jconrel.2006.09.008; Shiraishi K, 2011, INT J PHARMACEUT, V421, P379, DOI 10.1016/j.ijpharm.2011.10.006; Karshafian R, 2009, ULTRASOUND MED BIOL, V35, P847, DOI 10.1016/j.ultrasmedbio.2008.10.013; Lindner JR, 2000, CIRCULATION, V102, P2745; Tinkov S, 2010, J CONTROL RELEASE, V148, P368, DOI 10.1016/j.jconrel.2010.09.004; Un K, 2010, BIOMATERIALS, V31, P7813, DOI 10.1016/j.biomaterials.2010.06.058; van Wamel A, 2006, J CONTROL RELEASE, V112, P149, DOI 10.1016/j.jconrel.2006.02.007; Ueno Y, 2011, CANCER BIOL THER, V12, P270, DOI 10.4161/cbt.12.4.16259; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Lentacker I, 2010, MOL THER, V18, P101, DOI 10.1038/mt.2009.160; Ogawara K, 2009, J CONTROL RELEASE, V133, P4, DOI 10.1016/j.jconrel.2008.09.008; Un K, 2011, BIOMATERIALS, V32, P4659, DOI 10.1016/j.biomaterials.2011.03.013; Qin SP, 2009, PHYS MED BIOL, V54, pR27, DOI 10.1088/0031-9155/54/6/R01; GOORMAGHTIGH E, 1980, BIOCHIM BIOPHYS ACTA, V597, P1, DOI 10.1016/0005-2736(80)90145-5; Korpanty G, 2007, CLIN CANCER RES, V13, P323, DOI 10.1158/1078-0432.CCR-06-1313; Un K, 2012, HEPATOLOGY, V56, P259, DOI 10.1002/hep.25607; Fan CH, 2013, BIOMATERIALS, V34, P3706, DOI 10.1016/j.biomaterials.2013.01.099; DEWOLF FA, 1991, BIOSCIENCE REP, V11, P275; Kurosaki T, 2014, NANOMEDICINE; Kurosaki T, 2014, J CONTROL RELEASE, V176, P24, DOI 10.1016/j.jconrel.2013.12.023; Negishi Y, 2013, BIOMATERIALS, V34, P501, DOI 10.1016/j.biomaterials.2012.09.056; Pysz MA, 2011, INVEST RADIOL, V46, P187, DOI 10.1097/RLI.0b013e3181f9202d; Sax N, 2013, PHARM RES-DORDR, V30, P218, DOI 10.1007/s11095-012-0864-8; Yan F, 2011, ULTRASOUND MED BIOL, V37, P768, DOI 10.1016/j.ultrasmedbio.2011.02.006	27	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	JUN	2015	19						112	118		10.1016/j.actbio.2015.03.014		7	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CH6NA	WOS:000354152100012		
J	Xia, Y; Miyamoto, G; Yang, ZG; Zhang, C; Furuhara, T				Xia, Y.; Miyamoto, G.; Yang, Z. G.; Zhang, C.; Furuhara, T.			Direct measurement of carbon enrichment in the incomplete bainite transformation in Mo added low carbon steels	ACTA MATERIALIA			English	Article						Bainite; Steel; Carbon enrichment; EPMA; Incomplete transformation	CONTROLLED PRECIPITATE GROWTH; C-X ALLOYS; SOLUTE DRAG; TERNARY-SYSTEMS; FERRITE; AUSTENITE; KINETICS; BOUNDARIES; STASIS	The overall kinetics and carbon enrichment in austenite during the incomplete isothermal bainite transformation in Fe-0.1C-1.5Mn(0, 0.03, 0.3, 0.5, 1)Mo (mass%) alloys were investigated with quantitative metallography and Electron Probe Microanalysis in the transformation temperature range of 773-873 K. The incomplete transformation appears at 823-873 K when Mo addition exceeds 0.3 mass%; at 773 K substantial carbide precipitation accompanies bainite transformation and no transformation stasis is observed. Transformed fractions in the stasis stage are hardly affected by prior austenite grain size. Carbon concentrations in austenite in the stasis stage are lower than To line and decrease with the increase of Mo addition and temperature. To limit, solute drag and WBs limit theories are used to examine the experimentally measured carbon concentration limits in austenite, and their respective flaws are pointed out. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Xia, Y.; Yang, Z. G.; Zhang, C.] Tsinghua Univ, Key Lab Adv Mat, Sch Mat Sci & Engn, Minist Educ, Beijing 100084, Peoples R China; [Xia, Y.; Miyamoto, G.; Furuhara, T.] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	Miyamoto, G (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan.	miyamoto@imr.tohoku.ac.jp	Miyamoto, Goro/G-2802-2010; Furuhara, Tadashi/B-2149-2010		"Creation of Innovative Functions of Intelligent Materials on the Basis of Element Strategy" by CREST Basic Research Program; Ministry of Education, Culture, Sports, Science, and Technology [23360316 (2011-2013)]; Tohoku University; Tsinghua University; National Natural Science Foundation of China [51471094]	A part of this research was supported by "Creation of Innovative Functions of Intelligent Materials on the Basis of Element Strategy" by CREST Basic Research Program. T.F. gratefully acknowledges the financial support provided by the Ministry of Education, Culture, Sports, Science, and Technology through a Grant-in-Aid for Scientific Research (B) No. 23360316 (2011-2013). X.Y. gratefully acknowledges the financial support from the Joint Education Program between Tohoku University and Tsinghua University, and National Natural Science Foundation of China (Grant No. 51471094).	Aaronson H. I., 1970, PHASE TRANSFORMATION, P313; AARONSON HI, 1990, METALL TRANS A, V21, P1343, DOI 10.1007/BF02672557; BHADESHIA HKDH, 1980, ACTA METALL MATER, V28, P1265, DOI 10.1016/0001-6160(80)90082-6; Chen H, 2013, ACTA MATER, V61, P5458, DOI 10.1016/j.actamat.2013.05.034; Hillert M, 2004, METALL MATER TRANS A, V35A, P3693, DOI 10.1007/s11661-004-0275-5; Chen H, 2014, METALL MATER TRANS A, V45A, P3429, DOI 10.1007/s11661-014-2262-9; BRADLEY JR, 1981, METALL TRANS A, V12, P1729, DOI 10.1007/BF02643755; HILLERT M, 1976, ACTA METALL MATER, V24, P731, DOI 10.1016/0001-6160(76)90108-5; Caballero FG, 2009, ACTA MATER, V57, P8, DOI 10.1016/j.actamat.2008.08.041; Enomoto M, 1999, ACTA MATER, V47, P3533, DOI 10.1016/S1359-6454(99)00232-3; Guo H, 2007, METALL MATER TRANS A, V38A, P1152, DOI 10.1007/s11661-007-9139-0; BISS V, 1971, METALL TRANS, V2, P2267, DOI 10.1007/BF02917559; Aaronson HI, 2004, METALL MATER TRANS A, V35A, P1187, DOI 10.1007/s11661-004-0294-2; Liu ZQ, 2013, ACTA MATER, V61, P3120, DOI 10.1016/j.actamat.2013.02.003; REYNOLDS WT, 1990, METALL TRANS A, V21, P1433, DOI 10.1007/BF02672561; HEHEMANN RF, 1972, METALL TRANS, V3, P1077, DOI 10.1007/BF02642439; Singh SB, 1998, MAT SCI ENG A-STRUCT, V245, P72, DOI 10.1016/S0921-5093(97)00701-6; Aaronson HI, 2006, METALL MATER TRANS A, V37A, P1731, DOI 10.1007/s11661-006-0116-9; COATES DE, 1972, METALL TRANS, V3, P1203, DOI 10.1007/BF02642453; BHADESHIA HKDH, 1990, METALL TRANS A, V21, P767, DOI 10.1007/BF02656561; BHADESHIA HKDH, 1981, ACTA METALL MATER, V29, P1117, DOI 10.1016/0001-6160(81)90063-8; COATES DE, 1973, METALL TRANS, V4, P1077, DOI 10.1007/BF02645611; Furuhara T, 2014, METALL MATER TRANS A, V45A, P5990, DOI 10.1007/s11661-014-2584-7; Furuhara T, 2010, MATER SCI TECH-LOND, V26, P392, DOI 10.1179/026708309X12512744; GOLDENSTEIN H, 1990, METALL TRANS A, V21, P1465, DOI 10.1007/BF02672562; REYNOLDS WT, 1990, METALL TRANS A, V21, P1479, DOI 10.1007/BF02672563; Hillert M., 1960, GROWTH FERRITE BAINI; Hultgren A., 1947, T ASM, V39, P54; Ikawa H., 1980, T JPN WELD SOC, V11, P87; Steven W., 1956, J IRON STEEL I, V183, P349; Wan XL, 2013, J MATER SCI, V48, P4345, DOI 10.1007/s10853-013-7250-8; Xia Y., 2015, METALL MA A IN PRESS; ZENER C, 1946, T AM I MIN MET ENG, V167, P550	33	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	JUN 1	2015	91						10	18		10.1016/j.actamat.2015.03.021		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CH6NX	WOS:000354154400002		
J	Wang, J; Hata, S; Takahashi, YK; Sepehri-Amin, H; Varaprasad, BSDCS; Shiroyama, T; Schrefl, T; Hono, K				Wang, J.; Hata, S.; Takahashi, Y. K.; Sepehri-Amin, H.; Varaprasad, B. S. D. Ch. S.; Shiroyama, T.; Schrefl, T.; Hono, K.			Effect of MgO underlayer misorientation on the texture and magnetic property of FePt-C granular film	ACTA MATERIALIA			English	Article						Magnetic recording media; Heat assisted magnetic recording; Misorientation; FePt-C	TRANSMISSION-ELECTRON-MICROSCOPE; THIN-FILMS; ORIENTATION; MEDIA; DIFFRACTION; COERCIVITY; MICROSTRUCTURE; TEM	A transmission electron microscope (TEM) based orientation mapping technique and micromagnetic simulations were applied to study the influence of easy axis distribution (EAD) on magnetic properties of FePt-C granular films which were deposited on a single crystalline MgO (0 0 1) substrate and a (0 0 1)-textured poly-crystalline MgO underlayer. The FePt-C film on the polycrystalline MgO underlayer shows smaller perpendicular coercivity, broader switching field distribution and visible in-plane minor loop compared with that deposited on the single crystalline MgO (0 0 1) substrate. Although the grain sizes and their distributions in both films look similar in TEM, orientation mapping and texture analysis revealed that the polycrystalline MgO underlayer introduces significant misorientation in the (0 0 1)-textured FePt grains. Micromagnetic simulations successfully reproduced the large hysteresis in the in-plane magnetization by introducing the specific misorientation distribution of the FePt grains obtained from the texture analysis. The misoriented FePt grains were found to be grown from misoriented MgO grains, indicating that the improvement of the (0 0 1) texture of the MgO underlayer is essential to reduce the in-plane component of FePt based recording media. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Wang, J.; Takahashi, Y. K.; Sepehri-Amin, H.; Varaprasad, B. S. D. Ch. S.; Shiroyama, T.; Hono, K.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Hata, S.] Kyushu Univ, Dept Elect & Mat Sci, Kasuga, Fukuoka 8168580, Japan; [Schrefl, T.] Danube Univ Krems, Ctr Integrated Sensor Syst, Krems Donau, Austria	Hono, K (reprint author), Natl Inst Mat Sci, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	kazuhiro.hono@nims.go.jp	Hono, Kazuhiro/B-9202-2008	Hono, Kazuhiro/0000-0001-7367-0193	Advanced Storage Technology Consortium (ASTC) of the International Disk Drive Equipment and Materials Association (IDEMA), USA;  [26289232]	This work was supported in part by the Advanced Storage Technology Consortium (ASTC) of the International Disk Drive Equipment and Materials Association (IDEMA), USA, and the Grant-in-Aid (B) (Grant No. 26289232). The MEXT/JSPS Kakenhi (22102002, 25286027). ASTARTM analysis was performed at the Ultramicroscopy Research Center, Kyushu University.	Liu X, 2014, ACTA MATER, V64, P333, DOI 10.1016/j.actamat.2013.10.046; Weller D, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2013.2281027; Rauch EF, 2005, ARCH METALL MATER, V50, P87; Piramanayagam SN, 2007, J APPL PHYS, V102, DOI 10.1063/1.2750414; Varaprasad BSDCS, 2013, J APPL PHYS, V113, DOI 10.1063/1.4804661; CEBOLLADA F, 1995, PHYS REV B, V52, P13511, DOI 10.1103/PhysRevB.52.13511; Ho HA, 2014, J APPL PHYS, V116, DOI 10.1063/1.4902082; Zhang L, 2010, J MAGN MAGN MATER, V322, P2658, DOI 10.1016/j.jmmm.2010.04.003; Rauch EF, 2010, Z KRISTALLOGR, V225, P103, DOI 10.1524/zkri.2010.1205; Rauch EF, 2005, MATERIALWISS WERKST, V36, P552, DOI 10.1002/mawe.200500923; Christodoulides JA, 2001, IEEE T MAGN, V37, P1292, DOI 10.1109/20.950821; Varaprasad BSDCS, 2013, JOM-US, V65, P853, DOI 10.1007/s11837-013-0620-5; Schrefl T, 1998, J APPL PHYS, V83, P6262, DOI 10.1063/1.367666; Zhao ZL, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2168256; STONER EC, 1948, PHILOS TR R SOC S-A, V240, P599, DOI 10.1098/rsta.1948.0007; Bai J, 2004, J APPL PHYS, V96, P6690, DOI 10.1063/1.1808475; Dong KF, 2012, J APPL PHYS, V111, DOI 10.1063/1.3671430; ELHILO M, 1990, IEEE T MAGN, V26, P210, DOI 10.1109/20.50536; Harrell JW, 1997, J APPL PHYS, V81, P3800, DOI 10.1063/1.364774; Kodzuka M, 2012, J APPL PHYS, V111, DOI 10.1063/1.3688039; Maab R., 2006, J APPL PHYS, V100; PAUL DI, 1988, J APPL PHYS, V63, P3441, DOI 10.1063/1.340760; Perumal L. Zhang, 2010, J APPL PHYS, V108; Rauch ER, 2005, MATER SCI FORUM, V495-497, P197; Rouvimov S, 2009, MICROSC MICROANAL, V15, P1290, DOI 10.1017/S143192760909549X; SHTRIKMAN S, 1960, J APPL PHYS, V31, pS58, DOI 10.1063/1.1984604; Takahashi Perumal Y., 2009, J APPL PHYS, V105; Takahashi Perumal Y.K., 2008, APPL PHYS EXP, V1; Trichy GR, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2883933; Varaprasad BSDCS, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4880655; Wemsdorfer W., 2004, PHYS REV B, V70; Wicht S, 2013, J APPL PHYS, V114, DOI 10.1063/1.4817274; Wu XW, 2004, J MAGN MAGN MATER, V278, P285, DOI 10.1016/j.jmmm.2003.12.1388; Zhang L, 2011, J APPL PHYS, V109, DOI 10.1063/1.3536794; Zhang L, 2011, IEEE T MAGN, V47, P4062, DOI 10.1109/TMAG.2011.2157088; Zhou MJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2757597	36	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	JUN 1	2015	91						41	49		10.1016/j.actamat.2015.03.007		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CH6NX	WOS:000354154400005		
J	Kobayashi, S; Kamata, A; Watanabe, T				Kobayashi, Shigeaki; Kamata, Akiyuki; Watanabe, Tadao			A mechanism of grain growth-assisted intergranular fatigue fracture in electrodeposited nanocrystalline nickel-phosphorus alloy	ACTA MATERIALIA			English	Article						Nanocrystalline material; Fatigue fracture; Cyclic stress-induced grain growth; Grain boundary character distribution; Grain boundary geometrical configuration	LOW-CYCLE FATIGUE; BOUNDARY MIGRATION; SHEAR DEFORMATION; CRACK INITIATION; METALS; BEHAVIOR; MOTION; ALUMINUM; COPPER; NI	Quantitative investigation of the grain growth and resultant change in grain boundary microstructure during high-cycle fatigue was performed to understand intergranular fatigue fracture in electrodeposited nanocrystalline Ni - 2.0 mass% P alloys by using FE-SEM/EBSD technique. Pre-fatigued specimens had an average grain size of 45 nm, a sharp {0 0 1} texture and a high fraction of low-angle boundaries and of twin, or Sigma 3 coincidence site lattice (CSL) boundaries. The considerable grain growth occurred due to the migration of low-angle boundaries induced by shear stress during cyclic deformation. The misorientation angle of those low-angle boundaries increased covering the whole surface of fatigue-fractured specimen. A certain fraction of low-angle boundaries was transformed into high-angle random boundaries resultant from grain growth during high-cycle fatigue. Those random boundaries which surrounded the grown {0 0 1}-grains were aligned along shear bands at almost 45 degrees to the stress axis, and formed the diamond-shaped grain configuration, as reported in the literature on high temperature fatigue. The reported increase of the fatigue limit by nanocrystallization is likely reduced due to the cyclic stress-induced grain growth associated with the migration of low-angle boundaries composing nanograin cluster. Moreover, the random boundaries transformed from low-angle boundaries can be preferential sites for crack nucleation and propagation at the positions of initially formed shear bands during fatigue. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Kobayashi, Shigeaki; Kamata, Akiyuki] Ashikaga Inst Technol, Dept Innovat Engn, Fac Engn, Div Mech & Elect Engn, Ashikaga, Tochigi 3268558, Japan; [Watanabe, Tadao] Northeastern Univ, Key Lab Anisotropy & Texture Mat, Shenyang 110004, Peoples R China	Kobayashi, S (reprint author), Ashikaga Inst Technol, Dept Innovat Engn, Fac Engn, Div Mech & Elect Engn, Omae Cho 268-1, Ashikaga, Tochigi 3268558, Japan.	skoba@ashitech.ac.jp; tywata@fk9.so-net.ne.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [23560845]	The authors are grateful to Professor S. Tsurekawa (Kumamoto University, Japan) for the provision of FE-SEMI EBSD/OIM analysis. The present work was financially supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 23560845. One of the authors thanks Prof. Z.F. Zhang (Institute of Metal Research, Shenyang, China) for kind provision of recent literature on basic studies of fatigue fracture. He also thanks Prof. Zuo Liang and Prof. Zhao Xiang for their warmest hospitality to his pleasant stay at Northeastern University, Shenyang, China. Finally the authors would like to thank the editor and reviewers for their constructive and helpful comments which helped us greatly.	An XH, 2014, ACTA MATER, V74, P200, DOI 10.1016/j.actamat.2014.04.053; Cahn JW, 2006, ACTA MATER, V54, P4953, DOI 10.1016/j.actamat.2006.08.004; Winning M, 2002, ACTA MATER, V50, P353, DOI 10.1016/S1359-6454(01)00343-3; Winning M, 2005, ACTA MATER, V53, P2901, DOI 10.1016/j.actamat.2005.03.005; MACKENZIE JK, 1958, BIOMETRIKA, V45, P229, DOI 10.2307/2333059; Zhang ZF, 2000, MAT SCI ENG A-STRUCT, V284, P285, DOI 10.1016/S0921-5093(00)00796-6; Legros M, 2008, ACTA MATER, V56, P3380, DOI 10.1016/j.actamat.2008.03.032; Dao M, 2007, ACTA MATER, V55, P4041, DOI 10.1016/j.actamat.2007.01.038; Hanlon T, 2003, SCRIPTA MATER, V49, P675, DOI 10.1016/S1359-6462(03)00393-2; Molodov DA, 2007, ACTA MATER, V55, P1843, DOI 10.1016/j.actamat.2006.10.045; Hanlon T, 2005, INT J FATIGUE, V27, P1147, DOI 10.1016/j.ijfatigue.2005.06.035; Kobayashi S, 2008, J MATER SCI, V43, P3792, DOI 10.1007/s10853-007-2236-z; Rajabzadeh A, 2013, PHILOS MAG, V93, P1299, DOI 10.1080/14786435.2012.760760; Winning M, 2001, ACTA MATER, V49, P211, DOI 10.1016/S1359-6454(00)00321-9; Boyce BL, 2011, METALL MATER TRANS A, V42A, P1793, DOI 10.1007/s11661-011-0708-x; Gleiter H., 1992, Nanostructured Materials, V1, DOI 10.1016/0965-9773(92)90045-Y; Gianola DS, 2006, ACTA MATER, V54, P2253, DOI 10.1016/j.actamat.2006.01.023; LIU W, 1992, ACTA METALL MATER, V40, P1763, DOI 10.1016/0956-7151(92)90119-Y; Padilla HA, 2010, EXP MECH, V50, P5, DOI 10.1007/s11340-009-9301-2; Cavaliere P, 2009, INT J FATIGUE, V31, P1476, DOI 10.1016/j.ijfatigue.2009.05.004; Gleiter H, 2000, ACTA MATER, V48, P1, DOI 10.1016/S1359-6454(99)00285-2; Kumar KS, 2003, ACTA MATER, V51, P5743, DOI 10.1016/S1359-6454(02)00421-4; Tschopp MA, 2014, JOM-US, V66, P1000, DOI 10.1007/s11837-014-0978-z; Hibbard GD, 2002, SCRIPTA MATER, V47, P83, DOI 10.1016/S1359-6462(02)00098-2; Meirom RA, 2011, ACTA MATER, V59, P1141, DOI 10.1016/j.actamat.2010.10.047; Zhang ZF, 2008, PROG MATER SCI, V53, P1025, DOI 10.1016/j.pmatsci.2008.06.001; Cahn JW, 2004, ACTA MATER, V52, P4887, DOI 10.1016/j.actamat.2004.02.048; Watanabe T, 2011, J MATER SCI, V46, P4095, DOI 10.1007/s10853-011-5393-z; WATANABE T, 1989, ACTA METALL MATER, V37, P941, DOI 10.1016/0001-6160(89)90021-7; Hentschel T, 2000, ACTA MATER, V48, P933, DOI 10.1016/S1359-6454(99)00371-7; Birringer R., 1986, T JAPAN I METALS S, V27, P43; CHEN S, 1988, ACTA METALL MATER, V36, P3093, DOI 10.1016/0001-6160(88)90046-6; Cheng S, 2007, SCRIPTA MATER, V57, P217, DOI 10.1016/j.scriptamat.2007.04.013; Erb U., 1993, Nanostructured Materials, V2, DOI 10.1016/0965-9773(93)90180-J; Fan GJ, 2006, ACTA MATER, V54, P4781, DOI 10.1016/j.actamat.2006.06.016; Gottstein G., 1999, GRAIN BOUNDARY MIGRA, P129; Hashimoto S, 1999, INTERFACE SCI, V7, P159, DOI 10.1023/A:1008739820261; HEINZ A, 1990, ACTA METALL MATER, V38, P1933, DOI 10.1016/0956-7151(90)90305-Z; Huang Y, 2000, ACTA MATER, V48, P2017, DOI 10.1016/S1359-6454(99)00418-8; Kaneko Y, 1999, INTERFACE SCI, V7, P147, DOI 10.1023/A:1008787703423; Kobayashi S, 2003, MAT SCI ENG A-STRUCT, V358, P76, DOI 10.1016/S0921-5093(03)00285-5; Kobayashi S, 2009, SCRIPTA MATER, V61, P1032, DOI 10.1016/j.scriptamat.2009.08.021; Lejcek P., 2010, GRAIN BOUNDARY SEGRE, P111; LIM LC, 1987, ACTA METALL MATER, V35, P1653, DOI 10.1016/0001-6160(87)90113-1; Massalski T.B., 1986, BINARY ALLOY PHASE D, V2, P1739; Murr L.E., 1975, INTERFACIAL PHENOMEN, p[53, 145]; Neumann P., 1987, P C FATIGUE CHARLOTT, V1, P3; Ovid'ko IA, 2008, ACTA MATER, V56, P2718, DOI 10.1016/j.actamat.2008.02.004; Palmbo G., 1990, SCRIPTA METALL MATER, V24, P2347; Palmubo G., 1990, SCRIPTA METALL MATER, V24, P1347; Palumbo G., 1992, MAT INTERFACES, P190; RANDLE V, 1988, P ROY SOC LOND A MAT, V415, P239, DOI 10.1098/rspa.1988.0012; SINGH V, 1977, J MATER SCI, V12, P373, DOI 10.1007/BF00566281; SUZUKI M, 1966, Z METALLKD, V57, P484; WATANABE T, 1983, METALL TRANS A, V14, P531, DOI 10.1007/BF02643771; WATANABE T, 1987, SCRIPTA METALL MATER, V21, P427, DOI 10.1016/0036-9748(87)90174-8; Watanabe T, 2005, MAT SCI ENG A-STRUCT, V410, P140, DOI 10.1016/j.msea.2005.08.083; WESTWOOD HJ, 1972, METALL TRANS, V3, P1959, DOI 10.1007/BF02642585; WITNEY AB, 1995, SCRIPTA METALL MATER, V33, P2025, DOI 10.1016/0956-716X(95)00441-W; Yang Y, 2008, METALL MATER TRANS A, V39A, P1145, DOI 10.1007/s11661-008-9487-4; YAVARI P, 1983, J MATER SCI, V18, P3219, DOI 10.1007/BF00544146; Zhang ZF, 2003, ACTA MATER, V51, P347, DOI 10.1016/S1359-6454(02)00399-3; ZUO L, 1994, Z METALLKD, V85, P554	63	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	JUN 1	2015	91						70	82		10.1016/j.actamat.2015.03.028		13	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CH6NX	WOS:000354154400008		
J	Tochigi, E; Nakamura, A; Mizoguchi, T; Shibata, N; Ikuhara, Y				Tochigi, Eita; Nakamura, Atsutomo; Mizoguchi, Teruyasu; Shibata, Naoya; Ikuhara, Yuichi			Dissociation of the 1/3 <(1)over-bar101 > dislocation and formation of the anion stacking fault on the basal plane in alpha-Al2O3	ACTA MATERIALIA			English	Article						Alumina; Sapphire; Dislocations; Stacking fault; Low-angle grain boundary	SAPPHIRE ALPHA-AL2O3; LOW-ANGLE; BOUNDARY DISLOCATIONS; GRAIN-BOUNDARIES; CORE STRUCTURE; ALUMINA; SLIP; ENERGETICS; PRESSURE; CRYSTAL	Dislocation structures in the (0 0 0 1)/<(1) over bar 1 0 0 > 2 degrees tilt grain boundary of alumina (alpha-Al2O3) were investigated by atomic-resolution transmission electron microscopy (TEM). We found that the grain boundary basically consists of a periodic array of 1/3[(1) over bar 1 0 1], 1/3[0 (1) over bar 1 1], and 1/3[10 (1) over bar 1] dislocations, and these dislocations were dissociated into two partial dislocations with a stacking fault in between on the (0 0 0 1) plane. Atomic-resolution scanning TEM analysis revealed that the stacking fault is present on the anion sublattice, which has not been observed in alumina so far. The presence of the stable (0 0 0 1) anion stacking faults was theoretically supported using a first-principles calculation. Combining experimental and theoretical results, we demonstrate the dissociation reactions of the 1/3 <(1) over bar 1 0 1 > dislocation and the associated stacking fault. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Tochigi, Eita; Shibata, Naoya; Ikuhara, Yuichi] Univ Tokyo, Inst Engn Innovat, Bunkyo Ku, Tokyo 1138656, Japan; [Nakamura, Atsutomo] Nagoya Univ, Dept Mat Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Mizoguchi, Teruyasu] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Ikuhara, Yuichi] Kyoto Univ, Ctr Elements Strategy Initiat Struct Mat, Sakyo Ku, Kyoto 6068501, Japan	Tochigi, E (reprint author), Univ Tokyo, Inst Engn Innovat, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1138656, Japan.	tochigi@sigma.t.u-tokyo.ac.jp	Shibata, Naoya/E-5327-2013; Ikuhara, Yuichi/N-1001-2015; Ikuhara, Yuichi/F-3066-2010	Ikuhara, Yuichi/0000-0003-3886-005X; 	Elements Strategy Initiative for Structural Materials (ESISM) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT); Japan Society for the Promotion of Science (JSPS), "Nanotechnology Platform" [25106003]; MEXT, Japan [12024046]; JSPS KAKENHI [25889015, 26249092, 26630302]	A part of this study was supported by the Elements Strategy Initiative for Structural Materials (ESISM) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT), and a Grant-in-Aid for Scientific Research on Innovative Areas "Nano Informatics" (Grant No. 25106003) from Japan Society for the Promotion of Science (JSPS), "Nanotechnology Platform" (Project No. 12024046) of MEXT, Japan, and JSPS KAKENHI (Grant Nos. 25889015, 26249092, and 26630302).	Duesbery MS, 1998, ACTA MATER, V46, P1481, DOI 10.1016/S1359-6454(97)00367-4; Ikuhara Y, 2003, J AM CERAM SOC, V86, P595; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Findlay SD, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3265946; BILDESORENSEN JB, 1976, PHILOS MAG, V33, P877, DOI 10.1080/14786437608221921; CADOZ J, 1976, SCRIPTA METALL MATER, V10, P597, DOI 10.1016/0036-9748(76)90185-X; CHUNG DH, 1968, J APPL PHYS, V39, P5316, DOI 10.1063/1.1655961; FRANK FC, 1951, PHILOS MAG, V42, P809; GIESKE JH, 1968, PHYS STATUS SOLIDI, V29, P121, DOI 10.1002/pssb.19680290113; Heuer AH, 2010, SCIENCE, V330, P1227, DOI 10.1126/science.1192319; Hirsch P., 1965, ELECT MICROSCOPY THI; Hirth J. P., 1982, THEORY DISLOCATIONS; Jhon MH, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.214101; KENWAY PR, 1993, PHILOS MAG B, V68, P171, DOI 10.1080/01418639308226398; KRONBERG ML, 1957, ACTA METALL MATER, V5, P507, DOI 10.1016/0001-6160(57)90090-1; LAGERLOF KDP, 1984, ACTA METALL MATER, V32, P97, DOI 10.1016/0001-6160(84)90206-2; LAGERLOF KPD, 1994, J AM CERAM SOC, V77, P385, DOI 10.1111/j.1151-2916.1994.tb07006.x; LEE WE, 1985, J ELECTRON MICR TECH, V2, P247, DOI 10.1002/jemt.1060020309; Marinopoulos AG, 2001, PHIL MAG LETT, V81, P329, DOI 10.1080/09500830110039984; Matsunaga K, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.214102; MITCHELL TE, 1976, PHILOS MAG, V34, P441, DOI 10.1080/14786437608222034; Nakamura A, 2009, MATER TRANS, V50, P1008, DOI 10.2320/matertrans.MC200821; Nakamura A, 2006, PHILOS MAG, V86, P4657, DOI 10.1080/14786430600812820; Nakamura A, 2013, ACS NANO, V7, P6297, DOI 10.1021/nn4023334; Nakamura A, 2002, ACTA MATER, V50, P101, DOI 10.1016/S1359-6454(01)00318-4; Shibata N, 2007, SCIENCE, V316, P82, DOI 10.1126/science.1136155; Tochigi E, 2012, ACTA MATER, V60, P1293, DOI 10.1016/j.actamat.2011.11.027; Tochigi E, 2011, J MATER SCI, V46, P4428, DOI 10.1007/s10853-011-5430-y; Tochigi E, 2008, ACTA MATER, V56, P2015, DOI 10.1016/j.actamat.2007.12.041; Tochigi E, 2010, ACTA MATER, V58, P208, DOI 10.1016/j.actamat.2009.08.067; Tsuruta K, 2014, ACTA MATER, V65, P76, DOI 10.1016/j.actamat.2013.11.035	32	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	JUN 1	2015	91						152	161		10.1016/j.actamat.2015.02.033		10	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CH6NX	WOS:000354154400015		
J	Matsuura, A; Fujita, Y; Iyo, M; Hashimoto, K				Matsuura, Akiko; Fujita, Yuko; Iyo, Masaomi; Hashimoto, Kenji			Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine	ACTA NEUROPSYCHIATRICA			English	Article						D-amino acid oxidase; D-serine; phencyclidine; sodium benzoate	AMINO-ACID OXIDASE; INDUCED COGNITIVE DEFICITS; D-SERINE; GLUTAMATERGIC DYSFUNCTION; RECEPTOR HYPOFUNCTION; BEHAVIORAL-CHANGES; TRKB AGONIST; DOUBLE-BLIND; GENE G72; SCHIZOPHRENIA	Objective A recent clinical study demonstrated that sodium benzoate (SB), a prototype competitive d-amino acid oxidase inhibitor, was effective in the treatment of several symptoms, such as positive and negative symptoms, and cognitive impairment in medicated patients with schizophrenia. The objective of the study was to examine the effects of SB on behavioural abnormalities such as pre-pulse inhibition (PPI) deficits and hyperlocomotion in mice after a single administration of the N-methyl-d-aspartate (NMDA) receptor antagonist, phencyclidine (PCP). Methods The effects of SB on behavioural abnormalities (PPI deficits and hyperlocomotion) in mice after PCP administration were examined. Furthermore, effects of SB on tissue levels of amino acids were also examined. Results A single oral dose of SB (100, 300, or 1000 mg/kg) attenuated PPI deficits in mice after administration of PCP (3.0 mg/kg, s.c.) in a dose-dependent manner. In contrast, L-701,324 (10 mg/kg), an antagonist at the glycine site of the NMDA receptor, did not affect the effect of SB (1000 mg/kg) on PCP-induced PPI deficits. Furthermore, a single oral dose of SB (1000 mg/kg) significantly attenuated the hyperlocomotion in mice after administration of PCP (3.0 mg/kg, s.c.). However, a single oral dose of SB (1000 mg/kg) caused no changes to d-serine levels in plasma or in the frontal cortex, hippocampus, and striatum of these animals. Conclusion This study suggests that SB induced antipsychotic effects in the PCP model of schizophrenia, although it did not increase d-serine levels in the brain.	[Matsuura, Akiko; Fujita, Yuko; Hashimoto, Kenji] Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba 2608670, Japan; [Matsuura, Akiko; Iyo, Masaomi] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba 2608670, Japan	Hashimoto, K (reprint author), Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, 1-8-1 Inohana, Chiba 2608670, Japan.	hashimoto@faculty.chiba-u.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas of the Ministry of Education, Culture, Sports, Science and Technology, Japan (to K.H.).	Ren Q, 2013, PHARMACOL BIOCHEM BE, V106, P124, DOI 10.1016/j.pbb.2013.03.016; Yao JK, 2011, ANTIOXID REDOX SIGN, V15, P2011, DOI 10.1089/ars.2010.3603; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; Brahmachari S, 2009, J IMMUNOL, V183, P5917, DOI 10.4049/jimmunol.0803336; Hashimoto K, 2005, EUR J PHARMACOL, V519, P114, DOI 10.1016/j.ejphar.2005.07.002; Labrie V, 2012, NEUROPHARMACOLOGY, V62, P1484, DOI 10.1016/j.neuropharm.2011.01.030; Jana A, 2013, J NEUROIMMUNE PHARM, V8, P739, DOI 10.1007/s11481-013-9447-7; Zhang L, 2007, NEUROPSYCHOPHARMACOL, V32, P2004, DOI 10.1038/sj.npp.1301313; Fujita Y, 2008, PROG NEURO-PSYCHOPH, V32, P336, DOI 10.1016/j.pnpbp.2007.08.031; Krystal JH, 2005, ARCH GEN PSYCHIAT, V62, P985, DOI 10.1001/archpsyc.62.9.985; Kantrowitz JT, 2010, SCHIZOPHR RES, V121, P125, DOI 10.1016/j.schres.2010.05.012; Horio M, 2011, NEUROCHEM INT, V59, P853, DOI 10.1016/j.neuint.2011.08.017; Ren Q, 2014, PSYCHOPHARMACOLOGY, V231, P159, DOI 10.1007/s00213-013-3221-7; Hagiwara H, 2008, EUR NEUROPSYCHOPHARM, V18, P448, DOI 10.1016/j.euroneuro.2007.11.005; Ferraris DV, 2011, CURR PHARM DESIGN, V17, P103; Hashimoto K, 2013, EUR ARCH PSY CLIN N, V263, P367, DOI 10.1007/s00406-013-0399-y; Chen HX, 2012, PSYCHOPHARMACOLOGY, V222, P37, DOI 10.1007/s00213-011-2619-3; Hashimoto K, 2014, EXPERT OPIN THER TAR, V18, P1049, DOI 10.1517/14728222.2014.934225; Verrall L, 2007, EUR J NEUROSCI, V26, P1657, DOI 10.1111/j.1460-9568.2007.05769.x; Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010; Hashimoto K, 2008, EUR NEUROPSYCHOPHARM, V18, P414, DOI 10.1016/j.euroneuro.2007.07.009; Sacchi S, 2013, CURR PHARM DESIGN, V19, P2499; Lane HY, 2013, JAMA PSYCHIAT, V70, P1267, DOI 10.1001/jamapsychiatry.2013.2159; Ferraris D, 2008, J MED CHEM, V51, P3357, DOI 10.1021/jm800200u; Hashimoto K, 2007, NEUROPSYCHOPHARMACOL, V32, P514, DOI 10.1038/sj.npp.1301047; Anand A, 2000, ARCH GEN PSYCHIAT, V57, P270, DOI 10.1001/archpsyc.57.3.270; Hashimoto K, 2006, EUR J PHARMACOL, V553, P191, DOI 10.1016/j.ejphar.2006.09.055; Tanibuchi Y, 2009, EUR NEUROPSYCHOPHARM, V19, P861, DOI 10.1016/j.euroneuro.2009.07.005; Hashimoto K, 2008, BIOL PSYCHIAT, V63, P92, DOI 10.1016/j.biopsych.2007.04.034; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199; Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572; Detera-Wadleigh SD, 2006, BIOL PSYCHIAT, V60, P106, DOI 10.1016/j.biopsych.2006.01.019; Zhang L, 2006, PROG NEURO-PSYCHOPH, V30, P1381, DOI 10.1016/j.pnpbp.2006.05.015; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Kirkpatrick B, 2013, SCHIZOPHRENIA BULL, V39, P1174, DOI 10.1093/schbul/sbt141; Heresco-Levy U, 2005, BIOL PSYCHIAT, V57, P577, DOI 10.1016/j.biopsych.2004.12.037; Tsai GC, 1998, BIOL PSYCHIAT, V44, P1081, DOI 10.1016/S0006-3223(98)00279-0; Yamada K, 2005, BIOL PSYCHIAT, V57, P1493, DOI 10.1016/j.biopsych.2005.03.018; Hashimoto K, 2009, BIOL PSYCHIAT, V65, P1103, DOI 10.1016/j.biopsych.2009.01.002; OLNEY JW, 1995, NEUROPSYCHOPHARMACOL, V13, P335, DOI 10.1016/0893-133X(95)00079-S; Fukushima T, 2004, BIOMED CHROMATOGR, V18, P813, DOI 10.1002/bmc.394; Coyle JT, 2004, PSYCHOPHARMACOLOGY, V174, P32, DOI 10.1007/s00213-003-1709-2; Tsai GE, 2010, CURR PHARM DESIGN, V16, P522; Kvajo M, 2008, MOL PSYCHIATR, V13, P685, DOI 10.1038/sj.mp.4002052; Hashimoto K, 2005, PROG NEURO-PSYCHOPH, V29, P767, DOI 10.1016/j.pnpbp.2005.04.023; Matsuzawa D, 2011, ANTIOXID REDOX SIGN, V15, P2057, DOI 10.1089/ars.2010.3453; Khasnavis S, 2012, J NEUROIMMUNE PHARM, V7, P424, DOI 10.1007/s11481-011-9286-3; Krystal JH, 1999, HARVARD REV PSYCHIAT, V7, P125, DOI 10.1093/hrp/7.3.125; Aoyama C, 2004, BIOMED CHROMATOGR, V18, P630, DOI 10.1002/bmc.365; Calcia MA, 2012, SCHIZOPHR RES, V142, P83, DOI 10.1016/j.schres.2012.09.014; Coyle JT, 1996, HARVARD REV PSYCHIAT, V3, P241, DOI 10.3109/10673229609017192; Ermilov M, 2013, SCHIZOPHR RES, V150, P604, DOI 10.1016/j.schres.2013.09.018; Hashimoto Kenji, 2006, Clinical Psychopharmacology and Neuroscience, V4, P3; Hashimoto K, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-6; Hashimoto K, 2008, PROG NEURO-PSYCHOPH, V32, P1758, DOI 10.1016/j.pnpbp.2008.06.012; Hashimoto K, 2010, J PSYCHOPHARMACOL, V24, P1133, DOI 10.1177/0269881109348177; Hashimoto K, 2014, SCHIZOPHR RES, V156, P281, DOI 10.1016/j.schres.2014.04.008; Hashimoto K, 2005, CURR PSYCHIAT REV, V1, P151, DOI 10.2174/1573400054065569; Hashimoto Kenji, 2004, Current Medicinal Chemistry - Central Nervous System Agents, V4, P147, DOI 10.2174/1568015043357011; Horio M, 2009, OPEN CLIN CHEM J, V2, P16; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Klein JR, 1941, J BIOL CHEM, V138, P507; Madeira C, 2008, SCHIZOPHR RES, V101, P76, DOI 10.1016/j.schres.2008.02.002; Shirai Yumi, 2012, Clin Psychopharmacol Neurosci, V10, P94, DOI 10.9758/cpn.2012.10.2.94; Smith Sean M, 2010, Open Med Chem J, V4, P3, DOI 10.2174/1874104501004020003; Steullet P., 2014, SCHIZOPHR RES, DOI [10.1016/j.schres.2014.06.021, DOI 10.1016/J.SCHRES.2014.06.021, 10.1016/j.schres.2014.06.021.]; Weiser Mark, 2012, J Clin Psychiatry, V73, pe728, DOI 10.4088/JCP.11m07031	67	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1601-5215			ACTA NEUROPSYCHIATR	Acta Neuropsychiatr.	JUN	2015	27	3					159	167		10.1017/neu.2015.1		9	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CH9YC	WOS:000354391600004		
J	Tsunoda, K; Fujimaki, Y; Nito, T; Yamasoba, T; Tayama, N; Makiyama, K; Murofushi, T; Tsunoda, A; Ohshima, K; Nishiyama, K; Kano, S; Niimi, S				Tsunoda, Koichi; Fujimaki, Yoko; Nito, Takaharu; Yamasoba, Tatsuya; Tayama, Niro; Makiyama, Kiyoshi; Murofushi, Toshihisa; Tsunoda, Atsunobu; Ohshima, Kiyoshi; Nishiyama, Kohichiro; Kano, Shigeru; Niimi, Seiji			Patients' perceptions of vocal problems: results from a survey in the Tokyo area	ACTA OTO-LARYNGOLOGICA			English	Review						clinical survey; maximum phonation time; preliminary guidelines; sulcus vocalis; swallowing problem; vocal fatigue; voice problem	SULCUS-VOCALIS; PHONOSURGICAL TECHNIQUE; GLOTTAL INCOMPETENCE; FOLD AUGMENTATION; PARALYSIS; FASCIA	Laryngoscopy in cases of sulcus vocalis reveals bowed vocal folds, resulting in a spindle-shaped chink with glottal incompetence. The anatomic and functional problems and resulting incomplete glottal closure during phonation lead to the presenting symptoms of breathy hoarseness, decrease in maximum phonation time (MPT), and vocal fatigue. These symptoms, however, have been reported from the physician's viewpoint, not the patient's. Furthermore, no standardized guidelines for the treatment of sulcus vocalis have been established. Because the general attitude toward sulcus vocalis appears to have become 'It is only a vocal problem and does not significantly affect the patient's well-being,' knowledge of sulcus vocalis has decreased and knowledge about choices of therapy remain limited. We therefore conducted an epidemiological questionnaire survey on this pathological condition in voice clinics in seven hospitals in the Tokyo area to establish preliminary guidelines for the management of sulcus vocalis, in reference to the opinion of the patients. Here we report the summary of our preliminary study 'a survey for sulcus vocalis' and suggest guidelines for the management of such pathological conditions. Although these management guidelines may result in improvement in the symptoms of sulcus vocalis, patients and physicians should be aware that treatment of this condition is difficult and improvement is not guaranteed.	[Tsunoda, Koichi] Natl Hosp Org, Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Dept Artificial Organs & Med Device Creat & Otola, Tokyo, Japan; [Fujimaki, Yoko; Nito, Takaharu] Univ Tokyo, Dept Otolaryngol, Tokyo 113, Japan; [Tayama, Niro] Natl Ctr Global Hlth & Med, Dept Otolaryngol, Tokyo, Japan; [Makiyama, Kiyoshi] Nihon Univ Hosp, Dept Otolaryngol, Tokyo, Japan; [Murofushi, Toshihisa] Teikyo Mizonokuchi Hosp, Dept Otolaryngol, Kanagawa, Japan; [Tsunoda, Atsunobu] Tokyo Med & Dent Univ, Dept Otolaryngol & Head & Neck Surg, Tokyo, Japan; [Ohshima, Kiyoshi] Oshima Otolaryngol Clin, Tokyo, Japan; [Nishiyama, Kohichiro] Nishiyama Otolaryngol Clin, Kanagawa, Japan; [Kano, Shigeru] Kano Otolaryngol Clin, Toyama, Japan; [Niimi, Seiji] Int Univ Hlth & Welf, Dept Speech & Hearing, Otawara, Tochigi, Japan	Tsunoda, K (reprint author), Natl Inst Sensory Organs, Dept Artificial Organs & Med Device Creat, Meguro Ku, 2-5-1 Higashigaoka, Tokyo 1528902, Japan.	tsunodakoichi@kankakuki.go.jp			Ministry of Health, Labour and Welfare, Japan	This research was performed in part by grant in aid for Research on Measures for Intractable Diseases from the Ministry of Health, Labour and Welfare, Japan.	Ford CN, 1996, ANN OTO RHINOL LARYN, V105, P189; MIKAELIAN DO, 1991, LARYNGOSCOPE, V101, P465; ISSHIKI N, 1974, ACTA OTO-LARYNGOL, V78, P451, DOI 10.3109/00016487409126379; ARNOLD GE, 1962, ARCHIV OTOLARYNGOL, V76, P76; Brunings W, 1911, VERN VER DTSCH LARYN, V18, P525; Ford CN, 1999, LARYNGOSCOPE, V109, P1891, DOI 10.1097/00005537-199912000-00001; FORD CN, 1986, OTOLARYNG HEAD NECK, V94, P104; HIRANO M, 1990, ANN OTO RHINOL LARYN, V99, P679; LINDESTAD PA, 1994, ANN OTO RHINOL LARYN, V103, P547; Rihkanen H, 1998, LARYNGOSCOPE, V108, P51, DOI 10.1097/00005537-199801000-00010; RUBIN HJ, 1975, ARCH OTOLARYNGOL, V101, P114; Tsunoda K, 2013, COMMUN D ACROSS LANG, P68; Tsunoda Koichi, 2005, Laryngoscope, V115, P1, DOI 10.1097/01.mlg.0000183966.72921.31; Tsunoda K, 2003, ACTA OTO-LARYNGOL, V123, P555, DOI 10.1080/0036554021000028114; Tsunoda K, 1999, LARYNGOSCOPE, V109, P504, DOI 10.1097/00005537-199903000-00030; YAMAGUCHI H, 1993, J VOICE, V7, P250, DOI 10.1016/S0892-1997(05)80334-0	16	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	JUN	2015	135	6					532	535		10.3109/00016489.2014.999873		4	Otorhinolaryngology	Otorhinolaryngology	CH7KR	WOS:000354215700002		
J	Tanaka, D; Terada, Y; Nakashima, T; Sakatoku, A; Nakamura, S				Tanaka, Daisuke; Terada, Yohei; Nakashima, Takuya; Sakatoku, Akihiro; Nakamura, Shogo			Seasonal variations in airborne bacterial community structures at a suburban site of central Japan over a 1-year time period using PCR-DGGE method	AEROBIOLOGIA			English	Article						Atmosphere; Bacteria; Community; Bioaerosol; DGGE; Japan	16S RIBOSOMAL-RNA; GRADIENT GEL-ELECTROPHORESIS; WATER TREATMENT-PLANT; TEMPORAL VARIABILITY; MICROBIAL-POPULATIONS; ASIAN DUST; URBAN AREA; AIR; DIVERSITY; PROTEINS	Airborne bacteria could affect human health and climate. In this study, the bacterial community structures were investigated by analyzing air samples collected from a suburban location in Toyama, central Japan. Sixty samples were collected almost weekly between March 2009 and February 2010. A cultivation-independent approach, PCR plus denaturing gradient gel electrophoresis (DGGE), was used to analyze changes in the structure of the airborne bacterial communities. The DGGE profiles showed significant differences between sampling days, reflecting quite different bacterial profiles. Sequencing of DGGE bands revealed that the bacterial community was dominated by gamma-Proteobacteria, Firmicutes, alpha-Proteobacteria, Bacteroidetes, and Actinobacteria. The most frequently observed genus was Pseudomonas, followed by Bacillus. The airborne bacterial assemblage in winter differed from that in the other seasons. The differences could be attributed a number of factors, such as temperature, relative humidity, wind direction, and snowfall. In spring, the largest number of bands was classified as plant chloroplasts, such as Japanese cedar (Cryptomeria japonica) and Pinus spp., which are the major pollen allergen sources in Japan. The airborne bacterial abundance estimated by real-time TaqMan PCR ranged from 1.1 x 10(3) to 1.3 x 10(5) cells m(-3).	[Tanaka, Daisuke; Terada, Yohei; Nakashima, Takuya; Sakatoku, Akihiro; Nakamura, Shogo] Toyama Univ, Grad Sch Sci & Engn, Toyama 9308555, Japan	Tanaka, D (reprint author), Toyama Univ, Grad Sch Sci & Engn, Toyama 9308555, Japan.	tanakada@sci.u-toyama.ac.jp			Japan Society for the Promotion of Science KAKENHI [22510026, 25340055]	This work was supported by the Japan Society for the Promotion of Science KAKENHI Grant Numbers 22510026 and 25340055.	Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167; Xu ZQ, 2013, ENVIRON MONIT ASSESS, V185, P3993, DOI 10.1007/s10661-012-2844-1; Negrin MM, 2007, AEROBIOLOGIA, V23, P249, DOI 10.1007/s10453-007-9069-8; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Maki T, 2010, SCI TOTAL ENVIRON, V408, P4556, DOI 10.1016/j.scitotenv.2010.04.002; Fahlgren C, 2010, APPL ENVIRON MICROB, V76, P3015, DOI 10.1128/AEM.02092-09; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Burrows SM, 2009, ATMOS CHEM PHYS, V9, P9263; Haakensen M, 2008, INT J FOOD MICROBIOL, V125, P236, DOI 10.1016/j.ijfoodmicro.2008.04.002; Ranjard L, 2000, RES MICROBIOL, V151, P167, DOI 10.1016/S0923-2508(00)00136-4; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Bowers RM, 2012, ATMOS ENVIRON, V50, P41, DOI 10.1016/j.atmosenv.2012.01.005; Gao B, 2009, INT J SYST EVOL MICR, V59, P234, DOI 10.1099/ijs.0.002741-0; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; Jones AM, 2004, SCI TOTAL ENVIRON, V326, P151, DOI 10.1016/j.scitotenv.2003.11.021; Fierer N, 2008, APPL ENVIRON MICROB, V74, P200, DOI 10.1128/AEM.01467-07; Peccia J, 2006, ATMOS ENVIRON, V40, P3941, DOI 10.1016/j.atmosenv.2006.02.029; Christner BC, 2008, P NATL ACAD SCI USA, V105, P18854, DOI 10.1073/pnas.0809816105; Lee SH, 2010, SCI TOTAL ENVIRON, V408, P1349, DOI 10.1016/j.scitotenv.2009.10.061; Servin JA, 2008, MOL BIOL EVOL, V25, P1, DOI 10.1093/molbev/msm249; Harms G, 2003, ENVIRON SCI TECHNOL, V37, P343, DOI 10.1021/es0257164; Nehme B, 2008, ENVIRON MICROBIOL, V10, P665, DOI 10.1111/j.1462-2920.2007.01489.x; NEALE DB, 1989, THEOR APPL GENET, V77, P212, DOI 10.1007/BF00266189; Jaenicke R, 2005, SCIENCE, V308, P73, DOI 10.1126/science.1106335; Jeon EM, 2011, ATMOS ENVIRON, V45, P4313, DOI 10.1016/j.atmosenv.2010.11.054; Bertolini V, 2013, APPL MICROBIOL BIOT, V97, P6561, DOI 10.1007/s00253-012-4450-0; BLANCHARD DC, 1982, APPL ENVIRON MICROB, V43, P1001; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Fahlgren C, 2011, AEROBIOLOGIA, V27, P107, DOI 10.1007/s10453-010-9181-z; FANNIN KF, 1985, APPL ENVIRON MICROB, V49, P1191; Franzetti A, 2011, APPL MICROBIOL BIOT, V90, P745, DOI 10.1007/s00253-010-3048-7; Griffin D. W., 2001, AEROBIOLOGIA, V17, P203, DOI DOI 10.1023/A:1011868218901; Gupta RS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-71; Gupta RS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-106; Hanning IB, 2011, METHODS MOL BIOL, V733, P159, DOI 10.1007/978-1-61779-089-8_11; Harrison RM, 2005, INT J BIOMETEOROL, V49, P167, DOI 10.1007/s00484-004-0225-3; Kuske CR, 2006, CURR OPIN BIOTECH, V17, P291, DOI 10.1016/j.copbio.2006.04.001; Lee S, 2009, SCI TOTAL ENVIRON, V407, P5308, DOI 10.1016/j.scitotenv.2009.06.052; Li KJ, 2011, SCI TOTAL ENVIRON, V409, P5493, DOI 10.1016/j.scitotenv.2011.09.010; Li KJ, 2010, AEROBIOLOGIA, V26, P233, DOI 10.1007/s10453-010-9159-x; Marcos C, 2001, ANN ALLERG ASTHMA IM, V87, P39; Maron PA, 2006, ATMOS ENVIRON, V40, P8074, DOI 10.1016/j.atmosenv.2006.08.047; Matthias-Maser S, 2000, ATMOS ENVIRON, V34, P3805, DOI 10.1016/S1352-2310(00)00139-4; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695; Nishimura Y, 2010, MICROBES ENVIRON, V25, P22, DOI 10.1264/jsme2.ME09166; OHBA K, 1971, Silvae Genetica, V20, P101; Okubo Kimihiro, 2006, Allergol Int, V55, P379, DOI 10.2332/allergolint.55.379; Raven JA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-209; Shaffer BT, 1997, MICROBIAL ECOL, V34, P167, DOI 10.1007/s002489900046; Shen FX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065249; Tanaka D., 2011, Bulletin of Glaciological Research, V29, P31, DOI 10.5331/bgr.29.31; Zweifel UL, 2012, AEROBIOLOGIA, V28, P481, DOI 10.1007/s10453-012-9250-6	55	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0393-5965	1573-3025		AEROBIOLOGIA	Aerobiologia	JUN	2015	31	2					143	157		10.1007/s10453-014-9353-3		15	Biology; Environmental Sciences	Life Sciences & Biomedicine - Other Topics; Environmental Sciences & Ecology	CH7OL	WOS:000354226400002		
J	Chen, DZ; Tan, XH; Wang, HT; Wu, GS				Chen, Danny Z.; Tan, Xuehou; Wang, Haitao; Wu, Gangshan			Optimal Point Movement for Covering Circular Regions	ALGORITHMICA			English	Article						Computational geometry; Algorithms and data structures; Circular region coverage; Barrier coverage; Mobile sensors; Dynamic maximum matching; Circular convex bipartite graph	CONVEX BIPARTITE GRAPHS; LINEAR-TIME ALGORITHM; SLOPE SELECTION; MAXIMUM MATCHINGS; BARRIER COVERAGE; NETWORKS; SENSORS	Given n points in a circular region C in the plane, we study the problems of moving the n points to the boundary of G to form a regular n-gon such that the maximum (min-max) or the sum (min-sum) of the Euclidean distances traveled by the points is minimized. These problems have applications, e.g., in mobile sensor barrier coverage of wireless sensor networks. The min-max problem further has two versions: the decision version and the optimization version. For the min-max problem, we present an O(nlog(2) n) time algorithm for the decision version and an O(nlog(3) n) time algorithm for the optimization version. The previously best algorithms for the two problem versions take O(n (3.5)) time and O(n (3.5)logn) time, respectively. For the min-sum problem we show that a special case with all points initially lying on the boundary of the circular region can be solved in O(n (2)) time, improving a previous O(n (4)) time solution. For the general min-sum problem, we present a 3-approximation O(n (2)) time algorithm. In addition, a by-product of our techniques is an algorithm for dynamically maintaining the maximum matching of a circular convex bipartite graph; our algorithm can handle each vertex insertion or deletion on the graph in O(log(2) n) time. This result may be interesting in its own right.	[Chen, Danny Z.] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Tan, Xuehou] Tokai Univ, Hiratsuka, Kanagawa 2591292, Japan; [Wang, Haitao] Utah State Univ, Dept Comp Sci, Logan, UT 84322 USA; [Wu, Gangshan] Nanjing Univ, State Key Lab Novel Software Technol, Nanjing 210093, Jiangsu, Peoples R China	Wang, HT (reprint author), Utah State Univ, Dept Comp Sci, Logan, UT 84322 USA.	dchen@cse.nd.edu; tan@wing.ncc.u-tokai.ac.jp; haitao.wang@usu.edu; gswu@graphics.nju.edu.cn			NSF [CCF-0916606, CCF-1217906]	Chen's research was supported in part by NSF under Grants CCF-0916606 and CCF-1217906.	Akyildiz IF, 2002, COMPUT NETW, V38, P393, DOI 10.1016/S1389-1286(01)00302-4; Kumar S, 2007, WIREL NETW, V13, P817, DOI 10.1007/s11276-006-9856-0; Efrat A, 2001, ALGORITHMICA, V31, P1, DOI 10.1007/s00453-001-0016-8; MEGIDDO N, 1983, J ACM, V30, P852, DOI 10.1145/2157.322410; Chen A, 2007, MOBICOM'07: PROCEEDINGS OF THE THIRTEENTH ACM INTERNATIONAL CONFERENCE ON MOBILE COMPUTING AND NETWORKING, P63; Bhattacharya B, 2009, THEOR COMPUT SCI, V410, P5515, DOI 10.1016/j.tcs.2009.07.007; Tan XH, 2010, LECT NOTES COMPUT SC, V6213, P327; Bremner D, 2006, LECT NOTES COMPUT SC, V4168, P160; COLE R, 1987, J ACM, V34, P200, DOI 10.1145/7531.7537; Chen DZ, 2011, DISCRETE COMPUT GEOM, V46, P334, DOI 10.1007/s00454-011-9338-8; KATZ MJ, 1993, INFORM PROCESS LETT, V47, P115, DOI 10.1016/0020-0190(93)90234-Z; Brodal GS, 2007, LECT NOTES COMPUT SC, V4708, P406; Buss SR, 1998, SIAM J COMPUT, V27, P170, DOI 10.1137/S0097539794267243; CHANG MS, 1992, ALGORITHMICA, V8, P177, DOI 10.1007/BF01758842; COLE R, 1989, SIAM J COMPUT, V18, P792, DOI 10.1137/0218055; Dillencourt MB, 1992, INT J COMPUT GEOM AP, V2, P1, DOI 10.1142/S0218195992000020; Efrat A, 2000, INFORM PROCESS LETT, V75, P169, DOI 10.1016/S0020-0190(00)00096-X; GABOW HN, 1985, J COMPUT SYST SCI, V30, P209, DOI 10.1016/0022-0000(85)90014-5; Hu S, 2008, WASHINGTON POST; LIANG YD, 1995, INFORM PROCESS LETT, V56, P215, DOI 10.1016/0020-0190(95)00145-3; LIPSKI W, 1981, ACTA INFORM, V15, P329; MATOUSEK J, 1991, INFORM PROCESS LETT, V39, P183, DOI 10.1016/0020-0190(91)90177-J; Steiner G, 1996, COMPUT MATH APPL, V31, P91, DOI 10.1016/0898-1221(96)00079-X	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0178-4617	1432-0541		ALGORITHMICA	Algorithmica	JUN	2015	72	2					379	399		10.1007/s00453-013-9857-1		21	Computer Science, Software Engineering; Mathematics, Applied	Computer Science; Mathematics	CH5HM	WOS:000354066300003		
J	Ushikubo, M				Ushikubo, Mitsuko			Comparison Between Home and Hospital as the Place of Death for Individuals With Amyotrophic Lateral Sclerosis in the Last Stages of Illness	AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE			English	Article						ALS; end of life; death; home care; comparison; qualitative	OF-LIFE CARE; MULTIDISCIPLINARY CARE; FAMILY CAREGIVERS; ALS; END; VENTILATION; SERVICES; INSIGHTS; PATIENT; DISEASE	Introduction: Healthcare providers need to better understand the end-of-life situations of in-home amyotrophic lateral sclerosis (ALS) patients to support their desires about where to die and to allow peaceful death. Purpose: To clarify the situations of individuals with ALS in the last stages of illness according to the place of death as reported by home care nurses. Methods: Minimum structured interviews were conducted with 14 home care nurses, and data regarding 14 ALS patients who died were collected. Results: Six patients died at home, and eight died at the hospital. Many sudden deaths were observed among the patients who died at home, whereas pneumonia was often the cause of death in the hospital. Conclusion: Providing family education and ensuring the availability of local family physicians are vital to meeting a patient's desire to die at home. Home care nursing should be introduced in the early stage after diagnosis to provide support to patients for timely decision-making.	Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gunma 3718514, Japan	Ushikubo, M (reprint author), Gunma Univ, Grad Sch Hlth Sci, 3-39-22 Showa Machi, Maebashi, Gunma 3718514, Japan.	ushi2@gunma-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [23593425]	The author disclosed receipt of the following financial support for the research and/or authorship of this article: This study was supported by Grant-in-Aid for Scientific Research (KAKENHI Grant Number 23593425) of Japan Society for the Promotion of Science (JSPS).	Oliver DJ, 2010, AMYOTROPH LATERAL SC, V11, P339, DOI 10.3109/17482968.2010.487532; Hebert RS, 2009, J PAIN SYMPTOM MANAG, V37, P3, DOI 10.1016/j.jpainsymman.2007.12.010; Foley G, 2012, AMYOTROPH LATERAL SC, V13, P11, DOI 10.3109/17482968.2011.607500; Hardiman O, 2011, J NEUROL, V258, P359, DOI 10.1007/s00415-010-5830-y; Andersen PM, 2012, EUR J NEUROL, V19, P360, DOI 10.1111/j.1468-1331.2011.03501.x; Mitsumoto H, 2005, AMYOTROPH LATERAL SC, V6, P145, DOI 10.1080/14660820510028647; Yang R, 2011, AMYOTROPH LATERAL SC, V12, P206, DOI 10.3109/17482968.2011.572979; Rabkin J, 2013, AMYOTROPH LAT SCL FR, V14, P116, DOI 10.3109/17482968.2012.726226; Spataro R, 2010, ACTA NEUROL SCAND, V122, P217, DOI 10.1111/j.1600-0404.2009.01290.x; Gil J, 2008, EUR J NEUROL, V15, P1245, DOI 10.1111/j.1468-1331.2008.02307.x; Hogden A, 2013, PATIENT PREFER ADHER, V7, P171, DOI 10.2147/PPA.S40783; Miller RG, 2009, NEUROLOGY, V73, P1227, DOI 10.1212/WNL.0b013e3181bc01a4; Fukui S, 2011, J PAIN SYMPTOM MANAG, V42, P882, DOI 10.1016/j.jpainsymman.2011.02.024; Neudert C, 2001, J NEUROL, V248, P612, DOI 10.1007/s004150170140; Goy ER, 2008, J PALLIAT MED, V11, P548, DOI 10.1089/jpm.2007.0258; Hashizumi A, 2007, NANBYO ZAITAKU CARE, V13, P57; Barras ACH, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13830; Hodgen A, 2012, PATIENT PREFER ADHER, V6, P691; Hodgen A, 2012, PATIENT PREFER ADHER, V6, P829; Kimura Fumiharu, 2003, Rinsho Shinkeigaku, V43, P385; Krivickas LS, 1997, J NEUROL SCI, V152, pS82, DOI 10.1016/S0022-510X(97)00251-7; Kuhnlein P, 2008, AMYOTROPH LATERAL SC, V9, P91, DOI 10.1080/17482960701830495; Laub M, 2007, RESP MED, V101, P1074, DOI 10.1016/j.rmed.2006.10.007; Lederer Wolfgang, 2011, Wien Med Wochenschr, V161, P543, DOI 10.1007/s10354-011-0031-6; Lippo P, 2011, AMYOTROPH LATERAL SC, V12, P45; Mandler RN, 2001, AMYOTROPH LATERAL SC, V2, P203, DOI 10.1080/14660820152882214; O'Brien MR, 2012, PALLIATIVE MED, V26, P123, DOI 10.1177/0269216311398697; O'Brien MR, 2012, DISABIL REHABIL, V34, P247, DOI 10.3109/09638288.2011.605511; Ogino M, 2005, IRYO, V59, P389; Otani T, 2012, JPN PRIM CARE ASS, V35, P216; Pukan J, 2007, LANCET NEUROL, V6, P994; Ray R, 2009, P 20 INT S ALS MND G; Shimmons Z, 2005, NEUROLOGIST, V11, P257; Shingoku K, 2010, NANBYO ZAITAKU KEA, V16, P55; Torres Andrea L, 2012, Home Healthc Nurse, V30, P186, DOI 10.1097/NHH.0b013e318246d45a; Trail M, 2003, J NEUROL SCI, V209, P79, DOI 10.1016/S0022-510X(03)00003-0; Ushikubo M, 2012, INT J PALLIAT NURS, V18, P556; Ushikubo M, 2013, INT MED J, V20, P446; Wallace EM, 2012, AM J HOSP PALLIAT CA, V30, P253; Whitehead B, 2011, PALLIATIVE MED, V26, P368	40	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-9091	1938-2715		AM J HOSP PALLIAT ME	Am. J. Hosp. Palliat. Med.	JUN	2015	32	4					417	426		10.1177/1049909114525259		10	Health Care Sciences & Services	Health Care Sciences & Services	CH8DP	WOS:000354266700008		
J	Terada, S; Nackoney, J; Sakamaki, T; Mulavwa, MN; Yumoto, T; Furuichi, T				Terada, Saeko; Nackoney, Janet; Sakamaki, Tetsuya; Mulavwa, Mbangi Norbert; Yumoto, Takakazu; Furuichi, Takeshi			Habitat use of bonobos (Pan paniscus) at Wamba: Selection of vegetation types for ranging, feeding, and night-sleeping	AMERICAN JOURNAL OF PRIMATOLOGY			English	Article						bonobo; habitat selection; swamp forest; secondary forest; seasonality	SALONGA NATIONAL-PARK; GORILLA-GORILLA-GORILLA; CROSS RIVER GORILLA; WILD BONOBOS; PYGMY CHIMPANZEES; SEASONAL-CHANGES; KALINZU FOREST; FALLBACK FOODS; SWAMP FOREST; CONGO	Understanding the habitat requirements of great apes is essential for effective conservation strategies. We examined annual habitat use of a bonobo group in the Wamba field site within the Luo Scientific Reserve, Democratic Republic of the Congo. Using satellite imagery, we categorized the group's ranging area into three forest types: (1) primary and old secondary forest (P/OS), (2) young secondary forest and agriculture (YS/Ag), and (3) swamp forest (Sw). We tracked the group for 1 year (2007-2008) and compared usage of the three forest types for ranging, feeding, and night-sleeping. We also recorded what the bonobos ate and monitored monthly fruit availability in each forest type. The group ranged and fed more often in P/OS and less often in YS/Ag and Sw than expected based on habitat availability. Also, the group slept mostly in P/OS (94% of nights monitored), but also in YS/Ag (1%), and Sw (5%). Fruit availability in P/OS had no significant effect on habitat selection, but the group fed in YS/Ag most often during the two months when fruits in P/OS were least abundant. In June, when fruit of Uapaca spp. (selectively eaten by bonobos) was generally abundant in Sw, the group mostly ranged and slept there. The bonobos fed most often on herbaceous plants in all three forest types. In Sw, the bonobos frequently ate mushrooms. Our results show that semi-open forest with abundant herbaceous plants such as YS/Ag could be an important feeding habitat and may provide fallback food for bonobos when fruits are scarce. Furthermore, Sw can serve seasonally as a main habitat to complement P/OS if adequate food resources and tree nesting opportunities are available. We conclude that bonobos use diverse habitats depending on their needs and we highlight the importance of minor-use habitats for sustaining populations of target species in conservation planning. Am. J. Primatol. 77:701-713, 2015. (c) 2015 Wiley Periodicals, Inc.	[Terada, Saeko; Sakamaki, Tetsuya; Yumoto, Takakazu; Furuichi, Takeshi] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan; [Nackoney, Janet] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Mulavwa, Mbangi Norbert] Minist Sci Res, Res Ctr Ecol & Forestry, Mabali, Mbandaka, DEM REP CONGO	Furuichi, T (reprint author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan.	furuichi@pri.kyoto-u.ac.jp			Japan Ministry of the Environment, Environment Research and Technology Development fund [D-1007, F-061]; Japan Society for the Promotion of Science (JSPS) [17255005, 22255007, 25257487]; JSPS Asia-Africa Science Platform Program; JSPS Primate Origins of Human Evolution (HOPE) [AS-22-027, ITP-23-006, AS-24-031, ITP-25-002]	Contract grant sponsor: Japan Ministry of the Environment, Environment Research and Technology Development fund; contract grant numbers: D-1007, F-061; contract grant sponsor: Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research; contract grant numbers: 17255005, 22255007, 25257487; contract grant sponsor: JSPS Asia-Africa Science Platform Program; contract grant numbers: 2009-2011, 2012-2014; contract grant sponsor: JSPS Primate Origins of Human Evolution (HOPE); contract grant numbers: AS-22-027, ITP-23-006, AS-24-031, ITP-25-002.	Bergl RA, 2012, ORYX, V46, P278, DOI 10.1017/S0030605310001857; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Caro T, 2007, TRENDS ECOL EVOL, V22, P394, DOI 10.1016/j.tree.2007.06.003; TUTIN CEG, 1984, AM J PRIMATOL, V6, P313, DOI 10.1002/ajp.1350060403; Mulavwa MN, 2010, AM J PRIMATOL, V72, P575, DOI 10.1002/ajp.20810; Morgan D, 2006, INT J PRIMATOL, V27, P147, DOI 10.1007/s10764-005-9013-0; Rainey HJ, 2010, ORYX, V44, P124, DOI 10.1017/S003060530999010X; Sha JCM, 2013, AM J PRIMATOL, V75, P581, DOI 10.1002/ajp.22137; Furuichi T, 2001, INT J PRIMATOL, V22, P913, DOI 10.1023/A:1012057403512; Sakamaki T, 2013, PRIMATES, V54, P349, DOI 10.1007/s10329-013-0354-6; Plumptre AJ, 2006, PRIMATES, V47, P65, DOI 10.1007/s10329-005-0146-8; Poulsen JR, 2004, INT J PRIMATOL, V25, P285, DOI 10.1023/B:IJOP.0000019153.50161.58; Yamagiwa J, 2009, AM J PHYS ANTHROPOL, V140, P739, DOI 10.1002/ajpa.21102; Hashimoto C, 2001, INT J PRIMATOL, V22, P947, DOI 10.1023/A:1012061504420; Bwangoy JRB, 2010, REMOTE SENS ENVIRON, V114, P73, DOI 10.1016/j.rse.2009.08.004; Basabose AK, 2002, INT J PRIMATOL, V23, P263, DOI 10.1023/A:1013879427335; Furuichi T, 2001, INT J PRIMATOL, V22, P929, DOI 10.1023/A:1012009520350; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; Nackoney J, 2014, BIOL CONSERV, V170, P321, DOI 10.1016/j.biocon.2013.12.033; Powell RA, 2000, METH C CONS, P65; Mulavwa M, 2008, DEV PRIMATOL-PROG PR, P121, DOI 10.1007/978-0-387-74787-3_7; Doran-Sheehy DM, 2004, AM J PRIMATOL, V64, P207, DOI 10.1002/ajp.20075; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Sawyer SC, 2013, DIVERS DISTRIB, V19, P943, DOI 10.1111/ddi.12046; Harrison ME, 2011, INT J PRIMATOL, V32, P531, DOI 10.1007/s10764-010-9487-2; Potapov PV, 2012, REMOTE SENS ENVIRON, V122, P106, DOI 10.1016/j.rse.2011.08.027; Basabose AK, 2005, INT J PRIMATOL, V26, P33, DOI 10.1007/s10764-005-0722-1; Dupain J, 2004, ORYX, V38, P209, DOI 10.1017/S0030605304000365; Fruth B., 2008, PAN PANISCUS IUCN RE; Furuichi T, 2008, DEV PRIMATOL-PROG PR, P135, DOI 10.1007/978-0-387-74787-3_8; Furuichi Takeshi, 2012, P413; Georgiev AV, 2011, PRIMATES, V52, P309, DOI 10.1007/s10329-011-0256-4; Hashimoto C, 1998, INT J PRIMATOL, V19, P1045, DOI 10.1023/A:1020378320913; Hickey JR, 2013, BIODIVERS CONSERV, P1; Hickey JR, 2012, INT J PRIMATOL, V33, P381, DOI 10.1007/s10764-012-9581-8; Idani Gen'ichi, 1994, Tropics, V3, P309; Inogwabini BI, 2012, AFR J ECOL, V50, P285, DOI 10.1111/j.1365-2028.2012.01323.x; Inogwabini B-I, 2007, ORYX, P41; IUCN, 2014, IUCN RED LIST THREAT; IUCN and ICCN, 2012, BON PAN PAN CONS STR; Junker J, 2012, DIVERS DISTRIB, V18, P1077, DOI 10.1111/ddi.12005; Kano T, 1992, LAST APE PYGMY CHIMP, P248; Kano T, 1984, THE PYGMY CHIMPANZEE, P233; KANO T, 1983, INT J PRIMATOL, V4, P1, DOI 10.1007/BF02739358; KURODA S, 1979, Primates, V20, P161, DOI 10.1007/BF02373371; Manly B. F. J., 2002, RESOURCE SELECTION A; Mohneke M, 2008, DEV PRIMATOL-PROG PR, P151, DOI 10.1007/978-0-387-74787-3_9; Mwanza N., 2003, PAN AFRICA NEWS, V10, P29; OSFAC, 2010, OSFAC 2010 FOR COV F; Palminteri S, 2012, INT J PRIMATOL, V33, P401, DOI 10.1007/s10764-011-9573-0; R Core Team, 2014, R LANG ENV STAT COMP; Reinartz GE, 2006, INT J PRIMATOL, V27, P603, DOI 10.1007/s10764-006-9020-9; Reinartz GE, 2008, DEV PRIMATOL-PROG PR, P167, DOI 10.1007/978-0-387-74787-3_10; Serckx A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093742; Thompson JAM, 1997, THESIS U OXFORD; Torres J, 2010, BIOL CONSERV, V143, P416, DOI 10.1016/j.biocon.2009.11.007; WHITE FJ, 1992, AM J PRIMATOL, V26, P215, DOI 10.1002/ajp.1350260307; White GC, 1990, ANAL WILDLIFE RADIO, P383; Wrangham Richard W., 2008, P282	60	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0275-2565	1098-2345		AM J PRIMATOL	Am. J. Primatol.	JUN	2015	77	6					701	713		10.1002/ajp.22392		13	Zoology	Zoology	CH9TS	WOS:000354379900010		
J	Izumi, G; Koga, K; Nagai, M; Urata, Y; Takamura, M; Harada, M; Hirata, T; Hirota, Y; Ogawa, K; Inoue, S; Fujii, T; Osuga, Y				Izumi, Gentaro; Koga, Kaori; Nagai, Miwako; Urata, Yoko; Takamura, Masashi; Harada, Miyuki; Hirata, Tetsuya; Hirota, Yasushi; Ogawa, Kenji; Inoue, Satoshi; Fujii, Tomoyuki; Osuga, Yutaka			Cyclic Stretch Augments Production of Neutrophil Chemokines, Matrix Metalloproteinases, and Activin A in Human Endometrial Stromal Cells	AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Article						CXCL1; CXCL8; endometrium; remodeling	NONPREGNANT HUMAN UTERUS; SMOOTH-MUSCLE-CELLS; MECHANICAL STRETCH; PROGESTERONE WITHDRAWAL; INTERSTITIAL COLLAGENASE; TISSUE INHIBITORS; OVARIAN-STEROIDS; EPITHELIAL-CELLS; EARLY-PREGNANCY; EXPRESSION	ProblemThe aim of this study was to test our hypothesis: Contractile activity that occurs in the uterus during menstruation induces biochemical factors that enhance remodeling of the endometrium. Method of StudyCyclic stretch, mimicking contractile activity during menstruation, was applied to human endometrial stromal cells (ESC) using the Flexercell Tension system. The concentration and activity of CXCL8, CXCL1, MMPs, and activin A were measured using ELISAs and specific assays. Neutrophil chemotactic activity was evaluated using migration assays. ResultsCyclic stretch significantly induced ESC secretion of CXCL8 and CXCL1 and neutrophil chemotaxis. Stretch also increased MMP-1, MMP-2, and MMP-3 activity, activin A secretion, and activity in ESC. ConclusionThese results indicate that the contractile activities of the uterus during menstruation contribute to the remodeling of the endometrium, by inducing chemokine secretion, MMP expression, activity, and neutrophil chemotaxis.	[Izumi, Gentaro; Koga, Kaori; Nagai, Miwako; Urata, Yoko; Takamura, Masashi; Harada, Miyuki; Hirata, Tetsuya; Hirota, Yasushi; Fujii, Tomoyuki; Osuga, Yutaka] Univ Tokyo, Obstet & Gynecol, Tokyo 1138655, Japan; [Ogawa, Kenji] RIKEN, Chem Genet Lab, Saitama, Japan; [Inoue, Satoshi] Univ Tokyo, Antiaging Med, Tokyo 1138655, Japan	Koga, K (reprint author), Univ Tokyo, Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kawotan-tky@umin.ac.jp			Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science and Technology; Kanzawa Medical Research Foundation	The authors thank medical colleagues in the University of Tokyo Hospital and Dr. Kate Hale for editing the manuscript. This work was supported by grants from Ministry of Health, Labor and Welfare and Ministry of Education, Culture, Sports, Science and Technology and Kanzawa Medical Research Foundation (KK).	Critchley HOD, 1999, J CLIN ENDOCR METAB, V84, P240, DOI 10.1210/jc.84.1.240; RAWDANOWICZ TJ, 1994, J CLIN ENDOCR METAB, V79, P530, DOI 10.1210/jc.79.2.530; Curry TE, 2003, ENDOCR REV, V24, P428, DOI 10.1210/er.2002-0005; Salamonsen LA, 1997, J CLIN ENDOCR METAB, V82, P1409, DOI 10.1210/jc.82.5.1409; Salamonsen LA, 2002, J REPROD IMMUNOL, V57, P95, DOI 10.1016/S0165-0378(02)00011-6; Jones RL, 2000, MOL HUM REPROD, V6, P1107, DOI 10.1093/molehr/6.12.1107; Hua R, 2012, ENDOCRINOLOGY, V153, P481, DOI 10.1210/en.2011-1506; Haseneen NA, 2003, AM J PHYSIOL-LUNG C, V284, pL541, DOI 10.1152/ajplung.00290.2002; Kokorine I, 1996, J CELL SCI, V109, P2151; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Hawwa RL, 2011, LUNG, V189, P341, DOI 10.1007/s00408-011-9310-7; Pretto CM, 2008, J CLIN ENDOCR METAB, V93, P4126, DOI 10.1210/jc.2007-2636; Catalano RD, 2007, MOL HUM REPROD, V13, P641, DOI 10.1093/molehr/gam021; Moura J, 2013, ARCH DERMATOL RES, V305, P557, DOI 10.1007/s00403-013-1381-2; Vassilev V, 2005, J CLIN ENDOCR METAB, V90, P5848, DOI 10.1210/jc.2005-0762; Arici A, 1998, J CLIN ENDOCR METAB, V83, P1783, DOI 10.1210/jc.83.5.1783; CHALUBINSKI K, 1993, FERTIL STERIL, V59, P225; Cheng CW, 2007, BIOL REPROD, V76, P871, DOI 10.1095/biolreprod.106.057950; Chiu CZ, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-50; Freitas S, 1999, BIOL REPROD, V61, P1070, DOI 10.1095/biolreprod61.4.1070; Harada M, 2005, J CLIN ENDOCR METAB, V90, P1144, DOI 10.1210/jc.2004-1089; HENDRICK.CH, 1966, AM J OBSTET GYNECOL, V96, P824; HENDRICKS CH, 1964, J OBSTET GYN BR COMM, V71, P712; Hou X, 2009, GRAEF ARCH CLIN EXP, V247, P1477, DOI 10.1007/s00417-009-1135-1; Itoh H, 2012, J CLIN ENDOCR METAB, V97, pE888, DOI 10.1210/jc.2011-3073; Jones RL, 1997, HUM REPROD, V12, P1300; Kaitu'u-Lino TJ, 2009, ENDOCRINOLOGY, V150, P1904, DOI 10.1210/en.2008-0738; Lockwood CJ, 1998, ENDOCRINOLOGY, V139, P4607, DOI 10.1210/en.139.11.4607; Machida H, 2000, EUR J ENDOCRINOL, V143, P705, DOI 10.1530/eje.0.1430705; Orisaka M, 2007, EUR J OBSTET GYN R B, V135, P111, DOI 10.1016/j.ejogrb.2006.07.040; Paravicini TM, 2012, J AM SOC HYPERTENS, V6, P169, DOI 10.1016/j.jash.2012.01.002; Pereira AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026182; RODGERS WH, 1994, J CLIN INVEST, V94, P946, DOI 10.1172/JCI117461; SALAMONSEN LA, 1994, CELL BIOL INT, V18, P1139, DOI 10.1006/cbir.1994.1040; Shelton L, 2007, EXP EYE RES, V84, P314, DOI 10.1016/j.exer.2006.10.004; Wilgus TA, 2013, ADV WOUND CARE, V2, P379; Yamamoto H, 2002, RESPIROLOGY, V7, P103, DOI 10.1046/j.1440-1843.2002.00377.x; Yoshida M, 2002, MOL HUM REPROD, V8, P681, DOI 10.1093/molehr/8.7.681; YOSHIDA T, 1970, AM J OBSTET GYNECOL, V108, P450; Zhang J, 2000, BIOL REPROD, V62, P85, DOI 10.1095/biolreprod62.1.85; Zhao Y, 2013, AM J REPROD IMMUNOL, V69, P240, DOI 10.1111/aji.12061; Zhou HN, 2013, HEART, V99, P570, DOI 10.1136/heartjnl-2012-303355	42	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1046-7408	1600-0897		AM J REPROD IMMUNOL	Am. J. Reprod. Immunol.	JUN	2015	73	6					501	506		10.1111/aji.12359		6	Immunology; Reproductive Biology	Immunology; Reproductive Biology	CH9XN	WOS:000354390000003		
J	Itaoka, N; Nagamatsu, T; Schust, DJ; Ichikawa, M; Sayama, S; Iwasawa-Kawai, Y; Kawana, K; Yamashita, T; Osuga, Y; Fujii, T				Itaoka, Nao; Nagamatsu, Takeshi; Schust, Danny J.; Ichikawa, Mayuko; Sayama, Seisuke; Iwasawa-Kawai, Yuki; Kawana, Kei; Yamashita, Takahiro; Osuga, Yutaka; Fujii, Tomoyuki			Cervical Expression of Elafin and SLPI in Pregnancy and Their Association With Preterm Labor	AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Article						Antimicrobial peptide; biomarker; elafin; preterm labor; secretory leukocyte peptidase inhibitor	LEUKOCYTE PROTEASE INHIBITOR; EPITHELIAL-CELLS; PROTEINASE-INHIBITOR; INNATE IMMUNITY; AMNIOTIC-FLUID; ANTIMICROBIAL PEPTIDES; FETAL MEMBRANES; ELASTASE; SECRETION; TERM	ProblemElafin and secretory leukocyte peptidase inhibitor (SLPI) are unique among antimicrobial peptides (AMPs). This study aimed to determine the expression levels of these AMPs at the cervix during pregnancy and to investigate their association with preterm labor. Method of studyCervical epithelial cells were swabbed from normal pregnant women to evaluate the physiological expression of elafin and SLPI. Cross-sectional analysis was conducted to compare cervical expression levels for SLPI and elafin among three women's groups, controls (n=26), women with threatened preterm labor who delivered at term (t-TPL, n=23) and TPL who ended in preterm labor (p-TPL, n=19). ResultsElafin and SLPI proteins were detected in the squamous and glandular cells of the cervix. Cervical SLPI expression levels increased over the course of pregnancy, whereas elafin levels remained unchanged. Cervical mRNA expression levels of elafin and SLPI were significantly higher in p-TPL compared with t-TPL and control groups. ConclusionConstitutive expression of elafin and SLPI in cervical cells during pregnancy suggests their essential roles in local tissue homeostasis and immune defense. The elevations in cervical elafin and SLPI expression in the women with preterm delivery might reflect the local response to the pathogen invasion into the cervix preceding preterm labor.	[Itaoka, Nao; Nagamatsu, Takeshi; Ichikawa, Mayuko; Sayama, Seisuke; Iwasawa-Kawai, Yuki; Kawana, Kei; Yamashita, Takahiro; Osuga, Yutaka; Fujii, Tomoyuki] Univ Tokyo, Dept Obstet & Gynecol, Fac Med, Tokyo 1138655, Japan; [Schust, Danny J.] Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Columbia, MO USA	Nagamatsu, T (reprint author), Univ Tokyo, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tnag-tky@umin.ac.jp					Abbott DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100771; Ace Christopher I, 2004, Reprod Biol Endocrinol, V2, P54, DOI 10.1186/1477-7827-2-54; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Mahendroo M, 2012, REPRODUCTION, V143, P429, DOI 10.1530/REP-11-0466; Ganz T, 2003, INTEGR COMP BIOL, V43, P300, DOI 10.1093/icb/43.2.300; Patel MV, 2013, AM J REPROD IMMUNOL, V69, P463, DOI 10.1111/aji.12078; Scott A, 2011, BIOCHEM SOC T, V39, P1437, DOI 10.1042/BST0391437; Wilkinson TS, 2011, BIOCHEM SOC T, V39, P1409, DOI 10.1042/BST0391409; WATTS DH, 1992, OBSTET GYNECOL, V79, P351; King AE, 2007, PLACENTA, V28, P161, DOI 10.1016/j.placenta.2006.01.006; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Sallenave JM, 2010, AM J RESP CELL MOL, V42, P635, DOI 10.1165/rcmb.2010-0095RT; Horne AW, 2008, REPRODUCTION, V135, P739, DOI 10.1530/REP-07-0564; Bingle L, 2001, AM J RESP CELL MOL, V25, P84; Denison FC, 1999, J ENDOCRINOL, V161, P299, DOI 10.1677/joe.0.1610299; Gonzalez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026877; Helmig B R, 2002, J Matern Fetal Neonatal Med, V12, P237, DOI 10.1080/jmf.12.4.237.246; HELMIG R, 1995, EUR J OBSTET GYN R B, V59, P95, DOI 10.1016/0028-2243(94)02023-8; King AE, 2003, BIOCHEM BIOPH RES CO, V310, P594, DOI 10.1016/j.bbrc.2003.08.151; Lockwood CJ, 2002, NEW ENGL J MED, V346, P282, DOI 10.1056/NEJM200201243460412; Malamitsi-Puchner A, 2006, MEDIAT INFLAMM, DOI 10.1155/MI/2006/94381; Meyer M, 2014, AM J PHYSIOL-LUNG C, V306, pL269, DOI 10.1152/ajplung.00290.2013; Mihaila A, 2001, Z NATURFORSCH C, V56, P291; Nakai A, 2005, GYNECOL OBSTET INVES, V60, P87, DOI 10.1159/000084839; SALLENAVE JM, 1994, AM J RESP CELL MOL, V11, P733; Sallenave JM, 1997, J LEUKOCYTE BIOL, V61, P695; Schmid M, 2007, J LEUKOCYTE BIOL, V81, P907, DOI 10.1189/jlb.0906581; Stock SJ, 2009, REPROD SCI, V16, P1125, DOI 10.1177/1933719109341998; Sullivan AL, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-60; Van Wetering S, 2000, AM J PHYSIOL-LUNG C, V278, pL51; Weldon S, 2009, J IMMUNOL, V183, P8148, DOI 10.4049/jimmunol.0901716; Williams SE, 2006, CLIN SCI, V110, P21, DOI 10.1042/CS20050115	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1046-7408	1600-0897		AM J REPROD IMMUNOL	Am. J. Reprod. Immunol.	JUN	2015	73	6					536	544		10.1111/aji.12354		9	Immunology; Reproductive Biology	Immunology; Reproductive Biology	CH9XN	WOS:000354390000006		
J	Kamoi, M; Fukui, A; Kwak-Kim, J; Fuchinoue, K; Funamizu, A; Chiba, H; Yokota, M; Fukuhara, R; Mizunuma, H				Kamoi, Mai; Fukui, Atsushi; Kwak-Kim, Joanne; Fuchinoue, Kohei; Funamizu, Ayano; Chiba, Hitomi; Yokota, Megumi; Fukuhara, Rie; Mizunuma, Hideki			NK22 Cells in the Uterine Mid-Secretory Endometrium and Peripheral Blood of Women with Recurrent Pregnancy Loss and Unexplained Infertility	AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Article						Cytokine; human uterine endometrium; IL-22; NK cell; NK22 cell; RPL	NATURAL-KILLER-CELLS; INTRACELLULAR CYTOKINE EXPRESSION; ROR-GAMMA-T; CYTOTOXICITY RECEPTORS; IMPLANTATION FAILURES; SPONTANEOUS-ABORTIONS; NKP46(+) CELLS; STROMAL CELLS; IL-22; MISCARRIAGE	ProblemWe aimed to investigate natural killer 22 (NK22) cells in the peripheral blood and the uterine endometrium of women with unexplained recurrent pregnancy loss (URPL) and unexplained infertility (UI). Method of studyPeripheral blood and endometrial samples were collected from women with URPL (n=43) and UI (n=38). Intracellular cytokine production, such as IL-22, IFN- and TNF-, and the expression of NKp46 on NK cells were analyzed by three-color flow cytometry. ResultsThe percentages of endometrial CD56(+)/IL-22(+) and CD56(dim)/IL-22(+) cells in women with URPL were significantly higher than those of UI (P<0.05, respectively). In addition, the percentage of CD56(bright)/IL-22(+) cells in women with RPL was negatively correlated with those of CD56(bright)/IFN-(+) and CD56(bright)/TNF-(+) in both peripheral blood and endometrial NK cells. This was not seen in women with UI. The percentage of CD56(bright)/IL-22(+) cells was negatively correlated with CD56(bright)/NKp46 expressing NK cells in peripheral blood. ConclusionEndometrial NK22 cells are differently regulated in women with URPL and UI. Women with URPL have higher level of NK22 cells with a potential to induce NK2 shift than women with UI.	[Kamoi, Mai; Fukui, Atsushi; Fuchinoue, Kohei; Funamizu, Ayano; Chiba, Hitomi; Yokota, Megumi; Fukuhara, Rie; Mizunuma, Hideki] Hirosaki Univ, Grad Sch Med, Dept Obstet & Gynecol, Hirosaki, Aomori 0368562, Japan; [Kwak-Kim, Joanne] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Obstet & Gynecol, Reprod Med Program, Vernon Hills, IL USA	Fukui, A (reprint author), Hirosaki Univ, Grad Sch Med, Dept Obstet & Gynecol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	a.fukuipon@mac.com					Emmer PM, 2000, HUM REPROD, V15, P1163, DOI 10.1093/humrep/15.5.1163; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Yang XY, 2014, AUTOIMMUN REV, V13, P615, DOI 10.1016/j.autrev.2013.11.008; Borzychowski AM, 2005, EUR J IMMUNOL, V35, P3054, DOI 10.1002/eji.200425929; Fukui A, 2009, AM J REPROD IMMUNOL, V62, P371, DOI 10.1111/j.1600-0897.2009.00750.x; Stacey MA, 2014, CELL HOST MICROBE, V15, P471, DOI 10.1016/j.chom.2014.03.003; Higuma-Myojo S, 2005, AM J REPROD IMMUNOL, V54, P21, DOI 10.1111/j.1600-0897.2005.00279.x; Simonian PL, 2010, J EXP MED, V207, P2239, DOI 10.1084/jem.20100061; Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250; Tang AW, 2011, HUM REPROD, V26, P1971, DOI 10.1093/humrep/der164; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002; Keskin DB, 2007, P NATL ACAD SCI USA, V104, P3378, DOI 10.1073/pnas.061198104; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Fukui A, 2011, J REPROD IMMUNOL, V90, P105, DOI 10.1016/j.jri.2011.04.006; Lachapelle MH, 1996, J IMMUNOL, V156, P4027; Fukui A, 2008, FERTIL STERIL, V89, P157, DOI 10.1016/j.fertnstert.2007.02.012; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Male V, 2010, J IMMUNOL, V185, P3913, DOI 10.4049/jimmunol.1001637; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Fukui A, 2006, AM J REPROD IMMUNOL, V56, P312, DOI 10.1111/j.1600-0897.2006.00431.x; Lee SK, 2013, AM J REPROD IMMUNOL, V70, P398, DOI 10.1111/aji.12137; Lash GE, 2006, FASEB J, V20, P2512, DOI 10.1096/fj.06-6616com; Zhang JH, 2011, CELL MOL IMMUNOL, V8, P1, DOI 10.1038/cmi.2010.38; Vacca P, 2011, P NATL ACAD SCI USA, V108, P2402, DOI 10.1073/pnas.1016257108; Fukui A, 1999, AM J REPROD IMMUNOL, V41, P413; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Wang Y, 2013, INT J CLIN EXP PATHO, V6, P1781; Seshadri S, 2014, HUM REPROD UPDATE, V20, P429, DOI 10.1093/humupd/dmt056; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Satoh-Takayama N, 2009, J IMMUNOL, V183, P6579, DOI 10.4049/jimmunol.0901935; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Peritt D, 1998, J IMMUNOL, V161, P5821; Moffett A, 2004, BRIT MED J, V329, P1283, DOI 10.1136/bmj.329.7477.1283; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Biassoni R, 2003, J CELL MOL MED, V7, P376, DOI 10.1111/j.1582-4934.2003.tb00240.x; Funamizu A, 2014, AM J REPROD IMMUNOL, V71, P359, DOI 10.1111/aji.12206; Jabrane-Ferrat N, 2014, IMMUNOLOGY, V141, P490, DOI 10.1111/imm.12218; King A, 1991, Dev Immunol, V1, P169, DOI 10.1155/1991/83493; Kumar P, 2013, J CANCER, V4, P57, DOI 10.7150/jca.5048; Manaster I, 2008, PLACENTA, V29, pS60, DOI 10.1016/j.placenta.2007.10.006; Pirhonen Jaana, 2002, Journal of Immunology, V169, P5673; SAITO S, 1993, INT IMMUNOL, V5, P559, DOI 10.1093/intimm/5.5.559; Tchatalbachev S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-275; TERRANOVA PF, 1995, P SOC EXP BIOL MED, V209, P325; Veenstra van Nieuwenhoven AL, 2002, FERTIL STERIL, V77, P1032; Yokota M, 2013, AM J REPROD IMMUNOL, V69, P202, DOI 10.1111/aji.12062	50	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1046-7408	1600-0897		AM J REPROD IMMUNOL	Am. J. Reprod. Immunol.	JUN	2015	73	6					557	567		10.1111/aji.12356		11	Immunology; Reproductive Biology	Immunology; Reproductive Biology	CH9XN	WOS:000354390000008		
J	Yoneda, S; Shiozaki, A; Ito, M; Yoneda, N; Inada, K; Yonezawa, R; Kigawa, M; Saito, S				Yoneda, Satoshi; Shiozaki, Arihiro; Ito, Mika; Yoneda, Noriko; Inada, Kumiko; Yonezawa, Rika; Kigawa, Mika; Saito, Shigeru			Accurate Prediction of the Stage of Histological Chorioamnionitis before Delivery by Amniotic Fluid IL-8 Level	AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Article						Amniotic fluid; body temperature; histological chorioamnionitis; interleukin-8; preterm labor	FETAL INFLAMMATORY RESPONSE; PRETERM PREMATURE RUPTURE; CHRONIC LUNG-DISEASE; CEREBRAL-PALSY; INTACT MEMBRANES; UMBILICAL-CORD; NECROTIZING ENTEROCOLITIS; MULTIPLE-PROTEINS; PRELABOR RUPTURE; RISK-FACTOR	ObjectiveTo estimate the stage of histological chorioamnionitis (h-CAM) antenatally using clinical data. Materials and methodsFour hundred and twenty-eight singleton mothers were recruited. Clinical data including the levels of white blood cell count (WBC), C-reactive protein (CRP), amniotic fluid interleukin-8 (AF-IL-8) at Cesarean section, and maternal body temperature (MBT) were collected. ResultsHistological chorioamnionitis was present in 45.3% of the cases. Poor neonatal prognosis was highest (59.1%) in cases with h-CAM stage III. AF-IL-8 (odds ratio: 8.5, 95% CI: 5.1-14.8, P<0.0001) and MBT (odds ratio: 2.3, 95% CI: 1.13-4.1, P=0.0192) were independent risk factors for h-CAM. The cutoff value of AF-IL-8 for predicting each stage of h-CAM (stage I or higher, stage II or higher, and stage III) were 9.9ng/mL, 17.3ng/mL, and 55.9ng/mL, respectively. ConclusionThe stage of h-CAM was able to be predicted accurately by the level of AF-IL-8 before delivery.	[Yoneda, Satoshi; Shiozaki, Arihiro; Ito, Mika; Yoneda, Noriko; Inada, Kumiko; Yonezawa, Rika; Saito, Shigeru] Toyama Univ, Dept Obstet & Gynecol, Toyama 9300194, Japan; [Kigawa, Mika] Toyama Univ, Fac Med, Dept Publ Hlth, Toyama 9300194, Japan	Saito, S (reprint author), Toyama Univ, Dept Obstet & Gynecol, 2630 Sugitani, Toyama 9300194, Japan.	s30saito@med.u-toyama.ac.jp					Lahra MM, 2004, AM J OBSTET GYNECOL, V190, P147, DOI 10.1016/j.ajog.2003.07.012; Erdemir G, 2013, PEDIATR NEONATOL, V54, P267, DOI 10.1016/j.pedneo.2013.03.012; Yoon BH, 2000, AM J OBSTET GYNECOL, V182, P675; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Gantert M, 2010, J PERINATOL, V30, pS21, DOI 10.1038/jp.2010.96; Bashiri A, 2006, J PERINAT MED, V34, P5, DOI 10.1515/JPM.2006.001; ROMERO R, 1993, AM J OBSTET GYNECOL, V169, P805; Holst RM, 2009, OBSTET GYNECOL, V114, P268, DOI 10.1097/AOG.0b013e3181ae6a08; Shatrov JG, 2010, OBSTET GYNECOL, V116, P387, DOI 10.1097/AOG.0b013e3181e90046; vanHoeven KH, 1996, PEDIATR PATHOL LAB M, V16, P731; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Yoneda S, 2011, J OBSTET GYNAECOL RE, V37, P861, DOI 10.1111/j.1447-0756.2010.01453.x; Gulati S, 2012, AM J REPROD IMMUNOL, V67, P235, DOI 10.1111/j.1600-0897.2011.01084.x; van de Laar R, 2009, EUR J OBSTET GYN R B, V147, P124, DOI 10.1016/j.ejogrb.2009.09.017; Soraisham AS, 2013, J PERINATOL, V33, P70, DOI 10.1038/jp.2012.49; Zanardo V, 2006, HUM PATHOL, V37, P87, DOI 10.1016/j.humpath.2005.09.017; Lieberman E, 2000, PEDIATRICS, V105, P8, DOI 10.1542/peds.105.1.8; Kim CJ, 2001, HUM PATHOL, V32, P623, DOI 10.1053/hupa.2001.24992; Trochez-Martinez RD, 2007, BJOG-INT J OBSTET GY, V114, P796, DOI 10.1111/j.1471-0528.2007.01385.x; Yoon BH, 1996, AM J OBSTET GYNECOL, V174, P1433, DOI 10.1016/S0002-9378(96)70585-9; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; D'Alquen D, 2005, PEDIATR RES, V57, P263, DOI 10.1203/01.PDR.0000148713.48218.86; Lahra MM, 2009, ARCH DIS CHILD-FETAL, V94, pF13, DOI 10.1136/adc.2007.135889; Quan JX, 2014, J DIABETES, V6, P33, DOI 10.1111/1753-0407.12073; Yoon BH, 2003, BJOG-INT J OBSTET GY, V110, P124, DOI 10.1016/S1470-0328(03)00063-6; Ito M, 2010, J REPROD IMMUNOL, V84, P75, DOI 10.1016/j.jri.2009.09.005; Park CW, 2009, PLACENTA, V30, P56, DOI 10.1016/j.placenta.2008.09.017; Been JV, 2013, J PEDIATR-US, V162, P236, DOI 10.1016/j.jpeds.2012.07.012; COULTRIP LL, 1994, AM J OBSTET GYNECOL, V171, P901; Been JV, 2009, ARCH DIS CHILD-FETAL, V94, pF218, DOI 10.1136/adc.2008.150458; Been JV, 2009, AM J OBSTET GYNECOL, V201, p[587, e581]; Blanc WA, 1981, PERINATAL DIS INT AC, V22, P67; Cielecka-Kuszyk J, 2011, HEPATOL INT, V5, P934, DOI 10.1007/s12072-011-9268-9; Cobo T, 2012, J MATERN-FETAL NEO M, V25, P1995, DOI 10.3109/14767058.2012.666592; Guerrini A, 2014, PHYTOTHER RES, V28, P1173, DOI 10.1002/ptr.5109; Hofer N, 2013, AM J OBSTET GYNECOL, V209; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kacerovsky M, 2009, NEUROENDOCRINOL LETT, V30, P733; Kacerovsky M, 2014, AM J OBSTET GYNECOL, V211; Keeler SM, 2009, AM J OBSTET GYNECOL, V201; Kotecha S, 1996, EUR J PEDIATR, V155, pS14, DOI 10.1007/BF01958074; Lenki SG, 1994, AM J OBSTET GYNECOL, V170, P1345; Luo LH, 2000, AM J REPROD IMMUNOL, V43, P78, DOI 10.1111/j.8755-8920.2000.430203.x; Maeda K, 1997, GYNECOL OBSTET INVES, V43, P225; Nasef N, 2013, AM J PERINAT, V30, P59, DOI 10.1055/s-0032-1321501; Ogunyemi D, 2003, J Matern Fetal Neonatal Med, V13, P102, DOI 10.1080/jmf.13.2.102.109; Pacora P, 2002, J Matern Fetal Neonatal Med, V11, P18, DOI 10.1080/713605445; Plummer CP, 2012, J OBSTET GYNAECOL RE, V38, P198, DOI 10.1111/j.1447-0756.2011.01675.x; Roberts DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031819; Speer CP, 1999, EUR J PEDIATR, V158, pS18, DOI 10.1007/PL00014314; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179; Yaju Y, 2006, PHARMACOEPIDEM DR S, V15, P813, DOI 10.1002/pds.1317	54	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1046-7408	1600-0897		AM J REPROD IMMUNOL	Am. J. Reprod. Immunol.	JUN	2015	73	6					568	576		10.1111/aji.12360		9	Immunology; Reproductive Biology	Immunology; Reproductive Biology	CH9XN	WOS:000354390000009		
J	Waki, A; Sasazaki, S; Kobayashi, E; Mannen, H				Waki, A.; Sasazaki, S.; Kobayashi, E.; Mannen, H.			Paternal phylogeography and genetic diversity of East Asian goats	ANIMAL GENETICS			English	Article						Capra hircus; genetic structure; haplotype; SRY; untranslated region; Y chromosome	DOMESTIC GOATS; CAPRA-HIRCUS; MITOCHONDRIAL	This study was a first analysis of paternal genetic diversity for extensive Asian domestic goats using SRY gene sequences. Sequencing comparison of the SRY 3-untranslated region among 210 Asian goats revealed four haplotypes (Y1A, Y1B, Y2A and Y2B) derived from four variable sites including a novel substitution detected in this study. In Asian goats, the predominant haplotype was Y1A (62%) and second most common was Y2B (30%). Interestingly, the Y2B was a unique East Asian Y chromosomal variant, which differentiates eastern and western Eurasian goats. The SRY geographic distribution in Myanmar and Cambodia indicated predominant the haplotype Y1A in plains areas and a high frequency of Y2B in mountain areas. The results suggest recent genetic infiltration of modern breeds into South-East Asian goats and an ancestral SRY Y2B haplotype in Asian native goats.	[Waki, A.; Sasazaki, S.; Mannen, H.] Kobe Univ, Lab Anim Breeding & Genet, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan; [Kobayashi, E.] NARO Inst Livestock & Grassland Sci, Anim Breeding & Reprod Res Div, Tsukuba, Ibaraki 3050901, Japan	Mannen, H (reprint author), Kobe Univ, Lab Anim Breeding & Genet, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan.	mannen@kobe-u.ac.jp			Ministry of Education, Science, Sports and the Society for Researches on Native Livestock, Japan [14405029, 15405033, 16201046, 70111838, 19405043]	We thank Drs. Namikawa T., Maeda Y., Yamamoto Y., Amano T., Bouahom B., Dorji T., Phith L.C., Daing T., Faruque M.O. and Masangkay J.S. for help collecting samples. We also thank Drs. Lenstra J.A. and Cinar-Kul B. for providing unpublished information and valuable suggestions. This research project was supported in part by Grant-in-Aid nos. 14405029, 15405033, 16201046, 70111838 and 19405043 from the Ministry of Education, Science, Sports and the Society for Researches on Native Livestock, Japan.	Canon J, 2006, ANIM GENET, V37, P327, DOI 10.1111/j.1365-2052.2006.01461.x; Mannen H, 1998, GENETICS, V150, P1169; Mannen H, 2001, BIOCHEM GENET, V39, P145, DOI 10.1023/A:1010266207735; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; Chen SY, 2005, MOL PHYLOGENET EVOL, V37, P804, DOI 10.1016/j.ympev.2005.06.014; Cinar-Kul B., 2015, FRONT GENET, DOI [10.1111/jbg.12154, DOI 10.1111/JBG.12154]; Doro MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095969; Lin BZ, 2013, ANIM GENET, V44, P79, DOI 10.1111/j.1365-2052.2012.02358.x; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Nomura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067775; Pereira F, 2009, MOL BIOL EVOL, V26, P2765, DOI 10.1093/molbev/msp200; Pereira F, 2008, MOL PHYLOGENET EVOL, V49, P663, DOI 10.1016/j.ympev.2008.08.026; Sultana S, 2003, ANIM GENET, V34, P417, DOI 10.1046/j.0268-9146.2003.01040.x	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0268-9146	1365-2052		ANIM GENET	Anim. Genet.	JUN	2015	46	3					337	339		10.1111/age.12293		3	Agriculture, Dairy & Animal Science; Genetics & Heredity	Agriculture; Genetics & Heredity	CH4HX	WOS:000353995700017		
J	Kogure, Y; Yoshimi, A; Ueda, K; Nannya, Y; Ichikawa, M; Nakamura, F; Kurokawa, M				Kogure, Yasunori; Yoshimi, Akihide; Ueda, Koki; Nannya, Yasuhito; Ichikawa, Motoshi; Nakamura, Fumihiko; Kurokawa, Mineo			Modified ESHAP regimen for relapsed/refractory T cell lymphoma: a retrospective analysis	ANNALS OF HEMATOLOGY			English	Article						Salvage chemotherapy; Peripheral T cell lymphoma; Angioimmunoblastic T cell lymphoma; Bone marrow involvement; Retrospective study	NON-HODGKINS-LYMPHOMA; SINGLE-AGENT; PHASE-II; THERAPY; CHEMOTHERAPY; GEMCITABINE; CARBOPLATIN; EXPERIENCE	Peripheral T cell lymphomas account for approximately 10 % of all the non-Hodgkin lymphomas and are characterized by an aggressive clinical course and poor treatment outcome. In contrast to the improvement in the treatment of B cell lymphomas, there is no established standard chemotherapy regimen for relapsed/refractory T cell lymphomas. Our institute introduced modified ESHAP (mESHAP) regimen to reduce renal toxicity of standard ESHAP therapy, in which cisplatin was switched to carboplatin. We retrospectively analyzed the efficacy of mESHAP against relapsed/refractory T cell lymphomas. Twenty-two patients with relapsed/refractory T cell lymphomas were treated with mESHAP regimen at the University of Tokyo Hospital between January 2001 and December 2012. The median age was 59 years (range, 36-77). The diagnosis comprised peripheral T cell lymphoma, not otherwise specified (n = 10), angioimmunoblastic T cell lymphoma (AITL; n = 9), mycosis fungoides (n = 1), and anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma (n = 2). The median follow-up period was 9.5 months (range, 2.5-62.3). Complete remission (CR) was achieved in four patients (18 %) and partial remission (PR) in three patients (14 %). The median overall survival (OS) and progression-free survival (PFS) were 11.0 and 2.5 months, respectively. Leukopenia was the most frequent side effect and renal impairment was rare. According to a multivariate analysis, better OS and PFS were recorded in patients without bone marrow invasion (OS, hazard ratio (HR) 0.13, p = 0.0079; PFS, HR 0.13, p = 0.0044) or those with AITL (OS, HR 0.21, p = 0.021; PFS, HR 0.15, p = 0.0043). Although overall outcomes of mESHAP for relapsed/refractory T cell lymphomas were not excellent, this regimen remains one of the possible candidates for those with AITL histology or without bone marrow invasion.	[Kogure, Yasunori; Yoshimi, Akihide; Ueda, Koki; Nannya, Yasuhito; Ichikawa, Motoshi; Nakamura, Fumihiko; Kurokawa, Mineo] Univ Tokyo, Dept Hematol & Oncol, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan	Kurokawa, M (reprint author), Univ Tokyo, Dept Hematol & Oncol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kurokawa-tky@umin.ac.jp		Kogure, Yasunori/0000-0003-1158-5131	Pfizer Japan Inc.; Nippon Shinyaku Co., Ltd.; Bristol-Myers Squibb Company	This is not a sponsored trial, but we declare the potential COI with the pharmaceutical companies that deal with the drugs used in this study. YK reports no conflicts of interest; AY reports that he is a member of the technical advisory board for Nippon Kayaku Co., Ltd.; KU reports no conflicts of interest; YN reports grant from Pfizer Japan Inc. and Nippon Shinyaku Co., Ltd. and served as a member of advisory board of Bristol-Myers Squibb; MI reports grant from Pfizer Japan Inc.; FN reports no conflicts of interest; MK reports grants from Pfizer Japan Inc., grants and honorarium for speaking engagement from Nippon Shinyaku Co., Ltd., grant and honoraria for speaking engagement from Bristol-Myers Squibb Company. MK also reports that he is a member of the technical advisory board of Bristol-Myers Squibb Company.	Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Ogura M, 2014, J CLIN ONCOL, V32, P1157, DOI 10.1200/JCO.2013.52.0924; Horwitz SM, 2014, BLOOD, V123, P3095, DOI 10.1182/blood-2013-12-542142; Cheson BD, 1999, J CLIN ONCOL, V17, P1244; VELASQUEZ WS, 1994, J CLIN ONCOL, V12, P1169; Zinzani PL, 2010, ANN ONCOL, V21, P860, DOI 10.1093/annonc/mdp508; Coiffier B, 2012, J CLIN ONCOL, V30, P631, DOI 10.1200/JCO.2011.37.4223; LISTER TA, 1989, J CLIN ONCOL, V7, P1630; CALVERT AH, 1989, J CLIN ONCOL, V7, P1748; Zelenetz AD, 2003, ANN ONCOL, V14, P5, DOI 10.1093/annonc/mdg702; O'Connor OA, 2011, J CLIN ONCOL, V29, P1182, DOI 10.1200/JCO.2010.29.9024; Arkenau HT, 2007, HAEMATOL-HEMATOL J, V92, P271, DOI 10.3324/haematol.10737; SHIPP MA, 1993, NEW ENGL J MED, V329, P987; Savage KJ, 2004, ANN ONCOL, V15, P1467, DOI 10.1093/annonc/mdh392; Foss F, 2015, BRIT J HAEMATOL, V168, P811, DOI 10.1111/bjh.13222; Horwitz S, 2005, BLOOD, V106, p752A; Park Sang Hyoung, 2006, Korean Journal of Internal Medicine, V21, P159; Ueda K, 2010, J CHEMOTHERAPY, V22, P54; Uni M, 2013, ANN HEMATOL, V92, P859, DOI 10.1007/s00277-012-1642-8	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	JUN	2015	94	6					989	994		10.1007/s00277-015-2309-z		6	Hematology	Hematology	CH5HO	WOS:000354066500012		
J	Iwasaki, S; Fujimoto, C; Kinoshita, M; Kamogashira, T; Egami, N; Yamasoba, T				Iwasaki, Shinichi; Fujimoto, Chisato; Kinoshita, Makoto; Kamogashira, Teru; Egami, Naoya; Yamasoba, Tatsuya			Clinical Characteristics of Patients With Abnormal Ocular/Cervical Vestibular Evoked Myogenic Potentials in the Presence of Normal Caloric Responses	ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY			English	Article						vestibular; otolith; vestibular evoked myogenic potential; saccule; utricle	BONE CONDUCTED VIBRATION; MENIERES-DISEASE; EXTRAOCULAR POTENTIALS; ENDOLYMPHATIC HYDROPS; DROP ATTACKS; REFLEX; DYSFUNCTION; VERTIGO; SOUND; STIMULATION	Objective: To investigate the clinical features and vestibular symptoms of patients with abnormal ocular vestibular evoked myogenic potentials (oVEMPs) and/or cervical VEMPs (cVEMPs) in the presence of normal caloric responses. Study Design: Retrospective chart review. Setting: Tertiary referral center. Methods: One thousand five hundred twenty-one consecutive patients with balance problems who underwent the caloric, cVEMP, and oVEMP tests were included, and patients who showed abnormal oVEMPs and/or cVEMPs in the presence of normal caloric responses were selected. Clinical characteristics, diagnoses, and vestibular symptoms of the patients were analyzed. Results: Of the 1521 patients, 227 (15%) were found to have abnormal oVEMPs and/or cVEMP responses with normal caloric responses. Benign paroxysmal positional vertigo (BBPV), Meniere's disease, and vestibular migraine were the common diagnoses of these patients. Eighty-one patients (36%) could not be diagnosed with a recognizable disease. Multiple episodes of spinning vertigo with a duration of seconds to hours were their most common vestibular symptoms. Conclusion: BPPV, Meniere's disease, and vestibular migraine are the most frequent diagnoses showing abnormal oVEMP and/or cVEMPs without canal paresis. Apart from these clinical entities, a portion of undiagnosed patients with multiple episodes of vertigo might have a disease that involves the otolith organs only.	[Iwasaki, Shinichi; Fujimoto, Chisato; Kinoshita, Makoto; Kamogashira, Teru; Egami, Naoya; Yamasoba, Tatsuya] Univ Tokyo, Dept Otolaryngol, Fac Med, Tokyo 1138655, Japan	Iwasaki, S (reprint author), Univ Tokyo, Dept Otolaryngol, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	iwashin-tky@umin.ac.jp					Nakahara H, 2013, ACTA OTO-LARYNGOL, V133, P144, DOI 10.3109/00016489.2012.720030; Isu N, 2000, EXP BRAIN RES, V131, P262, DOI 10.1007/s002219900292; Bisdorff A, 2009, J VESTIBUL RES-EQUIL, V19, P1, DOI 10.3233/VES-2009-0343; Brandt T, 1993, J Vestib Res, V3, P373; [Anonymous], 1995, OTOLARYNGOL HEAD NEC, V113, P181; COLEBATCH JG, 1992, NEUROLOGY, V42, P1635; Young YH, 2013, LARYNGOSCOPE, V123, P484, DOI 10.1002/lary.23640; Chihara Y, 2012, ACTA OTO-LARYNGOL, V132, P1288, DOI 10.3109/00016489.2012.701326; Curthoys IS, 1998, EXP BRAIN RES, V123, P425, DOI 10.1007/s002210050587; Welgampola MS, 2005, NEUROLOGY, V64, P1682, DOI 10.1212/01.WNL.0000161876.20552.AA; Iwasaki S, 2007, NEUROLOGY, V68, P1227, DOI 10.1212/01.wnl.0000259064.80564.21; Rosengren SM, 2013, CURR OPIN NEUROL, V26, P74, DOI 10.1097/WCO.0b013e32835c5ef3; Murofushi T, 1999, ARCH OTOLARYNGOL, V125, P660; Schmal F, 2005, J VESTIBUL RES-EQUIL, V15, P215; Boldingh MI, 2011, CEPHALALGIA, V31, P1211, DOI 10.1177/0333102411409074; Fujimoto C, 2009, J NEUROL, V256, P1488, DOI 10.1007/s00415-009-5147-x; Murofushi T, 2012, NEUROSCI LETT, V515, P103, DOI 10.1016/j.neulet.2012.02.084; Chihara Y, 2007, CLIN NEUROPHYSIOL, V118, P2745, DOI 10.1016/j.clinph.2007.08.005; Curthoys IS, 2011, CLIN NEUROPHYSIOL, V122, P611, DOI 10.1016/j.clinph.2010.07.018; Egami N, 2013, J VESTIBUL RES-EQUIL, V23, P249, DOI 10.3233/VES-130484; von Brevern M, 2005, BRAIN, V128, P365, DOI 10.1093/brain/awh351; Rosengren SM, 2005, CLIN NEUROPHYSIOL, V116, P1938, DOI 10.1016/j.clinph.2005.03.019; Murofushi T, 2009, CEPHALALGIA, V29, P1259, DOI 10.1111/j.1468-2982.2009.01860.x; GRESTY MA, 1992, BRAIN, V115, P647, DOI 10.1093/brain/115.3.647; Iwasaki S, 2008, CLIN NEUROPHYSIOL, V119, P2135, DOI 10.1016/j.clinph.2008.05.028; OKUNO T, 1987, ANN OTO RHINOL LARYN, V96, P438; Murofushi T, 2013, NEUROSCI LETT, V553, P95, DOI 10.1016/j.neulet.2013.08.002; Uchino Y, 1996, J NEUROPHYSIOL, V76, P1896; Iwasaki S, 2013, ACTA OTO-LARYNGOL, V133, P708, DOI 10.3109/00016489.2013.767476; Iwasaki S, 2009, CLIN NEUROPHYSIOL, V120, P588, DOI 10.1016/j.clinph.2008.12.036; Baloh RW, 2001, CLIN NEUROPHYSIOLOGY; BALOH RW, 1977, ANN OTO RHINOL LARYN, V86, P24; Calzada AP, 2012, OTOL NEUROTOL, V33, P1593, DOI 10.1097/MAO.0b013e318271c48b; CURTHOYS IS, 1987, AVIAT SPACE ENVIR MD, V58, pA192; DIX MR, 1952, P ROY SOC MED, V45, P341; Furman JM, 2013, LANCET NEUROL, V12, P706, DOI 10.1016/S1474-4422(13)70107-8; Furman JM, 1997, NEUROLOGY, V48, P1161; Huang CH, 2012, OTOL NEUROTOL, V33, P1251, DOI 10.1097/MAO.0b013e31826352e8; Ishiyama G, 2001, NEUROLOGY, V57, P1103; Iwasaki S, 2005, OTOL NEUROTOL, V26, P1196, DOI 10.1097/01.mao.0000194890.44023.e6; Manzari L, 2012, EUR ARCH OTO-RHINO-L, V269, P2441, DOI 10.1007/s00405-012-2127-z; Pelosi S, 2013, AM J OTOLARYNG, V34, P490, DOI 10.1016/j.amjoto.2013.04.008; Saka N, 2014, ACTA OTO-LARYNGOL, V134, P233, DOI 10.3109/00016489.2013.861925; Seo T, 2008, AURIS NASUS LARYNX, V35, P27, DOI 10.1016/j.anl.2007.04.006	44	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-4894	1943-572X		ANN OTO RHINOL LARYN	Ann. Otol. Rhinol. Laryngol.	JUN	2015	124	6					458	465		10.1177/0003489414564997		8	Otorhinolaryngology	Otorhinolaryngology	CH6GR	WOS:000354135100006		
J	Yoshimura, T; Shibata, N; Hamano, Y; Yamanaka, K				Yoshimura, Tomohiro; Shibata, Nobuyuki; Hamano, Yoshimitsu; Yamanaka, Kazuya			Heterologous Production of Hyaluronic Acid in an epsilon-Poly-L-Lysine Producer, Streptomyces albulus	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							STREPTOCOCCUS-ZOOEPIDEMICUS; MOLECULAR-WEIGHT; GROUP-A; ORGANIZATION; POLYLYSINE; SYSTEM	Hyaluronic acid (HA) is used in a wide range of medical applications, where its performance and therapeutic efficacy are highly dependent on its molecular weight. In the microbial production of HA, it has been suggested that a high level of intracellular ATP enhances the productivity and molecular weight of HA. Here, we report on heterologous HA production in an epsilon-poly-L-lysine producer, Streptomyces albulus, which has the potential to generate ATP at high level. The hasA gene from Streptococcus zooepidemicus, which encodes HA synthase, was refactored and expressed under the control of a late-log growth phase-operating promoter. The expression of the refactored hasA gene, along with genes coding for UDP-glucose dehydrogenase, UDP-N-acetylglucosamine pyrophosphorylase, and UDP-glucose pyrophosphorylase, which are involved in HA precursor sugar biosynthesis, resulted in efficient production of HA in the 2.0 MDa range, which is greater than typical bacterial HA, demonstrating that a sufficient amount of ATP was provided to support the biosynthesis of the precursor sugars, which in turn promoted HA production. In addition, unlike in the case of streptococcal HA, S. albulus-derived HA was not cell associated. Based on these findings, our heterologous production system appears to have several advantages for practical HA production. We propose that the present system could be applicable to the heterologous production of a wide variety of molecules other than HA in the case their biosynthesis pathways require ATP in vivo.	[Yoshimura, Tomohiro; Shibata, Nobuyuki; Yamanaka, Kazuya] JNC Corp, Yokohama Res Ctr, Yokohama, Kanagawa, Japan; [Hamano, Yoshimitsu] Fukui Prefectural Univ, Dept Biosci, Eiheiji, Fukui, Japan	Yamanaka, K (reprint author), Kansai Univ, Dept Life Sci & Biotechnol, Suita, Osaka, Japan.	kazuyay@kansai-u.ac.jp			Kakenhi grants [23108520, 25660064]	This study was supported in part by Kakenhi grants 23108520 and 25660064 (to Y.H.).	Adam N, 2001, INFLAMM RES, V50, P294, DOI 10.1007/PL00000247; Yamanaka K, 2008, NAT CHEM BIOL, V4, P766, DOI 10.1038/nchembio.125; Hamano Y, 2005, J BIOSCI BIOENG, V99, P636, DOI 10.1263/jbb.99.636; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; ITZHAKI RF, 1972, ANAL BIOCHEM, V50, P569, DOI 10.1016/0003-2697(72)90067-X; Heldermon C, 2001, J BIOL CHEM, V276, P2037, DOI 10.1074/jbc.M002276200; Yamanaka K, 2011, J BIOSCI BIOENG, V111, P646, DOI 10.1016/j.jbiosc.2011.01.020; GOA KL, 1994, DRUGS, V47, P536; WESSELS MR, 1991, P NATL ACAD SCI USA, V88, P8317, DOI 10.1073/pnas.88.19.8317; WEISSMANN B, 1954, J AM CHEM SOC, V76, P1753, DOI 10.1021/ja01636a010; Yamanaka K, 2010, APPL ENVIRON MICROB, V76, P5669, DOI 10.1128/AEM.00853-10; Armstrong DC, 1997, APPL ENVIRON MICROB, V63, P2759; MACLENNAN AP, 1956, J GEN MICROBIOL, V14, P134; OREGAN M, 1994, INT J BIOL MACROMOL, V16, P283, DOI 10.1016/0141-8130(94)90056-6; Blank LM, 2008, J MOL EVOL, V67, P13, DOI 10.1007/s00239-008-9117-1; SHIMA S, 1977, AGR BIOL CHEM TOKYO, V41, P1807; Hiraki J, 1998, SEIBUTSU-KOGAKU KAIS, V76, P487; Chong BF, 2005, APPL MICROBIOL BIOT, V66, P341, DOI 10.1007/s00253-004-1774-4; Mao ZC, 2009, APPL MICROBIOL BIOT, V84, P63, DOI 10.1007/s00253-009-1963-2; Widner B, 2005, APPL ENVIRON MICROB, V71, P3747, DOI 10.1128/AEM.71.7.3747-3752.2005; Chen WY, 2009, J BIOL CHEM, V284, P18007, DOI 10.1074/jbc.M109.011999; CARTER GR, 1953, AM J VET RES, V14, P475; Dodd A, 2013, GENOME ANNOUNC, V1; Kieser T., 2000, PRACTICAL STREPTOMYC; Kito N, 2012, J BIOSCI BIOENG, V115, P523; Liu L, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-99; Ottaviani RA, 2007, J BONE JOINT SURG AM, V89A, P148, DOI 10.2106/JBJS.E.01135; PUTTICK MPE, 1995, J RHEUMATOL, V22, P1311; Simon R, 1983, NAT BIOTECHNOL, V1, P784, DOI DOI 10.1038/NBT1183-784; Swann DA, 1991, BIOMATERIALS NOVEL M, P286; Takahashi H, 2007, J BIOL CHEM, V282, P9073, DOI 10.1074/jbc.M611319200; Townsend KM, 2001, J CLIN MICROBIOL, V39, P924, DOI 10.1128/JCM.39.3.924-929.2001; Xu Z., 2014, GENOME ANNOUNC, V2	33	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JUN	2015	81	11					3631	3640		10.1128/AEM.00269-15		10	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CH3FA	WOS:000353912000006		
J	Hara, R; Nakano, M; Kino, K				Hara, Ryotaro; Nakano, Masashi; Kino, Kuniki			One-Pot Production of L-threo-3-Hydroxyaspartic Acid Using Asparaginase-Deficient Escherichia coli Expressing Asparagine Hydroxylase of Streptomyces coelicolor A3(2)	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							BETA-HYDROXYASPARTIC ACID; 4 OPTICAL ISOMERS; AMINO-ACID; ASPARTIC-ACID; TRANSPORTER; DERIVATIVES; PURIFICATION; RESOLUTION; BLOCKERS; RECEPTOR	We developed a novel process for efficient synthesis of L-threo-3-hydroxyaspartic acid (L-THA) using microbial hydroxylase and hydrolase. A well-characterized mutant of asparagine hydroxylase (AsnO-D241N) and its homologous enzyme (SCO2693-D246N) were adaptable to the direct hydroxylation of L-aspartic acid; however, the yields were strictly low. Therefore, the highly stable and efficient wild-type asparagine hydroxylases AsnO and SCO2693 were employed to synthesize L-THA. By using these recombinant enzymes, L-THA was obtained by L-asparagine hydroxylation by AsnO followed by amide hydrolysis by asparaginase via 3-hydroxyasparagine. Subsequently, the two-step reaction was adapted to one-pot bioconversion in a test tube. L-THA was obtained in a small amount with a molar yield of 0.076% by using intact Escherichia coli expressing the asnO gene, and thus, two asparaginase-deficient mutants of E. coli were investigated. A remarkably increased L-THA yield of 8.2% was obtained with the asparaginase I-deficient mutant. When the expression level of the asnO gene was enhanced by using the T7 promoter in E. coli instead of the lac promoter, the L-THA yield was significantly increased to 92%. By using a combination of the E. coli asparaginase I-deficient mutant and the T7 expression system, a whole-cell reaction in a jar fermentor was conducted, and consequently, L-THA was successfully obtained from L-asparagine with a maximum yield of 96% in less time than with test tube-scale production. These results indicate that asparagine hydroxylation followed by hydrolysis would be applicable to the efficient production of L-THA.	[Hara, Ryotaro; Kino, Kuniki] Waseda Univ, Res Inst Sci & Engn, Tokyo, Japan; [Nakano, Masashi; Kino, Kuniki] Waseda Univ, Dept Appl Chem, Fac Sci & Engn, Tokyo 169, Japan	Hara, R (reprint author), Waseda Univ, Res Inst Sci & Engn, Tokyo, Japan.	ryo_h@aoni.waseda.jp					Lebrun B, 1997, J BIOL CHEM, V272, P20336, DOI 10.1074/jbc.272.33.20336; Broca C, 1999, AM J PHYSIOL-ENDOC M, V277, pE617; Strieker M, 2007, ACS CHEM BIOL, V2, P187, DOI 10.1021/cb700012y; Bhushan R, 2004, AMINO ACIDS, V27, P231, DOI 10.1007/s00726-004-0118-0; JENNINGS MP, 1990, J BACTERIOL, V172, P1491; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; ANPEIJI S, 1983, B CHEM SOC JPN, V56, P2994, DOI 10.1246/bcsj.56.2994; Baba Tomoya, 2006, Mol Syst Biol, V2; Birdsall T C, 1998, Altern Med Rev, V3, P271; DEMAIN AL, 1958, J BACTERIOL, V75, P517; HANESSIAN S, 1993, CAN J CHEM, V71, P1401, DOI 10.1139/v93-181; ISHIYAMA T, 1975, J ANTIBIOT, V28, P821; JERLSTROM PG, 1989, GENE, V78, P37, DOI 10.1016/0378-1119(89)90312-0; KANEKO T, 1963, B CHEM SOC JPN, V36, P899, DOI 10.1246/bcsj.36.899; Kidd FL, 2000, NEUROPHARMACOLOGY, V39, P725, DOI 10.1016/S0028-3908(99)00270-1; LEA PJ, 1978, PHYTOCHEMISTRY, V17, P217, DOI 10.1016/S0031-9422(00)94149-9; Maeda T, 2010, J BIOCHEM, V148, P705, DOI 10.1093/jb/mvq106; Metzner L, 2004, J PHARMACOL EXP THER, V309, P28, DOI 10.1124/jpet.103.059014; OKAI H, 1967, B CHEM SOC JPN, V40, P2154, DOI 10.1246/bcsj.40.2154; SALLACH HJ, 1956, J BIOL CHEM, V223, P629; Sambrook J., 2012, MOL CLONING LAB MANU; Sanda F, 1999, POLYM J, V31, P353, DOI 10.1295/polymj.31.353; Shimamoto K, 2000, BIOORG MED CHEM LETT, V10, P2407, DOI 10.1016/S0960-894X(00)00487-X; Strieker M, 2008, CHEMBIOCHEM, V9, P374, DOI 10.1002/cbic.200700557; THOMASSET N, 1991, INT J CANCER, V49, P421, DOI 10.1002/ijc.2910490319	25	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JUN	2015	81	11					3648	3654		10.1128/AEM.03963-14		7	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CH3FA	WOS:000353912000008		
J	Sawada, K; Sato, T; Hamajima, H; Jayakody, LN; Hirata, M; Yamashiro, M; Tajima, M; Mitsutake, S; Nagao, K; Tsuge, K; Abe, F; Hanada, K; Kitagaki, H				Sawada, Kazutaka; Sato, Tomoya; Hamajima, Hiroshi; Jayakody, Lahiru Niroshan; Hirata, Miyo; Yamashiro, Mikako; Tajima, Marie; Mitsutake, Susumu; Nagao, Koji; Tsuge, Keisuke; Abe, Fumiyoshi; Hanada, Kentaro; Kitagaki, Hiroshi			Glucosylceramide Contained in Koji Mold-Cultured Cereal Confers Membrane and Flavor Modification and Stress Tolerance to Saccharomyces cerevisiae during Coculture Fermentation	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							FATTY-ACID ELONGATION; GLYCOSPHINGOLIPID SYNTHESIS; NONVESICULAR TRAFFICKING; STRUCTURAL DETERMINATION; CRYPTOCOCCUS-NEOFORMANS; ETHANOL TOLERANCE; MASS-SPECTROMETRY; KEY INHIBITOR; SAKE YEASTS; EXPRESSION	In nature, different microorganisms create communities through their physiochemical and metabolic interactions. Many fermenting microbes, such as yeasts, lactic acid bacteria, and acetic acid bacteria, secrete acidic substances and grow faster at acidic pH values. However, on the surface of cereals, the pH is neutral to alkaline. Therefore, in order to grow on cereals, microbes must adapt to the alkaline environment at the initial stage of colonization; such adaptations are also crucial for industrial fermentation. Here, we show that the yeast Saccharomyces cerevisiae, which is incapable of synthesizing glucosylceramide ( GlcCer), adapted to alkaline conditions after exposure to GlcCer from koji cereal cultured with Aspergillus kawachii. We also show that various species of GlcCer derived from different plants and fungi similarly conferred alkali tolerance to yeast. Although exogenous ceramide also enhanced the alkali tolerance of yeast, no discernible degradation of GlcCer to ceramide was observed in the yeast culture, suggesting that exogenous GlcCer itself exerted the activity. Exogenous GlcCer also increased ethanol tolerance and modified the flavor profile of the yeast cells by altering the membrane properties. These results indicate that GlcCer from A. kawachii modifies the physiology of the yeast S. cerevisiae and demonstrate a new mechanism for cooperation between microbes in food fermentation.	[Sawada, Kazutaka; Jayakody, Lahiru Niroshan; Nagao, Koji; Kitagaki, Hiroshi] Kagoshima Univ, United Grad Sch Agr Sci, Dept Biochem & Appl Biosci, Kagoshima 890, Japan; [Sawada, Kazutaka; Sato, Tomoya; Hamajima, Hiroshi; Jayakody, Lahiru Niroshan; Hirata, Miyo; Yamashiro, Mikako; Tajima, Marie; Kitagaki, Hiroshi] Saga Univ, Fac Agr, Dept Environm Sci, Saga, Saga 840, Japan; [Sawada, Kazutaka; Tsuge, Keisuke] Ind Technol Ctr Saga Prefecture, Saga, Saga, Japan; [Mitsutake, Susumu; Nagao, Koji] Saga Univ, Fac Agr, Dept Appl Biochem & Food Sci, Saga, Saga 840, Japan; [Abe, Fumiyoshi] Aoyama Gakuin Univ, Coll Sci & Engn, Dept Chem & Biol Sci, Sagamihara, Kanagawa, Japan; [Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan	Kitagaki, H (reprint author), Kagoshima Univ, United Grad Sch Agr Sci, Dept Biochem & Appl Biosci, Kagoshima 890, Japan.	ktgkhrs@cc.saga-u.ac.jp			Scientific Technique Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry [26056A]; JSPSKAKENHI grant [24580117]; Institute for Fermentation; Takeda Science Foundation	This study was supported in part by the Scientific Technique Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry (grant 26056A to H.K.), by a JSPSKAKENHI grant (grant 24580117; to H.K.), by a research grant from the Institute for Fermentation (to H.K.), and by the Takeda Science Foundation (to K.H.).	Abe F, 2009, BIOCHEMISTRY-US, V48, P8494, DOI 10.1021/bi900578y; Aciego-Pietri J. C., 2008, SOIL BIOL BIOCHEM, V40, P1856, DOI 10.1016/j.soilbio.2008.03.020; Saerens SMG, 2008, APPL ENVIRON MICROB, V74, P454, DOI 10.1128/AEM.01616-07; Abe F, 2009, BBA-BIOMEMBRANES, V1788, P743, DOI 10.1016/j.bbamem.2008.12.002; Cowart LA, 2003, J BIOL CHEM, V278, P30328, DOI 10.1074/jbc.M300656200; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Jayakody LN, 2013, APPL MICROBIOL BIOT, V97, P6589, DOI 10.1007/s00253-013-4997-4; Furukawa S, 2013, J BIOSCI BIOENG, V116, P533, DOI 10.1016/j.jbiosc.2013.05.017; Xie GF, 2007, J I BREWING, V113, P272; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Vecer J, 2014, FEBS LETT, V588, P443, DOI 10.1016/j.febslet.2013.11.038; Varela C, 2012, FOOD CHEM, V135, P2863, DOI 10.1016/j.foodchem.2012.06.127; Sugawara T, 2010, LIPIDS, V45, P451, DOI 10.1007/s11745-010-3417-0; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Jayakody LN, 2011, BIOTECHNOL LETT, V33, P285, DOI 10.1007/s10529-010-0437-z; Ishibashi Y, 2012, J BIOL CHEM, V287, P368, DOI 10.1074/jbc.M111.311340; Kitagaki H, 2009, J BIOL CHEM, V284, P10818, DOI 10.1074/jbc.M805029200; LENTZ BR, 1993, CHEM PHYS LIPIDS, V64, P99, DOI 10.1016/0009-3084(93)90060-G; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Ternes P, 2011, J BIOL CHEM, V286, P11401, DOI 10.1074/jbc.M110.193094; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; KINOSITA K, 1977, BIOPHYS J, V20, P289; Jayakody LN, 2012, APPL MICROBIOL BIOT, V94, P273, DOI 10.1007/s00253-012-3918-2; Ichikawa S, 1996, P NATL ACAD SCI USA, V93, P4638, DOI 10.1073/pnas.93.10.4638; Titus JH, 2002, J ARID ENVIRON, V52, P269, DOI 10.1006/jare.2002.1010; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; Simanshu DK, 2013, NATURE, V500, P463, DOI 10.1038/nature12332; THURSTON PA, 1981, J I BREWING, V87, P92; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Caspeta L, 2014, SCIENCE, V346, P75, DOI 10.1126/science.1258137; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; David D, 1998, J CELL BIOL, V143, P1167, DOI 10.1083/jcb.143.5.1167; Hanada K, 2014, BBA-MOL CELL BIOL L, V1841, P704, DOI 10.1016/j.bbalip.2013.06.006; HESSELTINE CW, 1983, ANNU REV MICROBIOL, V37, P575, DOI 10.1146/annurev.mi.37.100183.003043; Hirata M, 2011, J BREW SOC JPN, V106, P848; Hirata M, 2012, J AGR FOOD CHEM, V60, P11473, DOI 10.1021/jf303117e; Hong SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063769; Jayakody LN, 2015, APPL MICROBIOL BIOT, V99, P501, DOI 10.1007/s00253-014-6174-9; Kajiwara S, 1996, APPL ENVIRON MICROB, V62, P4309; Kitagaki H, 2013, ANNU REV FOOD SCI T, V4, P215, DOI 10.1146/annurev-food-030212-182545; Kitagaki H, 2007, BBA-BIOMEMBRANES, V1768, P2849, DOI 10.1016/j.bbamem.2007.07.019; OHTA K, 1983, APPL ENVIRON MICROB, V46, P821; PRENDERGAST FG, 1981, BIOCHEMISTRY-US, V20, P7333, DOI 10.1021/bi00529a002; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Shiroma S, 2014, APPL ENVIRON MICROB, V80, P1002, DOI 10.1128/AEM.03130-13; Sugama S., 1973, J BREW SOC JPN, V67, P672; Takahashi K, 2014, J OLEO SCI, V63, P15, DOI 10.5650/jos.ess13086; Takakuwa N, 2002, FEMS YEAST RES, V2, P533, DOI 10.1111/j.1567-1364.2002.tb00120.x; VANLANGEN H, 1989, EUR BIOPHYS J BIOPHY, V17, P37; Yamaji T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088124; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Yazawa H, 2009, YEAST, V26, P167, DOI 10.1002/yea.1659	52	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JUN	2015	81	11					3688	3698		10.1128/AEM.00454-15		11	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CH3FA	WOS:000353912000013		
J	Ukuda-Hosokawa, R; Sadoyama, Y; Kishaba, M; Kuriwada, T; Anbutsu, H; Fukatsu, T				Ukuda-Hosokawa, Rie; Sadoyama, Yasutsune; Kishaba, Misaki; Kuriwada, Takashi; Anbutsu, Hisashi; Fukatsu, Takema			Infection Density Dynamics of the Citrus Greening Bacterium "Candidatus Liberibacter asiaticus" in Field Populations of the Psyllid Diaphorina citri and Its Relevance to the Efficiency of Pathogen Transmission to Citrus Plants	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							SAO-PAULO STATE; HUANGLONGBING DISEASE; HEMIPTERA PSYLLIDAE; VECTOR; AMERICANUS; FLORIDA; BRAZIL; TREE; MANAGEMENT; HOMOPTERA	Huanglongbing, or citrus greening, is a devastating disease of citrus plants recently spreading worldwide, which is caused by an uncultivable bacterial pathogen, "Candidatus Liberibacter asiaticus," and vectored by a phloem-sucking insect, Diaphorina citri. We investigated the infection density dynamics of "Ca. Liberibacter asiaticus" in field populations of D. citri with experiments using field-collected insects to address how "Ca. Liberibacter asiaticus" infection density in the vector insect is relevant to pathogen transmission to citrus plants. Of 500 insects continuously collected from " Ca. Liberibacter asiaticus"-infected citrus trees with pathological symptoms in the spring and autumn of 2009, 497 (99.4%) were " Ca. Liberibacter asiaticus" positive. The infections were systemic across head-thorax and abdomen, ranging from 10(3) to 10(7) bacteria per insect. In spring, the infection densities were low in March, at similar to 10(3) bacteria per insect, increasing up to 10(6) to 10(7) bacteria per insect in April and May, and decreasing to 10(5) to 10(6) bacteria per insect in late May, whereas the infection densities were constantly similar to 10(6) to 10(7) bacteria per insect in autumn. Statistical analysis suggested that several factors, such as insect sex, host trees, and collection dates, may be correlated with "Ca. Liberibacter asiaticus" infection densities in field D. citri populations. Inoculation experiments with citrus seedlings using field-collected "Ca. Liberibacter asiaticus"-infected insects suggested that (i) "Ca. Liberibacter asiaticus"-transmitting insects tend to exhibit higher infection densities than do nontransmitting insects, (ii) a threshold level (similar to 10(6) bacteria per insect) of "Ca. Liberibacter asiaticus" density in D. citri is required for successful transmission to citrus plants, and (iii) D. citri attaining the threshold infection level transmits "Ca. Liberibacter asiaticus" to citrus plants in a stochastic manner. These findings provide valuable insights into understanding, predicting, and controlling this notorious citrus pathogen.	[Ukuda-Hosokawa, Rie] Okinawa Prefectural Plant Protect Ctr, Yaeyama Branch Off, Ishigaki, Okinawa, Japan; [Ukuda-Hosokawa, Rie] Okinawa Prefectural Agr Res Ctr, Itoman, Okinawa, Japan; [Sadoyama, Yasutsune] Okinawa Prefectural Plant Protect Ctr, Naha, Okinawa, Japan; [Kishaba, Misaki] Forestry & Fisheries Promot Ctr, Okinawa Prefectural Yaeyama Agr, Ishigaki, Okinawa, Japan; [Kuriwada, Takashi] Kagoshima Univ, Fac Educ, Zool Lab, Kagoshima 890, Japan; [Anbutsu, Hisashi; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Fukatsu, Takema] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Fukatsu, Takema] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	Fukatsu, T (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan.	t-fukatsu@aist.go.jp			Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry and Fishery [21087]	This study was supported by a grant from the Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry and Fishery (no. 21087) to R.U.-H.	Ammar E, 2013, J ECON ENTOMOL, V106, P25, DOI 10.1603/EC12245; Bove JM, 2003, ANNU REV PHYTOPATHOL, V41, P483, DOI 10.1146/annurev.phyto.41.052102.104034; Chiyaka C, 2012, P NATL ACAD SCI USA, V109, P12213, DOI 10.1073/pnas.1208326109; Manjunath KL, 2008, PHYTOPATHOLOGY, V98, P387, DOI 10.1094/PHYTO-98-4-0387; Coletta HD, 2010, EUR J PLANT PATHOL, V126, P53, DOI 10.1007/s10658-009-9523-2; Fukatsu T, 1999, MOL ECOL, V8, P1935, DOI 10.1046/j.1365-294x.1999.00795.x; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Fukatsu T, 1998, APPL ENVIRON MICROB, V64, P3599; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Ammar E, 2011, ANN ENTOMOL SOC AM, V104, P526, DOI 10.1603/AN10134; Nakabachi A, 2013, CURR BIOL, V23, P1478, DOI 10.1016/j.cub.2013.06.027; Anbutsu H, 2003, APPL ENVIRON MICROB, V69, P1428, DOI 10.1128/AEM.69.3.1428-1434.2003; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Teixeira DD, 2005, INT J SYST EVOL MICR, V55, P1857, DOI 10.1099/ijs.0.63677-0; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Ammar ED, 2011, J PHYTOPATHOL, V159, P726, DOI 10.1111/j.1439-0434.2011.01836.x; Bove JM, 2006, J PLANT PATHOL, V88, P7; Garnier M, 2000, INT J SYST EVOL MICR, V50, P2119; Gasparoto MCG, 2012, PLANT PATHOL, V61, P658, DOI 10.1111/j.1365-3059.2011.02569.x; Hall D. G., 2012, ENTOMOL EXP APPL, V146, P207; Kobori Y, 2012, ZOOLOGY, P87; Li WB, 2009, PHYTOPATHOLOGY, V99, P139, DOI 10.1094/PHYTO-99-2-0139; Lopes SA, 2009, PLANT DIS, V93, P257, DOI 10.1094/PDIS-93-3-0257; Mann RS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002610; Meyer JM, 2008, FLA ENTOMOL, V91, P294, DOI 10.1653/0015-4040(2008)91[294:MSOEIF]2.0.CO;2; Nachappa P, 2014, J INVERTEBR PATHOL, V115, P55, DOI 10.1016/j.jip.2013.10.008; Naito T, 2001, B OKINAWA AGR EXP ST, V23, P74; Nakabachi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082612; Ooishi Tsuyoshi, 2006, Kyushu Byogaichu Kenkyukaiho, V52, P66; R Development Core Team, 2010, R LANG ENV STAT COMP; Saha S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050067; Shen WS, 2013, EUR J PLANT PATHOL, V137, P727, DOI 10.1007/s10658-013-0283-7; Shinohara K., 2006, Kyushu Plant Protection Research, V52, P6; Subandiyah S, 2000, ZOOL SCI, V17, P983, DOI 10.2108/zsj.17.983; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Teixeira DC, 2008, MOL CELL PROBE, V22, P139, DOI 10.1016/j.mcp.2007.12.006; Toguchi A, 1997, PLANT PROTECT, V51, P565; Urasaki N., 2007, Japanese Journal of Phytopathology, V73, P25, DOI 10.3186/jjphytopath.73.25; Vilamiu RGD, 2012, AIP CONF PROC, V1479, P2315, DOI 10.1063/1.4756657	46	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JUN	2015	81	11					3728	3736		10.1128/AEM.00707-15		9	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CH3FA	WOS:000353912000018		
J	Imai, Y; Sato, S; Tanaka, Y; Ochi, K; Hosaka, T				Imai, Yu; Sato, Seizo; Tanaka, Yukinori; Ochi, Kozo; Hosaka, Takeshi			Lincomycin at Subinhibitory Concentrations Potentiates Secondary Metabolite Production by Streptomyces spp.	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							BIOSYNTHETIC GENE CLUSTERS; COMPLETE GENOME SEQUENCE; RIBOSOMAL-PROTEIN S12; RARE-EARTH-ELEMENTS; COELICOLOR A3(2); ANTIBIOTIC PRODUCTION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; RPOB MUTATIONS; RNA-POLYMERASE	Antibiotics have either bactericidal or bacteriostatic activity. However, they also induce considerable gene expression in bacteria when used at subinhibitory concentrations (below the MIC). We found that lincomycin, which inhibits protein synthesis by binding to the ribosomes of Gram-positive bacteria, was effective for inducing the expression of genes involved in secondary metabolism in Streptomyces strains when added to medium at subinhibitory concentrations. In Streptomyces coelicolor A3(2), lincomycin at 1/10 of its MIC markedly increased the expression of the pathway-specific regulatory gene actII-ORF4 in the blue-pigmented antibiotic actinorhodin (ACT) biosynthetic gene cluster, which resulted in ACT overproduction. Intriguingly, S. lividans 1326 grown in the presence of lincomycin at a subinhibitory concentration (1/12 or 1/3 of its MIC) produced abundant antibacterial compounds that were not detected in cells grown in lincomycin-free medium. Bioassay and mass spectrometry analysis revealed that some antibacterial compounds were novel congeners of calcium-dependent antibiotics. Our results indicate that lincomycin at subinhibitory concentrations potentiates the production of secondary metabolites in Streptomyces strains and suggest that activating these strains by utilizing the dose-response effects of lincomycin could be used to effectively induce the production of cryptic secondary metabolites. In addition to these findings, we also report that lincomycin used at concentrations for markedly increased ACT production resulted in alteration of the cytoplasmic protein (FoF1 ATP synthase alpha and beta subunits, etc.) profile and increased intracellular ATP levels. A fundamental mechanism for these unique phenomena is also discussed.	[Imai, Yu] Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Nagano, Japan; [Sato, Seizo] Nippon Suisan Kaisha Ltd, Cent Res Lab, Tokyo Innovat Ctr, Tokyo, Japan; [Tanaka, Yukinori; Ochi, Kozo] Hiroshima Inst Technol, Dept Life Sci, Hiroshima, Japan; [Hosaka, Takeshi] Shinshu Univ, Fac Agr, Dept Biosci Biotechnol, Nagano, Japan; [Hosaka, Takeshi] Shinshu Univ, Inst Biomed Sci, Dept Interdisciplinary Genome Sci & Cell Metab, Nagano, Japan	Hosaka, T (reprint author), Shinshu Univ, Fac Agr, Dept Biosci Biotechnol, Nagano, Japan.	thosaka@shinshu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25712008]	This work was financially supported by a grant-in-aid for Young Scientists (A) to T.H. from the Japan Society for the Promotion of Science (JSPS) (no. 25712008).	Amano S, 2010, J ANTIBIOT, V63, P486, DOI 10.1038/ja.2010.68; Amano S, 2011, J ANTIBIOT, V64, P703, DOI 10.1038/ja.2011.69; Herbert S, 2001, INFECT IMMUN, V69, P2996, DOI 10.1128/IAI.69.5.2996-3003.2001; Horinouchi S, 2001, J IND MICROBIOL BIOT, V27, P177, DOI 10.1038/sj.jim.7000068; Hosaka T, 2009, NAT BIOTECHNOL, V27, P462, DOI 10.1038/nbt.1538; Romero D, 2011, CHEM REV, V111, P5492, DOI 10.1021/cr2000509; Laureti L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/pnas.1019077108; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Baltz RH, 2011, J IND MICROBIOL BIOT, V38, P657, DOI 10.1007/s10295-010-0934-z; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Shima J, 1996, J BACTERIOL, V178, P7276; Schroeckh V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/pnas.0901870106; Hosaka T, 2006, MOL MICROBIOL, V61, P883, DOI 10.1111/j.1365-2958.2006.05285.x; Ochi K, 2013, APPL MICROBIOL BIOT, V97, P87, DOI 10.1007/s00253-012-4551-9; Wu MC, 2012, CURR OPIN BIOTECH, V23, P931, DOI 10.1016/j.copbio.2012.03.008; Neary JM, 2007, MICROBIOL-SGM, V153, P768, DOI 10.1099/mic.0.2006/002725-0; Calabrese EJ, 2003, ANNU REV PHARMACOL, V43, P175, DOI 10.1146/annurev.pharmtox.43.100901.140223; Wang GJ, 2008, APPL ENVIRON MICROB, V74, P2834, DOI 10.1128/AEM.02800-07; Senior AE, 2007, CELL, V130, P220, DOI 10.1016/j.cell.2007.07.004; Ochi K, 2004, ADV APPL MICROBIOL, V56, P155, DOI 10.1016/S0065-2164(04)56005-7; Gomez-Escribano JP, 2014, J IND MICROBIOL BIOT, V41, P425, DOI 10.1007/s10295-013-1348-5; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; GRAMAJO HC, 1993, MOL MICROBIOL, V7, P837, DOI 10.1111/j.1365-2958.1993.tb01174.x; Tanaka Y, 2010, J ANTIBIOT, V63, P477, DOI 10.1038/ja.2010.53; Oliynyk M, 2007, NAT BIOTECHNOL, V25, P447, DOI 10.1038/nbt1297; Chiang YM, 2011, CURR OPIN CHEM BIOL, V15, P137, DOI 10.1016/j.cbpa.2010.10.011; Huang JQ, 2001, GENE DEV, V15, P3183, DOI 10.1101/gad.943401; Ochi K, 2014, J IND MICROBIOL BIOT, V41, P403, DOI 10.1007/s10295-013-1349-4; Zhuo Y, 2010, P NATL ACAD SCI USA, V107, P11250, DOI 10.1073/pnas.1006085107; Yamanaka K, 2005, MICROBIOL-SGM, V151, P2899, DOI 10.1099/mic.0.28139-0; Craney A, 2012, CHEM BIOL, V19, P1020, DOI 10.1016/j.chembiol.2012.06.013; Zhu H, 2014, J IND MICROBIOL BIOT, V41, P371, DOI 10.1007/s10295-013-1309-z; Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9; Yoon V, 2014, J IND MICROBIOL BIOT, V41, P415, DOI 10.1007/s10295-013-1387-y; Tanaka Y, 2013, J BACTERIOL, V195, P2959, DOI 10.1128/JB.00147-13; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Nishimura K, 2007, J BACTERIOL, V189, P3876, DOI 10.1128/JB.01776-06; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Smanski MJ, 2009, ANTIMICROB AGENTS CH, V53, P1299, DOI 10.1128/AAC.01358-08; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; Onaka H, 2011, APPL ENVIRON MICROB, V77, P400, DOI 10.1128/AEM.01337-10; Genilloud O, 2014, ANTON LEEUW INT J G, V106, P173, DOI 10.1007/s10482-014-0204-6; Imai Y, 2012, J ANTIBIOT, V65, P323, DOI 10.1038/ja.2012.16; Kieser T., 2000, PRACTICAL STREPTOMYC; Lin JT, 2005, ANTIMICROB AGENTS CH, V49, P1915, DOI 10.1128/AAC.49.5.1915-1926.2005; Meng L, 2011, BIOSCI BIOTECH BIOCH, V75, P1576, DOI 10.1271/bbb.110277; OCHI K, 1987, J BACTERIOL, V169, P3608; Okamoto S, 2003, J BACTERIOL, V185, P601, DOI 10.1128/JB.185.2.601-609.2003; Sabina J, 2003, J BACTERIOL, V185, P6158, DOI 10.1128/JB.185.20.6158-6170.2003; Shibl MA, 1993, REV INFECT DIS, V5, P865; Soga N, 2011, FEBS J, V278, P2647, DOI 10.1111/j.1742-4658.2011.08191.x; Tojo S, 2014, J BACTERIOL, V196, P1514, DOI 10.1128/JB.01441-13; Xu J, 2002, MOL GENET GENOMICS, V268, P179, DOI 10.1007/s00438-002-0730-1; Yanai K, 2006, P NATL ACAD SCI USA, V103, P9661, DOI 10.1073/pnas.0603251103; Yim G, 2006, INT J MED MICROBIOL, V296, P163, DOI 10.1016/j.ijmm.2006.01.039	56	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JUN	2015	81	11					3869	3879		10.1128/AEM.04214-14		11	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CH3FA	WOS:000353912000033		
J	Nakajima, Y; Nedyalkov, N; Takami, A; Terakawa, M				Nakajima, Yasutaka; Nedyalkov, Nikolay; Takami, Akihiro; Terakawa, Mitsuhiro			Formation of periodic metal nanowire grating on silica substrate by femtosecond laser irradiation	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							SURFACE; PULSES; NANOSTRUCTURES; REFRACTION; TITANIUM; FILMS	We demonstrate a method to fabricate isolated metal nanowire gratings on a substrate by using femtosecond (fs) laser. By irradiating fs laser pulses with 500-fs pulse duration, 800 nm in central wavelength at a pulse repetition rate of 1 kHz, to platinum thin films with thicknesses of 48 and 576 nm deposited on fused silica substrates, two different periodicities of ripple structure were formed: the periodicity less than half of the laser wavelength and that comparable to the laser wavelength. Scanning electron microscopy and cross-sectional imaging after milling with focused ion beam revealed that the periodic aligned platinum structures were formed on the surface of a fused silica substrate. Energy-dispersive X-ray spectroscopy and atomic force microscopy supported the demonstration of nanowire gratings in which platinum and fused silica were alternately and periodically exposed. The results demonstrate the formation of isolated platinum nanowire gratings. The presented technique has potential to be used as a simple and high-throughput process for fabrication of plasmonic nanostructures for optical, electrical, and biomedical devices.	[Nakajima, Yasutaka; Terakawa, Mitsuhiro] Keio Univ, Sch Integrated Design Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Nedyalkov, Nikolay] Bulgarian Acad Sci, Inst Elect, BU-1784 Sofia, Bulgaria; [Takami, Akihiro; Terakawa, Mitsuhiro] Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Terakawa, M (reprint author), Keio Univ, Sch Integrated Design Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	terakawa@elec.keio.ac.jp					Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Tokonami S, 2012, ANAL CHIM ACTA, V716, P76, DOI 10.1016/j.aca.2011.12.025; Bonse J, 2013, APPL PHYS A-MATER, V110, P547, DOI 10.1007/s00339-012-7140-y; Henley SJ, 2007, APPL SURF SCI, V253, P8080, DOI 10.1016/j.apsusc.2007.02.132; Podolskiy VA, 2003, OPT EXPRESS, V11, P735, DOI 10.1364/OE.11.000735; Liang F, 2012, OPT EXPRESS, V20, P4389, DOI 10.1364/OE.20.004389; Bonse J, 2012, J LASER APPL, V24, DOI 10.2351/1.4712658; Ahsan MS, 2011, APPL SURF SCI, V257, P7771, DOI 10.1016/j.apsusc.2011.04.027; Smythe EJ, 2007, OPT EXPRESS, V15, P7439, DOI 10.1364/OE.15.007439; KANAYA K, 1972, J PHYS D APPL PHYS, V5, P43, DOI 10.1088/0022-3727/5/1/308; Sakabe S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.033409; Buividas R, 2014, PROG QUANT ELECTRON, V38, P119, DOI 10.1016/j.pquantelec.2014.03.002; Vorobyev AY, 2007, J APPL PHYS, V101, DOI 10.1063/1.2432288; Bonse J, 2005, J APPL PHYS, V97, DOI 10.1063/1.1827919; Gemini L, 2013, J APPL PHYS, V114, DOI 10.1063/1.4832829; Haustrup N, 2013, APPL SURF SCI, V278, P86, DOI 10.1016/j.apsusc.2012.10.201; Haustrup N, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4773301; Nishioka K, 2007, JPN J APPL PHYS 1, V46, P4154, DOI 10.1143/JJAP.46.4154; Petrovic SM, 2013, J APPL PHYS, V114, DOI 10.1063/1.4848016; Scorticati D, 2012, J NANOPHOTONICS, V6, DOI 10.1117/1.JNP.6.063528; Shalaev VM, 2005, OPT LETT, V30, P3356, DOI 10.1364/OL.30.003356; Shinonaga T, 2014, OPT EXPRESS, V22, P14696, DOI 10.1364/OE.22.014696	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	JUN	2015	119	4					1215	1221		10.1007/s00339-015-9166-4		7	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CH7AE	WOS:000354187100004		
J	Ganeev, RA; Suzuki, M; Yoneya, S; Kuroda, H				Ganeev, Rashid A.; Suzuki, Masayuki; Yoneya, Shin; Kuroda, Hiroto			High-order harmonic generation during propagation of the double-pulse beam through the drilled thin films	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							3RD-HARMONIC GENERATION; RARE-GASES; LASER; RADIATION; PROBE; IONS; ZNO	High-order harmonic generation using the femtosecond pulses propagating through the thin (similar to 0.1 mm) drilled films is demonstrated. The harmonics were observed in the case of double-pulse beams while using various films (Mo, In, polyethylene, paper). The harmonics up to the 25th order were generated during propagation through the drilled polyethylene film. The simplicity, absence of additional source of heating radiation, and artificial optimization using the adjustment of the double pulses have shown the possibility in application of this technique for the high-order harmonic generation in thin ablated films.	[Ganeev, Rashid A.; Suzuki, Masayuki; Yoneya, Shin; Kuroda, Hiroto] Saitama Med Univ, Ophthalmol & Adv Laser Med Ctr, Saitama 3500495, Japan	Ganeev, RA (reprint author), Saitama Med Univ, Ophthalmol & Adv Laser Med Ctr, Saitama 3500495, Japan.	rashid_ganeev@mail.ru					Haessler S, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/013051; Ganeev RA, 2006, OPT LETT, V31, P1699, DOI 10.1364/OL.31.001699; Elouga-Bom LB, 2008, J PHYS B-AT MOL OPT, V41, DOI 10.1088/0953-4075/41/21/215401; AKIYAMA Y, 1992, PHYS REV LETT, V69, P2176, DOI 10.1103/PhysRevLett.69.2176; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Ganeev RA, 1997, OPT COMMUN, V135, P251, DOI 10.1016/S0030-4018(96)00633-5; Ganeev RA, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4875738; Pertot Y, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3558999; WAHLSTROM CG, 1995, PHYS REV A, V51, P585, DOI 10.1103/PhysRevA.51.585; Haessler S, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/7/074012; Singhal H, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.023807; NOSAKA Y, 1993, J APPL POLYM SCI, V47, P1773, DOI 10.1002/app.1993.070471007; Petrov GI, 2003, APPL PHYS LETT, V83, P3993, DOI 10.1063/1.1623948; Narayanan V, 2006, OPT COMMUN, V260, P170, DOI 10.1016/j.optcom.2005.09.073; Kumar M, 2013, J APPL PHYS, V114, DOI 10.1063/1.4816253; FERRAY M, 1988, J PHYS B-AT MOL OPT, V21, pL31, DOI 10.1088/0953-4075/21/3/001; Elouga Bom L B, 2011, Opt Express, V19, P3077, DOI 10.1364/OE.19.003077; KHANARIAN G, 1993, APPL PHYS LETT, V63, P1462, DOI 10.1063/1.109656; Konorov S, 2003, J OPT A-PURE APPL OP, V5, P362, DOI 10.1088/1464-4258/5/4/309; Konorov SO, 2003, J RAMAN SPECTROSC, V34, P1018, DOI 10.1002/jrs.1080; MCPHERSON A, 1987, J OPT SOC AM B, V4, P595, DOI 10.1364/JOSAB.4.000595	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	JUN	2015	119	4					1231	1236		10.1007/s00339-015-9160-x		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CH7AE	WOS:000354187100006		
J	Amara, EH; Kheloufi, K; Tamsaout, T; Fabbro, R; Hirano, K				Amara, E. H.; Kheloufi, K.; Tamsaout, T.; Fabbro, R.; Hirano, K.			Numerical investigations on high-power laser cutting of metals	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							DROSS FORMATION; INERT-GAS; MELT; DYNAMICS; SHEETS; MODEL; FLOW	A theoretical approach based on a numerical simulation using experimental data is proposed as a contribution for the study of laser metal cutting under gas assistance. The aim is to simulate the stages of the kerf formation by considering the induced generated melt film dynamics, while it interacts with the laser beam and the assisting gas jet. For normal atmospheric conditions, a 3D model is developed using the finite volume method to solve the governing hydrodynamic equations, supplied with the species conservation equation. The present air, the metallic liquid, and the solid metal are considered as phases, where the interface positions are tracked by implementation of the volume-of-fluid method through Fluent CFD code, whereas an enthalpic method is used to take into account the material melting and resolidification. The results for six operating conditions in relation to the cutting velocity show an interesting agreement with the experimental observations.	[Amara, E. H.; Kheloufi, K.; Tamsaout, T.] Ctr Dev Technol Avancees, Laser Mat Proc Team, Algiers 16303, Algeria; [Fabbro, R.] Arts & Metiers ParisTech, Lab Proc & Ingn Mecan & Mat, F-75013 Paris, France; [Hirano, K.] Nippon Steel Corp Ltd, Chiyoda Ward, Tokyo 1008071, Japan	Amara, EH (reprint author), Ctr Dev Technol Avancees, Laser Mat Proc Team, POB 17, Algiers 16303, Algeria.	amara@cdta.dz					Tani G, 2003, APPL SURF SCI, V208, P142, DOI 10.1016/S0169-4332(02)01353-3; Kaplan AFH, 1996, J APPL PHYS, V79, P2198, DOI 10.1063/1.361098; Yilbas BS, 1997, HEAT MASS TRANSFER, V32, P175, DOI 10.1007/s002310050109; Zaitsev AV, 2005, QUANTUM ELECTRON+, V35, P200, DOI 10.1070/QE2005v035n02ABEH002728; HIRT CW, 1981, J COMPUT PHYS, V39, P201, DOI 10.1016/0021-9991(81)90145-5; VICANEK M, 1987, J PHYS D APPL PHYS, V20, P140, DOI 10.1088/0022-3727/20/1/021; VOLLER VR, 1987, INT J NUMER METH ENG, V24, P271, DOI 10.1002/nme.1620240119; SCHULZ W, 1987, J PHYS D APPL PHYS, V20, P481, DOI 10.1088/0022-3727/20/4/013; Yilbas BS, 2006, J PHYS D APPL PHYS, V39, P1451, DOI 10.1088/0022-3727/39/7/017; BRACKBILL JU, 1992, J COMPUT PHYS, V100, P335, DOI 10.1016/0021-9991(92)90240-Y; Otto A, 2010, PHYSCS PROC, V5, P35, DOI 10.1016/j.phpro.2010.08.120; Dahotre N. B., 2008, LASER FABRICATION MA; Duley W.W., 1976, CO2 LASERS EFFECTS A, P132; Golubev V.S., 2004, EPRINT 3; Hirano K, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/10/105502; Hirano K., 2012, THESIS PARISTECH; Kohl S., 2013, P ICALEO 2013 MIAM F, pUSA; Lampa C, 1998, LASER ENG, V7, P241; Lide D. R., 2004, CRC HDB CHEM PHYS; Makashev N. K., 1992, Soviet Journal of Quantum Electronics, V22, DOI 10.1070/QE1992v022n09ABEH003612; MAKASHEV NK, 1994, P SOC PHOTO-OPT INS, V2257, P2, DOI 10.1117/12.171629; Mazhukin V. I., 1994, Surveys on Mathematics for Industry, V4; Petring D., 1988, P SOC PHOTO-OPT INS, V1020, P123; Rajpurohit S. R., 2012, INT J ENG RES APPL, V2, P457; Rasheed J.H., 2013, PURE SCI, V9, P14; Ready J.F., 1997, IND APPL LASERS; Schulz W., 1989, P EUR SCI LAS WORKSH; Schuocker D., 1987, P SOC PHOTO-OPT INS, V801, P258; SCHUOCKER D, 1986, APPL PHYS B-PHOTO, V40, P9, DOI 10.1007/BF00697221; Sutherland W, 1893, PHILOS MAG, V36, P507, DOI [DOI 10.1080/14786449308620508, 10.1080/14786449308620508]; Teixidor D, 2014, INT J ADV MANUF TECH, V71, P1611, DOI 10.1007/s00170-013-5599-0; Toyerskani E., 2002, P ICALEO 2012 SCOTTS; VICANEK M, 1987, J PHYS D APPL PHYS, V20, P1191, DOI 10.1088/0022-3727/20/9/016; Wee LM, 2008, INT J ADV MANUF TECH, V36, P699, DOI 10.1007/s00170-006-0888-5	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	JUN	2015	119	4					1245	1260		10.1007/s00339-015-9154-8		16	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CH7AE	WOS:000354187100008		
J	Sathishkumar, K; Chandrasekaran, J; Babu, B; Sathish, CI; Matsushita, Y				Sathishkumar, K.; Chandrasekaran, J.; Babu, B.; Sathish, Clastin I.; Matsushita, Yoshitaka			Synthesis, growth, and characterization of bis (potassium) 2,4-dinitrophenolate monohydrate (BPDNP): a new third harmonic generation material	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							NONLINEAR-OPTICAL PROPERTIES; SODIUM P-NITROPHENOLATE; SINGLE-CRYSTAL; NLO CRYSTAL; 4-NITROPHENOLATE 4-NITROPHENOL; ELECTRICAL-PROPERTIES; THERMAL-PROPERTIES; HYDROXYBENZOATE; DERIVATIVES; DIHYDRATE	Novel semi-organic single crystals of bis (potassium) 2,4-dinitrophenolate monohydrate were grown by slow evaporation technique at room temperature. Single-crystal XRD confirms that the crystal belongs to monoclinic system with space group C2/c. H-1 NMR and C-13 NMR studies were conducted for the crystal. In order to know the purity, LC-MS studies were also conducted for the crystal. Functional groups present in the synthesized compound were confirmed by FT-IR analysis. UV-Vis studies show that the crystal has a lower cutoff wave length at 461 nm. Dielectric studies were carried out to study the charge transport mechanism in the crystal. Photoconductivity study exhibits the positive photoconductivity nature of the grown crystal. Nonlinear absorption coefficient (beta), nonlinear refraction (n (2)), and third-order susceptibility (chi ((3))) were also evaluated for the grown crystal.	[Sathishkumar, K.; Chandrasekaran, J.; Babu, B.] Sri Ramakrishna Mission Vidyalaya Coll Arts & Sci, Dept Phys, Coimbatore 641020, Tamil Nadu, India; [Sathish, Clastin I.] Natl Inst Mat Sci, Superconducting Properties Unit, Tsukuba, Ibaraki 3050044, Japan; [Matsushita, Yoshitaka] Natl Inst Mat Sci, Mat Anal Stn, Tsukuba, Ibaraki 3050044, Japan	Chandrasekaran, J (reprint author), Sri Ramakrishna Mission Vidyalaya Coll Arts & Sci, Dept Phys, Coimbatore 641020, Tamil Nadu, India.	jchandaravind@yahoo.com			DST, Government of India [SB/EMEQ-293/2013]	The authors gratefully acknowledge the financial support from the DST, Government of India, for the major research project (SB/EMEQ-293/2013). Also, the authors thank Prof. D. Sastikumar, NIT, Trichy, for extending Z-scan facilities.	Chen TL, 2012, CRYST GROWTH DES, V12, P2673, DOI 10.1021/cg300262t; Senthil S, 2009, PHYSICA B, V404, P1655, DOI 10.1016/j.physb.2009.01.042; Kandasamy A, 2007, CRYST GROWTH DES, V7, P183, DOI 10.1021/cg060446c; Boaz BM, 2005, J CRYST GROWTH, V279, P383, DOI 10.1016/j.jcrysgro.2005.02.039; Shanmugam G, 2013, J THERM ANAL CALORIM, V114, P1245, DOI 10.1007/s10973-013-3156-6; Brahadeeswaran S, 1999, J CRYST GROWTH, V205, P548, DOI 10.1016/S0022-0248(99)00302-4; Chandrasekaran J, 2013, OPTIK, V124, P4296, DOI 10.1016/j.ijleo.2013.01.041; D'silva ED, 2012, MATER RES BULL, V47, P3552, DOI 10.1016/j.materresbull.2012.06.063; Babu B, 2014, MATER SCI-POLAND, V32, P164, DOI 10.2478/s13536-013-0176-7; Prakash M, 2012, MATER MANUF PROCESS, V27, P519, DOI 10.1080/10426914.2011.593228; SHEIKBAHAE M, 1990, IEEE J QUANTUM ELECT, V26, P760, DOI 10.1109/3.53394; Babu GA, 2009, MATER CHEM PHYS, V117, P326, DOI 10.1016/j.matchemphys.2009.06.011; Muthuraman M, 1999, J MATER CHEM, V9, P1471, DOI 10.1039/a900613c; Babu B, 2013, MATER SCI-POLAND, V31, P151, DOI 10.2478/s13536-012-0082-4; Shanmugam G, 2013, SPECTROCHIM ACTA A, V114, P284, DOI 10.1016/j.saa.2013.05.070; Krishnakumar V, 2012, PHYSICA B, V407, P1119, DOI 10.1016/j.physb.2012.01.084; Shanmugam G, 2013, SPECTROCHIM ACTA A, V106, P175, DOI 10.1016/j.saa.2013.01.006; Arjunan S, 2012, MATER MANUF PROCESS, V27, P49, DOI 10.1080/10426914.2011.551907; Bube R. H, 1981, PHOTOCONDUCTIVITY SO; Dhanuskodi S, 2011, J MATER SCI, V46, P3169, DOI 10.1007/s10853-010-5200-2; Farrugia L. J., 1999, J APPL CRYSTALLOGR, V32, P837, DOI DOI 10.1107/S0021889899006020; Joshi V.N., 1990, PHOTOCONDUCTIVITY; Kamath L, 2014, OPT LASER TECHNOL, V56, P425, DOI 10.1016/j.optlastec.2013.09.025; Kannan V, 2013, J MOL STRUCT, V1049, P268, DOI 10.1016/j.molstruc.2013.06.055; Prasad L.G., 2010, PHYSICA B, V405, P1652, DOI DOI 10.1016/J.PHYSB.2009.12.062; Prasad L. Guru, 2013, Spectrochimica Acta, Part A (Molecular and Biomolecular Spectroscopy), V110, DOI 10.1016/j.saa.2013.03.014; Ramajothi J, 2006, J CRYST GROWTH, V289, P217, DOI 10.1016/j.jerysgro.2005.10.103; SADABS, 2001, EMP ABS CORR PROGR; SAINT, 2001, DAT RED CORR PROGR; Santhakumari R, 2011, SPECTROCHIM ACTA A, V78, P653, DOI 10.1016/j.saa.2010.11.043; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SMART, 2001, MOL AN RES TOOL; Uthrakumar R, 2010, PHYSICA B, V405, P4274, DOI 10.1016/j.physb.2010.07.024; Vanishri S, 2005, J CRYST GROWTH, V275, pE141, DOI 10.1016/j.jcrysgro.2004.10.102	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	JUN	2015	119	4					1355	1364		10.1007/s00339-015-9103-6		10	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CH7AE	WOS:000354187100020		
J	Ishikawa, S; Yamabe, T				Ishikawa, Shigeru; Yamabe, Tokio			The potential energy curve and Langmuir isotherm of hydrogen adsorption by a truncated carbon sphere	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							STORAGE MEDIA; NANOTUBES; SIZE; SIMULATIONS; NANOPORES	The potential energy curve for the adsorption of a hydrogen molecule by a truncated hollow sphere consisting of carbon atoms was evaluated by using the Lennard-Jones function for the pair interaction between a carbon atom and a hydrogen molecule. The sphere surface was regarded as a continuum with a uniform density identical to that of a graphite layer. The lower limit of the potential was found to be -200 meV when the sphere had a radius of 3.4 and no opening. By increasing the radius of the opening to 2.9 , the energy barrier for an incoming molecule disappeared and the lower limit increased to -150 meV, which is three times as deep as that observed for a graphite surface. The Langmuir isotherm for the truncated sphere of this size was evaluated based on the eigenvalues of the potential curve. We found that the pressure yielding a half occupancy was < 50 bar at a temperature below 250 K. This indicates that a carbon pore with this shape and size can store a hydrogen molecule under mild conditions.	[Ishikawa, Shigeru] Tokai Univ, Dept Chem, Fac Sci, Hiratsuka, Kanagawa 2591292, Japan; [Yamabe, Tokio] Nagasaki Inst Appl Sci, Nagasaki 8510193, Japan	Ishikawa, S (reprint author), Tokai Univ, Dept Chem, Fac Sci, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.	sisikawa@keyaki.cc.u-tokai.ac.jp					Hirscher M, 2001, APPL PHYS A-MATER, V72, P129, DOI 10.1007/s003390100816; Wang QY, 1999, J CHEM PHYS, V110, P577, DOI 10.1063/1.478114; Deng WQ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.166103; Eberle U, 2009, ANGEW CHEM INT EDIT, V48, P6608, DOI 10.1002/anie.200806293; Alonso JA, 2012, J MEX CHEM SOC, V56, P261; Cheng HS, 2005, J PHYS CHEM B, V109, P3780, DOI 10.1021/jp045358m; DAVID WIF, 1991, NATURE, V353, P147, DOI 10.1038/353147a0; Thomas KM, 2007, CATAL TODAY, V120, P389, DOI 10.1016/j.cattod.2006.09.015; Bhatia SK, 2006, LANGMUIR, V22, P1688, DOI 10.1021/la0523816; Benard P, 2001, LANGMUIR, V17, P1950, DOI 10.1021/la001381x; Cabria I, 2007, CARBON, V45, P2649, DOI 10.1016/j.carbon.2007.08.003; Fan WJ, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3158597; HAN SS, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2133928; Ishikawa S, 2010, APPL PHYS A-MATER, V99, P29, DOI 10.1007/s00339-010-5571-x; Ishikawa S, 2014, APPL PHYS A-MATER, V114, P1339, DOI 10.1007/s00339-013-7978-7; Knippenberg MT, 2006, J PHYS CHEM B, V110, P22957, DOI 10.1021/jp0647737; Kowalczyk P, 2007, LANGMUIR, V23, P3666, DOI 10.1021/la062572o; Kubo R., 2004, STAT MECH; Kuchta B, 2010, CARBON, V48, P223, DOI 10.1016/j.carbon.2009.09.009; MATTERA L, 1980, SURF SCI, V93, P515, DOI 10.1016/0039-6028(80)90279-4; Mpourmpakis G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2717170; Murata Y, 2001, J ORG CHEM, V66, P8187, DOI 10.1021/jo010798k; Murata Y, 2003, J AM CHEM SOC, V125, P7152, DOI 10.1021/ja0354162; Patchkovskii S, 2005, P NATL ACAD SCI USA, V102, P10439, DOI 10.1073/pnas.0501030102; Steele W.A., 1974, INTERACTION GASES SO; Stone A. J., 2002, THEORY INTERMOLECULA; Weng CI, 2007, COMP MATER SCI, V40, P300, DOI 10.1016/j.commatsci.2007.01.005; Yamabe T, 2004, SYNTHETIC MET, V145, P31, DOI 10.1016/j.synthmet.2004.03.014	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	JUN	2015	119	4					1365	1372		10.1007/s00339-015-9107-2		8	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CH7AE	WOS:000354187100021		
J	Nath, SKD				Nath, S. K. Deb			Adhesion and spreading of Ag nanoparticles on SiO2 substrates by molecular dynamics simulation	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							POLYMER PARTICLES; TEMPERATURE; SURFACES; SCALE; GROWTH; SIZE; FILM	To validate the present theoretical study of the adhesion and spreading of Ag nanoparticles on a SiO2 substrate, the pull-off force of Ag nanoparticles from a SiO2 substrate and optimum temperature required to make uniform thin Ag film on a SiO2 obtained by the present study are compared to those of experimental studies. Effects of Ag nanoparticle size and temperature on the pull-off force from the SiO2 substrate are studied using molecular dynamics simulations to understand the stability of Ag nanoparticles on a SiO2 substrate because the smoothness of its surface depends on the stability of Ag nanoparticles due to the application of the external force during its operation. During lateral sliding of Ag nanoparticle on a SiO2 substrate, a resistance force is developed which depends on the resultant adhesive force along the lateral direction of the SiO2 substrate. Effects of sizes of Ag nanoparticle on the lateral adhesive force are studied during sliding on a SiO2 substrate. Due to the dispersive adhesive force, Ag nanoparticle spreads on the SiO2 substrate. Effects of temperature on the spreading phenomenon of Ag nanoparticle on a SiO2 substrate are also studied.	[Nath, S. K. Deb] Kongju Natl Univ, Div Mech & Automot Engn, Cheonan, South Korea; [Nath, S. K. Deb] Tohoku Univ, Inst Mat Res, Computat Mat Res Initiat, Sendai, Miyagi 9808577, Japan	Nath, SKD (reprint author), Kongju Natl Univ, Div Mech & Automot Engn, Cheonan, South Korea.	sankar_20005@yahoo.com					Bradley JC, 2002, J ELECTROANAL CHEM, V522, P75, DOI 10.1016/S0022-0728(02)00662-9; Joo S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/5/055204; Katainen J, 2006, J COLLOID INTERF SCI, V304, P524, DOI 10.1016/j.jcis.2006.09.015; Sahu DR, 2006, THIN SOLID FILMS, V515, P932, DOI 10.1016/j.tsf.2006.07.061; Matveeva EG, 2007, ANAL BIOCHEM, V363, P239, DOI 10.1016/j.ab.2007.01.030; AGRAIT N, 1995, PHYS REV LETT, V74, P3995, DOI 10.1103/PhysRevLett.74.3995; DAW MS, 1984, PHYS REV B, V29, P6443, DOI 10.1103/PhysRevB.29.6443; Blaker JJ, 2004, BIOMATERIALS, V25, P1319, DOI 10.1016/j.biomaterials.2003.08.007; Bowling R.A., 1988, PARTICLES SURFACES, V1, P129; DERJAGUIN BV, 1984, POWDER TECHNOL, V37, P87, DOI 10.1016/0032-5910(84)80008-X; DERJAGUI.BV, 1969, POWDER TECHNOL, V2, P154, DOI 10.1016/0032-5910(69)80003-3; DERJAGUIN BV, 1976, J COLLOID INTERF SCI, V54, P59, DOI 10.1016/0021-9797(76)90285-X; Galashev A.E., 2011, COLLOID J RUSS ACAD+, V73, P764; Gautam A, 2007, SYNTHETIC MET, V157, P5, DOI 10.1016/j.synthmet.2006.11.009; Hozumi A, 2007, LANGMUIR, V23, P3265, DOI 10.1021/la0614051; Joo S, 2010, IEEE T ELECTRON PACK, V33, P129, DOI 10.1109/TEPM.2010.2044887; Kang B, 2014, J APPL PHYS, V115, DOI 10.1063/1.4865272; Krupp H., 1967, ADV COLLOID INTERFAC, V1, P111; Lee CY, 2007, MAT SCI ENG A-STRUCT, V467, P125, DOI 10.1016/j.msea.2007.02.077; Munetoh S, 2001, PHYS REV LETT, V86, P4879, DOI 10.1103/PhysRevLett.86.4879; NATH SKD, 2013, INT J NONCRYST SOLID, V376, P50; OVERBEEK JTG, 1952, J COLL SCI IMP U TOK, V7, P343, DOI 10.1016/0095-8522(52)90080-9; Piedade AP, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105103; Qi WH, 2002, J MATER SCI LETT, V21, P1743, DOI 10.1023/A:1020904317133; Raffi M, 2006, MATER CHEM PHYS, V99, P405, DOI 10.1016/j.matchemphys.2005.11.012; Roy D, 2004, ADV MATER, V16, P479, DOI 10.1002/adma.200306195; Singh N, 2006, REV ANAL CHEM, V25, P307; Vechio A.L.D., 2007, J APPL PHYS, V101; VOLD MJ, 1954, J COLL SCI IMP U TOK, V9, P451, DOI 10.1016/0095-8522(54)90032-X	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	JUN	2015	119	4					1379	1385		10.1007/s00339-015-9110-7		7	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CH7AE	WOS:000354187100023		
J	Inoue, T; Morimoto, T; Ohki, Y				Inoue, Takahiro; Morimoto, Takaaki; Ohki, Yoshimichi			Experimental observations on the crystalline structures of YAlO3 single crystal at high temperatures	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							YTTRIUM-ALUMINUM-GARNET	To understand the effects of thermal annealing on a high-permittivity gate insulating material YAlO3, its single crystal was annealed at various high temperatures ranging from 900 to 1300 A degrees C and was examined by various instrumental analyses such as X-ray diffraction, infrared absorption spectroscopy, laser confocal microscopy, and atomic force microscopy. As a result, it was clarified that the crystalline YAlO3 takes at least three structures in a temperature range up to 1300 A degrees C. Namely, it is perovskite below 1160 A degrees C, at which the garnet structure starts to appear, while an unknown structure appears at 1250 A degrees C. On the other hand, the sample surface also shows drastic changes if the temperature exceeds 1160 A degrees C. Furthermore, many elliptical spots are induced after the annealing at 1200 or 1250 A degrees C. Moreover, hydroxyl groups are generated at 1300 A degrees C. It is desirable to take these structural changes into account in determining the annealing temperature of YAlO3 for various industrial purposes such as the manufacture of semiconductor devices.	[Inoue, Takahiro; Morimoto, Takaaki; Ohki, Yoshimichi] Waseda Univ, Dept Elect Engn & Biosci, Tokyo 1698555, Japan; [Ohki, Yoshimichi] Waseda Univ, Res Inst Mat Sci & Technol, Tokyo 1698555, Japan	Inoue, T (reprint author), Waseda Univ, Dept Elect Engn & Biosci, Tokyo 1698555, Japan.	t.kiwoku@fuji.waseda.jp; yohki@waseda.jp			Power Academy; JSPS [25-3090]; Research Institute for Science and Engineering, Waseda University; Mitsubishi Materials Corporation; "Early Bird"	Part of this research was supported by Power Academy and JSPS Grant 25-3090 for JSPS Fellows. It was also supported by Research Institute for Science and Engineering, Waseda University, through the ENEOS Research Encouragement Prize and grants from Mitsubishi Materials Corporation and "Early Bird" for young researchers.	ABELL JS, 1974, J MATER SCI, V9, P527, DOI 10.1007/BF00551870; Morimoto T, 2008, JPN J APPL PHYS, V47, P6858, DOI 10.1143/JJAP.47.6858; Egilsson T, 1999, PHYS REV B, V59, P8008, DOI 10.1103/PhysRevB.59.8008; Agarwal AK, 1997, IEEE ELECTR DEVICE L, V18, P586, DOI 10.1109/55.644079; Hirata E, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.091102; Mathur S, 2004, J MATER CHEM, V14, P3259, DOI 10.1039/b406760f; Gervais M, 1997, MAT SCI ENG B-SOLID, V45, P108, DOI 10.1016/S0921-5107(96)02032-6; Han KR, 1999, J AM CERAM SOC, V82, P1598; Harima M., 2014, IEE JPN P INT S EL I, V180; Hornberger J., 2004, IEEE AER C MAR, V4, P2538; Hosoi T., 2012, IEEE INT ELECT DEVIC, V12, P159; Johnson CM, 2001, IEE P-CIRC DEV SYST, V148, P101, DOI 10.1049/ip-cds:20010166; Morimoto T., 2014, J I ENG ELECT DISCH, V57, P3; Neudeck PG, 1997, IEEE ELECTR DEVICE L, V18, P96, DOI 10.1109/55.556092; Nomura K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.021502; Ohwaki T., 2000, KOBE STEEL ENG REPOR, V50, P70; Shevlin SA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.146401; Shirai T, 2008, MATER SCI ENG B-ADV, V148, P221, DOI 10.1016/j.mseb.2007.09.033; Sim SM, 2000, J MATER SCI, V35, P713, DOI 10.1023/A:1004709401795; Singh V, 2010, APPL PHYS B-LASERS O, V98, P407, DOI 10.1007/s00340-009-3750-2; Watanabe H., 2011, APPL PHYS LETT, V99; Wilk D.G., 2000, J APPL PHYS, V87, P484; Yamasaka D., 2011, J APPL PHYS, V110; Yamasaka D, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.071501; Zhang QW, 2003, POWDER TECHNOL, V129, P86, DOI 10.1016/S0032-5910(02)00136-5; Zhao T., 2007, IEEE EL SHIP TECHN S, V145; Zorenko YV, 2004, OPT SPECTROSC+, V96, P532, DOI 10.1134/1.1719141	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	JUN	2015	119	4					1423	1429		10.1007/s00339-015-9115-2		7	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CH7AE	WOS:000354187100028		
J	Mizota, C; Yamanaka, T; Ichinose, A				Mizota, C.; Yamanaka, T.; Ichinose, A.			THE PROVENANCE OF HISTORICAL GUNPOWDER FROM SOUTH-WESTERN JAPAN: A STABLE ISOTOPIC APPROACH	ARCHAEOMETRY			English	Article						Gunpowder ingredients; Later 19th century; World ammunition market; Stable isotope; South-western Japan	NATIONAL-PARK; NITROGEN; NITRATE; CIRCULATION; GROUNDWATER; CALIFORNIA; ORIGINS; SULFUR; CARBON	Stable isotopic analysis was undertaken for the gunpowder ingredients from crude saltpetre and propellants from several types of gun that prevailed during the late 19th century in south-western Japan. Stable isotopic signatures for N-15(saltpetre nitrogen), S-34(native sulphur) and C-13(charcoal) (carbon) in crude saltpetre, gunpowder magazines bearing the trademark of mills from southern Scotland and cartridges for an improved Sharps rifle (with a US trademark) all imply common assemblages from the same source (saltpetre and native sulphur from British India and Sicily, respectively) in the United Kingdom (UK). One Pritchett patron is common for muzzle-loading Enfield rifles, while the other suggests a four-allied lead bullet for an unidentified hand gun. Propellants in the Pritchett patron from the same institution also suggest a common source of these rifles. On the contrary, the ingredients for an unidentified rifle and time fuse for a Paixhans gun with unique stylistic devices showed distinctive isotopic signatures, indicating a local Japanese origin. The Pritchett patron from the Kumamoto Museum involved a mixed provenance from the UK and Japan. The stable isotopic analysis provides direct evidence for the ultimate origin of the propellant.	[Mizota, C.] Beppu Univ, Res Inst Cultural Properties, Beppu, Oita 8748501, Japan; [Yamanaka, T.] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Earth Sci, Kita Ku, Okayama 7008530, Japan; [Ichinose, A.] Hist Museum, Saga 8438799, Japan	Mizota, C (reprint author), Beppu Univ, Res Inst Cultural Properties, Kita Ishigaki 82, Beppu, Oita 8748501, Japan.	mizota@iwate-u.ac.jp					JACKS G, 1983, ENVIRON GEOL, V5, P61; Suthar S, 2009, J HAZARD MATER, V171, P189, DOI 10.1016/j.jhazmat.2009.05.111; Bohlke JK, 1997, CHEM GEOL, V136, P135, DOI 10.1016/S0009-2541(96)00124-6; Mizota C, 2014, J ARCHAEOL SCI, V45, P90, DOI 10.1016/j.jas.2014.01.025; Gentile N, 2009, RAPID COMMUN MASS SP, V23, P2559, DOI 10.1002/rcm.4134; Codron J, 2005, J ARCHAEOL SCI, V32, P1757, DOI 10.1016/j.jas.2005.06.006; Datta PS, 1997, J CONTAM HYDROL, V27, P249, DOI 10.1016/S0169-7722(96)00099-X; UEDA A, 1979, GEOCHEM J, V13, P269; Pavuluri CM, 2010, ATMOS ENVIRON, V44, P3597, DOI 10.1016/j.atmosenv.2010.05.039; Benson S, 2006, FORENSIC SCI INT, V157, P1, DOI 10.1016/j.forsciint.2005.03.012; Balasubramaniam R., 2005, INDIAN J HIST SCI, V40, P663; Buchanan B. J, 2006, GUNPOWER EXPLOSIVES, P67; Cressy D, 2011, PAST PRESENT, P73, DOI 10.1093/pastj/gtr006; Dessau G., 1962, ECON GEOL, V57, P410; FitzGerald W. G, 1895, THE STRAND MAGAZINE, V9, P307; Frey JW, 2009, HISTORIAN, V71, P507; Goodenough R. A., 1868, NOTES ON GUNPOWDER, P1; GRAY E, 1982, J MATER SCI, V17, P3385, DOI 10.1007/BF00752183; Hall B. S., 1997, WEAPONS WARFARE RENA, P69; HEATON THE, 1987, S AFR J SCI, V83, P118; Hora T., 1991, GUNS TRANSMISSION IT; Hutchinson C. M., 1917, BULLETIN, V68, P1; Isomura T., 2006, INTRO GUNS JAPANESE, P114; Itagaki E., 2010, B JAPAN SEA RES I KA, V41, P53; Itagaki E., 2002, ANN RES I JAPAN SEA, V33, P111; Itagaki E., 2002, ANN RES I JAPAN SEA, V33, P129; Janik CJ, 2010, J VOLCANOL GEOTH RES, V189, P257, DOI 10.1016/j.jvolgeores.2009.11.014; Leather J. W., 1911, BULLETIN, V24, P1; Lien A. Y., 1991, STABLE ISOTOPES NATU, P91; LUNDY WT, 1950, IND ENG CHEM, V42, P2199, DOI 10.1021/ie50491a014; Marshall A, 1917, EXPLOSIVES, V1, P73; Mashima M, 1982, GEKKAN REKISHI TECHO, V10, P43; Mizota C., 2014, ARCHAEOMETR IN PRESS; Mormino V., 2004, SULFUR IN SICILY; National Museum of Japanese History, 2006, INTR GUNS JAP HIST, V147; National Museum of Japanese History, 2006, INTR GUNS JAP HIST, V131; Pagano R., 2012, MINERALOGICAL RECORD, V43, P161; Robinson D, 2001, TRENDS ECOL EVOL, V16, P153, DOI 10.1016/S0169-5347(00)02098-X; Sandler A, 1997, J GEOL, V105, P754; SCHOEN R, 1970, SCIENCE, V170, P1082, DOI 10.1126/science.170.3962.1082; Takeo Historical Museum, TAK NAB OLD DOC SER; Tokoro S., 1971, STUDY HIST GUNS; Turney CSM, 2006, GEOCHIM COSMOCHIM AC, V70, P960, DOI 10.1016/j.gca.2005.10.031	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-813X	1475-4754		ARCHAEOMETRY	Archaeometry	JUN	2015	57	3					582	596		10.1111/arcm.12141		15	Archaeology; Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Geosciences, Multidisciplinary	Archaeology; Chemistry; Geology	CH3WD	WOS:000353960500009		
J	Hayashi, K; Itoh, H				Hayashi, Kaori; Itoh, Hiroshi			Transcription Factors and Epigenetic Modulation: Its Therapeutic Implication in Chronic Kidney Disease	ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS			English	Review						Chronic kidney disease; Epigenetics; DNA methylation; Histone modification; Transcription factors	PLURIPOTENT STEM-CELLS; HISTONE DEACETYLASE INHIBITOR; DNA METHYLATION; ATTENUATES PROTEINURIA; FIBROBLAST ACTIVATION; EXPRESSION; FIBROSIS; INJURY; HYPERMETHYLATION; GENERATION	Recently emerging evidence has shown that epigenetic mechanisms are involved in initiation and progression of various diseases, including kidney diseases. In the present article, we review the current data regarding the role of epigenetic modulation in chronic kidney disease (CKD) and kidney fibrosis, including DNA methylation and histone modification. Especially we focused on the role of transcription factors in epigenetic modulation and the possibility of therapeutic target of CKD. We have recently reported that transcription factor Kruppel-like factor 4 (also known as gut-enriched Kruppel-like factor) is expressed in kidney podocytes (visceral epithelial cells) and modulates podocyte phenotype by gene-selective epigenetic control. Targeting transcription factors for epigenetic modification may be a good candidate for remission and regression of CKD. It is necessary for the therapy of CKD with an epigenetic-based approach to investigate organ-, tissue-, or gene-specific treatment methods for reduction of side effects.	[Hayashi, Kaori; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo 1608582, Japan	Hayashi, K (reprint author), Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kaorihayashi@a3.keio.jp					Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Smyth LJ, 2014, EPIGENETICS-US, V9, P366, DOI 10.4161/epi.27161; Van Beneden K, 2011, J AM SOC NEPHROL, V22, P1863, DOI 10.1681/ASN.2010111196; Tampe B, 2014, J AM SOC NEPHROL, V25, P905, DOI 10.1681/ASN.2013070723; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Sun GD, 2010, J AM SOC NEPHROL, V21, P2069, DOI 10.1681/ASN.2010060633; Hayashi K, 2014, J CLIN INVEST, V124, P2523, DOI 10.1172/JCI69557; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Ingrosso D, 2003, LANCET, V361, P1693, DOI 10.1016/S0140-6736(03)13372-7; Sun XF, 2013, EUR J PHARMACOL, V707, P147, DOI 10.1016/j.ejphar.2013.03.018; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Hervouet E, 2009, EPIGENETICS, V4, P487; Zhong YF, 2013, J AM SOC NEPHROL, V24, P801, DOI 10.1681/ASN.2012060590; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Deelman LE, 2010, ADV DRUG DELIVER REV, V62, P1369, DOI 10.1016/j.addr.2010.10.002; Azuma M, 2012, FASEB J, V26, P4264, DOI 10.1096/fj.12-211631; Shimizu H, 2010, J AM SOC NEPHROL, V21, P622, DOI 10.1681/ASN.2009030295; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Sun CY, 2012, KIDNEY INT, V81, P640, DOI 10.1038/ki.2011.445; Cosentino CC, 2013, J AM SOC NEPHROL, V24, P943, DOI 10.1681/ASN.2012111055; Hauser PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009463; Kinugasa F, 2010, TRANSPL IMMUNOL, V23, P18, DOI 10.1016/j.trim.2010.02.003; Lefevre GM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001142; Liu N, 2013, PLOS ONE, V8; Marumo T, 2010, AM J PHYSIOL-RENAL, V298, pF133, DOI 10.1152/ajprenal.00400.2009; Nanayakkara PWB, 2008, NEPHROL DIAL TRANSPL, V23, P2586, DOI 10.1093/ndt/gfn040	32	1	1	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0004-069X	1661-4917		ARCH IMMUNOL THER EX	Arch. Immunol. Ther. Exp.	JUN	2015	63	3					193	196		10.1007/s00005-014-0326-6		4	Immunology	Immunology	CH9XJ	WOS:000354389600004		
J	Suzuki, H; Hirashima, T; Okamoto, N; Yamadori, T; Tamiya, M; Morishita, N; Shiroyama, T; Takeoka, S; Osa, A; Azuma, Y; Kawase, I				Suzuki, Hidekazu; Hirashima, Tomonori; Okamoto, Norio; Yamadori, Tadahiro; Tamiya, Motohiro; Morishita, Naoko; Shiroyama, Takayuki; Takeoka, Sawa; Osa, Akio; Azuma, Yuichiro; Kawase, Ichiro			Relationship between progression-free survival and overall survival in patients with advanced non-small cell lung cancer treated with anticancer agents after first-line treatment failure	ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY			English	Article						anticancer agent; non-small cell lung cancer; overall survival; progression-free survival; survival post-progression	RANDOMIZED PHASE-II; METASTATIC COLORECTAL-CANCER; PLATINUM-BASED CHEMOTHERAPY; VANDETANIB PLUS DOCETAXEL; 2ND-LINE TREATMENT; DOUBLE-BLIND; GEFITINIB PLUS; OPEN-LABEL; END-POINT; TRIAL	AimThe hazard ratio of progression-free survival (PFS-HR) generally does not reflect that of overall survival (OS-HR) in advanced non-small cell lung cancer (NSCLC) patients treated with first-line therapy. Short survival post-progression (SPP) better reflects the PFS-HR and OS-HR in simulations. We aimed to evaluate whether the PFS-HR reflects the OS-HR in NSCLC clinical trials for post-first-line treatments. MethodWe reviewed clinical studies of post-first-line anticancer agents for NSCLC. We examined the sample size of the experimental arm (EA), median PFS (mPFS) or median time to progression in the EA, median overall survival (mOS) in the EA, the PFS-HR and the OS-HR. SPP was defined as the difference between mOS and mPFS. The association between mPFS and SPP, mPFS and mOS, and the PFS-HR and OS-HR was tested. We sought for the optimal point of correlation of PFS-HR and OS-HR by every 1 month of SPP. ResultsWe identified 32 trials (34 arms). mPFS and mOS were weakly correlated (correlation coefficient [r]=0.376; P=0.0286). The PFS-HR and OS-HR were also moderately correlated (r=0.415; P=0.015). The maximum r value was 0.770 (SPP<6 months; P<0.0001) when we tested the associations between the PFS-HR and OS-HR for SPP using 1-month increments. The estimated regression equation at this point was OS-HR=0.679x(PFS-HR)+0.349. ConclusionThe PFS-HR and OS-HR were strongly correlated in advanced NSCLC patients treated with post-first-line anticancer agents, with a SPP of less than 6 months.	[Suzuki, Hidekazu; Hirashima, Tomonori; Okamoto, Norio; Yamadori, Tadahiro; Tamiya, Motohiro; Morishita, Naoko; Shiroyama, Takayuki; Takeoka, Sawa; Osa, Akio; Azuma, Yuichiro; Kawase, Ichiro] Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Thorac Malignancy, Habikino, Osaka 588588, Japan	Suzuki, H (reprint author), Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Thorac Malignancy, 3-7-1 Habikino, Habikino, Osaka 588588, Japan.	suzukih@opho.jp					Heymach JV, 2007, J CLIN ONCOL, V25, P4270, DOI 10.1200/JCO.2006.10.5122; Lee JS, 2012, J CLIN ONCOL, V30, P1114, DOI 10.1200/JCO.2011.36.1709; Witta SE, 2012, J CLIN ONCOL, V30, P2248, DOI 10.1200/JCO.2011.38.9411; Herbst RS, 2010, LANCET ONCOL, V11, P619, DOI 10.1016/S1470-2045(10)70132-7; Smit EF, 2009, J CLIN ONCOL, V27, P2038, DOI 10.1200/JCO.2008.19.1650; Maruyama R, 2008, J CLIN ONCOL, V26, P4244, DOI 10.1200/JCO.2007.15.0185; Ramlau R, 2012, J CLIN ONCOL, V30, P3640, DOI 10.1200/JCO.2012.42.6932; Johnson KR, 2006, LANCET ONCOL, V7, P741, DOI 10.1016/S1470-2045(06)70800-2; Saad ED, 2010, ANN ONCOL, V21, P7, DOI 10.1093/annonc/mdp523; Ready N, 2011, J THORAC ONCOL, V6, P781, DOI 10.1097/JTO.0b013e31820a0ea6; Broglio KR, 2009, JNCI-J NATL CANCER I, V101, P1642, DOI 10.1093/jnci/djp369; Ramalingam SS, 2012, J CLIN ONCOL, V30, P3337, DOI 10.1200/JCO.2011.40.9433; Spigel DR, 2011, J CLIN ONCOL, V29, P2582, DOI 10.1200/JCO.2010.30.7678; Hayashi H, 2012, ANN ONCOL, V23, P1537, DOI 10.1093/annonc/mdr487; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Ramlau R, 2006, J CLIN ONCOL, V24, P2800, DOI 10.1200/JCO.2005.03.6491; Fleming TR, 2009, J CLIN ONCOL, V27, P2874, DOI 10.1200/JCO.2008.20.4107; Krzakowski M, 2010, J CLIN ONCOL, V28, P2167, DOI 10.1200/JCO.2009.23.4146; Lee DH, 2010, CLIN CANCER RES, V16, P1307, DOI 10.1158/1078-0432.CCR-09-1903; Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Hotta K, 2009, J THORAC ONCOL, V4, P311, DOI 10.1097/JTO.0b013e3181989bd2; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Natale RB, 2011, J CLIN ONCOL, V29, P1059, DOI 10.1200/JCO.2010.28.5981; Scagliotti GV, 2012, J CLIN ONCOL, V30, P2070, DOI 10.1200/JCO.2011.39.2993; Cullen MH, 2008, ANN ONCOL, V19, P939, DOI 10.1093/annonc/mdm592; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Han JY, 2011, CLIN CANCER RES, V17, P1553, DOI 10.1158/1078-0432.CCR-10-2525; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Buyse M, 2007, J CLIN ONCOL, V25, P5218, DOI 10.1200/JCO.2007.11.8836; Natale RB, 2009, J CLIN ONCOL, V27, P2523, DOI 10.1200/JCO.2008.18.6015; Ramalingam SS, 2011, J CLIN ONCOL, V29, P4574, DOI 10.1200/JCO.2011.36.6799; Chiappori A, 2010, J THORAC ONCOL, V5, P369, DOI 10.1097/JTO.0b013e3181cee24f; Cufer T, 2006, ANTI-CANCER DRUG, V17, P401, DOI 10.1097/01.cad.0000203381.99490.ab; desBoer RH, 2011, J CLIN ONCOL, V29, P1067; Hotta K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026646; Kelly K, 2012, J THORAC ONCOL, V7, P1041, DOI 10.1097/JTO.0b013e31824cc66c; Miksad RA, 2008, INT J TECHNOL ASSESS, V24, P371, DOI 10.1017/S0266462308080495; Paz-Ares L, 2008, BRIT J CANCER, V98, P1608, DOI 10.1038/sj.bjc.6604372; Segawa Y, 2010, J THORAC ONCOL, V5, P1430, DOI 10.1097/JTO.0b013e3181e3248e; Tang PA, 2007, J CLIN ONCOL, V25, P4562, DOI 10.1200/JCO.2006.08.1935	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-7555	1743-7563		ASIA-PAC J CLIN ONCO	Asia-Pac. J. Clin. Oncol.	JUN	2015	11	2					121	128		10.1111/ajco.12199		8	Oncology	Oncology	CH7JP	WOS:000354212500005		
J	Glas, DF; Morales, Y; Kanda, T; Ishiguro, H; Hagita, N				Glas, Dylan F.; Morales, Yoichi; Kanda, Takayuki; Ishiguro, Hiroshi; Hagita, Norihiro			Simultaneous people tracking and robot localization in dynamic social spaces	AUTONOMOUS ROBOTS			English	Article						Robot localization; Social robots; Sensor systems; Dynamic environments	MONTE-CARLO LOCALIZATION; MOBILE ROBOTS; ENVIRONMENTS; EXPLORATION; NAVIGATION; ALGORITHM; POSITION; FILTERS; SENSOR; SLAM	Accurate robot localization and people tracking are necessary for deploying service robots in crowded everyday environments such as shopping malls, and features like product displays change over time, making map-based localization using on-board sensors difficult. We propose the use of an external sensor system to track people together with one or more robots. This approach is more robust to occlusions than on-board sensing and is unaffected by changing map features. In our system, laser range finders track people and robots in the environment, and odometry data is used to associate each robot with a tracked entity and correct the robot's pose. Techniques are also presented for identifying and recovering from tracking errors. Simulation results show that our system can outperform localization using on-board sensors, both in tracking accuracy and in automatic recovery from errors. We demonstrate our system's effectiveness in simulation, in a controlled experiment in a real shopping mall environment, and in real human-robot interactions with customers in a busy shopping arcade.	[Glas, Dylan F.; Morales, Yoichi; Kanda, Takayuki; Hagita, Norihiro] ATR IRC, Keihanna Sci City, Kyoto, Japan; [Ishiguro, Hiroshi] Osaka Univ, IRL, Toyonaka, Osaka 560, Japan	Glas, DF (reprint author), ATR IRC, 2-2-2 Hikaridai, Keihanna Sci City, Kyoto, Japan.	dylan@atr.jp; yoichims@atr.jp; kanda@atr.jp; ishiguro@sys.es.osaka-u.ac.jp; hagita@atr.jp			Ministry of Internal Affairs and Communications of Japan; JST, CREST	Thanks to the staff of Universal CityWalk Osaka and Apita Town Keihanna for their cooperation in this research, and thanks to Dr. Satoshi Koizumi for his assistance in organizing the field trials. This research was supported in part by the Ministry of Internal Affairs and Communications of Japan, and in part by JST, CREST.	Amarasinghe D, 2008, IEEE INT CONF ROBOT, P4012, DOI 10.1109/ROBOT.2008.4543827; Glas DF, 2012, IEEE T SYST MAN CY A, V42, P530, DOI 10.1109/TSMCA.2011.2164243; Cui JS, 2007, COMPUT VIS IMAGE UND, V106, P300, DOI 10.1016/j.cviu.2006.07.015; Kanda T, 2004, P IEEE, V92, P1839, DOI 10.1109/JPROC.2004.835359; Dissanayake MWMG, 2001, IEEE T ROBOTIC AUTOM, V17, P229, DOI 10.1109/70.938381; Borrmann D, 2008, ROBOT AUTON SYST, V56, P130, DOI 10.1016/j.robot.2007.07.002; Fox D, 1999, J ARTIF INTELL RES, V11, P391; Bennewitz M, 2005, INT J ROBOT RES, V24, P31, DOI 10.1177/0278364904048962; Glas DF, 2010, IEEE INT C INT ROBOT, P2938; Schulz D, 2003, INT J ROBOT RES, V22, P99, DOI 10.1177/0278364903022002002; Fox D, 2003, INT J ROBOT RES, V22, P985, DOI 10.1177/0278364903022012001; Wang CC, 2003, IEEE INT CONF ROBOT, P842; Kose H, 2007, ROBOT AUTON SYST, V55, P480, DOI 10.1016/j.robot.2006.12.007; Thrun S, 1998, ARTIF INTELL, V99, P21, DOI 10.1016/S0004-3702(97)00078-7; Zhao HJ, 2008, IEEE INT CONF ROBOT, P1455; REID DB, 1979, IEEE T AUTOMAT CONTR, V24, P843, DOI 10.1109/TAC.1979.1102177; Lee JS, 2010, AUTON ROBOT, V29, P1, DOI 10.1007/s10514-010-9184-1; Kanda T, 2010, IEEE T ROBOT, V26, P897, DOI 10.1109/TRO.2010.2062550; Saffiotti A, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P2329, DOI 10.1109/IROS.2008.4650962; Glas DF, 2009, ADV ROBOTICS, V23, P405, DOI 10.1163/156855309X408754; Montemerlo M, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS I-IV, PROCEEDINGS, P695; Kanda T, 2004, HUM-COMPUT INTERACT, V19, P61, DOI 10.1207/s15327051hci1901&2_4; ELFES A, 1989, COMPUTER, V22, P46, DOI 10.1109/2.30720; Kanda T, 2009, IEEE T ROBOT, V25, P1382, DOI 10.1109/TRO.2009.2032969; Thrun S, 2001, ARTIF INTELL, V128, P99, DOI 10.1016/S0004-3702(01)00069-8; Urmson C, 2008, J FIELD ROBOT, V25, P425, DOI 10.1002/rob.20255; Burgard W, 2005, IEEE T ROBOT, V21, P376, DOI 10.1109/TRO.2004.839232; Gross HM, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P2005, DOI 10.1109/IROS.2009.5354497; Bevilacqua A., 2006, IEEE INT C VID SIGN, P89, DOI 10.1109/avss.2006.92; Billard A, 1999, CONNECT SCI, V11, P359, DOI 10.1080/095400999116304; BLACKMAN SS, 2004, AEROSPACE ELECT SYST, V19, P5, DOI DOI 10.1109/MAES.2004.1263228; Brscic D, 2013, IEEE T HUM-MACH SYST, V43, P522, DOI 10.1109/THMS.2013.2283945; Burgard W., 1998, P 15 NAT C ART INT A, P11; Fod A, 2002, P IEEE INT C ROB AUT, V3, P3024, DOI 10.1109/ROBOT.2002.1013691; Gerkey B., 2003, 11 INT C ADV ROB ICA, V1, P317; Glas DF, 2014, ADV ROBOTICS, V28, P573, DOI 10.1080/01691864.2013.879272; GLAS DF, 2009, IROS, P846; Hightower J., 2003, INT JOINT C ART INT, V18, P921; Hirasawa K., 2007, INT ROB SYST 2007 IR, P1479, DOI [10.1109/iros.2007.4399575, DOI 10.1109/IROS.2007.4399575]; Iwamura Y., 2011, Proceedings of the 2011 6th ACM/IEEE International Conference on Human-Robot Interaction (HRI 2011), DOI 10.1145/1957656.1957816; Moravec H., 1985, ROB AUT P 1985 IEEE, V2, P116; Mutlu B., 2008, P 3 ACM IEEE INT C H, P287, DOI DOI 10.1145/1349822.1349860; Pacchierotti E., 2006, IEEE RSJ IROS, P4965, DOI 10.1109/iros.2006.282519; Park S., 2007, ROB HUM INT COMM 200, P218, DOI 10.1109/roman.2007.4415083; Pizarro D, 2008, IEEE INT CONF ROBOT, P516, DOI 10.1109/ROBOT.2008.4543259; Saiki L. Y. M., 2011, P 6 INT C HUM ROB IN, P441, DOI 10.1145/1957656.1957815; Satake S., 2010, J ROBOT SOC JAPAN, V28, P327; Siegwart R, 2003, ROBOT AUTON SYST, V42, P203, DOI 10.1016/S0921-8890(02)00376-7; Sisbot E. A., 2005, 5 IEEE RAS INT C HUM, P181, DOI [10.1109/ichr.2005.1573565, DOI 10.1109/ICHR.2005.1573565]; Takahashi T., 2007, THESIS CARNEIGE MELL; Vu TD, 2007, IEEE INT VEH S, P190; Wolf DF, 2005, AUTON ROBOT, V19, P53, DOI 10.1007/s10514-005-0606-4	52	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5593	1573-7527		AUTON ROBOT	Auton. Robot.	JUN	2015	39	1					43	63		10.1007/s10514-015-9426-3		21	Computer Science, Artificial Intelligence; Robotics	Computer Science; Robotics	CH8DS	WOS:000354267000003		
J	Watanabe, Y; Nakamura, Y; Cao, X; Ohara, H; Yamazaki, Y; Murayama, N; Sugiyama, Y; Izumi-Nakaseko, H; Ando, K; Yamazaki, H; Sugiyama, A				Watanabe, Yudai; Nakamura, Yuji; Cao, Xin; Ohara, Hiroshi; Yamazaki, Yukiko; Murayama, Norie; Sugiyama, Yosuke; Izumi-Nakaseko, Hiroko; Ando, Kentaro; Yamazaki, Hiroshi; Sugiyama, Atsushi			Intravenous Administration of Apomorphine Does NOT Induce Long QT Syndrome: Experimental Evidence from In Vivo Canine Models	BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY			English	Article							TORSADES-DE-POINTES; PERIPHERAL MECHANISMS; HEART-RATE; DOGS; VARIABILITY; INTERVAL; AGONISTS; EMESIS	Apomorphine is a non-selective dopamine D-1/D-2 receptor agonist, which has been used for patients with Parkinson's disease and reported to induce QT interval prolongation and cardiac arrest. To clarify their causal link, we assessed the cardiovascular and pharmacokinetic profile of apomorphine with the halothane-anaesthetized canine model (n=4), whereas pro-arrhythmic potential of apomorphine was analysed with the chronic atrioventricular block canine model (n=4). In the halothane-anaesthetized model, 0.01mg/kg, i.v. of apomorphine hydrochloride over 10min., providing about 10 times of its therapeutic concentration, increased the heart rate and ventricular contraction; 0.1mg/kg over 10min., providing about 100 times of the therapeutic, prolonged the ventricular effective refractory period; and 1mg/kg over 10min., providing about 1000 times of the therapeutic, decreased the ventricular contraction, mean blood pressure and cardiac output together with the intraventricular conduction delay and prolongation of the effective refractory period, whereas the left ventricular end-diastolic pressure, atrioventricular nodal conduction or ventricular repolarization were hardly affected. Meanwhile, in the atrioventricular block model, 1mg/kg, i.v. of apomorphine hydrochloride over 10min. neither prolonged the QT interval nor induced torsade de pointes. These results suggest that apomorphine may possess a wide margin of cardiovascular safety contrary to our expectations.	[Watanabe, Yudai; Nakamura, Yuji; Cao, Xin; Ohara, Hiroshi; Yamazaki, Yukiko; Izumi-Nakaseko, Hiroko; Ando, Kentaro; Sugiyama, Atsushi] Toho Univ, Dept Pharmacol, Fac Med, Ota Ku, Tokyo 1438540, Japan; [Ohara, Hiroshi; Yamazaki, Yukiko] Toho Univ, Dept Internal Med, Fac Med, Div Cardiovasc Med,Ota Ku, Tokyo 1438540, Japan; [Murayama, Norie; Sugiyama, Yosuke; Yamazaki, Hiroshi] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo, Japan	Sugiyama, A (reprint author), Toho Univ, Dept Pharmacol, Fac Med, Ota Ku, 5-21-16 Omori Nishi, Tokyo 1438540, Japan.	atsushi.sugiyama@med.toho-u.ac.jp	Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261	Ministry of Education, Culture, Sports, Science and Technology in Japan [22590237, 25460344, S1101016]; Japan Science and Technology Agency [AS2116907E]; Toho University	This study was supported in part by Grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology in Japan (#22590237, #25460344, #S1101016), Japan Science and Technology Agency (#AS2116907E) and Toho University Joint Research Fund. The authors thank Ms. Misako Nakatani for her technical assistance.	KOCHWESER J, 1963, PHARMACOL REV, V15, P601; Vanderschuren LJMJ, 1999, J NEUROSCI, V19, P4123; MITCHELSON F, 1992, DRUGS, V43, P295; Thomsen MB, 2004, CIRCULATION, V110, P2453, DOI 10.1161/01.CIR.0000145162.64183.C8; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Di Chiara G, 1978, Adv Pharmacol Chemother, V15, P87, DOI 10.1016/S1054-3589(08)60482-2; Food and Drug Administration, FDA APPR LAB TEXT ND; Fridericia LS, 1920, ACTA MED SCAND, V53, P469; Humphrey SJ, 2006, J CARDIOVASC PHARM, V47, P337; LEES AJ, 1993, FUNDAM CLIN PHARM, V7, P121; Montastruc JL, 1996, BRIT J PHARMACOL, V117, P781; MONTASTRUC JL, 1985, ARCH INT PHARMACOD T, V277, P92; Montastruc J L, 1994, Clin Auton Res, V4, P303, DOI 10.1007/BF01821529; Nakayama H, 2001, TOXICOL APPL PHARM, V177, P157, DOI 10.1006/taap.2001.9297; PharmaPendium, POSTM REP AERS AP HY; Priston MJ, 1996, J CHROMATOGR B, V681, P161, DOI 10.1016/0378-4347(95)00534-X; RASCOL OJ, 1986, CLIN NEUROPHARMACOL, V9, P566, DOI 10.1097/00002826-198612000-00010; Rautsen DS, 1973, AM COLL EMERG PHYS, V2, P44; Satoh T, 1996, CIRCULATION, V94, P217; Sugiyama A, 2008, BRIT J PHARMACOL, V154, P1528, DOI 10.1038/bjp.2008.240; Sugiyama A, 2002, JPN J PHARMACOL, V88, P341, DOI 10.1254/jjp.88.341; VANDEWATER A, 1989, J PHARMACOL METHOD, V22, P207, DOI 10.1016/0160-5402(89)90015-6; ZUNINI GS, 1990, CAN J PHYSIOL PHARM, V68, P374	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-7835	1742-7843		BASIC CLIN PHARMACOL	Basic Clin. Pharmacol. Toxicol.	JUN	2015	116	6					468	475		10.1111/bcpt.12343		8	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CH7WA	WOS:000354246100004		
J	Mukai, Y; Senda, A; Toda, T; Hayakawa, T; Eliasson, E; Rane, A; Inotsume, N				Mukai, Yuji; Senda, Asuna; Toda, Takaki; Hayakawa, Toru; Eliasson, Erik; Rane, Anders; Inotsume, Nobuo			Drug-drug Interaction between Losartan and Paclitaxel in Human Liver Microsomes with Different CYP2C8 Genotypes	BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY			English	Article							IN-VITRO; CYTOCHROME P4502C8; METABOLISM; CYP3A4; POLYMORPHISMS; ANTAGONIST; INHIBITORS; SINGLE; CANCER; 2C8	The cytochrome P450 (CYP) 2C8*3 allele is associated with reduced metabolic activity of paclitaxel. This study was aimed to investigate the inhibitory effect of losartan on paclitaxel metabolism in human liver microsomes (HLMs) and to determine the impact of the CYP2C8*3 polymorphism. HLMs that contained the CYP2C8*1 homozygote (HL60) or CYP2C8*3 heterozygote (HL54) genotype were used for the inhibition study. Losartan, at a concentration of 50mol/L, significantly inhibited paclitaxel metabolism by 29% and 57% in the HL60 (p<0.001) and HL54 (p<0.01), respectively. When using HL60, losartan and the CYP3A4-selective inhibitors, erythromycin and ketoconazole, caused a greater inhibition of the paclitaxel metabolism than quercetin, a CYP2C8-selective inhibitor. This demonstrated that the paclitaxel metabolism was mainly catalysed by CYP3A4 in HL60. There were no significant differences found for the inhibitory effects caused by the four inhibitors of the paclitaxel metabolism in HL54, indicating that both CYP2C8 and CYP3A4 play important roles in paclitaxel metabolism in HL54. These findings suggest that 50mol/L of losartan inhibits both CYP2C8 and CYP3A4 in HLMs. In summary, losartan inhibited paclitaxel metabolism, with concentrations over 50mol/L in HLMs. The CYP2C8*3 allele carriers are likely susceptible to the interactions of losartan and CYP3A4 inhibitors to paclitaxel metabolism.	[Mukai, Yuji; Senda, Asuna; Toda, Takaki; Inotsume, Nobuo] Hokkaido Pharmaceut Univ, Sch Pharm, Div Clin Pharmacol, Otaru, Hokkaido 0470264, Japan; [Hayakawa, Toru] Hokkaido Pharmaceut Univ, Sch Pharm, Div Pharmacotherapy, Otaru, Hokkaido 0470264, Japan; [Eliasson, Erik; Rane, Anders] Karolinska Inst, Karolinska Univ Hosp, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden	Inotsume, N (reprint author), Hokkaido Pharmaceut Univ, Sch Pharm, Div Clin Pharmacol, 7-1 Katsuraoka Cho, Otaru, Hokkaido 0470264, Japan.	nobuo_inotsume@hokuyakudai.ac.jp			Karolinska Institutet, Stockholm, Sweden	The authors would like to thank Dr. Gunnel Tybring, Karolinska Institutet Biobank, for her assistance in preparation and genotyping of HLM samples. The authors would also like to thank Mr. Seiichiro Kudo, Dr. Moeko Ito and Dr. Sachiko Egawa, Hokkaido Pharmaceutical University School of Pharmacy, for their technical assistance. This work was supported by funds from the Karolinska Institutet, Stockholm, Sweden.	Bahadur N, 2002, BIOCHEM PHARMACOL, V64, P1579, DOI 10.1016/S0006-2952(02)01354-0; Henningsson A, 2003, EUR J CANCER, V39, P1105, DOI 10.1016/S0959-8049(03)00126-6; Green H, 2009, BASIC CLIN PHARMACOL, V104, P130, DOI 10.1111/j.1742-7843.2008.00351.x; Soyama A, 2001, BIOL PHARM BULL, V24, P1427, DOI 10.1248/bpb.24.1427; Dai D, 2001, PHARMACOGENETICS, V11, P597, DOI 10.1097/00008571-200110000-00006; BALDWIN SJ, 1995, XENOBIOTICA, V25, P261; Polasek TM, 2004, J PHARMACOL EXP THER, V311, P996, DOI 10.1124/jpet.104.071803; Bergmann TK, 2011, PHARMACOGENOMICS J, V11, P113, DOI 10.1038/tpj.2010.19; VONBAHR C, 1980, CLIN PHARMACOL THER, V27, P711; Naraharisetti SB, 2010, DRUG METAB DISPOS, V38, P889, DOI 10.1124/dmd.109.031542; Leskela S, 2011, PHARMACOGENOMICS J, V11, P121, DOI 10.1038/tpj.2010.13; Lin YS, 2002, MOL PHARMACOL, V62, P162, DOI 10.1124/mol.62.1.162; Yasar U, 2001, DRUG METAB DISPOS, V29, P1051; Paine MF, 1997, J PHARMACOL EXP THER, V283, P1552; RAHMAN A, 1994, CANCER RES, V54, P5543; Totah RA, 2005, CLIN PHARMACOL THER, V77, P341, DOI 10.1016/j.clpt.2004.12.267; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Cresteil T, 2002, DRUG METAB DISPOS, V30, P438, DOI 10.1124/dmd.30.4.438; Yasar U, 2003, PHARMACOGENETICS, V13, P715, DOI 10.1097/01.fpc.0000054141.14659.28; Bun SS, 2003, J CHEMOTHERAPY, V15, P266; Mukai Y, 2014, BIOL PHARM BULL, V37, P1550, DOI 10.1248/bpb.b14-00366; OHTAWA M, 1993, BRIT J CLIN PHARMACO, V35, P290; R Core Team, 2013, R LANG ENV STAT COMP; Soldner A, 2000, BRIT J PHARMACOL, V129, P1235, DOI 10.1038/sj.bjp.0703150; Takayama F, 1995, XENOBIO METAB DISPOS, V10, P223; Taniguchi R, 2005, J PHARMACOL SCI, V97, P83, DOI 10.1254/jphs.FP0040603; Vaclavikova R, 2004, DRUG METAB DISPOS, V32, P666, DOI 10.1124/dmd.32.6.666	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-7835	1742-7843		BASIC CLIN PHARMACOL	Basic Clin. Pharmacol. Toxicol.	JUN	2015	116	6					493	498		10.1111/bcpt.12355		6	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CH7WA	WOS:000354246100007		
J	Torii, Y; Goto, Y; Nakahira, S; Kozaki, S; Kaji, R; Ginnaga, A				Torii, Yasushi; Goto, Yoshitaka; Nakahira, Shinji; Kozaki, Shunji; Kaji, Ryuji; Ginnaga, Akihiro			Comparison of Systemic Toxicity between Botulinum Toxin Subtypes A1 and A2 in Mice and Rats	BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY			English	Article							CLOSTRIDIUM-BOTULINUM; INTRAMUSCULAR INJECTION; NEUROTOXIN; MECHANISMS; SAFETY; GENES	The adverse events caused by botulinum toxin type A (subtype A1) product, thought to be after-effects of toxin diffusion after high-dose administration, have become serious issues. A preparation showing less diffusion in the body than existing drugs has been sought. We have attempted to produce neurotoxin derived from subtype A2 (A2NTX) with an amino acid sequence different from that of neurotoxin derived from subtype A1 (A1NTX). In this study, to investigate whether A2NTX has the potential to resolve these issues, we compared the safety of A2NTX, a progenitor toxin derived from subtype A1 (A1 progenitor toxin) and A1NTX employing the intramuscular lethal dose 50% (im LD50) in mice and rats and the compound muscle action potential (CMAP) in rats. Mouse im LD50 values for A1 progenitor toxin and A2NTX were 93 and 166U/kg, respectively, and the rat im LD50 values were 117 and 153U/kg, respectively. In the rat CMAP test, the dose on the contralateral side, which caused a 50% reduction in the CMAP amplitude, that is, CMAP-TD50, was calculated as 19.0, 16.6 and 28.7U/kg for A1 progenitor toxin, A1NTX and A2NTX, respectively. The results indicate that A2NTX is safer than A1 progenitor toxin and A1NTX.	[Torii, Yasushi; Goto, Yoshitaka; Nakahira, Shinji; Ginnaga, Akihiro] Chemoserotherapeut Res Inst KAKETSUKEN, Kumamoto, Japan; [Torii, Yasushi] Osaka Univ, Grad Sch Med, Osaka, Japan; [Kozaki, Shunji] Osaka Prefecture Univ, Sch Life & Environm Sci, Dept Vet Sci, Osaka, Japan; [Kaji, Ryuji] Univ Tokushima, Grad Sch Med, Tokushima 770, Japan	Torii, Y (reprint author), Osaka Univ, 2-2 Yamadaoka, Suita, Osaka 5650821, Japan.	torii@bact.med.osaka-u.ac.jp					WIEGAND H, 1976, N-S ARCH PHARMACOL, V292, P161, DOI 10.1007/BF00498587; Dressler D, 2005, EUR NEUROL, V53, P3, DOI 10.1159/000083259; Arndt JW, 2006, J MOL BIOL, V362, P733, DOI 10.1016/j.jmb.2006.07.040; Jacobson MJ, 2008, APPL ENVIRON MICROB, V74, P2778, DOI 10.1128/AEM.02828-07; Dover N, 2009, J CLIN MICROBIOL, V47, P2349, DOI 10.1128/JCM.00799-09; Truong DD, 2006, PARKINSONISM RELAT D, V12, P331, DOI 10.1016/j.parkreldis.2006.06.002; Cote TR, 2005, J AM ACAD DERMATOL, V53, P407, DOI 10.1016/j.jaad.2005.06.011; Goldstein EM, 2006, J CHILD NEUROL, V21, P189, DOI 10.2310/7010.2006.00041; PEARCE LB, 1994, TOXICOL APPL PHARM, V128, P69, DOI 10.1006/taap.1994.1181; Torii Y, 2011, J PHARMACOL SCI, V117, P275, DOI 10.1254/jphs.11121FP; Mancini F, 2005, NEUROL SCI, V26, P26, DOI 10.1007/s10072-005-0378-9; Schiavo G, 2000, PHYSIOL REV, V80, P717; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Akaike N, 2013, J PHYSIOL-LONDON, V591, P1031, DOI 10.1113/jphysiol.2012.242131; Dressler D, 2007, DISABIL REHABIL, V29, P1761, DOI 10.1080/09638280701568296; Barash JR, 2014, J INFECT DIS, V209, P183, DOI 10.1093/infdis/jit449; JAHN R, 1994, ANN NY ACAD SCI, V733, P245, DOI 10.1111/j.1749-6632.1994.tb17274.x; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P2316, DOI 10.1001/jama.2009.780; Sakaguchi G, 1983, PHARMACOL THERAPEUT, V19, P165; Sakaguchi G, 1981, BIOMEDICAL ASPECTS B, P21; Sakamoto T, 2009, TOXICON, V54, P857, DOI 10.1016/j.toxicon.2009.06.020; SUGII S, 1975, INFECT IMMUN, V12, P1262; Tang-Liu DDS, 2003, TOXICON, V42, P461, DOI 10.1016/S0041-0101(03)00196-X; Torii Y, 2011, TOXICON, V57, P93, DOI 10.1016/j.toxicon.2010.10.009	24	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-7835	1742-7843		BASIC CLIN PHARMACOL	Basic Clin. Pharmacol. Toxicol.	JUN	2015	116	6					524	528		10.1111/bcpt.12351		5	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CH7WA	WOS:000354246100012		
J	Fujie, T; Shi, XT; Ostrovidov, S; Liang, XB; Nakajima, K; Chen, Y; Wu, HK; Khademhosseini, A				Fujie, Toshinori; Shi, Xuetao; Ostrovidov, Serge; Liang, Xiaobin; Nakajima, Ken; Chen, Yin; Wu, Hongkai; Khademhosseini, Ali			Spatial coordination of cell orientation directed by nanoribbon sheets	BIOMATERIALS			English	Article						Nanoribbon sheet; Micropattern; Bilayer; Cell orientation; Cell assembling; Myoblasts	SKELETAL-MUSCLE TISSUE; MICROENGINEERED HYDROGELS; STEM-CELLS; DRUG-LADEN; NANOSHEETS; MICROENVIRONMENTS; OSTEOGENESIS; ORGANIZATION; ELASTICITY; MYOGENESIS	Spatial coordination of cell orientation is of central importance in tissue/organ construction. In this study, we developed microfabricated poly(lactic-co-glycolic acid) (PLGA) nanoribbon sheets with unique structures, using spin-coating and micropatterning techniques, in order to generate a hierarchically assembled cellular structure consisting of murine skeletal myoblasts (C2C12). The nanoribbon sheets were composed of aligned PLGA nanoribbons in the center, and strips on four sides which take a role as bridges to connect and immobilize the aligned nanoribbons. Such unique structures facilitated the alignment of C2C12 cells into bilayer cell sheets, and cellular alignment was directed by the aligned direction of nanoribbons. The nanoribbon sheets also facilitated the construction of multilayer cell sheets with anisotropic (orthogonal) and isotropic (parallel) orientations. The enhanced expression of myogenic genes of C2C12 cells on the bilayer cell sheets demonstrated that the nanoribbons induced C2C12 cell differentiation into mature myoblasts. The micropatterned nanoribbon sheets may be a useful tool for directing cellular organization with defined alignment for regenerative medicine and drug screening applications. (C) 2015 Elsevier Ltd. All rights reserved.	[Fujie, Toshinori; Shi, Xuetao; Ostrovidov, Serge; Liang, Xiaobin; Nakajima, Ken; Wu, Hongkai; Khademhosseini, Ali] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808578, Japan; [Fujie, Toshinori] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo, Japan; [Chen, Yin; Wu, Hongkai] Hong Kong Univ Sci & Technol, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Chen, Yin; Wu, Hongkai] Hong Kong Univ Sci & Technol, Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Khademhosseini, Ali] Harvard Univ, Brigham & Womens Hosp, Harvard Mit Div Hlth Sci & Technol, MIT,Ctr Biomed Engn,Dept Med,Med Sch, Cambridge, MA 02139 USA; [Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Khademhosseini, Ali] King Abdulaziz Univ, Dept Phys, Jeddah 21569, Saudi Arabia	Wu, HK (reprint author), Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808578, Japan.	chhkwu@ust.hk; alik@rics.bwh.harvard.edu	Nakajima, Ken/A-7875-2010	Nakajima, Ken/0000-0001-7495-0445	World Premier International Research Center Initiative (WPI); JSPS KAKENHI from MEXT, Japan [25870050]; Mizuho Foundation for the Promotion of Sciences; Hong Kong RGC [GRF 604712, GRF 605210]	This work was supported by the World Premier International Research Center Initiative (WPI) and JSPS KAKENHI: Grant Number 25870050 (T. F.) from MEXT, Japan, and Mizuho Foundation for the Promotion of Sciences (T. F.). H. K. W. acknowledges the support of the Hong Kong RGC (GRF 604712 and GRF 605210).	Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h; Fujie T, 2009, ADV FUNCT MATER, V19, P2560, DOI 10.1002/adfm.200900103; Fujie T, 2007, ADV MATER, V19, P3549, DOI 10.1002/adma.200700661; Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8; Ross AM, 2012, SMALL, V8, P336, DOI 10.1002/smll.201100934; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Zorlutuna P, 2012, ADV MATER, V24, P1782, DOI 10.1002/adma.201104631; Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7; Fujie T, 2014, ADV MATER, V26, P1699, DOI 10.1002/adma.201304183; Kolewe ME, 2013, ADV MATER, V25, P4459, DOI 10.1002/adma.201301016; Shi XT, 2009, PHARM RES-DORD, V26, P422, DOI 10.1007/s11095-008-9759-0; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Takahashi H, 2013, BIOMATERIALS, V34, P7372, DOI 10.1016/j.biomaterials.2013.06.033; Elbert DL, 2011, CURR OPIN BIOTECH, V22, P674, DOI 10.1016/j.copbio.2011.04.001; Shi XT, 2012, ADV FUNCT MATER, V22, P3799, DOI 10.1002/adfm.201200914; Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873; Hosseini V, 2012, TISSUE ENG PT A, V18, P2453, DOI [10.1089/ten.TEA.2012.0181, 10.1089/ten.tea.2012.0181]; Al-Rekabi Z, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/6/066003; Bach AD, 2004, J CELL MOL MED, V8, P413, DOI 10.1111/j.1582-4934.2004.tb00466.x; Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o; Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056; Shi XT, 2014, ADV MATER, V26, P3290, DOI 10.1002/adma.201305804; Yamato M, 2004, MATER TODAY, V7, P42, DOI 10.1016/S1369-7021(04)00234-2; Shi XT, 2009, BIOMATERIALS, V30, P3996, DOI 10.1016/j.biomaterials.2009.04.021; WATERSTON RH, 1980, DEV BIOL, V77, P271, DOI 10.1016/0012-1606(80)90475-3; Nahmias Y, 2006, NAT PROTOC, V1, P2288, DOI 10.1038/nprot.2006.386; Shi XT, 2013, ADV HEALTHC MATER, V2, P1229, DOI 10.1002/adhm.201300012; Okamura Y, 2013, ADV MATER, V25, P545, DOI 10.1002/adma.201202851; Harrington H, 2014, MOL PHARMACEUT, V11, P2082, DOI 10.1021/mp5000295; Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X; Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Nagamori E, 2013, BIOMATERIALS, V34, P662, DOI 10.1016/j.biomaterials.2012.08.055; Jiang CY, 2006, ADV MATER, V18, P829, DOI 10.1002/adma.200502444; Zolnik BS, 2007, J CONTROL RELEASE, V122, P338, DOI 10.1016/j.jconrel.2007.05.034; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Tay CY, 2011, SMALL, V7, P1361, DOI 10.1002/smll.201100046; Shi XT, 2013, ADV HEALTHC MATER, V2, P846, DOI 10.1002/adhm.201200333; Nishiguchi A, 2011, ADV MATER, V23, P3506, DOI 10.1002/adma.201101787; Fujie T, 2013, NANO LETT, V13, P3185, DOI 10.1021/nl401237s; Ostrovidov S, 2014, BIOMATERIALS, V35, P6268, DOI 10.1016/j.biomaterials.2014.04.021; ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; JENNINGS CGB, 1992, DEV BIOL, V150, P121, DOI 10.1016/0012-1606(92)90012-6; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879; LI ZL, 1993, J BIOL CHEM, V268, P10403; Liu H, 2011, MACROMOLECULES, V44, P1779, DOI 10.1021/ma102965m; Nakajima K., 2010, POLYM PHYS SUSPENSIO, P129, DOI 10.1002/9780470600160.ch3; OKAZAKI K, 1966, P NATL ACAD SCI USA, V56, P1484, DOI 10.1073/pnas.56.5.1484; Ostrovidov S, 2014, TISSUE ENG PART B-RE, V20, P403, DOI [10.1089/ten.TEB.2013.0534, 10.1089/ten.teb.2013.0534]; Shi XT, 2013, ACS APPL MATER INTER, V5, P10583, DOI 10.1021/am402388k	50	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JUN	2015	53						86	94		10.1016/j.biomaterials.2015.02.028		9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CH3KO	WOS:000353929800009		
J	Ito, H; Ando, T; Ogiso, H; Arioka, Y; Saito, K; Seishima, M				Ito, Hiroyasu; Ando, Tatsuya; Ogiso, Hideyuki; Arioka, Yuko; Saito, Kuniaki; Seishima, Mitsuru			Inhibition of indoleamine 2,3-dioxygenase activity accelerates skin wound healing	BIOMATERIALS			English	Article						Wound healing; Wound closure; Amino acid; Inflammation; Cytokine; Animal model	CYTOTOXIC T-LYMPHOCYTES; TRYPTOPHAN CATABOLISM; CELL PROLIFERATION; GROWTH-FACTORS; LIVER-INJURY; HEPATITIS; MICE; INDUCTION; CYTOKINES; FIBROBLASTS	Skin wound healing is a complex process involving several stages that include inflammation, proliferation, and remodeling. In the inflammatory phase, pro-inflammatory cytokines and chemokines are induced at the wound site and, they contribute to the development of wound healing. These cytokines also induce indoleamine 2,3-dioxygenase (IDO1) activity; this is the rate-limiting and first enzyme in the L-tryptophan (TRP)-L-kynurenine (KYN) pathway. This study examined the effect of IDO1 on the process of skin wound healing. The expression of the Idol mRNA was enhanced after creating a wound in wildtype (WT) mice. TRP concentration was simultaneously reduced at the wound site. The rate of wound healing in IDO1 knockout (IDO-KO) mice was significantly higher than that in WT mice. 1-Methyl-DL-tryptophan (1-MT), a potent inhibitor of IDO1, increased the rate of wound healing in WT mice. The administration of TRP accelerated wound healing in vivo and in an in vitro experimental model, whereas the rate of wound healing was not affected by the administration of KYN. The present study identifies the role of IDO1 in skin wound healing, and indicates that the local administration of 1-MT or TRP may provide an effective strategy for accelerating wound healing. (C) 2015 Elsevier Ltd. All rights reserved.	[Ito, Hiroyasu; Ando, Tatsuya; Ogiso, Hideyuki; Arioka, Yuko; Seishima, Mitsuru] Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Gifu 5011194, Japan; [Saito, Kuniaki] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Sakyo Ku, Kyoto 6068507, Japan; [Saito, Kuniaki] Kyoto Univ, Fac Med, Sakyo Ku, Kyoto 6068507, Japan	Ito, H (reprint author), Gifu Univ, Grad Sch Med, Dept Informat Clin Med, 1-1 Yanagido, Gifu 5011194, Japan.	hito@gifu-u.ac.jp					SAITO K, 1992, NEUROSCIENCE, V51, P25, DOI 10.1016/0306-4522(92)90467-G; Hoshi M, 2012, J IMMUNOL, V188, P3980, DOI 10.4049/jimmunol.1100997; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Iwamoto N, 2009, LIVER INT, V29, P277, DOI 10.1111/j.1478-3231.2008.01748.x; Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com; Low QEH, 2001, AM J PATHOL, V159, P457, DOI 10.1016/S0002-9440(10)61717-8; Ohtaki H, 2014, BBA-MOL BASIS DIS, V1842, P1464, DOI 10.1016/j.bbadis.2014.04.015; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Kyriakides TR, 2009, MATRIX BIOL, V28, P65, DOI 10.1016/j.matbio.2009.01.001; Konturek PC, 2010, J PINEAL RES, V48, P318, DOI 10.1111/j.1600-079X.2010.00755.x; Fujigaki H, 2006, J BIOCHEM, V139, P655, DOI 10.1093/jb/mvj072; BRAUCHLE M, 1994, ONCOGENE, V9, P3199; Celinski K, 2011, J PINEAL RES, V50, P389, DOI 10.1111/j.1600-079X.2011.00855.x; Durr S, 2013, J LEUKOCYTE BIOL, V93, P681, DOI 10.1189/jlb.0712347; Fallarino F., 2002, Cell Death and Differentiation, V9, P1069, DOI 10.1038/sj.cdd.4401073; Getty AL, 2011, EXP CELL RES, V317, P51, DOI 10.1016/j.yexcr.2010.09.007; Hoshi M, 2009, LEUKEMIA RES, V33, P39, DOI 10.1016/j.leukres.2008.05.023; Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150; Hoshi M, 2014, INFECT IMMUN, V82, P4487, DOI 10.1128/IAI.02113-14; Ito H, 2010, J IMMUNOL, V185, P4554, DOI 10.4049/jimmunol.0904173; Ito H, 2014, IMMUNOLOGY, V142, P614, DOI 10.1111/imm.12274; MURRAY HW, 1989, INFECT IMMUN, V57, P845; O'Callaghan-Sunol C, 2006, CELL CYCLE, V5, P1431, DOI 10.4161/cc.5.13.2915; Pugazhenthi K, 2008, J PINEAL RES, V44, P387, DOI 10.1111/j.1600-079X.2007.00541.x; Tang AM, 1996, J DERMATOL SCI, V11, P41, DOI 10.1016/0923-1811(95)00418-1	29	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JUN	2015	53						221	228		10.1016/j.biomaterials.2015.02.098		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CH3KO	WOS:000353929800021		
J	Hoffecker, IT; Takemoto, N; Arima, Y; Iwata, H				Hoffecker, Ian T.; Takemoto, Naohiro; Arima, Yusuke; Iwata, Hiroo			Sequence-specific nuclease-mediated release of cells tethered by oligonucleotide phospholipids	BIOMATERIALS			English	Article						Restriction enzyme; ssDNA; Multicellular aggregate; Cell-cell adhesion; Membrane modification; Cell patterning	DNA; MEMBRANE; HYBRIDIZATION; ISLETS	Single-stranded oligonucleotide-conjugated lipids (ssDNA-PEG-lipids) that associate with the cell membrane confer to the cell an artificial adhesive capability via sequence-specific hybridization to complementary oligonucleotides, forming bonds of double stranded oligonucleotides (dsDNA). Such artificial tethers permit surface patterning of cells or controlled formation of cellular aggregates. However, the hybridization responsible for tethering cells to surfaces or to other cells is not trivially reversed under physiological conditions. In this study, we approach the unbinding of tethered cells by cleaving dsDNA bonds with restriction endonuclease BamHI or digesting bonds with the nonspecific nuclease Benzonase. The procedure was applied to CCRF-CEM cells bearing dsDNA suspended in isolation, cells tethered to glass substrates, and cells aggregated heterotypically with other ssDNA-bearing cells. Cells liberated from surfaces with BamHI could be flushed from flow chambers and viably recovered while the majority of cells not bearing enzyme recognition sequences were retained on the surface, and DNA-tethered cells could be nonspecifically recovered viably from surfaces after Benzonase treatment. Heterotypic aggregates of cells joined by recognition sequence DNA could be dispersed with 10 min exposure to BamHI while undispersed cells heterotypically aggregated with a control sequence remained. Likewise, 10 min exposure to Benzonase was sufficient to disperse aggregates independently of sequence. The potential to undo artificially engineered DNA-mediated adhesion offers new possibilities in the controlled arrangement of cells relative to other cells and in the study of membrane biophysics. (C) 2015 Elsevier Ltd. All rights reserved.	[Hoffecker, Ian T.; Takemoto, Naohiro; Arima, Yusuke; Iwata, Hiroo] Kyoto Univ, Inst Frontier Med Sci, Dept Reparat Mat, Sakyo Ku, Kyoto, Japan	Iwata, H (reprint author), Kyoto Univ, Inst Frontier Med Sci, Dept Reparat Mat, Sakyo Ku, Kyoto, Japan.	iwata@frontier.kyoto-u.ac.jp			Monbukagakusho Scholarship for graduate studies from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [24.3121]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [24.3121];  [2306]	The authors wish to thank Dr. Kazunori Hirayoshi for his insights on restriction enzyme selection. This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Nanomedicine Molecular Science" (No. 2306) and the Monbukagakusho Scholarship for graduate studies from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (No. 24.3121) of Japan. This study was also supported in part by the Japan Society for the Promotion of Science (JSPS) Fellows (No. 24.3121) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan.	Koley D, 2010, P NATL ACAD SCI USA, V107, P16783, DOI 10.1073/pnas.1011614107; Teramura Y, 2010, BIOCONJUGATE CHEM, V21, P792, DOI 10.1021/bc900494x; De Bank PA, 2007, BIOTECHNOL BIOENG, V97, P1617, DOI 10.1002/bit.21343; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Jakobsen U, 2008, J AM CHEM SOC, V130, P10462, DOI 10.1021/ja8030054; Sakurai K, 2011, BIOMATERIALS, V32, P3596, DOI 10.1016/j.biomaterials.2011.01.066; Teramura Y, 2007, BIOMATERIALS, V28, P4818, DOI 10.1016/j.biomaterials.2007.07.050; Shin DS, 2011, CHEM COMMUN, V47, P11942, DOI 10.1039/c1cc15046d; Chan YHM, 2009, P NATL ACAD SCI USA, V106, P979, DOI 10.1073/pnas.0812356106; Teramura Y, 2010, BIOMATERIALS, V31, P2229, DOI 10.1016/j.biomaterials.2009.11.098; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Deno S, 2014, BIOORGAN MED CHEM, V22, P350, DOI 10.1016/j.bmc.2013.11.023; Sakurai K, 2013, BIOMATERIALS, V34, P361, DOI 10.1016/j.biomaterials.2012.09.080; Sou K, 2000, BIOCONJUGATE CHEM, V11, P372, DOI 10.1021/bc990135y; Stephan MT, 2001, NANO TODAY, V6, P309; Takemoto N, 2013, BIOMATER SCI-UK, V1, P315, DOI 10.1039/c2bm00048b; Zhu H, 2008, COLLOID SURFACE B, V64, P260, DOI 10.1016/j.colsurfb.2008.02.010	18	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JUN	2015	53						318	329		10.1016/j.biomaterials.2015.02.059		12	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CH3KO	WOS:000353929800030		
J	Sakai, S; Liu, Y; Sengoku, M; Taya, M				Sakai, Shinji; Liu, Yang; Sengoku, Mikako; Taya, Masahito			Cell-selective encapsulation in hydrogel sheaths via biospecific identification and biochemical cross-linking	BIOMATERIALS			English	Article						Cell encapsulation; Enzyme; Hydrogel; Surface modification; Alginate; Gelatin	ALGINATE; IMMOBILIZATION; DELIVERY; CULTURES; SYSTEM; MATRIX	Selective encapsulation of a particular cell population from heterogeneous cell populations has potential applications such as studies in cell-to-cell communication, regenerative medicine, and cell therapies. However, there are no versatile methods for realizing this. Here we report a method based on biospecific identification of the target cells through antigen antibody reaction and subsequent enzymatic hydrogel sheath formation on the cell surfaces by horseradish peroxidase (HRP). Human hepatoma cell line HepG2 cells were selectively encapsulated in alginate-based hydrogel sheath from the mixture with mouse embryo fibroblast-like cell line 10T1/2 fibroblasts using anti-human CD326 antibody conjugated with HRP. The viability of the encapsulated cells was 93%. The cells released at 6 days of the encapsulation by degrading the sheath using alginate lyase grew almost the same as those free from encapsulation. The versatility of the method was confirmed using another antibody, cells, and hydrogel sheath material: Only human vein endothelial cells were encapsulated in gelatin-based hydrogel sheath from the mixture with 10T1/2 fibroblasts using anti-human CD31 antibody conjugated with HRP. The cell-selective encapsulation was also achieved by a system using a primary antibody with a secondary antibody conjugated with HRP. (C) 2015 Elsevier Ltd. All rights reserved.	[Sakai, Shinji; Liu, Yang; Sengoku, Mikako; Taya, Masahito] Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, Toyonaka, Osaka 5608531, Japan	Sakai, S (reprint author), Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, 1-3 Machikaneyama Cho, Toyonaka, Osaka 5608531, Japan.	sakai@cheng.es.osaka-u.ac.jp			Japan Society for the Promotion of Science KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [26630428]	This work was supported by Japan Society for the Promotion of Science KAKENHI grant (No. 26630428) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Sakai S, 2009, BIOMATERIALS, V30, P3371, DOI 10.1016/j.biomaterials.2009.03.030; Park KM, 2010, BIOMACROMOLECULES, V11, P706, DOI 10.1021/bm9012875; Chang TMS, 2005, NAT REV DRUG DISCOV, V4, P221, DOI 10.1038/nrd1659; SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E; Lee F, 2009, J CONTROL RELEASE, V134, P186, DOI 10.1016/j.jconrel.2008.11.028; Sakai S, 2007, ACTA BIOMATER, V3, P495, DOI 10.1016/j.actbio.2006.12.002; SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Gulden M, 2010, FREE RADICAL BIO MED, V49, P1298, DOI 10.1016/j.freeradbiomed.2010.07.015; Kurisawa M, 2005, CHEM COMMUN, P4312, DOI 10.1039/b506989k; Jin R, 2007, BIOMATERIALS, V28, P2791, DOI 10.1016/j.biomaterials.2007.02.032; Lee F, 2008, SOFT MATTER, V4, P880, DOI 10.1039/b719557e; Hu M, 2009, BIOMATERIALS, V30, P3523, DOI 10.1016/j.biomaterials.2009.03.004; Huang XB, 2012, J BIOSCI BIOENG, V114, P1, DOI 10.1016/j.jbiosc.2012.02.024; Teixeira LSM, 2012, BIOMATERIALS, V33, P1281, DOI 10.1016/j.biomaterials.2011.10.067; Sakai S, 2013, J MATER CHEM B, V1, P5067, DOI 10.1039/c3tb20780c; Sakai S, 2009, J MATER CHEM, V19, P230, DOI 10.1039/b812086b; Nishiguchi A, 2014, BIOMATERIALS, V35, P4739, DOI 10.1016/j.biomaterials.2014.01.079; Montel F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.188102; SMEETS EF, 1992, BIOTECH HISTOCHEM, V67, P241, DOI 10.3109/10520299209110072; Asano Y, 2014, MICROSCOPY-JPN, V63, P219, DOI 10.1093/jmicro/dfu005; BYLER RM, 1994, AM J PHYSIOL, V266, pH121; Kang AhRan, 2014, Biomaterials, V35, P2651, DOI 10.1016/j.biomaterials.2013.12.073; Ogushi Y, 2010, BIOCHEM ENG J, V51, P147, DOI 10.1016/j.bej.2010.06.008; Sakai S, 2012, J MATER CHEM, V22, P1944, DOI 10.1039/c1jm14460j; Sakai S, 2014, ACS MACRO LETT, V3, P972, DOI 10.1021/mz5004322; Takei T, 2011, J BIOSCI BIOENG, V112, P491, DOI 10.1016/j.jbiosc.2011.07.006	27	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JUN	2015	53						494	501		10.1016/j.biomaterials.2015.02.119		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CH3KO	WOS:000353929800046		
J	Luthy, M; Wheldon, MC; Haji-Cheteh, C; Atobe, M; Bond, PS; O'Brien, P; Hubbard, RE; Fairlamb, IJS				Luethy, Monique; Wheldon, Mary C.; Haji-Cheteh, Chehasnah; Atobe, Masakazu; Bond, Paul S.; O'Brien, Peter; Hubbard, Roderick E.; Fairlamb, Ian J. S.			Lead-oriented synthesis: Investigation of organolithium-mediated routes to 3-D scaffolds and 3-D shape analysis of a virtual lead-like library	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Lead-like library; Lead-oriented synthesis; 3-D shape analysis; Nitrogen heterocycles; Organolithium-mediated synthesis	N-BOC-PYRROLIDINE; CATALYZED ALPHA-ARYLATION; ASYMMETRIC DEPROTONATION; ORGANIC-MOLECULES; DRUG DISCOVERY; RING EXPANSION; LITHIATION; DIVERSITY; HETEROCYCLES; EQUIVALENTS	Synthetic routes to six 3-D scaffolds containing piperazine, pyrrolidine and piperidine cores have been developed. The synthetic methodology focused on the use of N-Boc alpha-lithiation-trapping chemistry. Notably, suitably protected and/or functionalised medicinal chemistry building blocks were synthesised via concise, connective methodology. This represents a rare example of lead-oriented synthesis. A virtual library of 190 compounds was then enumerated from the six scaffolds. Of these, 92 compounds (48%) fit the lead-like criteria of: (i) -1 <= AlogP <= 3; (ii) 14 <= number of heavy atoms <= 26; (iii) total polar surface area >= 50 angstrom(2). The 3-D shapes of the 190 compounds were analysed using a triangular plot of normalised principal moments of inertia (PMI). From this, 46 compounds were identified which had lead-like properties and possessed 3-D shapes in under-represented areas of pharmaceutical space. Thus, the PMI analysis of the 190 member virtual library showed that whilst scaffolds which may appear on paper to be 3-D in shape, only 24% of the compounds actually had 3-D structures in the more interesting areas of 3-D drug space. (C) 2015 Elsevier Ltd. All rights reserved.	[Luethy, Monique; Wheldon, Mary C.; Haji-Cheteh, Chehasnah; Atobe, Masakazu; Bond, Paul S.; O'Brien, Peter; Hubbard, Roderick E.; Fairlamb, Ian J. S.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Atobe, Masakazu] Asahi Kasei Pharma Corp, Izunokuni, Shizuoka 4102321, Japan; [Hubbard, Roderick E.] Vernalis R&D Ltd, Cambridge CB21 6GB, England	O'Brien, P (reprint author), Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England.	peter.obrien@york.ac.uk			EPSRC (DTA); EPSRC; Wellcome Trust (Chemical Biology Centre via C2D2); Royal Thai Government; Asahi Kasei Pharma Corporation	We thank the EPSRC (DTA to M.C.W. and Institutional Award to POB/REH/ML), the Wellcome Trust (Chemical Biology Centre via C2D2, PSB), the Royal Thai Government (scholarship to C.H.C.) and Asahi Kasei Pharma Corporation (secondment of MA to the University of York) for funding. We also thank Accelrys for provision of Pipeline Pilot and Dr Steve Roughley of Vernalis for advice on 3-D shape analysis.	Sauer WHB, 2003, J CHEM INF COMP SCI, V43, P987, DOI 10.1021/ci025599w; Keseru GM, 2009, NAT REV DRUG DISCOV, V8, P203, DOI 10.1038/nrd2796; Barker G, 2011, J ORG CHEM, V76, P5936, DOI 10.1021/jo2011347; Burchat AF, 1997, J ORGANOMET CHEM, V542, P281, DOI 10.1016/S0022-328X(97)00143-5; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Firth NC, 2012, J CHEM INF MODEL, V52, P2516, DOI 10.1021/ci300293f; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Waring MJ, 2010, EXPERT OPIN DRUG DIS, V5, P235, DOI 10.1517/17460441003605098; Barker G, 2010, ORG LETT, V12, P4176, DOI 10.1021/ol1017799; Wu SD, 1996, J AM CHEM SOC, V118, P715, DOI 10.1021/ja9524661; Wenlock MC, 2003, J MED CHEM, V46, P1250, DOI 10.1021/jm021053p; Stead D, 2010, J AM CHEM SOC, V132, P7260, DOI 10.1021/ja102043e; Xiao D, 2005, TETRAHEDRON LETT, V46, P7653, DOI 10.1016/j.tetlet.2005.08.148; McGrath NA, 2010, J CHEM EDUC, V87, P1348, DOI 10.1021/ed1003806; Gleeson MP, 2008, J MED CHEM, V51, P817, DOI 10.1021/jm701122q; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Hung AW, 2011, P NATL ACAD SCI USA, V108, P6799, DOI 10.1073/pnas.1015271108; Doveston R, 2014, DRUG DISCOV TODAY, V19, P813, DOI 10.1016/j.drudis.2013.11.006; Kenny PW, 2013, J COMPUT AID MOL DES, V27, P1, DOI 10.1007/s10822-012-9631-5; Campos KR, 2006, J AM CHEM SOC, V128, P3538, DOI 10.1021/ja0605265; Rayner PJ, 2013, J AM CHEM SOC, V135, P8071, DOI 10.1021/ja4033956; Stead D, 2008, ORG LETT, V10, P1409, DOI 10.1021/ol800109s; James T, 2014, ORG BIOMOL CHEM, V12, P2584, DOI 10.1039/c3ob42512f; Oprea TI, 2001, J CHEM INF COMP SCI, V41, P1308, DOI 10.1021/ci010366a; Hughes JD, 2008, BIOORG MED CHEM LETT, V18, P4872, DOI 10.1016/j.bmcl.2008.07.071; Beng TK, 2012, J AM CHEM SOC, V134, P14764, DOI 10.1021/ja306276w; Taylor RD, 2014, J MED CHEM, V57, P5845, DOI 10.1021/jm4017625; Doveston RG, 2015, ORG BIOMOL CHEM, V13, P859, DOI 10.1039/c4ob02287d; Nadin A, 2012, ANGEW CHEM INT EDIT, V51, P1114, DOI 10.1002/anie.201105840; BEAK P, 1989, TETRAHEDRON LETT, V30, P1197, DOI 10.1016/S0040-4039(00)72714-6; Baurin N, 2004, J CHEM INF COMP SCI, V44, P2157, DOI 10.1021/ci049806z; BEAK P, 1994, J ORG CHEM, V59, P276, DOI 10.1021/jo00081a002; Bilke J. L., 1935, ORG LETT, V2009, P11; COSSY J, 1995, TETRAHEDRON LETT, V36, P549, DOI 10.1016/0040-4039(94)02338-C; Ghose AK, 1998, J PHYS CHEM A, V102, P3762, DOI 10.1021/jp980230o; Lajiness MS, 2004, CURR OPIN DRUG DISC, V7, P470; Lee J, 2001, TETRAHEDRON LETT, V42, P6223, DOI 10.1016/S0040-4039(01)01223-0; MEYER AY, 1986, J COMPUT CHEM, V7, P144, DOI 10.1002/jcc.540070207; Morley A. D., 2013, DRUG DISCOV TODAY, V184, P1221; Pardo DG, 2014, CHEM-EUR J, V20, P4516, DOI 10.1002/chem.201304924; Ritchie T. J., 2009, DRUG DISCOV TODAY, V1011, P14; Sheikh N. S., 2012, J AM CHEM SOC, V133, P5300	43	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	JUN 1	2015	23	11					2680	2694		10.1016/j.bmc.2015.04.005		15	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CH4TL	WOS:000354025700010		
J	Singh, SB; Kaelin, DE; Wu, J; Miesel, L; Tan, CM; Meinke, PT; Olsen, DB; Lagrutta, A; Wei, CQ; Peng, XJ; Wang, X; Fukuda, H; Kishii, R; Takei, M; Shibata, T; Ohata, K; Takano, H; Kurasaki, H; Takeuchi, T; Nishimura, A; Fukuda, Y				Singh, Sheo B.; Kaelin, David E.; Wu, Jin; Miesel, Lynn; Tan, Christopher M.; Meinke, Peter T.; Olsen, David B.; Lagrutta, Armando; Wei, Changqing; Peng, Xuanjia; Wang, Xiu; Fukuda, Hideyuki; Kishii, Ryuta; Takei, Masaya; Shibata, Takeshi; Ohata, Kohei; Takano, Hisashi; Kurasaki, Haruaki; Takeuchi, Tomoko; Nishimura, Akinori; Fukuda, Yasumichi			Structure activity relationship of substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-4)	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Antibacterial; Broad-spectrum; Bacterial topoisomerase inhibitors; Gyrase inhibitors; ParC inhibitors	IIA TOPOISOMERASES; POTENT INHIBITORS; DERIVATIVES; DESIGN	Bacterial resistance is rapidly growing, necessitating the need to discover new agents. Novel bacterial topoisomerase inhibitors (NBTIs) are new class of broad-spectrum antibacterial agents targeting bacterial DNA gyrase and topoisomerase IV. This class of inhibitors binds to an alternative binding site relative to fluoroquinolones and shows no cross-resistance to quinolones. NBTIs consist of three structural motifs. A structure activity relationship of the left hand motif 1,5-naphthyridine of oxabicyclooctane-linked NBTIs is described. Fifty five compounds were evaluated against a panel of key Gram-positive and Gram-negative strains of bacteria, as well as for hERG activity and five compounds were tested for in vivo efficacy in murine model of Staphylococcus aureus infection. These studies suggest that only a narrow range (activating and deactivating) of substitutions at C-2 and C-7 are tolerated for optimal antibacterial activity and spectrum. An alkoxy (methoxy) and CN at C-2, and a halogen and hydroxyl at C-7, appeared to be preferred in this series. Substitutions on the other three carbons generally have detrimental effect on the activity. No clear hERG activity SAR emerged from these substitutions. (C) 2015 Elsevier Ltd. All rights reserved.	[Singh, Sheo B.; Kaelin, David E.; Wu, Jin; Miesel, Lynn; Tan, Christopher M.; Meinke, Peter T.] Merck Res Labs, Kenilworth, NJ 07033 USA; [Olsen, David B.; Lagrutta, Armando] Merck Res Labs, West Point, PA 19486 USA; [Wei, Changqing; Peng, Xuanjia; Wang, Xiu] WuXi AppTec, Shanghai, Peoples R China; [Fukuda, Hideyuki; Kishii, Ryuta; Takei, Masaya; Shibata, Takeshi; Ohata, Kohei; Takano, Hisashi; Kurasaki, Haruaki; Takeuchi, Tomoko; Nishimura, Akinori; Fukuda, Yasumichi] Kyorin Pharmaceut Co Ltd, Nogi, Tochigi 3290114, Japan	Singh, SB (reprint author), SBS Pharma Consulting LLC, Edison, NJ 08820 USA.	sheo.singh.215@gmail.com; yasumichi.fukuda@gmail.com					Miles TJ, 2013, BIOORG MED CHEM LETT, V23, P5437, DOI 10.1016/j.bmcl.2013.07.013; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Black MT, 2008, ANTIMICROB AGENTS CH, V52, P3339, DOI 10.1128/AAC.00496-08; Mitton-Fry MJ, 2013, BIOORG MED CHEM LETT, V23, P2955, DOI 10.1016/j.bmcl.2013.03.047; Miles TJ, 2011, BIOORG MED CHEM LETT, V21, P7483, DOI 10.1016/j.bmcl.2011.09.114; Reck F, 2011, J MED CHEM, V54, P7834, DOI 10.1021/jm2008826; Gomez L, 2007, BIOORG MED CHEM LETT, V17, P2723, DOI 10.1016/j.bmcl.2007.03.003; Bax BD, 2010, NATURE, V466, P935, DOI 10.1038/nature09197; Mayer C, 2014, CHEM REV, V114, P2313, DOI 10.1021/cr4003984; Zhanel GG, 2010, ANTIMICROB AGENTS CH, V54, P4684, DOI 10.1128/AAC.00469-10; Reck F, 2012, J MED CHEM, V55, P6916, DOI 10.1021/jm300690s; Black MT, 2009, CURR OPIN INVEST DR, V10, P804; Surivet JP, 2013, J MED CHEM, V56, P7396, DOI 10.1021/jm400963y; Singh SB, 2014, ACS MED CHEM LETT, V5, P609, DOI 10.1021/ml500069w; Miles TJ, 2011, BIOORG MED CHEM LETT, V21, P7489, DOI 10.1016/j.bmcl.2011.09.117; Wiener JJM, 2007, BIOORG MED CHEM LETT, V17, P2718, DOI 10.1016/j.bmcl.2007.03.004; Bisacchi GS, 2009, ANNU REP MED CHEM, V44, P379, DOI 10.1016/S0065-7743(09)04419-4; Fukuda Y., 2013, WO Patent, Patent No. [2,013,003,383, 2013003383]; Widdowson K, 2010, FUTURE MED CHEM, V2, P1619, DOI [10.4155/fmc.10.250, 10.4155/FMC.10.250]	19	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	JUN 1	2015	25	11					2409	2415		10.1016/j.bmcl.2015.04.002		7	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CH5ZR	WOS:000354115400029		
J	Kagawa, Y; Matsuura, K; Shimizu, T; Tsuneda, S				Kagawa, Yuki; Matsuura, Katsuhisa; Shimizu, Tatsuya; Tsuneda, Satoshi			Direct Measurement of Local Dissolved Oxygen Concentration Spatial Profiles in a Cell Culture Environment	BIOTECHNOLOGY AND BIOENGINEERING			English	Article						cardiomyocyte; oxygen microsensor; oxygen consumption; cell metabolism	PLURIPOTENT STEM-CELL; ENGINEERED CARDIAC TISSUE; IN-VITRO; CARDIOMYOCYTES; CONSUMPTION; SHEETS; GRADIENTS; HYPOXIA; HEPATOCYTES; FIBROBLASTS	Controlling local dissolved oxygen concentration (DO) in media is critical for cell or tissue cultures. Various biomaterials and culture methods have been developed to modulate DO. Direct measurement of local DO in cultures has not been validated as a method to test DO modulation. In the present study we developed a DO measurement system equipped with a Clarktype oxygen microelectrode manipulated with I p.m precision in three-dimensional space to explore potential applications for tissue engineering. By determining the microelectrode tip position precisely against the bottom plane of culture dishes with rat or human cardiac cells in static monolayer culture, we successfully obtained spatial distributions of DO in the medium. Theoretical quantitative predictions fit the obtained data well. Based on analyses of the variance between samples, we found the data reflected "local" oxygen consumption in the vicinity of the microelectrode and the detection of temporal changes in oxygen consumption rates of cultured cells was limited by the diffusion rate of oxygen in the medium. This oxygen measuring system monitors local oxygen consumption and production with high spatial resolution, and can potentially be used with recently developed oxygen modulating biomaterials to design microenvironments and non-invasively monitor local DO dynamics during culture. (C) 2015 Wiley Periodicals, Inc.	[Kagawa, Yuki; Tsuneda, Satoshi] Waseda Univ, Inst Nanosci & Nanotechnol, Shinjuku Ku, Tokyo 1628480, Japan; [Matsuura, Katsuhisa; Shimizu, Tatsuya] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo, Japan; [Tsuneda, Satoshi] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan	Tsuneda, S (reprint author), Waseda Univ, Inst Nanosci & Nanotechnol, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	stsuneda@waseda.jp			Japan Society for the Promotion of Science (JSPS)	Contract grant sponsor: Japan Society for the Promotion of Science (JSPS)	Acosta MA, 2009, BIOMATERIALS, V30, P3068, DOI 10.1016/j.biomaterials.2009.02.021; Kellner K, 2002, BIOTECHNOL BIOENG, V80, P73, DOI 10.1002/bit.10352; FOY BD, 1994, CELL TRANSPLANT, V3, P515; Ivashchenko CY, 2013, AM J PHYSIOL-HEART C, V305, pH913, DOI 10.1152/ajpheart.00819.2012; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Pedraza E, 2012, P NATL ACAD SCI USA, V109, P4245, DOI 10.1073/pnas.1113560109; Zhang P, 2012, AM J PHYSIOL-HEART C, V303, pH1385, DOI 10.1152/ajpheart.01167.2011; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007.; Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038; Robertson C, 2013, STEM CELLS, V31, P829, DOI 10.1002/stem.1331; Rana P, 2012, TOXICOL SCI, V130, P117, DOI 10.1093/toxsci/kfs233; Sekiya S, 2006, BIOCHEM BIOPH RES CO, V341, P573, DOI 10.1016/j.bbrc.2005.12.217; Balis UJ, 1999, METAB ENG, V1, P49, DOI 10.1006/mben.1998.0105; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; Nahmias Y, 2006, FASEB J, V20, P2531, DOI 10.1096/fj.06-6192fje; Malda J, 2007, TISSUE ENG, V13, P2153, DOI 10.1089/ten.2006.0417; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286; Matsuura K, 2012, BIOCHEM BIOPH RES CO, V425, P321, DOI 10.1016/j.bbrc.2012.07.089; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Brown DA, 2007, BIOTECHNOL BIOENG, V97, P962, DOI 10.1002/bit.21295; Cho CH, 2007, BIOTECHNOL BIOENG, V97, P188, DOI 10.1002/bit.21225; Demol J, 2011, BIOMATERIALS, V32, P107, DOI 10.1016/j.biomaterials.2010.08.093; Evenou F, 2010, TISSUE ENG PART C-ME, V16, P311, DOI 10.1089/ten.TEC.2009.0042; JSCC, 1990, JPN J CLIN CHEM, V19, P184; Kino-oka M, 2000, BIOTECHNOL BIOENG, V67, P234, DOI 10.1002/(SICI)1097-0290(20000120)67:2<234::AID-BIT13>3.0.CO;2-H; Kino-oka M, 2010, J BIOSCI BIOENG, V110, P363, DOI 10.1016/j.jbiosc.2010.03.009; Mamchaoui K, 2000, AM J PHYSIOL-LUNG C, V278, pL858; Park KM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5075; Pettersen EO, 2005, CELL PROLIFERAT, V38, P257, DOI 10.1111/j.1365-2184.2005.00345.x; Press W. H., 2007, NUMERICAL RECIPES; Radisic M, 2006, BIOTECHNOL BIOENG, V93, P332, DOI 10.1002/bit.20722; Sekine K, 2014, BIOCHEM BIOPH RES CO, V452, P834, DOI 10.1016/j.bbrc.2014.09.018; van Vlimmeren MAA, 2011, TISSUE ENG PART A, V18, P221; Wagner BA, 2011, FREE RADICAL BIO MED, V51, P700, DOI 10.1016/j.freeradbiomed.2011.05.024; YAMADA T, 1985, ANAL BIOCHEM, V145, P302, DOI 10.1016/0003-2697(85)90365-3; Zhu J, 2012, J NEUROSCI RES, V90, P422, DOI 10.1002/jnr.22765	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0006-3592	1097-0290		BIOTECHNOL BIOENG	Biotechnol. Bioeng.	JUN	2015	112	6					1263	1274		10.1002/bit.25531		12	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CH4DG	WOS:000353981400020		
J	Inamasu, J; Moriya, S; Oheda, M; Hasegawa, M; Hirose, Y				Inamasu, Joji; Moriya, Shigeta; Oheda, Motoki; Hasegawa, Mitsuhiro; Hirose, Yuichi			Role of catecholamines in acute hypertensive response: subarachnoid hemorrhage versus spontaneous intracerebral hemorrhage	BLOOD PRESSURE MONITORING			English	Article						acute hypertensive reaction; catecholamine; hypertensive emergency; spontaneous intracerebral hemorrhage; subarachnoid hemorrhage	SYMPATHETIC-NERVOUS-SYSTEM; STROKE; MANAGEMENT; SENSITIZATION; ACTIVATION; PRESSURE; STRESS	Background and objective Acute hypertensive response, defined as systolic blood pressure (SBP) 140 mmHg or more within 24 h of onset, is frequently observed in hemorrhagic stroke patients. Although catecholamine surge is pivotal in its pathogenesis, few studies have evaluated the relationship between admission SBP and plasma catecholamine levels. Patients and methods A prospective observational study was carried out to investigate potential differences in the acute hypertensive reaction between subarachnoid hemorrhage (SAH) and spontaneous intracerebral hemorrhage (SICH) by analyzing 200 SAH and 200 SICH patients. In each category, patients were quadrichotomized on the basis of their SBPs in emergency department: less than 140 mmHg, 140-184 mmHg, 185-219 mmHg, and 220 mmHg or more. The plasma catecholamine levels were compared among the four groups. Furthermore, multivariate regression analyses were carried out to identify variables correlated with hypertensive emergency (SBP = 185 mmHg). Results In SAH patients, there was a proportional increase in norepinephrine levels relative to the graded SBPs, and norepinephrine levels in the 220 mmHg or more group were significantly higher than those in the less than 140 mmHg group (1596 +/- 264 vs. 853 +/- 124 pg/ml, P = 0.03). By contrast, no proportional increase in norepinephrine levels to the graded SBPs was observed in SICH patients. Multivariate regression analyses showed that the initial Glasgow Coma Scale scores of 8 or less (odds ratio 2.251, 95% confidence interval 1.002-5.117) and plasma norepinephrine levels (odds ratio 1.002, 95% confidence interval 1.001-1.003) were correlated with hypertensive emergency in SAH patients. By contrast, none of the variables evaluated were correlated with hypertensive emergency in SICH patients. Conclusion An acute hypertensive response may be more complex, multifactorial, and less catecholamine dependent in SICH patients compared with SAH patients. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Inamasu, Joji; Moriya, Shigeta; Oheda, Motoki; Hasegawa, Mitsuhiro; Hirose, Yuichi] Fujita Hlth Univ Hosp, Dept Neurosurg, Toyoake, Aichi 4701192, Japan	Inamasu, J (reprint author), Fujita Hlth Univ Hosp, Dept Neurosurg, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	inamasu@fujita-hu.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [12345678]	The corresponding author (J.I.) received a research grant from the Japan Society for the Promotion of Science (JSPS KAKENHI grant number 12345678).	Parati G, 2012, EUR HEART J, V33, P1058, DOI 10.1093/eurheartj/ehs041; Brott T, 1998, STROKE, V29, P1504; Wakisaka Y, 2010, J CEREBR BLOOD F MET, V30, P56, DOI 10.1038/jcbfm.2009.183; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; GOLDSTEIN DS, 1983, HYPERTENSION, V5, P86; Sugimoto K, 2012, STROKE, V43, P1897, DOI 10.1161/STROKEAHA.111.646893; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Naredi S, 2000, STROKE, V31, P901; Qureshi AI, 2007, AM J EMERG MED, V25, P32, DOI 10.1016/j.ajem.2006.07.008; Qureshi AI, 2013, STROKE, V44, pS67, DOI 10.1161/STROKEAHA.111.000758; Qureshi AI, 2008, CIRCULATION, V118, P176, DOI 10.1161/CIRCULATIONAHA.107.723874; Esler M, 2010, HYPERTENSION, V55, P1090, DOI 10.1161/HYPERTENSIONAHA.110.151506; Inamasu J, 2014, NEUROREPORT, V25, P94, DOI 10.1097/WNR.0000000000000049; Inamasu J, 2013, INT J CARDIOL, V168, P1667, DOI 10.1016/j.ijcard.2013.03.096; KONARSKA M, 1990, PHYSIOL BEHAV, V47, P647, DOI 10.1016/0031-9384(90)90072-C; Kothari Rashmi U., 1996, Stroke, V27, P1304; Mansi JA, 1997, AM J PHYSIOL-REG I, V272, pR813; Ortega-Gutierrez S, 2013, NEUROCRIT CARE, V18, P13, DOI 10.1007/s12028-012-9782-1; Sun YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067402; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Woiciechowsky C, 2005, ACT NEUR S, V95, P373	21	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1359-5237	1473-5725		BLOOD PRESS MONIT	Blood Press. Monit.	JUN	2015	20	3					132	137		10.1097/MBP.0000000000000106		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CH5WF	WOS:000354105600004		
J	Tsuyuki, S; Yamaguchi, A; Kawata, Y; Kawaguchi, K				Tsuyuki, Shigeru; Yamaguchi, Ayane; Kawata, Yukiko; Kawaguchi, Kosuke			Assessing the effects of neoadjuvant chemotherapy on lymphatic pathways to sentinel lymph nodes in cases of breast cancer: Usefulness of the indocyanine green-fluorescence method	BREAST			English	Article						Sentinel lymph node biopsy; Indocyanine green (ICG)-fluorescence method; Lymphatic pathways; Neoadjuvant chemotherapy	PREOPERATIVE CHEMOTHERAPY; BLUE-DYE; BIOPSY; SURGERY; IDENTIFICATION; CARCINOMA	Backgrounds: It is not clear how lymphatic pathways to the sentinel lymph node (SLN) change during neoadjuvant chemotherapy (NAC) for breast cancer. Methods: Using the indocyanine green (ICG)-fluorescence method, we compared lymphatic pathways to the SLN (sentinel lymphatic pathways) and SLN location before and after NAC in 36 patients (38 breasts). Results: Despite that 42.8% of the sentinel lymphatic pathways were changed by NAC, the locations of the SLNs were not affected by NAC. Conclusion: These results suggest that the true SLN can be detected even after NAC, and that SLNB can be performed after NAC for clinically node-negative patients. (C) 2015 Elsevier Ltd. All rights reserved.	[Tsuyuki, Shigeru; Yamaguchi, Ayane; Kawata, Yukiko] Osaka Red Cross Hosp, Dept Breast Surg, Tennoji Ku, Osaka, Osaka 5438555, Japan; [Kawata, Yukiko; Kawaguchi, Kosuke] Kyoto Univ, Grad Sch Med, Dept Breast Surg, Sakyo Ku, Kyoto, Japan	Tsuyuki, S (reprint author), Osaka Red Cross Hosp, Dept Breast Surg, Tennoji Ku, 5-30 Fudegasaki Cho, Osaka, Osaka 5438555, Japan.	tyksgr@osaka-med.jrc.or.jp					Tagaya N, 2008, AM J SURG, V195, P850, DOI 10.1016/j.amjsurg.2007.02.032; Takeuchi M, 2012, BREAST J, V18, P535, DOI 10.1111/tbj.12004; Kuehn T, 2013, LANCET ONCOL, V14, P609, DOI 10.1016/S1470-2045(13)70166-9; Sugie T, 2013, ANN SURG ONCOL, V20, P2213, DOI 10.1245/s10434-013-2890-0; Xing Y, 2006, BRIT J SURG, V93, P539, DOI 10.1002/bjs.5209; Abe H, 2011, SURG TODAY, V41, P197, DOI 10.1007/s00595-009-4254-8; Cohen LF, 2000, AM J SURG PATHOL, V24, P1266, DOI 10.1097/00000478-200009000-00010; Han A, 2013, J BREAST CANCER, V16, P378, DOI 10.4048/jbc.2013.16.4.378; Hino M, 2008, SURG TODAY, V38, P585, DOI 10.1007/s00595-007-3686-2; Hirano A, 2012, ANN SURG ONCOL, V19, P4112, DOI 10.1245/s10434-012-2478-0; Kitai T, 2012, BREAST CANCER-TOKYO, V19, P343, DOI 10.1007/s12282-011-0286-1; Kuerer HM, 2002, SEMIN BREAST DIS, V5, P80; Sharkey FE, 1996, MODERN PATHOL, V9, P893; Ue H, 2007, ONCOL REP, V17, P1475; Veronesi P, 2007, BREAST, V16, pS67, DOI 10.1016/j.breast.2007.07.009; Vigario A, 2003, CLIN NUCL MED, V28, P553, DOI 10.1097/00003072-200307000-00004	16	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	JUN	2015	24	3					298	301		10.1016/j.breast.2015.02.034		4	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CG9HC	WOS:000353624600024		
J	Hayashi, H				Hayashi, Hajimu			Omission bias and perceived intention in children and adults	BRITISH JOURNAL OF DEVELOPMENTAL PSYCHOLOGY			English	Article						omission bias; moral judgement; perceived intention; antisocial situation; selfish situation	MORAL-JUDGMENTS; COMMISSION; MIND; COGNITION; EMOTIONS; BELIEF; ROLES	Omission bias refers to the tendency to judge acts of commission as morally worse than equivalent acts of omission. Children aged 7-8 and 11-12years, as well as adults, made moral judgements about acts of commission and omission in two conditions in which the protagonist obtained a self-directed benefit. In the antisocial condition, the other person was harmed; in the selfish condition, the other person was not harmed. The results showed that adults and both age groups of children judged that the agent who did something (act of commission) was morally worse than the agent who did nothing (omission) for both antisocial and selfish conditions, although this judgement tendency was clearer in the selfish condition than in the antisocial condition. Agent intention was held constant across commission and omission, but most participants rated the intention of the agent who did something as stronger than that of the agent who did nothing. These results suggest that omission bias occurs regardless of differences in age and situation. In addition, perceived intention appears to change in conjunction with omission bias.	[Hayashi, Hajimu] Kobe Univ, Grad Sch Human Dev & Environm, Div Dev Psychol, Kobe, Hyogo 6578501, Japan	Hayashi, H (reprint author), Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, 3-11 Tsurukabuto, Kobe, Hyogo 6578501, Japan.	hajimu@port.kobe-u.ac.jp			Japan Society for the Promotion of Science [23330199, 24730537]	This research was supported by grants-in-aid for scientific research (Nos. 23330199 and 24730537) from the Japan Society for the Promotion of Science.	Haidt J, 1996, EUR J SOC PSYCHOL, V26, P201, DOI 10.1002/(SICI)1099-0992(199603)26:2<201::AID-EJSP745>3.0.CO;2-J; Hauser M, 2007, MIND LANG, V22, P1, DOI 10.1111/j.1468-0017.2006.00297.x; SPRANCA M, 1991, J EXP SOC PSYCHOL, V27, P76, DOI 10.1016/0022-1031(91)90011-T; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Knobe J, 2005, TRENDS COGN SCI, V9, P357, DOI 10.1016/j.tics.2005.06.011; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Powell NL, 2012, J EXP CHILD PSYCHOL, V113, P186, DOI 10.1016/j.jecp.2012.03.006; Cushman F, 2008, COGNITION, V108, P353, DOI 10.1016/j.cognition.2008.03.006; Leslie AM, 2006, PSYCHOL SCI, V17, P421, DOI 10.1111/j.1467-9280.2006.01722.x; Hamlin JK, 2013, CURR DIR PSYCHOL SCI, V22, P186, DOI 10.1177/0963721412470687; Keller M, 2003, BRIT J DEV PSYCHOL, V21, P1, DOI 10.1348/026151003321164582; Anderson CJ, 2003, PSYCHOL BULL, V129, P139, DOI 10.1037//0033-2909.129.1.139; Nunez M, 1998, MIND LANG, V13, P153, DOI 10.1111/1468-0017.00071; Baron J, 2004, ORGAN BEHAV HUM DEC, V94, P74, DOI 10.1016/j.obhdp.2004.03.003; Blasi A, 1999, J THEOR SOC BEHAV, V29, P1, DOI 10.1111/1468-5914.00088; DeScioli P, 2011, PSYCHOL SCI, V22, P442, DOI 10.1177/0956797611400616; NELSONLEGALL SA, 1985, DEV PSYCHOL, V21, P332, DOI 10.1037//0012-1649.21.2.332; Cushman F, 2006, PSYCHOL SCI, V17, P1082, DOI 10.1111/j.1467-9280.2006.01834.x; Pellizzoni S, 2010, DEVELOPMENTAL SCI, V13, P265, DOI 10.1111/j.1467-7687.2009.00851.x; Knobe J, 2003, ANALYSIS, V63, P190, DOI 10.1111/1467-8284.00419; YUILL N, 1984, BRIT J DEV PSYCHOL, V2, P73; NELSON SA, 1980, CHILD DEV, V51, P823, DOI 10.1111/j.1467-8624.1980.tb02619.x; Talwar V, 2007, DEV PSYCHOL, V43, P804, DOI 10.1037/0012-1649.43.3.804; ARSENIO WF, 1985, MERRILL PALMER QUART, V31, P1; Astington JW, 2004, NEW DIR CHILD ADOLES, V103, P63, DOI 10.1002/cd.98; BARON J, 1993, MERRILL PALMER QUART, V39, P22; DeScioli P, 2011, EVOL HUM BEHAV, V32, P204, DOI 10.1016/j.evolhumbehav.2011.01.003; DeScioli P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046963; Hayashi H, 2007, JPN PSYCHOL RES, V49, P261, DOI 10.1111/j.1468-5884.2007.00352.x; Hayashi H, 2010, INFANT CHILD DEV, V19, P187, DOI 10.1002/icd.641; KARNIOL R, 1978, PSYCHOL BULL, V85, P76, DOI 10.1037/0033-2909.85.1.76; KeltikangasJarvinen L, 1997, J YOUTH ADOLESCENCE, V26, P467, DOI 10.1023/A:1024585406173; KordesdeVaal JH, 1996, ACTA PSYCHOL, V93, P161, DOI 10.1016/0001-6918(96)00027-3; Nunner-Winkler G., 1993, MORAL SELF, P269; Nunner-Winkler G., 1999, INDIVIDUAL DEV 3 12, P253; Piaget J., 1932, MORAL JUDGMENT CHILD; Siegal M, 1998, DEV PSYCHOL, V34, P332, DOI 10.1037//0012-1649.34.2.332; Smetana J. G., 2008, EUROPEAN J DEV SCI, V2, P324; Smetana J. G., 1993, CHILD PSYCHOL INTRO, P111; Turiel E., 1983, DEV SOCIAL KNOWLEDGE; Wynn K., 2008, INNATE MIND FDN FUTU, P330	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0261-510X	2044-835X		BRIT J DEV PSYCHOL	Br. J. Dev. Psychol.	JUN	2015	33	2					237	251		10.1111/bjdp.12082		15	Psychology, Developmental	Psychology	CH8BS	WOS:000354261500009		
J	Shimoda, M; Kubota, K; Shimizu, T; Katoh, M				Shimoda, M.; Kubota, K.; Shimizu, T.; Katoh, M.			Randomized clinical trial of adjuvant chemotherapy with S-1 versus gemcitabine after pancreatic cancer resection	BRITISH JOURNAL OF SURGERY			English	Article							PHASE-III TRIAL; DIHYDROPYRIMIDINE DEHYDROGENASE; THYMIDYLATE SYNTHASE; OROTATE PHOSPHORIBOSYLTRANSFERASE; COLORECTAL-CANCER; GASTRIC-CANCER; MESSENGER-RNA; EXPRESSION; FLUOROPYRIMIDINE; ADENOCARCINOMA	BackgroundRandomized studies of adjuvant chemotherapy using gemcitabine suggest a survival benefit after resection of pancreatic cancer. S-1 has also been shown to prolong survival in patients with unresectable pancreatic cancer. This study compared the effects of adjuvant chemotherapy with S-1 or gemcitabine after resection of pancreatic cancer in a randomized trial. MethodsPatients who had undergone resection of pancreatic cancer were registered in this randomized clinical trial. The primary endpoint was disease-free survival (DFS). Expression levels of thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) mRNAs in cancer tissues were measured as indicators of fluoropyrimidine sensitivity. ResultsOf 57 patients registered, 29 were allocated to the S-1 group and 28 to gemcitabine. DFS tended to be better with S-1 (median 146 (90 per cent c.i. 88 to 284) months versus 105 (70 to 284) months in the gemcitabine group; P=0188), with a similar pattern for overall survival: 215 (95 per cent c.i. 144 to 423) and 180 (133 to 428) months respectively (P=0293). When patients were divided into subgroups based on high or low DPD and TS expression, those with a DPD level below the median of 088 or a TS level of at least 200 had a significant prolongation of DFS after S-1 treatment compared with gemcitabine (P=0008 and P=0035 respectively). ConclusionOverall, S-1 did not improve DFS compared with gemcitabine after pancreatic cancer resection, but there seemed to be a DFS advantage in patients with low expression of DPD or high expression of TS. Reference number: UMIN000009118 (). Potential for tailored treatment	[Shimoda, M.; Kubota, K.; Shimizu, T.; Katoh, M.] Dokkyo Med Univ, Dept Surg 2, Mibu, Tochigi 3210293, Japan	Shimoda, M (reprint author), Dokkyo Med Univ, Dept Surg 2, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	mshimoda@dokkyomed.ac.jp					Okusaka T, 2008, CANCER CHEMOTH PHARM, V61, P615, DOI 10.1007/s00280-007-0514-8; Maeda A, 2008, JPN J CLIN ONCOL, V38, P227, DOI 10.1093/jjco/hym178; Kuramochi H, 2006, CLIN CANCER RES, V12, P29, DOI 10.1158/1078-0432.CCR-05-1275; Ichikawa W, 2003, BRIT J CANCER, V89, P1486, DOI 10.1038/sj.bjc.6601335; Valle JW, 2014, J CLIN ONCOL, V32, P504, DOI 10.1200/JCO.2013.50.7657; Fukui Y, 2008, INT J MOL MED, V22, P709, DOI 10.3892/ijmm_00000076; Mochizuki I, 2012, BRIT J CANCER, V106, P1268, DOI 10.1038/bjc.2012.86; Yoshioka H, 2013, ANN ONCOL, V24, P1326, DOI 10.1093/annonc/mds629; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Fujii Ryuta, 2003, Int J Clin Oncol, V8, P72, DOI 10.1007/s101470300013; Ide H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-420; Koizumi W, 2013, BRIT J CANCER, V109, P2079, DOI 10.1038/bjc.2013.555; LANGENBA.RJ, 1972, BIOCHEM BIOPH RES CO, V48, P1565, DOI 10.1016/0006-291X(72)90892-3; Lord RVN, 2000, J GASTROINTEST SURG, V4, P135, DOI 10.1016/S1091-255X(00)80049-9; Ogiuchi Y, 2008, ACTA HISTOCHEM CYTOC, V41, P39, DOI 10.1267/ahc.08002; Omata M, 2000, Nihon Geka Gakkai Zasshi, V101, P233; Saisho H, 2000, Nihon Geka Gakkai Zasshi, V101, P228; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sasako M, 2014, GASTRIC CANC; Shen XM, 2014, CELL BIOCH BIOPHYS; Shimoda M, 2009, PATHOBIOLOGY, V76, P193, DOI 10.1159/000218335; Sobin LH, 2009, INT UNION CANC UICC; Uesaka K, 2013, ASCO M S, V31, P145	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	JUN	2015	102	7					746	754		10.1002/bjs.9775		9	Surgery	Surgery	CH6ZA	WOS:000354184000005		
J	Marubashi, S; Gotoh, K; Akita, H; Takahashi, H; Ito, Y; Yano, M; Ishikawa, O; Sakon, M				Marubashi, S.; Gotoh, K.; Akita, H.; Takahashi, H.; Ito, Y.; Yano, M.; Ishikawa, O.; Sakon, M.			Anatomical versus non-anatomical resection for hepatocellular carcinoma	BRITISH JOURNAL OF SURGERY			English	Article							PROPENSITY SCORE METHODS; CLASSIFYING MICROVASCULAR INVASION; PRESERVED LIVER-FUNCTION; LONG-TERM SURVIVAL; HEPATIC RESECTION; INTRAHEPATIC RECURRENCE; TUMOR HEMODYNAMICS; MULTIVARIATE-ANALYSIS; RISK-FACTORS; HEPATECTOMY	BackgroundThe optimal surgical resection method in patients with HCC to minimize the risk of local recurrence has not yet been determined. The aim of this study was to compare the prognosis following anatomical versus non-anatomical hepatic resection for hepatocellular carcinoma (HCC). MethodsConsecutive patients with HCC without macroscopic vascular invasion, treated by curative resection between 1981 and 2012 at Osaka Medical Centre, were included in this retrospective study. The outcomes of patients selected by propensity score matching were compared. ResultsSome 1102 patients were included, 577 in the anatomical and 525 in the non-anatomical resection group. By propensity score matching, 329 patients were selected into each group. Demographic, preoperative and tumour variables were similar between the propensity score-matched groups, including tumour size, tumour multiplicity, -fetoprotein level and 15-min indocyanine green retention rate at 15min. The incidence of microvascular invasion was higher in the matched anatomical resection group (P=0048). Stratified analysis of recurrence-free and overall survival rates revealed no statistically significant differences between the two propensity score-matched groups (P=0704 and P=0381 respectively). There was also no significant difference in the early recurrence rate within 2years after resection between these groups (P=0726). Subset analysis of the early recurrence-free survival rate in patients with and without microvascular invasion revealed no significant differences between the groups (P=0312 and P=0479 respectively). ConclusionThe resection method had no impact on the risk of HCC recurrence or survival. Makes no difference	[Marubashi, S.; Gotoh, K.; Akita, H.; Takahashi, H.; Yano, M.; Ishikawa, O.; Sakon, M.] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka 5378511, Japan; [Ito, Y.] Osaka Med Ctr Canc & Cardiovasc Dis, Ctr Canc Control & Stat, Osaka 5378511, Japan	Marubashi, S (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	s-marubashi@umin.ac.jp					BELGHITI J, 1991, ANN SURG, V214, P114, DOI 10.1097/00000658-199108000-00004; Sasaki K, 2013, AM SURGEON, V79, P1163; MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; Roayaie S, 2009, GASTROENTEROLOGY, V137, P850, DOI 10.1053/j.gastro.2009.06.003; Utsunomiya T, 2014, ANN SURG, V259, P336, DOI 10.1097/SLA.0b013e31829291e9; Eguchi S, 2008, SURGERY, V143, P469, DOI 10.1016/j.surg.2007.12.003; [Anonymous], 1989, JPN J SURG, V19, P98; CHEN MF, 1994, ARCH SURG-CHICAGO, V129, P738; Ercolani G, 2003, ANN SURG, V237, P536, DOI 10.1097/00000658-200304000-00016; Yeh CN, 2002, J SURG ONCOL, V81, P195, DOI 10.1002/jso.10178; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; Poon RTP, 2002, ANN SURG, V235, P373, DOI 10.1097/00000658-200203000-00009; SHIRABE K, 1991, HEPATOLOGY, V14, P802, DOI 10.1002/hep.1840140510; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; [Anonymous], 2010, HEPATOL RES S1, V40, P2; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x; Ueno S, 2008, J HEPATO-BILIARY-PAN, V15, P493, DOI 10.1007/s00534-007-1312-8; Tiong L, 2011, BRIT J SURG, V98, P1210, DOI 10.1002/bjs.7669; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; Duffy JP, 2008, CANCER J, V14, P100, DOI 10.1097/PPO.0b013e31816a5c1f; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Gum PA, 2001, JAMA-J AM MED ASSOC, V286, P1187, DOI 10.1001/jama.286.10.1187; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Imamurai H, 1999, BRIT J SURG, V86, P1032, DOI 10.1046/j.1365-2168.1999.01185.x; Kaibori M, 2006, SURGERY, V139, P385, DOI 10.1016/j.surg.2005.08.035; Kang CM, 2010, J SURG RES, V160, P81, DOI 10.1016/j.jss.2009.01.021; Klein J.P., 1997, SURVIVAL ANAL TECHNI; Liver Cancer Study Group of Japan, 2003, GEN RUL CLIN PATH ST, P13; NAGASUE N, 1993, GASTROENTEROLOGY, V105, P488; Ochiai T, 2013, ANTICANCER RES, V33, P1689; Payen D, 2006, CRIT CARE, V10, DOI 10.1186/cc4925; Sakon M, 2013, HEPATOL RES, V43, P155, DOI 10.1111/hepr.12001; Sakon M, 2002, ARCH SURG-CHICAGO, V137, P94, DOI 10.1001/archsurg.137.1.94; Sakon M, 2000, J SURG ONCOL, V73, P179, DOI 10.1002/(SICI)1096-9098(200003)73:3<179::AID-JSO13>3.0.CO;2-M; Sumie S, 2014, ANN SURG ONCOL, V21, P1002, DOI 10.1245/s10434-013-3376-9; Tanaka K, 2008, SURGERY, V143, P607, DOI 10.1016/j.surg.2008.01.006; Tomimaru Y, 2012, DIGEST DIS SCI, V57, P1942, DOI 10.1007/s10620-012-2114-7; Wakai T, 2007, ANN SURG ONCOL, V14, P1356, DOI 10.1245/s10434-006-9318-z; Wu CC, 2005, BRIT J SURG, V92, P348, DOI 10.1002/bjs.4838; Yamamoto M, 2001, SURGERY, V130, P443, DOI 10.1067/msy.2001.116406; Zhou YM, 2011, LANGENBECK ARCH SURG, V396, P1109, DOI 10.1007/s00423-011-0784-9	43	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	JUN	2015	102	7					776	784		10.1002/bjs.9815		9	Surgery	Surgery	CH6ZA	WOS:000354184000008		
J	Kuroki, H; Hayashi, H; Nakagawa, S; Sakamoto, K; Higashi, T; Nitta, H; Hashimoto, D; Chikamoto, A; Beppu, T; Baba, H				Kuroki, H.; Hayashi, H.; Nakagawa, S.; Sakamoto, K.; Higashi, T.; Nitta, H.; Hashimoto, D.; Chikamoto, A.; Beppu, T.; Baba, H.			Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor beta signal activation and liver regeneration after hepatectomy in an experimental model	BRITISH JOURNAL OF SURGERY			English	Article							MAJOR HEPATECTOMY; CYCLIN D2; IN-VIVO; RATS; RESECTION; FIBROSIS; PROMOTES; FAILURE; MICE; GENE	BackgroundA strategy for accelerating liver regeneration after hepatectomy would offer great benefits in preventing postoperative liver failure and improving surgical outcomes. Transforming growth factor (TGF) is a potent inhibitor of hepatocyte proliferation. Recently, thrombospondin (TSP) 1 has been identified as a negative regulator of liver regeneration by activation of local TGF- signals. This study aimed to clarify whether the LSKL (leucine-serine-lysine-leucine) peptide, which inhibits TSP-1-mediated TGF- activation, promotes liver regeneration after hepatectomy in mice. MethodsMice were operated on with a 70 per cent hepatectomy or sham procedure. Operated mice received either LSKL peptide or normal saline intraperitoneally at abdominal closure and 6h after hepatectomy. Perioperative plasma TSP-1 levels were measured by enzyme-linked immunosorbent assay in patients undergoing hepatectomy. ResultsAdministration of LSKL peptide attenuated Smad2 phosphorylation at 6h. S-phase entry of hepatocytes was accelerated at 24 and 48h by LSKL peptide, which resulted in faster recovery of the residual liver and bodyweight. Haematoxylin and eosin tissue staining and blood biochemical examinations revealed no significant adverse effects following the two LSKL peptide administrations. In the clinical setting, plasma TSP-1 levels were lowest on the first day after hepatectomy. However, plasma TSP-1 levels at this stage were significantly higher in patients with subsequent liver dysfunction compared with levels in those without liver dysfunction following hepatectomy. ConclusionOnly two doses of LSKL peptide during the early period after hepatectomy can promote liver regeneration. The transient inhibition of TSP-1/TGF- signal activation using LSKL peptide soon after hepatectomy may be a promising strategy to promote subsequent liver regeneration. Although the mechanisms of liver regeneration after hepatectomy have been explored intensively in vivo, no therapeutic tools are thus far available to accelerate liver regeneration after hepatectomy in the clinical setting. Recently, the matricellular protein thrombospondin (TSP) 1, a major activator of latent transforming growth factor (TGF) 1, has been identified as a negative regulator of liver regeneration after hepatectomy. In this study, the inhibition of TSP-1-mediated TGF- signal activation by LSKL (leucine-serine-lysine-leucine) peptide in the early period after hepatectomy accelerated liver regeneration without any adverse effects. In addition, continuous high plasma TSP-1 levels after hepatectomy were associated with liver damage in humans. The transient inhibition of TSP-1/TGF- signal activation using LSKL peptide in the early period after hepatectomy could be a novel therapeutic strategy to accelerate liver regeneration after hepatectomy. A promising treatment target	[Kuroki, H.; Hayashi, H.; Nakagawa, S.; Sakamoto, K.; Higashi, T.; Nitta, H.; Hashimoto, D.; Chikamoto, A.; Beppu, T.; Baba, H.] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24791434]; Yokoyama Rinsho Yakuri Foundation; Takeda Science Foundation, Japan	This work was supported by a Grant-in-Aid for Young Scientists (B), the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 24791434) (to H.H.), Yokoyama Rinsho Yakuri Foundation (to H.H.) and Takeda Science Foundation, Japan (to H.H.).	Andreou A, 2013, J GASTROINTEST SURG, V17, P66, DOI 10.1007/s11605-012-2005-4; Fan ST, 2011, ANN SURG, V253, P745, DOI 10.1097/SLA.0b013e3182111195; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Reddy SK, 2011, J AM COLL SURGEONS, V212, P787, DOI 10.1016/j.jamcollsurg.2010.12.048; Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; HOELTING T, 1994, J CLIN ENDOCR METAB, V79, P401, DOI 10.1210/jc.79.2.401; Kim JW, 1998, GYNECOL ONCOL, V69, P230, DOI 10.1006/gyno.1998.5003; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Yang T, 2011, WORLD J SURG, V35, P2073, DOI 10.1007/s00268-011-1161-0; Hecht M, 2004, CANCER RES, V64, P6109, DOI 10.1158/0008-5472.CAN-04-1014; Belmadani S, 2007, AM J PATHOL, V171, P777, DOI 10.2353/ajpath.2007.070056; Kondou H, 2003, J HEPATOL, V39, P742, DOI 10.1016/S0168-8278(03)00377-5; Starlinger P, 2013, J HEPATOL, V58, P1053, DOI 10.1016/j.jhep.2012.11.037; Garcea G, 2009, J HEPATO-BILIARY-PAN, V16, P145, DOI 10.1007/s00534-008-0017-y; OLSEN PS, 1988, HEPATOLOGY, V8, P992, DOI 10.1002/hep.1840080503; Peters M, 2000, GASTROENTEROLOGY, V119, P1663, DOI 10.1053/gast.2000.20236; Huang SM, 2002, MOL CANCER THER, V1, P507; Hayashi H, 2012, HEPATOLOGY, V55, P1562, DOI 10.1002/hep.24800; Sweetwyne MT, 2012, MATRIX BIOL, V31, P178, DOI 10.1016/j.matbio.2012.01.006; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Kaibori M, 1997, J HEPATOL, V27, P381, DOI 10.1016/S0168-8278(97)80185-7; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Bouchard C, 2001, GENE DEV, V15, P2042, DOI 10.1101/gad.907901; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; desGraaf W, 2011, J NUCL MED, V52, P294; Glanemann M, 2009, INT J SURG, V7, P200, DOI 10.1016/j.ijsu.2009.03.004; Hayashi H, 2015, SURGERY, V157, P20, DOI 10.1016/j.surg.2014.06.013; Hayashi H, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00012; Ingenbleek Y, 2002, CLIN CHEM LAB MED, V40, P1281, DOI 10.1515/CCLM.2002.222; Jahn Stephan Christopher, 2012, Front Biosci (Schol Ed), V4, P749; JONES DE, 1995, AM J PHYSIOL-GASTR L, V268, pG872; Lu AL, 2011, AM J PATHOL, V178, P2573, DOI 10.1016/j.ajpath.2011.02.039; Makino H, 2005, J SURG RES, V127, P171, DOI 10.1016/j.jss.2005.04.029; Manizate F, 2010, ONCOLOGY-BASEL, V78, P131, DOI 10.1159/000315241; Nechemia-Arbely Y, 2011, J HEPATOL, V54, P922, DOI 10.1016/j.jhep.2010.08.017; Palavecino M, 2010, SURGERY, V147, P40, DOI 10.1016/j.surg.2009.06.027; Reddy SK, 2011, HPB, V13, P494, DOI 10.1111/j.1477-2574.2011.00330.x; Tiberio GAM, 2008, CYTOKINE, V42, P372, DOI 10.1016/j.cyto.2008.03.012; vansGameren MM, 1994, BLOOD, V84, P1434; Xie XS, 2010, ARCH PHARM RES, V33, P275, DOI 10.1007/s12272-010-0213-6; Yanagida H, 2006, J SURG RES, V130, P38, DOI 10.1016/j.jss.2005.08.002; Yee KO, 2004, AM J PATHOL, V165, P541, DOI 10.1016/S0002-9440(10)63319-6; Yoshikawa A, 1998, J SURG RES, V78, P54, DOI 10.1006/jsre.1998.5350	48	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	JUN	2015	102	7					813	825		10.1002/bjs.9765		13	Surgery	Surgery	CH6ZA	WOS:000354184000012		
J	Murakami, Y; Satoi, S; Motoi, F; Sho, M; Kawai, M; Matsumoto, I; Honda, G				Murakami, Y.; Satoi, S.; Motoi, F.; Sho, M.; Kawai, M.; Matsumoto, I.; Honda, G.		Multictr Study Grp	Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma	BRITISH JOURNAL OF SURGERY			English	Article							RANDOMIZED CONTROLLED-TRIAL; LONG-TERM SURVIVAL; VASCULAR RESECTION; ADJUVANT CHEMOTHERAPY; PHASE-II; CANCER; ADENOCARCINOMA; GEMCITABINE; INVOLVEMENT; SURGERY	BackgroundThe aim of this study was to determine the added value of portal or superior mesenteric vein (PV/SMV) resection during pancreatoduodenectomy for pancreatic head carcinoma. MethodsA multicentre observational study was conducted in patients with pancreatic head carcinoma who underwent pancreatoduodenectomy in seven Japanese hospitals between 2001 and 2012. Clinicopathological factors were compared between patients who did and did not undergo PV/SMV resection. Those with an impact on survival were identified by univariable and multivariable analysis. ResultsOf the 937 patients who underwent pancreatoduodenectomy, 435 (464 per cent) had PV/SMV resection, whereas the remaining 502 (536 per cent) did not. Some 715 and 639 per cent of patients with and without PV/SMV resection respectively had lymph node-positive disease. Patients who underwent PV/SMV resection had more advanced tumours. Perioperative mortality and morbidity rates did not differ between the two groups. Multivariable analysis revealed that PV/SMV resection was not an independent prognostic factor for overall survival (P=0268). Among the 435 patients in whom the PV/SMV was resected, borderline resectable tumours with arterial abutment (P=0021) and absence of adjuvant chemotherapy (P<0001) were independent predictors of poor survival in multivariable analysis. Patients with resectable or borderline resectable tumours with PV/SMV involvement had a median survival time with additional adjuvant chemotherapy of 437 and 297months respectively. Median survival time in patients with borderline resectable tumours with arterial abutment was 186months despite adjuvant chemotherapy. ConclusionPancreatoduodenectomy with PV/SMV resection and adjuvant chemotherapy in patients with pancreatic head carcinoma may provide good survival without increased mortality and morbidity. Potential role for adjuvant chemotherapy	[Murakami, Y.] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Surg, Hiroshima 7348551, Japan; [Satoi, S.] Kansai Med Univ, Dept Surg, Osaka, Japan; [Motoi, F.] Tohoku Univ, Div Gastroenterol Surg, Dept Surg, Sendai, Miyagi, Japan; [Sho, M.] Nara Med Univ, Dept Surg, Nara, Japan; [Kawai, M.] Wakayama Med Univ, Dept Surg 2, Wakayama, Japan; [Matsumoto, I.] Kobe Univ, Grad Sch Med, Dept Surg, Div Hepato Biliary Pancreat Surg, Kobe, Hyogo 657, Japan; [Honda, G.] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Surg, Tokyo, Japan	Murakami, Y (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	mura777@hiroshima-u.ac.jp					Riediger H, 2006, J GASTROINTEST SURG, V10, P1106, DOI 10.1016/j.gassur.2006.04.002; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Yamada S, 2013, PANCREAS, V42, P1004, DOI 10.1097/MPA.0b013e31827b2d7c; Murakami Y, 2013, J SURG ONCOL, V107, P414, DOI 10.1002/jso.23229; Nakao A, 2006, WORLD J SURG, V30, P976, DOI 10.1007/s00268-005-0438-6; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Ramacciato G, 2009, ANN SURG ONCOL, V16, P817, DOI 10.1245/s10434-008-0281-8; Ouaissi M, 2010, WORLD J SURG, V34, P2648, DOI 10.1007/s00268-010-0699-6; Tseng JF, 2004, J GASTROINTEST SURG, V8, P935, DOI 10.1016/j.gassur.2004.09.046; Sudo K, 2011, INT J RADIAT ONCOL, V80, P119, DOI 10.1016/j.ijrobp.2010.01.027; Wang CY, 2008, J GASTROINTEST SURG, V12, P2183, DOI 10.1007/s11605-008-0621-9; Kaneoka Y, 2009, SURGERY, V145, P417, DOI 10.1016/j.surg.2008.12.009; Hirano S, 2007, ANN SURG, V246, P46, DOI 10.1097/01.sla.0000258608.52615.5a; Hartel M, 2002, EUR J SURG, V168, P707, DOI 10.1080/00000000000000007; Wang JS, 2012, CANCER-AM CANCER SOC, V118, P3801, DOI 10.1002/cncr.26717; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Banz VM, 2012, EJSO-EUR J SURG ONC, V38, P72, DOI 10.1016/j.ejso.2011.08.134; Ishii H, 2010, JPN J CLIN ONCOL, V40, P573, DOI 10.1093/jjco/hyq011; Yekebas EF, 2008, ANN SURG, V247, P300, DOI 10.1097/SLA.0b013e31815aab22; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Chua TC, 2010, J GASTROINTEST SURG, V14, P1442, DOI 10.1007/s11605-009-1129-7; Harrison LE, 1996, ANN SURG, V224, P342, DOI 10.1097/00000658-199609000-00010; Jain S, 2005, HEPATO-GASTROENTEROL, V52, P1596; Muller SA, 2009, J GASTROINTEST SURG, V13, P784, DOI 10.1007/s11605-008-0791-5; NCCN Clinical Practice Guidelines in Oncology, 2012, NCCN CLIN PRACT GUID; Sahora K, 2011, SURGERY, V149, P311, DOI 10.1016/j.surg.2010.07.048; Shimada K, 2006, ANN SURG ONCOL, V13, P1569, DOI 10.1245/s10434-006-9143-4; Sobin LH, 2010, INT UNION CANC UICC; TAKAHASHI S, 1994, BRIT J SURG, V81, P1190, DOI 10.1002/bjs.1800810837	30	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	JUN	2015	102	7					837	846		10.1002/bjs.9799		10	Surgery	Surgery	CH6ZA	WOS:000354184000014		
J	Omiya, H; Yoshitani, K; Yamada, N; Kubota, Y; Takahashi, K; Kobayashi, J; Ohnishi, Y				Omiya, Hiroki; Yoshitani, Kenji; Yamada, Naoki; Kubota, Yosuke; Takahashi, Kanae; Kobayashi, Junjiro; Ohnishi, Yoshihiko			Preoperative brain magnetic resonance imaging and postoperative delirium after off-pump coronary artery bypass grafting: a prospective cohort study	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Article							WHITE-MATTER HYPERINTENSITIES; ASYMPTOMATIC CAROTID STENOSIS; ELDERLY-PATIENTS; CARDIAC-SURGERY; ON-PUMP; CARDIOPULMONARY BYPASS; COGNITIVE IMPAIRMENT; RATING-SCALE; RISK-FACTORS; MICROEMBOLI	Delirium after cardiac surgery is a serious complication, increasing morbidity and mortality. Despite its high expectations, off-pump coronary artery bypass grafting (OPCAB) has largely failed to reduce the incidence of postoperative neurological complications. To further investigate the reasons for this failure, we used perioperative brain magnetic resonance imaging (MRI) to determine the relation between MRI findings and postoperative delirium. Altogether, 98 patients undergoing elective OPCAB were enrolled in this prospective observational study. Patients underwent brain MRI and magnetic resonance angiography (MRA) before and after surgery to identify cerebral infarction, white matter lesions, and intracranial artery stenosis. Postoperative delirium in the intensive care unit was measured using the delirium rating scale. The relation between postoperative delirium and MRI findings was examined using logistic regression. Magnetic resonance imaging and MRA was completed in 88 (90%) of the patients. New ischemic lesions were present in seven (7.9%) patients. Delirium rating scale scores of 0, 1-7, and a parts per thousand yen 8 were found in 25 (31%), 48 (60%), and seven (9%) patients, respectively. Multivariate logistic regression analysis revealed that new ischemic lesions (odds ratio [OR] 11.07, 95% confidence interval [CI]: 1.53 to 80.03; P = 0.017), carotid artery stenosis (OR 7.06, 95% CI: 1.59 to 31.13; P = 0.010), history of myocardial infarction (OR 3.78, 95% CI: 1.05 to 13.65; P = 0.043), and deep subcortical white matter hyperintensity (OR 3.04, 95% CI: 1.14 to 8.12; P = 0.027) were significantly associated with postoperative delirium. Magnetic resonance imaging findings of new cerebral ischemic lesions, carotid stenosis, and deep subcortical white matter hyperintensity correlated significantly with postoperative delirium in patients who had undergone OPCAB surgery.	[Omiya, Hiroki; Yoshitani, Kenji; Kubota, Yosuke; Ohnishi, Yoshihiko] Natl Cerebral & Cardiovasc Ctr, Dept Anesthesiol, Suita, Osaka 5658565, Japan; [Yamada, Naoki] Natl Cerebral & Cardiovasc Ctr, Dept Radiol, Suita, Osaka, Japan; [Takahashi, Kanae] Natl Cerebral & Cardiovasc Ctr, Dept Adv Med Technol Dev, Suita, Osaka, Japan; [Kobayashi, Junjiro] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, Suita, Osaka, Japan	Yoshitani, K (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Anesthesiol, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	yoshitani.kenji.hp@ncvc.go.jp	Kobayashi, Junjiro/J-8547-2015		National Cerebral and Cardiovascular Centre [22-5-20]	This study was funded by a starter grant from National Cerebral and Cardiovascular Centre. '[Grant number 22-5-20]'. Trial registry number: UMIN000003485.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Robinson TN, 2009, ANN SURG, V249, P173, DOI 10.1097/SLA.0b013e31818e4776; Maldonado JR, 2013, AM J GERIAT PSYCHIAT, V21, P1190, DOI 10.1016/j.jagp.2013.09.005; Rudolph JL, 2009, CIRCULATION, V119, P229, DOI 10.1161/CIRCULATIONAHA.108.795260; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; [Anonymous], 2009, ANN THORAC SURG; Chaput AJ, 2012, CAN J ANESTH, V59, P304, DOI 10.1007/s12630-011-9658-4; Bokeriia LA, 2009, ANN THORAC SURG, V88, P349, DOI 10.1016/j.athoracsur.2009.02.031; Knipp SC, 2005, EUR J CARDIO-THORAC, V28, P88, DOI 10.1016/j.ejcts.2005.02.043; Houlind K, 2012, CIRCULATION, V125, P2431, DOI 10.1161/CIRCULATIONAHA.111.052571; Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905; Cerejeira J, 2010, ACTA NEUROPATHOL, V119, P737, DOI 10.1007/s00401-010-0674-1; Liu YH, 2009, ANESTH ANALG, V109, P1013, DOI 10.1213/ane.0b013e3181aed2bb; Rapp JH, 2008, STROKE, V39, P2354, DOI 10.1161/STROKEAHA.107.496737; Restrepo L, 2002, STROKE, V33, P2909, DOI 10.1161/01.STR.0000040408.75704.15; Romero JR, 2009, STROKE, V40, P1590, DOI 10.1161/STROKEAHA.108.535245; Abbott AL, 2005, STROKE, V36, P1128, DOI 10.1161/01.STR.0000166059.30464.0a; Gottesman RF, 2010, ANN NEUROL, V67, P338, DOI 10.1002/ana.21899; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Lamy A, 2012, NEW ENGL J MED, V366, P1489, DOI 10.1056/NEJMoa1200388; Miyazaki S, 2011, INTERACT CARDIOV TH, V12, P379, DOI 10.1510/icvts.2010.248872; FAZEKAS F, 1993, NEUROLOGY, V43, P1683; Garde E, 2000, LANCET, V356, P628, DOI 10.1016/S0140-6736(00)02604-0; KATZ ES, 1992, J AM COLL CARDIOL, V20, P70; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Djaiani George, 2006, Can J Anaesth, V53, P795; Franco JG, 2009, PSYCHOSOMATICS, V50, P255, DOI 10.1176/appi.psy.50.3.255; Grocott HP, 2007, J ANESTH, V21, P367, DOI 10.1007/s00540-007-0514-1; Hatano Y, 2013, AM J GERIAT PSYCHIAT, V21, P938, DOI 10.1016/j.jagp.2013.01.061; Mackinnon AD, 2005, STROKE, V36, P1726, DOI 10.1161/01.STR.0000173402.88560.ae; Marshall RS, 2012, NEUROLOGY, V78, P250, DOI 10.1212/WNL.0b013e31824365d3; Rudolph JL, 2009, PERFUSION-UK, V24, P409, DOI 10.1177/0267659109358207; Rudolph JL, 2005, J AM GERIATR SOC, V53, P462, DOI 10.1111/j.1532-5415.2005.53165.x; Saba L, 2009, AM J ROENTGENOL, V192, pW63, DOI 10.2214/AJR.07.3566; Shioiri A, 2010, AM J GERIAT PSYCHIAT, V18, P743, DOI 10.1097/JGP.0b013e3181d145c5; Streifler JY, 2001, STROKE, V32, P2753, DOI 10.1161/hs1201.099650; STROMHOLM T, 1995, EUR J VASC ENDOVASC, V10, P36, DOI 10.1016/S1078-5884(05)80196-0; Whitaker D, 2009, AM J SURG, V198, P254; Whitaker D, 2009, AM J SURG, V198, P295, DOI 10.1016/j.amjsurg.2008.11.019; Zheng S, 2014, BIOMED RES INT, V2014	40	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	JUN	2015	62	6					595	602		10.1007/s12630-015-0327-x		8	Anesthesiology	Anesthesiology	CH7ZR	WOS:000354255900006		
J	Watanabe, T; Yanabashi, K; Moriya, K; Maki, Y; Tsubokawa, N; Baba, H				Watanabe, Tatsunori; Yanabashi, Kazuhito; Moriya, Koji; Maki, Yutaka; Tsubokawa, Naoto; Baba, Hiroshi			Ultrasound-guided supraclavicular brachial plexus block in a patient with a cervical rib	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Letter									[Watanabe, Tatsunori; Baba, Hiroshi] Niigata Univ, Grad Sch Med & Dent Sci, Div Anesthesiol, Niigata, Japan; [Watanabe, Tatsunori; Yanabashi, Kazuhito; Moriya, Koji; Maki, Yutaka; Tsubokawa, Naoto] Niigata Hand Surg Fdn, Niigata, Japan	Watanabe, T (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Anesthesiol, Niigata, Japan.	tatsu-w@med.niigata-u.ac.jp					Thompson RW, 2012, MASTERY CARDIOTHORAC, VThird, P242; Tortorich J, 2013, J TENN DENT ASS, V93, P11; Tortorich Jordan, 2013, J Tenn Dent Assoc, V93, P8; Viertel VG, 2012, AM J NEURORADIOL, V33, P2191, DOI 10.3174/ajnr.A3143; Walden MJ, 2013, CLIN IMAG, V37, P938, DOI 10.1016/j.clinimag.2013.01.005	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	JUN	2015	62	6					671	673		10.1007/s12630-015-0331-1		3	Anesthesiology	Anesthesiology	CH7ZR	WOS:000354255900017		
J	Omiya, H; Yoshitani, K; Yamada, N; Kubota, Y; Takahashi, K; Kobayashi, J; Ohnishi, Y				Omiya, Hiroki; Yoshitani, Kenji; Yamada, Naoaki; Kubota, Yosuke; Takahashi, Kanae; Kobayashi, Junjiro; Ohnishi, Yoshihiko			Preoperative brain magnetic resonance imaging and postoperative delirium after off-pump coronary artery bypass grafting: a prospective cohort study (vol 62, pg 595, 2015)	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Correction									[Omiya, Hiroki; Yoshitani, Kenji; Kubota, Yosuke; Ohnishi, Yoshihiko] Natl Cerebral & Cardiovasc Ctr, Dept Anesthesiol, Suita, Osaka 5658565, Japan; [Yamada, Naoaki] Natl Cerebral & Cardiovasc Ctr, Dept Radiol, Suita, Osaka, Japan; [Takahashi, Kanae] Natl Cerebral & Cardiovasc Ctr, Dept Adv Med Technol Dev, Suita, Osaka, Japan; [Kobayashi, Junjiro] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, Suita, Osaka, Japan	Yoshitani, K (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Anesthesiol, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	yoshitani.kenji.hp@ncvc.go.jp	Kobayashi, Junjiro/J-8547-2015				Omiya H, 2015, CAN J ANESTH, V62, P595, DOI 10.1007/s12630-015-0327-x	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	JUN	2015	62	6					721	721		10.1007/s12630-015-0361-8		1	Anesthesiology	Anesthesiology	CH7ZR	WOS:000354255900022		
J	Ogawa, Y; Hamaguchi, S; Nishimaki, H; Kon, Y; Chiba, K; Sakurai, Y; Murakami, K; Arai, Y; Miyairi, T; Nakajima, Y				Ogawa, Yukihisa; Hamaguchi, Shingo; Nishimaki, Hiroshi; Kon, Yuri; Chiba, Kiyoshi; Sakurai, Yuka; Murakami, Kenji; Arai, Yasunori; Miyairi, Takeshi; Nakajima, Yasuo			Embolization by Direct Puncture with a Transpedicular Approach Using an Isocenter Puncture (ISOP) Method in a Patient with a Type II Endoleak After Endovascular Aortic Repair (EVAR)	CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article						Isocenter puncture (ISOP); Transpedicular; Type II endoleak; Embolization	PERCUTANEOUS VERTEBROPLASTY	Endovascular aortic repair (EVAR) requires further intervention in 20-30 % of cases, often due to type II endoleak (T2EL). Management options for T2EL include transarterial embolization, direct puncture (DP), or transcaval embolization. We report the case of an 80-year-old man with T2EL who successfully underwent DP embolization. Embolization by DP was performed with a transpedicular approach using an isocenter puncture (ISOP) method. An isocenter marker (ICM) was placed at a site corresponding to the aneurysm sac on fluoroscopy in two directions (frontal and lateral views). A vertebroplasty needle was inserted tangentially to the ICM under fluoroscopy and advanced to the anterior wall of the vertebral body. A 20 cm-length, 20-G-PTCD needle was inserted through the outer needle of the 13-G needle and advanced to the ICM. Sac embolization using 25 % N-buty-2-cyanoacrylate diluted with Lipiodol was performed. After complete embolization, rotational DA confirmed good filling of the sac with Lipiodol. The outer cannula and 13-G needle were removed and the procedure was completed. The patient was discharged the next day. Contrast-enhanced computed tomography 1 and 8 months later showed no Lipiodol washout in the aneurysm sac, no endoleak recurrence, and no expansion of the excluded aneurysm. DP with a transpedicular approach using ISOP may be useful when translumbar and transabdominal approaches prove difficult.	[Ogawa, Yukihisa; Hamaguchi, Shingo; Kon, Yuri; Murakami, Kenji; Arai, Yasunori; Nakajima, Yasuo] St Marianna Univ, Dept Radiol, Sch Med, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan; [Nishimaki, Hiroshi; Chiba, Kiyoshi; Sakurai, Yuka; Miyairi, Takeshi] St Marianna Univ, Dept Cardiovasc Surg, Sch Med, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan	Ogawa, Y (reprint author), St Marianna Univ, Dept Radiol, Sch Med, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	yukky.oct.22@gmail.com					Mehta M, 2010, J VASC SURG, V52, P1442, DOI 10.1016/j.jvs.2010.06.110; FLEMING JS, 1974, BRIT J RADIOL, V47, P34; Komemushi A, 2011, RADIOL RES PRACT; Mathis JM, 2003, AM J NEURORADIOL, V24, P1697; Sakaino S, 2008, RADIAT MED, V26, P70, DOI [10.1007/s11604-007-0197-4, 10.1007/s11604-007-0197]; Takizawa K, 2007, CARDIOVASC INTER RAD, V30, P757, DOI 10.1007/s00270-007-9022-9	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0174-1551	1432-086X		CARDIOVASC INTER RAD	Cardiovasc. Interv. Radiol.	JUN	2015	38	3					731	735		10.1007/s00270-015-1065-8		5	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CH6BY	WOS:000354122000028		
J	Yoshino, D; Sato, K; Sato, M				Yoshino, Daisuke; Sato, Kakeru; Sato, Masaaki			Endothelial Cell Response Under Hydrostatic Pressure Condition Mimicking Pressure Therapy	CELLULAR AND MOLECULAR BIOENGINEERING			English	Article						Positive pressure; Negative pressure; Endothelial morphology; Cellular area; Cell density; Cell cycle; Proliferation	VACUUM-ASSISTED CLOSURE; ACTIN NETWORKS; SHEAR-STRESS; PROLIFERATION; CYTOSKELETON; MORPHOLOGY; MIGRATION; CADHERIN; WOUNDS	Chronic wounds increase the risk of infection and may lead to complications or disease. Although treatment techniques involving topical negative pressure have been used widely to promote wound healing, the relationship between promotion of wound healing and negative pressure remains unclear. In the present study, we studied the effects of hydrostatic pressure (HP) on endothelial cells (ECs) during pressure treatment. We examined the morphologic and functional responses of ECs to HP using an experimental system developed to apply both negative and positive pressure to ECs. Morphologic parameters such as aspect ratio, orientation angle, and tortuosity did not change after exposure to HP for up to 24 h. In contrast, application of HP led to significant changes in cell area and cell density, and the formation of intercellular gaps was observed as early as 3 h before the cell density reached its peak value. We also found HP progressed EC cycle, which remained at rest according to contact inhibition. Although there were some differences with respect to trends in changes in those parameters, positive and negative pressures had similar effects on ECs. Considering the results of this study, we conclude that exposure to HP enhances the proliferation of ECs.	[Yoshino, Daisuke] Tohoku Univ, Inst Fluid Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Sato, Kakeru] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Sato, Masaaki] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Sato, Kakeru] Tokyo Gas Co Ltd, Minato Ku, Tokyo 1058527, Japan	Yoshino, D (reprint author), Tohoku Univ, Inst Fluid Sci, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	yoshino.d@m.tohoku.ac.jp					Hsu CC, 2010, AM J PHYSIOL-CELL PH, V299, pC528, DOI 10.1152/ajpcell.00504.2009; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; ZHAO SM, 1995, ARTERIOSCL THROM VAS, V15, P1781; Ubbink DT, 2008, BRIT J SURG, V95, P685, DOI 10.1002/bjs.6238; Baldwin C, 2009, ANN PLAS SURG, V62, P92, DOI 10.1097/SAP.0b013e31817762fd; Sato M, 2005, BIORHEOLOGY, V42, P421; Lambert KV, 2005, EUR J VASC ENDOVASC, V29, P219, DOI 10.1016/j.ejvs.2004.12.017; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; DeFranzo AJ, 2001, PLAST RECONSTR SURG, V108, P1184, DOI 10.1097/00006534-200110000-00013; Argenta LC, 1997, ANN PLAS SURG, V38, P563, DOI 10.1097/00000637-199706000-00002; Velnar T, 2009, J INT MED RES, V37, P1528; Pujol T, 2012, P NATL ACAD SCI USA, V109, P10364, DOI 10.1073/pnas.1121238109; de Paula J., 2006, ATKINS PHYS CHEM; Fisher A. B., 2001, AM J PHYSIOL-LUNG C, V281, P529; Genecov DG, 1998, ANN PLAS SURG, V40, P219, DOI 10.1097/00000637-199803000-00004; Hothorn T., 2014, HDB STAT ANAL USING; Ito T, 2006, J PHYS CHEM B, V110, P13572, DOI 10.1021/jp060612r; Muller-Marschhausen K, 2008, AM J PHYSIOL-CELL PH, V294, pC324, DOI 10.1152/ajpcell.00319.2007; Ohashi T., 2006, T JPN SOC MED BIOL E, V44, P454; Ohashi T, 2007, J BIOMECH, V40, P2399, DOI 10.1016/j.jbiomech.2006.11.023; Salwen SA, 1998, MED BIOL ENG COMPUT, V36, P520, DOI 10.1007/BF02523225; Schwartz EA, 1999, CIRC RES, V84, P315; Sugaya Y, 2003, JSME INT J C-MECH SY, V46, P1248, DOI 10.1299/jsmec.46.1248; Sullivan N., NEGATIVE PRESSURE WO; Ubbink DT, 2008, COCHRANE DB SYST REV, V16	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1865-5025	1865-5033		CELL MOL BIOENG	Cell. Mol. Bioeng.	JUN	2015	8	2					296	303		10.1007/s12195-015-0385-8		8	Cell & Tissue Engineering; Biophysics; Cell Biology	Cell Biology; Biophysics	CH4ET	WOS:000353986500007		
J	Hori, H; Saito, H; Sakai, H; Kitahara, T; Sakamoto, T				Hori, Hisao; Saito, Hiroki; Sakai, Hidenori; Kitahara, Toshiyuki; Sakamoto, Takehiko			Efficient decomposition of a new fluorochemical surfactant: Perfluoroalkane disulfonate to fluoride ions in subcritical and supercritical water	CHEMOSPHERE			English	Article						Fluorine; Surfactant; Alternative; Iron	DISPROPORTIONATION; DESTRUCTION; REACTOR; WUSTITE; IRON	Decomposition of -O3SC3F6SO3- in subcritical and supercritical water was investigated, and the results were compared with the results for C3F7SO3-. This is the first report on the decomposition of perfluoroalkane disulfonates, which are being introduced in electronics industry as greener alternatives to environmentally persistent and bioaccumulative perfluoroalkyl surfactants. Addition of zerovalent iron to the reaction system dramatically increased the yield of F- in the reaction solution: when the reaction of -O3SC3F6SO3- was carried out in subcritical water at 350 degrees C for 6 h, the F- yield was 70%, which was 23 times the yield without zerovalent iron. Prolonged reaction increased the F- formation: after 18 h, the F- yield from the reaction of -O3SC3F6SO3- reached 81%, which was 2.1 times the F- yield from the reaction of C3F7SO3-. Although the reactivity of FeO toward these substrates was lower than zerovalent iron in subcritical water, the reactivity was enhanced when the reaction temperature was elevated to supercritical state, at which temperature FeO underwent in situ disproportionation to form zerovalent iron, which acted as the reducing agent. When the reaction of -O3SC3F6SO3- was carried out in the presence of FeO in supercritical water at 380 degrees C for 18 h, the F- yield reached 92%, which was the highest yield among tested. (C) 2014 Elsevier Ltd. All rights reserved.	[Hori, Hisao; Saito, Hiroki; Sakai, Hidenori; Kitahara, Toshiyuki; Sakamoto, Takehiko] Kanagawa Univ, Fac Sci, Dept Chem, Hiratsuka, Kanagawa 2591293, Japan	Hori, H (reprint author), Kanagawa Univ, Fac Sci, Dept Chem, 2946 Tsuchiya, Hiratsuka, Kanagawa 2591293, Japan.	h-hori@kanagawa-u.ac.jp			Japan Society for the Promotion of Sciences (JSPS)	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Sciences (JSPS).	Kawasaki SI, 2006, PROCESS SAF ENVIRON, V84, P317, DOI 10.1205/psep.05187; Ahrens L, 2011, J ENVIRON MONITOR, V13, P20, DOI 10.1039/c0em00373e; Hori H, 2006, ENVIRON SCI TECHNOL, V40, P1049, DOI 10.1021/es0517419; Hawthorne SB, 2000, ENVIRON SCI TECHNOL, V34, P3224, DOI 10.1021/es991431o; STOLEN S, 1995, THERMOCHIM ACTA, V256, P91, DOI 10.1016/0040-6031(94)02166-L; BROUSSAR.L, 1969, J PHYS CHEM-US, V73, P1848, DOI 10.1021/j100726a035; Foy BR, 1996, ENVIRON SCI TECHNOL, V30, P2790, DOI 10.1021/es960041o; Giesy J. P., 2002, ENVIRON SCI TECHNOL, V36, p146A, DOI DOI 10.1021/ES022253T; Leitner W., 1999, CHEM SYNTHESIS USING; Rahman M.D., 2007, Photoactive Compounds, PCT International Patent Application, Patent No. [WO2007/007175 A2, 2007007175]; TESTER JW, 1993, ACS SYM SER, V518, P35; UNEP, 2009, 4 M C PART STOCKH CO; UNEP, 2011, PERS ORG POLL REV CO	13	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-6535	1879-1298		CHEMOSPHERE	Chemosphere	JUN	2015	129				SI		27	32		10.1016/j.chemosphere.2014.06.052		6	Environmental Sciences	Environmental Sciences & Ecology	CH0SL	WOS:000353732600004		
J	Jonsson, D; Finskas, O; Fujioka, Y; Stahlberg, A; Olmarker, K				Jonsson, Daniel; Finskas, Oscar; Fujioka, Yuki; Stahlberg, Anders; Olmarker, Kjell			Experimental Disc Herniation in the Rat Causes Downregulation of Serotonin Receptor 2c in a TNF-dependent Manner	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							NECROSIS-FACTOR-ALPHA; PAIN-RELATED BEHAVIOR; NERVE ROOT INJURY; SELECTIVE-INHIBITION; HISTOLOGIC-CHANGES; PCR; 5-HYDROXYTRYPTAMINE; ANTINOCICEPTION; SCIATICA; GENES	During recent decades, the knowledge of the pathophysiology of disc herniation and sciatica has drastically improved. What previously was considered a strict biomechanical process is now considered a more complex interaction between leaked nucleus pulposus and the tissue in the spinal canal. An inflammatory reaction, with tumor necrosis factor (TNF) playing an essential role, has been demonstrated. However, the exact mechanisms of the pathophysiology of disc herniation remain unknown. In this study we use an animal model to investigate (1) if and/or how experimental disc herniation affects gene expression in the early phase (24 hours postsurgery) in the dorsal root ganglion; and (2) if TNF inhibition can reduce any observed changes. A rat model of disc herniation was used. Twenty rats were evenly divided into four groups: na < ve, sham, disc herniation, and disc herniation with TNF inhibition. The dorsal root ganglion of the affected nerve root was harvested 24 hours after surgery and analyzed with a TaqMan Low Density Array(A (R)) quantitative polymerase chain reaction assay. Gene expression levels in sham were compared with disc herniation to assess question 1 and disc herniation to disc herniation with TNF inhibition to assess question 2. Experimental disc herniation caused a decrease in the expression of the serotonin receptor 2c gene (p = 0.022). TNF inhibition was found to reduce the observed decrease in expression of serotonin receptor 2c (p = 0.037). Our results suggest that a decrease in the expression of the serotonin receptor 2c gene may contribute to the pathophysiology of disc herniation. Further research on its involvement is warranted. This pilot study gives a brief insight into cellular changes that may contribute to the pathophysiology of disc herniation. This knowledge may contribute to the development of more and better treatment options for patients with disc herniation and sciatica.	[Jonsson, Daniel; Finskas, Oscar; Fujioka, Yuki; Olmarker, Kjell] Univ Gothenburg, Musculoskeletal Res, Dept Med Chem & Cell Biol, Inst Biomed,Sahlgrenska Acad, S-40530 Gothenburg, Sweden; [Fujioka, Yuki] Hiroshima Univ, Dept Orthopaed Surg, Programs Appl Biomed, Grad Sch Biomed Sci, Hiroshima, Japan	Olmarker, K (reprint author), Univ Gothenburg, Musculoskeletal Res, Dept Med Chem & Cell Biol, Inst Biomed,Sahlgrenska Acad, S-40530 Gothenburg, Sweden.	kjell.olmarker@gu.se			AFA Insurance; Stiftelsen Olle Engkvist byggmastare; IngaBritt och Arne Lundbergs forskningsstiftelse; Spine Society of Europe Task Force on Research; Swedish Research Council; Swedish Society for Medical Research	One of the authors (KO) is founder and part owner of Orthopaedic Research & Development AB, Stayble Therapeutics and Sciaticon AB, Molndal, Sweden. One of the authors (AS) is part owner of TATAA Biocenter, Gothenburg, Sweden. The institution of the corresponding author (KO) has received funding from AFA Insurance, Stiftelsen Olle Engkvist byggmastare, IngaBritt och Arne Lundbergs forskningsstiftelse, and the Spine Society of Europe Task Force on Research. One of the authors (AS) is supported by the Swedish Research Council and Swedish Society for Medical Research.	Kato K, 2008, SPINE, V33, P1330, DOI 10.1097/BRS.0b013e318173298b; Suzuki R, 2004, TRENDS PHARMACOL SCI, V25, P613, DOI 10.1016/j.tips.2004.10.002; Korhonen T, 2006, SPINE, V31, P2759, DOI 10.1097/01.brs.0000245873.23876.1e; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; OLMARKER K, 1993, SPINE, V18, P1425; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Olmarker K, 1998, SPINE, V23, P2538, DOI 10.1097/00007632-199812010-00008; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Jeong CY, 2004, EUR J PHARMACOL, V502, P205, DOI 10.1016/j.ejphar.2004.08.048; Byröd G, 1998, Eur Spine J, V7, P445, DOI 10.1007/s005860050106; Finskas O, 2013, SPINE, V38, P1744, DOI 10.1097/BRS.0b013e3182a0d264; Freeman BJC, 2013, SPINE, V38, P1986, DOI 10.1097/01.brs.0000435140.61593.4c; Kobayashi H, 2011, SPINE, V36, P210, DOI 10.1097/BRS.0b013e3181fea618; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Murata Y, 2004, SPINE, V29, P2477, DOI 10.1097/01.brs.0000144406.17512.ea; Nachemson A, 2000, BACKACHE NECK PAIN E; Olmarker K, 2003, SPINE, V28, P1635, DOI 10.1097/00007632-200308010-00002; Olmarker K, 2001, SPINE, V26, P863, DOI 10.1097/00007632-200104150-00007; Saito H, 2014, EUR SPINE J; Sasaki M, 2003, ANESTH ANALG, V96, P1072, DOI 10.1213/01.ANE.0000050560.15341.A8; Sommer Claudia, 2006, Curr Pain Headache Rep, V10, P101, DOI 10.1007/s11916-006-0020-4; Stahlberg A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-170	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JUN	2015	473	6					1913	1919		10.1007/s11999-014-3878-1		7	Orthopedics; Surgery	Orthopedics; Surgery	CH6FX	WOS:000354133000011		
J	Fujii, M; Nakamura, T; Hara, T; Nakashima, Y; Iwamoto, Y				Fujii, Masanori; Nakamura, Tetsuro; Hara, Toshihiko; Nakashima, Yasuharu; Iwamoto, Yukihide			Does Radiographic Coxa Profunda Indicate Increased Acetabular Coverage or Depth in Hip Dysplasia?	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							FEMOROACETABULAR IMPINGEMENT; PERIACETABULAR OSTEOTOMY; YOUNG-ADULT; OSTEOARTHRITIS; RETROVERSION; REPLACEMENT; JOINT	Although radiographic coxa profunda has been considered an indicator of acetabular overcoverage, recent studies suggest that radiographic coxa profunda is a nonspecific finding seen even in hip dysplasia. The morphologic features of coxa profunda in hip dysplasia and the frequency with which the two overlap are not well defined. We determined (1) the prevalence of radiographic coxa profunda in patients with hip dysplasia; (2) the morphologic differences of the acetabulum and pelvis between patients with hip dysplasia and control subjects; and (3) the morphologic differences between hip dysplasia with and without coxa profunda. We retrospectively reviewed the pelvic radiographs and CT scans of 70 patients (70 hips) with hip dysplasia. Forty normal hips were used as controls. Normal hips were defined as those with a lateral center-edge angle between 25A degrees and 40A degrees. Coxa profunda was defined as present when the acetabular fossa was observed to touch or was medial to the ilioischial line on an AP pelvic radiograph. CT measurements included acetabular version, acetabular coverage, acetabular depth, and rotational alignment of the innominate bone. The prevalence of coxa profunda was 44% (31 of 70 hips) in dysplastic hips and 73% (29 of 40 hips) in the control hips (odds ratio, 3.32; 95% CI, 1.43-7.68). Dysplastic hips had a more anteverted and globally shallow acetabulum with inwardly rotated innominate bone compared with the control hips (p < 0.001). Dysplastic hips with coxa profunda had a more anteverted acetabulum (p < 0.001) and inwardly rotated innominate bone (p < 0.002) compared with those without coxa profunda, whereas the acetabular coverage and depth did not differ between the two groups, with the numbers available. Radiographic coxa profunda was not a sign of increased acetabular coverage and depth in patients with hip dysplasia, but rather indicates classic acetabular dysplasia, defined by an anteverted acetabulum with anterolateral acetabular deficiency and an inwardly rotated pelvis. Thus, the presence of coxa profunda does not indicate a disease in addition to hip dysplasia, and the conventional maneuvers during periacetabular osteotomy are adequate for these patients. Level IV, diagnostic study.	[Fujii, Masanori; Nakamura, Tetsuro; Hara, Toshihiko] Kyushu Hosp, Dept Orthopaed Surg, Japan Community Hlth Care Org, Yahatanishi Ku, Kitakyushu, Fukuoka 8068501, Japan; [Nakashima, Yasuharu; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka 812, Japan	Fujii, M (reprint author), Kyushu Hosp, Dept Orthopaed Surg, Japan Community Hlth Care Org, Yahatanishi Ku, 1-8-1 Kishinoura, Kitakyushu, Fukuoka 8068501, Japan.	masanorif9@gmail.com					ANDA S, 1986, Acta Radiologica Diagnosis, V27, P443; Anderson LA, 2012, CLIN ORTHOP RELAT R, V470, P3375, DOI 10.1007/s11999-012-2509-y; LEWINNEK GE, 1978, J BONE JOINT SURG AM, V60, P217; Beck M, 2005, J BONE JOINT SURG BR, V87B, P1012, DOI 10.1302/0301-620X.87B7.15203; ARMBUSTER TG, 1978, RADIOLOGY, V128, P1; Siebenrock KA, 2003, J BONE JOINT SURG AM, V85A, P278; Clohisy JC, 2008, J BONE JOINT SURG AM, V90A, P47, DOI 10.2106/JBJS.H.00756; Dandachli W, 2008, J BONE JOINT SURG BR, V90B, P1428, DOI 10.1302/0301-620X.90B11.20073; Nepple JJ, 2013, J BONE JOINT SURG AM, V95A, P417, DOI 10.2106/JBJS.K.01664; Jamali AA, 2007, J ORTHOP RES, V25, P758, DOI 10.1002/jor.20380; Ganz R, 2003, CLIN ORTHOP RELAT R, P112, DOI 10.1097/01.blo.0000096804.78689.c2; HEYMAN CH, 1950, J BONE JOINT SURG AM, V32-A, P767; KLAUE K, 1991, J BONE JOINT SURG BR, V73, P423; Fujii M, 2011, CLIN ORTHOP RELAT R, V469, P1735, DOI 10.1007/s11999-010-1746-1; Yoshimura N, 1998, BRIT J RHEUMATOL, V37, P1193; CROWE JF, 1979, J BONE JOINT SURG AM, V61, P15; Henak CR, 2011, J BIOMECH, V44, P2201, DOI 10.1016/j.jbiomech.2011.06.011; Fujii M, 2010, J BONE JOINT SURG AM, V92A, P895, DOI 10.2106/JBJS.I.00046; Ganz R, 2007, HIP INT, V17, pS22; SHARP IK, 1961, J BONE JOINT SURG BR, V43, P268; Dudda M, 2011, ARTHRITIS RHEUM-US, V63, P2992, DOI 10.1002/art.30472; MASSIE WK, 1950, J BONE JOINT SURG AM, V32-A, P519; Albers CE, 2013, CLIN ORTHOP RELAT R, V471, P1602, DOI 10.1007/s11999-013-2799-8; Boone G, 2012, CLIN ORTHOP RELAT R, V470, P3368, DOI 10.1007/s11999-012-2539-5; Clohisy John C, 2006, J Bone Joint Surg Am, V88 Suppl 1 Pt 1, P65, DOI 10.2106/JBJS.E.00887; COOPERMAN DR, 1983, CLIN ORTHOP RELAT R, P79; GENDA E, 1995, ARCH ORTHOP TRAUM SU, V114, P202, DOI 10.1007/BF00444263; HARRIS WH, 1986, CLIN ORTHOP RELAT R, P20; MURPHY SB, 1990, CLIN ORTHOP RELAT R, P214; Myers SR, 1999, CLIN ORTHOP RELAT R, P93; RUELLE M, 1962, Rev Rhum Mal Osteoartic, V29, P476; Tannast M, 2012, CLIN ORTHOP RELAT R, V470, P3459, DOI 10.1007/s11999-012-2572-4; Tonnis D., 1987, CONGENITAL DYSPLASIA, P165; Wiberg G, 1939, ACTA CHIR SCAND S58, V83, P5	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JUN	2015	473	6					2056	2066		10.1007/s11999-014-4084-x		11	Orthopedics; Surgery	Orthopedics; Surgery	CH6FX	WOS:000354133000031		
J	Samura, T; Ikegaya, Y; Sato, YD				Samura, Toshikazu; Ikegaya, Yuji; Sato, Yasuomi D.			A neural network model of reliably optimized spike transmission	COGNITIVE NEURODYNAMICS			English	Review						Spike transmission; Power-law-distributed synchrony; Log-normally distributed synaptic weights; Synaptic background activity	NEURONAL AVALANCHES; CORTICAL NETWORKS; IN-VITRO; SINGLE NEURONS; FIRING RATES; HIPPOCAMPUS; CA3; DYNAMICS; SYNCHRONY; INFORMATION	We studied the detailed structure of a neuronal network model in which the spontaneous spike activity is correctly optimized to match the experimental data and discuss the reliability of the optimized spike transmission. Two stochastic properties of the spontaneous activity were calculated: the spike-count rate and synchrony size. The synchrony size, expected to be an important factor for optimization of spike transmission in the network, represents a percentage of observed coactive neurons within a time bin, whose probability approximately follows a power-law. We systematically investigated how these stochastic properties could matched to those calculated from the experimental data in terms of the log-normally distributed synaptic weights between excitatory and inhibitory neurons and synaptic background activity induced by the input current noise in the network model. To ensure reliably optimized spike transmission, the synchrony size as well as spike-count rate were simultaneously optimized. This required changeably balanced log-normal distributions of synaptic weights between excitatory and inhibitory neurons and appropriately amplified synaptic background activity. Our results suggested that the inhibitory neurons with a hub-like structure driven by intensive feedback from excitatory neurons were a key factor in the simultaneous optimization of the spike-count rate and synchrony size, regardless of different spiking types between excitatory and inhibitory neurons.	[Samura, Toshikazu] Yamaguchi Univ, Grad Sch Med, Dept Appl Mol Biosci, Ube, Yamaguchi 7558508, Japan; [Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Sato, Yasuomi D.] Goethe Univ Frankfurt, FIAS, D-60438 Frankfurt, Germany; [Sato, Yasuomi D.] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Sato, YD (reprint author), Goethe Univ Frankfurt, FIAS, Ruth Moufang Str 1, D-60438 Frankfurt, Germany.	sato@fias.uni-frankfurt.de			Funding Program for Next Generation World-Leading Researchers [LS023];  [25540110]	Y. D. S. was partially supported by a Grant-in-Aid for Challenging Exploring Research No. 25540110. Y. I. was partially supported by the Funding Program for Next Generation World-Leading Researchers (No. LS023).	Brown E, 2004, NEURAL COMPUT, V16, P673, DOI 10.1162/089976604322860668; Takahashi N, 2010, P NATL ACAD SCI USA, V107, P10244, DOI 10.1073/pnas.0914594107; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Larremore DB, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.058101; Hampson RE, 2004, P NATL ACAD SCI USA, V101, P3184, DOI 10.1073/pnas.0400162101; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Jiruska P, 2010, J NEUROSCI, V30, P5690, DOI 10.1523/JNEUROSCI.0535-10.2010; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Singer W, 2009, COGN NEURODYNAMICS, V3, P189, DOI 10.1007/s11571-009-9087-z; Yoshida M, 2002, NEURAL NETWORKS, V15, P1171, DOI 10.1016/S0893-6080(02)00092-8; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; Jensen MS, 1996, J PHYSIOL-LONDON, V492, P199; Touboul J, 2009, SIAM J APPL DYN SYST, V8, P1462, DOI 10.1137/080742762; Sarid L, 2007, P NATL ACAD SCI USA, V104, P16353, DOI 10.1073/pnas.0707853104; Ikegaya Y, 2013, CEREB CORTEX, V23, P293, DOI 10.1093/cercor/bhs006; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; Shlizerman E, 2012, NEURAL COMPUT, V24, P2078, DOI 10.1162/NECO_a_00308; Fujisawa S, 2006, CEREB CORTEX, V16, P639, DOI 10.1093/cercor/bhj010; Wang XJ, 1996, J NEUROSCI, V16, P6402; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Shew WL, 2011, J NEUROSCI, V31, P55, DOI 10.1523/JNEUROSCI.4637-10.2011; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Hampson RE, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066013; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; Taxidis J, 2012, HIPPOCAMPUS, V22, P995, DOI 10.1002/hipo.20930; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Beggs JM, 2003, J NEUROSCI, V23, P11167; Yang HD, 2012, J NEUROSCI, V32, P1061, DOI 10.1523/JNEUROSCI.2771-11.2012; Baker JL, 2007, COGN NEURODYNAMICS, V1, P237, DOI 10.1007/s11571-007-9018-9; GULYAS AI, 1993, EUR J NEUROSCI, V5, P1729, DOI 10.1111/j.1460-9568.1993.tb00240.x; Heinzle J, 2007, COGN NEURODYNAMICS, V1, P225, DOI 10.1007/s11571-007-9017-x; Hiratani N, 2013, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00102; Izhikevich E M, 2007, DYNAMICAL SYSTEMS NE; Klaus A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019779; Kwok HF, 2007, COGN NEURODYNAMICS, V1, P39, DOI 10.1007/s11571-006-9006-5; Li S, 2007, COGN NEURODYNAMICS, V1, P261, DOI 10.1007/s11571-007-9021-1; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; SMITH KL, 1995, J NEUROPHYSIOL, V74, P650; SteynRoss DA, 2010, SPR SER COMPUT NEURO, V4, P1; Tateno K, 1998, NEURAL NETWORKS, V11, P985, DOI 10.1016/S0893-6080(98)00086-0; Taxidis Jiannis, 2013, Front Comput Neurosci, V7, P3, DOI 10.3389/fncom.2013.00003; Teramae JN, 2013, SCI REP, V2, P485; Traub R, 1991, NEURONAL NETWORKS HI; Wagatsuma H, 2007, COGN NEURODYNAMICS, V1, P119, DOI 10.1007/s11571-006-9013-6	47	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1871-4080	1871-4099		COGN NEURODYNAMICS	Cogn. Neurodynamics	JUN	2015	9	3					265	277		10.1007/s11571-015-9329-1		13	Neurosciences	Neurosciences & Neurology	CH8RD	WOS:000354302800001		
J	Kurauchi, R; Watanabe, C; Fukuzawa, K; Tanaka, S				Kurauchi, Ryo; Watanabe, Chiduru; Fukuzawa, Kaori; Tanaka, Shigenori			Novel type of virtual ligand screening on the basis of quantum-chemical calculations for protein-ligand complexes and extended clustering techniques	COMPUTATIONAL AND THEORETICAL CHEMISTRY			English	Article						Virtual ligand screening (VLS); Self-organizing map (SOM); Multi-dimensional scaling (MDS); Fragment molecular orbital (FMO) method	MOLECULAR-ORBITAL METHOD; DRUG DISCOVERY; GENETIC ALGORITHM; RECEPTOR; BINDING; DOCKING; PREDICTION; MODULATORS; AFFINITY; POTENCY	We propose a novel method for virtual ligand screening to explore drug candidates binding to target proteins. Employing both information on the ligand-residue interactions calculated by the fragment molecular orbital method and the molecular properties represented by the MDL MACCS keys, a couple of advanced clustering analyses on the basis of the self-organizing map and the multi-dimensional scaling are carried out. In comparison to earlier, similar approaches, the present method can provide higher-dimensional, wider viewpoints to look for better inhibitors and to improve them with reducing the possibilities of false-positives and false-negatives for hit or lead compounds, thus accelerating drug designs. The feasibility and usefulness of the proposed methodology are then demonstrated through the application to the complex systems of estrogen receptor and its ligand molecules, in which a molecular modification to improve the binding property of drug candidates is also suggested. (C) 2015 Elsevier B.V. All rights reserved.	[Kurauchi, Ryo; Tanaka, Shigenori] Kobe Univ, Dept Computat Sci, Grad Sch Syst Informat, Nada Ku, Kobe, Hyogo 6578501, Japan; [Watanabe, Chiduru] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Fukuzawa, Kaori] Nihon Univ, Sch Dent Matsudo, Matsudo, Chiba 2718587, Japan	Tanaka, S (reprint author), Kobe Univ, Dept Computat Sci, Grad Sch Syst Informat, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	tanaka2@kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [26460035]	S.T. would like to acknowledge the Grants-in-Aid for Scientific Research (No. 26460035) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT).	Amari S., 2014, CBI GAKKAISHI, V2, P17; Amari S, 2006, J CHEM INF MODEL, V46, P221, DOI 10.1021/ci050262q; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Mobley DL, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4769292; Fedorov DG, 2007, J COMPUT CHEM, V28, P222, DOI 10.1002/jcc.20496; Knegtel RMA, 1997, J MOL BIOL, V266, P424, DOI 10.1006/jmbi.1996.0776; Deng Z, 2004, J MED CHEM, V47, P337, DOI 10.1021/jm030331x; Fukuzawa K, 2006, J COMPUT CHEM, V27, P948, DOI 10.1002/jcc.20399; Hayik SA, 2010, J CHEM THEORY COMPUT, V6, P3079, DOI 10.1021/ct100315g; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Fukuzawa K, 2006, J PHYS CHEM B, V110, P16102, DOI 10.1021/jp060770i; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; [Anonymous], 2006, MOL OP ENV MOE SOFTW; Fedorov DG, 2007, J PHYS CHEM A, V111, P6904, DOI 10.1021/jp0716740; Tanaka S, 2014, PHYS CHEM CHEM PHYS, V16, P10310, DOI 10.1039/c4cp00316k; Shoichet BK, 2002, CURR OPIN CHEM BIOL, V6, P439, DOI 10.1016/S1367-5931(02)00339-3; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; Watanabe C, 2013, J MOL GRAPH MODEL, V41, P31, DOI 10.1016/j.jmgm.2013.01.006; Lyne PD, 2002, DRUG DISCOV TODAY, V7, P1047, DOI 10.1016/S1359-6446(02)02483-2; Higuchi RI, 2007, J MED CHEM, V50, P2486, DOI 10.1021/jm061329j; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Kitaura K, 1999, CHEM PHYS LETT, V313, P701, DOI 10.1016/S0009-2614(99)00874-X; Kym PR, 2003, J MED CHEM, V46, P1016, DOI 10.1021/jm020335m; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Cho AE, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3239504; Ertl P, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-8; Fischer B, 2008, PROTEINS, V70, P1264, DOI 10.1002/prot.21607; Fujitani H, 2009, J CHEM THEORY COMPUT, V5, P1155, DOI 10.1021/ct8005437; Ilatovskiy AV, 2013, INT J QUANTUM CHEM, V113, P1669, DOI 10.1002/qua.24400; Ito M, 2007, J PHYS CHEM B, V111, P3525, DOI 10.1021/jp070054w; Kohonen T, 2000, SELF ORGANIZING MAPS; Kurisaki I, 2007, BIOPHYS CHEM, V130, P1, DOI 10.1016/j.bpc.2007.06.011; Mazanetz MP, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-2; Merz jr K. M., 2010, DRUG DESIGN STRUCTUR; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Okiyama Y, 2007, CHEM PHYS LETT, V449, P329, DOI 10.1016/j.cplett.2007.10.066; Okiyama Y, 2009, CHEM PHYS LETT, V467, P417, DOI 10.1016/j.cplett.2008.11.044; Okiyama Y, 2011, CHEM PHYS LETT, V509, P67, DOI 10.1016/j.cplett.2011.04.070; Takematsu K, 2009, J PHYS CHEM B, V113, P4991, DOI 10.1021/jp810997c; Tanaka S, 2013, CHEM PHYS LETT, V556, P272, DOI 10.1016/j.cplett.2012.11.085; Tanimoto T., 1957, 8 IBM; Torgerson W. S., 1958, THEORY METHODS SCALI; Watanabe H., 2010, CHEM BIO INF J, V10, P32; Watanabe H, 2010, CHEM PHYS LETT, V500, P116, DOI 10.1016/j.cplett.2010.10.017; Yang BWV, 2010, J MED CHEM, V53, P8241, DOI 10.1021/jm100957a	45	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2210-271X	1872-7999		COMPUT THEOR CHEM	Comput. Theor. Chem.	JUN 1	2015	1061						12	22		10.1016/j.comptc.2015.02.016		11	Chemistry, Physical	Chemistry	CH6KJ	WOS:000354145200003		
J	Chiba, S; Honda, T; Kondo, M; Takayanagi, T				Chiba, Sachie; Honda, Tomohiro; Kondo, Manami; Takayanagi, Toshiyuki			Direct dynamics study of the N(S-4) + CH3((2)A(2)'') reaction	COMPUTATIONAL AND THEORETICAL CHEMISTRY			English	Article						Reaction dynamics; Direct dynamics; Roaming; Potential energy surface	TITANS UPPER-ATMOSPHERE; METHYL RADICALS; NITROGEN-ATOMS; FORMALDEHYDE PHOTODISSOCIATION; SINGLET METHYLNITRENE; ROAMING ATOMS; AB-INITIO; DENSITY; CHEMISTRY; HYDROGEN	Direct dynamics simulations were performed to understand the mechanisms of the N(S-4) + CH3 reaction on both the triplet and singlet potential energy surfaces using the B3LYP/6-31(d, p) method with modified hybrid parameters for the exchange-correlation functional. The hybrid parameters were determined so as that the stationary-point energy levels on the potential energy surfaces reproduce those obtained at the CASPT2 results. The trajectories starting from the N(S-4) + CH3 reactants on the triplet potential surface mostly lead to the H + H2CN products via the CH3N intermediate. The relative translation energy distribution of this channel shows that the reaction dynamics is nonstatistical. The trajectories on the singlet potential energy surface were also propagated from the CH2=NH intermediate structure. We found that about 10% of the reactive trajectories showed "roaming dynamics," which lead to the H-2 + HCN/HNC products through intramolecular hydrogen abstraction. (C) 2015 Elsevier B.V. All rights reserved.	[Chiba, Sachie; Honda, Tomohiro; Takayanagi, Toshiyuki] Saitama Univ, Dept Chem, Sakura Ku, Saitama, Saitama 3388570, Japan; [Kondo, Manami] Kitasato Univ, Sch Sci, Dept Chem, Minami Ku, Sagamihara, Kanagawa 2520373, Japan	Takayanagi, T (reprint author), Saitama Univ, Dept Chem, Sakura Ku, 255 Shimo Okubo, Saitama, Saitama 3388570, Japan.	tako@mail.saitama-u.ac.jp					Albu TV, 2006, J PHYS CHEM A, V110, P7663, DOI 10.1021/jp0615454; Alves TV, 2008, CHEM PHYS LETT, V457, P36, DOI 10.1016/j.cplett.2008.03.081; Bowman JM, 2011, ANNU REV PHYS CHEM, V62, P531, DOI 10.1146/annurev-physchem-032210-103518; Chuang YY, 1999, J PHYS CHEM A, V103, P4893, DOI 10.1021/jp990969d; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Herath N, 2011, J PHYS CHEM LETT, V2, P642, DOI 10.1021/jz101731q; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963; VOSKO SH, 1980, CAN J PHYS, V58, P1200; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Suits AG, 2007, INT REV PHYS CHEM, V26, P585, DOI 10.1080/01442350701589908; NOODLEMAN L, 1995, COORDIN CHEM REV, V144, P199, DOI 10.1016/0010-8545(95)07011-L; TULLY JC, 1990, J CHEM PHYS, V93, P1061, DOI 10.1063/1.459170; Bowman JM, 2011, PHYS CHEM CHEM PHYS, V13, P8094, DOI 10.1039/c0cp02722g; Fu BN, 2012, P NATL ACAD SCI USA, V109, P9733, DOI 10.1073/pnas.1202672109; Bowman JM, 2011, PHYS TODAY, V64, P33; GONZALEZLAFONT A, 1991, J PHYS CHEM-US, V95, P4618, DOI 10.1021/j100165a009; Carpenter BK, 2013, CHEM REV, V113, P7265, DOI 10.1021/cr300511u; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Vuitton V, 2007, ICARUS, V191, P722, DOI 10.1016/j.icarus.2007.06.023; MARSTON G, 1989, J PHYS CHEM-US, V93, P5769, DOI 10.1021/j100352a024; Vuitton V, 2006, ASTROPHYS J, V647, pL175, DOI 10.1086/507467; Oyola Y, 2009, J AM CHEM SOC, V131, P3130, DOI 10.1021/ja807666d; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Besora M, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2953697; Bowman JM, 2014, MOL PHYS, V112, P2516, DOI 10.1080/00268976.2014.897395; Bowman JM, 2006, PHYS CHEM CHEM PHYS, V8, P321, DOI 10.1039/b512847c; Chiba S, 2014, CHEM PHYS LETT, V595, P103, DOI 10.1016/j.cplett.2014.01.033; Cimas A, 2006, J PHYS CHEM A, V110, P10912, DOI 10.1021/jp0634959; Frisch M.J., 2009, GAUSSIAN 09 REV D 01; GONZALEZ C, 1992, J AM CHEM SOC, V114, P9118, DOI 10.1021/ja00049a052; Hadjebar I, 2001, CHEM PHYS, V264, P153, DOI 10.1016/S0301-0104(00)00387-6; Hebrard E, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201218837; Kemnitz CR, 2000, J AM CHEM SOC, V122, P1098, DOI 10.1021/ja9907257; Kormos BL, 2002, J PHYS ORG CHEM, V15, P712, DOI 10.1002/poc.548; Kormos BL, 2003, J ORG CHEM, V68, P6375, DOI 10.1021/jo034527g; Maeda S, 2015, INT J QUANTUM CHEM, V115, P258, DOI 10.1002/qua.24757; MARSTON G, 1989, J CHEM PHYS, V91, P3483, DOI 10.1063/1.456878; RICHARDS C, 1994, J CHEM PHYS, V100, P481, DOI 10.1063/1.466963; Sadygov RG, 1997, J CHEM PHYS, V107, P4994, DOI 10.1063/1.474862; Stief L.J., 1988, CHEM PHYS LETT, V147, P570; Suits AG, 2008, ACCOUNTS CHEM RES, V41, P873, DOI 10.1021/ar8000734; Travers MJ, 1999, J CHEM PHYS, V111, P5349, DOI 10.1063/1.479795; Werner H.-J., MOLPRO IS PACKAGE AB; Yu T, 2013, J PHYS CHEM B, V117, P8422, DOI 10.1021/jp404292t	44	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2210-271X	1872-7999		COMPUT THEOR CHEM	Comput. Theor. Chem.	JUN 1	2015	1061						46	51		10.1016/j.comptc.2015.03.015		6	Chemistry, Physical	Chemistry	CH6KJ	WOS:000354145200007		
J	Grabda, M; Oleszek, S; Panigrahi, M; Kozak, D; Eckert, F; Shibata, E; Nakamura, T				Grabda, Mariusz; Oleszek, Sylwia; Panigrahi, Mrutyunjay; Kozak, Dmytro; Eckert, Franck; Shibata, Etsuro; Nakamura, Takashi			Theoretical selection of most effective ionic liquids for liquid-liquid extraction of NdF3	COMPUTATIONAL AND THEORETICAL CHEMISTRY			English	Article						Rare earth elements; Liquid-liquid extraction; Ionic liquids; COSMO-RS	ZETA VALENCE QUALITY; COSMO-RS; RARE-EARTHS; BASIS-SETS; SOLVENTS; APPROXIMATION; PREDICTION; SEPARATION; SOLVATION; TURBOMOLE	The purpose of this study was to select the most effective ionic liquid (IL) extraction solvents for NdF3 using a theoretical conductor-like screening model for real solvents (COSMO-RS) for predefined NdF3-IL systems. Chemical potentials of NdF3 were predicted in 900 hydrophobic ILs. On the basis of these predictions, a number of IL ions showing a significant decrease in their chemical potentials were selected. Considering the calculated physicochemical properties of ILs containing these specific ions, the most effective IL extraction solvents for liquid-liquid extraction of the salts were proposed. This study shows that the COSMO-RS approach can be applied before conducting extensive experiments to quickly screen the affinity of any rare earth element for many IL systems. (C) 2015 Elsevier B.V. All rights reserved.	[Grabda, Mariusz; Oleszek, Sylwia; Panigrahi, Mrutyunjay; Kozak, Dmytro; Shibata, Etsuro; Nakamura, Takashi] Tohoku Univ, IMRAM, Sendai, Miyagi 980, Japan; [Grabda, Mariusz; Oleszek, Sylwia] Polish Acad Sci, Inst Environm Engn, Zabrze, Poland; [Eckert, Franck] COSMOlogic GmbH & Co KG, D-50379 Leverkusen, Germany	Grabda, M (reprint author), Tohoku Univ, IMRAM, Sendai, Miyagi 980, Japan.	marusz@mail.tagen.tohoku.ac.jp			High Efficiency Rare Elements Extraction Technology Area in the Tohoku Innovation Materials Technology Initiatives for Reconstruction from the Ministry of Education, Culture, Sports, Science and Technology in Japan	This study is supported by the High Efficiency Rare Elements Extraction Technology Area in the Tohoku Innovation Materials Technology Initiatives for Reconstruction from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Diedenhofen M, 2010, FLUID PHASE EQUILIBR, V294, P31, DOI 10.1016/j.fluid.2010.02.002; Yao C, 2009, ANAL CHEM, V81, P5054, DOI 10.1021/ac900719m; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; [Anonymous], 1989, TURBOMOLE V6 5 2013; Bonhote P, 1996, INORG CHEM, V35, P1168, DOI 10.1021/ic951325x; Rout A, 2014, DALTON T, V43, P3186, DOI 10.1039/c3dt52541d; Gulde R, 2012, J CHEM THEORY COMPUT, V8, P4062, DOI 10.1021/ct300302u; VOSKO SH, 1980, CAN J PHYS, V58, P1200; Schafer A, 2000, PHYS CHEM CHEM PHYS, V2, P2187, DOI 10.1039/b000184h; SCHAFER A, 1994, J CHEM PHYS, V100, P5829; Jork C, 2005, J CHEM THERMODYN, V37, P537, DOI 10.1016/j.jct.2005.04.013; Steffen C, 2010, J COMPUT CHEM, V31, P2967, DOI 10.1002/jcc.21576; Binnemans K, 2013, J CLEAN PROD, V51, P1, DOI 10.1016/j.jclepro.2012.12.037; Klamt A, 2000, FLUID PHASE EQUILIBR, V172, P43, DOI 10.1016/S0378-3812(00)00357-5; Wellens S, 2013, PHYS CHEM CHEM PHYS, V15, P9663, DOI 10.1039/c3cp50819f; Meindersma GW, 2007, MONATSH CHEM, V138, P1125, DOI 10.1007/s00706-007-0757-4; Klamt A, 1998, J PHYS CHEM A, V102, P5074, DOI 10.1021/jp980017s; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Eckert F, 2002, AICHE J, V48, P369, DOI 10.1002/aic.690480220; Ciupka J, 2010, PHYS CHEM CHEM PHYS, V12, P13215, DOI 10.1039/c0cp00639d; Cieszynska A, 2012, HYDROMETALLURGY, V113, P79, DOI 10.1016/j.hydromet.2011.12.006; Diedenhofen M., 2012, COSMOCONF VERS 3 0; Eckert F., 2012, COSMOTHERM VERSION C; Eiden P, 2011, J PHYS CHEM B, V115, P300, DOI 10.1021/jp108059x; Grabda M, 2014, FLUID PHASE EQUILIBR, V383, P134, DOI 10.1016/j.fluid.2014.10.018; KLAMT A, 1995, J PHYS CHEM-US, V99, P2224, DOI 10.1021/j100007a062; MENON MP, 1989, J CHEM SOC FARAD T 1, V85, P2683, DOI 10.1039/f19898502683; Steele M. L., 1997, INORG CHEM, V16, P1225; Umecky T, 2013, J PHYS CHEM B, V117, P16219, DOI 10.1021/jp409324k; Vander Hoogerstraete T, 2013, INT J MOL SCI, V14, P21353, DOI 10.3390/ijms141121353	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2210-271X	1872-7999		COMPUT THEOR CHEM	Comput. Theor. Chem.	JUN 1	2015	1061						72	79		10.1016/j.comptc.2015.03.016		8	Chemistry, Physical	Chemistry	CH6KJ	WOS:000354145200010		
J	Uchida, K				Uchida, Kenetsu			Travel Time Reliability Estimation Model Using Observed Link Flows in a Road Network	COMPUTER-AIDED CIVIL AND INFRASTRUCTURE ENGINEERING			English	Article							ORIGIN-DESTINATION MATRICES; CAPACITY RELIABILITY; STOCHASTIC DEMAND; EQUILIBRIUM; VARIABLES; SYSTEMS	This article formulates a model that calculates travel time reliability in a road network. The sources of uncertainty addressed by the model are traffic capacity and travel demand. Because travel time reliability estimation problem, in general, is formulated as a path-based problem, path enumeration can be required in advance. Thus, the path travel time reliability can depend on a path set enumerated in advance. For the purpose of determining the unique travel time reliability, a model that estimates stochastic path flows by using observed link flows is then presented. This method does not require predefined path set. However, this method is similar to the standard maximum likelihood (ML) estimation method, the method presented in this study is easier to be solved because the number of unknown parameters is much smaller than that of the standard ML estimation method. Numerical experiments using two networks are carried out to demonstrate the model presented in this article.	Hokkaido Univ, Kita Ku, Sapporo, Hokkaido, Japan	Uchida, K (reprint author), Hokkaido Univ, Kita Ku, North 13 West 8, Sapporo, Hokkaido, Japan.	uchida@eng.hokudai.ac.jp					Adeli H., 2005, WAVELETS INTELLIGENT; Adeli H., 2009, INTELLIGENT INFRASTR; Lo HK, 2003, TRANSPORT RES B-METH, V37, P345, DOI 10.1016/S0191-2615(02)00017-6; Sumalee A, 2006, NETW SPAT ECON, V6, P205, DOI 10.1007/s11067-006-9280-0; Ghosh B, 2010, COMPUT-AIDED CIV INF, V25, P613, DOI 10.1111/j.1467-8667.2010.00681.x; Papola A, 2013, COMPUT-AIDED CIV INF, V28, P560, DOI 10.1111/mice.12007; Du ZP, 1997, TRANSPORT RES B-METH, V31, P225, DOI 10.1016/S0191-2615(96)00023-9; Lo HK, 2006, TRANSPORT RES B-METH, V40, P792, DOI 10.1016/j.trb.2005.10.003; Clark S, 2005, TRANSPORT RES B-METH, V39, P119, DOI 10.1016/j.trb.2003.10.006; Castillo E, 2014, COMPUT-AIDED CIV INF, V29, P496, DOI 10.1111/mice.12061; Isserlis L, 1918, BIOMETRIKA, V12, P134, DOI 10.2307/2331932; Hazelton ML, 2001, TRANSPORT RES B-METH, V35, P667, DOI 10.1016/S0191-2615(00)00009-6; JOHNSON NL, 1949, BIOMETRIKA, V36, P149, DOI 10.2307/2332539; Jiang XM, 2005, J TRANSP ENG-ASCE, V131, P771, DOI 10.1061/(ASCE)0733-947X(2005)131:10(771); Jiang XM, 2004, COMPUT-AIDED CIV INF, V19, P324, DOI 10.1111/j.1467-8667.2004.00360.x; Shao H, 2006, NETW SPAT ECON, V6, P173, DOI 10.1007/s11067-006-9276-6; Sumalee A, 2011, TRANSPORT RES C-EMER, V19, P338, DOI 10.1016/j.trc.2010.05.018; Szeto WY, 2011, COMPUT-AIDED CIV INF, V26, P595, DOI 10.1111/j.1467-8667.2011.00717.x; Chen A, 2002, TRANSPORT RES B-METH, V36, P225, DOI 10.1016/S0191-2615(00)00048-5; Chen A, 2011, TRANSPORT RES B-METH, V45, P1619, DOI 10.1016/j.trb.2011.05.028; Dharia A, 2003, ENG APPL ARTIF INTEL, V16, P607, DOI 10.1016/j.engappai.2003.09.011; Uchida K, 2014, TRANSPORT RES B-METH, V66, P129, DOI 10.1016/j.trb.2014.01.002; Noland RB, 2002, TRANSPORT REV, V22, P39, DOI 10.1080/01441640010022456; Asakura Y, 1999, J ADV TRANSPORT, V33, P147; Duthie JC, 2011, COMPUT-AIDED CIV INF, V26, P16, DOI 10.1111/j.1467-8667.2009.00637.x; Bell MGH, 2000, TRANSPORT RES B-METH, V34, P533, DOI 10.1016/S0191-2615(99)00042-9; Bras R. L., 1980, P 3 INT S STOCH HYDR, P95; Bureau of Public Roads, 1964, TRAFF ASS MAN; CASCETTA E, 1989, TRANSPORT RES B-METH, V23, P1, DOI 10.1016/0191-2615(89)90019-2; Filippov A. F., 1960, P 1 IFAC C, P923; George A., 1981, COMPUTER SOLUTION LA; Hazelton ML, 2000, TRANSPORT RES B-METH, V34, P549, DOI 10.1016/S0191-2615(99)00037-5; Hill I. D., 1976, Applied Statistics, V25, DOI 10.2307/2346693; Hill I. D., 1976, Applied Statistics, V25, DOI 10.2307/2346692; Jiang XM, 2003, J TRANSP ENG-ASCE, V129, P230, DOI 10.1061/(ASCE)0733-947X(2003)129:3(230); Karim A, 2002, J TRANSP ENG-ASCE, V128, P232, DOI 10.1061/(ASCE)0733-947X; Karim A, 2003, J TRANSP ENG-ASCE, V129, P134, DOI 10.1061/(ASCE)0733-947X(2003)129:2(134); Liu HX, 2007, TRANSPORT RES B-METH, V41, P448, DOI 10.1016/j.trb.2006.07.002; MICHEL AN, 1972, IEEE T CIRCUITS SYST, VCT19, P123, DOI 10.1109/TCT.1972.1083426; Nakayama S., 2003, P 82 ANN M TRANSP RE; Ng M, 2012, COMPUT-AIDED CIV INF, V27, P231, DOI 10.1111/j.1467-8667.2011.00724.x; SACTRA, 1999, TRANSP EC; Srivastava MS, 2002, LINEAR ALGEBRA APPL, V354, P255, DOI 10.1016/S0024-3795(02)00342-7; Sumalee A, 2011, TRANSPORT RES B-METH, V45, P41, DOI 10.1016/j.trb.2010.04.007; Sumalee A., 2007, TRANSPORT RES REC, V1964, P81; Szeto W. Y., 2010, COMPUT-AIDED CIV INF, V26, P311; TANYIMBOH TT, 1993, J OPER RES SOC, V44, P383, DOI 10.1057/jors.1993.68; Uchida K., 2014, J ADV TRANSPORT, V49, P73; Uchida K., 2009, DOBOKU GAKKAI RONB D, V65, P386; Uchida K., 2010, P 89 ANN M TRANSP RE; Watling D, 2002, TRANSPORT SCI, V36, P149, DOI 10.1287/trsc.36.2.149.560	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1093-9687	1467-8667		COMPUT-AIDED CIV INF	Comput.-Aided Civil Infrastruct. Eng.	JUN	2015	30	6			SI		449	463		10.1111/mice.12109		15	Computer Science, Interdisciplinary Applications; Construction & Building Technology; Engineering, Civil; Transportation Science & Technology	Computer Science; Construction & Building Technology; Engineering; Transportation	CI1FK	WOS:000354488100004		
J	Chen, J; O-tani, H; Hori, M				Chen, J.; O-tani, H.; Hori, M.			Stability analysis of soil liquefaction using a finite element method based on particle discretization scheme	COMPUTERS AND GEOTECHNICS			English	Article						Stability analysis; Soil liquefaction; Dilatancy effect; Detaching effect; Particle discretization scheme	INITIATION; FAILURE; FEM	Mathematically, liquefaction corresponds to the unstable solutions of the governing equations of soil dynamics. Stability analysis of these solutions facilitates the understanding of the triggering and development of liquefaction. This paper presents a numerical approach for stability analysis of the solutions of the governing equations. The governing equations are linearized for small perturbations and discretized using a finite element method (FEM) based on the particle discretization scheme (PDS). By solving the discretized governing equations with the developed PDS-FEM code, unstable solutions are captured for perturbations in the form of a three-dimensional spherical wave. The present approach considers the dilatancy effect and the detaching effect. The numerical results show that the dilatancy effect triggers and the detaching effect spatially expands the unstable solutions. The existence and expansion of the unstable solutions provide a new perspective on the triggering and development of liquefaction. (C) 2015 Elsevier Ltd. All rights reserved.	[Chen, J.; O-tani, H.; Hori, M.] RIKEN Adv Inst Computat Sci, Kobe, Hyogo 6500047, Japan; [Hori, M.] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	Chen, J (reprint author), RIKEN Adv Inst Computat Sci, 7-1-26 Minatojima Minami Machi, Kobe, Hyogo 6500047, Japan.	jchen@riken.jp; h.o-tani@riken.jp; hori@eri.u-tokyo.ac.jp					Amestoy PR, 2006, PARALLEL COMPUT, V32, P136, DOI 10.1016/j.parco.2005.07.004; Oliver J, 2006, COMPUT METHOD APPL M, V195, P4732, DOI 10.1016/j.cma.2005.09.020; Amestoy PR, 2001, SIAM J MATRIX ANAL A, V23, P15, DOI 10.1137/S0895479899358194; Hori M, 2005, J MECH PHYS SOLIDS, V53, P681, DOI 10.1016/j.jmps.2004.08.005; Chang MH, 2011, COMPUT GEOTECH, V38, P393, DOI 10.1016/j.compgeo.2011.01.003; Chen J, 2014, J JPN SOC CIVIL E A2, V70; Chen J, 2014, P 14 INT C INT ASS C, P661; FEAR CE, 1995, J GEOTECH ENG-ASCE, V121, P249, DOI 10.1061/(ASCE)0733-9410(1995)121:3(249); Huang Y, 2008, B ENG GEOL ENVIRON, V67, P31, DOI 10.1007/s10064-007-0097-y; ISHIHARA K, 1993, GEOTECHNIQUE, V43, P351; Jha SK, 2009, COMPUT GEOTECH, V36, P589, DOI 10.1016/j.compgeo.2008.10.004; Kramer S. L., 1996, GEOTECHNICAL EARTHQU; KRAMER SL, 1988, J GEOTECH ENG-ASCE, V114, P412; Oka F, 2013, COMPUTATIONAL MODELING OF MULTIPHASE GEOMATERIALS, P1; POULOS SJ, 1985, J GEOTECH ENG-ASCE, V111, P772; Seed RB, 2003, 26 ANN ASCE LOS ANGE; Wijerathne MLL, 2009, INT J NUMER METH ENG, V80, P46, DOI 10.1002/nme.2620; Wong Y.W., 2006, J MECH MATER STRUCT, V1, P1; Zienkiewicz OC, 1999, COMPUTATIONAL GEOMEC	19	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0266-352X	1873-7633		COMPUT GEOTECH	Comput. Geotech.	JUN	2015	67						64	72		10.1016/j.compgeo.2015.02.008		9	Computer Science, Interdisciplinary Applications; Engineering, Geological; Geosciences, Multidisciplinary	Computer Science; Engineering; Geology	CH6IN	WOS:000354140400005		
J	Sakaguchi, S; Worth, JRP; Jordan, GJ; Thomas, P; Ito, M				Sakaguchi, Shota; Worth, James R. P.; Jordan, Gregory J.; Thomas, Philip; Ito, Motomi			Development of nuclear microsatellite markers for the Tasmanian endemic conifer Diselma archeri Hook. F. (Cupressaceae)	CONSERVATION GENETICS RESOURCES			English	Article						Cupressaceae; Diselma archeri; Next generation sequencing; Tasmanian endemic		Novel microsatellite markers were developed for the Tasmanian endemic conifer Cheshunt Pine (Diselma archeri), a species vulnerable to increased fire frequency under warming and drying climates. Ten polymorphic microsatellite markers were developed and characterized. The number of alleles per locus ranged from 5 to 14, and average observed heterozygosity was 0.756. No significant departures from Hardy-Weinberg equilibrium were detected at all loci. These markers will be useful to investigate population genetics and the importance of clonality for reproduction, for better understandings of the species' history and ecology.	[Sakaguchi, Shota; Ito, Motomi] Univ Tokyo, Dept Gen Syst Studies, Lab Plant Evolut & Biodivers, Grad Sch Arts & Sci,Meguro Ku, Tokyo, Japan; [Worth, James R. P.; Jordan, Gregory J.] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia; [Thomas, Philip] Royal Bot Garden Edinburgh, Edinburgh EH3 5LR, Midlothian, Scotland	Sakaguchi, S (reprint author), Univ Tokyo, Dept Gen Syst Studies, Lab Plant Evolut & Biodivers, Grad Sch Arts & Sci,Meguro Ku, Tokyo, Japan.	sakaguci54@gmail.com; tmesipteris@gmail.com; Greg.Jordan@utas.edu.au; P.Thomas@rbge.ac.uk; cmito@mail.ecc.u-tokyo.ac.jp			Australian Research Council [DP120100501]; Japan Society for the Promotion of Science [JSPS KAKENHI 26850098]; Environment Research and Technology Development Fund of the Ministry of the Environment [4-1403]	The authors thank Samuel Martins and Stuart MacDonald for assistance in the field, the Department of Primary Industries, Parks, Water and Environment, Tasmania, for flora distribution data and providing collection permits, and Madoka Hirano for help with processing the sampled materials. Funding was provided by the Australian Research Council (DP120100501), a Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (JSPS KAKENHI 26850098), and the Environment Research and Technology Development Fund of the Ministry of the Environment (4-1403).	Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004; Goudet J, 1995, J HERED, V86, P485; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Gibson N, 1995, CONIFERS SO AUSTR; KIRKPATRICK JB, 1984, AUST J BOT, V32, P613, DOI 10.1071/BT9840613	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1877-7252	1877-7260		CONSERV GENET RESOUR	Conserv. Genet. Resour.	JUN	2015	7	2					369	372		10.1007/s12686-014-0368-4		4	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CH7JW	WOS:000354213300013		
J	Higashi, H; Setoguchi, H				Higashi, Hiroyuki; Setoguchi, Hiroaki			Isolation and characterization of microsatellite loci in Patrinia triloba var. takeuchiana (Valerianaceae)	CONSERVATION GENETICS RESOURCES			English	Article						Patrinia triloba var. takeuchiana; Endemic plant; Microsatellite loci	SOFTWARE	Patrinia triloba var. takeuchiana is an endangered plant endemic to Japan, and conservation activities on its behalf have begun recently. Fourteen polymorphic microsatellite loci were successfully isolated from P. triloba var. takeuchiana. The range of expected heterozygosity was 0.139-0.666 in the wild population. Four loci showed significant deviations from Hardy-Weinberg equilibrium. Two markers merit caution due to their significant linkage disequilibrium with other markers. The markers described here will be useful for conservation genetics and development of effective conservation programs for P. triloba var. takeuchiana.	[Higashi, Hiroyuki; Setoguchi, Hiroaki] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan	Higashi, H (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Yoshida Nihonmatsu Cho, Kyoto 6068501, Japan.	higashi.hiroyuki.27s@st.kyoto-u.ac.jp			Pro Natura Foundation Japan; Environment Research and Technology Development Fund of the Ministry of the Environment of Japan [4-1403]	This study was supported by Pro Natura Foundation Japan 2013 and by the Environment Research and Technology Development Fund of the Ministry of the Environment of Japan 4-1403.	Lian CL, 2006, J PLANT RES, V119, P415, DOI 10.1007/s10265-006-0274-2; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Doyle JJ, 1990, FOCUS, V12, P13; Ministry of the Environment Government of Japan, 2012, RED LIST MIN ENV	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1877-7252	1877-7260		CONSERV GENET RESOUR	Conserv. Genet. Resour.	JUN	2015	7	2					389	391		10.1007/s12686-014-0377-3		3	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CH7JW	WOS:000354213300018		
J	Hoffberg, SL; Bentley, KE; Lee, JB; Myhre, KE; Iwao, K; Glenn, TC; Mauricio, R				Hoffberg, Sandra L.; Bentley, Kerin E.; Lee, Jared B.; Myhre, Karin E.; Iwao, Keisuke; Glenn, Travis C.; Mauricio, Rodney			Characterization of 15 microsatellite loci in kudzu (Pueraria montana var. lobata) from the native and introduced ranges	CONSERVATION GENETICS RESOURCES			English	Article						454 Pyrosequencing; Clones; Illumina; Invasive; Kudzu; MiSeq		Kudzu (Pueraria montana var. lobata) is a perennial vine native to eastern Asia and an invasive in the United States, representing a significant threat to biodiversity. We characterized 15 polymorphic microsatellite loci in four populations from both the native and invasive ranges of kudzu. The number of alleles per locus ranged from 2 to 8 and observed heterozygosity ranged from 0.0 to 0.9. Consistent with vegetative reproduction, loci were initially not in Hardy-Weinberg equilibrium (HWE) and in linkage disequilibrium but when clones were removed, markers were in HWE and in linkage equilibrium. These loci provide valuable tools to study the diversity and invasion history of an important invasive species.	[Hoffberg, Sandra L.; Bentley, Kerin E.; Lee, Jared B.; Mauricio, Rodney] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Myhre, Karin E.] Univ Georgia, Dept Comparat Literature, Athens, GA 30602 USA; [Iwao, Keisuke] Momoyama Gakuin Univ, Dept Sociol, Izumi, Osaka 5941198, Japan; [Glenn, Travis C.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA	Mauricio, R (reprint author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	mauricio@uga.edu			National Science Foundation's Partnerships for International Research and Education (PIRE) program [OISE 0730218]; NSF [DGE0903734]	This work was supported by the National Science Foundation's Partnerships for International Research and Education (PIRE) program (OISE 0730218). KEB was supported by NSF Graduate Research Fellowship (DGE0903734).	Forseth IN, 2004, CRIT REV PLANT SCI, V23, P401, DOI 10.1080/07352680490505150; Matlack GR, 2002, NAT AREA J, V22, P241; Kartzinel TR, 2012, AM J BOT, V99, pE450, DOI 10.3732/ajb.1200232; Ward Daniel B., 1998, Castanea, V63, P76	4	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1877-7252	1877-7260		CONSERV GENET RESOUR	Conserv. Genet. Resour.	JUN	2015	7	2					403	405		10.1007/s12686-014-0381-7		3	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CH7JW	WOS:000354213300022		
J	Tsukagoshi, H; Terui, S; Abe, S				Tsukagoshi, H.; Terui, S.; Abe, S.			Isolation and characterization of eighteen polymorphic microsatellite DNA loci from masu salmon (Oncorhynchus masou) using next-generation sequencing and cross-species amplification	CONSERVATION GENETICS RESOURCES			English	Article						Masu salmon; Oncorhynchus masou; Fisheries resources; Microsatellite DNA; Next-generation sequencing; Cross-species amplification		A total of 18 novel microsatellite markers in masu salmon, an important fisheries resource around the Far East, were isolated using a next-generation sequencing approach. The number of alleles and expected heterozygosity per locus ranged 5-15 and 0.55847-0.92944, respectively. Four loci also were polymorphic in three other salmonid species after cross-species amplification. These newly isolated loci will provide important information for the sustainable adaptive management of masu salmon.	[Tsukagoshi, H.; Terui, S.; Abe, S.] Iwate Univ, Sanriku Fisheries Res Ctr, Kamaishi, Iwate 0260001, Japan	Tsukagoshi, H (reprint author), Iwate Univ, Sanriku Fisheries Res Ctr, Heita 3-75-1, Kamaishi, Iwate 0260001, Japan.	tsuk@iwate-u.ac.jp			MEXT Revitalization Project for the Creation of Fisheries Research and Education Center in Sanriku; JST Revitalization Promotion Program	We thank Fisheries Cooperative Association of Shimoakka, Noda, Iwate, for their help in collecting samples. This study was supported by MEXT Revitalization Project for the Creation of Fisheries Research and Education Center in Sanriku, and JST Revitalization Promotion Program.	Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47; Oosterhout C. V., 2004, MOL ECOL NOTES, V4, P535, DOI DOI 10.1111/J.1471-8286.2004.00684.X; Rozen S, 2000, Methods Mol Biol, V132, P365; Yu JN, 2010, ZOOL SCI, V27, P375, DOI 10.2108/zsj.27.375	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1877-7252	1877-7260		CONSERV GENET RESOUR	Conserv. Genet. Resour.	JUN	2015	7	2					441	443		10.1007/s12686-014-0391-5		3	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CH7JW	WOS:000354213300032		
J	Santos, BS; Romana-Eguia, MRR; Basiao, ZU; Ikeda, M				Santos, Brian S.; Romana-Eguia, Maria Rowena R.; Basiao, Zubaida U.; Ikeda, Minoru			Development and characterization of nine novel microsatellite markers for the milkfish Chanos chanos	CONSERVATION GENETICS RESOURCES			English	Article						Chanos chanos; Microsatellite markers; Milkfish; Population genetic structure		The milkfish, Chanos chanos, is an important aquaculture resource in Southeast Asia. Using NGS data, 72 microsatellite markers were developed. PCR product confirmation using agarose gel electrophoresis allowed the identification of 24 utilizable markers. Milkfish samples (n = 48) from a hatchery stock in Palawan, Philippines were analyzed for genetic variability at the aforementioned 24 loci. Consequently, nine of these microsatellite loci were noted to have high success rate in amplification, exhibited polymorphism with 19 maximum number of alleles and no null alleles. These are the first microsatellite markers to be developed and characterized for C. chanos that will efficiently enable genetic stock delineation and monitoring as well as marker-aided genetic improvement research.	[Santos, Brian S.; Basiao, Zubaida U.] Univ Philippines Diliman, Inst Biol, Quezon City 1101, Philippines; [Romana-Eguia, Maria Rowena R.] Southeast Asian Fisheries Dev Ctr, Dept Aquaculture, Rizal, Philippines; [Ikeda, Minoru] Grad Sch Agr Sci, Onagawa Field Ctr, Lab Integrat Aquat Biol, Oshika, Miyagi 9862242, Japan	Santos, BS (reprint author), Univ Philippines Diliman, Inst Biol, Quezon City 1101, Philippines.	bryzee13@yahoo.com			Department of Science and Technology-Philippine Council for Agriculture, Aquatic and Natural Resources Research and Development (DOST-PCAARRD); Southeast Asian Fisheries Development Center, Aquaculture Department (SEAFDEC/AQD) [Br-02-F2012B]	Funds for this study were provided by the Department of Science and Technology-Philippine Council for Agriculture, Aquatic and Natural Resources Research and Development (DOST-PCAARRD) and the Southeast Asian Fisheries Development Center, Aquaculture Department (SEAFDEC/AQD; study code Br-02-F2012B).	Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Shaw PW, 1999, HEREDITY, V83, P490, DOI 10.1038/sj.hdy.6885860	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1877-7252	1877-7260		CONSERV GENET RESOUR	Conserv. Genet. Resour.	JUN	2015	7	2					451	453		10.1007/s12686-014-0393-3		3	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CH7JW	WOS:000354213300034		
J	Sakaguchi, S; Worth, JRP; Jordan, GJ; Thomas, P; Ito, M				Sakaguchi, Shota; Worth, James R. P.; Jordan, Gregory J.; Thomas, Philip; Ito, Motomi			Development of nuclear and mitochondrial microsatellite markers for the relictual conifer genus Athrotaxis (Cupressaceae)	CONSERVATION GENETICS RESOURCES			English	Article						Athrotaxis; Cupressaseae; Microsatellites; Next generation sequencing; Tasmanian endemic		Athrotaxis D. Don (Cupressaceae) is a relictual conifer genus and is comprised of two or three ecologically divergent species endemic to Tasmania. Utilizing RNA-seq data obtained by next generation sequencing techniques, 16 polymorphic EST-SSR (simple sequence repeats in expressed sequence tags) markers with 2-15 alleles in nuclear and mitochondria genomes were developed and characterized. These markers will be used to investigate the speciation and hybridisation processes in the genus, the species' range-wide genetic structure and diversity and the importance of clonality in maintaining current populations.	[Sakaguchi, Shota; Ito, Motomi] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Lab Plant Evolut & Biodivers, Tokyo, Japan; [Worth, James R. P.; Jordan, Gregory J.] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia; [Thomas, Philip] Royal Bot Garden Edinburgh, Edinburgh EH3 5LR, Midlothian, Scotland	Sakaguchi, S (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Lab Plant Evolut & Biodivers, Tokyo, Japan.	sakaguci54@gmail.com; tmesipteris@gmail.com; Greg.Jordan@utas.edu.au; P.Thomas@rbge.ac.uk; cmito@mail.ecc.u-tokyo.ac.jp			Australian Research Council [DP120100501]; Japan Society for the Promotion of Science [JSPS KAKENHI 26850098]; Environment Research and Technology Development Fund of the Ministry of the Environment [4-1403]	The authors thank Samuel Martins and Stuart MacDonald for assistance in the field, Madoka Hirano for help with processing samples and the Department of Primary Industries, Parks, Water and Environment, Tasmanian Government, for providing collection permits. Funding was provided by the Australian Research Council (DP120100501), a Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (JSPS KAKENHI 26850098), and the Environment Research and Technology Development Fund of the Ministry of the Environment (4-1403).	NEALE DB, 1989, P NATL ACAD SCI USA, V86, P9347, DOI 10.1073/pnas.86.23.9347; Goudet J, 1995, J HERED, V86, P485; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Hill KD, 1998, FLORA AUSTR, V48, P505; Jordan GJ, 2004, AUST J BOT, V52, P765, DOI 10.1071/BT04029	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1877-7252	1877-7260		CONSERV GENET RESOUR	Conserv. Genet. Resour.	JUN	2015	7	2					477	481		10.1007/s12686-014-0400-8		5	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CH7JW	WOS:000354213300041		
J	Yamaguchi, K; Saito, M; Nakajima, M				Yamaguchi, Kohtaroh; Saito, Masataka; Nakajima, Masamichi			Identification and characterization of 12 tetranucleotide microsatellite markers in the white-spotted char Salvelinus leucomaenis	CONSERVATION GENETICS RESOURCES			English	Article						Next-generation sequencing; Tetranucleotide microsatellites; Genetic variation; White-spotted char; Salvelinus leucomaenis		The white-spotted char (Salvelinus leucomaenis) is an important species for Japanese fisheries, with a biogeographic range from Kamchatka in the Russian Federation to the Chugoku district in Japan. The population is decreasing owing to environmental changes and fishing pressure. Therefore, detailed information on this species is required to develop effective conservation strategies and harvesting practices. To provide tools for addressing the ecology and management for this species, we developed 12 polymorphic tetranucleotide microsatellite markers, which were optimized into four multiplexes. No null alleles were detected at any locus. The number of alleles per locus, and observed and expected heterozygosities across two populations were 1-19, 0.000-1.000, and 0.000-0.938, respectively. No significant linkage disequilibrium or departure from Hardy-Weinberg equilibrium was detected. These loci will be useful for conducting population genetics studies in this species.	[Yamaguchi, Kohtaroh] Saitama Prefecture Agr & Forestry Res Ctr, Fisheries Lab, Kazo, Saitama 3470011, Japan; [Saito, Masataka] Kagawa Nutr Univ, Lab Food Sci & Technol, Sakado, Saitama 3500288, Japan; [Nakajima, Masamichi] Tohoku Univ, Grad Sch Agr Sci, Lab Populat Genet Informat, Aoba Ku, Sendai, Miyagi 9818555, Japan	Yamaguchi, K (reprint author), Saitama Prefecture Agr & Forestry Res Ctr, Fisheries Lab, Kitakohama 1060-1, Kazo, Saitama 3470011, Japan.	yamaguchi.kotaro@pref.saitama.lg.jp			JSPS [25252035]; Research Foundation of the Institute of Nutrition Sciences, Kagawa Nutrition University	We would like to thank the Chichibu Fishermen's Cooperative Association, Susumu Yamanaka, Daisei Ando, Tadashi Okura, Yoshinari Otomo, Masashi Mizuochi, Shigeru Kibe, Hiromasa Yamaguchi, and Nobuhiko Taniguchi for their aid in sample collections and their suggestions. We would also like to thank Mariko Miyazaki for the laboratory assistance. This work was partly supported by JSPS Grants-in-Aid for Scientific Research, grant no. 25252035, and the Research Foundation of the Institute of Nutrition Sciences, Kagawa Nutrition University.	Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Nakamura T, 1999, NIPPON SUISAN GAKK, V65, P427; Yamaguchi K., 2008, FISH GENET BREED SCI, V38, P123	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1877-7252	1877-7260		CONSERV GENET RESOUR	Conserv. Genet. Resour.	JUN	2015	7	2					497	499		10.1007/s12686-014-0405-3		3	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CH7JW	WOS:000354213300046		
J	Nakahama, N; Izuno, A; Arima, K; Isagi, Y				Nakahama, Naoyuki; Izuno, Ayako; Arima, Kurumi; Isagi, Yuji			Development of microsatellite markers for two endangered grassland butterflies, Melitaea ambigua and M-protomedia (Nymphalidae), using Ion Torrent next-generation sequencing	CONSERVATION GENETICS RESOURCES			English	Article						Conservation; Endangered species; Melitaea; Next-generation sequencer		Melitaea ambigua and M. protomedia (Nymphalidae) are widely distributed in the grasslands of Northeast Asia. In Japan, these species have been threatened by habitat loss because of the rapid expansion of land development over recent decades. We isolated and characterised 18 polymorphic microsatellite loci (9 loci for each species) using a next-generation sequencer. The number of alleles and the expected heterozygosity per locus was 2-12 and 2-7, 0.10-0.86 and 0.13-0.76 in M. ambigua and M. protomedia, respectively. The markers can be useful for genetic studies for conservation such as evaluation of genetic diversity and genetic structure.	[Nakahama, Naoyuki; Izuno, Ayako; Arima, Kurumi; Isagi, Yuji] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan	Nakahama, N (reprint author), Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	naoyuki.halobates@gmail.com					Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24; Goudet J, 1995, J HERED, V86, P485; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Ministry of the Environment Japan, 2012, RED LIST INS JAP; Rozen S, 2000, Methods Mol Biol, V132, P365	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1877-7252	1877-7260		CONSERV GENET RESOUR	Conserv. Genet. Resour.	JUN	2015	7	2					525	527		10.1007/s12686-014-0412-4		3	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CH7JW	WOS:000354213300053		
J	Omondi, SF; Machua, J; Gicheru, J; Hanaoka, S				Omondi, Stephen Fredrick; Machua, Joseph; Gicheru, John; Hanaoka, So			Isolation and characterization of microsatellite markers for Acacia tortilis (Forsk.) Hayne	CONSERVATION GENETICS RESOURCES			English	Article						Acacia tortilis; Multipurpose tree; Genetic diversity; Microsatellite; Population; Conservation; Acacia tortilis (Forsk.)		Acacia tortilis is a drought tolerant multipurpose dryland tree species widely distributed in Africa and Asia. Its overexploitation has caused its population decrease. A set of 11 polymorphic nuclear microsatellite loci were isolated and characterized for A. tortilis using samples from three natural populations from Kenya. All the loci were polymorphic and on average, 14 alleles per locus were detected ranging from 12 to 16. Expected and observed heterozygosity ranged from 0.681 to 0.856 and 0.656-0.85 respectively. These microsatellite markers will provide valuable genetic data for studies and sustainable management strategy for A. tortilis.	[Omondi, Stephen Fredrick; Machua, Joseph; Gicheru, John] Kenya Forestry Res Inst, Nairobi, Kenya; [Hanaoka, So] Forestry & Forest Prod Res Inst, Forest Tree Breeding Ctr, Hitachi, Ibaraki 3191301, Japan	Omondi, SF (reprint author), Kenya Forestry Res Inst, POB 20412-00200, Nairobi, Kenya.	stephenf.omondi@gmail.com			Kenya Forestry Research Institute (KEFRI); Forest Tree Breeding Centre (FTBC); Forest and Forest Products Institute (FPRRI) of Japan under KEFRI/JICA "Project on development of drought tolerant trees for adaptation to climate change in drylands of Kenya''	This study was funded and conducted by collaboration between Kenya Forestry Research Institute (KEFRI) and Forest Tree Breeding Centre (FTBC) and Forest and Forest Products Institute (FPRRI) of Japan under KEFRI/JICA "Project on development of drought tolerant trees for adaptation to climate change in drylands of Kenya''. We are grateful to KEFRI Biotechnology and Forest FTBC laboratory staff for their support during the study.	Hamilton MB, 1999, BIOTECHNIQUES, V27, P500; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Hanaoka S, 2012, CONSERV GENET RESOUR, V4, P395, DOI 10.1007/s12686-011-9558-5; Untergasser A., 2007, NUCLEIC ACIDS RES, V35, P71; Winters G, 2013, CONSERV GENET RESOUR, V5, P807, DOI 10.1007/s12686-013-9913-9	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1877-7252	1877-7260		CONSERV GENET RESOUR	Conserv. Genet. Resour.	JUN	2015	7	2					529	531		10.1007/s12686-014-0413-3		3	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CH7JW	WOS:000354213300054		
J	Choi, H; Lim, M; Kitagaki, R; Noguchi, T; Kim, G				Choi, Hyeonggil; Lim, Myungkwan; Kitagaki, Ryoma; Noguchi, Takafumi; Kim, Gyuyong			Restrained shrinkage behavior of expansive mortar at early ages	CONSTRUCTION AND BUILDING MATERIALS			English	Article						Expansive additive; Ring test; Shrinkage; Restrained stress; Stress relaxation; Degree of restraint; Cracking	STRESS DEVELOPMENT; RESIDUAL-STRESS; RING SPECIMENS; CRACKING; CONCRETE	The purpose of this study was to qualitatively assess the shrinkage reduction and cracking restraint of expansive additives under various restraint conditions. The reduction of drying and autogenous shrinkages on the addition of expansive additives was confirmed. The results of a ring test performed to determine restrained shrinkage indicated that at the same age, the cracking potential of expansive mortar based on the stress/strength ratio remained lower than that of normal mortar, which confirmed that the generation of compressive stress at an early age reduced the restrained stress and restrained cracking. From the time that cracking occurred, the expansive mortar showed substantial stress relaxation, reducing the tensile stress caused by the interface restraint load. Moreover, the use of expansive additives could reduce the degree of restraint under the same restraint condition, preventing the occurrence of cracking due to shrinkage. (c) 2015 Elsevier Ltd. All rights reserved.	[Choi, Hyeonggil] Muroran Inst Technol, Grad Sch Engn, Sapporo, Hokkaido, Japan; [Lim, Myungkwan] Hankyong Natl Univ, Grad Sch Engn, Ansung, South Korea; [Kitagaki, Ryoma; Noguchi, Takafumi] Univ Tokyo, Dept Architecture, Tokyo, Japan; [Kim, Gyuyong] Chungnam Natl Univ, Dept Architectural Engn, Taejon, South Korea	Lim, M (reprint author), Hankyong Natl Univ, Grad Sch Engn, Ansung, South Korea.						AASHTO (American Association of State Highway and Transportation Officials, 1998, PP3499 AASHTO, P34; AIJ, 2006, REC PRACT CRACK CONT; Altoubat SA, 2001, ACI MATER J, V98, P323; See HT, 2003, ACI MATER J, V100, P239; Hossain AB, 2004, CEMENT CONCRETE COMP, V26, P531, DOI 10.1016/s09858-9465(03)00069-6; Weiss WJ, 2000, J ENG MECH-ASCE, V126, P93, DOI 10.1061/(ASCE)0733-9399(2000)126:1(93); Moon JH, 2006, CEMENT CONCRETE COMP, V28, P486, DOI 10.1016/j.cemconcomp.2005.10.008; Hiroshi H, 2010, SUMMARIES TECHNIC A, VA-1, P927; Hossain AB, 2006, CEMENT CONCRETE RES, V36, P189, DOI 10.1016/j.cemconres.2004.06.043; Momose H, 2011, J STRUCT CONSTR ENG, V76, P1367; Reol DY, 2012, KSCE J CIV ENG, V32, P317; Schlitter J, 2010, ASTM INT, V7, P13; Tiomoshenko SP, 1987, THEORY ELASTICITY; Ugural A, 1995, ADV STRENGTH APPL EL; Weiss W. J., 1999, THESIS NW U EVANSTON; Weiss WJ, 2001, IMPACT SPECIMEN GEOM, P645	16	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0950-0618	1879-0526		CONSTR BUILD MATER	Constr. Build. Mater.	JUN 1	2015	84						468	476		10.1016/j.conbuildmat.2015.03.075		9	Construction & Building Technology; Engineering, Civil; Materials Science, Multidisciplinary	Construction & Building Technology; Engineering; Materials Science	CH4KE	WOS:000354001600052		
J	Matsuo, Y; Ito, A; Masui, Y; Ito, M				Matsuo, Yoshie; Ito, Akiko; Masui, Yukiko; Ito, Masaaki			A case of allergic contact dermatitis caused by arbutin	CONTACT DERMATITIS			English	Article						allergic contact dermatitis; arbutin; CAS no; 497-76-7; cosmetics; patch testing; skin-whitening			[Matsuo, Yoshie; Ito, Akiko; Masui, Yukiko; Ito, Masaaki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Dermatol, Niigata 9518510, Japan	Matsuo, Y (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Dermatol, Chuo Ku, 1-757 Asahimachi Dori, Niigata, Niigata, Japan.	kv448375a@gmail.com					Hu ZM, 2009, J DERMATOL SCI, V55, P179, DOI 10.1016/j.jdermsci.2009.06.003; Hizawa T, 2005, J ENV DERMATOL, V12, P137; Kanto H., 2008, J ENV DERMATOL CUTAN, V2, P1; Sugimoto K, 2007, TRENDS GLYCOSCI GLYC, V19, P235, DOI 10.4052/tigg.19.235	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0105-1873	1600-0536		CONTACT DERMATITIS	Contact Dermatitis	JUN	2015	72	6					404	405		10.1111/cod.12375		2	Allergy; Dermatology	Allergy; Dermatology	CH9VA	WOS:000354383300011		
J	Gould, AL; Harii, S; Dunlap, PV				Gould, Alison L.; Harii, Saki; Dunlap, Paul V.			Cues from the reef: olfactory preferences of a symbiotically luminous cardinalfish	CORAL REEFS			English	Article						Siphamia tubifer; Apogonidae; Olfaction; Homing; Bioluminescence; Symbiosis	HOMING BEHAVIOR; SITE FIDELITY; FISH LARVAE; PERCIFORMES APOGONIDAE; SIPHAMIA-VERSICOLOR; ABILITY; CORALS; SOUND	The symbiotically luminous, reef-dwelling cardinalfish, Siphamia tubifer (Perciformes: Apogonidae), exhibits daily site fidelity, homing behavior, and a preference for the long-spined urchin, Diadema setosum, as its daytime host. The fish acquires its symbiont during larval development and releases large numbers of the bacteria with its feces daily at a host urchin. To examine the role of olfaction in site fidelity and homing by S. tubifer, juvenile and adult fish were tested in a two-channel choice flume for their olfactory preferences. Neither juveniles nor adults showed a preference for seawater conditioned by D. setosum. Juvenile fish, but not adults, preferred seawater conditioned by conspecific fish versus unconditioned seawater. Both juveniles and adults preferred seawater conditioned by their luminous symbiont and also preferred home site water to foreign reef water. These results suggest that S. tubifer uses chemical cues for homing and possibly settlement and symbiont acquisition, but not for host urchin recognition.	[Gould, Alison L.; Dunlap, Paul V.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Harii, Saki] Univ Ryukyus, Sesoko Stn, Trop Biosphere Res Ctr, Motobu, Okinawa 9050227, Japan	Gould, AL (reprint author), Univ Michigan, Dept Ecol & Evolutionary Biol, 830 North Univ Ave, Ann Arbor, MI 48109 USA.	algould@umich.edu			PADI Foundation	We thank J. Dobkowski and M. Grundler (University of Michigan) for technical assistance. Support was provided by the PADI Foundation.	Atema J, 2002, MAR ECOL PROG SER, V241, P151, DOI 10.3354/meps241151; Brown GE, 2003, FISH FISH, V4, P227, DOI 10.1046/j.1467-2979.2003.00132.x; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; Munday PL, 2013, MAR BIOL, V160, P2137, DOI 10.1007/s00227-012-2111-6; Coppock AG, 2013, J EXP MAR BIOL ECOL, V443, P21, DOI 10.1016/j.jembe.2013.02.026; Marnane MJ, 2000, J FISH BIOL, V57, P1590, DOI 10.1006/jfbi.2000.1422; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Gardiner NM, 2010, CORAL REEFS, V29, P845, DOI 10.1007/s00338-010-0642-1; Dixson DL, 2014, SCIENCE, V345, P892, DOI 10.1126/science.1255057; Dunlap PV, 2011, J MORPHOL, V272, P897, DOI 10.1002/jmor.10956; Devine BM, 2012, OECOLOGIA, V168, P269, DOI 10.1007/s00442-011-2081-2; Radford C, 2008, MAR ECOL PROG SER, V362, P37, DOI 10.3354/meps07444; Dunlap PV, 2012, J FISH BIOL, V81, P1340, DOI 10.1111/j.1095-8649.2012.03415.x; Dixson DL, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.53; Dixson DL, 2008, P ROY SOC B-BIOL SCI, V275, P2831, DOI 10.1098/rspb.2008.0876; Doving KB, 2006, CHEM SENSES, V31, P265, DOI 10.1093/chemse/bjj028; Fukumori K, 2010, ANIM COGN, V13, P385, DOI 10.1007/s10071-009-0285-1; Gerlach G, 2012, CHEM ECOLOGY AQUATIC, P75; Gould AL, 2014, MAR BIOL, V161, P2897, DOI 10.1007/s00227-014-2554-z; Kolm N, 2005, BEHAV ECOL, V16, P521, DOI 10.1093/beheco/ari022; Leis JM, 2003, J FISH BIOL, V63, P724, DOI 10.1046/j.1095-8649.2003.00182.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263	25	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0722-4028	1432-0975		CORAL REEFS	Coral Reefs	JUN	2015	34	2					673	677		10.1007/s00338-015-1278-y		5	Marine & Freshwater Biology	Marine & Freshwater Biology	CH7BC	WOS:000354189600032		
J	Tunthawiroon, P; Li, YP; Tang, N; Koizumi, Y; Chiba, A				Tunthawiroon, Phacharaphon; Li, Yunping; Tang, Ning; Koizumi, Yuichiro; Chiba, Akihiko			Effects of alloyed Si on the oxidation behaviour of Co-29Cr-6Mo alloy for solid-oxide fuel cell interconnects	CORROSION SCIENCE			English	Article						Cobalt; SEM; Interfaces; Oxidation	CR-MO ALLOY; HIGH-TEMPERATURE ELECTROLYSIS; FERRITIC STAINLESS-STEEL; STELLITE 6 ALLOYS; SOFC INTERCONNECT; INTERFACIAL REACTIONS; CORROSION BEHAVIOR; INTERNAL OXIDATION; INCONEL 617; MOLTEN AL	To evaluate the suitability of the Co-29Cr-6Mo alloy as an interconnect in solid-oxide fuel cells (SOFCs), the oxidation behaviour of Co-29Cr-6Mo alloys with various Si concentrations was investigated in air at 700-1000 degrees C. The presence of alloyed Si improved the oxide-scale adhesion by promoting the formation of a continuous Cr2O3 film. The SiO2 particles in the inner layer and the grain boundaries of alloy matrix beneath the inner layer inhibited the inward oxygen diffusion and outward chromium diffusion. The results indicate that the Co-29Cr-6Mo alloy with added Si is appropriate for SOFC applications. Crown Copyright (C) 2015 Published by Elsevier Ltd. All rights reserved.	[Tunthawiroon, Phacharaphon] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808577, Japan; [Li, Yunping] Cent S Univ, Mat Sci & Engn, Changsha, Hunan, Peoples R China; [Li, Yunping; Tang, Ning; Koizumi, Yuichiro; Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Li, YP (reprint author), Cent S Univ, Mat Sci & Engn, Changsha, Hunan, Peoples R China.	lyping@csu.edu.cn			Program NICHe at Tohoku University, Japan	This research was partially supported by Program NICHe at Tohoku University, Japan. The author would like to thank Isamu Yoshii, Kimio Waki, Shun Ito, and Issei Narita of IMR, Tohoku University, for contributing to the sample fabrication and preparation, EPMA analysis, and TEM observations.	Birol Y, 2010, T NONFERR METAL SOC, V20, P1656, DOI 10.1016/S1003-6326(09)60354-X; Seo HS, 2013, INT J HYDROGEN ENERG, V38, P2432, DOI 10.1016/j.ijhydene.2012.12.073; Tunthawiroon P, 2013, CORROS SCI, V77, P97, DOI 10.1016/j.corsci.2013.07.031; Huntz AM, 2003, APPL SURF SCI, V207, P255, DOI 10.1016/S0169-4332(02)01505-2; Xing JH, 2013, CORROS SCI, V75, P212, DOI 10.1016/j.corsci.2013.06.004; Shin Y, 2007, INT J HYDROGEN ENERG, V32, P1486, DOI 10.1016/j.ijhydene.2006.10.028; Pint BA, 1996, OXID MET, V45, P1, DOI 10.1007/BF01046818; Wu JW, 2010, J MATER SCI TECHNOL, V26, P293; Birol Y, 2010, MAT SCI ENG A-STRUCT, V527, P1938, DOI 10.1016/j.msea.2009.11.021; Li YP, 2013, CORROS SCI, V73, P72, DOI 10.1016/j.corsci.2013.03.026; Sachitanand R, 2013, INT J HYDROGEN ENERG, V38, P15328, DOI 10.1016/j.ijhydene.2013.09.044; Liu XH, 2014, CORROS SCI, V78, P200, DOI 10.1016/j.corsci.2013.09.017; Brisse A, 2012, ENRGY PROCED, V29, P53, DOI 10.1016/j.egypro.2012.09.008; Horita T, 2008, SOLID STATE IONICS, V179, P2216, DOI 10.1016/j.ssi.2008.07.024; Paul A, 2007, OXID MET, V67, P87, DOI 10.1007/s11085-006-9046-6; Tang N, 2014, CORROS SCI, V78, P244, DOI 10.1016/j.corsci.2013.10.004; Birol Y, 2010, MAT SCI ENG A-STRUCT, V527, P6091, DOI 10.1016/j.msea.2010.06.015; Li YP, 2014, CORROS SCI, V84, P147, DOI 10.1016/j.corsci.2014.03.020; Chen Y, 2014, WEAR, V310, P51, DOI 10.1016/j.wear.2013.12.010; Gong WJ, 2013, CORROS SCI, V77, P391, DOI 10.1016/j.corsci.2013.08.006; Tang N, 2011, CORROS SCI, V53, P4324, DOI 10.1016/j.corsci.2011.08.015; Tang N, 2012, CORROS SCI, V60, P32, DOI 10.1016/j.corsci.2012.04.015; KUMAR A, 1974, OXID MET, V8, P227, DOI 10.1007/BF00604042; Molin S, 2008, J POWER SOURCES, V181, P31, DOI 10.1016/j.jpowsour.2007.10.009; Yang ZG, 2003, J ELECTROCHEM SOC, V150, pA1188, DOI 10.1149/1.1595659; Lim KR, 2013, CORROS SCI, V73, P1, DOI 10.1016/j.corsci.2013.04.009; Mougin J, 2012, ENRGY PROCED, V29, P445, DOI 10.1016/j.egypro.2012.09.052; Ardigo MR, 2012, INT J HYDROGEN ENERG, V37, P8177, DOI 10.1016/j.ijhydene.2012.02.069; Atkinson A., 1985, REV MOD PHYS, V57; Berthod P., 2012, ISRN METALL, V2012, P1; Dong ZQ, 2012, CORROS SCI, V65, P461, DOI 10.1016/j.corsci.2012.08.048; ESPEVIK S, 1983, OXID MET, V20, P37, DOI 10.1007/BF00658126; GIL A, 1992, SOLID STATE IONICS, V58, P13, DOI 10.1016/0167-2738(92)90005-A; Gorr B, 2009, OXID MET, V71, P157, DOI 10.1007/s11085-008-9133-y; Hammer J. E., 2007, OXID MET, V67, P1, DOI DOI 10.1007/S11085-006-9041-Y; Hou P.Y., 1995, MAT SCI ENG A-STRUCT, V20, P1; HOU PY, 1990, OXID MET, V33, P357, DOI 10.1007/BF00666805; Jablonski PD, 2008, J POWER SOURCES, V180, P433, DOI 10.1016/j.jpowsour.2008.02.010; Jalilvand G, 2013, INT J HYDROGEN ENERG, V38, P12007, DOI 10.1016/j.ijhydene.2013.06.105; Koestad P. K., 1969, J ELECTROCHEM SOC, V116, P224; KOFSTAD PK, 1969, J ELECTROCHEM SOC, V116, P1542, DOI 10.1149/1.2411603; KOFSTAD PK, 1969, J ELECTROCHEM SOC, V116, P229, DOI 10.1149/1.2411803; Madeshia A, 2013, CORROS SCI, V73, P89, DOI 10.1016/j.corsci.2013.03.028; Molin S, 2014, J POWER SOURCES, V251, P488, DOI 10.1016/j.jpowsour.2013.09.100; MROWEC S, 1974, OXID MET, V8, P379, DOI 10.1007/BF00603388; Nii K., 1997, CORROS ENG, V26, P389; QUADAKKERS WJ, 1989, OXID MET, V32, P67, DOI 10.1007/BF00665269; Rashkeev SN, 2012, INT J HYDROGEN ENERG, V37, P1280, DOI 10.1016/j.ijhydene.2011.09.117; Sedriks A.J., 1996, CORROSION STAINLESS; Song YW, 2013, CORROS SCI, V72, P133, DOI 10.1016/j.corsci.2013.03.021; WALLWORK GR, 1976, REP PROG PHYS, V39, P401, DOI 10.1088/0034-4885/39/5/001; Yan JB, 2011, CORROS SCI, V53, P3588, DOI 10.1016/j.corsci.2011.07.002	52	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	JUN	2015	95						88	99		10.1016/j.corsci.2015.02.036		12	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CH4KC	WOS:000354001400009		
J	Sato, S; Yanagida, N; Ohtani, K; Koike, Y; Ebisawa, M				Sato, Sakura; Yanagida, Noriyuki; Ohtani, Kiyotaka; Koike, Yumi; Ebisawa, Motohiro			A review of biomarkers for predicting clinical reactivity to foods with a focus on specific immunoglobulin E antibodies	CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						component-resolved diagnostics; food allergy; food-specific IgE; oral food challenge; oral immunotherapy	COWS MILK ALLERGY; PEANUT ORAL IMMUNOTHERAPY; WHITE-SPECIFIC IGE; ARA H 1; EGG ALLERGY; NATURAL-HISTORY; JAPANESE CHILDREN; OMEGA-5 GLIADIN; HAZELNUT ALLERGY; WHEAT ALLERGY	Purpose of review The purpose of this study is to assess the latest studies that focus on specific immunoglobulin (Ig)E antibodies for predicting clinical reactivity to foods. Recent findings Persistent hen's egg and cow's milk allergy patients have higher antigen-specific IgE levels at all ages than those who have outgrown these allergies. Recent studies on the natural histories of hen's egg and cow's milk allergies suggested that baseline antigen-specific IgEs are the most important predictors of tolerance. Oral immunotherapy (OIT), which is a novel therapeutic approach for food allergy, requires biomarkers for predicting outcomes after therapy. Several studies indicate that the initial antigen-specific IgE level may be a useful biomarker for the prognosis of OIT. Recently, component-resolved diagnostics (CRD) has been used for food allergy diagnosis. Current studies have suggested that Ara h 2, omega-5 gliadin and ovomucoid are good diagnostic markers for peanut, wheat and egg allergies, respectively. Summary Antigen-specific IgE can be a useful biomarker for predicting clinical reactivity to food allergies. Monitoring hen's egg and cow's milk-specific IgE is useful for predicting prognosis, and baseline specific IgE levels may be associated with the outcome of OIT. The use of CRD provides us with a better tool for diagnosing food allergy.	[Sato, Sakura; Ohtani, Kiyotaka; Koike, Yumi; Ebisawa, Motohiro] Sagamihara Natl Hosp, Clin Res Ctr Allergol & Rheumatol, Dept Allergy, Sagamihara, Kanagawa 2520392, Japan; [Yanagida, Noriyuki] Sagamihara Natl Hosp, Dept Pediat, Sagamihara, Kanagawa 2520392, Japan	Sato, S (reprint author), Sagamihara Natl Hosp, Clin Res Ctr Allergol & Rheumatol, Dept Allergy, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa 2520392, Japan.	s-satou@sagamihara-hosp.gr.jp			Ministry of Health, Labour and Welfare in Japan	This work was supported by a Health and Labour Science Research grant for research on allergic disease and immunology from the Ministry of Health, Labour and Welfare in Japan.; Motohiro Ebisawa, MD, PhD, received supported from a Health and Labour Science Research Grant for research on allergic disease and immunology from the Ministry of Health, Labor and Welfare in Japan.	Agabriel C, 2014, PEDIAT ALLERG IMM-UK, V25, P662, DOI 10.1111/pai.12299; Pahr S, 2013, J ALLERGY CLIN IMMUN, V132, P1000, DOI 10.1016/j.jaci.2013.05.016; Cho J, 2015, ALLERGY ASTHMA IMMUN, V7, P37, DOI 10.4168/aair.2015.7.1.37; Jacobsen B, 2008, MOL NUTR FOOD RES, V52, pS176, DOI 10.1002/mnfr.200700414; Keet CA, 2013, J ALLERGY CLIN IMMUN, V132, P737, DOI 10.1016/j.jaci.2013.05.006; Vickery BP, 2010, ANN ALLERG ASTHMA IM, V105, P444, DOI 10.1016/j.anai.2010.09.030; Nicolaou N, 2010, J ALLERGY CLIN IMMUN, V125, P191, DOI 10.1016/j.jaci.2009.10.008; Masthoff LJN, 2013, J ALLERGY CLIN IMMUN, V132, P393, DOI 10.1016/j.jaci.2013.02.024; Jones Stacie M, 2009, J Allergy Clin Immunol, V124, P292, DOI 10.1016/j.jaci.2009.05.022; Bartnikas LM, 2013, J ALLER CL IMM-PRACT, V1, P354, DOI 10.1016/j.jaip.2013.04.002; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P492, DOI 10.1016/j.jaci.2013.12.1041; Ebisawa M, 2012, PEDIAT ALLERG IMM-UK, V23, P573, DOI 10.1111/j.1399-3038.2012.01332.x; Lemon-Mule H, 2008, J ALLERGY CLIN IMMUN, V122, P977, DOI 10.1016/j.jaci.2008.09.007; Matsuo H, 2008, ALLERGY, V63, P233, DOI 10.1111/j.1398-9995.2007.01504.x; Ito K, 2008, ALLERGY, V63, P1536, DOI 10.1111/j.1398-9995.2008.01753.x; Muraro A, 2014, ALLERGY, V69, P1008, DOI 10.1111/all.12429; Ebisawa M, 2013, J ALLERGY CLIN IMMUN, V132, P976, DOI 10.1016/j.jaci.2013.04.028; Savage JH, 2007, J ALLERGY CLIN IMMUN, V120, P1413, DOI 10.1016/j.jaci.2007.09.040; Asarnoj A, 2012, J ALLERGY CLIN IMMUN, V130, P468, DOI 10.1016/j.jaci.2012.05.019; Ito K, 2011, J ALLERGY CLIN IMMUN, V128, P673, DOI 10.1016/j.jaci.2011.04.025; Beyer K, 2008, J ALLERGY CLIN IMMUN, V122, P419, DOI 10.1016/j.jaci.2008.06.006; Wood RA, 2013, J ALLERGY CLIN IMMUN, V131, P805, DOI 10.1016/j.jaci.2012.10.060; Meglio P, 2004, ALLERGY, V59, P980, DOI 10.1111/j.1398-9995.2004.00542.x; Buchanan AD, 2007, J ALLERGY CLIN IMMUN, V119, P199, DOI 10.1016/j.jaci.2006.09.016; Longo G, 2008, J ALLERGY CLIN IMMUN, V121, P343, DOI 10.1016/j.jaci.2007.10.029; Sato S, 2014, INT ARCH ALLERGY IMM, V164, P1, DOI 10.1159/000361025; Blumchen K, 2010, J ALLERGY CLIN IMMUN, V126, P83, DOI 10.1016/j.jaci.2010.04.030; Ando H, 2008, J ALLERGY CLIN IMMUN, V122, P583, DOI 10.1016/j.jaci.2008.06.016; Nozawa A, 2014, PEDIAT ALLERG IMM-UK, V25, P323, DOI 10.1111/pai.12243; Savilahti EM, 2014, PEDIAT ALLERG IMM-UK, V25, P227, DOI 10.1111/pai.12186; Skripak JM, 2007, J ALLERGY CLIN IMMUN, V120, P1172, DOI 10.1016/j.jaci.2007.08.023; Vickery BP, 2014, J ALLERGY CLIN IMMUN, V133, P468, DOI 10.1016/j.jaci.2013.11.007; Celik-Bilgili S, 2005, CLIN EXP ALLERGY, V35, P268, DOI 10.1111/j.1365-2222.2005.02150.x; Syed A, 2014, J ALLERGY CLIN IMMUN, V133, P500, DOI 10.1016/j.jaci.2013.12.1037; Lewis SA, 2005, CLIN EXP ALLERGY, V35, P767, DOI 10.1111/j.1365-2222.2005.02252.x; Skripak JM, 2008, J ALLERGY CLIN IMMUN, V122, P1154, DOI 10.1016/j.jaci.2008.09.030; Vazquez-Ortiz M, 2014, CLIN EXP ALLERGY, V44, P130, DOI 10.1111/cea.12233; Keet CA, 2009, ANN ALLERG ASTHMA IM, V102, P410, DOI 10.1016/S1081-1206(10)60513-3; Shek LPC, 2004, J ALLERGY CLIN IMMUN, V114, P387, DOI 10.1016/j.jaci.2004.04.032; Astier C, 2006, J ALLERGY CLIN IMMUN, V118, P250, DOI 10.1016/j.jaci.2006.04.053; Le TM, 2013, J ALLERGY CLIN IMMUN, V131, P164, DOI 10.1016/j.jaci.2012.09.009; Burks AW, 2012, NEW ENGL J MED, V367, P233, DOI 10.1056/NEJMoa1200435; Keet CA, 2012, J ALLERGY CLIN IMMUN, V129, P448, DOI 10.1016/j.jaci.2011.10.023; Sampson HA, 1997, J ALLERGY CLIN IMMUN, V100, P444; Varshney P, 2011, J ALLERGY CLIN IMMUN, V127, P654, DOI 10.1016/j.jaci.2010.12.1111; Shibata R, 2011, ANN ALLERG ASTHMA IM, V107, P337, DOI 10.1016/j.anai.2011.07.013; Lieberman JA, 2013, J ALLER CL IMM-PRACT, V1, P75, DOI 10.1016/j.jaip.2012.11.002; BISHOP JM, 1990, J PEDIATR-US, V116, P862, DOI 10.1016/S0022-3476(05)80641-9; Yu GP, 2012, INT ARCH ALLERGY IMM, V159, P179, DOI 10.1159/000336391; Asero R, 2014, Eur Ann Allergy Clin Immunol, V46, P22; Baar A, 2014, ALLERGY, V69, P1316, DOI 10.1111/all.12464; Ben-Shoshan M, 2012, CURR ALLERGY ASTHM R, V12, P346, DOI 10.1007/s11882-012-0274-3; Boyce JA, 2010, J ALLERGY CLIN IMMUN, V126, P1105, DOI 10.1016/j.jaci.2010.10.008; Chin Stacy J, 2013, J Allergy Clin Immunol, V132, P476, DOI 10.1016/j.jaci.2013.02.017; Ebisawa M, 2015, J ALLER CL IMM-PRACT, V3, P131, DOI 10.1016/j.jaip.2014.10.014; Faber MA, 2014, INT ARCH ALLERGY IMM, V164, P200, DOI 10.1159/000365050; Haneda Y, 2012, J ALLERGY CLIN IMMUN, V129, P1681, DOI 10.1016/j.jaci.2012.03.041; Kattan JD, 2014, J ALLER CL IMM-PRACT, V2, P633, DOI 10.1016/j.jaip.2014.03.013; Montesinos E, 2010, PEDIAT ALLERG IMM-UK, V21, P634, DOI 10.1111/j.1399-3038.2009.00940.x; Narisety SD, 2014, J ALLERGY CLIN IMMUN; Nikolic J, 2014, J CHROMATOGR B, V962, P30, DOI 10.1016/j.jchromb.2014.05.020; Ortolani C, 2000, J ALLERGY CLIN IMMUN, V105, P577, DOI 10.1067/mai.2000.103052; Palosuo Kati, 2003, Curr Opin Allergy Clin Immunol, V3, P205, DOI 10.1097/00130832-200306000-00009; Peeters KABM, 2007, CLIN EXP ALLERGY, V37, P108, DOI 10.1111/j.1365-2222.2006.02628.x; Savilahti EM, 2014, INT ARCH ALLERGY IMM, V164, P32, DOI 10.1159/000361023; Sicherer SH, 2008, J ALLERGY CLIN IMMUN, V122, P413, DOI 10.1016/j.jaci.2008.05.012; Staden U, 2008, J ALLERGY CLIN IMMUN, V122, P418, DOI 10.1016/j.jaci.2008.06.002; Wangorsch A, 2015, MOL NUTR FOOD RES, V59, P582, DOI 10.1002/mnfr.201300620	68	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1528-4050	1473-6322		CURR OPIN ALLERGY CL	Curr. Opin. Allergy Clin. Immunol.	JUN	2015	15	3					250	258		10.1097/ACI.0000000000000162		9	Allergy; Immunology	Allergy; Immunology	CH0EA	WOS:000353690700010		
J	Kato, Y; Hickey, M; Treger, J; Erickson, K; Haga, K; Malone, C; Inagaki, A; Kruse, C; Kasahara, N				Kato, Y.; Hickey, M.; Treger, J.; Erickson, K.; Haga, K.; Malone, C.; Inagaki, A.; Kruse, C.; Kasahara, N.			RRV-MEDIATED PRODRUG ACTIVATOR GENE THERAPY COMBINED WITH ALLOREACTIVE T CELL IMMUNOTHERAPY FOR MALIGNANCIES IN THE CNS	CYTOTHERAPY			English	Meeting Abstract									[Kato, Y.; Kasahara, N.] Univ Calif Los Angeles, Mol & Med Pharmacol, Los Angeles, CA USA; [Hickey, M.; Treger, J.; Erickson, K.; Malone, C.; Kruse, C.] Univ Calif Los Angeles, Neurosurg, Los Angeles, CA USA; [Treger, J.; Haga, K.; Kasahara, N.] Univ Calif Los Angeles, Med, Los Angeles, CA USA; [Haga, K.] Sanriki Res Inst, Sapporo, Hokkaido, Japan; [Inagaki, A.; Kasahara, N.] Univ Miami, Cell Biol, Miami, FL USA; [Kasahara, N.] Univ Miami, Pathol, Miami, FL USA								0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	JUN	2015	17	6		S		176	S51	S52				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	CH6JK	WOS:000354142700161		
J	Takahashi, M; Uchiyama, T; Iwaya, S; Oiwa, E; Nishizawa, Y; Hashimoto, S; Bonehill, A; Kasahara, N; Narita, M				Takahashi, M.; Uchiyama, T.; Iwaya, S.; Oiwa, E.; Nishizawa, Y.; Hashimoto, S.; Bonehill, A.; Kasahara, N.; Narita, M.			LEUKEMIC PLASMACYTOID DENDRITIC CELL LINE TRANSDUCED WITH CATLR4 GENE AS A POTENT ANTIGEN PRESENTING CELLS FOR IMMUNOTHERAPY	CYTOTHERAPY			English	Meeting Abstract									[Takahashi, M.; Uchiyama, T.; Iwaya, S.; Oiwa, E.; Nishizawa, Y.; Narita, M.] Niigata Univ, Niigata, Japan; [Bonehill, A.] Free Univ Brussels, Brussels, Belgium; [Hashimoto, S.] Nagaoka Red Cross Hosp, Nagaoka, Niigata, Japan; [Kasahara, N.] Univ Calif Los Angeles, Los Angeles, CA USA			Bonehill, Aude/J-7363-2013	Bonehill, Aude/0000-0002-9372-6876				0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	JUN	2015	17	6		S		40	S18	S18				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	CH6JK	WOS:000354142700042		
J	Mizuhashi, F; Koide, K; Takahashi, M				Mizuhashi, Fumi; Koide, Kaoru; Takahashi, Mutsumi			Difference in vacuum-formed mouthguard thickness according to heating condition	DENTAL TRAUMATOLOGY			English	Article						mouthguard; heating condition; thickness; vacuum-forming	INJURIES; SPORTS; PREVENTION; PROTECTION; GUARDS	AimThe purpose of this study was to examine the differences of the vacuum-formed mouthguard thickness by the heating condition within the proper heating temperature. Materials and methodsThe material used in this study was a mouthguard sheet of 3.8-mm ethylene vinyl acetate. The sheets were formed by vacuum forming using a vacuum-pressure former. Three heating conditions were prepared: The sheet was heated until the center was displaced by 10, 15, and 20mm from baseline. We measured mouthguard thickness at the labial surface of the central incisor, buccal surface of the first molar, and occlusal surface of the first molar. Differences in thickness in different regions of mouthguards formed under different heating conditions were analyzed by two-way analysis of variance and Bonferroni method. ResultsWe found that mouthguard thickness differed in different regions of the central incisors and the first molars (P<0.01). The incisal (cusp) region was thinner than the cervical region. There was statistically significant difference among the heating conditions at the buccal surface of the first molar (P<0.01), and the thickness became larger as the sheet was heated. Mouthguard thickness at the labial surface of the central incisor and occlusal surface of the first molar did not differ among the three heating conditions. ConclusionsOur results suggest that the best heating condition within the proper temperature was the condition that the sheet was heated until its center displaced by 20mm. This finding is necessary knowledge when forming a mouthguard sheet.	[Mizuhashi, Fumi; Koide, Kaoru; Takahashi, Mutsumi] Nippon Dent Univ, Sch Life Dent Niigata, Dept Removable Prosthodont, Niigata 9518580, Japan	Mizuhashi, F (reprint author), Nippon Dent Univ, Sch Life Dent Niigata, Dept Removable Prosthodont, Chuo Ku, 1-8 Hamaura Cho, Niigata 9518580, Japan.	fumichan@ngt.ndu.ac.jp					Chi Howard H, 2007, Compend Contin Educ Dent, V28, P36; DelsRossi G, 2007, DENT TRAUMATOL, V23, P149; Eccelston JA, 1995, AUSTR DENT J, V40, P389; Geary JL, 2008, DENT TRAUMATOL, V24, P350, DOI 10.1111/j.1600-9657.2007.00550.x; Goran MW, 1986, J AM DENT ASSOC, V112, P663; Guevara P H, 2001, Gen Dent, V49, P402; JOHNSEN D C, 1991, Dental Clinics of North America, V35, P657; Johnston T, 1996, ENDOD DENT TRAUMATOL, V12, P277; KERR IL, 1986, SPORTS MED, V3, P415; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Low Danny, 2002, Ann R Australas Coll Dent Surg, V16, P153; Maeda Y, 2001, FABRICATING MANUAL M; NowjackRaymer RE, 1996, PUBLIC HEALTH REP, V111, P82; PARK JB, 1994, J PROSTHET DENT, V72, P373, DOI 10.1016/0022-3913(94)90556-8; Patrick DG, 2005, BRIT J SPORT MED, V39, P278, DOI 10.1136/bjsm.2004.012658; Santos Filho Paulo César de Freitas, 2007, J Contemp Dent Pract, V8, P89; Spinas E, 2007, Eur J Paediatr Dent, V8, P193; Takahashi F, 2003, J SPORTS DENT, V6, P30; Takahashi F, 2004, J SPORTS DENT, V7, P12; Waked EJ, 2005, QUINTESSENCE INT, V36, P462; Yamada J, 2003, J SPORTS DENT, V6, P42; Yamada Junko, 2007, J Prosthodont, V16, P452, DOI 10.1111/j.1532-849X.2007.00222.x	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	JUN	2015	31	3					233	237		10.1111/edt.12138		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CH7AM	WOS:000354188000010		
J	Chowdhury, RU; Churei, H; Takahashi, H; Shahrin, S; Fukasawa, S; Shrestha, A; Takashino, N; Negoro, T; Ueno, T				Chowdhury, Ruman U.; Churei, Hiroshi; Takahashi, Hidekazu; Shahrin, Sharika; Fukasawa, Shintaro; Shrestha, Abhishekhi; Takashino, Nami; Negoro, Takefumi; Ueno, Toshiaki			Suitable design of mouthguard for sports-active person with spaced dentition	DENTAL TRAUMATOLOGY			English	Article						mouthguard; malocclusion; spaced dentition; shock absorption; sports dentistry	INJURIES; FABRICATION; PREVENTION; PREVALENCE; PROTECTORS; ABSORPTION; SENSOR; GUARDS; IMPACT; TEETH	AimCustom-made mouthguard (MG) is popularly used by sports-active persons or athletes having either normo-occlussion or malocclusion to prevent dental injury. For sports-active person with malocclusion, specially designed mouthguard is often required. The purpose of this study was to make a suitable design custom-made mouthguard for sports-active person with spaced dentition by the shock absorption capability. Materials and methodsTwo different types of double layered mouthguards were made from a model of a sports-active person having spaced dentition with polyolefin sheets. One type was made by filling the interproximal spaces of the spaced dentition and the other type, which was devoid of interproximal space covering, without mouthguard materials (keeping space). The impact tests were carried out by a free-falling object via testing machine and a vertical rod. The strains of the dentition with mouthguard were measured by means of strain gage system to compare between two different designs of mouthguard. Unpaired t-test was carried out as statistical analysis. ResultThe strains of the dentition with mouthguard by filling the interproximal spaces were significantly low compared with the mouthguard by keeping spaces (P<0.05). ConclusionFor sports-active person with spaced dentition, it is important for reducing injury risks that the mouthguard covered the teeth and filled or embedded interproximal space certainly.	[Chowdhury, Ruman U.; Churei, Hiroshi; Shahrin, Sharika; Fukasawa, Shintaro; Shrestha, Abhishekhi; Ueno, Toshiaki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sports Med & Dent, Tokyo 1138549, Japan; [Takahashi, Hidekazu] Tokyo Med & Dent Univ, Fac Dent, Oral Biomat Engn, Tokyo 1138549, Japan; [Takashino, Nami] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Cariol & Operat Dent, Tokyo 1138549, Japan; [Negoro, Takefumi] TF Sakae Orthodont Clin, Nagoya, Aichi, Japan	Ueno, T (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sports Med & Dent, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	t.ueno.spmd@tmd.ac.jp					Abu Alhaija ESJ, 2005, COMMUNITY DENT HLTH, V22, P266; STEIGMAN S, 1985, ANGLE ORTHOD, V55, P167; Duarte-Pereira DMV, 2008, DENT TRAUMATOL, V24, P439, DOI 10.1111/j.1600-9657.2008.00595.x; Gebauer DP, 2011, CLIN J SPORT MED, V21, P95, DOI 10.1097/JSM.0b013e31820428b0; Bhalla A, 2013, DENT TRAUMATOL, V29, P218, DOI 10.1111/j.1600-9657.2012.01159.x; Chay S H, 2000, Ann R Australas Coll Dent Surg, V15, P83; Croll T P, 1992, J Esthet Dent, V4, P143, DOI 10.1111/j.1708-8240.1992.tb00684.x; Croll T P, 1989, Quintessence Int, V20, P571; Croll T P, 1999, J Clin Orthod, V33, P168; DesWet F, 1984, J DENT ASSOC S AFR, V39, P339; FDI World Dental Federation, 2008, FDI POL STAT SPORT M; HICKEY JC, 1967, J AM DENT ASSOC, V74, P735; KERR IL, 1986, SPORTS MED, V3, P415; Lieger O, 2006, DENT TRAUMATOL, V22, P1, DOI 10.1111/j.1600-9657.2006.00328.x; Low Danny, 2002, Ann R Australas Coll Dent Surg, V16, P153; Maeda M., 1994, JPN PROSTHODONT SOC, V38, P372; Maeda Y, 2008, DENT TRAUMATOL, V24, P475, DOI 10.1111/j.1600-9657.2008.00596.x; Miura J, 2007, DENT TRAUMATOL, V23, P9, DOI 10.1111/j.1600-9657.2006.00458.x; Newsome P R, 2001, Int J Paediatr Dent, V11, P396, DOI 10.1046/j.0960-7439.2001.00304.x; Nguyen QV, 1999, EUR J ORTHODONT, V21, P503, DOI 10.1093/ejo/21.5.503; Pacheco Gustavo, 2010, J Clin Orthod, V44, P41; Petti S, 1996, ENDOD DENT TRAUMATOL, V12, P294; Shahrin S, 2013, INT J SPORTS DENT, V6, P13; STENGER JM, 1964, J AM DENT ASSOC, V69, P273; Suzuki H, 2007, INT J ORAL MED SCI, V6, P14; Takeda T, 2004, DENT TRAUMATOL, V20, P29, DOI 10.1111/j.1600-4469.2004.00220.x; Takeda T, 2008, DENT TRAUMATOL, V24, P360, DOI 10.1111/j.1600-9657.2008.00576.x; Tomita T, 2006, J JPN PROSTHODONT SO, V50, P200; Tunc ES, 2012, DENT TRAUMATOL, V29, P378, DOI [10.1111/edt.12010, DOI 10.1111/EDT.12010]; Ueno T, 2001, J SPORTS DENT, V4, P1; WEHNER PJ, 1965, DENT CLIN N AM, P493; Yamada T, 1997, ENDOD DENT TRAUMATOL, V13, P40; Yamanaka Takuto, 2002, Journal of Medical and Dental Sciences, V49, P129	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	JUN	2015	31	3					238	242		10.1111/edt.12142		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CH7AM	WOS:000354188000011		
J	Katsura, T; Katakami, N; Irie, Y; Yamamoto, Y; Okusu, T; Kubo, F; Kanamaru, Y; Nakashoutani, I; Yoshiuchi, K; Sakamoto, K; Kaneto, H; Shimomura, I; Kosugi, K				Katsura, Takashi; Katakami, Naoto; Irie, Yoko; Yamamoto, Yuichi; Okusu, Takahiro; Kubo, Fumiyo; Kanamaru, Yozo; Nakashoutani, Ihoko; Yoshiuchi, Kazutomi; Sakamoto, Ken'ya; Kaneto, Hideaki; Shimomura, Iichiro; Kosugi, Keisuke			The Usefulness of a Cholesterol Absorption Inhibitor in Japanese Type 2 Diabetes Patients with Dyslipidemia	DIABETES TECHNOLOGY & THERAPEUTICS			English	Article							CORONARY-ARTERY-DISEASE; LDL CHOLESTEROL; STATIN THERAPY; HEART-DISEASE; EZETIMIBE; MARKERS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS; TRIGLYCERIDE; PROTEIN	Aim: Cholesterol absorption has been suggested to be an independent risk factor for cerebral and cardiovascular events. We studied the clinical efficacy of ezetimibe in Japanese patients with type 2 diabetes mellitus complicated by dyslipidemia, in whom increased cholesterol absorption had been reported. Subjects and Methods: Ninety-six patients with type 2 diabetes complicated by dyslipidemia received ezetimibe at 10 mg/day for 12 weeks. The lipid profile, a cholesterol synthesis marker (lathosterol), and cholesterol absorption markers (cholestanol, sitosterol, and campesterol) were measured before and after the therapy to evaluate the clinical efficacy of ezetimibe. Results: Serum low-density lipoprotein-cholesterol (LDL-C) levels were positively associated with cholesterol absorption markers but not associated with a cholesterol synthesis marker, suggesting that serum LDL-C levels are more strongly related to cholesterol absorption than synthesis. During the 12-week ezetimibe treatment period, cholesterol absorption markers significantly decreased, and serum lipid profiles, including LDL-C levels, significantly improved. The LDL-C-lowering rate was greater in those patients who had been receiving statin therapy and were newly started on ezetimibe additionally than in the ezetimibe monotherapy group (-31.4% vs. -18.4%; P<0.001). Conclusions: It is suggested that ezetimibe improves the lipid profile in Japanese type 2 diabetes patients with dyslipidemia through the substantial reduction of cholesterol absorption.	[Katsura, Takashi; Okusu, Takahiro; Kanamaru, Yozo; Nakashoutani, Ihoko; Yoshiuchi, Kazutomi; Sakamoto, Ken'ya; Kosugi, Keisuke] Osaka Police Hosp, Osaka 5430035, Japan; [Katsura, Takashi; Katakami, Naoto; Irie, Yoko; Yamamoto, Yuichi; Kubo, Fumiyo; Kaneto, Hideaki; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan	Kosugi, K (reprint author), Osaka Police Hosp, Tennouji Ku, 10-31 Kitayama Cho, Osaka 5430035, Japan.	ksgksk@oph.gr.jp			Osaka University	This research was funded by Osaka University.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Okada K, 2012, ATHEROSCLEROSIS, V224, P454, DOI 10.1016/j.atherosclerosis.2012.07.036; Matthan NR, 2009, J LIPID RES, V50, P1927, DOI 10.1194/jlr.P900039-JLR200; Rajaratnam RA, 2000, J AM COLL CARDIOL, V35, P1185, DOI 10.1016/S0735-1097(00)00527-1; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Teramoto T, 2005, CURR THER RES CLIN E, V66, P80, DOI 10.1016/j.curtheres.2005.04.004; Knopp RH, 1999, NEW ENGL J MED, V341, P498; Assmann G, 2006, NUTR METAB CARDIOVAS, V16, P13, DOI 10.1016/j.numecd.2005.04.001; Sudhop T, 2002, CIRCULATION, V106, P1943, DOI 10.1161/01.CIR.0000034044.95911.DC; Miettinen TA, 2003, ATHEROSCLEROSIS, V168, P343, DOI 10.1016/S0021-9150(03)00106-0; Sudhop T, 2009, J LIPID RES, V50, P2117, DOI 10.1194/jlr.P900004-JLR200; Thongtang N, 2012, ATHEROSCLEROSIS, V225, P388, DOI 10.1016/j.atherosclerosis.2012.09.001; Strandberg TE, 2006, J AM COLL CARDIOL, V48, P708, DOI 10.1016/j.jacc.2006.04.081; Davidson MH, 2004, INT J CLIN PRACT, V58, P746, DOI 10.1111/j.1368-5031.2004.00289.x; Weingartner O, 2009, CORONARY ARTERY DIS, V20, P376, DOI 10.1097/MCA.0b013e32832fa947; Descamps OS, 2011, ATHEROSCLEROSIS, V217, P308, DOI 10.1016/j.atherosclerosis.2011.06.010; GORDON T, 1981, ARCH INTERN MED, V141, P1128, DOI 10.1001/archinte.141.9.1128; GRIFFIN BA, 1994, ATHEROSCLEROSIS, V106, P241, DOI 10.1016/0021-9150(94)90129-5; Hiramitsu S, 2010, J ATHEROSCLER THROMB, V17, P106; Jones PH, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001800; Lally S, 2006, DIABETOLOGIA, V49, P1008, DOI 10.1007/s00125-006-0177-8; Malhotra P, 2013, AM J PHYSIOL-GASTR L, V304, pG203, DOI 10.1152/ajpgi.00288.2012; McKenney JM, 2006, AM J CARDIOL, V97, P89; Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202; Sasaki J, 2012, J ATHEROSCLER THROMB, V19, P485; Silbernagel G, 2009, J LIPID RES, V50, P334, DOI 10.1194/jlr.P800013-JLR200; Weingartner O, 2010, ATHEROSCLEROSIS, V210, P362, DOI 10.1016/j.atherosclerosis.2010.01.003	27	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1520-9156	1557-8593		DIABETES TECHNOL THE	Diabetes Technol. Ther.	JUN 1	2015	17	6					427	434		10.1089/dia.2014.0228		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CH6TF	WOS:000354168400011		
J	Hauser, E				Hauser, Eric			Units of Talk - Units of Action	DISCOURSE STUDIES			English	Book Review									[Hauser, Eric] Univ Electrocommun, Chofu, Tokyo 182, Japan; [Hauser, Eric] Univ Hawaii Manoa, Honolulu, HI 96822 USA	Hauser, E (reprint author), Univ Electrocommun, Chofu, Tokyo 182, Japan.						SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; SZCZEPEK B, 2013, UNITS TALK UNITS ACT	2	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1461-4456	1461-7080		DISCOURSE STUD	Discourse Stud.	JUN	2015	17	3					377	379		10.1177/1461445615571205		3	Communication	Communication	CI0ET	WOS:000354409900015		
J	Odagiri, H; Yasunaga, H; Matsui, H; Fushimi, K; Iizuka, T; Kaise, M				Odagiri, Hiroyuki; Yasunaga, Hideo; Matsui, Hiroki; Fushimi, Kiyohide; Iizuka, Toshiro; Kaise, Mitsuru			Hospital Volume and the Occurrence of Bleeding and Perforation After Colorectal Endoscopic Submucosal Dissection: Analysis of a National Administrative Database in Japan	DISEASES OF THE COLON & RECTUM			English	Article						Colorectal endoscopic submucosal dissection; Hospital volume; Perforation; Postoperative bleeding	MUCOSAL RESECTION; TUMORS; MULTICENTER; TECHNOLOGY; NEOPLASIA; OUTCOMES; SURGERY; CANCER; VIDEO	BACKGROUND: Colorectal endoscopic submucosal dissection has gained popularity as a minimally invasive technique for the treatment of colorectal neoplasms in many countries, including Japan. However, most previous studies of endoscopic submucosal dissection had relatively small sample sizes and only included patients treated at specialized centers. Associations between hospital volume and complication rates after colorectal endoscopic submucosal dissection are still poorly understood. OBJECTIVE: Our aim was to clarify the relationships between hospital volume and the occurrence rates of bleeding and perforation after colorectal endoscopic submucosal dissection. DESIGN: This was a retrospective cohort study. Hospital volume was defined as the number of colorectal endoscopic submucosal dissections performed at each hospital between April 2012 and March 2013 and was categorized into the following quartiles: 1) very low-volume (18 or less patients during the year), 2) low-volume (19-35 patients), 3) high-volume (36-58 patients), and 4) very high-volume (59 or more). SETTINGS: This study was based on a national inpatient data from the Japanese Diagnosis Procedure Combination database. PATIENTS: A total of 7567 patients with colorectal endoscopic submucosal dissection were included. MAIN OUTCOME MEASURES: Severe postoperative bleeding requiring endoscopic hemostasis or blood transfusion within 1 week after endoscopic submucosal dissection and perforation requiring open surgery were the main outcomes measured. RESULTS: Severe postoperative bleeding and perforation occurred in 331 (4.4%) and 13 patients (0.2%). Multivariable logistic regression analysis showed that the very high hospital volume group had a significantly lower proportion of severe postoperative bleeding than the very low hospital volume group (OR = 0.48 [95 % CI, 0.27-0.83]; p = 0.009). LIMITATIONS: This study lacked some information on clinicopathologic features including en bloc resection, curative resection, and relapse. Individual endoscopist experience could not be analyzed. CONCLUSIONS: The present study clearly showed a significant association between higher hospital volume and lower occurrence of severe postoperative bleeding.	[Odagiri, Hiroyuki; Yasunaga, Hideo; Matsui, Hiroki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1130033, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan; [Iizuka, Toshiro; Kaise, Mitsuru] Toranomon Gen Hosp, Dept Gastroenterol, Tokyo, Japan	Yasunaga, H (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasunagah-tky@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan [H26-policy-011]	Funding/Support: This work was supported by grants from the Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation grant H26-policy-011).	Saito Y, 2007, GASTROINTEST ENDOSC, V66, P966, DOI 10.1016/j.gie.2007.02.053; Probst A, 2012, ENDOSCOPY, V44, P660, DOI 10.1055/s-0032-1309403; Saito Y, 2014, DIGEST ENDOSC, V26, P52, DOI 10.1111/den.12196; Murata A, 2014, SURG ENDOSC, V28, P1298, DOI 10.1007/s00464-013-3326-4; Kim ES, 2011, ENDOSCOPY, V43, P573, DOI 10.1055/s-0030-1256339; Oka S, 2010, DIGEST ENDOSC, V22, P376, DOI 10.1111/j.1443-1661.2010.01016.x; Kobayashi N, 2012, J GASTROEN HEPATOL, V27, P728, DOI 10.1111/j.1440-1746.2011.06942.x; Saito Y, 2010, GASTROINTEST ENDOSC, V72, P1217, DOI 10.1016/j.gie.2010.08.004; Taku K, 2007, J GASTROEN HEPATOL, V22, P1409, DOI 10.1111/j.1440-1746.2007.05022.x; Nakajima T, 2013, SURG ENDOSC, V27, P3262, DOI 10.1007/s00464-013-2903-x; Yoshinaga S, 2008, GASTROINTEST ENDOSC, V67, P202, DOI 10.1016/j.gie.2007.09.054; Antillon MR, 2008, GASTROINTEST ENDOSC, V67, P332, DOI 10.1016/j.gie.2007.08.038; Tamegai Y, 2007, ENDOSCOPY, V39, P418, DOI 10.1055/s-2007-966427; Toyonaga T, 2009, DIGEST ENDOSC, V21, pS31, DOI 10.1111/j.1443-1661.2009.00872.x; Teoh AYB, 2010, SURG ENDOSC, V24, P1049, DOI 10.1007/s00464-009-0724-8; Sugimoto T, 2012, J CLIN GASTROENTEROL, V46, P124, DOI 10.1097/MCG.0b013e31822f3988; Gabbay J, 2006, BRIT MED J, V332, P64, DOI 10.1136/bmj.332.7533.64; Hurlstone DP, 2007, BRIT J SURG, V94, P1536, DOI 10.1002/bjs.5720; Kim YJ, 2013, DIGEST DIS SCI, V58, P1727, DOI 10.1007/s10620-013-2560-x; LEWIT EM, 1986, J HEALTH ECON, V5, P99, DOI 10.1016/0167-6296(86)90024-X; Matsuda S, 2009, EUROHEALTH, V14, P27; Provenzale D, 2003, AM J GASTROENTEROL, V98, P21; Saito Y, 2007, DIGEST ENDOSC, V19, pS34, DOI 10.1117/j.1443-1661.2007.00729.x; Uraoka T, 2009, DIGEST ENDOSC, V21, pS13, DOI 10.1111/j.1443-1661.2009.00863.x; Waddell JP, 2006, BMJ-BRIT MED J, V332, P112; Yoshio T, 2013, GASTROENT RES PRACT, V2013, P365	26	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0012-3706	1530-0358		DIS COLON RECTUM	Dis. Colon Rectum	JUN	2015	58	6					597	603		10.1097/DCR.0000000000000335		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CH5UI	WOS:000354100400013		
J	Katagiri, S; Hayashi, T; Takeuchi, T; Yamada, H; Gekka, T; Kawabe, K; Kurita, A; Tsuneoka, H				Katagiri, Satoshi; Hayashi, Takaaki; Takeuchi, Tomokazu; Yamada, Hisashi; Gekka, Tamaki; Kawabe, Kiyokazu; Kurita, Akira; Tsuneoka, Hiroshi			Somatic instability of expanded CAG repeats of ATXN7 in Japanese patients with spinocerebellar ataxia type 7	DOCUMENTA OPHTHALMOLOGICA			English	Article						SCA7; CAG repeat instability; Somatic mosaicism; Genetic anticipation; Japanese	SCA7 GENE; CEREBELLAR DEGENERATION; INFANTILE PHENOTYPE; EXPRESSION ANALYSIS; HUMAN BRAIN; MUTATION; FAMILY; DYSTROPHY; IDENTIFICATION; EXPANSION	Spinocerebellar ataxia type 7 (SCA7) is a disease characterized by progressive ataxia syndrome and retinal degeneration. SCA7 is caused by expansion of CAG repeats in the ataxin 7 gene. The purpose of this study was to describe the clinical and genetic features in a two-generation Japanese family with SCA7. The female proband underwent systemic examinations that included neurological and ophthalmic examinations and magnetic resonance imaging (MRI) scans. We interviewed her affected mother about the clinical history at the bedside. Genomic DNA was purified from peripheral blood lymphocytes. The number of CAG repeats in the proband, and her affected mother was determined by a polymerase chain reaction-based assay that used the GeneScan analysis software. Neurological examinations showed limb ataxia, truncal ataxia, explosive speech, and hyperactive deep tendon reflexes. The MRI scans showed atrophy of the cerebellum and fundus of pons and tegmentum. Ophthalmologically, loss of visual acuity, macular degenerations, and central scotomas were observed in both eyes. Full-field electroretinography revealed reduced cone responses with preserved rod responses. The mother had hand-motion vision. Genetic analysis revealed that various expanded CAG repeat lengths (43-57) and the peak number of repeats (47 and 48) were the same in both patients. The proband exhibited a typical phenotype of SCA7, which includes cone dystrophy and spinocerebellar ataxia. Genetic analysis demonstrated somatic instability of the CAG repeats in the blood lymphocytes and suggested that there was no genetic anticipation through the maternal transmission.	[Katagiri, Satoshi; Hayashi, Takaaki; Takeuchi, Tomokazu; Gekka, Tamaki; Tsuneoka, Hiroshi] Jikei Univ, Sch Med, Dept Ophthalmol, Minato Ku, Tokyo 1058461, Japan; [Yamada, Hisashi] Jikei Univ, Sch Med, Dept Mol Genet, Inst DNA Med, Tokyo 1058461, Japan; [Kawabe, Kiyokazu] Toho Univ, Dept Neurol, Omori Med Ctr, Tokyo, Japan; [Kurita, Akira] Jikei Univ, Sch Med, Dept Neurol, Tokyo 1058461, Japan; [Kurita, Akira] Teikyo Univ, Med Ctr, Dept Neurol, Chiba, Japan	Hayashi, T (reprint author), Jikei Univ, Sch Med, Dept Ophthalmol, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	taka@jikei.ac.jp		Katagiri, Satoshi/0000-0001-7787-8194	Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25462738]	This study was supported by Grants from the Ministry of Health, Labour and Welfare of Japan, and the Ministry of Education, Culture, Sports, Science, and Technology of Japan [Grant-in-Aid for Scientific Research (C) 25462738] (T.H.).	Aleman TS, 2002, EXP EYE RES, V74, P737, DOI 10.1006/exer.2002.1169; Abe T, 2000, ARCH OPHTHALMOL-CHIC, V118, P1415; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Johansson J, 1998, HUM MOL GENET, V7, P171, DOI 10.1093/hmg/7.2.171; Takeuchi T, 2010, INVEST OPHTH VIS SCI, V51, P1643, DOI 10.1167/iovs.09-4497; Bang OY, 2004, J NEUROL NEUROSUR PS, V75, P1452, DOI 10.1136/jnnp.2003.029819; Benton CS, 1998, NEUROLOGY, V51, P1081; Cancel G, 2000, BRAIN, V123, P2519, DOI 10.1093/brain/123.12.2519; Einum DD, 2001, NEUROGENETICS, V3, P83, DOI 10.1007/s100480000100; ENEVOLDSON TP, 1994, BRAIN, V117, P445, DOI 10.1093/brain/117.3.445; Gouw LG, 1998, HUM MOL GENET, V7, P525, DOI 10.1093/hmg/7.3.525; Gu WH, 2000, ARCH NEUROL-CHICAGO, V57, P1513, DOI 10.1001/archneur.57.10.1513; Hsieh M, 2000, J NEUROL, V247, P623, DOI 10.1007/s004150070131; Inaba H, 2009, INTERNAL MED, V48, P1461, DOI 10.2169/internalmedicine.48.2072; Lindenberg KS, 2000, BRAIN PATHOL, V10, P385; Martin JJ, 1999, J NEUROL SCI, V168, P37, DOI 10.1016/S0022-510X(99)00176-8; Martin Jean-Jacques, 2012, Handb Clin Neurol, V103, P475, DOI 10.1016/B978-0-444-51892-7.00030-9; MARTIN JJ, 1994, ACTA NEUROPATHOL, V88, P277; Maruyama H, 2002, AM J MED GENET, V114, P578, DOI 10.1002/ajmg.10514; Mauger C, 1999, MOL BRAIN RES, V74, P35, DOI 10.1016/S0169-328X(99)00256-9; Michalik A, 2004, EUR J HUM GENET, V12, P2, DOI 10.1038/sj.ejhg.5201108; Stevanin G, 1999, EUR J HUM GENET, V7, P889, DOI 10.1038/sj.ejhg.5200392; van de Warrenburg BPC, 2001, J NEUROL, V248, P911, DOI 10.1007/s004150170082	24	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0012-4486	1573-2622		DOC OPHTHALMOL	Doc. Ophthalmol.	JUN	2015	130	3					189	195		10.1007/s10633-015-9488-8		7	Ophthalmology	Ophthalmology	CH7HN	WOS:000354206700003		
J	Ito, N; Kameya, S; Gocho, K; Hayashi, T; Kikuchi, S; Katagiri, S; Gekka, T; Yamaki, K; Takahashi, H; Tsuneoka, H				Ito, Naoko; Kameya, Shuhei; Gocho, Kiyoko; Hayashi, Takaaki; Kikuchi, Sachiko; Katagiri, Satoshi; Gekka, Tamaki; Yamaki, Kunihiko; Takahashi, Hiroshi; Tsuneoka, Hiroshi			Multimodal imaging of a case of peripheral cone dystrophy	DOCUMENTA OPHTHALMOLOGICA			English	Article						Peripheral cone dystrophy; Adaptive optics; Parafovea; Cone density	ADAPTIVE OPTICS; PHOTORECEPTOR DENSITY; RESOLUTION; EYE; DYSFUNCTION; LENGTH	To characterize the peripheral cones in the images obtained by spectral-domain optical coherence tomography (OCT), swept source OCT, and adaptive optics fundus camera in a patient with peripheral cone dystrophy. A 28-year-old Japanese man underwent detailed ophthalmic evaluations including high-resolution imaging of the fundus of both eyes. The decimal best-corrected visual acuity was 1.2 in both eyes. The results of slit-lamp biomicroscopy and ophthalmoscopy were essentially normal. Fluorescein and indocyanine green angiographies did not show any hyper- or hypofluorescent areas of the retina. Goldmann perimetry showed full peripheral visual fields but relative central scotomas within the central 20A degrees. The results of the Humphrey Visual Field Analyzer showed a limited preservation of the central sensitivity. Color vision tests showed no errors in both eyes. Spectral-domain OCT showed attenuation of both the ellipsoid and interdigitation zones throughout the macular region except the center of the fovea. The scotopic full-field ERGs were normal, but the photopic ERGs were markedly reduced. Regular cone mosaics were not observed especially more than 450 mu m radius from the fovea in the adaptive optics retinal images. The parafoveal cone densities were severely decreased in both eyes. Our findings indicate that the peripheral cone dystrophy diagnosed by full-field ERGs and perimetry is due to a reduction in the density of parafoveal and peripheral cones.	[Ito, Naoko; Hayashi, Takaaki; Katagiri, Satoshi; Gekka, Tamaki; Tsuneoka, Hiroshi] Jikei Univ, Dept Ophthalmol, Sch Med, Minato Ku, Tokyo 1058461, Japan; [Kameya, Shuhei; Gocho, Kiyoko; Kikuchi, Sachiko; Yamaki, Kunihiko] Chiba Hokusoh Hosp, Dept Ophthalmol, Nippon Med Sch, Chiba 2701694, Japan; [Takahashi, Hiroshi] Nippon Med Sch, Dept Ophthalmol, Bunkyo Ku, Tokyo 1138602, Japan	Kameya, S (reprint author), Chiba Hokusoh Hosp, Dept Ophthalmol, Nippon Med Sch, 1715 Kamagari, Chiba 2701694, Japan.	shuheik@nms.ac.jp		Katagiri, Satoshi/0000-0001-7787-8194			Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Choi SS, 2006, INVEST OPHTH VIS SCI, V47, P2080, DOI 10.1167/iovs.05.0997; Li KY, 2010, INVEST OPHTH VIS SCI, V51, P6858, DOI 10.1167/iovs.10-5499; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Park SP, 2013, EXP EYE RES, V108, P1, DOI 10.1016/j.exer.2012.12.011; Baek J, 2013, DOC OPHTHALMOL, V126, P247, DOI 10.1007/s10633-013-9377-y; Bearse MA, 1996, J OPT SOC AM A, V13, P634; Errera MH, 2014, OPHTHALMOLOGY, V121, P1311, DOI 10.1016/j.ophtha.2013.12.036; Gocho K, 2013, BIOMED RES INT, DOI 10.1155/2013/676803; Gocho K, 2014, J OPHTHALMOLOGY, V2014, DOI [10.1155/2014/283603, DOI 10.1155/2014/283603]; Kitaguchi Y, 2009, AM J OPHTHALMOL, V148, pe102; Kondo M, 2004, OPHTHALMOLOGY, V111, P732, DOI 10.1016/j.ophtha.2003.07.005; KRILL AE, 1973, DOC OPHTHALMOL, V35, P1; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Lombardo M, 2012, J CATARACT REFR SURG, V38, P1147, DOI 10.1016/j.jcrs.2012.02.033; Lombardo M, 2012, OPHTHALMOLOGY, V119, P1498, DOI 10.1016/j.ophtha.2012.03.019; Lombardo M, 2013, SENSORS-BASEL, V13, P334, DOI 10.3390/s130100334; Miyake Y, 1996, AM J OPHTHALMOL, V122, P644; Mochizuki Yujin, 2012, Case Rep Ophthalmol, V3, P162, DOI 10.1159/000339129; PINCKERS A, 1977, OPHTHALMOLOGICA, V174, P145; SUTTER EE, 1992, VISION RES, V32, P433, DOI 10.1016/0042-6989(92)90235-B; Vaphiades MS, 2014, J NEURO-OPHTHALMOL, V34, P366, DOI 10.1097/WNO.0000000000000119; Wolfing JI, 2006, OPHTHALMOLOGY, V113, pe1011	24	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0012-4486	1573-2622		DOC OPHTHALMOL	Doc. Ophthalmol.	JUN	2015	130	3					241	251		10.1007/s10633-015-9490-1		11	Ophthalmology	Ophthalmology	CH7HN	WOS:000354206700008		
J	Oda, S; Fujiwara, R; Kutsuno, Y; Fukami, T; Itoh, T; Yokoi, T; Nakajima, M				Oda, Shingo; Fujiwara, Ryoichi; Kutsuno, Yuki; Fukami, Tatsuki; Itoh, Tomoo; Yokoi, Tsuyoshi; Nakajima, Miki			Targeted Screen for Human UDP-Glucuronosyltransferases Inhibitors and the Evaluation of Potential Drug-Drug Interactions with Zafirlukast	DRUG METABOLISM AND DISPOSITION			English	Article							HUMAN LIVER-MICROSOMES; IN-VITRO DATA; INTESTINAL METABOLISM; VALPROIC ACID; GLUCURONIDATION; PREDICTION; CLEARANCE; CYTOCHROME-P450; RAT; PHARMACOKINETICS	Inhibition of drug metabolizing enzymes is a major mechanism in drug-drug interactions (DDIs). A number of cases of DDIs via inhibition of UDP-glucuronosyltranseferases (UGTs) have been reported, although the changes in pharmacokinetics are relatively small in comparison with drugs that are metabolized by cytochrome P450s. Most of the past studies have investigated hepatic UGTs, although recent studies have revealed a significant contribution of UGTs in the small intestine to drug clearance. To evaluate potential DDIs caused by inhibition of intestinal UGTs, we assessed inhibitory effects of 578 compounds, including drugs, xenobiotics, and endobiotics, on human UGT1A8 and UGT1A10, which are major contributors to intestinal glucuronidation. We identified 29 inhibitors by monitoring raloxifene glucuronidation with recombinant UGTs. All of the inhibitors potently inhibited UGT1A1 activity, as well. We found that zafirlukast is a potent general inhibitor of UGT1As and a moderate inhibitor of UGT2Bs because it monitors 4-methylumbelliferone glucuronidation by recombinant UGTs. However, zafirlukast did not potently inhibit diclofenac glucuronidation, suggesting that the inhibitory effects might be substrate specific. Inhibitory effects of zafirlukast on some UGT substrates were further investigated in human liver and human small intestine microsomes in order to evaluate potential DDIs. The R values (the ratios of intrinsic clearance with and without an inhibitor) revealed that zafirlukast has potential to cause clinical DDIs in the small intestine. Although we could not identify specific UGT1A8 and UGT1A10 inhibitors, zafirlukast was identified as a general inhibitor for UGTs in vitro. The present study suggests that the inhibition of UGT in the small intestine would be an underlying mechanism for DDIs.	[Oda, Shingo; Fukami, Tatsuki; Yokoi, Tsuyoshi; Nakajima, Miki] Kanazawa Univ, Fac Pharmaceut Sci, Drug Metab & Toxicol, Kanazawa, Ishikawa 9201192, Japan; [Fujiwara, Ryoichi; Kutsuno, Yuki; Itoh, Tomoo] Kitasato Univ, Sch Pharm, Minato Ku, Tokyo, Japan	Nakajima, M (reprint author), Kanazawa Univ, Fac Pharmaceut Sci, Drug Metab & Toxicol, Kanazawa, Ishikawa 9201192, Japan.	nmiki@p.kanazawa-u.ac.jp	Nakajima, Miki/C-3990-2015				Ito K, 1998, ANNU REV PHARMACOL, V38, P461, DOI 10.1146/annurev.pharmtox.38.1.461; King C, 2001, TOXICOL SCI, V61, P49, DOI 10.1093/toxsci/61.1.49; Bjornsson TD, 2003, J CLIN PHARMACOL, V43, P443, DOI 10.1177/0091270003252519; Kato M, 2008, DRUG METAB PHARMACOK, V23, P87, DOI 10.2133/dmpk.23.87; Dekhuijzen PNR, 2002, CLIN PHARMACOKINET, V41, P105, DOI 10.2165/00003088-200241020-00003; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Emoto C, 2010, CURR DRUG METAB, V11, P678, DOI 10.2174/138920010794233503; Houston JB, 2000, DRUG METAB DISPOS, V28, P246; SAHAI J, 1994, J INFECT DIS, V169, P1103; Uchaipichat V, 2004, DRUG METAB DISPOS, V32, P413, DOI 10.1124/dmd.32.4.413; Zhang L, 2008, XENOBIOTICA, V38, P709, DOI 10.1080/00498250802017715 ; Kilford PJ, 2009, DRUG METAB DISPOS, V37, P82, DOI 10.1124/dmd.108.023853; Kemp DC, 2002, DRUG METAB DISPOS, V30, P694, DOI 10.1124/dmd.30.6.694; Ritter JK, 2007, EXPERT OPIN DRUG MET, V3, P93, DOI 10.1517/17425255.3.1.93; Ohno S, 2009, DRUG METAB DISPOS, V37, P32, DOI 10.1124/dmd.108.023598; Zhang DL, 2005, DRUG METAB DISPOS, V33, P1729, DOI 10.1124/dmd.105.005447; Court MH, 2012, XENOBIOTICA, V42, P266, DOI 10.3109/00498254.2011.618954; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Kiang TKL, 2005, PHARMACOL THERAPEUT, V106, P97, DOI 10.1016/j.pharmthera.2004.10.013; Rowland A, 2006, DRUG METAB DISPOS, V34, P1055, DOI 10.1124/dmd.106.009340; Shitara Y, 2004, J PHARMACOL EXP THER, V311, P228, DOI 10.1124/jpet.104.068536; Izukawa T, 2009, DRUG METAB DISPOS, V37, P1759, DOI 10.1124/dmd.109.027227; Kuehl GE, 2005, DRUG METAB DISPOS, V33, P1027, DOI 10.1124/dmd.104.002527; Kutsuno Y, 2014, DRUG METAB DISPOS, V42, P1146, DOI 10.1124/dmd.114.057083; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; Mizuma T, 2009, INT J PHARMACEUT, V378, P140, DOI 10.1016/j.ijpharm.2009.05.044; Fujiwara R, 2007, DRUG METAB DISPOS, V35, P747, DOI 10.1124/dmd.106.014191; Fujita K, 2011, CANCER CHEMOTH PHARM, V67, P237, DOI 10.1007/s00280-010-1445-3; Obach RS, 2006, J PHARMACOL EXP THER, V316, P336, DOI 10.1124/jpet.105.093229; Dresser GK, 2000, CLIN PHARMACOKINET, V38, P41, DOI 10.2165/00003088-200038010-00003; Cornish-Bowden A, 1995, FUNDAMENTALS ENZYME, P203; Court MH, 2005, METHOD ENZYMOL, V400, P104, DOI 10.1016/S0076-6879(05)00007-8; Diasio RB, 1998, BRIT J CLIN PHARMACO, V46, P1, DOI 10.1046/j.1365-2125.1998.00050.x; Emoto Chie, 2003, Drug Metab Pharmacokinet, V18, P287, DOI 10.2133/dmpk.18.287; Fujiwara R, 2009, DRUG METAB DISPOS, V37, P41, DOI 10.1124/dmd.108.022913; Hanioka N, 2001, BIOMED CHROMATOGR, V15, P328, DOI 10.1002/bmc.76.abs; Karonen T, 2012, EUR J CLIN PHARMACOL, V68, P681, DOI 10.1007/s00228-011-1158-5; Komura H, 2011, DRUG METAB REV, V43, P476, DOI 10.3109/03602532.2011.597401; Kutsuno Y., 2013, PHARM RES PERSPECT, V1, DOI DOI 10.1002/PRP2.225505556; Mano Y, 2007, DRUG METAB DISPOS, V35, P602, DOI 10.1124/dmd.106.014225; Morris RG, 2000, THER DRUG MONIT, V22, P656, DOI 10.1097/00007691-200012000-00003; Ritter JK, 2000, CHEM-BIOL INTERACT, V129, P171, DOI 10.1016/S0009-2797(00)00198-8; Savidge RD, 1998, DRUG METAB DISPOS, V26, P1069; Stingl JC, 2014, PHARMACOL THERAPEUT, V141, P92, DOI 10.1016/j.pharmthera.2013.09.002; Suttle A. B., 1997, Clinical Pharmacology and Therapeutics, V61, P186; WATKINS JB, 1983, DRUG METAB DISPOS, V11, P37	47	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0090-9556	1521-009X		DRUG METAB DISPOS	Drug Metab. Dispos.	JUN	2015	43	6					812	818		10.1124/dmd.114.062141		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH7AH	WOS:000354187500002		
J	Barrat, JA; Rouxel, O; Wang, K; Moynier, F; Yamaguchi, A; Bischoff, A; Langlade, J				Barrat, J. A.; Rouxel, O.; Wang, K.; Moynier, F.; Yamaguchi, A.; Bischoff, A.; Langlade, J.			Early stages of core segregation recorded by Fe isotopes in an asteroidal mantle	EARTH AND PLANETARY SCIENCE LETTERS			English	Article						iron isotopes; achondrite; ureilite; core	PRESSURE-TEMPERATURE RELATIONSHIPS; UREILITE PARENT BODY; EARLY SOLAR-SYSTEM; SIDEROPHILE ELEMENTS; OXYGEN-ISOTOPE; FRACTIONATION; METEORITES; CHONDRITES; ACCRETION; BODIES	Ureilite meteorites are achondrites that are debris of the mantle of a now disrupted differentiated asteroid rich in carbon. They provide a unique opportunity to study the differentiation processes of such a body. We analyzed the iron isotopic compositions of 30 samples from the Ureilite Parent Body (UPB) including 29 unbrecciated ureilites and one ureilitic trachyandesite (ALM-A) which is at present the sole large crustal sample of the UPB. The delta Fe-56 of the whole rocks fall within a restricted range, from 0.01 to 0.11 parts per thousand, with an average of +0.056 +/- 0.008 parts per thousand, which is significantly higher than that of chondrites. We show that this difference can be ascribed to the segregation of S-rich metallic melts at low degrees of melting at a temperature close to the Fe-FeS eutectic, and certainly before the onset of the melting of the silicates (<1100 degrees C), in agreement with the marked S depletions, and the siderophile element abundances of the ureilites. These results point to an efficient segregation of S-rich metallic melts during the differentiation of small terrestrial bodies. (C) 2015 Elsevier B.V. All rights reserved.	[Barrat, J. A.] Univ Bretagne Occidentale, CNRS, UMR 6538, Inst Univ Europeen Mer, F-29280 Plouzane, France; [Rouxel, O.] IFREMER, Ctr Brest, F-29280 Plouzane, France; [Wang, K.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Moynier, F.] Univ Paris Diderot, Inst Univ France, Inst Phys Globe Paris, Sorbonne Paris Cite, F-75238 Paris 05, France; [Moynier, F.] Inst Univ France, Paris, France; [Yamaguchi, A.] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Yamaguchi, A.] Grad Univ Adv Sci, Sch Multidisciplinary Sci, Dept Polar Sci, Tachikawa, Tokyo 1908518, Japan; [Bischoff, A.] Univ Munster, Inst Planetol, D-48149 Munster, Germany; [Langlade, J.] CNRS, UMS 3113, IUEM, F-29280 Plouzane, France	Barrat, JA (reprint author), Univ Bretagne Occidentale, CNRS, UMR 6538, Inst Univ Europeen Mer, Pl Nicolas Copernic, F-29280 Plouzane, France.	barrat@univ-brest.fr			Programme National de Planetologie (CNRS-INSU); NSF; NASA	Many samples analyzed during the course of this study were kindly provided by the National Institute of Polar Research and the NASA meteorite working group. US Antarctic meteorite samples are recovered by the Antarctic search for Meteorites (ANSMET) program which has been funded by NSF and NASA, and characterized and curated in the Department of Mineral Sciences of the Smithsonian Institution and Astromaterials Curation Office at NASA Johnson Space Center. We thank Bernard Marty for the editorial handling, Hilary Downes, Franck Poitrasson, and an anonymous reviewer for their fast and constructive comments, Albert Jambon, Mathieu Roskosz and Richard Greenwood for discussions, and Pascale Barrat for her help. We gratefully acknowledge the Programme National de Planetologie (CNRS-INSU) for financial support.	Poitrasson F, 2004, EARTH PLANET SC LETT, V223, P253, DOI 10.1016/j.epsl.2004.04.032; Schoenberg R, 2006, EARTH PLANET SC LETT, V252, P342, DOI 10.1016/j.epsl.2006.09.045; Goodrich CA, 2014, GEOCHIM COSMOCHIM AC, V135, P126, DOI 10.1016/j.gca.2014.02.028; Keil K, 2000, PLANET SPACE SCI, V48, P887, DOI 10.1016/S0032-0633(00)00054-4; Cohen BA, 2004, GEOCHIM COSMOCHIM AC, V68, P4249, DOI 10.1016/j.gca.2004.01.027; Downes H, 2008, GEOCHIM COSMOCHIM AC, V72, P4825, DOI 10.1016/j.gca.2008.06.028; Warren PH, 2012, METEORIT PLANET SCI, V47, P209, DOI [10.1111/J.1945-5100.2011.01320.x, 10.1111/j.1945-5100.2011.01320.x]; WASSON JT, 1988, PHILOS T R SOC A, V325, P535, DOI 10.1098/rsta.1988.0066; Blichert-Toft J, 2010, EARTH PLANET SC LETT, V296, P469, DOI 10.1016/j.epsl.2010.05.036; Bischoff A, 2014, P NATL ACAD SCI USA, V111, P12689, DOI 10.1073/pnas.1404799111; Clayton RN, 1996, GEOCHIM COSMOCHIM AC, V60, P1999, DOI 10.1016/0016-7037(96)00074-9; Greenwood RC, 2006, SCIENCE, V313, P1763, DOI 10.1126/science.1128865; Kruijer TS, 2014, SCIENCE, V344, P1150, DOI 10.1126/science.1251766; Goodrich CA, 2006, METEORIT PLANET SCI, V41, P925; Warren PH, 2011, GEOCHIM COSMOCHIM AC, V75, P6912, DOI 10.1016/j.gca.2011.09.011; Craddock PR, 2013, EARTH PLANET SC LETT, V365, P63, DOI 10.1016/j.epsl.2013.01.011; Poitrasson F, 2009, EARTH PLANET SC LETT, V278, P376, DOI 10.1016/j.epsl.2008.12.025; Yoshino T, 2003, NATURE, V422, P154, DOI 10.1038/nature01459; Greenwood RC, 2005, NATURE, V435, P916, DOI 10.1038/nature03612; Warren PH, 2006, GEOCHIM COSMOCHIM AC, V70, P2104, DOI 10.1016/j.gca.2005.12.026; Singletary SJ, 2003, METEORIT PLANET SCI, V38, P95; Wang K, 2012, GEOCHIM COSMOCHIM AC, V89, P31, DOI 10.1016/j.gca.2012.04.050; Goodrich CA, 2013, GEOCHIM COSMOCHIM AC, V112, P340, DOI 10.1016/j.gca.2012.06.022; Dauphas N, 2014, EARTH PLANET SC LETT, V398, P127, DOI 10.1016/j.epsl.2014.04.033; Craddock PR, 2011, GEOSTAND GEOANAL RES, V35, P101, DOI 10.1111/j.1751-908X.2010.00085.x; Rushmer T, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003413; Weyer S, 2005, EARTH PLANET SC LETT, V240, P251, DOI 10.1016/j.epsl.2005.09.023; Bruhn D, 2000, NATURE, V403, P883, DOI 10.1038/35002558; Rankenburg K, 2008, GEOCHIM COSMOCHIM AC, V72, P4642, DOI 10.1016/j.gca.2008.07.003; Hin RC, 2012, GEOCHIM COSMOCHIM AC, V93, P164, DOI 10.1016/j.gca.2012.06.011; Polyakov VB, 2007, GEOCHIM COSMOCHIM AC, V71, P3833, DOI 10.1016/j.gca.2007.05.019; Dauphas N, 2006, MASS SPECTROM REV, V25, P515, DOI 10.1002/mas.20078; Day JMD, 2012, GEOCHIM COSMOCHIM AC, V81, P94, DOI 10.1016/j.gca.2011.12.017; Teng FZ, 2013, GEOCHIM COSMOCHIM AC, V107, P12, DOI 10.1016/j.gca.2012.12.027; Shahar A, 2015, GEOCHIM COSMOCHIM AC, V150, P253, DOI 10.1016/j.gca.2014.08.011; Watson HC, 2011, PHYS EARTH PLANET IN, V186, P172, DOI 10.1016/j.pepi.2011.03.009; Bagdassarov N, 2009, PHYS EARTH PLANET IN, V177, P139, DOI 10.1016/j.pepi.2009.08.003; Goodrich CA, 2013, METEORIT PLANET SCI, V48, P1096, DOI 10.1111/maps.12131; Goodrich CA, 2013, GEOCHIM COSMOCHIM AC, V122, P280, DOI 10.1016/j.gca.2013.08.003; Halliday AN, 2013, NATURE, V497, P43, DOI 10.1038/497043a; HINTENBERGER H, 1978, EARTH PLANET SC LETT, V40, P187, DOI 10.1016/0012-821X(78)90089-4; Keil K, 2014, CHEM ERDE-GEOCHEM, V74, P311, DOI 10.1016/j.chemer.2014.02.001; Kullerud G., 1963, ANN REP GEOPHYS RES, V67, P4055; Mittlefehldt D.W., 1998, PLANETARY MAT REV MI, V3, P195; Moynier F, 2010, CHEM GEOL, V276, P374, DOI 10.1016/j.chemgeo.2010.07.005; Myiamoto M., 1985, J GEOPHYS RES S, V90, pD116; Polyakov VB, 2011, GEOCHIM COSMOCHIM AC, V75, P1957, DOI 10.1016/j.gca.2011.01.019; Pringle EA., 2014, P NATL ACAD SCI US; Saunier G, 2010, METEORIT PLANET SCI, V45, P195, DOI 10.1111/j.1945-5100.2010.01017.x; Schuessler JA, 2007, GEOCHIM COSMOCHIM AC, V71, P417, DOI 10.1016/j.gca.2006.09.012; SCOTT ERD, 1993, GEOPHYS RES LETT, V20, P415, DOI 10.1029/93GL00474; Vdovykin G.P., 1970, SPACE SCI REV, V10, P483; Wang K, 2013, METEORIT PLANET SCI, V48, P354, DOI 10.1111/maps.12060; Wang K, 2014, EARTH PLANET SC LETT, V392, P124, DOI 10.1016/j.epsl.2014.02.022; Wanke H., 1972, Meteoritics, V7; Warren PH, 2010, GEOCHIM COSMOCHIM AC, V74, P5109, DOI 10.1016/j.gca.2010.05.026; Yanai K., 1995, CATALOG ANTARCTIC ME	57	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0012-821X	1385-013X		EARTH PLANET SC LETT	Earth Planet. Sci. Lett.	JUN 1	2015	419						93	100		10.1016/j.epsl.2015.03.026		8	Geochemistry & Geophysics	Geochemistry & Geophysics	CH2JW	WOS:000353852500009		
J	Harada, M; Tajika, E; Sekine, Y				Harada, Mariko; Tajika, Eiichi; Sekine, Yasuhito			Transition to an oxygen-rich atmosphere with an extensive overshoot triggered by the Paleoproterozoic snowball Earth	EARTH AND PLANETARY SCIENCE LETTERS			English	Article						Paleoproterozoic; atmospheric oxygen; snowball Earth; the Great Oxidation Event; biogeochemical cycles	MASS-INDEPENDENT FRACTIONATION; PARTICULATE ORGANIC-MATTER; GREAT OXIDATION; CONTINENTAL-CRUST; PHANEROZOIC TIME; SULFUR ISOTOPES; GLOBAL CHANGE; SOUTH-AFRICA; CARBON-CYCLE; EVOLUTION	The Earth is thought to have multiple stable, steady-states regarding climate modes and atmospheric oxygen levels. The Paleoproterozoic is a remarkable period in Earth's history because of the simultaneous occurrence of large climatic and redox transitions between steady states; i.e., snowball Earth glaciation and the rise of oxygen. Geochemical evidence suggests that the oxygen rise was a dynamic transition with an extensive, long-term overshoot. However, previous models have not explained the dynamics of the oxygen rise, leaving its causal mechanism poorly understood. In the present study, we suggest that the oxygen transition with an overshoot occurred in response to a climatic transition at the termination of the snowball glaciation. Biogeochemical cycle modelling indicates that prolonged super-greenhouse conditions and effective nutrient input to the ocean after the glaciation lead to high levels of primary productivity and burial of organic carbon. This causes an abrupt jump of oxygen levels within similar to 10(4) yr after the glaciation and an extensive oxygen overshoot to the present atmospheric level. The overshoot persists for 108 yr because net consumption of oxygen in the atmosphere-ocean system is inefficient. We show that the post-glacial jump of oxygen levels occurred in biologically short timescale, which may have stimulated the ecological shift and/or biological innovations toward the prosperity of oxygen-dependent life. (C) 2015 Elsevier B.V. All rights reserved.	[Harada, Mariko; Sekine, Yasuhito] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan; [Tajika, Eiichi] Univ Tokyo, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan	Harada, M (reprint author), Univ Tokyo, Dept Earth & Planetary Sci, Kiban Bldg,Mb 408,5-1-5 Kashiwanoha, Kashiwa, Chiba 2778561, Japan.	harada@astrobio.k.u-tokyo.ac.jp			JSPS Fellows [13J09134]; Program for Leading Graduate Schools, MEXT, Japan, Sasakawa Scientific Research Grant [24-217]; MEXT [23103001]	We would like to thank J.F. Kasting and C. Goldblatt for their careful and constructive comments. This study was financially supported by Grant-in-Aid for JSPS Fellows (No. 13J09134), the Program for Leading Graduate Schools, MEXT, Japan, Sasakawa Scientific Research Grant (No. 24-217), and Grant-in-Aid for Scientific Research on Innovative Areas, MEXT (No. 23103001). Y.S. thanks to Taro Maeda for discussion on biological implications.	EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; Claire MW, 2006, GEOBIOLOGY, V4, P239, DOI 10.1111/j.1472-4669.2006.00084.x; Hawkesworth CJ, 2010, J GEOL SOC LONDON, V167, P229, DOI 10.1144/0016-76492009-072; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; Gaillard F, 2011, NATURE, V478, P229, DOI 10.1038/nature10460; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Planavsky NJ, 2010, NATURE, V467, P1088, DOI 10.1038/nature09485; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Moulton KL, 2000, AM J SCI, V300, P539, DOI 10.2475/ajs.300.7.539; Zahnle K, 2006, GEOBIOLOGY, V4, P271, DOI 10.1111/j.1472-4669.2006.00085.x; Karhu JA, 1996, GEOLOGY, V24, P867, DOI 10.1130/0091-7613(1996)024<0867:CIATRO>2.3.CO;2; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Payne JL, 2009, P NATL ACAD SCI USA, V106, P24, DOI 10.1073/pnas.0806314106; El Albani A, 2010, NATURE, V466, P100, DOI 10.1038/nature09166; Evans DA, 1997, NATURE, V386, P262, DOI 10.1038/386262a0; Papineau D, 2007, EARTH PLANET SC LETT, V255, P188, DOI 10.1016/j.epsl.2006.12.015; Yamanaka Y, 1996, GLOBAL BIOGEOCHEM CY, V10, P361, DOI 10.1029/96GB00634; CALDEIRA K, 1992, NATURE, V359, P226, DOI 10.1038/359226a0; Ozaki K, 2011, EARTH PLANET SC LETT, V304, P270, DOI 10.1016/j.epsl.2011.02.011; Paytan A, 2007, CHEM REV, V107, P563, DOI 10.1021/cr0503613; Hawkesworth CJ, 2006, NATURE, V443, P811, DOI 10.1038/nature05191; WALKER JCG, 1981, J GEOPHYS RES-OC ATM, V86, P9776, DOI 10.1029/JC086iC10p09776; Rye R, 1998, AM J SCI, V298, P621; Goldblatt C, 2006, NATURE, V443, P683, DOI 10.1038/nature05169; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Segura A, 2003, ASTROBIOLOGY, V3, P689, DOI 10.1089/153110703322736024; Hartmann J, 2014, CHEM GEOL, V363, P145, DOI 10.1016/j.chemgeo.2013.10.025; Farquhar J, 2007, NATURE, V449, P706, DOI 10.1038/nature06202; Sahoo SK, 2012, NATURE, V489, P546, DOI 10.1038/nature11445; Kendall B, 2010, NAT GEOSCI, V3, P647, DOI 10.1038/NGEO942; Bekker A, 2012, EARTH PLANET SC LETT, V317, P295, DOI 10.1016/j.epsl.2011.12.012; Jenkyns HC, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002788; KASTING JF, 1986, SCIENCE, V234, P1383, DOI 10.1126/science.11539665; Kirschvink JL, 2000, P NATL ACAD SCI USA, V97, P1400, DOI 10.1073/pnas.97.4.1400; Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Mills B, 2011, NAT GEOSCI, V4, P861, DOI [10.1038/ngeo1305, 10.1038/NGEO1305]; Ozaki K, 2013, EARTH PLANET SC LETT, V373, P129, DOI 10.1016/j.epsl.2013.04.029; BERNER RA, 1991, AM J SCI, V291, P339; BERNER RA, 1994, AM J SCI, V294, P56; Canfield DE, 2013, P NATL ACAD SCI USA, V110, P16736, DOI 10.1073/pnas.1315570110; Goto KT, 2013, EARTH PLANET SC LETT, V376, P145, DOI 10.1016/j.epsl.2013.06.018; Klemm DD, 2000, J AFR EARTH SCI, V30, P1, DOI 10.1016/S0899-5362(00)00005-1; Planavsky NJ, 2014, SCIENCE, V346, P635, DOI 10.1126/science.1258410; Schroeder S, 2008, TERRA NOVA, V20, P108, DOI 10.1111/j.1365-3121.2008.00795.x; Tajika E, 2003, EARTH PLANET SC LETT, V214, P443, DOI 10.1016/S0012-821X(03)00396-0	46	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0012-821X	1385-013X		EARTH PLANET SC LETT	Earth Planet. Sci. Lett.	JUN 1	2015	419						178	186		10.1016/j.eps1.2015.03.005		9	Geochemistry & Geophysics	Geochemistry & Geophysics	CH2JW	WOS:000353852500017		
J	Furukawa, Y				Furukawa, Yuichi			Leapfrogging cycles in international competition	ECONOMIC THEORY			English	Article						Perpetual leapfrogging; Innovation cycles; Growth cycles; Endogenous innovation; Knowledge spillovers	INTELLECTUAL PROPERTY-RIGHTS; FOREIGN DIRECT-INVESTMENT; GROWTH CYCLES; TECHNOLOGICAL LEADERSHIP; ECONOMIC-GROWTH; IMPLEMENTATION CYCLES; MARKET QUALITY; INNOVATION; MODEL; TRADE	Technological leadership has shifted at various times from one country to another. We propose a mechanism that explains this perpetual cycle of technological leapfrogging in a two-country model including the dynamic optimization of an infinitely lived consumer. In the model, each country accumulates knowledge stock over time because of domestic innovation and spillovers from foreign innovation. We show that if the international knowledge spillovers are reasonably efficient, technological leadership may shift first from one country to another, and then alternate between countries along an equilibrium path.	Chukyo Univ, Sch Econ, Showa Ku, Nagoya, Aichi 4668666, Japan	Furukawa, Y (reprint author), Chukyo Univ, Sch Econ, Showa Ku, 101-2 Yagoto Honmachi, Nagoya, Aichi 4668666, Japan.	you.furukawa@gmail.com			 [23730198/26780126]	The author acknowledges the hospitality and support of Simon Fraser University, where some of the work in this paper was completed. He would like to thank the two anonymous referees and Timothy Kehoe (Co-Editor) for their helpful suggestions and valuable advice. He is also grateful to Taro Akiyama, Gadi Barlevy, Eric Bond, Kenneth Chan, Fumio Dei, Patrick Francois, Takamune Fujii, Sam Gamtessa, Tetsugen Haruyama, Jun-ichi Itaya, Ronald Jones, Seokho Kim, Kozo Kiyota, Takashi Komatsubara, Yoshimasa Komoriya, Jiang Li, Yan Ma, Sugata Margit, Junya Masuda, Tsukasa Matsuura, Hiroshi Mukunoki, Takeshi Ogawa, Takao Ohkawa, Masayuki Okawa, Rui Ota, Yuki Saito, Hitoshi Sato, Kenji Sato, Yasuhiro Takarada, Hirokazu Takizawa, Yoshihiro Tomaru, Eiichi Tomiura, Makoto Yano, Taiyo Yoshimi, Eden Yu, Ryuhei Wakasugi, and conference/seminar participants at the European Economic Association Annual Congress 2013, the Western Economic Association International Pacific Rim Conference 2013, the Canadian Economics Association Annual Conference 2014, the Japan Society of International Economics Chubu Spring Meeting 2014, Chukyo University, Chuo University, Kobe University, and Yokohama National University for their helpful comments and advice on earlier versions of the paper. The partial financial support of a Grant-in-Aid for Young Scientists (B) #23730198/26780126 is gratefully acknowledged.	Aghion P, 2001, REV ECON STUD, V68, P467, DOI 10.1111/1467-937X.00177; Quah DT, 1996, EUR ECON REV, V40, P951, DOI 10.1016/0014-2921(95)00105-0; Giovannetti E, 2013, ENVIRON PLANN A, V45, P930, DOI 10.1068/a4572; ROMER PM, 1990, J POLIT ECON, V98, pS71, DOI 10.1086/261725; Chu AC, 2011, J ECON DYN CONTROL, V35, P876, DOI 10.1016/j.jedc.2010.11.003; Matsuyama K, 2007, AM ECON REV, V97, P503, DOI 10.1257/aer.97.1.503; Francois P, 2003, AM ECON REV, V93, P530, DOI 10.1257/000282803322156972; Krusell P, 1996, REV ECON STUD, V63, P301, DOI 10.2307/2297854; Lai ELC, 1998, J DEV ECON, V55, P133, DOI 10.1016/S0304-3878(97)00059-X; Branstetter L, 2006, J INT ECON, V68, P325, DOI 10.1016/j.jinteco.2005.06.006; Borensztein E, 1998, J INT ECON, V45, P115, DOI 10.1016/S0022-1996(97)00033-0; COHEN WM, 1989, ECON J, V99, P569, DOI 10.2307/2233763; Athreye S, 2009, IND CORP CHANGE, V18, P295, DOI 10.1093/icc/dtp002; Barnett RC, 2013, ECON THEOR, V52, P367, DOI 10.1007/s00199-011-0645-3; Barnett RC, 2008, EUR ECON REV, V52, P1055, DOI 10.1016/j.euroecorev.2007.10.001; Brezis E. S., 1998, J INT TRADE EC DEV, V7, P261, DOI 10.1080/09638199800000014; BREZIS ES, 1993, AM ECON REV, V83, P1211; BREZIS ES, 1995, ECON HIST REV, V48, P46; Broda C, 2006, Q J ECON, V121, P541, DOI 10.1162/qjec.2006.121.2.541; Carolan T., 1998, J DEV ECON, V57, P89; Dastidar K. G., 2014, PAC EC REV IN PRESS; Davids K, 2008, HIST SCI MED LIBR, V7, P1, DOI 10.1163/ej.9789004168657.i-634; Deneckere R., 1992, CYCLES CHAOS EC EQUI; Desmet K, 2002, ECON J, V112, P894, DOI 10.1111/1468-0297.00071; Drugeon JP, 2013, ECON THEOR, V52, P397, DOI 10.1007/s00199-011-0631-9; Feenstra RC, 1996, J DEV ECON, V49, P229, DOI 10.1016/0304-3878(95)00059-3; Francois P, 2009, REV ECON DYNAM, V12, P567, DOI 10.1016/j.red.2009.02.004; Francois P, 1999, J ECON THEORY, V85, P226, DOI 10.1006/jeth.1998.2503; Francois P, 2013, BEJ MACROECON, V13, P287; Francois P, 2008, INT ECON REV, V49, P901, DOI 10.1111/j.1468-2354.2008.00501.x; Furukawa Y., 2012, GROWTH MIRACLE UNPUB; Furukawa Y, 2014, INT J ECON THEORY, V10, P139, DOI 10.1111/ijet.12032; Furukawa Y., 2014, UNPUB; Gale D, 1996, REV ECON STUD, V63, P169, DOI 10.2307/2297849; GILBERT R, 1990, RAND J ECON, V21, P106, DOI 10.2307/2555497; Giovannetti E, 2001, INT ECON REV, V42, P671, DOI 10.1111/1468-2354.00129; Glass A., 1999, WORKING PAPERS OHIO, V99-11; Goh AT, 2002, INT ECON REV, V43, P1191, DOI 10.1111/1468-2354.t01-1-00053; Grossman G., 1991, INNOVATION GROWTH GL; Hall R. E., 1986, BROOKINGS PAPERS EC, V1986, P285; Harrington Jr J., 2010, DYNAMIC MODEL UNPUB; HELPMAN E, 1993, ECONOMETRICA, V61, P1247, DOI 10.2307/2951642; Iwaisako T., 2014, PRODUCT CYCLES UNPUB; Iwaisako T, 2013, ECON THEOR, V52, P631, DOI 10.1007/s00199-011-0658-y; Kaas L, 2007, ECON THEOR, V31, P19, DOI 10.1007/s00199-006-0081-y; Kitagawa A, 2005, ECON THEOR, V25, P751, DOI 10.1007/s00199-003-0458-0; KRUGMAN P, 1979, J POLIT ECON, V87, P253, DOI 10.1086/260755; Lee J, 2011, INT J IND ORGAN, V29, P718, DOI 10.1016/j.ijindorg.2011.03.006; Li CW, 2001, ECON J, V111, pC164; Matsuyama K, 1999, ECONOMETRICA, V67, P335, DOI 10.1111/1468-0262.00021; Matsuyama K, 2001, J ECON THEORY, V100, P220, DOI 10.1006/jeth.2000.2770; Mokyr J., 1990, LEVER RICHES TECHNOL; Motta M, 1997, INT ECON REV, V38, P809, DOI 10.2307/2527217; NELSON RR, 1992, J ECON LIT, V30, P1931; Nishimura K, 2008, INT J ECON THEORY, V4, P1, DOI 10.1111/j.1742-7363.2007.00065.x; Nishimura K, 2014, ECON THEOR, V55, P357, DOI 10.1007/s00199-013-0758-y; Obstfeld M., 2004, GLOBAL CAPITAL MARKE; Ohyama M., 1995, REV INT ECON, V3, P224, DOI 10.1111/j.1467-9396.1995.tb00065.x; Petrakos G, 2005, ENVIRON PLANN A, V37, P1837, DOI 10.1068/a37348; Quah DT, 1996, EUR ECON REV, V40, P1353, DOI 10.1016/0014-2921(95)00051-8; Rogers M, 2004, CAMBRIDGE J ECON, V28, P577, DOI 10.1093/cje/beh025; SHLEIFER A, 1986, J POLIT ECON, V94, P1163, DOI 10.1086/261428; Twomey M. J., 2000, CENTURY FOREIGN INVE; van de Klundert T, 2001, J INT ECON, V54, P211, DOI 10.1016/S0022-1996(00)00085-4; Yang HX, 2010, ECON THEOR, V43, P281, DOI 10.1007/s00199-009-0467-8; Yano M, 2009, JPN ECON REV, V60, P1, DOI 10.1111/j.1468-5876.2008.00471.x; Yano M, 2006, ECON THEOR, V29, P395, DOI 10.1007/s00199-005-0028-8	67	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-2259	1432-0479		ECON THEOR	Econ. Theory	JUN	2015	59	2					401	433		10.1007/s00199-014-0850-y		33	Economics	Business & Economics	CH7OS	WOS:000354227100007		
J	Moroni, MT; Morris, DM; Shaw, C; Stokland, JN; Harmon, ME; Fenton, NJ; Merganicova, K; Merganic, J; Okabe, K; Hagemann, U				Moroni, M. T.; Morris, D. M.; Shaw, C.; Stokland, J. N.; Harmon, M. E.; Fenton, N. J.; Merganicova, K.; Merganic, J.; Okabe, K.; Hagemann, U.			Buried Wood: A Common Yet Poorly Documented Form of Deadwood	ECOSYSTEMS			English	Article						coarse woody debris; disturbance history; carbon; paludification; boreal; bryophytes; moss; litter	BOREAL BLACK SPRUCE; LEAVED SECONDARY FOREST; SUB-ARCTIC BRYOPHYTE; WESTERN RED CEDAR; BRITISH-COLUMBIA; CARBON STOCKS; LITTER DECOMPOSITION; PACIFIC-NORTHWEST; DECIDUOUS FOREST; HARDWOOD FORESTS	Buried wood (BW: downed deadwood buried more than 50% by soil, litter, or ground vegetation) is a common but understudied part of forest ecosystems. We reviewed the literature and conducted a meta-analysis of BW that included new data from Australia, Belarus, Canada, Germany, Japan, Norway, Russia, Slovakia, Sweden, the USA, and Wales. Buried wood occurred in a wide range of forest types of natural and anthropogenic origin. In some forests, BW was effectively preserved and volumes of BW exceeded the volume of all other live and deadwood combined. Boreal and oroboreal coniferous forests contained large amounts of BW, whereas hardwood forests appeared to contain little BW due to differences in ground vegetation, wood decomposition pathways, and climatic and edaphic conditions. Coniferous forests growing on paludified ground represent areas with a large capacity to store BW. The largest quantity of BW reported was 935 m(3) ha(-1) in paludified black spruce (Picea mariana (Mill.)) forests, where typically mature live bole volumes are only 150 m(3) ha(-1). Buried wood can accumulate over several disturbance cycles (centuries), due to greatly reduced rates of decomposition following burial. As such, BW can represent a large forest C pool that is currently not recognized in forest C accounting using field measurements or models. Failing to account for wood burial can lead to underestimates of ecosystem deadwood stocks as well as misinterpretations of ecosystem dynamics. Buried wood and the burial process should be included in forest measurement and models, particularly for boreal and oroboreal ecosystems, to reduce uncertainty and improve accuracy in forest C accounting. This will require improvements to existing field sampling protocols and collection of long-term data on processes creating BW.	[Morris, D. M.] Ctr Northern Forest Ecosyst Res, Thunder Bay, ON P7B 5E1, Canada; [Shaw, C.] No Forestry Ctr, Canadian Forest Serv, Edmonton, AB T6H 3S5, Canada; [Stokland, J. N.] Norwegian Forest & Landscape Inst, N-1431 As, Norway; [Harmon, M. E.] Oregon State Univ, Coll Forestry, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Fenton, N. J.] Univ Quebec Abitibi Temiscamingue, Forest Res Inst, Rouyn Noranda, PQ J9X 5E4, Canada; [Merganicova, K.; Merganic, J.] Tech Univ Zvolen, Fac Forestry, Dept Forest Management & Geodesy, Zvolen 96053, Slovakia; [Merganicova, K.; Merganic, J.] Czech Univ Life Sci, Dept Forest Management, Fac Forestry & Wood Sci, Prague 16521 6, Suchdol, Czech Republic; [Okabe, K.] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Hagemann, U.] Leibniz Ctr Agr Landscape Res ZALF eV, Inst Landscape Biogeochem, D-15374 Muncheberg, Germany	Moroni, MT (reprint author), 6 Correa Pl, Tolmans Hill 7007, Australia.	martintmoroni@gmail.com			Global Environment Research Fund [S9]; ERDF [ITMS 26220120069]; US National Science Foundation [DEB-0823380]	We thank Glenda Russo for compiling BW data from the Canadian National Forest Inventory. For helping provide observations of BW, we thank Marie-Charlotte Nilsson for Swedish data, Richard Carrick for data from Wales, UK, Merten Minke for data from Belarus, Ekaterina Shorohova for data from Russia, and M. Hasegawa and S. Yamashita for data from Japan. Japanese observations were supported by the Global Environment Research Fund (S9). Data collection in the Forest School Enterprise (FSE) of the Technical University of Zvolen, Slovakia was supported by the Research and Development Operational Programme funded by ERDF under the project Centre of Excellence "Decision support in forest and country", ITMS 26220120069. The collection of data from the H. J. Andrews Experimental Forest was supported by a grant from the US National Science Foundation (DEB-0823380).	Ahti T., 1968, ANN BOT FENN, V5, P169; Andriesse JP, 1988, NATURE MANAGEMENT TR, V59; Fridman J, 2000, FOREST ECOL MANAG, V131, P23, DOI 10.1016/S0378-1127(99)00208-X; Lecomte N, 2006, ECOSYSTEMS, V9, P1215, DOI 10.1007/s10021-004-0168-x; Startsev N, 2008, J VEG SCI, V19, P253, DOI 10.3170/2008-8-18367; Fenton NJ, 2006, J VEG SCI, V17, P65, DOI 10.1658/1100-9233(2006)017[0065:FSIABB]2.0.CO;2; Woodall CW, 2009, ENVIRON MANAGE, V44, P624, DOI 10.1007/s00267-009-9358-9; Strukelj M, 2013, CAN J FOREST RES, V43, P785, DOI 10.1139/cjfr-2013-0086; Brais S, 2005, FOREST ECOL MANAG, V220, P216, DOI 10.1016/j.foreco.2005.08.013; LAMBERT RL, 1980, ECOLOGY, V61, P1460, DOI 10.2307/1939054; Jomura M, 2008, FOREST ECOL MANAG, V255, P149, DOI 10.1016/j.foreco.2007.09.002; Shetler G, 2008, CAN J FOREST RES, V38, P2328, DOI 10.1139/X08-057; Manies KL, 2005, CAN J FOREST RES, V35, P472, DOI 10.1139/X04-179; Debeljak M, 2006, ECOL INDIC, V6, P733, DOI 10.1016/j.ecolind.2005.08.031; Weedon JT, 2009, ECOL LETT, V12, P45, DOI 10.1111/j.1461-0248.2008.01259.x; Harden JW, 2000, GLOB CHANGE BIOL, V6, P174, DOI 10.1046/j.1365-2486.2000.06019.x; Jomura M, 2007, TELLUS B, V59, P211, DOI 10.1111/j.1600-0889.2006.00234.x; Bona KA, 2013, ECOSYSTEMS, V16, P1071, DOI 10.1007/s10021-013-9668-x; Naesset E, 1999, CAN J FOREST RES, V29, P372; TYRRELL LE, 1994, CAN J FOREST RES, V24, P1672, DOI 10.1139/x94-216; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; Wang CK, 2003, GLOBAL CHANGE BIOL, V9, P1066, DOI 10.1046/j.1365-2486.2003.00645.x; Augusto L, 2003, ANN FOREST SCI, V60, P823, DOI 10.1051/forest:2003077; Weir JMH, 2000, ECOL APPL, V10, P1162, DOI 10.1890/1051-0761(2000)010[1162:FFATSA]2.0.CO;2; Angers VA, 2010, FOREST ECOL MANAG, V259, P246, DOI 10.1016/j.foreco.2009.09.026; Hagemann U, 2009, CAN J FOREST RES, V39, P131, DOI 10.1139/X08-166; Lefort P, 2002, FOREST CHRON, V78, P665; Benscoter BW, 2007, J ECOL, V95, P151, DOI 10.1111/j.1365-2745.2006.01180.x; Aakala T, 2010, FOREST ECOL MANAG, V260, P770, DOI 10.1016/j.foreco.2010.05.035; HARMON ME, 1991, BIOSCIENCE, V41, P604, DOI 10.2307/1311697; Hicks WT, 2002, PLANT SOIL, V243, P67, DOI 10.1023/A:1019906101359; Moroni MT, 2009, CAN J SOIL SCI, V89, P343; Harmon ME, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001495; Smithwick EAH, 2002, ECOL APPL, V12, P1303, DOI 10.1890/1051-0761(2002)012[1303:PUBOCS]2.0.CO;2; Lang SI, 2009, J ECOL, V97, P886, DOI 10.1111/j.1365-2745.2009.01538.x; Cavard X, 2010, CAN J FOREST RES, V40, P37, DOI 10.1139/X09-171; Schmalholz M, 2011, BIODIVERS CONSERV, V20, P2575, DOI 10.1007/s10531-011-0092-2; Simard M, 2007, ECOL APPL, V17, P1619, DOI 10.1890/06-1795.1; Kemball KJ, 2005, CAN J BOT, V83, P1550, DOI 10.1139/b05-134; Fenton N, 2005, FOREST ECOL MANAG, V213, P151, DOI 10.1016/j.foreco.2005.03.017; Nilsson SG, 2002, FOREST ECOL MANAG, V161, P189, DOI 10.1016/S0378-1127(01)00480-7; Arseneault J, 2012, CAN J FOREST RES, V42, P1467, DOI [10.1139/X2012-054, 10.1139/x2012-054]; Kurz WA, 2009, ECOL MODEL, V220, P480, DOI 10.1016/j.ecolmodel.2008.10.018; Hajek T, 2011, BIOGEOCHEMISTRY, V103, P45, DOI 10.1007/s10533-010-9444-3; Cornwell WK, 2009, GLOBAL CHANGE BIOL, V15, P2431, DOI 10.1111/j.1365-2486.2009.01916.x; Hagemann U, 2010, ECOL MODEL, V221, P825, DOI 10.1016/j.ecolmodel.2009.11.024; Rheault H, 2009, ECOSCIENCE, V16, P183, DOI 10.2980/16-2-3216; Dioumaeva I, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000848; Asada T, 2003, BRYOLOGIST, V106, P516, DOI 10.1639/0007-2745(2003)106[516:GOMIRT]2.0.CO;2; Guby NAB, 1996, GLOBAL ECOL BIOGEOGR, V5, P327, DOI 10.2307/2997588; Chareb C, 2010, ETUDE COMP STRUCTURE; Clark DF, 1998, CAN J FOREST RES, V28, P284, DOI 10.1139/cjfr-28-2-284; Deckers J, 1998, WORLD REFERENCE BASE, V2; Deckers J, 1998, WORLD REFERENCE BASE, V1; Drobyshev I, 2012, DENDROCHRONOLOGIA, V30, P137, DOI 10.1016/j.dendro.2011.07.002; Dynesius M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013237; Eckstein J, 2009, DENDROCHRONOLOGIA, V27, P129, DOI 10.1016/j.dendro.2009.06.007; EDEN WJ, 1967, GEOL SOC AM BULL, V78, P1183, DOI 10.1130/0016-7606(1967)78[1183:BSPUAO]2.0.CO;2; Edvardsson J, 2012, J QUATERNARY SCI, V27, P553, DOI 10.1002/jqs.2543; Elumeeva TG, 2011, J VEG SCI, V22, P152, DOI 10.1111/j.1654-1103.2010.01237.x; FAO, 2000, GLOB FOR RES ASS 200; Fasth BG, 2011, J TORREY BOT SOC, V138, P192, DOI 10.3159/TORREY-D-10-00009.1; Fenton N, 2006, CAN J SOIL SCI, V86, P1; FOSTER DR, 1985, J ECOL, V73, P517, DOI 10.2307/2260491; Fox CA, 2011, CAN J SOIL SCI, V91, P823, DOI [10.4141/CJSS10032, 10.4141/cjss10032]; GLEBOV F Z, 1992, P241, DOI 10.1017/CBO9780511565489.011; Green R.N., 1993, FOREST SCI MONOGR, V29, P1; Grosenbaugh LR, 1948, J-FOR, V46, P299; Hagemann U, 2010, ECOSYSTEMS, V13, P600, DOI 10.1007/s10021-010-9343-4; Hall JE, 2001, NATL VEGETATION CLAS; HAMET-AHTI L, 1974, Annales Botanici Fennici, V11, P59; HARVEY A, 1981, INT282 USDA FOR SERV; HARVEY AE, 1976, FOREST SCI, V22, P393; Heinselman M, 1981, FOREST SUCCESSION CO, P375; Holeksa J, 2001, FORSTWISS CENTRALBL, V120, P256, DOI 10.1007/BF02796097; Hunt SL, 2010, SILVA FENN, V44, P563, DOI 10.14214/sf.128; KEENAN RJ, 1993, CAN J FOREST RES, V23, P1052, DOI 10.1139/x93-134; Kershaw M, 1994, 29 ONT MIN NAT RES N; Kira K, 1998, B FAC AGR KAGASHIMA, V48, P31; Klinka K, 1981, 8 BRIT COL MIN FOR; Korpel S., 1995, URWALDER WESTKARPATE; Kushnevskaya H, 2007, FOREST ECOL MANAG, V250, P25, DOI 10.1016/j.foreco.2007.03.006; LANG GE, 1981, CAN J FOREST RES, V11, P388; Little S, 1959, 118 USDA FOR SERV NE; LITTLE SN, 1988, FOREST SCI, V34, P152; Marshall PL, 2000, TR003 BRIT COL MIN F; MCFEE WW, 1966, SOIL SCI SOC AM PRO, V30, P513; MCPFE UNECE FAO, 2007, STAT EUR FOR 2007 MC; McRae D. J., 2001, Environmental Reviews, V9, P223, DOI 10.1139/er-9-4-223; Merganic J, 2004, EUR J FOR RES, V123, P75, DOI 10.1007/s10342-004-0013-y; Merganic J, 2003, DIVERSITY MONITORING; MESSIER C, 1992, CAN J FOREST RES, V22, P273, DOI 10.1139/x92-036; Ministere des Ressources Naturelles du Quebec, 1997, NORM INV FOR PLAC EC; Miyamoto A, 2008, LANDSCAPE URBAN PLAN, V86, P248, DOI 10.1016/j.landurbplan.2008.03.002; Moroni MT, 2010, FORESTRY, V83, P219, DOI 10.1093/forestry/cpq007; Moroni MT, 2006, CAN J FOREST RES, V36, P3194, DOI 10.1139/X06-195; Moroni MT, 2010, ECOSYSTEMS, V13, P452, DOI 10.1007/s10021-010-9331-8; Natural Resources Canada, 2004, CAN NAT INV GROUND S; Natural Resources Canada, 2004, CAN NAT INV DES OV V; Natural Resources Canada, 2013, CAN NAT FOR INV ONL; Natural Resources Canada, 2011, CAN NAT FOR INV NAT; Natural Resources Canada, 2008, CAN NAT FOR INV GROU; Oechel W.C., 1986, FOREST ECOSYSTEMS AL, P121; Saetre P, 1997, CAN J FOREST RES, V27, P2034, DOI 10.1139/cjfr-27-12-2034; Schmidt O., 2006, WOOD TREE FUNGI BIOL; Shaw CH, 2008, SOIL SCI SOC AM J, V72, P1611, DOI 10.2136/sssaj2007.0219; Siitonen Juha, 2001, Ecological Bulletins, V49, P11; Simard M, 2009, CAN J FOREST RES, V39, P546, DOI 10.1139/X08-195; Soil Classification Working Group (SCWG), 1998, CAN SYST SOIL CLASS; Soil Survey Staff, 1992, SMMS TECHN MON, V19; Stocks BJ, 2003, J GEOPHYS RES, V108, P1, DOI DOI 10.1029/2001JD000484; Stokland JN, 2012, ECOL BIODIVERS CONS, P10; Stokland JN, 2001, ECOL B, V49, P71; Stokland JN, 2003, FOREST BIODIVERSITY, P514; Swanson RV, 2001, AGR FOREST METEOROL, V108, P165, DOI 10.1016/S0168-1923(01)00243-X; TAMM C. O., 1953, MEDDELAND STATENS SKOGSFORSOK INST, V43, P1; Warren MW, 2012, BIOGEOSCIENCES, V9, P4477, DOI 10.5194/bg-9-4477-2012; Wellbrock N., 2006, BODENZUSTANDSERHEBUN; Yamashita S, 2012, FOREST ECOL MANAG, V283, P27, DOI 10.1016/j.foreco.2012.07.014; ZABEL RA, 1992, WOOD MICROBIOLOGY DE; Zeng Ning, 2008, Carbon Balance Manag, V3, P1, DOI 10.1186/1750-0680-3-1; Zielonka T, 2001, ECOL B, V49, P159	122	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1432-9840	1435-0629		ECOSYSTEMS	Ecosystems	JUN	2015	18	4					605	628		10.1007/s10021-015-9850-4		24	Ecology	Environmental Sciences & Ecology	CH6DM	WOS:000354126300005		
J	Ushimi, Y; Ito, Y; Horiuchi, H; Kadota, M; Nozaki, Y; Hotta, Y; Shiratori, S				Ushimi, Yoshimitsu; Ito, Yoshihiro; Horiuchi, Hideya; Kadota, Michio; Nozaki, Yoshimi; Hotta, Yoshio; Shiratori, Seimei			Quartz Crystal Microbalance Sensor for NH3 Gas with Compensation of Humidity Drift	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						ammonia gas; ammonia sensor; humidity drift; odor monitoring; quartz crystal microbalance; semiconductor gas sensor	THIN-FILM	A quartz crystal microbalance (QCM) sensor coated with a sensing film has been studied as a gas-sensing device with high gas selectivity and high sensor sensitivity. One of the problems to be solved for practical applications is that the resonant frequency of a QCM sensor drifts due to the influence of humidity. We investigated a method for compensating the humidity drift of a QCM sensor for NH3 gas by using an element coated with a reference film that was prepared by modifying the phosphate group of zirconium phosphate in the sensing film with sodium hydroxide. The response characteristics of the reference element were measured. The results showed good agreement with the humidity response of the sensor element when not responding to ammonia gas. It was found that compensation of the humidity drift was successfully accomplished by calculating the frequency difference between the sensor element and the reference element. An application to small QCM (1.3 x 0.9 mm) is also presented. (C) 2015 Wiley Periodicals, Inc.	[Ushimi, Yoshimitsu; Ito, Yoshihiro; Horiuchi, Hideya; Kadota, Michio] Murata Mfg Co Ltd, Kyoto, Japan; [Nozaki, Yoshimi; Hotta, Yoshio] SNT Co, Kawasaki, Kanagawa, Japan; [Shiratori, Seimei] Keio Univ, Dept Measurement Engn, Yokohama, Kanagawa 223, Japan	Ushimi, Y (reprint author), Murata Mfg Co Ltd, Kyoto, Japan.						Ding B, 2004, SENSOR ACTUAT B-CHEM, V101, P373, DOI 10.1016/j.snb.2004.04.008; Kikuchi M, 2005, SENSOR ACTUAT B-CHEM, V108, P564, DOI 10.1016/j.snb.2004.12.122; Ding B, 2005, SENSOR ACTUAT B-CHEM, V106, P477, DOI 10.1016/j.snb.2004.09.010; Kikuchi M, 2006, SCI TECHNOL ADV MAT, V7, P156, DOI 10.1016/j.stam.2005.12.004; Kikuchi M, 2006, IEEJ T SM, V126, P631, DOI 10.1541/ieejsmas.126.631; Kim JH, 2004, SENSOR ACTUAT B-CHEM, V102, P241, DOI 10.1016/j.snb.2004.04.026; Kiyoyama T, 1986, PRACTICAL GUIDE CHEM, P222; Kushida S, 2001, 20019101 I EL INF CO, V101, P13; Lee SW, 2010, ANAL CHEM, V82, P2228, DOI 10.1021/ac901813q; Munoz-Aguirre S, 2007, SENSOR ACTUAT B-CHEM, V123, P1101, DOI 10.1016/j.snb.2006.11.025; Nimsuk N, 2008, SENSOR ACTUAT B-CHEM, V134, P252, DOI 10.1016/j.snb.2008.04.047; Omori T, 1998, EXPANDED SENSOR TECH, P241; Shiratori S, 2001, THIN SOLID FILMS, V393, P243, DOI 10.1016/S0040-6090(01)01076-8; Tsujita W, 2006, ELECTRON COMM JPN 2, V89, P14, DOI 10.1002/ecjb.10062	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	JUN	2015	98	6					1	7		10.1002/ecj.11653		7	Engineering, Electrical & Electronic	Engineering	CH8CG	WOS:000354262900001		
J	Iwasaki, T; Ono, T; Otani, Y; Fukuda, Y; Okamoto, H				Iwasaki, Takuro; Ono, Toshiro; Otani, Yohei; Fukuda, Yukio; Okamoto, Hiroshi			Interface State Density Evaluation of p-Type and n-Type Ge/GeNx Structures by Conductance Technique	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						conductance technique; Ge; MIS; Ge-MIS; interface state	MOSFETS	Ge-MIS structures have attracted attention as next-generation CMOS devices. We have reported that a GeNx/Ge structure with a low interface state density can be made by the electron cyclotron resonance (ECR) plasma technique, and that the interface state density of Ge-MIS structures can be evaluated through characteristic analysis in the inversion region even at room temperature. In this report, we evaluate the interface state density of p-type and n-type GeNx/Ge structures using the conductance technique at low temperature and characteristic analysis at room temperature, and the related process dependences. We have successfully evaluated the interface characteristics of GeNx/Ge structures. The interface state density was systematically distributed with respect to the midgap, and the density near the midgap was close to that of the GeO2/Ge structure. (C) 2015 Wiley Periodicals, Inc.	[Iwasaki, Takuro; Okamoto, Hiroshi] Hirosaki Univ, Hirosaki, Aomori, Japan; [Ono, Toshiro] Hirosaki Univ, Fac Sci, Hirosaki, Aomori, Japan; [Otani, Yohei; Fukuda, Yukio] Tokyo Univ Sci, Fac Syst Engn, Chino City, Nagano, Japan	Iwasaki, T (reprint author), Hirosaki Univ, Hirosaki, Aomori, Japan.						Martens K, 2006, IEEE ELECTR DEVICE L, V27, P405, DOI 10.1109/LED.2006.873767; Kim H, 2004, APPL PHYS LETT, V85, P2902, DOI 10.1063/1.1797564; Afanas'ev VV, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1947372; Fukuda Y, 2010, IEEE T ELECTRON DEV, V57, P282, DOI 10.1109/TED.2009.2035030; Bai WP, 2006, IEEE ELECTR DEVICE L, V27, P175, DOI 10.1109/LED.2006.870242; Chui CO, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P437; Fukuda Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.090204; Fukuda Y, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3647621; Fukuda Y, 2007, IEEE T ELECTRON DEV, V54, P2878, DOI 10.1109/TED.2007.907111; Lee CH, 2009, APPL PHYS EXPRESS, V2; Maeda T, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2679941; Matsubara H, 2008, APPL PHYS LETT, V93; NICOLLIA.EH, 1967, BELL SYST TECH J, V46, P1055; Otani Y, 2008, JPN J APPL PHYS, V47, P7553, DOI 10.1143/JJAP.47.75531; Ritenour A., 2003, IEDM, P433; Shang H, 2003, IEEE ELECTR DEVICE L, V24, P242, DOI 10.1109/LED.2003.810879; Yu DS, 2004, IEEE ELECTR DEVICE L, V25, P138, DOI 10.1109/LED.2004.824249	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	JUN	2015	98	6					8	15		10.1002/ecj.11655		8	Engineering, Electrical & Electronic	Engineering	CH8CG	WOS:000354262900002		
J	Nishida, T				Nishida, Takeshi			State Feedback Control Using Particle Filter	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						Kalman filter; observer; particle filter; state estimation; state feedback control system	SEQUENTIAL MONTE-CARLO; KALMAN	Since particle filters can be used in non-Gaussian and nonlinear system models, they have a wider range of applications than Kalman filters. In this paper, a construction method for a state feedback control system using a particle filter as an observer for probabilistic state estimation is described. In order to assure robustness to non-Gaussian noise, a maximum a-posteriori probability estimation extraction method and an method for evaluation of the effective sample size have been incorporated into the particle filter. The effectiveness of the constructed system was verified experimentally, and the effectiveness of the state observer constructed with the particle filter is demonstrated through a comparison with a Kalman filter. (C) 2015 Wiley Periodicals, Inc.	Kyushu Inst Technol, Kitakyushu, Fukuoka, Japan	Nishida, T (reprint author), Kyushu Inst Technol, Kitakyushu, Fukuoka, Japan.						Aiyo S, 1989, MEAS CONTROL, V4, P309; Doucet A, 2000, STAT COMPUT, V10, P197, DOI 10.1023/A:1008935410038; Candy JV, 2007, IEEE SIGNAL PROC MAG, V24, P73, DOI 10.1109/MSP.2007.4286566; Liu JS, 1998, J AM STAT ASSOC, V93, P1032, DOI 10.2307/2669847; Boers Y, 2003, IEEE SIGNAL PROC LET, V10, P300, DOI 10.1109/LSP.2003.817175; Rigatos GG, 2010, MATH COMPUT SIMULAT, V81, P590, DOI 10.1016/j.matcom.2010.05.003; Cappe O, 2007, P IEEE, V95, P899, DOI 10.1109/JPROC.2007.893250; Godsill S, 2001, ANN I STAT MATH, V53, P82, DOI 10.1023/A:1017968404964; Doucet A, 2001, STAT ENG IN, P3; Driesen J., 2008, IEEE POW EN SOC GEN, P1; Ikoma Norikazu, 2010, J ADV COMPUTATIONAL, V14, P272; Ikoma T, 2008, 21 CENTURY STAT SCI, P305; Katayama T, 2000, APPL KALMAN FILTERS, P182; Rigatos GG, 2009, ISA T, V48, P62, DOI 10.1016/j.isatra.2008.10.005; Saha S, 2008, P EUSIPCO, P25; Silverman BW, 1986, DENSITY ESTIMATION S; Stahl D, 2011, SYST CONTROL LETT, V60, P632, DOI 10.1016/j.sysconle.2011.05.001; Thrun S, 2005, PROBABILISTIC ROOBOT; Ueda R., 2011, J ROB SOC JPN, V29, P404; Zhou SHK, 2004, IEEE T IMAGE PROCESS, V13, P1491, DOI 10.1109/TIP.2004.836152	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	JUN	2015	98	6					16	25		10.1002/ecj.11658		10	Engineering, Electrical & Electronic	Engineering	CH8CG	WOS:000354262900003		
J	Tanaka, D; Asahara, H; Aihara, K; Kousaka, T				Tanaka, Daiki; Asahara, Hiroyuki; Aihara, Kazuyuki; Kousaka, Takuji			Basic Properties of Two-Dimensional Composite Dynamical System with Spike Noise	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						border-collision bifurcation; composite dynamical system; period-doubling bifurcation; Poincare; map; spike noise	BORDER-COLLISION BIFURCATIONS; DC-DC CONVERTERS; PIECEWISE-SMOOTH MAPS; H-BRIDGE INVERTER; BOOST CONVERTERS; SWITCHING DELAY; CHAOS; CIRCUIT; BEHAVIOR	Bifurcation phenomena in a composite dynamic system are studied in order to understand the basic properties of systems. Recently, it has been reported that unavoidable non-ideal switching, e.g., spike noise or a time delay, occurs due to switching and seriously affects the behavior of the trajectory in a composite dynamical system operating in high-frequency switching ranges. We have analyzed the basic properties of a simple one-dimensional composite dynamical system with nonideal switching in order to understand the essence of the dynamical effects of nonideal switching. In the engineering field, there are many two- or more dimensional systems. Naturally, nonideal switching can occur in two- or more dimensional systems. However, no paper analyzes the effect of nonideal switching in such systems. In this paper, we study the basic properties of a two-dimensional composite dynamical system with spike noise. First, we describe a model of a two-dimensional composite dynamical system. Next, the behavior of the waveforms in a system with ideal switching and a system with spike noise is shown. Then, we sample the data of the waveforms in every period for the external force and define a Poincare map. Finally, using the Poincare map, we derive two-parameter bifurcation diagrams and discuss the basic properties of a system with spike noise. (C) 2015Wiley Periodicals, Inc.	[Tanaka, Daiki; Kousaka, Takuji] Oita Univ, Fac Engn, Oita, Oita, Japan; [Asahara, Hiroyuki] Fukuoka Univ, Grad Sch, Dept Elect Engn, Fukuoka, Fukuoka, Japan; [Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Tokyo, Japan	Tanaka, D (reprint author), Oita Univ, Fac Engn, Oita, Oita, Japan.				Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST, Aihara Innovative Mathematical Modeling Project)	Thus research was supported by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST, Aihara Innovative Mathematical Modeling Project) designed by the Council for Science and Technology Policy through the Japan Society for the Promotion of Science.	Akatsu S, 2007, INT J BIFURCATION CH, V17; Zhou YF, 2003, INT J BIFURCAT CHAOS, V13, P3459, DOI 10.1142/S0218127403008685; Robert B, 2002, INT J CONTROL, V75, P1356, DOI 10.1080/0020717021000023771; Sushko I, 2006, CHAOS SOLITON FRACT, V29, P756, DOI 10.1016/j.chaos.2005.08.107; Chan WCY, 1997, IEEE T CIRCUITS-I, V44, P1129, DOI 10.1109/81.645154; Benadero L, 2003, INT J BIFURCAT CHAOS, V13, P427, DOI 10.1142/S0218127403006728; Banerjee S, 2000, IEEE T CIRCUITS-I, V47, P633, DOI 10.1109/81.847870; NUSSE HE, 1995, INT J BIFURCAT CHAOS, V5, P189, DOI 10.1142/S0218127495000156; Aroudi A.E., 1999, IEEE T CIRCUITS SYST, V146, P1374; Asahara H, 2012, IEEJ T EIS, V132, P1886; Asahara H, 2011, INT J BIFURCAT CHAOS, V21, P985, DOI 10.1142/S0218127411028817; Asahara H., 2009, J SIGNAL PROCESS, V13, P307; Asahara Hiroyuki, 2009, IEICE Transactions on Fundamentals of Electronics, Communications and Computer Sciences, VJ92-A; Asahara H, 2011, INT J CIRC THEOR APP, V39, P1177, DOI 10.1002/cta.695; Banerjee S, 2001, CHAOS NONLINEAR CONT; Banerjee S, 2004, IEEE T CIRCUITS-II, V51, P649, DOI 10.1109/TCSII.2004.838438; Bernardo M, 2001, PHYSICA D, V160, P222; Bernardo M, 2002, CHAOS CIRCUITS SYSTE, V16, P317; Bernardo M., 2008, PIECEWISE SMOOTH DYN; Cheng KWE, 2003, IEE P-ELECT POW APPL, V150, P126, DOI 10.1049/ip-epa:20030228; Deane JHB, 1990, IEEE T POWER ELECTR, V29, P491; Fossas E, 1996, IEEE T CIRCUITS-I, V43, P13, DOI 10.1109/81.481457; Fournier-Prunaret D, 2011, COMMUN NONLINEAR SCI, V16, P916, DOI 10.1016/j.cnsns.2010.05.021; Gardini L, 2012, MATH COMPUT SIMULATI; Hamill D. C., 1992, IEEE Transactions on Power Electronics, V7, DOI 10.1109/63.124574; Huang YH, 2009, INT J CIRC THEOR APP, V37, P109, DOI 10.1002/cta.529; Inaba N., 1986, Electronics and Communications in Japan, Part 1 (Communications), V69, DOI 10.1002/ecja.4410690601; Iu HHC, 2001, INT J CIRC THEOR APP, V29, P281, DOI 10.1002/cta.145; Kabe T, 2007, IEICE T FUND ELECTR, VE90A, P448, DOI 10.1093/ietfec/e90-a.2.448; Kato T, 2007, IEEJ T ELECT INFORM, V127, P1826, DOI 10.1541/ieejeiss.127.1826; Kawakami H, 1992, RIMS KOKYUROKU, V804, P38; Kousaka T, 2002, T IEEJ, V122-C, P1908; Kousaka T, 2009, IEICE ELECTRON EXPR, V6, P806, DOI 10.1587/elex.6.806; Kuboshima M, 1997, IEICE T FUND ELECTR, V9, P1122; Ma Y, 2005, IEEE T CIRCUITS-II, V52, P581, DOI 10.1109/TSCII.2005.850488; Maruyama T, 1989, IEICE T A, V72, P1814; Matsuo A, 2012, CHAOS SOLITON FRACT, V45, P795, DOI 10.1016/j.chaos.2012.02.011; Matsuo A, 2012, IEICE T FUND ELECTR, VE95A, P1329, DOI 10.1587/transfun.E95.A.1329; NUSSE HE, 1992, PHYSICA D, V57, P39, DOI 10.1016/0167-2789(92)90087-4; Tse C. K., 2003, COMPLEX BEHAV SWITCH; TSE CK, 1994, IEEE T CIRCUITS-I, V41, P16, DOI 10.1109/81.260215; YORKE JA, 1983, B AM MATH SOC, V9, P319, DOI 10.1090/S0273-0979-1983-15191-1	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	JUN	2015	98	6					26	35		10.1002/ecj.11659		10	Engineering, Electrical & Electronic	Engineering	CH8CG	WOS:000354262900004		
J	Sugihara, Y; Honda, T; Urano, Y; Watanabe, M; Noguchi, S; Igarashi, H				Sugihara, Yoshihiko; Honda, Toshifumi; Urano, Yuta; Watanabe, Masahiro; Noguchi, So; Igarashi, Hajime			Classification and Size Estimation of Wafer Defects by Using Scattered Light Distribution	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						parametric eigenspace method; scattered light distribution; wafer inspection		Usually, wafer inspection is a two-step process. The first step, which is very important, consists of detection of defects on the wafer. The second step classification of the detected defects, which is done after defect detection as necessary. Recently, it has become necessary to perform simultaneous detection and classification of wafer defects in order to reduce the wafer inspection time while maintaining high resolution of inspection. Optical wafer inspection is the most effective method for detecting and classifying defects and estimating their size in a short time. In this method, the scattered light distribution is compared with a database of previous scattered light distributions and pattern matching is used to classify defects and estimate their size. Therefore, to achieve optical wafer inspection based on scattered light distribution, it is necessary to gather scattered light distribution data for many samples of various kinds. The first aim of this study is to develop a defect classification and size estimation method utilizing the scattered light distribution. We propose a method of classifying defects on wafers and estimating their size. The proposed method is based on pattern matching utilizing a parametric eigenspace. The second aim of the paper is to validate the proposed method by applying it to scattered light distribution samples. The light scattering distribution samples were generated by discrete dipole approximation (DDA) simulation. A database of the light scattering distribution is easily created using the simulation. (C) 2015 Wiley Periodicals, Inc.	[Sugihara, Yoshihiko; Igarashi, Hajime] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan; [Watanabe, Masahiro; Noguchi, So] Hokkaido Univ, Grad Sch Informat Sci, Sapporo, Hokkaido, Japan; [Honda, Toshifumi; Urano, Yuta; Watanabe, Masahiro] Hitachi Ltd, Yokohama Res Lab, Yokohama, Kanagawa, Japan	Sugihara, Y (reprint author), Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan.						Akiyama N., 2000, Journal of the Japan Society of Precision Engineering, V66; Akiyama N., 2001, Journal of the Japan Society of Precision Engineering, V67; Dou L, 1997, IEEE SEMI ADV SEM MA; Lorenzi G, 2003, P SOC PHOTO-OPT INS, V5041, P39, DOI 10.1117/12.485232; Murase H, 1996, IEEE P ICPR; Schmehl R, 1997, J OPT SOC AM A, V14, P3026, DOI 10.1364/JOSAA.14.003026; Stokowski S, 1998, AIP CONF PROC, V449, P405; Urano Y, 2009 C SOC PREC ENG	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	JUN	2015	98	6					36	43		10.1002/ecj.11706		8	Engineering, Electrical & Electronic	Engineering	CH8CG	WOS:000354262900005		
J	Usami, K; Kano, R; Kawai, K; Noda, T; Shiramatsu, TI; Saito, N; Takahashi, H				Usami, Kenichi; Kano, Ryuji; Kawai, Kensuke; Noda, Takahiro; Shiramatsu, Tomoyo Isoguchi; Saito, Nobuhito; Takahashi, Hirokazu			State-Dependent Modulation of Cortical Synchrony by Vagus Nerve Stimulation in Adult Rats	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						cerebral cortex; local field potential; neuronal synchrony; phase-locking; rat; vagus nerve stimulation	COGNITION; SEIZURES; EPILEPSY; RHYTHMS; TRIAL	Vagus nerve stimulation (VNS) is a palliative treatment for intractable epilepsy. Therapeutic mechanisms of VNS have not been elucidated. In this study, we measured the local field potential (LFP) with high-spatial resolution using a microelectrode array in adult rats, and analyzed VNS-induced phase modulation at a local network level. Eight adult Wistar rats (270-330 g) were used. Each rat underwent implantation of a VNS system under 1.5% isoflurane anesthesia. One week after implantation, right temporal craniotomy was performed under the same anesthesia as previously. Subsequently, a microelectrode array was placed in the temporal lobe cortex, and the LFP was recorded with a sampling rate of 1000 Hz. Phase-locking values (PLV) between all pairs of electrodes in varied frequency bands were calculated in order to evaluate the effect of VNS in terms of synchrony of neuronal activities. The PLV was calculated both in a normal state and in an epileptic state induced by kainic acid. VNS increased the PLV in a normal state, particularly in the high- band. In an epileptic state, on the other hand, VNS increased the PLV in the high- band and decreased the PLV in the and low- bands. These results suggest that VNS modulates neural activities in a band-specific and state-dependent manner so as to keep cortical synchrony within the optimal state. (C) 2015 Wiley Periodicals, Inc.	[Usami, Kenichi; Kawai, Kensuke; Saito, Nobuhito] Univ Tokyo, Grad Sch Med, Dept Neurosurg, Tokyo 1138654, Japan; [Kano, Ryuji; Shiramatsu, Tomoyo Isoguchi] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Mechanoinformat, Tokyo 1138654, Japan; [Noda, Takahiro] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1138654, Japan; [Takahashi, Hirokazu] Univ Tokyo, PRESTO, JST, Tokyo 1138654, Japan	Usami, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Neurosurg, Tokyo 1138654, Japan.				Comprehensive Research on Disability Health and Welfare;  [24650252]	This study was assisted by Grant-in-Aid for Scientific Research (24650252) and Comprehensive Research on Disability Health and Welfare. The VNS system used in the experiments was provided by Cyberonics (US).	Schindler K, 2007, CLIN NEUROPHYSIOL, V118, P1955, DOI 10.1016/j.clinph.2007.06.006; GEORGE R, 1995, NEUROLOGY, V45, P224; Handforth A, 1998, NEUROLOGY, V51, P48; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Ben-Menachem E, 2002, LANCET NEUROL, V1, P477, DOI 10.1016/S1474-4422(02)00220-X; Henry TR, 2002, NEUROLOGY, V59, pS3; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Boon P, 2006, SEIZURE-EUR J EPILEP, V15, P259, DOI 10.1016/j.seizure.2006.02.014; Kano R, 2013, IEEJ T C, V113C, P1493; Koo B, 2001, J CLIN NEUROPHYSIOL, V18, P434, DOI 10.1097/00004691-200109000-00008; SALINSKY MC, 1993, EPILEPSIA, V34, P299, DOI 10.1111/j.1528-1157.1993.tb02415.x; Vonck K, 2007, ACTA NEUROCHIR SUPPL, V97, P321	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	JUN	2015	98	6					44	50		10.1002/ecj.11735		7	Engineering, Electrical & Electronic	Engineering	CH8CG	WOS:000354262900006		
J	Hashimoto, K; Uchida, M				Hashimoto, Kazuma; Uchida, Masafumi			Control of Balloon Fish Robot Based on Traveling Wave Equation	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						airship robot; fish robot; traveling wave	OPTIMIZATION	Fish have excellent swimming ability underwater. Airship robots capable of performing low-speed, low-altitude flight with low energy have been investigated. Airship robots that perform swimming in the air in a manner similar to aquatic organisms by combining these features have been investigated and developed. The BFR (Balloon Fish Robot) is one such of type of robot. This paper deals with the simulated motion of the BFR and parameter optimization for the propulsion efficiency of an aquatic organism-like airship robot propelled by traveling waves. The controlling expression of the BFR is written as a traveling-wave equation. The equations of motion are defined by means of the controlling expression and the drag force. Comparative simulation and experimental investigation of the forward air speed of the BFR were used to evaluate its validity. The highest propulsion efficiency parameter was investigated by calculating using the experimental air speed, the maximum amplitude of the tail fin, and the traveling-wave frequency. (C) 2015 Wiley Periodicals, Inc.	[Hashimoto, Kazuma; Uchida, Masafumi] Univ Electrocommun, Grad Sch Informat & Engn, Tokyo, Japan	Hashimoto, K (reprint author), Univ Electrocommun, Grad Sch Informat & Engn, Tokyo, Japan.						Yu JZ, 2004, IEEE T SYST MAN CY B, V34, P1798, DOI 10.1109/TSMCB.2004.831151; Yu JZ, 2005, IEEE INT CONF ROBOT, P3306; LIGHTHILL MJ, 1960, J FLUID MECH, V9, P305, DOI 10.1017/S0022112060001110; Barrett D., 1996, AUT UND VEH TECHN 19, P1; Bueno S, 2002, IEEE RSJ INT C INT R, P43; Hygounenc E, 2003, IEEE INT CONF ROBOT, P540; Nakashima M, 1996, T JPN SOC MECH ENG-B, V62, P3044; Ohosawa K, 2007, BUOYANT FLIGHT REPOR, V35, P78; Okudera Y, 2012, BUOYANT FLIGHT REPOR, V40, P69; Sato K, 2011, 16 INT S ART LIF ROB; Sato K, 2011, BUOYANT FLIGHT REPOR, V39, P33; Shibata T, 2012, J IEICE, V95, P442; Takada Y, 2008, JSME; Tanaka I, 1996, HYDRODYNAMICS RESIST; Watanabe M, 2002, T JAPAN SOC MECH ENG, V68, P188; Yu JZ, 2007, IEEE T ROBOT, V23, P382, DOI 10.1109/TRO.2007.892221; Yu JZ, 2006, P AMER CONTR CONF, V1-12, P4129; Zhang H., 1999, P IEEE INT C ROB AUT, V1, P618	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	JUN	2015	98	6					51	59		10.1002/ecj.11738		9	Engineering, Electrical & Electronic	Engineering	CH8CG	WOS:000354262900007		
J	Oshiro, K; Masui, T				Oshiro, Ken; Masui, Toshihiko			Diffusion of low emission vehicles and their impact on CO2 emission reduction in Japan	ENERGY POLICY			English	Article						Climate change mitigation; Demand side management; Low emission vehicle	ENERGY	In order to achieve the long-term CO2 emission reduction target in Japan, diffusion of low emission vehicles can contribute by integration of intermittent renewable energy by demand side management using low emission vehicles, such as smart charging battery electric vehicle (BEV), in addition to improvement of energy efficiency and carbon intensity. In this study, impact of the low emission vehicles is assessed using AIM/Enduse model with 10 regions in Japan. The model is revised to integrate power generation sector and to separate the transportation demand into small, medium and large size vehicles in order to reflect the availability of BEV and fuel-cell electric vehicle (FCEV) in each vehicle size. In the Reference case, hybrid vehicle accounts for more than a half of transport demand in 2050. However, by introducing the carbon tax to achieve the 2 degree target, the share of both BEV and FCEV in 2050 reaches around 90% and 60% in passenger and freight transport, respectively. In addition, electricity demand pattern is transformed by demand side management in 2050 while integrating more intermittent renewable energy into electricity system. As a result, the CO2 emissions from transport sector in 2050 decreases by approximately 81% compared to the 1990 level. (C) 2014 Elsevier Ltd. All rights reserved.	[Oshiro, Ken] Tokyo Inst Technol, Meguro Ku, Tokyo 1528552, Japan; [Masui, Toshihiko] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan	Oshiro, K (reprint author), Tokyo Inst Technol, Meguro Ku, Ookayama 2-12-1, Tokyo 1528552, Japan.	oshiro.k.ab@m.titech.ac.jp			Ministry of Environment of Japan [2A-1103, 2-1402]	This research was supported by the Environment Research and Technology Development Fund (2A-1103 and 2-1402) of the Ministry of Environment of Japan.	Akashi O., 2007, ALIGNING CLIMATE CHA; Krey V, 2014, CLIMATIC CHANGE, V123, P369, DOI 10.1007/s10584-013-0947-5; Kiviluoma J, 2011, ENERGY, V36, P1758, DOI 10.1016/j.energy.2010.12.053; Lund H, 2008, ENERG POLICY, V36, P3578, DOI 10.1016/j.enpol.2008.06.007; Ashina S., 2009, 2009 INT EN WORKSH; Ashina S, 2012, ENERG POLICY, V41, P584, DOI 10.1016/j.enpol.2011.11.020; Central Environmental Council, 2012, REP MEAS POL 2013; Fujino J, 2008, CLIM POLICY, V8, pS108, DOI 10.3763/cpol.2007.0491; GIO, 2014, NAT GHGS INV REP JAP; IEA (International Energy Agency), 2013, WORLD EN OUTL; IEA (International Energy Agency), 2012, EN TECHN PERSP; IEEJ, 2013, EDMC HDB EN EC STAT; IPCC, 2014, SUMM POL CLIM CHANG; IPSS, 2012, POP PROJ JAP JAN 201; Kainuma M, 2003, CLIMATE POLICY ASSES; Matsuo Y., 2014, J JPN SOC ENERGY RES, V35, P23; Ministry of Economy Trade and Industry (METI), 2014, STRAT EN PLAN; MUT, 2012, DOM TRANSP STAT HDB; Steward D, 2009, LIFECYCLE COST ANAL	19	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-4215	1873-6777		ENERG POLICY	Energy Policy	JUN	2015	81						215	225		10.1016/j.enpol.2014.09.010		11	Energy & Fuels; Environmental Sciences; Environmental Studies	Energy & Fuels; Environmental Sciences & Ecology	CH2JX	WOS:000353852600022		
J	Ishida, S; Nozaki, D; Grossart, HP; Kagami, M				Ishida, Seiji; Nozaki, Daiki; Grossart, Hans-Peter; Kagami, Maiko			Novel basal, fungal lineages from freshwater phytoplankton and lake samples	ENVIRONMENTAL MICROBIOLOGY REPORTS			English	Article							FOOD-WEB DYNAMICS; MOLECULAR DIVERSITY; COMMUNITY STRUCTURE; PARASITIC CHYTRIDS; SEQUENCE ALIGNMENT; YEASTS; PICOEUKARYOTES; ECOSYSTEMS; PHYLOGENY; ENZYMES	Zoosporic fungal parasites are known to control the extent and development of blooms of numerous phytoplankton species. Despite the obvious importance of ecological interactions between parasitic fungi and their phytoplanktonic hosts, their diversity remains largely unknown due to methodological limitations. Here, a method to genetically analyse fungi directly from single, infected colonies of the phytoplanktonic host was applied to field samples of large diatom species from mesotrophic Lake Biwa and eutrophic Lake Inba, Japan. Although previous research on interaction between lacustrine fungi and large phytoplankton has mainly focused on the role of parasitic Chytridiomycota, our results revealed that fungi attached to large diatoms included not only members of Chytridiomycota, but also members of Aphelida, Cryptomycota and yeast. The fungi belonging to Chytridiomycota and Aphelida form novel, basal lineages. Environmental clone libraries also support the occurrence of these lineages in Japanese lakes. The presented method enables us to better characterize individual fungal specimens on phytoplankton, and thus facilitate and improve the investigation of ecological relationships between fungi and phytoplankton in aquatic ecosystems.	[Ishida, Seiji; Nozaki, Daiki; Kagami, Maiko] Toho Univ, Fac Sci, Dept Environm Sci, Funabashi, Chiba 274, Japan; [Grossart, Hans-Peter] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Expt Limnol, Stechlin, Brandenburg, Germany; [Grossart, Hans-Peter] Univ Potsdam, Inst Biochem & Biol, Potsdam, Brandenburg, Germany	Ishida, S (reprint author), Toho Univ, Fac Sci, Dept Environm Sci, Funabashi, Chiba 274, Japan.	Ishida.seiji.2@gmail.com			Ministry of Education, Culture, Sports, and Technology of Japan [25281012]; JSPS-DAAD [RC 21315007]; Leibniz-MycoLink project	We thank Shohei Fujinaga, Takeshi Hiraoka, Syuhei Ban and Shoko Hosoi-Tanabe for their sampling collection, and Kimiko Uchii, Michelle A. Maier, Solvig Pinnow and Gen Morimoto for their technical assistance. This study was supported by a grant from a Grant-in-Aid for Scientific Research (B) (25281012) given from the Ministry of Education, Culture, Sports, and Technology of Japan to MK and by a JSPS-DAAD Grant (RC 21315007) and the Leibniz-MycoLink project given to HPG.	Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/nmeth.2604, 10.1038/NMETH.2604]; Truett GE, 2000, BIOTECHNIQUES, V29, P52; Karpov SA, 2013, PROTIST, V164, P195, DOI 10.1016/j.protis.2012.08.001; Monchy S, 2011, ENVIRON MICROBIOL, V13, P1433, DOI 10.1111/j.1462-2920.2011.02444.x; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Karpov SA, 2014, PROTIST, V165, P512, DOI 10.1016/j.protis.2014.05.003; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Gutman J, 2009, EUR J PHYCOL, V44, P509, DOI 10.1080/09670260903161024; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Rasconi S, 2009, APPL ENVIRON MICROB, V75, P2545, DOI 10.1128/AEM.02211-08; Takishita K, 2005, EXTREMOPHILES, V9, P185, DOI 10.1007/s00792-005-0432-9; James TY, 2013, CURR BIOL, V23, P1548, DOI 10.1016/j.cub.2013.06.057; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hoffman Y, 2008, MYCOL RES, V112, P70, DOI [10.1016/j.mycres.2007.09.002, 10.1016/i.mycres.2007.09.002]; Duarte AWF, 2013, EXTREMOPHILES, V17, P1023, DOI 10.1007/s00792-013-0584-y; Smit E, 1999, APPL ENVIRON MICROB, V65, P2614; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Lefevre E, 2007, ENVIRON MICROBIOL, V9, P61, DOI 10.1111/j.1462-2920.2006.01111.x; Kagami M, 2007, HYDROBIOLOGIA, V578, P113, DOI 10.1007/s10750-006-0438-z; Kutty SN, 2008, YEAST, V25, P465, DOI 10.1002/yea.1599; Wurzbacher CM, 2010, AQUAT MICROB ECOL, V59, P125, DOI 10.3354/ame01385; ROSA CA, 1995, HYDROBIOLOGIA, V308, P103, DOI 10.1007/BF00007394; Brandao LR, 2011, FEMS MICROBIOL ECOL, V76, P1, DOI 10.1111/j.1574-6941.2010.01030.x; Jobard M, 2012, ENVIRON MICROBIOL, V14, P2480, DOI 10.1111/j.1462-2920.2012.02771.x; Kagami M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00166; Kagami M, 2012, MICROB ECOL, V63, P358, DOI 10.1007/s00248-011-9913-9; Lefevre E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002324; Letcher PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056232; Rasconi S, 2012, ENVIRON MICROBIOL, V14, P2151, DOI 10.1111/j.1462-2920.2011.02690.x; Sime-Ngando T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00361; Wurzbacher C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094643	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1758-2229			ENV MICROBIOL REP	Environ. Microbiol. Rep.	JUN	2015	7	3					435	441		10.1111/1758-2229.12268		7	Environmental Sciences; Microbiology	Environmental Sciences & Ecology; Microbiology	CH9RY	WOS:000354375100008		
J	Kaneko, H				Kaneko, Hajime			On the beta-expansions of 1 and algebraic numbers for a Salem number beta	ERGODIC THEORY AND DYNAMICAL SYSTEMS			English	Article							REAL NUMBERS; DYNAMICS; DIGITS; UNITY	We study the digits of beta- expansions in the case where beta is a Salem number. We introduce new upper bounds for the numbers of occurrences of consecutive 0s in the expansion of 1. We also give lower bounds for the numbers of non-zero digits in the beta-expansions of algebraic numbers. As applications, we give criteria for transcendence of the values of power series at certain algebraic points.	Nihon Univ, Dept Math, Coll Sci & Technol, Chiyoda Ku, Tokyo 1018308, Japan	Kaneko, H (reprint author), Nihon Univ, Dept Math, Coll Sci & Technol, Chiyoda Ku, 1-8-14 Kanda Surugadai, Tokyo 1018308, Japan.	kanekoha@math.cst.nihon-u.ac.jp			JSPS	I am deeply grateful to Professor Yann Bugeaud for careful reading of the manuscript and for giving useful advice. I would like to thank the referees for careful reading of the manuscript and for giving valuable suggestions. This work is supported by the JSPS fellowship.	Adamczewski B, 2004, CR MATH, V338, P511, DOI 10.1016/j.crma.2004.02.002; Adamczewski B, 2012, CR MATH, V350, P1, DOI 10.1016/j.crma.2011.12.002; Boyd DW, 1996, MATH COMPUT, V65, P861, DOI 10.1090/S0025-5718-96-00700-4; Adamczewski B, 2007, ANN MATH, V165, P547; [Anonymous], 1844, CR HEBD ACAD SCI, V18, P883; Adamczewski B, 2007, ERGOD THEOR DYN SYST, V27, P1695, DOI 10.1017/S0143385707000223; Bailey D. H., 2004, J THEOR NOMBR BORDX, V16, P487; Bertrand A., 1977, C R ACAD SCI PARIS A, V285, pA419; BLANCHARD F, 1989, THEOR COMPUT SCI, V65, P131, DOI 10.1016/0304-3975(89)90038-8; BOREL E, 1950, CR HEBD ACAD SCI, V230, P591; Boyd D. W., 1989, NUMBER THEORY, P57; Bugeaud Y., 2012, CAMBRIDGE TRACTS MAT, V193; Bugeaud Y., 2009, INTEGERS, V9, P215, DOI 10.1515/INTEG.2009.021; Bugeaud Y, 2007, REND SEMIN MAT U PAD, V118, P217; Corvaja P, 2002, COMPOS MATH, V131, P319, DOI 10.1023/A:1015594913393; Dubickas A, 2011, MATH SLOVACA, V61, P705, DOI 10.2478/s12175-011-0040-3; Kaneko H, 2010, J AUST MATH SOC, V89, P233, DOI 10.1017/S1446788710001503; Kaneko H., 2012, UNIF DISTRIB THEORY, V7, P141; LIOUVILLE J., 1844, CR HEBD ACAD SCI, V18, P910; Mahler K, 1929, MATH ANN, V101, P342, DOI 10.1007/BF01454845; NISHIOKA K., 1996, LECT NOTES MATH, V1631; Parry W., 1960, ACTA MATH ACAD SCI H, V11, P401, DOI 10.1007/BF02020954; Renyi A., 1957, ACTA MATH ACAD SCI H, V8, P477, DOI 10.1007/BF02020331; Rivoal T, 2008, J AUST MATH SOC, V85, P95, DOI 10.1017/S1446788708000591; Schmidt K., 1980, B LOND MATH SOC, V12, P269, DOI 10.1112/blms/12.4.269; Shidlovskii A. B., 1989, W DEGRUYTER STUDIES, V12; Verger-Gaugry JL, 2006, ANN I FOURIER, V56, P2565	27	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0143-3857	1469-4417		ERGOD THEOR DYN SYST	Ergod. Theory Dyn. Syst.	JUN	2015	35		4				1243	1262		10.1017/etds.2013.99		20	Mathematics, Applied; Mathematics	Mathematics	CH9CH	WOS:000354333100011		
J	Komasawa, N; Fujiwara, S; Haba, M; Mihara, R; Minami, T				Komasawa, Nobuyasu; Fujiwara, Shunsuke; Haba, Masanori; Mihara, Ryosuke; Minami, Toshiaki			Comparison of Quick Track and Melker for emergent invasive airway management during chest compression A crossover simulation trial	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Letter							CRICOTHYROTOMY; DEVICES		[Komasawa, Nobuyasu; Fujiwara, Shunsuke; Mihara, Ryosuke; Minami, Toshiaki] Osaka Med Coll, Dept Anaesthesiol, Takatsuki, Osaka 5698686, Japan; [Haba, Masanori] Japanese Red Cross Wakayama Hosp, Dept Anaesthesiol, Wakayama, Japan	Komasawa, N (reprint author), Osaka Med Coll, Dept Anaesthesiol, Daigaku Machi 2-7, Takatsuki, Osaka 5698686, Japan.	ane078@poh.osaka-med.ac.jp					Fikkers BG, 2004, ANAESTHESIA, V59, P1008, DOI 10.1111/j.1365-2044.2004.03794.x; Metterlein T, 2011, J EMERG MED, V41, P326, DOI 10.1016/j.jemermed.2010.04.008; Helmstaedter V, 2012, ANAESTHESIST, V61, P310, DOI 10.1007/s00101-012-2008-2; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Vadodaria BS, 2004, ANAESTHESIA, V59, P73, DOI 10.1111/j.1365-2044.2004.03456.x	5	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0265-0215	1365-2346		EUR J ANAESTH	Eur. J. Anaesth.	JUN	2015	32	6					440	442		10.1097/EJA.0000000000000144		4	Anesthesiology	Anesthesiology	CH5TK	WOS:000354098000014		
J	Komasawa, N; Fujiwara, S; Mihara, R; Minami, T				Komasawa, Nobuyasu; Fujiwara, Shunsuke; Mihara, Ryosuke; Minami, Toshiaki			Comparison of McGrath and Pentax-AWS Airwayscope for tracheal intubation by anaesthesiologists during chest compression in a manikin A randomised crossover trial	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Letter							MACINTOSH LARYNGOSCOPE; VIDEOLARYNGOSCOPE		[Komasawa, Nobuyasu; Fujiwara, Shunsuke; Mihara, Ryosuke; Minami, Toshiaki] Osaka Med Coll, Dept Anaesthesiol, Takatsuki, Osaka 5698686, Japan	Komasawa, N (reprint author), Osaka Med Coll, Dept Anaesthesiol, Daigaku Machi 2-7, Takatsuki, Osaka 5698686, Japan.	ane078@poh.osaka-med.ac.jp					Niforopoulou P, 2010, ACTA ANAESTH SCAND, V54, P1050, DOI 10.1111/j.1399-6576.2010.02285.x; Sharma DJ, 2010, ANAESTH INTENS CARE, V38, P39; Taylor AM, 2013, ANAESTHESIA, V68, P142, DOI 10.1111/anae.12075; Komasawa N, 2010, J ANESTH, V24, P582, DOI 10.1007/s00540-010-0950-1	4	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0265-0215	1365-2346		EUR J ANAESTH	Eur. J. Anaesth.	JUN	2015	32	6					442	443		10.1097/EJA.0000000000000185		3	Anesthesiology	Anesthesiology	CH5TK	WOS:000354098000015		
J	Nicoletti, C; Muller, C; Hayashi, C; Nakaseko, M; Tobita, I; Laubli, T				Nicoletti, Corinne; Mueller, Christian; Hayashi, Chiemi; Nakaseko, Masaru; Tobita, Itoko; Laeubli, Thomas			Circadian rhythm of heart rate and physical activity in nurses during day and night shifts	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Shift work; Circadian rhythm; Heart rate; Nurse; Activity	RATE-VARIABILITY; WORK; RISK; CANCER; PATTERNS; HEALTHY	The study investigates if the circadian rhythm of heart rate is apparent during the working periods of day and night shifts in Swiss and Japanese nurses and if it is influenced by work organization. For a better interpretation of the heart rate, the activity profile over these working periods was monitored. Heart rate and activity profile of 18 Swiss and 24 Japanese nurses were measured during one day and one night shift. The day and the night shift data of each subject were combined, resulting in an approximately 18-h working period. A significant time effect of the mean hourly value of the heart rate was found in Swiss nurses (change in amplitude 7.1 bpm) as well as in Japanese nurses (11.8 bpm). These effects could be modeled with cosine curves for the Swiss and Japanese subjects. For the activity level significant time effects, similar to the ones in heart rate, were found in Swiss nurses (87 % of SD) but not in Japanese nurses (26 % of SD). We found a significant time effect in heart rate similar to the known circadian rhythm under normal sleep-wake conditions while working in the studied shift work schedules. In the Japanese nurses, studied heart rate followed a circadian rhythm independently of the level of physical activity. Therefore, an activity profile following the circadian rhythm, especially a reduced workload from 2 to 4 a.m., is proposed. The proposed activity profile could be reached with an adapted work organization.	[Nicoletti, Corinne; Laeubli, Thomas] ETH, Dept Hlth Sci & Technol, CH-8092 Zurich, Switzerland; [Mueller, Christian] SBB AG, Swiss Fed Railways, Occupat Hlth Management, CH-3000 Bern, Switzerland; [Hayashi, Chiemi; Nakaseko, Masaru; Tobita, Itoko] Jikei Inst, Grad Sch Hlth Sci, Occupat Ergon Unit, Management Hlth Care Sci,,Yodogawa Ku, Osaka 5320003, Japan; [Nakaseko, Masaru; Laeubli, Thomas] Kyoto Inst Technol, Holist Prosthet Res Ctr, Sakyo Ku, Kyoto 6068585, Japan	Nicoletti, C (reprint author), ETH, Dept Hlth Sci & Technol, Sonneggstrasse 3, CH-8092 Zurich, Switzerland.	corinne.nicoletti@hest.ethz.ch			Swiss Federal Institute of Technology (ETH) Zurich; Kyoto Technical Institute; Graduate School of Health Sciences, Jikei Institute (Osaka, Japan)	We thank the Swiss Federal Institute of Technology (ETH) Zurich, the Kyoto Technical Institute and the Graduate School of Health Sciences, Jikei Institute (Osaka, Japan) for their financial support.	Schernhammer ES, 2003, J NATL CANCER I, V95, P825; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Ruggiero JS, 2014, BIOL RES NURS, V16, P134, DOI 10.1177/1099800413476571; Bracci M, 2014, SCAND J WORK ENV HEA, V40, P295, DOI 10.5271/sjweh.3414; Costa G, 1996, APPL ERGON, V27, P9, DOI 10.1016/0003-6870(95)00047-X; Riedel M, 2011, CHRONOBIOL INT, V28, P697, DOI 10.3109/07420528.2011.603170; Bonde JP, 2012, SCAND J WORK ENV HEA, V38, P380, DOI 10.5271/sjweh.3282; Estryn-Behar M, 2008, OCCUP MED-OXFORD, V58, P107, DOI 10.1093/occmed/kqm142; HUIKURI HV, 1990, AM J CARDIOL, V65, P391, DOI 10.1016/0002-9149(90)90308-N; Ruger M, 2009, REV ENDOCR METAB DIS, V10, P245, DOI 10.1007/s11154-009-9122-8; Parent ME, 2012, AM J EPIDEMIOL, V176, P751, DOI 10.1093/aje/kws318; Atkinson G, 2007, EUR J APPL PHYSIOL, V99, P331, DOI 10.1007/s00421-006-0361-z; Bortz J., 2010, STAT HUMAN SOZIALWIS; CLARKE JM, 1976, LANCET, V2, P508; COLQUHOUN WP, 1988, INT ARCH OCC ENV HEA, V60, P273, DOI 10.1007/BF00378473; Edwards Marie P, 2013, Dynamics, V24, P30; Fisher AJ, 2013, BIOL PSYCHOL, V93, P65, DOI 10.1016/j.biopsycho.2013.01.012; Flo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033981; GOTO T, 1994, J HUM HYPERTENS, V8, P11; Grandjean E, 1991, PHYSL ARBEITSGESTALT; Guo YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071107; Santhi N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001233; Ito H, 2001, INT J CARDIOL, V79, P231, DOI 10.1016/S0167-5273(01)00439-9; KNAUTH P, 1979, APPL ERGON, V10, P9, DOI 10.1016/0003-6870(79)90003-6; Laubli T, 2009, ARBEITSBEDINGUNGEN E; Leonardi GC, 2012, ONCOL REP, V28, P418, DOI 10.3892/or.2012.1839; Nicoletti C, 2013, APPL ERGON, V45, P741; Oyane NMF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070228; Bollinger T, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13984; Vyas MV, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4800	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	JUN	2015	115	6					1313	1320		10.1007/s00421-015-3110-3		8	Physiology; Sport Sciences	Physiology; Sport Sciences	CH9ZS	WOS:000354395900013		
J	Nicoletti, C; Muller, C; Hayashi, C; Nakaseko, M; Tobita, I; Laubli, T				Nicoletti, Corinne; Mueller, Christian; Hayashi, Chiemi; Nakaseko, Masaru; Tobita, Itoko; Laeubli, Thomas			Circadian rhythm of heart rate and physical activity in nurses during day and night shifts (vol 115, pg 1313, 2015)	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Correction									[Nicoletti, Corinne; Laeubli, Thomas] ETH, Dept Hlth Sci & Technol, CH-8092 Zurich, Switzerland; [Mueller, Christian] SBB AG, Swiss Fed Railways, Occupat Hlth Management, CH-3000 Bern, Switzerland; [Hayashi, Chiemi; Nakaseko, Masaru; Tobita, Itoko] Jikei Inst, Grad Sch Hlth Sci, Occupat Ergon Unit, Management Hlth Care Sci,Yodogawa Ku, Osaka 5320003, Japan; [Nakaseko, Masaru; Laeubli, Thomas] Kyoto Inst Technol, Holist Prosthet Res Ctr, Sakyo Ku, Kyoto 6068585, Japan	Nicoletti, C (reprint author), ETH, Dept Hlth Sci & Technol, Sonneggstrasse 3, CH-8092 Zurich, Switzerland.	corinne.nicoletti@hest.ethz.ch					Nicoletti C, 2015, EUR J APPL PHYSIOL, V115, P1313, DOI 10.1007/s00421-015-3110-3	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	JUN	2015	115	6					1321	1321		10.1007/s00421-015-3119-7		1	Physiology; Sport Sciences	Physiology; Sport Sciences	CH9ZS	WOS:000354395900014		
J	Inamasu, J; Oheda, M; Hayashi, T; Kato, Y; Hirose, Y				Inamasu, Joji; Oheda, Motoki; Hayashi, Takuro; Kato, Yoko; Hirose, Yuichi			Are admission systolic blood pressures predictive of outcomes in patients with spontaneous intracerebral haemorrhage after aggressive blood pressure management?	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						catecholamine; high blood pressure; nicardipine; outcomes; spontaneous intracerebral haemorrhage	ANTIHYPERTENSIVE TREATMENT; HEMATOMA ENLARGEMENT; ARTERIAL-PRESSURE; PROGNOSTIC VALUE; STROKE; NICARDIPINE	Objective High blood pressure (HBP) is observed frequently in patients with spontaneous intracerebral haemorrhage (SICH). Although HBP at admission has been associated with poor outcomes, most studies from which such conclusions were derived had been carried out decades earlier, when aggressive BP management was not implemented. In our institution, SICH patients showing HBP undergo aggressive BP management by intravenous nicardipine with target systolic BP (SBP) less than 140mmHg. We investigated whether responsiveness to intravenous nicardipine, haematoma expansion rate and activity of daily living 90 days after admission differed by the degree of admission SBP. Patients and methods A retrospective study was carried out by reviewing charts of 120 SICH patients admitted within 6 h of onset who were quadrichotomized on the basis of SBP: <140 mmHg (n=6), 140-184 mmHg (n=49), 185-219 mmHg (n=38) and >= 220 mmHg (n=27). The six patients with SBP less than 140 mmHg were excluded, and demographic and outcome variables of the latter three groups were compared. Whether plasma catecholamine levels differed among the three groups was also investigated. Results Optimal BP management (target SBP<140mmHg) within 2 h of arrival was achieved in 98%, haematoma expansion occurred in 7% and the 90-day mortality rate was 11%. Responsiveness to intravenous nicardipine, haematoma expansion rate and activity of daily living were not significantly different. Furthermore, plasma catecholamine levels did not differ significantly. Conclusion The lack of difference in the demographic and outcome variables in SICH patients managed by aggressive treatment to normalize the BP indicates that the previously reported association between HBP at admission and poor outcomes needs to be re-evaluated. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Inamasu, Joji; Oheda, Motoki] Fujita Hlth Univ Hosp, Dept Neurocrit Care, Toyoake, Aichi 4701192, Japan; [Hayashi, Takuro; Kato, Yoko; Hirose, Yuichi] Fujita Hlth Univ Hosp, Dept Neurosurg, Toyoake, Aichi 4701192, Japan	Inamasu, J (reprint author), Fujita Hlth Univ Hosp, Dept Neurocrit Care, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	inamasu@fujita-hu.ac.jp					DANDAPANI BK, 1995, STROKE, V26, P21; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Fujiwara N, 2005, J HYPERTENS, V23, P1055, DOI 10.1097/01.hjh.0000166847.95592.41; Zubkov AY, 2008, ARCH NEUROL-CHICAGO, V65, P1320, DOI 10.1001/archneur.65.10.1320; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Sugimoto K, 2012, STROKE, V43, P1897, DOI 10.1161/STROKEAHA.111.646893; Marti-Fabregas J, 2008, EUR J NEUROL, V15, P1085, DOI 10.1111/j.1468-1331.2008.02254.x; Fogelholm R, 1997, STROKE, V28, P1396; Ohwaki K, 2004, STROKE, V35, P1364, DOI 10.1161/01.STR.0000128795.38283.4b; Rodriguez-Luna D, 2013, EUR J NEUROL, V20, P1277, DOI 10.1111/ene.12180; Terayama Y, 1997, STROKE, V28, P1185; Butcher KS, 2013, STROKE, V44, P620, DOI 10.1161/STROKEAHA.111.000188; Qureshi AI, 2007, AM J EMERG MED, V25, P32, DOI 10.1016/j.ajem.2006.07.008; Sakamoto Y, 2013, STROKE, V44, P1846, DOI 10.1161/STROKEAHA.113.001212; Hwang SK, 2012, J KOREAN MED SCI, V27, P1085, DOI 10.3346/jkms.2012.27.9.1085; Liu-DeRyke X, 2008, NEUROCRIT CARE, V9, P167, DOI 10.1007/s12028-008-9057-z; Shinohara Y, 2011, J STROKE CEREBROVASC, V20, pS74, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.005; Woloszyn AV, 2012, NEUROCRIT CARE, V16, P376, DOI 10.1007/s12028-012-9700-6	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0969-9546	1473-5695		EUR J EMERG MED	Eur. J. Emerg. Med.	JUN	2015	22	3					170	175		10.1097/MEJ.0000000000000128		6	Emergency Medicine	Emergency Medicine	CH3ZW	WOS:000353971000005		
J	Kohda, N; Iijima, M; Kawaguchi, K; Toshima, H; Muguruma, T; Endo, K; Mizoguchi, I				Kohda, Naohisa; Iijima, Masahiro; Kawaguchi, Kyotaro; Toshima, Hirokazu; Muguruma, Takeshi; Endo, Kazuhiko; Mizoguchi, Itaru			Inhibition of enamel demineralization and bond-strength properties of bioactive glass containing 4-META/MMA-TBB-based resin adhesive	EUROPEAN JOURNAL OF ORAL SCIENCES			English	Article						bioactive glass; demineralization; ion release; nanoindentation; orthodontic adhesive	WHITE SPOT LESIONS; ORTHODONTIC ADHESIVES; IN-VITRO; BRACKETS; PREVALENCE; RELEASE; PRIMER; AGENT; VIVO	We investigated the enamel demineralization-prevention ability and shear bond strength (SBS) properties of 4-methacryloxyethyl trimellitic anhydride/methyl methacrylate-tri-n-butyl borane (4-META/MMA-TBB)-based resin containing various amounts (0-50%) of bioactive glass (BG). Disk-shaped specimens were immersed in distilled water and ions released were analysed by inductively coupled plasma atomic-emission spectroscopy. Samples were also immersed in lactic acid solution (pH 4.6) to estimate acid-neutralizing ability. Brackets were bonded to human premolars with BG-containing resins and the bonded teeth were alternately immersed in demineralizing (pH 4.55) and remineralizing (pH 6.8) solutions for 14d. The enamel hardness was determined by nanoindentation testing at twenty equidistant distances from the external surface. The SBS for each sample was examined. The amounts of ions released [calcium (Ca), sodium (Na), silicon (Si), and boron (B)] and the acid-neutralizing ability increased with increasing BG content. After alternating immersion, the specimens bonded with the BG-containing resin with high BG content were harder than those in the other groups in some locations 1-18.5m from the enamel surface. Bioactive glass-containing (10-40%) resin had bond strength equivalent to the control specimen. Thus, the SBS obtained for BG-containing resin (6.5-9.2MPa) was clinically acceptable, suggesting that this material has the ability to prevent enamel demineralization.	[Kohda, Naohisa; Iijima, Masahiro; Kawaguchi, Kyotaro; Muguruma, Takeshi; Mizoguchi, Itaru] Hlth Sci Univ Hokkaido, Sch Dent, Div Orthodont & Dentofacial Orthoped, Dept Oral Growth & Dev, Ishikari, Hokkaido 0610293, Japan; [Toshima, Hirokazu; Endo, Kazuhiko] Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Rehabil, Div Biomat & Bioengn, Ishikari, Hokkaido 0610293, Japan	Iijima, M (reprint author), Hlth Sci Univ Hokkaido, Sch Dent, Div Orthodont & Dentofacial Orthoped, Dept Oral Growth & Dev, 1757 Kanazawa, Ishikari, Hokkaido 0610293, Japan.	iijima@hoku-iryo-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24792249]	This research was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 24792249).	Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004; OGAARD B, 1989, AM J ORTHOD DENTOFAC, V96, P423, DOI 10.1016/0889-5406(89)90327-2; Iijima M, 2010, AM J ORTHOD DENTOFAC, V138, P735, DOI 10.1016/j.ajodo.2009.01.028; Boersma JG, 2005, CARIES RES, V39, P41, DOI 10.1159/000081655; Min JH, 2011, J DENT, V39, P629, DOI 10.1016/j.jdent.2011.07.001; Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0; Massera J, 2014, J MATER SCI-MATER M, V25, P657, DOI 10.1007/s10856-013-5120-1; Luan Q, 2008, J DENT RES, V87, P148; Papaioannou W, 2007, ANGLE ORTHOD, V77, P1090, DOI 10.2319/091706-375.1; Brown ML, 2011, ANGLE ORTHOD, V81, P1014, DOI 10.2319/120710-708.1; Cate J M, 1977, Caries Res, V11, P277; Chin MYH, 2009, AM J ORTHOD DENTOFAC, V136, P547, DOI 10.1016/j.ajodo.2007.10.053; Featherstone J D B, 2009, Adv Dent Res, V21, P4, DOI 10.1177/0895937409335590; FEATHERSTONE JDB, 1983, J DENT RES, V62, P1049, DOI 10.1177/00220345830620100801; Gorton J, 2003, AM J ORTHOD DENTOFAC, V123, P10, DOI 10.1067/mod.2003.47; Hashimoto M, 2010, J BIOMED MATER RES B, V94B, P127, DOI 10.1002/jbm.b.31632; Hench L.L., 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611; Iijima M, 2010, ANGLE ORTHOD, V80, P1095, DOI [10.2319/012010-43.1, 10.2319/012010.43.1]; IIJIMA Y, 1989, J DENT RES, V68, P1289; Manfred L, 2013, ANGLE ORTHOD, V83, P97, DOI 10.2319/110811-689.1; Meyer-Lueckel H, 2010, J DENT, V38, P641, DOI 10.1016/j.jdent.2010.05.002; Owens SE, 2000, ANGLE ORTHOD, V70, P352; Reynolds I.R., 1975, BRIT J ORTHODONT, V2, P171; Rschoppe P, 2011, J DENT, V39, P430; Sfondrini MF, 2001, AM J ORTHOD DENTOFAC, V119, P30, DOI 10.1067/mod.2001.111399; STEPHAN R. M., 1940, JOUR AMER DENTAL ASSOC, V27, P718; Sudjalim T. R., 2007, AM J ORTHOD DENTOFAC, V131, pe1; Tufekci E, 2014, AM J ORTHOD DENTOFAC, V146, P207, DOI 10.1016/j.ajodo.2014.05.016; ZERO DT, 1988, J DENT RES, V67, P1257, DOI 10.1177/00220345880670100201	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-8836	1600-0722		EUR J ORAL SCI	Eur. J. Oral Sci.	JUN	2015	123	3					202	207		10.1111/eos.12187		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CH6DG	WOS:000354125600010		
J	Takahashi, K; Hashimoto, S; Nakamura, H; Mori, A; Sato, A; Majima, T; Takai, S				Takahashi, Kenji; Hashimoto, Sanshiro; Nakamura, Hiroshi; Mori, Atsushi; Sato, Akiko; Majima, Tokifumi; Takai, Shinro			Medial meniscal posterior root/horn radial tears correlate with cartilage degeneration detected by T1 rho relaxation mapping	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Cartilage; Magnetic resonance imaging; Knee; T1 rho mapping; Osteoarthritis	TIBIOFEMORAL CONTACT MECHANICS; ARTICULAR-CARTILAGE; HEALTHY-SUBJECTS; 3 T; KNEE; OSTEOARTHRITIS; MRI; T-2; ABNORMALITIES; RELIABILITY	Objective: This study aimed to identify factors on routine pulse sequence MRI associated with cartilage degeneration observed on T1 rho relaxation mapping. Materials and methods: This study included 137 subjects with knee pain. T1 rho values were measured in the regions of interest on the surface layer of the cartilage on mid-coronal images of the femorotibial joint. Assessment of cartilage, subchondral bone, meniscus and ligaments was performed using routine pulse sequence MRI. Radiographic evaluation for osteoarthritis was also performed. Results: Multiple regression analysis revealed posterior root/horn tears to be independent factors increasing the T1 rho values of the cartilage in the medial compartment of the femorotibial joint. Even when adjusted for radiographically defined early-stage osteoarthritis, medial posterior meniscal radial tears significantly increased the T1 rho values. Conclusions: This study showed that posterior root/horn radial tears in the medial meniscus are particularly important MRI findings associated with cartilage degeneration observed on T1 rho relaxation mapping. Morphological factors of the medial meniscus on MRI provide findings useful for screening early-stage osteoarthritis. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Takahashi, Kenji; Nakamura, Hiroshi; Mori, Atsushi; Sato, Akiko; Takai, Shinro] Nippon Med Sch, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138603, Japan; [Hashimoto, Sanshiro] Minami Shinjuku Orthopaed Rehabil Clin, Shibuya Ku, Tokyo 1510053, Japan; [Majima, Tokifumi] Int Univ Hlth & Welf Hosp, Dept Orthopaed Surg, Nasushiobara, Tochigi 3292763, Japan	Takahashi, K (reprint author), Nippon Med Sch, Dept Orthopaed Surg, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	info@msrc.jp; nakamura@nms.ac.jp; atsu@nms.ac.jp; akiko-sato@nms.ac.jp; tkmajima@iuhw.ac.jp; takai-snr@nms.ac.jp					Zarins ZA, 2010, OSTEOARTHR CARTILAGE, V18, P1408, DOI 10.1016/j.joca.2010.07.012; Stahl R, 2009, EUR RADIOL, V19, P132, DOI 10.1007/s00330-008-1107-6; Seitz AM, 2012, J ORTHOP RES, V30, P934, DOI 10.1002/jor.22010; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037//0033-2909.86.2.420; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Regatte RR, 2002, ACAD RADIOL, V9, P1388, DOI 10.1016/S1076-6332(03)80666-9; Thomas E, 2014, RHEUMATOLOGY, V53, P338, DOI 10.1093/rheumatology/ket346; Costa CR, 2004, AM J ROENTGENOL, V183, P17; Li X, 2007, OSTEOARTHR CARTILAGE, V15, P789, DOI 10.1016/j.joca.2007.01.011; Choi JA, 2011, MAGN RESON IMAGING C, V19, P249, DOI 10.1016/j.mric.2011.02.010; Mosher TJ, 2011, RADIOLOGY, V258, P832, DOI 10.1148/radiol.10101174; Englund M, 2009, ARTHRITIS RHEUM, V60, P831, DOI 10.1002/art.24383; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Mosher TJ, 2000, RADIOLOGY, V214, P259; Joseph GB, 2012, OSTEOARTHR CARTILAGE, V20, P727, DOI 10.1016/j.joca.2012.04.003; Lee SJ, 2006, AM J SPORT MED, V34, P1334, DOI 10.1177/0363546506286786; REDFIELD AG, 1955, PHYS REV, V98, P1787, DOI 10.1103/PhysRev.98.1787; Keenan KE, 2011, OSTEOARTHR CARTILAGE, V19, P171, DOI 10.1016/j.joca.2010.11.009; Lee YG, 2008, J COMPUT ASSIST TOMO, V32, P452, DOI 10.1097/RCT.0b013e31812f4eb0; Akella SVS, 2001, MAGNET RESON MED, V46, P419, DOI 10.1002/mrm.1208; Bashir A, 1999, MAGNET RESON MED, V41, P857, DOI 10.1002/(SICI)1522-2594(199905)41:5<857::AID-MRM1>3.0.CO;2-E; Bohensky M, 2014, ARTHRIT CARE RES, V66, P1213, DOI 10.1002/acr.22279; Burnstein D, 2009, RADIOL CLIN N AM, V67, P5; Mehta VM, 2007, AM J SPORT MED, V35, P933, DOI 10.1177/0363546507299742; ROGERS J, 1990, BRIT MED J, V300, P367; Spector T D, 1993, Osteoarthritis Cartilage, V1, P203, DOI 10.1016/S1063-4584(05)80325-5; Takayama Y, 2013, EUR J RADIOL, V82, P192	27	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	JUN	2015	84	6					1098	1104		10.1016/j.ejrad.2015.02.008		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH4UC	WOS:000354027400013		
J	Noguchi, T; Kawashima, M; Nishihara, M; Egashira, Y; Azama, S; Irie, H				Noguchi, Tomoyuki; Kawashima, Masatou; Nishihara, Masashi; Egashira, Yoshiaki; Azama, Shinya; Irie, Hiroyuki			Noninvasive method for mapping CVR in moyamoya disease using ASL-MRI	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Arterial spin labeling; Moyamoya disease; Brain Perfusion; Pulse wave synchronization; MRI; SPECT	CEREBRAL-BLOOD-FLOW; CEREBROVASCULAR REACTIVITY; EMISSION-TOMOGRAPHY; IMAGING TECHNIQUES; ACETAZOLAMIDE TEST; CLINICAL-FEATURES; ARTERY OCCLUSION; PERFUSION; BRAIN; REVASCULARIZATION	Purpose: To project a noninvasive method for mapping cerebrovascular reserve (CVR) in moyamoya disease (MMD) using ASL-MRI. Methods: 16 MMD patients underwent cerebral blood flow (CBF) examinations by standard ASL-MRI, pulse-wave-synchronized ASL-MRI (pulsy ASL-MRI) which tagged the arterial blood coincident with a peak of a pulse wave, and single photon emission computed tomography (SPECT) imagings with iodine123-N-isopropyl-p-iodoamphetamine in the resting (rest-IMP) and after acetazolamide challenge (ACZ-IMP). Hemispheric 32-sided cerebral blood flow (CBF) values were measured with normalized CBF maps created from standard ASL-MRI (standard-ASL value), pulsy ASL-MRI (pulsy-ASL value), rest-IMP (rest-IMP value), and ACZ-IMP (ACZ-IMP value). CVR based on rest-IMP and ACZ-IMP values (IMP-CVR) was calculated. ASL-CVR was also calculated on the basis of corrected standard-ASL values and pulsy-ASL values, which were adjusted to the ACZ-IMP values and rest-IMP values, respectively, by the least-squares method. We assessed the relationships between rest-IMP values and pulsy-ASL values, ACZ-IMP values and standard-ASL values, and IMP-CVR and ASL-CVR. Results: Significant relationships were observed between rest-IMP values and pulsy-ASL values (correlation coefficient (r = 0.557, p < 0.01)), ACZ-IMP values and standard-ASL values (r = 0.825, p < 0.01), and IMP-CVR and ASL-CVR (r=0.736, p<0.01). Conclusions: ASL-MRI is equivalent to SPECT and that it might serve as a noninvasive method for mapping CVR in MMD. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Noguchi, Tomoyuki] Natl Ctr Global Hlth & Med, Dept Radiol, Shinjuku Ku, Tokyo 1628655, Japan; [Noguchi, Tomoyuki; Nishihara, Masashi; Egashira, Yoshiaki; Azama, Shinya; Irie, Hiroyuki] Saga Univ, Fac Med, Dept Radiol, Saga 8498501, Japan; [Noguchi, Tomoyuki; Kawashima, Masatou; Nishihara, Masashi; Egashira, Yoshiaki; Azama, Shinya; Irie, Hiroyuki] Saga Univ, Grad Sch Med, Saga 8498501, Japan; [Kawashima, Masatou] Saga Univ, Fac Med, Dept Neurosurg, Saga 8498501, Japan	Noguchi, T (reprint author), Natl Ctr Global Hlth & Med, Dept Radiol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	tnogucci@radiol.med.kyushu-u.ac.jp; bunta1974@yahoo.co.jp; azama-ssam-71257@b2.bunbun.ne.jp; irie@cc.saga-u.ac.jp			Japan Society for the Promotion of Science [24591774]	The current article is partly supported by Grant-in-Aid for Scientific Research of Japan Society for the Promotion of Science (#24591774).	Yoshiura T, 2009, EUR RADIOL, V19, P2819, DOI 10.1007/s00330-009-1511-6; Noguchi T, 2011, EUR J RADIOL, V80, pE557, DOI 10.1016/j.ejrad.2011.01.016; Kuroda S, 2001, STROKE, V32, P2110, DOI 10.1161/hs0901.095692; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288; Wang JJ, 2003, J MAGN RESON IMAGING, V18, P404, DOI 10.1002/jmri.10372; Luh WM, 1999, MAGNET RESON MED, V41, P1246, DOI 10.1002/(SICI)1522-2594(199906)41:6<1246::AID-MRM22>3.0.CO;2-N; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Wu WC, 2007, IEEE T MED IMAGING, V26, P84, DOI 10.1109/TMI.2006.886807; Noguchi T, 2010, INTERV NEURORADIOL, V16, P409; Noguchi T, 2008, AM J NEURORADIOL, V29, P688, DOI [10.3174/ajnr.A0903, 10.3174/ainr.A0903]; IIDA H, 1994, J NUCL MED, V35, P2019; Kimura H, 2005, J MAGN RESON IMAGING, V22, P189, DOI 10.1002/jmri.20382; YONAS H, 1993, J NEUROSURG, V79, P483, DOI 10.3171/jns.1993.79.4.0483; Wong EC, 1997, NMR BIOMED, V10, P237, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<237::AID-NBM475>3.0.CO;2-X; Ogasawara K, 2002, STROKE, V33, P1857, DOI 10.1161/33; Kuroda S, 2005, STROKE, V36, P2148, DOI 10.1161/01.STR.0000182256.32489.99; Wolf RL, 2008, AM J NEURORADIOL, V29, P681, DOI 10.3174/ajnr.A0901; Burke GM, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.1.FOCUS08310; Fukui M, 1997, CLIN NEUROL NEUROSUR, V99, pS238; HAUGE A, 1980, ACTA PHYSIOL SCAND, V110, P167, DOI 10.1111/j.1748-1716.1980.tb06647.x; Hoshi Hiroaki, 1994, Journal of Nuclear Medicine, V35, P44; Jefferson AL, 2006, AM J NEURORADIOL, V27, P98; Kuroda S, 2004, CHILD NERV SYST, V20, P302, DOI 10.1007/s00381-004-0924-4; KUWABARA Y, 1990, STROKE, V21, P272; Kuwabara Y, 1997, CLIN NEUROL NEUROSUR, V99, pS74, DOI 10.1016/S0303-8467(97)00061-9; Muroi C, 2003, J NEUROSURG ANESTH, V15, P131, DOI 10.1097/00008506-200304000-00011; Noguchi Tomoyuki, 2007, Magn Reson Med Sci, V6, P91, DOI 10.2463/mrms.6.91; Ogasawara K, 2006, NEUROL MED-CHIR, V46, P161, DOI 10.2176/nmc.46.161; ROGG J, 1989, AM J ROENTGENOL, V153, P605; SULLIVAN HG, 1987, J NEUROSURG, V67, P525, DOI 10.3171/jns.1987.67.4.0525; Takeuchi K, 1957, NO TO SHINKEI, V9, P37; VORSTRUP S, 1986, STROKE, V17, P1291; Warmuth C, 2007, J MAGN RESON IMAGING, V26, P353, DOI 10.1002/jmri.21011; Yamada M, 2005, NEUROL SURG TOKYO, V33, P337; Yanai H, 2011, STATCEL USEFUL ADDIN, V3rd; Zaharchuk G, 1999, MAGNET RESON MED, V41, P1093, DOI 10.1002/(SICI)1522-2594(199906)41:6<1093::AID-MRM4>3.0.CO;2-0	36	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	JUN	2015	84	6					1137	1143		10.1016/j.ejrad.2015.03.011		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH4UC	WOS:000354027400018		
J	Ueda, K; Honda, O; Satoh, Y; Kawai, M; Gyobu, T; Kanazawa, T; Hidaka, S; Yanagawa, M; Sumikawa, H; Tomiyama, N				Ueda, Ken; Honda, Osamu; Satoh, Yukihisa; Kawai, Misa; Gyobu, Tomoko; Kanazawa, Toru; Hidaka, Shojiro; Yanagawa, Masahiro; Sumikawa, Hiromitsu; Tomiyama, Noriyuki			Computed tomography (CT) findings in 88 neurofibromatosis 1 (NF1) patients: Prevalence rates and correlations of thoracic findings	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Neurofibromatosis 1 (NF1); CT; Lung; Mediastinum	DISEASE	Purpose: To evaluate the prevalence rates and the correlations of thoracic computed tomography (CT) findings of neurofibromatosis 1 (NF1) in 88 patients. Materials and methods: Chest CT images of 88 NF1 patients were independently reviewed by three observers, and the CT findings were evaluated. If abnormal findings were present, their number, size, and distribution were recorded. The prevalence rate of each CT finding was calculated, and the correlations between CT findings were analyzed. Results: Of the 88 cases, 13 were positive for cysts, 16 for emphysema, 8 for nodules, 8 for GGNs (ground glass nodules), 13 for mediastinal masses, 20 for scoliosis, 44 for subcutaneous nodules, and 34 for skin nodules. Cysts showed upper and peripheral dominant distributions. Regarding 13 mediastinal masses, 2 were diagnosed as malignant peripheral nerve sheath tumors (MPNSTs), 1 was diagnosed as primary lung cancer, 2 were diagnosed as lateral meningocele, 3 were diagnosed as neurofibromas, and the remaining 7 were considered neurofibromas. There was a significant correlation between the prevalence of subcutaneous nodules and that of skin nodules. Significant positive correlations were also seen between size and number, size and rate of central distribution, and number and rate of central distribution of cysts. Conclusion: Various CT findings were found in NF-1 patients, and the prevalence rates of subcutaneous and skin nodules were higher than other findings. Though the prevalence rates of subcutaneous nodules and skin nodules were significantly correlated, the other CT findings in NF-1 occurred independently. The number, size, and distribution of the cysts showed significant positive correlations with each other. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ueda, Ken; Honda, Osamu; Kawai, Misa; Gyobu, Tomoko; Kanazawa, Toru; Hidaka, Shojiro; Yanagawa, Masahiro; Tomiyama, Noriyuki] Osaka Univ, Grad Sch, Dept Radiol, Suita, Osaka 565, Japan; [Satoh, Yukihisa] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Diagnost Radiol, Osaka, Japan; [Sumikawa, Hiromitsu] Osaka Rosai Hosp, Dept Diagnost Radiol, Sakai, Osaka, Japan	Ueda, K (reprint author), Osaka Univ, Grad Sch, Dept Radiol, Suita, Osaka 565, Japan.						Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; de Andrade GC, 2003, ARQ NEURO-PSIQUIAT, V61, P677, DOI 10.1590/S0004-282X2003000400029; ICHIKAWA Y, 1994, J COMPUT ASSIST TOMO, V18, P745, DOI 10.1097/00004728-199409000-00012; [Anonymous], 1987, NIH CONSENS STATEMEN, V6, P1; BRASFIEL.RD, 1972, ANN SURG, V175, P86; Calzavara P G, 1988, Neurofibromatosis, V1, P318; Friedman JM, 1993, GENE REV; GEERTS Y, 1992, J SPINAL DISORD, V5, P116; GHOSH BC, 1973, CANCER, V31, P184, DOI 10.1002/1097-0142(197301)31:1<184::AID-CNCR2820310126>3.0.CO;2-8; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Kim Young-Jin, 2011, Korean J Thorac Cardiovasc Surg, V44, P383, DOI 10.5090/kjtcs.2011.44.5.383; Kristof AS, 2003, INTERSTITIAL LUNG DI, P851; Kurahara Y, 2013, INTERNAL MED, V52, P1431, DOI 10.2169/internalmedicine.52.0466; Oikonomou A, 2011, EUR J RADIOL, V80, pE520, DOI 10.1016/j.ejrad.2010.11.033; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; Ryu JH, 2005, CHEST, V128, P2381, DOI 10.1378/chest.128.4.2381; Zamora AC, 2007, EUR RESPIR J, V29, P210, DOI 10.1183/09031936.06.00044006	17	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	JUN	2015	84	6					1191	1195		10.1016/j.jrad.2015.02.024		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH4UC	WOS:000354027400026		
J	Shimizu, K; Makita, H; Hasegawa, M; Kimura, H; Fuke, S; Nagai, K; Yoshida, T; Suzuki, M; Konno, S; Ito, YM; Nishimura, M				Shimizu, Kaoruko; Makita, Hironi; Hasegawa, Masaru; Kimura, Hirokazu; Fuke, Satoshi; Nagai, Katsura; Yoshida, Takayuki; Suzuki, Masaru; Konno, Satoshi; Ito, Yoichi M.; Nishimura, Masaharu			Regional bronchodilator response assessed by computed tomography in chronic obstructive pulmonary disease	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Bronchodilation; Pulmonary function; Salmeterol/fluticasone propionate combination; Computed tomography	AIR-FLOW LIMITATION; THIN-SECTION CT; WALL THICKNESS; COPD PATIENTS; DIMENSIONS; AIRWAYS; TIOTROPIUM; EMPHYSEMA; ASTHMA; LUMEN	Background and objective: The reliability of CT assessment of regional bronchodilation is not universally accepted. In this study, using our proprietary 3D-CT software, we first examined airway inner luminal area (Ai) before and after inhalation of SFC in a group of COPD patients and then evaluated the same parameters for two sets of CT data obtained from clinically stable subjects with no intervention. Methods: We conducted CT at deep inspiration and pulmonary function tests before and one week after inhalation of SFC in 23 COPD patients. As a non-intervention group, we used two sets of CT data obtained with one-year interval in another group of subjects who demonstrated stable pulmonary function (n=8). We measured Ai at the mid-portions of 3rd to 6th generation in 8 bronchi of the right lung, a total of 32 identical sites before and after intervention. Results: The average bronchodilation at all sites (Delta Ai%: 28.2 + 4.1 (SE)%) (r= 0.65, p < 0.001) and that of each generation significantly correlated with % improvement of FEV1 (Delta FEV1%), which increased from 1.40 +/- 0.10L to 1.58 +/- 0.10L. When subjects were classified into two groups in terms of mean Delta FEV1%, even the poor responders (Delta FEV1% <14% above baseline, n=13) displayed significantly larger Delta Ai% compared with the non-intervention group (19.1 +/- 4.6% versus 2.1 +/- 3.9%). Inter-observer variability for overall AAi% was within acceptable levels. Conclusions: CT can reliably detect the regional bronchodilation in 3rd to 6th generation airways when Delta FEV1 is as small as 180 ml on average. This study was registered in the UMIN Clinical Trials Registry (UMIN-CTR) system (http://www.umin.ac.jp/No. UMIN 000002668). (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Shimizu, Kaoruko; Makita, Hironi; Hasegawa, Masaru; Kimura, Hirokazu; Fuke, Satoshi; Nagai, Katsura; Yoshida, Takayuki; Suzuki, Masaru; Konno, Satoshi; Nishimura, Masaharu] Hokkaido Univ, Dept Med, Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Ito, Yoichi M.] Hokkaido Univ, Dept Biostat, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Nishimura, M (reprint author), Hokkaido Univ, Dept Med, Sch Med, Kita Ku, N-15 W-7, Sapporo, Hokkaido 0608638, Japan.	ma-nishi@med.hokudai.ac.jp	Suzuki, Masaru/H-2087-2012	Suzuki, Masaru/0000-0002-2124-6793	Respiratory, Inflammation, Autoimmunity Innovative Medicines Unit, AstraZeneca, Melinda', Sweden; Ministry of Education, Science, Culture and Sports of Japan [17390239, 2139053]; Nippon Boehringer Ingelheim; Pfizer, Inc.; Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare, Japan	This study was supported by a research grant from the Respiratory, Inflammation, Autoimmunity Innovative Medicines Unit, AstraZeneca, Melinda', Sweden and a scientific research grant to the Hokkaido COPD Cohort Study from the Ministry of Education, Science, Culture and Sports of Japan (17390239 and 2139053 to M.N.); Nippon Boehringer Ingelheim; Pfizer, Inc.; and a grant to the Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare, Japan. None of them concerned the design and analysis of the study and writing of the manuscript.	Achenbach T, 2008, EUR RADIOL, V18, P2731, DOI 10.1007/s00330-008-1089-4; Coxson HO, 2009, AM J RESP CRIT CARE, V180, P588, DOI 10.1164/rccm.200901-0159PP; Shimizu K, 2010, RESP MED, V104, P1809, DOI 10.1016/j.rmed.2010.06.013; Grenier PA, 2002, EUR RADIOL, V12, P1022, DOI 10.1007/s00330-002-1342-1; Makita H, 2007, THORAX, V62, P932, DOI 10.1136/thx.2006.072777; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Hoshino M, 2013, RESPIRATION, V86, P280, DOI 10.1159/000351116; Okazawa M, 1996, AM J RESP CRIT CARE, V154, P1557; Hoshino M, 2011, RESPIROLOGY, V16, P95, DOI 10.1111/j.1440-1843.2010.01869.x; Hasegawa M, 2009, THORAX, V64, P332, DOI 10.1136/thx.2008.103671; Shimizu K, 2011, RESP MED, V105, P1275, DOI 10.1016/j.rmed.2011.04.007; Orlandi I, 2005, RADIOLOGY, V234, P604, DOI 10.1148/radiol.2342040013; King GG, 2004, EUR RESPIR J, V24, P211, DOI 10.1183/09031936.04.00047503; King GG, 2000, AM J RESP CRIT CARE, V161, P574; Matsuoka S, 2008, RADIOLOGY, V248, P1042, DOI 10.1148/radiol.2491071650; Aysola RS, 2008, CHEST, V134, P1183, DOI 10.1378/chest.07-2779; Bakker ME, 2012, RESP MED, V106, P677, DOI 10.1016/j.rmed.2011.11.013; de Jong PA, 2005, EUR RESPIR J, V26, P140, DOI 10.1183/09031936.05.00007105; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2003, GLOB STRAT DIAGN MAN; Hoshino M, 2014, RESPIROLOGY, V19, P403, DOI 10.1111/resp.12256; Kambara K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090040; Kundu S, 2013, EUR RADIOL, V23, P1564, DOI 10.1007/s00330-012-2746-1; Machin D., 2008, SAMPLE SIZE TABLES C; Montaudon M, 2007, RADIOLOGY, V242, P563, DOI 10.1148/radiol.2422060029; Nishimura Masaharu, 2008, Proc Am Thorac Soc, V5, P910, DOI 10.1513/pats.200809-109QC; Oguma T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076381; Reinhardt JM, 1997, IEEE T MED IMAGING, V16, P820, DOI 10.1109/42.650878; Yasui H, 2013, PULM PHARMACOL THER, V26, P336, DOI 10.1016/j.pupt.2013.01.005	30	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	JUN	2015	84	6					1196	1201		10.1016/j.jrad.2015.02.022		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH4UC	WOS:000354027400027		
J	Okada, F; Sato, H; Omeri, AK; Ono, A; Tokuyama, K; Ando, Y; Matsumoto, A; Ogata, M; Kohno, K; Takano, K; Mori, H				Okada, Fumito; Sato, Haruka; Omeri, Ahmad Khalid; Ono, Asami; Tokuyama, Kouhei; Ando, Yumiko; Matsumoto, Akira; Ogata, Masao; Kohno, Kazuhiro; Takano, Kuniko; Mori, Hiromu			Chest HRCT findings in acute transformation of adult T-cell lymphoma/leukemia	EUROPEAN RADIOLOGY			English	Article						Computed tomography; Chest; Adult T cell leukemia/lymphoma; Acute transformation; HTLV-1	SECTION CT FINDINGS; KLEBSIELLA-PNEUMONIAE PNEUMONIA; PULMONARY INFECTION; LEUKEMIA-LYMPHOMA; STRONGYLOIDES-STERCORALIS; CONCURRENT INFECTION; LEUKEMIA/LYMPHOMA; VIRUS	To assess chest high-resolution computed tomography (HRCT) findings in patients with acute transformation of adult T cell leukaemia/lymphoma (ATLL). We retrospectively identified 72 consecutive patients at our institution with ATLL between October 2000 and March 2014. The cases included acute type (n = 20), lymphoma type (n = 21), smouldering type (n = 24) and chronic type (n = 7). Sixteen (7 men, 9 women; aged 36-85 years, mean 63.3 years) of 31 patients (24 with smouldering and seven with chronic type; 51.6 %) developed acute transformation of ATLL, and had undergone chest HRCT examinations. Parenchymal abnormalities, enlarged lymph nodes, pericardial effusion, pleural effusion and skin lesions were evaluated on HRCT. Chest HRCT of 15 of the 16 patients showed abnormal findings, including ground-glass opacity (GGO) (n = 8), consolidation (n = 5), interlobular septal thickening (n = 5) and nodules (n = 5). Pleural effusion was found in five patients, lymph node enlargement in 10 patients and multiple skin thickening in two patients. Almost all patients with acute transformation of ATLL had abnormal findings on chest HRCT, which consisted mainly of lymph node enlargement, GGO, interlobular septal thickening, nodules and bilateral pleural effusions.	[Okada, Fumito; Sato, Haruka; Omeri, Ahmad Khalid; Ono, Asami; Tokuyama, Kouhei; Ando, Yumiko; Matsumoto, Akira; Mori, Hiromu] Oita Univ, Dept Radiol, Fac Med, Oita 8795593, Japan; [Ogata, Masao; Kohno, Kazuhiro; Takano, Kuniko] Oita Univ, Dept Med Oncol & Hematol, Fac Med, Oita 8795593, Japan	Okada, F (reprint author), Oita Univ, Dept Radiol, Fac Med, 1-1 Idaigaoka,Hasama Machi, Oita 8795593, Japan.	fumitook@oita-u.ac.jp					Stewart DM, 2011, ACTA HAEMATOL-BASEL, V126, P63, DOI 10.1159/000324799; [Anonymous], 1988, LANCET, V1, P217; UCHIYAMA T, 1977, BLOOD, V50, P481; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; Takasaki Y, 2010, BLOOD, V115, P4337, DOI 10.1182/blood-2009-09-242347; KUHLMAN JE, 1990, RADIOLOGY, V175, P711; DINCAN M, 1994, LEUKEMIA, V8, P682; DIXON AC, 1989, WESTERN J MED, V151, P632; Franquet T, 2011, RADIOLOGY, V260, P18, DOI 10.1148/radiol.11092149; Gasparetto EL, 2004, BRIT J RADIOL, V77, P724, DOI 10.1259/bjr/70800575; GIBBS WN, 1987, ANN INTERN MED, V106, P361; Hanaka M, 2013, RESPIR INVESTIG, V51, P41; Hansell DM, 2008, RADIOLOGY, V3, P697, DOI DOI 10.1148/RADI0L.2462070712; Ishitsuka K, 2008, BRIT J HAEMATOL, V143, P442, DOI 10.1111/j.1365-2141.2008.07351.x; Morikawa K, 2012, BRIT J RADIOL, V85, pE168, DOI 10.1259/bjr/65538472; NAKADA K, 1987, INT J CANCER, V40, P145, DOI 10.1002/ijc.2910400203; NAKADA K, 1984, LANCET, V1, P633; Okada F, 2012, BRIT J RADIOL, V85, pE357, DOI 10.1259/bjr/18544730; Okada F, 2005, J COMPUT ASSIST TOMO, V29, P626, DOI 10.1097/01.rct.0000167809.89352.93; Okada F, 2013, CLIN RADIOL, V68, pE331, DOI 10.1016/j.crad.2013.01.019; Okada F, 2009, EUR RADIOL, V19, P809, DOI 10.1007/s00330-008-1233-1; Okada F, 2012, BRIT J RADIOL, V85, P121, DOI 10.1259/bjr/48077494; Okada F, 2011, BRIT J RADIOL, V84, P1109, DOI 10.1259/bjr/42762966; Okada F, 2010, BRIT J RADIOL, V83, P854, DOI 10.1259/bjr/28999734; Ono A, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140051; SATO Y, 1990, Japanese Journal of Parasitology, V39, P376; SATO Y, 1989, CLIN IMMUNOL IMMUNOP, V52, P214, DOI 10.1016/0090-1229(89)90173-6; Tsukasaki K, 2004, INT J CANCER, V109, P875, DOI 10.1002/ijc.20028; WEBER J, 1990, BRIT MED J, V301, P71	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-7994	1432-1084		EUR RADIOL	Eur. Radiol.	JUN	2015	25	6					1607	1613		10.1007/s00330-014-3565-3		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH5EC	WOS:000354056800009		
J	Murata, S; Onozawa, S; Mine, T; Ueda, T; Sugihara, F; Yasui, D; Kumita, S; Satake, M				Murata, Satoru; Onozawa, Shiro; Mine, Takahiko; Ueda, Tatsuo; Sugihara, Fumie; Yasui, Daisuke; Kumita, Shin-ichiro; Satake, Mitsuo			Retrograde-outflow percutaneous isolated hepatic perfusion using cisplatin: A pilot study on pharmacokinetics and feasibility	EUROPEAN RADIOLOGY			English	Article						Liver; Isolation perfusion cancer chemotherapy; Percutaneous; Retrograde; Experimental	ISOLATED LIVER PERFUSION; HIGH-DOSE MELPHALAN; ARTERIAL INFUSION CHEMOTHERAPY; BALLOON CATHETER TECHNIQUES; IN-VIVO MICROSCOPY; PHASE-I; PHARMACOLOGICAL EVALUATION; HEPATOCELLULAR-CARCINOMA; TEMPORARY OCCLUSION; COLORECTAL-CANCER	This study aimed to evaluate the feasibility and underlying pharmacokinetics of the retrograde-outflow technique for percutaneous isolated hepatic perfusion (PIHP). Retrograde-outflow PIHP was performed in 12 male pigs (weight, 37-44 kg) by redirecting hepatic outflow through the portal vein. Blood with cisplatin (2.5 mg/kg) in an extracorporeal circuit was circulated through the liver under isolation using rotary pumps with balloon catheters. Hepatic angiographic examinations were conducted during perfusion, and histopathological examinations of the organs were conducted after perfusion. The maximum platinum concentration (C (max)), area under the concentration-time curve (AUC), and chronologic laboratory data were measured. Retrograde-outflow isolated hepatic angiography confirmed that contrast media flowed into the portal veins in all 12 pigs. The hepatic veins and inferior vena cava were not opacified. Hepatic C (max) (86.3 mg/l) was 39-fold greater than systemic C (max) (2.2 mg/l), and hepatic AUC (1330.8 min center dot mg/l) was 30-fold greater than systemic AUC (44.6 min center dot mg/l). Histopathological examinations revealed no ischaemic changes or other abnormalities in the liver, duodenum, small intestine, or colon. Within 1 week of the procedure, chronologic laboratory data (n = 3) normalized or returned to pre-therapy levels. The retrograde-outflow technique appears to enable safe and feasible PIHP therapy.	[Murata, Satoru; Onozawa, Shiro; Mine, Takahiko; Ueda, Tatsuo; Sugihara, Fumie; Yasui, Daisuke; Kumita, Shin-ichiro] Nippon Med Sch, Dept Radiol, Ctr Adv Med Technol, Bunkyou Ku, Tokyo 1138602, Japan; [Satake, Mitsuo] Natl Canc Ctr Hosp East, Dept Diagnost Radiol, Chiba 2778577, Japan	Murata, S (reprint author), Nippon Med Sch, Dept Radiol, Ctr Adv Med Technol, Bunkyou Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	genji@nms.ac.jp			Third Term Comprehensive Control Research for Cancer; Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Pharmaceuticals and Medical Devices Agency (PMDA) of the Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science and Technology, Japan	The scientific guarantor of this publication is Satoru Murata. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. This study has received funding by grants from the Third Term Comprehensive Control Research for Cancer, the Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Pharmaceuticals and Medical Devices Agency (PMDA) of the Ministry of Health, Labor and Welfare, and the Grant-in-Aid for Scientific Research (S and B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. No complex statistical methods were necessary for this paper. Institutional Review Board approval was not required because this was an experimental animal study. Written informed consent was not required for this study because this was an experimental animal study. Approval from the institutional animal care committee was obtained. Some study subjects or cohorts have not been previously reported. Methodology: prospective, experimental, performed at one institution.	Ackerman BN, 1972, CANCER, V29, P435; Alexander HR, 2009, ANN SURG ONCOL, V16, P1852, DOI 10.1245/s10434-009-0482-9; YAMADA R, 1983, RADIOLOGY, V148, P397; Nouso K, 2013, BRIT J CANCER, V109, P1904, DOI 10.1038/bjc.2013.542; Beheshti M V, 1992, J Vasc Interv Radiol, V3, P453, DOI 10.1016/S1051-0443(92)71988-5; Christoforidis D, 2002, EUR J SURG ONCOL, V28, P875, DOI 10.1053/ejso.2002.1328; HAFSTROM LR, 1994, SURG ONCOL, V3, P103, DOI 10.1016/0960-7404(94)90005-1; Kan Z, 1997, EUR RADIOL, V7, P1071, DOI 10.1007/s003300050256; KAN ZX, 1994, INVEST RADIOL, V29, P671, DOI 10.1097/00004424-199407000-00002; KAN ZX, 1993, RADIOLOGY, V187, P621; Kemeny N, 2001, Lancet Oncol, V2, P418, DOI 10.1016/S1470-2045(00)00419-8; MARINELLI A, 1990, BRIT J CANCER, V62, P891, DOI 10.1038/bjc.1990.404; MARINELLI A, 1991, BRIT J CANCER, V64, P1069, DOI 10.1038/bjc.1991.466; Mocellin S, 2007, ANN SURG ONCOL, V14, P802, DOI 10.1245/s10434-006-9108-7; MURATA S, 1995, RADIOLOGY, V197, P351; Murata S, 1997, RADIOLOGY, V202, P715; Murata S, 2014, ACTA RADIOL, V55, P737, DOI 10.1177/0284185113505258; Ortega-Deballon P, 2010, ANN SURG ONCOL, V17, P898, DOI 10.1245/s10434-009-0775-z; Pilati P, 2004, WORLD J SURG, V28, P775, DOI 10.1007/s00268-004-7430-4; Pingpank JF, 2005, J CLIN ONCOL, V23, P3465, DOI 10.1200/JCO.2005.00.927; RAVIKUMAR TS, 1994, J CLIN ONCOL, V12, P2723; Rothbarth J, 2002, J PHARMACOL EXP THER, V303, P736, DOI 10.1124/jpet.102.037895; Rothbarth J, 2003, BRIT J SURG, V90, P1391, DOI 10.1002/bjs.4308; Rothbarth J, 2004, EUR J CANCER, V40, P1812, DOI 10.1016/j.ejca.2004.04.009; Savier E, 2003, ARCH SURG-CHICAGO, V138, P325, DOI 10.1001/archsurg.138.3.325; Tsai WL, 2014, PLOS ONE, DOI [10.1371/journal.pone.0092784, DOI 10.1371/J0URNAL.P0NE.0092784]; UCHIDA H, 1993, CARDIOVASC INTER RAD, V16, P67, DOI 10.1007/BF02602980; Vahrmeijer AL, 2000, BRIT J CANCER, V82, P1539; van Etten B, 2004, ANN SURG ONCOL, V11, P598, DOI 10.1245/ASO.2004.09.021; van Iersel LBJ, 2007, EJSO-EUR J SURG ONC, V33, P874, DOI 10.1016/j.ejso.2007.02.022; van Iersel LBJ, 2008, ANN ONCOL, V19, P1127, DOI 10.1093/annonc/mdn032; van Ijken MGA, 1998, ANN SURG, V228, P763, DOI 10.1097/00000658-199812000-00007; Yoon S S, 1999, Oncologist, V4, P197; Zeh HJ, 2009, ANN SURG ONCOL, V16, P385, DOI 10.1245/s10434-008-0179-5	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-7994	1432-1084		EUR RADIOL	Eur. Radiol.	JUN	2015	25	6					1631	1638		10.1007/s00330-014-3558-2		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH5EC	WOS:000354056800012		
J	Tachibana, Y; Obata, T; Yoshida, M; Hori, M; Kamagata, K; Suzuki, M; Fukunaga, I; Kamiya, K; Yokoyama, K; Hattori, N; Inoue, T; Aoki, S				Tachibana, Yasuhiko; Obata, Takayuki; Yoshida, Mariko; Hori, Masaaki; Kamagata, Koji; Suzuki, Michimasa; Fukunaga, Issei; Kamiya, Kouhei; Yokoyama, Kazumasa; Hattori, Nobutaka; Inoue, Tomio; Aoki, Shigeki			Analysis of normal-appearing white matter of multiple sclerosis by tensor-based two-compartment model of water diffusion	EUROPEAN RADIOLOGY			English	Article						Multiple sclerosis; Diffusion tensor imaging; Brain; Magnetic resonance imaging; Computer-assisted image processing	HIGH B-VALUES; HUMAN BRAIN; COMPARTMENTATION; COEFFICIENT; ANISOTROPY; KURTOSIS; TISSUE	To compare the significance of the two-compartment model, considering diffusional anisotropy with conventional diffusion analyzing methods regarding the detection of occult changes in normal-appearing white matter (NAWM) of multiple sclerosis (MS). Diffusion-weighted images (nine b-values with six directions) were acquired from 12 healthy female volunteers (22-52 years old, median 33 years) and 13 female MS patients (24-48 years old, median 37 years). Diffusion parameters based on the two-compartment model of water diffusion considering diffusional anisotropy was calculated by a proposed method. Other parameters including diffusion tensor imaging and conventional apparent diffusion coefficient (ADC) were also obtained. They were compared statistically between the control and MS groups. Diffusion of the slow diffusion compartment in the radial direction of neuron fibers was elevated in MS patients (0.121 x 10(-3) mm2/s) in comparison to control (0.100 x 10(-3) mm(2)/s), the difference being significant (P = 0.001). The difference between the groups was not significant in other comparisons, including conventional ADC and fractional anisotropy (FA) of diffusion tensor imaging. The proposed method was applicable to clinically acceptable small data. The parameters obtained by this method improved the detectability of occult changes in NAWM compared to the conventional methods.	[Tachibana, Yasuhiko; Obata, Takayuki] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Inage Ku, Chiba 2638555, Japan; [Tachibana, Yasuhiko; Inoue, Tomio] Yokohama City Univ, Grad Sch Med, Dept Radiol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Tachibana, Yasuhiko; Yoshida, Mariko; Hori, Masaaki; Kamagata, Koji; Suzuki, Michimasa; Fukunaga, Issei; Kamiya, Kouhei; Aoki, Shigeki] Juntendo Univ, Sch Med, Dept Radiol, Bunkyo Ku, Tokyo 1138431, Japan; [Yokoyama, Kazumasa; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138431, Japan	Obata, T (reprint author), Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	t_obata@nirs.go.jp		Kamagata, Koji/0000-0001-5028-218X; Obata, Takayuki/0000-0001-7678-5033			Maier SE, 2001, RADIOLOGY, V219, P842; Rocca MA, 2000, NEUROLOGY, V55, P882; Clark CA, 2000, MAGNET RESON MED, V44, P852, DOI 10.1002/1522-2594(200012)44:6<852::AID-MRM5>3.0.CO;2-A; Moll NM, 2011, ANN NEUROL, V70, P764, DOI 10.1002/ana.22521; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Brugieres P, 2004, AM J NEURORADIOL, V25, P692; Yoshida M, 2013, JPN J RADIOL, V31, P50, DOI 10.1007/s11604-012-0147-7; Maier SE, 2004, MAGNET RESON MED, V51, P321, DOI 10.1002/mrm.10685; Cercignani M, 1999, ITAL J NEUROL SCI, V20, pS246, DOI 10.1007/s100729970005; Grinberg F, 2011, NEUROIMAGE, V57, P1087, DOI 10.1016/j.neuroimage.2011.04.050; Le Bihan D, 2007, PHYS MED BIOL, V52, pR57, DOI 10.1088/0031-9155/52/7/R02; Phuttharak Warinthorn, 2007, Journal of the Medical Association of Thailand, V90, P2689; Sijens PE, 2006, EUR RADIOL, V16, P898, DOI 10.1007/s00330-005-0033-0; Tachibana Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063869	15	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-7994	1432-1084		EUR RADIOL	Eur. Radiol.	JUN	2015	25	6					1701	1707		10.1007/s00330-014-3572-4		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH5EC	WOS:000354056800021		
J	Iwasa, T; Osakabe, M				Iwasa, Takuya; Osakabe, Masahiro			Effects of combination between web density and size of spider mite on predation by a generalist and a specialist phytoseiid mite	EXPERIMENTAL AND APPLIED ACAROLOGY			English	Article						Web size; Web density; Euseius sojaensis; Neoseiulus womersleyi; Tetranychidae; Phytoseiidae	SOJAENSIS EHARA ACARINA; SPINNING BEHAVIOR; PREY; RESPONSES; TETRANYCHIDAE; FOOD	Complicated three-dimensional webs of silk threads produced by Tetranychus spider mites provide protection from predation by many generalist phytoseiid mite species. Accessibility to prey may be the most significant criterion for successful predation in complicated webs. To assess the protective effects of combination between web size and density, we compared predation on eggs of the two-spotted spider mite, Tetranychus urticae, by a generalist (Euseius sojaensis) and a specialist (Neoseiulus womersleyi) phytoseiid mite in the laboratory under manipulated web size and density. Web sizes negatively affected to the predation. Significant interactions were found between phytoseiid mite species and prey distribution; egg consumption by E. sojaensis was more in uniform distribution, but that by N. womersleyi, in contrast, was larger in contagious distribution. However, the egg consumption by E. sojaensis and N. womersleyi were both mitigated in larger webs. This area size depending mitigation was more effective to the predation by E. sojaensis. Although the mechanism of web size depending mitigation is unknown, web sizes might affect prey searching efficiency of this phytoseiid mite. Consequently, combination between web density and size are likely to affect not only a generalist E. sojaensis but also a specialist N. wormersleyi.	[Iwasa, Takuya; Osakabe, Masahiro] Kyoto Univ, Grad Sch Agr, Lab Ecol Informat, Kyoto 6068502, Japan	Osakabe, M (reprint author), Kyoto Univ, Grad Sch Agr, Lab Ecol Informat, Kyoto 6068502, Japan.	mhosaka@kais.kyoto-u.ac.jp					HOY MA, 1981, ENTOMOL EXP APPL, V29, P241; McMurtry JA, 1997, ANNU REV ENTOMOL, V42, P291, DOI 10.1146/annurev.ento.42.1.291; SABELIS MW, 1992, EXP APPL ACAROL, V16, P203, DOI 10.1007/BF01193804; HISLOP RG, 1981, J CHEM ECOL, V7, P895, DOI 10.1007/BF00992387; Furuichi H, 2005, J APPL ENTOMOL, V129, P336, DOI 10.1111/j.1439-0418.2005.00978.336-339; McMURTRY JAMES A., 1964, ANN ENTOMOL SOC AMER, V57, P649; McMURTRY J. A., 1965, ANN ENTOMOL SOC AMER, V58, P49; OSAKABE M, 1988, APPL ENTOMOL ZOOL, V23, P45; OSAKABE M, 1986, APPL ENTOMOL ZOOL, V21, P322; OSAKABE M, 1987, APPL ENTOMOL ZOOL, V22, P594; Ozawa M, 2009, ECOL RES, V24, P257, DOI 10.1007/s11284-008-0501-5; R-Core-Development-Team, 2012, R LANG ENV STAT COMP; SABELIS MW, 1984, PHYSIOL ENTOMOL, V9, P437, DOI 10.1111/j.1365-3032.1984.tb00786.x; SAITO Y, 1983, ACAROLOGIA, V24, P377; SAITO Y, 1977, JPN J APPL ENTOMOL Z, V21, P27; Shimoda T, 2010, BIOL CONTROL, V53, P273, DOI 10.1016/j.biocontrol.2010.02.007; Shimoda T, 2009, EXP APPL ACAROL, V47, P111, DOI 10.1007/s10493-008-9205-3; Shinmen T, 2010, EXP APPL ACAROL, V52, P111, DOI 10.1007/s10493-010-9356-x; Yano S, 2012, BEHAV ECOL SOCIOBIOL, V66, P845, DOI 10.1007/s00265-012-1332-5; Yano S, 2009, ECOL RES, V24, P1173, DOI 10.1007/s11284-009-0598-1	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0168-8162	1572-9702		EXP APPL ACAROL	Exp. Appl. Acarol.	JUN	2015	66	2					219	225		10.1007/s10493-015-9902-7		7	Entomology	Entomology	CH7CL	WOS:000354193100004		
J	Maeda, T; Kokawa, M; Nango, N; Miura, M; Araki, T; Yamada, M; Takeya, K; Sagara, Y				Maeda, Tatsuro; Kokawa, Mito; Nango, Nobuhito; Miura, Makoto; Araki, Tetsuya; Yamada, Masaharu; Takeya, KAiji; Sagara, Yasuyuki			Development of a Quantification Method of the Gluten Matrix in Bread Dough by Fluorescence Microscopy and Image Analysis	FOOD AND BIOPROCESS TECHNOLOGY			English	Article						Acid magenta; Gluten skeleton; Computer vision; Bone histomorphometry	RHEOLOGICAL PROPERTIES; WHEAT DOUGH; MICROSTRUCTURE; PROTEINS; STARCH; LIGHT; BONE	The gluten matrix in bread dough develops through the mixing process, and its microstructure is known to greatly affect the quality of the end product. In this study, a novel method to quantify the gluten matrix was developed by applying image analysis methods used in the area of bone histomorphometry to fluorescence images of dough. Acquisition of clear images of the gluten matrix and the incorporated starch has been made possible by a novel fluorescence visualization method using acid magenta and the blue fluorescent filter. The images with high contrast between gluten, starch, and other constituents allowed accurate binarization between gluten and background. Bread dough at four mixing stages was made to observe gluten development. Three parameters were extracted from the gluten area: gluten thickness, total length of gluten per area, and average length of gluten. At the final (optimum) mixing stage, gluten thickness and average length of gluten showed minimum values, while the total length of gluten showed the maximum value. This showed that at the final mixing stage, gluten strands become thin and highly branched. In addition, thin membrane-like structures were observed at the over-mixing stage, indicating the breakdown of gluten structure. Further application of this quantification method to flours with different gluten content would enable comprehensive understanding of the gluten formation in dough.	[Maeda, Tatsuro] Nisshin Foods Inc, Food Res Ctr, Chuo Ward, Tokyo 1038544, Japan; [Kokawa, Mito] Natl Agr & Food Res Org, Natl Food Res Inst, Analyt Sci Div, Tsukuba, Ibaraki 3058642, Japan; [Nango, Nobuhito] Ratoc Syst Engn Co Ltd, Bunkyo Ward, Tokyo 1120014, Japan; [Miura, Makoto] Iwate Univ, Dept Biol Chem & Food Sci, Fac Agr, Morioka, Iwate 0208550, Japan; [Araki, Tetsuya] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ward, Tokyo 1138657, Japan; [Yamada, Masaharu] Kogakuin Univ, Dept Appl Chem, Fac Engn, Hachioji, Tokyo 26651, Japan; [Takeya, KAiji] Tumugi Bakery, Sakura, Chiba 043377, Japan; [Sagara, Yasuyuki] Food Kansei Commun Corp, Bunkyo Ward, Tokyo 1130022, Japan	Maeda, T (reprint author), Nisshin Foods Inc, Food Res Ctr, Chuo Ward, 19-12 Koami Cho,Nihonbashi, Tokyo 1038544, Japan.	maeda.tatsuro@nisshin.com					AACC International, 1999, 544002 AACC INT, V11th, DOI [10.1094/AACCIntMethod-54-40.02, DOI 10.1094/AACCINTMETHOD-54-40.02]; ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Kokawa M, 2012, J CEREAL SCI, V55, P15, DOI 10.1016/j.jcs.2011.09.002; Peighambardoust SH, 2006, J CEREAL SCI, V43, P183, DOI 10.1016/j.jcs.2005.10.004; Lynch EJ, 2009, FOOD RES INT, V42, P885, DOI 10.1016/j.foodres.2009.03.014; Durrenberger MB, 2001, LEBENSM-WISS TECHNOL, V34, P11, DOI 10.1006/fstl.2000.0739; PAREDESLOPEZ O, 1983, CEREAL CHEM, V60, P24; Wieser H, 2007, FOOD MICROBIOL, V24, P115, DOI 10.1016/j.fm.2006.07.004; Peighambardoust SH, 2010, J CEREAL SCI, V51, P21, DOI 10.1016/j.jcs.2009.09.002; PARFITT AM, 1987, J BONE MINER RES, V2, P595; BECHTEL DB, 1978, CEREAL CHEM, V55, P392; Autio K, 1997, CEREAL FOOD WORLD, V42, P702; Autio K, 2001, LEBENSM-WISS TECHNOL, V34, P18, DOI 10.1006/fstl.2000.0725; Autio K, 1997, TRENDS FOOD SCI TECH, V8, P181, DOI 10.1016/S0924-2244(97)01039-X; Fulcher R.G., 1989, FLUORESCENCE ANAL FO, P59; Gonzalez RC, 2008, DIGITAL IMAGE PROCES; Hoseney R. C, 1985, CEREAL FOODS WORLD, V30; Lee L, 2001, CEREAL CHEM, V78, P447, DOI 10.1094/CCHEM.2001.78.4.447; Li W, 2004, J CEREAL SCI, V39, P403, DOI 10.1016/j.jcs.2004.02.004; Maeda T, 2009, FOOD SCI TECHNOL RES, V15, P117, DOI 10.3136/fstr.15.117; Maeda T, 2013, CEREAL CHEM, V90, P175, DOI 10.1094/CCHEM-10-12-0132-R; MERZ WA, 1970, ACTA ANAT, V75, P54; Nevatia R., 1982, MACHINE PERCEPTION; Parkkonen T, 1997, FOOD SCI TECHNOL-LEB, V30, P743; Schluentz EJ, 2000, J TEXTURE STUD, V31, P41, DOI 10.1111/j.1745-4603.2000.tb00283.x; SIMMONDS DH, 1972, CEREAL CHEM, V49, P324; Upadhyay R, 2012, J FOOD ENG, V109, P104, DOI 10.1016/j.jfoodeng.2011.09.028	27	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1935-5130	1935-5149		FOOD BIOPROCESS TECH	Food Bioprocess Technol.	JUN	2015	8	6					1349	1354		10.1007/s11947-015-1497-9		6	Food Science & Technology	Food Science & Technology	CH8AD	WOS:000354257100016		
J	Huang, T; Onishi, A; Shi, F; Morisugi, M; Cherry, M				Huang, Tao; Onishi, Akio; Shi, Feng; Morisugi, Masafumi; Cherry, Mjo Lwin			Regional characteristics of industrial energy efficiency in China: application of stochastic frontier analysis method	FRONTIERS OF ENVIRONMENTAL SCIENCE & ENGINEERING			English	Article						industrial energy efficiency; stochastic frontier analysis; total-factor energy efficiency; single factor energy efficiency	TECHNICAL EFFICIENCY; INCOME INEQUALITY; DECOMPOSITION; PRODUCTIVITY; INTENSITY; AUSTRALIA	This paper analyzed regional industrial energy efficiency in China with Total-Factor Energy Efficiency (TFEE). The East region has the best energy efficiency and the Central and the West regions stand as the second and the third respectively. However, it is found that industrial energy efficiency of all regions increased from 1998 to 2006. This result is consistent with level of economic development of every region. The industries of all provinces in China are not yet at the frontier efficiency position, therefore, to the frontier as target, their technology levels and production processes should be adjusted accordingly. Compared with the conventional energy efficiency, the inverse of energy intensity, which is defined as the ratio of actual output to energy input, is regarded as Single-Factor Energy Efficiency (SFEE) index. Although TFEE ranks are not changed for each region, they are different for each province. The comparative result also shows that the substitution among inputs (labor, capital stock, and energy) to produce the output is significant. The SFEE scores could be over-estimated if energy is taken as the single input in the production. Finally, we identified determining factors affecting industrial energy efficiency using Tobit model. The results indicate that an increase of per capita Gross Domestic Product (GDP), the percentage of output value of industry invested by Hong Kong, Macao, Taiwan and abroad, energy price and investment of scientific and technological activities for industry could be possible contributors and drivers to the industrial energy efficiency. However, increasing of heavy industry will lead to worse industrial energy efficiency.	[Huang, Tao] Lanzhou Univ, Coll Earth & Environm Sci, Lanzhou 730000, Peoples R China; [Onishi, Akio] Toyama Prefectural Univ, Grad Sch Engn, Toyama 9390398, Japan; [Shi, Feng; Cherry, Mjo Lwin] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Morisugi, Masafumi] Meijo Univ, Grad Sch Urban Sci, Gifu 5090292, Japan	Huang, T (reprint author), Lanzhou Univ, Coll Earth & Environm Sci, Lanzhou 730000, Peoples R China.	stht01@163.com					Aiger C A, 1977, J ECONOMETRICS, V6, P21; Zweig D, 2005, FOREIGN AFF, V84, P25, DOI 10.2307/20031703; Boyd GA, 2000, ENERG POLICY, V28, P289, DOI 10.1016/S0301-4215(00)00016-1; FARE R, 1978, J ECON THEORY, V19, P150, DOI 10.1016/0022-0531(78)90060-1; Ang BW, 2000, ENERGY, V25, P1149, DOI 10.1016/S0360-5442(00)00039-6; Mukherjee K, 2008, ENERG POLICY, V36, P662, DOI 10.1016/j.enpol.2007.10.015; SINTON JE, 1994, ENERG POLICY, V22, P239, DOI 10.1016/0301-4215(94)90162-7; Patterson MG, 1996, ENERG POLICY, V24, P377, DOI 10.1016/0301-4215(96)00017-1; WILSON B, 1994, ENERG POLICY, V22, P287, DOI 10.1016/0301-4215(94)90003-5; Mukherjee K, 2008, ENERG ECON, V30, P76, DOI 10.1016/j.eneco.2006.11.004; MEEUSEN W, 1977, INT ECON REV, V18, P435, DOI 10.2307/2525757; Hu JL, 2006, ENERG POLICY, V34, P3206, DOI 10.1016/j.enpol.2005.06.015; Zheng JH, 1998, J COMP ECON, V26, P465, DOI 10.1006/jcec.1998.1540; Chen J, 1996, J COMP ECON, V22, P141, DOI 10.1006/jcec.1996.0015; CHRISTEN.LR, 1973, REV ECON STAT, V55, P28, DOI 10.2307/1927992; Coelli T. J., 1992, J PROD ANAL, V3, P153, DOI DOI 10.1007/BF00158774; Greene W. H., 2000, ECONOMETRIC ANAL; Haishun S, 1999, ECON TRANSIT, V7, P615; KAMBARA T, 1992, CHINA QUART, P608; Kaneko S., 2004, International Journal of Agricultural Resources, Governance and Ecology, V3, P231, DOI 10.1504/IJARGE.2004.006038; Kebede T A, 2001, THESIS AGR U NORWAY; KOJIMA K, 1982, HITOTSUB J ECON, V23, P1; NBS (National Bureau of Statistics of China), 2013, CHIN STAT YB 2012; NBS (National Bureau of Statistics of China), 1999, CHIN STAT YB 1999 20; NBSP (National Bureau of Statistics of every Province in China), 1999, PROV STAT YB 1999 20; PATTERSON MG, 1993, ENERGY, V18, P741, DOI 10.1016/0360-5442(93)90033-A; PITT MM, 1981, J DEV ECON, V9, P43, DOI 10.1016/0304-3878(81)90004-3; RENSHAW EF, 1981, ENERG ECON, V3, P36, DOI 10.1016/0140-9883(81)90005-0; Seeiford L M, 1990, J ECONOMETRICS, V46, P7; Shahiduzzaman M, 2013, ENERG POLICY, V56, P341, DOI 10.1016/j.enpol.2012.12.069; Smil V, 1990, CHINAS ENERGY; Steinbuks J, 2012, ENERG J, V33, P1, DOI 10.5547/ISSN0195-6574-EJ-Vol33-No1-1; Sun H., 1998, FOREIGN INVESTMENT E; UNDP (United Nations Development Programme), 2009, CHIN HUM DEV REP 200; Yao SJ, 1997, ECON TRANSIT, V5, P97, DOI 10.1111/j.1468-0351.1997.tb00005.x	35	2	2	HIGHER EDUCATION PRESS	BEIJING	SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA	2095-2201	2095-221X		FRONT ENV SCI ENG	Front. Env. Sci. Eng.	JUN	2015	9	3					506	521		10.1007/s11783-014-0656-y		16	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CH8EX	WOS:000354270200015		
J	Li, Z; Qi, R; An, W; Mino, T; Shoji, T; Verstraete, W; Gu, J; Li, ST; Xu, SW; Yang, M				Li, Zheng; Qi, Rong; An, Wei; Mino, Takashi; Shoji, Tadashi; Verstraete, Willy; Gu, Jian; Li, Shengtao; Xu, Shiwei; Yang, Min			Simulation of long-term nutrient removal in a full-scale closed-loop bioreactor for sewage treatment: an example of Bayesian inference	FRONTIERS OF ENVIRONMENTAL SCIENCE & ENGINEERING			English	Article						activated sludge model; Bayesian inference; biological nutrient removal; closed-loop bioreactor; oxidation ditch; denitrifying polyphosphate accumulating organisms	WATER TREATMENT PLANTS; BIOLOGICAL PHOSPHORUS REMOVAL; ACTIVATED-SLUDGE SYSTEMS; PHOSPHATE-ACCUMULATING ORGANISMS; WASTE-WATER; MODEL; WWTP; CALIBRATION; NITROGEN; NETHERLANDS	In this study, the performance of nitrogen and phosphorus removal in a full-scale closed-loop bioreactor (oxidation ditch) system was simulated using the ASM2d model. Routine data describing the process for two years were compiled for calibration and validation. To overcome the identifiability problem, the classic Bayesian inference approach was utilized for parameter estimation. The calibrated model could describe the long-term trend of nutrient removal and short-term variations of the process performance, showing that the Bayesian method was a reliable and useful tool for the parameter estimation of the activated sludge models. The anoxic phosphate uptake by polyphosphate accumulating organisms (PAO) contributed 71.2% of the total Poly-P storage, which reveals the dominance of denitrifying phosphorus removal process under the oxygen limiting conditions. It was found that 58.7% of the anoxic Poly-P storage and denitrification by PAO in the reactor was achieved in the aerated compartment, implying that the PAO's anoxic activity was significantly stimulated by the low dissolved oxygen (DO) level in this compartment due to the oxygen gradient caused by brush aerator.	[Li, Zheng; Qi, Rong; An, Wei; Yang, Min] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Aquat Chem, Beijing 100086, Peoples R China; [Mino, Takashi] Univ Tokyo, Sociocultural Environm Studies, Kashiwa, Chiba 2778563, Japan; [Shoji, Tadashi] Cent Res Inst Elect Power Ind, Environm Sci Res Lab, Chiba 2701194, Japan; [Verstraete, Willy] Univ Ghent, Lab Microbial Ecol & Technol LabMET, B-9000 Ghent, Belgium; [Gu, Jian; Li, Shengtao; Xu, Shiwei] Beijing Drainage Grp Co Ltd, Beijing 100044, Peoples R China	Yang, M (reprint author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Aquat Chem, Beijing 100086, Peoples R China.	yangmin@rcees.ac.cn			National Natural Science Foundation of China [20921140094]; Chinese Academy of Sciences [KSCX2-YW-G-054]; Crucial Special Project- National Water Pollution Control and Management Science [2008ZX07314-003]	The authors gratefully acknowledge the financial support from the National Natural Science Foundation of China (Grant No. 20921140094), Chinese Academy of Sciences (KSCX2-YW-G-054) and the Crucial Special Project-National Water Pollution Control and Management Science (2008ZX07314-003).	Alex J, 1999, WATER SCI TECHNOL, V39, P55, DOI 10.1016/S0273-1223(99)00053-0; Yang J, 2007, J HYDROL, V340, P167, DOI 10.1016/j.jhydrol.2007.04.006; Rieger L, 2001, WATER RES, V35, P3887, DOI 10.1016/S0043-1354(01)00110-5; Lopez-Vazquez CM, 2008, WATER RES, V42, P2349, DOI 10.1016/j.watres.2008.01.001; Kuba T, 1997, WATER RES, V31, P777, DOI 10.1016/S0043-1354(96)00370-3; KUBA T, 1993, WATER SCI TECHNOL, V27, P241; Hu ZR, 2007, BIOTECHNOL BIOENG, V98, P1242, DOI 10.1002/bit.21508; Ahn J, 2002, WATER RES, V36, P403, DOI 10.1016/S0043-1354(01)00222-6; Brun R, 2002, WATER RES, V36, P4113, DOI 10.1016/S0043-1354(02)00104-5; Makinia J, 2005, WATER RES, V39, P1489, DOI 10.1016/j.watres.2005.01.023; Kuba T, 1997, WATER SCI TECHNOL, V36, P75, DOI 10.1016/S0273-1223(97)00713-0; KERRNJESPERSEN JP, 1993, WATER RES, V27, P617, DOI 10.1016/0043-1354(93)90171-D; Omlin M, 1999, ECOL MODEL, V115, P45, DOI 10.1016/S0304-3800(98)00174-4; Barker PS, 1997, WATER ENVIRON RES, V69, P969, DOI 10.2175/106143097X125669; Van Veldhuizen HM, 1999, WATER RES, V33, P3459, DOI 10.1016/S0043-1354(99)00064-0; Gernaey KV, 2004, ENVIRON MODELL SOFTW, V19, P763, DOI 10.1016/j.envsoft.2003.03.005; REICHERT P, 1994, WATER SCI TECHNOL, V30, P21; Hao XD, 2001, WATER RES, V35, P2851, DOI 10.1016/S0043-1354(00)00596-0; Meijer SCF, 2002, WATER SCI TECHNOL, V45, P145; Roeleveld PJ, 2002, WATER SCI TECHNOL, V45, P77; Brdjanovic D, 2000, WATER RES, V34, P846, DOI 10.1016/S0043-1354(99)00219-5; Carrette R, 2001, WATER SCI TECHNOL, V44, P17; Clescerl L. S., 1998, STANDARD METHODS EXA; DERCO J, 1994, WATER SCI TECHNOL, V30, P345; Garcia-Usach F, 2006, WATER SCI TECHNOL, V53, P199, DOI 10.2166/wst.2006.422; Henze M., 2000, ACTIVATED SLUDGE MOD; Hulsbeek JJW, 2002, WATER SCI TECHNOL, V45, P127; Ingildsen P, 2006, WATER SCI TECHNOL, V53, P105, DOI 10.2166/wst.2006.115; Kong YH, 2004, APPL ENVIRON MICROB, V70, P5383, DOI 10.1128/AEM.70.9.5383.5390.2004; Langergraber G, 2004, WATER SCI TECHNOL, V50, P131; Lee JW, 2012, BIOPROC BIOSYST ENG, V35, P359, DOI 10.1007/s00449-011-0574-3; Machado VC, 2009, ENVIRON MODELL SOFTW, V24, P1274, DOI 10.1016/j.envsoft.2009.05.001; Meijer S. C. F., 2004, THESIS DELFT U TECHN; Meijer SCF, 2002, WATER RES, V36, P4667, DOI 10.1016/S0043-1354(02)00192-6; Meijer SCF, 2001, WATER RES, V35, P2711, DOI 10.1016/S0043-1354(00)00567-4; Melcer H., 2003, METHODS WASTEWATER C; Reichert P, 2007, TECHNICAL REPORT; Reichert P, 1998, TECHNICAL REPORT; Reichert P, 2006, WATER SCI TECHNOL, V53, P267, DOI 10.2166/wst.2006.029; Ruano MV, 2007, WATER SCI TECHNOL, V56, P107, DOI 10.2166/wst.2007.605; Schuwirth N, 2008, FRESHWATER BIOL, V53, P1372, DOI 10.1111/j.1365-2427.2008.01970.x; Shoji T, 2003, WATER SCI TECHNOL, V47, P23; Sin G, 2008, BIOTECHNOL BIOENG, V100, P516, DOI 10.1002/bit.21769; Vanrolleghem P A, 2003, P WAT ENV FED WEFTEC, V40, P210; Weijers SR, 1997, WATER SCI TECHNOL, V36, P69, DOI 10.1016/S0273-1223(97)00463-0; Wichern M, 2001, WATER SCI TECHNOL, V44, P49; Zobrist J, 2006, J HYDROL, V329, P207, DOI 10.1016/j.jhydrol.2006.02.014	47	0	0	HIGHER EDUCATION PRESS	BEIJING	SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA	2095-2201	2095-221X		FRONT ENV SCI ENG	Front. Env. Sci. Eng.	JUN	2015	9	3					534	544		10.1007/s11783-014-0660-2		11	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CH8EX	WOS:000354270200018		
J	Inomata, N; Hironaka, K; Sawada, K; Kuriwada, T; Yamahira, K				Inomata, Nobuyuki; Hironaka, Kumiko; Sawada, Kouji; Kuriwada, Takashi; Yamahira, Kazunori			Discrepancy in the degree of population differentiation between color-morph frequencies and neutral genetic loci in the damselfly Ischnura senegalensis in Okinawa Island, Japan	GENETICA			English	Article						Color polymorphism; Divergent selection; Damselfly	MULTILOCUS GENOTYPE DATA; DEPENDENT SELECTION; FEMALE DIMORPHISM; POLYMORPHISM; SOFTWARE; COENAGRIONIDAE; INHERITANCE; DIVERGENCE; INFERENCE; PATTERNS	Evaluation of relative contribution of natural selection and stochastic processes to population differentiation has been of great interest in evolutionary biology. In a damselfly, Ischnura senegalensis, females show color dimorphism (gynochrome vs. androchrome), and color-morph frequencies are known to greatly vary among local populations within Okinawa Island, a small island of Ryukyu Archipelago, Japan. In this study, to examine the effects of natural selection and stochastic processes on the within-island variation in color-morph frequencies, we compared the degree of population differentiation at the color-morph locus with that at a mitochondrial DNA region and ten nuclear microsatellite loci. F (ST) values at the neutral loci were close to zero, indicating presence of sufficient gene flow (dispersal of adult individuals) between the local populations. In contrast, F (ST) values at the color-morph locus were significantly different from zero. These results suggest that variation in female color-morph frequencies observed among local populations in Okinawa Island has been caused by divergent selection acting on the phenotype and/or genes tightly linked with the color locus.	[Inomata, Nobuyuki; Hironaka, Kumiko] Fukuoka Womens Univ, Dept Environm Sci, Int Coll Arts & Sci, Higashi Ku, Fukuoka 8138529, Japan; [Sawada, Kouji] Fukuoka High Sch, Hakata Ku, Fukuoka, Japan; [Kuriwada, Takashi] Kagoshima Univ, Fac Educ, Kagoshima 890, Japan; [Yamahira, Kazunori] Univ Ryukyus, Trop Biosphere Res Ctr, Okinawa, Japan	Inomata, N (reprint author), Fukuoka Womens Univ, Dept Environm Sci, Int Coll Arts & Sci, Higashi Ku, 1-1-1 Kasumigaoka, Fukuoka 8138529, Japan.	inomata@fwu.ac.jp			Collaborative Research of Tropical Biosphere Research Center, University of the Ryukyus; Tropical Biosphere Research Center Project Grant, University of the Ryukyus	We would like to thank three anonymous reviewers for helpful comments on this manuscript. We would like to thank A.E. Szmidt for valuavle help and K. Teshima and J. Kusumi for useful suggestions. This study was supported by the Collaborative Research of Tropical Biosphere Research Center, University of the Ryukyus to N.I. and K.S. and by the Tropical Biosphere Research Center Project Grant, University of the Ryukyus to K.Y.	Abbott JK, 2008, MOL ECOL, V17, P1597, DOI 10.1111/j.1365-294X.2007.03641.x; Andres JA, 1990, HEREDITY, V82, P328; Andres JA, 2002, HEREDITY, V63, P677; Andres JA, 2000, EVOLUTION, V54, P2156, DOI 10.1111/j.0014-3820.2000.tb01258.x; Iserbyt A, 2010, J ZOOL, V282, P256, DOI 10.1111/j.1469-7998.2010.00735.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Pritchard JK, 2000, GENETICS, V155, P945; [Anonymous], 2012, CONSERV GENET RESOUR, DOI DOI 10.1007/S12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Sanchez-Guillen RA, 2005, BIOL J LINN SOC, V85, P471, DOI 10.1111/j.1095-8312.2005.00506.x; Gillespie RG, 1998, EVOLUTION, V52, P775, DOI 10.2307/2411271; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Takahashi Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-256; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Takahashi Y, 2010, EVOLUTION, V64, P3620, DOI 10.1111/j.1558-5646.2010.01083.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Falush D, 2003, GENETICS, V164, P1567; Sanchez-Guillen RA, 2011, HEREDITY, V107, P513, DOI 10.1038/hdy.2011.36; Cooper IA, 2010, AM NAT, V176, P566, DOI 10.1086/656491; Cordero A, 1990, HEREDITY, V64, P346, DOI DOI 10.1038/HDY.1990.42; Core Team R, 2014, R LANG ENV STAT COMP; Fincke Ola M., 2005, International Journal of Odonatology, V8, P183; Goudet J., 2001, FSTAT PROGRAM ESTIMA; HILTON DFJ, 1987, ENTOMOL NEWS, V98, P221; JOHNSON C, 1966, HEREDITY, V21, P453, DOI 10.1038/hdy.1966.44; JOHNSON C, 1964, GENETICS, V49, P513; Kurita T, 2014, APPL ENTOMOL ZOOL, V49, P623, DOI 10.1007/s13355-014-0292-9; RAYMOND M, 1995, J HERED, V86, P248; Sawada K, 2014, ODONATOLOGICA, V43, P227; Takahashi Y, 2014, HEREDITY, V112, P391, DOI 10.1038/hdy.2013.117; Takahashi Y., 2011, B KANTO BRANCH ECOL, V59, P8; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.2307/2408641; Wellenreuther M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020440	35	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0016-6707	1573-6857		GENETICA	Genetica	JUN	2015	143	3					271	277		10.1007/s10709-015-9821-x		7	Genetics & Heredity	Genetics & Heredity	CH5FK	WOS:000354060500002		
J	Takigahira, T; Kohyama, TI; Suwito, A; Kimura, MT				Takigahira, Tomohiro; Kohyama, Tetsuo I.; Suwito, Awit; Kimura, Masahito T.			Genetic analyses of resistance against Leptopilina victoriae in Drosophila bipectinata	GENETICA			English	Article						AFLP; Cross experiment; Geographic variation; Mendelian inheritance	PARASITIC WASPS; MELANOGASTER; BOULARDI; POPULATIONS; COEVOLUTION; RESPONSES; HISTORY; HOSTS	Drosophila bipectinata from Iriomote-jima (IR) is susceptible to the endoparasitoid Leptopilina victoriae from Kota Kinabalu (L. victoriae KK), but D. bipectinata from Kota Kinabalu (KK) and Bogor (BG) is resistant. The cross experiments between the resistant (KK) and susceptible (IR) populations of D. bipectinata suggested that the resistance to this parasitoid is a dominant trait and controlled by a single locus or few linked loci on an autosome. In the AFLP analysis using the IR, KK and BG populations of D. bipectinata and the resistant and susceptible populations derived from a mixed population of these three geographic populations, a DNA fragment almost specific to susceptible flies was detected. It also revealed that genes from the IR population were more frequently maintained in the mixed population compared with those from the KK and BG populations, suggesting that at least a number of genes from the IR population are more advantageous under the laboratory conditions. This explains our previous results that the resistance was lowered in the mixed population although the resistance itself is suggested to incur only low costs; i.e., the resistance gene(s) from the KK and BG populations would have been linked with some genes that are disadvantageous under the laboratory conditions.	[Takigahira, Tomohiro; Kohyama, Tetsuo I.; Kimura, Masahito T.] Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan; [Suwito, Awit] Res Ctr Biol LIPI, Museum Zool Bogoriense, Div Zool, Bogor, Indonesia	Takigahira, T (reprint author), Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan.	takigahira@ees.hokudai.ac.jp		Kohyama, Tetsuo/0000-0002-4567-2893	Ministry of Education, Science, Sports, Culture and Technology of Japan [23370005]	We thank M. J. Toda, M. Kondo and M. B. Lakim who provided us with D. bipectinata and L. victoriae Kota Kinabalu. We also thank K. W. Matsubayashi, F. Y. Nomano, B. Novkovic and N. Kasuya for fruitful discussions and their assistance in the collection and maintenance of laboratory populations and the members of Laboratory of Systematics and Evolution in Department of Natural History Sciences, Hokkaido University for their help with molecular experiments. This study was supported by Grant-in-Aids from the Ministry of Education, Science, Sports, Culture and Technology of Japan (No. 23370005).	Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Moreau SJM, 2005, INSECT BIOCHEM MOLEC, V35, P1209, DOI 10.1016/j.ibmb.2005.07.003; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Novkovic B, 2012, EUR J ENTOMOL, V109, P517; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Sgro CM, 2000, AM NAT, V156, P341, DOI 10.1086/303394; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Kopp A, 2005, GENET RES, V85, P23, DOI 10.1017/S0016672305007317; VET LEM, 1985, OIKOS, V44, P487, DOI 10.2307/3565790; Arrigo Nils, 2012, Methods Mol Biol, V888, P155, DOI 10.1007/978-1-61779-870-2_10; Lemeunier F., 1986, P147; CARTON Y, 1992, HEREDITY, V69, P393; Carton Y., 1986, Genetics and Biology of Drosophila, V3e, P347; Colinet D, 2007, PLOS PATHOG, V3, P2029, DOI 10.1371/journal.ppat.0030203; Colinet D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001206; Dubuffet A, 2007, HEREDITY, V98, P21, DOI 10.1038/sj.hdy.6800893; Dubuffet A, 2009, ADV PARASIT, V70, P147, DOI 10.1016/S0065-308X(09)70006-5; Dupas S, 2009, ADV PARASIT, V70, P281, DOI 10.1016/S0065-308X(09)70011-9; Dupas S, 1998, J HERED, V89, P306, DOI 10.1093/jhered/89.4.306; Dupas S, 2003, HEREDITY, V90, P84, DOI 10.1038/sj.hdy.6800182; Felsenstein J, 2010, PHYLIP PHYLOGENY INF; Godfray H.C.J., 1994, PARASITOIDS BEHAV EV; Hawkins B.A., 1994, PATTERN PROCESS HOST; Hita M, 2006, GENET RES, V88, P81, DOI 10.1017/S001667230600841X; Houle D, 2003, AM NAT, V161, P50, DOI 10.1086/345480; Jeffereys H, 1961, THEORY PROBABILITY, V3rd; Mortimer NT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002819; R Development Core Team, 2009, R LANG ENV STAT COMP; Takigahira T, 2014, ECOL RES IN PRESS, V29; VANLENTEREN JC, 1978, NETH J ZOOL, V28, P213; Vass E, 2000, J PARASITOL, V86, P1259, DOI 10.1645/0022-3395(2000)086[1259:DAIAOD]2.0.CO;2; Wheeler M.R., 1972, U TEXAS PUBL, V7213, P1	34	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0016-6707	1573-6857		GENETICA	Genetica	JUN	2015	143	3					279	285		10.1007/s10709-015-9824-7		7	Genetics & Heredity	Genetics & Heredity	CH5FK	WOS:000354060500003		
J	Sorimachi, A; Tokonami, S; Kranrod, C; Ishikawa, T				Sorimachi, Atsuyuki; Tokonami, Shinji; Kranrod, Chutima; Ishikawa, Tetsuo			Preliminary Experiments Using a Passive Detector for Measuring Indoor 220Rn Progeny Concentrations with an Aerosol Chamber	HEALTH PHYSICS			English	Article						aerosols; cancer; Rn-220; Rn-222	THORON EQUILIBRIUM FACTOR; RADON PROGENY; DEPOSITION VELOCITIES; UNATTACHED FRACTION; TURBULENT-FLOW; DAUGHTER; SURFACES; RN-220; FIELD; AIR	This paper describes preliminary experiments using a passive detector for integrating measurements of indoor thoron (Rn-220) progeny concentrations with an aerosol chamber. A solid state nuclear detector (CR-39) covered with a thin aluminum-vaporized polyethylene plate (Mylar film) was used to detect only alpha particles emitted from Po-212 due to Rn-220 progeny deposited on the detector surfaces. The initial experiment showed that Mylar film with area density of more than 5 mg cm(-2) was suitable to cut off completely alpha particles of 7.7 MeV from Po-214 of Rn-222 progeny decay. In the experiment using the passive detector, it was observed that the net track density increased linearly with an increase of time-integrating Rn-220 progeny concentration. As a result of dividing deposition rates by atom concentrations, the deposition velocity was given as 0.023 cm s(-1) for total Rn-220 progeny. The model estimates of deposition velocities were 0.330 cm s(-1) for unattached Rn-220 progeny and 0.0011 cm s(-1) for aerosol-attached Rn-220 progeny using Lai-Nazaroff formulae. These deposition velocities were in the same range with the results reported in the literature. It was also found that the exposure experiments showed little influence of vertical profiles and surface orientations of the passive detector in the chamber on the detection responses, which was in good agreement with that in the model estimates. Furthermore, it was inferred that the main uncertainty of the passive detector was inhomogeneous deposition of Rn-220 progeny onto its detection surfaces.	[Sorimachi, Atsuyuki; Tokonami, Shinji] Hirosaki Univ, Inst Radiat Emergency Med, Hirosaki, Aomori 0368564, Japan; [Kranrod, Chutima; Ishikawa, Tetsuo] Natl Inst Radiol Sci, Inage Ku, Chiba 2638555, Japan	Sorimachi, A (reprint author), Hirosaki Univ, Inst Radiat Emergency Med, 66-1 Hon Cho, Hirosaki, Aomori 0368564, Japan.	sorimac@fmu.ac.jp			Special Coordination Funds for Promoting Science and Technology of Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by the grant-in-aid "Construction of Natural Radiation Exposure Study Network" from the Special Coordination Funds for Promoting Science and Technology of Ministry of Education, Culture, Sports, Science and Technology of Japan.	Tokonami S, 2010, RADIAT PROT DOSIM, V141, P335, DOI 10.1093/rpd/ncq246; Cheng YS, 1997, AEROSOL SCI TECH, V27, P131, DOI 10.1080/02786829708965462; CHENG YS, 1980, J AEROSOL SCI, V11, P313, DOI 10.1016/0021-8502(80)90105-6; CURRIE LA, 1968, ANAL CHEM, V40, P586, DOI 10.1021/ac60259a007; Janik M, 2013, J RADIAT RES, V54, P597, DOI 10.1093/jrr/rrs129; BIGU J, 1985, J AEROSOL SCI, V16, P157, DOI 10.1016/0021-8502(85)90083-7; Chen J, 2012, RADIAT PROT DOSIM, V149, P155, DOI 10.1093/rpd/ncr228; GUO Q, 1992, RADIAT PROT DOSIM, V45, P357; Harley N, 2010, RADIAT PROT DOSIM, V141, P357, DOI 10.1093/rpd/ncq228; Ichitsubo H, 2004, J AEROSOL SCI, V35, P217, DOI 10.1016/j.jaerosci.2003.08.002; ISRAELI M, 1985, HEALTH PHYS, V49, P1069, DOI 10.1097/00004032-198512000-00003; Ito Y., 2014, THESIS HIROSAKI U SC; JACOBI W, 1972, HEALTH PHYS, V22, P441, DOI 10.1097/00004032-197205000-00002; KNUTSON EO, 1983, HEALTH PHYS, V45, P445, DOI 10.1097/00004032-198308000-00020; Lai ACK, 2000, J AEROSOL SCI, V31, P463; MELLANDER H, 1992, RADIAT PROT DOSIM, V45, P65; Mishra R, 2009, J AEROSOL SCI, V40, P1, DOI 10.1016/j.jaerosci.2008.08.001; Morawska L, 1996, J AEROSOL SCI, V27, P305, DOI 10.1016/0021-8502(95)00553-6; PORSTENDORFER J, 1978, HEALTH PHYS, V34, P465, DOI 10.1097/00004032-197805000-00007; RAMAMURTHI M, 1989, HEALTH PHYS, V56, P189, DOI 10.1097/00004032-198902000-00006; SCOTT AG, 1983, HEALTH PHYS, V45, P481, DOI 10.1097/00004032-198308000-00024; SHIMADA M, 1989, J AEROSOL SCI, V20, P419, DOI 10.1016/0021-8502(89)90075-X; Shimada M, 1989, J COLLOID INTERF SCI, V128, P1579; Sorimachi A, 2014, REV SCI INSTRUM, V85; Sorimachi A, 2009, REV SCI INSTRUM, V80; Tokonami S, 1999, RADIAT PROT DOSIM, V81, P285; Tokonami S, 2002, JPN J HLTH PHYS, V37, P59; Tokonami S, 2005, JPN J HLTH PHYS, V40, P183; Toohey R. E., 1984, Radiation Protection Dosimetry, V7; United Nations Scientific Committee on the Effects of Atomic Radiation, 2006, EFF ION RAD 2006 REP; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, SOURC EFF ION RAD 20; Zhuo W, 2000, JPN J HLTH PHYS, V35, P365; Zhuo WH, 2005, INT CONGR SER, V1276, P219, DOI 10.1016/j.ics.2004.10.001	33	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0017-9078	1538-5159		HEALTH PHYS	Health Phys.	JUN	2015	108	6					597	606		10.1097/HP.0000000000000284		10	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CH9AQ	WOS:000354328800005		
J	Nakayama, S; Parratt, SR; Hutchence, KJ; Lewis, Z; Price, TAR; Hurst, GDD				Nakayama, S.; Parratt, S. R.; Hutchence, K. J.; Lewis, Z.; Price, T. A. R.; Hurst, G. D. D.			Can maternally inherited endosymbionts adapt to a novel host? Direct costs of Spiroplasma infection, but not vertical transmission efficiency, evolve rapidly after horizontal transfer into D-melanogaster	HEREDITY			English	Article							MALE-KILLING SPIROPLASMA; SPECIES COMPLEX; WOLBACHIA; WILLISTONI; SYMBIONTS; DIVERSITY; SIMULANS; HYDEI; FLY	Maternally inherited symbionts are common in arthropods and many have important roles in host adaptation. The observation that specific symbiont lineages infect distantly related host species implies new interactions are commonly established by lateral transfer events. However, studies have shown that symbionts often perform poorly in novel hosts. We hypothesized selection on the symbiont may be sufficiently rapid that poor performance in a novel host environment is rapidly ameliorated, permitting symbiont maintenance. Here, we test this prediction for a Spiroplasma strain transinfected into the novel host Drosophila melanogaster. In the generations immediately following transinfection, the symbiont had low transmission efficiency to offspring and imposed severe fitness costs on its host. We observed that effects on host fitness evolved rapidly, being undetectable after 17 generations in the novel host, whereas vertical transmission efficiency was poorly responsive over this period. Our results suggest that long-term symbiosis may more readily be established in cases where symbionts perform poorly in just one aspect of symbiosis.	[Nakayama, S.; Parratt, S. R.; Hutchence, K. J.; Lewis, Z.; Price, T. A. R.; Hurst, G. D. D.] Univ Liverpool, Inst Integrat Biol, Evolut Ecol & Behav, Liverpool L69 3BX, Merseyside, England	Nakayama, S (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Biol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8120053, Japan.	nakayama58611@gmail.com	Hurst, Gregory/C-2723-2008	Hurst, Gregory/0000-0002-7163-7784	JSPS KAKEN [09J05297, 12J03363]	We thank Mr S Price for helping with microinjection and rearing flies, and for advice on our experiment procedure, respectively. The microinjection device was kindly provided by Professor N Wedell (University of Exeter, UK). Dr E Kasuya (Kyushu University, Japan) kindly provided advice on the data analyses. We also thank Dr A Yamawo (JSPS fellow, Kyushu University, Japan) and three anonymous referees for comments on the manuscript. This work was supported by JSPS KAKEN (09J05297 and 12J03363) to SN.	RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.2307/2409177; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; Williamson DL, 1999, INT J SYST BACTERIOL, V49, P611; Haselkorn TS, 2013, EVOLUTION, V67, P934, DOI 10.1111/evo.12020; Hamilton PT, 2014, MOL ECOL, V23, P1558, DOI 10.1111/mec.12603; Jaenike J, 2007, BIOL LETTERS, V3, P23, DOI 10.1098/rsbl.2006.0577; Zug R, 2012, J EVOLUTION BIOL, V25, P2149, DOI 10.1111/j.1420-9101.2012.02601.x; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; Gasparich GE, 2004, INT J SYST EVOL MICR, V54, P893, DOI 10.1099/ijs.0.02688-0; Haselkorn TS, 2009, MOL ECOL, V18, P1294, DOI 10.1111/j.1365-294X.2009.04085.x; Haine ER, 2008, P R SOC B, V275, P353, DOI 10.1098/rspb.2007.1211; Jaenike J, 2012, TRENDS ECOL EVOL, V27, P226, DOI 10.1016/j.tree.2011.10.005; Kageyama D, 2006, APPL ENVIRON MICROB, V72, P6667, DOI 10.1128/AEM.00803-06; Raychoudhury R, 2009, EVOLUTION, V63, P165, DOI 10.1111/j.1558-5646.2008.00533.x; Jiggins FM, 2011, SCIENCE, V332, P185, DOI 10.1126/science.1205386; Carrington LB, 2010, P ROY SOC B-BIOL SCI, V277, P2059, DOI 10.1098/rspb.2010.0166; Clancy DJ, 1997, AM NAT, V149, P975, DOI 10.1086/286033; COUNCE SJ, 1962, J EXP ZOOL, V151, P17, DOI 10.1002/jez.1401510103; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Herren JK, 2013, MBIO, V4, DOI 10.1128/mBio.00532-12; Hutchence KJ, 2011, J INVERTEBR PATHOL, V109, P243; Hutchence KJ, 2011, THESIS U LIVERPOOL L; Montenegro H, 2006, GENETICA, V127, P207, DOI 10.1007/s10709-005-3766-4; Montenegro H, 2005, INSECT MOL BIOL, V14, P281, DOI 10.1111/j.1365-2583.2005.00558.x; Mouton L, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S10; Osaka R, 2013, SYMBIOSIS, V60, P79, DOI 10.1007/s13199-013-0241-3; Pool JE, 2006, HEREDITY, V97, P27, DOI 10.1038/sj.hdy.6800830; Russell JA, 2005, APPL ENVIRON MICROB, V71, P7987, DOI 10.1128/AEM.71.12.7987-7994.2005; SAKAGUCHI B, 1963, GENETICS, V48, P841; SAS Institute, 2009, JMP 8; Tinsley MC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-238; WALSH PS, 1991, BIOTECHNIQUES, V10, P506; Weeks AR, 2007, PLOS BIOL, V5, P99; Williamson DL, 1979, MYCOPLASMAS, P175; Xie JL, 2010, PLOS ONE, V5, P1	37	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0018-067X	1365-2540		HEREDITY	Heredity	JUN	2015	114	6					539	543		10.1038/hdy.2014.112		5	Ecology; Evolutionary Biology; Genetics & Heredity	Environmental Sciences & Ecology; Evolutionary Biology; Genetics & Heredity	CH9WI	WOS:000354386700002		
J	Yeh, YC; Nitadori, J; Kadota, K; Yoshizawa, A; Rekhtman, N; Moreira, AL; Sima, CS; Rusch, VW; Adusumilli, PS; Travis, WD				Yeh, Yi-Chen; Nitadori, Jun-ichi; Kadota, Kyuichi; Yoshizawa, Akihiko; Rekhtman, Natasha; Moreira, Andre L.; Sima, Camelia S.; Rusch, Valerie W.; Adusumilli, Prasad S.; Travis, William D.			Using frozen section to identify histological patterns in stage I lung adenocarcinoma of 3cm: accuracy and interobserver agreement	HISTOPATHOLOGY			English	Article						frozen sections; histological subtype; invasion; limited resection; lung adenocarcinoma; micropapillary; solid	SIGNIFICANTLY POOR-PROGNOSIS; DISTINCT PATHOLOGICAL MARKER; GROUND-GLASS OPACITY; MICROPAPILLARY PATTERN; LIMITED RESECTION; INTERNATIONAL-ASSOCIATION; SUBLOBAR RESECTION; IASLC/ATS/ERS CLASSIFICATION; PULMONARY ADENOCARCINOMA; INVASIVE ADENOCARCINOMA	AimsThe IASLC/ATS/ERS classification of lung adenocarcinoma provides a prognostically significant histological subclassification. The aim of this study was to investigate the accuracy, limitations and interobserver agreement of frozen sections for predicting histological subtype. Methods and resultsFrozen section and permanent section slides from 361 resected stage I lung adenocarcinomas 3cm in size were reviewed for predominant histological subtype and the presence or absence of lepidic, acinar, papillary, micropapillary and solid patterns. Fifty cases were additionally reviewed by three pathologists to determine interobserver agreement. To test the accuracy of frozen section in judging degree of invasion, five pathologists reviewed frozen section slides from 35 cases with a predominantly lepidic pattern. There was moderate agreement on predominant histological subtype between frozen sections and final diagnosis (=0.565). Frozen sections had high specificity for micropapillary and solid patterns (94% and 96%, respectively), but sensitivity was low (37% and 69%, respectively). The interobserver agreement was satisfactory (>0.6, except for the acinar pattern). ConclusionsFrozen section can provide information on the presence of aggressive histological patternsmicropapillary and solidwith high specificity but low sensitivity. It was difficult to predict the predominant pattern on the basis of frozen sections, mostly because of sampling issues.	[Yeh, Yi-Chen; Nitadori, Jun-ichi; Kadota, Kyuichi; Yoshizawa, Akihiko; Rusch, Valerie W.; Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Thorac Serv, New York, NY 10065 USA; [Yeh, Yi-Chen] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Yeh, Yi-Chen] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Nitadori, Jun-ichi] Tokyo Univ Hosp, Dept Thorac Surg, Tokyo 113, Japan; [Rekhtman, Natasha; Moreira, Andre L.; Travis, William D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Sima, Camelia S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA	Travis, WD (reprint author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10065 USA.	adusumip@mskcc.org; travisw@mskcc.org			International Association for the Study of Lung Cancer Young Investigator Award; National Lung Cancer Partnership/LUNGevity Foundation Research Grant; American Association for Thoracic Surgery Third Edward D. Churchill Research Scholarship; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center; New York State Empire Clinical Research Investigator Program; National Cancer Institute [1R21CA164568-01A1, 1R21CA164585-01A1, U54CA137788, U54CA132378]; US Department of Defense [PR101053, LC110202]	This work was supported, in part, by the International Association for the Study of Lung Cancer Young Investigator Award, a National Lung Cancer Partnership/LUNGevity Foundation Research Grant, the American Association for Thoracic Surgery Third Edward D. Churchill Research Scholarship, William H. Goodwin and Alice Goodwin, the Commonwealth Foundation for Cancer Research and the Experimental Therapeutics Center, the New York State Empire Clinical Research Investigator Program, the National Cancer Institute (grants 1R21CA164568-01A1, 1R21CA164585-01A1, U54CA137788, and U54CA132378), and the US Department of Defense (grants PR101053 and LC110202).	Myung JK, 2008, LUNG CANCER, V59, P198, DOI 10.1016/j.lungcan.2007.08.023; Xu LR, 2012, AM J SURG PATHOL, V36, P273, DOI 10.1097/PAS.0b013e31823b3eeb; Koike T, 2013, J THORAC CARDIOV SUR, V146, P372, DOI 10.1016/j.jtcvs.2013.02.057; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Kadota K, 2012, MODERN PATHOL, V25, P1117, DOI 10.1038/modpathol.2012.58; Nakamura H, 2004, LUNG CANCER-J IASLC, V44, P61, DOI 10.1016/j.lungcan.2003.09.025; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Schuchert MJ, 2011, ANN THORAC SURG, V91, P1059, DOI 10.1016/j.athoracsur.2010.11.038; Warth A, 2012, EUR RESPIR J, V40, P1221, DOI 10.1183/09031936.00219211; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Xu X, 2010, J THORAC ONCOL, V5, P39, DOI 10.1097/JTO.0b013e3181c09f9c; Wisnivesky JP, 2010, ANN SURG, V251, P550, DOI 10.1097/SLA.0b013e3181c0e5f3; Blasberg JD, 2010, J THORAC ONCOL, V5, P1583, DOI 10.1097/JTO.0b013e3181e77604; Kilicgun A, 2010, THORAC CARDIOV SURG, V58, P93, DOI 10.1055/s-0029-1186240; Kamiya K, 2008, MODERN PATHOL, V21, P992, DOI 10.1038/modpathol.2008.79; Donington J, 2012, CHEST, V142, P1620, DOI 10.1378/chest.12-0790; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb; Solis LM, 2012, CANCER-AM CANCER SOC, V118, P2889, DOI 10.1002/cncr.26584; Russell PA, 2011, J THORAC ONCOL, V6, P1496, DOI 10.1097/JTO.0b013e318221f701; Riquet M, 2006, ANN THORAC SURG, V81, P1988, DOI 10.1016/j.athoracsur.2006.01.021; Koike T, 2009, ANN THORAC SURG, V88, P1106, DOI 10.1016/j.athoracsur.2009.06.051; Ohtaki Y, 2011, ANN THORAC SURG, V91, P1051, DOI 10.1016/j.athoracsur.2010.11.071; Thunnissen E, 2012, MODERN PATHOL, V25, P1574, DOI 10.1038/modpathol.2012.106; Yoshizawa A, 2013, J THORAC ONCOL, V8, P52, DOI 10.1097/JTO.0b013e3182769aa8; Amin MB, 2002, AM J SURG PATHOL, V26, P358, DOI 10.1097/00000478-200203000-00010; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Barletta JA, 2010, CANCER-AM CANCER SOC, V116, P659, DOI 10.1002/cncr.24831; Warth A, 2012, J CLIN ONCOL, V30, P1438, DOI 10.1200/JCO.2011.37.2185; Yoshida J, 2005, J THORAC CARDIOV SUR, V129, P991, DOI 10.1016/j.jtcvs.2004.07.038; Nitadori J, 2013, JNCI-J NATL CANCER I, V105, P1212, DOI 10.1093/jnci/djt166; Fukui T, 2007, J THORAC ONCOL, V2, P546, DOI 10.1097/JTO.0b013e318060d30d; Kadota K, 2014, AM J SURG PATHOL, V38, P448, DOI 10.1097/PAS.0000000000000134; Kawakami T, 2007, MODERN PATHOL, V20, P514, DOI 10.1038/modpathol.3800765; Makimoto Y, 2005, HISTOPATHOLOGY, V46, P677, DOI 10.1111/j.1365-2559.2005.02.126.x; Miyoshi T, 2003, AM J SURG PATHOL, V27, P101, DOI 10.1097/00000478-200301000-00011; Motoi N, 2008, AM J SURG PATHOL, V32A, P810, DOI 10.1097/PAS.0b013e31815cb162; Motoi N, 2011, J THORAC ONCOL, V6, pS566; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Sanchez-Mora N, 2008, HUM PATHOL, V39, P324, DOI 10.1016/j.humpath.2007.05.029; Tsutsumida H, 2007, MODERN PATHOL, V20, P638, DOI 10.1038/modpathol.3800780; Walts AE, 2012, ARCH PATHOL LAB MED, V136, P1515, DOI 10.5858/arpa.2012-0042-OA; Watanabe Takehiro, 2005, Jpn J Thorac Cardiovasc Surg, V53, P29, DOI 10.1007/s11748-005-1005-7; Yamato Y, 2001, ANN THORAC SURG, V71, P971, DOI 10.1016/S0003-4975(00)02507-8; Yoshioka M, 2009, ANN THORAC CARDIOVAS, V15, P82; Zhang J, 2011, HISTOPATHOLOGY, V59, P1204, DOI 10.1111/j.1365-2559.2011.04050.x	46	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	JUN	2015	66	7					922	938		10.1111/his.12468		17	Cell Biology; Pathology	Cell Biology; Pathology	CH9YU	WOS:000354393400002		
J	Watanabe, Y; Shiraishi, K; Takahashi, F; Yoshida, A; Suzuki, K; Asamura, H; Takeuchi, M; Furuta, K; Tsuta, K				Watanabe, Yukio; Shiraishi, Kouya; Takahashi, Fumiaki; Yoshida, Akihiko; Suzuki, Kenji; Asamura, Hisao; Takeuchi, Masahiro; Furuta, Koh; Tsuta, Koji			Biomarker expression and druggable gene alterations for development of an appropriate therapeutic protocol for pulmonary adenosquamous carcinoma	HISTOPATHOLOGY			English	Article						adenosquamous carcinoma; biomarker expression; druggable gene alterations	CELL LUNG-CANCER; GROWTH-FACTOR RECEPTOR; IN-SITU HYBRIDIZATION; III BETA-TUBULIN; K-RAS GENES; SQUAMOUS-CELL; PROTEIN EXPRESSION; COPY NUMBER; MUTATIONAL ANALYSIS; CHINESE PATIENTS	AimsPulmonary adenosquamous carcinoma (ASC) is more aggressive than adenocarcinoma (AC) and squamous cell carcinoma (SCC). The genetic features and biomarkers of ASC are not well known. Here, we attempted to identify potential therapeutic markers for ASC. Methods and resultsSurgically resected ASC samples from 65 patients were analysed. We examined the expression of III-tubulin, thymidylate synthase, breast cancer susceptibility gene 1 and ribonucleotide reductase M1 (RRM1); identified mutations in epidermal growth factor receptor (EGFR), KRAS, BRAF and HER2; and detected ALK, ROS1 and RET rearrangements. Gene amplification and expression of EGFR, human epidermal growth factor receptor 2 (HER2), fibroblast growth factor receptor-1 and MET were also examined. III-Tubulin showed the highest expression (P=0.002), and its expression was more frequent in the AC than in the SCC component (P=0.013). RRM1 expression was more frequent in the SCC component (P=0.046). EGFR and KRAS mutations were detected in both components (21.5 and 10.9%, respectively). ALK and ROS1 rearrangements and MET amplification were detected in both components in one (1.5%) case. ConclusionsIn ASC, drug response-specific gene alterations could occur in both AC and SCC components, suggesting that patients with confirmed or suspected ASC should undergo further testing for driver gene analyses.	[Watanabe, Yukio; Yoshida, Akihiko; Furuta, Koh; Tsuta, Koji] Natl Canc Ctr, Div Pathol, Tokyo 1040045, Japan; [Watanabe, Yukio; Suzuki, Kenji] Juntendo Univ, Sch Med, Dept Thorac Surg, Tokyo 113, Japan; [Watanabe, Yukio; Asamura, Hisao] Natl Canc Ctr, Div Thorac Surg, Tokyo 1040045, Japan; [Shiraishi, Kouya] Natl Canc Ctr, Res Inst, Div Genome Biol, Tokyo 104, Japan; [Takahashi, Fumiaki; Takeuchi, Masahiro] Kitasato Univ, Sch Pharm, Dept Clin Med Biostat, Tokyo, Japan	Tsuta, K (reprint author), Natl Canc Ctr, Div Pathol, Chuo Ku, 1-1 Tsukiji 5 Chome, Tokyo 1040045, Japan.	ktsuta@ncc.go.jp			National Cancer Centre Research and Development Fund [23-A-2, 23-A-11, 23-A-35, 24-A-1];  [25460446]	We thank Susumu Wakai, Karin Yokozawa, Shoko Nakamura and Ryousuke Yamaga for their skillful technical assistance. This work was supported in part by the National Cancer Centre Research and Development Fund (23-A-2), (23-A-11), (23-A-35) and (24-A-1), and a Grant-in-Aid for Scientific Research (C) Grant Number 25460446.	Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Onozato R, 2009, J THORAC ONCOL, V4, P5, DOI 10.1097/JTO.0b013e3181913e0e; Kang SM, 2007, CANCER, V109, P581, DOI 10.1002/cncr.22413; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Wang R, 2012, J CLIN ONCOL, V30, P4352, DOI 10.1200/JCO.2012.44.1477; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Dziadziuszko R, 2012, J THORAC ONCOL, V7, P340, DOI 10.1097/JTO.0b013e318240ca0d; Paik JH, 2011, J THORAC ONCOL, V6, P466, DOI 10.1097/JTO.0b013e31820b82e8; Wang R, 2014, J THORAC ONCOL, V9, P760, DOI 10.1097/JTO.0b013e3182a406d1; Tochigi N, 2011, AM J CLIN PATHOL, V135, P783, DOI 10.1309/AJCP08IQZAOGYLFL; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Cai W, 2013, ANN ONCOL, V24, P1822, DOI 10.1093/annonc/mdt071; Cooke DT, 2010, ANN THORAC SURG, V90, P943, DOI 10.1016/j.athoracsur.2010.05.025; Tsuta K, 2012, J THORAC ONCOL, V7, P331, DOI 10.1097/JTO.0b013e318241655f; Tsuta K, 2011, J THORAC ONCOL, V6, P1190, DOI 10.1097/JTO.0b013e318219ac78; Schildhaus HU, 2012, MODERN PATHOL, V25, P1473, DOI 10.1038/modpathol.2012.102; Watanabe Y, 2014, ANN THORAC SURG, V97, P245, DOI 10.1016/j.athoracsur.2013.09.018; Paik PK, 2012, MOL CANCER THER, V11, P2535, DOI 10.1158/1535-7163.MCT-12-0163; Chaft JE, 2012, J THORAC ONCOL, V7, P768, DOI 10.1097/JTO.0b013e31824c9485; Douillard JY, 2014, J THORAC ONCOL, V9, P717, DOI 10.1097/JTO.0000000000000141; Toyooka S, 2006, INT J CANCER, V118, P1588, DOI 10.1002/ijc.21500; Song ZB, 2013, J CHIN MED ASSOC, V76, P481, DOI 10.1016/j.jcma.2013.05.007; Soung YH, 2005, VIRCHOWS ARCH, V446, P483, DOI 10.1007/s00428-005-1254-y; Azuma K, 2009, CANCER CHEMOTH PHARM, V64, P565, DOI 10.1007/s00280-008-0907-3; Jia XL, 2011, LUNG CANCER, V74, P396, DOI 10.1016/j.lungcan.2011.04.005; Kang CH, 2010, LUNG CANCER, V68, P478, DOI 10.1016/j.lungcan.2009.07.004; Marchetti A, 2005, J CLIN ONCOL, V23, P857, DOI 10.1200/JCO.2005.08.043; NAUNHEIM KS, 1987, ANN THORAC SURG, V44, P462; Shiozawa T, 2013, PATHOL INT, V63, P77, DOI 10.1111/pin.12033; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Shu C, 2013, MODERN PATHOL, V26, P239, DOI 10.1038/modpathol.2012.158; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Sasaki H, 2007, LUNG CANCER, V55, P129, DOI 10.1016/j.lungcan.2006.09.003; Seve P, 2007, CLIN CANCER RES, V13, P994, DOI 10.1158/1078-0432.CCR-06-1503; Dragnev KH, 2014, CLIN LUNG CANCER, V15, pE37, DOI 10.1016/j.cllc.2014.01.003; Dutt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020351; Fukui T, 2008, CLIN CANCER RES, V14, P4751, DOI 10.1158/1078-0432.CCR-07-5207; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Maus MKH, 2013, J THORAC ONCOL, V8, P582, DOI 10.1097/JTO.0b013e318287c3c5; Mordant P, 2013, ANN THORAC SURG, V95, P1189, DOI 10.1016/j.athoracsur.2012.12.037; Powrozek T, 2014, ASIA-PAC J CLIN ONCO, V10, P340, DOI 10.1111/ajco.12177; Shelton DA, 2012, DIAGN CYTOPATHOL, V40, P830, DOI 10.1002/dc.21664; Travis WD, 2004, WHO CLASSIFICATION T; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Yoshida A, 2013, AM J SURG PATHOL, V37, P554, DOI 10.1097/PAS.0b013e3182758fe6	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	JUN	2015	66	7					939	948		10.1111/his.12556		10	Cell Biology; Pathology	Cell Biology; Pathology	CH9YU	WOS:000354393400003		
J	Ide, F; Kikuchi, K; Sakashita, H; Muramatsu, T; Kusama, K				Ide, Fumio; Kikuchi, Kentaro; Sakashita, Hideaki; Muramatsu, Takashi; Kusama, Kaoru			Neurovascular involvement in central odontogenic fibroma: a potential source of confusion with invasive carcinoma	HISTOPATHOLOGY			English	Letter									[Ide, Fumio; Kikuchi, Kentaro; Kusama, Kaoru] Meikai Univ, Sch Dent, Div Oral Pathol, Saitama, Japan; [Sakashita, Hideaki] Meikai Univ, Sch Dent, Dept Diagnost & Therapeut Sci, Div Oral & Maxillofacial Surg 2, Saitama, Japan; [Muramatsu, Takashi] Tokyo Dent Coll, Dept Endodont & Clin Cariol, Tokyo, Japan	Ide, F (reprint author), Meikai Univ, Sch Dent, Div Oral Pathol, Saitama, Japan.						Alawi F, 2004, ORAL SURG ORAL PATHO, V98, P201, DOI 10.1016/j.tripleo.2004.06.030; Woolgar JA, 2009, ORAL ONCOL, V45, P361, DOI 10.1016/j.oraloncology.2008.07.016; Slater LJ, 1999, SEMIN DIAGN PATHOL, V16, P325; Hussain O, 2013, OR SURG OR MED OR PA, V116, pE283, DOI 10.1016/j.oooo.2013.01.018; KINNEY LA, 1993, J ORAL MAXIL SURG, V51, P321; Orban B. Is, 1926, Z STOMATOL, V24, P515	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	JUN	2015	66	7					1044	1046		10.1111/his.12567		3	Cell Biology; Pathology	Cell Biology; Pathology	CH9YU	WOS:000354393400017		
J	Hino-Fukuyo, N; Kikuchi, A; Arai-Ichinoi, N; Niihori, T; Sato, R; Suzuki, T; Kudo, H; Sato, Y; Nakayama, T; Kakisaka, Y; Kubota, Y; Kobayashi, T; Funayama, R; Nakayama, K; Uematsu, M; Aoki, Y; Haginoya, K; Kure, S				Hino-Fukuyo, Naomi; Kikuchi, Atsuo; Arai-Ichinoi, Natsuko; Niihori, Tetsuya; Sato, Ryo; Suzuki, Tasuku; Kudo, Hiroki; Sato, Yuko; Nakayama, Tojo; Kakisaka, Yosuke; Kubota, Yuki; Kobayashi, Tomoko; Funayama, Ryo; Nakayama, Keiko; Uematsu, Mitsugu; Aoki, Yoko; Haginoya, Kazuhiro; Kure, Shigeo			Genomic analysis identifies candidate pathogenic variants in 9 of 18 patients with unexplained West syndrome	HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; INFANTILE EPILEPTIC ENCEPHALOPATHY; LINKED MENTAL-RETARDATION; COPY NUMBER VARIANTS; DNA-SEQUENCING DATA; CALCIUM-CHANNEL; INTELLECTUAL DISABILITY; DEVELOPMENTAL DELAY; 16P13.11 PREDISPOSE; OPTIC ATROPHY	West syndrome, which is narrowly defined as infantile spasms that occur in clusters and hypsarrhythmia on EEG, is the most common early-onset epileptic encephalopathy (EOEE). Patients with West syndrome may have clear etiologies, including perinatal events, infections, gross chromosomal abnormalities, or cases followed by other EOEEs. However, the genetic etiology of most cases of West syndrome remains unexplained. DNA from 18 patients with unexplained West syndrome was subjected to microarray-based comparative genomic hybridization (array CGH), followed by trio-based whole-exome sequencing in 14 unsolved families. We identified candidate pathogenic variants in 50 % of the patients (n = 9/18). The array CGH revealed candidate pathogenic copy number variations in four cases (22 %, 4/18), including an Xq28 duplication, a 16p11.2 deletion, a 16p13.1 deletion and a 19p13.2 deletion disrupting CACNA1A. Whole-exome sequencing identified candidate mutations in known epilepsy genes in five cases (36 %, 5/14). Three candidate de novo mutations were identified in three cases, with two mutations occurring in two new candidate genes (NR2F1 and CACNA2D1) (21 %, 3/14). Hemizygous candidate mutations in ALG13 and BRWD3 were identified in the other two cases (14 %, 2/14). Evaluating a panel of 67 known EOEE genes failed to identify significant mutations. Despite the heterogeneity of unexplained West syndrome, the combination of array CGH and whole-exome sequencing is an effective means of evaluating the genetic background in unexplained West syndrome. We provide additional evidence for NR2F1 as a causative gene and for CACNA2D1 and BRWD3 as candidate genes for West syndrome.	[Hino-Fukuyo, Naomi; Kikuchi, Atsuo; Arai-Ichinoi, Natsuko; Sato, Ryo; Suzuki, Tasuku; Kudo, Hiroki; Sato, Yuko; Nakayama, Tojo; Kakisaka, Yosuke; Kubota, Yuki; Kobayashi, Tomoko; Uematsu, Mitsugu; Kure, Shigeo] Tohoku Univ, Dept Pediat, Sch Med, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Niihori, Tetsuya; Aoki, Yoko] Tohoku Univ, Dept Med Genet, Sch Med, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Kakisaka, Yosuke] Tohoku Univ, Dept Epileptol, Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kobayashi, Tomoko] Tohoku Univ, Dept Educ & Training, Div Genom Med Support & Genet Counseling, Tohoku Med Megabank Org ToMMo,Aoba Ku, Sendai, Miyagi 9808573, Japan; [Funayama, Ryo; Nakayama, Keiko] Tohoku Univ, Div Cell Proliferat, United Ctr Adv Res, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Funayama, Ryo; Nakayama, Keiko] Tohoku Univ, Div Cell Proliferat, United Ctr Translat Med, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Haginoya, Kazuhiro] Takuto Rehabil Ctr Children, Dept Pediat Neurol, Taihaku Ku, Sendai, Miyagi 9820241, Japan	Kikuchi, A (reprint author), Tohoku Univ, Dept Pediat, Sch Med, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	akikuchi-thk@umin.ac.jp			Biomedical Research Core of Tohoku University Graduate School of Medicine; Ministry of Health labor and Welfare, Japan; JSPS KAKENHI [25461536]	The authors thank the patients, families, and doctors who participated in this study. We thank Yoko Chiba and Kumi Ito, Miyuki Tsuda, Mami Kikuchi, Makiko Nakagawa, and Kiyotaka Kuroda for technical assistance. We also acknowledge the support of the Biomedical Research Core of Tohoku University Graduate School of Medicine. This work was supported by grant from the Ministry of Health labor and Welfare, Japan (to SK) and JSPS KAKENHI Grant Number 25461536.	Al-Kateb H, 2013, AM J MED GENET A, V161A, P377, DOI 10.1002/ajmg.a.35650; Mefford HC, 2011, ANN NEUROL, V70, P974, DOI 10.1002/ana.22645; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Michaud JL, 2014, HUM MOL GENET, V23, P4846, DOI 10.1093/hmg/ddu199; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Auvin S, 2009, EPILEPSIA, V50, P2501, DOI 10.1111/j.1528-1167.2009.02189.x; Paciorkowski AR, 2011, EUR J HUM GENET, V19, P1238, DOI 10.1038/ejhg.2011.121; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; Tiwari VN, 2013, J CHILD NEUROL, V28, P1191, DOI 10.1177/0883073812453496; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Lux AL, 2004, EPILEPSIA, V45, P1416, DOI 10.1111/j.0013-9580.2004.02404.x; Pellock JM, 2010, EPILEPSIA, V51, P2175, DOI 10.1111/j.1528-1167.2010.02657.x; Hannes FD, 2009, J MED GENET, V46, P223, DOI 10.1136/jmg.2007.055202; Jouvenceau A, 2001, LANCET, V358, P801, DOI 10.1016/S0140-6736(01)05971-2; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Bosch DGM, 2014, AM J HUM GENET, V94, P303, DOI 10.1016/j.ajhg.2014.01.002; Yamatogi Y, 2002, BRAIN DEV-JPN, V24, P13, DOI 10.1016/S0387-7604(01)00392-8; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Trevathan E, 1999, EPILEPSIA, V40, P748, DOI 10.1111/j.1528-1157.1999.tb00773.x; Heinzen EL, 2010, AM J HUM GENET, V86, P707, DOI 10.1016/j.ajhg.2010.03.018; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Ng BG, 2013, AM J HUM GENET, V92, P632, DOI 10.1016/j.ajhg.2013.03.012; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Armentano M, 2007, NAT NEUROSCI, V10, P1277, DOI 10.1038/nn1958; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Kodera H, 2013, HUM MUTAT, V34, P1708, DOI 10.1002/humu.22446; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Labrum RW, 2009, J MED GENET, V46, P786, DOI 10.1136/jmg.2009.067967; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Timal S, 2012, HUM MOL GENET, V21, P4151, DOI 10.1093/hmg/dds123; Balasubramanian M, 2011, EUR J MED GENET, V54, P314, DOI 10.1016/j.ejmg.2011.01.008; Dimassi S, 2014, EPILEPSIA, V55, P370, DOI 10.1111/epi.12502; Field M, 2007, AM J HUM GENET, V81, P367, DOI 10.1086/520677; Huang W, 2014, J MED GENET, V51, P159, DOI 10.1136/jmedgenet-2013-101978; Kubota T, 1999, HUM GENET, V104, P49, DOI 10.1007/s004390050909; Nagamani SCS, 2012, NEUROGENETICS, V13, P333, DOI 10.1007/s10048-012-0340-y; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Riant F, 2008, ARCH NEUROL-CHICAGO, V65, P817, DOI 10.1001/archneur.65.6.817; Rio M, 2010, EUR J HUM GENET, V18, P285, DOI 10.1038/ejhg.2009.159; Tang K, 2010, DEVELOPMENT, V137, P725, DOI 10.1242/dev.040568; Vengoechea J, 2012, EUR J HUM GENET, V20, P1197, DOI 10.1038/ejhg.2012.78; Vergult S, 2015, EUR J HUM GENET, V23, P628, DOI 10.1038/ejhg.2014.141; Viggiano E, 2013, CLIN GENET, V84, P265, DOI 10.1111/cge.12048; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	52	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6717	1432-1203		HUM GENET	Hum. Genet.	JUN	2015	134	6					649	658		10.1007/s00439-015-1553-6		10	Genetics & Heredity	Genetics & Heredity	CH7DQ	WOS:000354196200011		
J	Hasegawa, M; Satoh, T; Nagashima, T; Mendez, M; Konishi, T				Hasegawa, M.; Satoh, T.; Nagashima, T.; Mendez, M.; Konishi, T.			Below 100-fs Timing Jitter Seamless Operations in 10-GSample/s 3-bit Photonic Analog-to-Digital Conversion	IEEE PHOTONICS JOURNAL			English	Article						Photonic analog-to-digital conversion; optical sampling; optical quantization; optical coding; SSFS	OPTICAL QUANTIZATION; FIBER	We experimentally realize seamless operations with below 100-fs timing jitter in a 10-GSample/s 3-bit photonic analog-to-digital converter (ADC) with an input 2.5-GHz sinusoidal electrical signal. To address the energy efficiency, it is necessary to explore some serial approaches to get most operations in a photonic ADC done before serial-to-parallel conversion to save the number of devices. To press forward with the work on subsequent operations after optical sampling in a photonic ADC, we have investigated optical quantization and coding and demonstrated their performances. The experimental results successfully demonstrated seamless operations in a photonic ADC, i.e., sampling, quantization, and coding, while keeping its parallel-configuration-free characteristics and low timing jitter below 100 fs. This demonstration could address the energy efficiency by reduction of the number of devices, including electrical ADCs for subsequent operations after optical sampling in existing high-performance photonic ADCs.	[Hasegawa, M.; Satoh, T.; Nagashima, T.; Mendez, M.; Konishi, T.] Osaka Univ, Grad Sch Engn, Osaka 5650871, Japan	Hasegawa, M (reprint author), Osaka Univ, Grad Sch Engn, Osaka 5650871, Japan.						Abedin KS, 2004, IEEE J SEL TOP QUANT, V10, P1203, DOI 10.1109/JSTQE.2004.837229; Mulvad HCH, 2009, ELECTRON LETT, V45, P280, DOI 10.1049/el:20090206; Camatel S, 2006, IEEE PHOTONIC TECH L, V18, P142, DOI 10.1109/LPT.2005.860377; Khilo A, 2012, OPT EXPRESS, V20, P4454, DOI 10.1364/OE.20.004454; Konishi T, 2002, J OPT SOC AM B, V19, P2817, DOI 10.1364/JOSAB.19.002817; Nishitani T, 2008, IEEE J SEL TOP QUANT, V14, P724, DOI 10.1109/JSTQE.2008.916251; Nishitani T, 2007, OPT EXPRESS, V15, P15812, DOI 10.1364/OE.15.015812; Pant R, 2010, OPT COMMUN, V283, P2258, DOI 10.1016/j.optcom.2010.01.051; Valley GC, 2007, OPT EXPRESS, V15, P1955, DOI 10.1364/OE.15.001955; Konishi T, 2011, OPT EXPRESS, V19, P16106, DOI 10.1364/OE.19.016106; Nishitani T, 2007, IEICE T ELECTRON, VE90C, P479, DOI 10.1093/ietele/e90-c.2.479; Satoh T, 2013, IEICE T ELECTRON, VE96C, P223, DOI 10.1587/transele.E96.C.223; VONDERLINDE D, 1986, APPL PHYS B-PHOTO, V39, P201; Yoshida M, 2008, OPT EXPRESS, V16, P829, DOI 10.1364/OE.16.000829	14	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1943-0655	1943-0647		IEEE PHOTONICS J	IEEE Photonics J.	JUN	2015	7	3							7201007	10.1109/JPHOT.2015.2425878		7	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CH7AN	WOS:000354188100003		
J	Sanosaka, M; Fujimoto, M; Ohkawara, T; Nagatake, T; Itoh, Y; Kagawa, M; Kumagai, A; Fuchino, H; Kunisawa, J; Naka, T; Takemori, H				Sanosaka, Masato; Fujimoto, Minoru; Ohkawara, Tomoharu; Nagatake, Takahiro; Itoh, Yumi; Kagawa, Mai; Kumagai, Ayako; Fuchino, Hiroyuki; Kunisawa, Jun; Naka, Tetsuji; Takemori, Hiroshi			Salt-inducible kinase 3 deficiency exacerbates lipopolysaccharide-induced endotoxin shock accompanied by increased levels of pro-inflammatory molecules in mice	IMMUNOLOGY			English	Article						AMP-activated protein kinase; endotoxin shock; interleukin-12p40; interleukin-1; interleukin-6; inducible nitric oxide synthase; macrophage; salt-inducible kinases; tumour necrosis factor-	TOLL-LIKE RECEPTOR-4; REGULATORY MACROPHAGES; SIGNAL-TRANSDUCTION; COACTIVATOR TORC2; EXPRESSION; CREB; ACTIVATION; PHOSPHORYLATION; ACETYLATION; RESPONSES	Macrophages play important roles in the innate immune system during infection and systemic inflammation. When bacterial lipopolysaccharide (LPS) binds to Toll-like receptor 4 on macrophages, several signalling cascades co-operatively up-regulate gene expression of inflammatory molecules. The present study aimed to examine whether salt-inducible kinase [SIK, a member of the AMP-activated protein kinase (AMPK) family] could contribute to the regulation of immune signal not only in cultured macrophages, but also in vivo. LPS up-regulated SIK3 expression in murine RAW264.7 macrophages and exogenously over-expressed SIK3 negatively regulated the expression of inflammatory molecules [interleukin-6 (IL-6), nitric oxide (NO) and IL-12p40] in RAW264.7 macrophages. Conversely, these inflammatory molecule levels were up-regulated in SIK3-deficient thioglycollate-elicited peritoneal macrophages (TEPM), despite no impairment of the classical signalling cascades. Forced expression of SIK3 in SIK3-deficient TEPM suppressed the levels of the above-mentioned inflammatory molecules. LPS injection (10mg/kg) led to the death of all SIK3-knockout (KO) mice within 48hr after treatment, whereas only one mouse died in the SIK1-KO (n=8), SIK2-KO (n=9) and wild-type (n=8 or 9) groups. In addition, SIK3-KO bone marrow transplantation increased LPS sensitivity of the recipient wild-type mice, which was accompanied by an increased level of circulating IL-6. These results suggest that SIK3 is a unique negative regulator that suppresses inflammatory molecule gene expression in LPS-stimulated macrophages.	[Sanosaka, Masato; Itoh, Yumi; Kagawa, Mai; Kumagai, Ayako; Takemori, Hiroshi] Natl Inst Biomed Innovat, Lab Cell Signalling & Metab Dis, Ibaraki, Osaka, Japan; [Fujimoto, Minoru; Ohkawara, Tomoharu; Naka, Tetsuji] Natl Inst Biomed Innovat, Lab Immune Signalling, Ibaraki, Osaka, Japan; [Nagatake, Takahiro; Kunisawa, Jun] Natl Inst Biomed Innovat, Lab Vaccine Mat, Ibaraki, Osaka, Japan; [Fuchino, Hiroyuki] Natl Inst Biomed Innovat, Res Ctr Med Plant Resources, Tsukuba, Ibaraki, Japan	Sanosaka, M (reprint author), Natl Inst Biomed Innovat NIBIO, Lab Cell Signalling & Metab Dis, 7-6-8 Asagi, Ibaraki, Osaka 5670085, Japan.	m-sanosaka@nibio.go.jp; takemori@nibio.go.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [24790333]; Adaptable and Seamless Technology Transfer Programme through target-driven research and development, JST; Ministry of Health, Labour, and Welfare; MEXT; Strategic Research Foundation at Private Universities; Uehara Memorial Foundation	MS, TeN and HT designed the research. MS and HT wrote the paper. MS, MF, TO, TaN, YI, AK, MK, HF, JK and HT performed the experiments. We thank Ms Tomoko Onishi for her technical assistance and Dr Alejandro M. Bertorello (Karolinska Institute, Sweden) for providing us with SIK1-KO mice. This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (24790333), Adaptable and Seamless Technology Transfer Programme through target-driven research and development, JST, the grant from the Ministry of Health, Labour, and Welfare (2013-2017, 2014-2016), Scientific Research on Innovative Areas, a MEXT Grant-in-Aid Project 2012-2013; Strategic Research Foundation at Private Universities (2013-2017), and a grant from the Uehara Memorial Foundation.	Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Takemori H, 2009, ENDOCR J, V56, P121; Das M, 2009, CELL, V136, P249, DOI 10.1016/j.cell.2008.11.017; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Salomao R, 2012, SHOCK, V38, P227, DOI 10.1097/SHK.0b013e318262c4b0; Pauls E, 2013, J IMMUNOL, V191, P2717, DOI 10.4049/jimmunol.1203268; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Kawai T, 2001, J IMMUNOL, V167, P5887; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; Cao WS, 2008, J EXP MED, V205, P1491, DOI 10.1084/jem.20071728; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Fleming BD, 2011, EUR J IMMUNOL, V41, P2498, DOI 10.1002/eji.201141717; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233; Piras V, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00070; Serrat N, 2014, J IMMUNOL, V192, P418, DOI 10.4049/jimmunol.1203500; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Takemori H, 2007, FEBS J, V274, P3202, DOI 10.1111/j.1742-4658.2007.05889.x; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Luan B, 2014, CELL METAB, V19, P1058, DOI 10.1016/j.cmet.2014.03.024; Becker L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033297; Chi HB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.141pe44; Eneling K, 2012, FASEB J, V26, P3230, DOI 10.1096/fj.12-205609; Ferrante CJL, 2012, ADV WOUND CARE, V1, P10, DOI [10.1089/wound.2011.0307, DOI 10.1089/WOUND.2011.0307]; GRAVES RA, 1991, GENE DEV, V5, P428, DOI 10.1101/gad.5.3.428; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; Jeong Y, 2013, J LEUKOCYTE BIOL, V95, P1; Kim SY, 2013, MOL ENDOCRINOL, V27, P1958, DOI 10.1210/me.2013-1240; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Ohmori Y, 2000, REQUIREMENT STAT1 LP, V1; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Uebi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037803; Zhang X, 2008, CURR PROTOC IMMUNOL, V83, P1411, DOI DOI 10.1002/0471142735.IM1401S83	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0019-2805	1365-2567		IMMUNOLOGY	Immunology	JUN	2015	145	2					268	278		10.1111/imm.12445		11	Immunology	Immunology	CH6ZN	WOS:000354185400009		
J	Shigetani, Y; Yoshiba, K; Kuratate, M; Takei, E; Yoshiba, N; Yamanaka, Y; Ohshima, H; Okiji, T				Shigetani, Y.; Yoshiba, K.; Kuratate, M.; Takei, E.; Yoshiba, N.; Yamanaka, Y.; Ohshima, H.; Okiji, T.			Temporospatial localization of dentine matrix protein 1 following direct pulp capping with calcium hydroxide in rat molars	INTERNATIONAL ENDODONTIC JOURNAL			English	Article						calcium hydroxide; dental pulp capping; dental pulp exposure; dentine matrix protein 1; nestin; osteopontin	MINERAL TRIOXIDE AGGREGATE; INTEGRIN-BINDING LIGAND; N-LINKED GLYCOPROTEINS; IN-VITRO; HYDROXYAPATITE FORMATION; NESTIN EXPRESSION; TOOTH DEVELOPMENT; OSTEOPONTIN; CELLS; TEETH	AimTo examine the temporospatial expression of dentine matrix protein 1 (DMP1; a noncollagenous protein involved in mineralized tissue formation), osteopontin (another noncollagenous protein detected during reparative dentinogenesis) and nestin (a marker of differentiating/differentiated odontoblasts), following direct pulp capping with calcium hydroxide in rat molars. MethodologyThe maxillary first molars of 8-week-old Wistar rats had their pulps exposed and capped with calcium hydroxide. The pulp-capped teeth were collected from 6h to 14days postoperatively and processed for immunohistochemistry for DMP1, osteopontin and nestin. Cell proliferation was monitored using 5-bromo-2-deoxyuridine (BrdU) labelling. ResultsThe capped pulps initially exhibited superficial necrotic changes followed by the formation of new matrix and its mineralization. DMP1 immunoreactivity was observed in the matrix beneath the necrotic layer from 6h onwards and present in the outer portion of the newly formed mineralized matrix from 7days onwards. Osteopontin displayed a similar expression pattern, although it occupied a narrower area than DMP1 at 6 and 12h. Nestin-immunoreactive cells appeared beneath the DMP1-immunoreactive area at 1day, were distributed beneath the newly formed matrix at 5days and exhibited odontoblast-like morphology by 14days. BrdU-positive cells significantly increased at 2 and 3days (P<0.05) and then decreased. ConclusionsThe deposition of DMP1 at exposed pulp sites preceded the appearance of nestin-immunoreactive cells, active cell proliferation and new matrix formation after pulp capping with calcium hydroxide in rat molars, suggesting that DMP1 acts as a trigger of pulp repair. The colocalization of DMP1 and osteopontin suggests that these two proteins play complementary roles.	[Shigetani, Y.; Yoshiba, K.; Kuratate, M.; Takei, E.; Yoshiba, N.; Yamanaka, Y.; Okiji, T.] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Div Cariol Operat Dent & Endodont, Niigata 9518514, Japan; [Ohshima, H.] Niigata Univ, Grad Sch Med & Dent Sci, Dept Tissue Regenerat & Reconstruct, Div Anat & Cell Biol Hard Tissue, Niigata 9518514, Japan	Okiji, T (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Div Cariol Operat Dent & Endodont,Chuo Ku, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.	t-okiji@dent.niigata-u.ac.jp			Japan Society for the Promotion of Science [23390433, 23792167]	This study was supported in part by Grants-in-Aid for Scientific Research (nos. 23390433 to T. O. and 23792167 to Y. S.) from the Japan Society for the Promotion of Science. The authors do not have any conflict of interests to declare.	Terling C, 1995, INT J DEV BIOL, V39, P947; Ishimatsu H, 2009, J ENDODONT, V35, P858, DOI 10.1016/j.joen.2009.03.049; Goldberg M, 2004, CRIT REV ORAL BIOL M, V15, P13; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Chaussain C, 2009, EUR CELLS MATER, V18, P84; Almushayt A, 2006, GENE THER, V13, P611, DOI 10.1038/sj.gt.3302687; SMITH AJ, 1995, INT J DEV BIOL, V39, P273; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200; Baba O, 2004, MATRIX BIOL, V23, P371, DOI 10.1016/j.matnio.2004.07.008; HUNTER GK, 1994, BIOCHEM J, V300, P723; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; LIAW L, 1995, J CLIN INVEST, V95, P713, DOI 10.1172/JCI117718; Moses KD, 2006, EUR J ORAL SCI, V114, P216, DOI 10.1111/j.1600-0722.2006.00353.x; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279; McKee MD, 1996, MICROSC RES TECHNIQ, V33, P141, DOI 10.1002/(SICI)1097-0029(19960201)33:2<141::AID-JEMT5>3.0.CO;2-W; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Tran XV, 2012, J DENT RES, V91, P1166, DOI 10.1177/0022034512460833; FITZGERALD M, 1990, ARCH ORAL BIOL, V35, P707, DOI 10.1016/0003-9969(90)90093-P; About I, 2000, AM J PATHOL, V157, P287, DOI 10.1016/S0002-9440(10)64539-7; He G, 2003, CONNECT TISSUE RES, V44, P240, DOI 10.1080/03008200390181726; Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198; Bindslev HOrsted- P, 2010, TXB ENDODONTOLOGY, V2nd, P47; Dammaschke T, 2010, J ENDODONT, V36, P814, DOI 10.1016/j.joen.2010.02.001; Ishikawa Y, 2010, HISTOCHEM CELL BIOL, V134, P227, DOI 10.1007/s00418-010-0727-5; Kulkarni GV, 2000, ARCH ORAL BIOL, V45, P475, DOI 10.1016/S0003-9969(00)00010-8; Kuratate M, 2008, J ENDODONT, V34, P970, DOI 10.1016/j.joen.2008.03.021; LESOT H, 1993, CELL MATER, V3, P201; Min KS, 2008, J ENDODONT, V34, P666, DOI 10.1016/j.joen.2008.03.009; Murray PE, 2003, INT ENDOD J, V36, P106, DOI 10.1046/j.1365-2591.2003.00632.x; Shigetani Y, 2013, ODONTOLOGY, V101, P186, DOI 10.1007/s10266-012-0078-x; Shigetani Y, 2011, J ENDODONT, V37, P1086, DOI 10.1016/j.joen.2011.05.020; Tecles O, 2008, J BIOMED MATER RES B, V85B, P180, DOI 10.1002/jbm.b.30933; Xie XH, 2014, DENT TRAUMATOL, V30, P285, DOI 10.1111/edt.12093	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0143-2885	1365-2591		INT ENDOD J	Int. Endod. J.	JUN	2015	48	6					573	581		10.1111/iej.12351		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CH8NY	WOS:000354294300010		
J	Mifude, C; Kaseda, K				Mifude, C.; Kaseda, K.			PDGF-AA-induced filamentous mitochondria benefit dermal papilla cells in cellular migration	INTERNATIONAL JOURNAL OF COSMETIC SCIENCE			English	Article						ageing; cell culture; hair growth; mitochondria; platelet-derived growth factor-AA; skin physiology	HAIR FOLLICLE; GROWTH-FACTOR; FIBROBLASTS; MORPHOLOGY; DISEASES; ALPHA; PHASE	Synopsis ObjectivesHuman dermal papilla cells (HDPCs) play essential roles in hair follicular morphogenesis and postnatal hair growth cycles. Previous reports demonstrated that platelet-derived growth factor-AA (PDGF-AA) enhanced the formation of dermal condensates in hair follicular development. Additionally, PDGF-AA induces/maintains the anagen phase of the hair cycle. It is likely that mitochondrial morphology and functions are tightly coupled with maintenance of these energy-demanding activities. However, little is known about the mitochondrial regulation in HDPCs. Thus, we investigated the PDGF-involved mitochondrial regulation in HDPCs. MethodsThe mitochondrial morphologies of HDPCs were examined in the presence or absence of PDGF-AA under a fluorescent microscope. ATP production and cellular motility were investigated. The relationship between mitochondrial morphology and the cellular functions was discussed. ResultsWe observed that primary HDPCs contained mitochondria with filamentous and/or rounded morphologies. Both types of mitochondria showed similar membrane potentials. Interestingly, in the presence of PDGF-AA, but not PDGF-BB, the balance between the two morphologies shifted towards the filamentous form. Concomitantly, both mitochondrial enzymatic activity and total cellular ATP level were augmented by PDGF-AA. These two parameters were closely correlated, suggesting the mitochondrial involvement in the PDGF-augmented ATP production. Moreover, PDGF-AA accelerated the migration of HDPCs in a gap-filling assay, but did not change the rate of cellular proliferation. Notably, filamentous mitochondria dominated migrating HDPCs. ConclusionPDGF-AA benefits HDPCs in the process of migration, by increasing the number of filamentous mitochondria. Resume ObjectifLes cellules de papilles dermiques humaines (HDPCs) jouent un role essentiel dans la morphogenese folliculaire des cheveux et des cycles postnatales de croissance des cheveux. Des rapports anterieurs ont demontre que le facteur de croissance AA derive des plaquettes (PDGF-AA) ameliore la formation de condensats dermiques pendant le developpement folliculaire des cheveux. En outre, PDGF-AA induit/maintient la phase anagene du cycle pilaire. Il est probable que la morphologie et la fonction mitochondriale sont etroitement couplees avec le maintien de ces activites exigeant de l'energie. Toutefois, on en sait peu sur la regulation mitochondriale dans les HDPCs. Ainsi, nous avons etudie la regulation mitochondriale impliquant le PDGF dans HDPCs. MethodesLes morphologies des HDPCs mitochondriales ont ete examinees en presence ou en l'absence de PDGF-AA sous un microscope a fluorescence. Nous avons etudie la production d'ATP cellulaire et la motilite. La relation entre la morphologie mitochondriale et les fonctions cellulaires a ete discutee. ResultatsNous avons observe que les HDPCs primaires contenaient des mitochondries aux morphologies filamenteux et/ou arrondies. Les deux types de mitochondries ont montre des potentiels de membrane similaires. Fait interessant, en presence de PDGF-AA, mais pas du PDGF-BB, l'equilibre entre les deux morphologies est deplace vers la forme filamenteuse. En meme temps, a la fois l'activite enzymatique mitochondriale et le niveau de l'ATP cellulaire total ont ete augmentes par PDGF-AA. Ces deux parametres sont etroitement correles, suggerant l'implication du PDGF augmente dans la production mitochondriale d'ATP. De plus, le PDGF-AA a accelere la migration des HDPCs dans un test de scratch', mais ne modifie pas le taux de proliferation cellulaire. Notamment, les mitochondries filamenteuses dominaient la migration des HDPCs.	[Mifude, C.; Kaseda, K.] Saravio Cosmet Ltd, Saravio Cent Inst, Beppu, Oita 8740840, Japan	Kaseda, K (reprint author), Saravio Cosmet Ltd, Saravio Cent Inst, 1356-6 Oaza Tsurumi, Beppu, Oita 8740840, Japan.	kaseda@saravio.jp					Stock P, 2007, MOL CANCER THER, V6, P1932, DOI 10.1158/1535-7163.MCT-06-0720; Tomita Y, 2006, J DERMATOL SCI, V43, P105, DOI 10.1016/j.jdermsci.2006.03.012; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Karlsson L, 1999, DEVELOPMENT, V126, P2611; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; Yu DW, 2004, J INVEST DERMATOL, V123, P283, DOI 10.1111/j.0022-202X.2004.23212.x; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Picard M, 2013, AM J PHYSIOL-REG I, V304, pR393, DOI 10.1152/ajpregu.00584.2012; Warda M, 2013, EXPERT REV PROTEOMIC, V10, P97, DOI [10.1586/epr.12.69, 10.1586/EPR.12.69]; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Ma QY, 2011, ANN NEUROL, V70, P920, DOI 10.1002/ana.22549; Schneider L, 2010, CELL PHYSIOL BIOCHEM, V25, P279, DOI 10.1159/000276562; Vidali S, 2014, J INVEST DERMATOL, V134, P33, DOI 10.1038/jid.2013.286; Asakawa K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00424; Bertoni-Freddari C, 2003, NATURWISSENSCHAFTEN, V90, P68, DOI 10.1007/s00114-002-0398-8; BREATHNA.AS, 1968, J ANAT, V102, P511; Feichtinger RG, 2014, EXP DERMATOL, V23, P607, DOI 10.1111/exd.12484; Gosslau A, 2001, COMP BIOCHEM PHYS A, V128, P241, DOI 10.1016/S1095-6433(00)00303-2; JAKOVCIC S, 1978, J CELL BIOL, V77, P887, DOI 10.1083/jcb.77.3.887; Mirmirani P, 2010, AGING HAIR, P67, DOI 10.1007/978-3-642-02636-2_8; Silengo M, 2003, EUR J PEDIATR, V162, P459, DOI 10.1007/s00431-003-1228-5; Wappler EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063206; Wartenberg M, 1998, INT J CANCER, V75, P855, DOI 10.1002/(SICI)1097-0215(19980316)75:6<855::AID-IJC7>3.0.CO;2-U; WU PC, 1984, ARCH PATHOL LAB MED, V108, P914	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-5463	1468-2494		INT J COSMETIC SCI	Int. J. Cosmetic Sci.	JUN	2015	37	3					266	271		10.1111/ics.12190		6	Chemistry, Applied; Dermatology	Chemistry; Dermatology	CH7JC	WOS:000354211200002		
J	Bergman, IM; Okumura, N; Uenishi, H; Hammer, SE; Knoll, A; Edfors, I; Juul-Madsen, HR				Bergman, I. M.; Okumura, N.; Uenishi, H.; Hammer, S. E.; Knoll, A.; Edfors, I.; Juul-Madsen, H. R.			Wild boars from Sweden, Austria, the Czech Republic and Japan possess intact mannose-binding lectin 2 (MBL2) genes	INTERNATIONAL JOURNAL OF IMMUNOGENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; HAPLOTYPE RECONSTRUCTION; COLLAGENOUS LECTINS; DOMESTIC PIGS; EVOLUTION	The two-nucleotide deletion recently detected in the mannose-binding lectin 2 gene in purebred and crossbred domestic pigs was not found among 68 wild boars representing 4 populations from Europe and Asia. This suggests that the deletion is a result of breeding and/or genetic drift/bottle necks.	[Bergman, I. M.; Juul-Madsen, H. R.] Aarhus Univ, Fac Sci & Technol, Dept Anim Sci, DK-8830 Tjele, Denmark; [Okumura, N.] Inst Soc Technoinnovat Agr Forestry & Fisheries, Anim Res Div, Tsukuba, Ibaraki, Japan; [Uenishi, H.] Natl Inst Agrobiol Sci, Anim Genome Res Unit, Agrogen Res Ctr, Tsukuba, Ibaraki, Japan; [Uenishi, H.] Natl Inst Agrobiol Sci, Div Anim Sci, Anim Immune & Cell Biol Res Unit, Tsukuba, Ibaraki, Japan; [Hammer, S. E.] Univ Vet Med Vienna, Inst Immunol, Dept Pathobiol, Vienna, Austria; [Knoll, A.] Mendel Univ Brno, Ceitec Mendelu, Brno, Czech Republic; [Edfors, I.] Linnaeus Univ, Sch Nat Sci, Fac Sci & Engn, Kalmar, Sweden	Juul-Madsen, HR (reprint author), Aarhus Univ, Dept Anim Sci, Postboks 50, DK-8830 Tjele, Denmark.	helle.juulmadsen@agrsci.dk			Department of Animal Science, Aarhus University, Denmark	This work was supported by Department of Animal Science, Aarhus University, Denmark. We would like to thank Ms. Helle Handll Christensen for excellent technical assistance.	Stephan K, 2007, EUR J IMMUNOL, V37, P212, DOI 10.1002/eji.200636156; Iwaki D, 2006, J IMMUNOL, V177, P8626; Selman L, 2012, IMMUNOBIOLOGY, V217, P851, DOI 10.1016/j.imbio.2011.12.008; Phatsara C, 2007, INT J IMMUNOGENET, V34, P55, DOI 10.1111/j.1744-313X.2007.00656.x; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Takahashi K, 2011, EXPERT REV ANTI-INFE, V9, P1179, DOI [10.1586/eri.11.136, 10.1586/ERI.11.136]; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Bergman IM, 2010, IMMUNOGENETICS, V62, P49, DOI 10.1007/s00251-009-0409-4; Bergman IM, 2013, INT J IMMUNOGENET, V40, P131, DOI 10.1111/j.1744-313X.2012.01132.x; Bergman I. M., 2011, INT J IMMUNOGENET, V39, P68; Bergman IM, 2014, IMMUNOGENETICS, V66, P171, DOI 10.1007/s00251-014-0758-5; Chen SY, 2013, IMMUNOGENETICS, V65, P737, DOI 10.1007/s00251-013-0718-5; Jann OC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-288; Keirstead ND, 2011, VET IMMUNOL IMMUNOP, V142, P1, DOI 10.1016/j.vetimm.2011.02.011; Lillie BN, 2006, IMMUNOGENETICS, V58, P983, DOI 10.1007/s00251-006-0160-z; Lillie BN, 2005, VET IMMUNOL IMMUNOP, V108, P97, DOI 10.1016/j.vetimm.2005.07.001; Lillie BN, 2007, DEV COMP IMMUNOL, V31, P830, DOI 10.1016/j.dci.2006.11.002; Semang K, 2013, MOL BREEDING, V33, P1	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-3121	1744-313X		INT J IMMUNOGENET	Int. J. Immunogenet.	JUN	2015	42	3					204	207		10.1111/iji.12195		4	Genetics & Heredity; Immunology	Genetics & Heredity; Immunology	CH9WX	WOS:000354388300011		
J	Konuma, T; Kato, S; Yuji, K; Ohno, N; Uchimaru, K; Takahashi, S; Tojo, A				Konuma, T.; Kato, S.; Yuji, K.; Ohno, N.; Uchimaru, K.; Takahashi, S.; Tojo, A.			Clearance of blasts from peripheral blood during induction chemotherapy using exponential decay model predicts complete remission and long-term survival in adult acute myeloid leukemia	INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY			English	Letter							ACUTE LYMPHOBLASTIC-LEUKEMIA; POOR-PROGNOSIS; THERAPY; CHILDREN		[Konuma, T.; Kato, S.; Yuji, K.; Ohno, N.; Uchimaru, K.; Takahashi, S.; Tojo, A.] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Tokyo, Japan	Konuma, T (reprint author), Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Tokyo, Japan.	tkonuma@ims.u-tokyo.ac.jp					Gianfaldoni G, 2008, BLOOD, V111, P1746, DOI 10.1182/blood-2007-10-121103; Lacombe F, 2009, LEUKEMIA, V23, P350, DOI 10.1038/leu.2008.296; Elliott MA, 2007, BLOOD, V110, P4172, DOI 10.1182/blood-2007-07-104091; Arellano M, 2012, CANCER-AM CANCER SOC, V118, P5278, DOI 10.1002/cncr.27494; GAJJAR A, 1995, BLOOD, V86, P1292; Manabe A, 2008, HAEMATOL-HEMATOL J, V93, P1155, DOI 10.3324/haematol.12365; Vainstein V, 2014, LEUKEMIA, V28, P713, DOI 10.1038/leu.2013.341; Slovak ML, 2000, BLOOD, V96, P4075; Gianfaldoni G, 2006, BRIT J HAEMATOL, V134, P54, DOI 10.1111/j.1365-2141.2006.06100.x; RAUTONEN J, 1988, BLOOD, V71, P989	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-5521	1751-553X		INT J LAB HEMATOL	Int. J. Lab. Hematol.	JUN	2015	37	3					E59	E62		10.1111/ijlh.12302		4	Hematology	Hematology	CH4TB	WOS:000354024700002		
J	Ishida, Y; Zhao, DW; Ohkuchi, A; Kuwata, T; Yoshitake, H; Yuge, K; Takizawa, T; Matsubara, S; Suzuki, M; Saito, S; Takizawa, T				Ishida, Yoichi; Zhao, Dongwei; Ohkuchi, Akihide; Kuwata, Tomoyuki; Yoshitake, Hiroshi; Yuge, Kazuya; Takizawa, Takami; Matsubara, Shigeki; Suzuki, Mitsuaki; Saito, Shigeru; Takizawa, Toshihiro			Maternal peripheral blood natural killer cells incorporate placenta-associated microRNAs during pregnancy	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						microRNA; chromosome 19 microRNA cluster; mRNA; maternal peripheral blood; natural killer cell; human placenta	NK CELLS; T-CELLS; IDENTIFICATION; ENVIRONMENT; ACTIVATION; REGULATORS; SIGNATURES; EVOLUTION; RESPONSES; EXOSOMES	Although recent studies have demonstrated that microRNAs (miRNAs or miRs) regulate fundamental natural killer (NK) cellular processes, including cytotoxicity and cytokine production, little is known about the miRNA-gene regulatory relationships in maternal peripheral blood NK (pNK) cells during pregnancy. In the present study, to determine the roles of miRNAs within gene regulatory networks of maternal pNK cells, we performed comprehensive miRNA and gene expression profiling of maternal pNK cells using a combination of reverse transcription quantitative PCR (RT-qPCR)-based miRNA array and DNA microarray analyses and analyzed the differential expression levels between first-and third-trimester pNK cells. Furthermore, we constructed regulatory networks for miRNA-mediated gene expression in pNK cells during pregnancy by Ingenuity Pathway Analysis (IPA). PCR-based array analysis revealed that the placenta-derived miRNAs [chromosome 19 miRNA cluster (C19MC) miRNAs] were detected in pNK cells during pregnancy. Twenty-five miRNAs, including six C19MC miRNAs, were significantly upregulated in the third-compared to first-trimester pNK cells. The rapid clearance of C19MC miRNAs also occurred in the pNK cells following delivery. Nine miRNAs, including eight C19MC miRNAs, were significantly downregulated in the post-delivery pNK cells compared to those of the third-trimester. DNA microarray analysis identified 69 NK cell function-related genes that were differentially expressed between the first-and third-trimester pNK cells. On pathway and network analysis, the observed gene expression changes of pNK cells likely contribute to the increase in the cytotoxicity, as well as the cell cycle progression of third-compared to first-trimester pNK cells. Thirteen of the 69 NK cell function-related genes were significantly downregulated between the first-and third-trimester pNK cells. Nine of the 13 downregulated NK-function-associated genes were in silico target candidates of 12 upregulated miRNAs, including C19MC miRNA miR-512-3p. The results of this study suggest that the transfer of placental C19MC miRNAs into maternal pNK cells occurs during pregnancy. The present study provides new insight into maternal NK cell functions.	[Ishida, Yoichi; Ohkuchi, Akihide; Kuwata, Tomoyuki; Matsubara, Shigeki; Suzuki, Mitsuaki] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi 3290498, Japan; [Ishida, Yoichi; Zhao, Dongwei; Yoshitake, Hiroshi; Yuge, Kazuya; Takizawa, Takami; Takizawa, Toshihiro] Nippon Med Sch, Grad Sch Med, Dept Mol Med & Anat, Tokyo 1138602, Japan; [Saito, Shigeru] Toyama Univ, Fac Med, Dept Obstet & Gynecol, Toyama 9300194, Japan	Takizawa, T (reprint author), Nippon Med Sch, Grad Sch Med, Dept Mol Med & Anat, 1-1-5 Sendagi, Tokyo 1138602, Japan.	t-takizawa@nms.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (Japan) [23390386, 24390383]; Ministry of Health, Labour and Welfare (Japan) [H26-itaku(nan)-ippan-082]; MEXT	The authors are indebted to Mr. Takuji Kosuge and Ms. Kazuko Tanaka (Nippon Medical School) for their technical assistance. This study was supported in part by Grants-in-Aids for Scientific Research (no. 23390386 to S. Saito; no. 24390383 to T. Takizawa) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (Japan), by Grant-in-Aid [no. H26-itaku(nan)-ippan-082 to S. Saito] from the Ministry of Health, Labour and Welfare (Japan), and by a grant from the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2013-2017) to T. Takizawa.	Allantaz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029979; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Li DM, 2009, J IMMUNOL, V182, P1033; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Vivier E, 2011, SCIENCE, V331, P44, DOI 10.1126/science.1198687; Leong JW, 2014, EUR J IMMUNOL, V44, P2862, DOI 10.1002/eji.201444798; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Yusa S, 2002, J IMMUNOL, V168, P5047; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Elliott JM, 2010, J EXP MED, V207, P2073, DOI 10.1084/jem.20100986; Kalkunte S, 2008, AM J REPROD IMMUNOL, V59, P425, DOI 10.1111/j.1600-0897.2008.00595.x; Van Kaer L, 2004, IMMUNOL RES, V30, P139, DOI 10.1385/IR:30:2:139; Santoni A, 2008, AM J REPROD IMMUNOL, V59, P417, DOI 10.1111/j.1600-0897.2008.00598.x; Liu X, 2012, IMMUNOL LETT, V143, P208, DOI 10.1016/j.imlet.2012.02.014; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Moffett A, 2014, J CLIN INVEST, V124, P1872, DOI 10.1172/JCI68107; Joncker NT, 2010, J EXP MED, V207, P2065, DOI 10.1084/jem.20100570; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477; Beaulieu AM, 2013, IMMUNOL REV, V253, P40, DOI 10.1111/imr.12045; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Carrega P, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00347; Curran EM, 2001, CELL IMMUNOL, V214, P12, DOI 10.1006/cimm.2002.1886; Dybkaer K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-230; Jabrane-Ferrat N, 2014, IMMUNOLOGY, V141, P490, DOI 10.1111/imm.12218; Kambe Saori, 2014, Biol Reprod, V91, P129, DOI 10.1095/biolreprod.114.121616; Lu SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021611; Morales-Prieto DM, 2014, PLACENTA, V35, pS39, DOI 10.1016/j.placenta.2013.11.017; Taylor DD, 2006, J IMMUNOL, V176, P1534; Ueda N, 2006, INT IMMUNOL, V18, P1397, DOI 10.1093/intimm/dxl073; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; van den Heuvel MJ, 2005, AM J REPROD IMMUNOL, V54, P322, DOI 10.1111/j.1600-0897.2005.00336.x; Wang P, 2012, J IMMUNOL, V189, P211, DOI 10.4049/jimmunol.1200609	35	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	JUN	2015	35	6					1511	1524		10.3892/ijmm.2015.2157		14	Medicine, Research & Experimental	Research & Experimental Medicine	CH5MY	WOS:000354081100004		
J	Aoyama, Y; Yamamoto, T; Sakaguchi, N; Ishige, M; Tanaka, T; Ichihara, T; Ohara, K; Kouzan, H; Kinosada, Y; Fukao, T				Aoyama, Yuka; Yamamoto, Toshiyuki; Sakaguchi, Naomi; Ishige, Mika; Tanaka, Toju; Ichihara, Tomoko; Ohara, Katsuaki; Kouzan, Hiroko; Kinosada, Yasutomi; Fukao, Toshiyuki			Application of multiplex ligation-dependent probe amplification, and identification of a heterozygous Alu-associated deletion and a uniparental disomy of chromosome 1 in two patients with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						multiplex ligation-dependent probe amplification; mitochondrial 3-hydroxy-3-methylglutaryl CoA lyase; Alu element; uniparental disomy; microarray	THIOLASE T2 DEFICIENCY; DMD GENE; MLPA; MUTATION; DUPLICATIONS; ISODISOMY; DISEASE	Mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase (HMGCL) deficiency is an autosomal recessive disorder affecting the leucine catabolic pathway and ketone body synthesis, and is clinically characterized by metabolic crises with hypoketotic hypoglycemia, metabolic acidosis and hyperammonemia. In the present study, we initially used PCR with genomic followed by direct sequencing to investigate the molecular genetic basis of HMGCL deficiency in two patients clinically diagnosed with the condition. Although we identified a mutation in each patient, the inheritance patterns of these mutations were not consistent with disease causation. Therefore, we investigated HMGCL using multiplex ligation-dependent probe amplification (MLPA) to determine the copy numbers of all exons. A heterozygous deletion that included exons 2-4 was identified in one of the patients. MLPA revealed that the other patient had two copies for all HMGCL exons. Paternal uniparental isodisomy of chromosome 1 was confirmed in this patient by microarray analysis. These findings indicate that MLPA is useful for the identification of genomic aberrations and mutations other than small-scale nucleotide alterations. To the best of our knowledge, this is the first study describing HMGCL deficiency caused by uniparental disomy.	[Aoyama, Yuka; Kinosada, Yasutomi] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Med Informat Sci Div, Gifu 5011194, Japan; [Aoyama, Yuka] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 4878501, Japan; [Yamamoto, Toshiyuki] Tokyo Womens Med Univ, Inst Integrated Med Sci TIIMS, Tokyo 1628666, Japan; [Sakaguchi, Naomi; Fukao, Toshiyuki] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu 5011194, Japan; [Ishige, Mika] Nihon Univ, Sch Med, Dept Pediat, Sapporo, Hokkaido 0630005, Japan; [Tanaka, Toju] NHO Hokkaido Med Ctr, Dept Pediat & Clin Res, Sapporo, Hokkaido 0630005, Japan; [Ichihara, Tomoko; Ohara, Katsuaki; Kouzan, Hiroko] Takamatsu Red Cross Hosp, Dept Pediat, Takamatsu, Kagawa 7600017, Japan	Fukao, T (reprint author), Gifu Univ, Grad Sch Med, Dept Pediat, 1-1 Yanagido, Gifu 5011194, Japan.	toshi-gif@umin.net			Ministry of Education, Culture, Sports, Science and Technology of Japan [26114708, 24591505]; Ministry of Health, Labor and Welfare of Japan	We are grateful to the patients for their participation in this study. The present study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (26114708, 24591505) and Health and Labor Science Research Grants for Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan to T.F.	Janssen B, 2005, NEUROGENETICS, V6, P29, DOI 10.1007/s10048-004-0204-1; Riveiro-Alvarez R, 2007, MOL VIS, V13, P96; Lalic T, 2005, EUR J HUM GENET, V13, P1231, DOI 10.1038/sj.ejhg.501465; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757; Fukao T, 2014, J INHERIT METAB DIS, V37, P541, DOI 10.1007/s10545-014-9704-9; Roberts JL, 2012, P NATL ACAD SCI USA, V109, P10456, DOI 10.1073/pnas.1202249109; Gatta V, 2005, HUM GENET, V117, P92, DOI 10.1007/s00439-005-1270-7; Fukao T, 2013, MOL GENET METAB, V110, P184, DOI 10.1016/j.ymgme.2013.07.004; Fukao T, 2007, MOL GENET METAB, V92, P375, DOI 10.1016/j.ymgme.2007.07.007; Le Beyec J, 2013, J CLIN ENDOCR METAB, V98, pE397, DOI 10.1210/jc.2012-2779; Muroi J, 2000, HUM GENET, V107, P320, DOI 10.1007/s004390000363; Nimmo G, 2010, AM J MED GENET A, V152A, P1812, DOI 10.1002/ajmg.a.33489; Sen SK, 2006, AM J HUM GENET, V79, P41; Shimojima K, 2013, J NEUROL SCI, V330, P123, DOI 10.1016/j.jns.2013.04.017; Tomoko T, 2008, J JPN PEDIAT SOC, V112, P1249; Wang SP, 1996, GENOMICS, V33, P99, DOI 10.1006/geno.1996.0164; Wassink TH, 2005, HUM GENET, V117, P200, DOI 10.1007/s00439-005-1257-4; Zeng WQ, 2006, AM J MED GENET A, V140A, P1004, DOI 10.1002/ajmg.a.31186; Zhang GX, 2006, MOL GENET METAB, V89, P222, DOI 10.1016/j.ymgme.2006.06.010; Zhi JZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-407	20	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	JUN	2015	35	6					1554	1560		10.3892/ijmm.2015.2184		7	Medicine, Research & Experimental	Research & Experimental Medicine	CH5MY	WOS:000354081100008		
J	Ibusuki, K; Sakiyama, T; Kanmura, S; Maeda, T; Iwashita, Y; Nasu, Y; Sasaki, F; Taguchi, H; Hashimoto, S; Numata, M; Uto, H; Tsubouchi, H; Ido, A				Ibusuki, Kazunari; Sakiyama, Toshio; Kanmura, Shuji; Maeda, Takuro; Iwashita, Yuji; Nasu, Yuichiro; Sasaki, Fumisato; Taguchi, Hiroki; Hashimoto, Shinichi; Numata, Masatsugu; Uto, Hirofumi; Tsubouchi, Hirohito; Ido, Akio			Human neutrophil peptides induce interleukin-8 in intestinal epithelial cells through the P2 receptor and ERK1/2 signaling pathways	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						human neutrophil peptide; interleukin-8; intestinal epithelial cell; P2 receptor; extracellular signal-regulated kinase 1/2	INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; PURINERGIC RECEPTORS; CARCINOMA-CELLS; EXPRESSION; RELEASE; IL-8; DEFENSINS; INHIBITION; ACTIVATION	Human neutrophil peptides (HNPs) are antimicrobial peptides produced predominantly by neutrophils. We have previously reported that HNP 1-3 levels are increased in the sera and plasma of patients with active ulcerative colitis. The increased expression of interleukin-8 (IL-8) has also been demonstrated in the colonic mucosa of patients with active ulcerative colitis. HNPs induce IL-8 in lung epithelial cells and monocytes through the P2Y(6) signaling pathway. However, the association between HNPs and IL-8 in the intestinal mucosa has not yet been investigated. In the present study, we investigated the effects of HNP-1 on the production of IL-8 by human intestinal epithelial cells and the underlying signaling mechanisms. We observed a significant increase in IL-8 expression in the human colon carcinoma cell line, Caco-2, following treatment with HNP-1. The non-selective P2 receptor antagonists, suramin and pyridoxal phosphate-6-azo (benzene-2,4-disulfonic acid) tetrasodium salt hydrate (PPADS), significantly blocked the HNP-1-induced expression of IL-8 in the Caco-2 cells. The P2Y(6)-specific antagonist, MRS2578, led to a significant but partial decrease in IL-8 expression, suggesting that P2 receptors in addition to P2Y(6) are involved in the HNP-1-induced production of IL-8 by Caco-2 cells. In agreement with this finding, HNP-1 also significantly increased IL-8 production in the P2Y(6)-negative human colon cancer cell line, HT-29, and this increase was blocked by treatment with suramin and PPADS. HNP-1 significantly increased the phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) and p38 mitogen-activated protein kinase (MAPK) in the HT-29 cells. However, the HNP-1-induced production of IL-8 was suppressed by the ERK1/2 inhibitor, U0126, but not by the p38 MAPK inhibitor, SB203580. In conclusion, our data demonstrate that HNP-1 induces IL-8 production not only through P2Y(6), but also through additional P2 receptors via an ERK1/2-dependent mechanism in intestinal epithelial cells.	[Ibusuki, Kazunari; Sakiyama, Toshio; Kanmura, Shuji; Maeda, Takuro; Iwashita, Yuji; Nasu, Yuichiro; Sasaki, Fumisato; Taguchi, Hiroki; Hashimoto, Shinichi; Numata, Masatsugu; Uto, Hirofumi; Tsubouchi, Hirohito; Ido, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Digest & Lifestyle Dis, Kagoshima 8908544, Japan	Kanmura, S (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Digest & Lifestyle Dis, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	skanmura@m2.kufm.kagoshima-u.ac.jp					Li J, 2009, INVEST OPHTH VIS SCI, V50, P644, DOI 10.1167/iovs.08-1838; Grbic DM, 2008, J IMMUNOL, V180, P2659; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Otte JM, 2009, REGUL PEPTIDES, V156, P104, DOI 10.1016/j.regpep.2009.03.009; MITSUYAMA K, 1994, CLIN EXP IMMUNOL, V96, P432; Mortaz E, 2011, BBA-MOL BASIS DIS, V1812, P1104, DOI 10.1016/j.bbadis.2011.06.002; Kottgen M, 2003, J CLIN INVEST, V111, P371, DOI 10.1172/JCI200316711; Khare V, 2013, BIOCHEM PHARMACOL, V85, P234, DOI 10.1016/j.bcp.2012.10.026; Brazil JC, 2013, INFLAMM BOWEL DIS, V19, P1556, DOI 10.1097/MIB.0b013e318281f54e; Khine AA, 2006, BLOOD, V107, P2936, DOI 10.1182/blood-2005-06-2314; Jijon HB, 2002, AM J PHYSIOL-CELL PH, V283, pC31, DOI 10.1152/ajpcell.00113.2001; Asakura K, 2009, J GASTROENTEROL, V44, P659, DOI 10.1007/s00535-009-0057-3; Ahn JK, 2013, RHEUMATOLOGY, V52, P1368, DOI 10.1093/rheumatology/ket147; Kanmura S, 2009, INFLAMM BOWEL DIS, V15, P909, DOI 10.1002/ibd.20854; Liu CY, 2007, LIFE SCI, V80, P749, DOI 10.1016/j.lfs.2006.11.016; Kaiser GC, 1999, GASTROENTEROLOGY, V116, P602, DOI 10.1016/S0016-5085(99)70182-4; Hashimoto S, 2012, INFLAMM BOWEL DIS, V18, P667, DOI 10.1002/ibd.21855; Chertov O, 1996, J BIOL CHEM, V271, P2935; Communi D, 1999, BRIT J PHARMACOL, V128, P1199, DOI 10.1038/sj.bjp.0702909; Coutinho-Silva R, 2005, AM J PHYSIOL-GASTR L, V288, pG1024, DOI 10.1152/ajpgi.00211.2004; TERRITO MC, 1989, J CLIN INVEST, V84, P2017, DOI 10.1172/JCI114394; Amenomori M, 2010, EXP LUNG RES, V36, P411, DOI 10.3109/01902141003714049; Syeda F, 2008, J CELL PHYSIOL, V214, P820, DOI 10.1002/jcp.21279; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; MAZZUCCHELLI L, 1994, AM J PATHOL, V144, P997; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Waetzig GH, 2003, ALIMENT PHARM THERAP, V18, P17, DOI 10.1046/j.0269-2813.2003.01642.x; Bahrami F, 2014, MEDIAT INFLAMM, V2014; Delbro D. S., 2005, Autonomic & Autacoid Pharmacology, V25, P163, DOI 10.1111/j.1474-8673.2005.00345.x; Kolachala VL, 2008, AM J PHYSIOL-GASTR L, V294, pG401, DOI 10.1152/ajpgi.00454.2007; Kruse R, 2012, J UROLOGY, V188, P2419, DOI 10.1016/j.juro.2012.07.095; McAlroy HL, 2000, BRIT J PHARMACOL, V131, P1651, DOI 10.1038/sj.bjp.0703743; Nylund G, 2004, AUTON NEUROSCI-BASIC, V112, P69, DOI 10.1016/j.autneu.2004.04.003; Rodriguez-Peralvarez ML, 2012, INFLAMM BOWEL DIS, V18, P1864, DOI 10.1002/ibd.22865; Sakamoto N, 2005, AM J PHYSIOL-LUNG C, V288, pL508, DOI 10.1152/ajplung.00076.2004; Somers GR, 1998, LAB INVEST, V78, P1375; Subramanian S, 2008, INFLAMM BOWEL DIS, V14, P162, DOI 10.1002/ibd.20296; van Wetering S, 2002, INFLAMM RES, V51, P8, DOI 10.1007/PL00000282	39	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	JUN	2015	35	6					1603	1609		10.3892/ijmm.2015.2156		7	Medicine, Research & Experimental	Research & Experimental Medicine	CH5MY	WOS:000354081100013		
J	Onodera, T; Kuriyama, I; Andoh, T; Ichikawa, H; Sakamoto, Y; Lee-Hiraiwa, E; Mizushina, Y				Onodera, Takefumi; Kuriyama, Isoko; Andoh, Tooru; Ichikawa, Hideki; Sakamoto, Yuka; Lee-Hiraiwa, Eibai; Mizushina, Yoshiyuki			Influence of particle size on the in vitro and in vivo anti-inflammatory and anti-allergic activities of a curcumin lipid nanoemulsion	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						curcumin; lipid nanoemulsion; anti-inflammatory; tumor necrosis factor-alpha; anti-allergic; beta-hexosaminidase	NEUTRON-CAPTURE THERAPY; DNA-POLYMERASE-LAMBDA; WT1 GENE-EXPRESSION; CHEMOPREVENTIVE AGENT; LIPOPHILIC DRUGS; CLINICAL-TRIAL; EMULSIONS; CELLS; BIODISTRIBUTION; PHARMACOKINETICS	The polyphenolic compound, curcumin, is a natural yellow pigment component of turmeric. It exerts various biological effects, such as anti-inflammatory effects, and we have previously demonstrated that curcumin is a specific inhibitor of DNA polymerase.. Curcumin is characterized by poor bioavailability as it is water-insoluble, is poorly absorbed and is systemically eliminated. In order to increase the bioavailability of curcumin, in this study, we produced a curcumin-loaded lipid nanoemulsion of various particle sizes (50, 100 and 200 nm). The curcumin lipid nanoemulsion was prepared by a modified thin-film hydration method followed by sonication. To identify the optimal particle size which exhibits the strongest physiological activity, we investigated the inhibitory effects of the obtained nanoemulsions against inflammatory and allergic activities. In in vitro cell culture experiments, the 100-nm curcumin lipid nanoemulsion showed the most prominent inhibitory effect on the production of tumor necrosis factor-alpha (TNF-alpha) induced by lipopolysaccharide (LPS) in RAW264.7 murine macrophages, and on the release of beta-hexosaminidase induced by the calcium ionophore, A23187, in rat basophilic leukemia RBL-2H3 cells. In an in vivo experiment, in which mice were administered the curcumin-loaded lipid nanoemulsion of various particle sizes, the 100-nm curcumin lipid nanoemulsion showed the most prominent anti-inflammatory and anti-allergic effects, inhibiting 12-O-tetradecanoylphorbol-13-acetate-induced inflammatory ear edema and immunoglobulin E (IgE)-induced passive cutaneous anaphylactic (PCA) reaction. The effects of particle size on serum curcumin absorption were also assessed in mice, and the 100-nm lipid nanoemulsion showed the greatest absorption. The results from our study suggest that the physiological activities of curcumin lipid nanoemulsions differ depending on particle size. Our data indicate that the curcumin lipid nanoemulsion with a particle size of 100 nm has potential for use in enhancing the bioavailability and medical value of curcumin.	[Onodera, Takefumi; Sakamoto, Yuka] Kobe Gakuin Univ, Fac Nutr, Lab Food & Nutr Sci, Kobe, Hyogo 6512180, Japan; [Onodera, Takefumi; Kuriyama, Isoko; Andoh, Tooru; Ichikawa, Hideki; Lee-Hiraiwa, Eibai; Mizushina, Yoshiyuki] Kobe Gakuin Univ, Cooperat Res Ctr Life Sci, Kobe, Hyogo 6518586, Japan; [Kuriyama, Isoko; Lee-Hiraiwa, Eibai] Kobe Gakuin Univ, Fac Pharmaceut Sci, Pharmacol Lab, Kobe, Hyogo 6518586, Japan; [Andoh, Tooru; Ichikawa, Hideki] Kobe Gakuin Univ, Fac Pharmaceut Sci, Lab Pharmaceut Technol, Kobe, Hyogo 6518586, Japan; [Mizushina, Yoshiyuki] Shinshu Univ, Grad Sch Agr, Matsumoto, Nagano 3994598, Japan	Mizushina, Y (reprint author), Shinshu Univ, Grad Sch Agr, 8304 Minamiminowa Mura, Matsumoto, Nagano 3994598, Japan.	mizushina@shinshu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT, Japan); MEXT [24580205]; 25th Cosmetology Research Foundation (Japan)	This study was supported in part by the Ministry of Education, Culture, Sports, Science and Technology (MEXT, Japan)-Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016. Y.M. acknowledges Grants-in-Aid for Scientific Research (C) (no. 24580205) from MEXT, and the 25th (2014) Cosmetology Research Foundation (Japan).	Vareed SK, 2008, CANCER EPIDEM BIOMAR, V17, P1411, DOI 10.1158/1055-9965.EPI-07-2693; Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704; Metcalfe DD, 2009, J ALLERGY CLIN IMMUN, V124, P639, DOI 10.1016/j.jaci.2009.08.035; Anand P, 2007, MOL PHARM, V4, P807, DOI 10.1021/mp700113r; Goutayer M, 2010, EUR J PHARM BIOPHARM, V75, P137, DOI 10.1016/j.ejpb.2010.02.007; Anuchapreeda S, 2008, CANCER CHEMOTH PHARM, V62, P585, DOI 10.1007/s00280-007-0642-1; Solans C, 2005, CURR OPIN COLLOID IN, V10, P102, DOI 10.1016/j.cocis.2005.06.004; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; RAZIN E, 1983, J EXP MED, V157, P189, DOI 10.1084/jem.157.1.189; Texier I, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3213606; Maiti K, 2007, INT J PHARMACEUT, V330, P155, DOI 10.1016/j.ijpharm.2006.09.025; Dorai T, 2001, PROSTATE, V47, P293, DOI 10.1002/pros.1074.abs; Li L, 2005, CANCER, V104, P1322, DOI 10.1002/cncr.21300; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Porter CJH, 2007, NAT REV DRUG DISCOV, V6, P231, DOI 10.1038/nrd2197; Garcea G, 2005, CANCER EPIDEM BIOMAR, V14, P120; POLASA K, 1992, MUTAGENESIS, V7, P107, DOI 10.1093/mutage/7.2.107; Kanai M, 2011, CANCER CHEMOTH PHARM, V68, P157, DOI 10.1007/s00280-010-1470-2; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; MARANHAO RC, 1994, CANCER RES, V54, P4660; Limtrakul PN, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-1; Payton F, 2007, J NAT PROD, V70, P143, DOI 10.1021/np060263s; AMMON HPT, 1993, J ETHNOPHARMACOL, V38, P113; Sato H, 2012, BIOSCI BIOTECH BIOCH, V76, P84, DOI 10.1271/bbb.110536; Anuchapreeda S, 2006, ACTA PHARMACOL SIN, V27, P360, DOI 10.1111/j.1745-7254.2006.00291.x; Anuchapreeda S, 2006, ARCH PHARM RES, V29, P80, DOI 10.1007/BF02977473; Anuchapreeda S, 2002, CHIANG MAI MED B, V41, P189; Anuchapreeda S, 2012, J NANOTECHNOL, V2012; AZUINE MA, 1992, NUTR CANCER, V17, P77; BANERJEE A, 1978, INDIAN J MED RES, V68, P864; SHANKAR T N B, 1979, Indian Journal of Experimental Biology, V17, P1363; Chinsriwongkul Akhayachatra, 2007, PDA J Pharm Sci Technol, V61, P461; Hung CF, 2005, INT J PHARM, V289, P197, DOI 10.1016/j.ijpharm.2004.11.008; HURST WJ, 1984, J AM OIL CHEM SOC, V61, P1462, DOI 10.1007/BF02636365; Kurihara A, 1996, BIOPHARM DRUG DISPOS, V17, P331, DOI 10.1002/(SICI)1099-081X(199605)17:4<331::AID-BDD959>3.0.CO;2-B; LIU F, 1995, PHARMACEUT RES, V12, P1060, DOI 10.1023/A:1016274801930; Miyamoto M, 1999, BIOL PHARM BULL, V22, P1331; Miyamoto M, 1999, CHEM PHARM BULL, V47, P203; Mizushina Y, 2003, LIPIDS, V38, P1065, DOI 10.1007/s11745-006-1162-1; Mizushina Y, 2011, INHIBITION DNA POLYM, P777; Mizushina Y, 2003, BIOCHEM PHARMACOL, V66, P1935, DOI 10.1016/S0006-2952(03)00551-3; Nishida M, 2010, INT J MOL MED, V25, P761, DOI 10.3892/ijmm_00000402; Patel D, 2007, DRUG DEV IND PHARM, V33, P1318, DOI 10.1080/03639040701385527; RAO DS, 1970, J NUTR, V100, P1307; ROY RG, 1976, INDIAN J MED RES, V64, P1451; Sawada T, 1971, SHOYAKUGAKU ZASSHI, V25, P11; Soler-Rodriguez AM, 2000, J IMMUNOL, V164, P2674; Sonneville-Aubrun O, 2004, ADV COLLOID INTERFAC, V108, P145, DOI 10.1016/S0001-8686(03)00146-5; Suzuki T, 2000, BLOOD, V96, P2584; Takeuchi T, 2006, GENES CELLS, V11, P223, DOI 10.1111/j.1365-2443.2006.00937.x; Wang YM, 1999, PHARMACEUT RES, V16, P930, DOI 10.1023/A:1018846607804; WHEELER JJ, 1994, J PHARM SCI, V83, P1558, DOI 10.1002/jps.2600831108	52	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	JUN	2015	35	6					1720	1728		10.3892/ijmm.2015.2186		9	Medicine, Research & Experimental	Research & Experimental Medicine	CH5MY	WOS:000354081100028		
J	Yamaguchi, M; Murata, T				Yamaguchi, Masayoshi; Murata, Tomiyasu			Suppressive effects of exogenous regucalcin on the proliferation of human pancreatic cancer MIA PaCa-2 cells in vitro	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						regucalcin; cell proliferation; pancreatic cancer; MIA PaCa-2 cells; Pt45P1 cells; apoptosis; cell signaling; carcinogenesis	BINDING PROTEIN REGUCALCIN; HEPATOMA H4-II-E CELLS; RAT-LIVER; GENE-EXPRESSION; INVOLVEMENT; OVEREXPRESSION; ACTIVATOR; CLONING; DNA	Regucalcin plays a pivotal role as a suppressor protein in signal transduction in various types of cells and tissues. The regucalcin gene is localized on the X chromosome. and its expression has been shown to be suppressed in various types of tumor tissue in animal and human subjects, suggesting a potential role of regucalcin in carcinogenesis. This study was undertaken to determine the effects of exogenous regucalcin on the proliferation of cloned human pancreatic cancer MIA PaCa-2 cells in vitro. The proliferation of the MIA PaCa-2 cells was suppressed following culture with regucalcin (0.01-10 nM). Such an effect was also observed in pancreatic cancer Pt45P1 cells, that highly expressed tissue factor (high TF), or Pt45P1 cells, that highly expressed alternativly spliced variants of tissue factor (asTF). In the MIA PaCa-2 cells, the suppressive effects of regucalcin on cell proliferation were not enhanced either in the presence of tumor necrosis factor-alpha (TNF-alpha), or in the presence of Bay K 8644, PD98059, staurosporine, wortmannin or 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB). However, this was not the case for gemcitabine, which was shown to suppress cell proliferation. Exogenous regucalcin did not cause apoptotic cell death in the MIA PaCa-2 cells in vitro. These findings demonstrate that exogenous regucalcin exerts suppressive effects on the proliferation of human pancreatic MIA PaCa-2 cells and that these effects are mediated through the inhibition of various signaling pathways related to nuclear factor-beta-B (NF-beta B), extracellular signal-regulated kinase (ERK), protein kinase C, calcium signaling, phosphatidylinositol 3-kinase (PI3K) or nuclear transcription activity in vitro. Our data suggest that exogenous regucalcin exerts suppressive effects on the proliferation of human pancreatic cancer cells.	[Yamaguchi, Masayoshi] Emory Univ, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA 30322 USA; [Murata, Tomiyasu] Meijo Univ, Fac Pharmaceut Sci, Dept Analyt Neurosci, Nagoya, Aichi, Japan	Yamaguchi, M (reprint author), Emory Univ, Dept Hematol & Med Oncol, Sch Med, 1365-C Clifton Rd NE, Atlanta, GA 30322 USA.	yamamasa1155@yahoo.co.jp					Yamaguchi M, 2000, LIFE SCI, V66, P1769, DOI 10.1016/S0024-3205(99)00602-5; Yamaguchi M, 2013, APOPTOSIS, V18, P1145, DOI 10.1007/s10495-013-0859-x; Ninomiya I, 2014, ONCOL LETT, V8, P2709, DOI 10.3892/ol.2014.2553; Yamaguchi M, 1996, MOL CELL BIOCHEM, V165, P145; Yamaguchi M, 2010, MOL CELL BIOCHEM, V341, P119, DOI 10.1007/s11010-010-0443-4; Nakagawa T, 2005, INT J MOL MED, V16, P637; Palangat M, 2011, MOL CELL BIOL, V31, P3312, DOI 10.1128/MCB.05318-11; Tsurusaki Y, 2003, J CELL BIOCHEM, V90, P619, DOI 10.1002/jcb.10652; SHIMOKAWA N, 1995, MOL CELL BIOCHEM, V151, P157, DOI 10.1007/BF01322338; YAMAGUCHI M, 1993, MOL CELL BIOCHEM, V122, P65, DOI 10.1007/BF00925738; Yamaguchi M, 2013, CELL PROLIFERAT, V46, P243, DOI 10.1111/cpr.12036; Cano-Abad MF, 2001, J BIOL CHEM, V276, P39695, DOI 10.1074/jbc.M102334200; Yamaguchi M, 2011, MOL CELL BIOCHEM, V353, P101, DOI 10.1007/s11010-011-0779-4; Thiselton DL, 2002, GENOMICS, V79, P560, DOI 10.1006/geno.2002.6733; YAMAGUCHI M, 1978, CHEM PHARM BULL, V26, P1915; Yamaguchi M, 2011, MOL CELL BIOCHEM, V346, P147, DOI 10.1007/s11010-010-0601-8; Tang SC, 2014, WORLD J GASTROENTERO, V20, P10825, DOI 10.3748/wjg.v20.i31.10825; Yamaguchi M, 2013, METABOLISM, V62, P1045, DOI 10.1016/j.metabol.2013.01.023; Misawa H, 2000, INT J MOL MED, V6, P191; SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A; Yamaguchi M, 2005, J CELL BIOCHEM, V95, P1169, DOI 10.1002/jcb.20490; YAMAGUCHI M, 1988, CHEM PHARM BULL, V36, P3532; Lee ZH, 2000, MOL PHARMACOL, V58, P1536; Tsurusaki Y, 2004, INT J MOL MED, V14, P277; Yamaguchi M, 2013, CELL TISSUE RES, V354, P331, DOI 10.1007/s00441-013-1665-z; Yamaguchi M, 2014, MOL CELL BIOCHEM, V391, P157, DOI 10.1007/s11010-014-1998-2; YAMAGUCHI M, 1991, FEBS LETT, V279, P281, DOI 10.1016/0014-5793(91)80168-3; Maia C, 2009, J CELL BIOCHEM, V107, P667, DOI 10.1002/jcb.22158; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Yamaguchi M, 2005, INT J MOL MED, V15, P371; Chen QW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-52; Chen SY, 2014, ONCOL LETT, V8, P2333, DOI 10.3892/ol.2014.2521; Misawa H, 2002, J CELL BIOCHEM, V84, P143, DOI 10.1002/jcb.1274; Murata T, 2014, INT J MOL MED, V34, P1141, DOI 10.3892/ijmm.2014.1858; Serrano-Nascimento C, 2014, ENDOCRINOLOGY, V155, P1145, DOI 10.1210/en.2013-1665; Yamaguchi M, 2014, J CANC RES CLIN ONCO; Yamaguchi M, 2013, HORM STUD, V1, P1	37	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	JUN	2015	35	6					1773	1778		10.3892/ijmm.2015.2164		6	Medicine, Research & Experimental	Research & Experimental Medicine	CH5MY	WOS:000354081100036		
J	Liotta, G; Stecca, G; Kaihara, T				Liotta, Giacomo; Stecca, Giuseppe; Kaihara, Toshiya			Optimisation of freight flows and sourcing in sustainable production and transportation networks	INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS			English	Article						Mixed integer linear programming; Supply chain network; Bill-of-Materials; Multi-commodity flow; Multi-modal transport; Sustainability; Carbon footprint	SUPPLY-CHAIN MANAGEMENT; DESIGN; LOGISTICS; MODELS	Global supply chains require integrated cost optimisation of sourcing, production and distribution through flexible networks of suppliers, manufacturers and logistics operators. The minimisation of environmental impacts of freight flows must be considered for sustainable development and should turn into a competitive advantage. To these aims, the paper presents a model integrating supply, production networks and sustainable freight transportation for strategic and tactical decision-making. Bill-of-Materials constraints are included in the model. The objective function considers sourcing, production and transportation costs as well as carbon dioxide emissions as environmental impacts of transport over a multimodal network. Computational experiments demonstrate the effectiveness of the model for cost-emissions analysis. (C) 2014 Elsevier B.V. All rights reserved.	[Liotta, Giacomo] Univ Southern Denmark, Dept Technol & Innovat, DK-5230 Odense M, Denmark; [Stecca, Giuseppe] CNR, Ist Anal Sistemi & Informat, I-00185 Rome, Italy; [Stecca, Giuseppe; Kaihara, Toshiya] Kobe Univ, Grad Sch Syst Informat, Kobe, Hyogo 6578501, Japan	Stecca, G (reprint author), CNR, Ist Anal Sistemi & Informat, Via Taurini 19, I-00185 Rome, Italy.	gil@iti.sdu.dk; giuseppe.stecca@iasi.cnr.it; kaihara@kobe-u.ac.jp	Liotta, Giacomo/B-2111-2013	Liotta, Giacomo/0000-0003-4844-6039			Chaabane A, 2011, PROD PLAN CONTROL, V22, P727, DOI 10.1080/09537287.2010.543554; Hassini E, 2012, INT J PROD ECON, V140, P69, DOI 10.1016/j.ijpe.2012.01.042; Seuring S, 2008, J CLEAN PROD, V16, P1699, DOI 10.1016/j.jclepro.2008.04.020; Fahimnia B, 2013, J MANUF SYST, V32, P1, DOI 10.1016/j.jmsy.2012.07.005; SteadieSeifi M, 2014, EUR J OPER RES, V233, P1, DOI 10.1016/j.ejor.2013.06.055; Sundarakani B, 2010, INT J PROD ECON, V128, P43, DOI 10.1016/j.ijpe.2010.01.018; Bocken NMP, 2014, J CLEAN PROD, V65, P42, DOI 10.1016/j.jclepro.2013.11.039; Yan H, 2003, COMPUT OPER RES, V30, P2135, DOI 10.1016/S0305-0548(02)00127-2; Goetschalckx M, 2002, EUR J OPER RES, V143, P1, DOI 10.1016/S0377-2217(02)00142-X; Dotoli M, 2006, IEEE T SYST MAN CY A, V36, P62, DOI [10.1109/TSMCA.2005.859189, 10.1109/TSMCA.2006.859189]; Ageron B, 2012, INT J PROD ECON, V140, P168, DOI 10.1016/j.ijpe.2011.04.007; Srivastava SK, 2007, INT J MANAG REV, V9, P53, DOI 10.1111/j.1468-2370.2007.00202.x; Moccia L, 2011, NETWORKS, V57, P53, DOI 10.1002/net.20383; Wang F, 2011, DECIS SUPPORT SYST, V51, P262, DOI 10.1016/j.dss.2010.11.020; Eskigun E, 2005, EUR J OPER RES, V165, P182, DOI 10.1016/j.ejor.2003.11.029; Nieuwenhuis P, 2012, INT J PROD ECON, V140, P138, DOI 10.1016/j.ijpe.2012.01.034; Bilgen B, 2004, INT J TECHNOL MANAGE, V28, P151, DOI 10.1504/IJTM.2004.005059; Galiano G., 2010, P 8 IEEE INT C IND I, P940; Gendron B., 1998, TELECOMMUNICATIONS N; GEOFFRIO.AM, 1974, MANAGE SCI, V20, P822, DOI 10.1287/mnsc.20.5.822; Government of Canada, 2008, TURN CORN REG FRAM I; Le TPN, 2013, J INTELL MANUF, V24, P653, DOI 10.1007/s10845-011-0613-6; Liotta G., IEEE T IND IN PRESS; Martel A, 2005, APPL OPTIMIZAT, V98, P265; Olhager J., 2013, P 25 NORD LOG RES NE; Quariguasi Frota Neto J., 2008, INT J PROD ECON, V111, P195, DOI DOI 10.1016/J.IJPE.2006.10.014; Schade W., 2006, COMPETE FINAL REPORT; Shaw K, 2013, PROD PLAN CONTROL, V24, P851, DOI 10.1080/09537287.2012.666878; Stecca G., 2013, IFIP AICT, V408, P559, DOI Springer; Taticchi Paolo, 2013, International Journal of Productivity & Performance Management, V62, DOI 10.1108/IJPPM-03-2013-0037	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-5273	1873-7579		INT J PROD ECON	Int. J. Prod. Econ.	JUN	2015	164						351	365		10.1016/j.ijpe.2014.12.016		15	Engineering, Industrial; Engineering, Manufacturing; Operations Research & Management Science	Engineering; Operations Research & Management Science	CH6IZ	WOS:000354141600031		
J	Shibamoto, Y				Shibamoto, Yuta			The Expanding Role of Radiation Oncology in Japan	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS			English	Editorial Material							PROTON THERAPY; CANCER		Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Nagoya, Aichi 4678601, Japan	Shibamoto, Y (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Nagoya, Aichi 4678601, Japan.	yshiba@med.nagoya-cu.ac.jp					Hoppe BS, 2014, CANCER-AM CANCER SOC, V120, P1076, DOI 10.1002/cncr.28536; Chalubinska-Fendler J, 2014, INT J RADIAT ONCOL, V90, P480, DOI 10.1016/j.ijrobp.2014.05.031; Duchesne GM, 2014, INT J RADIAT ONCOL, V90, P1, DOI 10.1016/j.ijrobp.2014.03.044; Iwata H, 2013, J THORAC ONCOL, V8, P726, DOI 10.1097/JTO.0b013e318288ab02; Numasaki H, 2013, INT J CLIN ONCOL, V18, P775, DOI 10.1007/s10147-012-0468-7; Shibamoto Y., 2013, LUNG CANC MANAGE, V2, P353; Zietman Anthony, 2013, Rep Pract Oncol Radiother, V18, P338, DOI 10.1016/j.rpor.2013.06.001	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0360-3016	1879-355X		INT J RADIAT ONCOL	Int. J. Radiat. Oncol. Biol. Phys.	JUN 1	2015	92	2					200	203		10.1016/j.ijrobp.2015.01.003		4	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CH4FO	WOS:000353989000003		
J	Matsumoto, H; Makabe, T; Morita, T; Ikuhara, K; Kajigase, A; Okamoto, Y; Ashikawa, E; Kobayashi, E; Hagino, H				Matsumoto, Hiromi; Makabe, Tomoyuki; Morita, Tetsuji; Ikuhara, Kanae; Kajigase, Akira; Okamoto, Yuta; Ashikawa, Eiichi; Kobayashi, Eri; Hagino, Hiroshi			Accelerometry-based gait analysis predicts falls among patients with a recent fracture who are ambulatory: a 1-year prospective study	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						accelerometer; falls; fracture; gait analysis	OSTEOPOROTIC FRACTURES; MUSCLE STRENGTH; OLDER-ADULTS; RISK; VARIABILITY; HIP; RELIABILITY; PREFECTURE; BALANCE; COHORT	The aim of this prospective study was to assess whether accelerometry-based gait analysis is associated with the incidence of falls among individuals who are ambulatory and recently had a fracture, and to compare the ability to discriminate body function and structure and activity measures. A total of 100 patients who fulfilled our inclusion criteria were enrolled. At hospital discharge, the following outcomes were assessed: timed-up-and-go test, five-times-sit-to-stand test, one-leg standing test, 5-m gait test, and gait analysis using a wireless three-axis accelerometer. Root mean square (RMS) and autocorrelation (AC) values were analyzed on the basis of the acceleration waveform. Follow-up assessment of falls and subsequent fractures was performed 12 months after the fracture. Eighty-five percent of the participants completed the follow-up at 12 months. During the 12 months of follow-up, 61 falls were reported by 34 patients (31 women, three men), for a fall rate of 40.0% (34/85). The fall group had significantly poorer body function and structure and activity measures compared with the no-fall group. In accelerometry-based gait analysis, RMS and AC in the vertical axis and RMS in the anteroposterior axis were significantly lower in the fall group compared with the no-fall group. Multivariate logistic regression analysis showed that only AC in the vertical axis was a significant predictor of falls. This finding suggests that trunk acceleration AC in the vertical axis showed good discriminative ability for predicting the incidence of falls among patients who are ambulatory and recently had a fracture. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Matsumoto, Hiromi; Kobayashi, Eri; Hagino, Hiroshi] Tottori Univ Hosp, Rehabil Div, Yonago, Tottori 6838504, Japan; [Makabe, Tomoyuki; Morita, Tetsuji] Misasa Onsen Hosp, Rehabil Div, Tottori, Japan; [Ikuhara, Kanae; Kajigase, Akira] Nojima Hosp, Rehabil Div, Tottori, Japan; [Okamoto, Yuta] Shimizu Hosp, Rehabil Div, Tottori, Japan; [Ashikawa, Eiichi] Hakuai Hosp, Rehabil Div, Tottori, Japan; [Hagino, Hiroshi] Tottori Univ, Sch Hlth Sci, Tottori 680, Japan	Matsumoto, H (reprint author), Tottori Univ Hosp, Rehabil Div, Nishicho36-1, Yonago, Tottori 6838504, Japan.	h.matsumoto@med.tottori-u.ac.jp			ministry of Health, Labour and Welfare of Japan [23-25 Chojyu Kagaku kenkyu jigyou]	Hiromi Matsumoto, Eri kobayashi, and Hiroshi Hagino were supported by a Grant-in-Aid from the ministry of Health, Labour and Welfare of Japan (23-25 Chojyu Kagaku kenkyu jigyou).	Senden R, 2012, GAIT POSTURE, V36, P296, DOI 10.1016/j.gaitpost.2012.03.015; Peel NM, 2013, J GERONTOL A-BIOL, V68, P39, DOI 10.1093/gerona/gls174; MILNE JS, 1974, ANN HUM BIOL, V1, P327, DOI 10.1080/03014467400000351; Henriksen M, 2004, GAIT POSTURE, V19, P288, DOI 10.1016/S0966-6362(03)00069-9; Lyles KW, 2008, OSTEOPOROSIS INT, V19, P1225, DOI 10.1007/s00198-008-0569-3; CUMMINGS SR, 1994, OSTEOPOROSIS INT, V4, P67; Vellas BJ, 1997, J AM GERIATR SOC, V45, P735; van Helden S, 2006, OSTEOPOROSIS INT, V17, P348, DOI 10.1007/s00198-005-2026-x; Nishiguchi S, 2012, TELEMED E-HEALTH, V18, P292, DOI 10.1089/tmj.2011.0132; Kobsar D, 2014, GAIT POSTURE, V39, P553, DOI 10.1016/j.gaitpost.2013.09.008; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Palombaro KM, 2009, PHYS THER, V89, P1315, DOI 10.2522/ptj.20080401; Sawa R, 2014, GAIT POSTURE, V40, P123, DOI 10.1016/j.gaitpost.2014.03.002; Hagino H, 1999, BONE, V24, P265, DOI 10.1016/S8756-3282(98)00175-6; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Moe-Nilssen R, 2010, GAIT POSTURE, V32, P98, DOI 10.1016/j.gaitpost.2010.03.019; Moe-Nilssen R, 2005, GAIT POSTURE, V21, P164, DOI 10.1016/j.gaitpost.2004.01.013; Arai T, 2011, PHYS THER JAPAN, V38, P165; Caby B, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-1; Collin C, 1988, Int Disabil Stud, V10, P61; CSUKA M, 1985, AM J MED, V78, P77, DOI 10.1016/0002-9343(85)90465-6; Doi T, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-7; Hausdorff Jeffrey M, 2005, J Neuroeng Rehabil, V2, P19, DOI 10.1186/1743-0003-2-19; Ishii S, 2012, PHYS THER JAPAN, V39, P230; Johnell O, 2004, Osteoporos Int, V15, P175; Kojima M, 2008, J PHYS THER SCI, V20, P243; Kristensen MT, 2007, PHYS THER, V87, P24; Morris R, 2007, AGE AGEING, V36, P78, DOI 10.1093/ageing/afl147; Muraki S, 2013, BONE, V52, P516, DOI 10.1016/j.bone.2012.10.020; Orimo H, 2009, ARCH OSTEOPOROS, V4, P71; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142; Ruan Wen-Dong, 2011, Chin J Traumatol, V14, P74; Sakuma M, 2008, J BONE MINER METAB, V26, P373, DOI 10.1007/s00774-007-0841-1; van Helden S, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-55; Yamada M, 2012, RHEUMATOL INT, V32, P3869, DOI 10.1007/s00296-011-2283-2; Yamada M, 2006, PHYS THER JAPAN, V33, P14; Yau DTY, 2013, CALCIFIED TISSUE INT, V92, P287, DOI 10.1007/s00223-012-9681-7	38	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	JUN	2015	38	2					131	136		10.1097/MRR.0000000000000099		6	Rehabilitation	Rehabilitation	CH1ZQ	WOS:000353822800005		
J	Tsoh, J; Peisah, C; Narumoto, J; Wongpakaran, N; Wongpakaran, T; O'Neill, N; Jiang, T; Ogano, S; Mimura, M; Kato, Y; Chiu, H				Tsoh, Joshua; Peisah, Carmelle; Narumoto, Jin; Wongpakaran, Nahathai; Wongpakaran, Tinakon; O'Neill, Nick; Jiang, Tao; Ogano, Shoichi; Mimura, Masaru; Kato, Yuka; Chiu, Helen			Comparisons of guardianship laws and surrogate decision-making practices in China, Japan, Thailand and Australia: a review by the Asia Consortium, International Psychogeriatric Association (IPA) capacity taskforce	INTERNATIONAL PSYCHOGERIATRICS			English	Article						Australia; China; Hong Kong; Japan; Thailand; aged; Asia; dementia	LIFE UNEASY PATERNALISM; COMPETENCE; END	Background: The International Psychogeriatric Association (IPA) capacity taskforce was established to promote the autonomy, proper access to care, and dignity of persons with decision-making disabilities (DMDs) across nations. The Asia Consortium of the taskforce was established to pursue these goals in the Asia-Pacific region. This paper is part of the Asia Consortium's initiative to promote understanding and advocacy in regard to surrogate decision-making across the region. Method: The current guardianship laws are compared, and jurisdictional variations in the processes for proxy decision-making to support persons with DMDs and other health and social needs in China, Japan, Thailand, and Australia are explored. Results: The different Asia-Pacific countries have various proxy decision-making mechanisms in place for persons with DMDs, which are both formalized according to common law, civil law, and other legislation, and shaped by cultural practices. Various processes for guardianship and mechanisms for medical decision-making and asset management exist across the region. Processes that are still evolving across the region include those that facilitate advanced planning as a result of the paucity of legal structures for enduring powers of attorney (EPA) and guardianship in some regions, and the struggle to achieve consensual positions in regard to end-of-life decision-making. Formal processes for supporting decision-making are yet to be developed. Conclusions: The diverse legal approaches to guardianship and administration must be understood to meet the challenges of the rapidly ageing population in the Asia-Pacific region. Commonalities in the solutions and difficulties faced in encountering these challenges have global significance.	[Tsoh, Joshua; Chiu, Helen] CUHK, Dept Psychiat, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Tsoh, Joshua; Chiu, Helen] Prince Wales Hosp, Dept Psychiat, Hksar, Peoples R China; [Tsoh, Joshua; Peisah, Carmelle; O'Neill, Nick] Capac Australia, Sydney, NSW, Australia; [Peisah, Carmelle; O'Neill, Nick] Univ New S Wales, Sydney, NSW, Australia; [Peisah, Carmelle; O'Neill, Nick] Univ Sydney, Discipline Psychiat, Sydney, NSW 2006, Australia; [Narumoto, Jin; Kato, Yuka] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Psychiat, Kyoto, Japan; [Narumoto, Jin; Jiang, Tao; Ogano, Shoichi; Mimura, Masaru; Kato, Yuka] Japan Sci & Technol Agcy, Ctr Innovat Program, Yokosuka, Kanagawa, Japan; [Wongpakaran, Nahathai; Wongpakaran, Tinakon] Chiang Mai Univ, Dept Psychiat, Geriatr Psychiat Unit, Fac Med, Chiang Mai, Thailand; [Jiang, Tao] Shanghai Univ Polit Sci & Law, Fac Law, Shanghai, Peoples R China; [Ogano, Shoichi] Fac Law Polit & Econ, Dept Policy Studies, Chiba, Japan; [Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan	Tsoh, J (reprint author), CUHK, Dept Psychiat, Fac Med, Hong Kong, Hong Kong, Peoples R China.	tsohmy@ha.org.hk					[Anonymous], 2006, ACC EC; Ting Fion H., 2011, Hong Kong Medical Journal, V17, P105; Au D, 2009, HONG KONG GUARD C HO; Chan T. C., 2009, Hong Kong Medical Journal, V15, P213; Chiu C, 2009, HONG KONG GUARD C HO; Hertogh CMPM, 2011, INT PSYCHOGERIATR, V23, P511, DOI 10.1017/S1041610211000184; Hui Edwin C, 2007, Hong Kong Med J, V13, P493; Kim S. Y. H, 2010, EVALUATION CAPACITY; Le BH, 2011, MED J AUSTRALIA, V195, P476, DOI 10.5694/mja11.10590; Peisah C., 2011, CAPACITY AND THE LAW; Peisah C, 2013, INT PSYCHOGERIATR, V25, P1571, DOI 10.1017/S1041610213001014; Reutens SG, 2012, MED J AUSTRALIA, V196, P312, DOI 10.5694/mja11.11596; Robinson D., 2009, HONG KONG GUARD C HO; United Nations, 2005, HONG KONG GUARD C HO; United Nations, 2012, UN CONV RIGHTS PERS; Wong J. G., 2003, Hong Kong Medical Journal, V9, P284	16	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1041-6102	1741-203X		INT PSYCHOGERIATR	Int. Psychogeriatr.	JUN	2015	27	6					1029	1037		10.1017/S104161021400266X		9	Psychology, Clinical; Geriatrics & Gerontology; Gerontology; Psychiatry; Psychology	Psychology; Geriatrics & Gerontology; Psychiatry	CH5RU	WOS:000354093800017		
J	Thompson, L				Thompson, Lee			Assessing the sociology of sport: On Western hegemony and alternative discourses	INTERNATIONAL REVIEW FOR THE SOCIOLOGY OF SPORT			English	Article						alternative discourses; ethnocentrism; Japan; social science powers; Western hegemony		On the 50th anniversary of the ISSA and IRSS, Lee Thompson, a key foundational scholar in the development of the sociology of sport in Japan, whose work has helped bridge understandings from the West, considers the distinctive character of socio-cultural inquiry about sport in Japan. In assessing the trajectory of the field in Japan, Thompson notes that Japan has not been one of the social science powers' and that its theoretical and methodological lenses were often reliant on strategies developed in the West. In addition, the influence of Japanese scholarship in the field has been stifled because of limited dissemination in outlets publishing in the English language. A key challenge is for the theoretical and geographic range of research published in Japanese scholarly outlets to be mirrored in the breadth of work published by Japanese scholars in English language outlets: with the increased demands of globalization and neo-liberal reforms, there are increased pressures to publish in international (English language) journals. In looking to the future, the dangers of Western hegemony' in publication standards and the tensions in giving standing to particularized Asia-centered alternative discourses are discussed.	Waseda Univ, Nishitokyo 1870003, Japan	Thompson, L (reprint author), Waseda Univ, Higashifushimi 3-4-1, Nishitokyo 1870003, Japan.	thompson@waseda.jp					Alatas S. F, 2003, CURR SOCIOL, V51, P599, DOI DOI 10.1177/00113921030516003; Gantman ER, 2012, SCIENTOMETRICS, V93, P967, DOI 10.1007/s11192-012-0736-3; Inagaki M, 2001, SUPTSU BUNKA NO DATS; Japan Society for the Promotion of Science (JSPS), 2011, JINB SHAK NO KOK NI; Keim W, 2011, INT SOCIOL, V26, P123, DOI 10.1177/0268580909351324; Koto Y, 2010, ISA HDB  DIVERSE SOC, P325; Kuhn M, 2010, INT SOCIAL SCI ASIA, P11; Machimura T, 2010, FACING UNEQUAL WORLD, V2, P201; Manzenreiter M, 2008, SOCIAL SCI JAPAN J, V11, P83; Okamoto K, 2013, THEORIES STRATEGIES, P55; Patel S, 2013, THEORIES STRATEGIES, P119; PATEL S, 2010, ISA HDB DIVERSE SOCI; Sato Y, 2010, FACING UNEQUAL WORLD, V2, P192; Weidemann D., 2013, THEORIES STRATEGIES, P105	14	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1012-6902	1461-7218		INT REV SOCIOL SPORT	Int. Rev. Sociol. Sport	JUN-AUG	2015	50	4-5			SI		617	622		10.1177/1012690214539340		6	Hospitality, Leisure, Sport & Tourism; Sociology	Social Sciences - Other Topics; Sociology	CH8EA	WOS:000354267800047		
J	Nagai, M; Yamaguchi, M; Mori, K; Furuta, T; Ashino, H; Kurosawa, H; Kasahara, H; Minami, M; Fujii, H				Nagai, Michiko; Yamaguchi, Masayuki; Mori, Kensaku; Furuta, Toshihiro; Ashino, Hiroki; Kurosawa, Hiroyuki; Kasahara, Hiroyuki; Minami, Manabu; Fujii, Hirofumi			Magnetic Resonance-Based Visualization of Thermal Ablative Margins Around Hepatic Tumors by Means of Systemic Ferucarbotran Administration Before Radiofrequency Ablation Animal Study to Reveal the Connection Between Excess Iron Deposition and T2*-Weighted Hypointensity in Ablative Margins	INVESTIGATIVE RADIOLOGY			English	Article						hepatic tumor; thermal ablation; ablative margins; magnetic resonance imaging; superparamagnetic iron oxides	SUPERPARAMAGNETIC IRON-OXIDE; HEPATOCELLULAR-CARCINOMA; SIGNAL RECOVERY; CONTRAST AGENT; RAT LIVERS; IMAGES; MRI; MODEL; INTENSITY; CANCER	Objective: The objective of this study was to demonstrate experimentally that radiofrequency ablation (RFA) of ferucarbotran-accumulated healthy liver tissues causes excess iron deposition in the ablated liver tissues on postablation days and produces sustained T2*-weighted low signals indicative of ablative margins surrounding hepatic tumors. Materials and Methods: We conducted 3 experiments using 30 rats. In experiment 1, we administered either ferucarbotran (n = 6) or saline (n = 4), acquired T2*-weighted images (T2*-WIs) of the liver by using a 3-T magnetic resonance scanner, and subsequently performed RFA of healthy liver lobes. We acquired follow-up T2*WIs up to day 7 and histologically analyzed the liver specimens. In another 4 rats, we performed sham operation, instead of RFA, in ferucarbotran-accumulated liver lobes, followed by the same image acquisition and histological analysis. In experiment 2, we administered Fe-59-labeled ferucarbotran, subsequently performed either RFA (n = 4) or sham operation (n = 4) in the liver, and acquired autoradiograms of the liver specimens on day 7. In experiment 3, we conducted RFA treatment for 8 rats bearing orthotopic hepatic tumors after ferucarbotran administration and monitored tumor growth by using serial T2*-WIs. Results: On days 4 and 7 of the experiment 1, T2*-WIs of 6 rats with systemic ferucarbotran administration and subsequent hepatic RFA showed low-signal regions indicative of ablated liver tissues, whereas high-signal areas were seen in 4 saline-administered rats. Neither high nor low signal areas were detected in 4 shamoperated rats. Histologically, larger amounts of iron were observed in the RFA-induced necrotic liver tissues in the ferucarbotran-administered rats than in the saline-administered-rats. The Fe-59 autoradiography of the rats in experiment 2 revealed accumulation of ferucarbotran-derived iron in necrotic liver tissues. Among 6 hepatic tumors grown in 6 rats of the experiment 3, a total of 4 tumors were stable in size, but the other 2 increased markedly on day 7. Retrospectively, T2*-WIs showed the former tumor sites surrounded completely by low-signal areas on day 4. Conclusions: The RFA of ferucarbotran-accumulated healthy liver tissues in the rats caused excess iron deposition in the ablated liver tissues and produced sustained T2*-weighted hypointense regions. Similar hypointense regions surrounding hepatic tumors were indicative of ablative margins.	[Nagai, Michiko; Yamaguchi, Masayuki; Mori, Kensaku; Furuta, Toshihiro; Fujii, Hirofumi] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Funct Imaging, Kashiwa, Chiba 2778577, Japan; [Nagai, Michiko; Mori, Kensaku; Minami, Manabu] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Radiol, Tsukuba, Ibaraki, Japan; [Furuta, Toshihiro] Univ Tokyo, Grad Sch Med, Dept Radiol, Tokyo, Japan; [Ashino, Hiroki; Kurosawa, Hiroyuki; Kasahara, Hiroyuki] Fujifilm RI Pharma Co Ltd, Sammu, Chiba, Japan	Yamaguchi, M (reprint author), Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Funct Imaging, Kashiwanoha 6-5-1, Kashiwa, Chiba 2778577, Japan.	masyamag@east.ncc.go.jp			Health and Labor Science Research Grant; Ministry of Health, Labor, and Welfare of Japan [21-5]	Authors Ashino, Kurosawa, and Kasahara are employees of Fujifilm RI Pharma Co, Ltd; supported by Health and Labor Science Research Grant for the Third-Term Comprehensive 10-Year Strategy for Cancer Control and a Grant-in-Aid for Cancer Research (21-5) from the Ministry of Health, Labor, and Welfare of Japan to author Fujii.	WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167; Kakite S, 2011, EUR J RADIOL, V78, P282, DOI 10.1016/j.ejrad.2011.01.048; Miyazaki M, 2011, JPN J RADIOL, V29, P138, DOI 10.1007/s11604-010-0529-7; Gillams AM, 2005, BRIT J CANCER, V92, P1825, DOI 10.1038/sj.bjc.6602582; Reimer P, 2003, EUR RADIOL, V13, P1266, DOI 10.1007/s00330-002-1721-7; Guo Y, 2012, MAGN RESON IMAGING, V30, P133, DOI 10.1016/j.mri.2011.09.007; Koda M, 2013, J GASTROENTEROL, V48, P1283, DOI 10.1007/s00535-012-0747-0; Mori K, 2009, RADIOLOGY, V251, P557, DOI 10.1148/radiol.2512081161; Ni Y, 2005, ABDOM IMAGING, V30, P381, DOI 10.1007/s00261-004-0253-9; Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908; Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161; Limanond P, 2003, AM J ROENTGENOL, V181, P1635; Guo Y, 2010, CANCER RES, V70, P1555, DOI 10.1158/0008-5472.CAN-09-3067; Lee SH, 2011, INVEST RADIOL, V46, P77, DOI 10.1097/RLI.0b013e3181f23fcd; Morimoto M, 2002, HEPATOLOGY, V35, P1467, DOI 10.1053/jhep.2002.33635; Bangard C, 2008, J MAGN RESON IMAGING, V28, P263, DOI 10.1002/jmri.21423; Blanco E, 2004, J BIOMED MATER RES A, V69A, P398, DOI 10.1002/jbm.a.30001; Furuta T, 2014, MAGN RESON MATER PHY, V27, P501, DOI 10.1007/s10334-014-0434-7; Furuta T, 2013, MAGN RESON MATER PHY, V26, P313, DOI 10.1007/s10334-012-0354-3; Kasper HU, 2010, PATHOL INT, V60, P149, DOI 10.1111/j.1440-1827.2009.02498.x; Lawaczeck R, 1997, ACTA RADIOL, V38, P584; Minami Y, 2011, INT J HEPATOL, V2011, DOI DOI 10.4061/2011/104685.PUBMED:21994847; Mitsuda M, 2013, MAGN RESON MED SCI, V12, P95, DOI 10.2463/mrms.2012-0038; Mori Y, 2015, HEPATOL RES, V45, P75, DOI 10.1111/hepr.12311; Sakakibara M, 2014, AM J ROENTGENOL, V202, pW487, DOI 10.2214/AJR.13.11384; Yamaguchi M, 2013, J MAGN RESON IMAGING, V38, P225, DOI 10.1002/jmri.23969	26	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0020-9996	1536-0210		INVEST RADIOL	Invest. Radiol.	JUN	2015	50	6					376	383				8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH9UC	WOS:000354380900002		
J	Ogaki, M; Sakai, T				Ogaki, Masao; Sakai, Toyotaka			CONFERENCE ON NORMATIVE ECONOMICS FROM THE TRADITIONAL AND NONTRADITIONAL VIEWS: INTRODUCTION	JAPANESE ECONOMIC REVIEW			English	Editorial Material									[Ogaki, Masao; Sakai, Toyotaka] Keio Univ, Tokyo 108, Japan	Ogaki, M (reprint author), Keio Univ, Tokyo 108, Japan.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1352-4739	1468-5876		JPN ECON REV	Jpn. Econ. Rev.	JUN	2015	66	2			SI		147	149		10.1111/jere.12071		3	Economics	Business & Economics	CH7AA	WOS:000354186700001		
J	Bhatt, V; Ogaki, M; Yaguchi, Y				Bhatt, Vipul; Ogaki, Masao; Yaguchi, Yuichi			NORMATIVE BEHAVIOURAL ECONOMICS BASED ON UNCONDITIONAL LOVE AND MORAL VIRTUE	JAPANESE ECONOMIC REVIEW			English	Article							WELFARE	An important difficulty in many models of behavioural economics is that preferences are endogenous and unstable. Therefore, preferences may not provide the most desirable yardstick to evaluate social states. The present paper proposes unconditional love as a candidate for such a yardstick. The concept of unconditional love, although lofty, is often hard to apply for practical policy recommendations. We propose an intermediary learning stage, where learning to unconditionally love is desirable, and policies that promote such learning are deemed to be good. We illustrate the use of this principle in models of endogenous altruism.	[Bhatt, Vipul] James Madison Univ, Harrisonburg, VA 22807 USA; [Ogaki, Masao] Keio Univ, Tokyo 108, Japan; [Yaguchi, Yuichi] Chuo Univ, Tokyo, Japan	Bhatt, V (reprint author), James Madison Univ, Harrisonburg, VA 22807 USA.				JSPS KAKENHI [22330062, 25285063]	This paper was prepared in part while Ogaki was a visiting scholar of the Institute for Monetary and Economic Studies at the Bank of Japan. We would like to extend our special thanks to Noah Smith for many comments and discussions about many aspects of this paper. We would also like to thank an anonymous referee, Shinsuke Ikeda, Miles Kimball, Nobu Kiyotaki, Colin McCkenzie, Herakles Polemarchakis, and seminar and session participants at the Bank of Japan, the Bank of Korea, Keio University, the 2011 Association of Behavioral Economics and Finance Meeting, the 10th Biennial Pacific Rim Conference of the Western Economic Association International in 2013, the 2013 Japanese Economic Association Meeting, and the Society of Advancement of Economic Theory Satellite Conference on "Normative Economics from the Traditional and Nontraditional Views" on 22 August 2014. Ogaki's research was partially supported by JSPS KAKENHI 22330062, 25285063. Views expressed in this paper are those of the authors and do not necessarily reflect the official views of the Bank of Japan.	Akabayashi H., 2014, KEIO IES DISCUSSION, VDP201, P4; Akkemik K. A., 2013, EUR REG SCI ASS 2013; Rabin M, 1998, J ECON LIT, V36, P11; Sunstein CR, 2003, U CHICAGO LAW REV, V70, P1159, DOI 10.2307/1600573; Beshears J, 2008, J PUBLIC ECON, V92, P1787, DOI 10.1016/j.jpubeco.2008.04.010; Bernheim BD, 2004, AM ECON REV, V94, P1558, DOI 10.1257/0002828043052222; Gul F, 2001, ECONOMETRICA, V69, P1403, DOI 10.1111/1468-0262.00252; Bernheim BD, 2007, AM ECON REV, V97, P464, DOI 10.1257/aer.97.2.464; Beauregard M, 2009, PSYCHIAT RES-NEUROIM, V172, P93, DOI 10.1016/j.pscychresns.2008.11.003; Becker GS, 1997, Q J ECON, V112, P729, DOI 10.1162/003355397555334; Bernheim B. D., 2005, 11518 NBER; Bhatt V., 2014, IMES DISCUSSION PAPE; Bhatt V., 2014, KEIO IES DISCUSSION; Bhatt V, 2012, INT ECON REV, V53, P791, DOI 10.1111/j.1468-2354.2012.00701.x; Cherkasova E. V., 2004, HEARTS WORK DU UNPUB; Downey DB, 2002, RES EDUC PRODUCT, P113; Gul F, 2007, AM ECON REV, V97, P471, DOI 10.1257/aer.97.2.471; Harris Sam, 2010, MORAL LANDSCAPE SCI; Heng J., 2014, STRAITS TIMES; Kandori M., 2008, J ECON THEORY, V140, P328, DOI 10.1016/j.jet.2007.02.002; KANEKO M, 1979, ECONOMETRICA, V47, P423, DOI 10.2307/1914191; Kszegi B., 2007, AM ECON REV, V97, P477; Kszegi B., 2008, J PUBLIC ECON, V92, P1821; Kubota K., 2013, CULTURES WORLD UNPUB; Kubota K., 2013, TIME DISCOUNTING INT; Mulligan C. B., 1997, PARENTAL PRIORITIES; Sandel M. J., 2009, JUSTICS WHATS RIGHT; Sen A, 1970, COLLECTIVE CHOICE SO; Temkin L. S., 2011, RETHINKING GOOD MORA; U. S. Department of Education, 2005, HELP YOUR CHILD HOM	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1352-4739	1468-5876		JPN ECON REV	Jpn. Econ. Rev.	JUN	2015	66	2			SI		226	246		10.1111/jere.12067		21	Economics	Business & Economics	CH7AA	WOS:000354186700005		
J	Tamate, S				Tamate, Shintaro			EXTERNAL NORMS AND SYSTEMATICALLY OBSERVED NORMS	JAPANESE ECONOMIC REVIEW			English	Article							ECONOMICS; PREFERENCE; CHOICE; COMMITMENT; FAIRNESS; ALTERNATIVES; RATIONALITY; PSYCHOLOGY; DECISIONS; REVERSALS	Both Amartya Sen and behavioural economics criticize the rationality assumption and attempt to make it more realistic so that it can explain individuals' real and non-trivial normative behaviours. However, their criteria to determine the triviality of a behaviour are quite different. Sen regards a behaviour as non-trivial if such a behaviour is judged to be ethically meaningful, while behavioural economics attends to systematic biases in behaviours. Because of this difference, the predictive analysis of each approach has distinct merit and demerit. Specifying a certain external norm enables us to analyse the interaction of complicated normative behaviours.	Kanagawa Univ, Yokosuka, Kanagawa, Japan	Tamate, S (reprint author), Kanagawa Univ, Yokosuka, Kanagawa, Japan.						Anderson E, 2001, ECON PHILOS, V17, P21; Rabin M, 1998, J ECON LIT, V36, P11; HUBER J, 1982, J CONSUM RES, V9, P90, DOI 10.1086/208899; TVERSKY A, 1993, MANAGE SCI, V39, P1179, DOI 10.1287/mnsc.39.10.1179; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; Masatlioglu Y, 2012, AM ECON REV, V102, P2183, DOI 10.1257/aer.102.5.2183; KAHNEMAN D, 1986, AM ECON REV, V76, P728; Konow J, 2003, J ECON LIT, V41, P1188, DOI 10.1257/002205103771800013; Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Pettit P, 2005, ECON PHILOS, V21, P15, DOI 10.1017/S0266267104000367; Baigent N., 2007, ANAL KRITIK, V29, P139; Baigent N, 1996, ECON THEORY, V8, P239, DOI 10.1007/s001990050089; BAZERMAN MH, 1992, ADMIN SCI QUART, V37, P220, DOI 10.2307/2393222; Bossert W, 2011, SOC CHOICE WELFARE, V37, P729, DOI 10.1007/s00355-011-0568-8; Bossert W, 2009, ECON PHILOS, V25, P139, DOI 10.1017/S0266267109990010; Cudd AE, 2014, ECON PHILOS, V30, P35, DOI 10.1017/S0266267114000030; Dietrich F., 2012, 43231 MPRA; Elster J., 1983, SOUR GRAPES STUDIES; Fehr E., 2006, ADV EC ECONOMETRICS, P208; Gaertner W, 1999, SOC CHOICE WELFARE, V16, P629, DOI 10.1007/s003550050165; Hausman DM, 2005, ECON PHILOS, V21, P33, DOI 10.1017/S0266267104000379; Kahneman D., 2011, THINKING FAST SLOW; Kahneman D., 1986, J BUS, V59, P285, DOI DOI 10.1086/296367; LEHMANN DR, 1994, J MARKETING RES, V31, P364, DOI 10.2307/3152223; Marshall A., 1890, PRINCIPLES EC; O'Neill O., 1985, MORALITY UNIVERSALIT, P159; Peacock M. S., 2011, RATIONALITY MARKETS, V2, P35; RABIN M, 1993, AM ECON REV, V83, P1281; Roemer J. E, 2012, 1854 COWL FDN; Roemer J. E., 2006, 1582 COWL FDN; Roemer JE, 2010, SCAND J ECON, V112, P1, DOI 10.1111/j.1467-9442.2009.01592.x; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Sen A., 1992, INEQUALITY REEXAMINE; Sen A, 2008, ECONOMICA, V75, P617, DOI 10.1111/j.1468-0335.2007.00660.x; SEN A, 1983, J PHILOS, V80, P5, DOI 10.2307/2026284; SEN A., 1987, ETHICS EC; Sen A. K., 1992, OBJECTIVITY POSITION; Sen A. K., 1989, SOC RES, V71, P583; Sen A. K., 1993, RATIONALITY FREEDOM, P121; Sen A. K., 1980, CHOICE WELFARE MEASU, P353; SEN A, 1980, OXFORD ECON PAP, V32, P353; Sen A. K., 1997, RATIONALITY FREEDOM, P159; SEN A, 1985, J PHILOS, V82, P169, DOI 10.2307/2026184; LICHTENS.S, 1971, J EXP PSYCHOL, V89, P46, DOI 10.1037/h0031207; Thaler R. H., 1992, WINNERS CURSE PARADO; Xu Y., 2007, ANAL KRITIK, V29, P329	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1352-4739	1468-5876		JPN ECON REV	Jpn. Econ. Rev.	JUN	2015	66	2			SI		247	259		10.1111/jere.12064		13	Economics	Business & Economics	CH7AA	WOS:000354186700006		
J	Sakai, T				Sakai, Toyotaka			A SEARCH FOR THE GENERAL WILL IN A SPATIAL MODEL	JAPANESE ECONOMIC REVIEW			English	Article							BORDA COUNT; CONDORCET; STABILITY; MAJORITY; THEOREM; RULE	In Book IV, Chapter II of The Social Contract, Jean-Jacques Rousseau argued that the nearer opinion approaches unanimity in an assembly, the greater is the dominance of the general will. The present study revisits this classical argument in a one-dimensional spatial model with variable agendas. The study obtains a sufficient condition under which the Borda winner and the Condorcet winner almost coincide so that we can unambiguously find an alternative that conforms to the general will. This condition describes the existence of certain sympathy among voters on the evaluation of alternatives, and it is much weaker than the unanimity requirement.	Keio Univ, Tokyo 108, Japan	Sakai, T (reprint author), Keio Univ, Tokyo 108, Japan.				KAKENHI [24220003]	The author thanks an anonymous referee, Yoko Kawada, Noriaki Okamoto and Shuhei Otani for their helpful comments. This paper was presented at the conference on "Normative Economics from the Traditional and Nontraditional Views" held at Keio University. This research is financially supported by KAKENHI (24220003).	BLACK D, 1976, PUBLIC CHOICE, V28, P1, DOI 10.1007/BF01718454; GROFMAN B, 1988, AM POLIT SCI REV, V82, P567, DOI 10.2307/1957401; FISHBURN PC, 1976, PUBLIC CHOICE, V28, P79, DOI 10.1007/BF01718459; MOULIN H, 1980, PUBLIC CHOICE, V35, P437, DOI 10.1007/BF00128122; SEN A, 1977, ECONOMETRICA, V45, P53, DOI 10.2307/1913287; FARKAS D, 1979, ECONOMETRICA, V47, P1305, DOI 10.2307/1911965; Black D, 1948, J POLIT ECON, V56, P23, DOI 10.1086/256633; GROFMAN B, 1983, THEOR DECIS, V15, P261, DOI 10.1007/BF00125672; Arrow K. J., 1951, SOCIAL CHOICE INDIVI; ARROW KENNETH J., 1963, SOCIAL CHOICE INDIVI; Black D, 2011, THEORY COMMITTEES EL; Black D, 1948, ECONOMETRICA, V16, P245, DOI 10.2307/1907278; Condorcet de M., 1972, ESSAI APPL ANAL PROB; COUGHLIN P, 1979, ECON LETT, V4, P131, DOI 10.1016/0165-1765(79)90222-2; de Borda J. -C., 1784, HIST ACAD ROYALE SCI, P657; Douglass R, 2013, AM J POLIT SCI, V57, P735, DOI 10.1111/ajps.12020; DOWNS A, 1957, J POLIT ECON, V65, P135, DOI 10.1086/257897; DUMMETT M, 1961, ECONOMETRICA, V29, P33, DOI 10.2307/1907685; FELD SL, 1988, PUBLIC CHOICE, V59, P167, DOI 10.1007/BF00054452; LADHA KK, 1992, AM J POLIT SCI, V36, P617, DOI 10.2307/2111584; McLean I., 1994, CONDORCET FDN SOCIAL; MOULIN H, 1984, SOC CHOICE WELFARE, V1, P127, DOI 10.1007/BF00452885; Okamoto N., 2013, BORDA RULE PAIRWISE; Rawls J., 2008, LECT HIST POLITICAL; Rousseau Jean-Jacques, 1973, SOCIAL CONTRACT DISC; Saari D. G., 1995, BASIC GEOMETRY VOTIN; Saari DG, 2010, THEORY DECIS SER C G, V43, P1, DOI 10.1007/978-3-642-02865-6_1; Saari DG, 2006, SOC CHOICE WELFARE, V26, P107, DOI 10.1007/s00355-005-0046-2; Sreenivasan G, 2000, PHILOS REV, V109, P545, DOI 10.2307/2693624; YOUNG HP, 1988, AM POLIT SCI REV, V82, P1231, DOI 10.2307/1961757	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1352-4739	1468-5876		JPN ECON REV	Jpn. Econ. Rev.	JUN	2015	66	2			SI		260	270		10.1111/jere.12063		11	Economics	Business & Economics	CH7AA	WOS:000354186700007		
J	Nakamura, Y				Nakamura, Yuta			MAXIMUM LIKELIHOOD SOCIAL CHOICE RULE	JAPANESE ECONOMIC REVIEW			English	Article								This study is related to a Condorcetian problem of information aggregation that finds a true social ordering using individual orderings, that are supposed to partly contain the truth. In this problem, we introduce a new maximum likelihood rule and analyse its performance. This rule selects an alternative that maximizes the probability of realizing individual orderings, conditional on the alternative being the top according to a true social ordering. We show that under a neutrality condition of alternatives, the probability that our rule selects the true top alternative is higher than that of any other rule.	Keio Univ, Tokyo 108, Japan	Nakamura, Y (reprint author), Keio Univ, Tokyo 108, Japan.						KEMENY JG, 1959, DAEDALUS, V88, P577; Ben-Yashar R, 2001, SOC CHOICE WELFARE, V18, P737, DOI 10.1007/s003550000080; Black D., 2011, THEORY COMMITTEES EL; Condorcet M. J. A. N. C., 1785, ESSAI APPL ANAL PROB; Conitzer V, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P109; Conitzer V, 2005, P 21 ANN C UNC ART I, P145; Drissi-Bakhkhat M, 2004, SOC CHOICE WELFARE, V23, P161, DOI 10.1007/s00355-003-0242-x; Young H.P., 1995, J ECON PERSPECT, V9, P51; YOUNG HP, 1988, AM POLIT SCI REV, V82, P1231, DOI 10.2307/1961757	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1352-4739	1468-5876		JPN ECON REV	Jpn. Econ. Rev.	JUN	2015	66	2			SI		271	284		10.1111/jere.12065		14	Economics	Business & Economics	CH7AA	WOS:000354186700008		
J	Ene, V; Herzog, J; Hibi, T				Ene, Viviana; Herzog, Juergen; Hibi, Takayuki			Linearly related polyominoes	JOURNAL OF ALGEBRAIC COMBINATORICS			English	Article						Binomial ideals; Linear syzygies; Polyominoes	DETERMINANTAL IDEALS; FREE RESOLUTIONS; SYZYGIES; MATRICES; RINGS	We classify all convex polyomino ideals which are linearly related or have a linear resolution. Convex stack polyominoes whose ideals are extremal Gorenstein are also classified. In addition, we characterize, in combinatorial terms, the distributive lattices whose join-meet ideals are extremal Gorenstein or have a linear resolution.	[Ene, Viviana] Ovidius Univ, Fac Math & Comp Sci, Constanta 900527, Romania; [Ene, Viviana] Acad Romana, Simion Stoilow Inst Math, Res Grp, Project ID PCE 2011 1023, Bucharest 014700, Romania; [Herzog, Juergen] Univ Duisburg Essen, Fachbereich Math, D-45117 Essen, Germany; [Hibi, Takayuki] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Pure & Appl Math, Toyonaka, Osaka 5600043, Japan	Ene, V (reprint author), Ovidius Univ, Fac Math & Comp Sci, Bd Mamaia 124, Constanta 900527, Romania.	vivian@univ-ovidius.ro; juergen.herzog@uni-essen.de; hibi@math.sci.osaka-u.ac.jp			Grant UEFISCDI [PN-II-ID-PCE- 2011-3-1023]	We would like to thank the referees for their valuable comments. Viviana Ene was supported by the Grant UEFISCDI, PN-II-ID-PCE- 2011-3-1023.	Ohsugi H, 2000, OSAKA J MATH, V37, P745; SCHENZEL P, 1980, J ALGEBRA, V64, P93, DOI 10.1016/0021-8693(80)90136-2; Ohsugi H, 1999, ADV APPL MATH, V22, P25, DOI 10.1006/aama.1998.0615; DILWORTH RP, 1950, ANN MATH, V51, P161, DOI 10.2307/1969503; Bjorner A., 1982, ORDERED SETS NATO AD, V83, P583; Bruns W, 1997, J PURE APPL ALGEBRA, V122, P185, DOI 10.1016/S0022-4049(97)00051-0; CoCoATeam, COCOA SYST DOING COM; Decker W., 2012, SINGULAR 3 1 6 COMPU; Eisenbud David, 1995, GRADUATE TEXTS MATH, V150; Ene V., 2013, ELECTRON J COMB, V20, P20; HASHIMOTO M, 1990, NAGOYA MATH J, V118, P203; Herzog J., MSRI P IN PRESS; Herzog J, 2011, GRAD TEXTS MATH, V260, P3, DOI 10.1007/978-0-85729-106-6; Hibi T., 1992, ALGEBRAIC COMBINATOR; Hibi T., 1987, ADV STUDIES PURE MAT, V11; KURANO K, 1989, J ALGEBRA, V124, P414, DOI 10.1016/0021-8693(89)90140-3; LASCOUX A, 1978, ADV MATH, V30, P202, DOI 10.1016/0001-8708(78)90037-3; Qureshi AA, 2012, J ALGEBRA, V357, P279, DOI 10.1016/j.jalgebra.2012.01.032; SHARPE DW, 1964, Q J MATH, V15, P155, DOI 10.1093/qmath/15.1.155; SHARPE DW, 1965, P LOND MATH SOC, V15, P645	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0925-9899	1572-9192		J ALGEBR COMB	J. Algebr. Comb.	JUN	2015	41	4					949	968		10.1007/s10801-014-0560-3		20	Mathematics	Mathematics	CH5FP	WOS:000354061000002		
J	Fujimoto, M; Nishihara, GN; Prathep, A; Terada, R				Fujimoto, Midori; Nishihara, Gregory N.; Prathep, Anchana; Terada, Ryuta			The effect of irradiance and temperature on the photosynthesis of an agarophyte, Gelidiella acerosa (Gelidiales, Rhodophyta), from Krabi, Thailand	JOURNAL OF APPLIED PHYCOLOGY			English	Article						Agarophyte; Algae; Gelidiella acerosa; Photosynthesis; Pulse amplitude modulation (PAM)-chlorophyll fluorometry; Temperature tolerance	RED ALGA; TEMPORAL VARIATION; FORSSKAL FELDMANN; HAMEL RHODOPHYTA; ANDAMAN SEA; GROWTH; LIGHT; JAPAN; PHILIPPINES; TOLERANCE	The effect of irradiance and temperature on the photosynthesis of an agarophyte from Thailand, Gelidiella acerosa (Gelidiales, Rhodophyta), was determined using dissolved oxygen sensors and pulse-amplitude modulated fluorometry (PAM). A model of the net photosynthesis-irradiance (P-E) curve at 28 A degrees C revealed that the saturation and compensation irradiances were 83 (95 % Bayesian credible interval (BCI), 52-128) mu mol photons m(-2) s(-1) and 37 (BCI, 29-45) mu mol photons m(-2) s(-1), respectively. Gross photosynthesis and dark respiration were also determined over a range of temperatures (16-40 A degrees C), revealing that the gross photosynthetic rate was highest at 18.4 (BCI, 15.9-20.8) mg O-2 g(ww) (-1) min(-1) at 29.2 (BCI, 26.8-32.1) A degrees C. Dark respiration rate could be fitted to a second-order polynomial regression (P < 0.01) over the range of the experimental temperatures, and the magnitudes of the rates ranged from 0.49 to 0.93 mg O-2 g(ww) (-1) min(-1) A degrees C-1. The highest value of the maximum effective quantum yield (I broken vertical bar(PSII) at 0 mu mol photons m(-2) s(-1)) occurred at 27.7 (BCI, 26.5-28.9) A degrees C and was 0.57 (BCI, 0.55-0.58), and the values of I broken vertical bar(PSII) decreased above and below 27.7 A degrees C. Although this species is considered to be well-adapted to the current seawater temperatures of the region, the results of the experiments also suggest that they are likely close to the limiting temperature conditions.	[Fujimoto, Midori; Terada, Ryuta] Kagoshima Univ, Fac Fisheries, Kagoshima 8900056, Japan; [Nishihara, Gregory N.] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Inst East China Sea Res, Nagasaki 8512213, Japan; [Prathep, Anchana] Prince Songkla Univ, Dept Biol, Seaweed & Seagrass Res Unit, Fac Sci, Hat Yai 90112, Songkhla, Thailand	Terada, R (reprint author), Kagoshima Univ, Fac Fisheries, 4-50-20 Shimoarata, Kagoshima 8900056, Japan.	terada@fish.kagoshima-u.ac.jp	Terada, Ryuta/O-2813-2013; 	Terada, Ryuta/0000-0003-3193-6592; Nishihara, Gregory/0000-0003-2543-1301	JSPS-Asian CORE Program in the Atmosphere and Ocean Research Institute; University of Tokyo; Japanese Ministry of Education, Culture, Sport and Technology [22510033, 25340012, 25450260]; Plant Genetic Conservation Project under Royal Initiation	We express our gratitude to Khanjanapaj Lewmanomont, Eric Coppejans and Ken-ichi Hayashizaki, for their valuable suggestions at the field survey in Krabi, Thailand. We also thank Jaruwan Mayakun, Anuchit Darakrai, Supattra Pongparadon, Ekkalak Ratanachot, and Takashi Tsunoda for their kind assistances to complete the field survey. This research was sponsored in part by a JSPS-Asian CORE Program in the Atmosphere and Ocean Research Institute, the University of Tokyo (AP and RT), and by a Grant-in-Aid for Scientific Research (nos. 22510033, 25340012, and 25450260) from the Japanese Ministry of Education, Culture, Sport and Technology (RT and GNN); partially funded by Plant Genetic Conservation Project Under the Royal Initiation of Her Royal Highness Princess Maha Chakri Sirindhorn (AP).	Abbott I. A., 1999, MARINE RED ALGAE HAW; Alexandrov GA, 2007, ECOL MODEL, V200, P189, DOI 10.1016/j.ecolmodel.2006.07.012; Gelman A, 2004, J AM STAT ASSOC, V99, P537, DOI 10.1198/016214504000000458; Fujimoto M, 2014, PHYCOL RES, V62, P77, DOI 10.1111/pre.12049; Brown BE, 1996, CORAL REEFS, V15, P151, DOI 10.1007/BF01145885; Watanabe Y, 2014, PHYCOL RES, V62, P187, DOI 10.1111/pre.12053; BELL EC, 1993, MAR BIOL, V117, P337, DOI 10.1007/BF00345679; Gelman A, 2006, BAYESIAN ANAL, V1, P515; Davison IR, 1996, J PHYCOL, V32, P197, DOI 10.1111/j.0022-3646.1996.00197.x; Prathep A, 2007, AQUAT BOT, V86, P132, DOI 10.1016/j.aquabot.2006.09.011; Tanzil JTI, 2009, CORAL REEFS, V28, P519, DOI 10.1007/s00338-008-0457-5; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Salvucci ME, 2004, PLANT PHYSIOL, V134, P1460, DOI 10.1104/pp.103.038323; Zemke-White WL, 1999, J APPL PHYCOL, V11, P369; Roleda MY, 1997, BOT MAR, V40, P63, DOI 10.1515/botm.1997.40.1-6.63; PLATT T, 1980, J MAR RES, V38, P687; Roleda MY, 1997, BOT MAR, V40, P487, DOI 10.1515/botm.1997.40.1-6.487; Edwards MS, 2010, AQUAT BOT, V92, P119, DOI 10.1016/j.aquabot.2009.10.017; DRING MJ, 1982, MAR ECOL PROG SER, V8, P301, DOI 10.3354/meps008301; LUNING K, 1984, HELGOLANDER MEERESUN, V38, P305, DOI 10.1007/BF01997486; Armisen R, 1987, FAO TECHNICAL PAPER, P1; Bunsom C, 2012, PHYCOL RES, V60, P169, DOI 10.1111/j.1440-1835.2012.00648.x; Chihara M, 1963, PHYCOLOGIA, V3, P69, DOI 10.2216/i0031-8884-3-2-69.1; Coppejans E, 2011, SEAWEEDS MU KO THA L; Dongsansuk A, 2013, PHOTOSYNTHETICA, V51, P13, DOI 10.1007/s11099-012-0070-2; EDWARDS P, 1984, HYDROBIOLOGIA, V116, P246, DOI 10.1007/BF00027676; Fujimoto M, 2014, FISHERIES SCI, V80, P695, DOI 10.1007/s12562-014-0750-x; Ganzon-Fortes ET, 1997, J APPL PHYCOL, V9, P525; Ganzon-Fortes ET, 1999, HYDROBIOLOGIA, V399, P321; Ganzon-Fortes Edna T., 1994, P149; GanzonFortes ET, 1997, BOT MAR, V40, P93, DOI 10.1515/botm.1997.40.1-6.93; HENLEY WJ, 1993, J PHYCOL, V29, P729, DOI 10.1111/j.0022-3646.1993.00729.x; Kowalczyk N, 2013, BBA-BIOENERGETICS, V1827, P834, DOI 10.1016/j.bbabio.2013.04.004; Kubler JE, 1993, MAR BIOL, V117, P325; Larkum AWD, 2003, ADV PHOTO RESPIRAT, V14, P277; Larkum AWD, 2003, ADV PHOTO RESPIRAT, V14, P11; Lewmanomont K, 1995, COMMON SEAWEEDS SEAG; Lideman, 2013, J APPL PHYCOL, V25, P399, DOI 10.1007/s10811-012-9874-5; Lin SM, 2008, PHYCOLOGIA, V47, P168, DOI 10.2216/07-30.1; McHugh DJ, 1991, HYDROBIOLOGIA, V221, P12; Muraoka Daisuke, 1998, Bulletin of the Faculty of Fisheries Hokkaido University, V49, P31; Nishihara GN, 2004, J APPL PHYCOL, V16, P303, DOI 10.1023/B:JAPH.0000047790.59265.fb; Ohno M, 1998, SEAWEED RESOURCES WO, P1; Praiboon J., 2006, SCI ASIA, V32, P11, DOI DOI 10.2306/SCIENCEASIA1513-1874.2006.32(S1).011; Prathep A, 2009, AQUAT BOT, V90, P179, DOI 10.1016/j.aquabot.2008.09.003; Prathep Anchana, 2005, ScienceAsia, V31, P225, DOI 10.2306/scienceasia1513-1874.2005.31.225; R Development Core Team, 2013, R LANG ENV STAT COMP; RAO PS, 1973, J PHYCOL, V9, P333; Rohocek K, 2002, PHOTOSYNTHETICA, V40, P13; Santelices B, 1985, TAXONOMY EC SEAWEEDS, P17; Schagerl M, 2011, MAR BIOL, V158, P2471, DOI 10.1007/s00227-011-1748-x; Serisawa Yukihiko, 2001, Phycological Research, V49, P1; SMITH CM, 1986, OECOLOGIA, V70, P6, DOI 10.1007/BF00377105; Stan Development Team, 2013, STAN C LIB PROB SAMP; Terada R, 2013, J APPL PHYCOL, V25, P1863, DOI 10.1007/s10811-013-0030-7; THOMAS PC, 1975, BOT MAR, V18, P241, DOI 10.1515/botm.1975.18.4.241; Tsutsui I, 2012, INT AGR SERIES, V21; Villanueva RD, 1999, BOT MAR, V42, P175, DOI 10.1515/BOT.1999.020; Vo TD, 2014, FISHERIES SCI, V80, P281, DOI 10.1007/s12562-013-0690-x; Watanabe Y, 2014, J APPL PHYCOL, V26, P2405, DOI 10.1007/s10811-014-0264-z; Webb WL, 1974, OECOLOGIA, V17, P281; Yokono M, 2011, BBA-BIOENERGETICS, V1807, P847, DOI 10.1016/j.bbabio.2011.03.014	64	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0921-8971	1573-5176		J APPL PHYCOL	J. Appl. Phycol.	JUN	2015	27	3					1235	1242		10.1007/s10811-014-0409-0		8	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	CH5PE	WOS:000354087000020		
J	Gao, X; Endo, H; Agatsuma, Y				Gao, Xu; Endo, Hikaru; Agatsuma, Yukio			Effect of increased seawater temperature on biomass, growth, and maturation of Saccharina japonica near its southern limit in northern Japan	JOURNAL OF APPLIED PHYCOLOGY			English	Article						Global warming; Phenology; Standing biomass; Growth; Maturation; Saccharina japonica	RECENT CLIMATE-CHANGE; LAMINARIA-JAPONICA; WEST-COAST; GIANT-KELP; SEA; COMMUNITIES; SEAWEEDS; ALGAE; RESPONSES; SORUS	Recent studies on global warming report that increases in seawater temperature cause coastal ecosystem changes, including a shift in marine algal distribution in temperate regions. To assess the influence of increased seawater temperature on ecophysiological responsiveness and potential shifts in abundance and distribution of kelp, we investigated the seasonal changes in standing biomass, growth, and maturation of natural populations of Saccharina japonica by taking monthly measurements in 2005, 2006, and 2007 in Matsushima Bay, northern Honshu, Japan, which is the southernmost range of this species. Compared to kelps collected in 2005, a sharp decline in standing biomass, later sporophyte occurrence, early growth, greater erosion, and failed sporophyte reproduction were found in kelps collected in 2006, which was a year characterized by relatively high seawater temperature. The population of S. japonica was absent in 2007, when the seawater temperature was higher than that in 2005 and 2006. These results suggest that the seawater temperature in Matsushima Bay is unfavorable for the development and reproduction of this cold-water kelp. If seawater temperatures in this bay remain high over long time periods because of continuous global warming, the southern limit of distribution of S. japonica likely will shift further north.	[Gao, Xu; Endo, Hikaru; Agatsuma, Yukio] Tohoku Univ, Grad Sch Agr Sci, Lab Marine Plant Ecol, Sendai, Miyagi 9818555, Japan	Gao, X (reprint author), Tohoku Univ, Grad Sch Agr Sci, Lab Marine Plant Ecol, Sendai, Miyagi 9818555, Japan.	algaepanda69@163.com					Andersen GS, 2011, J MARINE BIOL; Holbrook SJ, 1997, ECOL APPL, V7, P1299; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; Christie H, 2003, J MAR BIOL ASSOC UK, V83, P687, DOI 10.1017/S0025315403007653h; Diez I, 2012, ESTUAR COAST SHELF S, V99, P108, DOI 10.1016/j.ecss.2011.12.027; Voerman SE, 2013, MAR ENVIRON RES, V90, P119, DOI 10.1016/j.marenvres.2013.06.006; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Bartsch I, 2013, J PHYCOL, V49, P1061, DOI 10.1111/jpy.12125; Tseng CK, 2001, J APPL PHYCOL, V13, P375, DOI 10.1023/A:1017972812576; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Gomez I, 2009, BOT MAR, V52, P593, DOI 10.1515/BOT.2009.073; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Schiel DR, 2004, ECOLOGY, V85, P1833, DOI 10.1890/03-3107; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; Moy FE, 2012, MAR BIOL RES, V8, P309, DOI 10.1080/17451000.2011.637561; Hawkins SJ, 2008, CLIM RES, V37, P123, DOI 10.3354/cr00768; Lignell R, 2003, LIMNOL OCEANOGR, V48, P189; Hiscock K, 2004, AQUAT CONSERV, V14, P333, DOI 10.1002/aqc.628; WIENCKE C, 1994, BOT MAR, V37, P247, DOI 10.1515/botm.1994.37.3.247; Zemke-White WL, 1999, J APPL PHYCOL, V11, P369; Muller R, 2009, BOT MAR, V52, P617, DOI 10.1515/BOT.2009.080; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Lima FP, 2007, GLOBAL CHANGE BIOL, V13, P2592, DOI 10.1111/j.1365-2486.2007.01451.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Buchholz C, 1999, J APPL PHYCOL, V11, P579, DOI 10.1023/A:1008116828263; Dubi A, 1995, P 24 INT C COAST ENG, P142; Edwards MS, 2006, MAR ECOL PROG SER, V320, P79, DOI 10.3354/meps320079; Edwards MS, 2005, MAR BIOL, V147, P273, DOI 10.1007/s00227-004-1548-7; FIELD JG, 1977, S AFR J SCI, V73, P7; Funano T, 1980, SCI REP HOKKAIDO FIS, V22, P17; Gao X, 2013, J APPL PHYCOL, V25, P269, DOI 10.1007/s10811-012-9861-x; Hiraoka M., 2005, AQUABIOLOGY, V27, P485; IPCC, 2001, CLIMATE CHANGE 2001; JACKSON GA, 1977, LIMNOL OCEANOGR, V22, P979; Japan Meteorological Agency, 2013, LONG TERM VAR SURF S; KAWASHIMA S, 1984, Japanese Journal of Phycology, V32, P379; Kinoshita T, 1947, RES ENHANCEMENT LAMI, P79; Kirihara S, 2003, SUISANZOSHUKU, V51, P273; Kirihara S, 2006, J APPL PHYCOL, V18, P521, DOI 10.1007/s10811-006-9057-3; Kitadai Y, 2003, SUISANZOSHOKU, V51, P15; Kumura T, 2006, FISHERIES SCI, V72, P860, DOI 10.1111/j.1444-2906.2006.01228.x; LEE JA, 1986, J PHYCOL, V22, P276, DOI 10.1111/j.1529-8817.1986.tb00024.x; LEVITT GJ, 1993, T ROY SOC S AFR, V48, P339; Lorentsen SH, 2010, BIOL CONSERV, V143, P2054, DOI 10.1016/j.biocon.2010.05.013; LUNING K, 1988, J PHYCOL, V24, P310, DOI 10.1111/j.1529-8817.1988.tb00178.x; MAIRH OP, 1991, INDIAN J MAR SCI, V20, P55; McConnico LA, 2005, J EXP MAR BIOL ECOL, V324, P61, DOI 10.1016/j.jembe.2005.04.006; Mizuta H, 1999, FISHERIES SCI, V65, P103; Mizuta H, 1999, J APPL PHYCOL, V11, P585, DOI 10.1023/A:1008163412333; Nabata S, 2003, FISHERIES AQUATIC LI, P412; Nakahara H, 1984, SCI PAP I ALGOL RES, P77; Nakawaki T, 2001, SUISAN ZOSHOKU, V49, P439; Narita M, 2008, AQUACULTURE SCI, V56, P387; Nimura K, 2002, BOT MAR, V45, P184, DOI 10.1515/BOT.2002.017; Nishida Yoshinori, 2003, Bulletin of the Japanese Society of Fisheries Oceanography, V67, P88; NOVACZEK I, 1984, MAR BIOL, V81, P189, DOI 10.1007/BF00393117; Okada Y, 1980, B HOKKAIDO REG FISH, V45, P51; Pehike C, 2008, CLIM RES, V37, P135; Sanbonsuga Y, 1973, B HOKKAIDO REG FISH, V39, P61; Sanbonsuga Y, 1978, B HOKKAIDO REG FISH, V43, P79; Suzuki S, 2008, J APPL PHYCOL, V20, P833, DOI 10.1007/s10811-007-9283-3; tom Dieck I, 1992, PHYCOLOGIA, V31, P147, DOI 10.2216/i0031-8884-31-2-147.1; Tsuda F, 2006, KAIYO MONTHLY, V38, P210; ZIMMERMAN RC, 1984, J MAR RES, V42, P591	66	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0921-8971	1573-5176		J APPL PHYCOL	J. Appl. Phycol.	JUN	2015	27	3					1263	1270		10.1007/s10811-014-0417-0		8	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	CH5PE	WOS:000354087000023		
J	Shiono, T; Kusumoto, B; Maeshiro, R; Fujii, SJ; Gotzenberger, L; de Bello, F; Kubota, Y				Shiono, Takayuki; Kusumoto, Buntarou; Maeshiro, Ryo; Fujii, Shin-Jiro; Goetzenberger, Lars; de Bello, Francesco; Kubota, Yasuhiro			Climatic drivers of trait assembly in woody plants in Japan	JOURNAL OF BIOGEOGRAPHY			English	Article						Climate harshness; climate seasonality; dispersal limitation; environmental filtering; functional diversity; Japanese archipelago; monsoon climate; null model; plant functional traits; trait biogeography	FUNCTIONAL DIVERSITY; FISH COMMUNITIES; ECOLOGICAL PROCESSES; ECONOMICS SPECTRUM; SPECIES-DIVERSITY; GLOBAL PATTERNS; LEAF-LONGEVITY; BETA DIVERSITY; SCALE; WORLDWIDE	AimA trait-based biogeographical approach can be used to shed light on species-sorting mechanisms that are driven by the interactions between species traits and abiotic conditions along large-scale gradients. We tested the hypothesis that geographical patterns of woody plant assemblages are driven largely by environmental filtering, in relation to climate harshness and seasonality, acting on key functional traits. LocationJapanese archipelago. MethodsUsing a large-scale grid-based dataset of 773 woody species and five functional traits measured in the field, spanning the Japanese archipelago, we analysed the influence of climate harshness (absolute minimum temperature and precipitation of driest month) and climate seasonality (temperature and precipitation seasonality, and the length of period suitable for photosynthesis) on three aspects of community trait structure: community mean trait values, functional richness and functional divergence. To confirm whether the influence of climate-based species sorting on functional structure was stronger than the impact of dispersal limitation, we used null models that did or did not account for the difference in regional species pools as a result of vicariance. ResultsWhile climate harshness and historical dispersal limitation had a some influence on trait structure, temperature seasonality played a significant role. Greater seasonality was associated with functional similarity in wood density and leaf nitrogen concentration, but also contributed to increased diversity in leaf thickness, specific leaf area and maximum height. Main conclusionsOur results demonstrate the importance of climate harshness and seasonality in shaping the geographical variation of functional trait structures in woody plant assemblages, while we found that species richness decreases with increasing climate harshness. Climate seasonality results in the convergence and divergence of co-occurring traits across different vegetation zones. This suggests that seasonal environmental variability acts not only as a filter of species traits but also as a driver creating a greater difference in functional strategies among woody plant species.	[Shiono, Takayuki; Kusumoto, Buntarou; Maeshiro, Ryo; Fujii, Shin-Jiro; Kubota, Yasuhiro] Univ Ryukyus, Fac Sci, Nishihara, Okinawa 9030213, Japan; [Goetzenberger, Lars; de Bello, Francesco] Acad Sci Czech Republic, Inst Bot, Trebon, Czech Republic	Kubota, Y (reprint author), Univ Ryukyus, Fac Sci, 1 Senbaru, Nishihara, Okinawa 9030213, Japan.	kubota.yasuhiro@gmail.com			Japan Society for the Promotion of Science [21310025, 21247006]; European Union [GA-2010-267243]	We thank Ms Kana Kubota for compiling the flora data and measuring traits. We are also grateful to a number of people for sampling permission and to researchers who have helped collect woody plants. This study is part of the Project of Mapping Biodiversity in Japan led by Y.K. Financial support was provided by the Japan Society for the Promotion of Science (numbers 21310025 and 21247006). L.G. received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement number GA-2010-267243 'PLANT FELLOWS'.	Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; ELLNER S, 1987, VEGETATIO, V69, P199, DOI 10.1007/BF00038701; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; Woodward FI, 2004, PHILOS T ROY SOC B, V359, P1465, DOI 10.1098/rstb.2004.1525; Naeem S, 2003, ECOL LETT, V6, P567, DOI 10.1046/j.1461-0248.2003.00471.x; Kichenin E, 2013, FUNCT ECOL, V27, P1254, DOI 10.1111/1365-2435.12116; Mason NWH, 2013, J VEG SCI, V24, P794, DOI 10.1111/jvs.12013; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Schleuter D, 2012, GLOBAL ECOL BIOGEOGR, V21, P1083, DOI 10.1111/j.1466-8238.2012.00763.x; Kikuzawa K, 1996, VEGETATIO, V122, P61, DOI 10.1007/BF00052816; MAY RM, 1972, P NATL ACAD SCI USA, V69, P1109, DOI 10.1073/pnas.69.5.1109; Freschet GT, 2011, GLOBAL ECOL BIOGEOGR, V20, P755, DOI 10.1111/j.1466-8238.2011.00651.x; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Kikuzawa K, 2013, GLOBAL ECOL BIOGEOGR, V22, P982, DOI 10.1111/geb.12042; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Gotzenberger L, 2012, BIOL REV, V87, P111, DOI 10.1111/j.1469-185X.2011.00187.x; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Lusk CH, 2008, TRENDS ECOL EVOL, V23, P299, DOI 10.1016/j.tree.2008.02.006; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Pringle EG, 2011, BIOTROPICA, V43, P299, DOI 10.1111/j.1744-7429.2010.00697.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Onoda Y, 2011, ECOL LETT, V14, P301, DOI 10.1111/j.1461-0248.2010.01582.x; Mason NWH, 2008, J ANIM ECOL, V77, P285, DOI 10.1111/j.1365-2656.2007.01350.x; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Ingram T, 2009, ECOLOGY, V90, P2444, DOI 10.1890/08-1841.1; Swenson NG, 2012, GLOBAL ECOL BIOGEOGR, V21, P798, DOI 10.1111/j.1466-8238.2011.00727.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Albert CH, 2010, FUNCT ECOL, V24, P1192, DOI 10.1111/j.1365-2435.2010.01727.x; Barber C. B., 2014, GEOMETRY MESH GENERA; Canavero A, 2009, AUSTRAL ECOL, V34, P741, DOI 10.1111/j.1442-9993.2009.01980.x; Chao A., 1984, THEORY APPL, V11, P265; Chessel D., 2013, CRAN R PACKAGE ADE4; desBello F., 2013, ECOGRAPHY, V36, P393; desBello F., 2012, GLOBAL ECOL BIOGEOGR, V21, P312; desBello F., 2009, J VEG SCI, V20, P475; Dray S., 2013, PACKFOR FORWARD SELE; Fischer A. G., 1960, EVOLUTION, V14, P61; JMA, 2002, MESH CLIM DAT 2000; Kubota Y, 2015, ECOGRAPHY, V38, P639, DOI 10.1111/ecog.00981; Kubota Y, 2014, J BIOGEOGR, V41, P1267, DOI 10.1111/jbi.12290; Kubota Y, 2011, J BIOGEOGR, V38, P1006, DOI 10.1111/j.1365-2699.2011.02491.x; Kusumoto B, 2015, J APPL ECOL, V52, P171, DOI 10.1111/1365-2664.12367; Latham Roger Earl, 1993, P294; Legendre P., 1998, NUMERICAL ECOLOGY; LISTER BC, 1981, ECOLOGY, V62, P1548, DOI 10.2307/1941511; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Maeshiro R, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00125.1; Mason NWH, 2007, OECOLOGIA, V153, P441, DOI 10.1007/s00442-007-0727-x; Oksanen J., 2012, VEGAN COMMUNITY ECOL; R Core Team, 2012, R LANG ENV STAT COMP; Satake Y., 1989, WILDFLOWERS JAPAN; Wang T, 2006, INT J CLIMATOL, V26, P383, DOI 10.1002/joc.1247; Yonekura K., 2003, BGPLANTS JAPANESE SC; Zhang SB, 2011, GLOBAL ECOL BIOGEOGR, V20, P241, DOI 10.1111/j.1466-8238.2010.00582.x	61	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-0270	1365-2699		J BIOGEOGR	J. Biogeogr.	JUN	2015	42	6					1176	1186		10.1111/jbi.12503		11	Ecology; Geography, Physical	Environmental Sciences & Ecology; Physical Geography	CH8LY	WOS:000354289100016		
J	Namiuchi, S; Sugie, T; Saji, K; Takii, T; Suda, A; Kato, A				Namiuchi, Shigeto; Sugie, Tadashi; Saji, Kenya; Takii, Toru; Suda, Akira; Kato, Atsushi			The systemic inflammation-based Glasgow Prognostic Score as a prognostic factor in patients with acute heart failure	JOURNAL OF CARDIOVASCULAR MEDICINE			English	Article						albumin; C-reactive protein; inflammation; malnutrition	PRESERVED EJECTION FRACTION; SERUM-ALBUMIN; HOSPITAL DEATH; RISK MODEL; MORTALITY; SURVIVAL; HYPOALBUMINEMIA; PREDICTION; PROTECT; CANCER	AimsBy combining C-reactive protein and serum albumin concentrations, the Glasgow Prognostic Score (GPS) provides valuable predictions of prognosis in patients with cancer. Both systemic inflammatory response and malnutrition are also common in patients with heart failure. We evaluated the efficacy of the GPS for predicting the prognoses of patients with acute decompensated heart failure (ADHF).MethodsWe investigated 336 patients who were admitted with ADHF. The GPS (0, 1, and 2) was defined as follows: patients with both elevated C-reactive protein (>1.0mg/dl) and hypoalbuminemia (<3.5g/dl) were allocated a score of 2, patients with only one of these biochemical abnormalities were allocated a score of 1, and patients with neither of these abnormalities were allocated a score of 0.ResultsDuring the follow-up period (meanSD: 504 +/- 471 days), 71 patients (21.1%) died. Relative to a GPS of 0, the hazard ratios for all-cause death were 3.40 (95% confidence interval 1.81-6.45) for a GPS of 2 and 1.97 (95% confidence interval 1.06-3.66) for a GPS of 1, as determined using adjusted Cox proportional-hazards analysis.ConclusionsThe GPS, which is based on systemic inflammation, is useful for predicting the prognoses of hospitalized patients with ADHF.	[Namiuchi, Shigeto; Sugie, Tadashi; Saji, Kenya; Takii, Toru; Suda, Akira; Kato, Atsushi] Sendai City Med Ctr, Dept Cardiol, Sendai, Miyagi 9830824, Japan	Namiuchi, S (reprint author), Sendai City Med Ctr, Dept Cardiol, Miyagino Ku, 5-22-1 Tsurugaya, Sendai, Miyagi 9830824, Japan.	nami@openhp.or.jp					McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Sato Y, 1999, CLIN CARDIOL, V22, P811; White M, 2006, CLIN SCI, V110, P483, DOI 10.1042/CS20050317; Cohen-Solal A, 2009, J AM COLL CARDIOL, V53, P2343, DOI 10.1016/j.jacc.2009.02.058; Tsutamoto T, 1998, J AM COLL CARDIOL, V31, P391, DOI 10.1016/S0735-1097(97)00494-4; Cleland JG, 2014, CIRC-HEART FAIL, V7, P76, DOI 10.1161/CIRCHEARTFAILURE.113.000284; O'Connor CM, 2010, J AM COLL CARDIOL, V55, P872, DOI 10.1016/j.jacc.2009.08.083; Lassus J, 2013, INT J CARDIOL, V168, P2186, DOI 10.1016/j.ijcard.2013.01.228; Deswal A, 2001, CIRCULATION, V103, P2055; Berry C, 2001, EUR J HEART FAIL, V3, P283, DOI 10.1016/S1388-9842(01)00123-4; McMillan DC, 2008, P NUTR SOC, V67, P257, DOI 10.1017/S0029665108007131; Kinugasa Y, 2013, CIRC J, V77, P705, DOI 10.1253/circj.CJ-12-1091; Nunez J, 2011, AM J CARDIOL, V107, P1034, DOI 10.1016/j.amjcard.2010.11.029; Milo-Cotter O, 2011, CARDIOLOGY, V119, P96, DOI 10.1159/000330409; Arques S, 2011, ARCH CARDIOVASC DIS, V104, P502, DOI 10.1016/j.acvd.2011.06.003; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Liu M, 2012, EUR J HEART FAIL, V14, P39, DOI 10.1093/eurjhf/hfr154; Uthamalingam S, 2010, AM HEART J, V160, P1149, DOI 10.1016/j.ahj.2010.09.004; Uthamalingam S, 2011, AM J CARDIOL, V107, P433, DOI 10.1016/j.amjcard.2010.09.039; O'Connor CM, 2012, EUR J HEART FAIL, V14, P605, DOI 10.1093/eurjhf/hfs029; Arques S, 2011, J CARD FAIL, V17, P451, DOI 10.1016/j.cardfail.2011.02.010; Aziz Emad F, 2011, Heart Int, V6, pe2, DOI 10.4081/hi.2011.e2; Bonilla-Palomas JL, 2014, J CARD FAIL, V20, P350, DOI 10.1016/j.cardfail.2014.01.016; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Kinugasa Y, 2009, CIRC J, V73, P2276; Shiba Nobuyuki, 2011, EPMA J, V2, P425, DOI 10.1007/s13167-011-0097-7; Zairis MN, 2010, INT J CARDIOL, V141, P284, DOI 10.1016/j.ijcard.2008.12.017	27	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1558-2027	1558-2035		J CARDIOVASC MED	J. Cardiovasc. Med.	JUN	2015	16	6			SI		409	415		10.2459/JCM.0000000000000184		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH5HQ	WOS:000354066700003		
J	Suehiro, K; Tanaka, K; Yamada, T; Matsuura, T; Mori, T; Funao, T; Nishikawa, K				Suehiro, Koichi; Tanaka, Katsuaki; Yamada, Tokuhiro; Matsuura, Tadashi; Mori, Takashi; Funao, Tomoharu; Nishikawa, Kiyonobu			The ability of the Vigileo-FloTrac system to measure cardiac output and track cardiac output changes during one-lung ventilation	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Cardiac output; One-lung ventilation; Systemic vascular resistance; Vigileo-FloTrac system	PREDICT FLUID RESPONSIVENESS; STROKE VOLUME VARIATIONS; VASCULAR-RESISTANCE; ARTERIAL-PRESSURE; SOFTWARE VERSION; PULSE PRESSURE; SEPTIC SHOCK; SURGERY; THERMODILUTION; AGREEMENT	This study was aimed at comparing the cardiac output (CO) measured by the Vigileo (TM)-FloTrac (TM) system with that estimated by the thermodilution pulmonary artery catheter (PAC) during one-lung ventilation (OLV) and determining the reliability of this system in tracking phenylephrine-induced CO changes during OLV. Sixteen patients scheduled for descending aorta replacement were enrolled. The study was performed 30 min after starting OLV under stable hemodynamic conditions. We recorded hemodynamic variables, CO measured by PAC thermodilution (ICO), CO measured by Vigileo (TM)-FloTrac (TM) system (Version 3.02, Edwards Lifesciences, Irvine, CA, USA) (APCO), and systemic vascular resistance index (SVRI) before (T0) and after (T1) phenylephrine (100 mu g) administration. We used Bland-Altman analysis to compare ICO and APCO. Polar plot and four-quadrant plot were used to assess the tracking ability of the Vigileo (TM)-FloTrac (TM) system against ICO after administration of phenylephrine. Ninety hemodynamic interventions were performed. Bland-Altman analysis revealed that the mean bias between APCO and ICO was 0.05 L/min and the percentage error, 46.9 %. Four-quadrant plot analysis showed a concordance rate of 24.7 %, while polar plot analysis showed that the concordance rate was 13.3 %; the angular bias, -45.9A degrees; radial limit of agreement, 85.3A degrees. The bias between APCO and ICO was significantly correlated with the SVRI value (p < 0.001, r(2) = 0.822). The reliability of the Vigileo (TM)-FloTrac (TM) system during OLV to estimate CO and track phenylephrine-induced CO changes was not acceptable.	[Suehiro, Koichi; Tanaka, Katsuaki; Yamada, Tokuhiro; Matsuura, Tadashi; Mori, Takashi; Funao, Tomoharu; Nishikawa, Kiyonobu] Osaka City Univ, Dept Anesthesiol, Grad Sch Med, Abeno Ku, Osaka, Osaka 5458586, Japan	Suehiro, K (reprint author), Osaka City Univ, Dept Anesthesiol, Grad Sch Med, Abeno Ku, 1-5-7 Asahimachi, Osaka, Osaka 5458586, Japan.	suehirokoichi@yahoo.co.jp					Akiyoshi K, 2011, J ANESTH, V25, P178, DOI 10.1007/s00540-010-1087-y; American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization, 2003, ANESTHESIOLOGY, V99, P988; Marque S, 2013, J CLIN MONIT COMPUT, V27, P273, DOI 10.1007/s10877-013-9431-z; Critchley LA, 2010, ANESTH ANALG, V111, P1180, DOI 10.1213/ANE.0b013e3181f08a5b; Derichard A, 2009, BRIT J ANAESTH, V103, P678, DOI 10.1093/bja/aep267; Biais M, 2008, BRIT J ANAESTH, V101, P761, DOI 10.1093/bja/aen277; Slagt C, 2013, J CLIN MONIT COMPUT, V27, P171, DOI 10.1007/s10877-012-9410-9; Suehiro K, 2013, BRIT J ANAESTH, V111, P170, DOI 10.1093/bja/aet022; Lahner D, 2009, BRIT J ANAESTH, V103, P346, DOI 10.1093/bja/aep200; Critchley LAH, 1999, J CLIN MONITOR COMP, V15, P85, DOI 10.1023/A:1009982611386; Cannesson M, 2012, J APPL PHYSIOL, V113, P281, DOI 10.1152/japplphysiol.00126.2012; Biancofiore G, 2011, ANESTH ANALG, V113, P515, DOI 10.1213/ANE.0b013e31822401b2; BENUMOF JL, 1985, ANESTH ANALG, V64, P821; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; Critchley LA, 2011, J CARDIOTHOR VASC AN, V25, P536, DOI 10.1053/j.jvca.2011.01.003; Biais M, 2010, BRIT J ANAESTH, V104, P407, DOI 10.1093/bja/aeq031; BLAND JM, 1986, LANCET, V1, P307; Haas S, 2012, CRIT CARE RES PRACT, V2012, DOI DOI 10.1155/2012/687018; MALMKVIST G, 1989, BRIT J ANAESTH, V63, P696, DOI 10.1093/bja/63.6.696; Pereira de Souza, 2011, BRIT J ANAESTH, V106, P856; Sotomi Y, 2013, J CLIN MONIT COMPUT, V27, P639, DOI 10.1007/s10877-013-9481-2; Trepte C, 2012, BRIT J ANAESTH, V108, P922, DOI 10.1093/bja/aes032	22	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	JUN	2015	29	3					333	339		10.1007/s10877-014-9609-z		7	Anesthesiology	Anesthesiology	CH5US	WOS:000354101400003		
J	Tamai, T				Tamai, Toshiki			Redistributive taxation, wealth distribution, and economic growth	JOURNAL OF ECONOMICS			English	Article						Redistributive tax; Inequality; Economic growth	INCOME-DISTRIBUTION; ENDOGENOUS GROWTH; INEQUALITY; POLITICS; POLICY; MODEL	This paper examines the relationship between wealth distribution and economic growth in an endogenous growth model with heterogeneous households and redistributive taxation. In this paper, we incorporate an endogenous determination of redistributive policy into the model, focusing on the relation between pre- and post-tax inequality. Endogenous redistributive policy affects wealth distribution and economic growth. Therefore, the relation between post-tax inequality and economic growth is different from that between pre-tax inequality and economic growth. Results show that there exists a negative correlation between pre-tax inequality and economic growth, whereas there exists an inverted-U relationship between post-tax inequality and economic growth in a voting equilibrium.	Kinki Univ, Fac Econ, Higashi Ku, Osaka 5778502, Japan	Tamai, T (reprint author), Kinki Univ, Fac Econ, Higashi Ku, 3-4-1 Kowakae, Osaka 5778502, Japan.	tamai@kindai.ac.jp			Japan Society for the Promotion of Science [22730268]	I thank two anonymous referees and Giacomo Corneo, the Editor of this journal, for their helpful comments and suggestions. I am also grateful to Shinya Fujita, Akira Kamiguchi and the seminar participants at Nagoya University for their advice and comments. This work was supported by a Grant-in-Aid for Young Scientists (B) (No. 22730268) of the Japan Society for the Promotion of Science.	ALESINA A, 1994, Q J ECON, V109, P465, DOI 10.2307/2118470; Rehme G, 2007, ECONOMICA, V74, P493, DOI 10.1111/j.1468-0335.2006.00555.x; Kuznets S, 1955, AM ECON REV, V45, P1; GALOR O, 1993, REV ECON STUD, V60, P35, DOI 10.2307/2297811; Barro RJ, 2000, J ECON GROWTH, V5, P5, DOI 10.1023/A:1009850119329; Knowles S, 2005, J DEV STUD, V41, P135, DOI 10.1080/0022038042000276590; Champernowne DG, 1953, ECON J, V63, P318, DOI 10.2307/2227127; Forbes KJ, 2000, AM ECON REV, V90, P869, DOI 10.1257/aer.90.4.869; Aghion P, 1999, J ECON LIT, V37, P1615, DOI 10.1257/jel.37.4.1615; Corneo G, 1999, EUR ECON REV, V43, P1665, DOI 10.1016/S0014-2921(98)00046-4; Deininger K, 1998, J DEV ECON, V57, P259, DOI 10.1016/S0304-3878(98)00099-6; Caselli F, 2000, AM ECON REV, V90, P909, DOI 10.1257/aer.90.4.909; Atkinson A. B., 2000, HDB INCOME DISTRIBUT; Balisacan AM, 2003, ECON LETT, V79, P53, DOI 10.1016/S0165-1765(02)00287-2; Barro R. J., 1995, EC GROWTH; BERTOLA G, 1993, AM ECON REV, V83, P1184; Cowell F.A., 2011, MEASURING INEQUALITY; Creedy J., 1977, REV INCOME WEALTH, V23, P405, DOI 10.1111/j.1475-4991.1977.tb00026.x; Dahan M., 1998, J ECON GROWTH, V3, P29, DOI 10.1023/A:1009769930916; Garcia-Penalosa C, 2011, J MONEY CREDIT BANK, V43, P1543, DOI 10.1111/j.1538-4616.2011.00458.x; GRUNER HP, 1995, J ECON, V62, P1, DOI 10.1007/BF01227535; Hendel I, 2005, J PUBLIC ECON, V89, P841, DOI 10.1016/j.jpubeco.2004.11.004; KUZNETS S, 1963, ECON DEV CULT CHANGE, V11, P1, DOI 10.1086/450006; Lambert P., 2001, DISTRIBUTION REDISTR; Li H., 1998, REV DEV ECON, V2, P318, DOI DOI 10.1111/1467-9361.00045; OECD, 2008, GROW UN INC DISTR PO; OKUNO N, 1981, Q J ECON, V96, P171, DOI 10.2307/2936148; Owen AL, 1998, J MONETARY ECON, V41, P71, DOI 10.1016/S0304-3932(97)00067-6; PEROTTI R, 1993, REV ECON STUD, V60, P755, DOI 10.2307/2298098; Perotti Roberto, 1996, J ECON GROWTH, V1, P149, DOI DOI 10.1007/BF00138861; PERSSON T, 1994, AM ECON REV, V84, P600; Rehme G, 1999, EC WORKING PAPERS EU, Veco99/14; Rehme G, 2000, EC WORKING PAPERS EU, Veco2000/13; Rehme G, 2003, GROWTH INEQUALITY TH; Rehme G, 2011, SCOT J POLIT ECON, V58, P262, DOI 10.1111/j.1467-9485.2011.00546.x; Rehme G, 2003, FINANZARCHIV, V59, P479, DOI 10.1628/0015221032500810; ROMER PM, 1986, J POLIT ECON, V94, P1002, DOI 10.1086/261420; STIGLITZ JOSEPH, 1980, LECT PUBLIC EC; Tamai T, 2009, J ECON, V97, P217, DOI 10.1007/s00712-009-0059-x; Tamai T, 2010, J PUBLIC ECON, V94, P1067, DOI 10.1016/j.jpubeco.2010.06.019	40	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0931-8658	1617-7134		J ECON	J. Econ.	JUN	2015	115	2					133	152		10.1007/s00712-014-0424-2		20	Economics	Business & Economics	CI0BV	WOS:000354401600002		
J	Miyagiwa, K				Miyagiwa, Kaz			THE 2011 AMERICA INVENTS ACT: DOES IT UNDERMINE INNOVATION?	JOURNAL OF ECONOMICS & MANAGEMENT STRATEGY			English	Article							MARKET-STRUCTURE; DISCLOSURE; PATENTS; DEFENSE; GAMES	With the 2011 America Invents Act, the United States discarded its century-old first-to-invent patent-awarding system in favor of a first-to-file rule. Critics have argued that the first-to-file rule rewards speed in patent applications rather than creativity, thereby undermining innovation. We evaluate this concern within a dynamic model of a patent race, and find first-to-invent (weakly) more conducive to innovation than first-to-file. Defending prior users' rights can promote both pro- and anti-R&D effect of a switch to first-to-file.	[Miyagiwa, Kaz] Florida Int Univ, Dept Econ, Miami, FL 33199 USA; [Miyagiwa, Kaz] Osaka Univ, ISER, Osaka, Japan	Miyagiwa, K (reprint author), Florida Int Univ, Dept Econ, Miami, FL 33199 USA.	kmiyagiw@fiu.edu			Microsoft's Academic Research Program	The author is grateful to an anonymous referee and the co-editor for helpful comments and suggestions for revising the paper, and thanks Yuka and seminar participants for their comments on earlier versions. The author also thanks CORE and the Universite catholique de Louvain for their hospitality during his visit. A research grant from Microsoft's Academic Research Program is gratefully acknowledged. Any opinions expressed or remaining errors are the author's.	Abram D. S., 2012, STANFORD LAW REV, V65, P517; SCOTCHMER S, 1990, RAND J ECON, V21, P131, DOI 10.2307/2555499; KANDORI M, 1993, ECONOMETRICA, V61, P29, DOI 10.2307/2951777; Lemley MA, 2005, J ECON PERSPECT, V19, P75, DOI 10.1257/0895330054048650; CARLSSON H, 1993, ECONOMETRICA, V61, P989, DOI 10.2307/2951491; Denicolo V, 2004, J ECON MANAGE STRAT, V13, P517, DOI 10.1111/j.1430-9134.2004.00021.x; FUDENBERG D, 1983, EUR ECON REV, V22, P3, DOI 10.1016/0014-2921(83)90087-9; Aoki R, 1996, J JPN INT ECON, V10, P233, DOI 10.1006/jjie.1996.0013; Cohen L. R., 2005, 0522 AER BROOK JOINT, P05; Cooper W. R., 1992, Q J ECON, V107, P739; Cooper W. R., 1990, AM ECON REV, V80, P218; Harsanyi J. C., 1988, GEN THEORY EQUILIBRI; Kappos D. J., 2012, REPORT PRIOR USER RI; LEE T, 1980, Q J ECON, V94, P429, DOI 10.2307/1884551; Lo S.-t., 2009, 14926 NAT BUR EC RES; LOURY GC, 1979, Q J ECON, V93, P395, DOI 10.2307/1883165; Maurer SM, 2002, ECONOMICA, V69, P535, DOI 10.1111/1468-0335.00299; Miyagiwa K, 2015, INT J IND ORGAN, V39, P81, DOI 10.1016/j.ijindorg.2015.02.004; Shapiro C, 2006, AM ECON REV, V96, P92, DOI 10.1257/000282806777211865	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1058-6407	1530-9134		J ECON MANAGE STRAT	J. Econ. Manage. Strategy	SUM	2015	24	2			SI		211	227		10.1111/jems.12092		17	Economics; Management	Business & Economics	CH7CS	WOS:000354193800001		
J	Anno, H; Shirataki, R				Anno, Hiroaki; Shirataki, Ritsuko			Effect of Heat Treatment in Air on Thermoelectric Properties of Polycrystalline Type-I Silicon-Based Clathrate: Ba8Al15Si31	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Silicon clathrate; thermal stability; chemical composition; Seebeck coefficient; electrical conductivity; thermal conductivity	LATTICE THERMAL CONDUCTIVITY; HIGH TEMPERATURES; BA8AL14SI31; RESISTANCE; STABILITY; PHASES; SR; GA; GE; AL	The effect of heat treatment in air on the thermoelectric properties was investigated for polycrystalline Ba8Al15Si31, where the Al content is almost at the maximum in the Ba8Al (x) Si46-x system, to evaluate the thermal stability in air at high temperatures, which is indispensable for practical use in thermoelectric applications. Samples were prepared by combining arc melting and spark plasma sintering techniques. Heat treatments were performed in air at 873 K for 10 days and 20 days. The Seebeck coefficient, electrical conductivity, and thermal conductivity were measured before and after the heat treatments. The microstructure and chemical composition were also analyzed before and after the heat treatments, using scanning electron microscopy with energy-dispersive x-ray spectroscopy. Although an oxidation layer was formed on the surface by the heat treatment in air, the chemical composition of the interior of Ba8Al15Si31 was found to be stable in air at 873 K for 10 days and 20 days. The Seebeck coefficient, the electrical conductivity, and the thermal conductivity were found to be almost unchanged after the heat treatment, indicating that Ba8Al15Si31 clathrate is promising as a thermoelectric material with high thermal stability for use in air at 873 K.	[Anno, Hiroaki; Shirataki, Ritsuko] Tokyo Univ Sci, Dept Elect Engn, Yamaguchi 7560884, Japan	Anno, H (reprint author), Tokyo Univ Sci, Dept Elect Engn, 1-1-1 Daigaku Dori, Yamaguchi 7560884, Japan.	anno@rs.tus.ac.jp			JST, CREST; JSPS KAKENHI [25420763]	The authors would like thank Professor emeritus Naoki Toshima, of Tokyo University of Science, Yamaguchi, for use of Xe flash analyzer. This work was supported by JST, CREST and JSPS KAKENHI Grant Number 25420763.	Anno H, 2014, PHYS STATUS SOLIDI A, V211, P1288, DOI 10.1002/pssa.201300145; Anno H, 2013, J ELECTRON MATER, V42, P2326, DOI 10.1007/s11664-012-2418-6; Anno H, 2014, J ELECTRON MATER, V43, P1847, DOI 10.1007/s11664-013-2887-2; Condron CL, 2006, CHEM MATER, V18, P4939, DOI 10.1021/cm061483u; Slack GA, 1997, MATER RES SOC SYMP P, V478, P47; Condron CL, 2006, INORG CHEM, V45, P9381, DOI 10.1021/ic061241w; Anno H, 2013, J MATER SCI, V48, P2846, DOI 10.1007/s10853-012-6977-y; Tsujii N, 2011, J SOLID STATE CHEM, V184, P1293, DOI 10.1016/j.jssc.2011.03.038; Mudryk Y, 2002, J PHYS-CONDENS MAT, V14, P7991, DOI 10.1088/0953-8984/14/34/318; ABELES B, 1963, PHYS REV, V131, P1906, DOI 10.1103/PhysRev.131.1906; Roudebush JH, 2012, INORG CHEM, V51, P4161, DOI 10.1021/ic2024814; Roudebush JH, 2011, J SOLID STATE CHEM, V184, P1176, DOI 10.1016/j.jssc.2011.02.027; Yadav GG, 2011, NANOSCALE, V3, P3555, DOI 10.1039/c1nr10555h; KLEMENS PG, 1960, PHYS REV, V119, P507, DOI 10.1103/PhysRev.119.507; CALLAWAY J, 1960, PHYS REV, V120, P1149, DOI 10.1103/PhysRev.120.1149; Condron CL, 2008, INORG CHEM, V47, P8204, DOI 10.1021/ic800772m; Condron CL, 2007, INORG CHEM, V46, P4523, DOI 10.1021/ic070078h; Condron CL, 2007, INORG CHEM, V46, P2556, DOI 10.1021/ic062115v; EISENMANN B, 1986, J LESS-COMMON MET, V118, P43, DOI 10.1016/0022-5088(86)90609-0; Goldsmid H.J., 1986, ELECT REFRIGERATION, P58; Kikuchi D, 2014, J ELECTRON MATER, V43, P2141, DOI 10.1007/s11664-014-2991-y; Mugita N., 2011, MATER SCI ENG, V18; Nagatomo Y, 2012, J PHYS CONF SER, V379, DOI 10.1088/1742-6596/379/1/012008; Onizuka Y, 2014, J ELECTRON MATER, V43, P2059, DOI 10.1007/s11664-013-2948-6; Roudebush JH, 2012, INORG CHEM, V51, P1805, DOI 10.1021/ic202095e; Rowe D.M., 1995, CRC HDB THERMOELECTR, P407; Uemura T, 2006, T MRS JAP, V31, P311; Yang J., 2004, THERMAL CONDUCTIVITY, P1, DOI 10.1007/0-387-26017-X_1	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					1413	1419		10.1007/s11664-014-3385-x		7	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700006		
J	Nomura, M; Maire, J				Nomura, M.; Maire, J.			Mechanism of the Reduced Thermal Conductivity of Fishbone-Type Si Phononic Crystal Nanostructures	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Phononics; phononic crystal; nanoscale heat transport; thermoreflectance	PHOTONIC CRYSTALS; TRANSPORT	The mechanism of the reduced thermal conductivity of fishbone-type phononic crystal (PnC) nanostructures, in which ballistic phonon transport is dominant, was investigated with consideration of both the wave and particle nature of phonons. Phononic band diagrams were calculated for an Si nanowire and a fishbone-type PnC structure with a period of 100 nm, and a clear reduction of the group velocity of phonons, because of a zone-folding effect, was shown. Air-suspended Si nanowires and fishbone-type PnC structures were fabricated by electron beam (EB) lithography, and their thermal conductivities were measured by use of the originally developed micro time-domain thermoreflectance method. The PnC structure had a much lower thermal conductivity. We measured the thermal conductivity of a variety of PnC structures with different fin widths to investigate the mechanism of the reduced thermal conductivity observed. The result indicates that the increase of the phonon traveling distance. as a result of the fins, also results in reduced thermal conductivity.	[Nomura, M.; Maire, J.] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Nomura, M.] Univ Tokyo, Inst Nano Quantum Informat Elect, Meguro Ku, Tokyo 1538505, Japan; [Maire, J.] Univ Tokyo, LIMMS CNRS IIS UMI 2820, Meguro Ku, Tokyo 1538505, Japan	Nomura, M (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan.	nomura@iis.u-tokyo.ac.jp			Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; JSPS through Core-to-Core Program, JSPS KAKENHI [25709090]; Foundation for the Promotion of Industrial Science	The authors thank J. Shiomi, T. Hori, and K. Hirakawa for fruitful discussion and Y. Arakawa for technical support. This work was supported by: the Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; by the JSPS through Core-to-Core Program, JSPS KAKENHI (25709090); and by The Foundation for the Promotion of Industrial Science.	ROWE DM, 1981, NATURE, V290, P765, DOI 10.1038/290765a0; Jain A, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.195301; Maldovan M, 2013, NATURE, V503, P209, DOI 10.1038/nature12608; Eichenfield M, 2009, NATURE, V459, P550, DOI 10.1038/nature08061; Baba T, 2008, NAT PHOTONICS, V2, P465, DOI 10.1038/nphoton.2008.146; Luckyanova MN, 2012, SCIENCE, V338, P936, DOI 10.1126/science.1225549; Kashiwagi M, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3543852; Gorishnyy T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.115501; Hochbaum AI, 2008, NATURE, V451, P163, DOI 10.1038/nature06381; Ishizaki K, 2013, NAT PHOTONICS, V7, P133, DOI 10.1038/NPHOTON.2012.341; Nomura M, 2010, NAT PHYS, V6, P279, DOI 10.1038/NPHYS1518; Seol JH, 2010, SCIENCE, V328, P213, DOI 10.1126/science.1184014; Cahill DG, 2004, REV SCI INSTRUM, V75, P5119, DOI 10.1063/1.1819431; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; Minnich AJ, 2009, ENERG ENVIRON SCI, V2, P466, DOI 10.1039/b822664b; Hone J, 2000, SCIENCE, V289, P1730, DOI 10.1126/science.289.5485.1730; Shi L, 2012, NANOSC MICROSC THERM, V16, P79, DOI 10.1080/15567265.2012.667514; Bera C, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.115502; Dechaumphai E, 2012, J APPL PHYS, V111, DOI 10.1063/1.3699056; Gillet JN, 2009, J HEAT TRANS-T ASME, V131, DOI 10.1115/1.3072927; Henry A. S., 2008, J COMPUT THEOR NANOS, V5, P1, DOI DOI 10.1166/JCTN.2008.001A; Hopkins PE, 2011, NANO LETT, V11, P107, DOI 10.1021/nl102918q; Maire J, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.06JE09; Narayanamurti V., 1979, PHYS REV LETT, V2, P2012; Shiomi J., 2011, J HEAT TRANSF SOC JP, V50, P21; Yu JK, 2010, NAT NANOTECHNOL, V5, P718, DOI 10.1038/nnano.2010.149; Zen N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4435	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					1426	1431		10.1007/s11664-014-3387-8		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700008		
J	Meng, XN; Suzuki, R				Meng, Xiangning; Suzuki, Ryosuke O.			Simulation Analysis of Tilted Polyhedron-Shaped Thermoelectric Elements	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Thermoelectric generation; thermoelectric module; polyhedron elements; finite-element analysis	POWER-GENERATION; SYSTEMS	The generation of thermoelectricity is considered a promising approach to harness the waste heat generated in industries, automobiles, gas fields, and other man-made processes. The waste heat can be converted to electricity via a thermoelectric (TE) generator. In this light, the generator performance depends on the geometric configuration of its constituent elements as well as their material properties. Our previous work reported TE behaviors for modules consisting of parallelogram-shaped elements, because elements with tilted laminate structures provide increased mechanical stability and efficient heat-transferring ability from the hot surface to the cold surface. Here, we study TE elements in the shape of a polyhedron that is obtained by mechanically truncating the edges of a parallelogram element in order to further enhance the generator performance and reduce TE material usage. The TE performance of the modules consisting of these polyhedron elements is numerically simulated by using the finite-volume method. The output power, voltage, and current of the polyhedral TE module are greater than those of the parallelogram-element module. The polyhedron shape positively affects heat transfer and the flow of electric charges in the light of increasing the efficiency of conversion from heat to electricity. By varying the shape of the truncated portions, we determine the optimal shape that enables homogeneous heat flux distribution and slow diffusion of thermal energy to obtain the better efficiency of conversion of heat into electricity. We believe that the findings of our study can significantly contribute to the design policy in TE generation.	[Meng, Xiangning; Suzuki, Ryosuke O.] Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 0608628, Japan; [Meng, Xiangning] Northeastern Univ, Sch Met & Mat, Shenyang 110819, Peoples R China; [Suzuki, Ryosuke O.] Japan Sci & Technol Agcy, JST, Tokyo, Japan	Meng, XN (reprint author), Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 0608628, Japan.	mengxn@eng.hokudai.ac.jp; rsuzuki@eng.hokudai.ac.jp			JST-CREST; JSPS [24656574, 26630490]	The authors are grateful to financial support from JST-CREST, Research Grant-in-Aid of JSPS (Nos. 24656574 and 26630490), and JSPS Fellowship.	Chen M, 2011, INT J HEAT MASS TRAN, V54, P345, DOI 10.1016/j.ijheatmasstransfer.2010.08.024; Sakamoto T, 2010, J ELECTRON MATER, V39, P1708, DOI 10.1007/s11664-010-1155-y; Kanno T, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4732142; Koumoto K, 2013, J AM CERAM SOC, V96, P1, DOI 10.1111/jace.12076; Sahin AZ, 2013, ENERG CONVERS MANAGE, V65, P26, DOI 10.1016/j.enconman.2012.07.020; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Aoki T, 2011, J CERAM SOC JPN, V119, P382, DOI 10.2109/jcersj2.119.382; Fujisaka T, 2013, J ELECTRON MATER, V42, P1688, DOI 10.1007/s11664-012-2400-3; Meng X, 2014, J ELECTRON MATER, V43, P1509, DOI 10.1007/s11664-013-2768-8; Meng XN, 2014, MATER TRANS, V55, P1219, DOI 10.2320/matertrans.E-M2014822; Rowe D.M., 1995, CRC HDB THERMOELECTR, P445; Suzuki RO, 2012, J ELECTRON MATER, V41, P1766, DOI 10.1007/s11664-012-2074-x; Takahashi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01501; Takezawa A, 2012, INT J NUMER METH ENG, V90, P1363, DOI 10.1002/nme.3375	14	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					1469	1476		10.1007/s11664-014-3418-5		8	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700015		
J	Takagiwa, Y; Yoshida, T; Yanagihara, D; Kimura, K				Takagiwa, Y.; Yoshida, T.; Yanagihara, D.; Kimura, K.			Thermoelectric Properties of Pseudogap Ti10Ru19B8 and Ti9TM2Ru18B8 (TM: Cr-Cu) Compounds	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Thermoelectric properties; pseudogap; complex structure borides; spark plasma sintering; electronic structure calculation	CRYSTAL-CHEMISTRY; QUASI-CRYSTALS; BORIDES; PERFORMANCE; MAGNETISM; LADDERS; BANDS; MN; NI	The thermoelectric properties of ternary Ti10Ru19B8 and quaternary Ti9TM2Ru18B8 (TM: Cr, Mn, Fe, Co, Ni, Cu) compounds were investigated in the temperature range from 373 K to 973 K. They form pseudogaps in the electronic densities of states near the Fermi level, E (F), which is suitable for thermoelectric materials. We synthesized crack-free pellet samples using arc-melting followed by spark plasma sintering. A maximum dimensionless figure of merit zT (max) was 0.09 at 973 K for Ti10Ru19B8 whereas a large power factor of 1.4 mW/m K-2 was obtained at that temperature. The phonon thermal conductivity decreased through TM substitutions; however, the power factor also decreased due to an additional electronic density of states originated from TM d-states around E (F); that is, excitations of both holes and electrons.	[Takagiwa, Y.; Yoshida, T.; Yanagihara, D.; Kimura, K.] Univ Tokyo, Dept Adv Mat Sci, Kashiwa, Chiba 2778561, Japan	Takagiwa, Y (reprint author), Univ Tokyo, Dept Adv Mat Sci, Kiban Toh 502,5-1-5 Kashiwanoha, Kashiwa, Chiba 2778561, Japan.	takagiwa@phys.mm.t.u-tokyo.ac.jp			Thermal & Electric Energy Technology Foundation (TEET); KAKENHI from JSPS [24360262, 26709051]	This work is supported by the Thermal & Electric Energy Technology Foundation (TEET) and KAKENHI Nos. 24360262 and 26709051 from JSPS.	Toberer ES, 2011, J MATER CHEM, V21, P15843, DOI 10.1039/c1jm11754h; Pei YZ, 2011, NATURE, V473, P66, DOI 10.1038/nature09996; Wang H, 2014, ENERG ENVIRON SCI, V7, P804, DOI 10.1039/c3ee43438a; Takagiwa Y, 2014, J ELECTRON MATER, V43, P2206, DOI 10.1007/s11664-014-3008-6; Avila MA, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2831926; HUBBARD CR, 1976, J APPL CRYSTALLOGR, V9, P169, DOI 10.1107/S0021889876010807; Nolas GS, 2000, APPL PHYS LETT, V77, P1855, DOI 10.1063/1.1311597; Kanatzidis MG, 2010, CHEM MATER, V22, P648, DOI 10.1021/cm902195j; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Brgoch J., 2011, J AM CHEM SOC, V133, P683; Edagawa K, 2001, MAT SCI ENG A-STRUCT, V312, P293, DOI 10.1016/S0921-5093(00)01875-X; Fokwa BPT, 2008, INORG CHEM, V47, P2113, DOI 10.1021/ic7020963; Fokwa BPT, 2010, Z KRISTALLOGR, V225, P180, DOI 10.1524/zkri.2010.1239; Fokwa B.P.T., 2009, ALLG CHEM, V635, P2258; Goerens C, 2011, INORG CHEM, V50, P6289, DOI 10.1021/ic200668j; Goerens C, 2013, J SOLID STATE CHEM, V204, P283, DOI 10.1016/j.jssc.2013.05.040; Takagiwa Y, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/4/044802; Nishino Y, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.094425; Takagiwa Y, 2009, Z KRISTALLOGR, V224, P21, DOI 10.1524/zkri.2009.1061; Takagiwa Y, 2013, J APPL PHYS, V113, DOI 10.1063/1.4775602	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					1483	1490		10.1007/s11664-014-3423-8		8	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700017		
J	Saini, S; Mele, P; Honda, H; Matsumoto, K; Miyazaki, K; Luna, LM; Hopkins, PE				Saini, S.; Mele, P.; Honda, H.; Matsumoto, K.; Miyazaki, K.; Luna, L. Molina; Hopkins, P. E.			Influence of Postdeposition Cooling Atmosphere on Thermoelectric Properties of 2% Al-Doped ZnO Thin Films Grown by Pulsed Laser Deposition	JOURNAL OF ELECTRONIC MATERIALS			English	Article						c-Axis orientation; Al-doped ZnO thin films; pulsed laser deposition; Seebeck coefficient; power factor; thermoelectric oxides	OXIDE	We have investigated the thermoelectric properties of 2% Al-doped ZnO (AZO) thin films depending on the postdeposition cooling atmosphere [in oxygen pressure (AZO-O) or vacuum (AZO-V)]. Thin films were grown by pulsed laser deposition on sapphire () substrates at various deposition temperatures ( to ). All films were c-axis oriented. The electrical conductivity of AZO-V thin films was higher than that of AZO-O thin films across the whole temperature range from 300 K to 600 K, due to the optimal carrier concentration () of AZO-V samples. Furthermore, the thermoelectric performance of AZO-V films increased with the deposition temperature; for instance, the highest power factor of and dimensionless figure of merit of 0.07 at 600 K were found for AZO-V thin film deposited at .	[Saini, S.; Mele, P.] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 7398530, Japan; [Honda, H.] Hiroshima Univ, Grad Sch Adv Sci Matter, Higashihiroshima 7398530, Japan; [Matsumoto, K.; Miyazaki, K.] Kyushu Inst Technol, Dept Mat Sci, Kitakyushu, Fukuoka 8048550, Japan; [Luna, L. Molina] Tech Univ Darmstadt, Dept Mat & Geosci, Darmstadt, Germany; [Hopkins, P. E.] Univ Virginia, Dept Mech & Aerosp Engn, Charlottesville, VA USA	Saini, S (reprint author), Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 7398530, Japan.	ssaini@hiroshima-u.ac.jp; pmele@hiroshima-u.ac.jp					Gao PX, 2005, J APPL PHYS, V97, DOI 10.1063/1.1847701; Singh B, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3525575; Hong RJ, 2005, THIN SOLID FILMS, V473, P58, DOI 10.1016/j.tsf.2004.06.159; Ali GM, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/41/415103; SETO JYW, 1975, J APPL PHYS, V46, P5247, DOI 10.1063/1.321593; Kim KK, 2005, J APPL PHYS, V97, DOI 10.1063/1.1863416; Shan FK, 2007, J APPL PHYS, V101, DOI 10.1063/1.2437122; Schmidt AJ, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3006335; Fergus JW, 2012, J EUR CERAM SOC, V32, P525, DOI 10.1016/j.jeurceramsoc.2011.10.007; Kaur M, 2009, J NANOSCI NANOTECHNO, V9, P5293, DOI 10.1166/jnn.2009.1118; Wiff JP, 2009, MATER LETT, V63, P2470, DOI 10.1016/j.matlet.2009.08.036; Ohtaki M, 1996, J APPL PHYS, V79, P1816, DOI 10.1063/1.360976; Mele P, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4812401; Abutaha AI, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4790644; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Hopkins PE, 2010, J HEAT TRANS-T ASME, V132, DOI 10.1115/1.4000993; Cahill D.G., 2002, J HEAT TRANSF, V124; Mele P., 2009, MATER RES SOC S P, V1166, P3; Nolas G.S., 2004, THERMAL CONDUCTIVITY, P114; Saini S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.060306	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					1547	1553		10.1007/s11664-014-3471-0		7	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700027		
J	Kusagaya, K; Hagino, H; Tanaka, S; Miyazaki, K; Takashiri, M				Kusagaya, K.; Hagino, H.; Tanaka, S.; Miyazaki, K.; Takashiri, M.			Structural and Thermoelectric Properties of Nanocrystalline Bismuth Telluride Thin Films Under Compressive and Tensile Strain	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Nanocrystalline; bismuth telluride; thin films; compressive strain; tensile strain	FLASH EVAPORATION METHOD; TRANSISTORS; ELECTRONICS; FABRICATION; IMPROVEMENT; DEVICES; MERIT	To investigate the effect of strain on bismuth telluride films, we applied different compressive and tensile strains to thin films by changing the bending radius of a flexible substrate so the strain ranged from -0.3% (compressive) to +0.3% (tensile). The structural properties of the strained thin films, composed of nanosized grains, were analyzed by x-ray diffraction and scanning electron microscopy. For all samples the main peak was the (015) diffraction peak; crystal orientation along the (015) growth direction was slightly enhanced by application of compressive strain. The thermoelectric properties of strained bismuth telluride thin films were evaluated by measurement of electrical conductivity, Seebeck coefficient, and power factor. The magnitude and direction of the applied strain did not significantly affect the power factor, because when the strain changed from compressive to tensile the electrical conductivity increased and the absolute Seebeck coefficient decreased.	[Kusagaya, K.; Takashiri, M.] Tokai Univ, Dept Mat Sci, Hiratsuka, Kanagawa 2591292, Japan; [Hagino, H.; Miyazaki, K.] Kyushu Inst Technol, Dept Mech & Control Engn, Tobata Ku, Kitakyushu, Fukuoka 8048550, Japan; [Tanaka, S.] Nihon Univ, Dept Mech Engn, Coll Engn, Koriyama, Fukushima 9638642, Japan	Takashiri, M (reprint author), Tokai Univ, Dept Mat Sci, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.	takashiri@tokai-u.jp		Takashiri, Masayuki/0000-0001-7041-6595			Takashiri M, 2012, J APPL PHYS, V112, DOI 10.1063/1.4759326; Maier D, 2002, SOLID STATE COMMUN, V122, P565, DOI 10.1016/S0038-1098(02)00142-4; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; Popescu A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.205302; Wang GF, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2360191; Takashiri M, 2014, INT J HEAT MASS TRAN, V76, P376, DOI 10.1016/j.ijheatmasstransfer.2014.04.048; Polvani DA, 2001, CHEM MATER, V13, P2068, DOI 10.1021/cm000888q; Suo Z, 1999, APPL PHYS LETT, V74, P1177, DOI 10.1063/1.123478; Sekitani T, 2010, NAT MATER, V9, P1015, DOI [10.1038/nmat2896, 10.1038/NMAT2896]; Meng JF, 2001, J APPL PHYS, V90, P2836, DOI 10.1063/1.1394905; Hsu CT, 2011, APPL ENERG, V88, P1291, DOI 10.1016/j.apenergy.2010.10.005; He JQ, 2010, ADV FUNCT MATER, V20, P764, DOI 10.1002/adfm.200901905; Weber J, 2006, SENSOR ACTUAT A-PHYS, V132, P325, DOI 10.1016/j.sna.2006.04.054; Takashiri M, 2007, SENSOR ACTUAT A-PHYS, V138, P329, DOI 10.1016/j.sna.2007.05.030; Sekitani T, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1868868; Buist R. J., 1995, CRC HDB THERMOELECTR; Chen FC, 2011, SEMICOND SCI TECH, V26, DOI 10.1088/0268-1242/26/3/034005; Menard E, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1866637; Meng JF, 2003, J APPL PHYS, V94, P4485, DOI 10.1063/1.1599049; Samson D, 2011, SENSOR ACTUAT A-PHYS, V172, P240, DOI 10.1016/j.sna.2010.12.020; Shafai C, 1997, J VAC SCI TECHNOL A, V15, P2798, DOI 10.1116/1.580826; Takashiri M, 2014, J ELECTRON MATER, V43, P1881, DOI 10.1007/s11664-013-2896-1; Takashiri M, 2014, J APPL PHYS, V115, DOI 10.1063/1.4881676; Takashiri M., 2010, J ALLOY COMPD, V490, P44; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; Wijngaards DDL, 2000, SENSOR ACTUAT A-PHYS, V85, P316, DOI 10.1016/S0924-4247(00)00417-9	26	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					1632	1636		10.1007/s11664-014-3496-4		5	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700039		
J	Hirayama, N; Iida, T; Funashima, H; Morioka, S; Sakamoto, M; Nishio, K; Kogo, Y; Takanashi, Y; Hamada, N				Hirayama, Naomi; Iida, Tsutomu; Funashima, Hiroki; Morioka, Shunsuke; Sakamoto, Mariko; Nishio, Keishi; Kogo, Yasuo; Takanashi, Yoshifumi; Hamada, Noriaki			First-Principles Study on Structural and Thermoelectric Properties of Al- and Sb-Doped Mg2Si	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Thermoelectric effect; magnesium silicide; first-principles calculation; pseudopotential method; full-potential linearized augmented-plane-wave method; Seebeck coefficient		We theoretically investigate the structural and thermoelectric properties of magnesium silicide (Mg2Si) incorporating Al or Sb atoms as impurities using first-principles calculations. We optimized the structural properties through variable-cell relaxation using a pseudopotential method based on density functional theory. The result indicates that the lattice constant can be affected by the insertion of impurity atoms into the system, mainly because the ionic radii of these impurities differ from those of the matrix constituents Mg and Si. We then estimate, on the basis of the optimized structures, the site preferences of the impurity atoms using a formation energy calculation. The result shows a nontrivial concentration-dependence of the site occupation, such that Al tends to go into the Si, Mg, and interstitial sites with comparable formation energies at low doping levels (< 2 at.%); it can start to substitute for the Mg sites preferentially at higher doping levels (< 4 at.%). Sb, on the other hand, shows a strong preference for the Si sites at all impurity concentrations. Furthermore, we obtain the temperature-dependence of the thermoelectromotive force (Seebeck coefficient) of the Al- and Sb-doped Mg2Si using the full-potential linearized augmented-plane-wave method and the Boltzmann transport equation.	[Hirayama, Naomi; Iida, Tsutomu; Morioka, Shunsuke; Sakamoto, Mariko; Nishio, Keishi; Kogo, Yasuo; Takanashi, Yoshifumi] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Mat Sci & Technol, Katsushika Ku, Tokyo 162, Japan; [Funashima, Hiroki] Osaka Univ, Sch Engn Sci, Toyonaka, Osaka 560, Japan; [Hamada, Noriaki] Tokyo Univ Sci, Fac Sci & Technol, Dept Phys, Noda, Chiba, Japan	Hirayama, N (reprint author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Mat Sci & Technol, Katsushika Ku, 6-3-1 Niijuku, Tokyo 162, Japan.	hirayama@rs.tus.ac.jp			JSPS KAKENHI [26820099]	The authors are grateful to Prof. M. Geshi for his professional guidance and insightful comments. This research was partially supported by JSPS KAKENHI Grant Number (26820099).	MORRIS RG, 1958, PHYS REV, V109, P1909, DOI 10.1103/PhysRev.109.1909; Akasaka M, 2008, J APPL PHYS, V104, DOI 10.1063/1.2946722; Oto Y, 2013, PHYS STATUS SOLIDI C, V10, P1857, DOI 10.1002/pssc.201300353; Kasai H., 2005, INTRO COMPUTATIONAL; SHANNON RD, 1969, ACTA CRYSTALL B-STRU, VB 25, P925, DOI 10.1107/S0567740869003220; Zhang X., 2013, APPL PHYS LETT, V103	6	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					1656	1662		10.1007/s11664-014-3508-4		7	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700043		
J	Zheng, D; Tanaka, S; Miyazaki, K; Takashiri, M				Zheng, D.; Tanaka, S.; Miyazaki, K.; Takashiri, M.			Evaluation of Specific Heat, Sound Velocity and Lattice Thermal Conductivity of Strained Nanocrystalline Bismuth Antimony Telluride Thin Films	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Strain; nanocrystalline; crystal orientation; lattice thermal conductivity; bismuth antimony telluride	FLASH EVAPORATION METHOD; THERMOELECTRIC PROPERTIES; HIGH-TEMPERATURES; FABRICATION; BI2TE3; TRANSPORT; DEVICES; MERIT; POWER	To investigate the effect of strain on specific heat, sound velocity and lattice thermal conductivity of nanocrystalline bismuth antimony telluride thin films, we performed both experimental study and modeling. The nanocrystalline thin films had mostly preferred crystal orientation along c-axis, and strains in the both directions of c-axis and a-b-axis. It was found that the thermal conductivity of nanocrystalline thin films decreased greatly as compared with that of bulk alloys. To gain insight into the thermal transport in the strained nanocrystalline thin films, we estimated the lattice thermal conductivity based on the phonon transport model of full distribution of mean free paths accounting for the effects of grain size and strain which was influenced to both the sound velocity and the specific heat. As a result, the lattice thermal conductivity was increased when the strain was shifted from compressive to tensile direction. We also confirmed that the strain was influenced by the lattice thermal conductivity but the reduction of the lattice thermal conductivity of thin films can be mainly attributed to the nano-size effect rather than the strain effect. Finally, it was found that the measured lattice thermal conductivities were in good agreement with modeling.	[Zheng, D.; Takashiri, M.] Tokai Univ, Dept Mat Sci, Hiratsuka, Kanagawa 2591292, Japan; [Tanaka, S.] Nihon Univ, Dept Mech Engn, Coll Engn, Koriyama, Fukushima 9638642, Japan; [Miyazaki, K.] Kyushu Inst Technol, Dept Mech & Control Engn, Tobata Ku, Kitakyushu, Fukuoka 8048550, Japan	Takashiri, M (reprint author), Tokai Univ, Dept Mat Sci, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.	takashiri@tokai-u.jp		Takashiri, Masayuki/0000-0001-7041-6595			Takashiri M, 2012, J APPL PHYS, V112, DOI 10.1063/1.4759326; Maier D, 2002, SOLID STATE COMMUN, V122, P565, DOI 10.1016/S0038-1098(02)00142-4; Biswas K, 2011, NAT CHEM, V3, P160, DOI [10.1038/nchem.955, 10.1038/NCHEM.955]; JENKINS JO, 1972, PHYS REV B, V5, P3171, DOI 10.1103/PhysRevB.5.3171; ROSI FD, 1959, J PHYS CHEM SOLIDS, V10, P191, DOI 10.1016/0022-3697(59)90074-5; ABELES B, 1963, PHYS REV, V131, P1906, DOI 10.1103/PhysRev.131.1906; Takashiri M, 2014, INT J HEAT MASS TRAN, V76, P376, DOI 10.1016/j.ijheatmasstransfer.2014.04.048; Huang BL, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.125209; da Silva LW, 2004, INT J HEAT MASS TRAN, V47, P2417, DOI 10.1016/j.ijheatmasstransfer.2003.11.024; Li XB, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.245318; Hsu CT, 2011, APPL ENERG, V88, P1291, DOI 10.1016/j.apenergy.2010.10.005; Takashiri M, 2008, J ALLOY COMPD, V462, P351, DOI 10.1016/j.jallcom.2007.08.054; Weber J, 2006, SENSOR ACTUAT A-PHYS, V132, P325, DOI 10.1016/j.sna.2006.04.054; Takashiri M, 2007, SENSOR ACTUAT A-PHYS, V138, P329, DOI 10.1016/j.sna.2007.05.030; Abramson AR, 2002, J HEAT TRANS-T ASME, V124, P963, DOI 10.1115/1.1495516; CALLAWAY J, 1959, PHYS REV, V113, P1046, DOI 10.1103/PhysRev.113.1046; Buist R. J., 1995, CRC HDB THERMOELECTR; Han YJ, 1996, PHYS REV B, V54, P8977, DOI 10.1103/PhysRevB.54.8977; Kajihara T., 1998, P 17 INT C THERM ICT, P129; Lin JG, 2000, PHYSICA C, V336, P249, DOI 10.1016/S0921-4534(00)00293-8; Newnham R. E., 2005, PROPERTIES MAT ANISO; Shafai C, 1997, J VAC SCI TECHNOL A, V15, P2798, DOI 10.1116/1.580826; Takashiri M, 2008, THIN SOLID FILMS, V516, P6336, DOI 10.1016/j.tsf.2007.12.130; Takashiri M, 2007, J ALLOY COMPD, V441, P246, DOI 10.1016/j.jallcom.2006.09.136; Takashiri M, 2006, J APPL PHYS, V100, DOI 10.1063/1.2337392; Takashiri M, 2007, J APPL PHYS, V101, DOI 10.1063/1.2717867; Takashiri M., 2010, J ALLOY COMPD, V490, P44; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; Venkatasubramanian R, 2000, PHYS REV B, V61, P3091, DOI 10.1103/PhysRevB.61.3091; Wang Z., 2011, NANO LETT, V6, P2206; Wijngaards DDL, 2000, SENSOR ACTUAT A-PHYS, V85, P316, DOI 10.1016/S0924-4247(00)00417-9; Wu L., 2009, J APPL PHYS, V105, P09; Yang F, 2010, J APPL PHYS, V108, DOI 10.1063/1.3457334	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					1679	1687		10.1007/s11664-014-3518-2		9	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700047		
J	Choi, S; Kurosaki, K; Yusufu, A; Ohishi, Y; Muta, H; Yamanaka, S				Choi, Seongho; Kurosaki, Ken; Yusufu, Aikebaier; Ohishi, Yuji; Muta, Hiroaki; Yamanaka, Shinsuke			Thermoelectric Properties of p-Type Tl-Filled Skutterudites: Tl (x) Fe1.5Co2.5Sb12	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Skutterudite; thermoelectric; Seebeck coefficient; effective mass; thermal conductivity	MERIT	Polycrystalline samples of Tl-filled p-type skutterudites Tl (x) Fe1.5Co2.5Sb12 (x = 0, 0.2, 0.4, 0.5, 0.6, and 0.7) were prepared and their high-temperature thermoelectric properties were examined from room temperature to 773 K. The samples with x = 0.5 and 0.6 approximated to the skutterudite single phase, although all samples contained some secondary phases. On the other hand, all samples showed a positive Seebeck coefficient, and the Tl-filled samples exhibited definitely low thermal conductivity in comparison with the non-filled one. The sample with x = 0.4 yielded the highest dimensionless figure of merit of 0.30 at 724 K.	[Choi, Seongho; Kurosaki, Ken; Yusufu, Aikebaier; Ohishi, Yuji; Muta, Hiroaki; Yamanaka, Shinsuke] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Yamanaka, Shinsuke] Univ Fukui, Res Inst Nucl Engn, Tsuruga, Fukui 9140055, Japan	Choi, S (reprint author), Osaka Univ, Grad Sch Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	shchoi@ms.see.eng.osaka-u.ac.jp; kurosaki@see.eng.osaka-u.ac.jp	Kurosaki, Ken/E-8081-2012		Ministry of Education, Culture, Sports, Science and Technology of Japan [25289220]	This work was supported by a Grant-in-Aid for Scientific Research (No. 25289220) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Liu XH, 2013, ADV ENERGY MATER, V3, P1238, DOI 10.1002/aenm.201300174; Cho JY, 2012, ACTA MATER, V60, P2104, DOI 10.1016/j.actamat.2011.12.022; Harnwunggmoung A, 2012, J APPL PHYS, V112, DOI 10.1063/1.4748340; Ahn JH, 2011, MATER RES BULL, V46, P1490, DOI 10.1016/j.materresbull.2011.04.024; Dong YK, 2014, J SOLID STATE CHEM, V209, P1, DOI 10.1016/j.jssc.2013.10.009; Shi X, 2011, J AM CHEM SOC, V133, P7837, DOI 10.1021/ja111199y; Li GH, 2013, J ELECTRON MATER, V42, P1463, DOI 10.1007/s11664-012-2290-4; Pei YZ, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3182800; Chen LD, 2001, J APPL PHYS, V90, P1864, DOI 10.1063/1.1388162; Harnwunggmoung A, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3430739; Rogl G, 2014, ACTA MATER, V76, P434, DOI 10.1016/j.actamat.2014.05.051; Harnwunggmoung A, 2011, J APPL PHYS, V110, DOI 10.1063/1.3606417; Hermann RP, 2005, AM J PHYS, V73, P110, DOI [10.1119/1.1783899, 10.1119/1.173899]; Zhao XY, 2006, J APPL PHYS, V99, DOI 10.1063/1.2172705; Rogl G, 2013, ACTA MATER, V61, P6778, DOI 10.1016/j.actamat.2013.07.052; Jiang QH, 2014, J MATER CHEM A, V2, P5785, DOI 10.1039/c3ta13952b; Pei YZ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2397538; Singh DJ, 1997, PHYS REV B, V56, pR1650; Goldsmid HJ, 1999, J ELECTRON MATER, V28, P869, DOI 10.1007/s11664-999-0211-y; He T, 2006, CHEM MATER, V18, P759, DOI 10.1021/cm052055b; Hermann RP, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.135505; Katsuyama S, 1998, J APPL PHYS, V84, P6708, DOI 10.1063/1.369048; Kim D, 2013, APL MATER, V1, DOI 10.1063/1.4821626; Liu RH, 2011, J APPL PHYS, V109, DOI 10.1063/1.3533743; Liu RH, 2011, J MATER RES, V26, P1813, DOI 10.1557/jmr.2011.85; Long GJ, 2002, J APPL PHYS, V92, P7236, DOI 10.1063/1.1525069; Mallik RC, 2008, MET MATER-INT, V14, P223, DOI 10.3365/met.mat.2008.04.223; Park KH, 2010, PHYS SCRIPTA, VT139, DOI 10.1088/0031-8949/2010/T139/014009; Sales BC, 2000, PHYS REV B, V61, P2475, DOI 10.1103/PhysRevB.61.2475; Tritt TM, 2006, MRS BULL, V31, P188, DOI 10.1557/mrs2006.44; Yang J., 2000, PHYS REV B, V63, DOI DOI 10.1103/PHYSREVB.63.014410; Yang J, 2007, J APPL PHYS, V102, DOI 10.1063/1.2794716; Yoon G, 2002, THERMOCHIM ACTA, V388, P151, DOI 10.1016/S0040-6031(02)00024-2	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					1743	1749		10.1007/s11664-014-3539-x		7	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700054		
J	Kinemuchi, Y; Mimura, K; Kato, K				Kinemuchi, Yoshiaki; Mimura, Ken-ichi; Kato, Kazumi			Enhanced Thermopower in Nano-SrTiO3 Via Rare Earth Doping	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Thermopower; nanostructuring; rare earth doping; SrTiO3; grain boundary potential	THERMOELECTRIC PROPERTIES; DOPED SRTIO3; PERFORMANCE	Doped perovskite titanates are known to exhibit non-linear electrical conductivity when they are in polycrystalline form. This non-linear behavior is attributed to the barrier potential at the grain boundary (GB). In this paper, we focus on the influence of the barrier potential on the thermopower (S) of rare earth (RE)-doped SrTiO3 with a grain size of 20 nm. |S| was found to increase linearly for smaller RE dopants despite the use of identical carrier concentrations. Capacitance-voltage measurements showed that the barrier potential increased linearly for the smaller RE dopants. Energy-selective scattering by the GB potential was evaluated theoretically, and allowed us to qualitatively explain the enhanced S in this system. The results indicate that the GB nature, which is a crucial factor for nanostructured thermoelectric materials, can be tuned by RE doping in this system.	[Kinemuchi, Yoshiaki; Mimura, Ken-ichi; Kato, Kazumi] Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan	Kinemuchi, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Moriyama Ku, 2266-98 Anagahora, Nagoya, Aichi 4638560, Japan.	y.kinemuchi@aist.go.jp					Bell LE, 2008, SCIENCE, V321, P1457, DOI 10.1126/science.1158899; Muta H, 2003, J ALLOY COMPD, V350, P292, DOI 10.1016/S0925-8388(02)00972-6; Okuda T, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.113104; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; SUNSTROM JE, 1992, CHEM MATER, V4, P346, DOI 10.1021/cm00020a022; Kinemuchi Y, 2014, J ELECTRON MATER, V43, P2011, DOI 10.1007/s11664-013-2937-9; Biswas K, 2012, NATURE, V489, P414, DOI 10.1038/nature11439; Kinemuchi Y, 2011, J APPL PHYS, V110, DOI 10.1063/1.3669392; Waser R., 1992, Integrated Ferroelectrics, V2, DOI 10.1080/10584589208215729; Moizhes B.Y., 1992, P 11 INT C THERM, V232; Nishio K, 1997, JPN J APPL PHYS 1, V36, P170, DOI 10.1143/JJAP.36.170; Ravich Y.I., 1995, CRC HDB THERMOELECTR, P67	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					1773	1776		10.1007/s11664-014-3549-8		4	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700058		
J	Hu, XK; Nagase, K; Jood, P; Ohta, M; Yamamoto, A				Hu, Xiaokai; Nagase, Kazuo; Jood, Priyanka; Ohta, Michihiro; Yamamoto, Atsushi			Power Generation Evaluated on a Bismuth Telluride Unicouple Module	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Thermoelectric; heat flow; module; water flow; efficiency	THERMOELECTRIC GENERATORS; HEAT; EFFICIENCY; SYSTEM; DESIGN	The power generated by a thermoelectric unicouple module made of Bi2Te3 alloy was evaluated by use of a newly developed instrument. An electrical load was connected to the module, and the terminal voltage and output power of the module were obtained by altering electric current. Water flow was used to cool the cold side of the module and for heat flow measurement, by monitoring inlet and outlet temperatures. When the electric current was increased, heat flow was enhanced as a result of the Peltier effect and Joule heating. Voltage, power, heat flow, and efficiency as functions of current were determined for hot-side temperatures from 50 to 220A degrees C. Maximum power output and peak conversion efficiency could thus be easily derived for each temperature.	[Hu, Xiaokai; Nagase, Kazuo; Jood, Priyanka; Ohta, Michihiro; Yamamoto, Atsushi] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Tsukuba, Ibaraki 3058568, Japan	Yamamoto, A (reprint author), Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, 1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	a.yamamoto@aist.go.jp	Ohta, Michihiro/J-8460-2015	Ohta, Michihiro/0000-0002-9093-7117	Ministry of Economy, Trade, and Industry, government of Japan [DEA303 510D1B1]	We would like to thank the Ministry of Economy, Trade, and Industry, government of Japan, for funding support under the framework of the international cooperation project for research and standardization of Clean Energy Technologies (DEA303 510D1B1).	Anatychuk LI, 2011, J ELECTRON MATER, V40, P1292, DOI 10.1007/s11664-011-1619-8; Wang H, 2014, J ELECTRON MATER, V43, P2274, DOI 10.1007/s11664-014-3044-2; Bell LE, 2008, SCIENCE, V321, P1457, DOI 10.1126/science.1158899; Sandoz-Rosado E, 2009, J ELECTRON MATER, V38, P1239, DOI 10.1007/s11664-009-0744-0; Rauscher L, 2005, MEAS SCI TECHNOL, V16, P1054, DOI 10.1088/0957-0233/16/5/002; Rowe DM, 1998, J POWER SOURCES, V73, P193, DOI 10.1016/S0378-7753(97)02801-2; Faraji AY, 2013, J ELECTRON MATER, V42, P1535, DOI 10.1007/s11664-012-2314-0; Carmo JP, 2011, MEASUREMENT, V44, P2194, DOI 10.1016/j.measurement.2011.07.015; Faraji AY, 2014, J ELECTRON MATER, V43, P1940, DOI 10.1007/s11664-013-2916-1; Izam Abd Jalil M., 2013, AM J ENG APPL SCI, V6; Kolodner P, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4872276; Takazawa H., 2006, P 2006 INT C THERM, P189	12	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					1785	1790		10.1007/s11664-014-3556-9		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700060		
J	Kitagawa, H; Matsuura, T; Kato, T; Kamata, KY				Kitagawa, Hiroyuki; Matsuura, Tsukasa; Kato, Toshihito; Kamata, Kin-Ya			Thermoelectric Properties of Cu-Doped n-Type Bi2Te2.85Se0.15 Prepared by Liquid Phase Growth Using a Sliding Boat	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Bismuth telluride; liquid phase growth; thermoelectric properties; carrier concentration	SINGLE-CRYSTAL; ALLOYS; BI0.5SB1.5TE3; BI2TE3	N-type Bi2Te2.85Se0.15 thermoelectric materials were prepared by liquid phase growth (LPG) using a sliding boat, a simple and short fabrication process for Bi2Te3-related materials. Cu was selected as a donor dopant, and its effect on thermoelectric properties was investigated. Thick sheets and bars of Cu (x) Bi-2 Te2.85Se0.15 (x=0-0.25) of 1-2mm in thickness were obtained using the process. X-ray diffraction patterns and scanning electron micrographs showed that the in-plane direction tended to correspond to the hexagonal c-plane, which is the preferred direction for thermoelectric conversion. Cu-doping was effective in controlling conduction type and carrier (electron) concentration. The conduction type was p-type for undoped Bi2Te2.85Se0.15 and became n-type after Cu-doping. The Hall carrier concentration was increased by Cu-doping. Small resistivity was achieved in Cu0.02Bi2Te2.85Se0.15 owing to an optimized amount of Cu-doping and high crystal orientation. As a result, the maximum power factor near 310K for Cu0.02Bi2Te2.85Se0.15 was approximately 4x10(-3)W/K(2)m and had good reproducibility. Furthermore, the thermal stability of Cu0.02Bi2Te2.85Se0.15 was also confirmed by thermal cycling measurements of electrical resistivity. Thus, n-type Bi2Te2.85Se0.15 with a large power factor was prepared using the present LPG process.	[Kitagawa, Hiroyuki; Matsuura, Tsukasa] Shimane Univ, Dept Phys & Mat Sci, Matsue, Shimane 6908504, Japan; [Kato, Toshihito] Mitsui Engn & Shipbldg Co Ltd, Chiba Technol Ctr, Ichihara, Chiba 2908531, Japan; [Kamata, Kin-Ya] Mitsui Engn & Shipbldg Co Ltd, Tamano Technol Ctr, Okayama 7060014, Japan	Kitagawa, H (reprint author), Shimane Univ, Dept Phys & Mat Sci, Matsue, Shimane 6908504, Japan.	kitagawa@riko.shimane-u.ac.jp			KAKENHI from the Japan Society for the Promotion of Science (JSPS) [24560884]	This work was supported by KAKENHI Grant Number 24560884 from the Japan Society for the Promotion of Science (JSPS).	Svechnikova TE, 2000, INORG MATER+, V36, P556, DOI 10.1007/BF02757952; Liu WS, 2011, ADV ENERGY MATER, V1, P577, DOI 10.1002/aenm.201100149; CARLE M, 1995, J PHYS CHEM SOLIDS, V56, P201, DOI 10.1016/0022-3697(94)00166-9; Sokolov OB, 2004, J CRYST GROWTH, V262, P442, DOI 10.1016/j.jcrysgro.2003.10.073; WIESE JR, 1960, J PHYS CHEM SOLIDS, V15, P13, DOI 10.1016/0022-3697(60)90094-9; Fujimoto S, 2007, J ALLOY COMPD, V443, P182, DOI 10.1016/j.jallcom.2007.03.037; GREENAWA.DL, 1965, J PHYS CHEM SOLIDS, V26, P1585, DOI 10.1016/0022-3697(65)90092-2; Hyun DB, 1998, J MATER SCI, V33, P5595, DOI 10.1023/A:1004460030657; KAIBE H, 1989, J PHYS CHEM SOLIDS, V50, P945, DOI 10.1016/0022-3697(89)90045-0; Kinemuchi Y, 2009, J ELECTRON MATER, V38, P1089, DOI 10.1007/s11664-008-0640-z; Kitagawa H, 2003, SCRIPTA MATER, V49, P309, DOI 10.1016/S1359-6462(03)00278-1; Kitagawa H, 2013, J ELECTRON MATER, V42, P2043, DOI 10.1007/s11664-013-2518-y; OHSUGI IJ, 1990, J APPL PHYS, V68, P5692, DOI 10.1063/1.346985; Sokolov O.B., 2003, J THERMOELECTR, V4, P48; YIM WM, 1972, SOLID STATE ELECTRON, V15, P1121, DOI 10.1016/0038-1101(72)90172-4; Zhitinskaya MK, 2007, SEMICONDUCTORS+, V41, P1140, DOI 10.1134/S1063782607100028; Zhou YF, 2010, J CRYST GROWTH, V312, P775, DOI 10.1016/j.jcrysgro.2009.12.061	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					1870	1875		10.1007/s11664-014-3578-3		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700072		
J	Miao, L; Kang, YP; Li, C; Tanemura, S; Wan, CL; Iwamoto, Y; Shen, Y; Lin, H				Miao, L.; Kang, Y. P.; Li, C.; Tanemura, S.; Wan, C. L.; Iwamoto, Y.; Shen, Y.; Lin, H.			Experimental Performance of a Solar Thermoelectric Cogenerator Comprising Thermoelectric Modules and Parabolic Trough Concentrator without Evacuated Tube	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Thermoelectric modules; solar thermoelectric cogenerator; parabolic trough concentrator; electrical power; electrical conversion efficiency; solar thermal conversion efficiency	POWER-GENERATION; COLLECTORS; OPTIMIZATION	A prototype practical solar-thermoelectric cogenerator composed of (1) a primary component of a pile of solar-selective absorber (SSA) slab, thermoelectric (TE) modules, and a depressed water flow tube (multichannel cooling heat sink, MCS), and (2) a parabolic trough concentrator with aperture area of 2A, mA, A integral-A, 2A, m and eastA cent a,not signaEuroewest focal axis was constructed. Its cogeneration performance under the best climatic and solar insolation conditions in Guangzhou, China was tested. For simplicity, the evacuated glass tube to cover the primary component was eliminated from the system. Six Bi2Te3 TE modules were arranged in series, directly bonded to the rear surface of the solar absorber slab. The hot-side temperature of the TE module reached up to 152A,A degrees C. The experimentally obtained instantaneous results for the solar to electrical conversion efficiency, heat exchange coefficient of the MCS, and overall system efficiency under the best environmental and solar insolation conditions were about 1.14%, 56.1%, and 49.5%, respectively. To justify these values, an equivalent thermal network diagram based on a single-temperature-node heat transfer model representing the respective system components was used to analyze the thermal transfer and losses of the system. Finally, electrical power of 18A,A W was generated, with 2A,A L/min of hot water at 37A,A degrees C being produced and stored in the insulated container.	[Miao, L.; Tanemura, S.] Guilin Univ Elect Technol, Sch Mat Sci & Engn, Guangxi Collaborat Innovat Ctr Struct & Property, Guangxi Key Lab Informat Mat, Guilin 541004, Peoples R China; [Kang, Y. P.; Iwamoto, Y.] Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Li, C.] E China Normal Univ, Minist Educ, Key Lab Polarized Mat & Devices, Shanghai 200062, Peoples R China; [Wan, C. L.] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan; [Shen, Y.; Lin, H.] Tsinghua Univ, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China	Miao, L (reprint author), Guilin Univ Elect Technol, Sch Mat Sci & Engn, Guangxi Collaborat Innovat Ctr Struct & Property, Guangxi Key Lab Informat Mat, Guilin 541004, Peoples R China.	miaolei@ms.giec.ac.cn			National Natural Science Foundation of China [51172234]; State Key Laboratory of New Ceramic and Fine Processing, Tsinghua University	This work was supported by the National Natural Science Foundation of China (Grant No. 51172234) and State Key Laboratory of New Ceramic and Fine Processing, Tsinghua University.	Champier D, 2010, ENERGY, V35, P935, DOI 10.1016/j.energy.2009.07.015; Riffat SB, 2003, APPL THERM ENG, V23, P913, DOI 10.1016/S1359-4311(03)00012-7; Zhang M, 2013, APPL ENERG, V109, P51, DOI 10.1016/j.apenergy.2013.03.008; Chen JC, 1996, J APPL PHYS, V79, P2717, DOI 10.1063/1.361143; [Anonymous], 1983, E90582 ASTM; Rowe DM, 1998, J POWER SOURCES, V73, P193, DOI 10.1016/S0378-7753(97)02801-2; [Anonymous], 1977, 9377 ASHRAE; Amatya R, 2010, J ELECTRON MATER, V39, P1735, DOI 10.1007/s11664-010-1190-8; Omer SA, 1998, SOL ENERG MAT SOL C, V53, P67, DOI 10.1016/S0927-0248(98)00008-7; TELKES M, 1954, J APPL PHYS, V25, P765, DOI 10.1063/1.1721728; COLLARESPERFIRA M, 1991, SOL ENERGY, V47, P457, DOI 10.1016/0038-092X(91)90114-C; Duffie J., 1974, SOLAR ENERGY THERMAL, P120; Gao Min, 1992, Journal of Power Sources, V38; Li C, 2014, ENERG CONVERS MANAGE, V86, P944, DOI 10.1016/j.enconman.2014.06.010; Matsuura K., 1991, P 10 INT THERM C; Meng F., 2011, ENERGY, V10, P1; Mgbemene CA, 2010, J SOL ENERG-T ASME, V132, DOI 10.1115/1.4001670; Miao L., 2012, J ELECT MAT, V41, P6; Scherrer H, 2003, J POWER SOURCES, V115, P141, DOI 10.1016/S0378-7753(02)00597-9; Shuja SZ, 2007, INT J ENERG RES, V31, P455, DOI 10.1002/er.1258; Titt T.M., 2006, THERMOELECTRIC HDB, P23	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					1972	1983		10.1007/s11664-015-3626-7		12	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700088		
J	Yamasaka, S; Nakamura, Y; Ueda, T; Takeuchi, S; Yamamoto, Y; Arai, S; Tanji, T; Tanaka, N; Sakai, A				Yamasaka, Shuto; Nakamura, Yoshiaki; Ueda, Tomohiro; Takeuchi, Shotaro; Yamamoto, Yuta; Arai, Shigeo; Tanji, Takayoshi; Tanaka, Nobuo; Sakai, Akira			Fabrication of Si Thermoelectric Nanomaterials Containing Ultrasmall Epitaxial Ge Nanodots with an Ultrahigh Density	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Germanium; silicon; nanodots; molecular beam epitaxy; thermoelectrics	MOLECULAR-BEAM EPITAXY; THERMAL-CONDUCTIVITY; STRAIN RELAXATION; SILICON; MERIT; GERMANIUM; FIGURE; SUPERLATTICES; ISLANDS; DEVICES	A Si-based nanomaterial is proposed for use as a thermoelectric material. Ultrasmall epitaxial Ge nanodots (NDs) with an ultrahigh density are introduced into Si films as phonon scatterers using an ultrathin SiO2 film technique. The nanomaterial has the stacked structure Si/Ge NDs/Si on Si substrates. Reflection high-energy electron diffraction reveals epitaxial growth of the Ge NDs and Si layers in all of the stacking stages. Sharp interfaces of the Ge NDs/Si in the stacked structures were observed by high-angle annular field scanning transmission electron microscopy. The Ge NDs were controlled in terms of their composition and strain: main parts of the NDs did not alloy with Si, and the elastic strain was relaxed. These features were confirmed by Raman scattering and x-ray diffraction measurements. The fabrication techniques used to make the simple Si-based stacked structure with strain-relaxed almost pure Ge NDs are useful to develop thermoelectric nanomaterials.	[Yamasaka, Shuto; Nakamura, Yoshiaki; Ueda, Tomohiro; Takeuchi, Shotaro; Sakai, Akira] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Nakamura, Yoshiaki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Yamamoto, Yuta; Arai, Shigeo; Tanji, Takayoshi; Tanaka, Nobuo] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Nakamura, Y (reprint author), Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama Cho, Toyonaka, Osaka 5608531, Japan.	nakamura@ee.es.osaka-u.ac.jp	Takeuchi, Shotaro/F-2886-2014; Nakamura, Yoshiaki/H-6852-2013	Takeuchi, Shotaro/0000-0002-3919-9083; 			Kim W, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.045901; Nakamura Y, 2015, NANO ENERGY, V12, P845, DOI 10.1016/j.nanoen.2014.11.029; HICKS LD, 1993, PHYS REV B, V47, P16631, DOI 10.1103/PhysRevB.47.16631; Shklyaev AA, 2000, PHYS REV B, V62, P1540, DOI 10.1103/PhysRevB.62.1540; Harman TC, 2002, SCIENCE, V297, P2229, DOI 10.1126/science.1072886; Hochbaum AI, 2008, NATURE, V451, P163, DOI 10.1038/nature06381; Pernot G, 2010, NAT MATER, V9, P491, DOI [10.1038/nmat2752, 10.1038/NMAT2752]; Joshi G, 2008, NANO LETT, V8, P4670, DOI 10.1021/nl8026795; Huxtable ST, 2002, APPL PHYS LETT, V80, P1737, DOI 10.1063/1.1455693; Bux SK, 2009, ADV FUNCT MATER, V19, P2445, DOI 10.1002/adfm.200900250; Liu JL, 2002, J APPL PHYS, V92, P6804, DOI 10.1063/1.1518756; HICKS LD, 1993, PHYS REV B, V47, P12727, DOI 10.1103/PhysRevB.47.12727; STILES MD, 1990, PHYS REV B, V41, P5280, DOI 10.1103/PhysRevB.41.5280; Chen PX, 2014, J APPL PHYS, V115, DOI 10.1063/1.4863115; Pages O, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.045201; TSANG JC, 1994, J APPL PHYS, V75, P8098, DOI 10.1063/1.356554; Kato R, 2008, INT J THERMOPHYS, V29, P2062, DOI 10.1007/s10765-008-0536-4; Tang JY, 2010, NANO LETT, V10, P4279, DOI 10.1021/nl102931z; Nakamura Y, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2067711; Hochbaum AI, 2009, NANO LETT, V9, P3550, DOI 10.1021/nl9017594; Minnich AJ, 2009, ENERG ENVIRON SCI, V2, P466, DOI 10.1039/b822664b; Li QM, 2005, J APPL PHYS, V98, DOI 10.1063/1.2067708; Yu B, 2012, NANO LETT, V12, P2077, DOI 10.1021/nl3003045; Shklyaev AA, 2008, PHYS-USP+, V51, P133, DOI 10.1070/PU2008v051n02ABEH006344; Nakamura Y, 2011, CRYST GROWTH DES, V11, P3301, DOI 10.1021/cg200609u; Ohta H, 2007, NAT MATER, V6, P129, DOI 10.1038/nmat1821; Buljan M, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1485-9; Liu J, 2004, J APPL PHYS, V96, P916, DOI 10.1063/1.1738530; Nakamura Y, 2014, J APPL PHYS, V115, DOI 10.1063/1.4862642; Nakamura Y, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/9/095305; Nakamura Y, 2007, J APPL PHYS, V102, DOI 10.1063/1.2822271; Serincan U, 2004, SEMICOND SCI TECH, V19, P247, DOI 10.1088/0268-1242/19/2/021; Shklyaev AA, 2007, J APPL PHYS, V101, DOI 10.1063/1.2435063; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; Yasar-Inceoglu O, 2013, MATER LETT, V101, P76, DOI 10.1016/j.matlet.2013.03.080; Yu JK, 2010, NAT NANOTECHNOL, V5, P718, DOI 10.1038/nnano.2010.149	36	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					2015	2020		10.1007/s11664-015-3643-6		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700092		
J	Kudo, S; Hagino, H; Tanaka, S; Miyazaki, K; Takashiri, M				Kudo, S.; Hagino, H.; Tanaka, S.; Miyazaki, K.; Takashiri, M.			Determining the Thermal Conductivity of Nanocrystalline Bismuth Telluride Thin Films Using the Differential 3 omega Method While Accounting for Thermal Contact Resistance	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Thermal conductivity; bismuth telluride; thin films; differential 3 omega method; thermal contact resistance	MEAN FREE-PATH; THERMOELECTRIC PERFORMANCE; DIFFUSIVITY MEASUREMENT; DEVICES	We have estimated the thermal conductivity of nanocrystalline bismuth telluride thin films using the differential 3 omega method, taking into account the thermal contact resistance (TCR) between the substrate and thin-film layers. The thin films were prepared on alumina substrates by radio-frequency (RF) magnetron sputtering at temperature of 200A degrees C. Film thickness varied between 0.8 mu m and 3.1 mu m. The structural properties of the films were analyzed using x-ray diffraction analysis. Their electrical conductivity, Seebeck coefficient, and power factor were evaluated. For measurement of thermal properties by the differential 3 omega method, SiO2 thin films were deposited onto the samples, to act as insulating layers. Thin aluminum wire was then patterned onto the SiO2 layer. The observed variations in temperature amplitude as a function of film thickness indicated that the TCR contribution was very small and could therefore be neglected when estimating the thermal conductivity of the thin films. The thermal conductivity of the nanocrystalline bismuth telluride thin films with thickness of 0.8 mu m and 2.1 mu m were determined to be 0.55 W/(m K) and 0.48 W/(m K), respectively.	[Kudo, S.; Takashiri, M.] Tokai Univ, Dept Mat Sci, Hiratsuka, Kanagawa 2591292, Japan; [Hagino, H.; Miyazaki, K.] Kyushu Inst Technol, Dept Mech & Control Engn, Tobata Ku, Kitakyushu, Fukuoka 8048550, Japan; [Tanaka, S.] Nihon Univ, Dept Mech Engn, Coll Engn, Koriyama, Fukushima 9638642, Japan	Takashiri, M (reprint author), Tokai Univ, Dept Mat Sci, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.	takashiri@tokai-u.jp		Takashiri, Masayuki/0000-0001-7041-6595			Jacquot A, 2010, J ELECTRON MATER, V39, P1621, DOI 10.1007/s11664-010-1265-6; Taketoshi N, 2001, MEAS SCI TECHNOL, V12, P2064, DOI 10.1088/0957-0233/12/12/306; Takashiri M, 2012, J APPL PHYS, V112, DOI 10.1063/1.4759326; Harman TC, 2002, SCIENCE, V297, P2229, DOI 10.1126/science.1072886; HATTA I, 1985, REV SCI INSTRUM, V56, P1643, DOI 10.1063/1.1138117; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; Takashiri M, 2014, INT J HEAT MASS TRAN, V76, P376, DOI 10.1016/j.ijheatmasstransfer.2014.04.048; Takashiri M, 2008, J ALLOY COMPD, V462, P351, DOI 10.1016/j.jallcom.2007.08.054; Takashiri M, 2010, THIN SOLID FILMS, V519, P619, DOI 10.1016/j.tsf.2010.08.013; PICHARD CR, 1980, J PHYS F MET PHYS, V10, P2009, DOI 10.1088/0305-4608/10/9/016; Borca-Tasciuc T, 2001, REV SCI INSTRUM, V72, P2139, DOI 10.1063/1.1353189; CAHILL DG, 1990, REV SCI INSTRUM, V61, P802, DOI 10.1063/1.1141498; Das VD, 1999, J APPL PHYS, V86, P1518, DOI 10.1063/1.370923; Takashiri M, 2006, J APPL PHYS, V100, DOI 10.1063/1.2337392; Takashiri M, 2013, J CRYST GROWTH, V372, P199, DOI 10.1016/j.jcrysgro.2013.03.028; Takashiri M, 2007, J APPL PHYS, V101, DOI 10.1063/1.2717867; Takashiri M., 2010, J ALLOY COMPD, V490, P44; TELLIER CR, 1978, THIN SOLID FILMS, V51, P311, DOI 10.1016/0040-6090(78)90293-6; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; Wang Z., 2011, NANO LETT, V6, P2206	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					2021	2025		10.1007/s11664-015-3646-3		5	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700093		
J	Nishino, S; Koyano, M; Ohdaira, K				Nishino, Shunsuke; Koyano, Mikio; Ohdaira, Keisuke			Thermal Conductivity Measurements of Aggregated (Bi1-x Sb (x) )(2)Te-3 Nanoparticles Using 3 omega Method	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Bismuth telluride; nanostructure; particles; thermal conductivity; 3 omega method	CARBON NANOTUBES; POWER-GENERATION; FILMS; FABRICATION; SILICON; DEVICES	Using the 3 omega method based on the two heat flow model, the thermal conductivity of as-dried and thermally treated samples of (Bi1-x Sb (x) )(2)Te-3 inks in the form of aggregated nanoparticles was measured. For the as-dried sample, kappa (sample) was 0.2 W K-1 m(-1) to 0.3 W K-1 m(-1). That of the thermally treated sample was 0.4 W K-1 m(-1) to 0.7 W K-1 m(-1). Organic solvent remained in the as-dried sample, covering the (Bi1-x Sb (x) )(2)Te-3 nanoparticles. In the region where organic solvent remained between the nanoparticles, heat flow was impeded because the thermal conductivity of the organic solvent is lower than that of the (Bi1-x Sb (x) )(2)Te-3 nanoparticles. However, in the thermally treated sample, the organic solvent evaporated and the nanoparticles grew due to the effects of the thermal treatment process. In this case, factors impeding heat flow, such as the interfacial thermal resistance between the particles, were limited. Therefore, this difference in kappa (sample), which is consistent with the grain growth as ascertained from powder x-ray diffraction measurements, can be attributed to the evaporation of the organic solvent.	[Nishino, Shunsuke; Koyano, Mikio] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan; [Koyano, Mikio; Ohdaira, Keisuke] Japan Adv Inst Sci & Technol, Green Devices Res Ctr, Nomi, Ishikawa 9231292, Japan	Nishino, S (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, 1-1 Asahidai, Nomi, Ishikawa 9231292, Japan.	s_nishino@jaist.ac.jp			Marubun Research Promotion Foundation; Jaist Research Grant	We would like to express our thanks to the Marubun Research Promotion Foundation and Jaist Research Grant for their financial aid, and we thank T. Ohkuma at JAIST for producing the p-type (Bi<INF>1-x</INF>Sb<INF>x</INF>)<INF>2</INF>Te<INF>3</INF> ink.	Kato K, 2014, J ELECTRON MATER, V43, P1733, DOI 10.1007/s11664-013-2852-0; Hu XJ, 2006, J HEAT TRANS-T ASME, V128, P1109, DOI 10.1115/1.2352778; Okada S, 1997, JPN J APPL PHYS 1, V36, P7035, DOI 10.1143/JJAP.36.7035; Kim MY, 2014, J ELECTRON MATER, V43, P1933, DOI 10.1007/s11664-013-2915-2; Oh DW, 2008, INT J HEAT FLUID FL, V29, P1456, DOI 10.1016/j.ijheatfluidflow.2008.04.007; RAMIRES MLV, 1995, J PHYS CHEM REF DATA, V24, P1377; Holtzman A, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/49/495711; CAHILL DG, 1990, REV SCI INSTRUM, V61, P802, DOI 10.1063/1.1141498; Chavez R., 2014, J ELECT MAT, V43, P2736; Choi TY, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1957118; Hokazono M, 2014, J ELECTRON MATER, V43, P2196, DOI 10.1007/s11664-014-3003-y; Kajitani T, 2014, J ELECTRON MATER, V43, P1993, DOI 10.1007/s11664-013-2933-0; Koyano M., 2013, 32 INT C THERM KOB D; Nemoto T, 2014, J ELECTRON MATER, V43, P1890, DOI 10.1007/s11664-013-2897-0; Nishino S, 2014, J ELECTRON MATER, V43, P2151, DOI 10.1007/s11664-014-2993-9; Takashiri M, 2014, J ELECTRON MATER, V43, P1881, DOI 10.1007/s11664-013-2896-1; Takashiri M, 2007, J APPL PHYS, V101, DOI 10.1063/1.2717867; Tanaka T., 2013, 32 INT C THERM KOB, pP180	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					2034	2038		10.1007/s11664-015-3650-7		5	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700095		
J	Ohishi, Y; Miyazaki, Y; Muta, H; Kurosaki, K; Yamanaka, S; Uchida, N; Tada, T				Ohishi, Yuji; Miyazaki, Yoshinobu; Muta, Hiroaki; Kurosaki, Ken; Yamanaka, Shinsuke; Uchida, Noriyuki; Tada, Tetsuya			Carrier Transport Properties of p-Type Silicon-Metal Silicide Nanocrystal Composite Films	JOURNAL OF ELECTRONIC MATERIALS			English	Article						p-Type silicon; metal silicide; nanocomposite; thermoelectric property; carrier transport property; potential barrier	THERMAL-CONDUCTIVITY; MOBILITY	In this study, we synthesized p-type nanocomposite films consisting of Si-nickel silicide and Si-molybdenum silicide nanocrystals and measured the temperature dependence of their electrical properties. To evaluate grain boundary potential barrier height, we developed a theoretical model taking into account the effect of ionized impurities, acoustic phonons, and grain boundaries. The potential barrier height was sufficiently low not to substantially affect carrier transport in the Si-nickel silicide composite film. Carrier transport in the Si-molybdenum silicide composite film was found to be affected by a scattering mechanism not included in this model. Thus, the transition metal significantly affects carrier transport and the thermoelectric properties of Si-metal silicide nanocomposite films.	[Ohishi, Yuji; Miyazaki, Yoshinobu; Muta, Hiroaki; Kurosaki, Ken; Yamanaka, Shinsuke] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Yamanaka, Shinsuke] Univ Fukui, Res Inst Nucl Engn, Tsuruga, Fukui, Japan; [Uchida, Noriyuki; Tada, Tetsuya] Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, Tsukuba, Ibaraki 3058562, Japan	Ohishi, Y (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	ohishi@see.eng.osaka-u.ac.jp	Kurosaki, Ken/E-8081-2012		ALCA (Advanced Low Carbon Technology Research and Development Program) of the Japan Science and Technology Agency	This work was supported by ALCA (the Advanced Low Carbon Technology Research and Development Program) of the Japan Science and Technology Agency.	THOMAS O, 1985, SOLID STATE COMMUN, V55, P629, DOI 10.1016/0038-1098(85)90827-0; Bell LE, 2008, SCIENCE, V321, P1457, DOI 10.1126/science.1158899; Kajikawa Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4770452; Bux SK, 2009, ADV FUNCT MATER, V19, P2445, DOI 10.1002/adfm.200900250; Yamada T, 2011, INTERMETALLICS, V19, P908, DOI 10.1016/j.intermet.2011.02.003; SHANKS HR, 1963, PHYS REV, V130, P1743, DOI 10.1103/PhysRev.130.1743; Minnich AJ, 2009, ENERG ENVIRON SCI, V2, P466, DOI 10.1039/b822664b; Kishimoto K, 2002, J APPL PHYS, V92, P5331, DOI 10.1063/1.1512964; Ohishi Y, 2013, THIN SOLID FILMS, V534, P238, DOI 10.1016/j.tsf.2013.02.127; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; COLGAN EG, 1983, J ELECTRON MATER, V12, P413, DOI 10.1007/BF02651140; LING CH, 1972, THIN SOLID FILMS, V14, P267, DOI 10.1016/0040-6090(72)90428-2; Lundstrom M., 2000, FUNDAMENTALS CARRIER; MASETTI G, 1983, IEEE T ELECTRON DEV, V30, P764, DOI 10.1109/T-ED.1983.21207; Rowe D.M., 1995, CRC HDB THERMOELECTR; Schierning G, 2011, J APPL PHYS, V110, DOI 10.1063/1.3658021; Uchida N., 2013, MRS P, V1456; Uchida N, 2013, J APPL PHYS, V114, DOI 10.1063/1.4823814; YOSHIDA M, 1967, JPN J APPL PHYS, V6, P573, DOI 10.1143/JJAP.6.573	19	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					2074	2079		10.1007/s11664-015-3663-2		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700101		
J	Anno, H; Nishinaka, T; Hokazono, M; Oshima, N; Toshima, N				Anno, Hiroaki; Nishinaka, Takahiko; Hokazono, Masahiro; Oshima, Nobuaki; Toshima, Naoki			Thermoelectric Power-Generation Characteristics of PEDOT:PSS Thin-Film Devices with Different Thicknesses on Polyimide Substrates	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Conducting polymer; PEDOT:PSS; thermoelectric device; power-generation characteristics; film thickness dependence	ACID-DOPED POLYANILINE; ELECTRICAL-CONDUCTIVITY; ENHANCEMENT; POLY(3,4-ETHYLENEDIOXYTHIOPHENE); TRANSPARENT; EFFICIENCY; NANOFILMS	We fabricated cast films of complexes of poly(3,4-ethylenedioxythiophene) and polystyrene sulfonic acid (PEDOT:PSS) at various thicknesses, t = 3-20 mu m, on flexible polyimide substrates, and studied their thermoelectric properties. We also fabricated in-plane film devices consisting of five couples of PEDOT:PSS and Ag electrodes, measuring their output power characteristics as a function of film thickness. The Seebeck coefficient and electrical conductivity of a PEDOT:PSS film with a thickness of similar to 20 mu m on a polyimide substrate were similar to 15 mu V/K and 500 S/cm, respectively, near room temperature. As the film thickness decreased from similar to 10 mu m to 3 mu m, the electrical conductivity increased remarkably to 1200 S/cm, while the Seebeck coefficient remained almost constant with film thickness. The maximum electric power for an in-plane PEDOT:PSS film device with a thickness of 10 mu m was 1.3 mu W at Delta T = 100 K. Its open-circuit voltage was 7.3 mV, and its internal resistance was 11 Omega. The measured power-generation characteristics of the film device agreed with values estimated from the dependence of thermoelectric properties on film thickness for PEDOT:PSS films on polyimide substrates. Assuming single PEDOT:PSS legs, defined as the direction of heat transport, we estimated the expected electrical power density at Delta T = 100 K as similar to 650 mu W/cm(2) for a film thickness t = 10 mu m, and 1400 mu W/cm(2) for t = 3 mu m.	[Anno, Hiroaki; Hokazono, Masahiro; Oshima, Nobuaki] Tokyo Univ Sci, Dept Elect Engn, Sanyo Onoda 7560884, Japan; [Anno, Hiroaki; Oshima, Nobuaki; Toshima, Naoki] Tokyo Univ Sci, Adv Mat Inst, Sanyo Onoda 7560884, Japan; [Nishinaka, Takahiko] Tokyo Univ Sci, Grad Sch Engn, Sanyo Onoda 7560884, Japan; [Toshima, Naoki] Tokyo Univ Sci, Dept Appl Chem, Sanyo Onoda 7560884, Japan	Anno, H (reprint author), Tokyo Univ Sci, Dept Elect Engn, 1-1-1 Daigaku Dori, Sanyo Onoda 7560884, Japan.	anno@rs.tus.ac.jp			Regional Innovation Strategy Support Program (Global Type) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was performed at the Yamaguchi Green Materials Cluster (Yamaguchi Green Valley), supported by the Regional Innovation Strategy Support Program (Global Type) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. We would like to thank UBE Industries, Ltd. for providing the polyimide films.	Culebras M, 2014, J MATER CHEM A, V2, P10109, DOI 10.1039/c4ta01012d; Luo JJ, 2013, J MATER CHEM A, V1, P7576, DOI 10.1039/c3ta11209h; Park T, 2013, ENERG ENVIRON SCI, V6, P788, DOI 10.1039/c3ee23729j; Liu CC, 2012, J ELECTRON MATER, V41, P639, DOI 10.1007/s11664-012-1942-8; Bubnova O, 2011, NAT MATER, V10, P429, DOI [10.1038/nmat3012, 10.1038/NMAT3012]; Zotti G, 2003, MACROMOLECULES, V36, P3337, DOI 10.1021/ma021715k; Pomfret SJ, 1998, ADV MATER, V10, P1351, DOI 10.1002/(SICI)1521-4095(199811)10:16<1351::AID-ADMA1351>3.0.CO;2-8; Xia YJ, 2012, ADV MATER, V24, P2436, DOI 10.1002/adma.201104795; Cho B, 2014, NANO LETT, V14, P3321, DOI 10.1021/nl500748y; Wei QS, 2013, ADV MATER, V25, P2831, DOI 10.1002/adma.201205158; Kim GH, 2013, NAT MATER, V12, P719, DOI [10.1038/nmat3635, 10.1038/NMAT3635]; Bubnova O, 2014, NAT MATER, V13, P190, DOI [10.1038/nmat3824, 10.1038/NMAT3824]; Lee SH, 2014, J MATER CHEM A, V2, P7288, DOI 10.1039/c4ta00700j; Fabretto M, 2011, POLYMER, V52, P1725, DOI 10.1016/j.polymer.2011.02.028; Yamashita M, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3647574; Park H, 2014, J MATER CHEM A, V2, P6532, DOI 10.1039/c3ta14960a; Massonnet N, 2014, J MATER CHEM C, V2, P1278, DOI 10.1039/c3tc31674b; YAMAURA M, 1988, SYNTHETIC MET, V26, P209, DOI 10.1016/0379-6779(88)90238-X; Badre C, 2012, ADV FUNCT MATER, V22, P2723, DOI 10.1002/adfm.201200225; Kong FF, 2013, SYNTHETIC MET, V185, P31, DOI 10.1016/j.synthmet.2013.09.046; Hokazono M, 2014, J ELECTRON MATER, V43, P2196, DOI 10.1007/s11664-014-3003-y; Hokazono M., 2013, T MAT RES SOC JPN, V38, P309; Kim JY, 2002, SYNTHETIC MET, V126, P311, DOI 10.1016/S0379-6779(01)00576-8; Kirchmeyer S., 2011, PEDOT PRINCIPLES APP, P113; Luo JJ, 2014, J APPL PHYS, V115, DOI 10.1063/1.4864749; Rowe D M, 2006, THERMOELECTRICS HDB, P1; Sondergaard R. R., 2013, ENERGY SCI ENG, V1, P81; Wei Q, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.031601; Yan H, 2000, CHEM LETT, P392, DOI 10.1246/cl.2000.392; Yan H, 1999, CHEM LETT, P1217, DOI 10.1246/cl.1999.1217; Yang Y., 2007, PHYS PROPERTIES POLY, V2nd, P155, DOI 10.1007/978-0-387-69002-5_10	31	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					2105	2112		10.1007/s11664-015-3668-x		8	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700105		
J	Kuroki, T; Murai, R; Makino, K; Nagano, K; Kajihara, T; Kaibe, H; Hachiuma, H; Matsuno, H				Kuroki, Takashi; Murai, Ryota; Makino, Kazuya; Nagano, Kouji; Kajihara, Takeshi; Kaibe, Hiromasa; Hachiuma, Hirokuni; Matsuno, Hidetoshi			Research and Development for Thermoelectric Generation Technology Using Waste Heat from Steelmaking Process	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Exhaust heat; heat recovery; thermoelectric generation system		In Japan, integrated steelworks have greatly lowered their energy use over the past few decades through investment in energy-efficient processes and facilities, maintaining the highest energy efficiency in the world. However, in view of energy security, the steelmaking industry is strongly required to develop new technologies for further energy saving. Waste heat recovery can be one of the key technologies to meet this requirement. To recover waste heat, particularly radiant heat from steel products which has not been used efficiently yet, thermoelectric generation (TEG) is one of the most effective technologies, being able to convert heat directly into electric power. JFE Steel Corporation (JFE) implemented a 10-kW-class grid-connected TEG system for JFE's continuous casting line with KELK Ltd. (KELK), and started verification tests to generate electric power using radiant heat from continuous casting slab at the end of fiscal year 2012. The TEG system has 56 TEG units, each containing 16 TEG modules. This paper describes the performance and durability of the TEG system, which has been investigated under various operating conditions at the continuous casting line.	[Kuroki, Takashi; Murai, Ryota; Matsuno, Hidetoshi] JFE Steel Corp, Environm Proc Res Dept, Steel Res Lab, Kawasaki Ku, Kawasaki, Kanagawa 2100855, Japan; [Makino, Kazuya; Nagano, Kouji; Kajihara, Takeshi; Kaibe, Hiromasa; Hachiuma, Hirokuni] KELK Ltd, Thermo Generat Business Dev Div, Hiratsuka, Kanagawa 2548543, Japan	Kuroki, T (reprint author), JFE Steel Corp, Environm Proc Res Dept, Steel Res Lab, Kawasaki Ku, 1-1 Minamiwataridacho, Kawasaki, Kanagawa 2100855, Japan.	ta-kuroki@jfe-steel.co.jp					Kuroki T, 2014, J ELECTRON MATER, V43, P2405, DOI 10.1007/s11664-014-3094-5; Kaibe H, 2012, AIP CONF PROC, V1449, P524, DOI 10.1063/1.4731609; Uemura K., 1988, NETSUDENHANDOUTAI SO, P26	3	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JUN	2015	44	6					2151	2156		10.1007/s11664-015-3722-8		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CH1WT	WOS:000353813700112		
J	Feng, SS; Kuang, JJ; Lu, TJ; Ichimiya, K				Feng, S. S.; Kuang, J. J.; Lu, T. J.; Ichimiya, K.			Heat Transfer and Pressure Drop Characteristics of Finned Metal Foam Heat Sinks Under Uniform Impinging Flow	JOURNAL OF ELECTRONIC PACKAGING			English	Article						metal foam; finned metal foam; impinging jet; electronic cooling	CONFINED SLOT JET; FORCED-CONVECTION; THERMAL-CHARACTERISTICS; FLUID-FLOW; AIR-JET; IMPINGEMENT; SUBJECT; CHANNEL; DESIGN; MEDIA	A numerical investigation was carried out to characterize the thermal performance of finned metal foam heat sinks subject to an impinging air flow. The main objective of the study was to quantify the effects of all relevant configurational parameters (channel length, channel width, fin thickness, and fin height) of the heat sink upon the thermal performance. Open-cell aluminum foam having fixed porosity of 0.9118 and fixed pore density of five pores per inch (PPI) was used in the study. A previously validated model based on the porous medium approach was employed for the numerical simulation. Various simulation cases for different combinations of channel parameters were carried out to obtain the Nusselt number correlation. Based on the inviscid impinging flow, a pressure drop correlation was derived for impinging flow in finned metal foam heat sinks. By using these correlations, the thermal performance of finned metal foam heat sinks was compared with the conventional plate-fin heat sinks. It was demonstrated that the finned metal foam heat sinks outperformed the plate-fin heat sinks on the basis of given weight or given pumping power.	[Feng, S. S.; Kuang, J. J.; Lu, T. J.] Xi An Jiao Tong Univ, MOE Key Lab Multifunct Mat & Struct LMMS, Xian 710049, Shaanxi, Peoples R China; [Feng, S. S.; Lu, T. J.] Xi An Jiao Tong Univ, State Key Lab Mech Struct Strength & Vibrat, Xian 710049, Shaanxi, Peoples R China; [Kuang, J. J.] Xi An Jiao Tong Univ, Sch Energy & Power Engn, Xian 710049, Shaanxi, Peoples R China; [Ichimiya, K.] Univ Yamanashi, Dept Mech Engn, Kofu, Yamanashi 4008511, Japan	Lu, TJ (reprint author), Xi An Jiao Tong Univ, MOE Key Lab Multifunct Mat & Struct LMMS, Xian 710049, Shaanxi, Peoples R China.	tjlu@mail.xjtu.edu.cn			National Natural Science Foundation of China [51206128]; National Basic Research Program of China [2011CB610305]; National "111" Project of China [B06024]; China Postdoctoral Science Foundation [2012M521766]; Shaanxi Province Science Foundation; Fundamental Research Funds for the Central Universities of China	This work was supported by the National Natural Science Foundation of China (51206128), the National Basic Research Program of China (2011CB610305), the National "111" Project of China (B06024), China Postdoctoral Science Foundation funded project (2012M521766), Shaanxi Province Science Foundation funded project, and the Fundamental Research Funds for the Central Universities of China.	Zhao CY, 2002, INT J HEAT MASS TRAN, V45, P4857, DOI 10.1016/S0017-9310(02)00180-1; Giuliano MR, 2012, J POWER SOURCES, V216, P345, DOI 10.1016/j.jpowsour.2012.05.074; Jeng TM, 2005, INT J HEAT MASS TRAN, V48, P4685, DOI 10.1016/j.ijheatmasstranfer.2005.06.032; Mavridou S, 2010, APPL THERM ENG, V30, P935, DOI 10.1016/j.applthermaleng.2010.01.003; Feng SS, 2013, INT J NUMER METHOD H, V23, P88, DOI 10.1108/09615531311289123; Feng SS, 2014, INT J HEAT MASS TRAN, V77, P1063, DOI 10.1016/j.ijheatmasstransfer.2014.05.053; DeGroot CT, 2009, J ELECTRON PACKAGING, V131, DOI 10.1115/1.3103934; Ejlali A, 2009, INT COMMUN HEAT MASS, V36, P674, DOI 10.1016/j.icheatmasstransfer.2009.03.001; Shih WH, 2006, J HEAT TRANS-T ASME, V128, P530, DOI 10.1115/1.2188461; Kim DK, 2009, INT J HEAT MASS TRAN, V52, P3510, DOI 10.1016/j.ijheatmasstransfer.2009.02.041; Marafie A, 2008, NUMER HEAT TR A-APPL, V54, P665, DOI 10.1080/10407780802339064; Jang SP, 2005, J HEAT TRANS-T ASME, V127, P770, DOI 10.1115/1.1924628; Rallabandi AP, 2010, INT J HEAT MASS TRAN, V53, P4663, DOI 10.1016/j.ijheatmasstransfer.2010.06.027; Bar-Cohen A., 2014, ASME J ELECT PACKAG, V137; Bhattacharya A, 2002, J ELECTRON PACKAGING, V124, P155, DOI 10.1115/1.1464877; Biber CR, 1997, IEEE T COMPON PACK A, V20, P458, DOI 10.1109/95.650935; Calmidi VV, 2000, J HEAT TRANS-T ASME, V122, P557, DOI 10.1115/1.1287793; Catton I., 2013, ASME J HEAT TRANSFER, V136; Do KH, 2010, INT J HEAT MASS TRAN, V53, P2318, DOI 10.1016/j.ijheatmasstransfer.2009.12.049; Duan Z., 2005, ASME J ELECT PACKAG, V128, P412; Duan Z., 2006, ASME J ELECT PACKAG, V129, P190; Eckert E. R. G., 1980, ANAL HEAT MASS TRANS; Ellsworth J. M. J., 2014, ASME J ELECT PACKAG, V136; Feng SS, 2010, J HEAT TRANS-T ASME, V132, DOI 10.1115/1.4002285; HUNT ML, 1988, INT J HEAT MASS TRAN, V31, P301, DOI 10.1016/0017-9310(88)90013-0; HWANG GJ, 1995, J HEAT TRANS-T ASME, V117, P725, DOI 10.1115/1.2822636; Kondo Y, 1998, J ELECTRON PACKAGING, V120, P259, DOI 10.1115/1.2792631; Krishnan S, 2012, IEEE T COMP PACK MAN, V2, P266, DOI 10.1109/TCPMT.2011.2175448; Kuang JJ, 2012, HEAT TRANSFER ENG, V33, P642, DOI 10.1080/01457632.2012.630270; Kuo S. M., 1988, InterSociety Conference on Thermal Phenomena in the Fabrication and Operation of Electronic Components: I-THERM '88 (Cat. No.88CH2590-8), DOI 10.1109/ITHERM.1988.28684; Lu TJ, 2002, ACTA MECH SINICA, V18, P457; Bhattacharya A, 2006, J ELECTRON PACKAGING, V128, P259, DOI 10.1115/1.2229225; Mills AF, 1995, BASIC HEAT MASS TRAN; Nakayama W., 2013, ASME J HEAT TRANSFER, V136; Patankar S. V., 1980, NUMERICAL HEAT TRANS, P102; Ranjan R., 2014, ASME J ELECT PACKAG, V136; Jeng TM, 2005, INT J HEAT MASS TRAN, V48, P3140, DOI 10.1016/j.ijheatmasstransfer.2005.02.016; VAFAI K, 1981, INT J HEAT MASS TRAN, V24, P195, DOI 10.1016/0017-9310(81)90027-2; Webb R. L., 2002, 8 INT C THERM THERM, P243	39	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	1043-7398	1528-9044		J ELECTRON PACKAGING	J. Electron. Packag.	JUN	2015	137	2							021014	10.1115/1.4029722		12	Engineering, Electrical & Electronic; Engineering, Mechanical	Engineering	CH3WZ	WOS:000353963000014		
J	Ichikawa, N				Ichikawa, Norimitsu			Measurement and calculation of electrostatically induced voltage generated on an ungrounded metal box	JOURNAL OF ELECTROSTATICS			English	Article						Electrostatically induced voltage; Moving charged body; Ungrounded metal box; Malfunction and failure	HUMAN-BODY; DISCHARGE	When a charged body passes by the front of an ungrounded metal box such as a box of electronic equipment, an electrostatically induced voltage is generated. The induced voltage can cause malfunctions and failure of the equipment. However, whether a voltage is induced in the metal box by a moving charged body and how much is induced is not clear. In this study, measured induced voltages are compared with values calculated for two capacitance-measuring methods. The results will be helpful to estimate the possibility of malfunction and failure by induced voltage and whether a standard test method should be considered. (C) 2015 Elsevier B.V. All rights reserved.	Kogakuin Univ, Dept Elect Engn, Nakano Ku, Hachioji, Tokyo 1920015, Japan	Ichikawa, N (reprint author), Kogakuin Univ, Dept Elect Engn, Nakano Ku, Hachioji, Tokyo 1920015, Japan.	ichikawa@cc.kogakuin.ac.jp			JSPS KAKENHI [25820107]	The author thanks Mr. S. Takei and Mr. I. Yamakawa for help with the experiments. This study is partially supported by JSPS KAKENHI Grant Number 25820107.	Greason WD, 2003, J ELECTROSTAT, V59, P285, DOI 10.1016/S0304-3886(03)00090-1; Greason WD, 2011, IEEE T IND APPL, V47, P1910, DOI 10.1109/TIA.2011.2154371; HONDA M, 1989, IEEE T IND APPL, V25, P939, DOI 10.1109/28.41261; Ichikawa N., 2010, J I ELECT INSTALLATI, V30, P599; Ichikawa N., 2013, ESA ANN M EL 1 9 FLO, P1; Ichikawa N, 2007, J ELECTROSTAT, V65, P414, DOI 10.1016/j.elstat.2006.10.011; Ichikawa N, 2010, J ELECTROSTAT, V68, P315, DOI 10.1016/j.elstat.2010.03.004; Jack N, 2013, IEEE T DEVICE MAT RE, V13, P379, DOI 10.1109/TDMR.2013.2262606; Llovera P, 2009, J ELECTROSTAT, V67, P457, DOI 10.1016/j.elstat.2009.01.004; McAteer O.J., 1990, ELECTROSTATIC DISCHA, P169; Strojny JA, 1997, J ELECTROSTAT, V40-1, P547, DOI 10.1016/S0304-3886(97)00101-0; TIAN H, 1995, IEEE T MAGN, V31, P2624, DOI 10.1109/20.490073; Wallash AJ, 1995, ELECTRICAL OVERSTRESS/ELECTROSTATIC DISCHARGE SYMPOSIUM PROCEEDINGS - 1995, P322, DOI 10.1109/EOSESD.1995.478300; Watanabe M., 2014, J I ELECTROST JPN, V38, P183	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3886	1873-5738		J ELECTROSTAT	J. Electrost.	JUN	2015	75						14	18		10.1016/j.elstat.2015.02.001		5	Engineering, Electrical & Electronic	Engineering	CH6PD	WOS:000354157600003		
J	Yao, SL; Wu, ZL; Han, JY; Tang, XJ; Jiang, BQ; Lu, H; Yamamoto, S; Kodama, S				Yao, Shuiliang; Wu, Zuliang; Han, Jingyi; Tang, Xiujuan; Jiang, Boqiong; Lu, Hao; Yamamoto, Sin; Kodama, Satoshi			Study of ozone generation in an atmospheric dielectric barrier discharge reactor	JOURNAL OF ELECTROSTATICS			English	Article						O-3 generation; DBD; Pulsed discharge; Model; Energy efficiency	AIR-FED OZONIZERS; CORONA DISCHARGE; OXYGEN; MIXTURES; PLASMA; MODEL; WIRE; FOOD; DBD	Ozone (O-3) generation in a dielectric barrier discharge (DBD) reactor driven by a pulsed power supply was investigated at atmospheric pressure and room temperature. An O-3 generation efficiency model is established in which discharge power, O-2 concentration, gas flow rate, and volume of the discharge space are included. Constants in the O-3 generation efficiency model were obtained by fitting the model with experiment results. O-3 concentration can be simply calculated from the energy density and initial O-2 concentration. Comparison on O-3 concentrations from calculation with references is given. (C) 2015 Elsevier B.V. All rights reserved.	[Yao, Shuiliang; Wu, Zuliang; Han, Jingyi; Tang, Xiujuan; Jiang, Boqiong; Lu, Hao] Zhejiang Gongshang Univ, Sch Environm Sci & Engn, Hangzhou 310018, Zhejiang, Peoples R China; [Yamamoto, Sin] Res Inst Innovat Technol Earth, Chem Res Grp, Kizugawa, Kyoto 6190292, Japan; [Kodama, Satoshi] Tokyo Inst Technol, Dept Chem Engn, Meguro Ku, Tokyo 1528552, Japan	Wu, ZL (reprint author), Zhejiang Gongshang Univ, Sch Environm Sci & Engn, 18 Xuezheng St, Hangzhou 310018, Zhejiang, Peoples R China.	wuzuliang@zjgsu.edu.cn			Zhejiang Provincial Natural Science Foundation of China [LY13B070004]; Program for Zhejiang Leading Team of ST Innovation [2013TD07]; Natural Science Foundation Key Program of Zhejiang Province [Z5100294]	Financial supports are provided by Zhejiang Provincial Natural Science Foundation of China (No. LY13B070004), the Program for Zhejiang Leading Team of S&T Innovation (No. 2013TD07), and the Natural Science Foundation Key Program of Zhejiang Province (No. Z5100294).	Huang WD, 2007, OZONE-SCI ENG, V29, P107, DOI 10.1080/01919510601186527; Wei LS, 2014, VACUUM, V104, P61, DOI 10.1016/j.vacuum.2014.01.009; Malik MA, 2014, PLASMA CHEM PLASMA P, V34, P93, DOI 10.1007/s11090-013-9497-x; KOGELSCHATZ U, 1988, OZONE-SCI ENG, V10, P367; ELIASSON B, 1987, J PHYS D APPL PHYS, V20, P1421, DOI 10.1088/0022-3727/20/11/010; Ono R, 2007, J PHYS D APPL PHYS, V40, P176, DOI 10.1088/0022-3727/40/1/011; Simek M, 2012, PLASMA CHEM PLASMA P, V32, P743, DOI 10.1007/s11090-012-9382-z; Bocci V, 2009, MED RES REV, V29, P646, DOI 10.1002/med.20150; Simek M, 2002, J PHYS D APPL PHYS, V35, P1171, DOI 10.1088/0022-3727/35/11/311; Shao T, 2009, J ELECTROSTAT, V67, P215, DOI 10.1016/j.elstat.2008.12.001; Kossyi IA, 1992, PLASMA SOURCES SCI T, V1, P207, DOI 10.1088/0963-0252/1/3/011; Chen JH, 2002, PLASMA CHEM PLASMA P, V22, P495, DOI 10.1023/A:1021315412208; Chen JH, 2005, IEEE T PLASMA SCI, V33, P808, DOI 10.1109/TPS.2005.844530; Kim MH, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/30/305201; Kogelschatz U, 1999, PURE APPL CHEM, V71, P1819, DOI 10.1351/pac199971101819; LEE C, 1994, J ELECTROCHEM SOC, V141, P1546, DOI 10.1149/1.2054960; Khadre MA, 2001, J FOOD SCI, V66, P1242, DOI 10.1111/j.1365-2621.2001.tb15196.x; Xu JY, 2013, J ELECTROSTAT, V71, P435, DOI 10.1016/j.elstat.2012.12.011; Hirneisen KA, 2010, COMPR REV FOOD SCI F, V9, P3, DOI 10.1111/j.1541-4337.2009.00092.x; Boonduang S., 2012, PROCEDIA ENG, V32, P936; BRAUN D, 1991, J PHYS D APPL PHYS, V24, P564, DOI 10.1088/0022-3727/24/4/007; Buntat Z., 2009, APPL PHYS RES, V1, P2; Chang MB, 1997, OZONE-SCI ENG, V19, P241, DOI 10.1080/01919519708547304; Chen HL, 2006, OZONE-SCI ENG, V28, P111, DOI 10.1080/01919510600559393; ELIASSON B, 1984, J PHYS B-AT MOL OPT, V17, pL797, DOI 10.1088/0022-3700/17/22/006; Fang Z, 2008, J ELECTROSTAT, V66, P421, DOI 10.1016/j.elstat.2008.04.007; Francke KP, 2003, PLASMA CHEM PLASMA P, V23, P47, DOI 10.1023/A:1022412718224; Gottschalk C., 2010, OZONATION WATER WAST; GUREVICH AV, 1995, PHYS LETT A, V201, P234, DOI 10.1016/0375-9601(95)00223-P; HADJZIANE S, 1990, J PHYS D APPL PHYS, V23, P1390, DOI 10.1088/0022-3727/23/11/007; Hoboken N.J., 2010, WHITES HDB CHLORINAT, Vfifth; Horinouchi T, 2005, OZONE-SCI ENG, V27, P53, DOI 10.1080/01919510590909011; Humpert C, 2005, OZONE-SCI ENG, V27, P59, DOI 10.1080/01919510590909048; Kim JG, 1999, J FOOD SAFETY, V19, P17, DOI 10.1111/j.1745-4565.1999.tb00231.x; Lee HM, 2004, OZONE-SCI ENG, V26, P551, DOI 10.1080/01919510490885361; Manning TJ, 2001, OZONE-SCI ENG, V23, P95, DOI 10.1080/01919510108961992; Muhammad A.M., 2014, CHEM ENG J, V256, P222; Murata T, 2004, OZONE-SCI ENG, V26, P429, DOI 10.1080/01919510490507577; Park S.L., 2006, J ELECTROSTAT, V64, P275, DOI 10.1016/j.elstat.2005.06.007; Pekarek S., 2013, EUR PHYS J D, V67, P1; Rickard G.D., 2004, COCHRANE DB SYST REV, V3; SCHMIDTSZALOWSKI K, 1989, PLASMA CHEM PLASMA P, V9, P235, DOI 10.1007/BF01054284; Shao T., 2010, IEEE T PLASMA SCI, V41, P3069; Simek M, 2010, PLASMA CHEM PLASMA P, V30, P607, DOI 10.1007/s11090-010-9245-4; Sung TL, 2013, VACUUM, V90, P65, DOI 10.1016/j.vacuum.2012.10.003; Takaki K., 2009, VACUUM, V83, P128; Wei LS, 2014, EUR PHYS J D, V68, DOI 10.1140/epjd/e2013-40556-8; YAGI S, 1979, J PHYS D APPL PHYS, V12, P1509, DOI 10.1088/0022-3727/12/9/013; Yehia A, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3682983	49	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3886	1873-5738		J ELECTROSTAT	J. Electrost.	JUN	2015	75						35	42		10.1016/j.elstat.2015.03.001		8	Engineering, Electrical & Electronic	Engineering	CH6PD	WOS:000354157600006		
J	Kayo, C; Oka, H; Hashimoto, S; Mizukami, M; Takagi, S				Kayo, Chihiro; Oka, Hiroyasu; Hashimoto, Seiji; Mizukami, Midori; Takagi, Shigesada			Socioeconomic development and wood consumption	JOURNAL OF FOREST RESEARCH			English	Article						Environmental Kuznets curve; Forest area; Human development index; Panel data analysis; Per capita GDP	ENVIRONMENTAL KUZNETS CURVE; FOREST PRODUCTS; CARBON-DIOXIDE; PER-CAPITA; DEMAND; FLOWS; PAPERBOARD; EMISSIONS; ENERGY; TRADE	To show the relationship between socioeconomic development and wood consumption for the investigation of future changes in wood demand in countries where socioeconomic development is expected, we analyzed panel data on per capita GDP, the human development index (HDI), and other factors in relation to per capita wood consumption for 33 OECD and 6 BRIICS countries. An increasing linear trend was found between per capita GDP and per capita consumption for sawn wood. However, the consumption declined over time when the same economic level was attained. In the case of plywood, reconstituted panels, and paper/paperboard, the results suggest that an environmental Kuznets curve, represented as an inverted-U curve, exists between per capita GDP and per capita consumption, confirming a tendency for consumption to reach saturation and then decline as economic development progresses. For wood fuel, an increasing linear trend was confirmed between economic level and per capita consumption, indicating the recent promotion of biofuel in developed countries. However, economic level alone might not be sufficient for explaining the demand for wood. The consumption of sawn wood, plywood, reconstituted panels, and paper/paperboard declined over time for a given HDI level. Rising population density and urbanization can contribute to a decrease in per capita wood consumption, whereas the larger the country's forest area, the greater per capita wood consumption. In particular, there is an increasing tendency to use the latest forms of wood fuel under sustainable forest management.	[Kayo, Chihiro] Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Environm Conservat, Fuchu, Tokyo 1838509, Japan; [Oka, Hiroyasu] Forestry & Forest Prod Res Inst, Dept Forest Policy & Econ, Tsukuba, Ibaraki 3058687, Japan; [Hashimoto, Seiji] Ritsumeikan Univ, Dept Environm Syst Engn, Coll Sci & Engn, Shiga 5258577, Japan; [Mizukami, Midori; Takagi, Shigesada] Mizuho Information & Res Inst Inc, Environm & Energy Div 1, Tokyo 1018443, Japan	Kayo, C (reprint author), Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Environm Conservat, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	kayoc@cc.tuat.ac.jp			JSPS KAKENHI [26870181]; Agriculture, Forestry and Fisheries Research Council; Ministry of the Environment [S-11-2]	This research was supported by JSPS KAKENHI Grant Number 26870181, the Agriculture, Forestry and Fisheries Research Council Project, Development of Climate Change Mitigation Technologies in the field of Forests and Forestry (2010-2014), and the Environment Research and Technology Development Fund (S-11-2) of the Ministry of the Environment.	Kastner T, 2011, GLOBAL ENVIRON CHANG, V21, P947, DOI 10.1016/j.gloenvcha.2011.05.003; Mao JS, 2009, J IND ECOL, V13, P112, DOI 10.1111/j.1530-9290.2009.00109.x; Erb KH, 2009, ECOL ECON, V69, P328, DOI 10.1016/j.ecolecon.2009.06.025; Meyfroidt P, 2010, P NATL ACAD SCI USA, V107, P20917, DOI 10.1073/pnas.1014773107; Koop G, 1999, J DEV ECON, V58, P231, DOI 10.1016/S0304-3878(98)00110-2; Michinaka T, 2011, FOREST POLICY ECON, V13, P435, DOI 10.1016/j.forpol.2011.05.011; Steinberger JK, 2010, ECOL ECON, V70, P425, DOI 10.1016/j.ecolecon.2010.09.014; Simangunsong BCH, 2001, SCAND J FOREST RES, V16, P155, DOI 10.1080/028275801300088242; Winjum JK, 1998, FOREST SCI, V44, P272; Bringezu S, 2004, ECOL ECON, V51, P97, DOI 10.1016/j.ecolecon.2004.04.010; Galeotti M, 2006, ECOL ECON, V57, P152, DOI 10.1016/j.ecolecon.2005.03.031; Binder CR, 2006, J IND ECOL, V10, P111, DOI 10.1162/108819806775545475; Canas A, 2003, ECOL ECON, V46, P217, DOI 10.1016/S0921-8009(03)00123-X; Chas-Amil ML, 2000, APPL ECON, V32, P987; Cole M. A., 1997, ENVIRON DEV ECON, V2, P401, DOI 10.1017/S1355770X97000211; Dias RA, 2006, ENERG POLICY, V34, P1026, DOI 10.1016/j.enpol.2004.09.008; Holtsmark B, 2015, GCB BIOENERGY, V7, P195, DOI 10.1111/gcbb.12110; Kayo C, 2014, ENVIRON SCI POLICY, V37, P215, DOI 10.1016/j.envsci.2013.09.006; Kayo C, 2012, J IND ECOL, V16, P529, DOI 10.1111/j.1530-9290.2011.00419.x; Kitamura Y, 2005, EC RES SERIES HITOTS, V53; McCarthy P, 2010, J FOREST ECON, V16, P127, DOI 10.1016/j.jfe.2009.11.001; Michinaka T., 2013, J FOR PLANN, V18, P141; Mills Busa JH, 2013, ECOL ECON, V94, P116; Mills Busa JH, 2013, CONSERV LETT, V6, P192; Min Kyung-taek, 2012, Bulletin of the Forestry and Forest Products Research Institute, V11, P1; Panayotou T, 1993, WP238 ILO TECHN EMPL; Tachibana S, 2005, PANEL DATA ANAL INT, P71; UNDP (United Nations Development Programme), 2011, HUM DEV REP HDR 2011; United Nations Development Programme (UNDP), 2012, INT HUM DEV IND; Whiteman A., 2002, Unasylva (English ed.), V53, P41; World Bank, 2012, WORLD DEV IND	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	JUN	2015	20	3					309	320		10.1007/s10310-015-0481-6		12	Forestry	Forestry	CH8OO	WOS:000354295900001		
J	Yamamoto, K; Murase, Y; Etou, C; Shibuya, K				Yamamoto, Kazukiyo; Murase, Yasuhisa; Etou, Chikako; Shibuya, Kenichi			Estimation of relative illuminance within forests using small-footprint airborne LiDAR	JOURNAL OF FOREST RESEARCH			English	Article						Airborne LiDAR; Hinoki cypress; Relative illuminance	LEAF-AREA INDEX; PHOTON FLUX-DENSITY; GAP FRACTION; LIGHT; TEMPERATE; HETEROGENEITY; PLANTATIONS; CANOPIES; COVER; LAI	To evaluate canopy metrics at landscape or regional levels, remote sensing techniques have usually been employed. In particular, ratio metrics such as laser penetration index (LPI: %) calculated as the percentage of ground returns of laser pulses within the forest from light detection and ranging (LiDAR) data have proved to be closely related to canopy metrics obtained in the field. In our previous study, we successfully proposed a new methodology that automatically and easily separated the laser pulses into those of canopy and below-canopy returns. In this study, we assessed the effectiveness of LPI that was calculated using our methodology to estimate relative illuminance (RI: %) and also evaluated the optimal scale to calculate LPI for estimating RI. We found that LPI was closely related to RI (P < 0.01), and might not be affected by the increase of pulse density by overlapping surveys. We further found that a radius of less than 5.0 m in the cylindrical plot to calculate LPI might not be suitable for estimating canopy metrics, especially for LiDAR data with relatively low pulse density.	[Yamamoto, Kazukiyo; Murase, Yasuhisa] Nagoya Univ, Lab Forest Environm & Resources, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Yamamoto, Kazukiyo; Murase, Yasuhisa] Japan Sci & Technol Agcy, CREST, Okayama, Japan; [Etou, Chikako; Shibuya, Kenichi] Aero Asahi Corp, Asahi, Japan	Yamamoto, K (reprint author), Nagoya Univ, Lab Forest Environm & Resources, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	kazukiyo@agr.nagoya-u.ac.jp			JSPS KAKENHI [24580217]	This work was partially supported by JSPS KAKENHI Grant Number 24580217. We thank the staff of Ecohydrology Research Institute, The University of Tokyo Forests, Graduate School of Agricultural and Life Sciences, University of Tokyo for their help in the field survey.	Gray AN, 1996, J ECOL, V84, P635, DOI 10.2307/2261327; Riano D, 2004, AGR FOREST METEOROL, V124, P269, DOI 10.1016/j.agrformet.2004.02.005; Jennings SB, 1999, FORESTRY, V72, P59, DOI 10.1093/forestry/72.1.59; Evans JS, 2007, IEEE T GEOSCI REMOTE, V45, P1029, DOI 10.1109/TGRS.2006.890412; Anderson MC, 2004, REMOTE SENS ENVIRON, V92, P447, DOI 10.1016/j.rse.2004.03.019; Morsdorf F, 2006, REMOTE SENS ENVIRON, V104, P50, DOI 10.1016/j.rse.2006.04.019; Turner DP, 1999, REMOTE SENS ENVIRON, V70, P52, DOI 10.1016/S0034-4257(99)00057-7; Gendron F, 1998, AGR FOREST METEOROL, V92, P55, DOI 10.1016/S0168-1923(98)00082-3; Welles JM, 1996, J EXP BOT, V47, P1335, DOI 10.1093/jxb/47.9.1335; Peduzzi A, 2012, FOREST ECOL MANAG, V270, P54, DOI 10.1016/j.foreco.2011.12.048; Nicotra AB, 1999, ECOLOGY, V80, P1908; Solberg S, 2006, REMOTE SENS ENVIRON, V102, P364, DOI 10.1016/j.rse.2006.03.001; Jakubowski MK, 2013, REMOTE SENS ENVIRON, V130, P245, DOI 10.1016/j.rse.2012.11.024; Richardson JJ, 2009, AGR FOREST METEOROL, V149, P1152, DOI 10.1016/j.agrformet.2009.02.007; CANHAM CD, 1994, CAN J FOREST RES, V24, P337, DOI 10.1139/x94-046; Jensen JLR, 2011, REMOTE SENS ENVIRON, V115, P3625, DOI 10.1016/j.rse.2011.08.023; SPANNER MA, 1990, REMOTE SENS ENVIRON, V33, P97, DOI 10.1016/0034-4257(90)90036-L; CANHAM CD, 1990, CAN J FOREST RES, V20, P620, DOI 10.1139/x90-084; Wright EF, 1998, CAN J FOREST RES, V28, P871, DOI 10.1139/cjfr-28-6-871; Birky AK, 2001, ECOL MODEL, V143, P43, DOI 10.1016/S0304-3800(01)00354-4; Hagihara A., 1982, Journal of the Japanese Forestry Society, V64, P220; Hirata Y, 2005, JAPANESE J FOREST PL, V39, P81; Ishida M, 2004, CAN J FOREST RES, V34, P2208, DOI 10.1139/X04-103; Monsi M., 1953, JAPANESE J BOTANY, V14, P22; Muraoka H, 2001, FUNCT ECOL, V15, P798, DOI 10.1046/j.0269-8463.2001.00581.x; Shimomoto M, 2000, B KYUSHU U FOR, V81, P31; Takahashi T, 2000, NAGOYA U FOR SCI, V19, P49; Takahashi T, 2005, J FOR RES-JPN, V10, P305, DOI 10.1007/s10310-005-0150-2; Yamamoto K, 2011, J FOREST RES-JPN, V16, P425, DOI 10.1007/s10310-010-0234-5; Zang Y, 2005, AGR FOR METEOROL, V133, P166; Zao K, 2009, REMOTE SENS ENVIRON, V113, P1628	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	JUN	2015	20	3					321	327		10.1007/s10310-015-0484-3		7	Forestry	Forestry	CH8OO	WOS:000354295900002		
J	Minami, Y; Oba, M; Kojima, S; Richardson, JS				Minami, Yoshi; Oba, Mai; Kojima, Satoru; Richardson, John S.			Distribution pattern of coniferous seedlings after a partial harvest along a creek in a Canadian Pacific northwest forest	JOURNAL OF FOREST RESEARCH			English	Article						Competition; Facilitation; Regeneration; Riparian forest; Shrub species	PHOTON FLUX-DENSITY; WESTERN RED CEDAR; HEMISPHERICAL PHOTOGRAPHY; VANCOUVER-ISLAND; CENTRAL JAPAN; DOUGLAS-FIR; UNDERSTORY; GROWTH; VEGETATION; ESTABLISHMENT	In managed forests, partial harvest within riparian areas is one way to provide harvest opportunities and maintain some of the functions of riparian vegetation. We examined the response of coniferous seedlings to a 50 %-partial harvest in a second-growth, coniferous riparian forest in the Pacific Northwest. Partial canopy opening facilitated the establishment of Tsuga heterophylla and Thuja plicata, but Pseudotsuga menziesii did not show the same tendency. Results suggested that differences in seedling establishment were related to differences in light. Increased light availability also stimulated growth of Rubus spectabilis, especially in moist sites, and the dense cover precluded establishment of coniferous seedlings. Once R. spectabilis was established, continued stem recruitment maintained a dense stable cover, and even intense disturbance did not affect the stability of the populations. R. spectabilis would be a major competitor to constrain conifer seedlings to regenerate in riparian zones. Although Gaultheria shallon extended their cover, competition from dense G. shallon was not as severe as from R. spectabilis.	[Minami, Yoshi; Oba, Mai] Tamagawa Univ, Coll Agr, Machida, Tokyo 1948610, Japan; [Kojima, Satoru] Northern Oikoscape Res Ateleir, Mitaka, Tokyo 1810013, Japan; [Richardson, John S.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V6T 1Z4, Canada	Minami, Y (reprint author), Tamagawa Univ, Coll Agr, Tamagawa Gakuen 6-1-1, Machida, Tokyo 1948610, Japan.	yoshi-min@agr.tamagawa.ac.jp					Bennett JN, 2003, CAN J FOREST RES, V33, P1516, DOI 10.1139/X03-069; Richardson JS, 2005, J AM WATER RESOUR AS, V41, P935, DOI 10.1111/j.1752-1688.2005.tb03778.x; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Ares A, 2009, APPL VEG SCI, V12, P472, DOI 10.1111/j.1654-109X.2009.01042.x; HARMON ME, 1989, ECOLOGY, V70, P48, DOI 10.2307/1938411; Fahey RT, 2007, J ECOL, V95, P1098, DOI 10.1111/j.1365-2745.2007.01283.x; RICH PM, 1993, AGR FOREST METEOROL, V65, P107, DOI 10.1016/0168-1923(93)90040-O; Nelson CR, 2005, ECOL APPL, V15, P196, DOI 10.1890/03-6002; Gomez-Aparicio L, 2005, J ECOL, V93, P1194, DOI 10.1111/j.1365-2745.2005.01047.x; TAPPEINER JC, 1993, CAN J FOREST RES, V23, P1775, DOI 10.1139/x93-224; Kiffney PM, 2003, J APPL ECOL, V40, P1060, DOI 10.1111/j.1365-2664.2003.00855.x; Gonzalez-Alday J, 2009, PLANT ECOL, V201, P211, DOI 10.1007/s11258-008-9490-2; Richardson JS, 2012, FRESHW SCI, V31, P232, DOI 10.1899/11-031.1; CHRISTY EJ, 1984, J ECOL, V72, P75, DOI 10.2307/2260007; Machado JL, 1999, CAN J FOREST RES, V29, P1438, DOI 10.1139/cjfr-29-9-1438; Naiman RJ, 2000, BIOSCIENCE, V50, P996, DOI 10.1641/0006-3568(2000)050[0996:REAMIT]2.0.CO;2; Beach EW, 2001, CAN J FOREST RES, V31, P471, DOI 10.1139/cjfr-31-3-471; Boudreau S, 2005, BIOL CONSERV, V126, P279, DOI 10.1016/j.biocon.2005.06.004; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Dosono PJ, 2006, NORTH J APPL FOR, V23, P288; EASTER MJ, 1994, CAN J FOREST RES, V24, P2050, DOI 10.1139/x94-263; FRASER LH, 1995, FOREST ECOL MANAG, V75, P27, DOI 10.1016/0378-1127(95)03546-M; Gomi T, 2006, WATER RESOUR RES, V42, P11; Harrington TB, 2006, CAN J FOREST RES, V36, P2439, DOI 10.1139/X06-139; Hibbs DE, 1996, NORTHWEST SCI, V70, P213; Hovstad KA, 2009, PLANT ECOL, V204, P33, DOI 10.1007/s11258-008-9563-2; Hughes NM, 2009, ARCT ANTARCT ALP RES, V41, P112, DOI [10.1657/1938-4246(08-021)[HUGHES]2.0.CO;2, 10.1657/1523-0430-41.1.112]; Katsumata N, 2008, LINDBERGIA, V33, P50; Kennedy PG, 2001, FOREST ECOL MANAG, V154, P193, DOI 10.1016/S0378-1127(00)00622-8; Keyes CR, 2001, NORTHWEST SCI, V75, P204; MALLIK AU, 1995, ENVIRON MANAGE, V19, P675, DOI 10.1007/BF02471950; Mallik AU, 2001, AGRON J, V93, P85; Minore Don, 1994, New Forests, V8, P249, DOI 10.1007/BF00025371; Naiman RJ, 2005, RIPARIA ECOLOGY CONS; NAKAMURA T, 1992, ECOL RES, V7, P155, DOI 10.1007/BF02348494; Narukawa Y, 2001, ECOL RES, V16, P617, DOI 10.1046/j.1440-1703.2001.00424.x; Pojar J, 2004, PLANTS COASTAL BRIT; Richardson JS, 2010, STREAMLINE, V13, P1; Sugita H, 2001, ECOL RES, V16, P423, DOI 10.1046/j.1440-1703.2001.00408.x; TAPPEINER J, 1991, ECOLOGY, V72, P609, DOI 10.2307/2937201; Tappeiner JC, 2001, CAN J FOREST RES, V31, P1629; The University of British Columbia, 2010, M KNAPP RES FOR; Villarin LA, 2009, FOREST ECOL MANAG, V257, P1375, DOI 10.1016/j.foreco.2008.12.007	43	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	JUN	2015	20	3					328	336		10.1007/s10310-015-0479-0		9	Forestry	Forestry	CH8OO	WOS:000354295900003		
J	Ishida, B; Masaki, T; Miyamoto, A; Tanaka, H; Nakashizuka, T				Ishida, Bin; Masaki, Takashi; Miyamoto, Asako; Tanaka, Hiroshi; Nakashizuka, Tohru			Projection of the probability of local extinction of canopy tree species in forest landscapes	JOURNAL OF FOREST RESEARCH			English	Article						Forest management; Local extinction probability; Natural forest conservation; Satoyama management; Tree composition	DISTURBANCE REGIME; DECIDUOUS FORESTS; TEMPERATE FOREST; CENTRAL JAPAN; HUMAN IMPACT; DYNAMICS; RESERVE; REGENERATION; VEGETATION	Tree species are endangered mainly by the exploitation of old-growth forests, and in Japan by a change from traditional coppicing (Satoyama) to monoculture plantations. The protection of old-growth forest or the revival of traditional Satoyama management might avoid local extinctions. To evaluate these possibilities, we developed a model to project the dominance and probabilities of local extinction of tree species in deciduous forests by combining land-use change and canopy tree replacement matrices. The land-use change matrix represents the probability of land-use transition during a unit interval (25 years). We calculated the probabilities of transition among old-growth forest, immature secondary forest, mature secondary forest, conifer plantation, and pasture from historical records. The probabilities of canopy replacement in old-growth and secondary forests were estimated from canopy-understory associations. Changes in canopy composition after logging of old-growth and secondary forests and forest recovery following abandonment of clear-cut plantations and pasture were estimated from field data. Using the combined matrix model, we projected the abundance and probabilities of local extinction of 19 tree species under four scenarios: business as usual, forest protection, Satoyama (traditional coppice management), and Satoyama forest protection. Satoyama management increased the abundance of disturbance-dependent species but contributed little to the reduction of local extinction. Forest protection decreased extinction probabilities and the dominance of tree species did not change greatly. In particular, forest protection greatly decreased the local extinction probabilities of species with continuous recruitment in old-growth forest, such as Fagus crenata, F. japonica, and Acer mono, but Satoyama did not.	[Ishida, Bin; Nakashizuka, Tohru] Tohoku Univ, Grad Sch Life Sci, Dept Environm Life Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Masaki, Takashi; Tanaka, Hiroshi] Forestry & Forest Prod Res Inst, Dept Forest Vegetat, Tsukuba, Ibaraki 305, Japan; [Miyamoto, Asako] Forestry & Forest Prod Res Inst, Dept Forest Management, Tsukuba, Ibaraki 305, Japan	Ishida, B (reprint author), Tohoku Univ, Grad Sch Life Sci, Dept Environm Life Sci, Aoba Ku, 6-3 Aramaki, Sendai, Miyagi 9808578, Japan.	ishida_bin@yahoo.co.jp			Ministry of Environment Japan [S9-3]; Japan Society for the Promotion of Science [23370007]	We would like to thank the staff of the Laboratory of Plant Ecology, Tohoku University, for their helpful comments about the study. This study was partly supported by grants from Ministry of Environment Japan (S9-3) and the Japan Society for the Promotion of Science (23370007).	Turner MG, 1987, LANDSCAPE ECOL, V1, P29, DOI 10.1007/BF02275263; Takada T, 2010, LANDSCAPE ECOL, V25, P561, DOI 10.1007/s10980-009-9433-x; Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042; WHITE PS, 1979, BOT REV, V45, P229, DOI 10.1007/BF02860857; Katoh K, 2009, BIOL CONSERV, V142, P1930, DOI 10.1016/j.biocon.2009.02.030; WATT AS, 1947, J ECOL, V35, P1, DOI 10.2307/2256497; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; FARJON A, 1993, BIODIVERS CONSERV, V2, P304; Gonzales RS, 2010, FOREST ECOL MANAG, V259, P2133, DOI 10.1016/j.foreco.2010.02.028; Katsuki T, 2008, JPN J FOR ENV, V50, P25; Likens G.E., 1989, LONG TERM STUDIES EC; Masaki T, 1999, J VEG SCI, V10, P805, DOI 10.2307/3237305; MASAKI T, 1992, VEGETATIO, V98, P97, DOI 10.1007/BF00045549; Miyamoto A, 2008, LANDSCAPE URBAN PLAN, V86, P248, DOI 10.1016/j.landurbplan.2008.03.002; Mizoguchi Y, 2002, ECOL STU AN, V158, P11; NAKASHIZUKA T, 1987, VEGETATIO, V69, P169, DOI 10.1007/BF00038698; Nakashizuka T, 2002, ECOL STU AN, V158, P67; Nakashizuka T, 1995, VEGETATIO, V121, P23, DOI 10.1007/BF00044669; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; OHKUBO T, 1992, VEGETATIO, V101, P65, DOI 10.1007/BF00031916; Osawa M, 2004, FOREST ECOL MANAG, V189, P375; Pickett STA, 1985, ECOLOGY NATURAL DIST; R Development Core Team, 2011, R LANG ENV STAT COMP; Rist L, 2011, FOR ECOL MANAG, V268, P57; Ruth DF, 2007, ECOL APPL, V17, P1031; Saeki I, 2005, LANDSC ECOL ENG, V1, P135, DOI DOI 10.1007/S11355-005-0015-Z; Suzuki S, 2007, AM J BOT, V94, P128; Suzuki W, 2002, ECOL STU AN, V158, P27; Takada T, 1996, VEGETATIO, V124, P211; Takeuchi K., 2003, P9; WHITE P S, 1987, Natural Areas Journal, V7, P14; Wunderle MJ, 1997, FOR ECOL MANAG, V99, P223; YAMAMOTO SI, 1989, BOT MAG TOKYO, V102, P93, DOI 10.1007/BF02488116	33	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	JUN	2015	20	3					337	346		10.1007/s10310-015-0483-4		10	Forestry	Forestry	CH8OO	WOS:000354295900004		
J	Katagiri, N; Hijii, N				Katagiri, Nana; Hijii, Naoki			Effects of sika deer browsing on the arthropod communities on understory vegetation in a thinned Japanese cypress plantation	JOURNAL OF FOREST RESEARCH			English	Article						Arthropod community; Cascading effect; Sika deer; Thinned cypress plantation; Understory vegetation	WHITE-TAILED DEER; FOREST ECOSYSTEMS; MT. OHDAIGAHARA; PREY SELECTION; BOREAL FOREST; HERBIVORY; HARDWOOD; IMPACT; MOOSE; INVERTEBRATES	We assessed how arthropod communities on understory vegetation are affected by sika deer browsing in a Japanese cypress plantation in central Japan, about 5 years after thinning, by comparing understory plants and arthropod communities between fenced and unfenced plots at two different scales. Deer browsing reduced the volume of plants per plot, which is a quantitative index of understory habitat for arthropods. As a result, the per-plot abundances of the herbivore guild and the tourist guild, including epiphyte fauna, scavengers, ants, and unknown taxa, which mainly use plants as temporary rests or habitats, decreased. Because the abundance of prey (herbivores and tourists) declined, the per-plot abundance of the predator guild, including parasitoids, also decreased. Thus, the negative effect of deer browsing cascaded from understory vegetation to higher trophic levels on a per-plot scale. In the plants preferred by deer, however, browsing increased the number of twigs and leaves per unit plant volume, which represents the structural complexity of plants and thus is an index of habitat quality for arthropods. At the per-unit-plant-volume scale, the abundances of the herbivore and tourist guilds increased, followed by a subsequent increment in the abundance of the predator guild. In the present thinned plantation, deer browsing improved the habitat quality (per unit plant volume), although it reduced the quantity of habitat (per plot). Thus, deer browsing had a positive cascading effect on the abundance of arthropod communities at the unit-plant-volume scale, but the negative effect at the plot scale outweighed this positive effect.	[Katagiri, Nana; Hijii, Naoki] Nagoya Univ, Lab Forest Protect, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Katagiri, N (reprint author), Nagoya Univ, Lab Forest Protect, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	katagiri.nana@j.mbox.nagoya-u.ac.jp					Halaj J, 2000, OIKOS, V90, P139, DOI 10.1034/j.1600-0706.2000.900114.x; Roininen H, 1997, OIKOS, V80, P481, DOI 10.2307/3546621; Seiwa K, 2012, FOREST ECOL MANAG, V269, P177, DOI 10.1016/j.foreco.2011.12.014; Pinzon J, 2011, ENVIRON ENTOMOL, V40, P797, DOI 10.1603/EN11081; Rooney TP, 2001, FORESTRY, V74, P201, DOI 10.1093/forestry/74.3.201; Stewart AJA, 2001, FORESTRY, V74, P259, DOI 10.1093/forestry/74.3.259; Lind EM, 2012, ENVIRON ENTOMOL, V41, P1409, DOI 10.1603/EN12094; Takatsuki S, 2009, BIOL CONSERV, V142, P1922, DOI 10.1016/j.biocon.2009.02.011; Naef-Daenzer L, 2000, J AVIAN BIOL, V31, P206, DOI 10.1034/j.1600-048X.2000.310212.x; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Takada M, 2008, ENVIRON ENTOMOL, V37, P938, DOI 10.1603/0046-225X(2008)37[938:CROWST]2.0.CO;2; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Martin JL, 2010, BIOL INVASIONS, V12, P353, DOI 10.1007/s10530-009-9628-8; Speed JDM, 2013, FOREST ECOL MANAG, V289, P289, DOI 10.1016/j.foreco.2012.10.051; Wardle DA, 2001, ECOL MONOGR, V71, P587, DOI 10.1890/0012-9615(2001)071[0587:IBMINZ]2.0.CO;2; Horsley SB, 2003, ECOL APPL, V13, P98, DOI 10.1890/1051-0761(2003)013[0098:WTDIOT]2.0.CO;2; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Allombert S, 2005, CONSERV BIOL, V19, P1917, DOI 10.1111/j.1523-1739.2005.00280.x; MORAN VC, 1982, J ANIM ECOL, V51, P289, DOI 10.2307/4325; Sayer J, 2004, FOREST ECOL MANAG, V201, P3, DOI 10.1016/j.foreco.2004.06.008; Gomez Jose M., 2007, P104, DOI 10.1017/CBO9780511542701.006; Hartley MJ, 2002, FOREST ECOL MANAG, V155, P81, DOI 10.1016/S0378-1127(01)00549-7; Nyffeler M, 1999, J ARACHNOL, V27, P317; Suzuki M, 2008, ECOL RES, V23, P151, DOI 10.1007/s11284-007-0348-1; DANELL K, 1985, OIKOS, V44, P75, DOI 10.2307/3544046; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; BAINES D, 1994, J APPL ECOL, V31, P776, DOI 10.2307/2404167; Bernays EA, 1994, HOST PLANT SELECTION; Brousseau PM, 2013, BIODIVERS CONSERV, V22, P77, DOI 10.1007/s10531-012-0400-5; FAO, 2010, 163 FAO; Faraway J.J., 2005, EXTENDING LINEAR MOD; Fujiki D, 2010, J FOREST RES-JPN, V15, P140, DOI 10.1007/s10310-009-0172-2; Fukumoto H, 2013, B MIE PREF FOR RES I, V5, P13; HIJII N, 1986, Ecological Research, V1, P97, DOI 10.1007/BF02347014; Japan Forestry Agency, 2013, WHIT PAP FOR FOR; Koike S, 2014, J ZOOL, V293, P227, DOI 10.1111/jzo.12138; Kumar S, 2006, J FOREST RES-JPN, V11, P337, DOI 10.1007/s10310-006-0216-9; Lessard JP, 2012, BASIC APPL ECOL, V13, P59, DOI 10.1016/j.baae.2011.11.001; Maas-Hebner KG, 2005, FOREST ECOL MANAG, V208, P331, DOI 10.1016/j.foreco.2005.01.013; Maleque MA, 2007, J FOREST RES-JPN, V12, P14, DOI 10.1007/s10310-006-0243-6; Melis C, 2007, BIODIVERS CONSERV, V16, P1321, DOI 10.1007/s10531-005-6230-y; Miyashita T, 2004, ECOSCIENCE, V11, P74; Mizutani Mizuki, 2002, Ornithological Science, V1, P71, DOI 10.2326/osj.1.71; R Development Core Team, 2014, R LANG ENV STAT COMP; Shimada H, 2010, B MIE PREFECT FOR RE, V2, P43; Sullivan TP, 2007, FOREST ECOL MANAG, V240, P32, DOI 10.1016/j.foreco.2006.11.020; Suominen O, 1999, OIKOS, V84, P215, DOI 10.2307/3546716; Suominen O, 2003, ECOGRAPHY, V26, P503, DOI 10.1034/j.1600-0587.2003.03445.x; Taki H, 2010, FOREST ECOL MANAG, V259, P607, DOI 10.1016/j.foreco.2009.11.019; Wheatall L, 2013, CONSERV BIOL, V27, P1107, DOI 10.1111/cobi.12077; WHITHAM TG, 1985, SCIENCE, V228, P1089, DOI 10.1126/science.228.4703.1089; Yokoyama S, 1998, FOREST ECOL MANAG, V103, P49, DOI 10.1016/S0378-1127(97)00175-8	53	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	JUN	2015	20	3					347	356		10.1007/s10310-015-0486-1		10	Forestry	Forestry	CH8OO	WOS:000354295900005		
J	Hirobe, M; Miyamoto, S; Sakamoto, K; Kondo, J; Otoda, T; Akaji, Y; Yamanaka, N				Hirobe, Muneto; Miyamoto, Sho; Sakamoto, Keiji; Kondo, Junji; Otoda, Takashi; Akaji, Yasuaki; Yamanaka, Norikazu			The spatial distributions of understory trees in relation to dwarf bamboo cover in a cool-temperate deciduous broadleaf forest in Japan	JOURNAL OF FOREST RESEARCH			English	Article						Dwarf bamboo; SADIE; Spatial associations; Spatial distributions; Understory trees	NORTHERN JAPAN; COUNT DATA; BEECH; REGENERATION; DYNAMICS; DISTURBANCES	Dwarf bamboo is a major understory vegetation in Japanese forests, and is recognized to be an ecological filter for the seedlings of overstory tree species. However, the effects of dwarf bamboo cover on the entire understory tree community, including shrubs, have not been fully assessed. Using spatial analysis by distance indices (SADIE), we analyzed the spatial distributions of, and the spatial associations between, Sasa palmata cover and understory trees (diameter at breast height < 2 cm, height a parts per thousand yen50 cm) in a cool-temperate deciduous broadleaf forest dominated by Fagus crenata. In a 20 m x 240 m area, we found 49 total species, among 11,686 stems. Cephalotaxus harringtonia var. nana, plus Lindera umbellata and F. crenata stems accounted for about 50 % of the overall total. The SADIE analysis based on 5 m x 5 m quadrats demonstrated that most species, among the 20 tree species we examined, showed significantly aggregated distributions (P < 0.05) and/or significant spatial dissociations (P < 0.05) with S. palmata cover. However, for C. harringtonia var. nana, L. umbellata, Meliosma tenuis, and Ligustrum tschonoskii, their spatial distributions were independent, or significantly associated (P < 0.05) with S. palmata cover. Our results indicates that dwarf bamboo acts as an ecological filter, not only for the seedlings of overstory tree species but also for other understory trees, in the cool-temperate deciduous broadleaf forest.	[Hirobe, Muneto; Kondo, Junji; Otoda, Takashi] Okayama Univ, Grad Sch Environm & Life Sci, Lab Forest Ecol, Okayama 7008530, Japan; [Miyamoto, Sho] Okayama Univ, Fac Agr, Okayama 7008530, Japan; [Sakamoto, Keiji; Akaji, Yasuaki] Okayama Univ, Lab Physiol Plant Ecol, Grad Sch Environm & Life Sci, Okayama 7008530, Japan; [Yamanaka, Norikazu] Tottori Univ, Arid Land Res Ctr, Tottori 680, Japan	Hirobe, M (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, Lab Forest Ecol, Okayama 7008530, Japan.	mhirobe@okayama-u.ac.jp			Yakumo Foundation for Environmental Science	We wish to thank the members of the Laboratory of Forest Ecology and of the Laboratory of Physiological Plant Ecology, Okayama University, for their help in the field. Dr. J. Sano and the staff of University Forest at Hiruzen, Field Science Center, Tottori University supported our activity in the field. Coordinating editor and two anonymous reviewers improved this paper substantially. This study was partly financed by a grant from The Yakumo Foundation for Environmental Science (2007).	Abe M, 2002, J VEG SCI, V13, P565, DOI 10.1658/1100-9233(2002)013[0565:TEOSAC]2.0.CO;2; Akaji Y, 2013, ECOSCIENCE, V20, P339, DOI 10.2980/20-4-3640; Perry JN, 2002, ECOSCIENCE, V9, P133; Perry JN, 1999, ECOL LETT, V2, P106, DOI 10.1046/j.1461-0248.1999.22057.x; Dolezal J, 2009, COMMUNITY ECOL, V10, P225, DOI 10.1556/ComEc.10.2009.2.13; Hiura T, 1996, CAN J FOREST RES, V26, P289, DOI 10.1139/x26-032; Hukusima Tukasa, 1995, Japanese Journal of Ecology (Sendai), V45, P79; Ito H, 2007, ECOL RES, V22, P706, DOI 10.1007/s11284-006-0066-0; Kubo T, 1998, ECOL MODEL, V111, P223, DOI 10.1016/S0304-3800(98)00115-X; NAKASHIZUKA T, 1987, VEGETATIO, V69, P169, DOI 10.1007/BF00038698; NAKASHIZUKA T, 1988, Ecological Research, V3, P21, DOI 10.1007/BF02348692; Shidei T, 1974, FLORA VEGETATION JAP, P87; Soil Survey Staff, 2010, KEYS SOIL TAX; Torimaru T, 2009, J VEG SCI, V20, P944, DOI 10.1111/j.1654-1103.2009.01099.x; Umeki K, 1999, J VEG SCI, V10, P815, DOI 10.2307/3237306; Yamamoto S, 1995, J VEG SCI, V6, P875, DOI 10.2307/3236402; Yonekura K, 2003, BG PLANTS	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	JUN	2015	20	3					357	362		10.1007/s10310-015-0480-7		6	Forestry	Forestry	CH8OO	WOS:000354295900006		
J	Iwaizumi, MG; Aizawa, M; Watanabe, A; Goto, S				Iwaizumi, Masakazu G.; Aizawa, Mineaki; Watanabe, Atsushi; Goto, Susumu			Highly polymorphic nuclear microsatellite markers reveal detailed patterns of genetic variation in natural populations of Yezo spruce in Hokkaido (vol 20, pg 301, 2015)	JOURNAL OF FOREST RESEARCH			English	Correction									[Iwaizumi, Masakazu G.] Forestry & Forest Prod Res Inst, Kansai Reg Breeding Off, Forest Tree Breeding Ctr, Katsuta, Okayama 7094335, Japan; [Aizawa, Mineaki] Utsunomiya Univ, Dept Forest Sci, Fac Agr, Utsunomiya, Tochigi 3218505, Japan; [Watanabe, Atsushi] Kyushu Univ, Dept Forest Environm Sci, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan; [Goto, Susumu] Univ Tokyo, Grad Sch Agr & Life Sci, Univ Forests, Div Res, Tokyo 1138657, Japan	Iwaizumi, MG (reprint author), Forestry & Forest Prod Res Inst, Kansai Reg Breeding Off, Forest Tree Breeding Ctr, 1043 Uetsukinaka, Katsuta, Okayama 7094335, Japan.	ganchan@affrc.go.jp					IWAIZUMI MG, 2015, J FOR RES, V20, P301, DOI DOI 10.1007/S10310-014-0477-7	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	JUN	2015	20	3					364	364		10.1007/s10310-015-0489-y		1	Forestry	Forestry	CH8OO	WOS:000354295900008		
J	Ohata, K; Nonaka, K; Ban, S; Matsuhashi, N				Ohata, K.; Nonaka, K.; Ban, S.; Matsuhashi, N.			Gastroenterology: Simultaneous practice of narrow band imaging and confocal laser endomicroscopy for a case of early duodenal cancer	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Ohata, K.; Nonaka, K.; Matsuhashi, N.] NTT Med Ctr Tokyo, Dept Gastroenterol, Tokyo, Japan; [Ban, S.] Saiseikai Kawaguchi Gen Hosp, Dept Pathol, Kawaguchi, Japan	Ohata, K (reprint author), NTT Med Ctr Tokyo, Dept Gastroenterol, Tokyo, Japan.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JUN	2015	30	6					966	966		10.1111/jgh.12895		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH4VZ	WOS:000354032700002		
J	Kochi, S; Kurahara, K; Matsumoto, T; Kawasaki, K; Oshiro, Y; Tokumoto, M; Saka, A; Fuchigami, T				Kochi, S.; Kurahara, K.; Matsumoto, T.; Kawasaki, K.; Oshiro, Y.; Tokumoto, M.; Saka, A.; Fuchigami, T.			Gastrointestinal: Endoscopic findings of collagenous gastroenterocolitis with protein-losing enteropathy	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Kochi, S.; Kurahara, K.; Kawasaki, K.; Tokumoto, M.; Saka, A.; Fuchigami, T.] Matsuyama Red Cross Hosp, Div Gastroenterol, Matsuyama, Ehime, Japan; [Oshiro, Y.] Matsuyama Red Cross Hosp, Div Pathol, Matsuyama, Ehime, Japan; [Matsumoto, T.] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan	Kochi, S (reprint author), Matsuyama Red Cross Hosp, Div Gastroenterol, Matsuyama, Ehime, Japan.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JUN	2015	30	6					967	967		10.1111/jgh.12896		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH4VZ	WOS:000354032700003		
J	Yoshizawa, N; Fuke, H; Hashimoto, A; Shimizu, A; Sugimoto, K; Shiraki, K; Isaji, S				Yoshizawa, N.; Fuke, H.; Hashimoto, A.; Shimizu, A.; Sugimoto, K.; Shiraki, K.; Isaji, S.			Hepatology: Atypical images for multiple focal nodular hyperplasia	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Yoshizawa, N.; Fuke, H.; Hashimoto, A.; Shimizu, A.] Saiseikai Matsusaka Gen Hosp, Internal Med, Matsusaka, Japan; [Sugimoto, K.; Shiraki, K.] Mie Univ, Sch Med, Dept Internal Med 1, Tsu, Mie, Japan; [Isaji, S.] Mie Univ, Sch Med, Dept Surg 1, Tsu, Mie, Japan	Yoshizawa, N (reprint author), Saiseikai Matsusaka Gen Hosp, Internal Med, Matsusaka, Japan.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JUN	2015	30	6					969	969		10.1111/jgh.12870		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH4VZ	WOS:000354032700005		
J	Sekimoto, T; Maruyama, H; Kondo, T; Shimada, T; Kiyono, S; Yokosuka, O				Sekimoto, Tadashi; Maruyama, Hitoshi; Kondo, Takayuki; Shimada, Taro; Kiyono, Soichiro; Yokosuka, Osamu			Potential stagnation in the splanchnic hemodynamics demonstrated by the dynamic microbubbles in chronic liver disease	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						cirrhosis; portal hemodynamics; portal hypertension	SUPERIOR MESENTERIC-ARTERY; CONTRAST-ENHANCED ULTRASOUND; CHRONIC HEPATITIS-C; PORTAL-HYPERTENSION; CIRRHOTIC RATS; ECHO-DOPPLER; BLOOD-FLOW; HEALTHY-SUBJECTS; PULSED DOPPLER; CIRCULATION	Background and AimImpaired splanchnic hemodynamics are well-documented phenomena in cirrhosis. However, comprehensive hemodynamic features from the superior mesenteric artery (SMA) to the superior mesenteric vein (SMV) via intestinal capillaries have not been studied. The aim was to examine splanchnic hemodynamics and their relationship with clinical presentations. MethodsContrast-enhanced ultrasound was performed for both the SMA and SMV under fasting conditions and postprandially following ingestion of a liquid diet. The microbubble traveling time (MTT) was determined as the difference between the contrast onset in the SMA and SMV, indicating the time required for microbubble transit through the splanchnic circulation. ResultsThere were 192 subjects for fasting conditions (81 cirrhosis, 72 chronic hepatitis, 39 healthy controls), and 74/192 for postprandial conditions (44 cirrhosis, 11 chronic hepatitis, 19 healthy controls). The MTT (fasting; postprandial) was significantly longer in cirrhosis (7.72.9s; 7.0 +/- 0.3s) than in controls (5.4 +/- 2.3s, P<0.001; 3.9 +/- 0.9s, P<0.001) and chronic hepatitis (6.3 +/- 2.5s, P=0.007; 5.1 +/- 1.4s, P=0.013). The MTT ratio (postprandial/fasting) showed disease-related changes: 0.75 +/- 0.20 in controls, 0.78 +/- 0.15 in chronic hepatitis, and 1.00 +/- 0.28 in cirrhosis (P=0.003, vs controls; P=0.036, vs chronic hepatitis). ConclusionsThe real-time observation of traveling microbubble on the sonogram revealed a prolonged transit with a weak postprandial response in the intestinal circulation, suggesting better understanding of underlying pathophysiology of splanchnic hemodynamics in chronic liver disease.	[Sekimoto, Tadashi; Maruyama, Hitoshi; Kondo, Takayuki; Shimada, Taro; Kiyono, Soichiro; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba 2608670, Japan	Maruyama, H (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	maru-cib@umin.ac.jp					Henriksen JH, 1998, J HEPATOL, V29, P328, DOI 10.1016/S0168-8278(98)80022-6; Orlacchio A, 2011, ULTRASOUND MED BIOL, V37, P1, DOI 10.1016/j.ultrasmedbio.2010.10.012; MURRAY JF, 1958, AM J MED, V24, P358, DOI 10.1016/0002-9343(58)90322-X; ZWIEBEL WJ, 1995, RADIOLOGY, V194, P807; Maruyama H, 2009, LIVER INT, V29, P708, DOI 10.1111/j.1478-3231.2008.01875.x; VALLANCE P, 1991, LANCET, V337, P776, DOI 10.1016/0140-6736(91)91384-7; Breitman DR, 1997, HEPATOLOGY, V26, P1380; desVries PJ, 1994, J HEPATOL, V21, P966; Ezkurdia N, 2012, LIVER INT, V32, P1295, DOI 10.1111/j.1478-3231.2012.02762.x; Gaiani S, 2003, ULTRASOUND MED BIOL, V29, P643, DOI 10.1016/S0301-5629(02)00793-7; GAIANI S, 1989, HEPATOLOGY, V9, P815, DOI 10.1002/hep.1840090604; Iwao T, 1997, J HEPATOL, V27, P817, DOI 10.1016/S0168-8278(97)80318-2; Ludwig D, 1998, J HEPATOL, V28, P631, DOI 10.1016/S0168-8278(98)80287-0; OHNISHI K, 1985, RADIOLOGY, V154, P495; OHNISHI K, 1987, AM J GASTROENTEROL, V82, P507; OKAZAKI K, 1986, SCAND J GASTROENTERO, V21, P1029, DOI 10.3109/00365528608996416; PAK JM, 1993, HEPATOLOGY, V18, P1175; Parikh S, 2009, DIGEST DIS SCI, V54, P1178, DOI 10.1007/s10620-008-0491-8; Piscaglia F, 1998, AM J GASTROENTEROL, V93, P1925; PUGLIESE D, 1987, AM J GASTROENTEROL, V82, P1052; Ridolfi F, 2007, DIGEST LIVER DIS, V39, P929, DOI 10.1016/j.dld.2007.06.006; SABBA C, 1991, HEPATOLOGY, V13, P714, DOI 10.1016/0270-9139(91)92569-T; SATO S, 1987, RADIOLOGY, V164, P347; Taourel P, 1998, J CLIN ULTRASOUND, V26, P131, DOI 10.1002/(SICI)1097-0096(199803/04)26:3<131::AID-JCU4>3.0.CO;2-N; TSUNODA T, 1988, AM J GASTROENTEROL, V83, P398; Yang YY, 2005, J HEPATOL, V42, P652, DOI 10.1016/j.jhep.2004.11.044	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JUN	2015	30	6					1001	1008		10.1111/jgh.12875		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH4VZ	WOS:000354032700011		
J	Tomeno, W; Kawashima, K; Yoneda, M; Saito, S; Ogawa, Y; Honda, Y; Kessoku, T; Imajo, K; Mawatari, H; Fujita, K; Saito, S; Hirayasu, Y; Nakajima, A				Tomeno, Wataru; Kawashima, Keigo; Yoneda, Masato; Saito, Satoru; Ogawa, Yuji; Honda, Yasushi; Kessoku, Takaomi; Imajo, Kento; Mawatari, Hironori; Fujita, Koji; Saito, Satoru; Hirayasu, Yoshio; Nakajima, Atsushi			Non-alcoholic fatty liver disease comorbid with major depressive disorder: The pathological features and poor therapeutic efficacy	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						major depressive disorder; non-alcoholic fatty liver disease; steatohepatitis	MOOD DISORDERS; STEATOHEPATITIS; HEALTH; CARE; PREVALENCE; MANAGEMENT; OUTCOMES; IMPACT	Background and AimMajor depressive disorder (MDD) is an important public health problem, and it is often comorbid with many chronic diseases. The purpose of this study was to identify the clinical features of non-alcoholic fatty liver disease (NAFLD) patients comorbid with MDD and to investigate the influence of MDD on the effect of treatment in patients with NAFLD. MethodsA total of 258 patients with biopsy-proven NAFLD were included. MDD was diagnosed according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision. The patients were followed up for 48 weeks under standard care for NAFLD, which consisted mainly of lifestyle modification. ResultsThere were 32 patients comorbid with MDD. They were characterized by more severe histological steatosis and higher NAFLD activity score, and also significantly higher levels of serum aminotransferase, -glutamyl transpeptidase and ferritin, than age-and-sex-matched NAFLD patients without MDD. Moreover, NAFLD patients with MDD showed poor response to the standard care for NAFLD, in body weight loss and in other parameters. Particularly, NAFLD patients with unstable MDD (not in full/partial remission) showed severe resistance to the treatment. ConclusionThis is the first study to demonstrate the clinical features and response to therapy of NAFLD patients comorbid with MDD. The comorbid state of MDD was associated with more severe histological liver steatosis and worse treatment outcomes in patients with NAFLD. Further investigations are required to develop new lifestyle modification programs that enable NAFLD patients with MDD to achieve the treatment goal.	[Tomeno, Wataru; Kawashima, Keigo; Yoneda, Masato; Ogawa, Yuji; Honda, Yasushi; Kessoku, Takaomi; Imajo, Kento; Mawatari, Hironori; Fujita, Koji; Saito, Satoru; Nakajima, Atsushi] Yokohama City Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Yokohama, Kanagawa 2360004, Japan; [Saito, Satoru; Hirayasu, Yoshio] Yokohama City Univ, Grad Sch Med, Dept Psychiat, Yokohama, Kanagawa 2360004, Japan; [Kawashima, Keigo] Nagoya City Univ, Grad Sch Med Sci, Dept Virol & Liver Unit, Nagoya, Aichi, Japan; [Yoneda, Masato] Univ Miami, Miller Sch Med, Schiff Ctr Liver Dis, Miami, FL 33136 USA	Nakajima, A (reprint author), Yokohama City Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, 3-9 Fuku Ura, Yokohama, Kanagawa 2360004, Japan.	nakajima-tky@umin.ac.jp			Japan Society for Promotion of Science	This study was funded in part by Young Scientists (B) from Japan Society for Promotion of Science to Y.M.	American Psychiatric Association [APA], 2000, DIAGN STAT MAN MENT; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1056/NEJMra011775; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Williams JW, 2004, ANN INTERN MED, V140, P1015; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Kessler RC, 2007, ANNU REV CLIN PSYCHO, V3, P137, DOI 10.1146/annurev.clinpsy.3.022806.091444; Liou I, 2006, J CLIN GASTROENTEROL, V40, pS11; Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464; Stewart KE, 2015, LIVER INT, V35, P936, DOI 10.1111/liv.12483; Kessler RC, 2006, AM J PSYCHIAT, V163, P1561, DOI 10.1176/appi.ajp.163.9.1561; Katon WJ, 2008, DIABETES CARE, V31, P1155, DOI 10.2337/dc08-0032; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Weinstein AA, 2011, PSYCHOSOMATICS, V52, P127, DOI 10.1016/j.psym.2010.12.019; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; Katon W, 2002, J PSYCHOSOM RES, V53, P859, DOI 10.1016/S0022-3999(02)00313-6; Tomeno W, 2013, EXPERT OPIN EMERG DR, V18, P279, DOI 10.1517/14728214.2013.811232; Wang PS, 2003, INT J METH PSYCH RES, V12, P22, DOI 10.1002/mpr.139; desGroot M, 2001, PSYCHOSOM MED, V63, P619; Iwasa M, 2010, HEPATOL RES, V40, P1188, DOI 10.1111/j.1872-034X.2010.00724.x; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Katz IR, 1996, AM J GERIAT PSYCHIAT, V4, P1; Mori S, 2004, J GASTROENTEROL, V39, P391, DOI 10.1007/s00535-003-1308-3; Richardson Lisa K, 2008, Diabetes Care, V31, P880, DOI 10.2337/dc07-2215; Sanyal A. J., 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Youssef NA, 2013, LIVER INT, V33, P1362	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JUN	2015	30	6					1009	1014		10.1111/jgh.12897		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH4VZ	WOS:000354032700012		
J	Tang, WP; Akahoshi, T; Piao, JS; Narahara, S; Murata, M; Kawano, T; Hamano, N; Ikeda, T; Hashizume, M				Tang, Wei-Ping; Akahoshi, Tomohiko; Piao, Jing-Shu; Narahara, Sayoko; Murata, Masaharu; Kawano, Takahito; Hamano, Nobuhito; Ikeda, Tetsuo; Hashizume, Makoto			Basic fibroblast growth factor-treated adipose tissue-derived mesenchymal stem cell infusion to ameliorate liver cirrhosis via paracrine hepatocyte growth factor	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						ADSCs; bFGF; HGF; liver cirrhosis; RNA interference	HEPATIC STEM/PROGENITOR CELLS; BONE-MARROW; CLINICAL-IMPLICATIONS; STROMAL CELLS; APOPTOSIS; DISEASE; TRANSPLANTATION; MYOFIBROBLASTS; FIBROSIS; MICE	Background and AimRecent studies show that adipose tissue-derived mesenchymal stem cells have potential clinical applications. However, the mechanism has not been fully elucidated yet. Here, we investigated the effect of basic fibroblast growth factor-treated adipose tissue-derived mesenchymal stem cells infusion on a liver fibrosis rat model and elucidated the underlying mechanism. MethodsAdipose tissue-derived mesenchymal stem cells were infused into carbon tetrachloride-induced hepatic fibrosis rats through caudal vein. Liver functions and pathological changes were assessed. A co-culture model was used to clarify the potential mechanism. ResultsBasic fibroblast growth factor treatment markedly improved the proliferation, differentiation, and hepatocyte growth factor expression ability of adipose tissue-derived mesenchymal stem cells. Although adipose tissue-derived mesenchymal stem cells infusion alone slightly ameliorated liver functions and suppressed fibrosis progression, basic fibroblast growth factor-treatment significantly enhanced the therapeutic effect in association with elevated hepatocyte growth factor expression. Moreover, double immunofluorescence staining confirmed that the infused cells located in fibrosis area. Furthermore, co-culture with adipose tissue-derived mesenchymal stem cell led to induction of hepatic stellate cell apoptosis and enhanced hepatocyte proliferation. However, these effects were significantly weakened by knockdown of hepatocyte growth factor. Mechanism investigation revealed that co-culture with adipose tissue-derived mesenchymal stem cells activated c-jun N-terminal kinase-p53 signaling in hepatic stellate cell and promoted apoptosis. ConclusionsBasic fibroblast growth factor treatment enhanced the therapeutic effect of adipose tissue-derived mesenchymal stem cells, and secretion of hepatocyte growth factor from adipose tissue-derived mesenchymal stem cells plays a critical role in amelioration of liver injury and regression of fibrosis.	[Tang, Wei-Ping; Akahoshi, Tomohiko; Piao, Jing-Shu; Narahara, Sayoko; Murata, Masaharu; Kawano, Takahito; Hamano, Nobuhito; Hashizume, Makoto] Kyushu Univ, Fac Med, Dept Disaster & Emergency Med, Fukuoka 8128582, Japan; [Akahoshi, Tomohiko; Ikeda, Tetsuo] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan	Akahoshi, T (reprint author), Kyushu Univ, Fac Med, Dept Disaster & Emergency Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tomohiko@surg2.med.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKENHI) [25462096]	This work was financially supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKENHI no. 25462096).	McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Modi AA, 2010, HEPATOLOGY, V51, P201, DOI 10.1002/hep.23279; Lin CL, 2013, J GASTROEN HEPATOL, V28, P10, DOI 10.1111/jgh.12010; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Vinken M, 2014, ARCH TOXICOL, V88, P199, DOI 10.1007/s00204-013-1123-4; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589; Dmitrieva RI, 2012, CELL CYCLE, V11, P377, DOI 10.4161/cc.11.2.18858; Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026; Kallis YN, 2007, GUT, V56, P716, DOI 10.1136/gut.2006.098442; Hikita H, 2011, HEPATOLOGY, V54, P240, DOI 10.1002/hep.24305; Banas A, 2008, STEM CELLS, V26, P2705, DOI 10.1634/stemcells.2008-0034; Banas A, 2009, J GASTROEN HEPATOL, V24, P70, DOI 10.1111/j.1440-1746.2008.05496.x; Xu LM, 2014, J GASTROEN HEPATOL, V29, P1620, DOI 10.1111/jgh.12653; Thabut D, 2010, J HEPATOL, V53, P976, DOI 10.1016/j.jhep.2010.07.004; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Flaquer M, 2012, DIABETOLOGIA, V55, P2059, DOI 10.1007/s00125-012-2535-z; Trim N, 2000, AM J PATHOL, V156, P1235, DOI 10.1016/S0002-9440(10)64994-2; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Watson MR, 2008, J HEPATOL, V48, P589, DOI 10.1016/j.jhep.2007.12.019; Zaragosi LE, 2006, STEM CELLS, V24, P2412, DOI 10.1634/stemcells.2006-0006; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Conner EA, 1999, CARCINOGENESIS, V20, P583, DOI 10.1093/carcin/20.4.583; Estes BT, 2010, NAT PROTOC, V1, P1559; Gupta K, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt167; Kakinuma S, 2009, J GASTROENTEROL, V44, P167, DOI 10.1007/s00535-008-2297-z; Kim WH, 2005, AM J PATHOL, V166, P1017, DOI 10.1016/S0002-9440(10)62323-1; Kiyohashi K, 2013, HEPATOLOGY, V57, P2502, DOI 10.1002/hep.26293; Kodama Takahiro, 2010, Gastroenterology, V138, P2487, DOI 10.1053/j.gastro.2010.02.054; Kwon Y, 2015, ONCOGENE, V34, P144, DOI 10.1038/onc.2013.539; Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x; Puissant Bénédicte, 2005, Br J Haematol, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; SHIOTA G, 1995, HEPATOLOGY, V21, P106, DOI 10.1016/0270-9139(95)90416-6; Trim JE, 2000, J BIOL CHEM, V275, P6657, DOI 10.1074/jbc.275.9.6657; Zhu CZ, 2014, J GASTROEN HEPATOL, V29, P1102, DOI 10.1111/jgh.12468	37	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JUN	2015	30	6					1065	1074		10.1111/jgh.12893		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH4VZ	WOS:000354032700019		
J	Murakawa, M; Asahina, Y; Nakagawa, M; Sakamoto, N; Nitta, S; Kusano-Kitazume, A; Watanabe, T; Kawai-Kitahata, F; Otani, S; Taniguchi, M; Goto, F; Nishimura-Sakurai, Y; Itsui, Y; Azuma, S; Kakinuma, S; Watanabe, M				Murakawa, Miyako; Asahina, Yasuhiro; Nakagawa, Mina; Sakamoto, Naoya; Nitta, Sayuri; Kusano-Kitazume, Akiko; Watanabe, Takako; Kawai-Kitahata, Fukiko; Otani, Satoshi; Taniguchi, Miki; Goto, Fumio; Nishimura-Sakurai, Yuki; Itsui, Yasuhiro; Azuma, Seishin; Kakinuma, Sei; Watanabe, Mamoru			Impaired induction of interleukin 28B and expression of interferon lambda 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						hepatitis C virus; NS3 protease inhibitor; pegylated interferon; peripheral blood mononuclear cells; type III interferon	GENOME-WIDE ASSOCIATION; GENETIC-VARIATION; ANTIVIRAL RESPONSE; VIRUS-REPLICATION; INNATE IMMUNITY; IFN-LAMBDA; III IFN; IL28B; INFECTION; SUPPRESSION	Background and AimInterferon (IFN) plays an important role in innate immunity to protect against hepatitis C viral (HCV) infection. Single nucleotide polymorphisms (SNPs) near IL28B (IFN3) are strongly associated with treatment response to IFN therapy in chronic hepatitis C (CHC) patients. Recently, IFN4 related to IL28B-unfavorable allele was discovered. However, the impact of IFNs on CHC is unknown. We aimed to investigate the mechanism underlying responsiveness to IFN-based therapy in CHC associated with SNPs near IL28B. MethodsWe evaluated the basal mRNA levels and ex-vivo induction of IFN expression including IFN4 in peripheral blood mononuclear cells (PBMCs) from 50 CHC patients treated with pegylated-IFN/RBV. Furthermore, we investigated the effect of IFN4 on induction of IL28B in vitro. ResultsWhen PBMCs were stimulated with IFN and polyinosinic-polycytidylic acid, IL28B induction was significantly lower in patients with IL28B-unfavorable genotype (rs12979860 CT/TT) than those with IL28B-favorable genotype (rs12979860 CC; P=0.049). IL28B induction was lower in nonresponders than in relapsers (P=0.04), and it was also lower in nonsustained virological responder patients for triple therapy including NS3 protease inhibitors. IFN4mRNA was detected in 12 of 26 patients with IL28B-unfavorable SNP, and IFN4 expression was associated with lower IL28B induction in patients with IL28B-unfavorable genotype (P=0.04) and nonresponse to IFN therapy (P=0.003). Overexpression of IFN4 suppressed IL28B induction and promoter activation. ConclusionsImpaired induction of IL28B, related to IFN4 expression in PBMCs of IL28B-unfavorable patients, is associated with nonresponse to IFN-based therapy for hepatitis C viral infection.	[Murakawa, Miyako; Asahina, Yasuhiro; Nakagawa, Mina; Nitta, Sayuri; Kusano-Kitazume, Akiko; Watanabe, Takako; Kawai-Kitahata, Fukiko; Otani, Satoshi; Taniguchi, Miki; Goto, Fumio; Nishimura-Sakurai, Yuki; Itsui, Yasuhiro; Azuma, Seishin; Kakinuma, Sei; Watanabe, Mamoru] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Tokyo 1138519, Japan; [Asahina, Yasuhiro; Kakinuma, Sei] Tokyo Med & Dent Univ, Dept Liver Dis Control, Tokyo 1138519, Japan; [Sakamoto, Naoya] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan	Asahina, Y (reprint author), Tokyo Med & Dent Univ, Dept Liver Dis Control, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	asahina.gast@tmd.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japanese Ministry of Welfare, Health, and Labor; Japan Society for the Promotion of Science; Japan Health Sciences Foundation	This study was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; the Japanese Ministry of Welfare, Health, and Labor; the Japan Society for the Promotion of Science; and the Japan Health Sciences Foundation.	Alter MJ, 1997, HEPATOLOGY S1, V26, p62S; Amanzada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084026; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Li MC, 2009, J LEUKOCYTE BIOL, V86, P23, DOI [10.1189/jlb.1208761, 10.1189/JLB.1208761]; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Osterlund PI, 2007, J IMMUNOL, V179, P3434; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Booth D, 2013, NAT GENET, V45, P119, DOI 10.1038/ng.2537; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Yoshio S, 2013, HEPATOLOGY, V57, P1705, DOI 10.1002/hep.26182; Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Nakagawa M, 2005, GASTROENTEROLOGY, V129, P1031, DOI 10.1053/j.gastro.2005.06.031; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474; Asahina Y, 2012, HEPATOLOGY, V55, P20, DOI 10.1002/hep.24623; Asahina Y, 2008, GASTROENTEROLOGY, V134, P1396, DOI 10.1053/j.gastro.2008.02.019; Asahina Yasuhiro, 2013, J Clin Transl Hepatol, V1, P39, DOI 10.14218/JCTH.2013.005XX; Dolganiuc A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044915; Forestier N, 2012, LIVER INT, V32, P44, DOI 10.1111/j.1478-3231.2011.02720.x; Kotenko SV, 2002, CYTOKINE GROWTH F R, V13, P223, DOI 10.1016/S1359-6101(02)00012-6; Lupberger Joachim, 2013, Hepatology, V58, P439, DOI 10.1002/hep.26443; Makowska Z, 2012, CYTOKINE, V59, P460, DOI 10.1016/j.cyto.2012.06.015; Murata K, 2014, J GASTROENTEROL, V49, P126, DOI 10.1007/s00535-013-0814-1; Sakamoto N, 2011, J MED VIROL, V83, P871, DOI 10.1002/jmv.22038; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Stone AEL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003316; Tasaka M, 2007, J GEN VIROL, V88, P3323, DOI 10.1099/vir.0.83056-0	35	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JUN	2015	30	6					1075	1084		10.1111/jgh.12902		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH4VZ	WOS:000354032700020		
J	Naitoh, I; Nakazawa, T; Hayashi, K; Miyabe, K; Shimizu, S; Kondo, H; Nishi, Y; Yoshida, M; Umemura, S; Hori, Y; Kato, A; Okumura, F; Sano, H; Ohara, H; Joh, T				Naitoh, Itaru; Nakazawa, Takahiro; Hayashi, Kazuki; Miyabe, Katsuyuki; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Yoshida, Michihiro; Umemura, Shuichiro; Hori, Yasuki; Kato, Akihisa; Okumura, Fumihiro; Sano, Hitoshi; Ohara, Hirotaka; Joh, Takashi			Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and IgG4-related sclerosing cholangitis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						cholangiogram; diverticulum-like outpouching; IgG4-related sclerosing cholangitis; intraductal ultrasonography; primary sclerosing cholangitis	AUTOIMMUNE PANCREATITIS; BILE-DUCT; CHOLANGIOGRAPHY; SPECTRUM	Background and AimComparisons of intraductal ultrasonography (IDUS) findings between primary sclerosing cholangitis (PSC) and IgG4-related sclerosing cholangitis (IgG4-SC) have not been elucidated. We aimed to clarify the differences in transpapillary IDUS findings between PSC and IgG4-SC. MethodsWe retrospectively compared transpapillary IDUS findings between 15 patients with PSC and 35 patients with IgG4-SC between 2004 and 2014. ResultsIDUS findings of circular-asymmetric wall thickness, irregular inner margin, diverticulum-like outpouching, unclear outer margin, heterogeneous internal echo, and disappearance of three layers were significantly higher in PSC than in IgG4-SC (P<0.001). Irregular inner margin, diverticulum-like outpouching, and disappearance of three layers were specific IDUS findings for PSC compared to IgG4-SC. Diverticulum-like outpouching on IDUS and endoscopic retrograde cholangiogram (ERC) was observed in 10 (67%) and five (33%) of 15 patients with PSC, respectively. However, based on IDUS and ERC, diverticulum-like outpouching was not observed in any patient with IgG4-SC. All five patients with diverticulum-like outpouching on ERC had diverticulum-like outpouching on IDUS, and five (50%) of 10 patients without diverticulum-like outpouching on ERC had diverticulum-like outpouching on IDUS. ConclusionsThe IDUS findings differed between PSC and IgG4-SC. Irregular inner margin, diverticulum-like outpouching, and disappearance of three layers are specific IDUS findings for PSC compared to IgG4-SC. IDUS is a more useful procedure than ERC for the early detection of diverticulum-like outpouching.	[Naitoh, Itaru; Nakazawa, Takahiro; Hayashi, Kazuki; Miyabe, Katsuyuki; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Yoshida, Michihiro; Umemura, Shuichiro; Hori, Yasuki; Kato, Akihisa; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi 4678601, Japan; [Ohara, Hirotaka] Nagoya City Univ, Grad Sch Med Sci, Dept Community Based Med Educ, Nagoya, Aichi 4678601, Japan; [Okumura, Fumihiro; Sano, Hitoshi] Gifu Prefectural Tajimi Hosp, Dept Gastroenterol, Tajimi, Japan	Nakazawa, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	tnakazaw@med.nagoya-cu.ac.jp			Ministry of Health Labor and Welfare, Japan	This work was supported by "Research on Measures for Intractable Diseases" Project: matching fund subsidy from Ministry of Health Labor and Welfare, Japan.	Scheuer PJ, 1998, MAYO CLIN PROC, V73, P179; Nakazawa T, 2005, PANCREAS, V30, P20; Ohara H, 2012, J HEPATO-BIL-PAN SCI, V19, P536, DOI 10.1007/s00534-012-0521-y; Hamano H, 2005, GASTROINTEST ENDOSC, V62, P152, DOI 10.1016/S0016-5107(05)00561-4; Naitoh I, 2011, J GASTROENTEROL, V46, P269, DOI 10.1007/s00535-010-0319-0; Matsubayashi H, 2014, J DIGEST DIS, V15, P394, DOI 10.1111/1751-2980.12149; Zen Y, 2004, AM J SURG PATHOL, V28, P1193, DOI 10.1097/01.pas.0000136449.37936.6c; Graham RPD, 2014, HUM PATHOL, V45, P1722, DOI 10.1016/j.humpath.2014.04.006; Zhang LZ, 2010, AM J SURG PATHOL, V34, P88, DOI 10.1097/PAS.0b013e3181c6c09a; Nakazawa T, 2004, GASTROINTEST ENDOSC, V60, P937, DOI 10.1016/S0016-5107(04)02229-1; Naitoh I, 2009, J GASTROENTEROL, V44, P1147, DOI 10.1007/s00535-009-0108-9; Hayashi K, 2007, HEPATO-GASTROENTEROL, V54, P2146; Kubota K, 2011, DIGEST ENDOSC, V23, P10, DOI 10.1111/j.1443-1661.2010.01039.x; Lindor KD, 2003, SCHIFFS DIS LIVER, P673; LUDWIG J, 1989, AM J SURG PATHOL, V13, P43; Matsubayashi H, 2014, J DIGEST DIS, V15, P578, DOI 10.1111/1751-2980.12176; Nakazawa T, 2006, PANCREAS, V32, P229, DOI 10.1097/01.mpa.0000202941.85955.07; Shimizu S, 2013, J GASTROEN HEPATOL, V28, P68, DOI 10.1111/j.1440-1746.2012.07283.x; Tamada K, 2001, ABDOM IMAGING, V26, P623, DOI 10.1007/s002610000208	19	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JUN	2015	30	6					1104	1109		10.1111/jgh.12894		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH4VZ	WOS:000354032700023		
J	Wakabayashi, I				Wakabayashi, I.			Light-to-moderate alcohol intake reduces lipid accumulation product and attenuates its relation to hypertension	JOURNAL OF HUMAN HYPERTENSION			English	Article							CORONARY-HEART-DISEASE; RISK-FACTOR; CARDIOVASCULAR RISK; DIABETES-MELLITUS; METAANALYSIS; CHOLESTEROL; OBESITY; MEN; TRIGLYCERIDE; ASSOCIATION	Lipid accumulation product (LAP), an index calculated by using triglyceride level and waist circumference, has been shown to predict hypertension, diabetes and cardiovascular disease. Alcohol is known to influence blood pressure and blood lipids. The aim of this study was to clarify the relationships among alcohol intake, LAP and hypertension. The subjects, middle-aged Japanese men (n = 21 572), were divided into non-, light (<22 g ethanol per day), moderate (>= 22 and <44 g ethanol per day) and heavy (. 44 g ethanol per day) drinkers. The relationships between alcohol intake and LAP and between LAP and hypertension were investigated. There were U-and J-shaped relationships between alcohol intake and LAP in subjects with and without hypertension, respectively. The adjusted odds ratios with their 95% confidence intervals for hypertension in subjects with vs subjects without high LAP were 3.04 (2.69-3.43, P<0.01), 2.32 (1.92-2.81, P<0.01), 2.10 (1.89-2.33, P<0.01) and 2.11 (1.87-2.38, P<0.01) in non-, light, moderate and heavy drinkers, respectively. Thus, the positive association between LAP and hypertension is weaker in drinkers than in nondrinkers. The results suggest that light-to-moderate alcohol drinking reduces LAP level in patients with hypertension and attenuates the relation of LAP to hypertension.	Hyogo Coll Med, Dept Environm & Prevent Med, Nishinomiya, Hyogo 6638501, Japan	Wakabayashi, I (reprint author), Hyogo Coll Med, Dept Environm & Prevent Med, Mukogawa Cho 1-1, Nishinomiya, Hyogo 6638501, Japan.	wakabaya@hyo-med.ac.jp					Yeomans MR, 2010, PHYSIOL BEHAV, V100, P82, DOI 10.1016/j.physbeh.2010.01.012; Taylor B, 2009, ADDICTION, V104, P1981, DOI 10.1111/j.1360-0443.2009.02694.x; McLaughlin T, 2003, ANN INTERN MED, V139, P802; Sumner AE, 2005, ARCH INTERN MED, V165, P1395, DOI 10.1001/archinte.165.12.1395; Sowers JR, 2003, AM J MED, V115, P37, DOI 10.1016/S0002-9343(03)00518-7; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Klop B, 2013, CURR OPIN LIPIDOL, V24, P321, DOI 10.1097/MOL.0b013e3283606845; [Anonymous], 2013, J HLTH WELFARE STAT, V60, P101; Kahn HS, 2006, DIABETES CARE, V29, P151, DOI 10.2337/diacare.29.01.06.dc05-1805; [Anonymous], 2005, J JPN SOC INT MED, V94, P794; Labreuche J, 2009, ATHEROSCLEROSIS, V203, P331, DOI 10.1016/j.atherosclerosis.2008.08.040; Ioachimescu AG, 2010, OBESITY, V18, P1836, DOI 10.1038/oby.2009.453; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; Suter PM, 2005, CRIT REV CL LAB SCI, V42, P197, DOI 10.1080/10408360590913542; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Bozorgmanesh M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-45; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; Ellison RC, 2004, AM HEART J, V147, P529, DOI 10.1016/j.ahj.2003.10.033; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Kahn Henry S, 2005, BMC Cardiovasc Disord, V5, P26, DOI 10.1186/1471-2261-5-26; Klatsky AL, 2003, J CARDIOVASC RISK, V10, P21, DOI 10.1097/01.hjr.0000051960.68260.79; Mostafa SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050931; Ronksley PE, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d671; Salem Raneem O, 2005, Am J Clin Pathol, V123 Suppl, pS96; SAVOLAINEN MJ, 1995, CURR OPIN LIPIDOL, V6, P243; Shimomura T, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-104; Van de Wiel A., 2012, INT J VASC MED, V2012, DOI DOI 10.1155/2012/862504; Wakabayashi I, 2014, J ATHEROSCLER THROMB, V21, P282; Wakabayashi I, 2014, METAB SYNDR RELAT D, V12, P70, DOI 10.1089/met.2013.0110; Wakabayashi I, 2013, ALCOHOL ALCOHOLISM, V48, P535, DOI 10.1093/alcalc/agt032; Wehr E, 2011, OBESITY, V19, P1873, DOI 10.1038/oby.2011.42	32	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9240	1476-5527		J HUM HYPERTENS	J. Hum. Hypertens.	JUN	2015	29	6					359	365		10.1038/jhh.2014.97		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CH5TM	WOS:000354098200005		
J	Fukunaga-Kalabis, M; Hristova, DM; Wang, JX; Li, L; Heppt, MV; Wei, Z; Gyurdieva, A; Webster, MR; Oka, M; Weeraratna, AT; Herlyn, M				Fukunaga-Kalabis, Mizuho; Hristova, Denitsa M.; Wang, Joshua X.; Li, Ling; Heppt, Markus V.; Wei, Zhi; Gyurdieva, Alexandra; Webster, Marie R.; Oka, Masahiro; Weeraratna, Ashani T.; Herlyn, Meenhard			UV-Induced Wnt7a in the Human Skin Microenvironment Specifies the Fate of Neural Crest-Like Cells via Suppression of Notch	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							MELANOCYTE STEM-CELLS; SIGNALING PATHWAYS; WNT/BETA-CATENIN; BETA-CATENIN; CANCER; NUMB; EXPRESSION; BINDING; DIFFERENTIATION; TRANSCRIPTION	Multipotent stem cells with neural crest-like properties have been identified in the dermis of human skin. These neural crest stem cell (NCSC)-like cells display self-renewal capacity and differentiate into neural crest derivatives, including epidermal pigment-producing melanocytes. NCSC-like cells share many properties with aggressive melanoma cells, such as high migratory capabilities and expression of the neural crest markers. However, little is known about which intrinsic or extrinsic signals determine the proliferation or differentiation of these neural crest-like stem cells. Here we show that, in NCSC-like cells, Notch signaling is highly activated, similar to melanoma cells. Inhibition of Notch signaling reduced the proliferation of NCSC-like cells, induced cell death, and downregulated noncanonical Wnt5a, suggesting that the Notch pathway contributes to the maintenance and motility of these stem cells. In three-dimensional skin reconstructs, canonical Wnt signaling promoted the differentiation of NCSC-like cells into melanocytes. This differentiation was triggered by the endogenous Notch inhibitor Numb, which is upregulated in the stem cells by Wnt7a derived from UV-irradiated keratinocytes. Together, these data reveal a cross talk between the two conserved developmental pathways in postnatal human skin, and highlight the role of the skin microenvironment in specifying the fate of stem cells.	[Fukunaga-Kalabis, Mizuho; Hristova, Denitsa M.; Wang, Joshua X.; Li, Ling; Heppt, Markus V.; Gyurdieva, Alexandra; Webster, Marie R.; Weeraratna, Ashani T.; Herlyn, Meenhard] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Heppt, Markus V.] Univ Munich, Dept Dermatol & Allergol, Munich, Germany; [Wei, Zhi] New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA; [Oka, Masahiro] Kobe Univ, Grad Sch Med, Dept Internal Related, Div Dermatol, Kobe, Hyogo 657, Japan	Fukunaga-Kalabis, M (reprint author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	mkalabis@wistar.org; herlynm@wistar.org			National Cancer Institute of the National Institutes of Health [P30CA10815, P01CA025874, R01CA076674]; Alfred Marchionini Foundation; Dr Miriam and Sheldon G. Adelson Medical Research Foundation; Bohringer Ingelheim Fonds (MD-fellowship); Cancer Center Support Grant (CCSG) [CA010815]	We thank J. Hayden and F. Keeney (Wistar Microscopy Facility) and R. Delgiacco (Wistar Histotechnology Facility) for technical support. Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers P30CA10815, P01CA025874, R01CA076674, the Alfred Marchionini Foundation, and the Dr Miriam and Sheldon G. Adelson Medical Research Foundation. M.V.H. was supported by the Bohringer Ingelheim Fonds (MD-fellowship). Support for Core Facilities utilized in this study was provided by the Cancer Center Support Grant (CCSG) CA010815 to the Wistar Institute.	Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Li L, 2010, J CELL SCI, V123, P853, DOI 10.1242/jcs.061598; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200511124; Sczaniecka M, 2012, J BIOL CHEM, V287, P14052, DOI 10.1074/jbc.M111.303875; Fukunaga-Kalabis M, 2006, J CELL BIOL, V175, P563, DOI 10.1083/jcb.200602132; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Okamura Y, 2008, DEVELOPMENT, V135, P3555, DOI 10.1242/dev.022319; Seite S, 2010, BRIT J DERMATOL, V163, P903, DOI 10.1111/j.1365-2133.2010.10018.x; Pece S, 2011, BBA-REV CANCER, V1815, P26, DOI 10.1016/j.bbcan.2010.10.001; Carmon KS, 2008, MOL CANCER RES, V6, P1017, DOI 10.1158/1541-7786.MCR-08-0039; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Yamada T, 2010, BIOCHEM BIOPH RES CO, V396, P837, DOI 10.1016/j.bbrc.2010.04.167; Zabierowski SE, 2011, STEM CELLS, V29, P1752, DOI 10.1002/stem.740; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Joannides A, 2004, LANCET, V364, P172, DOI 10.1016/S0140-6736(04)16630-0; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Shan JF, 2005, BIOCHEMISTRY-US, V44, P15495, DOI 10.1021/bi0512602; Yamada T, 2013, J INVEST DERMATOL, V133, P2753, DOI 10.1038/jid.2013.235; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Hu B, 2010, GENE DEV, V24, P1519, DOI 10.1101/gad.1886910; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Weng AP, 2004, CURR OPIN GENET DEV, V14, P48, DOI 10.1016/j.gde.2003.11.004; Arad S, 2007, J INVEST DERMATOL, V127, P2629, DOI 10.1038/sj.jid.5700893; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Izrailit J, 2012, CANCER LETT, V317, P115, DOI 10.1016/j.canlet.2011.11.028; Janikova M, 2012, NEOPLASMA, V59, P6, DOI 10.4149/neo_2012_002; Koyanagi M, 2007, CIRC RES, V101, P1139, DOI 10.1161/CIRCRESAHA.107.151381; Li Ling, 2013, Methods Mol Biol, V989, P235, DOI 10.1007/978-1-62703-330-5_18; Li L., 2011, JOVE-J VIS EXP, V54, P2937; Liu XH, 2013, J BIOL CHEM, V288, P17990, DOI 10.1074/jbc.M113.478487; Motohashi T, 2009, STEM CELLS, V27, P888, DOI 10.1634/stemcells.2008-0678; Nikopoulos GN, 2007, STEM CELLS, V25, P3133, DOI 10.1634/stemcells.2007-0327; Pourreyron C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031827; Sakakibara S, 1997, J NEUROSCI, V17, P8300; Zuurbier L, 2010, LEUKEMIA, V24, P2014, DOI 10.1038/leu.2010.204	46	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	JUN	2015	135	6					1521	1532		10.1038/jid.2015.59		12	Dermatology	Dermatology	CH9XF	WOS:000354389200012		
J	Vorobyev, A; Ujiie, H; Recke, A; Buijsrogge, JJA; Jonkman, MF; Pas, HH; Iwata, H; Hashimoto, T; Kim, SC; Kim, JH; Groves, R; Samavedam, U; Gupta, Y; Schmidt, E; Zillikens, D; Shimizu, H; Ludwig, RJ				Vorobyev, Artem; Ujiie, Hideyuki; Recke, Andreas; Buijsrogge, Jacqueline J. A.; Jonkman, Marcel F.; Pas, Hendri H.; Iwata, Hiroaki; Hashimoto, Takashi; Kim, Soo-Chan; Kim, Jong Hoon; Groves, Richard; Samavedam, Unni; Gupta, Yask; Schmidt, Enno; Zillikens, Detlef; Shimizu, Hiroshi; Ludwig, Ralf J.			Autoantibodies to Multiple Epitopes on the Non-Collagenous-1 Domain of Type VII Collagen Induce Blisters	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							EPIDERMOLYSIS-BULLOSA-ACQUISITA; DERMAL-EPIDERMAL SEPARATION; NONCOLLAGENOUS NC1 DOMAIN; HUMAN SKIN; IMMUNOELECTRON MICROSCOPY; SUBCLASS DISTRIBUTION; PEMPHIGOID DISEASES; ANCHORING FIBRILS; PEPTIDE SEQUENCES; BASEMENT-MEMBRANE	Epidermolysis bullosa acquisita (EBA) is an autoimmune blistering disease of the skin and mucous membranes, characterized by autoantibodies against type VII collagen (COL7), a major component of anchoring fibrils. Different clinical EBA phenotypes are described, including mechanobullous and inflammatory variants. Most EBA patients' sera react with epitopes located within the non-collagenous 1 (NC1) domain of human COL7. However, it has remained unclear whether antibody binding to these different epitopes is pathogenically relevant. To address this issue, we generated recombinant proteins covering the entire NC1 domain. IgG reactivity with these proteins was analyzed in sera of 69 EBA patients. Most recognized clusters of epitopes throughout the NC1 domain. No correlation was detected between antibody specificity and clinical phenotype. To study the pathogenicity of antibodies specific to different NC1 subdomains, rabbit antibodies were generated. All these antibodies caused dermal-epidermal separation ex vivo. Antibodies against two of these subdomains were injected into mice carrying null mutations of mouse COL7 and the human COL7 transgene and induced subepidermal blisters. We here document that autoantibodies to COL7, independent of the targeted epitopes, induce blisters both ex vivo and in vivo. In addition, using COL7-humanized mice, we provide in vivo evidence of pathogenicity of autoantibodies binding to human COL7.	[Vorobyev, Artem; Recke, Andreas; Iwata, Hiroaki; Samavedam, Unni; Gupta, Yask; Schmidt, Enno; Zillikens, Detlef; Ludwig, Ralf J.] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Ujiie, Hideyuki; Shimizu, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan; [Buijsrogge, Jacqueline J. A.; Jonkman, Marcel F.; Pas, Hendri H.] Univ Groningen, Univ Med Ctr Groningen, Dept Dermatol, Groningen, Netherlands; [Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Fukuoka, Japan; [Hashimoto, Takashi] Kurume Univ, Inst Cutaneous Cell Biol, Fukuoka, Japan; [Kim, Soo-Chan; Kim, Jong Hoon] Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Kim, Soo-Chan; Kim, Jong Hoon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Cutaneous Biol Res Inst, Seoul, South Korea; [Groves, Richard] St Thomas Hosp, St Johns Inst Dermatol, Dept Immunodermatol, London, England	Vorobyev, A (reprint author), Lubeck Inst Expt Dermatol, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	artem.vorobyev@uksh.de	Recke, Andreas/C-8963-2009; Ludwig, Ralf/A-2629-2008; Schmidt, Enno/C-4008-2009; Pas, Hendri/G-9749-2011	Recke, Andreas/0000-0002-7674-1804; Ludwig, Ralf/0000-0002-1394-1737; Pas, Hendri/0000-0001-8823-2591	Research Training Group "Modulation of Autoimmunity" [DFG GRK1727/1]; Research Training Group "Genes, Environment and Inflammation" [DFG GRK1743/1]	This work was supported by the Research Training Groups "Modulation of Autoimmunity" (DFG GRK1727/1) and "Genes, Environment and Inflammation" (DFG GRK1743/1).	Recke A, 2010, J AUTOIMMUN, V34, P435, DOI 10.1016/j.jaut.2009.11.003; WOODLEY DT, 1984, NEW ENGL J MED, V310, P1007, DOI 10.1056/NEJM198404193101602; Sitaru C, 2006, J IMMUNOL, V177, P3461; Komorowski L, 2013, J AM ACAD DERMATOL, V68, pE89, DOI 10.1016/j.jaad.2011.12.032; Sitaru C, 2002, AM J PATHOL, V161, P301, DOI 10.1016/S0002-9440(10)64182-X; Recke A, 2014, J IMMUNOL, V193, P1600, DOI 10.4049/jimmunol.1400160; Schmidt E, 2013, LANCET, V381, P320, DOI 10.1016/S0140-6736(12)61140-4; Kasperkiewicz M, 2012, J PATHOL, V228, P8, DOI 10.1002/path.4023; Sitaru C, 2005, J CLIN INVEST, V115, P870, DOI 10.1172/JCI200521386; Woodley DT, 2005, J INVEST DERMATOL, V124, P958, DOI 10.1111/j.0022-202X.2005.23702.x; Ludwig RJ, 2012, J INVEST DERMATOL, V132, P1409, DOI 10.1038/jid.2011.466; Ludwig RJ, 2013, TRENDS MOL MED, V19, P501, DOI 10.1016/j.molmed.2013.06.003; van der Steen LP, 2012, J IMMUNOL, V189, P1594, DOI 10.4049/jimmunol.1101763; Buijsrogge JJA, 2011, BRIT J DERMATOL, V165, P92, DOI 10.1111/j.1365-2133.2011.10346.x; Kim JH, 2011, ACTA DERM-VENEREOL, V91, P307, DOI 10.2340/00015555-1065; Chiriac MT, 2007, J PATHOL, V212, P56, DOI 10.1002/path.2157; Saleh MA, 2011, J DERMATOL SCI, V62, P169, DOI 10.1016/j.jdermsci.2011.03.003; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; Gupta R, 2012, CLIN DERMATOL, V30, P60, DOI 10.1016/j.clindermatol.2011.03.011; Chen M, 1997, J BIOL CHEM, V272, P14516, DOI 10.1074/jbc.272.23.14516; Shimanovich I, 2004, J PATHOL, V204, P519, DOI 10.1002/path.1674; Ishii N, 2010, J DERMATOL, V37, P220, DOI 10.1111/j.1346-8138.2009.00799.x; GAMMON WR, 1984, J AM ACAD DERMATOL, V11, P820, DOI 10.1016/S0190-9622(84)80459-4; Woodley DT, 2006, J INVEST DERMATOL, V126, P1323, DOI 10.1038/sj.jid.5700254; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; BERNARD P, 1991, J INVEST DERMATOL, V97, P259, DOI 10.1111/1523-1747.ep12480369; Brittingham R, 2006, BIOCHEM BIOPH RES CO, V343, P692, DOI 10.1016/j.bbrc.2006.03.034; Chen M, 2007, AM J PATHOL, V170, P2009, DOI 10.2353/ajpath.2007.061212; Csorba K, 2010, CELL MOL LIFE SCI, V67, P1343, DOI 10.1007/s00018-009-0256-3; DAHL MGC, 1979, BRIT J DERMATOL, V101, P475, DOI 10.1111/j.1365-2133.1979.tb00030.x; Di Zenzo G, 2011, J INVEST DERMATOL, V131, P2271, DOI 10.1038/jid.2011.180; FINE JD, 1989, J INVEST DERMATOL, V92, P27, DOI 10.1111/1523-1747.ep13070463; Gandhi K, 2000, J CLIN IMMUNOL, V20, P416, DOI 10.1023/A:1026451530967; Hirose M, 2011, J IMMUNOL, V187, P1176, DOI 10.4049/jimmunol.1100596; Ishii N, 2009, BRIT J DERMATOL, V160, P1090, DOI 10.1111/j.1365-2133.2008.08952.x; Ishii N, 2004, BRIT J DERMATOL, V150, P843, DOI 10.1111/j.1365-2133.2004.05933.x; Ito K, 2009, AM J PATHOL, V175, P2508, DOI 10.2353/ajpath.2009.090347; Iwata H, 2013, J IMMUNOL, V191, P2978, DOI 10.4049/jimmunol.1300310; JONES DA, 1995, J INVEST DERMATOL, V104, P231, DOI 10.1111/1523-1747.ep12612780; KURZHALS G, 1991, ARCH DERMATOL, V127, P391, DOI 10.1001/archderm.127.3.391; LAPIERE JC, 1993, J CLIN INVEST, V92, P1831, DOI 10.1172/JCI116774; Leineweber S, 2011, FEBS LETT, V585, P1748, DOI 10.1016/j.febslet.2011.04.071; LIU Z, 1995, J IMMUNOL, V155, P5449; Ludwig RJ, 2013, ISRN DERMATOLOGY, V25; Ludwig RJ, 2012, AUTOIMMUNITY, V45, P102, DOI 10.3109/08916934.2011.606451; Mihai S, 2007, J CELL MOL MED, V11, P1117, DOI 10.1111/j.1582-4934.2007.00081.x; Oostingh GJ, 2005, J DERMATOL SCI, V37, P182, DOI 10.1016/j.jdermsci.2004.11.010; PARENTE MG, 1991, P NATL ACAD SCI USA, V88, P6931, DOI 10.1073/pnas.88.16.6931; ROENIGK HH, 1971, ARCH DERMATOL, V103, P1, DOI 10.1001/archderm.103.1.1; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; Rousselle P, 1997, J CELL BIOL, V138, P719, DOI 10.1083/jcb.138.3.719; Sitaru C, 2002, J INVEST DERMATOL, V118, P664, DOI 10.1046/j.1523-1747.2002.01720.x; TANAKA T, 1994, J INVEST DERMATOL, V102, P706, DOI 10.1111/1523-1747.ep12374333; WOODLEY DT, 1986, J INVEST DERMATOL, V86, P668, DOI 10.1111/1523-1747.ep12275978; ZAMBRUNO G, 1994, J AM ACAD DERMATOL, V31, P884, DOI 10.1016/S0190-9622(94)70252-7	55	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	JUN	2015	135	6					1565	1573		10.1038/jid.2015.51		9	Dermatology	Dermatology	CH9XF	WOS:000354389200017		
J	Ouji, Y; Ishizaka, S; Nakamura-Uchiyama, F; Okuzaki, D; Yoshikawa, M				Ouji, Yukiteru; Ishizaka, Shigeaki; Nakamura-Uchiyama, Fukumi; Okuzaki, Daisuke; Yoshikawa, Masahide			Partial Maintenance and Long-Term Expansion of Murine Skin Epithelial Stem Cells by Wnt-3a In Vitro	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							HAIR FOLLICLE; PROMOTES DIFFERENTIATION; DERMAL PAPILLA; SELF-RENEWAL; WNT-B-10; ACTIVATION; CATENIN; CD34; PROLIFERATION; HOMEOSTASIS	CD49f(+)CD34(+) cells, a skin epithelial stem cell (EpSC)-rich population, were prepared from adult mouse skin and cultured in the presence of Wnt-3a without feeder cells. CD34 expression was retained in about 10% of the cells, which had proliferated about 1,000-fold by day 10, although completely lost by day 14. CD49f(+)CD34(+) cells sorted on day 10 retained canonical Wnt-responsiveness, proliferated markedly in the presence of Wnt-3a, maintained undifferentiated epithelial cell marker expression, and promoted hair follicle development in vivo. Those were subjected to a second 10-day culture with Wnt-3a and sorted, and then the same procedures were repeated a total of 15 times. CD49f(+)CD34(+) cells obtained from each of those cultures retained the same EpSC characteristics as the original cells. CD34(+) and CD34(-) cells were found to produce Wnt-3a and Wnt/beta-catenin inhibitors, respectively. CD34(+) cells resided as small cellular clusters surrounded by a large amount of CD34(-) cells. Furthermore, we found that exogenous Wnt-3a delayed the conversion of CD34(+) cells to CD34(-) cells and induced CD34(-) cells to suppress the production of Wnt/beta-catenin inhibitors, likely leading to generation of a microenvironment favorable for maintaining EpSCs. Our results suggest the possibility of partial long-term maintenance of EpSCs in vitro by Wnt-3a.	[Ouji, Yukiteru; Nakamura-Uchiyama, Fukumi; Yoshikawa, Masahide] Nara Med Univ, Dept Pathogen Infect & Immun, Kashihara, Nara 6348521, Japan; [Ouji, Yukiteru; Ishizaka, Shigeaki; Yoshikawa, Masahide] Nara Med Univ, Dept Parasitol, Program Tissue Engn, Kashihara, Nara 6348521, Japan; [Okuzaki, Daisuke] Osaka Univ, Microbial Dis Res Inst, Ctr Infect Dis, DNA Chip Dev, Suita, Osaka 565, Japan	Ouji, Y (reprint author), Nara Med Univ, Dept Pathogen Infect & Immun, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	oujix@naramed-u.ac.jp; myoshika@naramed-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKENHI)	We thank TT Sun (New York University School of Medicine, NY) for the AE13 and AE13 antibodies, B Vogelstein (Howard Hughes Medical Institute) for the pTOPELASH and pFOPELASH plasmids, J Kishimoto (Shiseido Co., Ltd., Japan) for the transplantation chambers and explaining the grafting method technique, and 5 Shimada for technical assistance. This research was funded by a Grant-in-Aid for Young Scientists (B) and a Grant-in-Aid for Scientific Research (C) (to YO) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKENHI).	Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Ouji Y, 2006, BIOCHEM BIOPH RES CO, V345, P581, DOI 10.1016/j.bbrc.2006.04.142; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Tickenbrock L, 2005, BLOOD, V105, P3699, DOI 10.1182/blood-2004-07-2924; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Carmon KS, 2010, ANAL BIOCHEM, V401, P288, DOI 10.1016/j.ab.2010.03.009; Trempus CS, 2007, CANCER RES, V67, P4173, DOI 10.1158/0008-5472.CAN-06-3128; Kishimoto J, 2000, GENE DEV, V14, P1181; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Lien WH, 2014, NAT CELL BIOL, V16, P179, DOI 10.1038/ncb2903; Miki T, 2011, STEM CELL REV REP, V7, P836, DOI 10.1007/s12015-011-9275-1; Lim XH, 2013, SCIENCE, V342, P1226, DOI 10.1126/science.1239730; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Kandyba E, 2013, P NATL ACAD SCI USA, V110, P1351, DOI 10.1073/pnas.1121312110; Pinto D, 2005, EXP CELL RES, V306, P357, DOI 10.1016/j.yexcr.2005.02.022; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Brun J, 2013, BONE, V53, P6, DOI 10.1016/j.bone.2012.11.020; Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003; Kandyba E, 2014, STEM CELLS, V32, P534, DOI 10.1002/stem.1548; Kumar S, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-44; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Ouji Y, 2013, BIOCHEM BIOPH RES CO, V438, P493, DOI 10.1016/j.bbrc.2013.07.108; Ouji Y, 2010, J BIOSCI BIOENG, V110, P217, DOI 10.1016/j.jbiosc.2010.01.020; Ouji Y, 2006, BIOCHEM BIOPH RES CO, V342, P1063, DOI 10.1016/j.bbrc.2006.02.028; Ouji Y, 2006, BIOCHEM BIOPH RES CO, V342, P28, DOI 10.1016/j.bbrc.2006.01.104; Ouji Y, 2008, BIOCHEM BIOPH RES CO, V367, P299, DOI 10.1016/j.bbrc.2007.12.091; Tiedemann H, 2001, DEV GROWTH DIFFER, V43, P469; Toyofuku T, 2000, J CELL BIOL, V150, P225, DOI 10.1083/jcb.150.1.225; Van Camp JK, 2013, STEM CELL REV, V10, P207; Yokoyama Noriko, 2007, J Mol Signal, V2, P11, DOI 10.1186/1750-2187-2-11	37	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	JUN	2015	135	6					1598	1608		10.1038/jid.2014.510		11	Dermatology	Dermatology	CH9XF	WOS:000354389200021		
J	Shimizuhira, C; Otsuka, A; Yamamoto, Y; Kabashima, K				Shimizuhira, Chihiro; Otsuka, Atsushi; Yamamoto, Yosuke; Kabashima, Kenji			Re: Natural Killer T Cells Are Essential for the Development of Contact Hypersensitivity in BALB/c Mice Response	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Letter									[Shimizuhira, Chihiro; Otsuka, Atsushi; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Yamamoto, Yosuke] Kyoto Univ, Grad Sch Med, Dept Healthcare Epidemiol, Kyoto, Japan	Shimizuhira, C (reprint author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan.	otsukamn@kuhp.kyoto-u.ac.jp; kaba@kuhp.kyoto-u.ac.jp					Lee JH, 2015, J INVEST DERMATOL, V135, P1686, DOI 10.1038/jid.2015.49	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	JUN	2015	135	6					1687	1687		10.1038/jid.2015.39		1	Dermatology	Dermatology	CH9XF	WOS:000354389200031		
J	Tsukamoto, T; Hirose, N; Kasamatsu, A; Mimura, T; Matsui, T; Suda, Y				Tsukamoto, Takahiro; Hirose, Nobumitsu; Kasamatsu, Akifumi; Mimura, Takashi; Matsui, Toshiaki; Suda, Yoshiyuki			Formation of GeSn layers on Si (001) substrates at high growth temperature and high deposition rate by sputter epitaxy method	JOURNAL OF MATERIALS SCIENCE			English	Article							GE1-XSNX ALLOYS; FILMS	GeSn layers are formed on Si substrates by the sputter epitaxy method. Flat GeSn layers with 11.5 % Sn content are obtained. In the X-ray diffraction spectra of the GeSn layers with 11.5 % Sn content grown at 523 K, a sharp Ge (004) peak appears at about 64.5306 degrees and the full width at half maximum is about 0.0984 degrees. However, the surface segregation of Sn is observed in the GeSn layers with 11.5 % Sn content at growth temperatures of 548 K and above in this study, which increases the surface roughness. The crystallinity of the GeSn layers formed on Si substrates strongly depends on the growth temperature, but the primary factor degrading the crystallinity is the large lattice mismatch between Si and GeSn. According to a transmission electron microscope image, some dislocations appear at the interface of the GeSn layer grown at 523 K and Si owing to the large lattice mismatch, but there is no Sn surface segregation and a highly ordered atomic arrangement is observed in the upper region. It is considered that a high deposition rate limits Sn surface segregation and enables the growth of GeSn layers at relatively high temperatures, resulting in improved crystallinity. The band gap of the GeSn layers with 8.4 % Sn content is determined by Fourier transform infrared spectroscopy measurement and is about 0.52 eV, which indicates that band gap narrowing occurs.	[Tsukamoto, Takahiro; Suda, Yoshiyuki] Tokyo Univ Agr & Technol, Grad Sch Engn, Tokyo 1848588, Japan; [Hirose, Nobumitsu; Kasamatsu, Akifumi; Mimura, Takashi; Matsui, Toshiaki] Natl Inst Informat & Communicat Technol, Tokyo 1848795, Japan	Tsukamoto, T (reprint author), Tokyo Univ Agr & Technol, Grad Sch Engn, 2-24-16 Naka Cho, Tokyo 1848588, Japan.	t-tsuka@cc.tuat.ac.jp	TSUKAMOTO, Takahiro/F-9253-2013; SUDA, Yoshiyuki/G-1167-2013		JSPS KAKENHI [25820121]	This work was supported by JSPS KAKENHI Grant Numbers 25820121. This work was partly carried out in Advanced ICT Devices Lab in NICT.	Mathews J, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3521391; de Guevara HPL, 2004, APPL PHYS LETT, V84, P4532, DOI 10.1063/1.1758772; Chibane Y, 2010, J APPL PHYS, V107, DOI 10.1063/1.3326162; He G, 1997, PHYS REV LETT, V79, P1937, DOI 10.1103/PhysRevLett.79.1937; Zhang DL, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4801957; Coppinger M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4800448; Gupta S, 2013, J APPL PHYS, V113, DOI 10.1063/1.4792649; Roucka R, 2011, IEEE J QUANTUM ELECT, V47, P213, DOI 10.1109/JQE.2010.2077273; Su SJ, 2011, J CRYST GROWTH, V317, P43, DOI 10.1016/j.jcrysgro.2011.01.015; Tonkikh AA, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4813913; de Guevara HPL, 2003, APPL PHYS LETT, V83, P4942, DOI 10.1063/1.1634374; Nakamura M, 2012, THIN SOLID FILMS, V520, P3201, DOI 10.1016/j.tsf.2011.10.153; Hanafusa H, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.024102; Hanafusa H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.055502; Hanafusa H, 2008, JPN J APPL PHYS, V47, P3020, DOI 10.1143/JJAP.47.3020; Tsukamoto T, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4907863; Roucka R, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3554747; Yoshikawa M, 2012, ECS TRANSACTIONS, V50, P145, DOI 10.1149/05009.0145ecst; Mathews J, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3238327; Asano T, 2013, THIN SOLID FILMS, V531, P504, DOI 10.1016/j.tsf.2012.12.063; Chen R, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3658632; Chen R, 2013, J CRYST GROWTH, V365, P29, DOI 10.1016/j.jcrysgro.2012.12.014; D'Costa VR, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125207; Grzybowski G, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4745770; GURDAL O, 1995, APPL PHYS LETT, V67, P956, DOI 10.1063/1.114707; Lopez MR, 1998, J APPL PHYS, V84, P2219; Nakamura Y, 2007, J APPL PHYS, V102, DOI 10.1063/1.2822271; Nakamura Y, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2753737; Naruse N, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3093806; Oehme M, 2011, IEEE PHOTONIC TECH L, V23, P1751, DOI 10.1109/LPT.2011.2169052; Su Shaojian, 2011, Opt Express, V19, P6400, DOI 10.1364/OE.19.006400; Tsukamoto T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826501; Yin WJ, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.161203; Zheng J, 2014, ECS SOLID STATE LETT, V3, pP111, DOI 10.1149/2.0081409ssl	34	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-2461	1573-4803		J MATER SCI	J. Mater. Sci.	JUN	2015	50	12					4366	4370		10.1007/s10853-015-8990-4		5	Materials Science, Multidisciplinary	Materials Science	CH5QA	WOS:000354089200022		
J	Ishida, S; Nojima, T; Hagiwara, I				Ishida, Sachiko; Nojima, Taketoshi; Hagiwara, Ichiro			Design of Deployable Membranes Using Conformal Mapping	JOURNAL OF MECHANICAL DESIGN			English	Article								This paper proposes a new method for designing the crease patterns of deployable membranes that can be wrapped up compactly. The method utilizes conformal mapping and the origami folding technique. The mapping of the flow with circulation can be used to control the angles between the fold lines, produce elements of the same shape, and maintain regularity of the fold lines. The proposed method thus enables the systematic and efficient design of complex patterns based on simple ones. The proposed method was successfully used to produce the patterns of Nojima and other extended new patterns of deployable membranes consisting of discrete equiangular spirals. The patterns were wrapped and used to form pillars such as regular polygonal, rectangular, and diamond pillars. Toward the industrial application of the proposed method, this paper also discusses pattern design for space-saving storage and to reduce the effect of thickness when using versatile materials.	[Ishida, Sachiko] Meiji Univ, Dept Mech Engn, Kawasaki, Kanagawa 2148571, Japan; [Nojima, Taketoshi; Hagiwara, Ichiro] Meiji Univ, Meiji Inst Adv Study Math Sci, Nakano Ku, Tokyo 1648525, Japan	Ishida, S (reprint author), Meiji Univ, Dept Mech Engn, 1-1-1 Higashimita, Kawasaki, Kanagawa 2148571, Japan.	sishida@meiji.ac.jp; taketoshinojima@gmail.com; ihagi@meiji.ac.jp			government of Japan [20226006]; Japan Science Society	This work was supported by Grants-in-Aid for Scientific Research of the government of Japan (Grant No. 20226006) and the Sasakawa Scientific Research Grant of the Japan Science Society.	Zirbel SA, 2013, J MECH DESIGN, V135, DOI 10.1115/1.4025372; [Anonymous], 2000, Patent Publication, Patent No. [O/ 2001/ 081821, 0818212001]; [Anonymous], 2000, International Application, Patent No. [PCT/ JP2000/ 007348, 0073482000]; Gu XF, 2004, IEEE T MED IMAGING, V23, P949, DOI 10.1109/TMI.2004.831226; Guest SD, 1996, ACTA ASTRONAUT, V38, P103, DOI 10.1016/0094-5765(96)00009-4; Tsuda Y, 2011, ACTA ASTRONAUT, V69, P833, DOI 10.1016/j.actaastro.2011.06.005; Nojima T, 2002, JSME INT J C-MECH SY, V45, P364, DOI 10.1299/jsmec.45.364; Johnson L, 2007, ACTA ASTRONAUT, V61, P376, DOI 10.1016/j.actaastro.2007.01.047; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Freeland R. E., 1998, 49 INT ASTR C MELB A; Guest S. D., 1992, P 1 INT SEM STRUCT M, P203; Ishida S, 2014, J MECH DESIGN, V136, DOI 10.1115/1.4027848; Miyake I., 2013, DOMUS, V974, P16; Natori M. C., 2013, P ASME 2013 INT DES; Natori M. C, 1999, JPN SOC MECH ENG, V102, P48; Nojima T., 2004, JPN SOC MECH ENG C, V70, P251; Nojima T., 2003, INT J JPN SOC MECH C, V46, P1547; Reynolds W. D., 2013, P ASME 2013 INT DES; Spiegel M. R., 1964, SCHAUMS OUTLINE THEO	19	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	1050-0472			J MECH DESIGN	J. Mech. Des.	JUN	2015	137	6							061404	10.1115/1.4030296		6	Engineering, Mechanical	Engineering	CH3GT	WOS:000353918100004		
J	Mondal, R; Bhattacharjee, J; Sahoo, T				Mondal, R.; Bhattacharjee, J.; Sahoo, T.			Forced Flexural Gravity Wave Motion in Two-Layer Fluid	JOURNAL OF OFFSHORE MECHANICS AND ARCTIC ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							SURFACE-WAVES; VERTICAL WALL; WATER WAVES; ICE-COVER; HYDROELASTICITY; VLFS	Generation of flexural gravity waves in a two-layer fluid due to the forced motion of a vertical rigid wavemaker is studied in both finite and infinite water depths. The two-dimensional (2D) fluid domain having an interface is covered by a semi-infinite ice sheet, which is modeled as an elastic beam. As an application of the wavemaker problem, flexural gravity wave reflection by a vertical cliff is analyzed. Under the assumptions of small amplitude water wave theory and structural response, the mathematical models are solved using a recently developed expansion formulae and the associated orthogonal mode-coupling relations as appropriate for finite and infinite water depths. Effect of three types of edges such as free edge, simply supported edge, and built-in edge on the wave reflection by the vertical cliff is analyzed whilst, for the wavemaker, the floating ice sheet is assumed to have free edge. Effect of various physical parameters on the wave motion is studied by analyzing the reflection coefficients, deflection of the ice sheet, interface elevation, strain and shear force on the floating ice sheet.	[Mondal, R.; Bhattacharjee, J.; Sahoo, T.] Indian Inst Technol, Dept Ocean Engn & Naval Architecture, Kharagpur 721302, W Bengal, India; [Mondal, R.] Univ Tokyo, Grad Sch Frontier Sci, Dept Ocean Technol Policy & Environm, Kashiwa, Chiba 2778563, Japan	Sahoo, T (reprint author), Indian Inst Technol, Dept Ocean Engn & Naval Architecture, Kharagpur 721302, W Bengal, India.	ramnarayaniitkgp@gmail.com; joydip@naval.iitkgp.ernet.in; tsahoo1967@gmail.com			National Board of Higher Mathematics, Government of India, Mumbai [2/40(3)/2014-RD-II/5296]	R.M. acknowledges the financial support received from National Board of Higher Mathematics, Government of India, Mumbai bearing Grant No. 2/40(3)/2014-R&D-II/5296 as a postdoctoral fellow of Indian Institute of Technology, Kharagpur, India.	Watanabe E, 2004, ENG STRUCT, V26, P245, DOI 10.1016/j.engstruct.2003.10.001; Squire VA, 2007, COLD REG SCI TECHNOL, V49, P110, DOI 10.1016/j.coldregions.2007.04.007; Havelock TH, 1929, PHILOS MAG, V8, P569; Manam SR, 2006, P ROY SOC A-MATH PHY, V462, P263, DOI 10.1098/rspa.2005.1562; URSELL F, 1947, P CAMB PHILOS SOC, V43, P374; Bhattacharjee J, 2008, WAVE MOTION, V45, P133, DOI 10.1016/j.wavemoti.2007.04.006; Bhattacharjee J, 2012, J ENG MATH, V75, P29, DOI 10.1007/s10665-011-9511-3; Brocklehurst P, 2010, J ENG MATH, V68, P215, DOI 10.1007/s10665-010-9386-8; Chakrabarti A, 2003, INT J ENG SCI, V41, P1145, DOI 10.1016/S0020-7225(02)00375-0; Chen XJ, 2006, OCEAN ENG, V33, P439, DOI 10.1016/j.oceaneng.2004.04.010; CHRISTENSEN FT, 1987, COLD REG SCI TECHNOL, V13, P215, DOI 10.1016/0165-232X(87)90001-2; Korobkin A, 2011, PHILOS T R SOC A, V369, P2803, DOI 10.1098/rsta.2011.0116; Mohanty SK, 2014, J FLUID STRUCT, V45, P28, DOI 10.1016/j.jfluidstructs.2013.11.018; Mondal R, 2012, WAVE MOTION, V49, P501, DOI 10.1016/j.wavemoti.2012.02.002; Mondal R, 2014, OCEAN ENG, V88, P446, DOI 10.1016/j.oceaneng.2014.07.008; RHODESRO.PF, 1971, PROC CAMB PHILOS S-M, V70, P323; SCHULKES RMSM, 1987, J FLUID MECH, V180, P297, DOI 10.1017/S0022112087001812; Squire VA, 2008, INT OFFSHORE POLAR E, P1; STOKER JJ, 1947, Q APPL MATH, V5, P1; Tkacheva LA, 2013, J APPL MECH TECH PH+, V54, P651, DOI 10.1134/S0021894413040160; URSELL F, 1960, J FLUID MECH, V7, P33, DOI 10.1017/S0022112060000037; Wang CM, 2011, PROCEDIA ENGINEER, V14, DOI 10.1016/j.proeng.2011.07.007; Williams T., 2002, IC ENV P 16 IAHR INT, V2, P318	23	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0892-7219	1528-896X		J OFFSHORE MECH ARCT	J. Offshore Mech. Arct. Eng. Trans. ASME	JUN	2015	137	3							031101	10.1115/1.4029896		12	Engineering, Ocean; Engineering, Mechanical	Engineering	CH0NQ	WOS:000353718100001		
J	Toyoda, S; Goto, S; Okabe, T; Kimura, H; Igi, S				Toyoda, Shunsuke; Goto, Sota; Okabe, Takatoshi; Kimura, Hideto; Igi, Satoshi			Metallurgical Design and Performance of High-Frequency Electric Resistance Welded Linepipe With High-Quality Weld Seam Suitable for Extra-Low-Temperature Services	JOURNAL OF OFFSHORE MECHANICS AND ARCTIC ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							CLEAVAGE FRACTURE; PART II; BEHAVIOR; STEEL; TRANSITION; INCLUSIONS; DUCTILE; VOIDS	To clarify the effect of inclusions on the Charpy impact properties, the 2 mm V-notched Charpy properties of X60-X80-grades steel were numerically simulated using the finite element method code ABAQUS. The yield strength and the tensile strength of the steel were 562 MPa and 644 MPa, respectively. The striker's velocity and the temperature dependency of the stress-strain curve were taken into account. To estimate the effect of nonmetallic inclusions, a 200 mu m long virtual inclusion with a 1 mu m edge radius was situated at the maximum point of the stress triaxiality. Four types of microcrack initiation were determined: (a) ductile void generation in the matrix, (b) cleavage crack generation in the matrix, (c) void generation by inclusion fracture, and (d) void generation by matrix-inclusion interface debonding. Without inclusions, a ductile microvoid was generated when the striker stroke was 3.3 mm, independent of the temperature. With inclusions, an inclusion fracture occurred when the striker stroke was 0.6 mm at room temperature. The striker stroke decreased as the temperature decreased. Based on the above numerical estimation results, high-frequency electric resistance welded (HFW) linepipe with high-quality weld seam MightySeam (R) has been developed. Controlling the morphology and distribution of oxides generated during the welding process by means of temperature and deformation distribution control is the key factor for improving the low-temperature toughness. The Charpy transition temperature of the developed HFW pipe was much lower than -45 degrees C. Based on the low-temperature hydrostatic burst test with a notched weld seam at -20 degrees C, the MightySeam (R) weld provides a fracture performance that is the same as UOE double submerged arc welded pipe. The pipe has been used in actual, highly demanding, and severe environments.	[Toyoda, Shunsuke] JFE Steel Corp, Steel Res Lab, Kawasaki Ku, Kawasaki, Kanagawa 2100855, Japan; [Goto, Sota; Okabe, Takatoshi; Kimura, Hideto] JFE Steel Corp, Steel Res Lab, Handa, Aichi 4758611, Japan; [Kimura, Hideto] JFE Technores Corp, Kawasaki Ku, Kawasaki, Kanagawa 2100855, Japan; [Igi, Satoshi] JFE Steel Corp, Steel Res Lab, Chuo Ku, Chiba 2600835, Japan	Toyoda, S (reprint author), JFE Steel Corp, Steel Res Lab, Kawasaki Ku, 1-1 Minamiwatarida Cho, Kawasaki, Kanagawa 2100855, Japan.	s-toyoda@jfe-steel.co.jp; s-goto@jfe-steel.co.jp; ta-okabe@jfe-steel.co.jp; h-kimura@jfe-tec.co.jp; s-igi@jfe-steel.co.jp					Chen JH, 2003, ACTA MATER, V51, P1841, DOI 10.1016/S1359-6454(02)00581-5; Tanguy B, 2005, ENG FRACT MECH, V72, P413, DOI 10.1016/j.engfracmech.2004.03.011; Yan W, 2007, METALL MATER TRANS A, V38A, P1211, DOI 10.1007/s11661-007-9161-2; Bose WW, 2007, MAT SCI ENG A-STRUCT, V452, P401, DOI 10.1016/j.msea.2006.10.096; Fujimatsu T., 2006, TECHNICAL REPORT, V131; Goto S., 2013, RIO PIP C EXP, P1; Gurson A.L., 1977, ASME, V99, P2; Huh H, 2012, INT J AUTO TECH-KOR, V13, P43, DOI 10.1007/s12239-012-0005-8; Inoue T., 2013, 18 JFE, P18; Kiefner JF, 1973, ASTM STP, P461; Lincourt C., 2009, MAT SCI TECHN C, V3, P1687; Ludwik P, 1909, ELEMENTE TECHNOLOGIS; Masamura K., 2012, J SOC PIPING ENG JPN, P14; Matsui Y., 2012, IPC201290213, P1; Nakamoto H., 2004, T JSCES JPN; Nakamoto H., 2005, J JPN SOC MECH ENG, V71, P428; Nakata H., 2008, 12 JFE, P27; Okabe T., 2011, FINITE ELEMENT ANAL, P662; TVERGAARD V, 1982, INT J FRACTURE, V18, P237; TVERGAARD V, 1981, INT J FRACTURE, V17, P389, DOI 10.1007/BF00036191; Yang WJ, 2003, J NUCL MATER, V317, P234, DOI 10.1016/S0022-3115(03)00106-5	21	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0892-7219	1528-896X		J OFFSHORE MECH ARCT	J. Offshore Mech. Arct. Eng. Trans. ASME	JUN	2015	137	3							031401	10.1115/1.4029762		11	Engineering, Ocean; Engineering, Mechanical	Engineering	CH0NQ	WOS:000353718100005		
J	Endo, T; Nakamura, J; Sato, Y; Asada, M; Yamada, R; Takase, M; Takaori, K; Oguchi, A; Iguchi, T; Higashi, AY; Ohbayashi, T; Nakamura, T; Muso, E; Kimura, T; Yanagita, M				Endo, Tomomi; Nakamura, Jin; Sato, Yuki; Asada, Misako; Yamada, Ryo; Takase, Masayuki; Takaori, Koji; Oguchi, Akiko; Iguchi, Taku; Higashi, Atsuko Y.; Ohbayashi, Tetsuya; Nakamura, Tomoyuki; Muso, Eri; Kimura, Takeshi; Yanagita, Motoko			Exploring the origin and limitations of kidney regeneration	JOURNAL OF PATHOLOGY			English	Article						acute kidney injury; regeneration; chronic kidney disease; fibrosis; tubule; nephron	EPITHELIAL-CELLS REPAIR; PROGENITOR-LIKE CELLS; ACUTE-RENAL-FAILURE; STEM-CELLS; PROXIMAL TUBULES; ADULT KIDNEY; URETERAL OBSTRUCTION; BMP ANTAGONIST; INJURY; DISEASE	Epidemiological findings indicate that acute kidney injury (AKI) increases the risk for chronic kidney disease (CKD), although the molecular mechanism remains unclear. Genetic fate mapping demonstrated that nephrons, functional units in the kidney, are repaired by surviving nephrons after AKI. However, the cell population that repairs damaged nephrons and their repair capacity limitations remain controversial. To answer these questions, we generated a new transgenic mouse strain in which mature proximal tubules, the segment predominantly damaged during AKI, could be genetically labelled at desired time points. Using this strain, massive proliferation of mature proximal tubules is observed during repair, with no dilution of the genetic label after the repair process, demonstrating that proximal tubules are repaired mainly by their own proliferation. Furthermore, acute tubular injury caused significant shortening of proximal tubules associated with interstitial fibrosis, suggesting that proximal tubules have a limited capacity to repair. Understanding the mechanism of this limitation might clarify the mechanism of the AKI-to-CKD continuum. Copyright (c) 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.	[Endo, Tomomi; Nakamura, Jin; Sato, Yuki; Asada, Misako; Yamada, Ryo; Takase, Masayuki; Takaori, Koji; Oguchi, Akiko; Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto 6068507, Japan; [Endo, Tomomi; Muso, Eri] Kitano Hosp, Dept Nephrol & Dialysis, Tazuke Kofukai Med Res Inst, Osaka, Japan; [Takase, Masayuki; Iguchi, Taku] Mitsubishi Tanabe Pharma Corp, Dev 2, Pharmacol Res Labs 2, Div Res, Saitama, Japan; [Iguchi, Taku] Kyoto Univ, TMK Project, Grad Sch Med, Kyoto 6068507, Japan; [Higashi, Atsuko Y.; Nakamura, Tomoyuki] Kansai Med Univ, Dept Pharmacol, Osaka, Japan; [Ohbayashi, Tetsuya] Tottori Univ, Div Lab Anim Sci, Res Ctr Biosci & Technol, Tottori 680, Japan; [Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan	Yanagita, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Nephrol, Sakyo Ku, Shogoin Kawahara Cho 54, Kyoto 6068507, Japan.	motoy@kuhp.kyoto-u.ac.jp			Funding Program for Next-Generation World-leading Researchers; Japan Society for the Promotion of Science (JSPS); CREST from Japan Science and Technology Agency; Integration research for agriculture and interdisciplinary fields from National Agriculture and Food Research Organization	We thank Professors Y Kaziro, Y Nabeshima, and S Nagata for their valuable comments and discussion. We greatly appreciate Dr Okuda for great support and valuable discussion. We also greatly appreciate Professor F Costantini for kindly providing the R26ECFP mice. We are very grateful to Ms A Hosotani, S Kobashi, Y Eguchi, T Haga, A Morita, and M Ozone for their excellent technical assistance. This study was supported by the Funding Program for Next-Generation World-leading Researchers, Grant-in-Aid for Scientific Research B from Japan Society for the Promotion of Science (JSPS), CREST from Japan Science and Technology Agency, and Integration research for agriculture and interdisciplinary fields from National Agriculture and Food Research Organization.	Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; McCampbell KK, 2012, BIOCHEM J, V444, P153, DOI 10.1042/BJ20120176; Higashi AY, 2009, J IMMUNOL, V182, P5633, DOI 10.4049/jimmunol.0802413; Goldstein SL, 2013, CLIN J AM SOC NEPHRO, V8, P476, DOI 10.2215/CJN.12101112; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Wakisaka Y, 2003, J HISTOCHEM CYTOCHEM, V51, P1515; Thornhill BA, 2007, KIDNEY INT, V72, P1103, DOI 10.1038/sj.ki.5002512; Langworthy M, 2009, J AM SOC NEPHROL, V20, P311, DOI 10.1681/ASN.2008010094; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; Kusaba T, 2014, P NATL ACAD SCI USA, V111, P1527, DOI 10.1073/pnas.1310653110; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Maeshima A, 2003, J AM SOC NEPHROL, V14, P3138, DOI 10.1097/01.ASN.0000098685.43700.28; Kitamura S, 2005, FASEB J, V19, P1789, DOI 10.1096/fj.05-3942.com; Angelotti ML, 2012, STEM CELLS, V30, P1714, DOI 10.1002/stem.1130; Asada N, 2011, J CLIN INVEST, V121, P3981, DOI 10.1172/JCI57301; Nakhoul N, 2011, CONTRIB NEPHROL, V169, P37, DOI 10.1159/000313944; Kazama I, 2008, J AM SOC NEPHROL, V19, P2181, DOI 10.1681/ASN.2007111212; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Bonventre JV, 2013, CLIN J AM SOC NEPHRO, V8, P1606, DOI 10.2215/CJN.06040613; Vogetseder A, 2007, AM J PHYSIOL-CELL PH, V292, pC807, DOI 10.1152/ajpcell.00301.2006; Dennen P, 2010, CRIT CARE MED, V38, P261, DOI 10.1097/CCM.0b013e3181bfb0b5; Ishani A, 2011, ARCH INTERN MED, V171, P226, DOI 10.1001/archinternmed.2010.514; Yanagita M, 2001, J BIOL CHEM, V276, P42364, DOI 10.1074/jbc.M107488200; Lindgren D, 2011, AM J PATHOL, V178, P828, DOI 10.1016/j.ajpath.2010.10.026; Barker N, 2012, CELL REP, V2, P540, DOI 10.1016/j.celrep.2012.08.018; Berger K, 2014, P NATL ACAD SCI USA, V111, P1533, DOI 10.1073/pnas.1316177111; Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; James MT, 2010, LANCET, V376, P2096, DOI 10.1016/S0140-6736(10)61271-8; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Loverre A, 2008, TRANSPLANTATION, V85, P1112, DOI 10.1097/TP.0b013e31816a8891; Reule S, 2011, ORGANOGENESIS, V7, P135, DOI 10.4161/org.7.2.16285; Smeets B, 2013, J PATHOL, V229, P645, DOI 10.1002/path.4125; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Okuda T, 2004, MOL CELL BIOL, V24, P3949, DOI 10.1128/MCB.24.9.3949-3956.2004; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Gupta S, 2006, J AM SOC NEPHROL, V17, P3028, DOI 10.1681/ASN.2006030275; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Challen GA, 2006, J AM SOC NEPHROL, V17, P1896, DOI 10.1681/ASN.2005111228; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Vogetseder A, 2008, AM J PHYSIOL-CELL PH, V294, pC22, DOI 10.1152/ajpcell.00227.2007; Duffield JS, 2011, KIDNEY INT, V79, P494, DOI 10.1038/ki.2010.338; Forbes MS, 2011, AM J PHYSIOL-RENAL, V301, pF110, DOI 10.1152/ajprenal.00022.2011; Hebert LA, 2000, KIDNEY INT, V57, P1962, DOI 10.1046/j.1523-1755.2000.00045.x; Kohan DE, 2008, KIDNEY INT, V74, P427, DOI 10.1038/ki.2008.146; Lachat P, 2002, HISTOCHEM CELL BIOL, V118, P399, DOI 10.1007/s00418-002-0460-9; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Little MH, 2008, CELL STEM CELL, V2, P191, DOI 10.1016/j.stem.2008.02.007; Little MH, 2009, J AM SOC NEPHROL, V20, P2112, DOI 10.1681/ASN.2009010066; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Pagtalunan ME, 1999, J AM SOC NEPHROL, V10, P366; Sanoff S, 2011, CONTRIB NEPHROL, V171, P213, DOI 10.1159/000327332; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Shimono A, 1999, MECH DEVELOP, V83, P39, DOI 10.1016/S0925-4773(99)00025-8; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tanaka M, 2008, KIDNEY INT, V73, P181, DOI 10.1038/sj.ki.5002626; Tanaka T, 2004, AM J PATHOL, V165, P1979, DOI 10.1016/S0002-9440(10)63249-X; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; WELLING LW, 1988, PEDIATR NEPHROL, V2, P108; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445	61	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3417	1096-9896		J PATHOL	J. Pathol.	JUN	2015	236	2					251	263		10.1002/path.4514		13	Oncology; Pathology	Oncology; Pathology	CH8YA	WOS:000354321400013		
J	Imajima, Y; Kitano, M; Ueda, T				Imajima, Yukari; Kitano, Motohiro; Ueda, Takafumi			Intramedullary Fixation Using Kirschner Wires in Children With Osteogenesis Imperfecta	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						osteogenesis imperfecta; nonelongating rod; wire exchange	LONG BONES; PAMIDRONATE; FRACTURE; RODS; OSTEOTOMY; NAIL	Background: Surgical treatment for osteogenesis imperfecta (OI) remains controversial. The use of elongating rods has become a mainstay in this treatment, and there have been many reports of the results of this procedure. In contrast, using nonelongating rods is considered to be the classic method. This older method is still used by surgeons who are concerned about the possibility of trauma on the articular surface due to arthrotomy at the insertion of the elongating rod or who are working in developing countries with fewer resources. We are among those who prefer the use of nonelongating rods to elongating rods. This article presents the results of intramedullary fixation using nonelongating rods such as Kirschner wires (K-wires) in children with OI and the proper timing of wire exchange to prevent further fracture. Methods: We treated 29 femora in 17 patients with OI by means of stabilization using K-wires. For these patients we calculated revision-free survival and analyzed the details of any fractures that occurred after the primary surgery. We also investigated the relations between the wire length ratio, which was defined as the ratio of the intramedullary wire length divided by the femoral length, and the fracture type. Results: The revision-free survival for the 29 primary procedures was 63% at 3 years, and 36% at 5 years. All fractures that occurred at the wire tip required additional surgery, whereas only 51% of fractures at other sites required additional surgery. The wire length ratio of wire-tip fractures was significantly lower than that of fractures at other sites. There is a significant difference in the incidence of wire-tip fractures and other fractures between ratios of 65% and 75%. Conclusions: Wire exchange surgeries should be performed before the wire length ratio drops to <70%. This information could be useful for preventing further fractures that require surgery when OI patients are treated by intramedullary fixation with nonelongating rods.	[Imajima, Yukari; Kitano, Motohiro; Ueda, Takafumi] Osaka Natl Hosp, Dept Orthopaed Surg, Chuo Ku, Osaka 5400006, Japan	Imajima, Y (reprint author), Osaka Natl Hosp, Dept Orthopaed Surg, Chuo Ku, 2-1-14 Hoenzaka, Osaka 5400006, Japan.	yimajima@onh.go.jp					SOFIELD HA, 1959, J BONE JOINT SURG AM, V41, P1371; MARAFIOTI RL, 1977, J BONE JOINT SURG AM, V59, P467; Cho TJ, 2007, J BONE JOINT SURG AM, V89A, P1028, DOI 10.2106/JBJS.F.00814; Green JK, 2005, J ORTHOP RES, V23, P1315, DOI 10.1016/j.orthres.2005.04.007; Joseph B, 2005, J PEDIATR ORTHOP B, V14, P311; Park SS, 2013, BONE JOINT J, V95B, P254, DOI 10.1302/0301-620X.95B2.29491; Munns CFJ, 2004, J BONE MINER RES, V19, P1779, DOI 10.1359/JBMR.040814; Cho TJ, 2011, J BONE JOINT SURG BR, V93B, P634, DOI 10.1302/0301-620X.93B5.25499; Astrom E, 1998, ACTA PAEDIATR, V87, P64; BAILEY R W, 1963, Surg Forum, V14, P455; BAILEY RW, 1981, CLIN ORTHOP RELAT R, P171; Bembi B, 1997, J PEDIATR-US, V131, P622, DOI 10.1016/S0022-3476(97)70074-X; El-Adl G, 2009, ACTA ORTHOP BELG, V75, P200; Fassier F, 2010, PED ORTH SOC N AM AN; Glorieux FH, 1998, NEW ENGL J MED, V339, P947, DOI 10.1056/NEJM199810013391402; Lascombes P, 2013, J PEDIATR ORTHOPED, V33, P403, DOI 10.1097/BPO.0b013e318285c54d; Lim CT, 2012, J ORTHOP SURG-HONG K, V20, P115; Nicolaou N, 2012, J Child Orthop, V6, P21, DOI 10.1007/s11832-011-0380-0; Nicolaou N, 2011, J BONE JOINT SURG AM, V93A, P1994, DOI 10.2106/JBJS.J.01893; Panzica M, 2004, ARCH ORTHOP TRAUM SU, V124, P341, DOI 10.1007/s00402-004-0644-y	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	JUN	2015	35	4					431	434				4	Orthopedics; Pediatrics	Orthopedics; Pediatrics	CH8ON	WOS:000354295800023		
J	Rengarajan, T; Nandakumar, N; Rajendran, P; Ganesh, MK; Balasubramanian, MP; Nishigaki, I				Rengarajan, Thamaraiselvan; Nandakumar, Natarajan; Rajendran, Peramaiyan; Ganesh, Mohanraj Karthik; Balasubramanian, Maruthaiveeran Periyasamy; Nishigaki, Ikuo			D-pinitol mitigates tumor growth by modulating interleukins and hormones and induces apoptosis in rat breast carcinogenesis through inhibition of NF-kappa B	JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY			English	Article						D-pinitol; Apoptosis; DMBA; Breast cancer; NF-kappa B; Bcl-2; Caspase-3; p53	GLUTARALDEHYDE COAGULATION TEST; PROMOTES APOPTOSIS; NECROSIS-FACTOR; CANCER CELLS; CA 15-3; EXPRESSION; MARKERS; PROLIFERATION; DISEASE; BCL-2	Breast cancer is the most prevalent malignant neoplasm in the world, and chemoprevention through dietary intervention strategy is an emerging option to reduce the incidence. d-pinitol (DP), a major component of soya bean, possesses attractive biological actions. We have investigated whether d-pinitol have an effect on tumor growth in vivo against 7,12-dimethylbenz(a)anthracene (DMBA)-initiated rat mammary carcinogenesis and investigated its mechanism of action. Tumors were induced in Sprague-Dawley (SD) rats by a gastric dose of 20 mg/kg DMBA, and after 13 weeks of induction period, the rats were orally administered with d-pinitol for 45 days. At the end of the assay, animals in carcinogen control group prompted a tumor incidence of 100 % and developed a tumor volume of 8.35 +/- 0.56, which was significantly reduced to 5.74 +/- 0.32 for the animals treated with d-pinitol. The d-pinitol treatment not only decreased the tumor volume but also further examination revealed that tumors from animals that received d-pinitol reduced nuclear factor kappa B (NF-kappa B) activation which in turn results in modulation of its downstreaming p53 and proteins of caspase-3 family. Bcl-2 expression and caspase-3 activation were also decreased after d-pinitol supplementation leading to induction of apoptosis and finally cell death. Furthermore, the status of the inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-2, IL-6, and tumor markers, lipid profile, and hormones was also significantly declined up on d-pinitol administration. Thus, it reveals the collective involvement of the abovementioned parameters along with NF-kappa B signaling through which d-pinitol induces apoptosis and subsequently suppresses breast cancer during DMBA-induced rat breast carcinogenesis.	[Rengarajan, Thamaraiselvan] Univ Sains Malaysia, Sch Med Sci, Dept Chem Pathol, Kelantan 16150, Malaysia; [Rengarajan, Thamaraiselvan; Nandakumar, Natarajan; Balasubramanian, Maruthaiveeran Periyasamy] Univ Madras, Dr ALM Post Grad Inst Basic Med Sci, Dept Pharmacol & Environm Toxicol, Madras 600113, Tamil Nadu, India; [Rajendran, Peramaiyan; Nishigaki, Ikuo] NPO Int Lab Biochem, Nakagawa Ku, Nagoya, Aichi 4540926, Japan; [Nandakumar, Natarajan] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel; [Ganesh, Mohanraj Karthik] Univ Madras, Dept Anat, Dr ALM PG IBMS, Madras 600113, Tamil Nadu, India	Balasubramanian, MP (reprint author), Univ Madras, Dr ALM Post Grad Inst Basic Med Sci, Dept Pharmacol & Environm Toxicol, Taramani Campus, Madras 600113, Tamil Nadu, India.	mpbalupet@rediffmail.com			Department of Science and Technology (DST), New Delhi	The authors are extremely grateful to Dr. R. Venkatakrishna Murali, M.D., Ph.D., Professor and Head, Department of Pharmacology and Environmental Toxicology, Dr. A.L. Mudhaliar Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai-600113 for providing the laboratory facilities and the financial assistance from Department of Science and Technology (DST), New Delhi in the form of DST-PURSE-JRF is gratefully acknowledged and one of the authors "Natarajan Nandakumar" thank Prof. Jacob Gopas PhD, MPH (BGU, Israel) for his useful comments and encouragement. We thank Dr. S. Prakash, Ph.D., Assistant Professor, Department of Anatomy, Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai for interpreting the immunofluorescence micrographs and suggestions. We are also thankful to Mrs. Rita Rajan, CMC Vellore for transmission electron microscope studies and Dr. Sarasabharathy for interpretation.	Aggarwal BB, 2005, CANC TREAT, V126, P103, DOI 10.1007/0-387-24361-5_5; Ahmed Olal I, 2006, Egypt J Immunol, V13, P61; Alexander P, 1975, CRITICAL FACTORS CAN, P213; Anbuselvam C, 2007, CHEM-BIOL INTERACT, V168, P229, DOI 10.1016/j.cbi.2007.04.007; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Kushlinskii NE, 2004, B EXP BIOL MED+, V137, P182, DOI 10.1023/B:BEBM.0000028135.91289.e9; Suchi K, 2011, ANTICANCER RES, V31, P67; Kumar A, 2004, J MOL MED-JMM, V82, P434, DOI 10.1007/s00109-004-0555-y; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Pizarro JG, 2011, NEUROCHEM RES, V36, P187, DOI 10.1007/s11064-010-0296-y; Zuccari DAPD, 2012, ACTA HISTOCHEM, V114, P571, DOI 10.1016/j.acthis.2011.10.007; Santer FR, 2010, ENDOCR-RELAT CANCER, V17, P241, DOI 10.1677/ERC-09-0200; Shyamala G, 2002, J STEROID BIOCHEM, V80, P137, DOI 10.1016/S0960-0760(01)00182-0; Chen Y, 2011, CANCER BIOL THER, V11, P497, DOI 10.4161/cbt.11.5.14667; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Sivakumar S, 2010, CHEM-BIOL INTERACT, V188, P237, DOI 10.1016/j.cbi.2010.07.014; Sethi G, 2008, MOL CANCER THER, V7, P1604, DOI 10.1158/1535-7163.MCT-07-2424; Dabrosin C, 2005, J ENDOCRINOL, V187, P103, DOI 10.1677/joe.1.06163; Vinothkumar V, 2012, MOL CELL BIOCHEM, V369, P17, DOI 10.1007/s11010-012-1364-1; Rengarajan T, 2014, ASIAN PAC J CANCER P, V15, P1757, DOI 10.7314/APJCP.2014.15.4.1757; Barros Alfredo Carlos S D, 2004, Rev Hosp Clin Fac Med Sao Paulo, V59, P257, DOI 10.1590/S0041-87812004000500006; Cagnol S, 2011, J SIGNAL TRANSDUCT, P12; CHANDY KG, 1983, CLIN EXP IMMUNOL, V52, P207; Chatterton RT, 2003, J STEROID BIOCHEM, V86, P159, DOI 10.1016/S0960-0760(03)00266-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Conney AH, 1997, P SOC EXP BIOL MED, V216, P243; DAMEN J, 1984, BIOCHIM BIOPHYS ACTA, V793, P287, DOI 10.1016/0005-2760(84)90331-X; Dao JL, 1959, P SOC EXP BIOL MED, V102, P635; Eun Jung P, 2002, CANC MET REV, V21, P231; Fentiman IS, 2001, INT J CLIN PRACT, V55, P527; Floch J, 1951, J BIOL CHEM, V226, P497; Geren RI, 1972, CANC CHEMOTHER REP, V3, P1; Guney N, 2009, ASIAN PAC J CANCER P, V10, P669; Horn WT, 1981, J LIPID RES, V23, P377; Jose MM, 2008, ARCH TOXICOL, V82, P273; Kachoie P, 2013, CYTOKINE GROWTH F R, V24, P163; Katz, 1983, LARYNGOSCOPE, V93, P445; Kozłowski L, 2003, Rocz Akad Med Bialymst, V48, P82; KUMAR K, 1991, BIOCHEM INT, V23, P581; LAMOUREUX G, 1982, CANCER, V49, P502, DOI 10.1002/1097-0142(19820201)49:3<502::AID-CNCR2820490318>3.0.CO;2-D; Leifeld L, 2006, LIVER INT, V26, P872, DOI 10.1111/j.1478-3231.2006.01300.x; Lin TH, 2013, INT J MOL SCI, V14, P9790, DOI 10.3390/ijms14059790; Liu FS, 2008, J CHIN MED ASSOC, V71, P628, DOI 10.1016/S1726-4901(09)70005-X; Ludwig RL, 1996, MOL CELL BIOL, V16, P49; Nandakumar N, 2011, JETO, V9, P265; Nandhakumar R, 2012, MOL CELL BIOCHEM, V364, P79, DOI 10.1007/s11010-011-1207-5; O'Donovan N, 2003, CLIN CANCER RES, V9, P738; PAREKH AC, 1970, ANAL CHEM, V42, P1423, DOI 10.1021/ac60294a044; PHILLIPS DV, 1982, J AGR FOOD CHEM, V30, P456, DOI 10.1021/jf00111a011; Premkumar VG, 2007, BASIC CLIN PHARMACOL, V100, P387, DOI 10.1111/j.1742-7843.2007.00065.x; Pugalendhi P, 2010, INT J BIOL MED RES, V1, P264; Reed John C., 1995, Current Opinion in Oncology, V7, P541, DOI 10.1097/00001622-199511000-00012; Rengarajan T, 2012, BIOMED PREVENT NUTR, V2, P25; Rice EW, 1970, STANDARD METHODS CLI, V6, P213; ROBERTS MM, 1975, CANCER, V36, P221, DOI 10.1002/1097-0142(197507)36:1<221::AID-CNCR2820360124>3.0.CO;2-P; Satpathy PK, 1996, INDIAN VET J, V73, P257; Sierra A, 2005, DRUG RESIST UPDATE, V8, P247, DOI 10.1016/j.drup.2005.07.001; STIEBER P, 1992, EUR J CLIN CHEM CLIN, V30, P809; TENNANT B, 1979, J AM VET MED ASSOC, V174, P848; Thiyagarajan R, 2012, FOOD CHEM TOXICOL, V50, P867; Uehara M, 2008, INT J CLIN ONCOL, V13, P447, DOI 10.1007/s10147-008-0773-3; VANHANDEL E, 1961, CLIN CHEM, V7, P249; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776	65	0	0	SERVICIO PUBLICACIONES UNIVERSIDAD NAVARRA	PAMPLONA	CAMPUS UNIV, CARRETERA DEL SADAR S-N, APARTADO 177, 31080 PAMPLONA, SPAIN	1138-7548	1877-8755		J PHYSIOL BIOCHEM	J. Physiol. Biochem.	JUN	2015	71	2					191	204		10.1007/s13105-015-0397-9		14	Biochemistry & Molecular Biology; Physiology	Biochemistry & Molecular Biology; Physiology	CH7MX	WOS:000354221900003		
J	Arawatari, R; Ono, T				Arawatari, Ryo; Ono, Tetsuo			A POLITICAL ECONOMY MODEL OF EARNINGS MOBILITY AND REDISTRIBUTION POLICY	JOURNAL OF PUBLIC ECONOMIC THEORY			English	Article							SOCIAL-SECURITY; UNEQUAL SOCIETIES; EQUILIBRIUM; INEQUALITY; RETIREMENT; GOVERNMENT; DYNAMICS; GROWTH	This paper presents a politico-economic model that includes a mutual link between life cycle earnings mobility and redistributive politics. The model demonstrates that when an economy features a high opportunity of upward mobility and high risk of downward mobility, it attains a unique equilibrium where unskilled, low-income agents support a low redistribution because of the hope of upward mobility in future. In contrast, the economy attains multiple equilibria when mobility opportunity and risk are low: one is an unskilled-majority equilibrium defined by low mobility and the other is a skilled-majority equilibrium defined by high mobility. The paper gives a comparison between the political equilibrium and the social planner's allocation in terms of mobility, and shows that the skilled-majority equilibrium realizes mobility close to the optimal one.	[Arawatari, Ryo] Nagoya Univ, Grad Sch Econ, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Ono, Tetsuo] Osaka Univ, Grad Sch Econ, Toyonaka, Osaka 5600043, Japan	Arawatari, R (reprint author), Nagoya Univ, Grad Sch Econ, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	arawatari@soec.nagoya-u.ac.jp; tono@econ.osaka-u.ac.jp			Nomura Foundation	The authors would like to thank associate editor and two anonymous referees for their valuable comments and suggestions. Financial support of the Nomura Foundation is gratefully acknowledged.	Alesina A, 2005, J PUBLIC ECON, V89, P897, DOI 10.1016/j.jpubeco.2004.05.009; Song Z, 2012, ECONOMETRICA, V80, P2785, DOI 10.3982/ECTA8910; Gonzalez-Eiras M, 2012, EUR ECON REV, V56, P97, DOI 10.1016/j.euroecorev.2011.05.007; Forni L, 2005, REV ECON DYNAM, V8, P178, DOI 10.1016/j.red.2004.10.003; Gonzalez-Eiras M, 2008, J MONETARY ECON, V55, P197, DOI 10.1016/j.jmoneco.2007.10.005; Benabou R, 2000, AM ECON REV, V90, P96, DOI 10.1257/aer.90.1.96; Arawatari R, 2011, ECON GOV, V12, P353, DOI 10.1007/s10101-011-0099-x; Arawatari R, 2009, J ECON THEORY, V144, P1249, DOI 10.1016/j.jet.2008.11.002; Arawataria R, 2013, J ECON THEORY, V148, P353, DOI 10.1016/j.jet.2012.12.010; ARAWATARI R., 2012, DISCUSSION PAPERS EC; Azariadis C, 2002, J ECON THEORY, V103, P255, DOI 10.1006/jeth.2001.2857; Benabou R, 2001, Q J ECON, V116, P447, DOI 10.1162/00335530151144078; Chen KJ, 2014, SCAND J ECON, V116, P982, DOI 10.1111/sjoe.12072; Conde-Ruiz JI, 2013, J PUBLIC ECON THEORY, V15, P477, DOI 10.1111/jpet.12026; D'Amato M, 2010, J PUBLIC ECON, V94, P628, DOI 10.1016/j.jpubeco.2010.05.004; Glomm G, 1995, EUROPEAN J POLITICAL, V11, P653; Grossman GM, 1998, ECON J, V108, P1299, DOI 10.1111/1468-0297.00344; Hassler J, 2003, AM ECON REV, V93, P87, DOI 10.1257/000282803321455179; Hassler J, 2005, J MONETARY ECON, V52, P1331, DOI 10.1016/j.jmoneco.2005.08.012; Hassler J, 2007, J ECON THEORY, V133, P127, DOI 10.1016/j.jet.2005.07.013; PIKETTY T, 1995, Q J ECON, V110, P551, DOI 10.2307/2946692; Quadrini V, 1999, J PUBLIC ECON, V74, P263, DOI 10.1016/S0047-2727(99)00029-8; SAINT-PAUL G., 1997, J ECON GROWTH, V2, P155; Song Z, 2011, REV ECON DYNAM, V14, P613, DOI 10.1016/j.red.2011.05.001; Song Z, 2012, INT ECON REV, V53, P175, DOI 10.1111/j.1468-2354.2011.00676.x	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1097-3923	1467-9779		J PUBLIC ECON THEORY	J. Public. Econ. Theory.	JUN	2015	17	3					346	382		10.1111/jpet.12112		37	Economics	Business & Economics	CH7CY	WOS:000354194400004		
J	Shin'ya, U				Shin'ya, Ueda			On the financial structure and personnel organisation of the Trinh Lords in seventeenth to eighteenth-century North Vietnam	JOURNAL OF SOUTHEAST ASIAN STUDIES			English	Article								After the restoration of the Le dynasty, the Red River delta region was flooded with military men who set up and controlled irregular departments from the end of the sixteenth to the first half of the seventeenth century. The imperial administration became a shell during the Le-Tr?nh period, with the Tr?nh Lords as de facto rulers who constructed their own parallel government on the basis of these local departments. This analysis of contemporary inscriptions indicates that the Tr?nh Lords subsequently expanded their administration and secured their rule by absorbing large numbers of Red River delta literati, while retaining many eunuchs in influential financial and military roles. Overall, the Tr?nh bureaucracy, comprising of the L?c Phien and L?c Cung, was a kind of financial organisation combined with a military district system because it harnessed the existing military organisation.		Shin'ya, U (reprint author), Osaka Univ, Suita, Osaka 565, Japan.	uedashinya_vnjp@yahoo.co.jp					[Anonymous], 1762, TAN THAN LUC; [Anonymous], 1628, MAU THAN KHOA; [Anonymous], 1273, BACH TY THU VU, P1273; [Anonymous], 1969, KHAM DINH VIET THONG; [Anonymous], DANG GIA PHA HE TOAN, V4-6, P114; [Anonymous], CHINH HOA TIEN DANH, V421, p27a; [Anonymous], 1353, DAM THI GIA KE; [Anonymous], 2004, NGHIEN CUU LICH, V332, P21; [Anonymous], 2013, J ORIENTAL RES, V72, P100; Chingho Chen, 1984, DAI VIET KY TOAN THU; Giac Ngyen Si, 1961, TRIEU CHIEU LINH THI, P400; Hung Do Duc, 1950, CHUA TRINH VI TRI VA, P298; Manh Trinh Khac, 2005, TONG TAP THAC BAN KH, V1-22; Masahiko Wada, 1978, VIETNAMESE EUNUCHS L, V10, P23; Minoru Shimao, 2010, COMMON PEOPLE CULTUR, P101; Minoru Shimao, 2000, RECONSTRUCTION BLOOD, P213; Ngan Le Kim, 1974, CHE CHINH TRI VIET N, P363; Nghi Dang Phuong, 1969, I PUBLIQUES VIETNAM; Nhue Nguyen Duc, 1997, NGHIEN CUU LICH, V294, P46; Riichiro Fujiwara, 1986, STUDIES HIST SE ASIA, P541; Shinya Ueda, E STUDIES, V119, P91; Shinya Ueda, 2009, J RES DEP TOYO BUNKO, V91, P103; Shinya Ueda, 2010, LOCAL ADM MARITIME W, P256; Shinya Ueda, 2006, TENRI B S ASIAN STUD, V33, P24; Shinya Ueda, 2008, SE ASIAN STUDIES, V46, P38; Sy Le Dinh, 1995, CHUA TRINH 6 TRI VAI, P298; Takao Yao, 2009, POLITICS SOC EARLY D, P117; Takashi Hasuda, 2005, MACHIKANEYAMA RONSO, V39, P1; Tana Li, 2012, A REID STUDY SE ASIA, P246; Tana Li, 1998, NGUYEN COCHINCHINA S; TAYLOR KW, 1987, J SOUTHE ASIAN STUD, V18, P1; Taylor KW, 1998, J ASIAN STUD, V57, P949, DOI 10.2307/2659300; Whitmore J. K., 1995, ESSAYS VIETNAMESE PA, P116; Yumio Sakurai, 1987, FORMATION VIETNAMESE	34	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-4634	1474-0680		J SOUTHEAST ASIAN ST	J. Southeast Asian Stud.	JUN	2015	46	2					246	273		10.1017/S0022463415000077		28	Area Studies; Asian Studies	Area Studies; Asian Studies	CH6AG	WOS:000354117000005		
J	Wasa, K				Wasa, Kiyotaka			Thin Films as Material Engineering	JOURNAL OF SUPERCONDUCTIVITY AND NOVEL MAGNETISM			English	Article						Thin films; Room-temperature diamonds; Layer-by-layer sputtering; High-T-C superconductors; High-T-C ferroelectrics; ZnO SAW; Piezoelectric MEMS	AMORPHOUS-SILICON; SPUTTER-DEPOSITION; SOLAR-CELLS; SI; SUPERCONDUCTIVITY; DEVICES; DIAMOND; PLASMA; SYSTEM; CARBON	Thin films are defined as a two-dimensional material created by condensing, one-by-one, atomic/ lecular/ionic species of matter in contrast to a bulk three-dimensional material. The thin-films have been used for more than a half century for making optical coating, electronic devices, instrument hard coatings, and/or decorative parts. However, e thin-film technology is still being developed on a daily basis since it is a key technology in the twenty-first century for the development of new functional devices. It is also noted that the thin-film technology saves materials and energy consumption. Thin film process is an environment-benign technology. Several deposition processes are used for the thin-film deposition including thermal deposition, chemical vapor deposition, and sputtering deposition. The present author has studied on the sputtering deposition for academic and industrial use for more than 40 years. The sputtering deposition carries exotic/interesting phenomena due to the presence of highly energetic sputtered species. In this paper, the first fundamentals of thin-film materials are described. Then several exotic/interesting phenomena observed in the sputtering deposition are discussed as possible future materials science and technology. The exotic/interesting phenomena include room-temperature growth of diamonds, phase control of high-Curie temperature (T (C)) oxide superconductors, multilayered structure with enhanced piezoelectricity, and extraordinary high-performance ferroelectric thin-films.	Yokohama City Univ, Grad Sch, Nara 6310045, Japan	Wasa, K (reprint author), Yokohama City Univ, Grad Sch, 2-7-27 Chiyogaoka, Nara 6310045, Japan.	kiyotaka.wasa@gmail.com					Ai R, 2000, P SOC PHOTO-OPT INS, V4058, P426, DOI 10.1117/12.397861; AISENBER.S, 1971, J APPL PHYS, V42, P2953, DOI 10.1063/1.1660654; TABATA H, 1994, APPL PHYS LETT, V65, P1970, DOI 10.1063/1.112837; Kanno I, 2003, SENSOR ACTUAT A-PHYS, V107, P68, DOI 10.1016/S0924-4247(03)00234-6; Baek SH, 2011, SCIENCE, V334, P958, DOI 10.1126/science.1207186; JAFFE H, 1965, PR INST ELECTR ELECT, V53, P1372, DOI 10.1109/PROC.1965.4253; YAMAZAKI O, 1980, IEEE T SON ULTRASON, V27, P369; Choi KJ, 2004, SCIENCE, V306, P1005, DOI 10.1126/science.1103218; Parkin SSP, 1999, J APPL PHYS, V85, P5828, DOI 10.1063/1.369932; TIEN PK, 1971, APPL OPTICS, V10, P2395, DOI 10.1364/AO.10.002395; ROSSETTI GA, 1991, APPL PHYS LETT, V59, P2524, DOI 10.1063/1.105940; NEWNHAM RE, 1978, MATER RES BULL, V13, P525, DOI 10.1016/0025-5408(78)90161-7; Wasa K, 2012, J MICROELECTROMECH S, V21, P451, DOI 10.1109/JMEMS.2011.2181156; KINO GS, 1973, J APPL PHYS, V44, P1480, DOI 10.1063/1.1662397; READ MH, 1965, APPL PHYS LETT, V7, P51, DOI 10.1063/1.1754294; CARLSON DE, 1977, RCA REV, V38, P211; Wasa K, 2012, IEEE T ULTRASON FERR, V59, P6, DOI 10.1109/TUFFC.2012.2150; SPEAR WE, 1975, SOLID STATE COMMUN, V17, P1193, DOI 10.1016/0038-1098(75)90284-7; WEIMER PK, 1962, P IRE, V50, P1462, DOI 10.1109/JRPROC.1962.288190; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; Auuciello O., 1998, PHYS TODAY, V51, P22; Bickley W.P., 1962, VIDE, V99, P214; Bunshah R. F., 1994, HDB DEPOSITION TECHN; Bunshah R. F., 1982, DEPOSITION TECHNOLOG; Charles K., 1986, INTRO SOLID STATE PH, V6th; Chen YB, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2819684; Chopra K. L., 1969, THIN FILM PHENOMENA; Chopra K.L., 2001, LECT YOK CIT U; Cross L. E., 1993, FERROELECTRIC CERAMI, P1; Elshabini Aicha A.R., 1998, THIN FILM TECHNOLOGY; Enokihara A, 1997, J SUPERCOND, V10, P49, DOI 10.1007/BF02763951; Francombe M.H., 1987, PHYS THIN FILMS, V13; HADA T, 1970, JPN J APPL PHYS, V9, P1078, DOI 10.1143/JJAP.9.1078; Hamakawa Y., 1993, MRS BULL, V18, P56; Hamakawa Y., 1999, P NESC 99 OS, P25; Hamakawa Y., 1985, 18 IEEE PHOT SPEC C; Hanzawa H., 2014, IEEE T UFFC, V61, P1552; Hass G., 1982, PHYS THIN FILMS, V12; Hass G., 1978, PHYS THIN FILMS, V10; Hass G., 1980, PHYS THIN FILMS, V11; ICHIKAWA Y, 1990, PHYSICA C, V171, P121, DOI 10.1016/0921-4534(90)90463-O; Jagannathan B, 1997, SOL ENERG MAT SOL C, V46, P289, DOI 10.1016/S0927-0248(97)00012-3; Jona F., 1993, FERROELECTRIC CRYSTA, P216; Kanbara H, 2000, JPN J APPL PHYS 1, V39, P3049, DOI 10.1143/JJAP.39.3049; KITABATAKE M, 1986, APPL PHYS LETT, V49, P927, DOI 10.1063/1.97615; KITABATAKE M, 1985, J APPL PHYS, V58, P1693, DOI 10.1063/1.336066; Koba R.J, 1993, DIAMOND FILMS COATIN, P147; Kusao K., 1963, JPN J APPL PHYS, V7, P437; Lakin K.M., 1980, P IEEE ULTRASON S, V29; Liu H., 1995, DIAMOIND CHEM VAPOR, P14; Mahan J. E., 2000, PHYS VAPOR DEPOSITIO; Maissel L I G R, 1970, HDB THIN FILM TECHNO; Muralt P., 2005, P 2005 IEEE ULTR S, V1, P315; Nassau K, 1993, DIAMOND FILMS COATIN, P35; Ohring M., 1992, MAT SCI THIN FILMS; Pehrsson P E, 1993, DIAMOND FILMS COATIN, P68; Pulker H.K., 1984, COATING ON GLASS; SILVA SRP, 1994, J MATER SCI, V29, P4962, DOI 10.1007/BF01151085; Spear W.E., 1972, J NONCRYST SOLIDS, V11, P219; STUART RV, 1964, J APPL PHYS, V35, P1819, DOI 10.1063/1.1713748; Takahashi M., 1971, CPM7122 IEC, P1; TOZER BA, 1965, P I ELECTR ENG, V112, P218; Trolier-McKinstry S, 2004, J ELECTROCERAM, V12, P7, DOI 10.1023/B:JECR.0000033998.72845.51; Trolier-McKinstry S, 2011, IEEE T ULTRASON FERR, V58, P1782, DOI 10.1109/TUFFC.2011.2015; Tsai CS, 1996, P IEEE, V84, P853, DOI 10.1109/5.503142; Vossen J. L., 1978, THIN FILM PROCESSES; Wasa K., 2014, P 2014 ISAF PENN STA, V2nd; Wasa K., 2009, 9 INT WORKSH MICR NA, P61; Wasa K, 2012, HANDBOOK OF SPUTTER DEPOSITION TECHNOLOGY: FUNDAMENTALS AND APPLICATIONS FOR FUNCTIONAL THIN FILMS, NANOMATERIALS, AND MEMS, 2ND EDITION, P1; WASA K, 1967, IEEE TR PARTS MATER, VPMP3, P71, DOI 10.1109/TPMP.1967.1135730; WASA K, 1969, REV SCI INSTRUM, V40, P693, DOI 10.1063/1.1684039; Wasa K., 2012, J MICROELECTROMECH S, V59, P6; Wasa K., 1981, U.S. Patent, Patent No. [4.288.307, 4288307]; WASA K, 1984, J LIGHTWAVE TECHNOL, V2, P710, DOI 10.1109/JLT.1984.1073666; WASA K, 1967, PR INST ELECTR ELECT, V55, P2179, DOI 10.1109/PROC.1967.6113; WASA K, 1978, THIN SOLID FILMS, V52, P31, DOI 10.1016/0040-6090(78)90252-3; Wasa K., 1976, Japanese Patent, Patent No. [51-84840, 5184840]; Wasa K, 1995, B MATER SCI, V18, P937, DOI 10.1007/BF02745181; Wehner W.K, 1989, COMMUNICATION; Yamauchi N, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3126060; Yamauchi N., 2008, P 2008 IEEE ULTR S, V1920; Ye V.Z.-G, 2009, MRS BULL, V34, P277; Yoshida S, 2014, IEEE T ULTRASON FERR, V61, P1552, DOI 10.1109/TUFFC.2014.3069	83	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1939	1557-1947		J SUPERCOND NOV MAGN	J. Supercond. Nov. Magn	JUN	2015	28	6					1665	1680		10.1007/s10948-014-2949-6		16	Physics, Applied; Physics, Condensed Matter	Physics	CH2BK	WOS:000353828900003		
J	Sakurai, K; Muguruma, K; Nagahara, H; Kimura, K; Toyokawa, T; Amano, R; Kubo, N; Tanaka, H; Ohtani, H; Yashiro, M; Maeda, K; Ohira, M; Hirakawa, K				Sakurai, Katsunobu; Muguruma, Kazuya; Nagahara, Hisashi; Kimura, Kenjiro; Toyokawa, Takahiro; Amano, Ryosuke; Kubo, Naoshi; Tanaka, Hiroaki; Ohtani, Hiroshi; Yashiro, Masakazu; Maeda, Kiyoshi; Ohira, Masaichi; Hirakawa, Kosei			The Outcome of Surgical Treatment for Elderly Patients With Gastric Carcinoma	JOURNAL OF SURGICAL ONCOLOGY			English	Article						gastric cancer; elderly patients; gastrectomy; long-term outcome; postoperative treatment	LAPAROSCOPY-ASSISTED GASTRECTOMY; ORAL FLUOROPYRIMIDINE; OPERATIVE MORTALITY; CANCER SURGERY; PATIENTS OLDER; S-1; AGE; CLASSIFICATION; COMPLICATIONS; RESECTION	BackgroundThe aim of this study was to clarify the operative mortality and long-term survival of gastrectomy for elderly patients with gastric cancer. MethodsA total of 461 patients who underwent gastrectomy for gastric cancer in our hospital were classified as elderly group (80 years-old, 95 patients) and control group (60-69 years-old, 366 patients). ResultsThe frequency of comorbidities was significantly (P<0.05) higher in elderly group (74.7%) than that in the control group (49.5%). No significant difference of the postoperative complication rate was found between the elderly group (23.2%) and the control group (23.2%). Adjuvant chemotherapy was 9.5% in the elderly group, which was significantly less than 29.0% of the control group (P<0.05). Stage II and III elderly patients had worse disease specific survival (DSS) than controls did. In the elderly, overall survival (OS) was significantly worse than DSS in stage I patients (P<0.05). ConclusionsThe operative complication rate of elderly patients was comparable to the control group. Comorbidity and occurrence of secondary malignant disease should be followed for elderly patients at stage I. For stage II and III disease patients, a novel drug which is acceptable for the elderly is needed as a postoperative therapy. J. Surg. Oncol. 2015 111:848-854. (c) 2014 Wiley Periodicals, Inc.	[Sakurai, Katsunobu; Muguruma, Kazuya; Nagahara, Hisashi; Kimura, Kenjiro; Toyokawa, Takahiro; Amano, Ryosuke; Kubo, Naoshi; Tanaka, Hiroaki; Ohtani, Hiroshi; Yashiro, Masakazu; Maeda, Kiyoshi; Ohira, Masaichi; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 5458585, Japan	Sakurai, K (reprint author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	m1157473@med.osaka-cu.ac.jp					Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4; Mochiki E, 2005, WORLD J SURG, V29, P1585, DOI 10.1007/s00268-005-0208-5; Hwang SH, 2009, J AM COLL SURGEONS, V208, P186, DOI 10.1016/j.jamcollsurg.2008.10.023; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Katai H, 1998, JPN J CLIN ONCOL, V28, P112, DOI 10.1093/jjco/28.2.112; Endo S, 2011, GASTRIC CANCER, V14, P139, DOI 10.1007/s10120-011-0022-8; Tsushima T, 2013, INT J CLIN ONCOL, V18, P10, DOI 10.1007/s10147-011-0335-y; Katai H, 2004, SURG ONCOL, V13, P235, DOI 10.1016/j.suronc.2004.09.007; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; HABU H, 1989, HEPATO-GASTROENTEROL, V36, P71; Sano T, 2011, GASTRIC CANCER, V14, P97, DOI 10.1007/s10120-011-0040-6; Bittner R, 1996, ANN SURG, V224, P37, DOI 10.1097/00000658-199607000-00006; Takeshita H, 2013, WORLD J SURG, V37, P2891, DOI 10.1007/s00268-013-2210-7; Tokunaga M, 2008, J GASTROINTEST SURG, V12, P1502, DOI 10.1007/s11605-008-0567-y; Yasuda K, 2004, BRIT J SURG, V91, P1061, DOI 10.1002/bjs.4615; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Saidi RF, 2004, J SURG RES, V118, P15, DOI 10.1016/S0022-4804(03)00353-6; Aoyama T, 2012, GASTRIC CANCER, V15, P76, DOI 10.1007/s10120-011-0068-7; Boyle P, 2008, IARC WORLD CANC REPO; Gretschel S, 2006, WORLD J SURG, V30, P1468, DOI 10.1007/s00268-005-0633-5; Japanese Gastric Cancer Association, 2014, JAP GASTR CANC TREAT; Kojima K, 2010, J SURG RES, V161, P259; Matsuda T, 2008, JPN J CLIN ONCOL, V38, P641, DOI 10.1093/jjco/hyn074; Otani Y, 2000, J GASTROEN HEPATOL, V15, P507, DOI 10.1046/j.1440-1746.2000.02191.x; Otsuji E, 2005, J SURG ONCOL, V91, P232, DOI 10.1002/jso.20330; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Statistical and Information Department MoH, LAB WELF LIF EXP MAJ; THOMAS DR, 1995, J AM GERIATR SOC, V43, P811; Wu CW, 2000, WORLD J SURG, V24, P465; Yamada H, 2013, INT J SURG, V11, P467, DOI 10.1016/j.ijsu.2013.04.005; Yamanaka T, 2008, CANCER CHEMOTH PHARM, V61, P335, DOI 10.1007/s00280-007-0595-4	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4790	1096-9098		J SURG ONCOL	J. Surg. Oncol.	JUN 1	2015	111	7					848	854		10.1002/jso.23896		7	Oncology; Surgery	Oncology; Surgery	CH4IE	WOS:000353996400010		
J	Park, SY; Choi, GS; Park, JS; Kim, HJ; Sakai, Y; Hasegawa, S; Watanabe, T; Kim, SH				Park, Soo Yeun; Choi, Gyu-Seog; Park, Jun Seok; Kim, Hye Jin; Sakai, Yoshiharu; Hasegawa, Suguru; Watanabe, Toshiaki; Kim, Seon Hahn			Distinctive Oncological Features of Stage IIIA Colorectal Cancer: Analysis of Prognostic Factors for Selective Adjuvant Chemotherapy	JOURNAL OF SURGICAL ONCOLOGY			English	Article						colorectal cancer; stage IIIA; prognosis; adjuvant chemotherapy	AMERICAN JOINT COMMITTEE; RECTAL-CANCER; COLON-CANCER; POOLED ANALYSIS; 7TH EDITION; SURVIVAL; TUMOR; CLASSIFICATION; CATEGORIZATION; FLUOROURACIL	IntroductionIn the seventh TNM classification, stage IIIA includes tumors with early stage of bowel wall invasion and regional lymph node metastasis. We investigated the validity of the current TNM classification of patients with stage IIIA colorectal cancer and identified prognostic factors of them for ameliorating treatment strategies for them. MethodsThis study included the participation of four tertiary hospitals. A total of 4,236 patients with Stages I-IIIB colorectal cancer were analyzed. The primary end point was the 5-year relapse-free survival. ResultsThe 5-year relapse-free survival of patients with stage IIIA disease was similar to that of patients with stage IIA. The 5-year relapse-free survival was 88.9% in the chemotherapy group (n=152) and 82.3% in the no-chemotherapy group (n=36, P=0.111). Tumor differentiation (moderate or poor) and venous invasion were independent prognostic factors of relapse-free survival. ConclusionsThe relapse-free survival of patients with stage IIIA tumors was similar to that of patients with stage IIA tumors, and the prognosis of stage IIIA tumors varied significantly by the tumor factors identified. These factors can be used to predict the risk of disease recurrence and to optimize the use of adjuvant chemotherapy. J. Surg. Oncol. 2015 111:882-890. (c) 2014 Wiley Periodicals, Inc.	[Park, Soo Yeun; Park, Jun Seok; Kim, Hye Jin] Kyungpook Natl Univ, Med Ctr, Colorectal Canc Ctr, Sch Med, Taegu 702210, South Korea; [Sakai, Yoshiharu; Hasegawa, Suguru] Kyoto Univ Hosp, Dept Surg, Kyoto 606, Japan; [Watanabe, Toshiaki] Univ Tokyo, Fac Med, Dept Surg Oncol, Tokyo 113, Japan; [Kim, Seon Hahn] Korea Univ, Anam Hosp, Dept Surg, Seoul, South Korea	Choi, GS (reprint author), Kyungpook Natl Univ, Med Ctr, Colorectal Canc Ctr, 807 Hogukro, Taegu 702210, South Korea.	kyuschoi@mail.knu.ac.kr			Biomedical Research Institute; Kyungpook National University Hospital	Grant sponsor: Biomedical Research Institute.; Grant sponsor: Kyungpook National University Hospital (2012).	Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Gunderson LL, 2010, J CLIN ONCOL, V28, P256, DOI 10.1200/JCO.2009.23.9194; Chang HC, 2012, ANN SURG ONCOL, V19, P2477, DOI 10.1245/s10434-012-2303-9; Kim KH, 2011, COLORECTAL DIS, V13, pE220, DOI 10.1111/j.1463-1318.2011.02625.x; Al-Sukhni E, 2012, ANN SURG ONCOL, V19, P2212, DOI 10.1245/s10434-011-2210-5; Gunderson LL, 2010, J CLIN ONCOL, V28, P264, DOI 10.1200/JCO.2009.24.0952; Benson AB, 2013, J NATL COMPR CANC NE, V11, P519; Gunderson LL, 2004, J CLIN ONCOL, V22, P1785, DOI 10.1200/JCO.2004.08.173; Gray R, 2001, LANCET, V358, P1291; Dukes CE, 1940, J PATHOL BACTERIOL, V50, P527, DOI 10.1002/path.1700500314; LABIANCA R, 1995, LANCET, V345, P939; Kariv Y, 2008, DIS COLON RECTUM, V51, P1459, DOI 10.1007/s10350-008-9346-9; Lan YT, 2012, INT J COLORECTAL DIS, V27, P657, DOI 10.1007/s00384-011-1366-6; Lee Yoo Sung, 2012, J Korean Soc Coloproctol, V28, P259, DOI 10.3393/jksc.2012.28.5.259; Mukai M, 2011, ONCOL REP, V26, P209, DOI 10.3892/or.2011.1280; Nitsche Ulrich, 2011, Ann Surg, V254, P793, DOI 10.1097/SLA.0b013e3182369101; Park JS, 2012, J SURG ONCOL, V106, P674, DOI 10.1002/jso.23117; Gray R, 2007, LANCET, V370, P2020; Sobin LH, 2009, TNM CLASSIFICATION M; Sobin LH, 2002, TNM CLASSIFICATION M; Sobin LH, 1997, TNM CLASSIFICATION M	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4790	1096-9098		J SURG ONCOL	J. Surg. Oncol.	JUN 1	2015	111	7					882	890		10.1002/jso.23892		9	Oncology; Surgery	Oncology; Surgery	CH4IE	WOS:000353996400015		
J	Zhang, ZW; Yang, JJ; Yu, YS; Huang, HY; Ye, WX; Yan, WY; Shen, H; Ii, M; Shen, ZY				Zhang, Zhiwei; Yang, Junjie; Yu, Yunsheng; Huang, Haoyue; Ye, Wenxue; Yan, Weiya; Shen, Han; Ii, Masaaki; Shen, Zhenya			Preoperative ejection fraction determines early recovery of left ventricular end-diastolic dimension after aortic valve replacement for chronic severe aortic regurgitation	JOURNAL OF SURGICAL RESEARCH			English	Article						Aortic regurgitation; Aortic valve replacement; Left ventricular end-diastolic dimension; Recovery; Ejection fraction	ASYMPTOMATIC PATIENTS; STROKE VOLUME; DILATATION; GUIDELINES; STENOSIS; SURVIVAL; OUTCOMES	Background: In patients with chronic severe aortic regurgitation (AR), aortic valve replacement (AVR) has been proved to promote left ventricular (LV) remodeling, especially LV end-diastolic dimension (LVEDD) reduction. However, there is little research whether postoperative LVEDD could return to normal parameter after AVR. The objective of this study was to determine predictors for the recovery of dilated LVEDD early after AVR. Methods: The echocardiographic data of 105 patients, who underwent AVR for chronic pure AR between January 2005 and December 2011, were analyzed at the preoperative (3-7 d), early (6-8 mo), and late (2-y) postoperative stages, retrospectively. According to the baseline level, LVEDD >70 mm or LV end-systolic dimension (LVESD) >50 mm or LVESD index >25 mm/m(2) were defined as severe LV dilation. Patients were then categorized into two groups (group 1: severe LV dilation; group 2: nonsevere LV dilation). Results: In all patients, four-fifth of the reduction in LV dimension occurred at early (6 -8 mo) postoperative stage. The patients in both groups had significant decreases in the LVEDD and LVESD early after AVR, with an additional but insignificant reduction at late postoperative stage. The ejection fraction (EF) in both groups significantly increased at either early or late stage. However, the LVEDD and LVESD in group 1 were larger than those in group 2, and the EF in group 1 was lower than that in group 2 at early postoperative stage. By multivariate analysis, we found that the preoperative EF was a good predictor for the recovery of dilated LVEDD early after AVR (P = 0.009). Receiver-operating characteristics analysis showed that EF >52% was the best cut-off value for the recovery of LVEDD. Conclusions: In patients with chronic pure AR, preoperative EF may be a good predictor for successful recovery of dilated LVEDD early after AVR. (C) 2015 Elsevier Inc. All rights reserved.	[Zhang, Zhiwei; Yu, Yunsheng; Huang, Haoyue; Ye, Wenxue; Yan, Weiya; Shen, Han; Shen, Zhenya] Soochow Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Suzhou, Peoples R China; [Zhang, Zhiwei; Yang, Junjie; Yu, Yunsheng; Huang, Haoyue; Ye, Wenxue; Yan, Weiya; Shen, Han; Shen, Zhenya] Soochow Univ, Affiliated Hosp 1, Inst Cardiovasc Sci, Suzhou, Peoples R China; [Ii, Masaaki] Osaka Med Coll, Dept Pharmacol, Grp Translat Stem Cell Res, Osaka, Japan	Shen, ZY (reprint author), Soochow Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Suzhou, Peoples R China.	shenzhenya2014@126.com					Nishimura RA, 2014, CIRCULATION, V129, pE521, DOI 10.1161/CIR.0000000000000031; Enriquez-Sarano M, 2004, NEW ENGL J MED, V351, P1539, DOI 10.1056/NEJMcp030912; Borer JS, 1998, CIRCULATION, V97, P525; LEWIS JF, 1984, CIRCULATION, V70, P425; Brown ML, 2009, ANN THORAC SURG, V87, P1170, DOI 10.1016/j.athoracsur.2008.12.086; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; CARABELLO BA, 1990, CIRCULATION, V82, P1051; BONOW RO, 1991, CIRCULATION, V84, P1625; Chaliki HP, 2002, CIRCULATION, V106, P2687, DOI 10.1161/01.CIR.0000038498.59829.38; Klodas E, 1996, J AM COLL CARDIOL, V27, P670, DOI 10.1016/0735-1097(95)00525-0; BONOW RO, 1988, CIRCULATION, V78, P1108; Cho SH, 2010, CIRC J, V74, P2340, DOI 10.1253/circj.CJ-10-0278; Enache R, 2010, ECHOCARDIOGR-J CARD, V27, P915, DOI 10.1111/j.1540-8175.2010.01193.x; Ferrari R, 2009, CIRC J, V73, P1973; Lamb HJ, 2002, J AM COLL CARDIOL, V40, P2182, DOI 10.1016/S0735-1097(02)02604-9; Park HW, 2012, AM J CARDIOL, V109, P1782, DOI 10.1016/j.amjcard.2012.02.024; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Senechal M, 2011, AM J CARDIOL, V108, P1008, DOI 10.1016/j.amjcard.2011.05.035; TORNOS MP, 1995, AM HEART J, V130, P333, DOI 10.1016/0002-8703(95)90450-6; Vahanian A, 2012, EUR HEART J, V33, P2451	21	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN 1	2015	196	1					49	55		10.1016/j.jss.2015.02.069		7	Surgery	Surgery	CH9EE	WOS:000354338000007		
J	Matsuda, A; Miyashita, M; Matsumoto, S; Sakurazawa, N; Takahashi, G; Yamada, M; Uchida, E				Matsuda, Akihisa; Miyashita, Masao; Matsumoto, Satoshi; Sakurazawa, Nobuyuki; Takahashi, Goro; Yamada, Marina; Uchida, Eiji			Isoperistaltic versus antiperistaltic stapled side-to-side anastomosis for colon cancer surgery: a randomized controlled trial	JOURNAL OF SURGICAL RESEARCH			English	Article						Colon cancer; Anastomosis; Stapled side-to-side anastomosis; Surgery; Leakage	HAND-SEWN ANASTOMOSES; CROHNS-DISEASE; END ANASTOMOSIS; RESECTION; CARCINOMA; COLECTOMY	Background: Isoperistaltic stapled side-to-side anastomosis (SSSA), which is a modified technique from conventional antiperistaltic SSSA, has the benefits of antiperistaltic SSSA but requires less intestinal mobility. The aim of this randomized controlled trial was to evaluate short-term outcomes of isoperistaltic SSSA comparing them with antiperistaltic SSSA during colon cancer surgery. Materials and methods: We conducted a randomized controlled trial of patients with colon cancer who underwent elective curative resection and had enough intestinal mobility at anastomosis. The primary outcome was the presence of anastomotic failure, including leakage, hemorrhage, and stenosis. Results: Between July 2012 and January 2014, forty patients were enrolled (20 patients in each group). The study was suspended on detecting excess morbidity in the isoperistaltic SSSA group. No significant differences were observed in all preoperative backgrounds between the two groups. Anastomotic leakage was seen in two patients in the isoperistaltic SSSA group, compared with none in the antiperistaltic SSSA group, although the difference was not statistically significant (P = 0.487). One patient in the antiperistaltic SSSA group had anastomotic stenosis, which improved conservatively, compared with none in the isoperistaltic SSSA group (P = 1.000). No anastomotic hemorrhage was seen in either group. There was no significant difference in the median postoperative hospital stay (P = 0.313). Conclusions: This study did not show any short-term advantage or disadvantage of isoperistaltic SSSA compared with that of antiperistaltic SSSA. However, considering that anastomotic leakage occurred only in the isoperistaltic SSSA group, additional modifications are recommended to perform safe isoperistaltic SSSA for colon surgery. (C) 2015 Elsevier Inc. All rights reserved.	[Matsuda, Akihisa; Miyashita, Masao; Matsumoto, Satoshi; Sakurazawa, Nobuyuki; Takahashi, Goro] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Surg, Inzai, Chiba 2701694, Japan; [Uchida, Eiji] Nippon Med Sch, Dept Surg, Tokyo 113, Japan	Matsuda, A (reprint author), Chiba Hokusoh Hosp, Nippon Med Sch, Dept Surg, 1715 Kamagari, Inzai, Chiba 2701694, Japan.	a-matsu@nms.ac.jp					Yamamoto S, 2014, ANN SURG, V260, P23, DOI 10.1097/SLA.0000000000000499; Resegotti A, 2005, DIS COLON RECTUM, V48, P464, DOI 10.1007/s10350-004-0786-6; Green BL, 2013, BRIT J SURG, V100, P75, DOI 10.1002/bjs.8945; STEICHEN FM, 1968, SURGERY, V64, P948; KRACHT M, 1993, INT J COLORECTAL DIS, V8, P29, DOI 10.1007/BF00341273; Choy PYG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004320.pub3; Cologne KG, 2015, J AM COLL SURGEONS, V220, P281, DOI 10.1016/j.jamcollsurg.2014.12.007; Galandiuk S, 1998, DIGEST SURG, V15, P655, DOI 10.1159/000018671; Hallbook O, 1996, BRIT J SURG, V83, P389, DOI 10.1002/bjs.1800830330; Hashemi M, 1998, DIS COLON RECTUM, V41, P1293, DOI 10.1007/BF02258231; Kawaguchi K, 2012, RINSHO GEKA, V67, P1202; Kawahara H, 2007, INT SURG, V92, P34; Kawahara H, 2009, HEPATO-GASTROENTEROL, V56, P352; Kusunoki M, 1998, DIGEST SURG, V15, P679, DOI 10.1159/000018677; KYZER S, 1992, INT J COLORECTAL DIS, V7, P125, DOI 10.1007/BF00360351; Munoz-Juarez M, 2001, DIS COLON RECTUM, V44, P20, DOI 10.1007/BF02234814; Negami N, 2010, NIHON RINSHO GEKA GA, V71, P1216, DOI 10.3919/jjsa.71.1216; Tewari M, 2005, J SURG ONCOL, V89, P99, DOI 10.1002/jso.20191; Veldkamp R, 2009, LANCET ONCOL, V10, P44; Yamamoto T, 1999, SURG TODAY, V29, P679	20	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN 1	2015	196	1					107	112		10.1016/j.jss.2015.02.059		6	Surgery	Surgery	CH9EE	WOS:000354338000016		
J	Koutakis, P; Myers, SA; Cluff, K; Ha, DM; Haynatzki, G; McComb, RD; Uchida, K; Miserlis, D; Papoutsi, E; Johanning, JM; Casale, GP; Pipinos, II				Koutakis, Panagiotis; Myers, Sara A.; Cluff, Kim; Ha, Duy M.; Haynatzki, Gleb; McComb, Rodney D.; Uchida, Koji; Miserlis, Dimitrios; Papoutsi, Evlampia; Johanning, Jason M.; Casale, George P.; Pipinos, Iraklis I.			Abnormal myofiber morphology and limb dysfunction in claudication	JOURNAL OF SURGICAL RESEARCH			English	Article						Claudication; Walking distance; Myofiber morphology	PERIPHERAL ARTERIAL-DISEASE; SKELETAL-MUSCLE; OXIDATIVE DAMAGE; INTERMITTENT CLAUDICATION; GASTROCNEMIUS-MUSCLE; JOINT POWERS; SARCOPENIA; STRENGTH; ONSET; DEGENERATION	Background: Peripheral artery disease (PAD), which affects an estimated 27 million people in Europe and North America, is caused by atherosclerotic plaques that limit blood flow to the legs. Chronic, repeatedischemiainthe lower legmuscles of PAD patients is associated with loss of normal myofiber morphology and myofiber degradation. In this study, we tested the hypothesis that myofiber morphometrics of PAD calf muscle are significantly different from normal calf muscle and correlate with reduced calf muscle strength and walking performance. Methods: Gastrocnemius biopsies were collected from 154 PAD patients (Fontaine stage II) and 85 control subjects. Morphometric parameters of gastrocnemius fibers were determined and evaluated for associations with walking distances and calf muscle strength. Results: Compared with control myofibers, PAD myofiber cross-sectional area, major and minor axes, equivalent diameter, perimeter, solidity, and density were significantly decreased (P < 0.005), whereas roundness was significantly increased (P < 0.005). Myofiber morphometric parameters correlated with walking distances and calf muscle strength. Multiple regression analyses demonstrated myofiber cross-sectional area, roundness, and solidity as the best predictors of calf muscle strength and 6-min walking distance, whereas cross-sectional area was the main predictor of maximum walking distance. Conclusions: Myofiber morphometrics of PAD gastrocnemius differ significantly from those of control muscle and predict calf muscle strength and walking distances of the PAD patients. Morphometric parameters of gastrocnemius myofibers may serve as objective criteria for diagnosis, staging, and treatment of PAD. (C) 2015 Elsevier Inc. All rights reserved.	[Koutakis, Panagiotis; Ha, Duy M.; Miserlis, Dimitrios; Papoutsi, Evlampia; Johanning, Jason M.; Casale, George P.; Pipinos, Iraklis I.] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE USA; [Myers, Sara A.] Univ Nebraska, Nebraska Biomechan Core Facil, Omaha, NE 68182 USA; [Cluff, Kim] Wichita State Univ, Dept Ind & Mfg Engn, Wichita, KS USA; [Haynatzki, Gleb] Univ Nebraska Med Ctr, Dept Biostat, Coll Publ Hlth, Omaha, NE USA; [McComb, Rodney D.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Uchida, Koji] Nagoya Univ, Grad Sch Bioagricultural Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan; [Pipinos, Iraklis I.] VA Nebraska Western Iowa Hlth Care Syst, Dept Surg & VA Res Serv, Omaha, NE USA	Casale, GP (reprint author), Univ Nebraska Med Ctr 987690, Dept Surg, Omaha, NE 68198 USA.	gpcasale@unmc.edu; ipipinos@unmc.edu			NIH [R01AG034995]; Charles and Mary Heider Fund for Excellence in Vascular Surgery; Alexander S. Onassis Public Benefit Foundation [F-ZD036]; American Heart Association Pre-Doctoral Fellowship [13PRE13860010]; Department of Veterans' Affairs, Veterans Health Administration, Rehabilitation Research, and Development Service [1I01RX000604]; National Institute of General Medical Sciences of the National Institutes of Health [P20GM109090]; VA Nebraska-Western Iowa Health Care System	This work was primarily supported by NIH grant R01AG034995, by the Charles and Mary Heider Fund for Excellence in Vascular Surgery, by the Alexander S. Onassis Public Benefit Foundation F-ZD036, and by the American Heart Association Pre-Doctoral Fellowship 13PRE13860010. Secondary funding was provided by the Department of Veterans' Affairs, Veterans Health Administration, Rehabilitation Research, and Development Service 1I01RX000604 and by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM109090. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Furthermore, this material is the result of work supported with resources and the use of facilities at the VA Nebraska-Western Iowa Health Care System.	Celis R, 2009, J VASC SURG, V49, P127, DOI 10.1016/j.jvs.2008.08.013; Pipinos II, 2008, VASC ENDOVASC SURG, V42, P101, DOI 10.1177/1538574408315995; Weiss DJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-230; Koutakis P, 2010, J VASC SURG, V52, P340, DOI 10.1016/j.jvs.2010.03.005; Pipinos II, 2006, FREE RADICAL BIO MED, V41, P262, DOI 10.1016/j.freeradbiomed.2006.04.003; Myers SA, 2011, CLIN BIOMECH, V26, P729, DOI 10.1016/j.clinbiomech.2011.03.005; Brass EP, 2000, VASC MED, V5, P55, DOI 10.1177/1358836X0000500109; Hortobagyi T, 2000, J PHYSIOL-LONDON, V524, P293, DOI 10.1111/j.1469-7793.2000.00293.x; Brevetti G, 2010, CIRCULATION, V122, P1862, DOI 10.1161/CIRCULATIONAHA.109.918417; Cluff K, 2013, AM J PHYSIOL-REG I, V305, pR291, DOI 10.1152/ajpregu.00525.2012; Wurdeman SR, 2012, GAIT POSTURE, V36, P506, DOI 10.1016/j.gaitpost.2012.05.004; McDermott MM, 2012, J AM COLL CARDIOL, V59, P1159, DOI 10.1016/j.jacc.2011.12.019; Scott-Pandorf MM, 2007, J VASC SURG, V46, P491, DOI 10.1016/j.jvs.2007.05.029; Chumlea WMC, 2011, J NUTR HEALTH AGING, V15, P450, DOI 10.1007/s12603-011-0092-7; Koutakis P, 2014, REDOX BIOL, V2, P921, DOI 10.1016/j.redox.2014.07.002; Dodson S, 2011, ANNU REV MED, V62, P265, DOI 10.1146/annurev-med-061509-131248; Koutakis P, 2010, J VASC SURG, V51, P80, DOI 10.1016/j.jvs.2009.07.117; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Bloch RJ, 2003, EXERC SPORT SCI REV, V31, P73, DOI 10.1097/00003677-200304000-00004; Barillaro C, 2013, AGING CLIN EXP RES, V25, P119, DOI 10.1007/s40520-013-0030-0; Bauer TA, 2004, J VASC SURG, V40, P488, DOI 10.1016/j.jvs.2004.06.025; Brotto M, 2012, J PHARMACOL EXP THER, V343, P540, DOI 10.1124/jpet.112.191759; Creasy T S, 1990, Eur J Vasc Surg, V4, P135, DOI 10.1016/S0950-821X(05)80427-X; Fanin M, 2013, NEUROPATH APPL NEURO, V39, P762, DOI 10.1111/nan.12034; Gardner AW, 2001, VASC MED, V6, P9, DOI 10.1177/1358836X0100600103; GARDNER AW, 1992, MED SCI SPORT EXER, V24, P163; Hedberg B, 1989, Eur J Vasc Surg, V3, P315, DOI 10.1016/S0950-821X(89)80067-2; HEDBERG B, 1988, INT ANGIOL, V7, P50; Koutakis P, 2015, J HISTOCHEM CYTOCHEM, V63, P256, DOI 10.1369/0022155415569348; MAKITIE J, 1977, ARCH PATHOL LAB MED, V101, P658; Makris KI, 2007, VASCULAR, V15, P336, DOI 10.2310/6670.2007.00054; McDermott MM, 2007, J VASC SURG, V46, P87, DOI 10.1016/j.jvs.2007.02.064; McDermott MM, 2004, J VASC SURG, V39, P523, DOI 10.1016/j.jvs.2003.08.038; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; PERNOW B, 1968, SCAND J CLIN LAB INV, V21, P277, DOI 10.3109/00365516809076995; Pipinos Iraklis I, 2007, Vasc Endovascular Surg, V41, P481, DOI 10.1177/1538574407311106; REGENSTEINER JG, 1993, CIRCULATION, V87, P413; Sanger JW, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/858606; Sanger JW, 2004, MYOLOGY, P45; Spirig R, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/181394	40	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN 1	2015	196	1					172	179		10.1016/j.jss.2015.02.011		8	Surgery	Surgery	CH9EE	WOS:000354338000025		
J	Nishi, Y; Inagaki, T; Li, YR; Hirama, S; Kikuchi, N				Nishi, Yasuyuki; Inagaki, Terumi; Li, Yanrong; Hirama, Sou; Kikuchi, Norio			Unsteady Flow Analysis of an Axial Flow Hydraulic Turbine with Collection Devices Comprising a Different Number of Blades	JOURNAL OF THERMAL SCIENCE			English	Article						Hydraulic Turbine; Runner; Collection Device; Performance; Unsteady Flow Analysis		We previously devised a new type of portable hydraulic turbine that uses the kinetic energy of an open-channel flow to improve output power by catching and accelerating the flow. The turbine contains an axial flow runner with an appended collection device and a diffuser section that is not axisymmetric. The objective of this study is to determine how interference between the collection device and the runner influences performance characteristics of the turbine. We investigated the performance characteristics of the turbine and flow field for different numbers of blades during both unsteady and steady flow. During an unsteady flow, the maximum values of power coefficients for three and two blades increased by approximately 8.8% and 21.4%, respectively, compared to those during a steady flow. For the three-blade runner, the power coefficient showed small fluctuations, but for the two-blade runner, the power coefficient showed large fluctuations. These fluctuations in the power coefficient are attributed to fluctuations in the loading coefficient, which were generated by interference between the runner and the diffuser section of the collection device.	[Nishi, Yasuyuki; Inagaki, Terumi; Li, Yanrong] Ibaraki Univ, Dept Mech Engn, Hitachi, Ibaraki 3168511, Japan; [Hirama, Sou] Ibaraki Univ, Grad Sch Sci & Engn, Hitachi, Ibaraki 3168511, Japan; [Kikuchi, Norio] Ibasei Ltd, Hitachi, Ibaraki 3170064, Japan	Nishi, Y (reprint author), Ibaraki Univ, Dept Mech Engn, 4-12-1 Nakanarusawa Cho, Hitachi, Ibaraki 3168511, Japan.				Program for Revitalization Promotion, JST	We acknowledge that a part of the study has been subsidized by Program for Revitalization Promotion, JST (Potential Test Type alpha). We express our gratitude here.	Khan MJ, 2009, APPL ENERG, V86, P1823, DOI 10.1016/j.apenergy.2009.02.017; Gaden DLF, 2010, RENEW ENERG, V35, P1152, DOI 10.1016/j.renene.2009.11.023; Ohya Y, 2010, ENERGIES, V3, P634, DOI 10.3390/en3040634; ANSYS Inc., 2010, ANSYS CFX SOLV MOD G, P142; Anyi M, 2010, ENERGY SUSTAIN DEV, V14, P110, DOI 10.1016/j.esd.2010.02.003; CAPECCHI D, 2013, ADV HIST STUDIES, V2, P131; Cui B., 2012, OPEN J FLUID DYNAMIC, V2, P305; Fujiwara Y., 1987, T JAPAN SOC MECH ENG, V90, P212; Inagalci A., 2005, TURBOMACHINERY, V33, P614; Inoue M., 2002, TURBOMACHINERY, V30, P497; Matsumiya H., 2001, TURBOMACHINERY, V29, P519; Nakajima M., 2008, J FLUID SCI TECHNOLO, V3, P420, DOI DOI 10.1016/J.RENENE.2009.07.004; Nicolet Christophe, 2010, International Journal of Fluid Machinery and Systems, V4, DOI 10.5293/IJFMS.2011.4.1.179; Nishi Y, 2013, TURBOMACHINERY, V41, P233; Nishi Y., 2014, INT J ROTATING MACHI, V2014, P1; Nishi Y, 2014, TURBOMACHINERY, V42, P107; Ohya Y., 2002, J JPN SOC AERONAUT S, V50, P477, DOI 10.2322/jjsass.50.477; Reynolds T. S., 1983, STRONGER 100 MEN HIS; Sun H., 2012, J JAPAN SOC NAVAL AR, V16, P25; Toshimitsu K, 2008, J THERM SCI, V17, P375, DOI 10.1007/s11630-008-0375-4	20	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1003-2169	1993-033X		J THERM SCI	J. Therm. Sci.	JUN	2015	24	3					239	245	1003-2169(2015)03-0239-07	10.1007/s11630-015-0779-x		7	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CH6MU	WOS:000354151500005		
J	Zhang, G; Setoguchi, T; Kim, HD				Zhang, Guang; Setoguchi, Toshiaki; Kim, Heuy Dong			Numerical Simulation of Flow Characteristics in Micro Shock Tubes	JOURNAL OF THERMAL SCIENCE			English	Article						Micro shock tube; Shock wave propagation; Slip wall; Unsteady flow; CFD	PRESSURE	Recently micro shock tubes have been widely used in many engineering and industrial fields, but the characteristics of unsteady flow are not well known to date in micro shock tubes. Compared to conventional shock tubes with macro scales, flows related to shock waves in micro shock tubes are highly complicated. Stronger viscous and dissipative interactions make shock wave dynamic behaviors significantly different from theoretical predictions. In the present study, a CFD work was applied to the unsteady compressible Navier-Stokes equations which were solved using a fully implicit finite volume scheme. The diaphragm pressure ratio and shock tube diameter were varied to investigate their effects on micro shock tube flows. Different wall boundary conditions were also performed to observe shock wave and contact surface propagation with no slip and slip walls. Detailed flow characteristics at the foot of shock wave and contact surface propagation were known from the present numerical simulations.	[Zhang, Guang; Kim, Heuy Dong] Andong Natl Univ, Dept Mech Engn, Andong 760749, South Korea; [Setoguchi, Toshiaki] Saga Univ, Dept Mech Engn, Saga 840, Japan	Zhang, G (reprint author), Andong Natl Univ, Dept Mech Engn, Andong 760749, South Korea.				National Research Foundation of Korea (NRF) - Korea government (MEST) [2011-0017506]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2011-0017506).	Bhaskaran KA, 2002, PROG ENERG COMBUST, V28, P151, DOI 10.1016/S0360-1285(01)00011-9; Arun K. R., 2012, J KOREAN SOC VISUALI, V10, P40; Arun K. R., 2012, JMST, V27, P451; Brouillette M, 2003, SHOCK WAVES, V13, P3, DOI 10.1007/s00193-003-0191-4; DUFF RE, 1959, PHYS FLUIDS, V2, P207, DOI 10.1063/1.1705910; Hu Xiao, 2012, OPEN J FLUID DYNAMIC, V2, P285; Karniadakis G E. M., 2000, MICRO FLOWS FUNDAMEN; MIRELS H, 1963, PHYS FLUIDS, V6, P1201, DOI 10.1063/1.1706887; Ngomo D, 2010, COMPUT FLUIDS, V39, P1711, DOI 10.1016/j.compfluid.2010.06.005; Park J. O., 2014, J KOREAN SOC PROPULS, V17, P54; STURTEVA.B, 1969, PHYS FLUIDS, V12, P1723, DOI 10.1063/1.1692732; Sun M., 2001, P 24 INT S SHOCK WAV, P1321; Tanaki Kohsuke, 2009, 47 AIAA AER SCI M IN; Zeitoun DE, 2006, SHOCK WAVES, V15, P241, DOI 10.1007/s00193-006-0023-4; Zeitoun DE, 2009, SHOCK WAVES, V19, P307, DOI 10.1007/s00193-009-0202-1	15	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1003-2169	1993-033X		J THERM SCI	J. Therm. Sci.	JUN	2015	24	3					246	253	1003-2169(2015)03-0246-08	10.1007/s11630-015-0780-4		8	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CH6MU	WOS:000354151500006		
J	Kim, HJ; Takei, M; Lee, HJ; Lee, YW; Choi, YH; Doh, DH				Kim, Hyoung-June; Takei, Masahiro; Lee, Hyun Jin; Lee, Yeon Won; Choi, Yoon Hwan; Doh, Deog-Hee			Performance Analyses for a Cyclone Type Filter	JOURNAL OF THERMAL SCIENCE			English	Article						CFD; cyclone filter; design factors; filtering performances	FLOW	Flow characteristics inside a cyclone filter were investigated by the use of computational fluid dynamics (CFD). For computations, SST model was adopted. Parametric study was carried out considering the filtering performance. Revolution speeds were changed from 100 to 550 with 50 increments. A skirt is the driving source for cyclone operation. The influence of several design factors, such as the skirt length, the skirt gap and the return length to filtering performance was investigated under the particle diameter 100 mu m of debris material (Al, s.g.=2.7). The filtering performance was also investigated with the skirt length 28mm changing the debris diameters from l mu m to 50 mu m. The flow rate of the working fluid was maintained at 0.55kg/s. It has been verified that the most influential factors to the filtering efficiencies was the skirt gap between the cyclone generator and the cyclone vessel.	[Kim, Hyoung-June; Takei, Masahiro] Chiba Univ, Sch Mech Engn, Artificial Sci Div, Chiba, Japan; [Lee, Hyun Jin; Doh, Deog-Hee] Korea Maritime Univ, Div Mech & Energy Syst Engn, Busan, South Korea; [Lee, Yeon Won; Choi, Yoon Hwan] Pukyong Natl Univ, Dept Mech & Automot Engn, Busan 608737, South Korea	Kim, HJ (reprint author), Chiba Univ, Sch Mech Engn, Artificial Sci Div, Chiba, Japan.				Production Technology Commercialization Support Program through Ministry of Industry Ordinary [10-04]; National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A4A01005191]	The research was supported by the Production Technology Commercialization Support Program through Ministry of Industry Ordinary (10-04), and was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A4A01005191).	MORSI SA, 1972, J FLUID MECH, V55, P193, DOI 10.1017/S0022112072001806; Gimbun J., 2005, INT J COMPUTATIONAL, V6, P161, DOI 10.1080/15502280590923649; Heo K. S., 2007, EXPT STUDY PRESSURE, P235; Hyun D. G., 1996, J KOREA ASS PARTICLE, V10, P155; Ju J. I., 2003, J FLUID MACHINERY, V6, P34; Kim J. S., 2006, P KOR SOC FLU MACH A, P1576; Lee J. H., 2010, GAS FLOW FIELD HIGH, V2010, P3066; Menter F. R., 1993, P 24 AIAA FLUID DYN; Menter FR, 1994, AIAA J, V32, P269, DOI DOI 10.2514/3.12149; ZHOU LX, 1990, POWDER TECHNOL, V63, P45, DOI 10.1016/0032-5910(90)80006-K	10	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1003-2169	1993-033X		J THERM SCI	J. Therm. Sci.	JUN	2015	24	3					290	294	1003-2169(2015)03-0290-05	10.1007/s11630-015-0786-y		5	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CH6MU	WOS:000354151500012		
J	Takamatsu, K				Takamatsu, Kuniyoshi			A Rapid Evaluation Method of the Heat Removed by a VCS before Rise-to-Power Tests	JOURNAL OF THERMAL SCIENCE			English	Article						VCS; HTTR; RPV; Rise-to-power test		Before rise-to-power tests, the actual measured value of heat released from the Reactor Pressure Vessel (RPV) or removed by the Vessel Cooling System (VCS) cannot be obtained. It is difficult for operators to evaluate the reactor outlet coolant temperature supplied from the High Temperature Engineering Test Reactor (HTTR) before rise-to-power tests. Therefore, when the actual measured value of heat released from the RPV or removed by the VCS are changed during rise-to-power tests, operators need to evaluate quickly, within a few minutes, the heat removed by the VCS and the reactor outlet coolant temperature of 30 MW, at 100% reactor power, before the temperature achieves 967 degrees C which is the maximum temperature limit generating the reactor scram. In this paper, a rapid evaluation method for use by operators is presented. The difference between the experimental and analytical results was within 30 (kW) and it is appropriate that the presented evaluation method can be applied; therefore, operators can analyze the heat removed by the VCS quickly, within a few minutes, before and during Rise-to-Power Tests.	Japan Atom Energy Agcy, Nucl Hydrogen & Heat Applicat Res Ctr, Safety Design Grp, Ibaraki 3111393, Japan	Takamatsu, K (reprint author), Japan Atom Energy Agcy, Nucl Hydrogen & Heat Applicat Res Ctr, Safety Design Grp, 4002 Narita Cho, Ibaraki 3111393, Japan.						ANSYS Fluent ANSYS CFX, ANSYS FLUENT ANSYS C; BROCKMANN H, 1994, INT J HEAT MASS TRAN, V37, P1095, DOI 10.1016/0017-9310(94)90195-3; de Vahl Davis G, 1969, PHYS FLUIDS, V12, P198; Howell J.R., 2010, THERMAL RAD HEAT TRA; Saito S., 1994, JAERI, P1332; STAR-CCM+ STAR-CD, COMP FLUID DYN CFD S	6	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1003-2169	1993-033X		J THERM SCI	J. Therm. Sci.	JUN	2015	24	3					295	301	1003-2169(2015)03-0295-07	10.1007/s11630-015-0787-x		7	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CH6MU	WOS:000354151500013		
J	Mir, MC; Ercole, C; Takagi, T; Zhang, ZL; Velet, L; Remer, EM; Demirjian, S; Campbell, SC				Mir, Maria C.; Ercole, Cesar; Takagi, Toshio; Zhang, Zhiling; Velet, Lily; Remer, Erick M.; Demirjian, Sevag; Campbell, Steven C.			Decline in Renal Function after Partial Nephrectomy: Etiology and Prevention	JOURNAL OF UROLOGY			English	Review						nephrectomy; delayed graft function; ischemia	LAPAROSCOPIC PARTIAL NEPHRECTOMY; NEPHRON-SPARING SURGERY; PARENCHYMAL VOLUME PRESERVATION; INVASIVE PARTIAL NEPHRECTOMY; ROBOTIC PARTIAL NEPHRECTOMY; CHRONIC KIDNEY-DISEASE; CELL CARCINOMA; WARM ISCHEMIA; SIMPLE ENUCLEATION; SOLITARY KIDNEY	Purpose: Partial nephrectomy is the reference standard for the management of small renal tumors and is commonly used for localized kidney cancer. A primary goal of partial nephrectomy is to preserve as much renal function as possible. New baseline glomerular filtration rate after partial nephrectomy can have prognostic significance with respect to long-term outcomes. Recent studies provide an increased understanding of the factors that determine functional outcomes after partial nephrectomy as well as preventive measures to minimize functional decline. We review these advances, highlight ongoing controversies and stimulate further research. Materials and Methods: A comprehensive literature review consistent with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) criteria was performed from January 2006 to April 2014 using PubMed (R), Cochrane and Ovid Medline. Key words included partial nephrectomy, renal function, warm ischemia, hypothermia, nephron mass, parenchymal volume, surgical approaches to partial nephrectomy, preoperative and intraoperative imaging, enucleation, hemostatic agents and energy based resection. Relevant reviews were also examined as well as their cited references. An additional Google Scholar search was conducted to broaden the scope of the review. Only English language articles were included in the analysis. The primary outcomes of interest were the new baseline level of function after early postoperative recovery, percent decline in function, potential etiologies and preventive measures. Results: Decline in function after partial nephrectomy averages approximately 20% in the operated kidney, and can be due to incomplete recovery from the ischemic insult or loss of nephron mass related to parenchymal excision or collateral damage during reconstruction. Compensatory hypertrophy in the contralateral kidney after partial nephrectomy in adults is marginal and decline in global renal function for patients with 2 kidneys averages about 10%, although there is some variance based on tumor size and location. Irreversible ischemic injury can be minimized by pharmacological intervention or surgical approaches such as hypothermia, limited warm ischemia, or zero or segmental ischemia. Excessive loss of nephron mass can be minimized by improved preoperative or intraoperative imaging, use of a bloodless field, enucleation and vascular microdissection. Hemostatic agents or energy based resection that minimizes the need for parenchymal and capsular suturing can also optimize preservation of the vascularized nephron mass. Conclusions: Our understanding of the decline in renal function after partial nephrectomy has advanced considerably, including better appreciation of its magnitude and impact in various settings, possible etiologies and potential preventive measures. Many controversies persist and this remains an important area of investigation.	[Mir, Maria C.; Ercole, Cesar; Takagi, Toshio; Zhang, Zhiling; Velet, Lily; Remer, Erick M.; Demirjian, Sevag; Campbell, Steven C.] Cleveland Clin, Glickman Urol Kidney Inst, Cleveland, OH 44195 USA; [Remer, Erick M.] Cleveland Clin, Imaging Inst, Cleveland, OH 44195 USA; [Mir, Maria C.] Univ Miami, Dept Urol, Miami, FL USA; [Takagi, Toshio] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan; [Zhang, Zhiling] Sun Yat Sen Univ, Ctr Canc, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China	Campbell, SC (reprint author), Cleveland Clin, Ctr Urol Oncol, Glickman Urol Kidney Inst, Room Q10-120,9500 Euclid Ave, Cleveland, OH 44195 USA.	campbes3@ccf.org					Russo P, 2013, NAT REV UROL, V10, P292, DOI 10.1038/nrurol.2013.34; Huang WC, 2006, LANCET ONCOL, V7, P735, DOI 10.1016/S1470-2045(06)70803-8; Abe T, 2012, J ENDOUROL, V26, P1483, DOI 10.1089/end.2012.0122; Desai MM, 2014, EUR UROL, V66, P713, DOI 10.1016/j.eururo.2014.01.017; Baumert H, 2007, EUR UROL, V52, P1164, DOI 10.1016/j.eururo.2007.03.060; Smith GL, 2011, BJU INT, V107, P1054, DOI 10.1111/j.1464-410X.2010.09798.x; Longo N, 2014, EJSO-EUR J SURG ONC, V40, P762, DOI 10.1016/j.ejso.2014.01.007; Mir MC, 2013, UROLOGY, V82, P263, DOI 10.1016/j.urology.2013.03.068; O'Hara JF, 2013, UROLOGY, V81, P340, DOI 10.1016/j.urology.2012.09.041; Power NE, 2012, UROLOGY, V79, P821, DOI 10.1016/j.urology.2011.11.064; Parekh DJ, 2013, J AM SOC NEPHROL, V24, P506, DOI 10.1681/ASN.2012080786; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; NOVICK AC, 1983, UROL CLIN N AM, V10, P637; Sciarra A, 2013, J UROLOGY, V190, P698, DOI 10.1016/j.juro.2013.01.079; Simmons MN, 2012, J UROLOGY, V187, P1667, DOI 10.1016/j.juro.2011.12.068; Simmons MN, 2011, J UROLOGY, V186, P405, DOI 10.1016/j.juro.2011.03.154; Mir MC, 2014, J UROLOGY, V192, P665, DOI 10.1016/j.juro.2014.03.036; Campbell SC, 2009, J UROLOGY, V182, P1271, DOI 10.1016/j.juro.2009.07.004; Hung AJ, 2013, J UROLOGY, V189, P36, DOI 10.1016/j.juro.2012.09.042; Song C, 2011, J UROLOGY, V186, P53, DOI 10.1016/j.juro.2011.03.021; Gill IS, 2003, J UROLOGY, V170, P52, DOI 10.1097/01.ju.0000072332.02529.10; Gill IS, 2012, J UROLOGY, V187, P807, DOI 10.1016/j.juro.2011.10.146; Jackman SV, 1998, J ENDOUROL, V12, P441, DOI 10.1089/end.1998.12.441; McClintock TR, 2014, UROLOGY, V84, P327, DOI 10.1016/j.urology.2014.02.044; Nguyen MM, 2008, J UROLOGY, V179, P627, DOI 10.1016/j.juro.2007.09.086; Lane BR, 2011, J UROLOGY, V185, P421, DOI 10.1016/j.juro.2010.09.131; Ng CK, 2012, EUR UROL, V61, P67, DOI 10.1016/j.eururo.2011.08.040; Jeon HG, 2012, BJU INT, V109, P1468, DOI 10.1111/j.1464-410X.2011.10531.x; Song C, 2009, J UROLOGY, V181, P48, DOI 10.1016/j.juro.2008.09.030; Shao PF, 2011, EUR UROL, V59, P849, DOI 10.1016/j.eururo.2010.11.037; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Sharma N, 2008, J UROLOGY, V179, P1284, DOI 10.1016/j.juro.2007.11.071; Thompson RH, 2012, UROLOGY, V79, P356, DOI 10.1016/j.urology.2011.10.031; Becker F, 2009, EUR UROL, V56, P625, DOI 10.1016/j.eururo.2009.07.016; Minervini A, 2011, J UROLOGY, V185, P1604, DOI 10.1016/j.juro.2010.12.048; Thompson RH, 2010, EUR UROL, V58, P340, DOI 10.1016/j.eururo.2010.05.047; Campbell SC, 2012, J UROLOGY, V187, P388; Cohen J, 2013, J ENDOUROL, V27, P343, DOI 10.1089/end.2012.0194; Funahashi Y, 2009, EUR UROL, V55, P209, DOI 10.1016/j.eururo.2008.07.048; Golan S, 2014, J ENDOUROL, V28, P196, DOI 10.1089/end.2013.0486; Marley CS, 2011, J UROLOGY, V185, P2191, DOI 10.1016/j.juro.2011.02.013; O'Hara JF, 2002, J UROLOGY, V167, P24, DOI 10.1016/S0022-5347(05)65374-8; Omae K, 2014, INT J UROL, V21, P200, DOI 10.1111/iju.12213; POLASCIK TJ, 1995, J UROLOGY, V154, P1676, DOI 10.1016/S0022-5347(01)66748-X; Takagi T, 2014, J UROLOGY, V192, P30, DOI 10.1016/j.juro.2013.12.035; Takagi T, 2014, J UROLOGY, V192, P1612, DOI 10.1016/j.juro.2014.06.018; Uzzo RG, 2001, J UROLOGY, V166, P6, DOI 10.1016/S0022-5347(05)66066-1; Wijnen M H W A, 2002, J Cardiovasc Surg (Torino), V43, P483; Xu Y, 2013, CLIN RADIOL, V68, pE609, DOI 10.1016/j.crad.2013.06.002	49	7	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	JUN	2015	193	6					1889	1898		10.1016/j.juro.2015.01.093		10	Urology & Nephrology	Urology & Nephrology	CH7DV	WOS:000354196700007		
J	Wada, N; Ameda, K; Furuno, T; Okada, H; Date, I; Kakizaki, H				Wada, Naoki; Ameda, Kaname; Furuno, Tsuyoshi; Okada, Hiroki; Date, Ichiro; Kakizaki, Hidehiro			Evaluation of Prostaglandin E2 and E-Series Prostaglandin Receptor in Patients with Interstitial Cystitis	JOURNAL OF UROLOGY			English	Article						urinary bladder; cystitis, interstitial; dinoprostone; receptors, prostaglandin E; etiology	REGULATES TUMOR ANGIOGENESIS; NERVE GROWTH-FACTOR; BLADDER SYNDROME; PROSTATE-CANCER; URINARY-TRACT; EP2	Purpose: We evaluated PGE2 and EP receptor in patients with interstitial cystitis. Materials and Methods: Enrolled in the study were 20 female patients with interstitial cystitis (11 with and 9 without Hunner lesions), 9 female controls with another urological disease who needed a cystoscopic procedure and 10 normal volunteers. In all participants we determined O'Leary-Sant symptom and problem scores, and obtained voluntary urine specimens for PGE2 analysis. Using anesthesia the bladder was distended by saline in stepwise fashion from 100 ml to maximum capacity in patients with interstitial cystitis. Each time the infused saline was retrieved for PGE2 analysis. We also measured PGE2 and the expression of EP receptor mRNA in bladder biopsy tissue in patients with interstitial cystitis. Results: Symptom and problem indexes in patients with interstitial cystitis and Hunner lesions were significantly higher than in patients with interstitial cystitis without Hunner lesions. Urinary PGE2 in patients with interstitial cystitis and Hunner lesions was significantly higher than in patients with interstitial cystitis without lesions, controls and normal volunteers. PGE2 in retrieved saline in patients with interstitial cystitis and Hunner lesions increased depending on infusion volume but not in patients with interstitial cystitis without lesions. PGE2 content in bladder biopsy tissue was significantly higher in patients with interstitial cystitis and Hunner lesions than in controls. In patients with interstitial cystitis and Hunner lesions the expression of EP1 and EP2 mRNA was significantly higher than in controls. Conclusions: Our study showed increased PGE2 production and mRNA expression of EP1 and EP2 receptors in the bladder in patients with interstitial cystitis and Hunner lesions. Further studies are warranted to explore the pathophysiological and therapeutic implications.	[Wada, Naoki; Kakizaki, Hidehiro] Asahikawa Med Univ, Dept Renal & Urol Surg, Asahikawa, Hokkaido 0788510, Japan; [Ameda, Kaname; Furuno, Tsuyoshi] Hokkaido Mem Hosp Urol, Dept Urol, Sapporo, Hokkaido, Japan; [Okada, Hiroki; Date, Ichiro] Ono Pharmaceut Co Ltd, Minase Res Inst, Osaka, Japan	Wada, N (reprint author), Asahikawa Med Univ, Dept Renal & Urol Surg, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	nwada@asahikawa-med.ac.jp			Ono Pharmaceutical	Financial interest and/or other relationship with Ono Pharmaceutical.	Ahluwalia A, 2014, AM J PHYSIOL-GASTR L, V307, pG602, DOI 10.1152/ajpgi.00177.2014; Homma Y, 2009, INT J UROL, V16, P597, DOI 10.1111/j.1442-2042.2009.02326.x; Miki T, 2011, PAIN, V152, P1373, DOI 10.1016/j.pain.2011.02.019; Sarkar S, 2003, GASTROENTEROLOGY, V124, P18, DOI 10.1053/gast.2003.50022; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Yokoyama O, 2007, J UROLOGY, V177, P771, DOI 10.1016/j.juro.2006.09.076; Jain S, 2008, CANCER RES, V68, P7750, DOI 10.1158/0008-5472.CAN-07-6689; van de Merwe JP, 2008, EUR UROL, V53, P60, DOI 10.1016/j.eururo.2007.09.019; LYNES WL, 1987, J UROLOGY, V138, P746; Andersson KE, 2004, PHARMACOL REV, V56, P581, DOI 10.1124/pr.56.4.4; Liu HT, 2010, BJU INT, V106, P1681, DOI 10.1111/j.1464-410X.2009.08851.x; Peeker R, 2002, J UROLOGY, V167, P2470, DOI 10.1016/S0022-5347(05)65006-9; Kim JC, 2006, J UROLOGY, V175, P1773, DOI 10.1016/S0022-5347(05)00992-4; Narumiya S, 1999, PHYSIOL REV, V79, P1193; FELSEN D, 1994, J UROLOGY, V152, P355; Iwanaga K, 2012, J PHARMACOL EXP THER, V340, P604, DOI 10.1124/jpet.111.189845; Miyata Y, 2013, UROLOGY, V81, P136, DOI 10.1016/j.urology.2012.08.014; Peters KM, 2011, UROLOGY, V78, P301, DOI 10.1016/j.urology.2011.04.030; Rastogi P, 2008, AM J PHYSIOL-RENAL, V294, pF1129, DOI 10.1152/ajprenal.00572.2007; Ueda T, 2002, J UROLOGY, V167, P347, DOI 10.1016/S0022-5347(05)65466-3; Wheeler MA, 2002, J UROLOGY, V168, P1568, DOI 10.1097/01.ju.0000030583.31299.80	21	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	JUN	2015	193	6					1987	1993		10.1016/j.juro.2015.01.010		7	Urology & Nephrology	Urology & Nephrology	CH7DV	WOS:000354196700036		
J	Ito, H; Aizawa, N; Fujita, Y; Suzuki, M; Fukuhara, H; Homma, Y; Kubota, Y; Ito, M; Andersson, KE; Igawa, Y				Ito, Hiroki; Aizawa, Naoki; Fujita, Yasunori; Suzuki, Motofumi; Fukuhara, Hiroshi; Homma, Yukio; Kubota, Yoshinobu; Ito, Masafumi; Andersson, Karl-Erik; Igawa, Yasuhiko			Long-Term Caloric Restriction in Rats may Prevent Age Related Impairment of In Vitro Bladder Function	JOURNAL OF UROLOGY			English	Article						urinary bladder; caloric restriction; aging; muscle contraction; collagen	URINARY-TRACT SYMPTOMS; VOIDING DYSFUNCTION; OUTLET OBSTRUCTION; DETRUSOR; INCONTINENCE; ADAPTATION; MUSCLE; FUTURE; MEN	Purpose: Bladder function is often impaired with aging. In other organs caloric restriction has had a prophylactic effect on the biological changes associated with aging. We tested the hypothesis that long-term caloric restriction can prevent age related impaired bladder function in the rat. Materials and Methods: Fisher 344 male rats were divided into 3 groups, including 16 young rats at age 6 months with free access to normal food, 15 old rats at age 25 to 28 months with free access to normal food and 16 old rats at age 25 to 28 months fed with normal food 3 days per week since age 6 weeks (caloric restriction). We performed frequency volume measurements, in vitro organ bath functional studies using full-thickness longitudinal detrusor strips, evaluation of muscarinic and purinergic receptor mRNA expression, and histological examination with Masson trichrome staining of bladder tissue. Results: Frequency volume changes did not significantly differ among the 3 groups. The old group fed normal food showed weaker contractile responses to carbachol and electrical field stimulation (especially in the cholinergic component), lower M-3 receptor mRNA expression and higher collagen deposition compared to the young group. These age related bladder changes were milder in the old group with caloric restriction than in the old group fed normal food. Conclusions: This study suggests that in the rat long-term caloric restriction has a preventive effect against age related functional and morphological bladder changes. These changes include impaired detrusor contractility that may be related to decreased expression of M-3 receptors and to bladder wall fibrosis.	[Ito, Hiroki; Aizawa, Naoki; Igawa, Yasuhiko] Univ Tokyo, Grad Sch Med, Dept Continence Med, Tokyo 1138655, Japan; [Suzuki, Motofumi; Fukuhara, Hiroshi; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo 1138655, Japan; [Fujita, Yasunori; Ito, Masafumi] Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Tokyo, Japan; [Ito, Hiroki; Kubota, Yoshinobu] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 232, Japan; [Andersson, Karl-Erik] Aarhus Univ, Aarhus Inst Adv Studies, Aarhus, Denmark	Igawa, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Continence Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yigawa-jua@umin.ac.jp			Japanese Society of Geriatric Urology; Ministry of Education, Culture, Sport, Science and Technology of the Japanese Government [40159588, 80595257]	Supported by a grant from the Japanese Society of Geriatric Urology (HI), and Grants-in-Aid for Scientific Research 40159588 (YI) and 80595257 (NA) from the Ministry of Education, Culture, Sport, Science and Technology of the Japanese Government.	Aizawa N, 2013, J UROLOGY, V189, P1580, DOI 10.1016/j.juro.2012.10.060; Ponholzer A, 2006, EUR UROL, V50, P581, DOI 10.1016/j.eururo.2006.01.031; Yoshida M, 2001, EXP GERONTOL, V36, P99, DOI 10.1016/S0531-5565(00)00175-3; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; LEPOR H, 1992, J UROLOGY, V148, P414; van Koeveringe GA, 2014, NEUROUROL URODYNAM, V33, P591, DOI 10.1002/nau.22590; Chai TC, 2000, UROL RES, V28, P348; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; Frazier EP, 2006, N-S ARCH PHARMACOL, V373, P300, DOI 10.1007/s00210-006-0077-y; NISHIMOTO T, 1995, J UROLOGY, V153, P1701, DOI 10.1016/S0022-5347(01)67508-6; Ameda K, 1999, J UROLOGY, V162, P142, DOI 10.1097/00005392-199907000-00035; Rebrin I, 2007, BRAIN RES, V1127, P10, DOI 10.1016/j.brainres.2006.10.040; Lluel P, 2000, AM J PHYSIOL-REG I, V278, pR964; Zirkin BR, 2012, J ANDROL, V33, P1111, DOI 10.2164/jandrol.112.017160; Fry CH, 2011, BJU INT, V108, pE91, DOI 10.1111/j.1464-410X.2010.09845.x; Chen HL, 2005, EXP GERONTOL, V40, P498, DOI 10.1016/j.exger.2005.03.011; Varady KA, 2007, AM J CLIN NUTR, V86, P7; Igawa Y, 2014, J UROLOGY, V191, P1159, DOI 10.1016/j.juro.2013.10.027; Zhao WX, 2010, J UROLOGY, V184, P378, DOI 10.1016/j.juro.2010.03.004; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Redman LM, 2010, AGING CELL, V9, P32, DOI 10.1111/j.1474-9726.2009.00530.x; Chiarpotto E, 2006, IUBMB LIFE, V58, P695, DOI 10.1080/15216540601106365; Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986; ELBADAWI A, 1993, J UROLOGY, V150, P1657; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Lorenzini Antonello, 2014, Front Endocrinol (Lausanne), V5, P121, DOI 10.3389/fendo.2014.00121; RESNICK NM, 1987, JAMA-J AM MED ASSOC, V257, P3076, DOI 10.1001/jama.257.22.3076; Sawada N, 2013, EUR UROL, V64, P664, DOI 10.1016/j.eururo.2013.06.043; Sharma N, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-90; Taylor JA, 2006, AM J PHYSIOL-RENAL, V291, pF1343, DOI 10.1152/ajprenal.00144.2006	30	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	JUN	2015	193	6					2123	2130		10.1016/j.juro.2014.11.005		8	Urology & Nephrology	Urology & Nephrology	CH7DV	WOS:000354196700100		
J	Lopattananon, N; Julyanon, J; Masa, A; Kaesaman, A; Thongpin, C; Sakai, T				Lopattananon, Natinee; Julyanon, Juthapat; Masa, Abdulhakim; Kaesaman, Azizon; Thongpin, Chanchai; Sakai, Tadamoto			The role of nanofillers on (natural rubber)/(ethylene vinyl acetate)/clay nanocomposite in blending and foaming	JOURNAL OF VINYL & ADDITIVE TECHNOLOGY			English	Article							MECHANICAL-PROPERTIES; PHYSICAL-PROPERTIES; RUBBER FOAMS; IMPROVEMENT; MORPHOLOGY; DISPERSION; AGENT; CLAY; CELL	Nanocomposite foams were fabricated from 60/40 wt% ethylene vinyl acetate (EVA)/natural rubber (NR) blends by using azodicarbonamide as a blowing agent. Two different nanofillers (sodium montmorillonite and organoclay) were employed to study their effects on foam properties. The results were also compared with conventional (china clay)-filled foams. Transmission electron microscopy, X-ray diffraction, scanning electron microscopy, and three-dimensional Microfocus X-ray computed tomography scanning analysis were performed to characterize the EVA/NR blend morphology and foam structures. The results revealed that the nanofiller acted as a blend compatibilizer. Sodium montmorillonite was more effective in compatibilization, generating better phase-separated EVA/NR blend morphology and improving foam structure. Higher filler loading increased the specific tensile strength of rubber foams. The rubber nanocomposite foam showed superior specific tensile strength to the conventional rubber composite foam. The elastic recovery and compressive strength of the nanocomposite foams decreased with increasing filler content, whereas the opposite trend was observed for the conventional composite foams with china clay. The thermal conductivity measurement indicated that the nanofiller had better beneficial effect on thermal insulation over china clay filler. From the present study, the nanofillers played an important role in obtaining better blend morphology as compatibilizer, rather than the nucleating agent and the nanofiller content of 5 phr (parts by weight per hundred parts of rubber) was recommended for the production of EVA/NR nanocomposite foams. J. VINYL ADDIT. TECHNOL., 21:134-146, 2015. (c) 2014 Society of Plastics Engineers	[Lopattananon, Natinee; Julyanon, Juthapat; Masa, Abdulhakim; Kaesaman, Azizon] Prince Songkla Univ, Fac Sci & Technol, Dept Rubber Technol & Polymer Sci, Pattani, Thailand; [Thongpin, Chanchai] Silpakorn Univ, Fac Engn & Ind Technol, Dept Mat Sci & Engn, Nakhon Pathom, Thailand; [Sakai, Tadamoto] Shizuoka Univ, Tokyo Off, Minato Ku, Tokyo 1080023, Japan	Lopattananon, N (reprint author), Prince Songkla Univ, Fac Sci & Technol, Dept Rubber Technol & Polymer Sci, Pattani, Thailand.	lnatinee@bunga.pn.psu.ac.th			Prince of Songkla University [SAT530106S]	The authors gratefully acknowledge the financial support of the Prince of Songkla University (Grant Number SAT530106S). We are also grateful to Mr. M. Natsuhara (Shimadzu, Kyoto, Japan) for technical support on the 3D Micro-focus X-ray scanning analysis.	Alex R., 2010, RUBBER NANOCOMPOSITE, P212; Ariff ZM, 2008, J APPL POLYM SCI, V107, P2531, DOI 10.1002/app.27375; Zheng WG, 2010, J APPL POLYM SCI, V117, P2972, DOI 10.1002/app.32253; Ray SS, 2004, POLYMER, V45, P8403, DOI 10.1016/j.polymer.2004.10.009; Lee LJ, 2005, COMPOS SCI TECHNOL, V65, P2344, DOI 10.1016/j.compscitech.2005.06.016; Wang Y, 2003, MACROMOL RAPID COMM, V24, P231, DOI 10.1002/marc.200390026; Cao X, 2005, POLYMER, V46, P775, DOI 10.1016/j.polymer.2004.11.028; KUMAR V, 1990, POLYM ENG SCI, V30, P1323, DOI 10.1002/pen.760302010; Lee YH, 2007, J APPL POLYM SCI, V103, P2129, DOI 10.1002/app.24908; Gu Z, 2009, APPL CLAY SCI, V46, P241, DOI 10.1016/j.clay.2009.08.010; Nam PH, 2002, POLYM ENG SCI, V42, P1907, DOI 10.1002/pen.11083; Kiatkamjornwong S, 2000, PLAST RUBBER COMPOS, V29, P177; Kim DW, 2006, J APPL POLYM SCI, V102, P3259, DOI 10.1002/app.24677; Kim MS, 2004, J APPL POLYM SCI, V94, P2212, DOI 10.1002/app.21174; Kim SH, 2010, J APPL POLYM SCI, V117, P1992, DOI 10.1002/app.32116; Klemper D., 1991, HDB POLYM FOAMS FOAM; KUMAR V, 1993, INT POLYM PROC, V8, P73; Liang KW, 2011, J APPL POLYM SCI, V119, P1857, DOI 10.1002/app.32901; MITSUNAGA M., 2003, MACROMOL MATER ENG, V288, P534; Munusamy Y, 2008, J REINF PLAST COMP, V27, P1925, DOI 10.1177/0731684407084161; Park KW, 2008, POLYM ENG SCI, V48, P1183, DOI 10.1002/pen.21073; Park KW, 2007, J APPL POLYM SCI, V104, P3879, DOI 10.1002/app.26003; Rezaeian I, 2009, POLYM ADVAN TECHNOL, V20, P487, DOI 10.1002/pat.1298; Rothon R. N., 2001, RAPRA REV REPORTS, V12, P5; Shimbo M, 2007, J CELL PLAST, V43, P157, DOI 10.1177/0021955X06075585; Wang K. H., 2004, SPE ANTEC TECH PAPER, V50, P2510; Wimolmala E, 2009, J APPL POLYM SCI, V114, P2816, DOI 10.1002/app.30763; Xin ZX, 2009, J VINYL ADDIT TECHN, V15, P275, DOI 10.1002/vnl.20198; Xu ZR, 2008, MACROMOL SYMP, V264, P18, DOI 10.1002/masy.200850404; Zhang BS, 2010, MATER DESIGN, V31, P3106, DOI 10.1016/j.matdes.2009.12.041	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1083-5601	1548-0585		J VINYL ADDIT TECHN	J. Vinyl Addit. Technol.	JUN	2015	21	2					134	146		10.1002/vnl.21368		13	Chemistry, Applied; Materials Science, Textiles; Polymer Science	Chemistry; Materials Science; Polymer Science	CH8MO	WOS:000354290700009		
J	Sogabe, M; Okahisa, T; Taniguchi, T; Tomonari, T; Tanaka, T; Tanaka, H; Nakasono, M; Takayama, T				Sogabe, Masahiro; Okahisa, Toshiya; Taniguchi, Tatsuya; Tomonari, Tetsu; Tanaka, Takahiro; Tanaka, Hironori; Nakasono, Masahiko; Takayama, Tetsuji			Light alcohol consumption plays a protective role against non-alcoholic fatty liver disease in Japanese men with metabolic syndrome	LIVER INTERNATIONAL			English	Article						light alcohol consumption; men; metabolic syndrome; NAFLD; ultrasonography	SERUM ALANINE AMINOTRANSFERASE; NUTRITION EXAMINATION SURVEY; INSULIN SENSITIVITY; VISCERAL FAT; CARDIOVASCULAR-DISEASE; NATIONAL-HEALTH; RISK-FACTORS; POPULATION; PREVALENCE; ADIPONECTIN	Background & AimsAlthough excess alcohol consumption has been believed to cause liver injury, light alcohol consumption (LAC) has been reported to play a protective role against fatty liver in recent studies. However, the association between non-alcoholic fatty liver disease (NAFLD) and LAC in men with metabolic syndrome (MS) is unclear. The aim of this study was to examine the association between NAFLD and LAC in men with MS. MethodsSubjects were 1055 men with MS who underwent a regular health check-up and drank less 20g/day of alcohol. A distinction was made between non-drinkers and light drinkers and the association between NAFLD and LAC in men with MS was elucidated. NAFLD was referred as fatty liver with alanine aminotransferase (ALT) levels 31 IU/L in this study. ResultsAlanine aminotransferase (ALT), aspartate aminotransferase (AST) and the prevalence of NAFLD were significantly lower in light drinkers than in non-drinkers. Logistic regression analysis showed body mass index (BMI), waist circumference (WC), uric acid (UA), haemoglobin A1c (HbA1c), visceral fat type MS and LAC (odds ratios: 0.654; 95% confidence intervals: 0.473-0.906; <0.05) were significant predictors of the prevalence of NAFLD. ConclusionThe prevalence of NAFLD in light drinkers was significantly lower than in non-drinkers, and supporting previous reports studying the general population, LAC is one of the significant predictors of a decreased prevalence of NAFLD in men with MS.	[Sogabe, Masahiro; Okahisa, Toshiya] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Gen Med & Community Hlth Sci, Tokushima, Tokushima 7708503, Japan; [Sogabe, Masahiro] Kagawa Prefectural Canc Detect Ctr, Dept Gastroenterol, Takamatsu, Kagawa, Japan; [Nakasono, Masahiko] Tsurugi Municipal Handa Hosp, Dept Internal Med, Tokushima, Japan; [Taniguchi, Tatsuya; Tomonari, Tetsu; Tanaka, Takahiro; Tanaka, Hironori; Takayama, Tetsuji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Gastroenterol & Oncol, Tokushima, Tokushima 7708503, Japan	Sogabe, M (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Gen Med & Community Hlth Sci, 3-18-15 Kuramoto Cho, Tokushima, Tokushima 7708503, Japan.	tokushimakenananshi@yahoo.co.jp					Baik I, 2008, AM J CLIN NUTR, V87, P1455; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Costanzo S, 2010, J AM COLL CARDIOL, V55, P1339, DOI 10.1016/j.jacc.2010.01.006; Hamaguchi M, 2005, ANN INTERN MED, V143, P722; Pai JK, 2006, ATHEROSCLEROSIS, V186, P113, DOI 10.1016/j.atherosclerosis.2005.06.037; Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Donohue TM, 2007, WORLD J GASTROENTERO, V13, P4974; Bellentani S, 2000, ANN INTERN MED, V132, P112; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; Kiechl S, 1996, BRIT MED J, V313, P1040; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Dunn W, 2008, HEPATOLOGY, V47, P1947, DOI 10.1002/hep.22292; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Hiramine Y, 2011, J GASTROENTEROL, V46, P519, DOI 10.1007/s00535-010-0336-z; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Freiberg MS, 2004, DIABETES CARE, V27, P2954, DOI 10.2337/diacare.27.12.2954; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Tsumura K, 1999, DIABETES CARE, V22, P1432, DOI 10.2337/diacare.22.9.1432; Gunji T, 2009, AM J GASTROENTEROL, V104, P2189, DOI 10.1038/ajg.2009.361; Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P156, DOI 10.3748/wjg.v18.i2.156; Sierksma A, 2004, DIABETES CARE, V27, P184, DOI 10.2337/diacare.27.1.184; Yoon YS, 2004, AM J CLIN NUTR, V80, P217; BIZZARO N, 1992, ITAL J GASTROENTEROL, V24, P237; Zhou YJ, 2007, WORLD J GASTROENTERO, V13, P6419, DOI 10.3748/wjg.13.6419; Ruhl CE, 2005, CLIN GASTROENTEROL H, V3, P1260, DOI 10.1016/S1542-3565(05)00743-3; Palmentieri B, 2006, DIGEST LIVER DIS, V38, P485, DOI 10.1016/j.dld.2006.03.021; Rosell M, 2003, EUR J CLIN NUTR, V57, P227, DOI 10.1038/sj.ejcn.1601548; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Dixon JB, 2001, GASTROENTEROLOGY, V121, P91, DOI 10.1053/gast.2001.25540; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; Rimm EB, 1999, BRIT MED J, V319, P1523; Suzuki A, 2007, AM J GASTROENTEROL, V102, P1912, DOI 10.1111/j.1572-0241.2007.01274.x; Kondili LA, 2005, EUR J GASTROEN HEPAT, V17, P155, DOI 10.1097/00042737-200502000-00005; Hirooka M, 2005, INTERNAL MED, V44, P794, DOI 10.2169/internalmedicine.44.794; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Moriya A, 2011, ALIMENT PHARM THER, V33, P378, DOI 10.1111/j.1365-2036.2010.04520.x; Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513; Bellentani S, 1997, GUT, V41, P845; Caballeria L, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-41; Gigleux I, 2006, J NUTR, V136, P3027; Hamano M, 2013, HEPATOL RES, V43, P238, DOI 10.1111/j.1872-034X.2012.01066.x; Kawamoto R, 2007, J MED ULTRASON, V34, P93, DOI 10.1007/s10396-007-0137-z; Kawamoto R, 2010, J ATHEROSCLER THROMB, V17, P953; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Maher Jacquelyn J, 2002, Semin Gastrointest Dis, V13, P31; Neuschwander-Tetri BA, 2005, AM J MED SCI, V330, P326, DOI 10.1097/00000441-200512000-00011; Nishise Y, 2010, J CLIN ENDOCR METAB, V95, P3828, DOI 10.1210/jc.2009-1862; Stejskal David, 2005, Biomedical Papers (Olomouc), V149, P93; SUZUKI R, 1993, AM J MED, V95, P309, DOI 10.1016/0002-9343(93)90284-V; The Examination Committee for Criteria of Metabolic Syndrome in Japan, 2005, J JPN SOC INTERN MED, V94; Wei M, 2000, DIABETES CARE, V23, P18, DOI 10.2337/diacare.23.1.18; Yamada T, 2010, DIGEST DIS SCI, V55, P176, DOI 10.1007/s10620-008-0693-0; Yokoyama H, 2007, INTERNAL MED, V46, P1345, DOI 10.2169/internalmedicine.46.6196; You M, 2004, AM J PHYSIOL-GASTR L, V287, pG1, DOI 10.1152/ajpgi.00056.2004	57	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-3223	1478-3231		LIVER INT	Liver Int.	JUN	2015	35	6					1707	1714		10.1111/liv.12754		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH9NA	WOS:000354361200009		
J	Yamada, K; Mizukoshi, E; Sunagozaka, H; Arai, K; Yamashita, T; Takeshita, Y; Misu, H; Takamura, T; Kitamura, S; Zen, Y; Nakanuma, Y; Honda, M; Kaneko, S				Yamada, Kazutoshi; Mizukoshi, Eishiro; Sunagozaka, Hajime; Arai, Kuniaki; Yamashita, Tatsuya; Takeshita, Yumie; Misu, Hirofumi; Takamura, Toshinari; Kitamura, Seiko; Zen, Yoh; Nakanuma, Yasuni; Honda, Masao; Kaneko, Shuichi			Response to Importance of confounding factors in assessing fatty acid compositions in patients with non-alcoholic steatohepatitis	LIVER INTERNATIONAL			English	Letter							LIVER-DISEASE		[Yamada, Kazutoshi; Mizukoshi, Eishiro; Sunagozaka, Hajime; Arai, Kuniaki; Yamashita, Tatsuya; Honda, Masao; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa 9208641, Japan; [Takeshita, Yumie; Misu, Hirofumi; Takamura, Toshinari] Kanazawa Univ, Grad Sch Med, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9208641, Japan; [Kitamura, Seiko; Zen, Yoh] Kanazawa Univ Hosp, Div Pathol, Kanazawa, Ishikawa 9208641, Japan; [Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208641, Japan	Yamada, K (reprint author), Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa 9208641, Japan.						Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Iggman D, 2010, DIABETOLOGIA, V53, P850, DOI 10.1007/s00125-010-1669-0; Nakahara T, 2014, J GASTROENTEROL, V49, P1477, DOI 10.1007/s00535-013-0911-1; Okanoue T, 2011, J GASTROEN HEPATOL, V26, P153, DOI 10.1111/j.1440-1746.2010.06547.x	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-3223	1478-3231		LIVER INT	Liver Int.	JUN	2015	35	6					1773	1773		10.1111/liv.12755		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH9NA	WOS:000354361200018		
J	Izumi, K; Uchman, A				Izumi, Kentaro; Uchman, Alfred			Comment on "Occurrence of faecal pellet-filled simple and composite burrows in cold seep carbonates: A glimpse of a complex benthic ecosystem" by A. Mazumdar, RK Joshi and M. Kocherla [Marine Geology 289 (2011) 117-121]	MARINE GEOLOGY			English	Editorial Material						trace fossils; burrows; faecal pellets; Phymatoderma		The pellet-filled burrows described in Mazumdar et al. (2011) were originally not unequivocally ascribed to a specific ichnotaxon. In fact, these burrows match the diagnosis of the ichnogenus Phymatoderma, most likely Phymatoderma cf. melvillensis. There is the general similarity in overall shape such as branching pattern, as well as in detailed characteristics such as locally present meniscate fill structure. Furthermore, morphometrical parameters and general depositional setting are basically similar between the pellet-filled burrows and P. melvillensis. Based on the refined ichnotaxonomy, ethological interpretation by Mazumdar et al. (2011), especially about how the pellets were stuffed within the burrows, is refined. (C) 2014 Elsevier B.V. All rights reserved.	[Izumi, Kentaro] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Uchman, Alfred] Jagiellonian Univ, Inst Geol Sci, PL-30063 Krakow, Poland	Izumi, K (reprint author), Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	izumi@eps.s.u-tokyo.ac.jp					Uchman A, 2010, POL POLAR RES, V31, P83, DOI 10.4202/ppres.2010.06; Hara U, 2004, ANTARCT SCI, V16, P319, DOI 10.1017/S0954102004002159; Mazumdar A, 2011, MAR GEOL, V289, P117, DOI 10.1016/j.margeo.2011.09.003; Miller W, 2011, PALAEOGEOGR PALAEOCL, V307, P109, DOI 10.1016/j.palaeo.2011.05.002; Senowbari-Daryan B, 2007, FACIES, V53, P229, DOI 10.1007/s10347-006-0096-7; Bromley R.G., 1996, TRACE FOSSILS BIOL T; Brongniart A. T, 1849, DICT U HIST NAT, V13, P1; CORNISH F G, 1986, Palaios, V1, P478, DOI 10.2307/3514630; Feldmann R.M., 1998, ACTA PALAEONTOLOGICA, V43, P10; Fischer-Ooster C., 1858, FOSSILEN FUCOIDEN SC; Fu S., 1991, Courier Forschungsinstitut Senckenberg, V135, P1; Izumi K, 2015, ACTA PALAEO IN PRESS; Izumi K., 2012, PALAEOGEOGR PALAEOCL, V353-355, P116; Kennedy W. J., 1969, Palaeontology, V12, P549; Miller William III, 1998, Ichnos, V6, P23; Miller William III, 1998, Paleontological Research, V2, P266; Miller W. III, 1991, Ichnos, V1, P161; MINOURA K, 1992, MAR GEOL, V103, P487, DOI 10.1016/0025-3227(92)90034-F; Paull CK, 2005, GEO-MAR LETT, V25, P11, DOI 10.1007/s00367-004-0184-z; Schlotheim E. F., 1822, NACHTRAGE PETREFACTE; Seilacher A, 2007, TRACE FOSSIL ANAL; Uchman A., 1995, BERINGERIA, V15, P3, DOI DOI 10.1016/0031-0182(81)90053-5; Uchman A., 1999, BERINGERIA, V25, P65	23	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0025-3227	1872-6151		MAR GEOL	Mar. Geol.	JUN 1	2015	364						65	67		10.1016/j.margeo.2014.08.006		3	Geosciences, Multidisciplinary; Oceanography	Geology; Oceanography	CH6LN	WOS:000354148200007		
J	Maruyama, I; Tanimura, M; Mitani, Y; Ishikawa, S; Tateyama, S; Teramoto, A				Maruyama, Ippei; Tanimura, Makoto; Mitani, Yuji; Ishikawa, Shinsuke; Tateyama, Souichi; Teramoto, Atsushi			Control of cracking in full-scaled columns made of ultra-high-strength concrete	MATERIALS AND STRUCTURES			English	Article						Autogenous shrinkage; Ultra high-strength concrete; Cracking; Expansive additive; Shrinkage reducing agent; Thermal insulation	HIGH-PERFORMANCE CONCRETE; AUTOGENOUS SHRINKAGE; CEMENT PASTE; THERMAL-EXPANSION; DEPENDENCE; ADMIXTURE	Experiments have shown that autogenous shrinkage and elevated temperature due to hydration in reinforced concrete members composed of ultra-high-strength concrete, such as concrete that has a design strength of over 120 MPa cause surface cracks, internal cracks, and cracks around rebar. Since ultra-high-strength concrete is generally used in Japan as cast-in-place concrete or precast concrete, the mitigation of these cracks is a crucial issue because the concrete is expected to have high durability. In the present study, expansive additive, shrinkage reducing agent, combined use of expansive additive and shrinkage reducing agent, thermal insulation to control temperature differences within a member, and combined use of thermal insulation and expansive additive were evaluated by placing full-scale columns and cutting out specimens in order to observe the crack patterns in the columns. Ways to mitigate the cracks were found and characterized. Although thermal insulation generally suppressed surface cracks, the peak temperature increased and consequently so did the risk of internal cracks due to the higher peak temperature and the resultant increase in autogenous shrinkage. Partial replacement of binder with expansive additive reduced cracks around rebar and surface cracks, but the soundness of the bond increased the risk of internal cracks. Addition of shrinkage reducing agent reduced surface cracks and internal cracks. Combined use of expansive additive and shrinkage reducing agent appeared to give a combination of these advantages. The best way to mitigate cracking was combined use of thermal insulation and expansive additive. This method reduced all types of cracks.	[Maruyama, Ippei] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Tanimura, Makoto; Mitani, Yuji] Taiheiyo Cement Corp, Cent Res Lab, Sakura 2858655, Japan; [Ishikawa, Shinsuke; Tateyama, Souichi] Hazama Ando Corp, Tech Res Inst, Tsukuba, Ibaraki 3050822, Japan; [Teramoto, Atsushi] Shimizu Corp, Inst Technol, Koutouku 1358530, Japan	Maruyama, I (reprint author), Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, ES Bldg,546 Furo Cho, Nagoya, Aichi 4648603, Japan.	ippei@dali.nuac.nagoya-u.ac.jp; Makoto_Tanimura@taiheiyo-cement.co.jp; Yuuji_Mitani@taiheiyo-cement.co.jp; ishikawa.shinsuke@ad-hzm.co.jp; tateyama.souichi@ad-hzm.co.jp; teramoto@shimz.co.jp			Ministry of Land, Infrastructure, Transport and Tourism, Japan	This work was supported by a "Grant-in-Aid for Development of Leading Technology Related to Housings and Buildings" from the Ministry of Land, Infrastructure, Transport and Tourism, Japan.	Sellevold EJ, 2006, MATER STRUCT, V39, P809, DOI 10.1617/s11527-006-9086-z; Folliard KJ, 1997, CEMENT CONCRETE RES, V27, P1357, DOI 10.1016/S0008-8846(97)00135-X; Jensen OM, 1996, ACI MATER J, V93, P539; TAZAWA E, 1995, CEMENT CONCRETE RES, V25, P281, DOI 10.1016/0008-8846(95)00010-0; PAILLERE AM, 1989, ACI MATER J, V86, P139; Suzuki M, 2009, CEMENT CONCRETE RES, V39, P373, DOI 10.1016/j.cemconres.2009.01.007; Maltese C, 2005, CEMENT CONCRETE RES, V35, P2244, DOI 10.1016/j.cemconres.2004.11.021; Weber S, 1997, ADV CEM BASED MATER, V6, P59, DOI 10.1016/S1065-7355(97)00009-6; Collins M. P., 1993, CONCRETE INT, V15, P27; Gajda J., 2012, CONCRETE INT, V24, P59; Goto Y, 1971, ACI J P, V68, P244; Hori A, 1999, AUTOGENOUS SHRINKAGE, P93; Ito H, 2004, J ADV CONCR TECHNOL, V2, P155, DOI 10.3151/jact.2.155; Kovler K., 2005, CONCR INT, V27, P39; Maruyama I, 2006, INT RILEM JCI SEM CO, P104; Maruyama I, 2012, MATER STRUCT, V45, P1829, DOI 10.1617/s11527-012-9873-7; Maruyama I, 2013, CEMENT CONCRETE RES, V50, P41, DOI 10.1016/j.cemconres.2013.03.017; Maruyama I, 2011, CEMENT CONCRETE RES, V41, P380, DOI 10.1016/j.cemconres.2011.01.003; Meddah MS, 2011, CONSTR BUILD MATER, V25, P239, DOI 10.1016/j.conbuildmat.2010.06.033; Mitani Y, 2013, 3 INT C SUST CONSTR, pe325; Ohno T, 2000, P JAPAN SOC CIVIL EN, V49, P29; Powers TC, 1958, J AM CERAM SOC, V4, P1; Sato R, 1999, P 2 INT RES SEM SELF, P163; Tanimura M, 2002, P 3 INT RES SEM SELF, P205; Tanimura M, 2009, 4 INT C CONSTR MAT P, P485; Tazawa E, 1997, MAG CONCRETE RES, V49, P15; Tazawa E, 1999, AUTOGENOUS SHRINKAGE; Tazawa E, 1992, 4 CANMET ACI INT C F, P875; Wyrzykowski M, 2013, CEMENT CONCRETE RES, V53, P25, DOI 10.1016/j.cemconres.2013.05.016	29	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1359-5997	1871-6873		MATER STRUCT	Mater. Struct.	JUN	2015	48	6					1627	1643		10.1617/s11527-014-0260-4		17	Construction & Building Technology; Engineering, Civil; Materials Science, Multidisciplinary	Construction & Building Technology; Engineering; Materials Science	CH5TB	WOS:000354097100001		
J	Ishii, M; Sagaki, D; Shimakura, H				Ishii, Motohiro; Sagaki, Daisuke; Shimakura, Hiroki			Automorphisms of Niemeier lattices for Miyamoto's -orbifold construction	MATHEMATISCHE ZEITSCHRIFT			English	Article							VERTEX OPERATOR-ALGEBRAS; CENTRAL CHARGE	We classify, up to conjugation, all automorphisms of Niemeier lattices to which we can apply Miyamoto's orbifold construction. Using this classification, we prove that the VOAs obtained in Miyamoto (Symmetries, integrable systems and representations. Springer proceedings in mathematics and statistics, vol 40. Springer, London, pp 319-344, 2013) and Sagaki and Shimakura (Trans Am Math Soc, to appear) are all of holomorphic non-lattice VOAs which we can obtain by applying the -orbifold construction to a Niemeier lattice and its automorphism.	[Ishii, Motohiro; Shimakura, Hiroki] Tohoku Univ, Grad Sch Informat Sci, Res Ctr Pure & Appl Math, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Sagaki, Daisuke] Univ Tsukuba, Inst Math, Tsukuba, Ibaraki 3058571, Japan	Sagaki, D (reprint author), Univ Tsukuba, Inst Math, Tennodai 1-1-1, Tsukuba, Ibaraki 3058571, Japan.	ishii@math.is.tohoku.ac.jp; sagaki@math.tsukuba.ac.jp; shimakura@m.tohoku.ac.jp			Japan Society for the Promotion of Science Research Fellowships for Young Scientists; Sumitomo Foundation;  [26887002];  [23740003];  [23540013];  [26800001]	Motohiro Ishii was partially supported by the Japan Society for the Promotion of Science Research Fellowships for Young Scientists, and by Grant-in-Aid for Research Activity Start-up No. 26887002, Japan.; Daisuke Sagaki was partially supported by Grant-in-Aid for Young Scientists (B) No. 23740003, Japan.; Hiroki Shimakura was partially supported by Grant-in-Aid for Scientific Research (C) No. 23540013, Japan, by Grant-in-Aid for Young Scientists (B) No. 26800001, Japan, and by Grant for Basic Science Research Projects from The Sumitomo Foundation.	Dong CY, 2004, INT MATH RES NOTICES, P2989; Dong CY, 2004, PAC J MATH, V213, P253; DONG CY, 1993, J ALGEBRA, V161, P245, DOI 10.1006/jabr.1993.1217; LEPOWSKY J, 1985, P NATL ACAD SCI USA, V82, P8295, DOI 10.1073/pnas.82.24.8295; Dong CY, 2000, COMMUN MATH PHYS, V214, P1, DOI 10.1007/s002200000242; Dong CY, 1996, J PURE APPL ALGEBRA, V110, P259, DOI 10.1016/0022-4049(95)00095-X; CONWAY J. H., 1999, GRUNDLEHREN MATH WIS, V290; CONWAY J. H., 1985, ATLAS FINITE GROUPS; Dong C., 1993, GENERALIZED VERTEX A, V112; DONG C., 1999, CONT MATH, V248, P117; Humphreys J.E., 1978, INTRO LIE ALGEBRAS R, V9; KAC V. G., 1990, INFINITE DIMENSIONAL; Lam CH, 2008, COMMUN MATH PHYS, V277, P237, DOI 10.1007/s00220-007-0323-2; Lepowsky J., 2004, PROGR MATH, V227; Miyamoto M., 2013, SPRINGER P MATH STAT, V40, P319, DOI DOI 10.1007/978-1-4471-4863-0; Sagaki D., T AM MATH S IN PRESS; SCHELLEKENS AN, 1993, COMMUN MATH PHYS, V153, P159, DOI 10.1007/BF02099044	17	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5874	1432-1823		MATH Z	Math. Z.	JUN	2015	280	1-2					55	83		10.1007/s00209-015-1413-z		29	Mathematics	Mathematics	CH7UL	WOS:000354242000004		
J	Ikeda, T; Matsumura, T				Ikeda, Takeshi; Matsumura, Tomoo			Pfaffian sum formula for the symplectic Grassmannians	MATHEMATISCHE ZEITSCHRIFT			English	Article						Schubert classes; Symplectic Grassmannians; Torus equivariant cohomology; Giambelli type formula; Wilson's conjecture; Double Schubert polynomials	DOUBLE SCHUBERT POLYNOMIALS; EQUIVARIANT COHOMOLOGY; CLASSICAL-GROUPS; DEGENERACY LOCI; CALCULUS	We study the torus equivariant Schubert classes of the Grassmannian of non-maximal isotropic subspaces in a symplectic vector space. We prove a formula that expresses each of those classes as a sum of multi Schur-Pfaffians, whose entries are equivariantly modified special Schubert classes. Our result gives a proof to Wilson's conjectural formula, which generalizes the Giambelli formula for the ordinary cohomology proved by Buch-Kresch-Tamvakis, given in terms of Young's raising operators. Furthermore we show that the formula extends to a certain family of Schubert classes of the symplectic partial isotropic flag varieties.	[Ikeda, Takeshi] Okayama Univ Sci, Dept Appl Math, Okayama 7000005, Japan; [Matsumura, Tomoo] Korea Adv Inst Sci & Technol, Dept Math Sci, Daejeon 305701, South Korea	Ikeda, T (reprint author), Okayama Univ Sci, Dept Appl Math, Okayama 7000005, Japan.	ike@xmath.ous.ac.jp; tomoomatsumura@kaist.ac.kr					Anderson D, 2012, EMS SER CONGR REP, P71; Anderson D. D., PREPRINT; Ikeda T, 2011, ADV MATH, V226, P840, DOI 10.1016/j.aim.2010.07.008; [Anonymous], 1995, SYMMETRIC FUNCTIONS; Ikeda T, 2007, ADV MATH, V215, P1, DOI 10.1016/j.aim.2007.04.008; Buch AS, 2012, MATH ANN, V354, P801, DOI 10.1007/s00208-011-0752-2; KEMPF G, 1974, ACTA MATH-DJURSHOLM, V132, P153, DOI 10.1007/BF02392111; Kresch A, 2002, ANN I FOURIER, V52, P1681; Bjorner A., 2005, GRADUATE TEXTS MATH, V231; Buch A.S., J REINE ANGEW MATH; Buch A.S., ARXIV08112781; Fulton W., 1998, LECT NOTES MATH, V1689; Giambelli G.Z, 1902, MEM ACCAD SCI TORINO, V52, P171; Humphreys James E., 1990, CAMBRIDGE STUDIES AD, V29; Ikeda T, 2009, T AM MATH SOC, V361, P5193; Ivanov V.N, 2004, ZAP NAUC SEM S PETER, V307, P99; Kazarian M, 2000, I NEWTON I MATH SCI; Manivel L., 2001, SMF AMS TEXTS MONOGR, V6; Naruse H., COMMUNICATION; Pragacz P., 1991, LECT NOTES MATH, V1478, P130; Pragacz P, 1997, COMPOS MATH, V107, P11, DOI 10.1023/A:1000182205320; Schur I., 1911, J REINE ANGEW MATH, V139, P155; Tamvakis H., PREPRINT; Tamvakis H, 2014, J ALGEBRAIC GEOM, V23, P245; Wilson E, 2010, THESIS U MARYLAND CO	25	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5874	1432-1823		MATH Z	Math. Z.	JUN	2015	280	1-2					269	306		10.1007/s00209-015-1423-x		38	Mathematics	Mathematics	CH7UL	WOS:000354242000013		
J	Ito, T				Ito, Tetsuya			A kernel of a braid group representation yields a knot with trivial knot polynomials	MATHEMATISCHE ZEITSCHRIFT			English	Article						Knots; Dehornoy ordering; Quantum invariants		We show that a non-trivial, non-central normal subgroup of the braid groups contains a braid whose closure is a hyperbolic knot with arbitrary large genus. This shows that the non-faithfulness of a quantum representation implies that the corresponding quantum invariant fails to detect the unknot. The proof utilizes the Dehornoy ordering of the braid groups.	Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan	Ito, T (reprint author), Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan.	tetitoh@kurims.kyoto-u.ac.jp			JSPS [25887030]	This research was partially supported by JSPS Research Grant-in-Aid for Research Activity Start-up, Grant No. 25887030.	Bigelow S, 2002, J KNOT THEOR RAMIF, V11, P493, DOI 10.1142/S0218216502001779; Burckel S, 1997, J PURE APPL ALGEBRA, V120, P1, DOI 10.1016/S0022-4049(96)00072-2; Dehornoy P, 2008, J PURE APPL ALGEBRA, V212, P2413, DOI 10.1016/j.jpaa.2008.03.027; Dehornoy P., 2008, MATH SURVEYS MONOGRA, V148; Fenn R, 1999, PAC J MATH, V191, P49; Ito T, 2011, J KNOT THEOR RAMIF, V20, P1311, DOI 10.1142/S0218216511009169; Ito T., 2010, GROUPS COMPLEX CRYPT, V2, P123, DOI 10.1515/GCC.2010.009; Ito T, 2011, GEOM TOPOL, V15, P473, DOI 10.2140/gt.2011.15.473; LONG DD, 1986, MATH PROC CAMBRIDGE, V99, P79, DOI 10.1017/S0305004100063957; Ohtsuki T., 2002, SERIES KNOTS EVERYTH, V29; PAPADOPOULOS A, 1982, ANN SCI ECOLE NORM S, V15, P543	11	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5874	1432-1823		MATH Z	Math. Z.	JUN	2015	280	1-2					347	353		10.1007/s00209-015-1426-7		7	Mathematics	Mathematics	CH7UL	WOS:000354242000016		
J	Yan, HF; Shi, HB; Hiroki, O; Zhang, C; Xue, Z; Cai, B; Wang, GQ				Yan, Haofang; Shi, Haibin; Hiroki, Oue; Zhang, Chuan; Xue, Zhu; Cai, Bin; Wang, Guoqing			Modeling bulk canopy resistance from climatic variables for predicting hourly evapotranspiration of maize and buckwheat	METEOROLOGY AND ATMOSPHERIC PHYSICS			English	Article							PENMAN-MONTEITH; SIMPLE PARAMETERIZATION; SENSITIVITY-ANALYSIS; SURFACE EVAPORATION; IRRIGATED CROPS; TRANSPIRATION; REGION; FIELD	This study presents models for predicting hourly canopy resistance (r (c)) and evapotranspiration (ETc) based on Penman-Monteith approach. The micrometeorological data and ET (c) were observed during maize and buckwheat growing seasons in 2006 and 2009 in China and Japan, respectively. The proposed models of r (c) were developed by a climatic resistance (r (*)) that depends on climatic variables. Non-linear relationships between r (c) and r (*) were applied. The measured ETc using Bowen ratio energy balance method was applied for model validation. The statistical analysis showed that there were no significant differences between predicted ETc by proposed models and measured ETc for both maize and buckwheat crops. The model for predicting ETc at maize field showed better performance than predicting ETc at buckwheat field, the coefficients of determination were 0.92 and 0.84, respectively. The study provided an easy way for the application of Penman-Monteith equation with only general available meteorological database.	[Yan, Haofang; Cai, Bin] Jiangsu Univ, Res Ctr Fluid Machinery Engn & Technol, Zhenjiang 212013, Peoples R China; [Shi, Haibin] Inner Mongolia Agr Univ, Water Conservancy & Civil Engn Coll, Hohhot 010018, Peoples R China; [Hiroki, Oue] Ehime Univ, United Grad Sch Agr Sci, Matsuyama, Ehime 7908566, Japan; [Zhang, Chuan] Jiangsu Univ, Inst Agr Engn, Zhenjiang 212013, Peoples R China; [Xue, Zhu] Tianjing Agr Univ, Tianjin 300384, Peoples R China; [Wang, Guoqing] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing 210029, Jiangsu, Peoples R China	Shi, HB (reprint author), Inner Mongolia Agr Univ, Water Conservancy & Civil Engn Coll, Hohhot 010018, Peoples R China.	yanhaofang@yahoo.com; shi_haibin@sohu.com			national high technology research and development program (863 Program) project of China [2011AA100506]; Jiangsu universities engineering discipline construction project [1033000001]; Jiangsu University senior professional scientific research fund project [14JDG015, 14JDG017]; Agricultural machinery of Sanxin project in Jiangsu province [NJ2014-10]; key project of the National Natural Science Foundation of China [41330854]	This study has been financially supported by the national high technology research and development program (863 Program) project of China (grant 2011AA100506), Jiangsu universities engineering discipline construction project (1033000001), Jiangsu University senior professional scientific research fund project (14JDG015, 14JDG017), Agricultural machinery of Sanxin project in Jiangsu province (NJ2014-10) and the key project of the National Natural Science Foundation of China (41330854).	Allen R. G., 1998, IRRIG DRAIN; Alves L, 1998, T ASAE, V41, P345; BEVEN K, 1979, J HYDROL, V44, P169, DOI 10.1016/0022-1694(79)90130-6; Alves I, 2000, AGR WATER MANAGE, V42, P371, DOI 10.1016/S0378-3774(99)00041-4; Yan Haofang, 2011, Journal of Agricultural Meteorology, V67, P89; ALLEN RG, 1989, AGRON J, V81, P650; He Bin, 2009, Journal of Agricultural Meteorology, V65, P39; Katerji N, 2006, AGR FOREST METEOROL, V138, P142, DOI 10.1016/j.agrformet.2006.04.006; KATERJI N, 1983, AGRONOMIE, V3, P513, DOI 10.1051/agro:19830603; Ortega-Farias S, 2004, IRRIGATION SCI, V23, P1, DOI 10.1007/s00271-003-0087-1; Katerji N, 2011, HYDROL PROCESS, V25, P117, DOI 10.1002/hyp.7829; Rana G, 2008, HYDROL PROCESS, V22, P181, DOI 10.1002/hyp.6570; Farahani HJ, 2007, T ASABE, V50, P1627; Yan HF, 2012, METEOROL ATMOS PHYS, V118, P143, DOI 10.1007/s00703-012-0213-9; Rana G, 1997, AGR FOREST METEOROL, V86, P215, DOI 10.1016/S0168-1923(97)00009-9; Steduto P, 2003, THEOR APPL CLIMATOL, V74, P217, DOI 10.1007/s00704-002-0720-6; Brutsaert W. H., 1982, EVAPORATION ATMOSPHE; Jensen ME, 1990, ASCE MANUALS REPORTS; Lagos LO, 2013, IRRIGATION SCI, V31, P135, DOI 10.1007/s00271-011-0298-9; Li SE, 2014, HYDROL PROCESS, V28, P2312, DOI 10.1002/hyp.9768; Monteith J. L., 1973, PRINCIPLES ENV PHYS; Ortega-Farias S, 2010, AGR FOREST METEOROL, V150, P276, DOI 10.1016/j.agrformet.2009.11.012; Perez PJ, 2006, HYDROL PROCESS, V20, P515, DOI 10.1002/hyp.5919; Rana G, 2011, THEOR APPL CLIMATOL, V103, P413, DOI 10.1007/s00704-010-0308-5; RANA G, 1994, THEOR APPL CLIMATOL, V50, P61, DOI 10.1007/BF00864903; Rana G, 1998, THEOR APPL CLIMATOL, V60, P141, DOI 10.1007/s007040050039; Wight JR, 1993, MANAGEMENT IRRIGATIO, P953; Yan HF, 2015, THEOR APPL CLIMATOL, V122, P721, DOI 10.1007/s00704-014-1325-6; Yan HaoFang, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P103	29	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0177-7971	1436-5065		METEOROL ATMOS PHYS	Meteorol. Atmos. Phys.	JUN	2015	127	3					305	312		10.1007/s00703-015-0369-1		8	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CH7EO	WOS:000354198600005		
J	Aoshima, M; Yata, K				Aoshima, Makoto; Yata, Kazuyoshi			Asymptotic Normality for Inference on Multisample, High-Dimensional Mean Vectors Under Mild Conditions	METHODOLOGY AND COMPUTING IN APPLIED PROBABILITY			English	Article						Asymptotic normality; Confidence region; Cross-data-matrix methodology; Large p small n; Microarray; Two-stage procedure	CROSS-DATA-MATRIX; 2-STAGE PROCEDURES	In this paper, we consider the asymptotic normality for various inference problems on multisample and high-dimensional mean vectors. We verify that the asymptotic normality of concerned statistics is proved under mild conditions for high-dimensional data. We show that the asymptotic normality can be justified theoretically and numerically even for non-Gaussian data. We introduce the extended cross-data-matrix (ECDM) methodology to construct an unbiased estimator at a reasonable computational cost. With the help of the asymptotic normality, we show that the concerned statistics given by ECDM can ensure consistency properties for inference on multisample and high-dimensional mean vectors. We give several applications such as confidence regions for high-dimensional mean vectors, confidence intervals for the squared norm and the test of multisample mean vectors. We also provide sample size determination so as to satisfy prespecified accuracy on inference. Finally, we give several examples by using a microarray data set.	[Aoshima, Makoto; Yata, Kazuyoshi] Univ Tsukuba, Inst Math, Ibaraki 3058571, Japan	Aoshima, M (reprint author), Univ Tsukuba, Inst Math, Ibaraki 3058571, Japan.	aoshima@math.tsukuba.ac.jp; yata@math.tsukuba.ac.jp			Challenging Exploratory Research, Japan Society for the Promotion of Science (JSPS) [22300094, 23650142]; JSPS [23740066]	Research of the first author was partially supported by Grants-in-Aid for Scientific Research (B) and Challenging Exploratory Research, Japan Society for the Promotion of Science (JSPS), under Contract Numbers 22300094 and 23650142. Research of the second author was partially supported by Grant-in-Aid for Young Scientists (B), JSPS, under Contract Number 23740066.	Chen SX, 2010, ANN STAT, V38, P808, DOI 10.1214/09-AOS716; MCLEISH DL, 1974, ANN PROBAB, V2, P620, DOI 10.1214/aop/1176996608; Aoshima M, 2011, SEQUENTIAL ANAL, V30, P356, DOI 10.1080/07474946.2011.619088; Chiaretti S, 2004, BLOOD, V103, P2771, DOI 10.1182/blood-2003-09-3243; Yata K, 2010, J MULTIVARIATE ANAL, V101, P2060, DOI 10.1016/j.jmva.2010.04.006; Aoshima M, 2011, SEQUENTIAL ANAL, V30, P432, DOI 10.1080/07474946.2011.619102; Aoshima M, 2011, PROSTATE CANC BENCH, P13; Bai ZD, 1996, STAT SINICA, V6, P311; M Ghosh, 1997, ANN PROBAB; Pollard KS, 2005, STAT BIOL HLTH, V2005, P249; Srivastava M. S., 2005, J JAPAN STAT SOC, V35, P251; Yata K, 2012, METHODOL COMPUT APPL, V14, P459, DOI 10.1007/s11009-011-9233-z; Yata K, 2013, J MULTIVARIATE ANAL, V117, P313, DOI 10.1016/j.jmva.2013.03.007	13	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-5841	1573-7713		METHODOL COMPUT APPL	Methodol. Comput. Appl. Probab.	JUN	2015	17	2					419	439		10.1007/s11009-013-9370-7		21	Statistics & Probability	Mathematics	CH5RZ	WOS:000354094300008		
J	Matsumi, Y; Fujita, K; Takashima, Y; Yanagida, K; Morikawa, Y; Matsumoto-Nakano, M				Matsumi, Y.; Fujita, K.; Takashima, Y.; Yanagida, K.; Morikawa, Y.; Matsumoto-Nakano, M.			Contribution of glucan-binding protein A to firm and stable biofilm formation by Streptococcus mutans	MOLECULAR ORAL MICROBIOLOGY			English	Article						biofilm; glucan-binding protein; Streptococcus mutans	HEAT-SHOCK PROTEINS; VIRULENCE FACTORS; DENTAL-CARIES; GENE; ARCHITECTURE; PLAQUE	Glucan-binding proteins (Gbps) of Streptococcus mutans, a major pathogen of dental caries, mediate the binding of glucans synthesized from sucrose by the action of glucosyltransferases (GTFs) encoded by gtfB, gtfC, and gtfD. Several stress proteins, including DnaK and GroEL encoded by dnaK and groEL, are related to environmental stress tolerance. The contribution of Gbp expression to biofilm formation was analyzed by focusing on the expression levels of genes encoding GTFs and stress proteins. Biofilm-forming assays were performed using GbpA-, GbpB-, and GbpC-deficient mutant strains and the parental strain MT8148. The expression levels of gtfB, gtfC, gtfD, dnaK, and groEL were evaluated by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Furthermore, the structure of biofilms formed by these Gbp-deficient mutant strains was observed using confocal laser scanning microscopy (CLSM). Biofilm-forming assay findings demonstrated that the amount formed by the GbpA-deficient mutant strain (AD1) was nearly the same as that by the parental strain, while the GbpB- and GbpC-deficient mutant strains produced lower amounts than MT8148. Furthermore, RT-qPCR assay results showed that the expressions of gtfB, dnaK, and groEL in AD1 were elevated compared with MT8148. CLSM also revealed that the structure of biofilm formed by AD1 was prominently different compared with that formed by the parental strain. These results suggest that a defect in GbpA influences the expression of genes controlling biofilm formation, indicating its importance as a protein for firm and stable biofilm formation.	[Matsumi, Y.; Fujita, K.; Takashima, Y.; Yanagida, K.; Morikawa, Y.; Matsumoto-Nakano, M.] Okayama Univ, Dept Pediat Dent, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008525, Japan	Matsumoto-Nakano, M (reprint author), Okayama Univ, Dept Pediat Dent, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008525, Japan.	mnakano@cc.okayama-u.ac.jp			Japan Society for the Promotion of Science [2339047315]	This study was supported by a Grant-in Aid for Scientific Research (B) 2339047315 from the Japan Society for the Promotion of Science.	Marsh PD, 2003, ORAL DIS, V9, P16, DOI 10.1034/j.1601-0825.9.s1.4.x; Lynch DJ, 2007, FEMS MICROBIOL LETT, V268, P158, DOI 10.1111/j.1574-6968.2006.00576.x; Banas JA, 2003, CRIT REV ORAL BIOL M, V14, P89; CRAIG EA, 1993, MICROBIOL REV, V57, P402; TOBIAN JA, 1982, J BACTERIOL, V152, P215; OOSHIMA T, 1983, JPN J MED SCI BIOL, V36, P219; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Matsumoto-Nakano M, 2007, ORAL MICROBIOL IMMUN, V22, P30; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; JAYARAMAN GC, 1995, FEMS MICROBIOL LETT, V131, P255; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; HAMADA S, 1984, J DENT RES, V63, P407, DOI 10.1177/00220345840630031001; BOUVET A, 1981, J BACTERIOL, V146, P1075; Shah DSH, 2004, MICROBIOL-SGM, V150, P1947, DOI 10.1099/mic.0.26955-0; BANAS JA, 1990, INFECT IMMUN, V58, P667; Banas JA, 2007, FEMS MICROBIOL LETT, V267, P80, DOI 10.1111/j.1574-6968.2006.00557.x; HAMADA S, 1989, J GEN MICROBIOL, V135, P335; Hazlett KRO, 1999, INFECT IMMUN, V67, P3909; Inagaki S, 2009, ORAL MICROBIOL IMMUN, V24, P104, DOI 10.1111/j.1399-302X.2008.00480.x; Klein MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045795; Kolter R, 1998, SCIENCE, V280, P226, DOI 10.1126/science.280.5361.226; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-105; KURAMITSU HK, 1993, CRIT REV ORAL BIOL M, V4, P159; Matsumoto-Nakano M, 2006, J BACTERIOL, V188, P8095, DOI 10.1128/JB.00908-06; PERRY D, 1985, INFECT IMMUN, V50, P130; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2041-1006	2041-1014		MOL ORAL MICROBIOL	Mol. Oral Microbiol.	JUN	2015	30	3					217	226		10.1111/omi.12085		10	Dentistry, Oral Surgery & Medicine; Microbiology	Dentistry, Oral Surgery & Medicine; Microbiology	CH7EF	WOS:000354197700004		
J	Hutcherson, JA; Bagaitkar, J; Nagano, K; Yoshimura, F; Wang, H; Scott, DA				Hutcherson, J. A.; Bagaitkar, J.; Nagano, K.; Yoshimura, F.; Wang, H.; Scott, D. A.			Porphyromonas gingivalis RagB is a proinflammatory signal transducer and activator of transcription 4 agonist	MOLECULAR ORAL MICROBIOLOGY			English	Article						inflammation; monocyte; periodontitis; Porphyromonas gingivalis; signal transducer and activator of transcription 4; Toll-like receptor	IFN-GAMMA; PROTEINS; PATHOGEN; ANTIBODY; LOCUS; STAT4; IDENTIFICATION; INFLAMMATION; MACROPHAGES; VIRULENCE	Periodontal diseases are semi-ubiquitous and caused by chronic, plaque-induced inflammation. The 55-kDa immunodominant RagB outer membrane protein of Porphyromonas gingivalis, a keystone periodontal pathogen, has been proposed to facilitate nutrient transport. However, potential interactions between RagB and the innate response have not been examined. We determined that RagB exposure led to the differential and dose-related expression of multiple genes encoding proinflammatory mediators [interleukin-1 (IL-1), IL-1, IL-6, IL-8 and CCL2; all P<0.05] in primary human monocytes and to the secretion of tumor necrosis factor and IL-8, but not interferon- or IL-12. RagB was shown to be a Toll-like receptor 2 (TLR2) and TLR4 agonist that activated signal transducer and activator of transcription 4 and nuclear factor-B signaling, as determined by a combination of blocking antibodies, pharmaceutical inhibitors and gene silencing. In keeping, a ragB mutant similarly exhibited reduced inflammatory capacity, which was rescued by ragB complementation. These results suggest that RagB elicits a major pro-inflammatory response in primary human monocytes and, therefore, could play an important role in the etiology of periodontitis and systemic sequelae.	[Hutcherson, J. A.; Bagaitkar, J.; Wang, H.; Scott, D. A.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Nagano, K.; Yoshimura, F.] Univ Louisville, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA; [Wang, H.; Scott, D. A.] Aichi Gakui Univ, Dept Microbiol, Nagoya, Aichi, Japan	Scott, DA (reprint author), Univ Louisville, Oral Immunol & Infect Dis, 501 South Preston St, Louisville, KY 40292 USA.	dascot07@louisville.edu	Wang, Huizhi/M-8229-2015		NIDCR [R01DE019826]	This work was kindly supported by NIDCR (R01DE019826; DAS).	Imai M, 2005, EUR J ORAL SCI, V113, P391, DOI 10.1111/j.1600-0722.2005.00235.x; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Shirota H, 2005, J IMMUNOL, V174, P4579; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Bagaitkar J, 2009, ENVIRON MICROBIOL, V11, P1242, DOI 10.1111/j.1462-2920.2008.01852.x; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Kim YK, 2007, J IMMUNOL, V178, P5375; Good SR, 2009, J IMMUNOL, V183, P3839, DOI 10.4049/jimmunol.0901411; Frucht DM, 2000, J IMMUNOL, V164, P4659; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Remoli ME, 2007, J LEUKOCYTE BIOL, V81, P355, DOI 10.1189/jlb.0506319; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; Kocgozlu L, 2009, J DENT RES, V88, P741, DOI 10.1177/0022034509341166; Zeller I, 2014, J PERIODONTOL, V85, P837, DOI 10.1902/jop.2013.130336; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Matsukawa A, 2001, J EXP MED, V193, P679, DOI 10.1084/jem.193.6.679; Iltanen S, 2006, INFLAMM BOWEL DIS, V12, P389, DOI 10.1097/01.MIB.0000218765.84087.42; Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; Bagaitkar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009323; Bergstrom J, 2003, J CLIN PERIODONTOL, V30, P107, DOI 10.1034/j.1600-051X.2003.00272.x; Bolam DN, 2012, CURR OPIN STRUC BIOL, V22, P563, DOI 10.1016/j.sbi.2012.06.006; Bonass WA, 2000, INFECT IMMUN, V68, P4012, DOI 10.1128/IAI.68.7.4012-4017.2000; Consortium TU, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI DOI 10.1093/NAR/GKT1140; Curtis MA, 1999, J PERIODONTAL RES, V34, P400, DOI 10.1111/j.1600-0765.1999.tb02273.x; Dolgilevich S., 2011, J ORAL MICROBIOL, V3, DOI [10.3402/jom.v3i0.5764, DOI 10.3402/JOM.V3I0.5764]; Grohmann U, 2001, J IMMUNOL, V167, P221; Hall LMC, 2005, INFECT IMMUN, V73, P4253, DOI 10.1128/IAI.73.7.4253-4262.2005; Hanley SA, 1999, INFECT IMMUN, V67, P1157; Kamezaki K, 2004, INT IMMUNOL, V16, P1173, DOI 10.1093/intimm/dxh118; Kim HS, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4048; Klein BA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-578; Phansopa C., 2013, BIOCHEM J, V458, P499; Ronnblom L, 2011, UPSALA J MED SCI, V116, P227, DOI 10.3109/03009734.2011.624649; Shi XJ, 2007, INFECT IMMUN, V75, P2071, DOI 10.1128/IAI.01785-06; Wei B, 2001, INFECT IMMUN, V69, P6044, DOI 10.1128/IAI.69.10.6044-6054.2001; Zheng D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059604	37	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2041-1006	2041-1014		MOL ORAL MICROBIOL	Mol. Oral Microbiol.	JUN	2015	30	3					242	252		10.1111/omi.12089		11	Dentistry, Oral Surgery & Medicine; Microbiology	Dentistry, Oral Surgery & Medicine; Microbiology	CH7EF	WOS:000354197700006		
J	Aistleitner, C; Fukuyama, K				Aistleitner, Christoph; Fukuyama, Katusi			Extremal discrepancy behavior of lacunary sequences	MONATSHEFTE FUR MATHEMATIK			English	Article						Discrepancy theory; Uniform distribution modulo 1; Lacunary sequences; Metric number theory; Law of the iterated logarithm	ITERATED LOGARITHM; LAW; SERIES	In 1975 Walter Philipp proved the law of the iterated logarithm (LIL) for the discrepancy of lacunary sequences: for any sequence satisfying the Hadamard gap condition we have or almost all . In recent years there has been significant progress concerning the precise value of the limsup in this LIL for special sequences having a "simple" number-theoretic structure. However, since the publication of Philipp's paper there has been no progress concerning the lower bound in this LIL for generic lacunary sequences . The purpose of the present paper is to collect known results concerning this problem, to investigate what the optimal value in the lower bound could be, and for which special sequences a small value of the limsup in this LIL can be obtained. We formulate three open problems, which could serve as the main targets for future research.	[Aistleitner, Christoph; Fukuyama, Katusi] Kobe Univ, Grad Sch Sci, Dept Math, Kobe, Hyogo 6578501, Japan	Aistleitner, C (reprint author), Kobe Univ, Grad Sch Sci, Dept Math, Kobe, Hyogo 6578501, Japan.	aistleitner@finanz.math.tugraz.at; fukuyama@math.kobe-u.ac.jp			Schrodinger scholarship of the Austrian Research Foundation (FWF); KAKENHI [24340017, 24340020]	C. Aistleitner is supported by a Schrodinger scholarship of the Austrian Research Foundation (FWF). K. Fukuyama is supported by KAKENHI 24340017 and 24340020.	Aistleitner C, 2010, MONATSH MATH, V161, P255, DOI 10.1007/s00605-009-0165-4; Aistleitner C, 2010, T AM MATH SOC, V362, P5967; Aistleitner C, 2011, STOCH DYNAM, V11, P183, DOI 10.1142/S021949371100322X; Aistleitner C, 2013, T AM MATH SOC, V365, P3713; Aistleitner C, 2010, MONATSH MATH, V160, P1, DOI 10.1007/s00605-008-0067-x; SALEM R, 1947, P NATL ACAD SCI USA, V33, P333, DOI 10.1073/pnas.33.11.333; Fukuyama K, 2008, ACTA MATH HUNG, V118, P155, DOI 10.1007/s10474-007-6201-8; Dick J., 2010, DIGITAL NETS SEQUENC; Drmota M., 1997, P LECT NOTES MATH, V1651; Erdos P., 1955, NEDERL AKAD WETENSCH, V17, P77; Fukuyama K, 2012, STUD SCI MATH HUNG, V49, P52, DOI 10.1556/SScMath.2011.1186; Fukuyama K., 2012, SUGAKU EXPOSITION, V25, P189; Gal I. S., 1955, NEDERL AKAD WETENSCH, V17, P65; Izumi M., 1968, PUBL RAMANUJAN I, V1, P101; KAC M, 1949, B AM MATH SOC, V55, P641, DOI 10.1090/S0002-9904-1949-09242-X; KAHANE JP, 1964, B AM MATH SOC, V70, P199, DOI 10.1090/S0002-9904-1964-11080-6; Kuipers L., 1974, UNIFORM DISTRIBUTION; Philipp W, 1975, ACTA ARITH, V26, P241; Schoissengeier J, 1998, GLASGOW MATH J, V40, P393; Takahashi S., 1972, TOHOKU MATH J, V2, P319; Weyl H., 1916, EINS MATH ANN, V77, P313; Zygmund A., 1988, TRIGONOMETRIC SERIES, VII; Zygmund A., 1988, TRIGONOMETRIC SERIES, VI	23	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0026-9255	1436-5081		MONATSH MATH	Mon.heft. Math.	JUN	2015	177	2					167	184		10.1007/s00605-014-0693-4		18	Mathematics	Mathematics	CI0CH	WOS:000354402900001		
J	Asano, F; Tokuda, I				Asano, Fumihiko; Tokuda, Isao			Indirectly controlled limit cycle walking of combined rimless wheel based on entrainment to active wobbling motion	MULTIBODY SYSTEM DYNAMICS			English	Article						Combined rimless wheel; Passive dynamic walking; Entrainment; Wobbling mass	PASSIVE DYNAMIC WALKING; LOADS	It has been clarified that a passive combined rimless wheel (CRW) that consists of two identical eight-legged rimless wheels can increase the walking speed either by adjusting the phase difference between the fore and rear legs or by using a passive wobbling mass that vibrates up-and-down in the body frame. Toward a further speeding-up of the CRW, this paper investigates the effect of an active wobbling mass driven by an actuator and the effect of an indirect excitation control. First, we develop the mathematical model and numerically show that the CRW generates a walking motion, which is entrained to the up-and-down motion of the active wobbling mass at frequencies higher than the natural frequency of the CRW. We discuss the gait properties mainly from the viewpoints of frequency and phase relationships. Second, we conduct verification experiments using our prototype CRW machine and describe the results.	[Asano, Fumihiko] Japan Adv Inst Sci & Technol, Sch Informat Sci, Nomi, Ishikawa 9231292, Japan; [Tokuda, Isao] Ritsumeikan Univ, Coll Sci & Engn, Dept Mech Engn, Kusatsu, Shiga 5258577, Japan	Asano, F (reprint author), Japan Adv Inst Sci & Technol, Sch Informat Sci, 1-1 Asahidai, Nomi, Ishikawa 9231292, Japan.	fasano@jaist.ac.jp; isao@fc.ritsumei.ac.jp					Tedrake R, 2004, IEEE INT CONF ROBOT, P4656, DOI 10.1109/ROBOT.2004.1302452; Asano F, 2012, IEEE INTL CONF CONTR, P1039, DOI 10.1109/CCA.2012.6402345; Rome LC, 2005, SCIENCE, V309, P1725, DOI 10.1126/science.1111063; Rome LC, 2006, NATURE, V444, P1023, DOI 10.1038/4441023a; Ackerman J, 2011, IEEE INT C INT ROBOT, P203, DOI 10.1109/IROS.2011.6048723; Chevallereau C, 2003, IEEE CONTR SYST MAG, V23, P57, DOI 10.1109/MCS.2003.1234651; Asano F, 2012, ADV ROBOTICS, V26, P155, DOI 10.1163/016918611X607699; Coleman MJ, 1997, DYNAM STABIL SYST, V12, P139, DOI 10.1080/02681119708806242; Inoue R, 2011, IEEE INT C INT ROBOT, P2747, DOI 10.1109/IROS.2011.6048184; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; Pikovsky A., 2003, SYNCHRONIZATION UNIV; Remy CD, 2010, INT J ROBOT RES, V29, P1173, DOI 10.1177/0278364909344635; Sugimoto Y, 2010, Proceedings of the SICE 2010 - 49th Annual Conference of the Society of Instrument and Control Engineers of Japan; Tanaka D, 2012, IEEE INT C INT ROBOT, P151, DOI 10.1109/IROS.2012.6385499	14	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1384-5640	1573-272X		MULTIBODY SYST DYN	Multibody Syst. Dyn.	JUN	2015	34	2					191	210		10.1007/s11044-014-9419-6		20	Mechanics	Mechanics	CH7JO	WOS:000354212400004		
J	Zhao, HH; Luo, J; Huang, ZH; Nagumo, T; Murayama, J; Zhang, LQ				Zhao, Haohua; Luo, Jun; Huang, Zhiheng; Nagumo, Takefumi; Murayama, Jun; Zhang, Liqing			Statistically Adaptive Image Denoising Based on Overcomplete Topographic Sparse Coding	NEURAL PROCESSING LETTERS			English	Article						Overcomplete; Sparse coding; Topographic constraints; Image denoising; Multi-category; Adaptive learning; Shrinkage	INDEPENDENT COMPONENT ANALYSIS; REPRESENTATIONS; DICTIONARIES; ALGORITHM	This paper presents a novel image denoising framework using overcomplete topographic model. To adapt to the statistics of natural images, we impose both spareseness and topograpgic constraints on the denoising model. Based on the overcomplete topographic model, our denoising system improves the previous work on the following aspects: multi-category based sparse coding, adaptive learning, local normalization, lasso shrinkage function, and subset selection. A large number of simulations have been performed to show the performance of the modified model, demonstrating that the proposed model achieves better denoising performance.	[Zhao, Haohua; Huang, Zhiheng; Zhang, Liqing] Shanghai Jiao Tong Univ, Dept Comp Sci & Engn, Key Lab, Shanghai Educ Commiss Intelligent Interact & Cogn, Shanghai 200030, Peoples R China; [Luo, Jun; Nagumo, Takefumi; Murayama, Jun] Sony Corp, Tokyo, Japan	Zhang, LQ (reprint author), Shanghai Jiao Tong Univ, Dept Comp Sci & Engn, Key Lab, Shanghai Educ Commiss Intelligent Interact & Cogn, Shanghai 200030, Peoples R China.	haoh.zhao@sjtu.edu.cn; jun.luo@jp.sony.com; sylvon.wong@gmail.com; takefumi.nagumo@jp.sony.com; jun.murayama@jp.sony.com; zhang-lq@cs.sjtu.edu.cn			National Natural Science Foundation of China [61272251, 91120305]	The work of H. Zhao and L.Zhang was in part supported by the National Natural Science Foundation of China (Grant No. 61272251, 91120305).	Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; Chang SG, 2000, IEEE T IMAGE PROCESS, V9, P1532, DOI 10.1109/83.862633; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267; Mairal J, 2009, IEEE I CONF COMP VIS, P2272, DOI 10.1109/ICCV.2009.5459452; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hyvarinen A, 2001, NEURAL COMPUT, V13, P1527, DOI 10.1162/089976601750264992; Vincent P, 2010, J MACH LEARN RES, V11, P3371; Buades A, 2005, PROC CVPR IEEE, P60; Dong WS, 2011, PROC CVPR IEEE, P457; Dabov K, 2009, SPARS 09 SIGN PROC A; Hyvarinen A, 1999, INTELLIGENT SIGNAL P; Jain V., 2008, NIPS, V8, P769; LeCun Y., 1995, HDB BRAIN THEORY NEU, P3361; Ma LB, 2007, IEEE IJCNN, P1198, DOI 10.1109/IJCNN.2007.4371128; Ma LB, 2008, NEUROCOMPUTING, V71, P2217, DOI 10.1016/j.neucom.2007.06.013; Pati Y. C., 1993, C REC 27 AS C SIGN S, V1, P40; Xie J., 2012, P 26 ANN C NEUR INF, V25, P350; Zhao H., 2013, LNCS, V8228, P266; Zhao HH, 2011, LECT NOTES COMPUT SC, V7063, P308	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1370-4621	1573-773X		NEURAL PROCESS LETT	Neural Process. Lett.	JUN	2015	41	3			SI		357	369		10.1007/s11063-014-9384-3		13	Computer Science, Artificial Intelligence	Computer Science	CH7GK	WOS:000354203700005		
J	Toepel, U; Bielser, ML; Forde, C; Martin, N; Voirin, A; le Coutre, J; Murray, MM; Hudry, J				Toepel, Ulrike; Bielser, Marie-Laure; Forde, Ciaran; Martin, Nathalie; Voirin, Alexandre; le Coutre, Johannes; Murray, Micah M.; Hudry, Julie			Brain dynamics of meal size selection in humans	NEUROIMAGE			English	Article						EEG; Food image; Portion size; Satiety; Meal	POSTERIOR CINGULATE CORTEX; 3-FACTOR EATING QUESTIONNAIRE; HUMAN ORBITOFRONTAL CORTEX; PORTION-SIZE; COGNITIVE REGULATION; SPATIAL ATTENTION; ENERGETIC VALUE; FOOD REWARD; STIMULUS; LIKING	Although neuroimaging research has evidenced specific responses to visual food stimuli based on their nutritional quality (e.g., energy density, fat content), brain processes underlying portion size selection remain largely unexplored. We identified spatio-temporal brain dynamics in response to meal images varying in portion size during a task of ideal portion selection for prospective lunch intake and expected satiety. Brain responses to meal portions judged by the participants as 'too small', 'ideal' and 'too big' were measured by means of electro-encephalographic (EEG) recordings in 21 normal-weight women. During an early stage of meal viewing (105-145 ms), data showed an incremental increase of the head-surface global electric field strength (quantified via global field power; GFP) as portion judgments ranged from 'too small' to 'too big'. Estimations of neural source activity revealed that brain regions underlying this effect were located in the insula, middle frontal gyrus and middle temporal gyrus, and are similar to those reported in previous studies investigating responses to changes in food nutritional content. In contrast, during a later stage (230-270ms), GFPwasmaximal for the 'ideal' relative to the 'non-ideal' portion sizes. Greater neural source activity to 'ideal' vs. 'non-ideal' portion sizeswas observed in the inferior parietal lobule, superior temporal gyrus and mid-posterior cingulate gyrus. Collectively, our results provide evidence that several brain regions involved in attention and adaptive behavior track 'ideal' meal portion sizes as early as 230ms during visual encounter. That is, responses do not showan increase paralleling theamount of food viewed (and, in extension, the amount of reward), but are shaped by regulatory mechanisms. (C) 2015 The Authors. Published by Elsevier Inc.	[Toepel, Ulrike; Bielser, Marie-Laure; Murray, Micah M.] Univ Lausanne, Vaudois Univ Hosp Ctr, Dept Radiol, Lab Investigat Neurophysiol LINE, CH-1011 Lausanne, Switzerland; [Toepel, Ulrike; Bielser, Marie-Laure; Murray, Micah M.] Univ Lausanne, Vaudois Univ Hosp Ctr, Dept Clin Neurosci, CH-1011 Lausanne, Switzerland; [Forde, Ciaran; Martin, Nathalie; Voirin, Alexandre; le Coutre, Johannes; Hudry, Julie] Nestle Res Ctr, CH-1000 Lausanne 26, Switzerland; [Murray, Micah M.] Ctr Biomed Imaging CIBM Lausanne & Geneva, Electroencephalog Brain Mapping Core, Lausanne, Switzerland; [le Coutre, Johannes] Univ Tokyo, Org Interdisciplinary Res Projects, Bunkyo Ku, Tokyo 1138657, Japan; [Murray, Micah M.] Vanderbilt Univ, Dept Hearing & Speech Sci, Nashville, TN 37232 USA	Hudry, J (reprint author), Nestle Res Ctr, CH-1000 Lausanne 26, Switzerland.	julie.hudry@rdls.nestle.com	Centre d'imagerie Biomedicale, CIBM/B-5740-2012		Center for Biomedical Imaging (CIBM) of Geneva; Lausanne; Faculty of Biology and Medicine, University of Lausanne, Switzerland; Swiss National Science Foundation [320030-149982]; Swiss Brain League	The authors like to thank the anonymous reviewers for their constructive comments on the manuscript and Prof. Jeff M Brunstrom (School of Experimental Psychology, University of Bristol, Bristol, UK) for supplying the computer code that was used for image presentation in the familiarization task. We also like to thank Elisa Dreyer for her help in data recording. The Cartool software used for EEG data analysis has been programmed by Denis Brunet (Functional Brain Mapping Laboratory, Geneva, Switzerland) and is supported by the Center for Biomedical Imaging (CIBM) of Geneva and Lausanne. Ulrike Toepel is supported by an Interdisciplinary Research Grant from the Faculty of Biology and Medicine, University of Lausanne, Switzerland. Micah Murray is supported by the Swiss National Science Foundation (grant #320030-149982) and the Swiss Brain League (2014 Research Prize).	Andino Gonzalez S.L., 2005, HUM BRAIN MAPP, V24, P50; Andino SLG, 2005, EXP BRAIN RES, V166, P298, DOI 10.1007/s00221-005-2371-1; Wansink B, 2005, J NUTR EDUC BEHAV, V37, P242, DOI 10.1016/S1499-4046(06)60278-9; Murdaugh DL, 2012, NEUROIMAGE, V59, P2709, DOI 10.1016/j.neuroimage.2011.10.071; Toepel U, 2009, NEUROIMAGE, V44, P967, DOI 10.1016/j.neuroimage.2008.10.005; Michel CM, 2004, J CLIN NEUROPHYSIOL, V21, P71, DOI 10.1097/00004691-200403000-00001; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442; Michel CM, 2012, NEUROIMAGE, V61, P371, DOI 10.1016/j.neuroimage.2011.12.039; de Lauzon B, 2004, J NUTR, V134, P2372; Nijs IMT, 2007, APPETITE, V49, P38, DOI 10.1016/j.appet.2006.11.001; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; Garcia-Garcia I, 2013, EUR EAT DISORD REV, V21, P89, DOI 10.1002/erv.2216; Yokum S, 2013, INT J OBESITY, V37, P1565, DOI 10.1038/ijo.2013.39; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Rolls BJ, 2002, AM J CLIN NUTR, V76, P1207; Wilkinson LL, 2012, APPETITE, V59, P933, DOI 10.1016/j.appet.2012.09.007; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Hagemann D, 2003, BRAIN COGNITION, V52, P79, DOI 10.1016/S0278-2626(03)00011-3; Wansink B, 2005, OBES RES, V13, P93, DOI 10.1038/oby.2005.12; Spinelli L, 2000, BRAIN TOPOGR, V13, P115, DOI 10.1023/A:1026607118642; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Pearson JM, 2011, TRENDS COGN SCI, V15, P143, DOI 10.1016/j.tics.2011.02.002; Brunstrom JM, 2009, APPETITE, V52, P108, DOI 10.1016/j.appet.2008.09.002; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Cornier MA, 2010, PHYSIOL BEHAV, V99, P538, DOI 10.1016/j.physbeh.2010.01.008; Siep N, 2009, BEHAV BRAIN RES, V198, P149, DOI 10.1016/j.bbr.2008.10.035; Busch NA, 2004, CLIN NEUROPHYSIOL, V115, P1810, DOI 10.1016/j.clinph.2004.03.015; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Brogden N, 2010, APPETITE, V55, P551, DOI 10.1016/j.appet.2010.09.003; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Harris A, 2013, J NEUROSCI, V33, P18917, DOI 10.1523/JNEUROSCI.5816-12.2013; Mohanty A, 2008, CEREB CORTEX, V18, P2604, DOI 10.1093/cercor/bhn021; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Asmaro D, 2014, NUTRIENTS, V6, P319, DOI 10.3390/nu6010319; Brunet D, 2011, COMPUT INTEL NEUROSC, DOI 10.1155/2011/813870; Brunstrom JM, 2009, OBESITY, V17, P1884, DOI 10.1038/oby.2009.201; Brunstrom JM, 2010, APPETITE, V55, P25, DOI 10.1016/j.appet.2010.03.005; Btunstrom J.M., 2008, APPETITE, V51, P796; DECASTRO JM, 1995, PHYSIOL BEHAV, V57, P287, DOI 10.1016/0031-9384(94)00229-X; Drewnowski A., 2010, HUMAN PERCEPTIONS PR; Forde C.G., 2011, APPETITE, V57, P558; Grave de Peralta M., 2001, BRAIN TOPOGR, V14, P131, DOI DOI 10.1023/A:1012944913650; Grave de Peralta M.R., 2004, NEUROIMAGE, V21, P527, DOI DOI 10.1016/J.NEUR0IMAGE.2003.09.051; Kornmeier J, 2011, J VISION, V11, DOI 10.1167/11.9.12; LAHTEENMAKI L, 1995, PHYSIOL BEHAV, V57, P81, DOI 10.1016/0031-9384(94)00210-V; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Lietti CV, 2012, APPETITE, V58, P11, DOI 10.1016/j.appet.2011.09.016; Meule A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00669; Ohla K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032434; O'Shea G, 2012, AM J PSYCHOL, V125, P435; PERRIN F, 1987, ELECTROEN CLIN NEURO, V66, P75, DOI 10.1016/0013-4694(87)90141-6; Puce A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00282; ROLLS BJ, 1991, HEALTH PSYCHOL, V10, P133, DOI 10.1037/0278-6133.10.2.133; SKRANDIES W, 1990, Brain Topography, V3, P137, DOI 10.1007/BF01128870; SUNDAY SR, 1992, AM J CLIN NUTR, V55, P362; Toepel U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036778; Tzieropoulos H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00036; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3	67	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JUN	2015	113						133	142		10.1016/j.neuroimage.2015.03.041		10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CH9YN	WOS:000354392700013		
J	Yamada, K; Miyawaki, Y; Kamitani, Y				Yamada, Kentaro; Miyawaki, Yoichi; Kamitani, Yukiyasu			Inter-subject neural code converter for visual image representation	NEUROIMAGE			English	Article							CEREBRAL-CORTEX; HUMAN BRAIN; RECONSTRUCTION; PATTERNS; SPACE; MODEL; FMRI	Brain activity patterns differ from person to person, even for an identical stimulus. In functional brain mapping studies, it is important to align brain activity patterns between subjects for group statistical analyses. While anatomical templates are widely used for inter-subject alignment in functional magnetic resonance imaging (fMRI) studies, they are not sufficient to identify the mapping between voxel-level functional responses representing specific mental contents. Recent work has suggested that statistical learning methods could be used to transform individual brain activity patterns into a common space while preserving representational contents. Here, we propose a flexible method for functional alignment, "neural code converter," which converts one subject's brain activity pattern into another's representing the same content. The neural code converter was designed to learn statistical relationships between fMRI activity patterns of paired subjects obtained while they sawan identical series of stimuli. It predicts the signal intensity of individual voxels of one subject from a pattern of multiple voxels of the other subject. To test this method, we used fMRI activity patterns measured while subjects observed visual images consisting of random and structured patches. We show that fMRI activity patterns for visual images not used for training the converter could be predicted from those of another subject where brain activity was recorded for the same stimuli. This confirms that visual images can be accurately reconstructed from the predicted activity patterns alone. Furthermore, we show that a classifier trained only on predicted fMRI activity patterns could accurately classify measured fMRI activity patterns. These results demonstrate that the neural code converter can translate neural codes between subjects while preserving contents related to visual images. While this method is useful for functional alignment and decoding, it may also provide a basis for brain-to-brain communication using the converted pattern for designing brain stimulation. (C) 2015 Elsevier Inc. All rights reserved.	[Yamada, Kentaro] Honda Res & Dev Co Ltd, Fundamental Technol Res Ctr, Saitama 3510188, Japan; [Yamada, Kentaro; Miyawaki, Yoichi; Kamitani, Yukiyasu] ATR Computat Neurosci Labs, Kyoto 6190288, Japan; [Miyawaki, Yoichi] Natl Inst Informat & Communicat Technol, Kyoto 6190288, Japan; [Miyawaki, Yoichi] Univ Electrocommun, Tokyo 1828585, Japan; [Kamitani, Yukiyasu] Kyoto Univ, Grad Sch Informat, Kyoto 6068501, Japan	Kamitani, Y (reprint author), ATR Computat Neurosci Labs, 2-2-2 Hikaridai, Keihanna Sci City, Kyoto 6190288, Japan.	kmtn@atr.jp					Miyawaki Y, 2008, NEURON, V60, P915, DOI 10.1016/j.neuron.2008.11.004; Chadwick MJ, 2014, P NATL ACAD SCI USA, V111, P10720, DOI 10.1073/pnas.1319641111; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Van Essen DC, 2004, NEUROIMAGE, V23, pS97, DOI 10.1016/j.neuroimage.2004.07.024; Yamashita O, 2008, NEUROIMAGE, V42, P1414, DOI 10.1016/j.neuroimage.2008.05.050; Haxby JV, 2011, NEURON, V72, P404, DOI 10.1016/j.neuron.2011.08.026; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sato M, 2001, NEURAL COMPUT, V13, P1649, DOI 10.1162/089976601750265045; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Friston KJ, 2008, NEUROIMAGE, V39, P181, DOI 10.1016/j.neuroimage.2007.08.013; Bishop C. M., 2006, PATTERN RECOGNITION; Grau C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105225; Sabuncu M., 2009, CEREB CORTEX, V20, P130, DOI DOI 10.1093/CERC0R/BHP085; Sato M, 2004, NEUROIMAGE, V23, P806, DOI 10.1016/j.neuroimage.2004.06.037; Talairach J., 1988, COPLANAR STEREOTAXIC; Ting J.A., 2005, P ADV NEUR INF PROC, V18; Ting Jo-Anne, 2008, Neural Netw, V21, P1112, DOI 10.1016/j.neunet.2008.06.012; Toda A, 2011, NEUROIMAGE, V54, P892, DOI 10.1016/j.neuroimage.2010.09.057; Yamagishi K, 2011, INT WORK QUAL MULTIM, P37, DOI 10.1109/QoMEX.2011.6065709	25	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JUN	2015	113						289	297		10.1016/j.neuroimage.2015.03.059		9	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CH9YN	WOS:000354392700028		
J	Kawai, E; Shibata, N; Nagata, T; Shinagawa, S; Tgai, K; Ohnuma, T; Shimazaki, H; Toda, A; Kasanuki, K; Takayama, T; Suzuki, A; Nakayama, K; Yamada, H; Arai, H				Kawai, Eri; Shibata, Nobuto; Nagata, Tomoyuki; Shinagawa, Shunichiro; Tgai, Kenji; Ohnuma, Tohru; Shimazaki, Hiromi; Toda, Aiko; Kasanuki, Koji; Takayama, Toshiki; Suzuki, Ayako; Nakayama, Kazuhiko; Yamada, Hisashi; Arai, Heii			Genetic Association Between KIBRA Polymorphism and Alzheimer's Disease with in a Japanese Population	NEUROMOLECULAR MEDICINE			English	Article						KIBRA; Apolipoprotein E; Polymorphism; Alcohol; Alzheimer's disease; Single photon emission computed tomography	INFLUENCES EPISODIC MEMORY; AGE-DEPENDENT ASSOCIATION; WORKING-MEMORY; PERFORMANCE; RISK; VARIANTS; DISORDER; STRESS; HEALTH	KIBRA plays an important role in synaptic plasticity in human hippocampus related to cognitive function. Functional studies suggest that KIBRA is a potential candidate gene for memory and Alzheimer's disease (AD) risk. A single nucleotide polymorphism, Rs17070145 C allele affects the onset of AD in an age-dependent manner comparing with T/T genotypes and is also associated with risk of substance abuse and relapse. The aim of this case-control study was to investigate whether the rs17070145 polymorphism affected the onset of AD in an age-dependent manner in a Japanese population. We analysed KIBRA and APOE genotypes in 237 young AD cases, 154 age-matched control cases and 160 old AD cases. The analyses were performed by stratifying alcohol consumption and the APOE status. We used single photon emission computed tomography (SPECT) to analyse patients with AD with the rs17070145 polymorphism. The genotypic and allelic frequencies of the young AD group differed significantly from those of control and old AD groups. There was a significant association among high alcohol consumption (HAC-AD group) and the genotypic and allelic frequencies of the rs17070145 polymorphism. Logistic regression analyses demonstrate synergism between the APOE genotype and the rs17070145 C allele to increase the risk of AD in the young group; this was confirmed in the HAC-AD group. The SPECT study revealed hyperperfusion in the C allele carrier group was detected in the right inferior frontal gyrus compared with the T/T group. KIBRA rs17070145 affects specific phenotypes of patients with AD.	[Kawai, Eri; Shibata, Nobuto; Ohnuma, Tohru; Shimazaki, Hiromi; Toda, Aiko; Kasanuki, Koji; Takayama, Toshiki; Suzuki, Ayako; Arai, Heii] Juntendo Univ, Dept Psychiat, Sch Med, Bunkyo Ku, Tokyo 1138421, Japan; [Nagata, Tomoyuki; Shinagawa, Shunichiro; Tgai, Kenji; Nakayama, Kazuhiko] Jikei Univ, Sch Med, Dept Psychiat, Tokyo, Japan; [Nagata, Tomoyuki; Yamada, Hisashi] Jikei Univ, Sch Med, Inst DNA Med, Div Mol Genet, Tokyo, Japan	Shibata, N (reprint author), Juntendo Univ, Dept Psychiat, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	nshibata@juntendo.ac.jp			High Technology Research Center Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Sportology Center, Juntendo University Graduate School of Medicine	This study was partially supported by the High Technology Research Center Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Sportology Center, Juntendo University Graduate School of Medicine. We are grateful for the technical assistance of K. Yamamoto.	Mukamal KJ, 2001, STROKE, V32, P1939, DOI 10.1161/hs0901.095723; Milnik A, 2012, AM J MED GENET B, V159B, P958, DOI 10.1002/ajmg.b.32101; Reitz C, 2014, BIOCHEM PHARMACOL, V88, P640, DOI 10.1016/j.bcp.2013.12.024; Preuschhof C, 2010, NEUROPSYCHOLOGIA, V48, P402, DOI 10.1016/j.neuropsychologia.2009.09.031; Ohta S, 2006, J ALZHEIMERS DIS, V9, P155; Kauppi K, 2011, J NEUROSCI, V31, P14218, DOI 10.1523/JNEUROSCI.3292-11.2011; Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905; Schaper K, 2008, NEUROBIOL AGING, V29, P1123, DOI 10.1016/j.neurobiolaging.2007.02.001; Wang HF, 2013, MOL BIOL REP, V40, P7077, DOI 10.1007/s11033-013-2830-x; Frisardi V, 2010, AGEING RES REV, V9, P399, DOI 10.1016/j.arr.2010.04.007; Moller C, 2013, NEUROBIOL AGING, V34, P2014, DOI 10.1016/j.neurobiolaging.2013.02.013; Need AC, 2008, AM J MED GENET B, V147B, P667, DOI 10.1002/ajmg.b.30658; Almeida OP, 2008, J CELL MOL MED, V12, P1672, DOI 10.1111/j.1582-4934.2008.00229.x; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Vassos E, 2010, J PSYCHIATR RES, V44, P795, DOI 10.1016/j.jpsychires.2010.01.012; Bates TC, 2009, NEUROSCI LETT, V458, P140, DOI 10.1016/j.neulet.2009.04.050; Bauer LO, 2012, DRUG ALCOHOL DEPEN, V123, P154, DOI 10.1016/j.drugalcdep.2011.11.004; Burgess J. D., 2011, NEUROBIOL AGING, V32, DOI DOI 10.1016/J.NEUROBIOLAGING.2010.11.004; Corneveaux Jason J, 2010, Neurobiol Aging, V31, P901, DOI 10.1016/j.neurobiolaging.2008.07.014; Duning K, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.49; Hayashi N, 2010, DEMENT GERIATR COGN, V30, P302, DOI 10.1159/000320482; MCKHANN G, 1984, NEUROLOGY, V34, P939; Noel X, 2001, ALCOHOL ALCOHOLISM, V36, P556, DOI 10.1093/alcalc/36.6.556; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Rodriguez-Rodriguez E, 2009, NEUROBIOL AGING, V30, P322, DOI 10.1016/j.neurobiolaging.2007.07.003; Schneider A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.004.2010; Sedille-Mostafaie N, 2012, J NEURAL TRANSM, V119, P77, DOI 10.1007/s00702-011-0667-9; Vyas NS, 2014, PSYCHIAT RES, V220, P37, DOI 10.1016/j.psychres.2014.07.024; Wilker S, 2013, BIOL PSYCHIAT, V74, P664, DOI 10.1016/j.biopsych.2013.02.022; Yasuda Y, 2010, WORLD J BIOL PSYCHIA, V11, P852, DOI 10.3109/15622971003797258; Zhang HP, 2009, NEUROPSYCHOPHARMACOL, V34, P2508, DOI 10.1038/npp.2009.80	31	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1535-1084	1559-1174		NEUROMOL MED	Neuromol. Med.	JUN	2015	17	2					170	177		10.1007/s12017-015-8348-8		8	Neurosciences	Neurosciences & Neurology	CH7AI	WOS:000354187600008		
J	Kawai, E; Shibata, N; Nagata, T; Shinagawa, S; Tagai, K; Ohnuma, T; Shimazaki, H; Toda, A; Kasanuki, K; Takayama, T; Suzuki, A; Nakayama, K; Yamada, H; Arai, H				Kawai, Eri; Shibata, Nobuto; Nagata, Tomoyuki; Shinagawa, Shunichiro; Tagai, Kenji; Ohnuma, Tohru; Shimazaki, Hiromi; Toda, Aiko; Kasanuki, Koji; Takayama, Toshiki; Suzuki, Ayako; Nakayama, Kazuhiko; Yamada, Hisashi; Arai, Heii			Genetic Association Between KIBRA Polymorphism and Alzheimer's Disease with in a Japanese Population (vol 17, pg 170, 2015)	NEUROMOLECULAR MEDICINE			English	Correction									[Kawai, Eri; Shibata, Nobuto; Ohnuma, Tohru; Shimazaki, Hiromi; Toda, Aiko; Kasanuki, Koji; Takayama, Toshiki; Suzuki, Ayako; Arai, Heii] Juntendo Univ, Dept Psychiat, Sch Med, Bunkyo Ku, Tokyo 1138421, Japan; [Nagata, Tomoyuki; Shinagawa, Shunichiro; Tagai, Kenji; Nakayama, Kazuhiko] Jikei Univ, Dept Psychiat, Sch Med, Tokyo, Japan; [Nagata, Tomoyuki; Yamada, Hisashi] Jikei Univ, Inst DNA Med, Sch Med, Div Mol Genet, Tokyo, Japan	Shibata, N (reprint author), Juntendo Univ, Dept Psychiat, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	nshibata@juntendo.ac.jp					Kawai E, 2015, NEUROMOL MED, V17, P170, DOI 10.1007/s12017-015-8348-8	1	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1535-1084	1559-1174		NEUROMOL MED	Neuromol. Med.	JUN	2015	17	2					209	209		10.1007/s12017-015-8350-1		1	Neurosciences	Neurosciences & Neurology	CH7AI	WOS:000354187600012		
J	Craggs, LJL; Fenwick, R; Oakley, AE; Ihara, M; Kalaria, RN				Craggs, L. J. L.; Fenwick, R.; Oakley, A. E.; Ihara, M.; Kalaria, R. N.			Immunolocalization of platelet-derived growth factor receptor- (PDGFR-) and pericytes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						CADASIL; capillaries; dementia; pericyte; platelet-derived growth factor receptor; vascular smooth muscle cell; vascular dementia	SMOOTH-MUSCLE-CELLS; SMALL VESSEL DISEASES; WHITE-MATTER LESIONS; UNSELECTED COHORT; BETA EXPRESSION; NOTCH3 GENE; PATHOLOGY; BRAIN; PATHOGENESIS; MECHANISM	AimsCerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is identified by aggregates of NOTCH3 extracellular domain (N3ECD) along capillaries and the deposition of granular osmiophilic material (GOM). We assessed the pattern of distribution of pericytes in relation to N3ECD deposits in cerebral microvessels of CADASIL subjects. MethodsWe assessed post mortem brains from (n=50) subjects with CADASIL, cerebral small vessel disease, and similar-age cognitively normal and older controls. Immunohistochemical and immunofluorescent staining methods were used to study the distribution and quantify immunoreactivities of the platelet-derived growth factor receptor- (PDGFR-) (for pericytes) and microvascular markers in the frontal cortex and white matter. ResultsPDGFR- antibody stained cells typical of pericytes in capillaries and small arterioles in both the grey and white matter. PDGFR- reactive pericytes adopted crescent' morphology wrapped closely around capillary walls readily evident in cross-sections. We noted considerable overlap between PDGFR- and N3ECD imunoreactivities in capillaries. Quantitative analysis of PDGFR- immunoreactivity revealed significant differences in PDGFR- %A in CADASIL compared with young controls (P<0.05). PDGFR- %A was further positively correlated with the basement membrane marker collagen IV (r=0.529, P=0.009), but was not associated with GLUT-1, the marker for endothelial cells. ConclusionsOur results suggest increased expression of PDGFR- immunoreactive pericytes in cerebral microvessels in CADASIL compared with similar age controls. While we cannot confirm whether PDGFR--expressing pericytes produce N3ECD and hence GOM, our findings demonstrate that up-regulation of pericyte-like cells is associated with microvascular changes, including loss of vascular smooth muscle cells in CADASIL.	[Craggs, L. J. L.; Fenwick, R.; Oakley, A. E.; Kalaria, R. N.] Newcastle Univ, Inst Neurosci, Neurovasc Res Grp, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Ihara, M.] Natl Cerebral & Cardiovasc Ctr, Dept Stroke & Cerebrovasc Dis, Osaka, Japan	Kalaria, RN (reprint author), Newcastle Univ, Inst Neurosci, Neurovasc Res Grp, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.	raj.kalaria@ncl.ac.uk			UK Medical Research Council (MRC) [G0500247]; Newcastle Centre for Brain Ageing and Vitality (BBSRC); Newcastle Centre for Brain Ageing and Vitality (EPSRC); Newcastle Centre for Brain Ageing and Vitality (ESRC); Newcastle Centre for Brain Ageing and Vitality (MRC, LLHW); Alzheimer's Research (ARUK); UK MRC [G0400074]; Newcastle NIHR Biomedical Research Centre in Ageing and Age Related Diseases; Alzheimer's Society; ART as part of the Brains for Dementia Research Project	Our work is supported by grants from the UK Medical Research Council (MRC, G0500247), Newcastle Centre for Brain Ageing and Vitality (BBSRC, EPSRC, ESRC and MRC, LLHW) and Alzheimer's Research (ARUK). Tissue for this study was collected by the Newcastle Brain Tissue Resource, which is funded in part by a grant from the UK MRC (G0400074), by the Newcastle NIHR Biomedical Research Centre in Ageing and Age Related Diseases award to the Newcastle upon Tyne Hospitals NHS Foundation Trust, and by a grant from the Alzheimer's Society and ART as part of the Brains for Dementia Research Project.	Allan Louise M, 2011, Brain, V134, P3716, DOI 10.1093/brain/awr273; Craggs LJL, 2014, NEUROPATH APPL NEURO, V40, P591, DOI 10.1111/nan.12073; Lammie GA, 1997, STROKE, V28, P2222; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Wang T, 2008, PROG BIOPHYS MOL BIO, V96, P499, DOI 10.1016/j.pbiomolbio.2007.07.006; Arimura K, 2012, CURR NEUROVASC RES, V9, P1; Heldin CH, 1999, PHYSIOL REV, V79, P1283; Salabei JK, 2013, BIOCHEM J, V451, P375, DOI 10.1042/BJ20121344; Fisher M, 2009, STROKE, V40, pS13, DOI 10.1161/STROKEAHA.108.533117; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Schmidt H, 2011, BRAIN, V134, P3384, DOI 10.1093/brain/awr252; Deramecourt V, 2012, NEUROLOGY, V78, P1043, DOI 10.1212/WNL.0b013e31824e8e7f; Fernando MS, 2006, STROKE, V37, P1391, DOI 10.1161/01.STR.0000221308.94473.14; Weber DS, 2008, CIRC RES, V102, P1448, DOI 10.1161/CIRCRESAHA.108.179044; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; Carare RO, 2013, NEUROPATH APPL NEURO, V39, P593, DOI 10.1111/nan.12042; Fernandez-Klett F, 2013, J CEREBR BLOOD F MET, V33, P428, DOI 10.1038/jcbfm.2012.187; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; Betsholtz C, 2014, BRAIN PATHOL, V24, P387, DOI 10.1111/bpa.12158; Yamamoto Y, 2009, STROKE, V40, P2004, DOI 10.1161/STROKEAHA.108.528299; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Simpson JE, 2007, NEUROPATH APPL NEURO, V33, P410, DOI 10.1111/j.1365-2990.2007.00828.x; Hellberg C, 2010, RECENT RESULTS CANC, V180, P103, DOI 10.1007/978-3-540-78281-0_7; Kamouchi M, 2011, CELL MOL NEUROBIOL, V31, P175, DOI 10.1007/s10571-010-9605-x; Arboleda-Velasquez JF, 2014, INVEST OPHTH VIS SCI, V55, P5191, DOI 10.1167/iovs.14-14046; Cognat E, 2014, STROKE, V45, P842, DOI 10.1161/STROKEAHA.113.003339; Craggs LJL, 2013, BRAIN PATHOL, V23, P547, DOI 10.1111/bpa.12041; Dziewulska D, 2012, NEUROPATHOLOGY, V32, P515, DOI 10.1111/j.1440-1789.2011.01290.x; Joutel Anne, 2013, Hum Mutat, V34, pv, DOI 10.1002/humu.22198; Kalaria RN, 2004, J NEUROL SCI, V226, P35, DOI 10.1016/j.jns.2004.09.008; Liu G, 2013, BIOMED RES INT, DOI [10.1155/2013/903947, DOI 10.1155/2013/903947]; Rafalowska J, 2004, NEUROPATHOLOGY, V24, P16, DOI 10.1111/j.1440-1789.2003.00527.x; Sainson RCA, 2008, ANGIOGENESIS, V11, P41, DOI 10.1007/s10456-008-9098-0; Shimizu H, 2010, AM J PHYSIOL-CELL PH, V299, pC1144, DOI 10.1152/ajpcell.00536.2009; Yamamoto Y, 2011, NEUROPATH APPL NEURO, V37, P94, DOI 10.1111/j.1365-2990.2010.01147.x; Yamamoto Y, 2013, J NEUROPATH EXP NEUR, V72, P416, DOI 10.1097/NEN.0b013e31829020b5	45	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	JUN	2015	41	4					557	570		10.1111/nan.12188		14	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CI0YK	WOS:000354465900015		
J	Aida, T; Yoshida, J; Nomura, M; Tanimura, A; Iino, Y; Soma, M; Bai, N; Ito, Y; Cui, WP; Aizawa, H; Yanagisawa, M; Nagai, T; Takata, N; Tanaka, KF; Takayanagi, R; Kano, M; Gotz, M; Hirase, H; Tanaka, K				Aida, Tomomi; Yoshida, Junichi; Nomura, Masatoshi; Tanimura, Asami; Iino, Yusuke; Soma, Miho; Bai, Ning; Ito, Yukiko; Cui, Wanpeng; Aizawa, Hidenori; Yanagisawa, Michiko; Nagai, Terumi; Takata, Norio; Tanaka, Kenji F.; Takayanagi, Ryoichi; Kano, Masanobu; Goetz, Magdalena; Hirase, Hajime; Tanaka, Kohichi			Astroglial Glutamate Transporter Deficiency Increases Synaptic Excitability and Leads to Pathological Repetitive Behaviors in Mice	NEUROPSYCHOPHARMACOLOGY			English	Article							OBSESSIVE-COMPULSIVE DISORDER; NMDA RECEPTOR ANTAGONISTS; TOURETTE-SYNDROME; ANIMAL-MODELS; MUTANT MICE; GLAST; CIRCUITRY; AUTISM; PATHOPHYSIOLOGY; SCHIZOPHRENIA	An increase in the ratio of cellular excitation to inhibition (E/I ratio) has been proposed to underlie the pathogenesis of neuropsychiatric disorders, such as autism spectrum disorders (ASD), obsessive-compulsive disorder (OCD), and Tourette's syndrome (TS). A proper E/I ratio is achieved via factors expressed in neuron and glia. In astrocytes, the glutamate transporter GLT1 is critical for regulating an E/I ratio. However, the role of GLT1 dysfunction in the pathogenesis of neuropsychiatric disorders remains unknown because mice with a complete deficiency of GLT1 exhibited seizures and premature death. Here, we show that astrocyte-specific GLT1 inducible knockout (GLAST(CreERT2/+)/GLT(1flox/flox), iKO) mice exhibit pathological repetitive behaviors including excessive and injurious levels of self-grooming and tic-like head shakes. Electrophysiological studies reveal that excitatory transmission at corticostriatal synapse is normal in a basal state but is increased after repetitive stimulation. Furthermore, treatment with an N-methyl-D-aspartate (NMDA) receptor antagonist memantine ameliorated the pathological repetitive behaviors in iKO mice. These results suggest that astroglial GLT1 has a critical role in controlling the synaptic efficacy at corticostriatal synapses and its dysfunction causes pathological repetitive behaviors.	[Aida, Tomomi; Yoshida, Junichi; Iino, Yusuke; Soma, Miho; Bai, Ning; Ito, Yukiko; Cui, Wanpeng; Aizawa, Hidenori; Yanagisawa, Michiko; Tanaka, Kohichi] Tokyo Med & Dent Univ, Med Res Inst, Lab Mol Neurosci, Tokyo 1138510, Japan; [Nomura, Masatoshi; Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan; [Tanimura, Asami; Kano, Masanobu] Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Tokyo, Japan; [Nagai, Terumi; Takata, Norio] RIKEN, Brain Sci Inst, Lab Neuron Glia Circuitry, Saitama, Japan; [Tanaka, Kenji F.; Hirase, Hajime] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Goetz, Magdalena] Univ Munich, Inst Physiol, Physiol Genom, D-80539 Munich, Germany; [Tanaka, Kohichi] JST, CREST, Saitama, Japan; [Tanaka, Kohichi] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo 1138510, Japan	Tanaka, K (reprint author), Tokyo Med & Dent Univ, Med Res Inst, Lab Mol Neurosci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	tanaka.aud@mri.tmd.ac.jp			Strategic Research Program for Brain Sciences (SRPBS) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); MEXT [22700328]; Moritani Scholarship Foundation; Medical Research Institute (MRI), of TMDU; MRI of TMDU	This work was supported by the Strategic Research Program for Brain Sciences (SRPBS) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT, to KT and MK). Additional support was provided by a Grant-in-Aid for Science Research (22700328 to TA) from MEXT, grants to TA from The Moritani Scholarship Foundation, a grant to JY from the Medical Research Institute (MRI), of TMDU, and the Joint Usage/Research Program of the MRI of TMDU to KFT. The authors declare no conflict of interest.	Aida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036853; Ghaleiha A, 2013, J PSYCHIATR RES, V47, P175, DOI 10.1016/j.jpsychires.2012.09.015; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215; Nordstrom EJ, 2002, MOL PSYCHIATR, V7, P617, DOI 10.1038/sj.mp.4001144; Choudhury PR, 2012, PHARMACOL BIOCHEM BE, V100, P841, DOI 10.1016/j.pbb.2011.06.023; Shprecher DR, 2014, CURR OPIN NEUROL, V27, P484, DOI 10.1097/WCO.0000000000000119; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1046/j.1601-183X.2003.00037.x; Gilmour G, 2009, PSYCHOPHARMACOLOGY, V205, P203, DOI 10.1007/s00213-009-1530-7; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Fineberg NA, 2012, INT J NEUROPSYCHOPH, V15, P1173, DOI 10.1017/S1461145711001829; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Matsugami TR, 2006, P NATL ACAD SCI USA, V103, P12161, DOI 10.1073/pnas.0509144103; Lagerstrom MC, 2010, NEURON, V68, P529, DOI 10.1016/j.neuron.2010.09.016; Berridge KC, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-4; Bateup HS, 2013, NEURON, V78, P510, DOI 10.1016/j.neuron.2013.03.017; Ting JT, 2011, CURR OPIN NEUROBIOL, V21, P842, DOI 10.1016/j.conb.2011.04.010; Saab AS, 2012, SCIENCE, V337, P749, DOI 10.1126/science.1221140; Hiyoshi T, 2014, NEUROPHARMACOLOGY, V85, P384, DOI 10.1016/j.neuropharm.2014.05.037; Yamasaki M, 2014, J NEUROSCI, V34, P11534, DOI 10.1523/JNEUROSCI.1811-14.2014; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Shimogori T, 2010, NAT NEUROSCI, V13, P767, DOI 10.1038/nn.2545; Albin RL, 2006, TRENDS NEUROSCI, V29, P175, DOI 10.1016/j.tins.2006.01.001; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Cai X, 2013, NAT NEUROSCI, V16, P464, DOI 10.1038/nn.3355; Karlsson RM, 2012, NEUROPHARMACOLOGY, V63, P181, DOI 10.1016/j.neuropharm.2012.01.027; Kiryk A, 2008, NEUROTOX RES, V13, P19; Karlsson RM, 2008, BIOL PSYCHIAT, V64, P810, DOI 10.1016/j.biopsych.2008.05.001; Ahmari SE, 2013, SCIENCE, V340, P1234, DOI 10.1126/science.1234733; Kotermanski SE, 2009, J NEUROSCI, V29, P2774, DOI 10.1523/JNEUROSCI.3703-08.2009; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Adamczyk A, 2011, PSYCHIAT GENET, V21, P90, DOI 10.1097/YPG.0b013e328341a307; Cavanna AE, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4964; Cui W, 2014, J NEUROSCI, V34, P16273, DOI 10.1523/JNEUROSCI.1465-14.2014; Gaynor CM, 2001, PSYCHOPHARMACOLOGY, V153, P327, DOI 10.1007/s002130000558; HANDLEY SL, 1992, ADV BIOSCI, V85, P235; Hoshina N, 2013, NEURON, V78, P839, DOI 10.1016/j.neuron.2013.03.031; Singer HS, 2010, MED HYPOTHESES, V74, P862, DOI 10.1016/j.mehy.2009.11.028; Langen M, 2011, NEUROSCI BIOBEHAV R, V35, P356, DOI 10.1016/j.neubiorev.2010.02.005; Macri S, 2013, INT REV NEUROBIOL, V112, P211, DOI 10.1016/B978-0-12-411546-0.00008-1; Swerdlow NR, 2005, PHARMACOL THERAPEUT, V108, P281, DOI 10.1016/j.pharmthera.2005.05.003; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Wang L, 2009, BEHAV PHARMACOL, V20, P119, DOI 10.1097/FBP.0b013e32832a80ad; Wu Ke, 2012, Pharmacol Biochem Behav, V100, P726, DOI 10.1016/j.pbb.2011.10.007	46	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	JUN	2015	40	7					1569	1579		10.1038/npp.2015.26		11	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CH8YC	WOS:000354321600002		
